,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
8595,GO:0034097,3.15310120246454e-14,1,122,814,response to cytokine,BP,IL32;SAA1;CCL20;MMP9;RUNX1;FN1;ACTG1;IL16;IL1R2;PML;CYLD;MYBL2;TRAF1;RELB;TFRC;SOD2;HLA-B;CSF2;PTGES;MAP3K14;EDN1;GBP1;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;NLRC5;TP53;SQSTM1;IL24;IL27RA;NFKB1;IRS1;CDKN1A;TJP2;JUNB;TNF;CXCL16;PTPN14;NFKB2;PSMB9;FOSL1;TYMS;ZC3H12A;LCP1;ICAM1;CD274;CDK4;CDC42EP2;STAT5A;IL20;TNFRSF12A;IFNGR1;MCM2;XAF1;RELT;LIF;SFRP1;TRIM22;HLA-F;IRF1;PSME2;IL7R;GPER1;SRF;NFKBIA;EGR1;ETS1;ZFP36L1;ADAM17;TXLNA;IRS2;TRAF2;IL15;PRKCA;ZFP36L2;SYK;ROBO1;IFIT3;PDGFB;OXTR;SNRNP70;DPYSL3;SPPL2A;NPNT;IL1A;GPR75;TNFRSF21;TNIP2;ACSL1;ACKR3;SMAD7;KEAP1;HNRNPU;HNRNPF;PARP14;CXCL5;SOCS1;HSPA8;JUN;CCR6;TNFRSF10A;RAPGEF1;ZYX;CD38;TNFAIP3;PSMC3;CCL22;CXCL8;MAPK11;CXCL3;SRSF7;NOL3;GCLC;HSP90AB1;IL6R;IL36G;CCL5
6864,GO:0030334,8.60251579589493e-14,1,92,538,regulation of cell migration,BP,IGFBP3;CCL20;NRG1;MMP9;CYR61;PTGER4;HDAC9;FN1;CYP1B1;AMOT;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;DAPK3;EMP2;TP53;MARVELD3;IL24;ADAMTS9;LYN;TNF;CORO1C;CXCL16;PDPN;ZC3H12A;FLNA;EPHA2;ICAM1;CD274;BMP2;ITGAV;STAT5A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;EPPK1;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;ROBO1;AJUBA;PDGFB;DPYSL3;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;CXCL5;CITED2;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ACTN4;BMP7;PHLDB2;MYADM;DAG1;WNT4;CXCL8;EFNA1;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;IL6R;CCL5
4336,GO:0009888,2.51040120972119e-13,1,163,1231,tissue development,BP,KRT1;SPRR3;TRIM16;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;INHBA;HDAC9;FN1;CYP1B1;CTGF;KRT34;ADM;KRT15;FOSL2;JPH2;KRT4;TUFT1;CYP1A1;PML;TFCP2L1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;TGFB2;EDN1;TXNRD1;B4GALT1;KRTAP2-3;G6PD;HRNR;SIPA1L3;KRT9;HNRNPAB;FST;LFNG;KRT6A;CDKN1A;TJP2;ADAMTS9;JUNB;TNF;COL12A1;EFNB2;KRT5;CORO1C;TNC;PDPN;FGFR2;PBX1;COL4A1;PSMB9;KRT17;TYMS;FLNA;EPHA2;TSC22D3;ICAM1;BMP2;UBE4B;COL27A1;CDK4;ITGAV;ERRFI1;SFN;ADRB2;SVIL;IL20;SERPINE1;PGK1;ELF3;LIF;OSR2;SFRP1;TPM1;CC2D2A;SAFB2;WDR1;PSME2;LUC7L;EPPK1;TFIP11;SRF;NSUN2;EGR1;EDF1;SNAI2;ZFP36L1;RHOB;ADAM17;GPCPD1;VCL;RIPK4;KRT14;LGALS3;AKR1C2;NTN1;DDX17;ROBO1;AJUBA;PDGFB;SERPINH1;FHL2;NOM1;COL17A1;NPNT;SEMA3C;ROR1;COL5A2;MAFF;BAMBI;SMAD7;KEAP1;HNRNPU;TJP1;CLASP1;CAPNS1;VSIG1;ETS2;KLF10;MARVELD2;DUSP1;CITED2;CD109;FRAS1;JUN;ESR1;IKZF3;TCOF1;FOXN1;GLIPR2;CPT1A;ZNF703;RPTN;ARRDC3;LAMC1;GPNMB;EFNB1;SORBS2;BMP7;PHLDB2;RAPGEF1;MYADM;DAG1;TIMELESS;WNT4;RILPL2;AKR1C1;VPS52;PSMC3;EFNA1;MAPK11;MYO1E;BMP8A;BIN3;TP63;PHACTR4
9793,GO:0040012,5.18306242452342e-13,1,99,617,regulation of locomotion,BP,IGFBP3;CCL20;NRG1;MMP9;CYR61;PTGER4;HDAC9;FN1;CYP1B1;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;DAPK3;EMP2;TP53;MARVELD3;IL24;ADAMTS9;LYN;TNF;EFNB2;CORO1C;CXCL16;PDPN;ZC3H12A;FLNA;EPHA2;ICAM1;CD274;BMP2;ITGAV;STAT5A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;EPPK1;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;ROBO1;AJUBA;PDGFB;DPYSL3;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;CXCL5;CITED2;JUN;GLIPR2;CHMP4B;ZNF703;CCR6;ARRDC3;GPNMB;ZSWIM6;ACTN4;BMP7;PHLDB2;MYADM;DAG1;WNT4;CXCL8;EFNA1;CLDN7;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;IL6R;CCL5
19754,GO:2000145,9.04217148408493e-13,1,93,569,regulation of cell motility,BP,IGFBP3;CCL20;NRG1;MMP9;CYR61;PTGER4;HDAC9;FN1;CYP1B1;AMOT;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;DAPK3;EMP2;TP53;MARVELD3;IL24;ADAMTS9;LYN;TNF;CORO1C;CXCL16;PDPN;ZC3H12A;FLNA;EPHA2;ICAM1;CD274;BMP2;ITGAV;STAT5A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;EPPK1;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;ROBO1;AJUBA;PDGFB;DPYSL3;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;CXCL5;CITED2;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ACTN4;BMP7;PHLDB2;MYADM;DAG1;WNT4;CXCL8;EFNA1;CLDN7;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;IL6R;CCL5
5515,GO:0016477,3.18906006606867e-12,1,125,882,cell migration,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;KRT2;CYR61;PTGER4;HDAC9;S100P;FN1;CYP1B1;CTGF;TNS3;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;NEDD9;ADAMTS9;LYN;TNF;EFNB2;CORO1C;CXCL16;WWC1;PDPN;SLC7A5;SIRPA;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;STAT5A;TNFRSF12A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;WDR1;EPPK1;THBD;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;SYK;ROBO1;AJUBA;PDGFB;DPYSL3;MYH9;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;BAMBI;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;PPP1R9B;CXCL5;CITED2;JUN;FOXN1;GLIPR2;ZNF703;CCR6;LAMC1;RHOG;GPNMB;GP6;ACTN4;EFNB1;BMP7;TNFRSF10A;PHLDB2;MYADM;DAG1;WNT4;CCL22;CXCL8;EFNA1;SLC3A2;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;IL6R;BIN3;PHACTR4;CCL5
12920,GO:0051270,4.15476099255401e-12,1,96,612,regulation of cellular component movement,BP,IGFBP3;CCL20;NRG1;MMP9;CYR61;PTGER4;HDAC9;FN1;CYP1B1;AMOT;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;ADAMTS9;LYN;LAMP1;TNF;CORO1C;CXCL16;PDPN;ZC3H12A;FLNA;EPHA2;ICAM1;CD274;BMP2;ITGAV;STAT5A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;EPPK1;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;ROBO1;AJUBA;PDGFB;DPYSL3;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;CXCL5;CITED2;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ZSWIM6;ACTN4;BMP7;PHLDB2;MYADM;DAG1;WNT4;CXCL8;EFNA1;CLDN7;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;IL6R;CCL5
955,GO:0002376,5.03358842552244e-12,1,215,1853,immune system process,BP,IL32;KRT1;MAFB;SAA1;FTL;CCL20;FTH1;MMP9;RUNX1;PTGER4;INHBA;HDAC9;S100P;FN1;C1R;ACTG1;IL16;TAP1;IL1R2;PML;CYLD;SDC4;RELB;TFRC;CD83;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;MGAM;RSAD2;G6PD;TRAF3;EMP2;HRNR;NLRC5;TP53;SIPA1L3;NFE2L1;SQSTM1;IL27RA;FST;NFKB1;CDKN2B;LFNG;CDKN1A;TJP2;LYN;RAB32;AHR;JUNB;PLEKHO2;ARPC4;LAMP1;TNF;BAIAP2;EFNB2;CXCL16;PDPN;FGFR2;PBX1;NFKB2;PSMB9;SLC7A5;QPCT;SIRPA;ZC3H12A;LCP1;TNK1;ARMC6;SART1;ACAA1;EPHA2;TSC22D3;ICAM1;FANCC;CD274;ITGAV;L1CAM;KIF23;MYO10;CDC42EP2;RNF19B;IL20;MTUS1;IFNGR1;SERPINE1;PABPC4;ARPC1B;EBP;XAF1;RELT;LIF;SFRP1;TRIM22;HLA-F;WDR1;IRF1;PSME2;IL7R;PSPC1;THBD;GPER1;SRF;ELF4;TRIM29;NFKBIA;EGR1;DOCK10;ETS1;RRS1;ZFP36L1;AKAP8;ADAM17;TXLNA;VCL;IRS2;LGALS3;TRAF2;IL15;PRKCA;ZFP36L2;SYK;CMTM3;SLC7A2;DDX17;IFIT3;PDGFB;DCTN1;DNASE1;MYH9;SPPL2A;TAPBPL;COL17A1;IL1A;GLIPR1;TNFRSF21;TNIP2;RASGRP4;RBBP5;SEMA3C;SFPQ;LILRB3;SMAD7;CRCP;TAPBP;PQBP1;TRIB1;CREB3;THOC1;KLF10;PARP14;CXCL5;GALNT2;CAB39;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;IKZF3;FOXN1;COMMD9;CCR6;RHOG;GPNMB;XRCC6;GP6;KLF6;TAP2;HMGN2;EFNB1;PHLPP1;TNFRSF10A;RAPGEF1;ZYX;TINAGL1;KIF22;POLR3H;RAB27A;BLNK;WNT4;RBM14;TUBB;CD38;TNFAIP3;PSMC3;SPG21;CCL22;CXCL8;CTPS1;MYO1E;SLC3A2;CXCL3;PTPRB;CLTA;HSP90AB1;SWAP70;HERC6;IL6R;LAIR1;PARP1;IL36G;C1S;CCL5
2486,GO:0005730,8.78910199246127e-12,1,117,834,nucleolus,CC,MAP2;NFKBIE;PML;TFCP2L1;RBM19;GPRC5A;CD3EAP;MAP3K14;TXNRD1;RSAD2;NUAK1;TP53;PDCD11;TAF4B;CDKN1A;GNL3L;PKMYT1;SCD;PPAN;RRP1;ENC1;VMP1;NUP153;DNAJB1;C9ORF3;TYMS;FLNA;DDX23;CDK4;MYO10;RRP12;DAXX;NAT10;MTUS1;USP36;AEN;GRWD1;APTX;DHX37;PWP2;METTL1;DDX42;NFX1;PSPC1;TFIP11;NSUN2;RRP36;TXN2;LARP4B;EDF1;GEMIN4;POP1;RRS1;CD2BP2;AKAP8;DKC1;FEN1;ISG20L2;CBX5;URB2;TSR1;PUM3;POLR1A;DDX17;SENP3;DDX47;DDX49;DNTTIP2;FILIP1;UBTF;UTP14A;POLA1;UTP20;RPS9;NSUN5;SPTBN1;RRP7A;NOM1;RBBP5;DDX39A;NOP16;FTSJ3;WDR46;RCC2;NOP56;SMAD7;NOL9;ABT1;ORC1;DNTTIP1;RRP7BP;ARL6IP4;HSPA8;TCOF1;PES1;PAK1IP1;NOP2;NOP14;NOC2L;RBM4;XRCC6;KLF6;SMUG1;TRA2A;MPHOSPH8;EEF1D;RBM14;POLR1E;DDX24;SURF6;UTP4;NOL3;MKI67;POP4;PARP1;ORC4;APEX2
12422,GO:0048870,2.82182464322475e-11,1,129,951,cell motility,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;KRT2;CYR61;PTGER4;HDAC9;S100P;FN1;CYP1B1;CTGF;TNS3;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;IER2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;NEDD9;ADAMTS9;LYN;TNF;EFNB2;CORO1C;CXCL16;WWC1;DST;PDPN;SLC7A5;SIRPA;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;STAT5A;TNFRSF12A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;WDR1;EPPK1;THBD;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;SYK;ROBO1;AJUBA;PDGFB;DPYSL3;MYH9;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;BAMBI;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;PPP1R9B;CXCL5;CITED2;JUN;FOXN1;GLIPR2;ZNF703;CCR6;LAMC1;RHOG;GPNMB;GP6;ACTN4;EFNB1;BMP7;TNFRSF10A;PHLDB2;MYADM;DAG1;WNT4;CCL22;CXCL8;EFNA1;CLDN7;SLC3A2;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;BIN3;PHACTR4;CCL5
13128,GO:0051674,2.82182464322475e-11,1,129,951,localization of cell,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;KRT2;CYR61;PTGER4;HDAC9;S100P;FN1;CYP1B1;CTGF;TNS3;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;IER2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;NEDD9;ADAMTS9;LYN;TNF;EFNB2;CORO1C;CXCL16;WWC1;DST;PDPN;SLC7A5;SIRPA;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;STAT5A;TNFRSF12A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;WDR1;EPPK1;THBD;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;SYK;ROBO1;AJUBA;PDGFB;DPYSL3;MYH9;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;BAMBI;SMAD7;MTA2;TRIP6;CLASP1;TRIB1;CREB3;PPP1R9B;CXCL5;CITED2;JUN;FOXN1;GLIPR2;ZNF703;CCR6;LAMC1;RHOG;GPNMB;GP6;ACTN4;EFNB1;BMP7;TNFRSF10A;PHLDB2;MYADM;DAG1;WNT4;CCL22;CXCL8;EFNA1;CLDN7;SLC3A2;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;BIN3;PHACTR4;CCL5
2222,GO:0005125,3.41076625504698e-11,1,26,80,cytokine activity,MF,IL32;CCL20;NRG1;INHBA;IL16;CSF2;TGFB2;EDN1;IL24;TNF;CXCL16;BMP2;IL20;LIF;TXLNA;IL15;CMTM3;IL1A;CXCL5;BMP7;CCL22;CXCL8;CXCL3;BMP8A;IL36G;CCL5
8561,GO:0033993,3.50058991232103e-11,1,91,591,response to lipid,BP,TRIM16;CCL20;CRYAB;RUNX1;PTGER4;INHBA;NEFL;CTGF;CYP24A1;ADM;NQO1;CYP1A1;KRT13;CSF2;PTGES;TGFB2;EDN1;TP53;IL24;NOCT;NFKB1;CDKN1A;LYN;AHR;JUNB;TNF;TNC;FGFR2;NFKB2;FOSL1;TYMS;ZC3H12A;HMGCS1;ICAM1;CD274;CDK4;ERRFI1;DAXX;SERPINE1;ARPC1B;RELT;SFRP1;SAFB2;THBD;GPER1;NFKBIA;ETS1;SNAI2;ZFP36L1;AKAP8;ADAM17;IL15;AKR1C2;PRKCA;ZFP36L2;DDX17;NFKBIB;OXTR;SNRNP70;FHL2;TNFRSF21;TNIP2;LANCL2;ACSL1;YWHAH;HNRNPU;PAGR1;TRIB1;RUVBL2;SAFB;CXCL5;DUSP1;JUN;ESR1;CPT1A;ZNF703;INSIG1;BMP7;TNFRSF10A;ELK1;DAG1;RBM14;CD38;TNFAIP3;CXCL8;CXCL3;TRIML2;TBXA2R;PARP1;TP63;CCL5
6072,GO:0019221,3.80031486513071e-11,1,83,532,cytokine-mediated signaling pathway,BP,IL32;SAA1;CCL20;MMP9;RUNX1;FN1;IL16;IL1R2;PML;CYLD;TRAF1;SOD2;HLA-B;CSF2;MAP3K14;EDN1;GBP1;BIRC3;MID1;RSAD2;TRAF3;NLRC5;TP53;SQSTM1;IL24;IL27RA;NFKB1;IRS1;CDKN1A;TJP2;JUNB;TNF;PSMB9;LCP1;ICAM1;STAT5A;IL20;TNFRSF12A;IFNGR1;XAF1;RELT;LIF;TRIM22;HLA-F;IRF1;PSME2;IL7R;NFKBIA;EGR1;ADAM17;TXLNA;IRS2;TRAF2;IL15;SYK;ROBO1;IFIT3;PDGFB;SPPL2A;IL1A;GPR75;TNFRSF21;TNIP2;ACSL1;ACKR3;HNRNPF;PARP14;CXCL5;SOCS1;HSPA8;CCR6;TNFRSF10A;RAPGEF1;TNFAIP3;PSMC3;CCL22;CXCL8;CXCL3;NOL3;HSP90AB1;IL6R;IL36G;CCL5
15200,GO:0071345,4.22376397935438e-11,1,106,747,cellular response to cytokine stimulus,BP,IL32;SAA1;CCL20;MMP9;RUNX1;FN1;ACTG1;IL16;IL1R2;PML;CYLD;MYBL2;TRAF1;TFRC;SOD2;HLA-B;CSF2;MAP3K14;EDN1;GBP1;MAT2A;BIRC3;MID1;DAPK3;RSAD2;TRAF3;NLRC5;TP53;SQSTM1;IL24;IL27RA;NFKB1;IRS1;CDKN1A;TJP2;JUNB;TNF;PTPN14;PSMB9;ZC3H12A;LCP1;ICAM1;CDK4;CDC42EP2;STAT5A;IL20;TNFRSF12A;IFNGR1;MCM2;XAF1;RELT;LIF;SFRP1;TRIM22;HLA-F;IRF1;PSME2;IL7R;GPER1;NFKBIA;EGR1;ZFP36L1;ADAM17;TXLNA;IRS2;TRAF2;IL15;ZFP36L2;SYK;ROBO1;IFIT3;PDGFB;SNRNP70;DPYSL3;SPPL2A;NPNT;IL1A;GPR75;TNFRSF21;TNIP2;ACSL1;ACKR3;SMAD7;KEAP1;HNRNPU;HNRNPF;PARP14;CXCL5;SOCS1;HSPA8;CCR6;TNFRSF10A;RAPGEF1;ZYX;TNFAIP3;PSMC3;CCL22;CXCL8;MAPK11;CXCL3;SRSF7;NOL3;HSP90AB1;IL6R;IL36G;CCL5
6594,GO:0022610,4.35353551024414e-11,1,113,798,biological adhesion,BP,IL32;SAA1;CYR61;FN1;CYP1B1;CTGF;TENM3;C1QTNF1;CCDC80;ACTG1;PML;CYLD;HSPB1;PDLIM1;PCDH7;SDC4;TFRC;CD83;MAP3K14;FBN1;TGFB2;GBP1;DAPK3;B4GALT1;EMP2;NUAK1;NEDD9;ADAMTS9;LYN;CSRP1;TNF;COL12A1;BAIAP2;EFNB2;CDKN2A;CORO1C;TNC;DST;VMP1;PDPN;SIRPA;FLNA;SART1;EPHA2;ICAM1;CD274;BMP2;COL16A1;ITGAV;L1CAM;MYO10;PLEKHA7;TNFRSF12A;SERPINE1;SFRP1;TPM1;IRF1;IL7R;SRF;TRIM29;PARD3B;ETS1;SNAI2;ZFP36L1;RHOB;ADAM17;VCL;LGALS3;IL15;PRKCA;NTN1;SYK;ROBO1;AJUBA;BCAM;COL5A3;MYH9;COL17A1;NPNT;SDK1;TNFRSF21;RCC2;ACKR3;SMAD7;TRIP6;CLASP1;CITED2;SOCS1;ZNF703;PARD3;LAMC1;GPNMB;CNTNAP1;ACTN4;EFNB1;BMP7;AKIP1;PHLDB2;RAPGEF1;ZYX;TINAGL1;MYADM;DAG1;WNT4;CYTH1;CXCL8;EFNA1;CLDN7;HSP90AB1;SWAP70;FBLN2;MCAM;CCL5
6736,GO:0030154,6.53931527281947e-11,1,271,2518,cell differentiation,BP,IGFBP3;KRT1;MAFB;SPRR3;TRIM16;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CTGF;TENM3;CYP24A1;KRT34;ADM;KRT15;AMOT;FOSL2;KRT4;NEFM;ACTG1;CYP1A1;PML;TFCP2L1;CYLD;MYBL2;KRT10;SDC4;KRT13;WNT10A;RELB;TFRC;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;DAPK3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;HRNR;TP53;SIPA1L3;NFE2L1;SQSTM1;KRT9;HNRNPAB;STEAP4;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;RAB32;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;CORO1C;ENC1;TNC;TRIO;GPRIN1;PDPN;FGFR2;PBX1;TPM4;NFKB2;COL4A1;PSMB9;SLC7A5;EPHB6;KRT17;TYMS;ZC3H12A;FLNA;TNK1;ARMC6;SART1;KLF7;ZNF503;EPHA2;CCDC85B;GADD45B;ICAM1;FANCC;BMP2;UBE4B;COL27A1;ITGAV;ERRFI1;L1CAM;SFN;ANKS4B;ADRB2;IL20;TNFRSF12A;FOXD2;SERPINE1;PABPC4;PGK1;CSRP2;ELF3;LIF;OSR2;SFRP1;TPM1;ZFYVE27;SAFB2;DHCR7;WDR1;MKL1;IRF1;PSME2;IL7R;GPER1;SRF;NSUN2;ELF4;ABTB2;NFKBIA;SF1;EGR1;EDF1;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;ARHGEF28;RHOB;ADAM17;DHFR;VCL;IRS2;KRT14;LGALS3;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;ALYREF;SPTBN1;NEDD4L;SERPINH1;FHL2;DPYSL3;MYH9;NOM1;NPNT;IL1A;SDK1;TNFRSF21;RASGRP4;RBBP5;SEMA3C;LILRB3;SPEN;ROR1;RCC2;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;ENAH;KEAP1;HNRNPU;TJP1;CLASP1;PQBP1;CAPNS1;VSIG1;TRIB1;ABT1;PPP1R9B;ETS2;KLF10;RBM38;MARVELD2;CITED2;CD109;SOCS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;GLIPR2;CPT1A;RBM4;ZNF703;CCR6;RPTN;INSIG1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;KLF6;ZSWIM6;CNTNAP1;ACTN4;EFNB1;SORBS2;LRFN4;BMP7;AKIP1;ELK1;PHLDB2;RAPGEF1;MYADM;DAG1;RAB27A;BLNK;WNT4;RILPL2;AKR1C1;VPS52;CTDSP1;PSMC3;BRIP1;EFNA1;MAPK11;MYO1E;BMP8A;HES4;HSP90AB1;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4;FADS1
13831,GO:0060429,7.13051400591726e-11,1,113,812,epithelium development,BP,KRT1;SPRR3;TRIM16;SPRR2A;NRG1;KRT2;RUNX1;CYR61;INHBA;KRT34;ADM;KRT15;FOSL2;KRT4;CYP1A1;PML;TFCP2L1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;TGFB2;EDN1;B4GALT1;KRTAP2-3;HRNR;SIPA1L3;KRT9;FST;LFNG;KRT6A;CDKN1A;TJP2;TNF;EFNB2;KRT5;TNC;PDPN;FGFR2;PBX1;COL4A1;PSMB9;KRT17;TYMS;FLNA;EPHA2;ICAM1;BMP2;ERRFI1;SFN;IL20;SERPINE1;PGK1;ELF3;LIF;SFRP1;CC2D2A;SAFB2;WDR1;PSME2;EPPK1;SRF;NSUN2;EDF1;SNAI2;ZFP36L1;RHOB;ADAM17;VCL;RIPK4;KRT14;LGALS3;AKR1C2;NTN1;ROBO1;AJUBA;PDGFB;NOM1;NPNT;SEMA3C;ROR1;MAFF;SMAD7;KEAP1;TJP1;CLASP1;CAPNS1;VSIG1;MARVELD2;CITED2;CD109;FRAS1;JUN;ESR1;FOXN1;CPT1A;ZNF703;RPTN;BMP7;PHLDB2;RAPGEF1;MYADM;DAG1;TIMELESS;WNT4;RILPL2;AKR1C1;PSMC3;MYO1E;TP63;PHACTR4
3378,GO:0007155,7.30111462912846e-11,1,112,795,cell adhesion,BP,IL32;SAA1;CYR61;FN1;CYP1B1;CTGF;TENM3;C1QTNF1;CCDC80;ACTG1;PML;CYLD;HSPB1;PDLIM1;PCDH7;SDC4;TFRC;CD83;MAP3K14;FBN1;TGFB2;GBP1;DAPK3;B4GALT1;EMP2;NUAK1;NEDD9;ADAMTS9;LYN;CSRP1;TNF;COL12A1;BAIAP2;EFNB2;CDKN2A;CORO1C;TNC;DST;VMP1;PDPN;SIRPA;FLNA;SART1;EPHA2;ICAM1;CD274;BMP2;COL16A1;ITGAV;L1CAM;MYO10;PLEKHA7;TNFRSF12A;SERPINE1;SFRP1;TPM1;IRF1;IL7R;SRF;TRIM29;PARD3B;ETS1;SNAI2;ZFP36L1;RHOB;ADAM17;VCL;LGALS3;IL15;PRKCA;NTN1;SYK;ROBO1;AJUBA;BCAM;COL5A3;MYH9;COL17A1;NPNT;SDK1;TNFRSF21;RCC2;ACKR3;SMAD7;TRIP6;CLASP1;CITED2;SOCS1;ZNF703;PARD3;LAMC1;GPNMB;CNTNAP1;ACTN4;EFNB1;BMP7;AKIP1;PHLDB2;RAPGEF1;ZYX;TINAGL1;MYADM;DAG1;WNT4;CYTH1;CXCL8;EFNA1;CLDN7;SWAP70;FBLN2;MCAM;CCL5
4265,GO:0009611,9.40852326171757e-11,1,70,416,response to wounding,BP,KRT1;SAA1;SPRR3;CCL20;NRG1;CYR61;FN1;NEFL;CTGF;C1QTNF1;ADM;ACTG1;CYP1A1;HSPB1;SDC4;TGFB2;EDN1;B4GALT1;TP53;IL24;LYN;CSRP1;EHD1;TNC;DST;PDPN;FGFR2;FLNA;GGCX;TNFRSF12A;SERPINE1;PABPC4;TPM1;ANXA8;IRF1;EPPK1;THBD;SRF;TXN2;ETS1;ZFP36L1;RHOB;ADAM17;DHFR;VCL;CBX5;MAFK;PRKCA;ZFP36L2;SYK;AJUBA;PDGFB;DPYSL3;MYH9;IL1A;MAFF;CLASP1;CD109;JUN;RHOG;GP6;PHLDB2;DAG1;RAB27A;WNT4;TNFAIP3;NOL3;TBXA2R;MCAM;BIN3
12070,GO:0048018,2.96458327692756e-10,0.999999999939314,38,167,receptor ligand activity,MF,IL32;SAA1;CCL20;NRG1;INHBA;CTGF;ADM;IL16;WNT10A;CSF2;FBN1;TGFB2;EDN1;IL24;TNF;CXCL16;BMP2;CDC42EP2;EPGN;IL20;LIF;TXLNA;LGALS3;IL15;CMTM3;PDGFB;IL1A;SEMA3C;CXCL5;GPNMB;BMP7;WNT4;CCL22;CXCL8;CXCL3;BMP8A;IL36G;CCL5
9792,GO:0040011,4.81939715620797e-10,1,139,1095,locomotion,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;KRT2;CYR61;PTGER4;HDAC9;S100P;FN1;NEFL;CYP1B1;CTGF;TNS3;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;IER2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;NEDD9;ADAMTS9;LYN;TNF;EFNB2;CORO1C;CXCL16;WWC1;DST;PDPN;SLC7A5;CLN6;FOSL1;SIRPA;ZC3H12A;FLNA;LCP1;TNK1;KLF7;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;STAT5A;TNFRSF12A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;WDR1;EPPK1;THBD;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;SYK;CMTM3;ROBO1;AJUBA;PDGFB;SPTBN1;DPYSL3;MYH9;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;BAMBI;SMAD7;MTA2;TRIP6;ENAH;CLASP1;TRIB1;CREB3;PPP1R9B;CXCL5;CITED2;JUN;FOXN1;GLIPR2;CHMP4B;ZNF703;CCR6;ARRDC3;LAMC1;RHOG;GPNMB;GP6;ZSWIM6;ACTN4;EFNB1;BMP7;TNFRSF10A;PHLDB2;MYADM;DAG1;WNT4;CCL22;CXCL8;EFNA1;CLDN7;SLC3A2;CXCL3;CARD10;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;BIN3;PHACTR4;CCL5
6737,GO:0030155,8.17827189272515e-10,1,69,421,regulation of cell adhesion,BP,SAA1;CYR61;FN1;CYP1B1;C1QTNF1;CCDC80;PML;CYLD;SDC4;TFRC;CD83;MAP3K14;TGFB2;GBP1;DAPK3;EMP2;NUAK1;LYN;TNF;EFNB2;CDKN2A;CORO1C;TNC;PDPN;SIRPA;FLNA;SART1;EPHA2;ICAM1;CD274;BMP2;COL16A1;ITGAV;MYO10;SERPINE1;SFRP1;TPM1;IRF1;IL7R;SRF;ETS1;SNAI2;LGALS3;IL15;PRKCA;SYK;NPNT;TNFRSF21;RCC2;SMAD7;CLASP1;CITED2;SOCS1;ZNF703;GPNMB;ACTN4;EFNB1;BMP7;PHLDB2;MYADM;DAG1;WNT4;CYTH1;CXCL8;EFNA1;CLDN7;SWAP70;FBLN2;CCL5
6937,GO:0030545,1.44652605906699e-09,0.999999999619573,39,183,receptor regulator activity,MF,IL32;SAA1;CCL20;NRG1;INHBA;CTGF;ADM;IL16;WNT10A;CSF2;FBN1;TGFB2;EDN1;IL24;TNF;CXCL16;BMP2;CDC42EP2;LYPD6B;EPGN;IL20;LIF;TXLNA;LGALS3;IL15;CMTM3;PDGFB;IL1A;SEMA3C;CXCL5;GPNMB;BMP7;WNT4;CCL22;CXCL8;CXCL3;BMP8A;IL36G;CCL5
4382,GO:0010033,1.48439683271732e-09,1,233,2166,response to organic substance,BP,IL32;SAA1;TRIM16;CCL20;CRYAB;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;CYP1B1;CTGF;CYP24A1;ADM;ACTG1;NQO1;IL16;CYP1A1;IL1R2;PML;CYLD;HSPB1;MYBL2;TRAF1;KRT13;WNT10A;RELB;TFRC;SOD2;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;RSAD2;G6PD;TRAF3;NLRC5;PANX1;TP53;SQSTM1;IL24;NOCT;IL27RA;NFKB1;CDKN2B;IRS1;CDKN1A;TJP2;UBQLN2;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;CXCL16;TNC;FGFR2;PTPN14;NFKB2;COL4A1;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;SRSF2;LCP1;EPHA2;HMGCS1;ICAM1;CD274;BMP2;COL16A1;UBE4B;CDK4;ERRFI1;CDC42EP2;STAT5A;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;ARPC1B;MCM2;XAF1;ZC3H7B;RELT;LIF;SFRP1;TRIM22;ZFYVE27;SAFB2;HLA-F;IRF1;PSME2;IL7R;THBD;GPER1;SRF;DNAJB2;TXN2;NFKBIA;EGR1;ETS1;SNAI2;SRRT;ZFP36L1;AKAP8;ADAM17;TXLNA;DHFR;IRS2;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;SYK;DDX17;NFKBIB;ROBO1;IFIT3;PDGFB;OXTR;SNRNP70;SERPINH1;FHL2;DCTN1;DPYSL3;SPPL2A;NPNT;IL1A;SDK1;GPR75;TNFRSF21;TNIP2;LANCL2;SPRY4;ACSL1;COL5A2;ACKR3;BAMBI;SMAD7;TATDN2;YWHAH;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;UBE2J2;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;SAFB;KLF10;PARP14;CXCL5;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;CPT1A;MCM7;ZNF703;CCR6;INSIG1;PARD3;QDPR;SNIP1;BMP7;EFTUD2;TNFRSF10A;ELK1;RAPGEF1;ZYX;DAG1;RNF185;TIMELESS;WNT4;RBM14;AKR1C1;CD38;TNFAIP3;PSMC3;CCL22;BRIP1;CXCL8;MAPK11;CLDN7;SLC3A2;CXCL3;BMP8A;TRIML2;POLR2G;SRSF7;NOL3;GCLC;HSP90AB1;TBXA2R;IL6R;PARP1;TP63;IL36G;CCL5;BAIAP2L2;SH3BP4
12421,GO:0048869,2.03204472037213e-09,1,277,2674,cellular developmental process,BP,IGFBP3;KRT1;MAFB;SPRR3;TRIM16;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CTGF;TENM3;CYP24A1;KRT34;ADM;KRT15;AMOT;FOSL2;KRT4;NEFM;ACTG1;CYP1A1;PML;TFCP2L1;CYLD;MYBL2;KRT10;SDC4;KRT13;WNT10A;RELB;TFRC;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;DAPK3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;NUAK1;HRNR;TP53;SIPA1L3;NFE2L1;SQSTM1;KRT9;HNRNPAB;STEAP4;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;RAB32;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;CDKN2A;CORO1C;ENC1;TNC;TRIO;GPRIN1;PDPN;FGFR2;PBX1;TPM4;NFKB2;COL4A1;PSMB9;SLC7A5;EPHB6;KRT17;TYMS;ZC3H12A;FLNA;TNK1;ARMC6;SART1;KLF7;ZNF503;EPHA2;CCDC85B;GADD45B;ICAM1;FANCC;BMP2;UBE4B;COL27A1;ITGAV;ERRFI1;L1CAM;MYO10;SFN;CDC42EP2;ANKS4B;ADRB2;IL20;TNFRSF12A;FOXD2;SERPINE1;PABPC4;PGK1;CSRP2;ELF3;LIF;OSR2;SFRP1;TPM1;ZFYVE27;SAFB2;DHCR7;WDR1;MKL1;IRF1;PSME2;IL7R;GPER1;SRF;NSUN2;ELF4;ABTB2;NFKBIA;SF1;EGR1;EDF1;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;ARHGEF28;RHOB;ADAM17;DHFR;VCL;IRS2;KRT14;LGALS3;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;ALYREF;SPTBN1;NEDD4L;SERPINH1;FHL2;DPYSL3;MYH9;NOM1;NPNT;IL1A;SDK1;TNFRSF21;RASGRP4;RBBP5;SEMA3C;LILRB3;TBCCD1;SPEN;ROR1;RCC2;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;PALM2;ENAH;KEAP1;HNRNPU;TJP1;CLASP1;PQBP1;CAPNS1;VSIG1;TRIB1;ABT1;PPP1R9B;ETS2;KLF10;RBM38;MARVELD2;CITED2;CD109;SOCS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;GLIPR2;CPT1A;RBM4;ZNF703;CCR6;RPTN;INSIG1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;KLF6;ZSWIM6;CNTNAP1;ACTN4;EFNB1;SORBS2;LRFN4;BMP7;AKIP1;ELK1;PHLDB2;RAPGEF1;MYADM;DAG1;RAB27A;BLNK;WNT4;RILPL2;AKR1C1;VPS52;CTDSP1;PSMC3;BRIP1;EFNA1;MAPK11;MYO1E;BMP8A;HES4;HSP90AB1;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4;FADS1
19756,GO:2000147,2.288029650549e-09,1,56,319,positive regulation of cell motility,BP,CCL20;MMP9;CYR61;HDAC9;FN1;HSPB1;SOD2;TGFB2;EDN1;DAPK3;TP53;LYN;TNF;CXCL16;PDPN;ZC3H12A;FLNA;ICAM1;CD274;BMP2;ITGAV;STAT5A;SERPINE1;GPER1;ETS1;SNAI2;RHOB;ADAM17;FGFR1OP;IRS2;LGALS3;PRKCA;NTN1;PDGFB;IL1A;SEMA3C;ACKR3;TRIP6;CLASP1;CREB3;CXCL5;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ACTN4;BMP7;MYADM;CXCL8;CLDN7;CXCL3;SWAP70;MCAM;IL6R;CCL5
3273,GO:0006950,3.04396139205847e-09,1,273,2656,response to stress,BP,IL32;KRT1;SAA1;SPRR3;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;CYP1B1;CTGF;C1QTNF1;ADM;ACTG1;NQO1;CYP1A1;TAP1;IL1R2;PML;CYLD;HSPB1;PDLIM1;SDC4;RELB;BAG1;SOD2;ABCF1;CD83;HLA-B;CSF2;PTGES;MAP3K14;TGFB2;EDN1;GBP1;TXNRD1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;RSAD2;G6PD;TRAF3;NUAK1;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;IL24;IL27RA;NFKB1;CDKN1A;HSPG2;UBQLN2;LYN;JUNB;LAMP1;CSRP1;EHD1;GADD45A;TNF;CDKN2A;CXCL16;TNC;ASCC2;DST;PDPN;FGFR2;NUP153;NFKB2;DNAJB1;PSMB9;FOSL1;ZC3H12A;FLNA;TNK1;CADPS2;EPHA2;GADD45B;TSC22D3;ICAM1;FANCC;PITHD1;BMP2;UBE4B;CDK4;ERRFI1;GGCX;SFN;CDC42EP2;ANKS4B;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;PABPC4;PGK1;XAF1;AEN;ELF3;RELT;SFRP1;TPM1;TRIM22;APTX;HLA-F;ANXA8;IRF1;PSME2;EPPK1;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;DNAJB2;TXN2;ELF4;ABTB2;TRIM29;NFKBIA;EGR1;ETS1;SGK1;SNAI2;PRPF19;ZFP36L1;AKAP8;RHOB;ADAM17;FEN1;DHFR;VCL;IER3;NPAS2;CBX5;LGALS3;MAFK;TRAF2;IL15;PRKCA;ZFP36L2;SYK;SLC7A2;DDX17;AJUBA;GINS2;USP43;IFIT3;PDGFB;OXTR;PTTG1IP;POLA1;SERPINH1;DCTN1;DNASE1;DPYSL3;UHRF1;MYH9;IL1A;COPS3;ORAOV1;TNFRSF21;TNIP2;RBBP5;SFPQ;DDX39A;LILRB3;PXMP2;NUP214;MAFF;ACKR3;AFAP1L2;SMAD7;CRCP;TATDN2;CLASP1;PQBP1;PAGR1;UBE2J2;TRIB1;TPST1;CREB3;RUVBL2;TUSC1;THOC1;KLF10;PARP14;CXCL5;SUSD6;DUSP1;CAB39;CITED2;CD109;SOCS1;STAC;OXSR1;HSPA8;JUN;ESR1;FOXN1;MCM7;TFDP1;RBM4;CCR6;INSIG1;HERC2;RHOG;BCL2L2;ZNF365;XRCC6;GP6;CHCHD6;ACTN4;BMP7;SMUG1;PHLPP1;TNFRSF10A;PHLDB2;RAPGEF1;CHAF1A;ZYX;KIF22;DAG1;POLR3H;RNF185;RAB27A;TIMELESS;GPX4;BLNK;WNT4;RBM14;TRAF4;TUBB;CD38;TNFAIP3;PSMC3;CCL22;BRIP1;SUPT16H;CXCL8;MAPK11;CXCL3;POLR2G;NOL3;CDCA5;GCLC;HSP90AB1;TBXA2R;MCAM;IL6R;BIN3;PARP1;TP63;IL36G;C1S;TOP3A;CCL5;FADS1;APEX2
9835,GO:0042060,3.36765932074833e-09,1,58,343,wound healing,BP,KRT1;SAA1;SPRR3;CCL20;NRG1;CYR61;FN1;C1QTNF1;ACTG1;HSPB1;SDC4;TGFB2;EDN1;B4GALT1;TP53;IL24;LYN;CSRP1;EHD1;TNC;PDPN;FGFR2;FLNA;GGCX;TNFRSF12A;SERPINE1;PABPC4;TPM1;ANXA8;IRF1;EPPK1;THBD;SRF;ETS1;RHOB;ADAM17;VCL;CBX5;MAFK;PRKCA;SYK;AJUBA;PDGFB;MYH9;IL1A;MAFF;CLASP1;CD109;RHOG;GP6;PHLDB2;DAG1;RAB27A;WNT4;TNFAIP3;TBXA2R;MCAM;BIN3
7068,GO:0030855,5.03761472603387e-09,1,68,436,epithelial cell differentiation,BP,KRT1;SPRR3;TRIM16;SPRR2A;NRG1;KRT2;RUNX1;KRT34;KRT15;FOSL2;KRT4;CYP1A1;TFCP2L1;KRT10;KRT13;B4GALT1;KRTAP2-3;HRNR;SIPA1L3;KRT9;KRT6A;CDKN1A;TJP2;TNF;KRT5;PDPN;FGFR2;COL4A1;KRT17;TYMS;EPHA2;ICAM1;BMP2;ERRFI1;SFN;IL20;SERPINE1;PGK1;ELF3;LIF;SAFB2;EDF1;ZFP36L1;KRT14;LGALS3;AKR1C2;PDGFB;MAFF;KEAP1;TJP1;CAPNS1;VSIG1;MARVELD2;CD109;JUN;ESR1;FOXN1;CPT1A;ZNF703;RPTN;BMP7;RAPGEF1;MYADM;WNT4;RILPL2;AKR1C1;MYO1E;TP63
9798,GO:0040017,5.44992956402453e-09,1,58,344,positive regulation of locomotion,BP,CCL20;MMP9;CYR61;HDAC9;FN1;IL16;HSPB1;SOD2;TGFB2;EDN1;DAPK3;TP53;LYN;TNF;CXCL16;PDPN;ZC3H12A;FLNA;ICAM1;CD274;BMP2;ITGAV;STAT5A;SERPINE1;GPER1;ETS1;SNAI2;RHOB;ADAM17;FGFR1OP;IRS2;LGALS3;PRKCA;NTN1;PDGFB;IL1A;SEMA3C;ACKR3;TRIP6;CLASP1;CREB3;CXCL5;JUN;GLIPR2;CHMP4B;ZNF703;CCR6;GPNMB;ACTN4;BMP7;MYADM;CXCL8;CLDN7;CXCL3;SWAP70;MCAM;IL6R;CCL5
8481,GO:0033627,5.68354587291073e-09,0.999999999408983,16,38,cell adhesion mediated by integrin,BP,CYP1B1;FBN1;TGFB2;LYN;EPHA2;ICAM1;COL16A1;ITGAV;SERPINE1;SNAI2;ADAM17;SYK;NPNT;EFNA1;SWAP70;CCL5
12922,GO:0051272,6.19438725030405e-09,1,56,328,positive regulation of cellular component movement,BP,CCL20;MMP9;CYR61;HDAC9;FN1;HSPB1;SOD2;TGFB2;EDN1;DAPK3;TP53;LYN;TNF;CXCL16;PDPN;ZC3H12A;FLNA;ICAM1;CD274;BMP2;ITGAV;STAT5A;SERPINE1;GPER1;ETS1;SNAI2;RHOB;ADAM17;FGFR1OP;IRS2;LGALS3;PRKCA;NTN1;PDGFB;IL1A;SEMA3C;ACKR3;TRIP6;CLASP1;CREB3;CXCL5;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ACTN4;BMP7;MYADM;CXCL8;CLDN7;CXCL3;SWAP70;MCAM;IL6R;CCL5
6865,GO:0030335,9.50604240849668e-09,1,54,314,positive regulation of cell migration,BP,CCL20;MMP9;CYR61;HDAC9;FN1;HSPB1;SOD2;TGFB2;EDN1;DAPK3;TP53;LYN;TNF;CXCL16;PDPN;ZC3H12A;FLNA;ICAM1;CD274;BMP2;ITGAV;STAT5A;SERPINE1;GPER1;ETS1;SNAI2;RHOB;ADAM17;FGFR1OP;IRS2;LGALS3;PRKCA;PDGFB;IL1A;SEMA3C;ACKR3;TRIP6;CLASP1;CREB3;CXCL5;JUN;GLIPR2;ZNF703;CCR6;GPNMB;ACTN4;BMP7;MYADM;CXCL8;CXCL3;SWAP70;MCAM;IL6R;CCL5
2889,GO:0006396,1.0194447909551e-08,1,110,876,RNA processing,BP,USB1;PDCD11;NOCT;RRP1;CDKAL1;ZC3H12A;SRSF2;SART1;GEMIN5;DDX23;TRMT61A;ZMAT2;NAT10;FUS;PABPC4;USP36;AKAP8L;ZC3H7B;SAFB2;PUS1;DHX37;PWP2;METTL1;LUC7L;DDX42;PSPC1;TFIP11;NSUN2;RRP36;SF1;GEMIN4;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;NELFE;DKC1;ISG20L2;U2AF2;SHQ1;METTL2B;LGALS3;TSR1;RPLP1;SF3B4;ZFC3H1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;ALYREF;UTP14A;UTP20;RPS9;NSUN5;GEMIN8;SNRNP70;RRP7A;PRCC;RBM15B;SFPQ;DDX39A;FTSJ3;WDR46;SPEN;NOP56;NOL9;SUPT5H;WDR4;HNRNPU;HNRNPF;PQBP1;ABT1;PPP1R9B;SAFB;THOC1;TRUB2;RBM38;RRP7BP;ARL6IP4;TXNL4B;RPL27A;HSPA8;ESR1;PES1;NOP2;NOP14;RBM4;DUS2;TRMT1;SNIP1;METTL16;EFTUD2;TRA2A;PHF5A;DHX34;HSD17B10;UTP4;POLR2G;SRSF7;NOL3;POP4;RPUSD4;CLK4;MAGOH
1467,GO:0003723,1.09685817622603e-08,1,166,1483,RNA binding,MF,NQO1;DUSP14;RBM19;HSPB1;TFRC;ABCF1;CD3EAP;TRIM56;TP53;PDCD11;HNRNPAB;NOCT;CSRP1;GNL3L;CDKN2A;GPATCH4;PPAN;RRP1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;EIF5;DDX23;RRP12;ZMAT2;NAT10;FUS;PABPC4;CCDC124;USP36;AKAP8L;ZC3H7B;GRWD1;SAFB2;APTX;PUS1;DHX37;PWP2;METTL1;LUC7L;EPPK1;DDX42;CTIF;NFX1;PSPC1;SRF;NSUN2;RRP36;LARP4B;SF1;EDF1;POP1;RRS1;SRRT;ZFP36L1;ARHGEF28;AKAP8;NELFE;DKC1;DHFR;ISG20L2;U2AF2;PPRC1;LGALS3;TSR1;ACO1;SF3B4;ZFP36L2;PUM3;ZFC3H1;DDX17;IFIT3;DDX47;DDX49;DNTTIP2;RPS2;UBTF;ALYREF;UTP14A;PHAX;UTP20;RPS9;NSUN5;SPTBN1;SNRNP70;SERPINH1;RRP7A;MYH9;NOM1;ZNFX1;RBM15B;SFPQ;DDX39A;NOP16;FTSJ3;WDR46;SPEN;RCC2;NOP56;MRPS12;MRPS24;NOL9;SUPT5H;TRIP6;ERAL1;HNRNPU;HNRNPF;ABT1;MAZ;SAFB;THOC1;RPP25L;TRUB2;MRPL20;RBM38;ARL6IP4;RPL27A;HSPA8;JUN;TCOF1;PES1;EIF3B;NOP2;NOP14;NOC2L;RBM4;DUS2;XRCC6;TRMT1;CS;ACTN4;HMGN2;SORBS2;SNIP1;METTL16;CLUH;EFTUD2;TRA2A;PHF5A;EIF3I;ZYX;EIF5A;UBAP2L;EEF1D;DHX34;RBM14;SUPT16H;DDX24;HSD17B10;SURF6;SLC3A2;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;LRRC59;HSP90AB1;MKI67;POP4;RPUSD4;PARP1;MAGOH
9903,GO:0042221,1.33580096858665e-08,1,280,2777,response to chemical,BP,IL32;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;CYP1B1;CTGF;CYP24A1;ADM;AMOT;ACTG1;NQO1;IL16;CYP1A1;IL1R2;NFKBIE;PML;CYLD;HSPB1;MYBL2;TRAF1;KRT13;WNT10A;RELB;TFRC;SOD2;UGT1A6;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;RSAD2;G6PD;TRAF3;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;IL24;NOCT;IL27RA;NFKB1;CDKN2B;IRS1;CDKN1A;TJP2;UBQLN2;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;EFNB2;CXCL16;TNC;FGFR2;PTPN14;NFKB2;COL4A1;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;SRSF2;LCP1;ACAA1;KLF7;EPHA2;HMGCS1;ICAM1;FANCC;CD274;BMP2;COL16A1;UBE4B;CDK4;ITGAV;ERRFI1;L1CAM;CDC42EP2;STAT5A;ADRB2;IL20;DAXX;TNFRSF12A;MTUS1;IFNGR1;SLC5A6;SERPINE1;FUS;PGK1;ARPC1B;MCM2;EBP;XAF1;ZC3H7B;RELT;LIF;SFRP1;TPM1;TRIM22;ZFYVE27;SAFB2;APTX;HLA-F;IRF1;PSME2;IL7R;THBD;GPER1;SRF;DNAJB2;TXN2;ABTB2;NFKBIA;EGR1;ETS1;SNAI2;SRRT;CYP4B1;ZFP36L1;AKAP8;RHOB;ADAM17;TXLNA;DHFR;IRS2;KRT14;LGALS3;ACO1;TRAF2;ABCG2;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;CMTM3;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;PDGFB;OXTR;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;DPYSL3;SPPL2A;NPNT;IL1A;SDK1;GPR75;TNFRSF21;TNIP2;LANCL2;SEMA3C;SFPQ;SPRY4;PXMP2;ACSL1;COL5A2;ACKR3;BAMBI;SMAD7;TATDN2;YWHAH;ENAH;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;UBE2J2;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;SLC4A11;SAFB;KLF10;PARP14;CXCL5;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;CPT1A;MCM7;RBM4;ZNF703;CCR6;INSIG1;PARD3;QDPR;RHOG;GPNMB;ZSWIM6;EFNB1;SNIP1;BMP7;EFTUD2;TNFRSF10A;ELK1;RAPGEF1;ZYX;DAG1;RNF185;TIMELESS;GPX4;WNT4;RBM14;AKR1C1;CD38;TNFAIP3;PSMC3;CCL22;BRIP1;CXCL8;EFNA1;MAPK11;CLDN7;CTPS1;SLC3A2;CXCL3;BMP8A;TRIML2;SLC25A22;POLR2G;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;IL6R;PARP1;TP63;IL36G;CCL5;BAIAP2L2;SH3BP4
9915,GO:0042254,1.5104825771953e-08,1,51,317,ribosome biogenesis,BP,PDCD11;GNL3L;PPAN;RRP1;SART1;NAT10;LSG1;USP36;DHX37;PWP2;RRP36;GEMIN4;RRS1;RPLP2;DKC1;ISG20L2;SHQ1;URB2;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;UTP20;RPS9;NSUN5;RRP7A;NOM1;NOP16;FTSJ3;WDR46;NOP56;NOL9;ERAL1;ABT1;MRPL20;RRP7BP;RPL27A;PES1;PAK1IP1;NOP2;NOP14;NOC2L;METTL16;SURF6;UTP4;POP4
4473,GO:0010469,1.55456991183826e-08,1,41,216,regulation of signaling receptor activity,BP,IL32;CCL20;NRG1;INHBA;CTGF;ADM;IL16;WNT10A;GPRC5A;CSF2;FBN1;TGFB2;EDN1;IL24;TNF;CXCL16;BMP2;ERRFI1;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;SERPINE1;LIF;ADAM17;TXLNA;IL15;CMTM3;PDGFB;IL1A;CXCL5;GPNMB;BMP7;WNT4;CCL22;CXCL8;CXCL3;BMP8A;IL36G;CCL5
9868,GO:0042127,2.13801236743149e-08,1,126,1033,regulation of cell proliferation,BP,IGFBP3;FTH1;NRG1;MMP9;CYR61;INHBA;FN1;ODC1;P3H2;CYP1B1;CTGF;ADM;TNS3;FOSL2;KRT4;PML;SDC4;TFRC;SOD2;CSF2;PTGES;TGFB2;EDN1;B4GALT1;EMP2;NUAK1;TP53;MARVELD3;IL24;CDKN2B;IRS1;CDKN1A;LYN;AHR;JUNB;TNF;EFNB2;CDKN2A;TNC;PDPN;FGFR2;PTPN14;PBX1;FOSL1;FLNA;TNK1;ZNF503;CD274;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RELT;LIF;OSR2;SFRP1;TPM1;DHCR7;IRF1;EPPK1;IL7R;GPER1;SRF;DNAJB2;NFKBIA;SF1;EGR1;ETS1;SGK1;SNAI2;ZFP36L1;ADAM17;FGFR1OP;IRS2;LGALS3;IL15;AKR1C2;PRKCA;NTN1;SYK;ROBO1;IFIT3;PDGFB;UTP20;RPS9;IL1A;TNFRSF21;BAMBI;HNRNPU;CAPNS1;TRIB1;PPP1R9B;KLF10;CXCL5;CD109;JUN;ESR1;IKZF3;TFDP1;NOP2;SERTAD1;NACC1;ZNF703;LAMC1;RHOG;GPNMB;XRCC6;EFNB1;BMP7;TNFRSF10A;RAPGEF1;EIF5A;CD38;TNFAIP3;BRIP1;CXCL8;MAPK11;CLDN7;CXCL3;IL6R;TP63;CCL5;SH3BP4
3260,GO:0006928,2.47616929107767e-08,1,148,1263,movement of cell or subcellular component,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;KRT2;CYR61;PTGER4;HDAC9;S100P;FN1;NEFL;CYP1B1;CTGF;TNS3;AMOT;IL16;PML;HSPB1;STARD13;SDC4;SOD2;IER2;TGFB2;EDN1;DAPK3;B4GALT1;EMP2;TP53;MARVELD3;IL24;NEDD9;ADAMTS9;LYN;MYO1B;LAMP1;TNF;EFNB2;CORO1C;CXCL16;WWC1;DST;PDPN;TPM4;SLC7A5;SIRPA;ZC3H12A;FLNA;LCP1;TNK1;KLF7;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;KIF23;MYO10;STAT5A;TNFRSF12A;MTUS1;SERPINE1;AMOTL2;SFRP1;TPM1;WDR1;EPPK1;THBD;GPER1;SRF;DOCK10;ETS1;SGK1;SNAI2;RHOB;ADAM17;FGFR1OP;VCL;IRS2;LGALS3;PRKCA;NTN1;SYK;ROBO1;AJUBA;PDGFB;WDR34;SPTBN1;NEDD4L;DCTN1;DPYSL3;MYH9;IL1A;SEMA3C;TBCCD1;RCC2;ACKR3;BAMBI;SMAD7;MTA2;TRIP6;ENAH;CLASP1;TRIB1;CREB3;PPP1R9B;CXCL5;CITED2;HSPA8;JUN;BLOC1S2;FOXN1;GLIPR2;ZNF703;CCR6;LAMC1;RHOG;GPNMB;GP6;ZSWIM6;ACTN4;EFNB1;KIF24;BMP7;TNFRSF10A;PHLDB2;KIF22;MYADM;DAG1;WNT4;CCL22;CXCL8;EFNA1;CLDN7;MYO1E;SLC3A2;CXCL3;CARD10;CLTA;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;BIN3;PHACTR4;CCL5
8153,GO:0032879,2.58169035244284e-08,1,186,1685,regulation of localization,BP,IGFBP3;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;HDAC9;FN1;CYP1B1;C1QTNF1;AMOT;JPH2;IL16;IL1R2;PML;CYLD;HSPB1;STARD13;SDC4;SOD2;TGFB2;EDN1;GBP1;IKBKE;DAPK3;B4GALT1;RSAD2;G6PD;EMP2;PANX1;TP53;SQSTM1;MARVELD3;IL24;NFKB1;IRS1;CDKN1A;UBQLN2;ADAMTS9;LYN;LAMP1;EHD1;TNF;GNL3L;CORO1C;CXCL16;WWC1;PDPN;PTPN14;NUP153;SIRPA;JPH1;ZC3H12A;FLNA;LCP1;CYB5R1;CADPS2;EPHA2;CHP1;ICAM1;CD274;BMP2;GOSR1;ITGAV;SFN;STAT5A;ADRB2;MTUS1;SERPINE1;FXYD3;USP36;AKAP8L;AMOTL2;LIF;SFRP1;PARL;TPM1;TRIM22;WDR1;EPPK1;GPER1;SRF;TRIM29;NFKBIA;KCNA7;DOCK10;ETS1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;DKC1;SNX12;FGFR1OP;VCL;SHQ1;IRS2;LGALS3;TRAF2;REEP1;PRKCA;NTN1;SYK;POLR1A;ROBO1;AJUBA;PDGFB;OXTR;SPTBN1;NEDD4L;DPYSL3;IL1A;TNFRSF21;RUNDC1;SEMA3C;WDR46;TBCCD1;RCC2;NUP214;ACKR3;SMAD7;MTA2;DNAJC1;YWHAH;TRIP6;HNRNPU;CLASP1;RRAD;UBE2J2;TRIB1;CREB3;RUVBL2;KCNIP3;CXCL5;CAB39;CITED2;SOCS1;STAC;OXSR1;HSPA8;JUN;GLIPR2;CPT1A;TFDP1;RBM4;ZNF703;CCR6;INSIG1;PARD3;RHOG;GPNMB;ZSWIM6;ACTN4;SNIP1;BMP7;PHLDB2;SGSM1;RAPGEF1;MYADM;DAG1;RAB27A;WNT4;CD38;CXCL8;EFNA1;MAPK11;CLDN7;CXCL3;BMP8A;CARD10;NOL3;SNF8;CDCA5;HSP90AB1;SWAP70;TBXA2R;MCAM;IL6R;PARP1;TP63;CCL5
607,GO:0001775,2.63686820039989e-08,1,109,861,cell activation,BP,KRT1;MAFB;SAA1;FTL;FTH1;MMP9;KRT2;RUNX1;PTGER4;INHBA;HDAC9;S100P;CTGF;C1QTNF1;ACTG1;CYLD;HSPB1;SDC4;RELB;TFRC;CD83;CSF2;MAP3K14;EDN1;B4GALT1;MGAM;RSAD2;HRNR;IL27RA;NFKB1;LFNG;CDKN1A;LYN;AHR;PLEKHO2;LAMP1;CSRP1;EFNB2;PDPN;NFKB2;QPCT;SIRPA;ZC3H12A;FLNA;LCP1;SART1;ACAA1;ICAM1;CD274;ITGAV;SFRP1;IRF1;IL7R;THBD;GPER1;SRF;ELF4;EGR1;DOCK10;ZFP36L1;RHOB;ADAM17;TXLNA;VCL;IRS2;LGALS3;IL15;PRKCA;ZFP36L2;SYK;SLC7A2;PDGFB;DNASE1;MYH9;GLIPR1;TNFRSF21;TNIP2;LILRB3;SMAD7;THOC1;CAB39;SOCS1;HSPA8;JUN;IKZF3;FOXN1;COMMD9;CCR6;RHOG;GPNMB;XRCC6;GP6;KLF6;EFNB1;RAB27A;BLNK;WNT4;TUBB;CD38;TNFAIP3;PSMC3;CXCL8;CTPS1;PTPRB;GCLC;HSP90AB1;SWAP70;LAIR1;CCL5
3277,GO:0006955,3.36016667480052e-08,1,142,1223,immune response,BP,IL32;KRT1;SAA1;FTL;CCL20;FTH1;MMP9;RUNX1;PTGER4;S100P;C1R;ACTG1;IL16;TAP1;IL1R2;PML;CYLD;RELB;TFRC;CD83;HLA-B;CSF2;MAP3K14;TGFB2;EDN1;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;MGAM;RSAD2;TRAF3;EMP2;HRNR;NLRC5;IL27RA;NFKB1;LFNG;LYN;PLEKHO2;ARPC4;LAMP1;TNF;BAIAP2;CXCL16;NFKB2;PSMB9;QPCT;SIRPA;ZC3H12A;LCP1;TNK1;ACAA1;ICAM1;CD274;ITGAV;MYO10;CDC42EP2;RNF19B;IL20;IFNGR1;ARPC1B;XAF1;RELT;LIF;TRIM22;HLA-F;IRF1;PSME2;IL7R;PSPC1;GPER1;ELF4;TRIM29;NFKBIA;EGR1;DOCK10;ETS1;AKAP8;ADAM17;VCL;LGALS3;TRAF2;IL15;SYK;CMTM3;IFIT3;DNASE1;SPPL2A;COL17A1;IL1A;GLIPR1;TNFRSF21;TNIP2;SEMA3C;SFPQ;LILRB3;SMAD7;CRCP;TAPBP;PQBP1;THOC1;PARP14;CXCL5;CAB39;SOCS1;HSPA8;JUN;ESR1;COMMD9;CCR6;RHOG;XRCC6;TAP2;HMGN2;TNFRSF10A;RAPGEF1;ZYX;TINAGL1;POLR3H;RAB27A;BLNK;RBM14;TUBB;CD38;TNFAIP3;PSMC3;SPG21;CCL22;CXCL8;CXCL3;PTPRB;HSP90AB1;SWAP70;IL6R;LAIR1;IL36G;C1S;CCL5
7153,GO:0031012,3.37124605638125e-08,1,44,240,extracellular matrix,CC,KRT1;MMP9;CYR61;FN1;P3H2;CTGF;CCDC80;WNT10A;FBN1;TGFB2;HSPG2;ADAMTS9;COL12A1;NAV2;TNC;DST;FGFR2;COL4A1;ICAM1;COL16A1;COL27A1;L1CAM;COL9A2;SERPINE1;SFRP1;TFIP11;LGALS3;NTN1;PDGFB;BCAM;COL5A3;COL17A1;NPNT;COL5A2;FRAS1;RPTN;LAMC1;LRFN4;BMP7;TINAGL1;DAG1;COL4A4;WNT4;FBLN2
6764,GO:0030198,4.21820694792638e-08,0.99999998939401,41,213,extracellular matrix organization,BP,MMP9;CYR61;FN1;CYP1B1;CTGF;CCDC80;FBN1;TGFB2;B4GALT1;HSPG2;ADAMTS9;TNF;COL12A1;TNC;PDPN;NFKB2;COL4A1;LCP1;ICAM1;COL16A1;COL27A1;ITGAV;COL9A2;SERPINE1;ELF3;ETS1;PDGFB;SERPINH1;COLGALT1;COL5A3;NPNT;COL5A2;CLASP1;CAPNS1;LAMC1;PHLDB2;DAG1;FAM234A;COL4A4;MYO1E;FBLN2
14979,GO:0070887,4.93309108491128e-08,1,221,2119,cellular response to chemical stimulus,BP,IL32;SAA1;CCL20;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;CYP1B1;CTGF;CYP24A1;ACTG1;NQO1;IL16;CYP1A1;IL1R2;PML;CYLD;HSPB1;MYBL2;TRAF1;KRT13;WNT10A;TFRC;SOD2;UGT1A6;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;BIRC3;MID1;DAPK3;RSAD2;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;IL24;IL27RA;NFKB1;CDKN2B;IRS1;CDKN1A;TJP2;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;CXCL16;TNC;FGFR2;PTPN14;COL4A1;PSMB9;ZC3H12A;LCP1;ACAA1;EPHA2;HMGCS1;ICAM1;FANCC;CD274;BMP2;COL16A1;CDK4;ERRFI1;CDC42EP2;STAT5A;ADRB2;IL20;DAXX;TNFRSF12A;MTUS1;IFNGR1;SERPINE1;FUS;PGK1;MCM2;XAF1;ZC3H7B;RELT;LIF;SFRP1;TPM1;TRIM22;ZFYVE27;SAFB2;HLA-F;IRF1;PSME2;IL7R;GPER1;SRF;TXN2;ABTB2;NFKBIA;EGR1;ETS1;SNAI2;SRRT;ZFP36L1;AKAP8;RHOB;ADAM17;TXLNA;DHFR;IRS2;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;SYK;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;PDGFB;OXTR;SNRNP70;FHL2;DCTN1;DPYSL3;SPPL2A;NPNT;IL1A;GPR75;TNFRSF21;TNIP2;LANCL2;SFPQ;SPRY4;PXMP2;ACSL1;COL5A2;ACKR3;BAMBI;SMAD7;TATDN2;YWHAH;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;SAFB;KLF10;PARP14;CXCL5;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;CPT1A;MCM7;ZNF703;CCR6;INSIG1;PARD3;QDPR;RHOG;SNIP1;BMP7;EFTUD2;TNFRSF10A;ELK1;RAPGEF1;ZYX;DAG1;RNF185;TIMELESS;GPX4;WNT4;RBM14;AKR1C1;TNFAIP3;PSMC3;CCL22;BRIP1;CXCL8;MAPK11;CXCL3;BMP8A;POLR2G;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;IL6R;PARP1;TP63;IL36G;CCL5;BAIAP2L2;SH3BP4
15177,GO:0071310,5.0816316560172e-08,1,194,1804,cellular response to organic substance,BP,IL32;SAA1;CCL20;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;CYP1B1;CTGF;CYP24A1;ACTG1;IL16;CYP1A1;IL1R2;PML;CYLD;HSPB1;MYBL2;TRAF1;KRT13;WNT10A;TFRC;SOD2;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;MAT2A;BIRC3;MID1;DAPK3;RSAD2;TRAF3;NLRC5;TP53;SQSTM1;IL24;IL27RA;NFKB1;CDKN2B;IRS1;CDKN1A;TJP2;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;TNC;FGFR2;PTPN14;COL4A1;PSMB9;ZC3H12A;LCP1;HMGCS1;ICAM1;CD274;BMP2;COL16A1;CDK4;ERRFI1;CDC42EP2;STAT5A;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;MCM2;XAF1;ZC3H7B;RELT;LIF;SFRP1;TRIM22;ZFYVE27;SAFB2;HLA-F;IRF1;PSME2;IL7R;GPER1;SRF;NFKBIA;EGR1;SNAI2;SRRT;ZFP36L1;AKAP8;ADAM17;TXLNA;IRS2;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;SYK;DDX17;NFKBIB;ROBO1;IFIT3;PDGFB;OXTR;SNRNP70;FHL2;DCTN1;DPYSL3;SPPL2A;NPNT;IL1A;GPR75;TNFRSF21;TNIP2;LANCL2;SPRY4;ACSL1;COL5A2;ACKR3;BAMBI;SMAD7;TATDN2;YWHAH;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;SAFB;KLF10;PARP14;CXCL5;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;CPT1A;MCM7;ZNF703;CCR6;INSIG1;PARD3;SNIP1;BMP7;TNFRSF10A;ELK1;RAPGEF1;ZYX;DAG1;RNF185;TIMELESS;WNT4;RBM14;AKR1C1;TNFAIP3;PSMC3;CCL22;BRIP1;CXCL8;MAPK11;CXCL3;BMP8A;POLR2G;SRSF7;NOL3;GCLC;HSP90AB1;TBXA2R;IL6R;PARP1;TP63;IL36G;CCL5;BAIAP2L2;SH3BP4
718,GO:0001944,5.20805852879949e-08,1,68,455,vasculature development,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;AHR;JUNB;EFNB2;PDPN;FGFR2;PTPN14;COL4A1;FOSL1;ZC3H12A;EPHA2;ITGAV;ERRFI1;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;LIF;SFRP1;DHCR7;GPER1;SRF;EGR1;ETS1;ZFP36L1;RHOB;PRKCA;SYK;ROBO1;PDGFB;MYH9;IL1A;SEMA3C;ACKR3;SMAD7;JUN;FOXN1;GPNMB;BMP7;RAPGEF1;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM
4261,GO:0009605,6.50327454683208e-08,1,152,1337,response to external stimulus,BP,KRT1;SAA1;CCL20;NRG1;CYR61;PTGER4;C1R;ODC1;CYP24A1;C1QTNF1;ADM;AMOT;NQO1;IL16;CYP1A1;IL1R2;PML;HSPB1;CSF2;PTGES;MAP3K14;TGFB2;EDN1;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;G6PD;TRAF3;NLRC5;PANX1;TP53;IL24;NOCT;IL27RA;NFKB1;CDKN2B;CDKN1A;LYN;RAB32;JUNB;GADD45A;TNF;BAIAP2;EFNB2;CXCL16;TNC;PDPN;FGFR2;NFKB2;FOSL1;TYMS;ZC3H12A;SRSF2;CADPS2;KLF7;EPHA2;HMGCS1;ICAM1;CD274;CDK4;ITGAV;L1CAM;ADRB2;IL20;MTUS1;IFNGR1;SERPINE1;NMT2;RELT;SFRP1;TRIM22;IRF1;BANF1;EPPK1;THBD;GPER1;SRF;TXN2;NFKBIA;ETS1;SNAI2;AKAP8;ADAM17;IRS2;LGALS3;IL15;PRKCA;NTN1;SYK;CMTM3;SLC7A2;DDX17;NFKBIB;ROBO1;IFIT3;PDGFB;SPTBN1;DNASE1;NPNT;TNFRSF21;TNIP2;RASGRP4;SEMA3C;ACSL1;ACKR3;CRCP;ENAH;CLASP1;PQBP1;TRIB1;CREB3;PPP1R9B;KLF10;CXCL5;CD109;HSPA8;JUN;ESR1;RBM4;CCR6;RHOG;GPNMB;ZSWIM6;SMPD2;HMGN2;EFNB1;BMP7;PHLPP1;TNFRSF10A;PHLDB2;ZYX;DAG1;POLR3H;PDE6A;WNT4;TNFAIP3;CCL22;BRIP1;CXCL8;EFNA1;MAPK11;CXCL3;BMP8A;GCLC;SWAP70;TBXA2R;IL6R;C1S;CCL5;FADS1
1093,GO:0002682,6.70589001211715e-08,1,113,927,regulation of immune system process,BP,KRT1;MAFB;CCL20;RUNX1;PTGER4;INHBA;C1R;ACTG1;CYLD;SDC4;RELB;TFRC;CD83;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;TP53;IL27RA;NFKB1;CDKN1A;TJP2;LYN;AHR;ARPC4;LAMP1;TNF;BAIAP2;EFNB2;PSMB9;SIRPA;ZC3H12A;SART1;TSC22D3;ICAM1;CD274;MYO10;IL20;MTUS1;IFNGR1;SERPINE1;ARPC1B;LIF;SFRP1;HLA-F;IRF1;PSME2;IL7R;PSPC1;GPER1;NFKBIA;ETS1;ZFP36L1;ADAM17;IRS2;LGALS3;TRAF2;IL15;PRKCA;ZFP36L2;SYK;CMTM3;SLC7A2;DNASE1;SPPL2A;TAPBPL;COL17A1;IL1A;TNFRSF21;TNIP2;RBBP5;SFPQ;LILRB3;SMAD7;PQBP1;TRIB1;CREB3;THOC1;KLF10;PARP14;CXCL5;SOCS1;JUN;ESR1;IKZF3;FOXN1;CCR6;GPNMB;XRCC6;EFNB1;PHLPP1;RAPGEF1;RBM14;CD38;TNFAIP3;PSMC3;SPG21;CXCL8;CXCL3;HSP90AB1;SWAP70;IL6R;LAIR1;C1S;CCL5
2223,GO:0005126,6.77703746387899e-08,0.999999981818467,30,137,cytokine receptor binding,MF,CCL20;INHBA;TRAF1;CSF2;TGFB2;TRAF3;TNF;CXCL16;BMP2;IL20;LIF;ADAM17;TRAF2;IL15;IL1A;BAMBI;SMAD7;TRIP6;CXCL5;TGFBRAP1;BMP7;TRAF4;CCL22;CXCL8;CXCL3;BMP8A;NOL3;IL6R;IL36G;CCL5
3389,GO:0007166,7.64624496774615e-08,1,199,1866,cell surface receptor signaling pathway,BP,IGFBP3;IL32;SAA1;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CTGF;DTX2;ACTG1;IL16;IL1R2;PML;CYLD;HSPB1;TRAF1;WNT10A;RELB;BAG1;SOD2;GPRC5A;CD3EAP;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;BIRC3;MID1;DAPK3;RSAD2;TRAF3;EMP2;NLRC5;TP53;SQSTM1;IL24;NEDD9;IL27RA;FST;NFKB1;CDKN2B;LFNG;IRS1;CDKN1A;TJP2;LYN;JUNB;ARPC4;TNF;BAIAP2;EFNB2;WWC1;DST;TRIO;FGFR2;PBX1;COL4A1;PSMB9;EPHB6;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;ICAM1;CD274;BMP2;COL16A1;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;STAT5A;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;ARPC1B;XAF1;AMOTL2;ELF3;RELT;LIF;SFRP1;TRIM22;ZFYVE27;CC2D2A;HLA-F;IRF1;PSME2;IL7R;GPER1;NFKBIA;EGR1;JRK;IGSF3;SNAI2;ARHGEF28;ADAM17;TXLNA;IRS2;LGALS3;TRAF2;IL15;PRKCA;SYK;CMTM3;ROBO1;IFIT3;DDX47;PDGFB;OXTR;SPTBN1;RNF115;MYH9;SPPL2A;NPNT;IL1A;GPR75;TNFRSF21;TNIP2;RASGRP4;SEMA3C;SPRY4;LILRB3;SPEN;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;PALM2;HNRNPF;APH1A;TRIB1;RUVBL2;KLF10;PARP14;CXCL5;TGFBRAP1;CITED2;CD109;SOCS1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;ZNF703;CCR6;PARD3;BCL2L2;GP6;EFNB1;BMP7;TNFRSF10A;RAPGEF1;ZYX;PDE6A;BLNK;WNT4;RBM14;CD38;TNFAIP3;PSMC3;SPG21;CCL22;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;CXCL3;BMP8A;POLR2G;NOL3;GCLC;HSP90AB1;ADGRF3;IL6R;PARP1;TP63;IL36G;PHACTR4;CCL5;BAIAP2L2
15240,GO:0071396,8.14089590472675e-08,1,60,389,cellular response to lipid,BP,CCL20;RUNX1;PTGER4;INHBA;CYP24A1;KRT13;CSF2;EDN1;IL24;NFKB1;LYN;AHR;TNF;TNC;FGFR2;ZC3H12A;HMGCS1;ICAM1;CD274;CDK4;ERRFI1;DAXX;SERPINE1;SFRP1;SAFB2;GPER1;NFKBIA;SNAI2;ZFP36L1;AKAP8;IL15;AKR1C2;PRKCA;ZFP36L2;DDX17;NFKBIB;SNRNP70;FHL2;TNIP2;LANCL2;YWHAH;HNRNPU;PAGR1;TRIB1;RUVBL2;SAFB;ESR1;CPT1A;ZNF703;INSIG1;BMP7;ELK1;DAG1;RBM14;TNFAIP3;CXCL8;TBXA2R;PARP1;TP63;CCL5
15765,GO:0072358,8.39742043983688e-08,1,68,461,cardiovascular system development,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;AHR;JUNB;EFNB2;PDPN;FGFR2;PTPN14;COL4A1;FOSL1;ZC3H12A;EPHA2;ITGAV;ERRFI1;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;LIF;SFRP1;DHCR7;GPER1;SRF;EGR1;ETS1;ZFP36L1;RHOB;PRKCA;SYK;ROBO1;PDGFB;MYH9;IL1A;SEMA3C;ACKR3;SMAD7;JUN;FOXN1;GPNMB;BMP7;RAPGEF1;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM
3746,GO:0008283,8.64838449630485e-08,1,151,1329,cell proliferation,BP,IGFBP3;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;INHBA;FN1;ODC1;P3H2;CYP1B1;CTGF;ADM;TNS3;FOSL2;KRT4;CYP1A1;PML;SDC4;TFRC;SOD2;CSF2;PTGES;TGFB2;EDN1;TXNRD1;B4GALT1;EMP2;NUAK1;TP53;MARVELD3;IL24;CDKN2B;IRS1;CDKN1A;LYN;AHR;CDV3;JUNB;TNF;EFNB2;CDKN2A;TNC;PDPN;FGFR2;PTPN14;PBX1;FOSL1;FLNA;TNK1;ZNF503;EPHA2;CD274;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RELT;LIF;OSR2;SFRP1;TPM1;DHCR7;IRF1;EPPK1;IL7R;GPER1;SRF;DNAJB2;ELF4;NFKBIA;SF1;EGR1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;ADAM17;DKC1;TXLNA;FGFR1OP;IRS2;LGALS3;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;ROBO1;IFIT3;PDGFB;POLA1;UTP20;RPS9;UHRF1;IL1A;TNFRSF21;RASGRP4;BAMBI;HNRNPU;CAPNS1;TRIB1;PPP1R9B;KLF10;CXCL5;CITED2;CD109;JUN;ESR1;IKZF3;PES1;FOXN1;PAK1IP1;MCM7;TFDP1;NOP2;SERTAD1;NACC1;ZNF703;INSIG1;LAMC1;RHOG;GPNMB;BCL2L2;XRCC6;EFNB1;BMP7;TNFRSF10A;RAPGEF1;EIF5A;WNT4;CD38;TNFAIP3;BRIP1;CXCL8;MAPK11;CLDN7;CTPS1;CXCL3;MKI67;IL6R;TP63;CCL5;SH3BP4
1095,GO:0002684,8.81951098462405e-08,1,83,616,positive regulation of immune system process,BP,KRT1;CCL20;RUNX1;INHBA;C1R;ACTG1;CYLD;RELB;TFRC;CD83;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;TP53;IL27RA;NFKB1;CDKN1A;LYN;ARPC4;LAMP1;TNF;BAIAP2;EFNB2;PSMB9;SIRPA;ZC3H12A;SART1;ICAM1;CD274;MYO10;IL20;SERPINE1;ARPC1B;LIF;IRF1;PSME2;IL7R;PSPC1;NFKBIA;ETS1;ZFP36L1;ADAM17;IRS2;LGALS3;TRAF2;IL15;PRKCA;SYK;CMTM3;IL1A;TNFRSF21;TNIP2;SFPQ;PQBP1;TRIB1;CREB3;KLF10;CXCL5;SOCS1;JUN;ESR1;CCR6;XRCC6;EFNB1;RAPGEF1;RBM14;CD38;TNFAIP3;PSMC3;SPG21;CXCL8;CXCL3;HSP90AB1;SWAP70;IL6R;C1S;CCL5
7927,GO:0032502,9.6392405660802e-08,1,368,3894,developmental process,BP,IGFBP3;KRT1;MAFB;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;CYP24A1;KRT34;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;NEFM;ACTG1;NQO1;CYP1A1;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;SOD2;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;NUAK1;HRNR;TP53;SIPA1L3;NFE2L1;SQSTM1;KRT9;HNRNPAB;STEAP4;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;RAB32;AHR;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;CDKN2A;RING1;CORO1C;WWC1;NAV2;ENC1;TNC;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;PBX1;TPM4;NFKB2;COL4A1;PSMB9;SLC7A5;EPHB6;KRT17;FOSL1;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;TNK1;ARMC6;SART1;KLF7;ZNF503;EPHA2;HMGCS1;CCDC85B;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;BMP2;UBE4B;COL27A1;CDK4;KREMEN2;ITGAV;ERRFI1;L1CAM;MYO10;SFN;CDC42EP2;COL9A2;STAT5A;EPGN;ANKS4B;ADRB2;SVIL;IL20;TNFRSF12A;FOXD2;SERPINE1;PABPC4;PGK1;MCM2;EBP;CSRP2;AMOTL2;ELF3;RELT;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;SAFB2;DHCR7;WDR1;MKL1;IRF1;PSME2;LUC7L;EPPK1;IL7R;TFIP11;GPER1;SRF;NSUN2;ELF4;ABTB2;ZFP42;NFKBIA;SF1;EGR1;EDF1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;ARHGEF28;RHOB;ADAM17;GPCPD1;DHFR;VCL;RIPK4;IRS2;IER3;NPAS2;KRT14;LGALS3;ACO1;MAFK;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;AJUBA;CDKL1;PDGFB;OXTR;ALYREF;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;DPYSL3;COL5A3;RRP7A;MYH9;NOM1;COL17A1;NPNT;IL1A;SDK1;COPS3;TNFRSF21;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;TBCCD1;SPEN;ROR1;RCC2;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;PALM2;ENAH;KEAP1;HNRNPU;TJP1;CLASP1;PQBP1;APH1A;CAPNS1;VSIG1;TRIB1;ABT1;PPP1R9B;THOC1;ETS2;KLF10;ZNF267;RBM38;MARVELD2;DUSP1;CITED2;CD109;SOCS1;FRAS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;PAK1IP1;GLIPR2;CPT1A;RBM4;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;KLF6;ZSWIM6;TEAD4;CNTNAP1;ACTN4;EFNB1;SORBS2;LRFN4;BMP7;PHLPP1;TNFRSF10A;TPRA1;AKIP1;ELK1;PHLDB2;RAPGEF1;MYADM;DAG1;RAB27A;COL4A4;TIMELESS;GPX4;BLNK;WNT4;RILPL2;AKR1C1;VPS52;TRAF4;CTDSP1;TNFAIP3;PSMC3;SMARCC2;SLC4A2;BRIP1;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;BMP8A;HES4;CARD10;PTPRB;POLR2G;GCLC;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4;FADS1
12685,GO:0050900,1.10472599621829e-07,0.999999971301025,41,225,leukocyte migration,BP,SAA1;CCL20;MMP9;PTGER4;FN1;IL16;SDC4;TGFB2;EDN1;B4GALT1;TP53;LYN;TNF;CXCL16;SLC7A5;SIRPA;ICAM1;ITGAV;L1CAM;MTUS1;SERPINE1;WDR1;THBD;ADAM17;LGALS3;SYK;PDGFB;MYH9;IL1A;CREB3;CXCL5;CCR6;GP6;TNFRSF10A;CCL22;CXCL8;SLC3A2;CXCL3;SWAP70;IL6R;CCL5
6596,GO:0022613,1.24569595680008e-07,1,63,447,ribonucleoprotein complex biogenesis,BP,PDCD11;NOCT;GNL3L;PPAN;RRP1;SART1;GEMIN5;DDX23;NAT10;LSG1;USP36;DHX37;PWP2;LUC7L;RRP36;SF1;GEMIN4;RRS1;CD2BP2;PRPF19;RPLP2;DKC1;ISG20L2;SHQ1;URB2;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;UTP20;RPS9;NSUN5;GEMIN8;RRP7A;NOM1;NOP16;FTSJ3;WDR46;NOP56;NOL9;ERAL1;RUVBL2;ABT1;MRPL20;RRP7BP;TXNL4B;RPL27A;PES1;PAK1IP1;NOP2;NOP14;NOC2L;METTL16;SURF6;UTP4;NOL3;HSP90AB1;POP4
14570,GO:0070098,1.26995970134116e-07,0.999999990806234,11,22,chemokine-mediated signaling pathway,BP,CCL20;EDN1;ROBO1;GPR75;ACKR3;CXCL5;CCR6;CCL22;CXCL8;CXCL3;CCL5
14722,GO:0070371,1.63260598043527e-07,0.999999947628317,36,184,ERK1 and ERK2 cascade,BP,CCL20;CYR61;PTGER4;FN1;CTGF;GBP1;LYN;TNF;FGFR2;EPHB6;EPHA2;ICAM1;BMP2;ITGAV;ERRFI1;LIF;GPER1;ZFP36L1;NELFE;PRKCA;ZFP36L2;SYK;PDGFB;OXTR;NPNT;IL1A;SPRY4;ROR1;ACKR3;DUSP1;JUN;GLIPR2;GPNMB;RAPGEF1;CCL22;CCL5
8696,GO:0034329,1.76879892275648e-07,0.999999944187931,35,175,cell junction assembly,BP,RUNX1;FN1;ACTG1;SDC4;DAPK3;MARVELD3;TNF;KRT5;CORO1C;VMP1;FLNA;COL16A1;SFRP1;WDR1;SRF;SNAI2;VCL;KRT14;PRKCA;AJUBA;COL17A1;RCC2;SMAD7;TRIP6;TJP1;CLASP1;MARVELD2;ZNF703;PARD3;LAMC1;CNTNAP1;ACTN4;PHLDB2;RAPGEF1;WNT4
17752,GO:1901700,1.83249007840608e-07,1,121,1020,response to oxygen-containing compound,BP,TRIM16;CCL20;CRYAB;MMP9;PTGER4;INHBA;HDAC9;NEFL;CYP1B1;CTGF;CYP24A1;ADM;NQO1;CYP1A1;KRT13;SOD2;CSF2;PTGES;FBN1;TGFB2;EDN1;TXNRD1;G6PD;PANX1;TP53;IL24;NOCT;NFKB1;IRS1;CDKN1A;LYN;AHR;JUNB;TNF;BAIAP2;TNC;FGFR2;NFKB2;COL4A1;FOSL1;TYMS;ZC3H12A;SRSF2;HMGCS1;ICAM1;FANCC;CD274;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;SERPINE1;ARPC1B;RELT;SFRP1;TPM1;APTX;THBD;GPER1;SRF;TXN2;NFKBIA;EGR1;ETS1;SNAI2;ZFP36L1;AKAP8;RHOB;ADAM17;DHFR;IRS2;TRAF2;IL15;AKR1C2;PRKCA;NFKBIB;PDGFB;OXTR;SNRNP70;SDK1;TNFRSF21;TNIP2;LANCL2;PXMP2;ACSL1;COL5A2;TRIB1;RUVBL2;KLF10;CXCL5;DUSP1;SOCS1;JUN;ESR1;CPT1A;ZNF703;INSIG1;QDPR;BMP7;EFTUD2;TNFRSF10A;ELK1;RAPGEF1;DAG1;TIMELESS;AKR1C1;CD38;TNFAIP3;BRIP1;CXCL8;CLDN7;CXCL3;TRIML2;GCLC;HSP90AB1;TBXA2R;PARP1;CCL5;BAIAP2L2;SH3BP4
10301,GO:0043062,1.96733951796243e-07,0.999999946855033,43,242,extracellular structure organization,BP,MMP9;CYR61;FN1;CYP1B1;CTGF;CCDC80;SDC4;FBN1;TGFB2;B4GALT1;HSPG2;ADAMTS9;TNF;COL12A1;TNC;PDPN;NFKB2;COL4A1;LCP1;ICAM1;COL16A1;COL27A1;ITGAV;COL9A2;SERPINE1;ELF3;ETS1;PDGFB;SERPINH1;COLGALT1;COL5A3;NPNT;COL5A2;CLASP1;CAPNS1;LAMC1;BMP7;PHLDB2;DAG1;FAM234A;COL4A4;MYO1E;FBLN2
7921,GO:0032496,2.06194402818406e-07,0.999999935396053,38,205,response to lipopolysaccharide,BP,CCL20;PTGER4;ADM;CYP1A1;CSF2;PTGES;EDN1;IL24;NOCT;NFKB1;LYN;JUNB;TNF;FGFR2;NFKB2;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;RELT;THBD;NFKBIA;AKAP8;ADAM17;PRKCA;NFKBIB;TNFRSF21;TNIP2;TRIB1;CXCL5;JUN;TNFRSF10A;TNFAIP3;CXCL8;CXCL3;TBXA2R;CCL5
12277,GO:0048584,2.06726238092996e-07,1,159,1438,positive regulation of response to stimulus,BP,IGFBP3;KRT1;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;C1R;CYP1B1;CTGF;C1QTNF1;JPH2;ACTG1;IL16;PML;CYLD;HSPB1;RELB;TFRC;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;EMP2;NLRC5;TP53;IL24;IL27RA;NFKB1;CDKN2B;LFNG;IRS1;UBQLN2;LYN;ARPC4;LAMP1;GADD45A;TNF;BAIAP2;CDKN2A;WWC1;PDPN;FGFR2;PSMB9;EPHB6;TELO2;ZC3H12A;FLNA;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;MYO10;SFN;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;SERPINE1;ARPC1B;ELF3;LIF;SFRP1;TRIM22;IRF1;PSME2;IL7R;PSPC1;THBD;GPER1;NFKBIA;JRK;ETS1;NELFE;ADAM17;IRS2;NPAS2;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;NPNT;IL1A;TNFRSF21;TNIP2;LANCL2;RASGRP4;SFPQ;ROR1;ACKR3;BAMBI;AFAP1L2;SLC35C2;YWHAH;PQBP1;PAGR1;CREB3;PARP14;CXCL5;CITED2;SOCS1;JUN;ESR1;GLIPR2;TFDP1;CCR6;ARRDC3;GPNMB;XRCC6;CNTNAP1;ACTN4;BMP7;TNFRSF10A;RAPGEF1;EEF1D;TIMELESS;BLNK;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SPG21;CCL22;CXCL8;PPP2R1B;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;HSP90AB1;SWAP70;TBXA2R;IL6R;PARP1;TP63;C1S;CCL5
11787,GO:0046649,2.10569731184127e-07,1,59,392,lymphocyte activation,BP,MAFB;RUNX1;PTGER4;INHBA;HDAC9;CYLD;SDC4;RELB;TFRC;CD83;MAP3K14;RSAD2;IL27RA;LFNG;CDKN1A;LYN;AHR;LAMP1;EFNB2;SIRPA;LCP1;SART1;ICAM1;CD274;SFRP1;IRF1;IL7R;SRF;ELF4;EGR1;DOCK10;ZFP36L1;ADAM17;TXLNA;IRS2;LGALS3;IL15;ZFP36L2;SYK;MYH9;TNFRSF21;TNIP2;SMAD7;THOC1;SOCS1;IKZF3;FOXN1;CCR6;GPNMB;KLF6;EFNB1;RAB27A;BLNK;WNT4;CD38;TNFAIP3;CTPS1;SWAP70;CCL5
12411,GO:0048856,2.19909783458585e-07,1,343,3611,anatomical structure development,BP,IGFBP3;KRT1;MAFB;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;KRT34;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;NEFM;ACTG1;CYP1A1;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;HRNR;TP53;SIPA1L3;NFE2L1;KRT9;HNRNPAB;PANK2;NOCT;IL27RA;FST;CDKN2B;TAF4B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;AHR;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;RING1;CORO1C;NAV2;ENC1;TNC;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;PBX1;NFKB2;COL4A1;PSMB9;SLC7A5;EPHB6;KRT17;FOSL1;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;ARMC6;SART1;KLF7;EPHA2;HMGCS1;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;BMP2;UBE4B;COL27A1;CDK4;KREMEN2;ITGAV;ERRFI1;L1CAM;MYO10;SFN;CDC42EP2;COL9A2;STAT5A;EPGN;ADRB2;SVIL;IL20;TNFRSF12A;FOXD2;SERPINE1;PABPC4;PGK1;MCM2;EBP;CSRP2;AMOTL2;ELF3;RELT;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;SAFB2;DHCR7;WDR1;MKL1;IRF1;PSME2;LUC7L;EPPK1;IL7R;TFIP11;GPER1;SRF;NSUN2;ABTB2;ZFP42;NFKBIA;SF1;EGR1;EDF1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;RHOB;ADAM17;GPCPD1;DHFR;VCL;RIPK4;IRS2;IER3;NPAS2;KRT14;LGALS3;ACO1;MAFK;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;AJUBA;CDKL1;PDGFB;OXTR;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;DPYSL3;COL5A3;RRP7A;MYH9;NOM1;COL17A1;NPNT;IL1A;SDK1;COPS3;TNFRSF21;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;TBCCD1;SPEN;ROR1;RCC2;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;PALM2;ENAH;KEAP1;HNRNPU;TJP1;CLASP1;PQBP1;APH1A;CAPNS1;VSIG1;TRIB1;ABT1;PPP1R9B;THOC1;ETS2;KLF10;ZNF267;RBM38;MARVELD2;DUSP1;CITED2;CD109;SOCS1;FRAS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;PAK1IP1;GLIPR2;CPT1A;RBM4;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;KLF6;ZSWIM6;TEAD4;CNTNAP1;ACTN4;EFNB1;SORBS2;LRFN4;BMP7;PHLPP1;TNFRSF10A;TPRA1;AKIP1;PHLDB2;RAPGEF1;MYADM;DAG1;COL4A4;TIMELESS;GPX4;BLNK;WNT4;RILPL2;AKR1C1;VPS52;TRAF4;CTDSP1;TNFAIP3;PSMC3;SMARCC2;SLC4A2;BRIP1;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;BMP8A;HES4;CARD10;PTPRB;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4
4858,GO:0014070,2.23042860977633e-07,1,84,634,response to organic cyclic compound,BP,CRYAB;RUNX1;INHBA;NEFL;CYP1B1;CTGF;CYP24A1;ADM;NQO1;CYP1A1;CD83;PTGES;TGFB2;EDN1;G6PD;PANX1;TP53;NFKB1;CDKN1A;LYN;AHR;JUNB;TNF;TNC;FOSL1;TYMS;ZC3H12A;SRSF2;HMGCS1;ICAM1;BMP2;CDK4;ERRFI1;DAXX;ARPC1B;ZC3H7B;SFRP1;SAFB2;THBD;GPER1;TXN2;NFKBIA;EGR1;ETS1;SNAI2;SRRT;ZFP36L1;DHFR;IL15;ZFP36L2;DDX17;PDGFB;OXTR;FHL2;SDK1;ACSL1;YWHAH;HNRNPU;PQBP1;PAGR1;RUVBL2;PPP1R9B;SAFB;DUSP1;JUN;ESR1;CPT1A;ZNF703;INSIG1;SNIP1;BMP7;EFTUD2;ELK1;RAPGEF1;DAG1;RBM14;CD38;SLC3A2;GCLC;HSP90AB1;TBXA2R;PARP1;TP63;CCL5
1021,GO:0002521,2.36738717808818e-07,1,49,301,leukocyte differentiation,BP,MAFB;MMP9;RUNX1;PTGER4;INHBA;HDAC9;CYLD;RELB;TFRC;CD83;CSF2;FBN1;RSAD2;LFNG;TJP2;LYN;JUNB;TNF;SART1;EPHA2;IL20;LIF;SFRP1;IRF1;IL7R;SRF;EGR1;DOCK10;ZFP36L1;ADAM17;IL15;PRKCA;ZFP36L2;SYK;MYH9;LILRB3;SMAD7;TRIB1;KLF10;CD109;SOCS1;JUN;IKZF3;FOXN1;CCR6;KLF6;BLNK;WNT4;PARP1
506,GO:0001568,2.44408706097998e-07,1,64,436,blood vessel development,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;AHR;JUNB;EFNB2;FGFR2;COL4A1;FOSL1;ZC3H12A;EPHA2;ITGAV;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;SFRP1;DHCR7;GPER1;SRF;EGR1;ETS1;ZFP36L1;RHOB;PRKCA;SYK;ROBO1;PDGFB;MYH9;IL1A;SEMA3C;ACKR3;SMAD7;JUN;FOXN1;GPNMB;BMP7;RAPGEF1;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM
12241,GO:0048513,2.70400194938742e-07,1,219,2135,animal organ development,BP,KRT1;MAFB;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;NEFL;ODC1;CYP1B1;CTGF;TENM3;KRT34;ADM;TNS3;KRT15;FOSL2;JPH2;KRT4;TUFT1;CYP1A1;PML;TFCP2L1;CYLD;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;CD83;CSF2;FBN1;TGFB2;EDN1;B4GALT1;KRTAP2-3;RSAD2;G6PD;HRNR;SIPA1L3;NFE2L1;KRT9;HNRNPAB;FST;CDKN2B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;JUNB;TNF;BAIAP2;EFNB2;KRT5;RING1;CORO1C;TNC;PDPN;FGFR2;PBX1;NFKB2;COL4A1;PSMB9;KRT17;FOSL1;JPH1;SLC39A1;TYMS;FLNA;LCP1;ARMC6;SART1;EPHA2;HMGCS1;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;COL27A1;CDK4;ERRFI1;SFN;STAT5A;ADRB2;SVIL;IL20;SERPINE1;PABPC4;MCM2;EBP;ELF3;LIF;OSR2;SFRP1;TPM1;CC2D2A;SAFB2;DHCR7;WDR1;IRF1;PSME2;LUC7L;IL7R;TFIP11;GPER1;SRF;NSUN2;ZFP42;NFKBIA;SF1;EGR1;IGSF3;DOCK10;ETS1;SNAI2;RRS1;ZFP36L1;ADAM17;GPCPD1;IRS2;KRT14;LGALS3;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;CDKL1;PDGFB;OXTR;SERPINH1;FHL2;COL5A3;MYH9;NOM1;NPNT;SDK1;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;ROR1;COL5A2;MAFF;BAMBI;SMAD7;YWHAH;HNRNPU;CLASP1;APH1A;CAPNS1;TRIB1;ABT1;KLF10;CITED2;CD109;SOCS1;FRAS1;JUN;ESR1;IKZF3;TCOF1;FOXN1;GLIPR2;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;QDPR;GPNMB;BCL2L2;ZNF365;XRCC6;KLF6;TEAD4;EFNB1;SORBS2;BMP7;PHLDB2;DAG1;COL4A4;TIMELESS;BLNK;WNT4;VPS52;TRAF4;TNFAIP3;PSMC3;BRIP1;CXCL8;EFNA1;MAPK11;MYO1E;BMP8A;HSP90AB1;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4
10610,GO:0043588,2.7865878576108e-07,0.999999906824861,42,241,skin development,BP,KRT1;SPRR3;TRIM16;SPRR2A;KRT2;RUNX1;INHBA;KRT34;KRT15;FOSL2;KRT4;KRT10;KRT13;WNT10A;TGFB2;KRTAP2-3;HRNR;KRT9;FST;KRT6A;TNF;KRT5;FGFR2;KRT17;EPHA2;ERRFI1;SFN;IL20;SRF;NSUN2;ZFP36L1;KRT14;COL5A3;NOM1;COL5A2;CAPNS1;CD109;FRAS1;FOXN1;RPTN;ARRDC3;TP63
12800,GO:0051094,3.10967360078217e-07,1,103,831,positive regulation of developmental process,BP,IGFBP3;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;FN1;NEFL;CYP1B1;CTGF;TENM3;ADM;AMOT;RBM19;CYLD;HSPB1;TFRC;CD83;CSF2;TGFB2;EDN1;B4GALT1;NOCT;FST;NFKB1;ADAMTS9;LYN;JUNB;EHD1;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;ENC1;PDPN;FGFR2;KRT17;ZC3H12A;FLNA;SART1;BMP2;L1CAM;SFN;ADRB2;IL20;TNFRSF12A;SERPINE1;LIF;OSR2;SFRP1;ZFYVE27;IL7R;GPER1;SRF;EGR1;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;RHOB;IL15;PRKCA;NTN1;SYK;ROBO1;PDGFB;OXTR;NEDD4L;DPYSL3;NPNT;IL1A;SEMA3C;SPEN;BAMBI;CLASP1;TRIB1;KLF10;CITED2;SOCS1;JUN;FOXN1;GLIPR2;RBM4;ZNF703;PARD3;ZNF365;BMP7;PHLDB2;RAPGEF1;MYADM;DAG1;WNT4;TNFAIP3;CXCL8;MAPK11;HSP90AB1;TBXA2R;IL6R;PARP1;TP63
12356,GO:0048731,3.44636312279982e-07,1,287,2943,system development,BP,KRT1;MAFB;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;KRT34;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;NEFM;CYP1A1;PML;TFCP2L1;CYLD;HSPB1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;DAPK3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;HRNR;SIPA1L3;NFE2L1;KRT9;HNRNPAB;IL27RA;FST;CDKN2B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;AHR;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;RING1;CORO1C;NAV2;ENC1;TNC;GPRIN1;PDPN;FGFR2;PTPN14;PBX1;NFKB2;COL4A1;PSMB9;SLC7A5;KRT17;FOSL1;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;ARMC6;SART1;KLF7;EPHA2;HMGCS1;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;COL27A1;CDK4;ITGAV;ERRFI1;L1CAM;SFN;COL9A2;STAT5A;EPGN;ADRB2;SVIL;IL20;TNFRSF12A;SERPINE1;PABPC4;PGK1;MCM2;EBP;AMOTL2;ELF3;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;SAFB2;DHCR7;WDR1;IRF1;PSME2;LUC7L;IL7R;TFIP11;GPER1;SRF;NSUN2;ABTB2;ZFP42;NFKBIA;SF1;EGR1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;RHOB;ADAM17;GPCPD1;DHFR;VCL;IRS2;NPAS2;KRT14;LGALS3;MAFK;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;CDKL1;PDGFB;OXTR;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;DPYSL3;COL5A3;MYH9;NOM1;NPNT;IL1A;SDK1;TNFRSF21;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;SPEN;ROR1;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;ENAH;HNRNPU;CLASP1;PQBP1;APH1A;CAPNS1;TRIB1;ABT1;PPP1R9B;THOC1;ETS2;KLF10;CITED2;CD109;SOCS1;FRAS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;GLIPR2;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;PARD3;QDPR;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;KLF6;ZSWIM6;TEAD4;CNTNAP1;EFNB1;SORBS2;LRFN4;BMP7;PHLPP1;PHLDB2;RAPGEF1;DAG1;COL4A4;TIMELESS;BLNK;WNT4;VPS52;TRAF4;CTDSP1;TNFAIP3;PSMC3;SMARCC2;SLC4A2;BRIP1;CXCL8;EFNA1;MAPK11;MYO1E;BMP8A;HES4;CARD10;PTPRB;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4
6634,GO:0023014,3.82168683359771e-07,1,82,624,signal transduction by protein phosphorylation,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;DUSP14;CSF2;MAP3K14;TGFB2;EDN1;GBP1;MID1;MARVELD3;NFKB1;IRS1;LYN;GADD45A;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;ERRFI1;EPGN;ADRB2;DAXX;LIF;SFRP1;PSME2;GPER1;ZFP36L1;NELFE;IRS2;TRAF2;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;PDGFB;OXTR;SPTBN1;NPNT;IL1A;TNIP2;RASGRP4;SPRY4;ROR1;ACKR3;TRIB1;DUSP1;CAB39;OXSR1;JUN;GLIPR2;GPNMB;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;DAG1;TRAF4;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;DUSP8;CCL5
8697,GO:0034330,4.11734139823098e-07,0.999999860351673,38,205,cell junction organization,BP,RUNX1;FN1;ACTG1;SDC4;TGFB2;DAPK3;MARVELD3;TNF;KRT5;CORO1C;VMP1;FLNA;COL16A1;PLEKHA7;SFRP1;WDR1;SRF;SNAI2;VCL;KRT14;PRKCA;AJUBA;COL17A1;SDK1;RCC2;SMAD7;TRIP6;TJP1;CLASP1;MARVELD2;ZNF703;PARD3;LAMC1;CNTNAP1;ACTN4;PHLDB2;RAPGEF1;WNT4
82,GO:0000165,4.2618455779239e-07,1,80,606,MAPK cascade,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;DUSP14;CSF2;MAP3K14;TGFB2;EDN1;GBP1;MID1;MARVELD3;NFKB1;IRS1;LYN;GADD45A;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;ERRFI1;EPGN;ADRB2;DAXX;LIF;SFRP1;PSME2;GPER1;ZFP36L1;NELFE;IRS2;TRAF2;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;PDGFB;OXTR;SPTBN1;NPNT;IL1A;TNIP2;RASGRP4;SPRY4;ROR1;ACKR3;TRIB1;DUSP1;JUN;GLIPR2;GPNMB;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;DAG1;TRAF4;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;DUSP8;CCL5
12898,GO:0051240,5.31571240319327e-07,1,116,981,positive regulation of multicellular organismal process,BP,SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;CYP1B1;CTGF;TENM3;C1QTNF1;ADM;AMOT;RBM19;CYLD;HSPB1;TFRC;CD83;CSF2;TGFB2;EDN1;BIRC3;B4GALT1;RSAD2;PANX1;IL27RA;FST;NFKB1;LYN;TNF;BAIAP2;EFNB2;ENC1;PDPN;FGFR2;NFKB2;KRT17;ZC3H12A;FLNA;SART1;ICAM1;CD274;BMP2;L1CAM;STAT5A;ADRB2;IL20;TNFRSF12A;SERPINE1;LIF;OSR2;TPM1;ZFYVE27;IRF1;IL7R;THBD;GPER1;SRF;EGR1;ETS1;SRRT;PRPF19;ZFP36L1;RHOB;ADAM17;TRAF2;IL15;PRKCA;NTN1;SYK;ROBO1;PDGFB;OXTR;SPTBN1;NEDD4L;DPYSL3;NPNT;IL1A;SEMA3C;SPEN;BAMBI;AFAP1L2;CRCP;CLASP1;PQBP1;TRIB1;KLF10;CITED2;SOCS1;JUN;FOXN1;GLIPR2;ZNF703;CCR6;PARD3;ZNF365;XRCC6;BMP7;PHLDB2;RAPGEF1;DAG1;POLR3H;WNT4;CD38;TNFAIP3;CXCL8;MAPK11;TBXA2R;IL6R;PARP1;TP63
3274,GO:0006952,5.3361821351892e-07,1,108,910,defense response,BP,IL32;KRT1;SAA1;CCL20;PTGER4;INHBA;HDAC9;FN1;C1R;ACTG1;TAP1;IL1R2;PML;CYLD;RELB;ABCF1;CD83;HLA-B;PTGES;MAP3K14;EDN1;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;RSAD2;TRAF3;NLRC5;NFE2L1;IL27RA;NFKB1;HSPG2;LYN;LAMP1;TNF;CXCL16;NFKB2;PSMB9;FOSL1;ZC3H12A;TNK1;ICAM1;BMP2;CDC42EP2;IL20;IFNGR1;SERPINE1;XAF1;ELF3;RELT;TRIM22;HLA-F;IRF1;PSME2;NFX1;PSPC1;GPER1;ELF4;TRIM29;NFKBIA;EGR1;ETS1;AKAP8;ADAM17;LGALS3;IL15;SYK;SLC7A2;DDX17;IFIT3;DNASE1;IL1A;TNFRSF21;TNIP2;SFPQ;LILRB3;AFAP1L2;CRCP;PQBP1;TPST1;PARP14;CXCL5;SOCS1;ESR1;FOXN1;CCR6;XRCC6;TNFRSF10A;ZYX;POLR3H;RAB27A;BLNK;RBM14;TUBB;TNFAIP3;PSMC3;CCL22;CXCL8;CXCL3;HSP90AB1;TBXA2R;IL6R;IL36G;C1S;CCL5
16656,GO:0097529,5.70204041136114e-07,0.999999873253732,21,84,myeloid leukocyte migration,BP,SAA1;CCL20;PTGER4;TGFB2;EDN1;LYN;MTUS1;SERPINE1;WDR1;LGALS3;SYK;PDGFB;IL1A;CREB3;CXCL5;CCL22;CXCL8;CXCL3;SWAP70;IL6R;CCL5
11099,GO:0045111,6.46488305781308e-07,0.999999836423215,24,103,intermediate filament cytoskeleton,CC,KRT1;KRT2;NEFL;KRT34;KRT15;KRT4;NEFM;KRT10;KRT13;KRTAP2-3;KRT9;KRT6A;KRT5;DST;KRT17;EPPK1;GPER1;KRT14;IFFO2;NSFL1C;DCTN1;SAP30BP;NOL9;PHLDB2
878,GO:0002237,6.60368088487602e-07,0.999999770940953,38,214,response to molecule of bacterial origin,BP,CCL20;PTGER4;ADM;CYP1A1;CSF2;PTGES;EDN1;IL24;NOCT;NFKB1;LYN;JUNB;TNF;FGFR2;NFKB2;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;RELT;THBD;NFKBIA;AKAP8;ADAM17;PRKCA;NFKBIB;TNFRSF21;TNIP2;TRIB1;CXCL5;JUN;TNFRSF10A;TNFAIP3;CXCL8;CXCL3;TBXA2R;CCL5
11399,GO:0045785,8.17319815236699e-07,0.999999701965082,41,239,positive regulation of cell adhesion,BP,SAA1;CYR61;FN1;CCDC80;CYLD;SDC4;TFRC;CD83;MAP3K14;TGFB2;EMP2;LYN;TNF;EFNB2;PDPN;SIRPA;FLNA;SART1;ICAM1;CD274;COL16A1;ITGAV;MYO10;SFRP1;TPM1;IL7R;ETS1;IL15;PRKCA;SYK;NPNT;SMAD7;CITED2;SOCS1;EFNB1;BMP7;MYADM;DAG1;WNT4;FBLN2;CCL5
17632,GO:1901342,9.70651757778241e-07,0.999999666624477,35,189,regulation of vasculature development,BP,KRT1;RUNX1;HDAC9;CYP1B1;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EMP2;HSPG2;ADAMTS9;EFNB2;ZC3H12A;EPHA2;TNFRSF12A;SERPINE1;PGK1;SFRP1;GPER1;EGR1;ETS1;RHOB;PRKCA;PDGFB;IL1A;GPNMB;BMP7;WNT4;TNFAIP3;CXCL8;EFNA1;CARD10;TBXA2R
12612,GO:0050793,9.94974228213321e-07,0.999999609094864,176,1656,regulation of developmental process,BP,IGFBP3;KRT1;MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;ADM;AMOT;JPH2;PML;RBM19;CYLD;HSPB1;STARD13;WNT10A;TFRC;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;DAPK3;B4GALT1;G6PD;EMP2;NUAK1;NOCT;IL27RA;FST;NFKB1;LFNG;TJP2;HSPG2;ADAMTS9;LYN;JUNB;EHD1;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;WWC1;ENC1;TRIO;PDPN;FGFR2;PBX1;PSMB9;KRT17;ZC3H12A;FLNA;SART1;EPHA2;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;L1CAM;MYO10;SFN;CDC42EP2;STAT5A;ADRB2;IL20;TNFRSF12A;SERPINE1;PGK1;LIF;OSR2;SFRP1;TPM1;ZFYVE27;WDR1;IRF1;PSME2;LUC7L;EPPK1;IL7R;GPER1;SRF;NFKBIA;EGR1;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;RHOB;LGALS3;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;OXTR;NEDD4L;DPYSL3;MYH9;NPNT;IL1A;SDK1;TNFRSF21;RBBP5;SEMA3C;LILRB3;TBCCD1;SPEN;ROR1;RCC2;COL5A2;MAFF;BAMBI;SMAD7;YWHAH;PALM2;KEAP1;HNRNPU;CLASP1;PQBP1;TRIB1;THOC1;KLF10;RBM38;CITED2;CD109;SOCS1;JUN;ESR1;IKZF3;FOXN1;GLIPR2;RBM4;ZNF703;INSIG1;PARD3;GPNMB;ZNF365;ZSWIM6;ACTN4;BMP7;PHLPP1;PHLDB2;RAPGEF1;MYADM;DAG1;WNT4;CTDSP1;TNFAIP3;PSMC3;CXCL8;EFNA1;MAPK11;CARD10;HSP90AB1;TBXA2R;IL6R;PARP1;TP63;FADS1
19698,GO:2000026,1.00360377080483e-06,0.999999616622388,142,1276,regulation of multicellular organismal development,BP,KRT1;MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;ADM;AMOT;JPH2;PML;RBM19;CYLD;HSPB1;STARD13;WNT10A;TFRC;CD83;CSF2;FBN1;TGFB2;EDN1;B4GALT1;G6PD;EMP2;NOCT;IL27RA;FST;LFNG;TJP2;HSPG2;ADAMTS9;LYN;TNF;BAIAP2;EFNB2;ENC1;PDPN;FGFR2;PBX1;PSMB9;KRT17;ZC3H12A;FLNA;SART1;EPHA2;TSC22D3;BMP2;ERRFI1;L1CAM;SFN;ADRB2;IL20;TNFRSF12A;SERPINE1;PGK1;LIF;OSR2;SFRP1;ZFYVE27;WDR1;IRF1;PSME2;LUC7L;IL7R;GPER1;SRF;NFKBIA;EGR1;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;RHOB;LGALS3;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;OXTR;NEDD4L;DPYSL3;IL1A;SDK1;TNFRSF21;RBBP5;SEMA3C;LILRB3;SPEN;ROR1;COL5A2;MAFF;BAMBI;SMAD7;YWHAH;KEAP1;CLASP1;PQBP1;TRIB1;THOC1;KLF10;CITED2;CD109;SOCS1;JUN;ESR1;IKZF3;FOXN1;GLIPR2;ZNF703;PARD3;GPNMB;ZNF365;ZSWIM6;BMP7;PHLPP1;PHLDB2;RAPGEF1;MYADM;DAG1;WNT4;CTDSP1;TNFAIP3;PSMC3;CXCL8;EFNA1;MAPK11;CARD10;TBXA2R;TP63
2588,GO:0005882,1.04824242458416e-06,0.999999780493565,19,71,intermediate filament,CC,KRT1;KRT2;NEFL;KRT34;KRT15;KRT4;NEFM;KRT10;KRT13;KRTAP2-3;KRT9;KRT6A;KRT5;DST;KRT17;EPPK1;GPER1;KRT14;IFFO2
12897,GO:0051239,1.07520206154398e-06,0.999999573173074,191,1833,regulation of multicellular organismal process,BP,KRT1;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;C1QTNF1;ADM;AMOT;JPH2;IL1R2;PML;RBM19;CYLD;HSPB1;STARD13;WNT10A;RELB;TFRC;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;TRIM56;IKBKE;BIRC3;DAPK3;B4GALT1;RSAD2;G6PD;TRAF3;EMP2;NLRC5;PANX1;MARVELD3;NOCT;IL27RA;FST;NFKB1;LFNG;TJP2;HSPG2;ADAMTS9;LYN;TNF;BAIAP2;EFNB2;CORO1C;WWC1;ENC1;PDPN;FGFR2;PBX1;NFKB2;PSMB9;KRT17;ZC3H12A;FLNA;SART1;EPHA2;TSC22D3;ICAM1;CD274;BMP2;CDK4;KREMEN2;ERRFI1;L1CAM;SFN;STAT5A;ADRB2;IL20;TNFRSF12A;SERPINE1;FXYD3;PGK1;LIF;OSR2;SFRP1;TPM1;ZFYVE27;WDR1;IRF1;PSME2;LUC7L;EPPK1;IL7R;THBD;GPER1;SRF;NFKBIA;EGR1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;RHOB;ADAM17;LGALS3;TRAF2;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;OXTR;SPTBN1;NEDD4L;DPYSL3;NPNT;IL1A;SDK1;TNFRSF21;RBBP5;SEMA3C;LILRB3;SPEN;ROR1;COL5A2;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;YWHAH;KEAP1;CLASP1;PQBP1;TRIB1;KCNIP3;THOC1;KLF10;CITED2;CD109;SOCS1;JUN;DTX4;ESR1;IKZF3;FOXN1;GLIPR2;ZNF703;CCR6;ARRDC3;PARD3;GPNMB;ZNF365;XRCC6;ZSWIM6;BMP7;PHLPP1;PHLDB2;RAPGEF1;MYADM;DAG1;POLR3H;WNT4;CTDSP1;CD38;TNFAIP3;PSMC3;CXCL8;EFNA1;MAPK11;CARD10;NOL3;HSP90AB1;TBXA2R;IL6R;PARP1;TP63
2872,GO:0006364,1.0806145120116e-06,0.999999604354776,40,255,rRNA processing,BP,PDCD11;RRP1;SART1;NAT10;USP36;DHX37;PWP2;RRP36;GEMIN4;RRS1;RPLP2;DKC1;ISG20L2;SHQ1;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;UTP20;RPS9;NSUN5;RRP7A;FTSJ3;WDR46;NOP56;NOL9;ABT1;RRP7BP;RPL27A;PES1;NOP2;NOP14;METTL16;UTP4;POP4
9928,GO:0042274,1.22306234064981e-06,0.999999752226676,18,70,ribosomal small subunit biogenesis,BP,PDCD11;NAT10;PWP2;RRP36;RRS1;TSR1;NOB1;UTP14A;UTP20;RRP7A;NOM1;WDR46;ERAL1;ABT1;RRP7BP;NOP14;SURF6;UTP4
7453,GO:0031589,1.29417201804625e-06,0.999999522970103,39,224,cell-substrate adhesion,BP,CYR61;FN1;CTGF;CCDC80;SDC4;GBP1;DAPK3;EMP2;ADAMTS9;CDKN2A;CORO1C;PDPN;FLNA;COL16A1;ITGAV;L1CAM;TNFRSF12A;SERPINE1;SFRP1;SRF;VCL;AJUBA;BCAM;COL5A3;COL17A1;NPNT;RCC2;TRIP6;CLASP1;LAMC1;ACTN4;AKIP1;PHLDB2;ZYX;MYADM;DAG1;WNT4;EFNA1;FBLN2
3276,GO:0006954,1.4153549087603e-06,0.999999442956627,54,364,inflammatory response,BP,KRT1;SAA1;CCL20;PTGER4;HDAC9;FN1;C1R;IL1R2;RELB;ABCF1;PTGES;BIRC3;B4GALT1;NFE2L1;NFKB1;HSPG2;LYN;TNF;NFKB2;ZC3H12A;ICAM1;BMP2;IL20;SERPINE1;ELF3;RELT;NFX1;GPER1;NFKBIA;ETS1;IL15;SYK;SLC7A2;DNASE1;IL1A;TNFRSF21;TNIP2;AFAP1L2;TPST1;CXCL5;ESR1;CCR6;TNFRSF10A;ZYX;BLNK;TNFAIP3;CCL22;CXCL8;CXCL3;TBXA2R;IL6R;IL36G;C1S;CCL5
9862,GO:0042113,1.52655296691477e-06,0.999999526771761,29,145,B cell activation,BP,INHBA;HDAC9;CYLD;TFRC;IL27RA;LFNG;CDKN1A;LYN;AHR;SFRP1;IL7R;DOCK10;ZFP36L1;ADAM17;TXLNA;IRS2;ZFP36L2;SYK;TNFRSF21;TNIP2;THOC1;IKZF3;CCR6;KLF6;BLNK;CD38;TNFAIP3;CTPS1;SWAP70
2608,GO:0005912,1.53592724482579e-06,0.999999500179607,62,447,adherens junction,CC,TNS3;ACTG1;HSPB1;PDLIM1;SDC4;NEDD9;TJP2;HSPG2;LYN;CSRP1;BAIAP2;EFNB2;CORO1C;TNC;DST;TPM4;LAYN;FLNA;LCP1;EPHA2;CHP1;ICAM1;ITGAV;L1CAM;KIF23;SVIL;PLEKHA7;ARPC1B;CSRP2;TRIM29;PARD3B;RPLP2;RHOB;ADAM17;VCL;RPLP1;AJUBA;OXTR;RPS2;RPS9;FHL2;MYH9;SPRY4;NUP214;SMAD7;TRIP6;ENAH;TJP1;CLASP1;PPP1R9B;HSPA8;PARD3;RHOG;ACTN4;SORBS2;PHLDB2;ZYX;DAG1;CYTH1;SLC4A2;MYO1E;MCAM
9064,GO:0035295,1.63889466492107e-06,0.999999425050171,84,654,tube development,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;TNS3;AMOT;CYP1A1;PML;HSPB1;STARD13;SDC4;IRX2;TGFB2;EDN1;B4GALT1;EMP2;CDKN1A;HSPG2;ADAMTS9;JUNB;TNF;EFNB2;TNC;PDPN;FGFR2;PBX1;COL4A1;TYMS;ZC3H12A;EPHA2;BMP2;ITGAV;ERRFI1;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;LIF;SFRP1;CC2D2A;DHCR7;SRF;ETS1;ZFP36L1;RHOB;PRKCA;NTN1;SYK;ROBO1;OXTR;MYH9;NPNT;IL1A;SEMA3C;ACKR3;SMAD7;CITED2;JUN;ESR1;FOXN1;GPNMB;BMP7;DAG1;TIMELESS;WNT4;VPS52;TRAF4;TNFAIP3;SLC4A2;BRIP1;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM;TP63;PHACTR4
7001,GO:0030684,1.66389541822764e-06,0.999999637527053,19,74,preribosome,CC,PDCD11;PPAN;RRP1;NAT10;PWP2;RRP36;RRS1;TSR1;NOB1;UTP14A;UTP20;RRP7A;FTSJ3;WDR46;NOP56;RRP7BP;PES1;NOP14;NOC2L
12683,GO:0050896,1.7971426229253e-06,0.999998998924122,489,5524,response to stimulus,BP,IGFBP3;IL32;KRT1;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;C1R;ODC1;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;AMOT;JPH2;TUFT1;ACTG1;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;SDC4;KRT13;WNT10A;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;MGAM;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;IL24;NOCT;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;LYN;RAB32;AHR;JUNB;PLEKHO2;ARPC4;LAMP1;CSRP1;EHD1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;TNC;ASCC2;DST;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;NFKB2;COL4A1;DNAJB1;PSMB9;EPHB6;TELO2;KRT17;FOSL1;QPCT;SIRPA;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;TNK1;ACAA1;CADPS2;KLF7;EPHA2;CHP1;HMGCS1;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;CDK4;KREMEN2;ITGAV;ERRFI1;L1CAM;MYO10;GGCX;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;ANKS4B;GPR146;RNF19B;ADRB2;IL20;DAXX;TNFRSF12A;MTUS1;IFNGR1;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;EBP;NMT2;XAF1;AMOTL2;ZC3H7B;AEN;ELF3;RELT;LIF;SFRP1;TPM1;TRIM22;ZFYVE27;CC2D2A;SAFB2;APTX;HLA-F;ANXA8;IRF1;PSME2;BANF1;EPPK1;IL7R;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;DNAJB2;TXN2;ELF4;ABTB2;TRIM29;NFKBIA;EGR1;JRK;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;FEN1;TXLNA;DHFR;VCL;IRS2;IER3;NPAS2;KRT14;CBX5;LGALS3;ACO1;MAFK;TRAF2;ABCG2;IL15;AKR1C2;PRKCA;GPR132;ZFP36L2;NTN1;SYK;CMTM3;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;GINS2;USP43;IFIT3;DDX47;PDGFB;BCAM;OXTR;PTTG1IP;POLA1;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;DNASE1;RNF115;DPYSL3;UHRF1;MYH9;SPPL2A;COL17A1;NPNT;IL1A;SDK1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;LANCL2;RASGRP4;RBBP5;SEMA3C;SFPQ;DDX39A;SPRY4;LILRB3;SPEN;ROR1;PXMP2;ACSL1;RCC2;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;MTA2;YWHAH;TAPBP;PALM2;ENAH;KEAP1;M6PR;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;UBE2J2;TRIB1;TPST1;CREB3;RUVBL2;PPP1R9B;TUSC1;SLC4A11;MTFP1;KCNIP3;SAFB;THOC1;KLF10;PARP14;CXCL5;SUSD6;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;FOXN1;HCAR3;PAK1IP1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;LRRC27;TFDP1;OGFR;NOP2;NOC2L;RBM4;ZNF703;CCR6;ARRDC3;INSIG1;HERC2;PARD3;QDPR;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;GP6;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;ACTN4;HMGN2;EFNB1;THEM4;SNIP1;BMP7;SMUG1;PHLPP1;EFTUD2;TNFRSF10A;RNF7;CXORF36;TPRA1;AKIP1;ELK1;PHLDB2;RAPGEF1;CHAF1A;ZYX;TINAGL1;KIF22;MYADM;DAG1;CGNL1;POLR3H;PDE6A;RNF185;EEF1D;ASB6;RAB27A;TIMELESS;GPX4;BLNK;WNT4;RBM14;AKR1C1;TRAF4;TUBB;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;CTPS1;MYO1E;SLC3A2;CXCL3;BMP8A;TRIML2;CARD10;SLC25A22;PTPRB;POLR2G;DUSP8;SRSF7;NOL3;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;MCAM;ADGRF3;IL6R;BIN3;LAIR1;PARP1;TP63;IL36G;C1S;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;APEX2;SH3BP4
16787,GO:0098609,1.83598480153805e-06,0.999999400238419,62,441,cell-cell adhesion,BP,CYR61;CYP1B1;TENM3;C1QTNF1;ACTG1;CYLD;HSPB1;PDLIM1;PCDH7;SDC4;TFRC;CD83;MAP3K14;TGFB2;LYN;CSRP1;TNF;BAIAP2;EFNB2;VMP1;PDPN;SIRPA;FLNA;SART1;ICAM1;CD274;BMP2;ITGAV;MYO10;PLEKHA7;IRF1;IL7R;SRF;TRIM29;ETS1;SNAI2;ZFP36L1;VCL;LGALS3;IL15;PRKCA;NTN1;SYK;ROBO1;AJUBA;MYH9;NPNT;SDK1;TNFRSF21;SMAD7;CITED2;SOCS1;ZNF703;GPNMB;EFNB1;BMP7;RAPGEF1;MYADM;WNT4;CLDN7;SWAP70;CCL5
6781,GO:0030216,2.39523759083095e-06,0.999999236065039,29,152,keratinocyte differentiation,BP,KRT1;SPRR3;TRIM16;SPRR2A;KRT2;RUNX1;KRT34;KRT15;FOSL2;KRT4;KRT10;KRT13;KRTAP2-3;HRNR;KRT9;KRT6A;KRT5;KRT17;EPHA2;ERRFI1;SFN;IL20;ZFP36L1;KRT14;CAPNS1;CD109;FOXN1;RPTN;TP63
15211,GO:0071356,2.40303447251158e-06,0.999999135930298,35,203,cellular response to tumor necrosis factor,BP,CCL20;CYLD;TRAF1;MAP3K14;EDN1;BIRC3;TRAF3;NFKB1;TJP2;TNF;PSMB9;ZC3H12A;ICAM1;TNFRSF12A;RELT;SFRP1;PSME2;GPER1;NFKBIA;ZFP36L1;ADAM17;TRAF2;ZFP36L2;SYK;SNRNP70;SPPL2A;NPNT;TNFRSF21;TNFRSF10A;TNFAIP3;PSMC3;CCL22;CXCL8;NOL3;CCL5
480,GO:0001525,2.83693123350864e-06,0.999998819752658,49,320,angiogenesis,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;EFNB2;FGFR2;COL4A1;ZC3H12A;EPHA2;ITGAV;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;SFRP1;SRF;ETS1;RHOB;PRKCA;SYK;ROBO1;MYH9;IL1A;ACKR3;JUN;GPNMB;DAG1;TNFAIP3;CXCL8;EFNA1;CARD10;PTPRB;TBXA2R;MCAM
11197,GO:0045321,2.86036987589183e-06,0.999998661646972,93,766,leukocyte activation,BP,KRT1;MAFB;FTL;FTH1;MMP9;RUNX1;PTGER4;INHBA;HDAC9;S100P;CYLD;SDC4;RELB;TFRC;CD83;CSF2;MAP3K14;EDN1;B4GALT1;MGAM;RSAD2;HRNR;IL27RA;NFKB1;LFNG;CDKN1A;LYN;AHR;PLEKHO2;LAMP1;EFNB2;QPCT;SIRPA;ZC3H12A;LCP1;SART1;ACAA1;ICAM1;CD274;ITGAV;SFRP1;IRF1;IL7R;GPER1;SRF;ELF4;EGR1;DOCK10;ZFP36L1;ADAM17;TXLNA;VCL;IRS2;LGALS3;IL15;ZFP36L2;SYK;SLC7A2;DNASE1;MYH9;GLIPR1;TNFRSF21;TNIP2;LILRB3;SMAD7;THOC1;CAB39;SOCS1;HSPA8;JUN;IKZF3;FOXN1;COMMD9;CCR6;RHOG;GPNMB;XRCC6;KLF6;EFNB1;RAB27A;BLNK;WNT4;TUBB;CD38;TNFAIP3;PSMC3;CXCL8;CTPS1;PTPRB;HSP90AB1;SWAP70;LAIR1;CCL5
12242,GO:0048514,2.87666287556989e-06,0.999998835951801,55,376,blood vessel morphogenesis,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;JUNB;EFNB2;FGFR2;COL4A1;ZC3H12A;EPHA2;ITGAV;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;SFRP1;SRF;ETS1;ZFP36L1;RHOB;PRKCA;SYK;ROBO1;MYH9;IL1A;ACKR3;SMAD7;JUN;FOXN1;GPNMB;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM
1037,GO:0002548,3.05085938600917e-06,0.99999976152945,9,19,monocyte chemotaxis,BP,CCL20;LYN;SERPINE1;LGALS3;PDGFB;CREB3;CCL22;IL6R;CCL5
3712,GO:0008219,3.0785375928717e-06,0.999998237992274,166,1570,cell death,BP,IGFBP3;KRT1;SPRR3;CRYAB;SPRR2A;MMP9;KRT2;CYR61;INHBA;NEFL;CYP1B1;CTGF;KRT34;ADM;KRT15;FOSL2;KRT4;NQO1;PML;CYLD;HSPB1;MYBL2;KRT10;TRAF1;KRT13;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;EMP2;TP53;SQSTM1;KRT9;IL24;NFKB1;KRT6A;CDKN1A;LYN;AHR;JUNB;LAMP1;GADD45A;TNF;EFNB2;KRT5;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;KRT17;FOSL1;ZC3H12A;FLNA;EPHA2;CHP1;GADD45B;TSC22D3;ICAM1;CD274;BMP2;UBE4B;CDK4;DRAM1;ITGAV;SFN;DAXX;TNFRSF12A;SERPINE1;MCM2;XAF1;AEN;RELT;SFRP1;IRF1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;NPAS2;KRT14;LGALS3;TRAF2;PRKCA;NTN1;ROBO1;IFIT3;DDX47;BRMS1;PTTG1IP;FHL2;DNASE1;IL1A;BCL7C;GPR75;TNFRSF21;TNIP2;SFPQ;SAP30BP;ROR1;PRUNE2;ACKR3;YWHAH;APH1A;CAPNS1;CREB3;MTFP1;KCNIP3;THOC1;SUSD6;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;BLOC1S2;TFDP1;NOC2L;CHMP4B;RPTN;DUS2;GPNMB;BCL2L2;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;ELK1;EIF5A;GPX4;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;POLR2G;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5
14602,GO:0070161,3.143535538869e-06,0.999998666618836,63,464,anchoring junction,CC,TNS3;ACTG1;HSPB1;PDLIM1;SDC4;B4GALT1;NEDD9;TJP2;HSPG2;LYN;CSRP1;BAIAP2;EFNB2;CORO1C;TNC;DST;TPM4;LAYN;FLNA;LCP1;EPHA2;CHP1;ICAM1;ITGAV;L1CAM;KIF23;SVIL;PLEKHA7;ARPC1B;CSRP2;TRIM29;PARD3B;RPLP2;RHOB;ADAM17;VCL;RPLP1;AJUBA;OXTR;RPS2;RPS9;FHL2;MYH9;SPRY4;NUP214;SMAD7;TRIP6;ENAH;TJP1;CLASP1;PPP1R9B;HSPA8;PARD3;RHOG;ACTN4;SORBS2;PHLDB2;ZYX;DAG1;CYTH1;SLC4A2;MYO1E;MCAM
707,GO:0001932,3.38483837792665e-06,0.99999835616089,110,940,regulation of protein phosphorylation,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;GBP1;MID1;DBNDD2;EMP2;TP53;SQSTM1;MARVELD3;IL24;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;GPER1;EGR1;AKAP8;NELFE;ADAM17;FGFR1OP;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;SPRY4;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;TRIB1;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;GLIPR2;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;IL6R;CCL5
5335,GO:0016072,3.68971484134933e-06,0.999998511660541,42,284,rRNA metabolic process,BP,CD3EAP;PDCD11;RRP1;SART1;NAT10;USP36;DHX37;PWP2;RRP36;GEMIN4;RRS1;RPLP2;DKC1;ISG20L2;SHQ1;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;UTP20;RPS9;NSUN5;RRP7A;FTSJ3;WDR46;NOP56;NOL9;ABT1;RRP7BP;RPL27A;PES1;NOP2;NOP14;GTF3C2;METTL16;UTP4;POP4
8787,GO:0034470,3.9873867358629e-06,0.999998250488298,54,396,ncRNA processing,BP,USB1;PDCD11;RRP1;CDKAL1;SART1;TRMT61A;NAT10;USP36;PUS1;DHX37;PWP2;METTL1;NSUN2;RRP36;GEMIN4;POP1;RRS1;SRRT;RPLP2;DKC1;ISG20L2;SHQ1;METTL2B;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;UTP20;RPS9;NSUN5;RRP7A;FTSJ3;WDR46;NOP56;NOL9;WDR4;ABT1;RRP7BP;RPL27A;PES1;NOP2;NOP14;DUS2;TRMT1;METTL16;HSD17B10;UTP4;POP4;RPUSD4
548,GO:0001667,4.01757259742712e-06,0.999998362146362,43,271,ameboidal-type cell migration,BP,MMP9;KRT2;HDAC9;S100P;CYP1B1;AMOT;PML;HSPB1;STARD13;SDC4;TGFB2;EDN1;EMP2;MARVELD3;ADAMTS9;EFNB2;CORO1C;ZC3H12A;EPHA2;STAT5A;AMOTL2;EPPK1;SRF;ETS1;RHOB;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;SEMA3C;RCC2;MTA2;CLASP1;JUN;GLIPR2;CCR6;EFNB1;BMP7;EFNA1;CARD10;TBXA2R;PHACTR4
12661,GO:0050865,4.34894285814079e-06,0.999998146414152,47,309,regulation of cell activation,BP,RUNX1;INHBA;CTGF;C1QTNF1;CYLD;SDC4;TFRC;CD83;MAP3K14;IL27RA;CDKN1A;LYN;AHR;LAMP1;EFNB2;PDPN;SIRPA;ZC3H12A;SART1;CD274;SFRP1;IRF1;IL7R;THBD;GPER1;ZFP36L1;IRS2;LGALS3;IL15;PRKCA;ZFP36L2;SYK;SLC7A2;PDGFB;TNFRSF21;TNIP2;SMAD7;THOC1;SOCS1;IKZF3;FOXN1;GPNMB;EFNB1;CD38;TNFAIP3;GCLC;CCL5
12899,GO:0051241,4.53179794711551e-06,0.999997714126964,84,679,negative regulation of multicellular organismal process,BP,KRT1;MAFB;NRG1;PTGER4;INHBA;FN1;C1QTNF1;ADM;AMOT;IL1R2;PML;CYLD;STARD13;RELB;CD83;FBN1;TGFB2;EDN1;GBP1;IKBKE;G6PD;TRAF3;NLRC5;MARVELD3;NOCT;NFKB1;LFNG;TJP2;HSPG2;ADAMTS9;LYN;TNF;EFNB2;CORO1C;WWC1;PBX1;ZC3H12A;TSC22D3;CD274;BMP2;KREMEN2;ERRFI1;ADRB2;SERPINE1;PGK1;SFRP1;IRF1;LUC7L;EPPK1;THBD;SRF;NFKBIA;SNAI2;PRPF19;ZFP36L1;AKAP8;NTN1;ROBO1;PDGFB;OXTR;DPYSL3;TNFRSF21;SEMA3C;LILRB3;COL5A2;SMAD7;YWHAH;TRIB1;THOC1;ARRDC3;GPNMB;ZNF365;BMP7;WNT4;CTDSP1;CD38;TNFAIP3;EFNA1;MAPK11;CARD10;NOL3;HSP90AB1;TBXA2R;TP63
8830,GO:0034612,4.56463821108161e-06,0.999998277636783,36,217,response to tumor necrosis factor,BP,CCL20;CYLD;TRAF1;MAP3K14;EDN1;BIRC3;TRAF3;NFKB1;TJP2;TNF;CXCL16;PSMB9;ZC3H12A;ICAM1;TNFRSF12A;RELT;SFRP1;PSME2;GPER1;NFKBIA;ZFP36L1;ADAM17;TRAF2;ZFP36L2;SYK;SNRNP70;SPPL2A;NPNT;TNFRSF21;TNFRSF10A;TNFAIP3;PSMC3;CCL22;CXCL8;NOL3;CCL5
6958,GO:0030595,4.5655544595777e-06,0.999998768448286,22,102,leukocyte chemotaxis,BP,SAA1;CCL20;IL16;TGFB2;EDN1;LYN;CXCL16;MTUS1;SERPINE1;ADAM17;LGALS3;SYK;PDGFB;CREB3;CXCL5;CCR6;CCL22;CXCL8;CXCL3;SWAP70;IL6R;CCL5
2211,GO:0005102,5.01700318304737e-06,0.999997339196761,103,881,signaling receptor binding,MF,IL32;SAA1;CCL20;NRG1;CYR61;INHBA;S100P;FN1;CTGF;ADM;IL16;TAP1;TRAF1;WNT10A;HLA-B;CSF2;FBN1;TGFB2;EDN1;TRAF3;EMP2;PANX1;TP53;SQSTM1;IL24;IRS1;HSPG2;LYN;TNF;IGFL3;EFNB2;CXCL16;DST;PDPN;PTPN14;KRT17;SLC39A1;FLNA;LCP1;TNK1;ICAM1;BMP2;COL16A1;ITGAV;CDC42EP2;EPGN;IL20;DAXX;SERPINE1;FUS;LIF;SFRP1;HLA-F;ADAM17;TXLNA;KCTD10;IRS2;LGALS3;TRAF2;IL15;REEP1;PRKCA;SYK;CMTM3;PDGFB;FHL2;NPNT;IL1A;SEMA3C;BAMBI;SMAD7;YWHAH;TAPBP;TRIP6;PAGR1;ETS2;CXCL5;TGFBRAP1;SOCS1;HSPA8;ESR1;ARRDC3;GPNMB;TAP2;ACTN4;EFNB1;BMP7;BLNK;WNT4;TRAF4;TUBB;SPG21;CCL22;CXCL8;EFNA1;CXCL3;BMP8A;NOL3;HSP90AB1;IL6R;PARP1;IL36G;CCL5
3462,GO:0007275,5.02421669512397e-06,0.999996733130118,312,3304,multicellular organism development,BP,KRT1;MAFB;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;KRT34;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;NEFM;CYP1A1;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;TXNRD1;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;DBNDD2;RSAD2;G6PD;EMP2;HRNR;TP53;SIPA1L3;NFE2L1;KRT9;HNRNPAB;NOCT;IL27RA;FST;CDKN2B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;AHR;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;RING1;CORO1C;NAV2;ENC1;TNC;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;PBX1;NFKB2;COL4A1;PSMB9;SLC7A5;EPHB6;KRT17;FOSL1;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;ARMC6;SART1;KLF7;EPHA2;HMGCS1;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;BMP2;UBE4B;COL27A1;CDK4;KREMEN2;ITGAV;ERRFI1;L1CAM;SFN;COL9A2;STAT5A;EPGN;ADRB2;SVIL;IL20;TNFRSF12A;SERPINE1;PABPC4;PGK1;MCM2;EBP;CSRP2;AMOTL2;ELF3;RELT;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;SAFB2;DHCR7;WDR1;IRF1;PSME2;LUC7L;IL7R;TFIP11;GPER1;SRF;NSUN2;ABTB2;ZFP42;NFKBIA;SF1;EGR1;EDF1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;RHOB;ADAM17;GPCPD1;DHFR;VCL;IRS2;NPAS2;KRT14;LGALS3;ACO1;MAFK;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;CDKL1;PDGFB;OXTR;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;DPYSL3;COL5A3;RRP7A;MYH9;NOM1;NPNT;IL1A;SDK1;COPS3;TNFRSF21;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;SPEN;ROR1;COL5A2;MAFF;ACKR3;BAMBI;SMAD7;YWHAH;ENAH;KEAP1;HNRNPU;CLASP1;PQBP1;APH1A;CAPNS1;TRIB1;ABT1;PPP1R9B;THOC1;ETS2;KLF10;ZNF267;DUSP1;CITED2;CD109;SOCS1;FRAS1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;GLIPR2;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;PARD3;QDPR;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;KLF6;ZSWIM6;TEAD4;CNTNAP1;EFNB1;SORBS2;LRFN4;BMP7;PHLPP1;TNFRSF10A;TPRA1;PHLDB2;RAPGEF1;MYADM;DAG1;COL4A4;TIMELESS;GPX4;BLNK;WNT4;VPS52;TRAF4;CTDSP1;TNFAIP3;PSMC3;SMARCC2;SLC4A2;BRIP1;CXCL8;EFNA1;MAPK11;MYO1E;BMP8A;HES4;CARD10;PTPRB;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4
3905,GO:0008544,5.33468227089824e-06,0.999997820798712,42,270,epidermis development,BP,KRT1;SPRR3;TRIM16;SPRR2A;KRT2;RUNX1;INHBA;CTGF;KRT34;KRT15;FOSL2;KRT4;KRT10;KRT13;WNT10A;TGFB2;KRTAP2-3;HRNR;KRT9;FST;KRT6A;TNF;KRT5;FGFR2;KRT17;EPHA2;ERRFI1;SFN;IL20;ELF3;NSUN2;ZFP36L1;KRT14;NOM1;COL17A1;MAFF;KEAP1;CAPNS1;CD109;FOXN1;RPTN;TP63
12308,GO:0048646,5.53067219976581e-06,0.999997181123609,86,691,anatomical structure formation involved in morphogenesis,BP,KRT1;MAFB;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;ACTG1;PML;HSPB1;STARD13;SDC4;IRX2;TGFB2;EDN1;TXNRD1;B4GALT1;EMP2;LFNG;HSPG2;ADAMTS9;JUNB;EHD1;TNF;COL12A1;EFNB2;PDPN;FGFR2;PTPN14;NFKB2;COL4A1;ZC3H12A;EPHA2;ITGAV;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;SFRP1;TPM1;CC2D2A;WDR1;SRF;ETS1;SNAI2;RHOB;ADAM17;PRKCA;SYK;ROBO1;FHL2;RRP7A;MYH9;IL1A;SDK1;SEMA3C;COL5A2;ACKR3;CLASP1;ETS2;DUSP1;CITED2;CD109;JUN;TCOF1;GPNMB;CNTNAP1;BMP7;PHLDB2;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;CARD10;PTPRB;TBXA2R;MCAM;TP63;PHACTR4
12660,GO:0050864,5.68959303632764e-06,0.999998700737934,18,72,regulation of B cell activation,BP,INHBA;CYLD;TFRC;IL27RA;CDKN1A;LYN;AHR;SFRP1;ZFP36L1;IRS2;ZFP36L2;SYK;TNFRSF21;TNIP2;THOC1;IKZF3;CD38;TNFAIP3
1020,GO:0002520,5.69412104823264e-06,0.999997137647615,81,657,immune system development,BP,MAFB;MMP9;RUNX1;PTGER4;INHBA;HDAC9;PML;CYLD;RELB;TFRC;CD83;CSF2;FBN1;TGFB2;RSAD2;G6PD;SIPA1L3;NFE2L1;IL27RA;FST;CDKN2B;LFNG;TJP2;LYN;JUNB;TNF;PDPN;FGFR2;PBX1;NFKB2;PSMB9;ARMC6;SART1;EPHA2;IL20;PABPC4;EBP;LIF;SFRP1;WDR1;IRF1;PSME2;IL7R;SRF;NFKBIA;EGR1;DOCK10;ETS1;RRS1;ZFP36L1;ADAM17;LGALS3;IL15;PRKCA;ZFP36L2;SYK;MYH9;RASGRP4;RBBP5;LILRB3;SMAD7;TRIB1;THOC1;KLF10;CITED2;CD109;SOCS1;JUN;IKZF3;FOXN1;CCR6;KLF6;PHLPP1;BLNK;WNT4;TNFAIP3;PSMC3;MYO1E;SWAP70;HERC6;PARP1
11287,GO:0045597,6.03439405218627e-06,0.999997004395388,77,602,positive regulation of cell differentiation,BP,IGFBP3;TRIM16;NRG1;RUNX1;CYR61;INHBA;FN1;NEFL;CTGF;TENM3;ADM;CYLD;CD83;CSF2;TGFB2;EDN1;NOCT;NFKB1;ADAMTS9;LYN;JUNB;EHD1;TNF;BAIAP2;EFNB2;ENC1;PDPN;ZC3H12A;FLNA;SART1;BMP2;L1CAM;SFN;IL20;TNFRSF12A;SERPINE1;LIF;SFRP1;ZFYVE27;IL7R;GPER1;SRF;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;IL15;PRKCA;NTN1;SYK;ROBO1;NEDD4L;DPYSL3;NPNT;SEMA3C;SPEN;BAMBI;TRIB1;KLF10;SOCS1;JUN;FOXN1;GLIPR2;RBM4;ZNF703;ZNF365;BMP7;RAPGEF1;MYADM;DAG1;WNT4;MAPK11;HSP90AB1;IL6R;PARP1;TP63
14723,GO:0070372,6.1877347867698e-06,0.999997827499208,31,171,regulation of ERK1 and ERK2 cascade,BP,CCL20;CYR61;FN1;CTGF;GBP1;LYN;TNF;FGFR2;EPHB6;EPHA2;ICAM1;BMP2;ERRFI1;LIF;GPER1;NELFE;PRKCA;SYK;PDGFB;NPNT;IL1A;SPRY4;ROR1;ACKR3;DUSP1;JUN;GLIPR2;GPNMB;RAPGEF1;CCL22;CCL5
2407,GO:0005578,6.36616973213246e-06,0.999997675171401,33,187,proteinaceous extracellular matrix,CC,MMP9;CYR61;FN1;P3H2;CTGF;CCDC80;WNT10A;FBN1;HSPG2;ADAMTS9;COL12A1;NAV2;TNC;DST;COL4A1;COL16A1;COL27A1;COL9A2;SFRP1;TFIP11;NTN1;COL5A3;COL17A1;NPNT;COL5A2;FRAS1;RPTN;LAMC1;LRFN4;DAG1;COL4A4;WNT4;FBLN2
628,GO:0001817,7.05756100635462e-06,0.999996787893363,57,412,regulation of cytokine production,BP,SAA1;TRIM16;CCL20;RUNX1;PTGER4;INHBA;FN1;CYP1B1;IL1R2;PML;CYLD;HSPB1;RELB;CD83;CSF2;TGFB2;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;PANX1;IL27RA;NFKB1;LYN;TNF;NFKB2;ZC3H12A;CD274;ERRFI1;SERPINE1;IRF1;EGR1;SNAI2;AKAP8;ADAM17;TRAF2;IL15;SYK;SPTBN1;IL1A;TNFRSF21;AFAP1L2;SMAD7;CRCP;PQBP1;SOCS1;DTX4;GPNMB;XRCC6;POLR3H;TNFAIP3;MAPK11;HSP90AB1;IL6R
3747,GO:0008284,7.06483069223526e-06,0.999996568821233,70,542,positive regulation of cell proliferation,BP,NRG1;MMP9;CYR61;FN1;ODC1;CTGF;ADM;TNS3;FOSL2;PML;TFRC;CSF2;TGFB2;EDN1;B4GALT1;EMP2;IL24;IRS1;CDKN1A;LYN;TNF;EFNB2;TNC;FGFR2;PBX1;FOSL1;FLNA;CD274;BMP2;CDK4;ITGAV;STAT5A;EPGN;LIF;OSR2;SFRP1;IL7R;GPER1;EGR1;ETS1;ADAM17;FGFR1OP;IRS2;IL15;AKR1C2;PRKCA;NTN1;SYK;PDGFB;RPS9;BAMBI;HNRNPU;CAPNS1;CXCL5;JUN;ESR1;NOP2;SERTAD1;NACC1;ZNF703;LAMC1;RHOG;EFNB1;EIF5A;CD38;TNFAIP3;CLDN7;IL6R;TP63;CCL5
6687,GO:0030055,7.16185867603716e-06,0.999996864877958,51,360,cell-substrate junction,CC,TNS3;ACTG1;HSPB1;PDLIM1;SDC4;NEDD9;HSPG2;CSRP1;EFNB2;CORO1C;TNC;DST;TPM4;LAYN;FLNA;LCP1;EPHA2;CHP1;ICAM1;ITGAV;L1CAM;KIF23;SVIL;ARPC1B;CSRP2;EPPK1;RPLP2;RHOB;ADAM17;VCL;RPLP1;AJUBA;RPS2;RPS9;FHL2;MYH9;COL17A1;SPRY4;NUP214;TRIP6;ENAH;CLASP1;HSPA8;RHOG;ACTN4;SORBS2;PHLDB2;ZYX;DAG1;SLC4A2;MCAM
19491,GO:1990266,7.18124731594316e-06,0.999998824115442,13,43,neutrophil migration,BP,SAA1;CCL20;TGFB2;EDN1;WDR1;LGALS3;SYK;IL1A;CXCL5;CCL22;CXCL8;CXCL3;CCL5
2270,GO:0005201,7.68658504615579e-06,0.999998877387704,12,35,extracellular matrix structural constituent,MF,TUFT1;FBN1;COL12A1;COL4A1;COL27A1;COL9A2;COL5A3;COL5A2;LAMC1;TINAGL1;COL4A4;FBLN2
10506,GO:0043408,7.76160349485538e-06,0.999996196173005,64,476,regulation of MAPK cascade,BP,IGFBP3;SAA1;CCL20;NRG1;CYR61;INHBA;FN1;CTGF;C1QTNF1;DUSP14;MAP3K14;TGFB2;EDN1;GBP1;MID1;MARVELD3;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;ERRFI1;EPGN;ADRB2;DAXX;LIF;SFRP1;GPER1;NELFE;TRAF2;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;SPRY4;ROR1;ACKR3;TRIB1;DUSP1;JUN;GLIPR2;GPNMB;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;DUSP8;CCL5
9956,GO:0042325,7.91299965078361e-06,0.999995447988593,118,1041,regulation of phosphorylation,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;GBP1;MID1;DBNDD2;EMP2;NLRC5;TP53;SQSTM1;MARVELD3;IL24;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;FGFR2;NUP153;EPHB6;TELO2;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;GPER1;EGR1;AKAP8;NELFE;ADAM17;FGFR1OP;IRS2;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;HNRNPU;PPP1R14C;TRIB1;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;GLIPR2;MCM7;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;IL6R;CCL5
2267,GO:0005198,8.51324887012417e-06,0.999995805999845,64,510,structural molecule activity,MF,KRT1;SPRR3;CRYAB;SPRR2A;KRT2;MAP2;NEFL;KRT34;KRT15;KRT4;TUFT1;NEFM;ACTG1;KRT10;KRT13;FBN1;HRNR;KRT9;KRT6A;ARPC4;COL12A1;KRT5;WWC1;NUP153;TPM4;COL4A1;TELO2;KRT17;JPH1;COL27A1;COL9A2;ARPC1B;TPM1;PDE4DIP;RPLP2;VCL;KRT14;RPLP1;IFFO2;RPS2;RPS9;SPTBN1;COL5A3;COL5A2;NUP214;MRPS12;MRPS24;CCDC6;MRPL20;RPL27A;MRPL33;EIF3B;RPTN;LAMC1;SORBS2;TINAGL1;DAG1;COL4A4;MRPS2;TUBB;CLDN7;CARD10;CLTA;FBLN2
1047,GO:0002573,8.54721528007042e-06,0.999997350749317,25,125,myeloid leukocyte differentiation,BP,MAFB;MMP9;RUNX1;INHBA;RELB;TFRC;CSF2;FBN1;TJP2;LYN;JUNB;TNF;EPHA2;IL20;LIF;SFRP1;ZFP36L1;PRKCA;MYH9;LILRB3;TRIB1;KLF10;CD109;JUN;PARP1
15766,GO:0072359,8.69289205833498e-06,0.999995545046021,84,679,circulatory system development,BP,KRT1;NRG1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;JPH2;PML;HSPB1;STARD13;FBN1;TGFB2;EDN1;B4GALT1;G6PD;EMP2;HSPG2;ADAMTS9;AHR;JUNB;EFNB2;PDPN;FGFR2;PTPN14;COL4A1;FOSL1;ZC3H12A;EPHA2;BMP2;UBE4B;ITGAV;ERRFI1;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;LIF;SFRP1;TPM1;CC2D2A;DHCR7;GPER1;SRF;EGR1;ETS1;SNAI2;ZFP36L1;RHOB;PRKCA;SYK;ROBO1;CDKL1;PDGFB;OXTR;FHL2;MYH9;IL1A;SEMA3C;ACKR3;SMAD7;HNRNPU;CITED2;JUN;FOXN1;GPNMB;SORBS2;BMP7;RAPGEF1;DAG1;WNT4;TNFAIP3;CXCL8;EFNA1;MAPK11;MYO1E;CARD10;PTPRB;TBXA2R;MCAM
16606,GO:0097435,9.12114702563358e-06,0.999995676909313,63,469,supramolecular fiber organization,BP,CRYAB;KRT2;PTGER4;MAP2;NEFL;CYP1B1;CTGF;NEFM;ACTG1;SDC4;TGFB2;COBLL1;EDN1;MID1;EMP2;KRT9;NEDD9;MYO1B;ARPC4;COL12A1;BAIAP2;TPM4;KRT17;FLNA;LCP1;CHP1;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;EPPK1;SRF;RHOB;KRT14;SPTBN1;SERPINH1;DCTN1;COLGALT1;DPYSL3;COL5A3;SLAIN2;COL5A2;PALM2;CLASP1;PPP1R9B;MICAL3;HSPA8;RHOG;ACTN4;SORBS2;KIF24;KANK4;PHLDB2;ZYX;MYADM;CGNL1;WNT4;HSP90AB1;SWAP70;BIN3;BAIAP2L2
7374,GO:0031424,9.92301248828056e-06,0.99999748662633,19,86,keratinization,BP,KRT1;SPRR3;SPRR2A;KRT2;KRT34;KRT15;KRT4;KRT10;KRT13;KRTAP2-3;HRNR;KRT9;KRT6A;KRT5;KRT17;SFN;KRT14;CAPNS1;RPTN
12244,GO:0048518,1.04003568132191e-05,0.999992752681217,357,3892,positive regulation of biological process,BP,IGFBP3;KRT1;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;CYP1B1;CTGF;TENM3;C1QTNF1;CCDC80;ADM;TNS3;AMOT;FOSL2;JPH2;ACTG1;NQO1;IL16;CYP1A1;PML;TFCP2L1;RBM19;CYLD;HSPB1;MYBL2;TRAF1;SDC4;WNT10A;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CD83;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;RSAD2;G6PD;TRAF3;EMP2;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;UBQLN2;ADAMTS9;LYN;AHR;JUNB;ARPC4;LAMP1;EHD1;GADD45A;TNF;GNL3L;BAIAP2;ZBED1;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;ENC1;TNC;TRIO;PDPN;FGFR2;PBX1;NFKB2;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;ZC3H12A;FLNA;LCP1;CYB5R1;SART1;CADPS2;KLF7;EPHA2;CHP1;GADD45B;ICAM1;CD274;BMP2;COL16A1;CDK4;ITGAV;L1CAM;KIF23;MYO10;SFN;CDC42EP2;STAT5A;EPGN;RNF19B;ADRB2;SVIL;IL20;DAXX;TNFRSF12A;FOXD2;SERPINE1;ARPC1B;USP36;AKAP8L;ELF3;LIF;OSR2;SFRP1;TPM1;TRIM22;ZFYVE27;WDR1;MKL1;IRF1;PSME2;IL7R;PSPC1;THBD;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;JRK;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;IRS2;NPAS2;PPRC1;LGALS3;RPLP1;TRAF2;IL15;SF3B4;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;PDGFB;BRMS1;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SNRNP70;FHL2;DCTN1;COLGALT1;DPYSL3;UHRF1;SLAIN2;MYH9;NPNT;IL1A;TNFRSF21;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SAP30BP;WDR46;SPEN;ROR1;ACSL1;RCC2;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;CLASP1;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CXCL5;DUSP1;CAB39;CITED2;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;CPT1A;TFDP1;NOP2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;KLF6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;GLIS3;SNIP1;BMP7;METTL16;TNFRSF10A;ELK1;PHLDB2;PHF5A;RAPGEF1;EIF5A;UBAP2L;MYADM;DAG1;POLR3H;EEF1D;RAB27A;DHX34;TIMELESS;BLNK;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;POLR1E;CXCL3;BMP8A;CARD10;RNF144B;POLR2G;CREB5;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;FBLN2;MCAM;IL6R;PARP1;TP63;C1S;CCL5;BAIAP2L2;SH3BP4
10385,GO:0043207,1.05067648688969e-05,0.999994718979107,67,523,response to external biotic stimulus,BP,CCL20;PTGER4;ODC1;ADM;CYP1A1;PML;HSPB1;CSF2;PTGES;MAP3K14;EDN1;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;IL24;NOCT;IL27RA;NFKB1;LYN;JUNB;TNF;BAIAP2;FGFR2;NFKB2;FOSL1;ZC3H12A;ICAM1;CD274;CDK4;IFNGR1;SERPINE1;RELT;TRIM22;IRF1;BANF1;THBD;NFKBIA;AKAP8;ADAM17;IL15;PRKCA;SYK;DDX17;NFKBIB;IFIT3;TNFRSF21;TNIP2;CRCP;PQBP1;TRIB1;CXCL5;JUN;HMGN2;TNFRSF10A;POLR3H;TNFAIP3;CCL22;CXCL8;MAPK11;CXCL3;TBXA2R;IL6R;CCL5
13141,GO:0051707,1.05067648688969e-05,0.999994718979107,67,523,response to other organism,BP,CCL20;PTGER4;ODC1;ADM;CYP1A1;PML;HSPB1;CSF2;PTGES;MAP3K14;EDN1;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;IL24;NOCT;IL27RA;NFKB1;LYN;JUNB;TNF;BAIAP2;FGFR2;NFKB2;FOSL1;ZC3H12A;ICAM1;CD274;CDK4;IFNGR1;SERPINE1;RELT;TRIM22;IRF1;BANF1;THBD;NFKBIA;AKAP8;ADAM17;IL15;PRKCA;SYK;DDX17;NFKBIB;IFIT3;TNFRSF21;TNIP2;CRCP;PQBP1;TRIB1;CXCL5;JUN;HMGN2;TNFRSF10A;POLR3H;TNFAIP3;CCL22;CXCL8;MAPK11;CXCL3;TBXA2R;IL6R;CCL5
11092,GO:0045095,1.05932693500955e-05,0.999998766819352,10,26,keratin filament,CC,KRT1;KRT2;KRT4;KRT13;KRTAP2-3;KRT6A;KRT5;EPPK1;GPER1;KRT14
414,GO:0001101,1.07227832843051e-05,0.999995711403656,37,228,response to acid chemical,BP,TRIM16;PTGER4;CTGF;NQO1;KRT13;PTGES;EDN1;TP53;LYN;TNF;BAIAP2;TNC;FGFR2;COL4A1;TYMS;ZC3H12A;ICAM1;COL16A1;CDK4;SFRP1;EGR1;AKAP8;DHFR;AKR1C2;PDGFB;SNRNP70;LANCL2;ACSL1;COL5A2;DUSP1;SOCS1;CPT1A;AKR1C1;CD38;TRIML2;GCLC;SH3BP4
4550,GO:0010631,1.12279474928933e-05,0.999995700114883,34,202,epithelial cell migration,BP,MMP9;KRT2;HDAC9;S100P;CYP1B1;AMOT;HSPB1;STARD13;TGFB2;EDN1;EMP2;MARVELD3;ADAMTS9;EFNB2;CORO1C;ZC3H12A;EPHA2;STAT5A;EPPK1;SRF;ETS1;RHOB;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;CLASP1;JUN;GLIPR2;CCR6;EFNA1;CARD10;TBXA2R
10907,GO:0044452,1.21618917081387e-05,0.999995733241149,29,163,nucleolar part,CC,NFKBIE;TFCP2L1;CD3EAP;MAP3K14;TXNRD1;RSAD2;NUAK1;TAF4B;PWP2;PSPC1;POP1;RRS1;CD2BP2;DKC1;POLR1A;UBTF;RRP7A;NOP56;SMAD7;RRP7BP;TCOF1;PES1;KLF6;EEF1D;POLR1E;SURF6;UTP4;POP4;APEX2
16134,GO:0090132,1.25478113766083e-05,0.999995165933361,34,203,epithelium migration,BP,MMP9;KRT2;HDAC9;S100P;CYP1B1;AMOT;HSPB1;STARD13;TGFB2;EDN1;EMP2;MARVELD3;ADAMTS9;EFNB2;CORO1C;ZC3H12A;EPHA2;STAT5A;EPPK1;SRF;ETS1;RHOB;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;CLASP1;JUN;GLIPR2;CCR6;EFNA1;CARD10;TBXA2R
12254,GO:0048534,1.33209754800151e-05,0.999993001198657,76,620,hematopoietic or lymphoid organ development,BP,MAFB;MMP9;RUNX1;PTGER4;INHBA;HDAC9;PML;CYLD;RELB;TFRC;CD83;CSF2;FBN1;TGFB2;RSAD2;G6PD;SIPA1L3;NFE2L1;FST;CDKN2B;LFNG;TJP2;LYN;JUNB;TNF;PDPN;FGFR2;PBX1;NFKB2;PSMB9;ARMC6;SART1;EPHA2;IL20;PABPC4;EBP;LIF;SFRP1;WDR1;IRF1;PSME2;IL7R;SRF;NFKBIA;EGR1;DOCK10;ETS1;RRS1;ZFP36L1;ADAM17;LGALS3;IL15;PRKCA;ZFP36L2;SYK;MYH9;RASGRP4;RBBP5;LILRB3;SMAD7;TRIB1;KLF10;CITED2;CD109;SOCS1;JUN;IKZF3;FOXN1;CCR6;KLF6;BLNK;WNT4;PSMC3;MYO1E;HERC6;PARP1
16132,GO:0090130,1.3910088496489e-05,0.999994607458904,34,204,tissue migration,BP,MMP9;KRT2;HDAC9;S100P;CYP1B1;AMOT;HSPB1;STARD13;TGFB2;EDN1;EMP2;MARVELD3;ADAMTS9;EFNB2;CORO1C;ZC3H12A;EPHA2;STAT5A;EPPK1;SRF;ETS1;RHOB;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;CLASP1;JUN;GLIPR2;CCR6;EFNA1;CARD10;TBXA2R
15412,GO:0071674,1.42723091573156e-05,0.999998255944471,10,27,mononuclear cell migration,BP,CCL20;LYN;TNF;SERPINE1;LGALS3;PDGFB;CREB3;CCL22;IL6R;CCL5
6698,GO:0030097,1.48468284597313e-05,0.999992124796802,73,591,hemopoiesis,BP,MAFB;MMP9;RUNX1;PTGER4;INHBA;HDAC9;PML;CYLD;RELB;TFRC;CD83;CSF2;FBN1;TGFB2;RSAD2;G6PD;SIPA1L3;NFE2L1;FST;CDKN2B;LFNG;TJP2;LYN;JUNB;TNF;FGFR2;PBX1;PSMB9;ARMC6;SART1;EPHA2;IL20;PABPC4;EBP;LIF;SFRP1;WDR1;IRF1;PSME2;IL7R;SRF;NFKBIA;EGR1;DOCK10;ETS1;RRS1;ZFP36L1;ADAM17;LGALS3;IL15;PRKCA;ZFP36L2;SYK;MYH9;RASGRP4;RBBP5;LILRB3;SMAD7;TRIB1;KLF10;CD109;SOCS1;JUN;IKZF3;FOXN1;CCR6;KLF6;BLNK;WNT4;PSMC3;MYO1E;HERC6;PARP1
1098,GO:0002687,1.50150739767553e-05,0.999996454272835,17,71,positive regulation of leukocyte migration,BP,CCL20;EDN1;TP53;TNF;ICAM1;SERPINE1;ADAM17;LGALS3;IL1A;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
8482,GO:0033628,1.55019349146453e-05,0.999998086650201,10,27,regulation of cell adhesion mediated by integrin,BP,CYP1B1;TGFB2;LYN;EPHA2;SERPINE1;SNAI2;SYK;EFNA1;SWAP70;CCL5
4348,GO:0009913,1.55225921915308e-05,0.999994245484814,31,183,epidermal cell differentiation,BP,KRT1;SPRR3;TRIM16;SPRR2A;KRT2;RUNX1;KRT34;KRT15;FOSL2;KRT4;KRT10;KRT13;KRTAP2-3;HRNR;KRT9;KRT6A;KRT5;KRT17;EPHA2;ERRFI1;SFN;IL20;ZFP36L1;KRT14;MAFF;KEAP1;CAPNS1;CD109;FOXN1;RPTN;TP63
3589,GO:0008009,1.58514244788366e-05,0.999998999498799,7,14,chemokine activity,MF,CCL20;CXCL16;CXCL5;CCL22;CXCL8;CXCL3;CCL5
12373,GO:0048762,1.60389597470832e-05,0.999994674983415,26,137,mesenchymal cell differentiation,BP,NRG1;WNT10A;TGFB2;EDN1;HNRNPAB;CORO1C;PDPN;FGFR2;BMP2;SFRP1;SNAI2;DDX17;SEMA3C;BAMBI;SMAD7;CLASP1;TCOF1;GLIPR2;ZNF703;EFNB1;BMP7;PHLDB2;DAG1;WNT4;EFNA1;PHACTR4
2263,GO:0005178,1.6048361603469e-05,0.999995998498398,18,76,integrin binding,MF,NRG1;CYR61;FN1;CTGF;FBN1;EMP2;LYN;DST;LCP1;ICAM1;COL16A1;ITGAV;ADAM17;PRKCA;SYK;NPNT;GPNMB;ACTN4
13588,GO:0060055,1.80207236044634e-05,0.999998896986523,7,13,angiogenesis involved in wound healing,BP,B4GALT1;SERPINE1;SRF;ETS1;DAG1;TNFAIP3;MCAM
709,GO:0001934,1.84922070230255e-05,0.99998997731826,77,622,positive regulation of protein phosphorylation,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;CTGF;C1QTNF1;SDC4;CSF2;MAP3K14;TGFB2;EDN1;MID1;EMP2;TP53;SQSTM1;IL24;CDKN1A;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;LIF;GPER1;EGR1;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;PARP14;CAB39;SOCS1;OXSR1;JUN;GLIPR2;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;CCL5
9861,GO:0042110,1.88074279410875e-05,0.99999186387192,41,270,T cell activation,BP,MAFB;RUNX1;PTGER4;CYLD;SDC4;RELB;TFRC;CD83;MAP3K14;RSAD2;LFNG;LYN;EFNB2;SIRPA;LCP1;SART1;ICAM1;CD274;IRF1;IL7R;SRF;ELF4;EGR1;ZFP36L1;ADAM17;LGALS3;IL15;ZFP36L2;SYK;MYH9;TNFRSF21;SMAD7;SOCS1;FOXN1;CCR6;GPNMB;EFNB1;RAB27A;WNT4;CTPS1;CCL5
16998,GO:0099081,2.01308894802898e-05,0.99998914166307,75,604,supramolecular polymer,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;JPH2;KRT4;NEFM;ACTG1;CYLD;HSPB1;PDLIM1;KRT10;SDC4;KRT13;FBN1;MID1;DAPK3;KRTAP2-3;KLHL21;SQSTM1;KRT9;KRT6A;MYO1B;BAIAP2;KRT5;DST;TPM4;COL4A1;KRT17;JPH1;FLNA;LCP1;COL27A1;KIF23;SVIL;MTUS1;TPM1;WDR1;PDE4DIP;EPPK1;GPER1;VCL;KRT14;IFFO2;SPTBN1;FHL2;DCTN1;DPYSL3;TCP11L1;COL5A3;SLAIN2;NPNT;ZW10;RCC2;COL5A2;KEAP1;SPECC1;HNRNPU;CLASP1;DCXR;ACTN4;SORBS2;KIF24;INCENP;KIF22;DAG1;COL4A4;TUBB;TTLL5;BIN3
10397,GO:0043228,2.04673845773537e-05,0.999985468321601,302,3275,non-membrane-bounded organelle,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;JPH2;KRT4;NEFM;ACTG1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;SDC4;KRT13;RELB;GPRC5A;ABCF1;CD3EAP;MAP3K14;TXNRD1;MID1;DAPK3;TET3;KRTAP2-3;RSAD2;NUAK1;KLHL21;NLRC5;TP53;SIPA1L3;SQSTM1;PDCD11;KRT9;NOCT;NEDD9;TAF4B;KRT6A;CDKN1A;MYO1B;JUNB;MCM5;ARPC4;EHD1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CORO1C;PKMYT1;SCD;PPAN;RRP1;ENC1;DST;VMP1;PTPN14;NUP153;TPM4;DNAJB1;LSS;TELO2;KRT17;C9ORF3;JPH1;TYMS;ZC3H12A;FLNA;LCP1;GEMIN5;CHP1;CCDC85B;DDX23;CDK4;KIF23;MYO10;CDC42EP2;RRP12;SVIL;PLEKHA7;DAXX;NAT10;MTUS1;PABPC4;ARPC1B;MCM2;CCDC124;TOX4;USP36;AKAP8L;AEN;GRWD1;TPM1;CC2D2A;APTX;DHX37;WDR1;PWP2;IRF1;METTL1;PDE4DIP;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;RRP36;TXN2;LARP4B;ZFP42;SF1;EDF1;GEMIN4;SNAI2;POP1;RRS1;CD2BP2;PRPF19;ZFP36L1;RPLP2;AKAP8;ADAM17;DKC1;FEN1;ISG20L2;FGFR1OP;VCL;KRT14;CBX5;URB2;TSR1;RPLP1;PUM3;POLR1A;DDX17;AJUBA;SENP3;GINS2;DDX47;DDX49;DNTTIP2;FILIP1;CEP95;BRMS1;IFFO2;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;NSFL1C;SPTBN1;FHL2;DCTN1;DPYSL3;TCP11L1;RRP7A;UHRF1;SLAIN2;MYH9;NOM1;NPNT;ORAOV1;LANCL2;RBBP5;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;TBCCD1;ZW10;ROR1;RCC2;NOP56;SMAD7;MRPS12;MRPS24;NOL9;CCDC6;MTA2;TRIP6;ENAH;KEAP1;SPECC1;HNRNPU;TJP1;CLASP1;PQBP1;CEP41;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;THOC1;DNTTIP1;PRDM7;MRPL20;RRP7BP;ARL6IP4;CITED2;RPL27A;SOCS1;HSPA8;JUN;MRPL33;ESR1;CENPN;TCOF1;BLOC1S2;PES1;PAK1IP1;RCC1;DCXR;MCM7;NOP2;NOP14;NOC2L;RBM4;CENPO;HERC2;CNTROB;PARD3;RHOG;ZNF365;XRCC6;EDC4;KLF6;ACTN4;HMGN2;SORBS2;KIF24;SMUG1;TRA2A;KANK4;MPHOSPH8;PHLDB2;INCENP;IPO4;CHAF1A;ZYX;KIF22;MYADM;DAG1;CGNL1;POLR3H;EEF1D;TIMELESS;BLNK;RILPL2;MRPS2;RBM14;TRAF4;TUBB;PSMC3;SMARCC2;SUPT16H;POLR1E;DDX24;MYO1E;SURF6;UTP4;POLR2G;CLTA;NOL3;CDCA5;LRRC59;SWAP70;MKI67;TTLL5;BIN3;POP4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;APEX2
10401,GO:0043232,2.04673845773537e-05,0.999985468321601,302,3275,intracellular non-membrane-bounded organelle,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;JPH2;KRT4;NEFM;ACTG1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;SDC4;KRT13;RELB;GPRC5A;ABCF1;CD3EAP;MAP3K14;TXNRD1;MID1;DAPK3;TET3;KRTAP2-3;RSAD2;NUAK1;KLHL21;NLRC5;TP53;SIPA1L3;SQSTM1;PDCD11;KRT9;NOCT;NEDD9;TAF4B;KRT6A;CDKN1A;MYO1B;JUNB;MCM5;ARPC4;EHD1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CORO1C;PKMYT1;SCD;PPAN;RRP1;ENC1;DST;VMP1;PTPN14;NUP153;TPM4;DNAJB1;LSS;TELO2;KRT17;C9ORF3;JPH1;TYMS;ZC3H12A;FLNA;LCP1;GEMIN5;CHP1;CCDC85B;DDX23;CDK4;KIF23;MYO10;CDC42EP2;RRP12;SVIL;PLEKHA7;DAXX;NAT10;MTUS1;PABPC4;ARPC1B;MCM2;CCDC124;TOX4;USP36;AKAP8L;AEN;GRWD1;TPM1;CC2D2A;APTX;DHX37;WDR1;PWP2;IRF1;METTL1;PDE4DIP;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;RRP36;TXN2;LARP4B;ZFP42;SF1;EDF1;GEMIN4;SNAI2;POP1;RRS1;CD2BP2;PRPF19;ZFP36L1;RPLP2;AKAP8;ADAM17;DKC1;FEN1;ISG20L2;FGFR1OP;VCL;KRT14;CBX5;URB2;TSR1;RPLP1;PUM3;POLR1A;DDX17;AJUBA;SENP3;GINS2;DDX47;DDX49;DNTTIP2;FILIP1;CEP95;BRMS1;IFFO2;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;NSFL1C;SPTBN1;FHL2;DCTN1;DPYSL3;TCP11L1;RRP7A;UHRF1;SLAIN2;MYH9;NOM1;NPNT;ORAOV1;LANCL2;RBBP5;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;TBCCD1;ZW10;ROR1;RCC2;NOP56;SMAD7;MRPS12;MRPS24;NOL9;CCDC6;MTA2;TRIP6;ENAH;KEAP1;SPECC1;HNRNPU;TJP1;CLASP1;PQBP1;CEP41;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;THOC1;DNTTIP1;PRDM7;MRPL20;RRP7BP;ARL6IP4;CITED2;RPL27A;SOCS1;HSPA8;JUN;MRPL33;ESR1;CENPN;TCOF1;BLOC1S2;PES1;PAK1IP1;RCC1;DCXR;MCM7;NOP2;NOP14;NOC2L;RBM4;CENPO;HERC2;CNTROB;PARD3;RHOG;ZNF365;XRCC6;EDC4;KLF6;ACTN4;HMGN2;SORBS2;KIF24;SMUG1;TRA2A;KANK4;MPHOSPH8;PHLDB2;INCENP;IPO4;CHAF1A;ZYX;KIF22;MYADM;DAG1;CGNL1;POLR3H;EEF1D;TIMELESS;BLNK;RILPL2;MRPS2;RBM14;TRAF4;TUBB;PSMC3;SMARCC2;SUPT16H;POLR1E;DDX24;MYO1E;SURF6;UTP4;POLR2G;CLTA;NOL3;CDCA5;LRRC59;SWAP70;MKI67;TTLL5;BIN3;POP4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;APEX2
9027,GO:0035239,2.07364872563461e-05,0.999989079720302,69,539,tube morphogenesis,BP,KRT1;RUNX1;CYR61;HDAC9;FN1;CYP1B1;CTGF;ADM;AMOT;PML;HSPB1;STARD13;SDC4;IRX2;TGFB2;EDN1;B4GALT1;EMP2;HSPG2;ADAMTS9;JUNB;TNF;EFNB2;TNC;FGFR2;PBX1;COL4A1;ZC3H12A;EPHA2;BMP2;ITGAV;EPGN;TNFRSF12A;SERPINE1;PGK1;AMOTL2;SFRP1;CC2D2A;SRF;ETS1;ZFP36L1;RHOB;PRKCA;NTN1;SYK;ROBO1;MYH9;NPNT;IL1A;ACKR3;SMAD7;JUN;ESR1;FOXN1;GPNMB;BMP7;DAG1;TIMELESS;WNT4;TNFAIP3;CXCL8;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM;TP63;PHACTR4
16997,GO:0099080,2.13428540977719e-05,0.999988467048908,75,605,supramolecular complex,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;JPH2;KRT4;NEFM;ACTG1;CYLD;HSPB1;PDLIM1;KRT10;SDC4;KRT13;FBN1;MID1;DAPK3;KRTAP2-3;KLHL21;SQSTM1;KRT9;KRT6A;MYO1B;BAIAP2;KRT5;DST;TPM4;COL4A1;KRT17;JPH1;FLNA;LCP1;COL27A1;KIF23;SVIL;MTUS1;TPM1;WDR1;PDE4DIP;EPPK1;GPER1;VCL;KRT14;IFFO2;SPTBN1;FHL2;DCTN1;DPYSL3;TCP11L1;COL5A3;SLAIN2;NPNT;ZW10;RCC2;COL5A2;KEAP1;SPECC1;HNRNPU;CLASP1;DCXR;ACTN4;SORBS2;KIF24;INCENP;KIF22;DAG1;COL4A4;TUBB;TTLL5;BIN3
10882,GO:0044420,2.16361130852391e-05,0.999994196335219,19,85,extracellular matrix component,CC,FN1;P3H2;CCDC80;FBN1;HSPG2;COL12A1;TNC;DST;COL4A1;COL27A1;NTN1;COL5A3;COL17A1;NPNT;COL5A2;FRAS1;LAMC1;DAG1;COL4A4
2616,GO:0005925,2.2269828294273e-05,0.99998955196743,49,355,focal adhesion,CC,TNS3;ACTG1;HSPB1;PDLIM1;SDC4;NEDD9;HSPG2;CSRP1;EFNB2;CORO1C;TNC;DST;TPM4;LAYN;FLNA;LCP1;EPHA2;CHP1;ICAM1;ITGAV;L1CAM;KIF23;SVIL;ARPC1B;CSRP2;RPLP2;RHOB;ADAM17;VCL;RPLP1;AJUBA;RPS2;RPS9;FHL2;MYH9;SPRY4;NUP214;TRIP6;ENAH;CLASP1;HSPA8;RHOG;ACTN4;SORBS2;PHLDB2;ZYX;DAG1;SLC4A2;MCAM
4806,GO:0012501,2.34229954516648e-05,0.999984808891346,154,1484,programmed cell death,BP,IGFBP3;KRT1;SPRR3;CRYAB;SPRR2A;MMP9;KRT2;CYR61;INHBA;NEFL;CYP1B1;CTGF;KRT34;ADM;KRT15;KRT4;NQO1;PML;CYLD;HSPB1;MYBL2;KRT10;TRAF1;KRT13;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;TP53;SQSTM1;KRT9;IL24;NFKB1;KRT6A;CDKN1A;LYN;AHR;LAMP1;GADD45A;TNF;KRT5;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;KRT17;FOSL1;ZC3H12A;FLNA;EPHA2;GADD45B;TSC22D3;ICAM1;CD274;BMP2;UBE4B;CDK4;DRAM1;ITGAV;SFN;DAXX;TNFRSF12A;SERPINE1;MCM2;XAF1;AEN;RELT;SFRP1;IRF1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;KRT14;LGALS3;TRAF2;PRKCA;NTN1;ROBO1;IFIT3;DDX47;BRMS1;PTTG1IP;FHL2;DNASE1;IL1A;BCL7C;TNFRSF21;TNIP2;SFPQ;SAP30BP;ROR1;PRUNE2;ACKR3;YWHAH;APH1A;CAPNS1;CREB3;MTFP1;KCNIP3;THOC1;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;BLOC1S2;TFDP1;NOC2L;RPTN;BCL2L2;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;EIF5A;GPX4;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;POLR2G;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5
2615,GO:0005924,2.39475735047125e-05,0.999988730748439,49,356,cell-substrate adherens junction,CC,TNS3;ACTG1;HSPB1;PDLIM1;SDC4;NEDD9;HSPG2;CSRP1;EFNB2;CORO1C;TNC;DST;TPM4;LAYN;FLNA;LCP1;EPHA2;CHP1;ICAM1;ITGAV;L1CAM;KIF23;SVIL;ARPC1B;CSRP2;RPLP2;RHOB;ADAM17;VCL;RPLP1;AJUBA;RPS2;RPS9;FHL2;MYH9;SPRY4;NUP214;TRIP6;ENAH;CLASP1;HSPA8;RHOG;ACTN4;SORBS2;PHLDB2;ZYX;DAG1;SLC4A2;MCAM
12276,GO:0048583,2.60786717305813e-05,0.999981684572845,259,2712,regulation of response to stimulus,BP,IGFBP3;IL32;KRT1;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;FN1;C1R;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;ACTG1;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;WNT10A;RELB;TFRC;BAG1;SOD2;GPRC5A;HLA-B;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;UBQLN2;LYN;ARPC4;LAMP1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CXCL16;WWC1;TRIO;PDPN;FGFR2;NUP153;DNAJB1;PSMB9;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;MTUS1;IFNGR1;SERPINE1;ARPC1B;NMT2;ELF3;LIF;SFRP1;TRIM22;SAFB2;HLA-F;IRF1;PSME2;EPPK1;IL7R;PSPC1;TFIP11;THBD;GPER1;NFKBIA;EGR1;JRK;ETS1;SNAI2;RRS1;ARHGEF28;RHOB;NELFE;ADAM17;TXLNA;DHFR;IRS2;IER3;NPAS2;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;SLC7A2;ROBO1;AJUBA;PDGFB;PTTG1IP;DNASE1;RNF115;SPPL2A;COL17A1;NPNT;IL1A;TNFRSF21;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SPRY4;ROR1;NUP214;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;MTA2;YWHAH;CLASP1;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;THOC1;PARP14;CXCL5;DUSP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;TFDP1;NOP2;NOC2L;ZNF703;CCR6;ARRDC3;INSIG1;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;ZSWIM6;CNTNAP1;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;CXORF36;AKIP1;PHLDB2;RAPGEF1;ZYX;MYADM;DAG1;CGNL1;PDE6A;EEF1D;TIMELESS;BLNK;WNT4;RBM14;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;DUSP8;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;IL6R;LAIR1;PARP1;TP63;IL36G;C1S;PHACTR4;TOP3A;CCL5;SH3BP4
11285,GO:0045595,2.69393065062485e-05,0.999983274042941,125,1155,regulation of cell differentiation,BP,IGFBP3;MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;MAP2;FN1;NEFL;CTGF;TENM3;ADM;CYLD;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;G6PD;EMP2;NOCT;NFKB1;TJP2;ADAMTS9;LYN;JUNB;EHD1;TNF;BAIAP2;EFNB2;CORO1C;ENC1;TRIO;PDPN;FGFR2;PBX1;PSMB9;ZC3H12A;FLNA;SART1;CCDC85B;BMP2;ITGAV;ERRFI1;L1CAM;SFN;IL20;TNFRSF12A;SERPINE1;LIF;SFRP1;ZFYVE27;WDR1;IRF1;PSME2;IL7R;GPER1;SRF;NFKBIA;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;LGALS3;IL15;PRKCA;ZFP36L2;NTN1;SYK;DDX17;ROBO1;PDGFB;NEDD4L;DPYSL3;NPNT;SDK1;TNFRSF21;RBBP5;SEMA3C;LILRB3;SPEN;RCC2;COL5A2;MAFF;BAMBI;SMAD7;YWHAH;KEAP1;HNRNPU;CLASP1;PQBP1;TRIB1;KLF10;RBM38;CD109;SOCS1;JUN;IKZF3;FOXN1;GLIPR2;RBM4;ZNF703;INSIG1;ZNF365;ZSWIM6;ACTN4;BMP7;PHLDB2;RAPGEF1;MYADM;DAG1;WNT4;CTDSP1;PSMC3;EFNA1;MAPK11;HSP90AB1;IL6R;PARP1;TP63;FADS1
4363,GO:0009967,2.74865760093544e-05,0.999983149515423,117,1065,positive regulation of signal transduction,BP,IGFBP3;SAA1;TRIM16;CCL20;NRG1;MMP9;CYR61;INHBA;CYP1B1;CTGF;C1QTNF1;JPH2;PML;CYLD;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NLRC5;TP53;IL24;NFKB1;CDKN2B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;WWC1;FGFR2;PSMB9;EPHB6;TELO2;ZC3H12A;FLNA;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;SFN;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;ELF3;LIF;SFRP1;TRIM22;PSME2;IL7R;GPER1;JRK;NELFE;ADAM17;IRS2;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;ROR1;ACKR3;BAMBI;AFAP1L2;SLC35C2;YWHAH;PAGR1;PARP14;CITED2;SOCS1;JUN;ESR1;GLIPR2;TFDP1;ARRDC3;GPNMB;CNTNAP1;ACTN4;BMP7;TNFRSF10A;RAPGEF1;EEF1D;BLNK;WNT4;TRAF4;PSMC3;CCL22;PPP2R1B;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;PARP1;TP63;CCL5
3383,GO:0007160,2.76944060549502e-05,0.999990237529636,27,149,cell-matrix adhesion,BP,FN1;CTGF;SDC4;DAPK3;EMP2;ADAMTS9;CDKN2A;CORO1C;COL16A1;ITGAV;L1CAM;SERPINE1;SFRP1;SRF;VCL;AJUBA;BCAM;COL5A3;COL17A1;NPNT;RCC2;TRIP6;CLASP1;PHLDB2;ZYX;DAG1;WNT4
6956,GO:0030593,2.86832994887698e-05,0.999995502373947,11,36,neutrophil chemotaxis,BP,SAA1;CCL20;TGFB2;EDN1;LGALS3;SYK;CXCL5;CCL22;CXCL8;CXCL3;CCL5
14159,GO:0061041,2.8992577405935e-05,0.999992375096687,18,80,regulation of wound healing,BP,KRT1;C1QTNF1;EDN1;LYN;PDPN;TNFRSF12A;SERPINE1;EPPK1;THBD;PRKCA;SYK;PDGFB;CLASP1;CD109;PHLDB2;WNT4;TNFAIP3;TBXA2R
11028,GO:0044877,2.92457123277618e-05,0.999983592862691,80,666,protein-containing complex binding,MF,CRYAB;NRG1;MMP9;CYR61;FN1;CTGF;C1QTNF1;SACS;FBN1;EMP2;PANX1;NFE2L1;FST;IRS1;CDKN1A;LYN;MYO1B;RAB32;ARPC4;CORO1C;DST;TPM4;ZC3H12A;FLNA;LCP1;GEMIN5;ICAM1;COL16A1;ITGAV;MYO10;GTPBP6;ADRB2;SVIL;ARPC1B;TPM1;WDR1;ANXA8;EPPK1;CD2BP2;ADAM17;IRS2;KRT14;CBX5;LGALS3;PRKCA;SYK;AJUBA;PDGFB;SNRNP70;SERPINH1;DCTN1;COL5A3;UHRF1;MYH9;TAPBPL;NPNT;SMAD7;MTA2;M6PR;ERAL1;HNRNPU;CLASP1;PQBP1;PPP1R9B;DNTTIP1;ATG101;HSPA8;RCC1;GTF2E1;NOC2L;GPNMB;XRCC6;GP6;ACTN4;HMGN2;EIF5A;SMARCC2;SUPT16H;MYO1E;HSP90AB1
4262,GO:0009607,2.96269278266085e-05,0.999984135926799,68,549,response to biotic stimulus,BP,CCL20;PTGER4;ODC1;ADM;CYP1A1;PML;HSPB1;CSF2;PTGES;MAP3K14;EDN1;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;TP53;IL24;NOCT;IL27RA;NFKB1;LYN;JUNB;TNF;BAIAP2;FGFR2;NFKB2;FOSL1;ZC3H12A;ICAM1;CD274;CDK4;IFNGR1;SERPINE1;RELT;TRIM22;IRF1;BANF1;THBD;NFKBIA;AKAP8;ADAM17;IL15;PRKCA;SYK;DDX17;NFKBIB;IFIT3;TNFRSF21;TNIP2;CRCP;PQBP1;TRIB1;CXCL5;JUN;HMGN2;TNFRSF10A;POLR3H;TNFAIP3;CCL22;CXCL8;MAPK11;CXCL3;TBXA2R;IL6R;CCL5
3390,GO:0007167,3.06398821735373e-05,0.999982618576472,83,692,enzyme linked receptor protein signaling pathway,BP,IGFBP3;NRG1;MMP9;CYR61;INHBA;CTGF;ACTG1;PML;HSPB1;GPRC5A;CD3EAP;FBN1;TGFB2;NEDD9;FST;CDKN2B;IRS1;LYN;ARPC4;BAIAP2;EFNB2;TRIO;FGFR2;COL4A1;EPHB6;TNK1;EPHA2;BMP2;CDK4;ITGAV;ERRFI1;STAT5A;EPGN;ADRB2;ARPC1B;LIF;SFRP1;ZFYVE27;GPER1;EGR1;ARHGEF28;ADAM17;IRS2;PRKCA;SYK;ROBO1;PDGFB;SPTBN1;RNF115;NPNT;RASGRP4;SPRY4;ROR1;BAMBI;AFAP1L2;SMAD7;PALM2;HNRNPF;APH1A;KLF10;TGFBRAP1;CITED2;CD109;SOCS1;JUN;ZNF703;PARD3;GP6;EFNB1;BMP7;RAPGEF1;ZYX;BLNK;WNT4;RBM14;EFNA1;MAPK11;MYO1E;BMP8A;POLR2G;HSP90AB1;PARP1;BAIAP2L2
7357,GO:0031399,3.22571690439092e-05,0.999979315791662,135,1263,regulation of protein modification process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DBNDD2;G6PD;EMP2;NUAK1;TP53;SQSTM1;MARVELD3;IL24;CDKN2B;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;PKMYT1;WWC1;FGFR2;EPHB6;TELO2;UBE2C;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;PPP1R3B;GPER1;DNAJB2;EGR1;SNAI2;AKAP8;NELFE;ADAM17;U2AF2;FGFR1OP;RPLP1;TRAF2;IL15;PRKCA;PUM3;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;NSFL1C;NPNT;IL1A;SPRY4;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;PPP1R14C;TRIB1;DCUN1D2;RUVBL2;PPP1R9B;PARP14;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;JUN;GLIPR2;NOC2L;SERTAD1;ARRDC3;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;GCLC;HSP90AB1;SWAP70;IL6R;PHACTR4;CCL5
10572,GO:0043534,3.26529478340155e-05,0.999991317504376,18,81,blood vessel endothelial cell migration,BP,HDAC9;AMOT;HSPB1;STARD13;EMP2;EFNB2;EPHA2;STAT5A;SRF;ETS1;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;EFNA1;CARD10;TBXA2R
11932,GO:0046977,3.36580914671636e-05,1,4,4,TAP binding,MF,TAP1;HLA-F;TAPBP;TAP2
11933,GO:0046978,3.36580914671636e-05,1,4,4,TAP1 binding,MF,TAP1;HLA-F;TAPBP;TAP2
6580,GO:0022407,3.54961641287515e-05,0.999985089674169,36,231,regulation of cell-cell adhesion,BP,C1QTNF1;CYLD;SDC4;TFRC;CD83;MAP3K14;LYN;TNF;EFNB2;PDPN;SIRPA;SART1;ICAM1;CD274;BMP2;MYO10;IRF1;IL7R;ETS1;SNAI2;LGALS3;IL15;PRKCA;SYK;TNFRSF21;SMAD7;CITED2;SOCS1;ZNF703;GPNMB;EFNB1;BMP7;MYADM;WNT4;SWAP70;CCL5
10883,GO:0044421,3.91415826502916e-05,0.999972461861905,235,2506,extracellular region part,CC,IGFBP3;IL32;KRT1;SAA1;SPRR3;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;KRT2;CYR61;INHBA;S100P;FN1;C1R;P3H2;CTGF;C1QTNF1;KRT34;CCDC80;ADM;KRT15;ACTG1;NQO1;IL16;IGFL1;HSPB1;KRT10;SDC4;KRT13;WNT10A;TFRC;SOD2;GPRC5A;UGT1A6;CSF2;FBN1;TGFB2;COBLL1;EDN1;USB1;TXNRD1;PLBD1;PRSS23;B4GALT1;MGAM;G6PD;HRNR;SIPA1L3;SQSTM1;KRT9;STEAP4;IL24;CPA4;LFNG;KRT6A;HSPG2;ADAMTS9;LYN;MYO1B;ARPC4;LAMP1;CSRP1;EHD1;TNF;IGFL3;COL12A1;BAIAP2;KRT5;CXCL16;NAV2;TNC;DST;FGFR2;TPM4;COL4A1;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;CHP1;ICAM1;CD274;BMP2;COL16A1;COL27A1;DDX23;ITGAV;L1CAM;KIF23;PMM2;SFN;COL9A2;EPGN;IL20;PLEKHA7;MTUS1;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;LIF;SFRP1;SAFB2;WDR1;PSME2;DNPEP;BANF1;TFIP11;THBD;EDF1;DOCK10;GEMIN4;POP1;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;IL15;PRKCA;NTN1;ZFC3H1;CMTM3;CDKL1;PDGFB;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;DPYSL3;COL5A3;MYH9;SPPL2A;COL17A1;NPNT;IL1A;SDK1;GLIPR1;SEMA3C;SPEN;COL5A2;YWHAH;CLASP1;CAPNS1;RUVBL2;THOC1;A2ML1;CXCL5;GALNT2;CAB39;CD109;FRAS1;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;LRRC57;EIF3B;CHMP4B;RPTN;QDPR;LAMC1;RHOG;BCL2L2;OLFML3;GP6;CS;ACTN4;HMGN2;EFNB1;LRFN4;BMP7;TKT;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;COL4A4;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;CCL22;DNAJC9;CXCL8;PPP2R1B;EFNA1;MYO1E;SLC3A2;CXCL3;XPNPEP3;BMP8A;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;MCAM;LAIR1;IL36G;C1S;CCL5;SH3BP4
16657,GO:0097530,4.05584307300654e-05,0.999991245059104,14,56,granulocyte migration,BP,SAA1;CCL20;PTGER4;TGFB2;EDN1;WDR1;LGALS3;SYK;IL1A;CXCL5;CCL22;CXCL8;CXCL3;CCL5
17871,GO:1902105,4.1551371556472e-05,0.999984620104683,28,162,regulation of leukocyte differentiation,BP,MAFB;RUNX1;INHBA;CYLD;CD83;FBN1;TJP2;LYN;TNF;SART1;IL20;LIF;SFRP1;IRF1;IL7R;ZFP36L1;IL15;PRKCA;ZFP36L2;SYK;LILRB3;SMAD7;TRIB1;KLF10;SOCS1;JUN;IKZF3;FOXN1
19047,GO:1904894,4.16220385722254e-05,0.999992421888444,12,42,positive regulation of STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;IL20;LIF;IL7R;IL15;PARP14;SOCS1;IL6R;CCL5
7926,GO:0032501,4.19646179674117e-05,0.999969015597756,375,4171,multicellular organismal process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;NEFM;ACTG1;CYP1A1;IL1R2;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;KRT10;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;SOD2;IER2;CD83;CSF2;FBN1;TGFB2;EDN1;GBP1;TXNRD1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;MGAM;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;HRNR;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;MARVELD3;KRT9;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;KRT6A;CDKN1A;TJP2;HSPG2;ADAMTS9;LYN;AHR;JUNB;CSRP1;EHD1;TNF;COL12A1;BAIAP2;EFNB2;KRT5;RING1;CORO1C;WWC1;NAV2;ENC1;TNC;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;PBX1;TPM4;NFKB2;COL4A1;PSMB9;SLC7A5;CLN6;EPHB6;KRT17;FOSL1;C9ORF3;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;ARMC6;SART1;KLF7;EPHA2;HMGCS1;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;CD274;BMP2;COL16A1;UBE4B;COL27A1;CDK4;KREMEN2;ITGAV;ERRFI1;L1CAM;GGCX;SFN;COL9A2;STAT5A;EPGN;ADRB2;SVIL;IL20;TNFRSF12A;SERPINE1;FXYD3;PABPC4;PGK1;MCM2;EBP;CSRP2;AMOTL2;ELF3;RELT;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;SAFB2;DHCR7;WDR1;ANXA8;IRF1;PSME2;LUC7L;EPPK1;IL7R;TFIP11;THBD;GPER1;SRF;NSUN2;ABTB2;ZFP42;NFKBIA;SF1;EGR1;EDF1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;AKAP8;RHOB;ADAM17;GPCPD1;FEN1;DHFR;VCL;IRS2;NPAS2;KRT14;CBX5;LGALS3;ACO1;MAFK;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;SLC7A2;DDX17;ROBO1;NOB1;CDKL1;PDGFB;OXTR;ALYREF;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;COX5B;DPYSL3;COL5A3;RRP7A;MYH9;NOM1;NPNT;IL1A;SDK1;COPS3;TNFRSF21;RASGRP4;RBBP5;SEMA3C;SPRY4;LILRB3;SPEN;ROR1;COL5A2;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;YWHAH;ENAH;KEAP1;HNRNPU;CLASP1;PQBP1;APH1A;CAPNS1;VSIG1;TRIB1;ABT1;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;ZNF267;MARVELD2;DUSP1;CITED2;CD109;SOCS1;STAC;FRAS1;JUN;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;FOXN1;GLIPR2;CHMP4B;RBM4;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;HERC2;PARD3;QDPR;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;GP6;KLF6;ZSWIM6;TEAD4;CNTNAP1;EFNB1;SORBS2;LRFN4;BMP7;PHLPP1;TNFRSF10A;TPRA1;PHLDB2;RAPGEF1;MYADM;DAG1;POLR3H;PDE6A;RAB27A;COL4A4;TIMELESS;GPX4;BLNK;WNT4;AKR1C1;VPS52;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;SLC4A2;BRIP1;CXCL8;EFNA1;MAPK11;MYO1E;XPNPEP3;BMP8A;HES4;CARD10;PTPRB;POLR2G;CLTA;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;HERC6;IL6R;BIN3;PARP1;TP63;PHACTR4
13752,GO:0060326,4.25756113562944e-05,0.999985244979689,25,141,cell chemotaxis,BP,SAA1;CCL20;IL16;HSPB1;TGFB2;EDN1;LYN;CXCL16;EPHA2;MTUS1;SERPINE1;ADAM17;LGALS3;SYK;PDGFB;CREB3;CXCL5;CCR6;RHOG;CCL22;CXCL8;CXCL3;SWAP70;IL6R;CCL5
6590,GO:0022603,4.26584368803992e-05,0.999975337188238,84,712,regulation of anatomical structure morphogenesis,BP,KRT1;NRG1;RUNX1;HDAC9;MAP2;FN1;NEFL;CYP1B1;ADM;AMOT;PML;HSPB1;STARD13;WNT10A;TGFB2;EDN1;GBP1;DAPK3;B4GALT1;EMP2;LFNG;HSPG2;ADAMTS9;EHD1;TNF;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;PSMB9;ZC3H12A;FLNA;EPHA2;ICAM1;BMP2;L1CAM;MYO10;CDC42EP2;TNFRSF12A;SERPINE1;PGK1;LIF;SFRP1;TPM1;ZFYVE27;WDR1;PSME2;SRF;ETS1;SNAI2;RHOB;PRKCA;NTN1;ROBO1;NEDD4L;MYH9;IL1A;SEMA3C;TBCCD1;ROR1;RCC2;COL5A2;BAMBI;YWHAH;PALM2;CLASP1;PQBP1;CITED2;ESR1;GPNMB;ZSWIM6;ACTN4;BMP7;PHLDB2;MYADM;DAG1;WNT4;TNFAIP3;PSMC3;CXCL8;EFNA1;CARD10;TBXA2R
10730,GO:0044085,4.36006347598387e-05,0.999969177643442,234,2475,cellular component biogenesis,BP,CRYAB;NRG1;RUNX1;CYR61;PTGER4;MAP2;FN1;NEFL;CTGF;C1QTNF1;SACS;NEFM;ACTG1;PML;CYLD;MYBL2;TRAF1;SDC4;SOD2;CSF2;COBLL1;EDN1;GBP1;MAT2A;IKBKE;BIRC3;DAPK3;B4GALT1;EMP2;PANX1;TP53;SQSTM1;MARVELD3;PDCD11;NOCT;NEDD9;TAF4B;UBQLN2;MYO1B;RAB32;ARPC4;EHD1;TNF;GNL3L;BAIAP2;KRT5;CDKN2A;CORO1C;PPAN;RRP1;VMP1;NUP153;DNAJB1;FOSL1;UBE2C;ZC3H12A;FLNA;LCP1;SART1;TK1;GEMIN5;CADPS2;EPHA2;CHP1;ICAM1;FANCC;COL16A1;DDX23;KIF23;MYO10;CDC42EP2;ANKS4B;ADRB2;DAXX;NAT10;ARPC1B;MCM2;LSG1;USP36;GRWD1;SFRP1;TPM1;TRIM22;ZFYVE27;CC2D2A;DHX37;WDR1;PWP2;PDE4DIP;LUC7L;TFIP11;SRF;DNAJB2;RRP36;SF1;KCNA7;GEMIN4;SNAI2;RRS1;CD2BP2;PRPF19;RPLP2;RHOB;DKC1;ISG20L2;FGFR1OP;VCL;SHQ1;KCTD10;KRT14;URB2;TSR1;RPLP1;TRAF2;PRKCA;NTN1;DDX17;AJUBA;SENP3;DDX47;NOB1;DDX49;AASS;OXTR;RPS2;UBTF;UTP14A;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;DCTN1;DPYSL3;RRP7A;SLAIN2;NOM1;COL17A1;SDK1;RBBP5;NOP16;FTSJ3;WDR46;ZW10;RCC2;NOP56;SMAD7;NOL9;TAPBP;TRIP6;ERAL1;HNRNPU;TJP1;CLASP1;CEP41;RUVBL2;ABT1;PPP1R9B;MRPL20;RRP7BP;ATG101;MARVELD2;CAB39;TXNL4B;RPL27A;HSPA8;JUN;ESR1;CENPN;PES1;PAK1IP1;RCC1;CPT1A;DCXR;BCS1L;TRAPPC5;NOP2;NOP14;NOC2L;CHMP4B;NACC1;ZNF703;INSIG1;CENPO;CNTROB;PARD3;LAMC1;RHOG;XRCC6;SMPD2;CNTNAP1;ACTN4;KIF24;BMP7;METTL16;KCTD1;KANK4;PHLDB2;RAPGEF1;IPO4;CHAF1A;ZYX;MYADM;DAG1;FAM234A;RAB27A;GPX4;WNT4;RILPL2;RBM14;AKR1C1;TUBB;TNFAIP3;PSMC3;BRIP1;CLDN7;HSD17B10;SURF6;CARD10;UTP4;CLTA;NOL3;SNF8;HSP90AB1;SWAP70;TTLL5;BIN3;POP4;PARP1;TP63;CCL5;BAIAP2L2
4275,GO:0009636,4.41100613271669e-05,0.99997925411778,45,324,response to toxic substance,BP,CRYAB;HDAC9;NEFL;CYP1B1;NQO1;CYP1A1;SOD2;EDN1;TXNRD1;G6PD;TP53;NFKB1;CDKN1A;LYN;AHR;TNF;TNC;FGFR2;FOSL1;TYMS;ZC3H12A;ACAA1;ICAM1;FANCC;CDK4;DAXX;APTX;SRF;ABTB2;EGR1;ETS1;RHOB;DHFR;PDGFB;OXTR;DUSP1;JUN;BMP7;TIMELESS;GPX4;TNFAIP3;BRIP1;CLDN7;TBXA2R;CCL5
1096,GO:0002685,4.42743007745276e-05,0.99998682529567,20,100,regulation of leukocyte migration,BP,CCL20;PTGER4;EDN1;TP53;LYN;TNF;ICAM1;MTUS1;SERPINE1;ADAM17;LGALS3;IL1A;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
15138,GO:0071229,4.44303470374065e-05,0.999984594375704,25,137,cellular response to acid chemical,BP,PTGER4;KRT13;EDN1;LYN;TNF;BAIAP2;TNC;FGFR2;COL4A1;ZC3H12A;COL16A1;CDK4;SFRP1;EGR1;AKAP8;AKR1C2;PDGFB;SNRNP70;LANCL2;COL5A2;SOCS1;CPT1A;AKR1C1;GCLC;SH3BP4
7672,GO:0032101,4.47115369097663e-05,0.999977065056618,57,437,regulation of response to external stimulus,BP,KRT1;SAA1;PTGER4;C1R;C1QTNF1;IL16;IL1R2;HSPB1;EDN1;BIRC3;TRAF3;NFKB1;LYN;TNF;EFNB2;PDPN;ZC3H12A;IL20;MTUS1;SERPINE1;NMT2;EPPK1;THBD;GPER1;NFKBIA;ETS1;SNAI2;ADAM17;IL15;PRKCA;SYK;SLC7A2;ROBO1;PDGFB;DNASE1;SEMA3C;CLASP1;PQBP1;TRIB1;CREB3;CXCL5;CD109;ESR1;CCR6;ZSWIM6;PHLDB2;ZYX;PDE6A;WNT4;TNFAIP3;CXCL8;CXCL3;SWAP70;TBXA2R;IL6R;C1S;CCL5
10508,GO:0043410,4.52652585723265e-05,0.999978376987502,47,335,positive regulation of MAPK cascade,BP,IGFBP3;SAA1;CCL20;NRG1;CTGF;C1QTNF1;MAP3K14;TGFB2;EDN1;MID1;GADD45A;TNF;WWC1;FGFR2;EPHB6;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;DAXX;LIF;GPER1;NELFE;TRAF2;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;ROR1;ACKR3;JUN;GLIPR2;GPNMB;TNFRSF10A;RAPGEF1;TRAF4;CCL22;EFNA1;MAPK11;CCL5
15132,GO:0071222,4.55299286016479e-05,0.999985935163921,21,107,cellular response to lipopolysaccharide,BP,CCL20;CSF2;IL24;NFKB1;LYN;TNF;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;NFKBIA;AKAP8;PRKCA;NFKBIB;TNIP2;TRIB1;TNFAIP3;CXCL8;TBXA2R;CCL5
17037,GO:0099512,4.62796271726853e-05,0.999974196885454,73,598,supramolecular fiber,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;JPH2;KRT4;NEFM;ACTG1;CYLD;HSPB1;PDLIM1;KRT10;SDC4;KRT13;FBN1;MID1;DAPK3;KRTAP2-3;KLHL21;SQSTM1;KRT9;KRT6A;MYO1B;BAIAP2;KRT5;DST;TPM4;KRT17;JPH1;FLNA;LCP1;COL27A1;KIF23;SVIL;MTUS1;TPM1;WDR1;PDE4DIP;EPPK1;GPER1;VCL;KRT14;IFFO2;SPTBN1;FHL2;DCTN1;DPYSL3;TCP11L1;COL5A3;SLAIN2;NPNT;ZW10;RCC2;COL5A2;KEAP1;SPECC1;HNRNPU;CLASP1;DCXR;ACTN4;SORBS2;KIF24;INCENP;KIF22;DAG1;TUBB;TTLL5;BIN3
7599,GO:0031974,4.70948023479298e-05,0.999965133933734,381,4304,membrane-enclosed lumen,CC,IGFBP3;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;P3H2;CYP24A1;DTX2;FOSL2;IL16;NFKBIE;PML;TFCP2L1;RBM19;MYBL2;SDC4;RELB;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;PRSS23;ELMSAN1;RSAD2;NUAK1;HRNR;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;PANK2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;HSPG2;LYN;AHR;JUNB;MCM5;PLEKHO2;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;RING1;CARS2;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;TNC;ASCC2;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;COL4A1;DNAJB1;PSMB9;CLN6;TELO2;FOSL1;C9ORF3;QPCT;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;ACAA1;GEMIN5;CADPS2;FANCC;COL16A1;COL27A1;DDX23;CDK4;KIF23;MYO10;COL9A2;TRMT61A;STAT5A;RRP12;DAXX;NAT10;MTUS1;SERPINE1;FUS;MCM2;LSG1;TOX4;USP36;AKAP8L;AEN;ELF3;GRWD1;TRIM22;ZFYVE27;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;SRF;NSUN2;HS3ST1;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;VCL;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;URB2;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;COLGALT1;COL5A3;RRP7A;UHRF1;NOM1;COL17A1;COPS3;ORAOV1;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;SPEN;RCC2;NOP56;COL5A2;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;WDR4;KEAP1;ERAL1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;TRUB2;ANAPC15;MRPL20;RRP7BP;ARL6IP4;CAB39;TXNL4B;CITED2;SOCS1;HSPA8;JUN;MRPL33;ESR1;IKZF3;CENPN;TCOF1;PES1;PAK1IP1;RCC1;BRPF1;COMMD9;MCM7;TFDP1;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;LAMC1;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;THEM4;SORBS2;SNIP1;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;WNT4;MRPS2;RBM14;TUBB;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;HSD17B10;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;POP4;RPUSD4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2
10402,GO:0043233,4.70948023479298e-05,0.999965133933734,381,4304,organelle lumen,CC,IGFBP3;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;P3H2;CYP24A1;DTX2;FOSL2;IL16;NFKBIE;PML;TFCP2L1;RBM19;MYBL2;SDC4;RELB;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;PRSS23;ELMSAN1;RSAD2;NUAK1;HRNR;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;PANK2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;HSPG2;LYN;AHR;JUNB;MCM5;PLEKHO2;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;RING1;CARS2;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;TNC;ASCC2;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;COL4A1;DNAJB1;PSMB9;CLN6;TELO2;FOSL1;C9ORF3;QPCT;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;ACAA1;GEMIN5;CADPS2;FANCC;COL16A1;COL27A1;DDX23;CDK4;KIF23;MYO10;COL9A2;TRMT61A;STAT5A;RRP12;DAXX;NAT10;MTUS1;SERPINE1;FUS;MCM2;LSG1;TOX4;USP36;AKAP8L;AEN;ELF3;GRWD1;TRIM22;ZFYVE27;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;SRF;NSUN2;HS3ST1;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;VCL;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;URB2;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;COLGALT1;COL5A3;RRP7A;UHRF1;NOM1;COL17A1;COPS3;ORAOV1;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;SPEN;RCC2;NOP56;COL5A2;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;WDR4;KEAP1;ERAL1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;TRUB2;ANAPC15;MRPL20;RRP7BP;ARL6IP4;CAB39;TXNL4B;CITED2;SOCS1;HSPA8;JUN;MRPL33;ESR1;IKZF3;CENPN;TCOF1;PES1;PAK1IP1;RCC1;BRPF1;COMMD9;MCM7;TFDP1;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;LAMC1;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;THEM4;SORBS2;SNIP1;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;WNT4;MRPS2;RBM14;TUBB;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;HSD17B10;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;POP4;RPUSD4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2
14526,GO:0070013,4.70948023479298e-05,0.999965133933734,381,4304,intracellular organelle lumen,CC,IGFBP3;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;P3H2;CYP24A1;DTX2;FOSL2;IL16;NFKBIE;PML;TFCP2L1;RBM19;MYBL2;SDC4;RELB;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;PRSS23;ELMSAN1;RSAD2;NUAK1;HRNR;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;PANK2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;HSPG2;LYN;AHR;JUNB;MCM5;PLEKHO2;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;RING1;CARS2;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;TNC;ASCC2;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;COL4A1;DNAJB1;PSMB9;CLN6;TELO2;FOSL1;C9ORF3;QPCT;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;ACAA1;GEMIN5;CADPS2;FANCC;COL16A1;COL27A1;DDX23;CDK4;KIF23;MYO10;COL9A2;TRMT61A;STAT5A;RRP12;DAXX;NAT10;MTUS1;SERPINE1;FUS;MCM2;LSG1;TOX4;USP36;AKAP8L;AEN;ELF3;GRWD1;TRIM22;ZFYVE27;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;SRF;NSUN2;HS3ST1;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;VCL;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;URB2;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;COLGALT1;COL5A3;RRP7A;UHRF1;NOM1;COL17A1;COPS3;ORAOV1;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;SPEN;RCC2;NOP56;COL5A2;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;WDR4;KEAP1;ERAL1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;TRUB2;ANAPC15;MRPL20;RRP7BP;ARL6IP4;CAB39;TXNL4B;CITED2;SOCS1;HSPA8;JUN;MRPL33;ESR1;IKZF3;CENPN;TCOF1;PES1;PAK1IP1;RCC1;BRPF1;COMMD9;MCM7;TFDP1;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;LAMC1;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;THEM4;SORBS2;SNIP1;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;WNT4;MRPS2;RBM14;TUBB;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;HSD17B10;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;POP4;RPUSD4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2
4268,GO:0009617,4.97250173137693e-05,0.999977190707724,42,298,response to bacterium,BP,CCL20;PTGER4;ADM;CYP1A1;CSF2;PTGES;EDN1;IL24;NOCT;IL27RA;NFKB1;LYN;JUNB;TNF;BAIAP2;FGFR2;NFKB2;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;RELT;THBD;NFKBIA;AKAP8;ADAM17;PRKCA;SYK;NFKBIB;TNFRSF21;TNIP2;TRIB1;CXCL5;JUN;TNFRSF10A;TNFAIP3;CXCL8;CXCL3;TBXA2R;IL6R;CCL5
13868,GO:0060485,5.2011631361864e-05,0.999980477151726,28,163,mesenchyme development,BP,NRG1;WNT10A;TGFB2;EDN1;HNRNPAB;CORO1C;PDPN;FGFR2;BMP2;SFRP1;SNAI2;ZFP36L1;DDX17;SEMA3C;BAMBI;SMAD7;CLASP1;CITED2;TCOF1;GLIPR2;ZNF703;EFNB1;BMP7;PHLDB2;DAG1;WNT4;EFNA1;PHACTR4
6071,GO:0019220,5.27823591726723e-05,0.999966099838161,128,1195,regulation of phosphate metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;ADM;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;MID1;DBNDD2;EMP2;NUAK1;NLRC5;TP53;SQSTM1;MARVELD3;IL24;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;FGFR2;NUP153;EPHB6;TELO2;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;PPP1R3B;GPER1;EGR1;CD2BP2;AKAP8;NELFE;ADAM17;FGFR1OP;IRS2;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NSFL1C;NPNT;IL1A;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;HNRNPU;PPP1R14C;TRIB1;PPP1R9B;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;GLIPR2;MCM7;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;SWAP70;IL6R;PARP1;PHACTR4;CCL5
627,GO:0001816,5.31418125550661e-05,0.999972391030726,58,451,cytokine production,BP,SAA1;TRIM16;CCL20;RUNX1;PTGER4;INHBA;FN1;CYP1B1;IL1R2;PML;CYLD;HSPB1;RELB;CD83;CSF2;TGFB2;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;PANX1;IL27RA;NFKB1;LYN;TNF;NFKB2;ZC3H12A;CD274;ITGAV;ERRFI1;SERPINE1;IRF1;EGR1;SNAI2;AKAP8;ADAM17;TRAF2;IL15;SYK;SPTBN1;IL1A;TNFRSF21;AFAP1L2;SMAD7;CRCP;PQBP1;SOCS1;DTX4;GPNMB;XRCC6;POLR3H;TNFAIP3;MAPK11;HSP90AB1;IL6R
10198,GO:0042802,5.38050663288698e-05,0.999965529756972,124,1163,identical protein binding,MF,MAFB;FTL;CRYAB;MMP9;INHBA;S100P;FN1;NEFL;ODC1;TENM3;ACTG1;NQO1;TAP1;PML;HSPB1;TRAF1;SDC4;RELB;TFRC;SOD2;UGT1A6;FBN1;TGFB2;GBP1;MAT2A;MID1;DAPK3;G6PD;TP53;SQSTM1;NFKB1;EHD1;GADD45A;TNF;BAIAP2;ZBED1;FGFR2;NUP153;TPM4;CLN6;MSANTD3;TYMS;FLNA;LCP1;TK1;HMGCS1;SFN;ADRB2;FUS;AMOTL2;SFRP1;TPM1;SAFB2;PSME2;LUC7L;DNPEP;BANF1;SRF;TRIM29;NFKBIA;SF1;ETS1;PRPF19;FGFR1OP;CBX5;TRAF2;ABCG2;ROBO1;IFIT3;PDGFB;FHL2;UHRF1;MYH9;SPPL2A;SDK1;SNX8;SFPQ;DDX39A;YWHAH;KEAP1;HNRNPU;TPST1;RUVBL2;DNTTIP1;CXCL5;PCYT1A;ATG101;OXSR1;JUN;ESR1;IKZF3;GLIPR2;CPT1A;DCXR;TNPO3;CHMP4B;PARD3;QDPR;SCHIP1;BCL2L2;ACTN4;KIF24;KCTD1;TKT;CHAF1A;DAG1;TIMELESS;GPX4;RILPL2;TRAF4;CD38;TNFAIP3;PSMC3;CLDN7;CTPS1;NOL3;SNF8;HSP90AB1;IL6R;PARP1;TP63;C1S;CCL5;SH3BP4
7359,GO:0031401,5.48598891461522e-05,0.999967270830695,91,791,positive regulation of protein modification process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;CTGF;C1QTNF1;SDC4;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;EMP2;TP53;SQSTM1;IL24;CDKN1A;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;UBE2C;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;GPER1;EGR1;SNAI2;AKAP8;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;DCUN1D2;RUVBL2;PARP14;CAB39;SOCS1;HSPBP1;OXSR1;JUN;GLIPR2;ARRDC3;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;CCL5
11390,GO:0045765,5.57696552035135e-05,0.999978540927864,29,173,regulation of angiogenesis,BP,KRT1;RUNX1;HDAC9;CYP1B1;ADM;AMOT;PML;HSPB1;STARD13;TGFB2;EMP2;HSPG2;ADAMTS9;ZC3H12A;EPHA2;TNFRSF12A;SERPINE1;PGK1;SFRP1;ETS1;RHOB;PRKCA;IL1A;GPNMB;TNFAIP3;CXCL8;EFNA1;CARD10;TBXA2R
7601,GO:0031981,5.62898736588566e-05,0.99995868959187,319,3517,nuclear lumen,CC,TRIM16;CRYAB;NRG1;RUNX1;HDAC9;MAP2;S100P;CYP24A1;DTX2;FOSL2;IL16;NFKBIE;PML;TFCP2L1;RBM19;MYBL2;RELB;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;MAP3K14;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;ELMSAN1;RSAD2;NUAK1;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;GADD45A;GNL3L;BAIAP2;ZBED1;RING1;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;ASCC2;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;C9ORF3;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;CADPS2;FANCC;DDX23;CDK4;KIF23;MYO10;TRMT61A;STAT5A;RRP12;DAXX;NAT10;MTUS1;FUS;MCM2;LSG1;TOX4;USP36;AKAP8L;AEN;ELF3;GRWD1;TRIM22;ZFYVE27;SAFB2;APTX;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;SRF;NSUN2;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;URB2;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;FILIP1;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;FHL2;RRP7A;UHRF1;NOM1;COPS3;ORAOV1;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;SPEN;RCC2;NOP56;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;TATDN2;NOL9;SUPT5H;MTA2;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;ANAPC15;RRP7BP;ARL6IP4;TXNL4B;CITED2;SOCS1;HSPA8;JUN;ESR1;IKZF3;CENPN;TCOF1;PES1;PAK1IP1;RCC1;BRPF1;MCM7;TFDP1;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;XRCC6;EDC4;TRMT1;KLF6;TAP2;TEAD4;ACTN4;SORBS2;SNIP1;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;TIMELESS;GPX4;RBM14;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;SNF8;CDCA5;HSP90AB1;TBXA2R;MKI67;POP4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2
19169,GO:1905209,5.95475740387701e-05,0.999995143307103,7,15,positive regulation of cardiocyte differentiation,BP,NRG1;TGFB2;EDN1;EFNB2;GPER1;SEMA3C;BMP7
14668,GO:0070268,6.02673624219862e-05,0.999984597984428,16,73,cornification,BP,KRT1;SPRR3;SPRR2A;KRT2;KRT34;KRT15;KRT4;KRT10;KRT13;KRT9;KRT6A;KRT5;KRT17;KRT14;CAPNS1;RPTN
10888,GO:0044428,6.19695924273662e-05,0.999954130532859,341,3795,nuclear part,CC,TRIM16;CRYAB;NRG1;RUNX1;HDAC9;MAP2;S100P;CYP24A1;DTX2;AMOT;FOSL2;IL16;NFKBIE;PML;TFCP2L1;RBM19;MYBL2;RELB;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;PTGES;MAP3K14;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;ELMSAN1;RSAD2;NUAK1;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;GADD45A;GNL3L;BAIAP2;ZBED1;RING1;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;ASCC2;DST;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;C9ORF3;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;CADPS2;FANCC;DDX23;CDK4;KIF23;MYO10;TRMT61A;STAT5A;RRP12;ZMAT2;DAXX;NAT10;MTUS1;FUS;MCM2;LSG1;EBP;TOX4;USP36;AKAP8L;AEN;ELF3;GRWD1;TRIM22;ZFYVE27;SAFB2;APTX;DHCR7;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;URB2;LGALS3;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;CMTM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;FILIP1;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;FHL2;DCTN1;DNASE1;RRP7A;UHRF1;MYH9;NOM1;COPS3;ORAOV1;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;SPEN;RCC2;NOP56;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;TATDN2;NOL9;SUPT5H;MTA2;DNAJC1;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;ABT1;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;ANAPC15;PCYT1A;RRP7BP;ARL6IP4;TXNL4B;CITED2;SOCS1;HSPA8;JUN;ESR1;IKZF3;CENPN;TCOF1;PES1;PAK1IP1;RCC1;BRPF1;MCM7;TFDP1;TNPO3;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;XRCC6;EDC4;TRMT1;KLF6;TAP2;TEAD4;ACTN4;SORBS2;SNIP1;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;EIF5A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;TIMELESS;GPX4;RBM14;TUBB;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;POP4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2
3265,GO:0006935,6.38298380608856e-05,0.999968770092919,48,353,chemotaxis,BP,SAA1;CCL20;NRG1;CYR61;AMOT;IL16;HSPB1;TGFB2;EDN1;LYN;EFNB2;CXCL16;FOSL1;KLF7;EPHA2;ITGAV;L1CAM;MTUS1;SERPINE1;ADAM17;IRS2;LGALS3;PRKCA;NTN1;SYK;CMTM3;ROBO1;PDGFB;SPTBN1;SEMA3C;ACKR3;ENAH;CREB3;CXCL5;CCR6;RHOG;GPNMB;ZSWIM6;EFNB1;BMP7;DAG1;CCL22;CXCL8;EFNA1;CXCL3;SWAP70;IL6R;CCL5
3748,GO:0008285,6.49159129804252e-05,0.999965638253692,60,472,negative regulation of cell proliferation,BP,IGFBP3;FTH1;INHBA;P3H2;CYP1B1;ADM;KRT4;PML;SDC4;SOD2;PTGES;TGFB2;B4GALT1;TP53;MARVELD3;IL24;CDKN2B;CDKN1A;LYN;TNF;EFNB2;CDKN2A;PDPN;FGFR2;PTPN14;FOSL1;ZNF503;CD274;BMP2;SFN;LIF;SFRP1;TPM1;IRF1;EPPK1;GPER1;SRF;DNAJB2;SF1;ETS1;SNAI2;IL15;ROBO1;IFIT3;UTP20;IL1A;TNFRSF21;TRIB1;KLF10;CD109;JUN;TFDP1;GPNMB;BMP7;RAPGEF1;TNFAIP3;BRIP1;CXCL8;MAPK11;SH3BP4
12903,GO:0051249,6.56382636679293e-05,0.999971109958042,37,248,regulation of lymphocyte activation,BP,RUNX1;INHBA;CYLD;SDC4;TFRC;CD83;MAP3K14;IL27RA;CDKN1A;LYN;AHR;LAMP1;EFNB2;SIRPA;SART1;CD274;SFRP1;IRF1;IL7R;ZFP36L1;IRS2;LGALS3;IL15;ZFP36L2;SYK;TNFRSF21;TNIP2;SMAD7;THOC1;SOCS1;IKZF3;FOXN1;GPNMB;EFNB1;CD38;TNFAIP3;CCL5
17753,GO:1901701,6.76794751166463e-05,0.999960294093439,83,714,cellular response to oxygen-containing compound,BP,CCL20;MMP9;PTGER4;INHBA;HDAC9;CYP1B1;CYP24A1;NQO1;KRT13;SOD2;CSF2;FBN1;EDN1;TP53;IL24;NFKB1;IRS1;LYN;AHR;TNF;BAIAP2;TNC;FGFR2;COL4A1;ZC3H12A;HMGCS1;ICAM1;FANCC;CD274;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;SERPINE1;SFRP1;TPM1;GPER1;SRF;NFKBIA;EGR1;ETS1;SNAI2;ZFP36L1;AKAP8;RHOB;DHFR;IRS2;TRAF2;IL15;AKR1C2;PRKCA;NFKBIB;PDGFB;SNRNP70;TNIP2;LANCL2;PXMP2;COL5A2;TRIB1;RUVBL2;KLF10;SOCS1;JUN;ESR1;CPT1A;ZNF703;INSIG1;BMP7;ELK1;RAPGEF1;DAG1;TIMELESS;AKR1C1;TNFAIP3;BRIP1;CXCL8;GCLC;TBXA2R;PARP1;CCL5;BAIAP2L2;SH3BP4
12248,GO:0048522,6.78272149922444e-05,0.999949897515924,319,3481,positive regulation of cellular process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;ODC1;CYP1B1;CTGF;TENM3;C1QTNF1;ADM;TNS3;FOSL2;JPH2;NQO1;CYP1A1;PML;CYLD;HSPB1;MYBL2;SDC4;RELB;TFRC;SOD2;ARID3B;IER2;CD83;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;RSAD2;EMP2;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NOCT;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;UBQLN2;ADAMTS9;LYN;AHR;JUNB;ARPC4;LAMP1;EHD1;GADD45A;TNF;BAIAP2;ZBED1;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;ENC1;TNC;TRIO;PDPN;FGFR2;PBX1;NFKB2;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;ZC3H12A;FLNA;LCP1;CYB5R1;SART1;CADPS2;KLF7;EPHA2;CHP1;GADD45B;ICAM1;CD274;BMP2;COL16A1;CDK4;ITGAV;L1CAM;KIF23;SFN;CDC42EP2;STAT5A;EPGN;RNF19B;ADRB2;SVIL;IL20;DAXX;TNFRSF12A;FOXD2;SERPINE1;ARPC1B;USP36;AKAP8L;ELF3;LIF;OSR2;SFRP1;TPM1;TRIM22;ZFYVE27;WDR1;MKL1;IRF1;PSME2;IL7R;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;JRK;EDF1;ETS1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;U2AF2;FGFR1OP;SHQ1;IRS2;NPAS2;PPRC1;LGALS3;RPLP1;TRAF2;IL15;SF3B4;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;CMTM3;DDX17;ROBO1;AJUBA;PDGFB;BRMS1;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SNRNP70;FHL2;DCTN1;COLGALT1;DPYSL3;UHRF1;SLAIN2;MYH9;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SAP30BP;WDR46;SPEN;ROR1;ACSL1;RCC2;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;CLASP1;APH1A;PAGR1;CAPNS1;UBE2J2;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CXCL5;DUSP1;CAB39;CITED2;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;CPT1A;TFDP1;NOP2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;KLF6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;GLIS3;SNIP1;BMP7;METTL16;TNFRSF10A;ELK1;PHLDB2;PHF5A;RAPGEF1;EIF5A;MYADM;DAG1;EEF1D;RAB27A;TIMELESS;BLNK;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;CXCL3;BMP8A;CARD10;RNF144B;POLR2G;CREB5;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;MCAM;IL6R;PARP1;TP63;CCL5;BAIAP2L2;SH3BP4
9960,GO:0042330,6.81246377430524e-05,0.999966571655015,48,354,taxis,BP,SAA1;CCL20;NRG1;CYR61;AMOT;IL16;HSPB1;TGFB2;EDN1;LYN;EFNB2;CXCL16;FOSL1;KLF7;EPHA2;ITGAV;L1CAM;MTUS1;SERPINE1;ADAM17;IRS2;LGALS3;PRKCA;NTN1;SYK;CMTM3;ROBO1;PDGFB;SPTBN1;SEMA3C;ACKR3;ENAH;CREB3;CXCL5;CCR6;RHOG;GPNMB;ZSWIM6;EFNB1;BMP7;DAG1;CCL22;CXCL8;EFNA1;CXCL3;SWAP70;IL6R;CCL5
9958,GO:0042327,6.8477673759817e-05,0.999960594432343,78,656,positive regulation of phosphorylation,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;CTGF;C1QTNF1;SDC4;CSF2;MAP3K14;TGFB2;EDN1;MID1;EMP2;TP53;SQSTM1;IL24;IRS1;CDKN1A;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;LIF;GPER1;EGR1;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;PARP14;CAB39;SOCS1;OXSR1;JUN;GLIPR2;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;CCL5
15201,GO:0071346,6.93027957871574e-05,0.999977866112209,21,110,cellular response to interferon-gamma,BP,CCL20;ACTG1;PML;HLA-B;EDN1;GBP1;MID1;DAPK3;NLRC5;ICAM1;CDC42EP2;IFNGR1;TRIM22;HLA-F;IRF1;PARP14;SOCS1;ZYX;CCL22;HSP90AB1;CCL5
4285,GO:0009653,7.38119553798678e-05,0.999949436800765,172,1704,anatomical structure morphogenesis,BP,KRT1;MAFB;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;ADM;AMOT;TUFT1;ACTG1;PML;TFCP2L1;HSPB1;STARD13;SDC4;KRT13;WNT10A;IRX2;FBN1;TGFB2;EDN1;GBP1;TXNRD1;DAPK3;B4GALT1;EMP2;SIPA1L3;NFE2L1;PANK2;LFNG;HSPG2;ADAMTS9;JUNB;EHD1;TNF;COL12A1;BAIAP2;EFNB2;RING1;CORO1C;TNC;PDPN;FGFR2;PTPN14;PBX1;NFKB2;COL4A1;PSMB9;KRT17;SLC39A1;ZC3H12A;FLNA;KLF7;EPHA2;ICAM1;FANCC;ARFRP1;BMP2;UBE4B;COL27A1;ITGAV;ERRFI1;L1CAM;MYO10;CDC42EP2;EPGN;TNFRSF12A;FOXD2;SERPINE1;PGK1;AMOTL2;ELF3;LIF;OSR2;SFRP1;TPM1;ZFYVE27;CC2D2A;WDR1;PSME2;IL7R;SRF;DOCK10;ETS1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;VCL;RIPK4;IRS2;IER3;PRKCA;NTN1;SYK;ROBO1;AJUBA;SPTBN1;NEDD4L;SERPINH1;FHL2;RRP7A;MYH9;NPNT;IL1A;SDK1;SEMA3C;TBCCD1;ROR1;RCC2;COL5A2;ACKR3;BAMBI;SMAD7;YWHAH;PALM2;ENAH;CLASP1;PQBP1;VSIG1;ETS2;DUSP1;CITED2;CD109;FRAS1;JUN;ESR1;TCOF1;FOXN1;INSIG1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;ZSWIM6;CNTNAP1;ACTN4;EFNB1;LRFN4;BMP7;AKIP1;PHLDB2;MYADM;DAG1;TIMELESS;WNT4;RILPL2;VPS52;TNFAIP3;PSMC3;CXCL8;PPP2R1B;EFNA1;MYO1E;CARD10;PTPRB;TBXA2R;MCAM;BIN3;TP63;PHACTR4
11159,GO:0045216,7.53238377713433e-05,0.999970480489661,29,174,cell-cell junction organization,BP,RUNX1;SDC4;TGFB2;DAPK3;MARVELD3;TNF;CORO1C;COL16A1;PLEKHA7;SFRP1;WDR1;SRF;SNAI2;VCL;PRKCA;AJUBA;SDK1;RCC2;SMAD7;TRIP6;TJP1;CLASP1;MARVELD2;ZNF703;PARD3;CNTNAP1;ACTN4;PHLDB2;WNT4
14725,GO:0070374,7.5596346113378e-05,0.999974933417262,22,117,positive regulation of ERK1 and ERK2 cascade,BP,CCL20;CTGF;TNF;FGFR2;EPHB6;EPHA2;ICAM1;BMP2;GPER1;NELFE;PRKCA;PDGFB;NPNT;IL1A;ROR1;ACKR3;JUN;GLIPR2;GPNMB;RAPGEF1;CCL22;CCL5
16496,GO:0097191,8.05420024143523e-05,0.999968861394597,28,170,extrinsic apoptotic signaling pathway,BP,INHBA;PML;CYLD;TRAF1;CSF2;TGFB2;DAPK3;TNF;ICAM1;ITGAV;DAXX;TNFRSF12A;SERPINE1;SFRP1;GPER1;SNAI2;LGALS3;TRAF2;DDX47;IL1A;BLOC1S2;BCL2L2;TNFRSF10A;TNFAIP3;PPP2R1B;NOL3;GCLC;IL6R
19656,GO:1990904,8.21673821045147e-05,0.999952356158227,78,701,ribonucleoprotein complex,CC,ABCF1;SQSTM1;PDCD11;NOCT;GNL3L;PPAN;RRP1;ZC3H12A;SRSF2;SART1;GEMIN5;DDX23;ZMAT2;NAT10;FUS;PABPC4;PWP2;LUC7L;TFIP11;NSUN2;RRP36;LARP4B;SF1;GEMIN4;POP1;RRS1;CD2BP2;PRPF19;ZFP36L1;RPLP2;DKC1;U2AF2;CBX5;LGALS3;TSR1;RPLP1;SF3B4;AJUBA;NOB1;RPS2;ALYREF;UTP14A;UTP20;RPS9;SNRNP70;RRP7A;DDX39A;FTSJ3;WDR46;NOP56;MRPS12;MRPS24;HNRNPU;HNRNPF;PQBP1;MRPL20;RRP7BP;TXNL4B;RPL27A;SOCS1;HSPA8;MRPL33;PES1;NOP14;NOC2L;RBM4;EDC4;EFTUD2;PHF5A;BLNK;MRPS2;TUBB;PSMC3;HSD17B10;SURF6;POLR2G;POP4;MAGOH
7002,GO:0030686,8.6503729520997e-05,0.99998617245058,10,32,90S preribosome,CC,NAT10;PWP2;RRP36;UTP20;RRP7A;WDR46;RRP7BP;PES1;NOP14;NOC2L
12856,GO:0051174,8.76378698328914e-05,0.999942698363583,128,1208,regulation of phosphorus metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;ADM;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;MID1;DBNDD2;EMP2;NUAK1;NLRC5;TP53;SQSTM1;MARVELD3;IL24;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;FGFR2;NUP153;EPHB6;TELO2;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;PPP1R3B;GPER1;EGR1;CD2BP2;AKAP8;NELFE;ADAM17;FGFR1OP;IRS2;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NSFL1C;NPNT;IL1A;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;HNRNPU;PPP1R14C;TRIB1;PPP1R9B;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;GLIPR2;MCM7;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;SWAP70;IL6R;PARP1;PHACTR4;CCL5
4471,GO:0010467,8.81300615976635e-05,0.999933884943357,377,4264,gene expression,BP,MAFB;TRIM16;CRYAB;NRG1;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;CYP1B1;CTGF;C1QTNF1;FOSL2;IL16;IL1R2;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;WNT10A;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;BIRC3;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ENC1;TNC;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;C9ORF3;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;DDX23;CDK4;ZNF142;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ERAL1;HNRNPU;HNRNPF;PQBP1;APH1A;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;MRPL20;RHBDL2;RBM38;RRP7BP;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;MRPL33;ESR1;IKZF3;TCOF1;PES1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;DUS2;ARGLU1;RHOG;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;EIF3I;EIF5A;UBAP2L;MYADM;POLR3H;EEF1D;RAB27A;DHX34;TIMELESS;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;POLR1E;HSD17B10;XPNPEP3;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;GCLC;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;C1S;CCL5;FADS1;MAGOH
6907,GO:0030490,8.81371368575596e-05,0.999980734432125,13,53,maturation of SSU-rRNA,BP,PDCD11;NAT10;PWP2;RRP36;RRS1;TSR1;NOB1;UTP14A;UTP20;WDR46;ABT1;NOP14;UTP4
12900,GO:0051246,8.82035683938733e-05,0.999937979211012,196,2017,regulation of protein metabolic process,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;INHBA;FN1;C1R;ODC1;CTGF;C1QTNF1;IL1R2;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;TP53;SQSTM1;MARVELD3;IL24;NFKB1;CDKN2B;CDKN1A;UBQLN2;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;PKMYT1;WWC1;ENC1;FGFR2;NUP153;BACE2;PSMB9;CLN6;EPHB6;TELO2;KRT17;UBE2C;TYMS;ZC3H12A;FLNA;GEMIN5;EPHA2;CHP1;EIF5;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;RNF19B;ADRB2;IL20;DAXX;SERPINE1;AKAP8L;ZC3H7B;LIF;SFRP1;PARL;PPP1R3B;ANXA8;IRF1;PSME2;DPH2;CTIF;GPER1;DNAJB2;LARP4B;ABTB2;NFKBIA;EGR1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;ADAM17;SNX12;DHFR;U2AF2;FGFR1OP;ACO1;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;UHRF1;MYH9;NPNT;IL1A;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;DNAJC1;KEAP1;PPP1R14C;TRIB1;DCUN1D2;RUVBL2;PPP1R9B;A2ML1;PARP14;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;JUN;ESR1;TCOF1;GLIPR2;EIF3B;NOC2L;RBM4;SERTAD1;ARRDC3;DUS2;PARD3;GPNMB;XRCC6;SNIP1;BMP7;METTL16;PHLPP1;TNFRSF10A;RAPGEF1;EIF5A;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;DUSP8;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;TP63;C1S;PHACTR4;CCL5;MAGOH
6595,GO:0022612,8.87193554735245e-05,0.999974239279508,18,86,gland morphogenesis,BP,PML;TGFB2;B4GALT1;TNF;TNC;FGFR2;EPHA2;ELF3;SFRP1;SNAI2;NTN1;SEMA3C;ESR1;BMP7;DAG1;WNT4;TNFAIP3;TP63
647,GO:0001837,8.95385794146354e-05,0.99997287724538,19,94,epithelial to mesenchymal transition,BP,TGFB2;HNRNPAB;PDPN;FGFR2;BMP2;SFRP1;SNAI2;DDX17;BAMBI;SMAD7;CLASP1;TCOF1;GLIPR2;ZNF703;BMP7;PHLDB2;DAG1;WNT4;EFNA1
15129,GO:0071219,9.27647087966454e-05,0.99996967727343,21,112,cellular response to molecule of bacterial origin,BP,CCL20;CSF2;IL24;NFKB1;LYN;TNF;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;NFKBIA;AKAP8;PRKCA;NFKBIB;TNIP2;TRIB1;TNFAIP3;CXCL8;TBXA2R;CCL5
20268,GO:2001236,9.34948546316045e-05,0.999968453281138,22,120,regulation of extrinsic apoptotic signaling pathway,BP,INHBA;PML;CYLD;TRAF1;CSF2;DAPK3;TNF;ICAM1;ITGAV;TNFRSF12A;SERPINE1;SFRP1;GPER1;SNAI2;LGALS3;TRAF2;IL1A;TNFRSF10A;TNFAIP3;PPP2R1B;NOL3;GCLC
2405,GO:0005576,9.71157738047199e-05,0.999929355666728,255,2786,extracellular region,CC,IGFBP3;IL32;KRT1;SAA1;SPRR3;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;KRT2;CYR61;INHBA;S100P;FN1;C1R;P3H2;CTGF;C1QTNF1;KRT34;CCDC80;ADM;KRT15;TUFT1;ACTG1;NQO1;IL16;IL1R2;IGFL1;HSPB1;KRT10;SDC4;KRT13;WNT10A;TFRC;SOD2;GPRC5A;UGT1A6;CSF2;FBN1;TGFB2;COBLL1;EDN1;GBP1;USB1;TXNRD1;PLBD1;PRSS23;B4GALT1;MGAM;G6PD;GFOD1;HRNR;APOL6;SIPA1L3;SQSTM1;KRT9;STEAP4;IL24;FST;NFKB1;CPA4;LFNG;KRT6A;HSPG2;ADAMTS9;LYN;MYO1B;PLEKHO2;ARPC4;LAMP1;CSRP1;EHD1;TNF;IGFL3;COL12A1;BAIAP2;KRT5;CXCL16;NAV2;TNC;DST;FGFR2;TPM4;COL4A1;DNAJB1;PSMB9;SLC7A5;EPHB6;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;ACAA1;CHP1;ICAM1;CD274;BMP2;COL16A1;COL27A1;DDX23;ITGAV;L1CAM;KIF23;PMM2;SFN;COL9A2;LYPD6B;EPGN;IL20;PLEKHA7;MTUS1;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;LIF;SFRP1;SAFB2;WDR1;PSME2;DNPEP;BANF1;IL7R;TFIP11;THBD;EDF1;DOCK10;GEMIN4;POP1;RPLP2;RHOB;SNX12;UPK3B;TXLNA;VCL;KRT14;LGALS3;ACO1;RPLP1;IL15;PRKCA;C9ORF47;NTN1;ZFC3H1;CMTM3;CDKL1;PDGFB;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;DPYSL3;COL5A3;MYH9;SPPL2A;COL17A1;NPNT;IL1A;SDK1;GLIPR1;SEMA3C;SPEN;COL5A2;YWHAH;CLASP1;CAPNS1;RUVBL2;THOC1;A2ML1;CXCL5;GALNT2;CAB39;CD109;FRAS1;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;COMMD9;LRRC57;EIF3B;CHMP4B;RPTN;QDPR;LAMC1;RHOG;BCL2L2;OLFML3;XRCC6;GP6;CS;ACTN4;HMGN2;EFNB1;LRFN4;BMP7;TKT;OVCH2;CXORF36;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;COL4A4;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;PSMC3;CCL22;DNAJC9;CXCL8;PPP2R1B;EFNA1;MYO1E;SLC3A2;CXCL3;XPNPEP3;BMP8A;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;MCAM;IL6R;LAIR1;IL36G;C1S;CCL5;SH3BP4
11097,GO:0045109,0.000105068497760646,0.999990272550452,7,16,intermediate filament organization,BP,KRT2;NEFL;NEFM;KRT9;KRT17;EPPK1;KRT14
1153,GO:0002761,0.000114399887713397,0.999969041235621,16,73,regulation of myeloid leukocyte differentiation,BP,MAFB;RUNX1;INHBA;FBN1;TJP2;LYN;TNF;IL20;LIF;SFRP1;ZFP36L1;PRKCA;LILRB3;TRIB1;KLF10;JUN
15127,GO:0071216,0.000116699552943151,0.999958789101756,23,130,cellular response to biotic stimulus,BP,CCL20;CSF2;TP53;IL24;NFKB1;LYN;TNF;ZC3H12A;ICAM1;CD274;CDK4;SERPINE1;NFKBIA;AKAP8;PRKCA;SYK;NFKBIB;TNIP2;TRIB1;TNFAIP3;CXCL8;TBXA2R;CCL5
225,GO:0000466,0.000116903294675886,0.999985747401513,8,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,PDCD11;RRS1;UTP20;FTSJ3;NOL9;ABT1;PES1;NOP14
12354,GO:0048729,0.000119984752653152,0.999935636143045,57,450,tissue morphogenesis,BP,NRG1;CYR61;INHBA;ADM;PML;STARD13;SDC4;WNT10A;IRX2;TGFB2;EDN1;TXNRD1;B4GALT1;TNF;EFNB2;TNC;PDPN;FGFR2;PBX1;COL4A1;PSMB9;KRT17;FLNA;EPHA2;BMP2;UBE4B;LIF;SFRP1;TPM1;CC2D2A;WDR1;PSME2;SRF;SNAI2;RHOB;ADAM17;VCL;RIPK4;NTN1;AJUBA;NPNT;SEMA3C;ROR1;SMAD7;CLASP1;FRAS1;ESR1;FOXN1;BMP7;PHLDB2;DAG1;TIMELESS;WNT4;VPS52;PSMC3;TP63;PHACTR4
4533,GO:0010604,0.000120835171049771,0.999913546407368,213,2219,positive regulation of macromolecule metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CTGF;C1QTNF1;FOSL2;PML;HSPB1;MYBL2;SDC4;WNT10A;RELB;TFRC;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;TET3;EMP2;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NOCT;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;ZBED1;WWC1;TNC;FGFR2;PBX1;NFKB2;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;ZC3H12A;KLF7;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;PSME2;IL7R;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;U2AF2;IRS2;NPAS2;PPRC1;RPLP1;TRAF2;IL15;SF3B4;PRKCA;ZFP36L2;SYK;POLR1A;DDX17;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;NEDD4L;SNRNP70;FHL2;UHRF1;MYH9;NPNT;IL1A;TNIP2;SFPQ;ROR1;ACSL1;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;KEAP1;HNRNPU;PAGR1;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CAB39;CITED2;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;TFDP1;SERTAD1;ARRDC3;INSIG1;RHOG;GPNMB;XRCC6;KLF6;TEAD4;GLIS3;BMP7;METTL16;TNFRSF10A;ELK1;PHF5A;RAPGEF1;EIF5A;UBAP2L;DAG1;RAB27A;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;CARD10;RNF144B;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5
1105,GO:0002694,0.000127379003390702,0.999939907439588,40,284,regulation of leukocyte activation,BP,RUNX1;INHBA;CYLD;SDC4;TFRC;CD83;MAP3K14;IL27RA;CDKN1A;LYN;AHR;LAMP1;EFNB2;SIRPA;ZC3H12A;SART1;CD274;SFRP1;IRF1;IL7R;GPER1;ZFP36L1;IRS2;LGALS3;IL15;ZFP36L2;SYK;SLC7A2;TNFRSF21;TNIP2;SMAD7;THOC1;SOCS1;IKZF3;FOXN1;GPNMB;EFNB1;CD38;TNFAIP3;CCL5
8704,GO:0034341,0.000134140391180843,0.999953412050451,22,124,response to interferon-gamma,BP,CCL20;ACTG1;PML;HLA-B;EDN1;GBP1;MID1;DAPK3;NLRC5;CXCL16;ICAM1;CDC42EP2;IFNGR1;TRIM22;HLA-F;IRF1;PARP14;SOCS1;ZYX;CCL22;HSP90AB1;CCL5
15488,GO:0071840,0.000136105741715168,0.99989649463374,417,4801,cellular component organization or biogenesis,BP,IGFBP3;TRIM16;CRYAB;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;C1QTNF1;CCDC80;ADM;KRT15;AMOT;KRT4;SACS;NEFM;ACTG1;TAP1;PML;TFCP2L1;CYLD;MYBL2;TRAF1;SDC4;KRT13;TFRC;SOD2;CSF2;FBN1;TGFB2;COBLL1;EDN1;GBP1;MAT2A;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;DBNDD2;G6PD;EMP2;HRNR;PANX1;TP53;SIPA1L3;SQSTM1;MARVELD3;PDCD11;KRT9;PANK2;NOCT;NEDD9;CPA4;TAF4B;GNPTAB;KRT6A;CDKN1A;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;MCM5;ARPC4;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;EFNB2;KRT5;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;PPAN;RRP1;ENC1;TNC;DST;VMP1;GPRIN1;PDPN;FGFR2;NUP153;TPM4;NFKB2;COL4A1;DNAJB1;CLN6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;ZC3H12A;FLNA;LCP1;CYB5R1;TNK1;SART1;TK1;GEMIN5;CADPS2;KLF7;EPHA2;CHP1;CCDC85B;ICAM1;FANCC;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ITGAV;L1CAM;KIF23;MYO10;SFN;CDC42EP2;COL9A2;EPGN;ANKS4B;ADRB2;SVIL;PLEKHA7;DAXX;TNFRSF12A;NAT10;SERPINE1;ARPC1B;MCM2;LSG1;TOX4;USP36;AKAP8L;AMOTL2;ELF3;GRWD1;LIF;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;CC2D2A;PTGFRN;DHX37;WDR1;ANXA8;PWP2;PDE4DIP;LUC7L;BANF1;EPPK1;IL7R;TFIP11;GPER1;SRF;DNAJB2;RRP36;SF1;PARD3B;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;RRS1;CD2BP2;PRPF19;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;DHFR;ISG20L2;FGFR1OP;VCL;SHQ1;KCTD10;IRS2;KRT14;PPRC1;URB2;LGALS3;TSR1;RPLP1;TRAF2;REEP1;PRKCA;NTN1;SYK;DDX17;ROBO1;AJUBA;SENP3;GINS2;DDX47;NOB1;DDX49;PDGFB;AASS;BRMS1;OXTR;RPS2;UBTF;UTP14A;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SERPINH1;DCTN1;COLGALT1;DPYSL3;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;NOM1;COL17A1;NPNT;IL1A;SDK1;COPS3;SNX8;RBBP5;RUNDC1;SEMA3C;SFPQ;NOP16;BRD9;FTSJ3;WDR46;TBCCD1;ZW10;RCC2;NOP56;COL5A2;NUP214;BAMBI;TRAM2;SMAD7;MRPS12;MRPS24;NOL9;CCDC6;MTA2;YWHAH;TAPBP;TRIP6;PALM2;ENAH;SPECC1;M6PR;ERAL1;HNRNPU;TJP1;CLASP1;PQBP1;CAPNS1;UBE2J2;VSIG1;CEP41;RUVBL2;ABT1;PPP1R9B;MTFP1;TANGO2;MICAL3;SAFB;ANAPC15;PRDM7;MRPL20;RRP7BP;ATG101;MARVELD2;DUSP1;CAB39;TGFBRAP1;TXNL4B;RPL27A;HSPA8;JUN;MRPL33;ESR1;CENPN;BLOC1S2;PES1;PAK1IP1;RCC1;BRPF1;CPT1A;DCXR;MCM7;TFDP1;OGFR;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;CHMP4B;NACC1;ZNF703;INSIG1;CENPO;CNTROB;PARD3;LAMC1;RHOG;ZNF365;XRCC6;TAP2;CHCHD6;ZSWIM6;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SORBS2;KIF24;LRFN4;SNIP1;BMP7;METTL16;KCTD1;CLUH;KANK4;TOMM40;AKIP1;PHLDB2;SGSM1;INCENP;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;KIF22;MYADM;DAG1;TMEM165;FAM234A;CGNL1;RAB27A;COL4A4;GPX4;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;TUBB;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;SUPT16H;EFNA1;CLDN7;MYO1E;HSD17B10;SURF6;ATAD3C;CARD10;UTP4;CLTA;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;FBLN2;MKI67;TTLL5;BIN3;POP4;PARP1;TP63;PHACTR4;TOP3A;CCL5;BAIAP2L2;SH3BP4
6866,GO:0030336,0.000141665936661771,0.999944298634016,27,165,negative regulation of cell migration,BP,IGFBP3;NRG1;PTGER4;CYP1B1;STARD13;MARVELD3;IL24;ADAMTS9;CORO1C;SERPINE1;SFRP1;TPM1;EPPK1;SRF;RHOB;VCL;ROBO1;DPYSL3;SMAD7;CLASP1;TRIB1;CITED2;PHLDB2;DAG1;WNT4;CARD10;TBXA2R
4762,GO:0010941,0.00014189894752992,0.999906468307348,124,1188,regulation of cell death,BP,IGFBP3;CRYAB;MMP9;CYR61;INHBA;NEFL;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;HSPB1;MYBL2;TRAF1;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;TP53;SQSTM1;NFKB1;CDKN1A;LYN;JUNB;GADD45A;TNF;EFNB2;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;FOSL1;ZC3H12A;FLNA;EPHA2;CHP1;GADD45B;TSC22D3;ICAM1;CD274;BMP2;CDK4;ITGAV;SFN;DAXX;TNFRSF12A;SERPINE1;RELT;SFRP1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;NPAS2;LGALS3;TRAF2;PRKCA;ROBO1;IFIT3;BRMS1;PTTG1IP;FHL2;IL1A;GPR75;TNFRSF21;TNIP2;SFPQ;SAP30BP;ROR1;ACKR3;YWHAH;APH1A;CREB3;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;TFDP1;NOC2L;CHMP4B;DUS2;GPNMB;BCL2L2;ACTN4;BMP7;PHLPP1;TNFRSF10A;ELK1;GPX4;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;NOL3;GCLC;HSP90AB1;PARP1;TP63;CCL5
14803,GO:0070527,0.000147997582222868,0.99997131339928,11,40,platelet aggregation,BP,C1QTNF1;ACTG1;HSPB1;LYN;CSRP1;PDPN;FLNA;VCL;PRKCA;SYK;MYH9
12855,GO:0051173,0.000148845088956362,0.999893587167686,203,2097,positive regulation of nitrogen compound metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CTGF;C1QTNF1;ADM;FOSL2;PML;HSPB1;MYBL2;SDC4;RELB;TFRC;ARID3B;IER2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;TET3;EMP2;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NFKB1;CDKN2B;TAF4B;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;ZC3H12A;KLF7;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;PSME2;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;U2AF2;NPAS2;PPRC1;RPLP1;TRAF2;IL15;SF3B4;PRKCA;ZFP36L2;SYK;DDX17;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;NEDD4L;SNRNP70;FHL2;UHRF1;MYH9;NPNT;IL1A;TNIP2;SFPQ;ROR1;ACSL1;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;KEAP1;HNRNPU;PAGR1;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CAB39;CITED2;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;TFDP1;SERTAD1;ARRDC3;INSIG1;RHOG;GPNMB;XRCC6;KLF6;TEAD4;SMPD2;GLIS3;BMP7;METTL16;TNFRSF10A;ELK1;PHF5A;RAPGEF1;EIF5A;DAG1;TIMELESS;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;SUPT16H;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5
10579,GO:0043542,0.000149039926448496,0.99994500152677,24,140,endothelial cell migration,BP,HDAC9;S100P;CYP1B1;AMOT;HSPB1;STARD13;EDN1;EMP2;ADAMTS9;EFNB2;ZC3H12A;EPHA2;STAT5A;SRF;ETS1;RHOB;ADAM17;PRKCA;ROBO1;PDGFB;MYH9;EFNA1;CARD10;TBXA2R
2425,GO:0005604,0.000151883497739235,0.999959960013633,15,67,basement membrane,CC,FN1;P3H2;CCDC80;FBN1;HSPG2;TNC;DST;COL4A1;NTN1;COL17A1;NPNT;FRAS1;LAMC1;DAG1;COL4A4
11350,GO:0045682,0.000154956422386274,0.9999589986638,15,68,regulation of epidermis development,BP,TRIM16;RUNX1;TGFB2;FST;TNF;KRT17;ERRFI1;SFN;IL20;ZFP36L1;MAFF;KEAP1;CD109;FOXN1;TP63
11665,GO:0046427,0.000161885313649242,0.999968144196216,11,41,positive regulation of JAK-STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;IL20;LIF;IL15;PARP14;SOCS1;IL6R;CCL5
8601,GO:0034109,0.000163904689244178,0.99996166712246,13,54,homotypic cell-cell adhesion,BP,C1QTNF1;ACTG1;HSPB1;LYN;CSRP1;PDPN;FLNA;VCL;PRKCA;SYK;MYH9;ZNF703;CCL5
8509,GO:0033687,0.000168605842914103,0.999982643818376,7,17,osteoblast proliferation,BP,CYR61;JUNB;FGFR2;BMP2;ITGAV;OSR2;SFRP1
4368,GO:0009986,0.000168919267550606,0.999912644776893,49,374,cell surface,CC,CRYAB;NRG1;AMOT;KRT4;SDC4;TFRC;CD83;HLA-B;B4GALT1;EMP2;ADAMTS9;LAMP1;TNF;FGFR2;BACE2;LAYN;EPHA2;ICAM1;CD274;BMP2;ITGAV;L1CAM;TNFRSF12A;SFRP1;HLA-F;PTGFRN;IL7R;THBD;IGSF3;ADAM17;IL15;ROBO1;PDGFB;BCAM;ROR1;ACKR3;HNRNPU;CD109;CCR6;GP6;LRFN4;TNFRSF10A;DAG1;FAM234A;WNT4;CD38;SLC3A2;HSP90AB1;MCAM
2941,GO:0006468,0.000174559708260111,0.99988235699492,136,1319,protein phosphorylation,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;MID1;DAPK3;DBNDD2;EMP2;NUAK1;TP53;SQSTM1;MARVELD3;IL24;NFKB1;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;TRIO;FGFR2;PSMB9;EPHB6;TELO2;ZC3H12A;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;ADRB2;IL20;DAXX;AKAP8L;LIF;SFRP1;PSME2;GPER1;EGR1;SGK1;ZFP36L1;AKAP8;NELFE;ADAM17;FGFR1OP;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;CDKL1;PDGFB;OXTR;SPTBN1;NPNT;IL1A;CAMK1G;TNIP2;RASGRP4;SPRY4;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;TRIB1;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;GLIPR2;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;IL6R;CLK4;CCL5
3334,GO:0007044,0.000178871354147746,0.999949428480973,16,75,cell-substrate junction assembly,BP,FN1;SDC4;DAPK3;KRT5;CORO1C;COL16A1;SFRP1;KRT14;AJUBA;COL17A1;RCC2;TRIP6;CLASP1;LAMC1;PHLDB2;WNT4
19167,GO:1905207,0.00018013290723985,0.999972036058561,9,28,regulation of cardiocyte differentiation,BP,NRG1;TGFB2;EDN1;G6PD;EFNB2;BMP2;GPER1;SEMA3C;BMP7
4551,GO:0010632,0.000183089975461914,0.999928244791839,26,158,regulation of epithelial cell migration,BP,MMP9;HDAC9;HSPB1;STARD13;TGFB2;EDN1;EMP2;MARVELD3;ADAMTS9;CORO1C;ZC3H12A;EPHA2;STAT5A;EPPK1;ETS1;RHOB;ADAM17;PRKCA;PDGFB;CLASP1;JUN;GLIPR2;CCR6;EFNA1;CARD10;TBXA2R
8863,GO:0034660,0.000184934235153629,0.9998956969905,63,545,ncRNA metabolic process,BP,CD3EAP;USB1;PDCD11;NFKB1;CARS2;RRP1;CDKAL1;ZC3H12A;SART1;TRMT61A;NAT10;USP36;PUS1;DHX37;PWP2;METTL1;NSUN2;RRP36;GEMIN4;POP1;RRS1;SRRT;RPLP2;DKC1;ISG20L2;SHQ1;METTL2B;TSR1;RPLP1;DDX17;SENP3;DDX47;NOB1;DDX49;RPS2;UTP14A;PHAX;UTP20;RPS9;NSUN5;RRP7A;FTSJ3;WDR46;NOP56;NOL9;WDR4;ABT1;RRP7BP;RPL27A;PES1;GTF2E1;NOP2;NOP14;GTF3C2;DUS2;TRMT1;METTL16;AARSD1;HSD17B10;UTP4;POLR2G;POP4;RPUSD4
4566,GO:0010647,0.00020958121673631,0.99986123805724,120,1150,positive regulation of cell communication,BP,IGFBP3;SAA1;TRIM16;CCL20;NRG1;MMP9;CYR61;INHBA;CYP1B1;CTGF;C1QTNF1;JPH2;PML;CYLD;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NLRC5;TP53;SQSTM1;IL24;NFKB1;CDKN2B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;WWC1;FGFR2;PSMB9;EPHB6;TELO2;ZC3H12A;FLNA;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;SFN;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;ELF3;LIF;SFRP1;TRIM22;PSME2;IL7R;GPER1;JRK;NELFE;ADAM17;IRS2;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;OXTR;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;ROR1;ACKR3;BAMBI;AFAP1L2;SLC35C2;YWHAH;PAGR1;PARP14;CITED2;SOCS1;JUN;ESR1;GLIPR2;TFDP1;ARRDC3;GPNMB;CNTNAP1;ACTN4;BMP7;TNFRSF10A;RAPGEF1;EEF1D;BLNK;WNT4;TRAF4;CD38;PSMC3;CCL22;PPP2R1B;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;PARP1;TP63;CCL5
12310,GO:0048660,0.000213412976429153,0.999935544315034,17,85,regulation of smooth muscle cell proliferation,BP,IGFBP3;MMP9;EDN1;TP53;TNF;FGFR2;TPM1;GPER1;SF1;IL15;PDGFB;TRIB1;JUN;XRCC6;TNFAIP3;IL6R;CCL5
532,GO:0001650,0.000229057466889755,0.999919471351288,21,118,fibrillar center,CC,NFKBIE;TFCP2L1;CD3EAP;MAP3K14;TXNRD1;RSAD2;NUAK1;TAF4B;PSPC1;RRS1;CD2BP2;DKC1;UBTF;NOP56;SMAD7;TCOF1;KLF6;EEF1D;POLR1E;UTP4;APEX2
465,GO:0001503,0.000229680150666213,0.999894288881758,35,242,ossification,BP,IGFBP3;MMP9;RUNX1;CYR61;PTGER4;CTGF;CYP24A1;TUFT1;TGFB2;NOCT;JUNB;TNF;TNC;FGFR2;PBX1;TPM4;EPHA2;BMP2;KREMEN2;ADRB2;OSR2;SFRP1;SNAI2;ALYREF;FHL2;NPNT;COL5A2;HNRNPU;KLF10;GPNMB;BMP7;WNT4;BMP8A;IL6R;TP63
4362,GO:0009966,0.000231971879346364,0.999832143259662,205,2143,regulation of signal transduction,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;WNT10A;SOD2;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;CXCL16;WWC1;TRIO;FGFR2;PSMB9;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;NMT2;ELF3;LIF;SFRP1;TRIM22;SAFB2;IRF1;PSME2;IL7R;GPER1;NFKBIA;EGR1;JRK;SNAI2;RRS1;ARHGEF28;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;PTTG1IP;RNF115;SPPL2A;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;SPRY4;ROR1;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;MTA2;YWHAH;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;PARP14;CXCL5;DUSP1;CITED2;CD109;SOCS1;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;TFDP1;NOP2;NOC2L;ZNF703;ARRDC3;INSIG1;RHOG;GPNMB;BCL2L2;CNTNAP1;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;CXORF36;AKIP1;RAPGEF1;MYADM;DAG1;CGNL1;PDE6A;EEF1D;BLNK;WNT4;TRAF4;CYTH1;TNFAIP3;PSMC3;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;DUSP8;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;SH3BP4
11480,GO:0045936,0.000241774106323371,0.999867903941345,55,441,negative regulation of phosphate metabolic process,BP,IGFBP3;INHBA;DUSP14;HSPB1;GPRC5A;TGFB2;SH3RF2;GBP1;DBNDD2;MARVELD3;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;LIF;SFRP1;GPER1;CD2BP2;FGFR1OP;IRS2;AJUBA;PDGFB;SPRY4;SMAD7;HNRNPU;PPP1R14C;TRIB1;PPP1R9B;PARP14;DUSP1;CD109;SOCS1;JUN;DUS2;PARD3;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;DUSP8;SWAP70;PARP1
13148,GO:0051716,0.00024611769477631,0.999810883446886,407,4661,cellular response to stimulus,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;AMOT;JPH2;TUFT1;ACTG1;NQO1;IL16;CYP1A1;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;MYBL2;TRAF1;SDC4;KRT13;WNT10A;RELB;TFRC;BAG1;SOD2;GPRC5A;UGT1A6;CD3EAP;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;IKBKE;BIRC3;MID1;DAPK3;RSAD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;IL24;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;EHD1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;TNC;ASCC2;DST;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;NFKB2;COL4A1;DNAJB1;PSMB9;EPHB6;TELO2;KRT17;FOSL1;JPH1;ZC3H12A;FLNA;LCP1;TNK1;ACAA1;CADPS2;EPHA2;CHP1;HMGCS1;GADD45B;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;ANKS4B;GPR146;ADRB2;IL20;DAXX;TNFRSF12A;MTUS1;IFNGR1;SERPINE1;FUS;PGK1;ARPC1B;MCM2;EBP;NMT2;XAF1;AMOTL2;ZC3H7B;AEN;ELF3;RELT;LIF;SFRP1;TPM1;TRIM22;ZFYVE27;CC2D2A;SAFB2;APTX;HLA-F;IRF1;PSME2;IL7R;TFIP11;THBD;GPER1;SRF;TXN2;ABTB2;NFKBIA;EGR1;JRK;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;SRRT;PRPF19;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;FEN1;TXLNA;DHFR;IRS2;IER3;NPAS2;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;GPR132;ZFP36L2;NTN1;SYK;CMTM3;DDX17;NFKBIB;ROBO1;AJUBA;GINS2;USP43;IFIT3;DDX47;PDGFB;BCAM;OXTR;PTTG1IP;POLA1;SPTBN1;SNRNP70;FHL2;DCTN1;RNF115;DPYSL3;UHRF1;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;ORAOV1;GPR75;TNFRSF21;TNIP2;LANCL2;RASGRP4;RBBP5;SEMA3C;SFPQ;DDX39A;SPRY4;LILRB3;SPEN;ROR1;PXMP2;ACSL1;RCC2;COL5A2;NUP214;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;MTA2;YWHAH;PALM2;KEAP1;M6PR;HNRNPU;TJP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;UBE2J2;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;KCNIP3;SAFB;THOC1;KLF10;PARP14;CXCL5;SUSD6;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;HCAR3;PAK1IP1;BRPF1;GLIPR2;CPT1A;MCM7;LRRC27;TFDP1;OGFR;NOP2;NOC2L;RBM4;ZNF703;CCR6;ARRDC3;INSIG1;HERC2;PARD3;QDPR;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;GP6;CHCHD6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SNIP1;BMP7;SMUG1;PHLPP1;EFTUD2;TNFRSF10A;CXORF36;TPRA1;AKIP1;ELK1;RAPGEF1;CHAF1A;ZYX;KIF22;MYADM;DAG1;CGNL1;PDE6A;RNF185;EEF1D;ASB6;RAB27A;TIMELESS;GPX4;BLNK;WNT4;RBM14;AKR1C1;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;CXCL3;BMP8A;CARD10;POLR2G;DUSP8;SRSF7;NOL3;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;ADGRF3;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;APEX2;SH3BP4
16251,GO:0090304,0.000247358692503191,0.999810804043311,367,4171,nucleic acid metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;TK1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;MCM2;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;TATDN2;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;CHAF1A;KIF22;POLR3H;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
12309,GO:0048659,0.000248225011873108,0.999923930682285,17,86,smooth muscle cell proliferation,BP,IGFBP3;MMP9;EDN1;TP53;TNF;FGFR2;TPM1;GPER1;SF1;IL15;PDGFB;TRIB1;JUN;XRCC6;TNFAIP3;IL6R;CCL5
2409,GO:0005581,0.000248225382312818,0.999953726222898,10,35,collagen trimer,CC,C1QTNF1;COL12A1;COL4A1;COL16A1;COL27A1;COL9A2;COL5A3;COL17A1;COL5A2;COL4A4
4513,GO:0010563,0.000256651039844717,0.999859277069168,55,442,negative regulation of phosphorus metabolic process,BP,IGFBP3;INHBA;DUSP14;HSPB1;GPRC5A;TGFB2;SH3RF2;GBP1;DBNDD2;MARVELD3;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;LIF;SFRP1;GPER1;CD2BP2;FGFR1OP;IRS2;AJUBA;PDGFB;SPRY4;SMAD7;HNRNPU;PPP1R14C;TRIB1;PPP1R9B;PARP14;DUSP1;CD109;SOCS1;JUN;DUS2;PARD3;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;DUSP8;SWAP70;PARP1
6648,GO:0023056,0.000260498885527757,0.999826328263761,120,1156,positive regulation of signaling,BP,IGFBP3;SAA1;TRIM16;CCL20;NRG1;MMP9;CYR61;INHBA;CYP1B1;CTGF;C1QTNF1;JPH2;PML;CYLD;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NLRC5;TP53;SQSTM1;IL24;NFKB1;CDKN2B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;WWC1;FGFR2;PSMB9;EPHB6;TELO2;ZC3H12A;FLNA;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;SFN;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;ELF3;LIF;SFRP1;TRIM22;PSME2;IL7R;GPER1;JRK;NELFE;ADAM17;IRS2;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;OXTR;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;ROR1;ACKR3;BAMBI;AFAP1L2;SLC35C2;YWHAH;PAGR1;PARP14;CITED2;SOCS1;JUN;ESR1;GLIPR2;TFDP1;ARRDC3;GPNMB;CNTNAP1;ACTN4;BMP7;TNFRSF10A;RAPGEF1;EEF1D;BLNK;WNT4;TRAF4;CD38;PSMC3;CCL22;PPP2R1B;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;PARP1;TP63;CCL5
12555,GO:0050707,0.000261931069116745,0.999915876774325,18,95,regulation of cytokine secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;GBP1;PANX1;LYN;TNF;ZC3H12A;CD274;SYK;SPTBN1;IL1A;TNFRSF21;SOCS1;MAPK11
172,GO:0000377,0.000263249988781348,0.999870816620021,40,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SRSF2;SART1;GEMIN5;DDX23;ZMAT2;FUS;LUC7L;DDX42;PSPC1;TFIP11;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;U2AF2;SF3B4;DDX17;ALYREF;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;HNRNPU;HNRNPF;PQBP1;TXNL4B;HSPA8;RBM4;METTL16;EFTUD2;TRA2A;PHF5A;POLR2G;SRSF7;NOL3;MAGOH
184,GO:0000398,0.000263249988781348,0.999870816620021,40,298,mRNA splicing, via spliceosome,BP,SRSF2;SART1;GEMIN5;DDX23;ZMAT2;FUS;LUC7L;DDX42;PSPC1;TFIP11;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;U2AF2;SF3B4;DDX17;ALYREF;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;HNRNPU;HNRNPF;PQBP1;TXNL4B;HSPA8;RBM4;METTL16;EFTUD2;TRA2A;PHF5A;POLR2G;SRSF7;NOL3;MAGOH
11485,GO:0045944,0.000280665509245583,0.999824332941814,88,791,positive regulation of transcription by RNA polymerase II,BP,MAFB;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;MYBL2;RELB;ARID3B;IER2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;ETS1;NELFE;NPAS2;PPRC1;DDX17;PDGFB;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;SMAD7;SUPT5H;MTA2;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;TFDP1;SERTAD1;INSIG1;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;RBM14;PSMC3;SUPT16H;PARP1;TP63
2890,GO:0006397,0.000284469585171852,0.999844157874461,54,439,mRNA processing,BP,PDCD11;NOCT;SRSF2;SART1;GEMIN5;DDX23;ZMAT2;FUS;AKAP8L;SAFB2;LUC7L;DDX42;PSPC1;TFIP11;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;ZFP36L1;NELFE;U2AF2;LGALS3;SF3B4;DDX17;DDX47;ALYREF;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;SUPT5H;HNRNPU;HNRNPF;PQBP1;SAFB;THOC1;TRUB2;RBM38;ARL6IP4;TXNL4B;HSPA8;RBM4;METTL16;EFTUD2;TRA2A;PHF5A;POLR2G;SRSF7;NOL3;MAGOH
763,GO:0002009,0.000285155673844157,0.999847700172225,50,394,morphogenesis of an epithelium,BP,CYR61;ADM;PML;STARD13;SDC4;WNT10A;IRX2;TGFB2;EDN1;B4GALT1;TNF;EFNB2;TNC;PDPN;FGFR2;PBX1;COL4A1;PSMB9;KRT17;FLNA;EPHA2;BMP2;LIF;SFRP1;CC2D2A;WDR1;PSME2;SRF;SNAI2;RHOB;ADAM17;VCL;RIPK4;NTN1;AJUBA;NPNT;SEMA3C;ROR1;CLASP1;FRAS1;ESR1;FOXN1;BMP7;PHLDB2;DAG1;TIMELESS;WNT4;PSMC3;TP63;PHACTR4
12245,GO:0048519,0.000285559549135615,0.99978276073609,323,3629,negative regulation of biological process,BP,IGFBP3;KRT1;MAFB;SAA1;CRYAB;FTH1;NRG1;MMP9;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;KRT4;SACS;NQO1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;STARD13;SDC4;IRX2;RELB;BAG1;SOD2;GPRC5A;CD83;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;DBNDD2;RSAD2;G6PD;TRAF3;NLRC5;TP53;SQSTM1;MARVELD3;IL24;NOCT;IL27RA;FST;NFKB1;CDKN2B;LFNG;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;EFNB2;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;EPHB6;FOSL1;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;ZNF503;EPHA2;CHP1;CCDC85B;GADD45B;TSC22D3;ICAM1;CD274;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;SFN;ADRB2;DAXX;NAT10;SERPINE1;PABPC4;PGK1;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TPM1;TRIM22;ANXA8;IRF1;PSME2;LUC7L;BANF1;EPPK1;IL7R;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;TRIM29;NFKBIA;SF1;EGR1;ETS1;SNAI2;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;SNX12;UPK3B;DHFR;U2AF2;FGFR1OP;VCL;SHQ1;IRS2;IER3;NPAS2;CBX5;LGALS3;RPLP1;MAFK;TRAF2;IL15;PRKCA;GPR132;ZFP36L2;NTN1;POLR1A;DDX17;ROBO1;AJUBA;IFIT3;PDGFB;BRMS1;OXTR;RPS2;PTTG1IP;UTP20;RPS9;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;RNF115;DPYSL3;UHRF1;MYH9;TAPBPL;IL1A;ORAOV1;TNFRSF21;TNIP2;LANCL2;ZNF263;PRCC;SEMA3C;SFPQ;SPRY4;LILRB3;SPEN;ZW10;ROR1;RCC2;COL5A2;NUP214;ACKR3;BAMBI;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;YWHAH;KEAP1;HNRNPU;CLASP1;RRAD;PPP1R14C;TRIB1;CREB3;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;ANAPC15;DUSP1;CAB39;CITED2;CD109;RPL27A;SOCS1;OXSR1;HSPA8;JUN;ESR1;PAK1IP1;TFDP1;NOC2L;CHMP4B;RBM4;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;PARD3;GPNMB;BCL2L2;ZNF365;XRCC6;EDC4;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;TNFRSF10A;KANK4;TPRA1;MPHOSPH8;PHLDB2;RAPGEF1;MYADM;DAG1;CGNL1;DHX34;TIMELESS;GPX4;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;CXCL8;EFNA1;MAPK11;CLDN7;BMP8A;CARD10;RNF144B;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;PARP1;TP63;PHACTR4;CCL5;MAGOH;SH3BP4
12799,GO:0051093,0.000294153995884141,0.999828607053269,66,563,negative regulation of developmental process,BP,MAFB;NRG1;INHBA;AMOT;PML;CYLD;STARD13;FBN1;TGFB2;GBP1;G6PD;NOCT;LFNG;TJP2;HSPG2;ADAMTS9;LYN;TNF;EFNB2;CORO1C;WWC1;TRIO;PBX1;CCDC85B;TSC22D3;BMP2;ITGAV;ADRB2;SERPINE1;PGK1;SFRP1;IRF1;LUC7L;GPER1;NFKBIA;SNAI2;PRPF19;ZFP36L1;ZFP36L2;NTN1;ROBO1;PDGFB;DPYSL3;TNFRSF21;SEMA3C;LILRB3;RCC2;COL5A2;SMAD7;YWHAH;HNRNPU;CLASP1;TRIB1;THOC1;INSIG1;ZNF365;ACTN4;BMP7;PHLDB2;WNT4;CTDSP1;EFNA1;MAPK11;CARD10;TBXA2R;TP63
3388,GO:0007165,0.000294737733458863,0.999775344272957,328,3663,signal transduction,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;FN1;NEFL;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;AMOT;JPH2;TUFT1;ACTG1;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;SDC4;WNT10A;RELB;BAG1;SOD2;GPRC5A;CD3EAP;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;DST;TRIO;PDPN;FGFR2;PBX1;NFKB2;COL4A1;PSMB9;EPHB6;TELO2;KRT17;JPH1;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;CHP1;GADD45B;ICAM1;ARFRP1;CD274;BMP2;COL16A1;UBE4B;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;ARPC1B;EBP;NMT2;XAF1;AMOTL2;AEN;ELF3;RELT;LIF;SFRP1;TRIM22;ZFYVE27;CC2D2A;SAFB2;HLA-F;IRF1;PSME2;IL7R;THBD;GPER1;NFKBIA;EGR1;JRK;IGSF3;DOCK10;SGK1;SNAI2;RRS1;PRPF19;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;GPR132;ZFP36L2;NTN1;SYK;CMTM3;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;PDGFB;BCAM;OXTR;PTTG1IP;SPTBN1;FHL2;DCTN1;RNF115;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;GPR75;TNFRSF21;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SPRY4;LILRB3;SPEN;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;MTA2;YWHAH;PALM2;M6PR;TJP1;HNRNPF;RRAD;APH1A;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;KCNIP3;SAFB;THOC1;KLF10;PARP14;CXCL5;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;HCAR3;PAK1IP1;BRPF1;GLIPR2;LRRC27;TFDP1;OGFR;NOP2;NOC2L;ZNF703;CCR6;ARRDC3;INSIG1;PARD3;RHOG;GPNMB;BCL2L2;GP6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SNIP1;BMP7;PHLPP1;TNFRSF10A;CXORF36;TPRA1;AKIP1;RAPGEF1;ZYX;MYADM;DAG1;CGNL1;PDE6A;EEF1D;ASB6;RAB27A;BLNK;WNT4;RBM14;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;CXCL3;BMP8A;CARD10;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;TBXA2R;ADGRF3;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;SH3BP4
2380,GO:0005515,0.000303392339766521,0.999772267778731,679,8305,protein binding,MF,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;C1R;ODC1;CTGF;TENM3;C1QTNF1;DTX2;CCDC80;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;CYLD;IGFL1;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;SDC4;KRT13;WNT10A;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;ARID3B;CD83;HLA-B;CSF2;MAP3K14;FBN1;FAM46B;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;TXNRD1;MAT2A;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;KLHL21;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;PANK2;NEDD9;FST;NFKB1;CDKN2B;TAF4B;GNPTAB;IRS1;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;ARPC4;LAMP1;COMMD4;EHD1;GADD45A;TNF;IGFL3;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;GPATCH4;RING1;CORO1C;CXCL16;PKMYT1;WWC1;NAV2;ENC1;TNC;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;SLC16A9;SIRPA;UBE2C;MSANTD3;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;FAM69B;TK1;ACAA1;GEMIN5;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;DDX23;CDK4;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;PMM2;SFN;CDC42EP2;STAT5A;EPGN;ANKS4B;RNF19B;ZMAT2;METTL13;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TNFRSF12A;NAT10;MTUS1;IFNGR1;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;EBP;CSRP2;TOX4;USP36;AKAP8L;AMOTL2;ZC3H7B;AEN;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;SAFB2;APTX;HLA-F;PTGFRN;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;METTL1;PSME2;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;DNAJB2;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;TXLNA;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;LGALS3;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;ZNF778;ZFP36L2;PUM3;NTN1;ZFC3H1;PROSER2;SYK;CMTM3;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;IFIT3;DDX47;PDGFB;CEP95;BRMS1;BCAM;PREP;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;DNASE1;COX5B;RNF115;DPYSL3;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;SPPL2A;TAPBPL;NOM1;TMEM159;COL17A1;NPNT;IL1A;SDK1;COPS3;CAMK1G;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;BRD9;SAP30BP;FTSJ3;LILRB3;SPEN;ZW10;ROR1;PXMP2;C8ORF33;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TMEM140;GPN1;TRAM2;SMAD7;CRCP;MRPS12;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;SLC4A11;ORC1;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;PARP14;PRDM7;MRPL20;CXCL5;ANKRD52;SUSD6;PCYT1A;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;GBE1;JUN;ESR1;IKZF3;TCOF1;BLOC1S2;SLC22A4;PES1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;TFDP1;TNPO3;ZNF772;OGFR;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;ZNF703;CCR6;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;XRCC6;GP6;EDC4;TRMT1;KLF6;TAP2;CHCHD6;TEAD4;CNTNAP1;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;LRFN4;SNIP1;BMP7;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;RNF7;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;SLC41A2;DAG1;CGNL1;RNF185;EEF1D;ASB6;RAB27A;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SEC14L4;SMARCC2;SPG21;CCL22;SLC4A2;FAM207A;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;RSRP1;CLDN7;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;CXCL3;BMP8A;HES4;ZC3H18;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;IL6R;BIN3;LAIR1;IRGQ;POP4;RPUSD4;PARP1;CLK4;TP63;IL36G;C1S;PHACTR4;TOP3A;CCL5;TMEM51;ORC4;MAGOH;SH3BP4
3802,GO:0008380,0.000307580409907479,0.999836166621637,49,391,RNA splicing,BP,USB1;SRSF2;SART1;GEMIN5;DDX23;ZMAT2;FUS;AKAP8L;LUC7L;DDX42;PSPC1;TFIP11;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;U2AF2;LGALS3;SF3B4;DDX17;DDX47;ALYREF;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;HNRNPU;HNRNPF;PQBP1;PPP1R9B;THOC1;RBM38;ARL6IP4;TXNL4B;HSPA8;RBM4;METTL16;EFTUD2;TRA2A;PHF5A;POLR2G;SRSF7;NOL3;CLK4;MAGOH
3556,GO:0007596,0.000309266447767835,0.999862602312455,31,213,blood coagulation,BP,KRT1;SAA1;C1QTNF1;ACTG1;HSPB1;EDN1;LYN;CSRP1;EHD1;PDPN;FLNA;GGCX;SERPINE1;PABPC4;ANXA8;IRF1;THBD;SRF;RHOB;VCL;CBX5;MAFK;PRKCA;SYK;PDGFB;MYH9;MAFF;RHOG;GP6;RAB27A;TBXA2R
6782,GO:0030217,0.000313747830087844,0.999880546649741,23,137,T cell differentiation,BP,MAFB;RUNX1;PTGER4;CYLD;RELB;CD83;RSAD2;LFNG;SART1;IRF1;IL7R;SRF;EGR1;ZFP36L1;ADAM17;IL15;ZFP36L2;SYK;SMAD7;SOCS1;FOXN1;CCR6;WNT4
231,GO:0000479,0.000317498040522596,0.999971297540575,6,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,RRS1;TSR1;UTP20;NOL9;ABT1;NOP14
7754,GO:0032270,0.000319907859562325,0.999787879825476,113,1081,positive regulation of cellular protein metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;PML;SDC4;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;EMP2;TP53;SQSTM1;IL24;CDKN1A;UBQLN2;LYN;GADD45A;TNF;WWC1;FGFR2;CLN6;EPHB6;TELO2;KRT17;UBE2C;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;AKAP8L;LIF;PSME2;GPER1;LARP4B;NFKBIA;EGR1;SNAI2;AKAP8;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;RPS9;UHRF1;MYH9;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;KEAP1;TRIB1;DCUN1D2;RUVBL2;PARP14;CAB39;SOCS1;HSPBP1;OXSR1;JUN;ESR1;GLIPR2;ARRDC3;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;EIF5A;DAG1;TRAF4;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;GCLC;HSP90AB1;IL6R;CCL5
171,GO:0000375,0.000322173138638457,0.999840164292367,40,301,RNA splicing, via transesterification reactions,BP,SRSF2;SART1;GEMIN5;DDX23;ZMAT2;FUS;LUC7L;DDX42;PSPC1;TFIP11;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;U2AF2;SF3B4;DDX17;ALYREF;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;HNRNPU;HNRNPF;PQBP1;TXNL4B;HSPA8;RBM4;METTL16;EFTUD2;TRA2A;PHF5A;POLR2G;SRSF7;NOL3;MAGOH
5333,GO:0016070,0.000326534567390408,0.99975044577649,333,3757,RNA metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;DDX23;CDK4;ZNF142;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;DUS2;ARGLU1;RHOG;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;POLR3H;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;GCLC;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;CCL5;FADS1;MAGOH
12630,GO:0050817,0.000337396749777339,0.99984926916609,31,214,coagulation,BP,KRT1;SAA1;C1QTNF1;ACTG1;HSPB1;EDN1;LYN;CSRP1;EHD1;PDPN;FLNA;GGCX;SERPINE1;PABPC4;ANXA8;IRF1;THBD;SRF;RHOB;VCL;CBX5;MAFK;PRKCA;SYK;PDGFB;MYH9;MAFF;RHOG;GP6;RAB27A;TBXA2R
2269,GO:0005200,0.000342467513425311,0.999896459713709,16,80,structural constituent of cytoskeleton,MF,KRT2;NEFL;KRT15;NEFM;ACTG1;KRT9;ARPC4;KRT5;KRT17;ARPC1B;TPM1;KRT14;SPTBN1;CCDC6;SORBS2;TUBB
7752,GO:0032268,0.00034433091692135,0.999752428682819,182,1899,regulation of cellular protein metabolic process,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;IL1R2;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;DBNDD2;G6PD;EMP2;NUAK1;TP53;SQSTM1;MARVELD3;IL24;NFKB1;CDKN2B;CDKN1A;UBQLN2;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;PKMYT1;WWC1;ENC1;FGFR2;NUP153;CLN6;EPHB6;TELO2;KRT17;UBE2C;TYMS;ZC3H12A;GEMIN5;EPHA2;CHP1;EIF5;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;EPGN;RNF19B;ADRB2;IL20;DAXX;SERPINE1;AKAP8L;ZC3H7B;LIF;SFRP1;PPP1R3B;ANXA8;PSME2;DPH2;CTIF;GPER1;DNAJB2;LARP4B;NFKBIA;EGR1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;ADAM17;SNX12;DHFR;U2AF2;FGFR1OP;ACO1;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;RPS9;NSFL1C;SERPINH1;UHRF1;MYH9;NPNT;IL1A;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;DNAJC1;KEAP1;PPP1R14C;TRIB1;DCUN1D2;RUVBL2;PPP1R9B;A2ML1;PARP14;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;JUN;ESR1;TCOF1;GLIPR2;EIF3B;NOC2L;RBM4;SERTAD1;ARRDC3;DUS2;PARD3;GPNMB;XRCC6;SNIP1;BMP7;METTL16;PHLPP1;TNFRSF10A;RAPGEF1;EIF5A;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;SWAP70;IL6R;PHACTR4;CCL5;MAGOH
11087,GO:0045087,0.000348072699897449,0.99979747287601,64,553,innate immune response,BP,KRT1;SAA1;CCL20;C1R;ACTG1;PML;CYLD;RELB;HLA-B;EDN1;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;NLRC5;NFKB1;LYN;LAMP1;CXCL16;NFKB2;PSMB9;TNK1;ICAM1;CDC42EP2;IFNGR1;XAF1;TRIM22;HLA-F;IRF1;PSME2;PSPC1;GPER1;ELF4;TRIM29;NFKBIA;EGR1;AKAP8;LGALS3;SYK;IFIT3;TNIP2;SFPQ;CRCP;PQBP1;PARP14;SOCS1;ESR1;XRCC6;ZYX;POLR3H;RAB27A;RBM14;TUBB;TNFAIP3;PSMC3;CCL22;HSP90AB1;IL36G;C1S;CCL5
12357,GO:0048732,0.000348590043805379,0.99982646023298,40,296,gland development,BP,MAFB;NRG1;CYP1A1;PML;TFCP2L1;WNT10A;TGFB2;B4GALT1;TNF;TNC;FGFR2;PBX1;TYMS;EPHA2;HMGCS1;BMP2;STAT5A;ELF3;SFRP1;SRF;NFKBIA;IGSF3;ETS1;SNAI2;IRS2;NTN1;ROBO1;OXTR;SEMA3C;CITED2;JUN;ESR1;FOXN1;ZNF703;QDPR;BMP7;DAG1;WNT4;TNFAIP3;TP63
15340,GO:0071560,0.000355477702901375,0.99985389863914,26,165,cellular response to transforming growth factor beta stimulus,BP,PML;WNT10A;FBN1;TGFB2;EDN1;CDKN2B;FGFR2;SFRP1;ZFP36L1;ADAM17;ZFP36L2;SNRNP70;NPNT;BAMBI;SMAD7;KLF10;TGFBRAP1;CITED2;CD109;JUN;ZNF703;PARD3;ZYX;WNT4;HSP90AB1;PARP1
4512,GO:0010562,0.000363159688867891,0.999776542339517,79,702,positive regulation of phosphorus metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;CTGF;C1QTNF1;ADM;SDC4;CSF2;MAP3K14;TGFB2;EDN1;MID1;EMP2;TP53;SQSTM1;IL24;IRS1;CDKN1A;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;LIF;GPER1;EGR1;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;PARP14;CAB39;SOCS1;OXSR1;JUN;GLIPR2;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;CCL5
11481,GO:0045937,0.000363159688867891,0.999776542339517,79,702,positive regulation of phosphate metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;CTGF;C1QTNF1;ADM;SDC4;CSF2;MAP3K14;TGFB2;EDN1;MID1;EMP2;TP53;SQSTM1;IL24;IRS1;CDKN1A;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;LIF;GPER1;EGR1;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;PARP14;CAB39;SOCS1;OXSR1;JUN;GLIPR2;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;CCL22;EFNA1;MAPK11;BMP8A;CARD10;HSP90AB1;IL6R;CCL5
14208,GO:0061138,0.000373486563369716,0.999859546564418,22,129,morphogenesis of a branching epithelium,BP,ADM;PML;EDN1;B4GALT1;TNF;TNC;FGFR2;PBX1;COL4A1;EPHA2;BMP2;SFRP1;SRF;SNAI2;NPNT;SEMA3C;ESR1;BMP7;DAG1;TIMELESS;WNT4;TP63
12662,GO:0050866,0.00037428646548149,0.999871281811681,19,105,negative regulation of cell activation,BP,INHBA;C1QTNF1;CYLD;SDC4;LYN;ZC3H12A;CD274;SFRP1;IRF1;THBD;GPER1;LGALS3;PDGFB;TNFRSF21;SMAD7;THOC1;GPNMB;TNFAIP3;GCLC
19755,GO:2000146,0.000378415044978588,0.999840717086608,27,175,negative regulation of cell motility,BP,IGFBP3;NRG1;PTGER4;CYP1B1;STARD13;MARVELD3;IL24;ADAMTS9;CORO1C;SERPINE1;SFRP1;TPM1;EPPK1;SRF;RHOB;VCL;ROBO1;DPYSL3;SMAD7;CLASP1;TRIB1;CITED2;PHLDB2;DAG1;WNT4;CARD10;TBXA2R
7316,GO:0031325,0.000380455999087979,0.999721229681545,207,2180,positive regulation of cellular metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CTGF;C1QTNF1;ADM;FOSL2;PML;HSPB1;MYBL2;SDC4;RELB;TFRC;ARID3B;IER2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;TET3;EMP2;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;ZC3H12A;KLF7;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;TRIM22;MKL1;IRF1;PSME2;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;U2AF2;IRS2;NPAS2;PPRC1;RPLP1;TRAF2;IL15;SF3B4;PRKCA;ZFP36L2;SYK;DDX17;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;SNRNP70;FHL2;UHRF1;MYH9;NPNT;IL1A;TNIP2;SFPQ;ROR1;ACSL1;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;KEAP1;HNRNPU;PAGR1;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CAB39;CITED2;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;CPT1A;TFDP1;SERTAD1;ARRDC3;INSIG1;RHOG;GPNMB;XRCC6;KLF6;TEAD4;SMPD2;GLIS3;BMP7;METTL16;TNFRSF10A;ELK1;PHF5A;RAPGEF1;EIF5A;DAG1;RAB27A;TIMELESS;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;SUPT16H;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;CREB5;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5;SH3BP4
14822,GO:0070555,0.000389906836214117,0.999848645794398,23,144,response to interleukin-1,BP,CCL20;IL1R2;EDN1;SQSTM1;NFKB1;PSMB9;ZC3H12A;ICAM1;SFRP1;PSME2;NFKBIA;EGR1;ETS1;PRKCA;IL1A;TNIP2;CD38;PSMC3;CCL22;CXCL8;MAPK11;GCLC;CCL5
6699,GO:0030098,0.000398251260668863,0.999823011343248,30,203,lymphocyte differentiation,BP,MAFB;RUNX1;PTGER4;INHBA;HDAC9;CYLD;RELB;CD83;RSAD2;LFNG;SART1;SFRP1;IRF1;IL7R;SRF;EGR1;DOCK10;ZFP36L1;ADAM17;IL15;ZFP36L2;SYK;SMAD7;SOCS1;IKZF3;FOXN1;CCR6;KLF6;BLNK;WNT4
17798,GO:1901888,0.000399154695341281,0.999889653915473,14,65,regulation of cell junction assembly,BP,RUNX1;SDC4;DAPK3;TNF;CORO1C;COL16A1;SFRP1;SNAI2;RCC2;TJP1;CLASP1;PHLDB2;RAPGEF1;WNT4
3559,GO:0007599,0.000399617678720641,0.999819520237067,31,216,hemostasis,BP,KRT1;SAA1;C1QTNF1;ACTG1;HSPB1;EDN1;LYN;CSRP1;EHD1;PDPN;FLNA;GGCX;SERPINE1;PABPC4;ANXA8;IRF1;THBD;SRF;RHOB;VCL;CBX5;MAFK;PRKCA;SYK;PDGFB;MYH9;MAFF;RHOG;GP6;RAB27A;TBXA2R
4662,GO:0010810,0.000402208410973366,0.999843868361326,23,139,regulation of cell-substrate adhesion,BP,CYR61;FN1;CCDC80;SDC4;GBP1;DAPK3;EMP2;CDKN2A;CORO1C;PDPN;FLNA;COL16A1;SERPINE1;SFRP1;NPNT;RCC2;CLASP1;ACTN4;PHLDB2;MYADM;DAG1;WNT4;FBLN2
1099,GO:0002688,0.000407594149929479,0.999893441976308,13,60,regulation of leukocyte chemotaxis,BP,EDN1;LYN;MTUS1;SERPINE1;ADAM17;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
227,GO:0000469,0.00041243371790273,0.999936187883936,8,26,cleavage involved in rRNA processing,BP,RRP36;RRS1;TSR1;NOB1;UTP20;NOL9;ABT1;NOP14
12641,GO:0050839,0.000424706862967757,0.999770309463912,49,393,cell adhesion molecule binding,MF,NRG1;CYR61;S100P;FN1;CTGF;TENM3;PDLIM1;GPRC5A;FBN1;COBLL1;EMP2;TJP2;LYN;MYO1B;EHD1;BAIAP2;DST;DNAJB1;FLNA;LCP1;EPHA2;EIF5;ICAM1;COL16A1;ITGAV;SFN;TRIM29;ADAM17;VCL;PRKCA;SYK;RPS2;SPTBN1;MYH9;NPNT;NOP56;TJP1;HSPA8;CHMP4B;ARGLU1;GPNMB;ACTN4;PHLDB2;EEF1D;CLDN7;SLC3A2;LRRC59;HSP90AB1;SWAP70
764,GO:0002011,0.000426001304175525,0.999904656507175,11,44,morphogenesis of an epithelial sheet,BP,CYR61;PDPN;FLNA;SRF;ADAM17;AJUBA;CLASP1;BMP7;PHLDB2;DAG1;PHACTR4
11934,GO:0046979,0.000427687218099502,1,3,3,TAP2 binding,MF,TAP1;HLA-F;TAPBP
12982,GO:0051385,0.000453683221209861,0.999941437382531,7,20,response to mineralocorticoid,BP,NEFL;CTGF;EDN1;CDKN1A;FOSL1;GPER1;PARP1
3697,GO:0008202,0.000467844531521683,0.999792986394727,29,198,steroid metabolic process,BP,CYP1B1;CYP24A1;ADM;CYP1A1;TFCP2L1;G6PD;NFE2L1;PANK2;NFKB1;TNF;SCD;PBX1;LSS;CLN6;CYB5R1;ACAA1;HMGCS1;BMP2;EBP;DHCR7;SF1;EGR1;SNAI2;AKR1C2;YWHAH;ESR1;INSIG1;WNT4;AKR1C1
15339,GO:0071559,0.000473526403871543,0.999801279416546,26,168,response to transforming growth factor beta,BP,PML;WNT10A;FBN1;TGFB2;EDN1;CDKN2B;FGFR2;SFRP1;ZFP36L1;ADAM17;ZFP36L2;SNRNP70;NPNT;BAMBI;SMAD7;KLF10;TGFBRAP1;CITED2;CD109;JUN;ZNF703;PARD3;ZYX;WNT4;HSP90AB1;PARP1
12520,GO:0050663,0.0004850533393305,0.999829113092948,19,108,cytokine secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;GBP1;PANX1;LYN;TNF;ZC3H12A;CD274;ITGAV;SYK;SPTBN1;IL1A;TNFRSF21;SOCS1;MAPK11
15248,GO:0071407,0.000485512234638263,0.999730649577114,52,421,cellular response to organic cyclic compound,BP,RUNX1;INHBA;CYP1B1;CYP24A1;CYP1A1;EDN1;NFKB1;AHR;TNF;TNC;ZC3H12A;HMGCS1;ICAM1;BMP2;CDK4;ERRFI1;DAXX;ZC3H7B;SFRP1;SAFB2;GPER1;NFKBIA;EGR1;SNAI2;SRRT;ZFP36L1;IL15;ZFP36L2;DDX17;PDGFB;FHL2;YWHAH;HNRNPU;PQBP1;PAGR1;RUVBL2;PPP1R9B;SAFB;ESR1;ZNF703;INSIG1;SNIP1;BMP7;ELK1;RAPGEF1;DAG1;RBM14;GCLC;HSP90AB1;PARP1;TP63;CCL5
229,GO:0000472,0.000485816081129365,1,3,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;ABT1;NOP14
354,GO:0000967,0.000485816081129365,1,3,3,rRNA 5'-end processing,BP,UTP20;ABT1;NOP14
9957,GO:0042326,0.000488392963259621,0.999741618683522,45,351,negative regulation of phosphorylation,BP,IGFBP3;INHBA;DUSP14;HSPB1;GPRC5A;GBP1;DBNDD2;MARVELD3;CDKN2B;CDKN1A;LYN;GADD45A;CDKN2A;CORO1C;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;LIF;SFRP1;GPER1;FGFR1OP;IRS2;AJUBA;SPRY4;SMAD7;HNRNPU;TRIB1;PARP14;DUSP1;CD109;SOCS1;JUN;DUS2;PARD3;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;DUSP8
10210,GO:0042825,0.000489154275547908,1,3,3,TAP complex,CC,TAP1;TAPBP;TAP2
13977,GO:0060687,0.000493234487760882,0.999983633064937,4,6,regulation of branching involved in prostate gland morphogenesis,BP,FGFR2;SFRP1;ESR1;BMP7
230,GO:0000478,0.00050383965538248,0.999948675669307,6,15,endonucleolytic cleavage involved in rRNA processing,BP,RRS1;TSR1;UTP20;NOL9;ABT1;NOP14
18441,GO:1903524,0.000506228918820615,0.999906374590029,9,32,positive regulation of blood circulation,BP,CTGF;ADM;TGFB2;EDN1;ICAM1;TPM1;OXTR;CD38;TBXA2R
9985,GO:0042379,0.000506391668541056,0.999931591961004,7,22,chemokine receptor binding,MF,CCL20;CXCL16;CXCL5;CCL22;CXCL8;CXCL3;CCL5
11095,GO:0045104,0.000532436409992558,0.999900812340536,9,32,intermediate filament cytoskeleton organization,BP,KRT2;NEFL;NEFM;KRT9;KRT6A;DST;KRT17;EPPK1;KRT14
12921,GO:0051271,0.00053502835130409,0.99976124353025,29,197,negative regulation of cellular component movement,BP,IGFBP3;NRG1;PTGER4;CYP1B1;STARD13;MARVELD3;IL24;ADAMTS9;CORO1C;SERPINE1;SFRP1;TPM1;EPPK1;SRF;RHOB;VCL;ROBO1;DPYSL3;SEMA3C;SMAD7;CLASP1;TRIB1;CITED2;ACTN4;PHLDB2;DAG1;WNT4;CARD10;TBXA2R
6582,GO:0022409,0.000540386947184377,0.999785133948516,23,143,positive regulation of cell-cell adhesion,BP,CYLD;TFRC;CD83;MAP3K14;LYN;TNF;EFNB2;PDPN;SIRPA;SART1;ICAM1;CD274;MYO10;IL7R;ETS1;IL15;SYK;SMAD7;CITED2;SOCS1;EFNB1;BMP7;CCL5
12671,GO:0050878,0.000550471517693965,0.999718756964662,40,307,regulation of body fluid levels,BP,KRT1;SAA1;C1QTNF1;ADM;ACTG1;HSPB1;EDN1;EMP2;HRNR;LYN;CSRP1;EHD1;PDPN;FLNA;GGCX;SFN;STAT5A;SERPINE1;PABPC4;ANXA8;IRF1;THBD;SRF;RHOB;VCL;CBX5;MAFK;PRKCA;SYK;PDGFB;OXTR;MYH9;MAFF;SLC22A4;RPTN;RHOG;GP6;RAB27A;TBXA2R;TP63
3312,GO:0007015,0.000554780190331412,0.999722005341629,38,283,actin filament organization,BP,PTGER4;CTGF;SDC4;COBLL1;EMP2;NEDD9;MYO1B;ARPC4;BAIAP2;TPM4;FLNA;LCP1;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;SRF;RHOB;SPTBN1;DPYSL3;PALM2;CLASP1;PPP1R9B;MICAL3;RHOG;ACTN4;SORBS2;KANK4;PHLDB2;ZYX;MYADM;CGNL1;WNT4;SWAP70;BIN3;BAIAP2L2
15379,GO:0071621,0.00055521722626408,0.999869988562546,11,48,granulocyte chemotaxis,BP,SAA1;CCL20;TGFB2;EDN1;LGALS3;SYK;CXCL5;CCL22;CXCL8;CXCL3;CCL5
2248,GO:0005160,0.000556289766593259,0.999909814073207,8,26,transforming growth factor beta receptor binding,MF,INHBA;TGFB2;BMP2;BAMBI;SMAD7;TGFBRAP1;BMP7;BMP8A
18230,GO:1903034,0.00056772234222755,0.999804085943516,18,100,regulation of response to wounding,BP,KRT1;C1QTNF1;EDN1;LYN;PDPN;TNFRSF12A;SERPINE1;EPPK1;THBD;PRKCA;SYK;PDGFB;CLASP1;CD109;PHLDB2;WNT4;TNFAIP3;TBXA2R
12535,GO:0050684,0.000571818585483846,0.999802707022204,18,99,regulation of mRNA processing,BP,SRSF2;SAFB2;PRPF19;ZFP36L1;NELFE;U2AF2;SF3B4;DDX17;SNRNP70;RBM15B;SUPT5H;HNRNPU;SAFB;HSPA8;RBM4;METTL16;SRSF7;MAGOH
1101,GO:0002690,0.00057783982492077,0.999864408429186,11,47,positive regulation of leukocyte chemotaxis,BP,EDN1;SERPINE1;ADAM17;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
6761,GO:0030193,0.000590751794435233,0.999861415743634,11,46,regulation of blood coagulation,BP,KRT1;C1QTNF1;EDN1;LYN;PDPN;SERPINE1;THBD;PRKCA;SYK;PDGFB;TBXA2R
17358,GO:1900046,0.000590751794435233,0.999861415743634,11,46,regulation of hemostasis,BP,KRT1;C1QTNF1;EDN1;LYN;PDPN;SERPINE1;THBD;PRKCA;SYK;PDGFB;TBXA2R
18030,GO:1902533,0.00059991291355888,0.999629476208793,74,663,positive regulation of intracellular signal transduction,BP,IGFBP3;SAA1;CCL20;NRG1;CYP1B1;CTGF;C1QTNF1;JPH2;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;MID1;TP53;IL24;IRS1;LYN;GADD45A;TNF;WWC1;FGFR2;EPHB6;TELO2;ZC3H12A;FLNA;EPHA2;GADD45B;ICAM1;BMP2;ITGAV;EPGN;ADRB2;IL20;DAXX;LIF;TRIM22;IL7R;GPER1;NELFE;IRS2;TRAF2;IL15;AKR1C2;PRKCA;SYK;ROBO1;AJUBA;PDGFB;NPNT;IL1A;TNIP2;RASGRP4;SFPQ;ROR1;ACKR3;PARP14;SOCS1;JUN;ESR1;GLIPR2;GPNMB;ACTN4;TNFRSF10A;RAPGEF1;EEF1D;TRAF4;CCL22;EFNA1;MAPK11;CARD10;IL6R;CCL5
6822,GO:0030280,0.000610016483527949,0.999954016341724,5,11,structural constituent of epidermis,MF,KRT1;KRT2;KRT10;HRNR;RPTN
14163,GO:0061045,0.000619494781061113,0.999853810056856,11,46,negative regulation of wound healing,BP,KRT1;C1QTNF1;EDN1;SERPINE1;EPPK1;THBD;PDGFB;CLASP1;CD109;PHLDB2;WNT4
18028,GO:1902531,0.000629468164875854,0.999561884025454,132,1313,regulation of intracellular signal transduction,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CYP1B1;CTGF;C1QTNF1;AMOT;JPH2;DUSP14;PML;CYLD;HSPB1;STARD13;SOD2;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;NUAK1;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;TAF4B;IRS1;LYN;GADD45A;TNF;WWC1;TRIO;FGFR2;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;ITGAV;ERRFI1;EPGN;ADRB2;IL20;DAXX;LIF;SFRP1;TRIM22;IL7R;GPER1;SNAI2;RRS1;ARHGEF28;RHOB;NELFE;IRS2;IER3;TRAF2;IL15;AKR1C2;PRKCA;SYK;ROBO1;AJUBA;PDGFB;PTTG1IP;NPNT;IL1A;TNIP2;RASGRP4;SFPQ;SPRY4;ROR1;ACKR3;MTA2;TRIB1;CREB3;PARP14;DUSP1;SOCS1;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;NOP2;NOC2L;RHOG;GPNMB;BCL2L2;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;AKIP1;RAPGEF1;MYADM;DAG1;CGNL1;EEF1D;TRAF4;CYTH1;TNFAIP3;CCL22;BRIP1;SUPT16H;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;NOL3;IL6R;PARP1;TP63;TOP3A;CCL5;SH3BP4
12529,GO:0050673,0.000637435848854821,0.999688065219432,35,257,epithelial cell proliferation,BP,IGFBP3;KRT2;KRT4;TGFB2;B4GALT1;MARVELD3;CDKN2B;TNF;EFNB2;FGFR2;EPHA2;BMP2;ERRFI1;SFN;STAT5A;EPGN;OSR2;SFRP1;EPPK1;SNAI2;ZFP36L1;ADAM17;PRKCA;ROBO1;PDGFB;CD109;JUN;ESR1;FOXN1;ZNF703;LAMC1;BCL2L2;TNFAIP3;TP63;CCL5
2432,GO:0005615,0.000650691841661352,0.999514354683063,217,2397,extracellular space,CC,IGFBP3;IL32;KRT1;SAA1;SPRR3;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;KRT2;CYR61;INHBA;S100P;FN1;C1R;CTGF;C1QTNF1;KRT34;CCDC80;ADM;KRT15;ACTG1;NQO1;IL16;IGFL1;HSPB1;KRT10;SDC4;KRT13;WNT10A;TFRC;SOD2;GPRC5A;UGT1A6;CSF2;FBN1;TGFB2;COBLL1;EDN1;TXNRD1;PLBD1;PRSS23;B4GALT1;MGAM;G6PD;HRNR;SIPA1L3;SQSTM1;KRT9;STEAP4;IL24;CPA4;KRT6A;HSPG2;ADAMTS9;LYN;MYO1B;ARPC4;LAMP1;CSRP1;EHD1;TNF;IGFL3;COL12A1;BAIAP2;KRT5;CXCL16;TNC;DST;TPM4;COL4A1;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;CHP1;ICAM1;CD274;BMP2;DDX23;ITGAV;PMM2;SFN;EPGN;IL20;PLEKHA7;MTUS1;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;LIF;SFRP1;SAFB2;WDR1;PSME2;DNPEP;BANF1;THBD;EDF1;DOCK10;GEMIN4;POP1;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;IL15;PRKCA;ZFC3H1;CMTM3;CDKL1;PDGFB;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;DPYSL3;COL5A3;MYH9;SPPL2A;NPNT;IL1A;SDK1;GLIPR1;SEMA3C;SPEN;COL5A2;YWHAH;CLASP1;CAPNS1;RUVBL2;A2ML1;CXCL5;GALNT2;CAB39;CD109;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;LRRC57;EIF3B;CHMP4B;QDPR;LAMC1;RHOG;BCL2L2;GP6;CS;ACTN4;HMGN2;EFNB1;LRFN4;BMP7;TKT;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;CCL22;DNAJC9;CXCL8;PPP2R1B;EFNA1;MYO1E;SLC3A2;CXCL3;XPNPEP3;BMP8A;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;MCAM;LAIR1;IL36G;C1S;CCL5;SH3BP4
16495,GO:0097190,0.000662058088589366,0.999620589311457,55,468,apoptotic signaling pathway,BP,MMP9;INHBA;CYP1B1;PML;CYLD;HSPB1;TRAF1;SOD2;CSF2;TGFB2;IKBKE;DAPK3;TP53;CDKN1A;LAMP1;TNF;EPHA2;ICAM1;UBE4B;ITGAV;SFN;DAXX;TNFRSF12A;SERPINE1;AEN;RELT;SFRP1;GPER1;SNAI2;LGALS3;TRAF2;PRKCA;DDX47;PTTG1IP;IL1A;TNFRSF21;SFPQ;ACKR3;YWHAH;CREB3;JUN;BLOC1S2;TFDP1;NOC2L;BCL2L2;TNFRSF10A;WNT4;CD38;TNFAIP3;PPP2R1B;NOL3;GCLC;IL6R;PARP1;TP63
8602,GO:0034110,0.000668140516162933,0.999906450909232,7,21,regulation of homotypic cell-cell adhesion,BP,C1QTNF1;LYN;PDPN;PRKCA;SYK;ZNF703;CCL5
9794,GO:0040013,0.000682660184659936,0.999685521189478,30,209,negative regulation of locomotion,BP,IGFBP3;NRG1;PTGER4;CYP1B1;PML;STARD13;MARVELD3;IL24;ADAMTS9;CORO1C;SERPINE1;SFRP1;TPM1;EPPK1;SRF;RHOB;VCL;ROBO1;DPYSL3;SEMA3C;SMAD7;CLASP1;TRIB1;CITED2;ARRDC3;PHLDB2;DAG1;WNT4;CARD10;TBXA2R
12702,GO:0050920,0.000683029548618217,0.999743896910247,20,120,regulation of chemotaxis,BP,IL16;HSPB1;EDN1;LYN;EFNB2;MTUS1;SERPINE1;ADAM17;ROBO1;PDGFB;SEMA3C;CREB3;CXCL5;CCR6;ZSWIM6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
11094,GO:0045103,0.000685073624105364,0.999866882503563,9,33,intermediate filament-based process,BP,KRT2;NEFL;NEFM;KRT9;KRT6A;DST;KRT17;EPPK1;KRT14
12312,GO:0048662,0.000688540602476716,0.999883577057886,8,27,negative regulation of smooth muscle cell proliferation,BP,IGFBP3;TP53;TPM1;GPER1;SF1;IL15;TRIB1;TNFAIP3
10117,GO:0042635,0.000693498352931662,0.999946170904087,5,11,positive regulation of hair cycle,BP,TGFB2;FST;TNF;KRT17;FOXN1
13192,GO:0051798,0.000693498352931662,0.999946170904087,5,11,positive regulation of hair follicle development,BP,TGFB2;FST;TNF;KRT17;FOXN1
10049,GO:0042531,0.000700642366033268,0.999862677724724,9,34,positive regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;IL24;LYN;IL20;LIF;IL15;PARP14;IL6R;CCL5
8019,GO:0032652,0.00070407936315913,0.999830179467468,11,48,regulation of interleukin-1 production,BP,SAA1;TRIM16;CCL20;IL1R2;PML;HSPB1;PANX1;ZC3H12A;ERRFI1;EGR1;TNFAIP3
11272,GO:0045577,0.000710030081371819,0.999899522580614,7,21,regulation of B cell differentiation,BP,INHBA;CYLD;SFRP1;ZFP36L1;ZFP36L2;SYK;IKZF3
10247,GO:0042981,0.000722550540496167,0.99950920489423,112,1098,regulation of apoptotic process,BP,IGFBP3;CRYAB;MMP9;CYR61;INHBA;NEFL;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;HSPB1;MYBL2;TRAF1;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;TP53;SQSTM1;NFKB1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;FOSL1;ZC3H12A;FLNA;EPHA2;GADD45B;TSC22D3;ICAM1;CD274;BMP2;CDK4;ITGAV;SFN;TNFRSF12A;SERPINE1;RELT;SFRP1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;LGALS3;TRAF2;PRKCA;ROBO1;IFIT3;BRMS1;PTTG1IP;FHL2;IL1A;TNFRSF21;TNIP2;SFPQ;ROR1;ACKR3;YWHAH;APH1A;CREB3;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;TFDP1;NOC2L;BCL2L2;ACTN4;BMP7;PHLPP1;TNFRSF10A;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;NOL3;GCLC;HSP90AB1;PARP1;TP63;CCL5
15415,GO:0071677,0.000725307407086326,0.999943121341494,5,11,positive regulation of mononuclear cell migration,BP,TNF;SERPINE1;LGALS3;CREB3;CCL5
10304,GO:0043067,0.000727362099306292,0.999504937500643,113,1110,regulation of programmed cell death,BP,IGFBP3;CRYAB;MMP9;CYR61;INHBA;NEFL;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;HSPB1;MYBL2;TRAF1;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;TP53;SQSTM1;NFKB1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;FOSL1;ZC3H12A;FLNA;EPHA2;GADD45B;TSC22D3;ICAM1;CD274;BMP2;CDK4;ITGAV;SFN;TNFRSF12A;SERPINE1;RELT;SFRP1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;LGALS3;TRAF2;PRKCA;ROBO1;IFIT3;BRMS1;PTTG1IP;FHL2;IL1A;TNFRSF21;TNIP2;SFPQ;ROR1;ACKR3;YWHAH;APH1A;CREB3;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;TFDP1;NOC2L;BCL2L2;ACTN4;BMP7;PHLPP1;TNFRSF10A;GPX4;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;NOL3;GCLC;HSP90AB1;PARP1;TP63;CCL5
12901,GO:0051247,0.000734913492689024,0.999496660356909,117,1151,positive regulation of protein metabolic process,BP,IGFBP3;SAA1;CCL20;NRG1;MMP9;CYR61;INHBA;FN1;CTGF;C1QTNF1;PML;HSPB1;SDC4;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;EMP2;TP53;SQSTM1;IL24;CDKN1A;UBQLN2;LYN;GADD45A;TNF;WWC1;FGFR2;CLN6;EPHB6;TELO2;KRT17;UBE2C;ZC3H12A;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;AKAP8L;LIF;IRF1;PSME2;GPER1;LARP4B;NFKBIA;EGR1;SNAI2;AKAP8;NELFE;ADAM17;RPLP1;TRAF2;IL15;PRKCA;SYK;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;PTTG1IP;RPS9;NEDD4L;UHRF1;MYH9;NPNT;IL1A;ROR1;ACSL1;ACKR3;AFAP1L2;SMAD7;KEAP1;TRIB1;DCUN1D2;RUVBL2;PARP14;CAB39;SOCS1;HSPBP1;OXSR1;JUN;ESR1;GLIPR2;ARRDC3;GPNMB;XRCC6;BMP7;TNFRSF10A;RAPGEF1;EIF5A;DAG1;TRAF4;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;RNF144B;POLR2G;SNF8;GCLC;HSP90AB1;IL6R;CCL5
4504,GO:0010543,0.000737194501836872,0.999894989827019,7,21,regulation of platelet activation,BP,C1QTNF1;LYN;PDPN;THBD;PRKCA;SYK;PDGFB
12577,GO:0050731,0.000738440490743491,0.999738518654179,18,103,positive regulation of peptidyl-tyrosine phosphorylation,BP,NRG1;CSF2;TP53;IL24;LYN;ICAM1;EPGN;IL20;LIF;ADAM17;IL15;SYK;PDGFB;AFAP1L2;PARP14;EFNA1;IL6R;CCL5
13757,GO:0060333,0.00074351499530513,0.999791146864516,13,63,interferon-gamma-mediated signaling pathway,BP,PML;HLA-B;GBP1;MID1;NLRC5;ICAM1;IFNGR1;TRIM22;HLA-F;IRF1;PARP14;SOCS1;HSP90AB1
4292,GO:0009719,0.000744275785313274,0.999495717825224,110,1066,response to endogenous stimulus,BP,TRIM16;CRYAB;RUNX1;CYR61;PTGER4;INHBA;HDAC9;NEFL;CTGF;ADM;NQO1;PML;WNT10A;IER2;FBN1;TGFB2;EDN1;TP53;NFKB1;CDKN2B;IRS1;CDKN1A;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;TNC;FGFR2;COL4A1;FOSL1;TYMS;HMGCS1;ICAM1;BMP2;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;DAXX;ARPC1B;SFRP1;SAFB2;GPER1;SRF;TXN2;EGR1;ETS1;SNAI2;ZFP36L1;AKAP8;ADAM17;IRS2;AKR1C2;ZFP36L2;SYK;DDX17;OXTR;SNRNP70;FHL2;NPNT;LANCL2;SPRY4;ACSL1;COL5A2;BAMBI;SMAD7;YWHAH;HNRNPU;HNRNPF;PAGR1;RUVBL2;PPP1R9B;SAFB;KLF10;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;JUN;ESR1;MCM7;ZNF703;PARD3;QDPR;BMP7;ELK1;RAPGEF1;ZYX;DAG1;TIMELESS;WNT4;RBM14;AKR1C1;CD38;BRIP1;CXCL8;BMP8A;POLR2G;GCLC;HSP90AB1;TBXA2R;PARP1;TP63;CCL5;BAIAP2L2;SH3BP4
5334,GO:0016071,0.000746576138868066,0.999528522831503,78,737,mRNA metabolic process,BP,HSPB1;TP53;PDCD11;NOCT;PSMB9;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;DDX23;TRMT61A;ZMAT2;FUS;PABPC4;AKAP8L;SAFB2;PUS1;PSME2;LUC7L;DDX42;CTIF;PSPC1;TFIP11;SRF;SF1;GEMIN4;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;NELFE;DKC1;U2AF2;LGALS3;RPLP1;SF3B4;PRKCA;ZFP36L2;DDX17;DDX47;RPS2;ALYREF;RPS9;GEMIN8;SNRNP70;PRCC;RBM15B;SFPQ;DDX39A;SPEN;NUP214;SUPT5H;HNRNPU;HNRNPF;PQBP1;SAFB;THOC1;TRUB2;RBM38;ARL6IP4;TXNL4B;RPL27A;HSPA8;RBM4;EDC4;METTL16;EFTUD2;TRA2A;PHF5A;DHX34;PSMC3;POLR2G;SRSF7;NOL3;POP4;MAGOH
4341,GO:0009893,0.000759111921898754,0.999431007582592,219,2364,positive regulation of metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CTGF;C1QTNF1;ADM;FOSL2;PML;HSPB1;MYBL2;SDC4;WNT10A;RELB;TFRC;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;TGFB2;EDN1;BIRC3;MID1;TET3;EMP2;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;IL24;NOCT;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;ZBED1;WWC1;TNC;FGFR2;PBX1;NFKB2;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;ZC3H12A;KLF7;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;TRIM22;MKL1;IRF1;PSME2;IL7R;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;DHFR;U2AF2;IRS2;NPAS2;PPRC1;RPLP1;TRAF2;IL15;SF3B4;PRKCA;ZFP36L2;SYK;POLR1A;DDX17;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;RPS9;NEDD4L;SNRNP70;FHL2;UHRF1;MYH9;NPNT;IL1A;TNIP2;SFPQ;ROR1;ACSL1;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;KEAP1;HNRNPU;PAGR1;TRIB1;DCUN1D2;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;PARP14;CAB39;CITED2;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;GLIPR2;CPT1A;TFDP1;SERTAD1;ARRDC3;INSIG1;RHOG;GPNMB;XRCC6;KLF6;TEAD4;SMPD2;GLIS3;BMP7;METTL16;TNFRSF10A;ELK1;PHF5A;RAPGEF1;EIF5A;UBAP2L;DAG1;RAB27A;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;CARD10;RNF144B;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5;SH3BP4
12908,GO:0051254,0.000770566600956342,0.999473039685321,115,1120,positive regulation of RNA metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;MYBL2;RELB;ARID3B;IER2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;EDF1;ETS1;PRPF19;ZFP36L1;NELFE;U2AF2;NPAS2;PPRC1;SF3B4;ZFP36L2;DDX17;PDGFB;UBTF;ALYREF;SNRNP70;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;METTL16;ELK1;PHF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;POLR2G;CREB5;PARP1;TP63
8700,GO:0034333,0.000770911246293436,0.999770150744293,14,69,adherens junction assembly,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;VCL;AJUBA;RCC2;SMAD7;TRIP6;CLASP1;ZNF703;PHLDB2;WNT4
12749,GO:0051017,0.000780040174433672,0.999713337411927,19,110,actin filament bundle assembly,BP,PTGER4;CTGF;SDC4;NEDD9;MYO1B;BAIAP2;LCP1;SFRP1;TPM1;SRF;RHOB;DPYSL3;CLASP1;ACTN4;PHLDB2;ZYX;WNT4;SWAP70;BAIAP2L2
596,GO:0001763,0.000793358630468513,0.999682515989662,22,136,morphogenesis of a branching structure,BP,ADM;PML;EDN1;B4GALT1;TNF;TNC;FGFR2;PBX1;COL4A1;EPHA2;BMP2;SFRP1;SRF;SNAI2;NPNT;SEMA3C;ESR1;BMP7;DAG1;TIMELESS;WNT4;TP63
4602,GO:0010717,0.000795726888106852,0.999775169818922,13,62,regulation of epithelial to mesenchymal transition,BP,TGFB2;PDPN;BMP2;SFRP1;BAMBI;SMAD7;CLASP1;GLIPR2;ZNF703;BMP7;PHLDB2;DAG1;EFNA1
15980,GO:0080134,0.000799985678660307,0.999464291856705,102,984,regulation of response to stress,BP,KRT1;SAA1;CRYAB;PTGER4;C1R;CTGF;C1QTNF1;IL1R2;PML;CYLD;HSPB1;RELB;BAG1;SOD2;TGFB2;EDN1;IKBKE;BIRC3;MID1;RSAD2;TRAF3;NUAK1;NLRC5;TP53;MARVELD3;NFKB1;UBQLN2;LYN;LAMP1;GADD45A;TNF;CDKN2A;PDPN;NUP153;DNAJB1;PSMB9;ZC3H12A;GADD45B;BMP2;ERRFI1;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;SFRP1;IRF1;PSME2;EPPK1;PSPC1;TFIP11;THBD;GPER1;NFKBIA;ETS1;SNAI2;DHFR;IER3;NPAS2;TRAF2;IL15;PRKCA;SYK;SLC7A2;AJUBA;PDGFB;PTTG1IP;DNASE1;IL1A;TNIP2;SFPQ;NUP214;ACKR3;CLASP1;PQBP1;CREB3;THOC1;PARP14;CD109;SOCS1;HSPA8;ESR1;INSIG1;ZNF365;XRCC6;BMP7;PHLPP1;PHLDB2;RAPGEF1;ZYX;TIMELESS;WNT4;RBM14;TRAF4;TNFAIP3;PSMC3;NOL3;HSP90AB1;TBXA2R;PARP1;C1S;CCL5
14897,GO:0070696,0.000823002728318789,0.99993356201977,5,11,transmembrane receptor protein serine/threonine kinase binding,MF,INHBA;TGFB2;BMP2;BMP7;BMP8A
407,GO:0001091,0.000823376061980726,0.999905346212888,6,16,RNA polymerase II basal transcription factor binding,MF,TP53;AHR;HNRNPU;RUVBL2;ESR1;GTF2E1
10041,GO:0042493,0.000829521930317954,0.999491465640939,68,607,response to drug,BP,CRYAB;INHBA;HDAC9;NEFL;CYP1B1;NQO1;CYP1A1;NFKBIE;TFRC;TGFB2;EDN1;G6PD;PANX1;TP53;NFKB1;CDKN1A;LYN;AHR;JUNB;TNF;BAIAP2;TNC;FGFR2;FOSL1;TYMS;ZC3H12A;HMGCS1;ICAM1;CDK4;ERRFI1;DAXX;SLC5A6;EBP;SFRP1;APTX;TXN2;NFKBIA;EGR1;ETS1;CYP4B1;RHOB;ADAM17;DHFR;TRAF2;ABCG2;SLC7A2;PDGFB;OXTR;SDK1;SEMA3C;ACSL1;PPP1R9B;SLC4A11;DUSP1;JUN;CPT1A;MCM7;QDPR;EFTUD2;TIMELESS;CD38;TNFAIP3;CLDN7;CTPS1;SLC25A22;GCLC;HSP90AB1;TBXA2R
4548,GO:0010628,0.000831003534049278,0.999414676439965,135,1366,positive regulation of gene expression,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;FN1;CTGF;C1QTNF1;FOSL2;PML;MYBL2;WNT10A;RELB;CD3EAP;ARID3B;IER2;CSF2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;TNC;FGFR2;PBX1;NFKB2;KRT17;FOSL1;ZC3H12A;KLF7;BMP2;CDK4;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;IL7R;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;PRPF19;NELFE;U2AF2;NPAS2;PPRC1;SF3B4;POLR1A;DDX17;PDGFB;UBTF;ALYREF;RPS9;SNRNP70;FHL2;UHRF1;MYH9;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;PHF5A;EIF5A;UBAP2L;RAB27A;DHX34;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;MAPK11;POLR1E;POLR2G;CREB5;SNF8;PARP1;TP63;CCL5
6748,GO:0030168,0.000837350924481875,0.999700119567056,18,103,platelet activation,BP,SAA1;C1QTNF1;ACTG1;HSPB1;LYN;CSRP1;PDPN;FLNA;THBD;SRF;RHOB;VCL;PRKCA;SYK;PDGFB;MYH9;RHOG;GP6
3255,GO:0006915,0.000865004012441331,0.999388512888278,137,1394,apoptotic process,BP,IGFBP3;CRYAB;MMP9;CYR61;INHBA;NEFL;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;HSPB1;MYBL2;TRAF1;BAG1;SOD2;CSF2;MAP3K14;TGFB2;EDN1;IKBKE;BIRC3;DAPK3;B4GALT1;G6PD;TRAF3;TP53;SQSTM1;IL24;NFKB1;CDKN1A;LYN;AHR;LAMP1;GADD45A;TNF;CDKN2A;TRIO;PDPN;FGFR2;EPHB6;FOSL1;ZC3H12A;FLNA;EPHA2;GADD45B;TSC22D3;ICAM1;CD274;BMP2;UBE4B;CDK4;DRAM1;ITGAV;SFN;DAXX;TNFRSF12A;SERPINE1;MCM2;XAF1;AEN;RELT;SFRP1;IRF1;DDX42;GPER1;NFKBIA;EGR1;SGK1;SNAI2;ZFP36L1;RHOB;ADAM17;SHQ1;IRS2;IER3;LGALS3;TRAF2;PRKCA;NTN1;ROBO1;IFIT3;DDX47;BRMS1;PTTG1IP;FHL2;DNASE1;IL1A;BCL7C;TNFRSF21;TNIP2;SFPQ;SAP30BP;ROR1;PRUNE2;ACKR3;YWHAH;APH1A;CREB3;MTFP1;KCNIP3;THOC1;DUSP1;CITED2;OXSR1;JUN;ESR1;IKZF3;BLOC1S2;TFDP1;NOC2L;BCL2L2;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;EIF5A;WNT4;TRAF4;CD38;TNFAIP3;PPP2R1B;EFNA1;CLDN7;BMP8A;CARD10;RNF144B;POLR2G;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;CCL5
14358,GO:0061572,0.000875298766424057,0.999674868429689,19,111,actin filament bundle organization,BP,PTGER4;CTGF;SDC4;NEDD9;MYO1B;BAIAP2;LCP1;SFRP1;TPM1;SRF;RHOB;DPYSL3;CLASP1;ACTN4;PHLDB2;ZYX;WNT4;SWAP70;BAIAP2L2
1279,GO:0003073,0.000884820421370317,0.999799456020253,10,41,regulation of systemic arterial blood pressure,BP,ADM;SOD2;EDN1;EMP2;NAV2;C9ORF3;ADRB2;TPM1;PDGFB;OXTR
6145,GO:0019430,0.000901275136333514,0.99989236895562,6,17,removal of superoxide radicals,BP,NQO1;SOD2;TNF;FANCC;DHFR;BMP7
12076,GO:0048024,0.000930822266452607,0.999731854127631,13,63,regulation of mRNA splicing, via spliceosome,BP,SRSF2;PRPF19;U2AF2;SF3B4;DDX17;SNRNP70;RBM15B;HNRNPU;HSPA8;RBM4;METTL16;SRSF7;MAGOH
1286,GO:0003094,0.000931828923578521,0.999922594426237,5,11,glomerular filtration,BP,EMP2;PDGFB;MYO1E;XPNPEP3;MCAM
12576,GO:0050730,0.00095337160473652,0.999603089156023,23,149,regulation of peptidyl-tyrosine phosphorylation,BP,NRG1;GPRC5A;CSF2;TP53;IL24;LYN;ICAM1;ERRFI1;EPGN;IL20;LIF;SFRP1;ADAM17;FGFR1OP;IL15;SYK;PDGFB;AFAP1L2;PARP14;SOCS1;EFNA1;IL6R;CCL5
150,GO:0000305,0.000962844221718632,0.999852894954554,7,23,response to oxygen radical,BP,NQO1;SOD2;TXNRD1;TNF;FANCC;DHFR;BMP7
8483,GO:0033629,0.000981390046596173,0.999952570254732,4,7,negative regulation of cell adhesion mediated by integrin,BP,CYP1B1;SERPINE1;SNAI2;SWAP70
14391,GO:0061635,0.000997221004972603,0.999951590117354,4,7,regulation of protein complex stability,BP,SQSTM1;TAPBP;HSPA8;SNF8
1155,GO:0002763,0.0010051862353391,0.999791317909652,9,35,positive regulation of myeloid leukocyte differentiation,BP,RUNX1;TNF;IL20;LIF;ZFP36L1;PRKCA;TRIB1;KLF10;JUN
531,GO:0001649,0.00101703889321534,0.999584121956325,22,140,osteoblast differentiation,BP,IGFBP3;CYR61;CYP24A1;NOCT;JUNB;TNF;TNC;FGFR2;TPM4;EPHA2;BMP2;SFRP1;SNAI2;ALYREF;FHL2;NPNT;HNRNPU;GPNMB;BMP7;WNT4;IL6R;TP63
2607,GO:0005911,0.00101928249116072,0.99946589363876,39,300,cell-cell junction,CC,AMOT;PDLIM1;B4GALT1;PANX1;SIPA1L3;MARVELD3;TJP2;LYN;BAIAP2;FLNA;CDK4;PLEKHA7;AMOTL2;WDR1;EPPK1;TRIM29;PARD3B;ADAM17;VCL;AJUBA;OXTR;MYH9;COL17A1;SMAD7;YWHAH;TJP1;MARVELD2;PARD3;CNTNAP1;ACTN4;ZYX;MYADM;DAG1;CGNL1;TRAF4;CYTH1;CLDN7;MYO1E;BAIAP2L2
455,GO:0001228,0.00102155411477152,0.999485576270763,35,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MAFB;RUNX1;FOSL2;MYBL2;ARID3B;IER2;TP53;NFE2L1;NFKB1;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;FOXD2;ELF3;IRF1;SRF;ELF4;EGR1;ETS1;MAFF;CREB3;TUSC1;KLF10;JUN;ESR1;IKZF3;FOXN1;TFDP1;KLF6;ELK1;PARP1;TP63
629,GO:0001818,0.00102251060816364,0.999562456927185,24,160,negative regulation of cytokine production,BP,PTGER4;INHBA;FN1;IL1R2;PML;CYLD;RELB;CD83;TGFB2;GBP1;IKBKE;TRAF3;NLRC5;NFKB1;TNF;ZC3H12A;CD274;ERRFI1;AKAP8;TNFRSF21;SMAD7;GPNMB;TNFAIP3;HSP90AB1
12631,GO:0050818,0.00102489163288099,0.999740110646318,11,49,regulation of coagulation,BP,KRT1;C1QTNF1;EDN1;LYN;PDPN;SERPINE1;THBD;PRKCA;SYK;PDGFB;TBXA2R
8366,GO:0033256,0.00104183117616974,0.999948804451419,4,7,I-kappaB/NF-kappaB complex,CC,RELB;NFKB1;NFKB2;NFKBIA
10438,GO:0043292,0.00105218191893207,0.999578756833184,21,133,contractile fiber,CC,CRYAB;JPH2;ACTG1;HSPB1;PDLIM1;SDC4;SQSTM1;DST;TPM4;JPH1;FLNA;SVIL;TPM1;PDE4DIP;VCL;SPTBN1;FHL2;NPNT;ACTN4;SORBS2;DAG1
223,GO:0000462,0.00105354151364259,0.999777801470377,9,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,PDCD11;PWP2;RRP36;RRS1;TSR1;UTP20;WDR46;ABT1;NOP14
10442,GO:0043297,0.00107871682461584,0.99972467285229,11,49,apical junction assembly,BP,RUNX1;MARVELD3;TNF;WDR1;SRF;SNAI2;VCL;TJP1;MARVELD2;PARD3;ACTN4
17873,GO:1902107,0.00108133988886132,0.99963128533414,16,89,positive regulation of leukocyte differentiation,BP,RUNX1;CYLD;CD83;TNF;SART1;IL20;LIF;IL7R;ZFP36L1;IL15;PRKCA;SYK;TRIB1;KLF10;SOCS1;JUN
15242,GO:0071398,0.00108694593960017,0.999771735752354,9,35,cellular response to fatty acid,BP,PTGER4;EDN1;TNC;ZC3H12A;CDK4;SFRP1;AKAP8;AKR1C2;CPT1A
11804,GO:0046685,0.00109082595432025,0.999798618234876,8,29,response to arsenic-containing substance,BP,NEFL;CYP1A1;CDKN1A;ZC3H12A;DAXX;SRRT;RBM4;GCLC
6662,GO:0030016,0.0010949529253697,0.999571810169638,20,124,myofibril,CC,CRYAB;JPH2;ACTG1;HSPB1;PDLIM1;SDC4;SQSTM1;DST;TPM4;JPH1;FLNA;SVIL;TPM1;PDE4DIP;VCL;SPTBN1;FHL2;ACTN4;SORBS2;DAG1
10586,GO:0043549,0.00109988582666739,0.999310579094127,71,641,regulation of kinase activity,BP,SAA1;NRG1;CYR61;DUSP14;HSPB1;SDC4;GPRC5A;MAP3K14;TGFB2;EDN1;DBNDD2;EMP2;NLRC5;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;FGFR2;EPHB6;TELO2;EPHA2;CHP1;GADD45B;BMP2;CDK4;ERRFI1;SFN;EPGN;ADRB2;DAXX;SFRP1;EGR1;ADAM17;FGFR1OP;IRS2;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;SPRY4;ROR1;ACSL1;AFAP1L2;HNRNPU;TRIB1;DUSP1;CAB39;SOCS1;OXSR1;SERTAD1;DUS2;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;TNFAIP3;EFNA1;MAPK11;CARD10;DUSP8;HSP90AB1;CCL5
847,GO:0002162,0.00110866457732822,0.99994456731229,4,7,dystroglycan binding,MF,MAP2;VCL;CLASP1;DAG1
10048,GO:0042509,0.00112189921788483,0.999735581745272,10,43,regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;IL24;LYN;IL20;LIF;IL15;PARP14;SOCS1;IL6R;CCL5
15543,GO:0071944,0.00115964089662217,0.999106682655827,262,2890,cell periphery,CC,KRT1;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;KRT2;PTGER4;S100P;FN1;CTGF;TENM3;CYP24A1;C1QTNF1;SLC16A2;AMOT;JPH2;ACTG1;IL16;IL1R2;CYLD;HSPB1;KRT10;PCDH7;SDC4;TFRC;GPRC5A;CD83;HLA-B;TRIM16L;GBP1;B4GALT1;MGAM;G6PD;TRAF3;EMP2;HRNR;PANX1;SIPA1L3;STEAP4;NEDD9;IL27RA;IRS1;TJP2;HSPG2;UBQLN2;LYN;MYO1B;STOML1;CDV3;LAMP1;EHD1;TNF;BAIAP2;EFNB2;KRT5;CORO1C;CXCL16;WWC1;DST;VMP1;GPRIN1;PDPN;FGFR2;BACE2;TPM4;SLC7A5;EPHB6;KRT17;FOSL1;SLC16A9;SIRPA;UBE2C;JPH1;SLC39A1;FLNA;LCP1;CYB5R1;TNK1;CADPS2;EPHA2;CHP1;EIF5;ICAM1;CD274;BMP2;SLCO3A1;SLC7A5P2;KREMEN2;ITGAV;ERRFI1;L1CAM;MYO10;CDC42EP2;LYPD6B;EPGN;ANKS4B;GPR146;ADRB2;SVIL;TNFRSF12A;MTUS1;IFNGR1;SLC5A6;SERPINE1;FXYD3;CCDC124;EBP;NMT2;AMOTL2;RELT;SFRP1;ABCF2;TPM1;ZFYVE27;HLA-F;PTGFRN;WDR1;ANXA8;EPPK1;IL7R;NFX1;THBD;GPER1;NFKBIA;PARD3B;IGSF3;KCNA7;SGK1;FAM57A;ARHGEF28;RHOB;NELFE;ADAM17;UPK3B;VCL;IRS2;KRT14;LGALS3;TRAF2;ABCG2;IL15;PRKCA;GPR132;SYK;SLC7A2;ROBO1;AJUBA;PPIP5K1;PDGFB;FILIP1;BCAM;OXTR;UTP20;NSFL1C;SPTBN1;NEDD4L;DCTN1;MYH9;SPPL2A;TAPBPL;COL17A1;NPNT;SDK1;CAMK1G;GLIPR1;GPR75;TNFRSF21;LANCL2;RASGRP4;SPRY4;LILRB3;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC43A2;DNAJC1;YWHAH;TRIP6;PALM2;ENAH;M6PR;TJP1;CLASP1;HNRNPF;RRAD;APH1A;CAPNS1;VSIG1;PPP1R9B;SLC4A11;ORC1;MICAL3;KCNIP3;ETS2;RHBDL2;PCYT1A;MARVELD2;CD109;STAC;FRAS1;HSPA8;ESR1;IKZF3;SLC22A4;HCAR3;BRPF1;DCXR;LRRC27;CHMP4B;CCR6;RPTN;ARRDC3;PARD3;RHOG;GPNMB;GP6;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SORBS2;LRFN4;PHLPP1;TNFRSF10A;MPHOSPH8;PHLDB2;ZYX;SLC41A2;MYADM;DAG1;PDE6A;RAB27A;BLNK;WNT4;TRAF4;CYTH1;CD38;SLC4A2;DNAJC9;EFNA1;CLDN7;HSD17B10;SLC3A2;PTPRB;CLTA;SNF8;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;LAIR1;SLC2A6;BAIAP2L2
6700,GO:0030099,0.00116404961191684,0.999395755179383,37,294,myeloid cell differentiation,BP,MAFB;MMP9;RUNX1;INHBA;PML;RELB;TFRC;CSF2;FBN1;G6PD;NFE2L1;CDKN2B;TJP2;LYN;JUNB;TNF;EPHA2;IL20;PABPC4;LIF;SFRP1;WDR1;SRF;NFKBIA;ETS1;ZFP36L1;LGALS3;PRKCA;MYH9;RASGRP4;RBBP5;LILRB3;TRIB1;KLF10;CD109;JUN;PARP1
884,GO:0002250,0.00117188722075377,0.999456018001933,28,197,adaptive immune response,BP,C1R;TAP1;RELB;TFRC;RSAD2;EMP2;IL27RA;LYN;TNF;NFKB2;ICAM1;RNF19B;IRF1;IL7R;ADAM17;TRAF2;SYK;TNFRSF21;LILRB3;SMAD7;THOC1;CCR6;TAP2;RAB27A;TNFAIP3;SWAP70;LAIR1;C1S
12249,GO:0048523,0.00119857853499853,0.999067915151236,291,3280,negative regulation of cellular process,BP,IGFBP3;MAFB;CRYAB;FTH1;NRG1;MMP9;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CYP1B1;CTGF;C1QTNF1;ADM;JPH2;KRT4;SACS;NQO1;IL1R2;DUSP14;PML;TFCP2L1;CYLD;HSPB1;STARD13;SDC4;IRX2;RELB;BAG1;SOD2;GPRC5A;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;B4GALT1;DBNDD2;RSAD2;G6PD;NLRC5;TP53;SQSTM1;MARVELD3;IL24;NOCT;FST;NFKB1;CDKN2B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;EFNB2;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;EPHB6;FOSL1;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;ZNF503;EPHA2;CHP1;CCDC85B;GADD45B;TSC22D3;ICAM1;CD274;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;SFN;ADRB2;DAXX;NAT10;SERPINE1;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TPM1;TRIM22;ANXA8;IRF1;PSME2;EPPK1;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;TRIM29;NFKBIA;SF1;EGR1;ETS1;SNAI2;CD2BP2;SRRT;PRPF19;ZFP36L1;RHOB;NELFE;ADAM17;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;VCL;SHQ1;IRS2;IER3;NPAS2;CBX5;LGALS3;MAFK;TRAF2;IL15;PRKCA;GPR132;ZFP36L2;NTN1;ROBO1;AJUBA;IFIT3;PDGFB;BRMS1;PTTG1IP;UTP20;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;RNF115;DPYSL3;UHRF1;MYH9;IL1A;ORAOV1;TNFRSF21;TNIP2;LANCL2;ZNF263;PRCC;SEMA3C;SFPQ;SPRY4;LILRB3;SPEN;ZW10;ROR1;RCC2;COL5A2;NUP214;ACKR3;BAMBI;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;HNRNPU;CLASP1;PPP1R14C;TRIB1;CREB3;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;ANAPC15;DUSP1;CAB39;CITED2;CD109;SOCS1;OXSR1;HSPA8;JUN;ESR1;PAK1IP1;TFDP1;NOC2L;CHMP4B;RBM4;NACC1;ZNF703;INSIG1;DUS2;PARD3;GPNMB;BCL2L2;ZNF365;XRCC6;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;TNFRSF10A;KANK4;TPRA1;MPHOSPH8;PHLDB2;RAPGEF1;MYADM;DAG1;CGNL1;DHX34;TIMELESS;GPX4;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;CXCL8;EFNA1;MAPK11;CLDN7;BMP8A;CARD10;RNF144B;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;PARP1;TP63;PHACTR4;CCL5;SH3BP4
2592,GO:0005886,0.00121663216669183,0.999063680649321,256,2818,plasma membrane,CC,KRT1;SPRR3;TRIM16;CRYAB;SPRR2A;NRG1;KRT2;PTGER4;S100P;FN1;CTGF;TENM3;CYP24A1;C1QTNF1;SLC16A2;AMOT;JPH2;ACTG1;IL16;IL1R2;CYLD;HSPB1;KRT10;PCDH7;SDC4;TFRC;GPRC5A;CD83;HLA-B;TRIM16L;GBP1;B4GALT1;MGAM;G6PD;TRAF3;EMP2;HRNR;PANX1;SIPA1L3;STEAP4;NEDD9;IL27RA;IRS1;TJP2;HSPG2;UBQLN2;LYN;MYO1B;STOML1;CDV3;LAMP1;EHD1;TNF;BAIAP2;EFNB2;KRT5;CORO1C;CXCL16;WWC1;DST;VMP1;GPRIN1;PDPN;FGFR2;BACE2;SLC7A5;EPHB6;FOSL1;SLC16A9;SIRPA;UBE2C;JPH1;SLC39A1;FLNA;LCP1;CYB5R1;TNK1;CADPS2;EPHA2;CHP1;EIF5;ICAM1;CD274;BMP2;SLCO3A1;SLC7A5P2;KREMEN2;ITGAV;ERRFI1;L1CAM;MYO10;CDC42EP2;LYPD6B;EPGN;ANKS4B;GPR146;ADRB2;SVIL;TNFRSF12A;MTUS1;IFNGR1;SLC5A6;SERPINE1;FXYD3;CCDC124;EBP;NMT2;AMOTL2;RELT;SFRP1;ABCF2;TPM1;ZFYVE27;HLA-F;PTGFRN;WDR1;ANXA8;EPPK1;IL7R;NFX1;THBD;GPER1;NFKBIA;PARD3B;IGSF3;KCNA7;SGK1;FAM57A;ARHGEF28;RHOB;NELFE;ADAM17;UPK3B;VCL;IRS2;LGALS3;TRAF2;ABCG2;IL15;PRKCA;GPR132;SYK;SLC7A2;ROBO1;AJUBA;PPIP5K1;PDGFB;FILIP1;BCAM;OXTR;UTP20;NSFL1C;SPTBN1;NEDD4L;MYH9;SPPL2A;TAPBPL;COL17A1;NPNT;SDK1;CAMK1G;GLIPR1;GPR75;TNFRSF21;LANCL2;RASGRP4;SPRY4;LILRB3;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC43A2;DNAJC1;YWHAH;TRIP6;PALM2;ENAH;M6PR;TJP1;HNRNPF;RRAD;APH1A;CAPNS1;VSIG1;PPP1R9B;SLC4A11;ORC1;MICAL3;KCNIP3;ETS2;RHBDL2;PCYT1A;MARVELD2;CD109;STAC;FRAS1;HSPA8;ESR1;IKZF3;SLC22A4;HCAR3;BRPF1;DCXR;LRRC27;CHMP4B;CCR6;RPTN;ARRDC3;PARD3;RHOG;GPNMB;GP6;SMPD2;CNTNAP1;EFNB1;THEM4;SORBS2;LRFN4;PHLPP1;TNFRSF10A;MPHOSPH8;PHLDB2;ZYX;SLC41A2;MYADM;DAG1;PDE6A;RAB27A;BLNK;WNT4;TRAF4;CYTH1;CD38;SLC4A2;DNAJC9;EFNA1;CLDN7;HSD17B10;SLC3A2;PTPRB;CLTA;SNF8;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;LAIR1;SLC2A6;BAIAP2L2
12239,GO:0048511,0.00124589774454856,0.999428344473431,27,188,rhythmic process,BP,INHBA;PML;RELB;CSF2;TGFB2;TP53;NOCT;AHR;HS3ST2;NFKB2;TYMS;CDK4;SERPINE1;PSPC1;EGR1;ETS1;NPAS2;OXTR;SFPQ;HNRNPU;KLF10;JUN;ESR1;CPT1A;RBM4;PHLPP1;TIMELESS
8351,GO:0033209,0.00124613060244571,0.999492715111836,21,139,tumor necrosis factor-mediated signaling pathway,BP,CYLD;TRAF1;MAP3K14;BIRC3;TRAF3;TJP2;TNF;PSMB9;TNFRSF12A;RELT;PSME2;NFKBIA;ADAM17;TRAF2;SYK;SPPL2A;TNFRSF21;TNFRSF10A;TNFAIP3;PSMC3;NOL3
1154,GO:0002762,0.00129519454792408,0.99975418468166,8,29,negative regulation of myeloid leukocyte differentiation,BP,MAFB;INHBA;FBN1;TJP2;LYN;SFRP1;LILRB3;TRIB1
8472,GO:0033612,0.00131823244977185,0.999876201155595,5,12,receptor serine/threonine kinase binding,MF,INHBA;TGFB2;BMP2;BMP7;BMP8A
708,GO:0001933,0.00133124422852501,0.999279019374425,41,327,negative regulation of protein phosphorylation,BP,IGFBP3;DUSP14;HSPB1;GPRC5A;GBP1;DBNDD2;MARVELD3;CDKN2B;CDKN1A;LYN;GADD45A;CDKN2A;CORO1C;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;LIF;SFRP1;GPER1;FGFR1OP;SPRY4;SMAD7;TRIB1;PARP14;DUSP1;CD109;SOCS1;JUN;DUS2;PARD3;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;DUSP8
13845,GO:0060445,0.00134268441040852,0.999826352589176,6,17,branching involved in salivary gland morphogenesis,BP,TNF;FGFR2;SNAI2;SEMA3C;BMP7;DAG1
12558,GO:0050710,0.00136053223901513,0.99973807548561,8,30,negative regulation of cytokine secretion,BP,PTGER4;FN1;IL1R2;PML;GBP1;TNF;ZC3H12A;TNFRSF21
15874,GO:0072593,0.00136884020976243,0.999400057891807,24,165,reactive oxygen species metabolic process,BP,CRYAB;CYR61;CYP1B1;CTGF;NQO1;CYP1A1;SOD2;EDN1;G6PD;TP53;CDKN1A;GADD45A;TNF;ZC3H12A;ICAM1;FANCC;PARL;DHFR;SYK;SLC7A2;PDGFB;BMP7;RAB27A;HSP90AB1
7004,GO:0030688,0.00137418020661184,0.999869692339256,5,12,preribosome, small subunit precursor,CC,RRP1;TSR1;NOB1;UTP20;NOP14
8235,GO:0033002,0.00137934927962757,0.999464983673739,19,116,muscle cell proliferation,BP,IGFBP3;MMP9;TGFB2;EDN1;TP53;TNF;FGFR2;TPM1;GPER1;SF1;IL15;PDGFB;TRIB1;JUN;XRCC6;TNFAIP3;MAPK11;IL6R;CCL5
13167,GO:0051764,0.00139715641760875,0.999867000750391,5,12,actin crosslink formation,BP,BAIAP2;FLNA;LCP1;DPYSL3;BAIAP2L2
2609,GO:0005913,0.00140317629545706,0.999550698050948,14,74,cell-cell adherens junction,CC,PDLIM1;LYN;BAIAP2;PLEKHA7;TRIM29;PARD3B;VCL;OXTR;MYH9;SMAD7;TJP1;PARD3;ZYX;DAG1
10358,GO:0043170,0.00140382763284134,0.998886226187845,565,6842,macromolecule metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;C1QTNF1;DTX2;ADM;FOSL2;IL16;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;P4HA2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;HS3ST2;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;DKC1;FEN1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;CDKL1;DDX49;DNTTIP2;PDGFB;BRMS1;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;RNF115;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;ACSL1;NOP56;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;RRP7BP;GALNT2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;PES1;USP31;FOXN1;BRPF1;GLIPR2;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;SMPD2;KBTBD12;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;UBAP2L;TINAGL1;KIF22;MYADM;DAG1;TMEM165;POLR3H;MGAT2;RNF185;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;DPM3;WNT4;MRPS2;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;HSD17B10;XPNPEP3;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;C1S;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
796,GO:0002064,0.00144455873483018,0.999391528002424,22,143,epithelial cell development,BP,KRT2;FOSL2;TFCP2L1;B4GALT1;SIPA1L3;CDKN1A;TJP2;TNF;TYMS;EPHA2;ICAM1;SFN;PDGFB;TJP1;VSIG1;MARVELD2;ESR1;RAPGEF1;MYADM;RILPL2;MYO1E;TP63
18245,GO:1903055,0.00147659540365883,0.999857613534453,5,12,positive regulation of extracellular matrix organization,BP,PDPN;COLGALT1;CLASP1;PHLDB2;DAG1
3269,GO:0006940,0.00148459447481932,0.999710121107894,8,30,regulation of smooth muscle contraction,BP,EDN1;DAPK3;ADRB2;GPER1;SRF;OXTR;NPNT;TBXA2R
16508,GO:0097205,0.00149427297042144,0.999855507801589,5,12,renal filtration,BP,EMP2;PDGFB;MYO1E;XPNPEP3;MCAM
730,GO:0001959,0.00150598228343647,0.999393755878613,20,127,regulation of cytokine-mediated signaling pathway,BP,RUNX1;IL1R2;CYLD;TRAF1;EDN1;BIRC3;NLRC5;TNF;IFNGR1;ADAM17;TRAF2;SYK;ROBO1;SPPL2A;PARP14;SOCS1;TNFAIP3;NOL3;HSP90AB1;CCL5
12703,GO:0050921,0.001515841472105,0.999509335918397,14,76,positive regulation of chemotaxis,BP,IL16;HSPB1;EDN1;SERPINE1;ADAM17;PDGFB;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
10975,GO:0044754,0.00154749027203857,0.999905356136618,4,8,autolysosome,CC,FTL;FTH1;SQSTM1;LAMP1
20265,GO:2001233,0.00156054749788913,0.999167897493718,38,306,regulation of apoptotic signaling pathway,BP,MMP9;INHBA;PML;CYLD;HSPB1;TRAF1;SOD2;CSF2;DAPK3;TP53;TNF;ICAM1;ITGAV;SFN;TNFRSF12A;SERPINE1;SFRP1;GPER1;SNAI2;LGALS3;TRAF2;PTTG1IP;IL1A;SFPQ;ACKR3;YWHAH;CREB3;TFDP1;NOC2L;BCL2L2;TNFRSF10A;WNT4;TNFAIP3;PPP2R1B;NOL3;GCLC;PARP1;TP63
10537,GO:0043484,0.00160061065454867,0.999409553219103,17,100,regulation of RNA splicing,BP,SRSF2;PRPF19;U2AF2;SF3B4;DDX17;SNRNP70;RBM15B;HNRNPU;HNRNPF;PQBP1;RBM38;HSPA8;RBM4;METTL16;SRSF7;CLK4;MAGOH
6102,GO:0019322,0.00160406544334409,0.999968118167593,3,4,pentose biosynthetic process,BP,G6PD;PGD;TKT
16217,GO:0090257,0.00161842063236369,0.999362117418219,19,119,regulation of muscle system process,BP,CTGF;EDN1;DAPK3;G6PD;ZC3H12A;FLNA;ERRFI1;ADRB2;TPM1;GPER1;SRF;PRKCA;OXTR;NPNT;SMAD7;DAG1;NOL3;TBXA2R;PARP1
13910,GO:0060561,0.00162995553773759,0.99977703993184,6,18,apoptotic process involved in morphogenesis,BP,CRYAB;CYR61;TGFB2;B4GALT1;BMP7;PPP2R1B
886,GO:0002252,0.00164938392664785,0.998922986273445,79,749,immune effector process,BP,KRT1;FTL;FTH1;MMP9;PTGER4;S100P;C1R;ACTG1;PML;RELB;TFRC;MAP3K14;TGFB2;GBP1;TRIM56;BIRC3;B4GALT1;MGAM;RSAD2;TRAF3;EMP2;HRNR;NLRC5;IL27RA;NFKB1;LFNG;LYN;PLEKHO2;ARPC4;LAMP1;TNF;BAIAP2;QPCT;SIRPA;ZC3H12A;LCP1;ACAA1;ICAM1;ITGAV;MYO10;ARPC1B;TRIM22;WDR1;IRF1;IL7R;DOCK10;ADAM17;VCL;LGALS3;TRAF2;IL15;SYK;DDX17;IFIT3;DNASE1;GLIPR1;LILRB3;SMAD7;CRCP;PQBP1;THOC1;CXCL5;CAB39;HSPA8;COMMD9;CCR6;RHOG;XRCC6;RAPGEF1;POLR3H;RAB27A;TUBB;TNFAIP3;PSMC3;PTPRB;HSP90AB1;SWAP70;LAIR1;C1S
3450,GO:0007260,0.00164980424078051,0.999587485854138,10,45,tyrosine phosphorylation of STAT protein,BP,CSF2;IL24;LYN;IL20;LIF;IL15;PARP14;SOCS1;IL6R;CCL5
9853,GO:0042100,0.00165978431820535,0.999584642962562,10,45,B cell proliferation,BP,TFRC;CDKN1A;LYN;AHR;IL7R;IRS2;TNFRSF21;IKZF3;CD38;CTPS1
15272,GO:0071450,0.00167633826085464,0.999766007979867,6,19,cellular response to oxygen radical,BP,NQO1;SOD2;TNF;FANCC;DHFR;BMP7
15273,GO:0071451,0.00167633826085464,0.999766007979867,6,19,cellular response to superoxide,BP,NQO1;SOD2;TNF;FANCC;DHFR;BMP7
12956,GO:0051338,0.00168753579615506,0.998900179910312,78,731,regulation of transferase activity,BP,SAA1;NRG1;CYR61;DUSP14;HSPB1;SDC4;GPRC5A;MAP3K14;TGFB2;EDN1;DBNDD2;EMP2;NLRC5;TP53;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;FGFR2;EPHB6;TELO2;UBE2C;EPHA2;CHP1;GADD45B;BMP2;CDK4;ERRFI1;SFN;EPGN;ADRB2;DAXX;SFRP1;EGR1;ADAM17;DKC1;FGFR1OP;IRS2;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;RPS2;SPRY4;ROR1;ACSL1;AFAP1L2;SMAD7;HNRNPU;TRIB1;DCUN1D2;DUSP1;CAB39;SOCS1;OXSR1;SERTAD1;ARRDC3;DUS2;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;TNFAIP3;EFNA1;MAPK11;CARD10;DUSP8;HSP90AB1;CCL5
8788,GO:0034471,0.00168848629833022,0.999763967743088,6,19,ncRNA 5'-end processing,BP,POP1;UTP20;ABT1;NOP14;HSD17B10;POP4
10723,GO:0044057,0.00169267466172383,0.999138285550975,33,251,regulation of system process,BP,NRG1;INHBA;CTGF;C1QTNF1;ADM;TGFB2;EDN1;DAPK3;G6PD;EMP2;ZC3H12A;FLNA;ICAM1;ERRFI1;ADRB2;FXYD3;TPM1;GPER1;SRF;SGK1;PRKCA;PDGFB;OXTR;NPNT;TNFRSF21;SMAD7;KCNIP3;PARD3;DAG1;CD38;NOL3;TBXA2R;PARP1
11503,GO:0045987,0.00169997879750674,0.999765470636193,6,18,positive regulation of smooth muscle contraction,BP,EDN1;GPER1;SRF;OXTR;NPNT;TBXA2R
630,GO:0001819,0.00172430906557912,0.999120724595689,33,254,positive regulation of cytokine production,BP,SAA1;TRIM16;CCL20;RUNX1;PTGER4;CYP1B1;HSPB1;CD83;CSF2;BIRC3;RSAD2;PANX1;IL27RA;NFKB1;TNF;NFKB2;CD274;SERPINE1;IRF1;EGR1;ADAM17;TRAF2;IL15;SYK;SPTBN1;IL1A;AFAP1L2;CRCP;PQBP1;XRCC6;POLR3H;MAPK11;IL6R
10904,GO:0044449,0.0017528554012455,0.999303763487183,19,120,contractile fiber part,CC,CRYAB;JPH2;HSPB1;PDLIM1;SDC4;SQSTM1;DST;TPM4;JPH1;FLNA;SVIL;TPM1;VCL;SPTBN1;FHL2;NPNT;ACTN4;SORBS2;DAG1
14814,GO:0070542,0.0017880374749745,0.99950940021727,11,52,response to fatty acid,BP,PTGER4;CTGF;EDN1;TNC;ZC3H12A;CDK4;SFRP1;AKAP8;AKR1C2;ACSL1;CPT1A
10019,GO:0042448,0.00180229502877109,0.999884947784528,4,8,progesterone metabolic process,BP,ADM;EGR1;AKR1C2;AKR1C1
12665,GO:0050869,0.00180295884717713,0.999748274652724,6,18,negative regulation of B cell activation,BP,INHBA;LYN;SFRP1;TNFRSF21;THOC1;TNFAIP3
10209,GO:0042824,0.0018038562881314,0.999962594856519,3,4,MHC class I peptide loading complex,CC,TAP1;TAPBP;TAP2
2445,GO:0005654,0.00181897414523582,0.998581056053001,269,3043,nucleoplasm,CC,TRIM16;CRYAB;NRG1;RUNX1;HDAC9;S100P;CYP24A1;DTX2;FOSL2;IL16;PML;RBM19;MYBL2;RELB;ABCF1;CD3EAP;ARID3B;IER2;SH3RF2;TXNRD1;IKBKE;BIRC3;DAPK3;ELMSAN1;NUAK1;TP53;SQSTM1;PDCD11;HNRNPAB;P4HA2;NOCT;NEDD9;NFKB1;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;GADD45A;BAIAP2;ZBED1;RING1;PKMYT1;NAV2;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;UBE2C;JPH1;ZC3H12A;SRSF2;SART1;GEMIN5;CADPS2;FANCC;DDX23;CDK4;KIF23;TRMT61A;STAT5A;DAXX;NAT10;FUS;MCM2;LSG1;USP36;AKAP8L;AEN;ELF3;TRIM22;ZFYVE27;SAFB2;APTX;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;BANF1;DDX42;PSPC1;TFIP11;SRF;NSUN2;RRP36;ELF4;ABTB2;MED22;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;CD2BP2;SRRT;PRPF19;AKAP8;NELFE;DKC1;FEN1;ISG20L2;U2AF2;SHQ1;KCTD10;NPAS2;CBX5;PPRC1;TSR1;MAFK;TRAF2;IL15;SF3B4;PRKCA;PUM3;POLR1A;DDX17;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;GEMIN8;NSFL1C;NEDD4L;SNRNP70;FHL2;RRP7A;COPS3;TNIP2;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;SAP30BP;WDR46;SPEN;NOP56;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35C2;TATDN2;NOL9;SUPT5H;MTA2;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;CREB3;RUVBL2;PPP1R9B;ORC1;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;ANAPC15;ARL6IP4;TXNL4B;CITED2;SOCS1;HSPA8;JUN;ESR1;IKZF3;CENPN;PES1;RCC1;BRPF1;MCM7;TFDP1;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;NACC1;CENPO;GINS3;HERC2;ARGLU1;XRCC6;EDC4;TRMT1;TAP2;TEAD4;ACTN4;SORBS2;SNIP1;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;RNF7;AKIP1;ELK1;INCENP;PHF5A;UBAP2L;KIF22;DAG1;POLR3H;TIMELESS;GPX4;RBM14;CTDSP1;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;SURF6;ZC3H18;UTP4;POLR2G;SRSF7;SNF8;CDCA5;HSP90AB1;TBXA2R;MKI67;POP4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;MAGOH
8882,GO:0034694,0.0018233600655253,0.999744843030307,6,18,response to prostaglandin,BP,PTGER4;EDN1;TNC;SFRP1;AKAP8;AKR1C2
4688,GO:0010837,0.00182717404650164,0.999683991948208,7,24,regulation of keratinocyte proliferation,BP,EFNB2;SFN;EPPK1;SNAI2;ZFP36L1;CD109;TP63
2419,GO:0005593,0.00183980444760418,0.999961576090398,3,4,FACIT collagen trimer,CC,COL12A1;COL16A1;COL9A2
13887,GO:0060526,0.00184122414372813,0.999961535704242,3,4,prostate glandular acinus morphogenesis,BP,FGFR2;SFRP1;ESR1
13888,GO:0060527,0.00184122414372813,0.999961535704242,3,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,FGFR2;SFRP1;ESR1
5116,GO:0015440,0.00184122414372813,0.999961535704242,3,4,peptide-transporting ATPase activity,MF,TAP1;TAPBP;TAP2
8356,GO:0033220,0.00184122414372813,0.999961535704242,3,4,amide-transporting ATPase activity,MF,TAP1;TAPBP;TAP2
14018,GO:0060740,0.00188259875448562,0.999734833072394,6,18,prostate gland epithelium morphogenesis,BP,TNC;FGFR2;SFRP1;ESR1;BMP7;TP63
9054,GO:0035272,0.00189817366816675,0.999561332497714,9,38,exocrine system development,BP,TFCP2L1;TGFB2;TNF;FGFR2;IGSF3;SNAI2;SEMA3C;BMP7;DAG1
6848,GO:0030316,0.00192718674670352,0.999427203019774,12,60,osteoclast differentiation,BP,MAFB;TFRC;FBN1;TJP2;JUNB;TNF;EPHA2;IL20;SFRP1;LILRB3;KLF10;CD109
3514,GO:0007431,0.00193031693068451,0.99960431922167,8,31,salivary gland development,BP,TFCP2L1;TGFB2;TNF;FGFR2;SNAI2;SEMA3C;BMP7;DAG1
8750,GO:0034399,0.00198018149542732,0.999205124470867,19,119,nuclear periphery,CC,MAP2;PML;TP53;ENC1;NUP153;TELO2;AKAP8L;PSPC1;AKAP8;POLA1;UHRF1;SFPQ;HNRNPU;RUVBL2;THOC1;ZNF703;PHF5A;IPO4;DAG1
11352,GO:0045684,0.00202643067961061,0.999579074907184,8,32,positive regulation of epidermis development,BP,TRIM16;TGFB2;FST;TNF;KRT17;SFN;IL20;FOXN1
17633,GO:1901343,0.00203617322967047,0.999353312151464,13,68,negative regulation of vasculature development,BP,AMOT;PML;STARD13;TGFB2;HSPG2;ADAMTS9;SERPINE1;PGK1;PDGFB;BMP7;WNT4;CARD10;TBXA2R
17038,GO:0099513,0.00205116760237044,0.998765439749973,54,471,polymeric cytoskeletal fiber,CC,KRT1;SAA1;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;KRT4;NEFM;ACTG1;CYLD;KRT10;KRT13;MID1;DAPK3;KRTAP2-3;KLHL21;KRT9;KRT6A;MYO1B;BAIAP2;KRT5;DST;TPM4;KRT17;FLNA;LCP1;KIF23;SVIL;MTUS1;TPM1;WDR1;EPPK1;GPER1;KRT14;IFFO2;DCTN1;DPYSL3;TCP11L1;SLAIN2;ZW10;RCC2;KEAP1;SPECC1;HNRNPU;CLASP1;DCXR;KIF24;INCENP;KIF22;TUBB;TTLL5;BIN3
11477,GO:0045933,0.00206836409830728,0.999631030496522,7,25,positive regulation of muscle contraction,BP,CTGF;EDN1;GPER1;SRF;OXTR;NPNT;TBXA2R
17872,GO:1902106,0.00207157834860581,0.999419305626891,11,53,negative regulation of leukocyte differentiation,BP,MAFB;INHBA;CYLD;FBN1;TJP2;LYN;SFRP1;IRF1;LILRB3;SMAD7;TRIB1
13886,GO:0060525,0.00207674636965162,0.999862012949146,4,8,prostate glandular acinus development,BP,FGFR2;SFRP1;ESR1;TP63
8441,GO:0033559,0.00211164163638977,0.999363173915094,12,62,unsaturated fatty acid metabolic process,BP,CYP1B1;CYP1A1;FADS3;PTGES;EDN1;SCD;ACAA1;AKR1C2;ACSL1;SCD5;AKR1C1;FADS1
4690,GO:0010839,0.00216608033325048,0.99976383875137,5,13,negative regulation of keratinocyte proliferation,BP,EFNB2;SFN;EPPK1;SNAI2;CD109
3399,GO:0007178,0.00216633903347353,0.99893292266218,29,214,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CYR61;INHBA;PML;FBN1;TGFB2;FST;CDKN2B;BMP2;SFRP1;EGR1;ADAM17;SPTBN1;NPNT;BAMBI;SMAD7;PALM2;KLF10;TGFBRAP1;CITED2;CD109;JUN;ZNF703;PARD3;BMP7;ZYX;RBM14;BMP8A;HSP90AB1;PARP1
7994,GO:0032612,0.00222278459850386,0.999368605142889,11,55,interleukin-1 production,BP,SAA1;TRIM16;CCL20;IL1R2;PML;HSPB1;PANX1;ZC3H12A;ERRFI1;EGR1;TNFAIP3
221,GO:0000460,0.00225782421876066,0.999520257239253,8,33,maturation of 5.8S rRNA,BP,PDCD11;RRS1;UTP20;FTSJ3;NOL9;ABT1;PES1;NOP14
3439,GO:0007229,0.00226265506402035,0.999312862254456,12,61,integrin-mediated signaling pathway,BP,CTGF;EMP2;NEDD9;DST;FLNA;COL16A1;ITGAV;SYK;MYH9;RCC2;ZYX;PHACTR4
10826,GO:0044319,0.00227717061614501,0.999586610367807,7,25,wound healing, spreading of cells,BP,CYR61;PDPN;FLNA;ADAM17;AJUBA;CLASP1;PHLDB2
16323,GO:0090505,0.00227717061614501,0.999586610367807,7,25,epiboly involved in wound healing,BP,CYR61;PDPN;FLNA;ADAM17;AJUBA;CLASP1;PHLDB2
149,GO:0000303,0.00230326287891598,0.999652678965015,6,20,response to superoxide,BP,NQO1;SOD2;TNF;FANCC;DHFR;BMP7
4507,GO:0010557,0.00231867435256858,0.998338666833349,123,1251,positive regulation of macromolecule biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;HSPB1;MYBL2;RELB;ARID3B;IER2;CSF2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;IRS1;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;KRT17;FOSL1;ZC3H12A;KLF7;CHP1;BMP2;CDK4;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;NELFE;DKC1;IRS2;NPAS2;PPRC1;IL15;SYK;DDX17;PDGFB;UBTF;ALYREF;RPS9;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;PHF5A;EIF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;POLR2G;CREB5;HSP90AB1;PARP1;TP63;CCL5
9832,GO:0042056,0.00234611177339262,0.999732401994253,5,14,chemoattractant activity,MF,SAA1;LGALS3;PDGFB;GPNMB;CCL5
9800,GO:0040019,0.00235554017807428,0.999647609573096,6,19,positive regulation of embryonic development,BP,AMOT;RBM19;CLASP1;PHLDB2;DAG1;WNT4
4567,GO:0010648,0.00235771432413938,0.998381195238051,95,934,negative regulation of cell communication,BP,IGFBP3;NRG1;MMP9;INHBA;ADM;IL1R2;DUSP14;CYLD;HSPB1;SOD2;GPRC5A;CSF2;FBN1;TGFB2;EDN1;GBP1;NLRC5;MARVELD3;FST;LFNG;IRS1;UBQLN2;LYN;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;TNK1;EPHA2;CHP1;ICAM1;BMP2;KREMEN2;ITGAV;ERRFI1;ADRB2;SERPINE1;LIF;SFRP1;PSME2;GPER1;SRF;NFKBIA;EGR1;SNAI2;ADAM17;LGALS3;TRAF2;ROBO1;AJUBA;PDGFB;PTTG1IP;RNF115;IL1A;SPRY4;ROR1;ACKR3;BAMBI;SMAD7;TRIB1;CREB3;RUVBL2;PARP14;DUSP1;CD109;SOCS1;ESR1;PAK1IP1;NOC2L;INSIG1;BCL2L2;THEM4;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;CGNL1;WNT4;CD38;TNFAIP3;PSMC3;CXCL8;EFNA1;BMP8A;DUSP8;NOL3;GCLC;TP63;PHACTR4;CCL5;SH3BP4
4294,GO:0009725,0.00236912270683811,0.998470385877266,70,649,response to hormone,BP,TRIM16;CRYAB;RUNX1;PTGER4;INHBA;HDAC9;NEFL;CTGF;ADM;NQO1;FBN1;TGFB2;EDN1;NFKB1;IRS1;CDKN1A;LYN;JUNB;TNF;BAIAP2;TNC;FOSL1;TYMS;HMGCS1;ICAM1;CDK4;ERRFI1;STAT5A;DAXX;ARPC1B;SFRP1;SAFB2;GPER1;SRF;TXN2;EGR1;ETS1;ZFP36L1;AKAP8;IRS2;AKR1C2;ZFP36L2;DDX17;OXTR;FHL2;LANCL2;ACSL1;YWHAH;HNRNPU;PAGR1;RUVBL2;SAFB;DUSP1;SOCS1;JUN;ESR1;ZNF703;QDPR;BMP7;ELK1;DAG1;RBM14;AKR1C1;CD38;BRIP1;GCLC;TBXA2R;PARP1;TP63;BAIAP2L2
14644,GO:0070228,0.00239779020738512,0.999421845440432,9,40,regulation of lymphocyte apoptotic process,BP,TP53;LYN;TSC22D3;CD274;IRS2;LGALS3;NOC2L;EFNA1;CCL5
19733,GO:2000106,0.00241052729912319,0.99930791500586,11,55,regulation of leukocyte apoptotic process,BP,TP53;LYN;CDKN2A;TSC22D3;CD274;ADAM17;IRS2;LGALS3;NOC2L;EFNA1;CCL5
12530,GO:0050678,0.00249230818918597,0.998759129098025,29,218,regulation of epithelial cell proliferation,BP,KRT4;TGFB2;B4GALT1;MARVELD3;CDKN2B;TNF;EFNB2;FGFR2;BMP2;ERRFI1;SFN;STAT5A;EPGN;OSR2;SFRP1;EPPK1;SNAI2;ZFP36L1;ADAM17;PRKCA;ROBO1;PDGFB;CD109;JUN;ZNF703;LAMC1;TNFAIP3;TP63;CCL5
13881,GO:0060512,0.00257353206550669,0.999607927892375,6,19,prostate gland morphogenesis,BP,TNC;FGFR2;SFRP1;ESR1;BMP7;TP63
9184,GO:0035556,0.00257903963842259,0.998044196059127,184,1984,intracellular signal transduction,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;FN1;NEFL;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;TUFT1;DUSP14;PML;CYLD;HSPB1;STARD13;RELB;SOD2;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;NFKB1;TAF4B;IRS1;CDKN1A;TJP2;LYN;RAB32;AHR;GADD45A;TNF;CDKN2A;WWC1;TRIO;PDPN;FGFR2;NFKB2;PSMB9;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;LCP1;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;ITGAV;ERRFI1;SFN;CDC42EP2;STAT5A;EPGN;ADRB2;IL20;DAXX;AMOTL2;AEN;LIF;SFRP1;TRIM22;PSME2;IL7R;GPER1;NFKBIA;DOCK10;SGK1;SNAI2;RRS1;PRPF19;ZFP36L1;ARHGEF28;RHOB;NELFE;IRS2;IER3;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;ROBO1;AJUBA;PDGFB;OXTR;PTTG1IP;SPTBN1;NPNT;IL1A;CAMK1G;TNIP2;RASGRP4;SFPQ;SPRY4;ROR1;ACKR3;MTA2;TJP1;RRAD;TRIB1;CREB3;PPP1R9B;PARP14;DUSP1;CAB39;SOCS1;STAC;OXSR1;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;TFDP1;NOP2;NOC2L;CCR6;RHOG;GPNMB;BCL2L2;TEAD4;SMPD2;ACTN4;THEM4;SNIP1;BMP7;PHLPP1;TNFRSF10A;AKIP1;RAPGEF1;MYADM;DAG1;CGNL1;EEF1D;ASB6;RAB27A;BLNK;TRAF4;CYTH1;TNFAIP3;PSMC3;CCL22;BRIP1;SUPT16H;CXCL8;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;NOL3;TBXA2R;IL6R;PARP1;TP63;PHACTR4;TOP3A;CCL5;SH3BP4
12380,GO:0048771,0.00258586563079835,0.999031565937622,16,96,tissue remodeling,BP,TFRC;B4GALT1;EPHA2;ADRB2;ELF3;LIF;SFRP1;IL15;PRKCA;SYK;IL1A;SEMA3C;GPNMB;CD38;TNFAIP3;NOL3
18153,GO:1902895,0.00260017539784621,0.999603027281742,6,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,TGFB2;TP53;BMP2;SRF;PDGFB;JUN
6649,GO:0023057,0.0026033341612786,0.998205923037251,95,937,negative regulation of signaling,BP,IGFBP3;NRG1;MMP9;INHBA;ADM;IL1R2;DUSP14;CYLD;HSPB1;SOD2;GPRC5A;CSF2;FBN1;TGFB2;EDN1;GBP1;NLRC5;MARVELD3;FST;LFNG;IRS1;UBQLN2;LYN;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;TNK1;EPHA2;CHP1;ICAM1;BMP2;KREMEN2;ITGAV;ERRFI1;ADRB2;SERPINE1;LIF;SFRP1;PSME2;GPER1;SRF;NFKBIA;EGR1;SNAI2;ADAM17;LGALS3;TRAF2;ROBO1;AJUBA;PDGFB;PTTG1IP;RNF115;IL1A;SPRY4;ROR1;ACKR3;BAMBI;SMAD7;TRIB1;CREB3;RUVBL2;PARP14;DUSP1;CD109;SOCS1;ESR1;PAK1IP1;NOC2L;INSIG1;BCL2L2;THEM4;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;CGNL1;WNT4;CD38;TNFAIP3;PSMC3;CXCL8;EFNA1;BMP8A;DUSP8;NOL3;GCLC;TP63;PHACTR4;CCL5;SH3BP4
10098,GO:0042605,0.00266091557826117,0.999687312803132,5,14,peptide antigen binding,MF,TAP1;HLA-B;SLC7A5;HLA-F;TAPBP
12219,GO:0048468,0.00266216668421776,0.998074716793411,127,1297,cell development,BP,NRG1;KRT2;RUNX1;INHBA;HDAC9;MAP2;FN1;NEFL;TENM3;ADM;FOSL2;NEFM;ACTG1;TFCP2L1;SDC4;FBN1;TGFB2;EDN1;GBP1;B4GALT1;DBNDD2;G6PD;SIPA1L3;PANK2;TAF4B;CDKN1A;TJP2;LYN;EHD1;TNF;BAIAP2;EFNB2;CORO1C;ENC1;TNC;GPRIN1;PDPN;FGFR2;PBX1;TYMS;FLNA;KLF7;EPHA2;ICAM1;FANCC;BMP2;UBE4B;COL27A1;ITGAV;L1CAM;SFN;TNFRSF12A;PABPC4;LIF;SFRP1;TPM1;ZFYVE27;WDR1;GPER1;SRF;NSUN2;DOCK10;SGK1;SNAI2;SRRT;PRPF19;DHFR;VCL;IRS2;IL15;PRKCA;NTN1;ROBO1;PDGFB;SPTBN1;NEDD4L;SERPINH1;FHL2;DPYSL3;MYH9;IL1A;SDK1;TNFRSF21;SEMA3C;SPEN;ROR1;RCC2;YWHAH;ENAH;HNRNPU;TJP1;PQBP1;VSIG1;TRIB1;PPP1R9B;MARVELD2;JUN;ESR1;TCOF1;BLOC1S2;CCR6;PARD3;LAMC1;RHOG;ZNF365;ZSWIM6;CNTNAP1;ACTN4;EFNB1;SORBS2;LRFN4;BMP7;AKIP1;RAPGEF1;MYADM;DAG1;WNT4;RILPL2;CTDSP1;BRIP1;EFNA1;MYO1E;BMP8A;TTLL5;BIN3;TP63;PHACTR4
3385,GO:0007162,0.00266623932531663,0.998767063126287,24,169,negative regulation of cell adhesion,BP,CYP1B1;C1QTNF1;CYLD;SDC4;GBP1;CDKN2A;CORO1C;TNC;CD274;BMP2;SERPINE1;IRF1;SNAI2;LGALS3;TNFRSF21;RCC2;SMAD7;ZNF703;GPNMB;ACTN4;PHLDB2;MYADM;CLDN7;SWAP70
214,GO:0000447,0.0026797163707634,0.99979451500264,4,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,RRS1;UTP20;ABT1;NOP14
8376,GO:0033273,0.00268528434820236,0.99916430057492,12,63,response to vitamin,BP,CYP24A1;CYP1A1;TP53;TNC;TYMS;SRSF2;HMGCS1;SFRP1;SNAI2;IL15;BMP7;BRIP1
3701,GO:0008207,0.00268932213077964,0.999581356625403,6,20,C21-steroid hormone metabolic process,BP,ADM;BMP2;EGR1;AKR1C2;WNT4;AKR1C1
9971,GO:0042359,0.00269636487189726,0.999682150059915,5,14,vitamin D metabolic process,BP,CYP24A1;CYP1A1;NFKB1;TNF;SNAI2
15307,GO:0071496,0.00274968259748496,0.998585993436993,31,238,cellular response to external stimulus,BP,PTGER4;CYP24A1;MAP3K14;TP53;NFKB1;CDKN2B;CDKN1A;LYN;GADD45A;BAIAP2;TNC;FOSL1;ZC3H12A;CADPS2;ICAM1;SFRP1;IRF1;SRF;TXN2;SNAI2;IL15;PPP1R9B;KLF10;HSPA8;JUN;TNFRSF10A;DAG1;WNT4;BRIP1;GCLC;FADS1
11447,GO:0045893,0.00277302027720008,0.998048006161462,106,1058,positive regulation of transcription, DNA-templated,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;MYBL2;RELB;ARID3B;IER2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;EDF1;ETS1;NELFE;NPAS2;PPRC1;DDX17;PDGFB;UBTF;ALYREF;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;PHF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;CREB5;PARP1;TP63
18428,GO:1903508,0.00277302027720008,0.998048006161462,106,1058,positive regulation of nucleic acid-templated transcription,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;MYBL2;RELB;ARID3B;IER2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;EDF1;ETS1;NELFE;NPAS2;PPRC1;DDX17;PDGFB;UBTF;ALYREF;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;PHF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;CREB5;PARP1;TP63
15208,GO:0071353,0.00279623430732276,0.999468910266349,7,26,cellular response to interleukin-4,BP,PML;IL24;CDK4;MCM2;KEAP1;PARP14;HSP90AB1
18233,GO:1903037,0.00280556417908937,0.998696578303534,24,171,regulation of leukocyte cell-cell adhesion,BP,CYLD;SDC4;TFRC;CD83;MAP3K14;LYN;TNF;EFNB2;SIRPA;SART1;ICAM1;CD274;IRF1;IL7R;ETS1;LGALS3;IL15;SYK;TNFRSF21;SMAD7;SOCS1;GPNMB;EFNB1;CCL5
15202,GO:0071347,0.00285203696213293,0.998810854183442,19,128,cellular response to interleukin-1,BP,CCL20;IL1R2;EDN1;SQSTM1;NFKB1;PSMB9;ZC3H12A;ICAM1;SFRP1;PSME2;NFKBIA;EGR1;IL1A;TNIP2;PSMC3;CCL22;CXCL8;MAPK11;CCL5
10901,GO:0044446,0.00285267860796771,0.997706680781196,577,7071,intracellular organelle part,CC,IGFBP3;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;NEFL;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;NEFM;ACTG1;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;KRT10;PCDH7;SDC4;KRT13;FADS3;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;DBNDD2;RSAD2;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;TAF4B;GNPTAB;LFNG;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;PLEKHO2;ARPC4;LAMP1;HS3ST2;EHD1;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;CLN6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;CHP1;CCDC85B;FANCC;ARFRP1;COL16A1;GOSR1;COL27A1;DDX23;CDK4;KREMEN2;DRAM1;ITGAV;KIF23;MYO10;GGCX;SFN;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;NAT10;MTUS1;SERPINE1;FUS;ARPC1B;MCM2;LSG1;CCDC124;EBP;TOX4;ST6GALNAC5;USP36;AKAP8L;AEN;ELF3;GRWD1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;BANF1;EPPK1;IL7R;DDX42;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;RPLP2;AKAP8;RHOB;NELFE;DKC1;FEN1;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;PUM3;CMTM3;POLR1A;DDX17;AJUBA;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;IFFO2;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;DNASE1;COLGALT1;COX5B;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;SPPL2A;TAPBPL;NOM1;COL17A1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;LANCL2;PRCC;SNX8;RBBP5;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;WDR4;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;UBE2J2;CEP41;TPST1;CREB3;RUVBL2;ABT1;PPP1R9B;MTFP1;ORC1;LPCAT3;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;TRUB2;ANAPC15;MRPL20;PCYT1A;RRP7BP;GALNT2;ATG101;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPA8;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;PES1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;NACC1;ZNF703;INSIG1;CENPO;GINS3;HERC2;CNTROB;ARGLU1;LAMC1;RHOG;BCL2L2;ZNF365;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;ACTN4;HMGN2;THEM4;SORBS2;KIF24;SNIP1;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;TOMM40;AKIP1;MPHOSPH8;ELK1;SGSM1;INCENP;PHF5A;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;KIF22;MYADM;DAG1;TMEM165;CGNL1;POLR3H;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;DPM3;WNT4;RILPL2;MRPS2;RBM14;VPS52;TUBB;CTDSP1;CYTH1;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;ZC3H18;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;SLC25A44;SRSF7;CLTA;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;TTLL5;BIN3;LAIR1;POP4;RPUSD4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2
18081,GO:1902680,0.00285919205128132,0.99798515027974,106,1059,positive regulation of RNA biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;MYBL2;RELB;ARID3B;IER2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;EDF1;ETS1;NELFE;NPAS2;PPRC1;DDX17;PDGFB;UBTF;ALYREF;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;ELK1;PHF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;CREB5;PARP1;TP63
3491,GO:0007369,0.00288697096380311,0.998798278439806,19,122,gastrulation,BP,MMP9;INHBA;FN1;AMOT;TXNRD1;COL12A1;FGFR2;ARFRP1;ITGAV;SFRP1;SRF;COL5A2;CLASP1;ETS2;DUSP1;BMP7;PHLDB2;MYADM;DAG1
16322,GO:0090504,0.00292242601232447,0.999440414850601,7,26,epiboly,BP,CYR61;PDPN;FLNA;ADAM17;AJUBA;CLASP1;PHLDB2
2554,GO:0005829,0.00293596004664448,0.997644572544189,351,4105,cytosol,CC,IL32;KRT1;SPRR3;TRIM16;FTL;CRYAB;SPRR2A;FTH1;KRT2;RUNX1;MAP2;NEFL;ODC1;CTGF;KRT34;TNS3;KRT15;AMOT;KRT4;ACTG1;TRIM47;NQO1;IL16;NFKBIE;PML;CYLD;HSPB1;STARD13;KRT10;TRAF1;KRT13;RELB;BAG1;ABCF1;CD3EAP;MAP3K14;TRIM16L;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;KRTAP2-3;SPSB1;G6PD;TRAF3;EMP2;KLHL21;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;KRT9;P4HA2;PANK2;NEDD9;NFKB1;CDKN2B;IRS1;KRT6A;CDKN1A;TJP2;UBQLN2;LYN;RAB32;C15ORF39;AHR;CDV3;MCM5;ARPC4;LAMP1;GNL3L;BAIAP2;KRT5;CDKN2A;RING1;PKMYT1;WWC1;DST;TRIO;PDPN;NUP153;TPM4;NFKB2;DNAJB1;PSMB9;SLC7A5;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;PGD;UBE2C;TYMS;FLNA;SRSF2;LCP1;TNK1;ARMC6;SART1;TK1;GEMIN5;CHP1;HMGCS1;EIF5;TSC22D3;FANCC;ARFRP1;GOSR1;CDK4;ITGAV;ERRFI1;KIF23;MYO10;PMM2;SFN;CDC42EP2;STAT5A;RNF19B;SVIL;PLEKHA7;DAXX;PABPC4;PGK1;ARPC1B;LSG1;CCDC124;NMT2;XAF1;AMOTL2;ELF3;GRWD1;LIF;SFRP1;TPM1;TRIM22;ZFYVE27;CC2D2A;DHCR7;WDR1;ANXA8;MKL1;IRF1;METTL1;PSME2;DNPEP;BANF1;DPH2;DDX42;CTIF;NFX1;DNAJB2;LARP4B;ABTB2;NFKBIA;EDF1;DOCK10;GEMIN4;SGK1;CD2BP2;ZFP36L1;ARHGEF28;RPLP2;RHOB;ADAM17;GPCPD1;TXLNA;DHFR;FGFR1OP;VCL;SHQ1;KCTD10;IRS2;IER3;NPAS2;KRT14;TSR1;ACO1;RPLP1;TRAF2;IL15;AKR1C2;PRKCA;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;C9ORF78;IFIT3;NOB1;PPIP5K1;PREP;RPS2;ALYREF;UTP14A;PHAX;POLA1;WDR34;RPS9;GEMIN8;NSFL1C;SPTBN1;NEDD4L;DCTN1;RNF115;DPYSL3;SLAIN2;MYH9;IL1A;COPS3;TNIP2;LANCL2;DOHH;RASGRP4;SNX8;BORCS7;SPRY4;ZW10;RCC2;NUP214;AFAP1L2;GPN1;SMAD7;CRCP;TATDN2;CCDC6;YWHAH;TRIP6;WDR4;ENAH;KEAP1;ERAL1;TJP1;CLASP1;HNRNPF;PQBP1;CAPNS1;CEP41;CREB3;RUVBL2;ORC1;MICAL3;KCNIP3;THOC1;ETS2;TRUB2;PARP14;ANAPC15;RBM38;PCYT1A;ATG101;CAB39;TXNL4B;RPL27A;SOCS1;STAC;OXSR1;HSPA8;GBE1;JUN;DTX4;ESR1;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;PES1;BRPF1;COMMD9;MCM7;TFDP1;EIF3B;GTF2E1;TRAPPC5;NOC2L;CHMP4B;RBM4;RPTN;CENPO;DUS2;CNTROB;PARD3;QDPR;RHOG;BCL2L2;ACBD6;XRCC6;EDC4;KLF6;CHCHD6;ACTN4;THEM4;KIF24;SNIP1;PHLPP1;ZNF34;URGCP;TKT;EFTUD2;RNF7;KANK4;TOMM40;MPHOSPH8;PHLDB2;SGSM1;INCENP;EIF3I;RAPGEF1;ZYX;EIF5A;KIF22;UAP1L1;DAG1;POLR3H;EEF1D;ASB6;RAB27A;GPX4;BLNK;RILPL2;AKR1C1;VPS52;CYTH1;TNFAIP3;PSMC3;SPG21;DNAJC9;RRM2;MAPK11;CTPS1;SURF6;SLC3A2;RNF144B;CLTA;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;TTLL5;HERC6;TP63;BAIAP2L2;ORC4
15413,GO:0071675,0.00296928291862246,0.999528229023434,6,20,regulation of mononuclear cell migration,BP,LYN;TNF;SERPINE1;LGALS3;CREB3;CCL5
12902,GO:0051248,0.00302932447861055,0.997924511188969,89,886,negative regulation of protein metabolic process,BP,IGFBP3;CRYAB;NRG1;MMP9;INHBA;IL1R2;DUSP14;PML;HSPB1;GPRC5A;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;MARVELD3;NFKB1;CDKN2B;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;ENC1;NUP153;BACE2;TYMS;ZC3H12A;FLNA;CHP1;GADD45B;CDK4;ITGAV;ERRFI1;SFN;SERPINE1;ZC3H7B;LIF;SFRP1;ANXA8;GPER1;SRRT;ZFP36L1;SNX12;DHFR;U2AF2;FGFR1OP;ZFP36L2;AJUBA;SNRNP70;SERPINH1;SPRY4;NUP214;SMAD7;DNAJC1;PPP1R14C;TRIB1;PPP1R9B;A2ML1;PARP14;DUSP1;CD109;SOCS1;JUN;ESR1;NOC2L;RBM4;DUS2;PARD3;SNIP1;BMP7;METTL16;TNFRSF10A;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;SWAP70
11294,GO:0045604,0.00303988987835776,0.999165164914671,10,48,regulation of epidermal cell differentiation,BP,TRIM16;RUNX1;ERRFI1;SFN;IL20;ZFP36L1;MAFF;KEAP1;CD109;TP63
10621,GO:0043616,0.00307752886681638,0.999311546175978,8,33,keratinocyte proliferation,BP,KRT2;EFNB2;SFN;EPPK1;SNAI2;ZFP36L1;CD109;TP63
353,GO:0000966,0.00311226795416257,0.999495184068747,6,21,RNA 5'-end processing,BP,POP1;UTP20;ABT1;NOP14;HSD17B10;POP4
14900,GO:0070700,0.00311909707451539,0.999750243652268,4,9,BMP receptor binding,MF,TGFB2;BMP2;BMP7;BMP8A
12776,GO:0051051,0.00312927162705144,0.998338438637156,33,263,negative regulation of transport,BP,CRYAB;NRG1;MMP9;PTGER4;INHBA;FN1;IL1R2;PML;EDN1;GBP1;RSAD2;NFKB1;IRS1;UBQLN2;TNF;NUP153;ZC3H12A;CHP1;ICAM1;ITGAV;LIF;SFRP1;SNX12;IRS2;LGALS3;OXTR;NEDD4L;TNFRSF21;RRAD;CAB39;OXSR1;INSIG1;BMP8A
4364,GO:0009968,0.00313636996645516,0.997844343968855,90,886,negative regulation of signal transduction,BP,IGFBP3;NRG1;MMP9;ADM;IL1R2;DUSP14;CYLD;HSPB1;SOD2;GPRC5A;CSF2;FBN1;TGFB2;GBP1;NLRC5;MARVELD3;FST;LFNG;IRS1;UBQLN2;LYN;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;TNK1;EPHA2;CHP1;ICAM1;BMP2;KREMEN2;ITGAV;ERRFI1;ADRB2;SERPINE1;LIF;SFRP1;PSME2;GPER1;NFKBIA;EGR1;SNAI2;ADAM17;LGALS3;TRAF2;ROBO1;AJUBA;PDGFB;PTTG1IP;RNF115;IL1A;SPRY4;ROR1;ACKR3;BAMBI;SMAD7;TRIB1;CREB3;RUVBL2;PARP14;DUSP1;CD109;SOCS1;ESR1;PAK1IP1;NOC2L;INSIG1;BCL2L2;THEM4;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;CGNL1;WNT4;TNFAIP3;PSMC3;CXCL8;EFNA1;DUSP8;NOL3;GCLC;TP63;PHACTR4;CCL5;SH3BP4
4267,GO:0009615,0.00313792384989905,0.998410194981321,29,223,response to virus,BP,ODC1;CYP1A1;PML;HSPB1;MAP3K14;GBP1;TRIM56;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;TNF;FOSL1;ZC3H12A;IFNGR1;TRIM22;IRF1;BANF1;IL15;DDX17;IFIT3;CRCP;PQBP1;POLR3H;TNFAIP3;CCL22;MAPK11;CCL5
18526,GO:1903708,0.00313953733199752,0.998717487473634,18,116,positive regulation of hemopoiesis,BP,RUNX1;INHBA;CYLD;CD83;TNF;SART1;IL20;LIF;IL7R;ETS1;ZFP36L1;IL15;PRKCA;SYK;TRIB1;KLF10;SOCS1;JUN
2109,GO:0004888,0.0031430292781466,0.998236420797306,39,321,transmembrane signaling receptor activity,MF,PTGER4;IL1R2;GPRC5A;IL27RA;FGFR2;EPHB6;KRT17;EPHA2;ICAM1;GPR146;ADRB2;IFNGR1;EBP;RELT;SFRP1;IL7R;THBD;GPER1;GPR132;ROBO1;BCAM;OXTR;GPR75;TNFRSF21;LILRB3;ROR1;ACKR3;CRCP;M6PR;HCAR3;OGFR;CCR6;GP6;TNFRSF10A;TPRA1;PTPRB;TBXA2R;ADGRF3;IL6R
14030,GO:0060759,0.00316817238201896,0.99863273047996,20,135,regulation of response to cytokine stimulus,BP,RUNX1;IL1R2;CYLD;TRAF1;EDN1;BIRC3;NLRC5;TNF;IFNGR1;ADAM17;TRAF2;SYK;ROBO1;SPPL2A;PARP14;SOCS1;TNFAIP3;NOL3;HSP90AB1;CCL5
15227,GO:0071379,0.00318436795700714,0.999609444843589,5,14,cellular response to prostaglandin stimulus,BP,PTGER4;TNC;SFRP1;AKAP8;AKR1C2
3579,GO:0007623,0.00319919905274455,0.998618681844958,20,134,circadian rhythm,BP,PML;RELB;CSF2;TP53;NOCT;AHR;HS3ST2;TYMS;CDK4;SERPINE1;PSPC1;NPAS2;SFPQ;HNRNPU;KLF10;JUN;CPT1A;RBM4;PHLPP1;TIMELESS
15174,GO:0071305,0.00322631629065045,0.999603059252482,5,14,cellular response to vitamin D,BP,CYP24A1;TNC;SFRP1;SNAI2;IL15
12145,GO:0048247,0.00322652054593497,0.999472729555729,6,21,lymphocyte chemotaxis,BP,SAA1;CCL20;CXCL16;ADAM17;CCL22;CCL5
8510,GO:0033688,0.00322847599718428,0.999602729931691,5,14,regulation of osteoblast proliferation,BP,CYR61;FGFR2;BMP2;ITGAV;SFRP1
15125,GO:0071214,0.00323477075654171,0.998337051595302,30,231,cellular response to abiotic stimulus,BP,CRYAB;PTGER4;RELB;MAP3K14;TP53;NFKB1;CDKN1A;GADD45A;CHP1;ERRFI1;NMT2;SFRP1;IRF1;EGR1;SNAI2;ZFP36L1;RHOB;RUVBL2;CAB39;OXSR1;NOC2L;XRCC6;TNFRSF10A;ELK1;DAG1;PDE6A;EEF1D;GCLC;PARP1;TP63
17187,GO:0104004,0.00323477075654171,0.998337051595302,30,231,cellular response to environmental stimulus,BP,CRYAB;PTGER4;RELB;MAP3K14;TP53;NFKB1;CDKN1A;GADD45A;CHP1;ERRFI1;NMT2;SFRP1;IRF1;EGR1;SNAI2;ZFP36L1;RHOB;RUVBL2;CAB39;OXSR1;NOC2L;XRCC6;TNFRSF10A;ELK1;DAG1;PDE6A;EEF1D;GCLC;PARP1;TP63
12370,GO:0048754,0.00324325154823294,0.998712056423893,17,106,branching morphogenesis of an epithelial tube,BP,PML;EDN1;B4GALT1;TNF;TNC;FGFR2;PBX1;COL4A1;EPHA2;BMP2;SRF;NPNT;ESR1;BMP7;DAG1;TIMELESS;WNT4
15973,GO:0080090,0.00325134906980586,0.997375689387344,384,4501,regulation of primary metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;ODC1;CYP1B1;CTGF;C1QTNF1;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;IRX2;RELB;TFRC;SOD2;GPRC5A;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;BIRC3;MID1;DAPK3;TET3;ELMSAN1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;SCD;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;PARL;TRIM22;SAFB2;DHCR7;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;DNAJB2;ZNF787;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;ROBO1;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;GLIPR1;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;SPRY4;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;PPP1R14C;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;PRDM7;RBM38;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;GLIPR2;CPT1A;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;MPHOSPH8;ELK1;PHF5A;RAPGEF1;EIF5A;MYADM;DAG1;EEF1D;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;TP63;ZBTB12;C1S;PHACTR4;CCL5;FADS1;MAGOH
2590,GO:0005884,0.00329258950570607,0.998886055049677,13,73,actin filament,CC,AMOT;ACTG1;DAPK3;MYO1B;TPM4;FLNA;LCP1;TPM1;WDR1;DPYSL3;KEAP1;SPECC1;BIN3
14376,GO:0061614,0.00332456360517832,0.999246582938422,8,33,pri-miRNA transcription by RNA polymerase II,BP,TGFB2;TP53;FOSL1;BMP2;SRF;ETS1;PDGFB;JUN
3545,GO:0007567,0.00332730135765305,0.999728598523038,4,9,parturition,BP,CYP1A1;EDN1;OXTR;MAFF
14876,GO:0070661,0.00334504134560765,0.998481415232018,22,156,leukocyte proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IL7R;ELF4;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;WNT4;CD38;TNFAIP3;CTPS1;CCL5
12609,GO:0050789,0.00338669525631946,0.997280255266837,612,7497,regulation of biological process,BP,IGFBP3;IL32;KRT1;MAFB;SAA1;TRIM16;CCL20;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;CCDC80;ADM;TNS3;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;ACTG1;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;COMMD4;EHD1;GADD45A;TNF;GNL3L;BAIAP2;ZBED1;EFNB2;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;SCD;WWC1;ENC1;TNC;ASCC2;DST;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;CLN6;EPHB6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;RNF19B;ADRB2;SVIL;IL20;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;EBP;NMT2;TOX4;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;RELT;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;CC2D2A;SAFB2;DHCR7;HLA-F;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;PDE4DIP;LUC7L;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;ZNF787;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;SGK1;SNAI2;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;U2AF2;FGFR1OP;VCL;SHQ1;RIPK4;IRS2;IER3;NPAS2;CBX5;PPRC1;LGALS3;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;CDKL1;DNTTIP2;PDGFB;BRMS1;BCAM;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;UTP20;RPS9;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;RNF115;DPYSL3;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RASGRP4;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;ACSL1;RCC2;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;KEAP1;M6PR;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;ANAPC15;PRDM7;CXCL5;RBM38;ATG101;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;PES1;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;LRRC27;TFDP1;ZNF772;OGFR;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;LAMC1;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;GP6;ZNF132;EDC4;KLF6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TKT;TNFRSF10A;CXORF36;KANK4;TPRA1;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;PHF5A;RAPGEF1;ZYX;EIF5A;UBAP2L;MYADM;DAG1;CGNL1;POLR3H;PDE6A;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;BLNK;WNT4;RBM14;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;POLR1E;MYO1E;CXCL3;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;ADGRF3;IL6R;BIN3;LAIR1;PARP1;CLK4;TP63;ZBTB12;TXNDC15;IL36G;C1S;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;MAGOH;SH3BP4
15171,GO:0071295,0.00340614056065439,0.999443179582296,6,20,cellular response to vitamin,BP,CYP24A1;TNC;SFRP1;SNAI2;IL15;BRIP1
1106,GO:0002695,0.00344809420594659,0.998716073454752,15,90,negative regulation of leukocyte activation,BP,INHBA;CYLD;SDC4;LYN;ZC3H12A;CD274;SFRP1;IRF1;GPER1;LGALS3;TNFRSF21;SMAD7;THOC1;GPNMB;TNFAIP3
13842,GO:0060442,0.00344921931659955,0.99971573525645,4,9,branching involved in prostate gland morphogenesis,BP,FGFR2;SFRP1;ESR1;BMP7
12600,GO:0050776,0.00347512187134275,0.99777771608777,62,577,regulation of immune response,BP,KRT1;RUNX1;C1R;ACTG1;CYLD;RELB;TFRC;HLA-B;TGFB2;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;IL27RA;NFKB1;LYN;ARPC4;LAMP1;TNF;BAIAP2;PSMB9;ZC3H12A;ICAM1;MYO10;IFNGR1;ARPC1B;HLA-F;IRF1;PSME2;IL7R;PSPC1;NFKBIA;LGALS3;TRAF2;IL15;SYK;CMTM3;SPPL2A;COL17A1;TNFRSF21;TNIP2;SFPQ;SMAD7;PQBP1;THOC1;PARP14;SOCS1;JUN;ESR1;XRCC6;RAPGEF1;RBM14;CD38;TNFAIP3;PSMC3;SPG21;HSP90AB1;LAIR1;C1S;CCL5
7806,GO:0032355,0.0034759342091195,0.998757538691865,14,82,response to estradiol,BP,CRYAB;CTGF;NQO1;ARPC1B;SFRP1;GPER1;ETS1;OXTR;RUVBL2;DUSP1;ESR1;ZNF703;BMP7;CD38
4339,GO:0009891,0.00351065856718479,0.997434806167617,128,1325,positive regulation of biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;CTGF;FOSL2;PML;HSPB1;MYBL2;RELB;ARID3B;IER2;CSF2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;IRS1;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;KRT17;FOSL1;ZC3H12A;KLF7;CHP1;ICAM1;BMP2;CDK4;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;NELFE;DKC1;IRS2;NPAS2;PPRC1;IL15;SYK;DDX17;AJUBA;PDGFB;UBTF;ALYREF;RPS9;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;SMPD2;GLIS3;BMP7;ELK1;PHF5A;EIF5A;RAB27A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;POLR2G;CREB5;HSP90AB1;PARP1;TP63;CCL5
12773,GO:0051048,0.00351536456624237,0.99859010149721,17,109,negative regulation of secretion,BP,NRG1;PTGER4;INHBA;FN1;IL1R2;PML;EDN1;GBP1;RSAD2;IRS1;TNF;ZC3H12A;LIF;SFRP1;OXTR;TNFRSF21;BMP8A
4534,GO:0010605,0.0035300987074967,0.997302330070097,182,2012,negative regulation of macromolecule metabolic process,BP,IGFBP3;CRYAB;NRG1;MMP9;INHBA;HDAC9;CTGF;IL1R2;DUSP14;PML;TFCP2L1;HSPB1;IRX2;RELB;GPRC5A;CSF2;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;TP53;SQSTM1;MARVELD3;NOCT;FST;NFKB1;CDKN2B;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;CDKN2A;RING1;CORO1C;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;TYMS;ZC3H12A;FLNA;SRSF2;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;BMP2;CDK4;ITGAV;ERRFI1;SFN;DAXX;NAT10;SERPINE1;PABPC4;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TRIM22;ANXA8;IRF1;PSME2;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;SRRT;ZFP36L1;RPLP2;NELFE;DKC1;SNX12;UPK3B;DHFR;U2AF2;FGFR1OP;SHQ1;CBX5;RPLP1;MAFK;PRKCA;ZFP36L2;DDX17;AJUBA;PDGFB;BRMS1;RPS2;RPS9;NEDD4L;SNRNP70;SERPINH1;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPRY4;SPEN;NUP214;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;HNRNPU;PPP1R14C;TRIB1;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;DUSP1;CITED2;CD109;RPL27A;SOCS1;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;DUS2;PARD3;XRCC6;EDC4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;TNFRSF10A;MPHOSPH8;RAPGEF1;MYADM;DAG1;DHX34;TIMELESS;WNT4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;EFNA1;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;PARP1;TP63;MAGOH
10573,GO:0043535,0.00353678369277437,0.998857094372715,12,65,regulation of blood vessel endothelial cell migration,BP,HDAC9;HSPB1;STARD13;EPHA2;STAT5A;ETS1;ADAM17;PRKCA;PDGFB;EFNA1;CARD10;TBXA2R
14885,GO:0070670,0.00354700383820379,0.99929121215042,7,27,response to interleukin-4,BP,PML;IL24;CDK4;MCM2;KEAP1;PARP14;HSP90AB1
4271,GO:0009628,0.00354974089712912,0.997558263689986,88,868,response to abiotic stimulus,BP,CRYAB;PTGER4;CTGF;ADM;NQO1;CYP1A1;PML;PDLIM1;KRT13;RELB;BAG1;MAP3K14;TGFB2;EDN1;TP53;MARVELD3;NFKB1;CDKN1A;LYN;JUNB;GADD45A;TNF;TNC;NUP153;DNAJB1;PSMB9;FOSL1;CHP1;HMGCS1;TSC22D3;ICAM1;BMP2;UBE4B;CDK4;ERRFI1;ADRB2;DAXX;PGK1;NMT2;AEN;SFRP1;IRF1;PSME2;THBD;SRF;TXN2;NFKBIA;EGR1;ETS1;SNAI2;ZFP36L1;RHOB;ADAM17;FEN1;KRT14;AJUBA;OXTR;IL1A;COPS3;NUP214;RUVBL2;DUSP1;CAB39;CITED2;STAC;OXSR1;HSPA8;JUN;NOC2L;RBM4;XRCC6;SMPD2;ACTN4;BMP7;TNFRSF10A;ELK1;DAG1;PDE6A;EEF1D;TIMELESS;CD38;PSMC3;BRIP1;NOL3;GCLC;HSP90AB1;PARP1;TP63
14944,GO:0070830,0.0035514629353388,0.999087537013639,9,41,bicellular tight junction assembly,BP,RUNX1;MARVELD3;TNF;SRF;SNAI2;TJP1;MARVELD2;PARD3;ACTN4
11434,GO:0045859,0.00358886970996121,0.997693400462308,63,583,regulation of protein kinase activity,BP,SAA1;NRG1;CYR61;DUSP14;HSPB1;SDC4;GPRC5A;MAP3K14;TGFB2;EDN1;DBNDD2;EMP2;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;TELO2;CHP1;GADD45B;BMP2;CDK4;ERRFI1;SFN;EPGN;ADRB2;DAXX;SFRP1;EGR1;ADAM17;FGFR1OP;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;SPRY4;ACSL1;AFAP1L2;TRIB1;DUSP1;CAB39;SOCS1;OXSR1;SERTAD1;DUS2;XRCC6;BMP7;TNFRSF10A;RAPGEF1;DAG1;TRAF4;TNFAIP3;EFNA1;MAPK11;CARD10;DUSP8;HSP90AB1;CCL5
17725,GO:1901654,0.00361612103454316,0.998459018437603,19,127,response to ketone,BP,PTGER4;NEFL;TGFB2;EDN1;CDKN1A;AHR;FOSL1;TYMS;ICAM1;CDK4;ERRFI1;SFRP1;AKAP8;OXTR;DUSP1;ELK1;CD38;TBXA2R;PARP1
1446,GO:0003676,0.00362269656674516,0.997118613388084,281,3232,nucleic acid binding,MF,MAFB;TRIM16;RUNX1;FOSL2;NQO1;DUSP14;PML;TFCP2L1;RBM19;HSPB1;MYBL2;IRX2;RELB;TFRC;ABCF1;CD3EAP;ARID3B;IER2;TRIM56;TET3;ELMSAN1;NLRC5;TP53;NFE2L1;PDCD11;HNRNPAB;NOCT;NFKB1;TAF4B;AHR;JUNB;MCM5;HMGXB3;CSRP1;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;GPATCH4;PPAN;RRP1;PBX1;NUP153;NFKB2;TELO2;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;KLF7;ZNF503;EIF5;DDX23;ZNF142;STAT5A;RRP12;ZMAT2;FOXD2;NAT10;FUS;PABPC4;MCM2;CCDC124;TOX4;USP36;AKAP8L;ZC3H7B;AEN;ELF3;GRWD1;OSR2;SAFB2;APTX;PUS1;DHX37;PWP2;IRF1;METTL1;LUC7L;BANF1;EPPK1;DDX42;CTIF;NFX1;PSPC1;TFIP11;SRF;NSUN2;ZNF787;RRP36;ELF4;LARP4B;ZFP42;SF1;EGR1;JRK;EDF1;ETS1;SNAI2;POP1;RRS1;SRRT;ZFP36L1;ARHGEF28;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;NPAS2;PPRC1;LGALS3;TSR1;ACO1;MAFK;SF3B4;ZNF778;ZFP36L2;PUM3;ZFC3H1;POLR1A;DDX17;IFIT3;DDX47;DDX49;DNTTIP2;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;SPTBN1;SNRNP70;SERPINH1;ZNF407;RRP7A;UHRF1;MYH9;ZNF234;NOM1;ZNFX1;ZNF101;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;BRD9;ZNF697;FTSJ3;WDR46;SPEN;ZW10;RCC2;NOP56;MAFF;SMAD7;MRPS12;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;TRIP6;ERAL1;HNRNPU;HNRNPF;PQBP1;CREB3;RUVBL2;ABT1;MAZ;TUSC1;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PRDM7;MRPL20;RBM38;ARL6IP4;RPL27A;HSPA8;JUN;ESR1;IKZF3;TCOF1;PES1;FOXN1;RCC1;BRPF1;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;ZNF703;DUS2;XRCC6;ZNF132;TRMT1;KLF6;CS;TEAD4;ACTN4;HMGN2;SORBS2;GLIS3;SNIP1;METTL16;SMUG1;CLUH;ZNF34;EFTUD2;TRA2A;ELK1;PHF5A;EIF3I;ZYX;EIF5A;UBAP2L;KIF22;POLR3H;EEF1D;DHX34;TIMELESS;RBM14;TRAF4;TNFAIP3;SMARCC2;BRIP1;SUPT16H;AARSD1;POLR1E;DDX24;HSD17B10;SURF6;SLC3A2;HES4;ZC3H18;UTP4;POLR2G;SRSF7;CREB5;NOL3;LRRC59;HSP90AB1;SWAP70;MKI67;POP4;RPUSD4;PARP1;TP63;ZBTB12;TOP3A;ORC4;MAGOH;APEX2
12835,GO:0051145,0.0036266634583981,0.99916228503628,8,34,smooth muscle cell differentiation,BP,ADM;FGFR2;MKL1;GPER1;SRF;PDGFB;NPNT;WNT4
10884,GO:0044422,0.00370561934677073,0.997006354497962,583,7166,organelle part,CC,IGFBP3;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;NEFL;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;NEFM;ACTG1;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;PCDH7;SDC4;KRT13;FADS3;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;DBNDD2;RSAD2;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;TAF4B;GNPTAB;LFNG;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;PLEKHO2;ARPC4;LAMP1;HS3ST2;EHD1;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;PKMYT1;SCD;PPAN;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;CLN6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;CHP1;CCDC85B;FANCC;ARFRP1;COL16A1;GOSR1;COL27A1;DDX23;CDK4;KREMEN2;DRAM1;ITGAV;KIF23;MYO10;GGCX;SFN;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;NAT10;MTUS1;SLC5A6;SERPINE1;FUS;ARPC1B;MCM2;LSG1;CCDC124;EBP;TOX4;ST6GALNAC5;USP36;AKAP8L;AEN;ELF3;GRWD1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;BANF1;EPPK1;IL7R;DDX42;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;RPLP2;AKAP8;RHOB;NELFE;DKC1;FEN1;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;PUM3;CMTM3;POLR1A;DDX17;AJUBA;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;IFFO2;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;DNASE1;COLGALT1;COX5B;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;LANCL2;PRCC;SNX8;RBBP5;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;GPN1;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;WDR4;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;UBE2J2;CEP41;TPST1;CREB3;RUVBL2;ABT1;PPP1R9B;MTFP1;ORC1;LPCAT3;MICAL3;SAFB;THOC1;ETS2;DNTTIP1;TRUB2;ANAPC15;MRPL20;PCYT1A;RRP7BP;GALNT2;ATG101;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPA8;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;PES1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;NACC1;ZNF703;CCR6;INSIG1;CENPO;GINS3;HERC2;CNTROB;ARGLU1;LAMC1;RHOG;BCL2L2;ZNF365;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;ACTN4;HMGN2;THEM4;SORBS2;KIF24;SNIP1;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TRA2A;RNF7;TOMM40;AKIP1;MPHOSPH8;ELK1;SGSM1;INCENP;PHF5A;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;KIF22;MYADM;DAG1;TMEM165;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;DPM3;WNT4;RILPL2;MRPS2;RBM14;VPS52;TUBB;CTDSP1;CYTH1;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;MAPK11;METTL21A;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;ZC3H18;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;SLC25A44;SRSF7;CLTA;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;TBXA2R;MKI67;TTLL5;BIN3;LAIR1;POP4;RPUSD4;PARP1;TP63;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2
3515,GO:0007435,0.00374652258590669,0.999243682530527,7,27,salivary gland morphogenesis,BP,TGFB2;TNF;FGFR2;SNAI2;SEMA3C;BMP7;DAG1
15306,GO:0071495,0.00378532638227219,0.997368878496628,92,909,cellular response to endogenous stimulus,BP,RUNX1;CYR61;PTGER4;INHBA;HDAC9;CTGF;PML;WNT10A;FBN1;TGFB2;EDN1;TP53;NFKB1;CDKN2B;IRS1;LYN;AHR;JUNB;EHD1;TNF;BAIAP2;TNC;FGFR2;COL4A1;HMGCS1;ICAM1;BMP2;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;DAXX;SFRP1;SAFB2;GPER1;EGR1;SNAI2;ZFP36L1;AKAP8;ADAM17;IRS2;AKR1C2;ZFP36L2;DDX17;OXTR;SNRNP70;FHL2;NPNT;LANCL2;SPRY4;ACSL1;COL5A2;BAMBI;SMAD7;YWHAH;HNRNPU;HNRNPF;PAGR1;RUVBL2;PPP1R9B;SAFB;KLF10;DUSP1;TGFBRAP1;CITED2;CD109;SOCS1;JUN;ESR1;MCM7;ZNF703;PARD3;BMP7;ELK1;RAPGEF1;ZYX;TIMELESS;WNT4;RBM14;AKR1C1;BRIP1;CXCL8;BMP8A;POLR2G;GCLC;HSP90AB1;PARP1;TP63;CCL5;BAIAP2L2;SH3BP4
10568,GO:0043527,0.00379531535018815,0.99984961217942,3,5,tRNA methyltransferase complex,CC,TRMT61A;METTL1;WDR4
8497,GO:0033673,0.00380017220182123,0.998072954833588,28,214,negative regulation of kinase activity,BP,DUSP14;HSPB1;GPRC5A;DBNDD2;CDKN2B;CDKN1A;LYN;GADD45A;CDKN2A;CORO1C;CHP1;GADD45B;CDK4;ERRFI1;SFN;SFRP1;FGFR1OP;IRS2;AJUBA;SPRY4;HNRNPU;TRIB1;DUSP1;SOCS1;DUS2;BMP7;TNFAIP3;DUSP8
11302,GO:0045619,0.00380338495259814,0.998512842056393,16,100,regulation of lymphocyte differentiation,BP,RUNX1;INHBA;CYLD;CD83;SART1;SFRP1;IRF1;IL7R;ZFP36L1;IL15;ZFP36L2;SYK;SMAD7;SOCS1;IKZF3;FOXN1
502,GO:0001558,0.00381040178676286,0.99790824914651,35,286,regulation of cell growth,BP,IGFBP3;CRYAB;NRG1;CYR61;INHBA;FN1;CTGF;PML;TGFB2;EDN1;G6PD;TP53;CDKN1A;CDKN2A;CXCL16;KRT17;TNK1;CCDC85B;L1CAM;SFN;TNFRSF12A;SFRP1;ZFYVE27;SRF;DNAJB2;SGK1;ADAM17;FGFR1OP;NTN1;NEDD4L;SEMA3C;PPP1R9B;OGFR;CD38;SH3BP4
1267,GO:0003044,0.00383623711081007,0.999350093337005,6,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,SOD2;EDN1;C9ORF3;ADRB2;TPM1;OXTR
18231,GO:1903035,0.00385225016204794,0.998818116727691,11,57,negative regulation of response to wounding,BP,KRT1;C1QTNF1;EDN1;SERPINE1;EPPK1;THBD;PDGFB;CLASP1;CD109;PHLDB2;WNT4
8598,GO:0034103,0.00386193966441104,0.998991764545259,9,42,regulation of tissue remodeling,BP,TFRC;B4GALT1;SFRP1;IL15;PRKCA;SYK;GPNMB;CD38;TNFAIP3
15,GO:0000028,0.00389761632712079,0.999463240464644,5,18,ribosomal small subunit assembly,BP,PWP2;RRP7A;ERAL1;ABT1;RRP7BP
16320,GO:0090502,0.00392834027429065,0.998787605007672,11,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,ZC3H12A;POP1;RRS1;FEN1;TSR1;NOB1;UTP20;NOL9;ABT1;NOP14;POP4
14175,GO:0061061,0.0039465324883982,0.997672550775709,44,378,muscle structure development,BP,IGFBP3;CRYAB;NRG1;HDAC9;ADM;JPH2;ACTG1;TGFB2;EDN1;G6PD;EHD1;TNF;EFNB2;FGFR2;JPH1;TSC22D3;BMP2;UBE4B;SVIL;LIF;TPM1;WDR1;MKL1;LUC7L;GPER1;SRF;EGR1;ZFP36L1;GPCPD1;DDX17;PDGFB;FHL2;MYH9;NPNT;MAFF;SMAD7;HNRNPU;RBM38;RBM4;TEAD4;SORBS2;WNT4;MAPK11;BIN3
3605,GO:0008043,0.00403334417701231,1,2,2,intracellular ferritin complex,CC,FTL;FTH1
14677,GO:0070288,0.00403334417701231,1,2,2,ferritin complex,CC,FTL;FTH1
7093,GO:0030888,0.00408390187626089,0.99903356207202,8,35,regulation of B cell proliferation,BP,TFRC;CDKN1A;LYN;AHR;IRS2;TNFRSF21;IKZF3;CD38
4565,GO:0010646,0.00408402928073637,0.996821978440799,209,2313,regulation of cell communication,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;WNT10A;SOD2;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;CXCL16;WWC1;TRIO;FGFR2;PSMB9;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;NMT2;ELF3;LIF;SFRP1;TRIM22;SAFB2;IRF1;PSME2;IL7R;GPER1;SRF;NFKBIA;EGR1;JRK;SNAI2;RRS1;ARHGEF28;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;OXTR;PTTG1IP;RNF115;SPPL2A;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;SPRY4;ROR1;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;MTA2;YWHAH;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;PARP14;CXCL5;DUSP1;CITED2;CD109;SOCS1;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;CPT1A;TFDP1;NOP2;NOC2L;ZNF703;ARRDC3;INSIG1;RHOG;GPNMB;BCL2L2;CNTNAP1;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;CXORF36;AKIP1;RAPGEF1;MYADM;DAG1;CGNL1;PDE6A;EEF1D;BLNK;WNT4;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;DUSP8;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;SH3BP4
4731,GO:0010894,0.00409091441752566,0.99945566205958,5,15,negative regulation of steroid biosynthetic process,BP,NFKB1;BMP2;SNAI2;INSIG1;WNT4
6820,GO:0030278,0.0040952093800288,0.998281313107041,18,118,regulation of ossification,BP,CYR61;PTGER4;TGFB2;NOCT;TNF;FGFR2;PBX1;BMP2;KREMEN2;ADRB2;OSR2;SFRP1;SNAI2;NPNT;BMP7;WNT4;IL6R;TP63
1048,GO:0002576,0.00409805742128865,0.998573302146116,13,75,platelet degranulation,BP,FN1;PCDH7;TGFB2;LYN;FLNA;CYB5R1;SERPINE1;WDR1;VCL;SYK;PDGFB;CD109;ACTN4
12625,GO:0050810,0.00410615525400442,0.998645749497773,12,66,regulation of steroid biosynthetic process,BP,NFKB1;TNF;SCD;LSS;HMGCS1;BMP2;DHCR7;SF1;EGR1;SNAI2;INSIG1;WNT4
3182,GO:0006801,0.00412047888053918,0.99901968952568,8,36,superoxide metabolic process,BP,NQO1;SOD2;EDN1;TNF;FANCC;DHFR;SYK;BMP7
20269,GO:2001237,0.004139493135291,0.998557112467917,13,75,negative regulation of extrinsic apoptotic signaling pathway,BP,CSF2;TNF;ICAM1;ITGAV;SERPINE1;SNAI2;LGALS3;TRAF2;IL1A;TNFRSF10A;TNFAIP3;NOL3;GCLC
12966,GO:0051348,0.00415531658718494,0.997823028263275,30,237,negative regulation of transferase activity,BP,DUSP14;HSPB1;GPRC5A;DBNDD2;TP53;CDKN2B;CDKN1A;LYN;GADD45A;CDKN2A;CORO1C;CHP1;GADD45B;CDK4;ERRFI1;SFN;SFRP1;FGFR1OP;IRS2;AJUBA;SPRY4;SMAD7;HNRNPU;TRIB1;DUSP1;SOCS1;DUS2;BMP7;TNFAIP3;DUSP8
11788,GO:0046651,0.00416448085955701,0.998111653772402,21,149,lymphocyte proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IL7R;ELF4;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;WNT4;CD38;CTPS1;CCL5
19092,GO:1904996,0.00418973049562406,0.999827850272891,3,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF;ICAM1;ETS1
5934,GO:0018212,0.00419269173494486,0.997803065944356,30,234,peptidyl-tyrosine modification,BP,NRG1;GPRC5A;CSF2;TP53;IL24;LYN;FGFR2;TNK1;EPHA2;ICAM1;ERRFI1;STAT5A;EPGN;IL20;LIF;SFRP1;ADAM17;FGFR1OP;IL15;SYK;PDGFB;ROR1;AFAP1L2;TPST1;PARP14;SOCS1;EFNA1;IL6R;CLK4;CCL5
2532,GO:0005788,0.00423808543551356,0.997926815007561,25,185,endoplasmic reticulum lumen,CC,IGFBP3;CYR61;FN1;P3H2;FBN1;EDN1;PRSS23;P4HA2;COL12A1;TNC;COL4A1;CLN6;COL16A1;COL27A1;COL9A2;PDGFB;SERPINH1;COLGALT1;COL5A3;COL17A1;COL5A2;LAMC1;DAG1;COL4A4;WNT4
1024,GO:0002526,0.00426817107727361,0.998667789116313,11,59,acute inflammatory response,BP,SAA1;FN1;C1R;PTGES;B4GALT1;TNF;ICAM1;DNASE1;IL1A;IL6R;C1S
14601,GO:0070160,0.00426953352726626,0.998371009059827,15,91,occluding junction,CC,AMOT;SIPA1L3;MARVELD3;TJP2;CDK4;AMOTL2;EPPK1;PARD3B;TJP1;MARVELD2;PARD3;CGNL1;TRAF4;CYTH1;CLDN7
5635,GO:0016717,0.00433166538478959,0.999819824142952,3,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,SCD;SCD5;FADS1
7614,GO:0032000,0.0043327076784871,0.999819764831336,3,5,positive regulation of fatty acid beta-oxidation,BP,IRS1;IRS2;CPT1A
17228,GO:0110011,0.0043327076784871,0.999819764831336,3,5,regulation of basement membrane organization,BP,CLASP1;PHLDB2;DAG1
18765,GO:1904259,0.0043327076784871,0.999819764831336,3,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,CLASP1;PHLDB2;DAG1
18766,GO:1904261,0.0043327076784871,0.999819764831336,3,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,CLASP1;PHLDB2;DAG1
20245,GO:2001197,0.0043327076784871,0.999819764831336,3,5,basement membrane assembly involved in embryonic body morphogenesis,BP,CLASP1;PHLDB2;DAG1
14878,GO:0070663,0.00433874565010309,0.99816605340718,18,121,regulation of leukocyte proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;CD38;TNFAIP3;CCL5
4529,GO:0010594,0.00436560401492513,0.998209013298257,17,110,regulation of endothelial cell migration,BP,HDAC9;HSPB1;STARD13;EDN1;EMP2;ADAMTS9;ZC3H12A;EPHA2;STAT5A;ETS1;RHOB;ADAM17;PRKCA;PDGFB;EFNA1;CARD10;TBXA2R
2514,GO:0005767,0.0043695073824639,0.999594716938317,4,10,secondary lysosome,CC,FTL;FTH1;SQSTM1;LAMP1
18673,GO:1904018,0.00439714490548899,0.998194739909596,17,110,positive regulation of vasculature development,BP,RUNX1;HDAC9;CYP1B1;ADM;HSPB1;EFNB2;ZC3H12A;SERPINE1;GPER1;EGR1;ETS1;RHOB;PRKCA;PDGFB;IL1A;CXCL8;TBXA2R
4829,GO:0014033,0.00442297272283739,0.998614957289974,11,58,neural crest cell differentiation,BP,NRG1;WNT10A;EDN1;CORO1C;SFRP1;SNAI2;SEMA3C;TCOF1;EFNB1;BMP7;PHACTR4
13843,GO:0060443,0.00447329163166311,0.998924888639392,8,35,mammary gland morphogenesis,BP,PML;B4GALT1;FGFR2;EPHA2;ELF3;NTN1;ESR1;WNT4
8198,GO:0032943,0.00452043518169477,0.997934413333945,21,150,mononuclear cell proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IL7R;ELF4;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;WNT4;CD38;CTPS1;CCL5
7319,GO:0031328,0.00452625212324891,0.996671788557914,126,1311,positive regulation of cellular biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;FOSL2;PML;HSPB1;MYBL2;RELB;ARID3B;IER2;CSF2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;IRS1;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;KRT17;FOSL1;ZC3H12A;KLF7;CHP1;ICAM1;BMP2;CDK4;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;LARP4B;NFKBIA;EGR1;EDF1;ETS1;NELFE;DKC1;IRS2;NPAS2;PPRC1;IL15;SYK;DDX17;AJUBA;PDGFB;UBTF;ALYREF;RPS9;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;SMPD2;GLIS3;BMP7;ELK1;PHF5A;EIF5A;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;POLR2G;CREB5;HSP90AB1;PARP1;TP63;CCL5
4232,GO:0009410,0.00454999701449078,0.997835344356528,23,169,response to xenobiotic stimulus,BP,HDAC9;CYP1B1;NQO1;CYP1A1;UGT1A6;EDN1;TP53;AHR;ACAA1;ICAM1;ERRFI1;STAT5A;EGR1;PDGFB;OXTR;SDK1;ACSL1;PPP1R9B;MCM7;EFTUD2;AKR1C1;GCLC;HSP90AB1
7358,GO:0031400,0.0046301710362566,0.997133197067598,51,459,negative regulation of protein modification process,BP,IGFBP3;DUSP14;HSPB1;GPRC5A;SH3RF2;GBP1;DBNDD2;G6PD;MARVELD3;CDKN2B;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;LIF;SFRP1;GPER1;U2AF2;FGFR1OP;SPRY4;SMAD7;PPP1R14C;TRIB1;PPP1R9B;PARP14;DUSP1;CD109;SOCS1;JUN;NOC2L;DUS2;PARD3;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;DUSP8;GCLC;SWAP70
12557,GO:0050709,0.00469663122199493,0.998419997472433,12,68,negative regulation of protein secretion,BP,PTGER4;FN1;IL1R2;PML;GBP1;RSAD2;IRS1;TNF;ZC3H12A;SFRP1;TNFRSF21;BMP8A
12107,GO:0048146,0.00471896531176579,0.998851085897624,8,36,positive regulation of fibroblast proliferation,BP,FN1;FOSL2;PML;CDKN1A;CDK4;PDGFB;JUN;ESR1
9904,GO:0042222,0.00475436504326655,1,2,2,interleukin-1 biosynthetic process,BP,CCL20;EGR1
11227,GO:0045360,0.00475436504326655,1,2,2,regulation of interleukin-1 biosynthetic process,BP,CCL20;EGR1
11228,GO:0045362,0.00475436504326655,1,2,2,positive regulation of interleukin-1 biosynthetic process,BP,CCL20;EGR1
2435,GO:0005634,0.00477677112131988,0.996095977900526,472,5696,nucleus,CC,IGFBP3;KRT1;MAFB;TRIM16;CRYAB;FTH1;NRG1;KRT2;RUNX1;HDAC9;MAP2;S100P;CYP24A1;DTX2;KRT15;AMOT;FOSL2;KRT4;SACS;ACTG1;TRIM47;IL16;NFKBIE;PML;TFCP2L1;RBM19;HSPB1;MYBL2;KRT10;KRT13;IRX2;RELB;BAG1;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;PTGES;MAP3K14;SH3RF2;USB1;TXNRD1;IKBKE;BIRC3;DAPK3;TET3;PRSS23;ELMSAN1;RSAD2;G6PD;EMP2;NUAK1;HRNR;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;KRT9;HNRNPAB;P4HA2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;TJP2;UBQLN2;LYN;AHR;JUNB;MCM5;HMGXB3;COMMD4;CSRP1;GADD45A;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;ASCC2;DST;VMP1;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;C9ORF3;PGD;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;SART1;GEMIN5;CADPS2;KLF7;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;FANCC;PITHD1;UBE4B;DDX23;CDK4;ZNF142;ERRFI1;KIF23;MYO10;PMM2;SFN;TRMT61A;STAT5A;RRP12;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;FUS;PABPC4;MCM2;LSG1;EBP;CSRP2;TOX4;USP36;XAF1;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;OSR2;PARL;TRIM22;ZFYVE27;SAFB2;APTX;DHCR7;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;PDE4DIP;LUC7L;DNPEP;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;AKAP8;RHOB;NELFE;DKC1;FEN1;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;MAFK;TRAF2;ABCG2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;AJUBA;C9ORF78;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;FILIP1;BRMS1;PREP;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;FHL2;DCTN1;ZNF407;DNASE1;RRP7A;UHRF1;MYH9;ZNF234;NOM1;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ZW10;RCC2;NOP56;NUP214;MAFF;ACKR3;GPN1;SMAD7;CRCP;SLC35C2;TATDN2;NOL9;SUPT5H;MTA2;DNAJC1;TRIP6;WDR4;KEAP1;SPECC1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;ORC1;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;PARP14;ANAPC15;PRDM7;RBM38;PCYT1A;RRP7BP;DUSP1;ARL6IP4;TXNL4B;CITED2;SOCS1;HSPA8;JUN;ESR1;IKZF3;CENPN;TCOF1;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;DCXR;COMMD9;MCM7;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CENPO;GINS3;HERC2;ARGLU1;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;HMGN2;EFNB1;SORBS2;GLIS3;SNIP1;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;URGCP;TKT;EFTUD2;TRA2A;RNF7;AKIP1;MPHOSPH8;ELK1;INCENP;PHF5A;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;KIF22;DAG1;POLR3H;EEF1D;TIMELESS;GPX4;RBM14;TRAF4;TUBB;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;DNAJC9;BRIP1;SUPT16H;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;SURF6;SLC3A2;HES4;ZC3H18;UTP4;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;POP4;PARP1;CLK4;TP63;ZBTB12;TOP3A;BAIAP2L2;ORC4;MAGOH;APEX2;SH3BP4
4763,GO:0010942,0.00478188944785604,0.99699136244833,54,497,positive regulation of cell death,BP,IGFBP3;MMP9;CYR61;INHBA;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;MYBL2;TGFB2;DAPK3;B4GALT1;TP53;SQSTM1;CDKN1A;LYN;GADD45A;TNF;EFNB2;CDKN2A;TRIO;FOSL1;ZC3H12A;GADD45B;CD274;BMP2;CDK4;SFN;DAXX;TNFRSF12A;SFRP1;GPER1;EGR1;RHOB;SHQ1;TRAF2;ROBO1;BRMS1;SFPQ;SAP30BP;YWHAH;APH1A;DUSP1;JUN;TFDP1;BMP7;TNFRSF10A;ELK1;PPP2R1B;PARP1;TP63;CCL5
4658,GO:0010803,0.00478660774373631,0.998584327439094,10,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,CYLD;TRAF1;BIRC3;TNF;ADAM17;TRAF2;SYK;SPPL2A;TNFAIP3;NOL3
8018,GO:0032651,0.00480225138035349,0.998827306488974,8,36,regulation of interleukin-1 beta production,BP,TRIM16;PML;HSPB1;PANX1;ZC3H12A;ERRFI1;EGR1;TNFAIP3
4251,GO:0009451,0.00482000942470174,0.997885337983885,19,131,RNA modification,BP,CDKAL1;TRMT61A;NAT10;PUS1;METTL1;NSUN2;DKC1;METTL2B;NSUN5;FTSJ3;NOP56;WDR4;TRUB2;NOP2;DUS2;TRMT1;METTL16;HSD17B10;RPUSD4
4553,GO:0010634,0.00482606939498377,0.998062009773318,16,102,positive regulation of epithelial cell migration,BP,MMP9;HDAC9;HSPB1;TGFB2;EDN1;ZC3H12A;STAT5A;ETS1;RHOB;ADAM17;PRKCA;PDGFB;CLASP1;JUN;GLIPR2;CCR6
8770,GO:0034446,0.00490429033813639,0.998342917065219,12,67,substrate adhesion-dependent cell spreading,BP,FN1;GBP1;CORO1C;PDPN;FLNA;ITGAV;RCC2;LAMC1;ACTN4;AKIP1;MYADM;EFNA1
16117,GO:0090100,0.00490715188601104,0.998341824787294,12,67,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CYR61;INHBA;TGFB2;CDKN2B;BMP2;ADAM17;NPNT;CITED2;BMP7;BMP8A;HSP90AB1;PARP1
13702,GO:0060255,0.0049092865303401,0.996000621627024,386,4567,regulation of macromolecule metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;ODC1;CYP1B1;CTGF;C1QTNF1;FOSL2;IL16;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;SOD2;GPRC5A;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;TET3;ELMSAN1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;PARL;TRIM22;SAFB2;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;DNAJB2;ZNF787;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;DKC1;SNX12;UPK3B;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;PPP1R14C;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;PRDM7;RBM38;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;GLIPR2;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;MPHOSPH8;ELK1;PHF5A;RAPGEF1;EIF5A;UBAP2L;MYADM;DAG1;EEF1D;RAB27A;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;TP63;ZBTB12;C1S;PHACTR4;CCL5;FADS1;MAGOH
8699,GO:0034332,0.00491217012858179,0.998094838625886,15,92,adherens junction organization,BP,SDC4;DAPK3;CORO1C;COL16A1;PLEKHA7;SFRP1;VCL;AJUBA;RCC2;SMAD7;TRIP6;CLASP1;ZNF703;PHLDB2;WNT4
14643,GO:0070227,0.00491390168333274,0.998541084720557,10,52,lymphocyte apoptotic process,BP,TP53;LYN;TSC22D3;CD274;IRS2;LGALS3;TNFRSF21;NOC2L;EFNA1;CCL5
717,GO:0001942,0.00493286399855522,0.998332006334542,12,67,hair follicle development,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;NOM1;CD109;FOXN1;TP63
13895,GO:0060537,0.00495870111127434,0.99740046480837,29,226,muscle tissue development,BP,NRG1;HDAC9;JPH2;TGFB2;EDN1;G6PD;ADAMTS9;EFNB2;FGFR2;TSC22D3;BMP2;UBE4B;SVIL;TPM1;LUC7L;SRF;EGR1;GPCPD1;DDX17;FHL2;SEMA3C;MAFF;SMAD7;HNRNPU;SORBS2;BMP7;MAPK11;BIN3;TP63
3382,GO:0007159,0.00496995251418905,0.997534930651266,25,189,leukocyte cell-cell adhesion,BP,CYLD;SDC4;TFRC;CD83;MAP3K14;LYN;TNF;EFNB2;SIRPA;SART1;ICAM1;CD274;IRF1;IL7R;ETS1;LGALS3;IL15;SYK;TNFRSF21;SMAD7;SOCS1;GPNMB;EFNB1;BMP7;CCL5
6765,GO:0030199,0.00497446995538094,0.998934409392848,7,28,collagen fibril organization,BP,CYP1B1;TGFB2;COL12A1;SERPINH1;COLGALT1;COL5A3;COL5A2
1841,GO:0004497,0.00498613429872919,0.998641298338288,9,43,monooxygenase activity,MF,CYP1B1;CYP24A1;CYP1A1;CYP4B1;AKR1C2;DOHH;MICAL3;CYP20A1;AKR1C1
2455,GO:0005667,0.00503271890375131,0.997265743946446,32,259,transcription factor complex,CC,MAFB;HDAC9;PDLIM1;CD3EAP;ELMSAN1;TP53;HNRNPAB;TAF4B;AHR;JUNB;PBX1;CDK4;ZFP42;EDF1;ETS1;NPAS2;AJUBA;SFPQ;SMAD7;MTA2;HNRNPU;ABT1;JUN;TFDP1;GTF2E1;GTF3C2;XRCC6;TEAD4;RBM14;SNF8;PARP1;TP63
4303,GO:0009753,0.00504650092307718,1,2,2,response to jasmonic acid,BP,AKR1C2;AKR1C1
5979,GO:0018636,0.00504650092307718,1,2,2,phenanthrene 9,10-monooxygenase activity,MF,AKR1C2;AKR1C1
11948,GO:0047023,0.00504650092307718,1,2,2,androsterone dehydrogenase activity,MF,AKR1C2;AKR1C1
11955,GO:0047086,0.00504650092307718,1,2,2,ketosteroid monooxygenase activity,MF,AKR1C2;AKR1C1
11957,GO:0047115,0.00504650092307718,1,2,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,AKR1C2;AKR1C1
15239,GO:0071395,0.00504650092307718,1,2,2,cellular response to jasmonic acid stimulus,BP,AKR1C2;AKR1C1
3679,GO:0008176,0.00511572035821954,1,2,2,tRNA (guanine-N7-)-methyltransferase activity,MF,METTL1;WDR4
17191,GO:0106004,0.00511572035821954,1,2,2,tRNA (guanine-N7)-methylation,BP,METTL1;WDR4
14517,GO:0065009,0.0051241551256613,0.99600084246517,202,2246,regulation of molecular function,BP,IGFBP3;IL32;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;INHBA;FN1;NEFL;CYP1B1;CTGF;ADM;AMOT;JPH2;NQO1;IL16;DUSP14;NFKBIE;PML;CYLD;HSPB1;STARD13;TRAF1;SDC4;WNT10A;BAG1;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;BIRC3;DBNDD2;TRAF3;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;IL24;NFKB1;CDKN2B;LFNG;IRS1;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;ANKRD36C;TRIO;FGFR2;NFKB2;DNAJB1;PSMB9;EPHB6;TELO2;FOSL1;UBE2C;JPH1;ZC3H12A;FLNA;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ERRFI1;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;SERPINE1;FXYD3;LIF;SFRP1;TPM1;TRIM22;PPP1R3B;ANXA8;PSME2;TFIP11;GPER1;SRF;DNAJB2;NFKBIA;EGR1;EDF1;DOCK10;SGK1;CD2BP2;ARHGEF28;ADAM17;DKC1;TXLNA;DHFR;FGFR1OP;RIPK4;IRS2;PPRC1;RPLP1;TRAF2;IL15;SYK;CMTM3;NFKBIB;ROBO1;AJUBA;PDGFB;BRMS1;RPS2;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;UHRF1;NPNT;IL1A;RASGRP4;RUNDC1;SPRY4;ROR1;ACSL1;RCC2;BAMBI;AFAP1L2;SMAD7;DNAJC1;YWHAH;KEAP1;HNRNPU;RRAD;APH1A;PPP1R14C;TRIB1;DCUN1D2;RUVBL2;PPP1R9B;KCNIP3;A2ML1;CXCL5;DUSP1;CAB39;CD109;SOCS1;HSPBP1;STAC;OXSR1;JUN;ESR1;RCC1;TRAPPC5;SERTAD1;ARRDC3;HERC2;DUS2;RHOG;GPNMB;XRCC6;ACTN4;BMP7;TNFRSF10A;SGSM1;RAPGEF1;DAG1;WNT4;TRAF4;CYTH1;TNFAIP3;CCL22;DNAJC9;CXCL8;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;DUSP8;NOL3;CDCA5;HSP90AB1;TBXA2R;PARP1;TP63;IL36G;PHACTR4;CCL5;SH3BP4
8043,GO:0032692,0.00512896696350882,0.999266239144706,5,16,negative regulation of interleukin-1 production,BP,IL1R2;PML;ZC3H12A;ERRFI1;TNFAIP3
18104,GO:1902742,0.00518214200694215,0.999055757584231,6,22,apoptotic process involved in development,BP,CRYAB;CYR61;TGFB2;B4GALT1;BMP7;PPP2R1B
4864,GO:0014706,0.00523262322286389,0.997280061975892,28,217,striated muscle tissue development,BP,NRG1;HDAC9;JPH2;TGFB2;EDN1;G6PD;ADAMTS9;EFNB2;FGFR2;TSC22D3;BMP2;UBE4B;SVIL;TPM1;LUC7L;SRF;EGR1;GPCPD1;DDX17;FHL2;SEMA3C;MAFF;SMAD7;HNRNPU;SORBS2;BMP7;MAPK11;BIN3
1169,GO:0002792,0.00524888685321612,0.998206445968446,12,69,negative regulation of peptide secretion,BP,PTGER4;FN1;IL1R2;PML;GBP1;RSAD2;IRS1;TNF;ZC3H12A;SFRP1;TNFRSF21;BMP8A
7592,GO:0031960,0.00526742553994044,0.997862188584234,16,104,response to corticosteroid,BP,NEFL;CTGF;ADM;EDN1;CDKN1A;TNF;FOSL1;TYMS;ICAM1;ERRFI1;GPER1;ZFP36L1;ZFP36L2;HNRNPU;DUSP1;PARP1
15512,GO:0071887,0.00533429353494804,0.998173429306107,12,69,leukocyte apoptotic process,BP,TP53;LYN;CDKN2A;TSC22D3;CD274;ADAM17;IRS2;LGALS3;TNFRSF21;NOC2L;EFNA1;CCL5
7610,GO:0031996,0.00538433393555173,0.999469434171173,4,10,thioesterase binding,MF,TRAF1;TRAF3;TRAF2;TRAF4
545,GO:0001664,0.00541552097116961,0.997656642443078,18,124,G-protein coupled receptor binding,MF,SAA1;CCL20;ADM;WNT10A;EDN1;CXCL16;FLNA;SFRP1;REEP1;BAMBI;CXCL5;HSPA8;ARRDC3;WNT4;CCL22;CXCL8;CXCL3;CCL5
12106,GO:0048145,0.00542148875856245,0.998246130409853,11,61,regulation of fibroblast proliferation,BP,FTH1;FN1;FOSL2;PML;TP53;CDKN1A;CDK4;SFRP1;PDGFB;JUN;ESR1
12747,GO:0051015,0.00548295299323099,0.997627682005177,18,121,actin filament binding,MF,PANX1;MYO1B;ARPC4;CORO1C;TPM4;FLNA;LCP1;MYO10;SVIL;ARPC1B;TPM1;WDR1;ANXA8;AJUBA;MYH9;PPP1R9B;ACTN4;MYO1E
11320,GO:0045639,0.00551730340403314,0.998213409190281,11,60,positive regulation of myeloid cell differentiation,BP,RUNX1;INHBA;TNF;IL20;LIF;ETS1;ZFP36L1;PRKCA;TRIB1;KLF10;JUN
19888,GO:2000377,0.00554454616280235,0.997663524247367,17,114,regulation of reactive oxygen species metabolic process,BP,CRYAB;CYP1B1;EDN1;G6PD;TP53;CDKN1A;GADD45A;TNF;ZC3H12A;ICAM1;PARL;DHFR;SYK;PDGFB;BMP7;RAB27A;HSP90AB1
8382,GO:0033280,0.00555732516985767,0.99897226086574,6,22,response to vitamin D,BP,CYP24A1;TNC;SFRP1;SNAI2;IL15;BMP7
14957,GO:0070848,0.00557657867426598,0.99649539341416,52,472,response to growth factor,BP,CYR61;CTGF;PML;HSPB1;WNT10A;IER2;FBN1;TGFB2;EDN1;CDKN2B;EHD1;BAIAP2;TNC;FGFR2;EPHA2;BMP2;ERRFI1;SFRP1;ZFYVE27;EGR1;SNAI2;ZFP36L1;ADAM17;ZFP36L2;ROBO1;PDGFB;SNRNP70;NPNT;SPRY4;BAMBI;SMAD7;HNRNPF;KLF10;TGFBRAP1;CITED2;CD109;JUN;MCM7;ZNF703;PARD3;BMP7;ELK1;RAPGEF1;ZYX;WNT4;CXCL8;BMP8A;POLR2G;GCLC;HSP90AB1;PARP1;CCL5
11482,GO:0045939,0.00561884045226196,0.999178091222418,5,16,negative regulation of steroid metabolic process,BP,NFKB1;BMP2;SNAI2;INSIG1;WNT4
6686,GO:0030054,0.00565935249308006,0.996040262479597,87,871,cell junction,CC,TNS3;AMOT;ACTG1;HSPB1;PDLIM1;SDC4;B4GALT1;PANX1;SIPA1L3;MARVELD3;NEDD9;TJP2;HSPG2;LYN;CSRP1;BAIAP2;EFNB2;CORO1C;TNC;DST;PDPN;TPM4;LAYN;FLNA;LCP1;CADPS2;EPHA2;CHP1;ICAM1;CDK4;ITGAV;L1CAM;KIF23;SVIL;PLEKHA7;ARPC1B;CSRP2;AMOTL2;WDR1;EPPK1;GPER1;TRIM29;PARD3B;RPLP2;RHOB;ADAM17;VCL;RPLP1;SLC7A2;AJUBA;OXTR;RPS2;RPS9;FHL2;MYH9;COL17A1;SDK1;SPRY4;NUP214;SMAD7;YWHAH;TRIP6;ENAH;TJP1;CLASP1;PPP1R9B;MARVELD2;HSPA8;HCAR3;NACC1;PARD3;RHOG;CNTNAP1;ACTN4;SORBS2;PHLDB2;ZYX;MYADM;DAG1;CGNL1;TRAF4;CYTH1;SLC4A2;CLDN7;MYO1E;MCAM;BAIAP2L2
14515,GO:0065007,0.00566301062820668,0.99542126244178,639,7892,biological regulation,BP,IGFBP3;IL32;KRT1;MAFB;SAA1;TRIM16;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;CCDC80;ADM;SLC16A2;TNS3;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;ACTG1;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;STEAP4;IL24;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;COMMD4;CSRP1;EHD1;GADD45A;TNF;GNL3L;BAIAP2;ZBED1;EFNB2;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;SCD;WWC1;NAV2;ENC1;ANKRD36C;TNC;ASCC2;DST;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;SIRPA;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;RNF19B;ADRB2;SVIL;IL20;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;EBP;NMT2;TOX4;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;RELT;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;ABHD4;PDE4DIP;LUC7L;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;ZNF787;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;SGK1;SNAI2;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;U2AF2;FGFR1OP;VCL;SHQ1;RIPK4;IRS2;IER3;NPAS2;CBX5;PPRC1;LGALS3;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;CDKL1;DNTTIP2;PDGFB;BRMS1;BCAM;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;UTP20;RPS9;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;RNF115;DPYSL3;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RASGRP4;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;ACSL1;RCC2;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;KEAP1;M6PR;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;ANAPC15;PRDM7;CXCL5;RBM38;ATG101;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;SLC22A4;PES1;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;LRRC27;TFDP1;ZNF772;OGFR;ZNF512;EIF3B;GTF2E1;TRAPPC5;NOP2;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;HERC2;DUS2;ARGLU1;PARD3;LAMC1;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;GP6;ZNF132;EDC4;KLF6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TKT;TNFRSF10A;CXORF36;KANK4;TPRA1;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;PHF5A;RAPGEF1;ZYX;EIF5A;UBAP2L;MYADM;DAG1;TMEM165;CGNL1;POLR3H;PDE6A;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RBM14;AKR1C1;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;SLC4A2;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;AARSD1;POLR1E;MYO1E;CXCL3;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;ADGRF3;IL6R;BIN3;LAIR1;PARP1;CLK4;TP63;ZBTB12;TXNDC15;IL36G;C1S;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;MAGOH;SH3BP4
4663,GO:0010811,0.00566870625777069,0.997942134891217,13,77,positive regulation of cell-substrate adhesion,BP,CYR61;FN1;CCDC80;SDC4;EMP2;FLNA;COL16A1;SFRP1;NPNT;MYADM;DAG1;WNT4;FBLN2
15462,GO:0071798,0.00568323089715771,1,2,2,response to prostaglandin D,BP,TNC;AKR1C2
15463,GO:0071799,0.00568323089715771,1,2,2,cellular response to prostaglandin D stimulus,BP,TNC;AKR1C2
18235,GO:1903039,0.00568568748805291,0.997528743750343,18,123,positive regulation of leukocyte cell-cell adhesion,BP,CYLD;TFRC;CD83;MAP3K14;LYN;TNF;EFNB2;SIRPA;SART1;ICAM1;CD274;IL7R;ETS1;IL15;SYK;SOCS1;EFNB1;CCL5
12602,GO:0050778,0.00569659689951335,0.996466708277681,49,446,positive regulation of immune response,BP,KRT1;RUNX1;C1R;ACTG1;CYLD;RELB;TFRC;TGFB2;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;IL27RA;NFKB1;LYN;ARPC4;LAMP1;TNF;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;IRF1;PSME2;PSPC1;NFKBIA;LGALS3;TRAF2;IL15;SYK;CMTM3;TNFRSF21;TNIP2;SFPQ;PQBP1;ESR1;XRCC6;RAPGEF1;RBM14;CD38;TNFAIP3;PSMC3;SPG21;HSP90AB1;C1S;CCL5
12853,GO:0051171,0.00575178638700897,0.9953039575229,372,4384,regulation of nitrogen compound metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;ODC1;CYP1B1;CTGF;C1QTNF1;ADM;FOSL2;NQO1;IL16;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;IRX2;RELB;TFRC;SOD2;GPRC5A;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;TET3;ELMSAN1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;UBQLN2;LYN;AHR;JUNB;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;PARL;TRIM22;SAFB2;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;DNAJB2;ZNF787;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;ROBO1;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;SPRY4;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;PPP1R14C;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;PRDM7;RBM38;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;GLIPR2;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;MPHOSPH8;ELK1;PHF5A;RAPGEF1;EIF5A;MYADM;DAG1;EEF1D;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;TP63;ZBTB12;C1S;PHACTR4;CCL5;FADS1;MAGOH
4384,GO:0010035,0.0057566093320852,0.996616167344009,40,349,response to inorganic substance,BP,CRYAB;MMP9;NEFL;CYP1B1;NQO1;CYP1A1;SOD2;CSF2;PTGES;EDN1;TXNRD1;G6PD;TP53;JUNB;TNF;FOSL1;ZC3H12A;HMGCS1;ICAM1;FANCC;CDK4;DAXX;FUS;APTX;ETS1;RHOB;DHFR;KRT14;ACO1;TRAF2;NEDD4L;IL1A;DUSP1;JUN;QDPR;BMP7;TIMELESS;TNFAIP3;GCLC;PARP1
9937,GO:0042287,0.00575917746286291,0.999152469737111,5,16,MHC protein binding,MF,TAP1;KRT17;TAPBP;TAP2;TUBB
12272,GO:0048566,0.00577586165259104,0.999149413036761,5,16,embryonic digestive tract development,BP,TGFB2;TNF;FGFR2;VPS52;CXCL8
1454,GO:0003690,0.00591925049384022,0.996089126211564,64,601,double-stranded DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;MCM5;GADD45A;ZBED1;PBX1;NFKB2;FOSL1;KLF7;MCM2;ELF3;GRWD1;SAFB2;APTX;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;ETS1;AKAP8;FEN1;MAFK;UBTF;UHRF1;SFPQ;ZW10;MTA2;HNRNPU;PQBP1;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;SAFB;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;XRCC6;KLF6;ACTN4;ELK1;SMARCC2;PARP1;TP63;ORC4
5323,GO:0016049,0.00597508665101245,0.996480369708386,40,346,cell growth,BP,IGFBP3;CRYAB;NRG1;CYR61;INHBA;FN1;CTGF;PML;TGFB2;EDN1;G6PD;TP53;CDKN1A;HSPG2;CDKN2A;CXCL16;KRT17;TNK1;CCDC85B;L1CAM;SFN;TNFRSF12A;SFRP1;ZFYVE27;SRF;DNAJB2;SGK1;ADAM17;FGFR1OP;VCL;NTN1;NEDD4L;SEMA3C;PPP1R9B;OGFR;SORBS2;CD38;SLC3A2;BIN3;SH3BP4
3267,GO:0006937,0.00602238746944236,0.997793102002712,13,79,regulation of muscle contraction,BP,CTGF;EDN1;DAPK3;ZC3H12A;FLNA;ADRB2;TPM1;GPER1;SRF;OXTR;NPNT;SMAD7;TBXA2R
13230,GO:0051893,0.0060261392724475,0.998303360048362,9,44,regulation of focal adhesion assembly,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;RCC2;CLASP1;PHLDB2;WNT4
16123,GO:0090109,0.0060261392724475,0.998303360048362,9,44,regulation of cell-substrate junction assembly,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;RCC2;CLASP1;PHLDB2;WNT4
6646,GO:0023051,0.00603007744793773,0.995255416231615,210,2345,regulation of signaling,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;NRG1;MMP9;RUNX1;CYR61;INHBA;FN1;CYP1B1;CTGF;C1QTNF1;ADM;AMOT;JPH2;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;WNT10A;SOD2;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;GBP1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;UBQLN2;LYN;GADD45A;TNF;BAIAP2;CXCL16;WWC1;TRIO;FGFR2;PSMB9;EPHB6;TELO2;JPH1;ZC3H12A;FLNA;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;KREMEN2;ITGAV;ERRFI1;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;FXYD3;NMT2;ELF3;LIF;SFRP1;TRIM22;SAFB2;IRF1;PSME2;IL7R;GPER1;SRF;NFKBIA;EGR1;JRK;SNAI2;RRS1;ARHGEF28;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;SYK;CMTM3;ROBO1;AJUBA;PDGFB;OXTR;PTTG1IP;RNF115;SPPL2A;NPNT;IL1A;TNIP2;LANCL2;RASGRP4;SFPQ;SPRY4;ROR1;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;MTA2;YWHAH;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;PARP14;CXCL5;DUSP1;CITED2;CD109;SOCS1;JUN;ESR1;PAK1IP1;BRPF1;GLIPR2;CPT1A;TFDP1;NOP2;NOC2L;ZNF703;ARRDC3;INSIG1;RHOG;GPNMB;BCL2L2;CNTNAP1;ACTN4;THEM4;BMP7;PHLPP1;TNFRSF10A;CXORF36;AKIP1;RAPGEF1;MYADM;DAG1;CGNL1;PDE6A;EEF1D;BLNK;WNT4;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CXCL3;BMP8A;CARD10;DUSP8;NOL3;GCLC;HSP90AB1;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;SH3BP4
16272,GO:0090330,0.0060676478090177,0.999095595576819,5,16,regulation of platelet aggregation,BP,C1QTNF1;LYN;PDPN;PRKCA;SYK
469,GO:0001510,0.00609099389989117,0.997997472998713,11,61,RNA methylation,BP,TRMT61A;METTL1;NSUN2;METTL2B;NSUN5;FTSJ3;WDR4;NOP2;TRMT1;METTL16;HSD17B10
1094,GO:0002683,0.00610881399140213,0.996631262822232,32,268,negative regulation of immune system process,BP,MAFB;PTGER4;INHBA;CYLD;SDC4;FBN1;TGFB2;GBP1;NLRC5;IL27RA;TJP2;LYN;TNF;ZC3H12A;TSC22D3;CD274;SFRP1;IRF1;IL7R;GPER1;NFKBIA;ZFP36L1;LGALS3;TAPBPL;TNFRSF21;LILRB3;SMAD7;TRIB1;THOC1;PARP14;GPNMB;TNFAIP3
3377,GO:0007154,0.00611411053183518,0.995021952978948,338,3949,cell communication,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;FN1;NEFL;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;AMOT;JPH2;TUFT1;ACTG1;NQO1;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;SDC4;WNT10A;RELB;BAG1;SOD2;GPRC5A;CD3EAP;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;EMP2;NUAK1;NLRC5;PANX1;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;TNC;DST;TRIO;PDPN;FGFR2;PBX1;NFKB2;COL4A1;PSMB9;EPHB6;TELO2;KRT17;FOSL1;JPH1;ZC3H12A;FLNA;LCP1;TNK1;CADPS2;EPHA2;CHP1;GADD45B;ICAM1;ARFRP1;CD274;BMP2;COL16A1;UBE4B;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;ARPC1B;EBP;NMT2;XAF1;AMOTL2;AEN;ELF3;RELT;LIF;SFRP1;TRIM22;ZFYVE27;CC2D2A;SAFB2;HLA-F;IRF1;PSME2;IL7R;THBD;GPER1;SRF;TXN2;NFKBIA;EGR1;JRK;IGSF3;DOCK10;SGK1;SNAI2;RRS1;PRPF19;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;GPR132;ZFP36L2;NTN1;SYK;CMTM3;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;PDGFB;BCAM;OXTR;PTTG1IP;SPTBN1;FHL2;DCTN1;RNF115;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;GPR75;TNFRSF21;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SPRY4;LILRB3;SPEN;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;MTA2;YWHAH;PALM2;M6PR;TJP1;HNRNPF;RRAD;APH1A;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;KCNIP3;SAFB;THOC1;KLF10;PARP14;CXCL5;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;STAC;FRAS1;OXSR1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;HCAR3;PAK1IP1;BRPF1;GLIPR2;CPT1A;LRRC27;TFDP1;OGFR;NOP2;NOC2L;ZNF703;CCR6;ARRDC3;INSIG1;PARD3;RHOG;GPNMB;BCL2L2;GP6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SNIP1;BMP7;PHLPP1;TNFRSF10A;CXORF36;TPRA1;AKIP1;RAPGEF1;ZYX;MYADM;DAG1;CGNL1;PDE6A;EEF1D;ASB6;RAB27A;BLNK;WNT4;RBM14;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;CXCL3;BMP8A;CARD10;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;TBXA2R;ADGRF3;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;SH3BP4
5523,GO:0016493,0.0061325084406536,1,2,2,C-C chemokine receptor activity,MF,GPR75;CCR6
3335,GO:0007045,0.00615860408165912,0.997975058671961,11,60,cell-substrate adherens junction assembly,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;AJUBA;RCC2;TRIP6;CLASP1;PHLDB2;WNT4
12088,GO:0048041,0.00615860408165912,0.997975058671961,11,60,focal adhesion assembly,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;AJUBA;RCC2;TRIP6;CLASP1;PHLDB2;WNT4
3742,GO:0008277,0.00616623416282784,0.997735820244458,13,78,regulation of G-protein coupled receptor protein signaling pathway,BP,ADM;EDN1;UBQLN2;ADRB2;NMT2;GPER1;PRKCA;RASGRP4;PPP1R9B;ARRDC3;PDE6A;CXCL8;CCL5
6647,GO:0023052,0.00618005334961423,0.994968527295548,336,3923,signaling,BP,IGFBP3;IL32;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;FN1;NEFL;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;AMOT;JPH2;TUFT1;ACTG1;NQO1;IL16;IL1R2;DUSP14;PML;CYLD;HSPB1;STARD13;TRAF1;SDC4;WNT10A;RELB;BAG1;SOD2;GPRC5A;CD3EAP;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;RSAD2;TRAF3;EMP2;NUAK1;NLRC5;PANX1;TP53;SIPA1L3;SQSTM1;MARVELD3;IL24;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;GADD45A;TNF;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;WWC1;TNC;DST;TRIO;PDPN;FGFR2;PBX1;NFKB2;COL4A1;PSMB9;EPHB6;TELO2;KRT17;JPH1;ZC3H12A;FLNA;LCP1;TNK1;CADPS2;EPHA2;CHP1;GADD45B;ICAM1;ARFRP1;CD274;BMP2;COL16A1;UBE4B;CDK4;KREMEN2;ITGAV;ERRFI1;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;ADRB2;IL20;DAXX;TNFRSF12A;IFNGR1;SERPINE1;FXYD3;ARPC1B;EBP;NMT2;XAF1;AMOTL2;AEN;ELF3;RELT;LIF;SFRP1;TRIM22;ZFYVE27;CC2D2A;SAFB2;HLA-F;IRF1;PSME2;IL7R;THBD;GPER1;SRF;NFKBIA;EGR1;JRK;IGSF3;DOCK10;SGK1;SNAI2;RRS1;PRPF19;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;TXLNA;IRS2;IER3;LGALS3;TRAF2;IL15;AKR1C2;PRKCA;GPR132;ZFP36L2;NTN1;SYK;CMTM3;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;PDGFB;BCAM;OXTR;PTTG1IP;SPTBN1;FHL2;DCTN1;RNF115;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;GPR75;TNFRSF21;TNIP2;LANCL2;RASGRP4;SEMA3C;SFPQ;SPRY4;LILRB3;SPEN;ROR1;ACSL1;RCC2;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;MTA2;YWHAH;PALM2;M6PR;TJP1;HNRNPF;RRAD;APH1A;PAGR1;TRIB1;CREB3;RUVBL2;PPP1R9B;TUSC1;KCNIP3;SAFB;THOC1;KLF10;PARP14;CXCL5;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;BLOC1S2;HCAR3;PAK1IP1;BRPF1;GLIPR2;CPT1A;LRRC27;TFDP1;OGFR;NOP2;NOC2L;ZNF703;CCR6;ARRDC3;INSIG1;PARD3;RHOG;GPNMB;BCL2L2;GP6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;SNIP1;BMP7;PHLPP1;TNFRSF10A;CXORF36;TPRA1;AKIP1;RAPGEF1;ZYX;MYADM;DAG1;CGNL1;PDE6A;EEF1D;ASB6;RAB27A;BLNK;WNT4;RBM14;TRAF4;CYTH1;CD38;TNFAIP3;PSMC3;SPG21;CCL22;BRIP1;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;MYO1E;CXCL3;BMP8A;CARD10;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;TBXA2R;ADGRF3;IL6R;PARP1;TP63;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;SH3BP4
12105,GO:0048144,0.00618649557170938,0.997958826316422,11,62,fibroblast proliferation,BP,FTH1;FN1;FOSL2;PML;TP53;CDKN1A;CDK4;SFRP1;PDGFB;JUN;ESR1
6101,GO:0019321,0.00619464246974692,0.999340000044447,4,11,pentose metabolic process,BP,G6PD;PGD;DCXR;TKT
8017,GO:0032650,0.0062052293215412,0.999651851991955,3,6,regulation of interleukin-1 alpha production,BP,CCL20;IL1R2;PANX1
84,GO:0000171,0.00620590945027037,1,2,2,ribonuclease MRP activity,MF,POP1;POP4
16541,GO:0097278,0.0062098369699941,1,2,2,complement-dependent cytotoxicity,BP,RAB27A;HSP90AB1
18651,GO:1903964,0.00621179144186173,1,2,2,monounsaturated fatty acid metabolic process,BP,SCD;SCD5
18652,GO:1903966,0.00621179144186173,1,2,2,monounsaturated fatty acid biosynthetic process,BP,SCD;SCD5
14838,GO:0070576,0.00621239010013767,1,2,2,vitamin D 24-hydroxylase activity,MF,CYP24A1;CYP1A1
7424,GO:0031523,0.00621421689056339,1,2,2,Myb complex,CC,MYBL2;FLNA
5114,GO:0015433,0.00621439094080736,1,2,2,peptide antigen-transporting ATPase activity,MF,TAPBP;TAP2
6846,GO:0030314,0.00621439094080736,1,2,2,junctional membrane complex,CC,JPH2;JPH1
7857,GO:0032417,0.00621439094080736,1,2,2,positive regulation of sodium:proton antiporter activity,BP,CHP1;ACTN4
9355,GO:0035866,0.00621439094080736,1,2,2,alphav-beta3 integrin-PKCalpha complex,CC,ITGAV;PRKCA
11924,GO:0046967,0.00621439094080736,1,2,2,cytosol to ER transport,BP,TAP1;TAP2
13634,GO:0060129,0.00621439094080736,1,2,2,thyroid-stimulating hormone-secreting cell differentiation,BP,BMP2;WNT4
13885,GO:0060523,0.00621439094080736,1,2,2,prostate epithelial cord elongation,BP,FGFR2;ESR1
13890,GO:0060529,0.00621439094080736,1,2,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,FGFR2;TP63
15315,GO:0071505,0.00621439094080736,1,2,2,response to mycophenolic acid,BP,EGR1;PDGFB
15316,GO:0071506,0.00621439094080736,1,2,2,cellular response to mycophenolic acid,BP,EGR1;PDGFB
148,GO:0000302,0.00623082591323926,0.997005071488349,22,165,response to reactive oxygen species,BP,CRYAB;MMP9;CYP1B1;NQO1;SOD2;EDN1;TXNRD1;TP53;TNF;FOSL1;FANCC;TPM1;APTX;ETS1;RHOB;DHFR;TRAF2;PXMP2;DUSP1;JUN;BMP7;TNFAIP3
11348,GO:0045671,0.00628560682827161,0.999054959941311,5,16,negative regulation of osteoclast differentiation,BP,MAFB;FBN1;TJP2;SFRP1;LILRB3
6577,GO:0022404,0.00631484823080547,0.997789349433255,12,69,molting cycle process,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;NOM1;CD109;FOXN1;TP63
6578,GO:0022405,0.00631484823080547,0.997789349433255,12,69,hair cycle process,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;NOM1;CD109;FOXN1;TP63
16856,GO:0098773,0.00631484823080547,0.997789349433255,12,69,skin epidermis development,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;NOM1;CD109;FOXN1;TP63
16802,GO:0098644,0.00632048017004844,0.999048424433857,5,16,complex of collagen trimers,CC,COL4A1;COL27A1;COL5A3;COL5A2;COL4A4
5627,GO:0016705,0.00633789540091563,0.997464706542736,15,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,P3H2;CYP1B1;CYP24A1;CYP1A1;TET3;P4HA2;SCD;CYP4B1;AKR1C2;DOHH;MICAL3;SCD5;CYP20A1;AKR1C1;FADS1
12825,GO:0051130,0.00634261305026922,0.995515305186901,90,906,positive regulation of cellular component organization,BP,NRG1;MMP9;FN1;NEFL;CTGF;TENM3;PML;SDC4;CSF2;TGFB2;EDN1;TP53;LYN;ARPC4;EHD1;TNF;BAIAP2;CORO1C;ENC1;PDPN;FOSL1;SIRPA;UBE2C;FLNA;LCP1;CYB5R1;ICAM1;COL16A1;ITGAV;L1CAM;SFN;CDC42EP2;EPGN;ADRB2;TNFRSF12A;SERPINE1;ARPC1B;USP36;AKAP8L;LIF;SFRP1;TPM1;ZFYVE27;WDR1;GPER1;SRF;SNAI2;AKAP8;NELFE;DKC1;FEN1;NTN1;SYK;ROBO1;AJUBA;PDGFB;OXTR;NEDD4L;DCTN1;COLGALT1;DPYSL3;SLAIN2;IL1A;SFPQ;WDR46;YWHAH;HNRNPU;CLASP1;UBE2J2;RUVBL2;JUN;ESR1;TFDP1;RHOG;ACTN4;SNIP1;BMP7;PHLDB2;RAPGEF1;EIF5A;MYADM;DAG1;RAB27A;WNT4;PSMC3;CDCA5;SWAP70;PARP1;TP63;BAIAP2L2
19753,GO:2000144,0.00636851887597092,0.998777269952884,6,23,positive regulation of DNA-templated transcription, initiation,BP,TP53;FOSL1;SRF;JUN;ESR1;PSMC3
6067,GO:0019216,0.00638971756864806,0.996467597369622,32,262,regulation of lipid metabolic process,BP,CYR61;CTGF;CYP1A1;TXNRD1;PANK2;NFKB1;IRS1;LYN;TNF;SCD;LSS;HMGCS1;BMP2;CDK4;DHCR7;GPER1;SF1;EGR1;EDF1;SNAI2;IRS2;NPAS2;PDGFB;FHL2;GLIPR1;TNFRSF21;ACSL1;CPT1A;INSIG1;SMPD2;WNT4;FADS1
4721,GO:0010883,0.00644318139650918,0.998534663976769,7,30,regulation of lipid storage,BP,IKBKE;NFKB1;EHD1;TNF;ZC3H12A;ITGAV;NFKBIA
5902,GO:0018108,0.00646581219473628,0.996539046958384,29,231,peptidyl-tyrosine phosphorylation,BP,NRG1;GPRC5A;CSF2;TP53;IL24;LYN;FGFR2;TNK1;EPHA2;ICAM1;ERRFI1;STAT5A;EPGN;IL20;LIF;SFRP1;ADAM17;FGFR1OP;IL15;SYK;PDGFB;ROR1;AFAP1L2;PARP14;SOCS1;EFNA1;IL6R;CLK4;CCL5
12526,GO:0050670,0.00649814060565993,0.997213048491028,17,116,regulation of lymphocyte proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;CD38;CCL5
15284,GO:0071466,0.00650016431407639,0.997296318215951,16,107,cellular response to xenobiotic stimulus,BP,CYP1B1;NQO1;CYP1A1;UGT1A6;AHR;ACAA1;ICAM1;ERRFI1;STAT5A;EGR1;PDGFB;ACSL1;PPP1R9B;MCM7;AKR1C1;HSP90AB1
9927,GO:0042273,0.00658264200982962,0.997795556412911,11,67,ribosomal large subunit biogenesis,BP,PPAN;RRS1;NOP16;FTSJ3;NOL9;MRPL20;PES1;PAK1IP1;NOP2;NOC2L;SURF6
3283,GO:0006970,0.0065986699849528,0.997949828135624,10,53,response to osmotic stress,BP,RELB;MARVELD3;TNF;TSC22D3;ERRFI1;ZFP36L1;CAB39;OXSR1;XRCC6;HSP90AB1
8042,GO:0032691,0.0066276451203975,0.999279784464977,4,11,negative regulation of interleukin-1 beta production,BP,PML;ZC3H12A;ERRFI1;TNFAIP3
10134,GO:0042692,0.00664472250020827,0.996572612505062,26,201,muscle cell differentiation,BP,NRG1;HDAC9;ADM;ACTG1;EDN1;G6PD;EHD1;EFNB2;FGFR2;BMP2;TPM1;WDR1;MKL1;GPER1;SRF;PDGFB;FHL2;MYH9;NPNT;HNRNPU;RBM38;RBM4;SORBS2;WNT4;MAPK11;BIN3
13806,GO:0060395,0.00675426957721851,0.998244401676802,8,37,SMAD protein signal transduction,BP,INHBA;TGFB2;BMP2;JUN;BMP7;RBM14;BMP8A;PARP1
9790,GO:0040008,0.00680099879168944,0.995739062169521,49,447,regulation of growth,BP,IGFBP3;CRYAB;NRG1;CYR61;INHBA;FN1;CTGF;PML;TFCP2L1;TGFB2;EDN1;G6PD;TP53;SQSTM1;NEDD9;CDKN1A;TNF;CDKN2A;CXCL16;WWC1;FGFR2;KRT17;TNK1;CCDC85B;CDK4;L1CAM;SFN;STAT5A;ADRB2;TNFRSF12A;SFRP1;ZFYVE27;EPPK1;SRF;DNAJB2;SGK1;ADAM17;FGFR1OP;NTN1;NEDD4L;SEMA3C;RUVBL2;PPP1R9B;SOCS1;OGFR;TKT;CD38;MAPK11;SH3BP4
1088,GO:0002676,0.0068114297112294,0.999604402790859,3,6,regulation of chronic inflammatory response,BP,TNF;TNFAIP3;CCL5
7906,GO:0032479,0.006924109609098,0.997099946938098,16,107,regulation of type I interferon production,BP,CYLD;RELB;TRIM56;IKBKE;TRAF3;NLRC5;NFKB1;NFKB2;IRF1;SYK;CRCP;PQBP1;DTX4;XRCC6;POLR3H;TNFAIP3
6759,GO:0030183,0.00695351987922603,0.997405648564745,13,79,B cell differentiation,BP,INHBA;HDAC9;CYLD;LFNG;SFRP1;DOCK10;ZFP36L1;ADAM17;ZFP36L2;SYK;IKZF3;KLF6;BLNK
20270,GO:2001238,0.00695459738745618,0.997986910909083,9,46,positive regulation of extrinsic apoptotic signaling pathway,BP,INHBA;PML;CYLD;DAPK3;TNFRSF12A;SFRP1;GPER1;TRAF2;PPP2R1B
18243,GO:1903053,0.00698098711368231,0.998633029678088,6,23,regulation of extracellular matrix organization,BP,PDPN;ETS1;COLGALT1;CLASP1;PHLDB2;DAG1
14291,GO:0061384,0.00698676237475086,0.99863165557985,6,23,heart trabecula morphogenesis,BP,NRG1;TGFB2;UBE4B;SRF;FHL2;BMP7
8443,GO:0033561,0.006996570511776,0.998629321360306,6,23,regulation of water loss via skin,BP,KRT1;HRNR;SFN;SRF;RPTN;TP63
16070,GO:0090025,0.00702154989289747,0.999223957410046,4,11,regulation of monocyte chemotaxis,BP,LYN;SERPINE1;CREB3;CCL5
20266,GO:2001234,0.00705138740513296,0.996571819801174,22,166,negative regulation of apoptotic signaling pathway,BP,MMP9;HSPB1;SOD2;CSF2;TNF;ICAM1;ITGAV;SERPINE1;SNAI2;LGALS3;TRAF2;PTTG1IP;IL1A;ACKR3;CREB3;NOC2L;BCL2L2;TNFRSF10A;WNT4;TNFAIP3;NOL3;GCLC
3290,GO:0006979,0.00707248156731363,0.995878957369052,37,322,response to oxidative stress,BP,KRT1;CRYAB;MMP9;CYP1B1;NQO1;PML;HSPB1;PDLIM1;SOD2;EDN1;TXNRD1;G6PD;TP53;NFE2L1;TNF;FOSL1;ZC3H12A;FANCC;TPM1;APTX;TXN2;ETS1;RHOB;DHFR;TRAF2;SFPQ;PXMP2;DUSP1;OXSR1;JUN;BMP7;GPX4;CD38;TNFAIP3;NOL3;GCLC;PARP1
8199,GO:0032944,0.0071026449773848,0.996923569576474,17,117,regulation of mononuclear cell proliferation,BP,SDC4;TFRC;CDKN1A;LYN;AHR;CD274;IRF1;IRS2;LGALS3;IL15;SYK;TNFRSF21;IKZF3;GPNMB;EFNB1;CD38;CCL5
18446,GO:1903531,0.00710844991487674,0.997113313960546,15,98,negative regulation of secretion by cell,BP,PTGER4;INHBA;FN1;IL1R2;PML;EDN1;GBP1;RSAD2;IRS1;TNF;ZC3H12A;LIF;SFRP1;TNFRSF21;BMP8A
11416,GO:0045823,0.00711199433810502,0.998881211668892,5,17,positive regulation of heart contraction,BP,CTGF;ADM;TGFB2;EDN1;TPM1
12278,GO:0048585,0.00714884883318191,0.994787172775883,106,1101,negative regulation of response to stimulus,BP,IGFBP3;KRT1;SAA1;NRG1;MMP9;PTGER4;C1QTNF1;ADM;IL1R2;DUSP14;CYLD;HSPB1;SOD2;GPRC5A;CSF2;FBN1;TGFB2;EDN1;GBP1;NLRC5;MARVELD3;IL27RA;FST;NFKB1;LFNG;IRS1;UBQLN2;LYN;TNF;WWC1;FGFR2;PSMB9;EPHB6;ZC3H12A;TNK1;EPHA2;CHP1;ICAM1;BMP2;KREMEN2;ITGAV;ERRFI1;ADRB2;SERPINE1;LIF;SFRP1;PSME2;EPPK1;IL7R;TFIP11;THBD;GPER1;NFKBIA;EGR1;ETS1;SNAI2;ADAM17;LGALS3;TRAF2;ROBO1;AJUBA;PDGFB;PTTG1IP;RNF115;IL1A;SEMA3C;SPRY4;ROR1;ACKR3;BAMBI;SMAD7;CLASP1;TRIB1;CREB3;RUVBL2;THOC1;PARP14;DUSP1;CD109;SOCS1;ESR1;PAK1IP1;NOC2L;INSIG1;BCL2L2;THEM4;BMP7;PHLPP1;TNFRSF10A;PHLDB2;RAPGEF1;MYADM;DAG1;CGNL1;WNT4;TNFAIP3;PSMC3;CXCL8;EFNA1;DUSP8;NOL3;GCLC;TP63;PHACTR4;CCL5;SH3BP4
3550,GO:0007584,0.00715268868731688,0.996657488299412,20,145,response to nutrient,BP,CYP24A1;NQO1;CYP1A1;PANX1;TP53;CDKN2B;BAIAP2;TNC;TYMS;SRSF2;HMGCS1;SFRP1;SRF;SNAI2;IL15;ACSL1;BMP7;BRIP1;GCLC;TBXA2R
3275,GO:0006953,0.00715858027014358,0.998872068506163,5,17,acute-phase response,BP,SAA1;FN1;TNF;IL1A;IL6R
15908,GO:0072677,0.00723485288967027,0.99957028022968,3,6,eosinophil migration,BP,PTGER4;LGALS3;CCL5
6842,GO:0030307,0.00724680791499202,0.996854426401617,17,117,positive regulation of cell growth,BP,NRG1;FN1;TGFB2;EDN1;CXCL16;KRT17;L1CAM;SFN;TNFRSF12A;SFRP1;ZFYVE27;SRF;ADAM17;FGFR1OP;NTN1;NEDD4L;CD38
7003,GO:0030687,0.00731714384462464,0.998541746174213,6,24,preribosome, large subunit precursor,CC,PPAN;RRP1;RRS1;FTSJ3;PES1;NOC2L
996,GO:0002460,0.00731771586075545,0.996650685603949,19,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,C1R;RELB;TFRC;RSAD2;EMP2;IL27RA;TNF;NFKB2;ICAM1;IL7R;ADAM17;TRAF2;SMAD7;THOC1;CCR6;RAB27A;TNFAIP3;SWAP70;C1S
8498,GO:0033674,0.00732366738071229,0.995464225677312,46,413,positive regulation of kinase activity,BP,SAA1;NRG1;CYR61;SDC4;MAP3K14;TGFB2;EDN1;EMP2;IRS1;CDKN1A;LYN;GADD45A;TNF;FGFR2;EPHB6;TELO2;EPHA2;GADD45B;BMP2;EPGN;ADRB2;DAXX;EGR1;ADAM17;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;ROR1;ACSL1;AFAP1L2;CAB39;SOCS1;OXSR1;XRCC6;TNFRSF10A;RAPGEF1;DAG1;TRAF4;EFNA1;MAPK11;CARD10;HSP90AB1;CCL5
13911,GO:0060562,0.00735882664690719,0.996068983360732,28,222,epithelial tube morphogenesis,BP,ADM;PML;STARD13;SDC4;IRX2;TGFB2;EDN1;B4GALT1;TNF;EFNB2;TNC;FGFR2;PBX1;COL4A1;EPHA2;BMP2;SFRP1;CC2D2A;SRF;RHOB;NTN1;NPNT;ESR1;BMP7;DAG1;TIMELESS;WNT4;PHACTR4
10016,GO:0042445,0.00739053191114506,0.996785338111408,17,117,hormone metabolic process,BP,CYP1B1;ADM;CYP1A1;NFKB1;TNF;BACE2;C9ORF3;ACAA1;BMP2;DHCR7;EGR1;AKR1C2;YWHAH;SAFB;ESR1;WNT4;AKR1C1
16855,GO:0098772,0.00743986840140558,0.994551327274487,108,1131,molecular function regulator,MF,IGFBP3;IL32;SAA1;CCL20;NRG1;INHBA;FN1;NEFL;CTGF;ADM;IL16;HSPB1;STARD13;WNT10A;BAG1;CSF2;FBN1;TGFB2;EDN1;SH3RF2;BIRC3;SIPA1L3;IL24;CDKN2B;IRS1;CDKN1A;TNF;CDKN2A;RING1;CXCL16;ANKRD36C;TRIO;FGFR2;DNAJB1;FLNA;CHP1;BMP2;CDK4;ERRFI1;SFN;CDC42EP2;LYPD6B;EPGN;ADRB2;IL20;DAXX;SERPINE1;FXYD3;LIF;PPP1R3B;PSME2;DNAJB2;DOCK10;SGK1;ARHGEF28;TXLNA;FGFR1OP;IRS2;LGALS3;RPLP1;IL15;CMTM3;PDGFB;NSFL1C;SPTBN1;NEDD4L;SERPINH1;IL1A;RASGRP4;RUNDC1;SEMA3C;AFAP1L2;DNAJC1;YWHAH;PPP1R14C;TRIB1;PPP1R9B;KCNIP3;A2ML1;CXCL5;CAB39;CD109;SOCS1;HSPBP1;JUN;ESR1;RCC1;TRAPPC5;HERC2;DUS2;GPNMB;BMP7;SGSM1;RAPGEF1;WNT4;CYTH1;CCL22;CXCL8;CXCL3;BMP8A;NOL3;SNF8;HSP90AB1;TBXA2R;IL36G;PHACTR4;CCL5;SH3BP4
10958,GO:0044706,0.00745842700378079,0.996579820377681,19,135,multi-multicellular organism process,BP,MMP9;ADM;CYP1A1;TFCP2L1;EDN1;B4GALT1;EMP2;JUNB;VMP1;FOSL1;COL16A1;LIF;THBD;ETS1;OXTR;MAFF;ESR1;WNT4;CD38
6311,GO:0019956,0.00748246368149273,0.999157414752426,4,11,chemokine binding,MF,PDPN;ITGAV;ACKR3;CCR6
19587,GO:1990668,0.00751216752472495,0.999547510686871,3,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,TAP1;TAPBP;TAP2
9684,GO:0038061,0.00752291626231194,0.996813644770673,16,111,NIK/NF-kappaB signaling,BP,RELB;MAP3K14;IKBKE;BIRC3;NFKB1;TNF;NFKB2;PSMB9;PSME2;TRAF2;ACTN4;TNFRSF10A;AKIP1;TRAF4;PSMC3;CARD10
7988,GO:0032606,0.00752899746438003,0.99681564079622,16,108,type I interferon production,BP,CYLD;RELB;TRIM56;IKBKE;TRAF3;NLRC5;NFKB1;NFKB2;IRF1;SYK;CRCP;PQBP1;DTX4;XRCC6;POLR3H;TNFAIP3
13905,GO:0060556,0.00756183597016816,0.999543397999146,3,6,regulation of vitamin D biosynthetic process,BP,NFKB1;TNF;SNAI2
14571,GO:0070099,0.00756273025959812,0.999543323854054,3,6,regulation of chemokine-mediated signaling pathway,BP,EDN1;ROBO1;CCL5
16298,GO:0090399,0.0075716175038588,0.999144396012388,4,11,replicative senescence,BP,TP53;CDKN1A;CDKN2A;SERPINE1
4371,GO:0009991,0.00759276394483828,0.995488656134884,39,341,response to extracellular stimulus,BP,CYP24A1;ADM;NQO1;CYP1A1;G6PD;PANX1;TP53;NOCT;CDKN2B;CDKN1A;LYN;BAIAP2;TNC;FOSL1;TYMS;ZC3H12A;SRSF2;CADPS2;HMGCS1;ICAM1;ADRB2;SFRP1;SRF;TXN2;SNAI2;IL15;RASGRP4;ACSL1;PPP1R9B;KLF10;HSPA8;JUN;BMP7;WNT4;BRIP1;BMP8A;GCLC;TBXA2R;FADS1
14648,GO:0070232,0.00761823436516782,0.99846849398901,6,24,regulation of T cell apoptotic process,BP,TP53;TSC22D3;CD274;LGALS3;EFNA1;CCL5
7499,GO:0031670,0.00762896342420723,0.997758504961439,9,46,cellular response to nutrient,BP,CYP24A1;CDKN2B;BAIAP2;TNC;SFRP1;SRF;SNAI2;IL15;BRIP1
3117,GO:0006694,0.00763728093040935,0.996573518638366,18,127,steroid biosynthetic process,BP,ADM;TFCP2L1;G6PD;NFKB1;TNF;SCD;PBX1;LSS;CYB5R1;HMGCS1;BMP2;EBP;DHCR7;SF1;EGR1;SNAI2;INSIG1;WNT4
5443,GO:0016310,0.00763748072239745,0.994150915505881,151,1645,phosphorylation,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;GBP1;IKBKE;MID1;DAPK3;DBNDD2;EMP2;NUAK1;NLRC5;TP53;SQSTM1;MARVELD3;IL24;PANK2;NFKB1;CDKN2B;GNPTAB;IRS1;CDKN1A;LYN;HMGXB3;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;TRIO;FGFR2;NUP153;PSMB9;EPHB6;TELO2;ZC3H12A;TNK1;TK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;ADRB2;IL20;DAXX;PGK1;AKAP8L;LIF;SFRP1;PSME2;GPER1;EGR1;SGK1;ZFP36L1;AKAP8;NELFE;ADAM17;FGFR1OP;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;PPIP5K1;CDKL1;PDGFB;OXTR;SPTBN1;COX5B;NPNT;IL1A;CAMK1G;TNIP2;RASGRP4;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;NOL9;HNRNPU;PPP1R14C;TRIB1;PARP14;DUSP1;CAB39;CD109;SOCS1;OXSR1;JUN;ESR1;GLIPR2;MCM7;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;BMP7;PHLPP1;TNFRSF10A;RAPGEF1;MYADM;DAG1;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;BMP8A;CARD10;DUSP8;HSP90AB1;IL6R;CLK4;CCL5
3405,GO:0007186,0.00767444280456806,0.995343454481555,42,374,G-protein coupled receptor signaling pathway,BP,SAA1;CCL20;PTGER4;ADM;GPRC5A;EDN1;UBQLN2;CXCL16;TRIO;FLNA;GPR146;ADRB2;NMT2;SFRP1;GPER1;RHOB;ADAM17;AKR1C2;PRKCA;GPR132;OXTR;GPR75;RASGRP4;ACKR3;CRCP;PPP1R9B;CXCL5;ESR1;HCAR3;OGFR;CCR6;ARRDC3;PARD3;RHOG;TPRA1;PDE6A;CCL22;CXCL8;CXCL3;TBXA2R;ADGRF3;CCL5
13638,GO:0060137,0.00768034503481513,0.999533543186322,3,6,maternal process involved in parturition,BP,CYP1A1;EDN1;OXTR
12904,GO:0051250,0.00768348848258254,0.997094400659516,13,80,negative regulation of lymphocyte activation,BP,INHBA;CYLD;SDC4;LYN;CD274;SFRP1;IRF1;LGALS3;TNFRSF21;SMAD7;THOC1;GPNMB;TNFAIP3
7447,GO:0031581,0.00770561052792681,0.999124741403503,4,11,hemidesmosome assembly,BP,KRT5;KRT14;COL17A1;LAMC1
12854,GO:0051172,0.0077125316559779,0.99404839606603,161,1773,negative regulation of nitrogen compound metabolic process,BP,IGFBP3;CRYAB;NRG1;MMP9;INHBA;HDAC9;IL1R2;DUSP14;PML;TFCP2L1;HSPB1;IRX2;RELB;GPRC5A;CSF2;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;TP53;SQSTM1;MARVELD3;NOCT;FST;NFKB1;CDKN2B;CDKN1A;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;CDKN2A;RING1;CORO1C;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;SRSF2;CHP1;CCDC85B;GADD45B;TSC22D3;BMP2;CDK4;ITGAV;ERRFI1;SFN;DAXX;NAT10;SERPINE1;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TRIM22;ANXA8;IRF1;NFX1;PSPC1;TFIP11;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;SRRT;ZFP36L1;NELFE;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;SHQ1;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;SNRNP70;SERPINH1;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPRY4;SPEN;NUP214;SMAD7;SUPT5H;MTA2;DNAJC1;HNRNPU;PPP1R14C;TRIB1;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;DUSP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;DUS2;PARD3;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;TNFRSF10A;MPHOSPH8;RAPGEF1;MYADM;DAG1;DHX34;TIMELESS;WNT4;CTDSP1;CD38;TNFAIP3;SMARCC2;EFNA1;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;PARP1;TP63
15295,GO:0071479,0.00773249505310523,0.997364149817917,11,63,cellular response to ionizing radiation,BP,CRYAB;TP53;CDKN1A;GADD45A;SFRP1;EGR1;SNAI2;RHOB;XRCC6;ELK1;EEF1D
1486,GO:0003823,0.00773915101535346,0.99843889015399,6,24,antigen binding,MF,TAP1;HLA-B;SLC7A5;HLA-F;IL7R;TAPBP
11800,GO:0046677,0.00781103271171858,0.995856562620873,27,218,response to antibiotic,BP,CRYAB;NEFL;CYP1B1;NQO1;CYP1A1;EDN1;G6PD;TP53;AHR;TNC;FGFR2;FOSL1;TYMS;ZC3H12A;ICAM1;DAXX;APTX;EGR1;ETS1;RHOB;PDGFB;DUSP1;JUN;TIMELESS;TNFAIP3;CLDN7;TBXA2R
11286,GO:0045596,0.00783711434605887,0.995124695461699,46,420,negative regulation of cell differentiation,BP,MAFB;NRG1;INHBA;CYLD;FBN1;TGFB2;GBP1;G6PD;NOCT;TJP2;LYN;TNF;EFNB2;CORO1C;TRIO;PBX1;CCDC85B;BMP2;ITGAV;SFRP1;IRF1;GPER1;NFKBIA;SNAI2;PRPF19;ZFP36L1;ZFP36L2;NTN1;PDGFB;DPYSL3;SEMA3C;LILRB3;RCC2;COL5A2;SMAD7;YWHAH;HNRNPU;TRIB1;INSIG1;ZNF365;ACTN4;BMP7;WNT4;CTDSP1;EFNA1;TP63
14160,GO:0061042,0.00784314992560433,0.99951990931302,3,6,vascular wound healing,BP,SERPINE1;TNFAIP3;MCAM
18636,GO:1903935,0.0078734810991444,0.999517357138022,3,6,response to sodium arsenite,BP,NEFL;ZC3H12A;DAXX
5726,GO:0016866,0.00792163513682294,0.998394014661318,6,24,intramolecular transferase activity,MF,LSS;PMM2;PUS1;DKC1;TRUB2;RPUSD4
11098,GO:0045110,0.00792178147938446,0.999513285148379,3,6,intermediate filament bundle assembly,BP,NEFL;NEFM;KRT14
14149,GO:0061029,0.00793109321683289,0.999091430574183,4,11,eyelid development in camera-type eye,BP,INHBA;OSR2;SRF;JUN
8512,GO:0033690,0.00796982617664706,0.999509225211243,3,6,positive regulation of osteoblast proliferation,BP,CYR61;BMP2;ITGAV
9944,GO:0042303,0.00801983970333999,0.996950686154273,13,80,molting cycle,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;KRT14;NOM1;CD109;FOXN1;TP63
10115,GO:0042633,0.00801983970333999,0.996950686154273,13,80,hair cycle,BP,INHBA;WNT10A;TGFB2;FST;TNF;FGFR2;KRT17;NSUN2;KRT14;NOM1;CD109;FOXN1;TP63
13996,GO:0060710,0.00806496513798981,0.999501157810548,3,6,chorio-allantoic fusion,BP,CYR61;ZFP36L1;BMP7
232,GO:0000480,0.00808430446840479,0.999499513405523,3,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,UTP20;ABT1;NOP14
528,GO:0001637,0.00810279962857293,0.999497939359129,3,6,G-protein coupled chemoattractant receptor activity,MF,GPR75;ACKR3;CCR6
2138,GO:0004950,0.00810279962857293,0.999497939359129,3,6,chemokine receptor activity,MF,GPR75;ACKR3;CCR6
7753,GO:0032269,0.00811569289375652,0.994278296298947,83,849,negative regulation of cellular protein metabolic process,BP,IGFBP3;CRYAB;MMP9;IL1R2;DUSP14;PML;HSPB1;GPRC5A;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;MARVELD3;NFKB1;CDKN2B;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;ENC1;NUP153;TYMS;ZC3H12A;CHP1;GADD45B;CDK4;ERRFI1;SFN;SERPINE1;ZC3H7B;LIF;SFRP1;ANXA8;GPER1;SRRT;ZFP36L1;SNX12;DHFR;U2AF2;FGFR1OP;ZFP36L2;AJUBA;SERPINH1;SPRY4;NUP214;SMAD7;DNAJC1;PPP1R14C;TRIB1;PPP1R9B;A2ML1;PARP14;DUSP1;CD109;SOCS1;JUN;ESR1;NOC2L;RBM4;DUS2;PARD3;SNIP1;BMP7;METTL16;TNFRSF10A;RAPGEF1;MYADM;DAG1;CTDSP1;TNFAIP3;EFNA1;POLR2G;DUSP8;NOL3;GCLC;HSP90AB1;SWAP70
6069,GO:0019218,0.00812509629850661,0.996902905029353,13,81,regulation of steroid metabolic process,BP,PANK2;NFKB1;TNF;SCD;LSS;HMGCS1;BMP2;DHCR7;SF1;EGR1;SNAI2;INSIG1;WNT4
10032,GO:0042476,0.00814472328881899,0.996897116769507,13,80,odontogenesis,BP,INHBA;ADM;TUFT1;WNT10A;TGFB2;EDN1;TNC;FGFR2;BMP2;SERPINE1;OSR2;BMP7;TP63
6688,GO:0030056,0.00815859765950985,0.999493182223782,3,6,hemidesmosome,CC,DST;EPPK1;COL17A1
7184,GO:0031069,0.00817935081906643,0.99866799382907,5,17,hair follicle morphogenesis,BP,WNT10A;TGFB2;FGFR2;KRT17;TP63
12065,GO:0048013,0.00818132909389052,0.997026055222639,12,72,ephrin receptor signaling pathway,BP,MMP9;ACTG1;LYN;ARPC4;EFNB2;EPHB6;EPHA2;ARPC1B;ARHGEF28;APH1A;EFNB1;EFNA1
738,GO:0001968,0.00826095297925883,0.998651381682623,5,17,fibronectin binding,MF,IGFBP3;CTGF;CCDC80;SDC4;ITGAV
18066,GO:1902624,0.00826785496577375,0.998632754579934,5,18,positive regulation of neutrophil migration,BP,EDN1;IL1A;CXCL5;CXCL8;CXCL3
9079,GO:0035329,0.00830685576021791,0.997753740940196,8,38,hippo signaling,BP,AMOT;MAP3K14;TJP2;WWC1;AMOTL2;AJUBA;TJP1;TEAD4
3676,GO:0008173,0.00833950672484705,0.997307003534669,10,55,RNA methyltransferase activity,MF,TRMT61A;METTL1;NSUN2;METTL2B;NSUN5;FTSJ3;WDR4;NOP2;TRMT1;METTL16
18344,GO:1903311,0.00835859083766161,0.995379376565342,30,250,regulation of mRNA metabolic process,BP,HSPB1;NOCT;PSMB9;ZC3H12A;SRSF2;PABPC4;SAFB2;PSME2;PRPF19;ZFP36L1;NELFE;U2AF2;SF3B4;PRKCA;ZFP36L2;DDX17;SNRNP70;RBM15B;NUP214;SUPT5H;HNRNPU;SAFB;HSPA8;RBM4;METTL16;DHX34;PSMC3;POLR2G;SRSF7;MAGOH
5320,GO:0016043,0.00840199613606876,0.993071617658632,384,4592,cellular component organization,BP,IGFBP3;TRIM16;CRYAB;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;CYP1B1;CTGF;TENM3;C1QTNF1;CCDC80;ADM;KRT15;AMOT;KRT4;SACS;NEFM;ACTG1;TAP1;PML;TFCP2L1;CYLD;MYBL2;TRAF1;SDC4;KRT13;TFRC;SOD2;CSF2;FBN1;TGFB2;COBLL1;EDN1;GBP1;MAT2A;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;DBNDD2;G6PD;EMP2;HRNR;PANX1;TP53;SIPA1L3;SQSTM1;MARVELD3;KRT9;PANK2;NOCT;NEDD9;CPA4;TAF4B;GNPTAB;KRT6A;CDKN1A;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;MCM5;ARPC4;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;EFNB2;KRT5;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;PPAN;ENC1;TNC;DST;VMP1;GPRIN1;PDPN;FGFR2;NUP153;TPM4;NFKB2;COL4A1;DNAJB1;CLN6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;ZC3H12A;FLNA;LCP1;CYB5R1;TNK1;SART1;TK1;GEMIN5;CADPS2;KLF7;EPHA2;CHP1;CCDC85B;ICAM1;FANCC;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ITGAV;L1CAM;KIF23;MYO10;SFN;CDC42EP2;COL9A2;EPGN;ANKS4B;ADRB2;SVIL;PLEKHA7;DAXX;TNFRSF12A;NAT10;SERPINE1;ARPC1B;MCM2;TOX4;USP36;AKAP8L;AMOTL2;ELF3;GRWD1;LIF;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;CC2D2A;PTGFRN;WDR1;ANXA8;PWP2;PDE4DIP;LUC7L;BANF1;EPPK1;IL7R;TFIP11;GPER1;SRF;DNAJB2;SF1;PARD3B;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;RRS1;CD2BP2;PRPF19;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;DHFR;FGFR1OP;VCL;SHQ1;KCTD10;IRS2;KRT14;PPRC1;LGALS3;TRAF2;REEP1;PRKCA;NTN1;SYK;ROBO1;AJUBA;GINS2;PDGFB;AASS;BRMS1;OXTR;UBTF;POLA1;WDR34;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SERPINH1;DCTN1;COLGALT1;DPYSL3;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;COL17A1;NPNT;IL1A;SDK1;COPS3;SNX8;RBBP5;RUNDC1;SEMA3C;SFPQ;BRD9;WDR46;TBCCD1;ZW10;RCC2;COL5A2;NUP214;BAMBI;TRAM2;SMAD7;MRPS12;MRPS24;CCDC6;MTA2;YWHAH;TAPBP;TRIP6;PALM2;ENAH;SPECC1;M6PR;ERAL1;HNRNPU;TJP1;CLASP1;PQBP1;CAPNS1;UBE2J2;VSIG1;CEP41;RUVBL2;ABT1;PPP1R9B;MTFP1;TANGO2;MICAL3;SAFB;ANAPC15;PRDM7;MRPL20;RRP7BP;ATG101;MARVELD2;DUSP1;CAB39;TGFBRAP1;TXNL4B;HSPA8;JUN;MRPL33;ESR1;CENPN;BLOC1S2;PES1;RCC1;BRPF1;CPT1A;DCXR;MCM7;TFDP1;OGFR;BCS1L;GTF2E1;TRAPPC5;NOP2;NOC2L;CHMP4B;NACC1;ZNF703;INSIG1;CENPO;CNTROB;PARD3;LAMC1;RHOG;ZNF365;XRCC6;TAP2;CHCHD6;ZSWIM6;CNTNAP1;ACTN4;EFNB1;THEM4;SORBS2;KIF24;LRFN4;SNIP1;BMP7;KCTD1;CLUH;KANK4;TOMM40;AKIP1;PHLDB2;SGSM1;INCENP;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;KIF22;MYADM;DAG1;TMEM165;FAM234A;CGNL1;RAB27A;COL4A4;GPX4;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;TUBB;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;SUPT16H;EFNA1;CLDN7;MYO1E;HSD17B10;ATAD3C;CARD10;CLTA;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;FBLN2;MKI67;TTLL5;BIN3;PARP1;TP63;PHACTR4;TOP3A;CCL5;BAIAP2L2;SH3BP4
903,GO:0002285,0.00845792494950592,0.996493495799935,15,99,lymphocyte activation involved in immune response,BP,PTGER4;RELB;TFRC;IL27RA;LFNG;LAMP1;LCP1;ICAM1;DOCK10;LGALS3;SMAD7;THOC1;CCR6;RAB27A;SWAP70
18239,GO:1903047,0.0085001717222087,0.994088150680791,76,760,mitotic cell cycle process,BP,INHBA;CYP1A1;PML;MYBL2;EDN1;BIRC3;DAPK3;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;PKMYT1;PBX1;NUP153;PSMB9;UBE2C;TYMS;FLNA;CDK4;KIF23;SFN;EPGN;MCM2;AKAP8L;PSME2;BANF1;RRS1;ZFP36L1;AKAP8;RHOB;ADAM17;DHFR;FGFR1OP;PRKCA;GPR132;ZFP36L2;AJUBA;GINS2;PDGFB;POLA1;SPTBN1;DCTN1;IL1A;ORAOV1;PRCC;ZW10;RCC2;NUP214;HNRNPU;CLASP1;CEP41;PPP1R9B;ORC1;ANAPC15;DUSP1;RCC1;MCM7;TFDP1;CHMP4B;CNTROB;GPNMB;BMP7;TPRA1;INCENP;KIF22;TUBB;CTDSP1;PSMC3;RRM2;CDCA5;MKI67;BIN3;TP63;ORC4
887,GO:0002253,0.00851475138434999,0.994865766630529,40,356,activation of immune response,BP,KRT1;RUNX1;C1R;ACTG1;CYLD;RELB;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;IRF1;PSME2;PSPC1;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;TNIP2;SFPQ;PQBP1;ESR1;XRCC6;RAPGEF1;RBM14;CD38;TNFAIP3;PSMC3;SPG21;HSP90AB1;C1S
15850,GO:0072562,0.00851637195397527,0.997679910312588,8,39,blood microparticle,CC,KRT1;FN1;C1R;ACTG1;TFRC;DNPEP;HSPA8;C1S
12573,GO:0050727,0.00854434210915814,0.995694834341387,23,179,regulation of inflammatory response,BP,KRT1;SAA1;PTGER4;C1R;IL1R2;BIRC3;NFKB1;LYN;TNF;ZC3H12A;IL20;SERPINE1;GPER1;NFKBIA;ETS1;IL15;SLC7A2;DNASE1;ESR1;ZYX;TNFAIP3;C1S;CCL5
13155,GO:0051726,0.00855695752530729,0.993799591794884,97,1002,regulation of cell cycle,BP,INHBA;CTGF;CYP1A1;PML;CYLD;MYBL2;MAP3K14;TGFB2;EDN1;DAPK3;KLHL21;TP53;CDKN2B;LFNG;CDKN1A;JUNB;GADD45A;TNF;CDKN2A;RING1;PKMYT1;FGFR2;PBX1;PSMB9;FOSL1;UBE2C;GADD45B;BMP2;CDK4;KIF23;SFN;EPGN;SVIL;LIF;SFRP1;IRF1;PSME2;GPER1;NSUN2;PRPF19;ZFP36L1;RHOB;ADAM17;FEN1;FGFR1OP;CBX5;PRKCA;GPR132;ZFP36L2;CDKL1;PDGFB;DCTN1;IL1A;ORAOV1;PRCC;SFPQ;ZW10;RCC2;NUP214;AFAP1L2;HNRNPU;CLASP1;PAGR1;CEP41;PPP1R9B;THOC1;ANAPC15;DUSP1;CAB39;CITED2;OXSR1;HSPA8;JUN;PES1;RCC1;TFDP1;CHMP4B;SERTAD1;ZNF703;GPNMB;BMP7;TPRA1;TIMELESS;WNT4;RBM14;TUBB;CTDSP1;TNFAIP3;PSMC3;BRIP1;RRM2;CXCL8;CDCA5;HSP90AB1;MKI67;TP63;PHACTR4
2614,GO:0005923,0.00857576357199464,0.996570339652059,14,89,bicellular tight junction,CC,AMOT;MARVELD3;TJP2;CDK4;AMOTL2;EPPK1;PARD3B;TJP1;MARVELD2;PARD3;CGNL1;TRAF4;CYTH1;CLDN7
12360,GO:0048738,0.0086145093929507,0.996088238495579,18,126,cardiac muscle tissue development,BP,NRG1;JPH2;TGFB2;EDN1;G6PD;ADAMTS9;EFNB2;FGFR2;BMP2;UBE4B;TPM1;SRF;FHL2;SMAD7;HNRNPU;SORBS2;BMP7;MAPK11
7659,GO:0032088,0.0086762561518601,0.996989917063986,11,64,negative regulation of NF-kappaB transcription factor activity,BP,CYP1B1;CYLD;TRAF3;NLRC5;CDKN2A;ZC3H12A;CHP1;NFKBIA;BRMS1;BMP7;TNFAIP3
12556,GO:0050708,0.00871185993773101,0.995118543882635,31,259,regulation of protein secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;IRS1;LYN;TNF;ZC3H12A;CD274;SFRP1;GPER1;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;DNAJC1;SOCS1;CPT1A;CD38;MAPK11;BMP8A;CCL5
11396,GO:0045778,0.00873441550477386,0.997159622656607,10,55,positive regulation of ossification,BP,CYR61;TGFB2;BMP2;ADRB2;OSR2;NPNT;BMP7;WNT4;IL6R;TP63
10736,GO:0044092,0.00876531511518465,0.993909489103811,75,751,negative regulation of molecular function,BP,CRYAB;MMP9;CYP1B1;AMOT;NQO1;DUSP14;NFKBIE;CYLD;HSPB1;GPRC5A;TGFB2;SH3RF2;BIRC3;DBNDD2;TRAF3;NLRC5;TP53;NFKB1;CDKN2B;CDKN1A;LYN;GADD45A;TNF;GNL3L;CDKN2A;CORO1C;PKMYT1;ZC3H12A;FLNA;CHP1;GADD45B;CDK4;ERRFI1;SFN;ADRB2;SERPINE1;SFRP1;ANXA8;TFIP11;DNAJB2;NFKBIA;CD2BP2;FGFR1OP;IRS2;AJUBA;PDGFB;BRMS1;NEDD4L;SERPINH1;SPRY4;RCC2;SMAD7;KEAP1;HNRNPU;RRAD;PPP1R14C;TRIB1;RUVBL2;PPP1R9B;A2ML1;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;JUN;ESR1;DUS2;BMP7;TNFRSF10A;TNFAIP3;DUSP8;NOL3;SH3BP4
6601,GO:0022618,0.00879144825398171,0.995482926424249,24,193,ribonucleoprotein complex assembly,BP,NOCT;PPAN;SART1;GEMIN5;DDX23;PWP2;LUC7L;SF1;GEMIN4;RRS1;CD2BP2;PRPF19;SHQ1;GEMIN8;RRP7A;ERAL1;RUVBL2;ABT1;MRPL20;RRP7BP;TXNL4B;NOP2;NOL3;HSP90AB1
7871,GO:0032432,0.00880403270655602,0.997346569433302,9,47,actin filament bundle,CC,CRYAB;SIPA1L3;TPM4;LCP1;TPM1;MYH9;ROR1;ACTN4;ZYX
19771,GO:2000181,0.00885790476954357,0.99692169535077,11,63,negative regulation of blood vessel morphogenesis,BP,AMOT;PML;STARD13;TGFB2;HSPG2;ADAMTS9;SERPINE1;PGK1;WNT4;CARD10;TBXA2R
1035,GO:0002544,0.00892634940218418,0.998910238407754,4,12,chronic inflammatory response,BP,PTGES;TNF;TNFAIP3;CCL5
282,GO:0000784,0.00894215607344456,0.996133527326054,16,114,nuclear chromosome, telomeric region,CC,PML;MCM5;TELO2;NAT10;MCM2;TOX4;TFIP11;FEN1;CBX5;ALYREF;ORC1;THOC1;MCM7;XRCC6;PARP1;ORC4
3392,GO:0007169,0.00905631251189243,0.994125443416839,53,495,transmembrane receptor protein tyrosine kinase signaling pathway,BP,IGFBP3;NRG1;MMP9;CTGF;ACTG1;HSPB1;GPRC5A;CD3EAP;NEDD9;IRS1;LYN;ARPC4;BAIAP2;EFNB2;FGFR2;COL4A1;EPHB6;TNK1;EPHA2;BMP2;CDK4;ITGAV;ERRFI1;STAT5A;EPGN;ADRB2;ARPC1B;ZFYVE27;GPER1;ARHGEF28;ADAM17;IRS2;PRKCA;SYK;ROBO1;PDGFB;RNF115;RASGRP4;SPRY4;ROR1;AFAP1L2;HNRNPF;APH1A;SOCS1;EFNB1;RAPGEF1;BLNK;WNT4;EFNA1;MAPK11;MYO1E;POLR2G;BAIAP2L2
11347,GO:0045670,0.00908583402212734,0.997496248295382,8,39,regulation of osteoclast differentiation,BP,MAFB;FBN1;TJP2;TNF;IL20;SFRP1;LILRB3;KLF10
12552,GO:0050704,0.00910238326522593,0.998085363997946,6,25,regulation of interleukin-1 secretion,BP,SAA1;TRIM16;IL1R2;PML;PANX1;ZC3H12A
12796,GO:0051090,0.00917923390063864,0.994642076520855,35,302,regulation of DNA binding transcription factor activity,BP,CYP1B1;NFKBIE;CYLD;TRAF1;EDN1;TRAF3;NLRC5;NFKB1;TNF;CDKN2A;NFKB2;FOSL1;ZC3H12A;FLNA;CHP1;ICAM1;TRIM22;SRF;NFKBIA;SGK1;RIPK4;PPRC1;TRAF2;SYK;NFKBIB;BRMS1;ROR1;SMAD7;KEAP1;TRIB1;JUN;ESR1;BMP7;TNFAIP3;MAPK11
11479,GO:0045935,0.00920190339502058,0.993099545744906,121,1279,positive regulation of nucleobase-containing compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;ADM;FOSL2;PML;MYBL2;RELB;TFRC;ARID3B;IER2;CSF2;TGFB2;EDN1;TET3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NFKB1;CDKN2B;TAF4B;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;FOSL1;ZC3H12A;KLF7;BMP2;ADRB2;FOXD2;SERPINE1;AKAP8L;ELF3;LIF;OSR2;SFRP1;MKL1;IRF1;GPER1;SRF;ELF4;NFKBIA;EGR1;EDF1;ETS1;PRPF19;ZFP36L1;NELFE;DKC1;U2AF2;NPAS2;PPRC1;SF3B4;ZFP36L2;DDX17;PDGFB;UBTF;ALYREF;SNRNP70;FHL2;UHRF1;NPNT;IL1A;TNIP2;SFPQ;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;HNRNPU;PAGR1;CREB3;RUVBL2;SAFB;THOC1;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;TFDP1;SERTAD1;INSIG1;RHOG;XRCC6;KLF6;TEAD4;GLIS3;BMP7;METTL16;ELK1;PHF5A;TIMELESS;WNT4;RBM14;CD38;PSMC3;SMARCC2;SUPT16H;POLR2G;CREB5;HSP90AB1;PARP1;TP63
13139,GO:0051704,0.00921064941242993,0.99294562205545,143,1579,multi-organism process,BP,CCL20;MMP9;PTGER4;INHBA;FN1;ODC1;ADM;IL16;CYP1A1;TAP1;PML;TFCP2L1;HSPB1;TFRC;HLA-B;CSF2;PTGES;MAP3K14;EDN1;GBP1;TRIM56;IKBKE;BIRC3;B4GALT1;RSAD2;TRAF3;EMP2;NLRC5;TP53;SQSTM1;IL24;PANK2;NOCT;IL27RA;NFKB1;TAF4B;LYN;JUNB;LAMP1;TNF;BAIAP2;EFNB2;VMP1;FGFR2;NUP153;NFKB2;PSMB9;FOSL1;TYMS;ZC3H12A;EPHA2;ICAM1;FANCC;CD274;COL16A1;CDK4;ITGAV;DAXX;IFNGR1;SERPINE1;NMT2;ZC3H7B;RELT;LIF;TRIM22;IRF1;BANF1;NFX1;THBD;NSUN2;NFKBIA;ETS1;RPLP2;AKAP8;NELFE;ADAM17;CBX5;RPLP1;IL15;PRKCA;SYK;DDX17;NFKBIB;IFIT3;OXTR;RPS2;ALYREF;POLA1;RPS9;NEDD4L;TNFRSF21;TNIP2;RBM15B;SPEN;NUP214;MAFF;ACKR3;CRCP;SUPT5H;PQBP1;TRIB1;CREB3;THOC1;CXCL5;RPL27A;HSPA8;JUN;ESR1;RCC1;EIF3B;GTF2E1;CHMP4B;CCR6;HERC2;BCL2L2;XRCC6;TAP2;HMGN2;TNFRSF10A;ZYX;UBAP2L;DAG1;POLR3H;GPX4;WNT4;CD38;TNFAIP3;PSMC3;CCL22;SLC4A2;DNAJC9;BRIP1;CXCL8;MAPK11;CXCL3;POLR2G;SNF8;HSP90AB1;TBXA2R;TTLL5;IL6R;TP63;CCL5
15482,GO:0071826,0.00924246032801436,0.99515779312709,25,204,ribonucleoprotein complex subunit organization,BP,NOCT;PPAN;SART1;GEMIN5;DDX23;PWP2;LUC7L;TFIP11;SF1;GEMIN4;RRS1;CD2BP2;PRPF19;SHQ1;GEMIN8;RRP7A;ERAL1;RUVBL2;ABT1;MRPL20;RRP7BP;TXNL4B;NOP2;NOL3;HSP90AB1
9665,GO:0038023,0.00924572661133073,0.994289263925146,43,385,signaling receptor activity,MF,PTGER4;IL1R2;SDC4;GPRC5A;IL27RA;AHR;FGFR2;EPHB6;KRT17;EPHA2;ICAM1;ITGAV;GPR146;ADRB2;IFNGR1;EBP;RELT;SFRP1;IL7R;THBD;GPER1;GPR132;ROBO1;BCAM;OXTR;GPR75;TNFRSF21;LILRB3;ROR1;ACKR3;CRCP;M6PR;ESR1;HCAR3;OGFR;CCR6;GP6;TNFRSF10A;TPRA1;PTPRB;TBXA2R;ADGRF3;IL6R
13617,GO:0060089,0.00924572661133073,0.994289263925146,43,385,molecular transducer activity,MF,PTGER4;IL1R2;SDC4;GPRC5A;IL27RA;AHR;FGFR2;EPHB6;KRT17;EPHA2;ICAM1;ITGAV;GPR146;ADRB2;IFNGR1;EBP;RELT;SFRP1;IL7R;THBD;GPER1;GPR132;ROBO1;BCAM;OXTR;GPR75;TNFRSF21;LILRB3;ROR1;ACKR3;CRCP;M6PR;ESR1;HCAR3;OGFR;CCR6;GP6;TNFRSF10A;TPRA1;PTPRB;TBXA2R;ADGRF3;IL6R
13191,GO:0051797,0.009256540032781,0.998425620988528,5,18,regulation of hair follicle development,BP,TGFB2;FST;TNF;KRT17;FOXN1
7992,GO:0032610,0.00927550727091082,0.999335171876115,3,7,interleukin-1 alpha production,BP,CCL20;IL1R2;PANX1
6906,GO:0030488,0.00930446299144669,0.997707902380863,7,32,tRNA methylation,BP,TRMT61A;METTL1;NSUN2;METTL2B;WDR4;TRMT1;HSD17B10
3333,GO:0007043,0.00942186342825665,0.996340019181332,13,81,cell-cell junction assembly,BP,RUNX1;MARVELD3;TNF;WDR1;SRF;SNAI2;VCL;PRKCA;TJP1;MARVELD2;PARD3;CNTNAP1;ACTN4
8971,GO:0035051,0.00942340441352042,0.99633934365814,13,81,cardiocyte differentiation,BP,NRG1;TGFB2;EDN1;G6PD;EFNB2;BMP2;GPER1;SRF;FHL2;SEMA3C;HNRNPU;SORBS2;BMP7
18383,GO:1903391,0.00944211666772586,0.997121496510805,9,47,regulation of adherens junction organization,BP,SDC4;DAPK3;CORO1C;COL16A1;SFRP1;RCC2;CLASP1;PHLDB2;WNT4
2744,GO:0006139,0.00948093743845096,0.992159456115025,384,4607,nucleobase-containing compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;TXNRD1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;PGD;TYMS;ZC3H12A;FLNA;SRSF2;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;PMM2;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;COX5B;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;TATDN2;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;CHAF1A;KIF22;UAP1L1;POLR3H;PDE6A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
10380,GO:0043200,0.00958558840250724,0.996265107207915,13,82,response to amino acid,BP,CTGF;EDN1;TP53;LYN;TNF;BAIAP2;COL4A1;ICAM1;COL16A1;COL5A2;SOCS1;GCLC;SH3BP4
7674,GO:0032103,0.0095891440910111,0.995287338600966,21,161,positive regulation of response to external stimulus,BP,PTGER4;IL16;HSPB1;EDN1;TNF;SERPINE1;THBD;NFKBIA;ETS1;ADAM17;IL15;PRKCA;PDGFB;CREB3;CXCL5;CCR6;CXCL8;CXCL3;SWAP70;IL6R;CCL5
15454,GO:0071774,0.00964308071215723,0.995802951794257,16,110,response to fibroblast growth factor,BP,CTGF;IER2;TNC;FGFR2;SFRP1;SNAI2;ZFP36L1;ZFP36L2;SPRY4;HNRNPF;ELK1;WNT4;CXCL8;POLR2G;GCLC;CCL5
12261,GO:0048545,0.00973908170784523,0.994442111436368,32,270,response to steroid hormone,BP,RUNX1;NEFL;CTGF;ADM;TGFB2;EDN1;CDKN1A;TNF;FOSL1;TYMS;ICAM1;ERRFI1;DAXX;SFRP1;SAFB2;GPER1;ZFP36L1;ZFP36L2;DDX17;OXTR;FHL2;YWHAH;HNRNPU;PAGR1;SAFB;DUSP1;ESR1;BMP7;RBM14;CD38;PARP1;TP63
19890,GO:2000379,0.00984680283828291,0.996728743466656,10,57,positive regulation of reactive oxygen species metabolic process,BP,EDN1;TP53;CDKN1A;GADD45A;TNF;ZC3H12A;ICAM1;PDGFB;RAB27A;HSP90AB1
8275,GO:0033077,0.00985467474941589,0.996968346425833,9,48,T cell differentiation in thymus,BP,MAFB;IL7R;SRF;ZFP36L1;ADAM17;ZFP36L2;FOXN1;CCR6;WNT4
8026,GO:0032663,0.00996090725165875,0.997513264886585,7,32,regulation of interleukin-2 production,BP,RUNX1;CD83;GBP1;TRAF2;SPTBN1;IL1A;TNFAIP3
7489,GO:0031657,0.00996288635400241,0.998743376613608,4,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;CDKN2A;CDK4;ADAM17
2893,GO:0006400,0.00996591291709565,0.996272315221648,12,74,tRNA modification,BP,CDKAL1;TRMT61A;NAT10;PUS1;METTL1;NSUN2;METTL2B;WDR4;DUS2;TRMT1;HSD17B10;RPUSD4
13999,GO:0060713,0.00997437642401176,0.9982715320224,5,18,labyrinthine layer morphogenesis,BP,CYR61;ADM;FGFR2;ZFP36L1;BMP7
8210,GO:0032963,0.0100455044395561,0.99624210753124,12,73,collagen metabolic process,BP,MMP9;P3H2;CTGF;COL12A1;COL4A1;ERRFI1;SERPINH1;COL5A3;COL5A2;TRAM2;COL4A4;WNT4
10519,GO:0043433,0.0100486425809824,0.995476227122147,17,120,negative regulation of DNA binding transcription factor activity,BP,CYP1B1;NFKBIE;CYLD;TRAF3;NLRC5;CDKN2A;ZC3H12A;FLNA;CHP1;NFKBIA;BRMS1;SMAD7;KEAP1;TRIB1;ESR1;BMP7;TNFAIP3
723,GO:0001952,0.0100551700351012,0.996057926890203,13,82,regulation of cell-matrix adhesion,BP,SDC4;DAPK3;EMP2;CDKN2A;CORO1C;COL16A1;SERPINE1;SFRP1;RCC2;CLASP1;PHLDB2;DAG1;WNT4
9916,GO:0042255,0.0102229475594562,0.996802777893383,9,54,ribosome assembly,BP,PPAN;PWP2;RRS1;RRP7A;ERAL1;ABT1;MRPL20;RRP7BP;NOP2
2593,GO:0005887,0.0102417029721992,0.992850270883206,74,731,integral component of plasma membrane,CC,NRG1;TENM3;C1QTNF1;SLC16A2;PCDH7;SDC4;TFRC;GPRC5A;CD83;TRAF3;STEAP4;IL27RA;IRS1;LYN;LAMP1;TNF;EFNB2;PDPN;FGFR2;SLC7A5;EPHB6;SLC16A9;EPHA2;ICAM1;BMP2;SLCO3A1;SLC7A5P2;ITGAV;EPGN;ADRB2;IFNGR1;SLC5A6;FXYD3;EBP;RELT;THBD;GPER1;KCNA7;ADAM17;TRAF2;IL15;SLC7A2;ROBO1;BCAM;OXTR;MYH9;COL17A1;NPNT;GPR75;TNFRSF21;LILRB3;ROR1;SLC43A2;TRIP6;M6PR;APH1A;SLC4A11;KCNIP3;SLC22A4;HCAR3;CCR6;GPNMB;GP6;SMPD2;CNTNAP1;EFNB1;TNFRSF10A;ZYX;SLC4A2;EFNA1;PTPRB;TBXA2R;IL6R;SLC2A6
41,GO:0000083,0.0103288802150248,0.997766529787496,6,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TYMS;DHFR;POLA1;ORC1;TFDP1;RRM2
16113,GO:0090092,0.0103753853367681,0.995074641936484,19,139,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CYR61;INHBA;FBN1;TGFB2;FST;CDKN2B;BMP2;SFRP1;ADAM17;NPNT;BAMBI;SMAD7;CITED2;CD109;ZNF703;BMP7;BMP8A;HSP90AB1;PARP1
10731,GO:0044087,0.0103892613240449,0.992853317120473,68,667,regulation of cellular component biogenesis,BP,CRYAB;RUNX1;CYR61;PTGER4;MAP2;CTGF;SACS;CYLD;SDC4;CSF2;EDN1;DAPK3;TP53;UBQLN2;ARPC4;TNF;BAIAP2;CORO1C;DNAJB1;FOSL1;LCP1;EPHA2;ICAM1;COL16A1;MYO10;CDC42EP2;ARPC1B;USP36;SFRP1;TPM1;TFIP11;SRF;DNAJB2;SNAI2;SHQ1;PRKCA;AJUBA;OXTR;SPTBN1;DCTN1;DPYSL3;SLAIN2;RCC2;HNRNPU;TJP1;CLASP1;HSPA8;JUN;ESR1;CHMP4B;INSIG1;RHOG;SMPD2;BMP7;KANK4;PHLDB2;RAPGEF1;MYADM;DAG1;WNT4;RBM14;PSMC3;CLDN7;SNF8;SWAP70;BIN3;PARP1;BAIAP2L2
7207,GO:0031098,0.010410628961342,0.994276541672661,28,229,stress-activated protein kinase signaling cascade,BP,CRYAB;PTGER4;CTGF;MAP3K14;TGFB2;EDN1;MID1;MARVELD3;NFKB1;LYN;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;SFRP1;ZFP36L1;TRAF2;SYK;IL1A;TNIP2;TRIB1;OXSR1;PHLPP1;RAPGEF1;TRAF4;MAPK11
7633,GO:0032040,0.0104295359843615,0.997362326495944,7,33,small-subunit processome,CC,PDCD11;PWP2;UTP14A;UTP20;WDR46;NOP56;NOP14
11878,GO:0046885,0.0105067112889515,0.998155355653387,5,18,regulation of hormone biosynthetic process,BP,NFKB1;TNF;BMP2;EGR1;WNT4
40,GO:0000082,0.0105419160810462,0.994265737111602,27,222,G1/S transition of mitotic cell cycle,BP,INHBA;CYP1A1;PML;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;TYMS;CDK4;SFN;MCM2;PSME2;ADAM17;DHFR;GPR132;POLA1;ORC1;RCC1;MCM7;TFDP1;GPNMB;CTDSP1;RRM2;TP63;ORC4
19798,GO:2000241,0.0105591751933991,0.996015497110437,12,75,regulation of reproductive process,BP,INHBA;B4GALT1;LFNG;FGFR2;LIF;SFRP1;OXTR;DUSP1;CITED2;ESR1;BMP7;WNT4
6789,GO:0030225,0.0106732440884022,0.997675383363965,6,25,macrophage differentiation,BP,MMP9;INHBA;LIF;PRKCA;TRIB1;PARP1
12078,GO:0048026,0.0106822901507924,0.998624328168317,4,12,positive regulation of mRNA splicing, via spliceosome,BP,PRPF19;SF3B4;SNRNP70;HSPA8
11326,GO:0045649,0.0106980027448951,0.998621699471003,4,12,regulation of macrophage differentiation,BP,INHBA;LIF;PRKCA;TRIB1
3939,GO:0008625,0.0107127065663264,0.996160180248731,11,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,TNF;ICAM1;DAXX;SERPINE1;SFRP1;LGALS3;TRAF2;DDX47;BLOC1S2;TNFRSF10A;TNFAIP3
4274,GO:0009635,0.0107319637060259,0.998616013738682,4,12,response to herbicide,BP,NEFL;CYP1A1;ZC3H12A;DAXX
3419,GO:0007204,0.010760774009541,0.994988842461532,18,131,positive regulation of cytosolic calcium ion concentration,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;CD38;NOL3;SWAP70;TBXA2R
77,GO:0000154,0.0108025933490324,0.997238980011896,7,34,rRNA modification,BP,NAT10;DKC1;NSUN5;FTSJ3;NOP56;NOP2;METTL16
3400,GO:0007179,0.0108235115719462,0.994958371666129,18,130,transforming growth factor beta receptor signaling pathway,BP,PML;FBN1;TGFB2;CDKN2B;ADAM17;NPNT;BAMBI;SMAD7;KLF10;TGFBRAP1;CITED2;CD109;JUN;ZNF703;PARD3;ZYX;HSP90AB1;PARP1
6600,GO:0022617,0.0108335376374312,0.996347777017186,10,57,extracellular matrix disassembly,BP,MMP9;FN1;FBN1;HSPG2;PDPN;LCP1;ETS1;CLASP1;CAPNS1;LAMC1
13939,GO:0060603,0.0108664294514261,0.997623950799205,6,25,mammary gland duct morphogenesis,BP,PML;FGFR2;EPHA2;NTN1;ESR1;WNT4
15522,GO:0071900,0.0109585238533863,0.993155635846062,43,391,regulation of protein serine/threonine kinase activity,BP,SAA1;NRG1;DUSP14;HSPB1;MAP3K14;EDN1;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;PKMYT1;TELO2;GADD45B;BMP2;CDK4;SFN;EPGN;ADRB2;DAXX;SFRP1;ADAM17;TRAF2;SYK;ROBO1;AJUBA;PDGFB;SPRY4;ACSL1;TRIB1;DUSP1;CAB39;SERTAD1;BMP7;TNFRSF10A;RAPGEF1;TRAF4;TNFAIP3;MAPK11;CARD10;DUSP8;HSP90AB1
11170,GO:0045236,0.010975286703335,0.999162035433662,3,7,CXCR chemokine receptor binding,MF,CXCL5;CXCL8;CXCL3
17861,GO:1902074,0.0110137191497828,0.99856862719345,4,12,response to salt,BP,NEFL;EDN1;ZC3H12A;DAXX
12837,GO:0051147,0.0110303664287187,0.995440828368791,14,92,regulation of muscle cell differentiation,BP,NRG1;HDAC9;EDN1;G6PD;EHD1;EFNB2;FGFR2;BMP2;GPER1;SRF;PDGFB;RBM38;RBM4;MAPK11
15296,GO:0071480,0.0110728368167505,0.997554114855124,6,26,cellular response to gamma radiation,BP,CRYAB;TP53;CDKN1A;EGR1;XRCC6;ELK1
9823,GO:0042035,0.0111313500704643,0.996231649013914,10,57,regulation of cytokine biosynthetic process,BP,CCL20;INHBA;HSPB1;NFKB1;TNF;ERRFI1;IRF1;EGR1;SYK;IL1A
19641,GO:1990837,0.0111451764060749,0.992598247445311,56,529,sequence-specific double-stranded DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;MCM5;GADD45A;ZBED1;PBX1;NFKB2;FOSL1;KLF7;MCM2;ELF3;GRWD1;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;ETS1;MAFK;UBTF;UHRF1;SFPQ;ZW10;MTA2;HNRNPU;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;KLF6;ACTN4;ELK1;SMARCC2;PARP1;ORC4
7490,GO:0031658,0.011185442112405,0.999139860502288,3,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;CDKN2A;CDK4
17343,GO:1900025,0.011220028469193,0.998533688277601,4,12,negative regulation of substrate adhesion-dependent cell spreading,BP,GBP1;CORO1C;RCC2;ACTN4
3135,GO:0006725,0.0112615437805242,0.990642587633785,392,4723,cellular aromatic compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;TXNRD1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;SLC16A9;PGD;TYMS;ZC3H12A;FLNA;SRSF2;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;PMM2;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;ABCG2;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;COX5B;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;TATDN2;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;CHAF1A;KIF22;UAP1L1;POLR3H;PDE6A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;AKR1C1;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
538,GO:0001656,0.0112651125410174,0.996179322743496,10,57,metanephros development,BP,IRX2;FBN1;LIF;OSR2;EGR1;PDGFB;APH1A;FRAS1;BMP7;WNT4
5133,GO:0015629,0.0113403435670216,0.993076786458297,39,348,actin cytoskeleton,CC,CRYAB;AMOT;ACTG1;DAPK3;KLHL21;SIPA1L3;MYO1B;ARPC4;BAIAP2;CORO1C;TPM4;FLNA;LCP1;MYO10;SVIL;ARPC1B;TPM1;WDR1;ADAM17;VCL;FILIP1;SPTBN1;DCTN1;DPYSL3;MYH9;LANCL2;ROR1;KEAP1;SPECC1;TJP1;PPP1R9B;ACTN4;SORBS2;ZYX;MYADM;CGNL1;MYO1E;BIN3;BAIAP2L2
3552,GO:0007586,0.0113457906912228,0.996729066422246,8,41,digestion,BP,MGAM;TJP2;SGK1;ACO1;AKR1C2;OXTR;VSIG1;AKR1C1
16136,GO:0090136,0.0113539809320935,0.998510895248747,4,12,epithelial cell-cell adhesion,BP,CYP1B1;PLEKHA7;SRF;VCL
12886,GO:0051224,0.0113663192185972,0.995107483597329,15,104,negative regulation of protein transport,BP,PTGER4;FN1;IL1R2;PML;GBP1;RSAD2;IRS1;TNF;ZC3H12A;CHP1;SFRP1;SNX12;TNFRSF21;INSIG1;BMP8A
9859,GO:0042108,0.0113754064584946,0.997073512168819,7,33,positive regulation of cytokine biosynthetic process,BP,CCL20;HSPB1;TNF;IRF1;EGR1;SYK;IL1A
11014,GO:0044843,0.0114301750425401,0.993663631570909,28,234,cell cycle G1/S phase transition,BP,INHBA;CYP1A1;PML;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;TYMS;CDK4;SFN;MCM2;PSME2;ADAM17;DHFR;GPR132;POLA1;PAGR1;ORC1;RCC1;MCM7;TFDP1;GPNMB;CTDSP1;RRM2;TP63;ORC4
4464,GO:0010458,0.0114819624991696,0.997443390382282,6,26,exit from mitosis,BP,UBE2C;ZW10;CLASP1;PPP1R9B;CHMP4B;CDCA5
3627,GO:0008083,0.0115414930480633,0.995809038651398,11,68,growth factor activity,MF,NRG1;INHBA;CTGF;CSF2;TGFB2;BMP2;EPGN;LIF;PDGFB;BMP7;BMP8A
20271,GO:2001239,0.0115817772980291,0.996998927073884,7,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,INHBA;CSF2;DAPK3;TNF;SNAI2;IL1A;PPP2R1B
17305,GO:0140098,0.0116945658347264,0.992943088157229,37,331,catalytic activity, acting on RNA,MF,CD3EAP;USB1;NOCT;CARS2;CDKAL1;ZC3H12A;DDX23;TRMT61A;DHX37;METTL1;DDX42;NSUN2;POP1;FEN1;ISG20L2;METTL2B;POLR1A;DDX17;DDX47;NOB1;DDX49;NSUN5;DDX39A;FTSJ3;CRCP;WDR4;NOP2;DUS2;TRMT1;METTL16;POLR3H;DHX34;AARSD1;POLR1E;DDX24;POLR2G;POP4
8600,GO:0034105,0.011725819204795,0.997860414910889,5,19,positive regulation of tissue remodeling,BP,TFRC;B4GALT1;IL15;PRKCA;SYK
19090,GO:1904994,0.0118382891157221,0.99906994118416,3,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF;ICAM1;ETS1
6981,GO:0030656,0.011845171223157,0.999069195907114,3,7,regulation of vitamin metabolic process,BP,NFKB1;TNF;SNAI2
1358,GO:0003229,0.0118973026931745,0.996911968162163,7,33,ventricular cardiac muscle tissue development,BP,NRG1;TGFB2;ADAMTS9;FGFR2;UBE4B;TPM1;SMAD7
2942,GO:0006469,0.0119150293183521,0.993621273388741,25,202,negative regulation of protein kinase activity,BP,DUSP14;HSPB1;GPRC5A;DBNDD2;CDKN2B;CDKN1A;LYN;GADD45A;CDKN2A;CORO1C;CHP1;GADD45B;CDK4;ERRFI1;SFN;SFRP1;FGFR1OP;SPRY4;TRIB1;DUSP1;SOCS1;DUS2;BMP7;TNFAIP3;DUSP8
13030,GO:0051480,0.0119859426047265,0.994219677632089,19,142,regulation of cytosolic calcium ion concentration,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;PDE6A;CD38;NOL3;SWAP70;TBXA2R
4441,GO:0010332,0.0120281299514367,0.996161173879451,9,50,response to gamma radiation,BP,CRYAB;PML;TP53;CDKN1A;EGR1;XRCC6;ELK1;PARP1;TP63
17276,GO:0120114,0.0120324675011964,0.995361698772123,12,79,Sm-like protein family complex,CC,SART1;GEMIN5;DDX23;ZMAT2;LUC7L;GEMIN4;CD2BP2;GEMIN8;SNRNP70;TXNL4B;EFTUD2;PHF5A
12965,GO:0051347,0.0120429909737526,0.992124796866899,51,481,positive regulation of transferase activity,BP,SAA1;NRG1;CYR61;SDC4;MAP3K14;TGFB2;EDN1;EMP2;IRS1;CDKN1A;LYN;GADD45A;TNF;FGFR2;EPHB6;TELO2;UBE2C;EPHA2;GADD45B;BMP2;EPGN;ADRB2;DAXX;EGR1;ADAM17;DKC1;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;RPS2;ROR1;ACSL1;AFAP1L2;DCUN1D2;CAB39;SOCS1;OXSR1;ARRDC3;XRCC6;TNFRSF10A;RAPGEF1;DAG1;TRAF4;EFNA1;MAPK11;CARD10;HSP90AB1;CCL5
17963,GO:1902337,0.0121206924585428,0.999039220511051,3,7,regulation of apoptotic process involved in morphogenesis,BP,TGFB2;B4GALT1;BMP7
18968,GO:1904748,0.0121206924585428,0.999039220511051,3,7,regulation of apoptotic process involved in development,BP,TGFB2;B4GALT1;BMP7
12823,GO:0051128,0.0122048165414221,0.990428939537503,163,1801,regulation of cellular component organization,BP,IGFBP3;CRYAB;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;MAP2;FN1;NEFL;CTGF;TENM3;SACS;PML;CYLD;SDC4;CSF2;TGFB2;EDN1;GBP1;MID1;DAPK3;G6PD;TP53;SQSTM1;CDKN1A;UBQLN2;LYN;ARPC4;EHD1;TNF;GNL3L;BAIAP2;EFNB2;CDKN2A;CORO1C;CXCL16;PKMYT1;ENC1;PDPN;DNAJB1;KRT17;FOSL1;SIRPA;UBE2C;FLNA;LCP1;CYB5R1;TNK1;EPHA2;CCDC85B;ICAM1;COL16A1;ITGAV;L1CAM;MYO10;SFN;CDC42EP2;EPGN;ADRB2;TNFRSF12A;NAT10;SERPINE1;ARPC1B;USP36;AKAP8L;LIF;SFRP1;PARL;TPM1;ZFYVE27;WDR1;PDE4DIP;TFIP11;GPER1;SRF;DNAJB2;ETS1;SGK1;SNAI2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;FGFR1OP;LGALS3;NTN1;SYK;ROBO1;AJUBA;PDGFB;OXTR;SPTBN1;NEDD4L;DCTN1;COLGALT1;DPYSL3;UHRF1;SLAIN2;MYH9;IL1A;SDK1;RUNDC1;SEMA3C;SFPQ;WDR46;TBCCD1;ZW10;RCC2;BAMBI;YWHAH;PALM2;HNRNPU;TJP1;CLASP1;PQBP1;UBE2J2;RUVBL2;PPP1R9B;ANAPC15;DUSP1;HSPA8;JUN;ESR1;RCC1;TFDP1;OGFR;NOC2L;CHMP4B;INSIG1;RHOG;ZNF365;ZSWIM6;ACTN4;SNIP1;BMP7;KANK4;PHLDB2;SGSM1;RAPGEF1;EIF5A;MYADM;DAG1;RAB27A;WNT4;RBM14;CD38;PSMC3;EFNA1;CLDN7;NOL3;CDCA5;SWAP70;MKI67;BIN3;PARP1;TP63;BAIAP2L2;SH3BP4
15287,GO:0071470,0.0122332770541777,0.997237674600609,6,26,cellular response to osmotic stress,BP,RELB;ERRFI1;ZFP36L1;CAB39;OXSR1;XRCC6
3654,GO:0008134,0.0122462939766242,0.991916045923941,53,505,transcription factor binding,MF,MAFB;HDAC9;DAPK3;ELMSAN1;TP53;PDCD11;NFKB1;TAF4B;AHR;JUNB;BAIAP2;CDKN2A;FLNA;TSC22D3;DAXX;FUS;SRF;ZFP42;NFKBIA;ETS1;AKAP8;CBX5;PPRC1;MAFK;BRMS1;FHL2;SPEN;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PAGR1;TRIB1;RUVBL2;ETS2;JUN;ESR1;TFDP1;GTF2E1;NOC2L;ZNF703;TEAD4;ACTN4;KCTD1;TNFRSF10A;ELK1;PSMC3;POLR1E;HES4;SNF8;PARP1
6281,GO:0019885,0.0122485206280867,0.99902522210409,3,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,TAP1;TAPBP;TAP2
18524,GO:1903706,0.0122756721073244,0.99261546666321,36,332,regulation of hemopoiesis,BP,MAFB;RUNX1;INHBA;CYLD;CD83;CSF2;FBN1;TJP2;LYN;TNF;PSMB9;SART1;IL20;LIF;SFRP1;IRF1;PSME2;IL7R;NFKBIA;ETS1;ZFP36L1;LGALS3;IL15;PRKCA;ZFP36L2;SYK;RBBP5;LILRB3;SMAD7;TRIB1;KLF10;SOCS1;JUN;IKZF3;FOXN1;PSMC3
9978,GO:0042368,0.0122850095956214,0.999021215664581,3,7,vitamin D biosynthetic process,BP,NFKB1;TNF;SNAI2
11393,GO:0045773,0.0122966843546471,0.996787335489395,7,33,positive regulation of axon extension,BP,NRG1;FN1;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1
6310,GO:0019955,0.0123552750399482,0.995743067774309,10,58,cytokine binding,MF,TRIM16;IL1R2;GBP1;PDPN;ITGAV;IFNGR1;ACKR3;CD109;CCR6;IL6R
14148,GO:0061028,0.0123935730866116,0.996756970496307,7,33,establishment of endothelial barrier,BP,TJP2;TNF;ICAM1;TJP1;MARVELD2;RAPGEF1;MYADM
4502,GO:0010533,0.0124865714506954,0.999713205639398,2,3,regulation of activation of Janus kinase activity,BP,SOCS1;CCL5
7993,GO:0032611,0.0125168911864765,0.996317786660337,8,42,interleukin-1 beta production,BP,TRIM16;PML;HSPB1;PANX1;ZC3H12A;ERRFI1;EGR1;TNFAIP3
12271,GO:0048565,0.0125267185667412,0.995160881202673,12,75,digestive tract development,BP,CYP1A1;TGFB2;CDKN1A;TNF;FGFR2;TYMS;SFRP1;OXTR;VPS52;SLC4A2;CXCL8;TP63
10979,GO:0044770,0.0126059587998818,0.991662409063814,53,512,cell cycle phase transition,BP,INHBA;CYP1A1;PML;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;PKMYT1;PBX1;PSMB9;UBE2C;TYMS;CDK4;SFN;MCM2;AKAP8L;PSME2;ZFP36L1;AKAP8;ADAM17;DHFR;FGFR1OP;GPR132;ZFP36L2;AJUBA;POLA1;DCTN1;ORAOV1;ZW10;RCC2;CLASP1;PAGR1;CEP41;PPP1R9B;ORC1;ANAPC15;DUSP1;RCC1;MCM7;TFDP1;CHMP4B;GPNMB;TPRA1;TIMELESS;TUBB;CTDSP1;PSMC3;RRM2;CDCA5;TP63;ORC4
10913,GO:0044459,0.0128096025030937,0.990152788123631,134,1444,plasma membrane part,CC,CRYAB;NRG1;S100P;FN1;TENM3;C1QTNF1;SLC16A2;AMOT;CYLD;PCDH7;SDC4;TFRC;GPRC5A;CD83;HLA-B;B4GALT1;MGAM;G6PD;TRAF3;EMP2;SIPA1L3;STEAP4;IL27RA;IRS1;HSPG2;LYN;LAMP1;EHD1;TNF;BAIAP2;EFNB2;CORO1C;WWC1;DST;PDPN;FGFR2;SLC7A5;EPHB6;FOSL1;SLC16A9;LCP1;TNK1;CADPS2;EPHA2;ICAM1;CD274;BMP2;SLCO3A1;SLC7A5P2;ITGAV;ERRFI1;MYO10;EPGN;ADRB2;SVIL;IFNGR1;SLC5A6;FXYD3;EBP;AMOTL2;RELT;ABCF2;TPM1;ZFYVE27;HLA-F;EPPK1;IL7R;THBD;GPER1;PARD3B;KCNA7;RHOB;ADAM17;LGALS3;TRAF2;ABCG2;IL15;PRKCA;SYK;SLC7A2;ROBO1;PDGFB;BCAM;OXTR;SPTBN1;MYH9;COL17A1;NPNT;GPR75;TNFRSF21;SPRY4;LILRB3;ROR1;SMAD7;SLC43A2;TRIP6;M6PR;TJP1;APH1A;PPP1R9B;SLC4A11;KCNIP3;MARVELD2;STAC;SLC22A4;HCAR3;CHMP4B;CCR6;PARD3;GPNMB;GP6;SMPD2;CNTNAP1;EFNB1;THEM4;SORBS2;PHLPP1;TNFRSF10A;ZYX;DAG1;PDE6A;RAB27A;CYTH1;SLC4A2;EFNA1;CLDN7;SLC3A2;PTPRB;CLTA;HSP90AB1;TBXA2R;MCAM;IL6R;SLC2A6
401,GO:0001077,0.0128440629882371,0.99339236973716,22,170,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;MYBL2;ARID3B;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;SRF;ELF4;EGR1;ETS1;CREB3;KLF10;JUN;ESR1;KLF6;ELK1;TP63
5118,GO:0015459,0.0128455102086189,0.997067835431613,6,26,potassium channel regulator activity,MF,FLNA;CHP1;ADRB2;SGK1;NEDD4L;KCNIP3
11862,GO:0046851,0.0128650055344586,0.998956910636697,3,7,negative regulation of bone remodeling,BP,SFRP1;CD38;TNFAIP3
3696,GO:0008201,0.0129290334921199,0.994974772706884,12,77,heparin binding,MF,SAA1;CYR61;FN1;CTGF;CCDC80;FBN1;NAV2;FGFR2;SFRP1;COL5A3;GPNMB;BMP7
11344,GO:0045667,0.0129892685806383,0.994952467744815,12,76,regulation of osteoblast differentiation,BP,CYR61;NOCT;TNF;FGFR2;BMP2;SFRP1;SNAI2;NPNT;BMP7;WNT4;IL6R;TP63
15624,GO:0072110,0.013030203319638,0.998938383063557,3,7,glomerular mesangial cell proliferation,BP,EGR1;PDGFB;BMP7
15628,GO:0072124,0.013030203319638,0.998938383063557,3,7,regulation of glomerular mesangial cell proliferation,BP,EGR1;PDGFB;BMP7
8825,GO:0034599,0.0131566967754932,0.992794305751662,26,217,cellular response to oxidative stress,BP,MMP9;CYP1B1;NQO1;PML;HSPB1;SOD2;TXNRD1;G6PD;TP53;NFE2L1;TNF;ZC3H12A;FANCC;TPM1;TXN2;ETS1;RHOB;DHFR;TRAF2;SFPQ;PXMP2;JUN;BMP7;TNFAIP3;NOL3;PARP1
16549,GO:0097305,0.0132314386471076,0.994018251494733,16,114,response to alcohol,BP,PTGER4;INHBA;NQO1;G6PD;TP53;TNC;FGFR2;TYMS;HMGCS1;ICAM1;SFRP1;AKAP8;LANCL2;DAG1;CLDN7;TBXA2R
5467,GO:0016363,0.013259322008695,0.994385035450139,14,94,nuclear matrix,CC,PML;TP53;ENC1;AKAP8L;PSPC1;AKAP8;POLA1;UHRF1;SFPQ;HNRNPU;RUVBL2;THOC1;ZNF703;PHF5A
3228,GO:0006880,0.0132837077908562,0.999684607034992,2,3,intracellular sequestering of iron ion,BP,FTL;FTH1
16675,GO:0097577,0.0132837077908562,0.999684607034992,2,3,sequestering of iron ion,BP,FTL;FTH1
14781,GO:0070482,0.0133038758686974,0.992217026444131,32,282,response to oxygen levels,BP,CRYAB;CTGF;ADM;CYP1A1;PML;PDLIM1;TGFB2;EDN1;TP53;CDKN1A;PSMB9;ICAM1;BMP2;CDK4;PGK1;SFRP1;PSME2;SRF;TXN2;EGR1;ETS1;ZFP36L1;ADAM17;AJUBA;OXTR;CITED2;ACTN4;BMP7;CD38;PSMC3;BRIP1;NOL3
4312,GO:0009790,0.0133612479621687,0.990691281294658,68,672,embryo development,BP,MAFB;NRG1;MMP9;CYR61;INHBA;FN1;ADM;AMOT;RBM19;SDC4;IRX2;CSF2;FBN1;TGFB2;EDN1;TXNRD1;TET3;NOCT;LFNG;JUNB;TNF;COL12A1;FGFR2;PBX1;FOSL1;SLC39A1;ARFRP1;BMP2;ITGAV;ELF3;LIF;OSR2;SFRP1;CC2D2A;SRF;PRPF19;ZFP36L1;NTN1;PDGFB;RRP7A;MYH9;COPS3;SEMA3C;COL5A2;MAFF;KEAP1;CLASP1;ETS2;DUSP1;CITED2;FRAS1;TCOF1;INSIG1;TEAD4;EFNB1;BMP7;TPRA1;PHLDB2;MYADM;DAG1;WNT4;VPS52;PSMC3;CXCL8;EFNA1;MYO1E;TP63;PHACTR4
4367,GO:0009982,0.0133638645028152,0.998117065253831,4,13,pseudouridine synthase activity,MF,PUS1;DKC1;TRUB2;RPUSD4
2648,GO:0005984,0.0133980099959408,0.998896799983561,3,7,disaccharide metabolic process,BP,B4GALT1;MGAM;GANC
7802,GO:0032351,0.0134392572294782,0.998892108338398,3,7,negative regulation of hormone metabolic process,BP,NFKB1;BMP2;WNT4
7804,GO:0032353,0.0134392572294782,0.998892108338398,3,7,negative regulation of hormone biosynthetic process,BP,NFKB1;BMP2;WNT4
14945,GO:0070831,0.0134460476292359,0.998891335422672,3,7,basement membrane assembly,BP,CLASP1;PHLDB2;DAG1
10441,GO:0043296,0.0134904046739538,0.994075979573538,15,103,apical junction complex,CC,AMOT;MARVELD3;TJP2;CDK4;PLEKHA7;AMOTL2;EPPK1;PARD3B;TJP1;MARVELD2;PARD3;CGNL1;TRAF4;CYTH1;CLDN7
12355,GO:0048730,0.0135189295458377,0.997442526930707,5,19,epidermis morphogenesis,BP,WNT10A;TGFB2;FGFR2;KRT17;TP63
11775,GO:0046633,0.0135431524467351,0.998084115057979,4,13,alpha-beta T cell proliferation,BP,IRF1;ELF4;IL15;SYK
1310,GO:0003158,0.0135692344293355,0.99469503458483,12,76,endothelium development,BP,NRG1;STARD13;TJP2;TNF;PDPN;ICAM1;EDF1;RHOB;TJP1;MARVELD2;RAPGEF1;MYADM
19735,GO:2000108,0.0136111046698635,0.99739613905268,5,20,positive regulation of leukocyte apoptotic process,BP,TP53;LYN;CDKN2A;CD274;CCL5
6255,GO:0019838,0.0136310741195852,0.994422714586771,13,86,growth factor binding,MF,IGFBP3;TRIM16;CYR61;CTGF;IL1R2;FGFR2;COL4A1;ITGAV;PDGFB;RPS2;DUSP1;CD109;IL6R
12072,GO:0048020,0.0136325556908343,0.998798428725367,3,8,CCR chemokine receptor binding,MF,CCL20;CCL22;CCL5
7485,GO:0031649,0.0136418064566735,0.998065925188602,4,13,heat generation,BP,TNF;ADRB2;IL1A;ARRDC3
12642,GO:0050840,0.0136854098524203,0.996334277364645,7,34,extracellular matrix binding,MF,CYR61;ITGAV;LGALS3;BCAM;TINAGL1;DAG1;FBLN2
18463,GO:1903556,0.0136921632104533,0.996812638177276,6,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ZC3H12A;CD274;ERRFI1;AKAP8;GPNMB;TNFAIP3
12659,GO:0050863,0.0137426453538668,0.992761435858256,23,184,regulation of T cell activation,BP,RUNX1;CYLD;SDC4;TFRC;CD83;MAP3K14;LYN;EFNB2;SIRPA;SART1;CD274;IRF1;IL7R;LGALS3;IL15;SYK;TNFRSF21;SMAD7;SOCS1;FOXN1;GPNMB;EFNB1;CCL5
3827,GO:0008426,0.0137672241208835,0.999666791114427,2,3,protein kinase C inhibitor activity,MF,HSPB1;SFN
7069,GO:0030856,0.0137921263027155,0.99412680023429,14,95,regulation of epithelial cell differentiation,BP,TRIM16;RUNX1;TNF;ERRFI1;SFN;IL20;SERPINE1;LIF;ZFP36L1;MAFF;KEAP1;CD109;FOXN1;TP63
4722,GO:0010884,0.0138992084134419,0.998018270091142,4,13,positive regulation of lipid storage,BP,IKBKE;NFKB1;EHD1;ZC3H12A
2102,GO:0004871,0.0140518752791098,0.990184049071005,68,676,signal transducer activity,MF,NRG1;PTGER4;JPH2;IL1R2;SDC4;BAG1;GPRC5A;MAP3K14;IKBKE;TRAF3;IL27RA;FST;IRS1;LYN;AHR;FGFR2;EPHB6;KRT17;JPH1;FLNA;TNK1;EPHA2;ICAM1;ITGAV;STAT5A;GPR146;ADRB2;DAXX;IFNGR1;EBP;RELT;SFRP1;IL7R;THBD;GPER1;RHOB;IRS2;TRAF2;GPR132;SYK;NFKBIB;ROBO1;BCAM;OXTR;GPR75;TNFRSF21;LILRB3;ROR1;ACKR3;SMAD7;CRCP;M6PR;OXSR1;ESR1;HCAR3;OGFR;CCR6;RHOG;GP6;TNFRSF10A;TPRA1;EEF1D;BLNK;MAPK11;PTPRB;TBXA2R;ADGRF3;IL6R
3894,GO:0008528,0.0140598280411499,0.996707647888649,6,27,G-protein coupled peptide receptor activity,MF,OXTR;GPR75;ACKR3;CRCP;OGFR;CCR6
17637,GO:1901360,0.0141020007926095,0.988210654180399,401,4856,organic cyclic compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;CYP24A1;ADM;FOSL2;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;TXNRD1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;SCD;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;LSS;CLN6;TELO2;FOSL1;SLC16A9;PGD;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;PMM2;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;DHCR7;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;ABCG2;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;COX5B;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;TATDN2;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;CHAF1A;KIF22;UAP1L1;POLR3H;PDE6A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;AKR1C1;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
9541,GO:0036293,0.0142015174243232,0.991806213497349,30,262,response to decreased oxygen levels,BP,CRYAB;CTGF;ADM;CYP1A1;PML;PDLIM1;TGFB2;EDN1;TP53;PSMB9;ICAM1;BMP2;PGK1;SFRP1;PSME2;SRF;TXN2;EGR1;ETS1;ZFP36L1;ADAM17;AJUBA;OXTR;CITED2;ACTN4;BMP7;CD38;PSMC3;BRIP1;NOL3
12700,GO:0050918,0.014202557513795,0.996154562357162,7,35,positive chemotaxis,BP,SAA1;IL16;LGALS3;PDGFB;GPNMB;CXCL8;CCL5
14290,GO:0061383,0.0144273871975532,0.996094458729113,7,34,trabecula morphogenesis,BP,NRG1;TGFB2;UBE4B;SFRP1;SRF;FHL2;BMP7
9369,GO:0035886,0.0144635989709041,0.997912804760342,4,13,vascular smooth muscle cell differentiation,BP,ADM;GPER1;SRF;PDGFB
7315,GO:0031324,0.0144873410276678,0.988538678086204,168,1888,negative regulation of cellular metabolic process,BP,IGFBP3;CRYAB;NRG1;MMP9;INHBA;HDAC9;IL1R2;DUSP14;PML;TFCP2L1;HSPB1;IRX2;RELB;GPRC5A;CSF2;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;TP53;SQSTM1;MARVELD3;NOCT;FST;NFKB1;CDKN2B;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;SRSF2;CHP1;CCDC85B;GADD45B;TSC22D3;BMP2;CDK4;ITGAV;ERRFI1;SFN;DAXX;NAT10;SERPINE1;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TRIM22;ANXA8;IRF1;NFX1;PSPC1;TFIP11;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;CD2BP2;SRRT;ZFP36L1;NELFE;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;SHQ1;IRS2;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;SNRNP70;SERPINH1;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPRY4;SPEN;NUP214;SMAD7;SUPT5H;MTA2;DNAJC1;HNRNPU;PPP1R14C;TRIB1;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;DUSP1;CITED2;CD109;SOCS1;HSPA8;JUN;ESR1;NOC2L;CHMP4B;RBM4;NACC1;ZNF703;INSIG1;DUS2;PARD3;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;TNFRSF10A;MPHOSPH8;RAPGEF1;MYADM;DAG1;DHX34;TIMELESS;WNT4;CTDSP1;CD38;TNFAIP3;SMARCC2;EFNA1;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;PARP1;TP63
5910,GO:0018149,0.0146328952123449,0.996495226644549,6,30,peptide cross-linking,BP,KRT1;SPRR3;SPRR2A;KRT2;FN1;KRT10
11401,GO:0045787,0.0146529011422648,0.99121636468744,34,302,positive regulation of cell cycle,BP,CTGF;CYP1A1;PML;TGFB2;EDN1;TP53;LFNG;CDKN1A;GADD45A;FGFR2;PBX1;FOSL1;UBE2C;CDK4;KIF23;SFN;EPGN;SVIL;GPER1;ADAM17;FEN1;PRKCA;PDGFB;IL1A;SFPQ;RCC2;HNRNPU;PAGR1;THOC1;CITED2;TFDP1;WNT4;CDCA5;HSP90AB1
6593,GO:0022607,0.0146610374590197,0.988246486805889,193,2212,cellular component assembly,BP,CRYAB;NRG1;RUNX1;PTGER4;MAP2;FN1;NEFL;CTGF;C1QTNF1;SACS;NEFM;ACTG1;PML;CYLD;MYBL2;TRAF1;SDC4;SOD2;CSF2;COBLL1;EDN1;GBP1;MAT2A;IKBKE;BIRC3;DAPK3;B4GALT1;EMP2;PANX1;TP53;SQSTM1;MARVELD3;NOCT;NEDD9;TAF4B;UBQLN2;MYO1B;RAB32;ARPC4;EHD1;TNF;BAIAP2;KRT5;CDKN2A;CORO1C;PPAN;VMP1;NUP153;DNAJB1;FOSL1;UBE2C;ZC3H12A;FLNA;LCP1;SART1;TK1;GEMIN5;CADPS2;EPHA2;CHP1;ICAM1;FANCC;COL16A1;DDX23;KIF23;MYO10;CDC42EP2;ANKS4B;ADRB2;DAXX;ARPC1B;MCM2;GRWD1;SFRP1;TPM1;TRIM22;ZFYVE27;CC2D2A;WDR1;PWP2;PDE4DIP;LUC7L;TFIP11;SRF;DNAJB2;SF1;KCNA7;GEMIN4;SNAI2;RRS1;CD2BP2;PRPF19;RHOB;FGFR1OP;VCL;SHQ1;KCTD10;KRT14;TRAF2;PRKCA;NTN1;AJUBA;AASS;OXTR;UBTF;WDR34;GEMIN8;NSFL1C;SPTBN1;DCTN1;DPYSL3;RRP7A;SLAIN2;COL17A1;SDK1;RBBP5;ZW10;RCC2;SMAD7;TAPBP;TRIP6;ERAL1;HNRNPU;TJP1;CLASP1;CEP41;RUVBL2;ABT1;PPP1R9B;MRPL20;RRP7BP;ATG101;MARVELD2;CAB39;TXNL4B;HSPA8;JUN;ESR1;CENPN;RCC1;CPT1A;DCXR;BCS1L;TRAPPC5;NOP2;NOC2L;CHMP4B;NACC1;ZNF703;INSIG1;CENPO;CNTROB;PARD3;LAMC1;RHOG;XRCC6;CNTNAP1;ACTN4;KIF24;BMP7;KCTD1;KANK4;PHLDB2;RAPGEF1;IPO4;CHAF1A;ZYX;MYADM;DAG1;FAM234A;GPX4;WNT4;RILPL2;RBM14;AKR1C1;TUBB;TNFAIP3;PSMC3;BRIP1;CLDN7;HSD17B10;CARD10;CLTA;NOL3;SNF8;HSP90AB1;SWAP70;TTLL5;BIN3;PARP1;TP63;CCL5;BAIAP2L2
2382,GO:0005518,0.0146616220551353,0.995560877171609,8,42,collagen binding,MF,MMP9;FN1;C1QTNF1;PDGFB;SERPINH1;COL5A3;SMAD7;GP6
8145,GO:0032870,0.0146743205041681,0.990331101372475,50,474,cellular response to hormone stimulus,BP,RUNX1;PTGER4;INHBA;HDAC9;FBN1;EDN1;NFKB1;IRS1;LYN;JUNB;BAIAP2;TNC;HMGCS1;ICAM1;CDK4;ERRFI1;STAT5A;DAXX;SFRP1;SAFB2;GPER1;ZFP36L1;AKAP8;IRS2;AKR1C2;ZFP36L2;DDX17;OXTR;FHL2;LANCL2;ACSL1;YWHAH;HNRNPU;PAGR1;RUVBL2;SAFB;DUSP1;SOCS1;JUN;ESR1;ZNF703;BMP7;ELK1;RBM14;AKR1C1;BRIP1;GCLC;PARP1;TP63;BAIAP2L2
4669,GO:0010817,0.014713244196287,0.991327392368683,32,280,regulation of hormone levels,BP,INHBA;CYP1B1;C1QTNF1;ADM;SLC16A2;CYP1A1;EDN1;NFKB1;IRS1;LYN;TNF;BACE2;C9ORF3;ACAA1;BMP2;LIF;SFRP1;DHCR7;GPER1;EGR1;IRS2;AKR1C2;PRKCA;YWHAH;SAFB;ESR1;CPT1A;WNT4;AKR1C1;CD38;BMP8A;CCL5
18159,GO:1902905,0.0147981375297444,0.992698573963646,19,145,positive regulation of supramolecular fiber organization,BP,CTGF;SDC4;EDN1;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;DCTN1;COLGALT1;SLAIN2;CLASP1;RHOG;WNT4;SWAP70;BAIAP2L2
11380,GO:0045745,0.0148454659922418,0.997840700389769,4,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,UBQLN2;GPER1;PRKCA;ARRDC3
2812,GO:0006271,0.0148470798744344,0.997095976760329,5,20,DNA strand elongation involved in DNA replication,BP,FEN1;GINS2;POLA1;GINS3;PARP1
15910,GO:0072679,0.0149097545522714,0.999623318660092,2,3,thymocyte migration,BP,CCL20;CCR6
19215,GO:1905331,0.0149721799572521,0.997816643026938,4,13,negative regulation of morphogenesis of an epithelium,BP,TNF;CLASP1;BMP7;PHLDB2
9427,GO:0035994,0.014981202833528,0.997814927507902,4,13,response to muscle stretch,BP,EDN1;NFKB1;NFKBIA;JUN
14193,GO:0061098,0.015110852042726,0.99640397110908,6,27,positive regulation of protein tyrosine kinase activity,BP,EPGN;ADAM17;PDGFB;AFAP1L2;EFNA1;CCL5
14633,GO:0070201,0.0151690223226968,0.989858502660929,53,513,regulation of establishment of protein localization,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;TP53;IRS1;CDKN1A;LYN;TNF;PTPN14;ZC3H12A;LCP1;CYB5R1;CHP1;CD274;SFN;USP36;AKAP8L;SFRP1;PARL;GPER1;DKC1;SNX12;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;WDR46;DNAJC1;YWHAH;UBE2J2;SOCS1;HSPA8;CPT1A;TFDP1;INSIG1;SNIP1;CD38;MAPK11;BMP8A;HSP90AB1;TP63;CCL5
4021,GO:0009051,0.0151819508699895,0.999612681914945,2,3,pentose-phosphate shunt, oxidative branch,BP,G6PD;PGD
9074,GO:0035313,0.0151835477923048,0.997776369634601,4,13,wound healing, spreading of epidermal cells,BP,ADAM17;AJUBA;CLASP1;PHLDB2
8709,GO:0034349,0.0152292234738986,0.997767643187699,4,13,glial cell apoptotic process,BP,TP53;TRAF2;PRKCA;TNFRSF21
12613,GO:0050794,0.0152552037684147,0.987255123854554,576,7104,regulation of cellular process,BP,IGFBP3;IL32;MAFB;SAA1;TRIM16;CCL20;CRYAB;FTH1;NRG1;MMP9;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;TNS3;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;ACTG1;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;CDKN1A;TJP2;UBQLN2;ADAMTS9;LYN;RAB32;AHR;JUNB;ARPC4;LAMP1;COMMD4;EHD1;GADD45A;TNF;GNL3L;BAIAP2;ZBED1;EFNB2;CDKN2A;RING1;CORO1C;CXCL16;PKMYT1;WWC1;ENC1;TNC;ASCC2;DST;TRIO;PDPN;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;COL4A1;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;SIRPA;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;SFN;CDC42EP2;STAT5A;LYPD6B;EPGN;GPR146;RNF19B;ADRB2;SVIL;IL20;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;SERPINE1;FUS;PABPC4;ARPC1B;EBP;NMT2;TOX4;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;RELT;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;CC2D2A;SAFB2;DHCR7;HLA-F;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;PDE4DIP;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;ZNF787;TXN2;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;JRK;EDF1;IGSF3;DOCK10;ETS1;SGK1;SNAI2;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;TXLNA;DHFR;U2AF2;FGFR1OP;VCL;SHQ1;RIPK4;IRS2;IER3;NPAS2;CBX5;PPRC1;LGALS3;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;SYK;CMTM3;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;IFIT3;DDX47;CDKL1;DNTTIP2;PDGFB;BRMS1;BCAM;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;UTP20;RPS9;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;COLGALT1;RNF115;DPYSL3;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RASGRP4;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;SPRY4;BRD9;ZNF697;SAP30BP;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;ACSL1;RCC2;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;TATDN2;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;PALM2;KEAP1;M6PR;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;ANAPC15;PRDM7;CXCL5;RBM38;ATG101;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;JUN;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;PES1;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;LRRC27;TFDP1;ZNF772;OGFR;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;LAMC1;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;GP6;ZNF132;KLF6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;ACTN4;EFNB1;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;CXORF36;KANK4;TPRA1;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;PHF5A;RAPGEF1;ZYX;EIF5A;MYADM;DAG1;CGNL1;PDE6A;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;BLNK;WNT4;RBM14;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;MYO1E;CXCL3;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;ADGRF3;IL6R;BIN3;PARP1;CLK4;TP63;ZBTB12;TXNDC15;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;FADS1;MAGOH;SH3BP4
13754,GO:0060330,0.0152638645418296,0.996993203976883,5,20,regulation of response to interferon-gamma,BP,NLRC5;IFNGR1;PARP14;SOCS1;HSP90AB1
13758,GO:0060334,0.0152638645418296,0.996993203976883,5,20,regulation of interferon-gamma-mediated signaling pathway,BP,NLRC5;IFNGR1;PARP14;SOCS1;HSP90AB1
1343,GO:0003206,0.0152723898310884,0.993924539316146,12,77,cardiac chamber morphogenesis,BP,NRG1;CYR61;TGFB2;FGFR2;UBE4B;TPM1;SRF;FHL2;SEMA3C;SMAD7;CITED2;BMP7
16526,GO:0097237,0.0153450941512441,0.992234210736641,20,160,cellular response to toxic substance,BP,CYP1B1;NQO1;SOD2;TXNRD1;TP53;NFKB1;TNF;ZC3H12A;FANCC;DAXX;ABTB2;EGR1;ETS1;RHOB;DHFR;PDGFB;BMP7;TIMELESS;GPX4;TNFAIP3
11472,GO:0045926,0.0153558345035501,0.992090191799227,21,166,negative regulation of growth,BP,CRYAB;INHBA;PML;TGFB2;G6PD;TP53;SQSTM1;CDKN1A;TNF;CDKN2A;WWC1;TNK1;CCDC85B;ADRB2;SFRP1;DNAJB2;NTN1;SEMA3C;PPP1R9B;MAPK11;SH3BP4
9554,GO:0036315,0.0153756956071429,0.997739603213079,4,13,cellular response to sterol,BP,INHBA;HMGCS1;INSIG1;DAG1
2199,GO:0005080,0.0153769183071151,0.995769655421281,7,35,protein kinase C binding,MF,HDAC9;HSPB1;SDC4;SQSTM1;IRS1;SRSF2;ITGAV
12780,GO:0051055,0.0154110261255139,0.995758379812079,7,35,negative regulation of lipid biosynthetic process,BP,NFKB1;BMP2;GPER1;SNAI2;PDGFB;INSIG1;WNT4
3263,GO:0006931,0.015488246913224,0.999600585807677,2,3,substrate-dependent cell migration, cell attachment to substrate,BP,FN1;TNFRSF12A
15558,GO:0072001,0.0155802124518453,0.991572828435751,24,194,renal system development,BP,ODC1;SDC4;IRX2;FBN1;TGFB2;EFNB2;FGFR2;PBX1;COL4A1;BMP2;LIF;OSR2;SFRP1;EGR1;PDGFB;NPNT;SMAD7;APH1A;FRAS1;BMP7;COL4A4;WNT4;MYO1E;TP63
1168,GO:0002791,0.0156293690351946,0.990826666852149,31,271,regulation of peptide secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;IRS1;LYN;TNF;ZC3H12A;CD274;SFRP1;GPER1;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;DNAJC1;SOCS1;CPT1A;CD38;MAPK11;BMP8A;CCL5
4472,GO:0010468,0.0156836335985209,0.98701175471073,297,3511,regulation of gene expression,BP,MAFB;TRIM16;CRYAB;NRG1;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;CYP1B1;CTGF;C1QTNF1;FOSL2;IL16;IL1R2;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;WNT10A;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;BIRC3;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ENC1;TNC;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;SNX12;UPK3B;DHFR;U2AF2;SHQ1;RIPK4;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;POLA1;RPS9;NEDD4L;SNRNP70;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;RBM38;TGFBRAP1;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;EDC4;KLF6;TEAD4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EIF5A;UBAP2L;MYADM;EEF1D;RAB27A;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;GCLC;PARP1;CLK4;TP63;ZBTB12;C1S;CCL5;FADS1;MAGOH
13829,GO:0060426,0.0156905485774462,0.999592523440551,2,3,lung vasculature development,BP,ERRFI1;LIF
8071,GO:0032743,0.0156927177298044,0.996886661257215,5,20,positive regulation of interleukin-2 production,BP,RUNX1;CD83;TRAF2;SPTBN1;IL1A
19069,GO:1904950,0.0158783827135132,0.992870379590098,15,108,negative regulation of establishment of protein localization,BP,PTGER4;FN1;IL1R2;PML;GBP1;RSAD2;IRS1;TNF;ZC3H12A;CHP1;SFRP1;SNX12;TNFRSF21;INSIG1;BMP8A
7949,GO:0032545,0.0159749847250638,0.999581089960205,2,3,CURI complex,CC,RRP7A;RRP7BP
8779,GO:0034456,0.0159749847250638,0.999581089960205,2,3,UTP-C complex,CC,RRP7A;RRP7BP
12992,GO:0051403,0.015982864380092,0.991211906712288,25,206,stress-activated MAPK cascade,BP,CRYAB;PTGER4;CTGF;TGFB2;EDN1;MID1;MARVELD3;NFKB1;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;SFRP1;ZFP36L1;TRAF2;SYK;IL1A;TNIP2;TRIB1;PHLPP1;RAPGEF1;TRAF4;MAPK11
11696,GO:0046483,0.0159861695992748,0.986604462140879,389,4709,heterocycle metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;USB1;TXNRD1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;TELO2;FOSL1;SLC16A9;PGD;TYMS;ZC3H12A;FLNA;SRSF2;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;PMM2;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;RPLP1;MAFK;TRAF2;ABCG2;SF3B4;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;COX5B;RRP7A;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;TATDN2;NOL9;SUPT5H;MTA2;YWHAH;TRIP6;WDR4;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;ESR1;IKZF3;PES1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;CHAF1A;KIF22;UAP1L1;POLR3H;PDE6A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
11299,GO:0045616,0.0159915578582952,0.995565650663638,7,35,regulation of keratinocyte differentiation,BP,TRIM16;RUNX1;ERRFI1;IL20;ZFP36L1;CD109;TP63
1728,GO:0004322,0.0160388029936835,0.999578509029285,2,3,ferroxidase activity,MF,HEPHL1;FTH1
5639,GO:0016724,0.0160388029936835,0.999578509029285,2,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,HEPHL1;FTH1
8912,GO:0034751,0.0160491771891562,0.99957808893765,2,3,aryl hydrocarbon receptor complex,CC,AHR;HSP90AB1
574,GO:0001725,0.0160702741949365,0.995040239097126,8,43,stress fiber,CC,SIPA1L3;TPM4;LCP1;TPM1;MYH9;ROR1;ACTN4;ZYX
16651,GO:0097517,0.0160702741949365,0.995040239097126,8,43,contractile actin filament bundle,CC,SIPA1L3;TPM4;LCP1;TPM1;MYH9;ROR1;ACTN4;ZYX
8064,GO:0032732,0.0161031356893809,0.996093518010032,6,28,positive regulation of interleukin-1 production,BP,SAA1;TRIM16;CCL20;HSPB1;PANX1;EGR1
632,GO:0001821,0.0161055079837161,0.998487483522593,3,8,histamine secretion,BP,CSF2;EDN1;LYN
827,GO:0002102,0.0161083233140855,0.99611108318961,6,27,podosome,CC,TPM4;LCP1;SVIL;WDR1;VCL;TJP1
11861,GO:0046850,0.0161558293546606,0.996097023609456,6,27,regulation of bone remodeling,BP,TFRC;SFRP1;PRKCA;SYK;CD38;TNFAIP3
15217,GO:0071363,0.0161604549183457,0.989382246023915,48,455,cellular response to growth factor stimulus,BP,CYR61;CTGF;PML;HSPB1;WNT10A;FBN1;TGFB2;EDN1;CDKN2B;EHD1;BAIAP2;FGFR2;BMP2;ERRFI1;SFRP1;ZFYVE27;EGR1;SNAI2;ZFP36L1;ADAM17;ZFP36L2;ROBO1;PDGFB;SNRNP70;NPNT;SPRY4;BAMBI;SMAD7;HNRNPF;KLF10;TGFBRAP1;CITED2;CD109;JUN;MCM7;ZNF703;PARD3;BMP7;RAPGEF1;ZYX;WNT4;CXCL8;BMP8A;POLR2G;GCLC;HSP90AB1;PARP1;CCL5
4476,GO:0010481,0.0162567159117063,0.999569653248861,2,3,epidermal cell division,BP,SFN;TP63
4477,GO:0010482,0.0162567159117063,0.999569653248861,2,3,regulation of epidermal cell division,BP,SFN;TP63
8848,GO:0034641,0.0163067225237222,0.98630400971469,421,5137,cellular nitrogen compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;ODC1;CYP1B1;CTGF;ADM;FOSL2;NQO1;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;PTGES;FBN1;TGFB2;EDN1;USB1;TXNRD1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;TJP2;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;RRP1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;TELO2;KRT17;FOSL1;C9ORF3;SLC16A9;PGD;TYMS;ZC3H12A;FLNA;SRSF2;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;FANCC;BMP2;DDX23;CDK4;ZNF142;PMM2;TRMT61A;STAT5A;ZMAT2;ADRB2;DAXX;FOXD2;NAT10;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;TOX4;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;SAFB2;APTX;PUS1;DHX37;PWP2;MKL1;IRF1;METTL1;PSME2;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;SHQ1;RIPK4;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NEDD4L;SNRNP70;FHL2;ZNF407;DNASE1;COX5B;RRP7A;UHRF1;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;NOP56;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ERAL1;HNRNPU;HNRNPF;PQBP1;APH1A;PAGR1;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;TRUB2;PARP14;PRDM7;MRPL20;RBM38;RRP7BP;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;HSPA8;JUN;MRPL33;ESR1;IKZF3;TCOF1;SLC22A4;PES1;FOXN1;BRPF1;CPT1A;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;CCR6;INSIG1;GINS3;HERC2;DUS2;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;TRA2A;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;KIF22;UAP1L1;POLR3H;PDE6A;EEF1D;DHX34;TIMELESS;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
2111,GO:0004896,0.0163072316941137,0.994953505407882,8,43,cytokine receptor activity,MF,IL1R2;IL27RA;IFNGR1;IL7R;GPR75;ACKR3;CCR6;IL6R
906,GO:0002291,0.0164338089191309,0.999562407567923,2,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,ICAM1;LGALS3
4418,GO:0010212,0.0164461168642538,0.991969989621088,18,136,response to ionizing radiation,BP,CRYAB;PML;TP53;CDKN1A;GADD45A;ICAM1;AEN;SFRP1;THBD;EGR1;SNAI2;RHOB;KRT14;XRCC6;ELK1;EEF1D;PARP1;TP63
12532,GO:0050680,0.0165624031203894,0.993040480463476,13,87,negative regulation of epithelial cell proliferation,BP,KRT4;TGFB2;MARVELD3;CDKN2B;TNF;EFNB2;FGFR2;SFN;SFRP1;EPPK1;SNAI2;ROBO1;CD109
18918,GO:1904636,0.0165696258837191,0.999556821164072,2,3,response to ionomycin,BP,ZC3H12A;CDK4
18919,GO:1904637,0.0165696258837191,0.999556821164072,2,3,cellular response to ionomycin,BP,ZC3H12A;CDK4
18151,GO:1902893,0.0165704304117802,0.995973903667013,6,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,TGFB2;TP53;BMP2;SRF;PDGFB;JUN
3940,GO:0008626,0.0167545734780583,0.99954917288721,2,3,granzyme-mediated apoptotic signaling pathway,BP,LAMP1;UBE4B
411,GO:0001097,0.0167689106586326,0.999548578019613,2,3,TFIIH-class transcription factor binding,MF,HNRNPU;GTF2E1
14754,GO:0070427,0.0168214833902432,0.999546394288667,2,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,NFKBIA;TNFAIP3
13180,GO:0051785,0.0168524238532527,0.994741587776665,8,44,positive regulation of nuclear division,BP,EDN1;UBE2C;EPGN;PDGFB;IL1A;HNRNPU;WNT4;CDCA5
535,GO:0001653,0.0168780037363398,0.995861917617619,6,28,peptide receptor activity,MF,OXTR;GPR75;ACKR3;CRCP;OGFR;CCR6
3854,GO:0008467,0.0169027231832691,0.999543012326796,2,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST2;HS3ST1
18064,GO:1902622,0.0169146678887432,0.996550414057306,5,21,regulation of neutrophil migration,BP,EDN1;IL1A;CXCL5;CXCL8;CXCL3
12416,GO:0048863,0.0169335893188469,0.990877791958013,23,200,stem cell differentiation,BP,NRG1;RUNX1;WNT10A;TGFB2;EDN1;CORO1C;FGFR2;PSMB9;LIF;SFRP1;PSME2;SRF;SNAI2;ZFP36L2;SEMA3C;HNRNPU;ESR1;TCOF1;EFNB1;BMP7;PSMC3;TP63;PHACTR4
7005,GO:0030689,0.0169649959029715,0.999540413814126,2,3,Noc complex,CC,NOP14;NOC2L
7673,GO:0032102,0.0169797353222221,0.990869798964438,23,188,negative regulation of response to external stimulus,BP,KRT1;SAA1;PTGER4;C1QTNF1;IL1R2;EDN1;NFKB1;ZC3H12A;SERPINE1;EPPK1;THBD;GPER1;ETS1;SNAI2;ROBO1;PDGFB;SEMA3C;CLASP1;TRIB1;CD109;PHLDB2;WNT4;TNFAIP3
13958,GO:0060664,0.0170064500572317,0.999538681068218,2,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,TNF;FGFR2
4589,GO:0010693,0.0170064500572393,0.999538681068218,2,3,negative regulation of alkaline phosphatase activity,BP,TGFB2;TNF
19198,GO:1905292,0.0171868869471743,0.999531111568545,2,3,regulation of neural crest cell differentiation,BP,SEMA3C;BMP7
19199,GO:1905294,0.0171868869471743,0.999531111568545,2,3,positive regulation of neural crest cell differentiation,BP,SEMA3C;BMP7
19205,GO:1905310,0.0171868869471743,0.999531111568545,2,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,SEMA3C;BMP7
19206,GO:1905312,0.0171868869471743,0.999531111568545,2,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,SEMA3C;BMP7
2141,GO:0004954,0.0172132072667092,0.99953000368845,2,3,prostanoid receptor activity,MF,PTGER4;TBXA2R
14161,GO:0061043,0.0172187204032098,0.999529771508716,2,3,regulation of vascular wound healing,BP,SERPINE1;TNFAIP3
7497,GO:0031668,0.0172189340625388,0.990730621297881,23,187,cellular response to extracellular stimulus,BP,CYP24A1;TP53;CDKN2B;CDKN1A;LYN;BAIAP2;TNC;FOSL1;ZC3H12A;CADPS2;ICAM1;SFRP1;SRF;TXN2;SNAI2;IL15;PPP1R9B;KLF10;HSPA8;JUN;WNT4;BRIP1;FADS1
9500,GO:0036146,0.0172220222244787,0.999529632436266,2,3,cellular response to mycotoxin,BP,EGR1;PDGFB
12905,GO:0051251,0.0173116698344858,0.991134208868564,20,158,positive regulation of lymphocyte activation,BP,CYLD;TFRC;CD83;MAP3K14;CDKN1A;LYN;LAMP1;EFNB2;SIRPA;SART1;CD274;IL7R;IRS2;IL15;SYK;TNIP2;SOCS1;EFNB1;CD38;CCL5
10759,GO:0044194,0.0173161022764727,0.99952566354954,2,3,cytolytic granule,CC,LAMP1;RNF19B
2368,GO:0005488,0.0173531903901648,0.986440710066871,796,10131,binding,MF,HEPHL1;IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;CCDC80;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;IGFL1;HSPB1;STARD13;MYBL2;PDLIM1;TRAF1;PCDH7;SDC4;KRT13;WNT10A;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;FAM46B;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;TXNRD1;TMPPE;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;NEDD9;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;HMGXB3;ARPC4;LAMP1;COMMD4;CSRP1;EHD1;GADD45A;TNF;IGFL3;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;GPATCH4;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;LAYN;QPCT;SLC16A9;SIRPA;UBE2C;MSANTD3;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;PMM2;SFN;CDC42EP2;GTPBP6;STAT5A;RRP12;EPGN;ANKS4B;RNF19B;ZMAT2;METTL13;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;ANXA8L1;GANC;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;TOX4;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;NTN1;ZFC3H1;PROSER2;SYK;CMTM3;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;CEP95;BRMS1;BCAM;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COX5B;RNF115;DPYSL3;COL5A3;DCBLD1;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;TMEM159;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;SPEN;ZW10;ROR1;PXMP2;C8ORF33;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TMEM140;GPN1;TRAM2;SMAD7;CRCP;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;ORC1;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;PRDM7;MRPL20;CXCL5;RBM38;ANKRD52;SUSD6;PCYT1A;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;SLC22A4;PES1;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;CYP20A1;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;SLC41A2;DAG1;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SEC14L4;SMARCC2;SPG21;CCL22;CYB561D2;SLC4A2;FAM207A;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;RSRP1;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;CXCL3;XPNPEP3;ATAD3C;BMP8A;HES4;ZC3H18;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;TTLL5;IL6R;BIN3;LAIR1;IRGQ;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;IL36G;C1S;PHACTR4;TOP3A;CCL5;TMEM51;BAIAP2L2;ORC4;MAGOH;APEX2;SH3BP4
11883,GO:0046890,0.017394097476367,0.991653224533198,17,127,regulation of lipid biosynthetic process,BP,CYR61;NFKB1;TNF;SCD;LSS;HMGCS1;BMP2;CDK4;DHCR7;GPER1;SF1;EGR1;SNAI2;PDGFB;INSIG1;SMPD2;WNT4
7855,GO:0032415,0.0174327663080975,0.99952072520331,2,3,regulation of sodium:proton antiporter activity,BP,CHP1;ACTN4
14412,GO:0061689,0.0174529808825769,0.999519867648586,2,3,tricellular tight junction,CC,SIPA1L3;MARVELD2
4514,GO:0010564,0.017480040701885,0.987849279207541,62,622,regulation of cell cycle process,BP,CTGF;CYP1A1;PML;EDN1;DAPK3;KLHL21;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;RING1;PKMYT1;PBX1;PSMB9;UBE2C;CDK4;KIF23;SFN;EPGN;SVIL;LIF;SFRP1;PSME2;GPER1;ZFP36L1;ADAM17;FEN1;FGFR1OP;CBX5;GPR132;ZFP36L2;PDGFB;DCTN1;IL1A;ORAOV1;SFPQ;ZW10;RCC2;HNRNPU;CLASP1;PAGR1;CEP41;PPP1R9B;ANAPC15;DUSP1;RCC1;TFDP1;CHMP4B;GPNMB;BMP7;TPRA1;WNT4;RBM14;TUBB;CTDSP1;PSMC3;RRM2;CDCA5;HSP90AB1;MKI67;TP63
4772,GO:0010957,0.0174887055843616,0.99951835075854,2,3,negative regulation of vitamin D biosynthetic process,BP,NFKB1;SNAI2
11584,GO:0046137,0.0174887055843616,0.99951835075854,2,3,negative regulation of vitamin metabolic process,BP,NFKB1;SNAI2
8154,GO:0032880,0.0175152800658135,0.987621321108005,68,688,regulation of protein localization,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;IL1R2;PML;CYLD;TGFB2;GBP1;RSAD2;PANX1;TP53;SQSTM1;IRS1;CDKN1A;LYN;TNF;GNL3L;PTPN14;ZC3H12A;LCP1;CYB5R1;EPHA2;CHP1;CD274;SFN;USP36;AKAP8L;LIF;SFRP1;PARL;TRIM22;GPER1;TRIM29;DKC1;SNX12;IRS2;TRAF2;PRKCA;SYK;POLR1A;SPTBN1;NEDD4L;IL1A;TNFRSF21;WDR46;DNAJC1;YWHAH;UBE2J2;SOCS1;STAC;HSPA8;CPT1A;TFDP1;INSIG1;RHOG;SNIP1;CD38;MAPK11;BMP8A;CARD10;CDCA5;HSP90AB1;SWAP70;PARP1;TP63;CCL5
4774,GO:0010959,0.0175591612981907,0.990528080377159,23,188,regulation of metal ion transport,BP,JPH2;IL16;PML;G6PD;LYN;JPH1;FLNA;CHP1;ICAM1;ADRB2;FXYD3;GPER1;LGALS3;PDGFB;NEDD4L;YWHAH;RRAD;KCNIP3;CAB39;STAC;OXSR1;ACTN4;CCL5
16071,GO:0090026,0.0175651643576744,0.998294653270134,3,8,positive regulation of monocyte chemotaxis,BP,SERPINE1;CREB3;CCL5
1380,GO:0003278,0.0176025250723709,0.999513506391338,2,3,apoptotic process involved in heart morphogenesis,BP,CYR61;TGFB2
8581,GO:0034059,0.0176187992177878,0.999512812301213,2,3,response to anoxia,BP,CTGF;OXTR
16531,GO:0097252,0.0176474679473222,0.999511588712951,2,3,oligodendrocyte apoptotic process,BP,TP53;TNFRSF21
6665,GO:0030020,0.0176528402203008,0.999511359299501,2,3,extracellular matrix structural constituent conferring tensile strength,MF,COL12A1;COL9A2
2029,GO:0004768,0.0176600736036339,0.999511050349028,2,3,stearoyl-CoA 9-desaturase activity,MF,SCD;SCD5
5389,GO:0016215,0.0176600736036339,0.999511050349028,2,3,acyl-CoA desaturase activity,MF,SCD;SCD5
12,GO:0000023,0.0176648635192286,0.999510845724452,2,3,maltose metabolic process,BP,MGAM;GANC
1879,GO:0004558,0.0176648635192286,0.999510845724452,2,3,alpha-1,4-glucosidase activity,MF,MGAM;GANC
4617,GO:0010735,0.0176648635192286,0.999510845724452,2,3,positive regulation of transcription via serum response element binding,BP,MKL1;SRF
7883,GO:0032450,0.0176648635192286,0.999510845724452,2,3,maltose alpha-glucosidase activity,MF,MGAM;GANC
8515,GO:0033693,0.0176648635192286,0.999510845724452,2,3,neurofilament bundle assembly,BP,NEFL;NEFM
8620,GO:0034136,0.0176648635192286,0.999510845724452,2,3,negative regulation of toll-like receptor 2 signaling pathway,BP,LYN;TNFAIP3
10968,GO:0044729,0.0176648635192286,0.999510845724452,2,3,hemi-methylated DNA-binding,MF,EGR1;UHRF1
11893,GO:0046912,0.0176648635192286,0.999510845724452,2,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS1;CS
14016,GO:0060737,0.0176648635192286,0.999510845724452,2,3,prostate gland morphogenetic growth,BP,FGFR2;ESR1
14774,GO:0070471,0.0176648635192286,0.999510845724452,2,3,uterine smooth muscle contraction,BP,GPER1;OXTR
14775,GO:0070472,0.0176648635192286,0.999510845724452,2,3,regulation of uterine smooth muscle contraction,BP,GPER1;OXTR
14776,GO:0070474,0.0176648635192286,0.999510845724452,2,3,positive regulation of uterine smooth muscle contraction,BP,GPER1;OXTR
1420,GO:0003365,0.0176648635192286,0.999510845724452,2,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT;AMOTL2
6667,GO:0030023,0.0176648635192286,0.999510845724452,2,3,extracellular matrix constituent conferring elasticity,MF,FBN1;COL4A1
15696,GO:0072223,0.0176648635192286,0.999510845724452,2,3,metanephric glomerular mesangium development,BP,EGR1;PDGFB
15703,GO:0072239,0.0176648635192286,0.999510845724452,2,3,metanephric glomerulus vasculature development,BP,EGR1;PDGFB
17399,GO:1900127,0.0176648635192286,0.999510845724452,2,3,positive regulation of hyaluronan biosynthetic process,BP,NFKB1;PDGFB
18219,GO:1903011,0.0176648635192286,0.999510845724452,2,3,negative regulation of bone development,BP,FBN1;TJP2
18927,GO:1904672,0.0176648635192286,0.999510845724452,2,3,regulation of somatic stem cell population maintenance,BP,BMP7;TP63
20253,GO:2001205,0.0176648635192286,0.999510845724452,2,3,negative regulation of osteoclast development,BP,FBN1;TJP2
2414,GO:0005588,0.0176648635192287,0.999510845724452,2,3,collagen type V trimer,CC,COL5A3;COL5A2
4862,GO:0014701,0.0176648635192287,0.999510845724452,2,3,junctional sarcoplasmic reticulum membrane,CC,JPH2;JPH1
19045,GO:1904892,0.0176852414249361,0.992800284764015,12,80,regulation of STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;IL20;LIF;IL7R;IL15;PARP14;SOCS1;IL6R;CCL5
12559,GO:0050711,0.0177376772727609,0.998271427449133,3,8,negative regulation of interleukin-1 secretion,BP,IL1R2;PML;ZC3H12A
1482,GO:0003779,0.0177946850812405,0.989262162357091,33,292,actin binding,MF,COBLL1;GBP1;KLHL21;PANX1;MYO1B;ARPC4;CORO1C;ENC1;DST;TPM4;FLNA;LCP1;MYO10;SVIL;ARPC1B;TPM1;WDR1;ANXA8;MKL1;VCL;AJUBA;SPTBN1;DNASE1;MYH9;YWHAH;ENAH;HNRNPU;PPP1R9B;MICAL3;ACTN4;DAG1;MYO1E;PHACTR4
537,GO:0001655,0.0178290061688867,0.989972401667854,26,217,urogenital system development,BP,ODC1;SDC4;IRX2;FBN1;TGFB2;EFNB2;TNC;FGFR2;PBX1;COL4A1;BMP2;LIF;OSR2;SFRP1;EGR1;PDGFB;NPNT;SMAD7;APH1A;FRAS1;ESR1;BMP7;COL4A4;WNT4;MYO1E;TP63
18944,GO:1904705,0.0178485287265224,0.995568233705646,6,28,regulation of vascular smooth muscle cell proliferation,BP,MMP9;TNF;TPM1;GPER1;PDGFB;JUN
19649,GO:1990874,0.0178485287265224,0.995568233705646,6,28,vascular smooth muscle cell proliferation,BP,MMP9;TNF;TPM1;GPER1;PDGFB;JUN
2250,GO:0005164,0.0178597510845644,0.996306174159785,5,21,tumor necrosis factor receptor binding,MF,TRAF1;TRAF3;TNF;TRAF2;TRAF4
2971,GO:0006509,0.0178696558318395,0.994916359330297,7,36,membrane protein ectodomain proteolysis,BP,TNF;BACE2;ADAM17;MYH9;SPPL2A;APH1A;DAG1
9689,GO:0038066,0.0179722803089172,0.995530504907492,6,28,p38MAPK cascade,BP,GADD45A;ZC3H12A;GADD45B;BMP2;ZFP36L1;PHLPP1
16762,GO:0098552,0.0181905676235037,0.989292526837019,30,262,side of membrane,CC,NRG1;AMOT;CYLD;TFRC;CD83;HLA-B;B4GALT1;G6PD;TRAF3;LYN;LAMP1;TNF;TNK1;ICAM1;CD274;ITGAV;ERRFI1;HLA-F;IL7R;TRAF2;SYK;BCAM;SPPL2A;TAPBP;HSPA8;CHMP4B;CCR6;DAG1;CYTH1;MCAM
6762,GO:0030194,0.0182069363639095,0.997129502887231,4,14,positive regulation of blood coagulation,BP,PDPN;SERPINE1;THBD;TBXA2R
17360,GO:1900048,0.0182069363639095,0.997129502887231,4,14,positive regulation of hemostasis,BP,PDPN;SERPINE1;THBD;TBXA2R
19745,GO:2000121,0.0182468329515097,0.99820235310155,3,8,regulation of removal of superoxide radicals,BP,TNF;DHFR;BMP7
11435,GO:0045860,0.0182624669443089,0.988398305165294,40,370,positive regulation of protein kinase activity,BP,SAA1;NRG1;CYR61;SDC4;MAP3K14;TGFB2;EDN1;EMP2;CDKN1A;GADD45A;TNF;TELO2;GADD45B;BMP2;EPGN;ADRB2;DAXX;EGR1;ADAM17;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;ACSL1;AFAP1L2;CAB39;SOCS1;OXSR1;XRCC6;TNFRSF10A;RAPGEF1;DAG1;TRAF4;EFNA1;MAPK11;CARD10;HSP90AB1;CCL5
1008,GO:0002483,0.0183508334528721,0.998188148112541,3,8,antigen processing and presentation of endogenous peptide antigen,BP,TAP1;TAPBP;TAP2
17750,GO:1901698,0.0183584214866101,0.986866683892555,72,735,response to nitrogen compound,BP,TRIM16;HDAC9;NEFL;CTGF;ADM;NQO1;FBN1;EDN1;PANX1;TP53;NFKB1;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;TNF;BAIAP2;COL4A1;FOSL1;TYMS;ZC3H12A;HMGCS1;ICAM1;COL16A1;UBE4B;CDK4;ERRFI1;STAT5A;ADRB2;DAXX;ZC3H7B;SFRP1;THBD;GPER1;NFKBIA;EGR1;SRRT;ZFP36L1;DHFR;IRS2;TRAF2;SYK;OXTR;SDK1;COL5A2;PQBP1;UBE2J2;PPP1R9B;KLF10;DUSP1;SOCS1;JUN;ESR1;QDPR;SNIP1;BMP7;EFTUD2;RAPGEF1;DAG1;RNF185;TIMELESS;TNFAIP3;PSMC3;BRIP1;SLC3A2;GCLC;HSP90AB1;PARP1;BAIAP2L2;SH3BP4
7102,GO:0030898,0.0183962334271881,0.998181936995389,3,8,actin-dependent ATPase activity,MF,MYO1B;MYO10;MYH9
4345,GO:0009897,0.0184517315055259,0.991560431511505,15,108,external side of plasma membrane,CC,NRG1;AMOT;TFRC;CD83;B4GALT1;LAMP1;TNF;ICAM1;CD274;ITGAV;IL7R;BCAM;CCR6;DAG1;MCAM
16096,GO:0090073,0.0184700231491498,0.99817182880748,3,8,positive regulation of protein homodimerization activity,BP,GNL3L;TRAF2;TRAF4
12885,GO:0051223,0.0184918514453798,0.987689369200884,49,474,regulation of protein transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;TP53;IRS1;CDKN1A;LYN;TNF;PTPN14;ZC3H12A;LCP1;CYB5R1;CHP1;CD274;SFN;USP36;AKAP8L;SFRP1;PARL;GPER1;SNX12;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;WDR46;DNAJC1;UBE2J2;SOCS1;HSPA8;CPT1A;INSIG1;SNIP1;CD38;MAPK11;BMP8A;HSP90AB1;CCL5
13475,GO:0055010,0.0185957647182242,0.995339473049676,6,28,ventricular cardiac muscle tissue morphogenesis,BP,NRG1;TGFB2;FGFR2;UBE4B;TPM1;SMAD7
12531,GO:0050679,0.0186036530963351,0.991228385606859,16,119,positive regulation of epithelial cell proliferation,BP,B4GALT1;FGFR2;BMP2;STAT5A;EPGN;OSR2;SFRP1;ADAM17;PRKCA;PDGFB;JUN;ZNF703;LAMC1;TNFAIP3;TP63;CCL5
3678,GO:0008175,0.0186263184460271,0.995330071339209,6,28,tRNA methyltransferase activity,MF,TRMT61A;METTL1;NSUN2;METTL2B;WDR4;TRMT1
5538,GO:0016525,0.0187167669163196,0.993086985771541,10,61,negative regulation of angiogenesis,BP,AMOT;PML;STARD13;TGFB2;HSPG2;ADAMTS9;SERPINE1;PGK1;CARD10;TBXA2R
6077,GO:0019229,0.0188962838662728,0.995246838530946,6,28,regulation of vasoconstriction,BP,ADM;EDN1;ICAM1;OXTR;CD38;TBXA2R
11158,GO:0045214,0.0189764191721139,0.996013015586353,5,21,sarcomere organization,BP,ACTG1;EDN1;TPM1;WDR1;SRF
6073,GO:0019222,0.0190253518067188,0.983971170548006,405,4905,regulation of metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;C1R;ODC1;CYP1B1;CTGF;C1QTNF1;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;WNT10A;IRX2;RELB;TFRC;SOD2;GPRC5A;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TXNRD1;BIRC3;MID1;DAPK3;TET3;ELMSAN1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;SCD;WWC1;ENC1;TNC;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;PARL;TRIM22;SAFB2;DHCR7;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;DNAJB2;ZNF787;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;DKC1;SNX12;UPK3B;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;GLIPR1;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;CAPNS1;PPP1R14C;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;PRDM7;RBM38;ATG101;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;MPHOSPH8;ELK1;PHF5A;RAPGEF1;EIF5A;UBAP2L;MYADM;DAG1;EEF1D;RAB27A;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;TP63;ZBTB12;C1S;PHACTR4;CCL5;FADS1;MAGOH;SH3BP4
4335,GO:0009887,0.0190570900133493,0.98661441661164,64,643,animal organ morphogenesis,BP,MAFB;NRG1;CYR61;INHBA;CTGF;TENM3;ADM;TUFT1;PML;KRT13;WNT10A;IRX2;FBN1;TGFB2;EDN1;B4GALT1;LFNG;TNF;EFNB2;RING1;TNC;FGFR2;PBX1;PSMB9;SLC39A1;EPHA2;FANCC;BMP2;UBE4B;COL27A1;ERRFI1;SERPINE1;ELF3;LIF;OSR2;SFRP1;TPM1;PSME2;SRF;SNAI2;NTN1;SYK;SERPINH1;FHL2;NPNT;SDK1;SEMA3C;ROR1;COL5A2;SMAD7;CITED2;FRAS1;JUN;ESR1;FOXN1;INSIG1;BMP7;DAG1;WNT4;TNFAIP3;PSMC3;EFNA1;TP63;PHACTR4
8832,GO:0034614,0.0190615261037161,0.990979534986238,16,121,cellular response to reactive oxygen species,BP,MMP9;CYP1B1;NQO1;SOD2;TP53;TNF;FANCC;TPM1;ETS1;RHOB;DHFR;TRAF2;PXMP2;JUN;BMP7;TNFAIP3
4647,GO:0010769,0.0191597071040789,0.989428609377515,24,198,regulation of cell morphogenesis involved in differentiation,BP,NRG1;MAP2;FN1;NEFL;GBP1;BAIAP2;CORO1C;PDPN;FLNA;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;SEMA3C;RCC2;YWHAH;PQBP1;ZSWIM6;ACTN4;MYADM;EFNA1
6581,GO:0022408,0.0192245299247614,0.991439022260373,14,99,negative regulation of cell-cell adhesion,BP,C1QTNF1;CYLD;SDC4;CD274;BMP2;IRF1;SNAI2;LGALS3;TNFRSF21;SMAD7;ZNF703;GPNMB;MYADM;SWAP70
13473,GO:0055008,0.0192423990266801,0.994442518585517,7,36,cardiac muscle tissue morphogenesis,BP,NRG1;TGFB2;FGFR2;BMP2;UBE4B;TPM1;SMAD7
8703,GO:0034340,0.0192673846059612,0.992415970832488,11,73,response to type I interferon,BP,HLA-B;TRIM56;IKBKE;RSAD2;NLRC5;XAF1;HLA-F;IRF1;EGR1;IFIT3;HSP90AB1
3070,GO:0006636,0.0192694736272637,0.995109593876674,6,29,unsaturated fatty acid biosynthetic process,BP,FADS3;PTGES;EDN1;SCD;SCD5;FADS1
3599,GO:0008026,0.0192729680594866,0.991728415714659,13,88,ATP-dependent helicase activity,MF,DDX23;DHX37;DDX42;DDX17;DDX47;DDX49;DDX39A;RUVBL2;MCM7;XRCC6;DHX34;BRIP1;DDX24
14534,GO:0070035,0.0192729680594866,0.991728415714659,13,88,purine NTP-dependent helicase activity,MF,DDX23;DHX37;DDX42;DDX17;DDX47;DDX49;DDX39A;RUVBL2;MCM7;XRCC6;DHX34;BRIP1;DDX24
11879,GO:0046886,0.0192897049981187,0.998058462057831,3,8,positive regulation of hormone biosynthetic process,BP,TNF;EGR1;WNT4
9674,GO:0038034,0.0193231482113321,0.993273956465331,9,54,signal transduction in absence of ligand,BP,INHBA;CSF2;DAPK3;TNF;ITGAV;SNAI2;IL1A;BCL2L2;PPP2R1B
16497,GO:0097192,0.0193231482113321,0.993273956465331,9,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,INHBA;CSF2;DAPK3;TNF;ITGAV;SNAI2;IL1A;BCL2L2;PPP2R1B
39,GO:0000079,0.0193922015786026,0.992366079095766,11,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2B;CDKN1A;GADD45A;CDKN2A;PKMYT1;CDK4;SFN;ADAM17;PDGFB;SERTAD1;TNFAIP3
16145,GO:0090154,0.0194088858370024,0.998041814963693,3,8,positive regulation of sphingolipid biosynthetic process,BP,CYR61;TNF;SMPD2
19836,GO:2000304,0.0194088858370024,0.998041814963693,3,8,positive regulation of ceramide biosynthetic process,BP,CYR61;TNF;SMPD2
563,GO:0001704,0.0194397780627706,0.991984673069394,12,79,formation of primary germ layer,BP,MMP9;INHBA;FN1;TXNRD1;COL12A1;FGFR2;ITGAV;SRF;COL5A2;ETS2;DUSP1;BMP7
3186,GO:0006809,0.019468261611052,0.993747480671663,8,45,nitric oxide biosynthetic process,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;HSP90AB1
7085,GO:0030879,0.0195963107676458,0.991251725198764,14,99,mammary gland development,BP,NRG1;PML;B4GALT1;FGFR2;EPHA2;STAT5A;ELF3;IRS2;NTN1;ROBO1;OXTR;ESR1;ZNF703;WNT4
6675,GO:0030036,0.0197959593812311,0.986766503715665,49,471,actin cytoskeleton organization,BP,PTGER4;CTGF;AMOT;ACTG1;SDC4;COBLL1;EDN1;DAPK3;EMP2;NEDD9;MYO1B;ARPC4;TNF;BAIAP2;CORO1C;TPM4;FLNA;LCP1;ICAM1;KIF23;CDC42EP2;ARPC1B;AMOTL2;SFRP1;TPM1;WDR1;SRF;RHOB;SPTBN1;DPYSL3;MYH9;PALM2;SPECC1;CLASP1;PPP1R9B;MICAL3;RHOG;ACTN4;SORBS2;KANK4;PHLDB2;ZYX;MYADM;CGNL1;WNT4;SWAP70;BIN3;PHACTR4;BAIAP2L2
4588,GO:0010692,0.0198359009451571,0.997981832799301,3,8,regulation of alkaline phosphatase activity,BP,TGFB2;TNF;NPNT
1329,GO:0003181,0.0198774104220078,0.996780420243788,4,14,atrioventricular valve morphogenesis,BP,CYR61;TGFB2;BMP2;EFNA1
15625,GO:0072111,0.0198919004611742,0.996777349342384,4,14,cell proliferation involved in kidney development,BP,BMP2;EGR1;PDGFB;BMP7
12859,GO:0051179,0.0199027490935892,0.983273029874373,358,4302,localization,BP,HEPHL1;IGFBP3;KRT1;SAA1;TRIM16;FTL;CCL20;CRYAB;FTH1;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;S100P;FN1;NEFL;CYP1B1;CTGF;C1QTNF1;ADM;SLC16A2;TNS3;AMOT;JPH2;ACTG1;IL16;TAP1;IL1R2;NFKBIE;PML;CYLD;HSPB1;STARD13;PCDH7;SDC4;TFRC;SOD2;ABCF1;IER2;CSF2;FBN1;TGFB2;EDN1;GBP1;IKBKE;MID1;DAPK3;B4GALT1;MGAM;RSAD2;G6PD;EMP2;HRNR;KLHL21;APOL6;PANX1;TP53;SQSTM1;MARVELD3;STEAP4;IL24;NEDD9;NFKB1;GNPTAB;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;PLEKHO2;ARPC4;LAMP1;EHD1;TNF;GNL3L;BAIAP2;EFNB2;CORO1C;CXCL16;WWC1;DST;VMP1;PDPN;PTPN14;NUP153;PSMB9;SLC7A5;QPCT;SLC16A9;SIRPA;JPH1;SLC39A1;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ACAA1;GEMIN5;CADPS2;EPHA2;CHP1;TSC22D3;ICAM1;ARFRP1;CD274;BMP2;GOSR1;SLCO3A1;SLC7A5P2;ITGAV;L1CAM;KIF23;MYO10;PMM2;SFN;STAT5A;ANKS4B;ADRB2;TNFRSF12A;MTUS1;SLC5A6;SERPINE1;FXYD3;ARPC1B;LSG1;EBP;NMT2;USP36;AKAP8L;AMOTL2;LIF;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;WDR1;ANXA8;PSME2;BANF1;EPPK1;DDX42;THBD;GPER1;SRF;AP4S1;TRIM29;NFKBIA;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;RRS1;PRPF19;ZFP36L1;RPLP2;AKAP8;RHOB;ADAM17;DKC1;SNX12;TXLNA;U2AF2;FGFR1OP;VCL;VPS13B;SHQ1;IRS2;LGALS3;ACO1;RPLP1;TRAF2;ABCG2;REEP1;PRKCA;NTN1;SYK;POLR1A;SLC7A2;ROBO1;AJUBA;SLC43A3;PDGFB;OXTR;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;NEDD4L;DCTN1;COX5B;DPYSL3;MYH9;NPNT;IL1A;GLIPR1;TNFRSF21;SNX8;RUNDC1;SEMA3C;DDX39A;WDR46;LILRB3;TBCCD1;ZW10;ACSL1;RCC2;NUP214;ACKR3;BAMBI;TRAM2;SMAD7;SLC35A4;SLC35C2;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;KEAP1;M6PR;ZDHHC6;HNRNPU;CLASP1;RRAD;UBE2J2;CEP41;TRIB1;CREB3;RUVBL2;PPP1R9B;SLC4A11;TANGO2;MICAL3;KCNIP3;THOC1;CXCL5;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;STAC;FRAS1;OXSR1;HSPA8;JUN;ESR1;BLOC1S2;SLC22A4;PES1;FOXN1;GLIPR2;CPT1A;COMMD9;TFDP1;TNPO3;TRAPPC5;CHMP4B;RBM4;ZNF703;CCR6;INSIG1;HERC2;PARD3;LAMC1;RHOG;GPNMB;XRCC6;GP6;TAP2;ZSWIM6;CNTNAP1;ACTN4;EFNB1;THEM4;KIF24;SNIP1;BMP7;CLUH;TNFRSF10A;TOMM40;PHLDB2;SGSM1;RAPGEF1;IPO4;EIF5A;TINAGL1;KIF22;SLC41A2;MYADM;DAG1;TMEM165;RNF185;RAB27A;WNT4;RILPL2;AKR1C1;VPS52;TUBB;CYTH1;CD38;TNFAIP3;PSMC3;CCL22;SLC4A2;CXCL8;EFNA1;MAPK11;CLDN7;MYO1E;SLC3A2;CXCL3;BMP8A;CARD10;SLC25A22;PTPRB;SLC25A44;SRSF7;CLTA;NOL3;SNF8;CDCA5;HSP90AB1;SWAP70;TBXA2R;MCAM;TTLL5;IL6R;BIN3;LAIR1;PARP1;SLC2A6;TP63;PHACTR4;CCL5;MAGOH;SH3BP4
16068,GO:0090023,0.0199507849297442,0.996715424734363,4,15,positive regulation of neutrophil chemotaxis,BP,EDN1;CXCL5;CXCL8;CXCL3
11619,GO:0046321,0.0199764567029695,0.997961974577808,3,8,positive regulation of fatty acid oxidation,BP,IRS1;IRS2;CPT1A
4340,GO:0009892,0.0199963577413152,0.983852381002432,187,2162,negative regulation of metabolic process,BP,IGFBP3;CRYAB;NRG1;MMP9;INHBA;HDAC9;CTGF;IL1R2;DUSP14;PML;TFCP2L1;HSPB1;IRX2;RELB;GPRC5A;CSF2;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;DAPK3;DBNDD2;G6PD;TP53;SQSTM1;MARVELD3;NOCT;FST;NFKB1;CDKN2B;CDKN1A;UBQLN2;LYN;AHR;JUNB;GADD45A;TNF;GNL3L;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;TYMS;ZC3H12A;FLNA;SRSF2;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;BMP2;CDK4;ITGAV;ERRFI1;SFN;DAXX;NAT10;SERPINE1;PABPC4;ZC3H7B;ELF3;LIF;OSR2;SFRP1;TRIM22;ANXA8;IRF1;PSME2;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;CD2BP2;SRRT;ZFP36L1;RPLP2;NELFE;DKC1;SNX12;UPK3B;DHFR;U2AF2;FGFR1OP;SHQ1;IRS2;CBX5;RPLP1;MAFK;PRKCA;ZFP36L2;DDX17;AJUBA;PDGFB;BRMS1;RPS2;RPS9;NEDD4L;SNRNP70;SERPINH1;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPRY4;SPEN;NUP214;SMAD7;SLC35C2;SUPT5H;MTA2;DNAJC1;HNRNPU;PPP1R14C;TRIB1;RUVBL2;PPP1R9B;KCNIP3;THOC1;ETS2;KLF10;A2ML1;PARP14;DUSP1;CITED2;CD109;RPL27A;SOCS1;HSPA8;JUN;ESR1;NOC2L;CHMP4B;RBM4;NACC1;ZNF703;INSIG1;DUS2;PARD3;XRCC6;EDC4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;TNFRSF10A;MPHOSPH8;RAPGEF1;MYADM;DAG1;DHX34;TIMELESS;WNT4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;EFNA1;POLR2G;DUSP8;SRSF7;NOL3;GCLC;HSP90AB1;SWAP70;PARP1;TP63;MAGOH
3261,GO:0006929,0.0200377641687314,0.995729949047765,5,21,substrate-dependent cell migration,BP,FN1;TNFRSF12A;SNAI2;NTN1;ROBO1
14303,GO:0061436,0.0200593019773063,0.995724161152171,5,21,establishment of skin barrier,BP,KRT1;HRNR;SFN;RPTN;TP63
1452,GO:0003688,0.0201264773247511,0.996727534377505,4,14,DNA replication origin binding,MF,MCM5;MCM2;GRWD1;ORC4
12663,GO:0050867,0.0201773582680402,0.989129578416793,22,181,positive regulation of cell activation,BP,CTGF;CYLD;TFRC;CD83;MAP3K14;CDKN1A;LYN;LAMP1;EFNB2;PDPN;SIRPA;SART1;CD274;IL7R;IRS2;IL15;SYK;TNIP2;SOCS1;EFNB1;CD38;CCL5
7938,GO:0032526,0.0201855342996334,0.992005339497018,11,72,response to retinoic acid,BP,TRIM16;KRT13;PTGES;TP53;LYN;TNC;FGFR2;SNRNP70;DUSP1;CD38;TRIML2
15220,GO:0071372,0.0201890122930543,0.997931836906631,3,8,cellular response to follicle-stimulating hormone stimulus,BP,INHBA;HMGCS1;GCLC
17581,GO:1901203,0.0202063012733421,0.997929379899972,3,8,positive regulation of extracellular matrix assembly,BP,CLASP1;PHLDB2;DAG1
4376,GO:0010002,0.0202204195981047,0.997927372858836,3,8,cardioblast differentiation,BP,NRG1;TGFB2;SRF
2431,GO:0005614,0.0202661935297017,0.997920861814237,3,8,interstitial matrix,CC,CCDC80;NAV2;TNC
16335,GO:0090557,0.0202661935297017,0.997920861814237,3,8,establishment of endothelial intestinal barrier,BP,TJP2;ICAM1;TJP1
70,GO:0000146,0.0202917298413381,0.996692327837808,4,14,microfilament motor activity,MF,MYO1B;MYO10;MYH9;MYO1E
3546,GO:0007568,0.0203199516182927,0.988568266061436,25,213,aging,BP,CRYAB;CTGF;ADM;NQO1;CYP1A1;PML;TFCP2L1;SOD2;EDN1;NUAK1;TP53;CDKN1A;CDKN2A;NFKB2;TYMS;ICAM1;SERPINE1;SRF;KRT14;IL15;JUN;TPRA1;DAG1;GCLC;TP63
11107,GO:0045124,0.0204648540907277,0.995614857335154,5,21,regulation of bone resorption,BP,TFRC;PRKCA;SYK;CD38;TNFAIP3
174,GO:0000380,0.0207535912261416,0.993254356481574,8,45,alternative mRNA splicing, via spliceosome,BP,SRSF2;DDX17;RBM15B;SFPQ;HNRNPU;PQBP1;RBM4;MAGOH
14689,GO:0070304,0.020754182067138,0.99036292634206,15,109,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF;TGFB2;EDN1;MID1;LYN;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;TRAF2;SYK;IL1A;TRAF4
5382,GO:0016202,0.0208393850311232,0.991314716917881,12,80,regulation of striated muscle tissue development,BP,NRG1;HDAC9;JPH2;EDN1;G6PD;EFNB2;FGFR2;TSC22D3;BMP2;LUC7L;DDX17;MAPK11
17790,GO:1901861,0.0208393850311232,0.991314716917881,12,80,regulation of muscle tissue development,BP,NRG1;HDAC9;JPH2;EDN1;G6PD;EFNB2;FGFR2;TSC22D3;BMP2;LUC7L;DDX17;MAPK11
10311,GO:0043086,0.0210011049043523,0.985625036993381,54,538,negative regulation of catalytic activity,BP,CRYAB;MMP9;AMOT;NQO1;DUSP14;HSPB1;GPRC5A;TGFB2;SH3RF2;BIRC3;DBNDD2;TP53;NFKB1;CDKN2B;CDKN1A;LYN;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;CHP1;GADD45B;CDK4;ERRFI1;SFN;SERPINE1;SFRP1;ANXA8;TFIP11;CD2BP2;FGFR1OP;IRS2;AJUBA;SERPINH1;SPRY4;RCC2;SMAD7;HNRNPU;PPP1R14C;TRIB1;PPP1R9B;A2ML1;DUSP1;CD109;SOCS1;HSPBP1;DUS2;BMP7;TNFRSF10A;TNFAIP3;DUSP8;NOL3;SH3BP4
18525,GO:1903707,0.0210269135402834,0.990824914775938,13,96,negative regulation of hemopoiesis,BP,MAFB;INHBA;CYLD;FBN1;TJP2;LYN;SFRP1;IRF1;NFKBIA;ZFP36L1;LILRB3;SMAD7;TRIB1
10303,GO:0043066,0.0210818069282542,0.985234084653625,61,616,negative regulation of apoptotic process,BP,CRYAB;MMP9;CYR61;NEFL;NQO1;HSPB1;BAG1;SOD2;CSF2;EDN1;BIRC3;TP53;SQSTM1;NFKB1;CDKN1A;TNF;PDPN;FGFR2;EPHB6;ZC3H12A;FLNA;EPHA2;TSC22D3;ICAM1;ITGAV;SFN;SERPINE1;SFRP1;NFKBIA;SNAI2;IRS2;IER3;LGALS3;TRAF2;PRKCA;IFIT3;PTTG1IP;FHL2;IL1A;TNIP2;ROR1;ACKR3;CREB3;DUSP1;CITED2;JUN;NOC2L;BCL2L2;BMP7;TNFRSF10A;WNT4;CD38;TNFAIP3;EFNA1;CLDN7;RNF144B;NOL3;GCLC;HSP90AB1;TP63;CCL5
4549,GO:0010629,0.0210965141588186,0.983569611628768,127,1429,negative regulation of gene expression,BP,CRYAB;NRG1;HDAC9;CTGF;IL1R2;PML;TFCP2L1;HSPB1;IRX2;RELB;CSF2;TGFB2;EDN1;BIRC3;DAPK3;TP53;SQSTM1;NOCT;FST;NFKB1;CDKN1A;AHR;JUNB;TNF;CDKN2A;RING1;WWC1;ENC1;FGFR2;NUP153;NFKB2;DNAJB1;PSMB9;TYMS;ZC3H12A;FLNA;ZNF503;CCDC85B;TSC22D3;BMP2;DAXX;SERPINE1;PABPC4;ZC3H7B;ELF3;OSR2;SFRP1;IRF1;PSME2;CTIF;NFX1;PSPC1;GPER1;SRF;TRIM29;EGR1;SNAI2;SRRT;ZFP36L1;RPLP2;NELFE;SNX12;UPK3B;DHFR;U2AF2;SHQ1;CBX5;RPLP1;MAFK;PRKCA;ZFP36L2;DDX17;AJUBA;PDGFB;BRMS1;RPS2;RPS9;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;NUP214;SMAD7;SLC35C2;SUPT5H;MTA2;HNRNPU;KCNIP3;ETS2;KLF10;PARP14;CITED2;RPL27A;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;XRCC6;EDC4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;MPHOSPH8;MYADM;DHX34;TIMELESS;WNT4;CD38;PSMC3;SMARCC2;BRIP1;EFNA1;POLR2G;SRSF7;NOL3;GCLC;PARP1;TP63;MAGOH
11319,GO:0045638,0.02123782041848,0.991934914356642,10,68,negative regulation of myeloid cell differentiation,BP,MAFB;INHBA;FBN1;TJP2;LYN;SFRP1;NFKBIA;ZFP36L1;LILRB3;TRIB1
5588,GO:0016607,0.021314948579505,0.986561263905751,37,342,nuclear speck,CC,IL16;GADD45A;RING1;SRSF2;SART1;USP36;AKAP8L;TRIM22;DDX42;PSPC1;TFIP11;SGK1;CD2BP2;PRPF19;U2AF2;IL15;DDX17;ALYREF;SNRNP70;PRCC;SFPQ;DDX39A;TATDN2;HNRNPU;PQBP1;THOC1;ARL6IP4;RBM4;TAP2;TKT;EFTUD2;PHF5A;KIF22;RBM14;ZC3H18;TBXA2R;MAGOH
18445,GO:1903530,0.0213390463042642,0.986134793104422,42,398,regulation of secretion by cell,BP,SAA1;TRIM16;PTGER4;INHBA;FN1;C1QTNF1;IL1R2;PML;SDC4;TGFB2;EDN1;GBP1;RSAD2;PANX1;IRS1;LYN;LAMP1;TNF;ZC3H12A;CADPS2;CD274;LIF;SFRP1;GPER1;IRS2;TRAF2;PRKCA;SYK;OXTR;SPTBN1;IL1A;TNFRSF21;DNAJC1;CLASP1;SOCS1;CPT1A;RAB27A;CD38;MAPK11;BMP8A;SNF8;CCL5
9844,GO:0042089,0.0215458442860456,0.991840248653558,10,63,cytokine biosynthetic process,BP,CCL20;INHBA;HSPB1;NFKB1;TNF;ERRFI1;IRF1;EGR1;SYK;IL1A
13904,GO:0060548,0.021571861417047,0.984620964499129,67,687,negative regulation of cell death,BP,CRYAB;MMP9;CYR61;NEFL;CTGF;NQO1;HSPB1;BAG1;SOD2;CSF2;EDN1;BIRC3;TP53;SQSTM1;NFKB1;CDKN1A;TNF;PDPN;FGFR2;EPHB6;ZC3H12A;FLNA;EPHA2;TSC22D3;ICAM1;ITGAV;SFN;SERPINE1;SFRP1;NFKBIA;SNAI2;IRS2;IER3;NPAS2;LGALS3;TRAF2;PRKCA;IFIT3;PTTG1IP;FHL2;IL1A;TNIP2;ROR1;ACKR3;CREB3;DUSP1;CITED2;JUN;NOC2L;CHMP4B;DUS2;GPNMB;BCL2L2;BMP7;TNFRSF10A;GPX4;WNT4;CD38;TNFAIP3;EFNA1;CLDN7;RNF144B;NOL3;GCLC;HSP90AB1;TP63;CCL5
4828,GO:0014032,0.0216219851642168,0.992325686359718,9,54,neural crest cell development,BP,NRG1;EDN1;CORO1C;SNAI2;SEMA3C;TCOF1;EFNB1;BMP7;PHACTR4
9931,GO:0042277,0.0216690990635358,0.988428564930333,21,172,peptide binding,MF,CRYAB;INHBA;TAP1;HLA-B;PTGES;TGFB2;NUP153;BACE2;SLC7A5;C9ORF3;ITGAV;ADRB2;HLA-F;NFKBIA;OXTR;NUP214;TAPBP;TNPO3;IPO4;CLTA;HSP90AB1
785,GO:0002042,0.0218234658667481,0.99351328273109,7,37,cell migration involved in sprouting angiogenesis,BP,HDAC9;STARD13;EFNB2;SRF;ROBO1;CARD10;TBXA2R
10306,GO:0043069,0.0218480284891764,0.984621445172082,62,629,negative regulation of programmed cell death,BP,CRYAB;MMP9;CYR61;NEFL;NQO1;HSPB1;BAG1;SOD2;CSF2;EDN1;BIRC3;TP53;SQSTM1;NFKB1;CDKN1A;TNF;PDPN;FGFR2;EPHB6;ZC3H12A;FLNA;EPHA2;TSC22D3;ICAM1;ITGAV;SFN;SERPINE1;SFRP1;NFKBIA;SNAI2;IRS2;IER3;LGALS3;TRAF2;PRKCA;IFIT3;PTTG1IP;FHL2;IL1A;TNIP2;ROR1;ACKR3;CREB3;DUSP1;CITED2;JUN;NOC2L;BCL2L2;BMP7;TNFRSF10A;GPX4;WNT4;CD38;TNFAIP3;EFNA1;CLDN7;RNF144B;NOL3;GCLC;HSP90AB1;TP63;CCL5
12549,GO:0050701,0.0218672174819543,0.994263978072887,6,30,interleukin-1 secretion,BP,SAA1;TRIM16;IL1R2;PML;PANX1;ZC3H12A
17487,GO:1900407,0.0218790503057624,0.992207501844615,9,55,regulation of cellular response to oxidative stress,BP,HSPB1;SOD2;TP53;TNF;DHFR;SFPQ;BMP7;NOL3;PARP1
10305,GO:0043068,0.0221959990652032,0.985110727601903,48,471,positive regulation of programmed cell death,BP,IGFBP3;MMP9;CYR61;INHBA;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;MYBL2;TGFB2;DAPK3;B4GALT1;TP53;SQSTM1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;TRIO;FOSL1;ZC3H12A;GADD45B;CD274;BMP2;CDK4;SFN;TNFRSF12A;SFRP1;GPER1;RHOB;SHQ1;TRAF2;ROBO1;BRMS1;SFPQ;YWHAH;APH1A;DUSP1;JUN;TFDP1;BMP7;TNFRSF10A;PPP2R1B;TP63;CCL5
10121,GO:0042641,0.022295711700963,0.992044088658042,9,54,actomyosin,CC,SIPA1L3;TPM4;LCP1;TPM1;WDR1;MYH9;ROR1;ACTN4;ZYX
12981,GO:0051384,0.0224726977986576,0.99012597918113,13,92,response to glucocorticoid,BP,NEFL;ADM;EDN1;CDKN1A;TNF;FOSL1;TYMS;ICAM1;ERRFI1;ZFP36L1;ZFP36L2;HNRNPU;DUSP1
15861,GO:0072577,0.022479197267156,0.994089913115049,6,29,endothelial cell apoptotic process,BP,TNF;ICAM1;SERPINE1;GPER1;TNIP2;TNFAIP3
17586,GO:1901216,0.0224941673253235,0.991411889450476,10,64,positive regulation of neuron death,BP,NQO1;MYBL2;TGFB2;TP53;EFNB2;DAXX;EGR1;JUN;ELK1;PARP1
7492,GO:0031663,0.0225445800396006,0.993235726147239,7,38,lipopolysaccharide-mediated signaling pathway,BP,LYN;TNF;NFKBIA;PRKCA;TRIB1;TNFAIP3;CCL5
11427,GO:0045840,0.0225965270491012,0.993216909378669,7,38,positive regulation of mitotic nuclear division,BP,EDN1;UBE2C;EPGN;PDGFB;IL1A;HNRNPU;CDCA5
19411,GO:1905952,0.0226399284778808,0.990859265208983,11,74,regulation of lipid localization,BP,C1QTNF1;EDN1;IKBKE;NFKB1;EHD1;TNF;ZC3H12A;ITGAV;NFKBIA;IRS2;SYK
4369,GO:0009987,0.0227241697559778,0.982437887342654,818,10469,cellular process,BP,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;CCDC80;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;WNT10A;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CPA4;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;AHR;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;ENC1;TNC;ASCC2;DST;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;SIRPA;UBE2C;JPH1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;LYPD6B;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;GANC;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;IER3;NPAS2;KRT14;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;BCAM;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;NOM1;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;BCL7C;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TRAM2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;CXCL5;RBM38;SUSD6;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC27;SCD5;TFDP1;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;BMP7;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;TKT;EFTUD2;TNFRSF10A;TRA2A;RNF7;CXORF36;KANK4;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;SLC4A2;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SLC3A2;CXCL3;ATAD3C;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;TTLL5;HERC6;ADGRF3;IL6R;BIN3;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TXNDC15;OTUD6A;IL36G;PHACTR4;TOP3A;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
9707,GO:0038111,0.022724779045683,0.99484415136062,5,26,interleukin-7-mediated signaling pathway,BP,IRS1;STAT5A;IL7R;IRS2;SOCS1
16851,GO:0098760,0.022724779045683,0.99484415136062,5,26,response to interleukin-7,BP,IRS1;STAT5A;IL7R;IRS2;SOCS1
16852,GO:0098761,0.022724779045683,0.99484415136062,5,26,cellular response to interleukin-7,BP,IRS1;STAT5A;IL7R;IRS2;SOCS1
12297,GO:0048634,0.0228081403089685,0.990362128366971,12,81,regulation of muscle organ development,BP,NRG1;HDAC9;JPH2;EDN1;G6PD;EFNB2;FGFR2;TSC22D3;BMP2;LUC7L;DDX17;MAPK11
12771,GO:0051046,0.0229511565093162,0.984854875366151,44,423,regulation of secretion,BP,SAA1;TRIM16;NRG1;PTGER4;INHBA;FN1;C1QTNF1;IL1R2;PML;SDC4;TGFB2;EDN1;GBP1;RSAD2;PANX1;IRS1;LYN;LAMP1;TNF;ZC3H12A;CADPS2;CD274;LIF;SFRP1;GPER1;SGK1;IRS2;TRAF2;PRKCA;SYK;OXTR;SPTBN1;IL1A;TNFRSF21;DNAJC1;CLASP1;SOCS1;CPT1A;RAB27A;CD38;MAPK11;BMP8A;SNF8;CCL5
17513,GO:1900745,0.0229748847526432,0.996048930766976,4,15,positive regulation of p38MAPK cascade,BP,GADD45A;ZC3H12A;GADD45B;BMP2
3360,GO:0007096,0.0231922660315013,0.995999862214396,4,15,regulation of exit from mitosis,BP,UBE2C;ZW10;PPP1R9B;CDCA5
4284,GO:0009651,0.0233786109435779,0.995957679296329,4,15,response to salt stress,BP,TNF;ZFP36L1;XRCC6;HSP90AB1
8476,GO:0033619,0.0234456062043783,0.991547993964938,9,55,membrane protein proteolysis,BP,NFKB1;TNF;BACE2;PARL;ADAM17;MYH9;SPPL2A;APH1A;DAG1
13097,GO:0051608,0.0234812685682067,0.997338044428884,3,9,histamine transport,BP,CSF2;EDN1;LYN
12633,GO:0050820,0.0235289147848115,0.995923574613629,4,15,positive regulation of coagulation,BP,PDPN;SERPINE1;THBD;TBXA2R
14777,GO:0070475,0.0235341760549458,0.997329710577835,3,9,rRNA base methylation,BP,NSUN5;NOP2;METTL16
10981,GO:0044772,0.0236204214987302,0.98402272987675,49,485,mitotic cell cycle phase transition,BP,INHBA;CYP1A1;PML;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;PKMYT1;PBX1;PSMB9;UBE2C;TYMS;CDK4;SFN;MCM2;PSME2;ZFP36L1;ADAM17;DHFR;FGFR1OP;GPR132;ZFP36L2;AJUBA;POLA1;DCTN1;ORAOV1;ZW10;RCC2;CLASP1;CEP41;PPP1R9B;ORC1;ANAPC15;DUSP1;RCC1;MCM7;TFDP1;CHMP4B;GPNMB;TPRA1;TUBB;CTDSP1;PSMC3;RRM2;CDCA5;TP63;ORC4
9789,GO:0040007,0.023644064701851,0.983191584647107,64,650,growth,BP,IGFBP3;CRYAB;NRG1;CYR61;INHBA;FN1;CTGF;ADM;PML;TFCP2L1;TGFB2;EDN1;G6PD;TP53;SQSTM1;NEDD9;CDKN1A;HSPG2;TNF;CDKN2A;CXCL16;WWC1;TNC;FGFR2;KRT17;TYMS;TNK1;CCDC85B;COL27A1;CDK4;L1CAM;SFN;STAT5A;ADRB2;TNFRSF12A;SFRP1;ZFYVE27;DHCR7;EPPK1;SRF;DNAJB2;SGK1;PRPF19;ZFP36L1;ADAM17;FGFR1OP;VCL;NTN1;NEDD4L;SEMA3C;RUVBL2;PPP1R9B;SAFB;SOCS1;ESR1;OGFR;SORBS2;TKT;DAG1;CD38;MAPK11;SLC3A2;BIN3;SH3BP4
4947,GO:0014912,0.0237031456695454,0.995883951316172,4,15,negative regulation of smooth muscle cell migration,BP,IGFBP3;SERPINE1;TPM1;TRIB1
13538,GO:0055123,0.0237675413845517,0.989889135740106,12,82,digestive system development,BP,CYP1A1;TGFB2;CDKN1A;TNF;FGFR2;TYMS;SFRP1;OXTR;VPS52;SLC4A2;CXCL8;TP63
15594,GO:0072073,0.0238129585639995,0.989459108168962,13,91,kidney epithelium development,BP,SDC4;IRX2;EFNB2;FGFR2;PBX1;BMP2;LIF;SFRP1;NPNT;SMAD7;BMP7;WNT4;MYO1E
9858,GO:0042107,0.0238361950244807,0.990812895192371,10,64,cytokine metabolic process,BP,CCL20;INHBA;HSPB1;NFKB1;TNF;ERRFI1;IRF1;EGR1;SYK;IL1A
6919,GO:0030511,0.0238669849335032,0.994636441185258,5,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;ADAM17;NPNT;CITED2;HSP90AB1
18591,GO:1903846,0.0238669849335032,0.994636441185258,5,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;ADAM17;NPNT;CITED2;HSP90AB1
6843,GO:0030308,0.0239066885518295,0.988369184463463,16,122,negative regulation of cell growth,BP,CRYAB;INHBA;PML;TGFB2;G6PD;TP53;CDKN1A;CDKN2A;TNK1;CCDC85B;SFRP1;DNAJB2;NTN1;SEMA3C;PPP1R9B;SH3BP4
5452,GO:0016324,0.0239978669367983,0.987052137775951,21,171,apical plasma membrane,CC,FN1;MGAM;EMP2;SIPA1L3;PDPN;SLC7A5;ADRB2;AMOTL2;PARD3B;ADAM17;ABCG2;OXTR;MARVELD2;SLC22A4;PARD3;SORBS2;RAB27A;SLC4A2;SLC3A2;HSP90AB1;IL6R
13963,GO:0060669,0.0240723957943384,0.994578029525075,5,22,embryonic placenta morphogenesis,BP,CYR61;ADM;FGFR2;ZFP36L1;BMP7
20075,GO:2000725,0.0241230943902583,0.994563591067225,5,22,regulation of cardiac muscle cell differentiation,BP,NRG1;EDN1;G6PD;EFNB2;BMP2
14650,GO:0070234,0.0242068762066783,0.997223088119807,3,9,positive regulation of T cell apoptotic process,BP,TP53;CD274;CCL5
12306,GO:0048644,0.0242185707714834,0.991879400205691,8,46,muscle organ morphogenesis,BP,NRG1;TGFB2;FGFR2;BMP2;UBE4B;LIF;TPM1;SMAD7
8001,GO:0032623,0.0242412300720865,0.992616267848156,7,38,interleukin-2 production,BP,RUNX1;CD83;GBP1;TRAF2;SPTBN1;IL1A;TNFAIP3
2395,GO:0005539,0.024336474898846,0.988799874467386,14,103,glycosaminoglycan binding,MF,SAA1;CYR61;FN1;CTGF;CCDC80;FBN1;NAV2;FGFR2;LAYN;SFRP1;DPYSL3;COL5A3;GPNMB;BMP7
15382,GO:0071624,0.0244545044889435,0.995657129399326,4,16,positive regulation of granulocyte chemotaxis,BP,EDN1;CXCL5;CXCL8;CXCL3
2042,GO:0004784,0.0244583956685373,0.998868556124593,2,4,superoxide dismutase activity,MF,NQO1;SOD2
5636,GO:0016721,0.0244583956685373,0.998868556124593,2,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,NQO1;SOD2
19751,GO:2000142,0.0245373705139988,0.993390044761766,6,30,regulation of DNA-templated transcription, initiation,BP,TP53;FOSL1;SRF;JUN;ESR1;PSMC3
3710,GO:0008217,0.0245575032025065,0.989495864843337,12,83,regulation of blood pressure,BP,ADM;SOD2;EDN1;EMP2;NAV2;C9ORF3;ADRB2;TPM1;SGK1;PDGFB;OXTR;TBXA2R
16714,GO:0097696,0.0245674803776177,0.989065375325712,13,93,STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;STAT5A;IL20;LIF;IL7R;IL15;PARP14;SOCS1;IL6R;CCL5
13487,GO:0055024,0.024569047026749,0.991739317155114,8,46,regulation of cardiac muscle tissue development,BP,NRG1;JPH2;EDN1;G6PD;EFNB2;FGFR2;BMP2;MAPK11
6927,GO:0030520,0.0245848880219914,0.991732975892961,8,46,intracellular estrogen receptor signaling pathway,BP,RUNX1;DDX17;PAGR1;SAFB;ESR1;RBM14;PARP1;TP63
5550,GO:0016556,0.0246974556190115,0.995656008491454,4,15,mRNA modification,BP,TRMT61A;PUS1;DKC1;METTL16
13178,GO:0051783,0.0247705122420847,0.987053921287935,19,153,regulation of nuclear division,BP,EDN1;DAPK3;PKMYT1;UBE2C;EPGN;LIF;PDGFB;IL1A;ZW10;HNRNPU;PPP1R9B;ANAPC15;DUSP1;RCC1;CHMP4B;BMP7;WNT4;CDCA5;MKI67
20193,GO:2001044,0.0249236562963648,0.997108145158941,3,9,regulation of integrin-mediated signaling pathway,BP,EMP2;FLNA;PHACTR4
10199,GO:0042803,0.0250510623850371,0.982727465013868,53,531,protein homodimerization activity,MF,MAFB;CRYAB;S100P;ODC1;TENM3;TAP1;PML;HSPB1;TFRC;UGT1A6;TGFB2;GBP1;MID1;DAPK3;G6PD;SQSTM1;NFKB1;GADD45A;FGFR2;TPM4;CLN6;TYMS;FLNA;HMGCS1;ADRB2;TPM1;BANF1;SRF;FGFR1OP;CBX5;ABCG2;PDGFB;MYH9;SPPL2A;SFPQ;KEAP1;TPST1;RUVBL2;DNTTIP1;PCYT1A;JUN;IKZF3;GLIPR2;CHMP4B;QDPR;BCL2L2;ACTN4;TKT;TIMELESS;SNF8;HSP90AB1;IL6R;CCL5
6763,GO:0030195,0.025074714140291,0.993211229746681,6,30,negative regulation of blood coagulation,BP,KRT1;C1QTNF1;EDN1;SERPINE1;THBD;PDGFB
17359,GO:1900047,0.025074714140291,0.993211229746681,6,30,negative regulation of hemostasis,BP,KRT1;C1QTNF1;EDN1;SERPINE1;THBD;PDGFB
17893,GO:1902175,0.0251632217037724,0.994228473325688,5,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1;SOD2;SFPQ;NOL3;PARP1
12563,GO:0050715,0.0251850561172991,0.990194693834343,10,65,positive regulation of cytokine secretion,BP,SAA1;TRIM16;PTGER4;PANX1;TNF;CD274;SYK;SPTBN1;IL1A;MAPK11
18007,GO:1902475,0.025212378606021,0.99316526430822,6,30,L-alpha-amino acid transmembrane transport,BP,SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
5819,GO:0017085,0.0253109625171434,0.99551384155349,4,15,response to insecticide,BP,NEFL;CYP1A1;ZC3H12A;DAXX
6823,GO:0030282,0.0253838953142393,0.990720421190004,9,55,bone mineralization,BP,TUFT1;FGFR2;BMP2;ADRB2;OSR2;KLF10;GPNMB;BMP7;WNT4
2128,GO:0004930,0.0253878879046296,0.987245293745753,17,133,G-protein coupled receptor activity,MF,PTGER4;GPRC5A;GPR146;ADRB2;SFRP1;GPER1;GPR132;OXTR;GPR75;ACKR3;CRCP;HCAR3;OGFR;CCR6;TPRA1;TBXA2R;ADGRF3
8196,GO:0032940,0.0254440912708749,0.980953311960863,87,930,secretion by cell,BP,KRT1;SAA1;TRIM16;FTL;FTH1;MMP9;PTGER4;INHBA;S100P;FN1;CTGF;C1QTNF1;ADM;IL1R2;PML;PCDH7;SDC4;TGFB2;EDN1;GBP1;B4GALT1;MGAM;RSAD2;HRNR;PANX1;NFKB1;GNPTAB;IRS1;LYN;PLEKHO2;LAMP1;TNF;VMP1;QPCT;SIRPA;ZC3H12A;FLNA;CYB5R1;ACAA1;CADPS2;CHP1;CD274;ITGAV;SERPINE1;LIF;SFRP1;WDR1;GPER1;TXLNA;VCL;IRS2;LGALS3;TRAF2;PRKCA;SYK;PDGFB;OXTR;SPTBN1;IL1A;GLIPR1;TNFRSF21;LILRB3;DNAJC1;M6PR;CLASP1;TANGO2;MICAL3;CAB39;CD109;SOCS1;HSPA8;CPT1A;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;CD38;PSMC3;MAPK11;BMP8A;PTPRB;SNF8;HSP90AB1;LAIR1;CCL5
16556,GO:0097327,0.0255158161941993,0.989506426651477,11,74,response to antineoplastic agent,BP,NEFL;EDN1;ZC3H12A;ICAM1;CDK4;ERRFI1;DAXX;EGR1;DHFR;PDGFB;TIMELESS
19873,GO:2000352,0.0255746147761901,0.995452394131285,4,15,negative regulation of endothelial cell apoptotic process,BP,ICAM1;SERPINE1;TNIP2;TNFAIP3
15438,GO:0071711,0.0256949109283206,0.995424287909866,4,15,basement membrane organization,BP,COL4A1;CLASP1;PHLDB2;DAG1
18683,GO:1904029,0.025722439876266,0.98939970355931,11,75,regulation of cyclin-dependent protein kinase activity,BP,CDKN2B;CDKN1A;GADD45A;CDKN2A;PKMYT1;CDK4;SFN;ADAM17;PDGFB;SERTAD1;TNFAIP3
9533,GO:0036265,0.0257352409233497,0.998775950100875,2,4,RNA (guanine-N7)-methylation,BP,METTL1;WDR4
3917,GO:0008584,0.0257752762841792,0.988444479936596,13,94,male gonad development,BP,INHBA;TGFB2;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1
5586,GO:0016604,0.0258112903300607,0.981558962089659,64,654,nuclear body,CC,TRIM16;S100P;IL16;PML;IKBKE;DAPK3;TP53;SQSTM1;CDKN1A;GADD45A;RING1;TELO2;SRSF2;SART1;GEMIN5;DAXX;LSG1;USP36;AKAP8L;TRIM22;SAFB2;DDX42;PSPC1;TFIP11;ELF4;SF1;PARD3B;GEMIN4;SGK1;CD2BP2;PRPF19;NELFE;DKC1;U2AF2;CBX5;IL15;DDX17;ALYREF;PHAX;GEMIN8;SNRNP70;PRCC;SFPQ;DDX39A;TATDN2;HNRNPU;PQBP1;THOC1;ARL6IP4;RBM4;NACC1;TAP2;ACTN4;TKT;EFTUD2;INCENP;PHF5A;KIF22;RBM14;ZC3H18;TBXA2R;MKI67;TOP3A;MAGOH
6802,GO:0030246,0.0258609501966132,0.987296795218807,16,122,carbohydrate binding,MF,KRT1;P3H2;MGAM;G6PD;P4HA2;GALNT18;LAYN;GANC;GPCPD1;LGALS3;DCBLD1;M6PR;GALNT2;GBE1;TINAGL1;MGAT2
3943,GO:0008631,0.0258854223902842,0.991986812340812,7,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,CYP1B1;PML;HSPB1;SOD2;SFPQ;NOL3;PARP1
5793,GO:0017025,0.0259756455541173,0.99399178232024,5,23,TBP-class protein binding,MF,AHR;HNRNPF;RUVBL2;ESR1;PSMC3
12851,GO:0051169,0.0259914129883405,0.983822056591886,33,305,nuclear transport,BP,PML;TP53;CDKN1A;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;GEMIN5;CHP1;SFN;LSG1;AKAP8L;BANF1;NFKBIA;GEMIN4;RRS1;U2AF2;PTTG1IP;ALYREF;PHAX;GEMIN8;DDX39A;NUP214;THOC1;TNPO3;RBM4;IPO4;EIF5A;DAG1;SRSF7;HSP90AB1;MAGOH
4603,GO:0010718,0.026027185313285,0.991953667263984,7,38,positive regulation of epithelial to mesenchymal transition,BP,TGFB2;PDPN;BMP2;BAMBI;GLIPR2;ZNF703;BMP7
409,GO:0001094,0.0260936996853256,0.996917611849848,3,9,TFIID-class transcription factor binding,MF,TP53;AHR;RUVBL2
986,GO:0002443,0.0260982687908457,0.982158731529342,50,501,leukocyte mediated immunity,BP,KRT1;FTL;FTH1;MMP9;S100P;C1R;TFRC;B4GALT1;MGAM;RSAD2;EMP2;HRNR;IL27RA;NFKB1;LYN;PLEKHO2;LAMP1;TNF;QPCT;SIRPA;ACAA1;ICAM1;ITGAV;WDR1;IL7R;ADAM17;VCL;LGALS3;TRAF2;SYK;DNASE1;GLIPR1;LILRB3;SMAD7;THOC1;CXCL5;CAB39;HSPA8;COMMD9;CCR6;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;SWAP70;LAIR1;C1S
18029,GO:1902532,0.0261042137588593,0.982886168485219,41,391,negative regulation of intracellular signal transduction,BP,MMP9;DUSP14;HSPB1;SOD2;TGFB2;GBP1;MARVELD3;LYN;WWC1;ZC3H12A;TNK1;EPHA2;CHP1;ERRFI1;LIF;SFRP1;GPER1;SNAI2;AJUBA;PTTG1IP;SPRY4;ACKR3;CREB3;PARP14;DUSP1;SOCS1;ESR1;NOC2L;BCL2L2;THEM4;BMP7;PHLPP1;RAPGEF1;MYADM;DAG1;CGNL1;TNFAIP3;EFNA1;DUSP8;NOL3;SH3BP4
11016,GO:0044849,0.026128122004601,0.996911952560237,3,9,estrous cycle,BP,EGR1;ETS1;OXTR
9974,GO:0042362,0.0263375030827287,0.996877463026742,3,9,fat-soluble vitamin biosynthetic process,BP,NFKB1;TNF;SNAI2
111,GO:0000228,0.0263977676893081,0.982008967769184,49,495,nuclear chromosome,CC,PML;TP53;JUNB;MCM5;ZBED1;RING1;ENC1;TELO2;DAXX;NAT10;MCM2;TOX4;APTX;IRF1;TFIP11;SRF;ZFP42;SNAI2;RRS1;PRPF19;FEN1;CBX5;GINS2;BRMS1;ALYREF;POLA1;UHRF1;ORAOV1;MTA2;HNRNPU;RUVBL2;ORC1;THOC1;CITED2;JUN;ESR1;RCC1;MCM7;XRCC6;MPHOSPH8;INCENP;IPO4;CHAF1A;TIMELESS;SMARCC2;CDCA5;PARP1;TP63;ORC4
992,GO:0002449,0.0265370450884772,0.986593760950559,17,134,lymphocyte mediated immunity,BP,C1R;TFRC;RSAD2;EMP2;IL27RA;LAMP1;TNF;ICAM1;IL7R;TRAF2;SMAD7;THOC1;CCR6;RAB27A;TUBB;SWAP70;C1S
4670,GO:0010818,0.026664081522817,0.996823444133421,3,9,T cell chemotaxis,BP,CXCL16;ADAM17;CCL5
18392,GO:1903409,0.0267821971389138,0.989456015938506,10,66,reactive oxygen species biosynthetic process,BP,CYP1B1;NQO1;CYP1A1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;RAB27A;HSP90AB1
3183,GO:0006805,0.0267903096619364,0.989442198739553,10,67,xenobiotic metabolic process,BP,CYP1B1;NQO1;CYP1A1;UGT1A6;AHR;ACAA1;STAT5A;ACSL1;AKR1C1;HSP90AB1
8485,GO:0033631,0.0267980102493371,0.996801212413662,3,9,cell-cell adhesion mediated by integrin,BP,NPNT;SWAP70;CCL5
14192,GO:0061097,0.0267992095613002,0.990095339807111,9,56,regulation of protein tyrosine kinase activity,BP,GPRC5A;ERRFI1;EPGN;ADAM17;FGFR1OP;PDGFB;AFAP1L2;EFNA1;CCL5
547,GO:0001666,0.0268373014312416,0.983965661584991,28,254,response to hypoxia,BP,CRYAB;ADM;CYP1A1;PML;PDLIM1;TGFB2;EDN1;TP53;PSMB9;ICAM1;BMP2;PGK1;SFRP1;PSME2;SRF;TXN2;EGR1;ETS1;ZFP36L1;ADAM17;AJUBA;CITED2;ACTN4;BMP7;CD38;PSMC3;BRIP1;NOL3
4827,GO:0014031,0.0269693088868312,0.990021272778352,9,56,mesenchymal cell development,BP,NRG1;EDN1;CORO1C;SNAI2;SEMA3C;TCOF1;EFNB1;BMP7;PHACTR4
17342,GO:1900024,0.0271823773002535,0.991498607271737,7,39,regulation of substrate adhesion-dependent cell spreading,BP,GBP1;CORO1C;PDPN;FLNA;RCC2;ACTN4;MYADM
2239,GO:0005149,0.027203353349296,0.996733649218781,3,9,interleukin-1 receptor binding,MF,IL1A;TRIP6;IL36G
7314,GO:0031323,0.0272125956269058,0.976892863009873,381,4609,regulation of cellular metabolic process,BP,IGFBP3;MAFB;SAA1;TRIM16;CCL20;CRYAB;NRG1;MMP9;RUNX1;CYR61;INHBA;HDAC9;FN1;ODC1;CYP1B1;CTGF;C1QTNF1;ADM;FOSL2;NQO1;IL16;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;IRX2;RELB;TFRC;SOD2;GPRC5A;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;BIRC3;MID1;DAPK3;TET3;ELMSAN1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;PANK2;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;SFN;STAT5A;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;PARL;TRIM22;SAFB2;PPP1R3B;ANXA8;MKL1;IRF1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;DNAJB2;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;CD2BP2;SRRT;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;SNX12;DHFR;U2AF2;FGFR1OP;SHQ1;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;ROBO1;AJUBA;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;PTTG1IP;ALYREF;POLA1;RPS9;NSFL1C;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;SPRY4;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;CAPNS1;PPP1R14C;TRIB1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;PRDM7;RBM38;ATG101;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;GLIPR2;CPT1A;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;DUS2;ARGLU1;PARD3;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;PHLPP1;ZNF34;TNFRSF10A;MPHOSPH8;ELK1;PHF5A;RAPGEF1;EIF5A;MYADM;DAG1;EEF1D;RAB27A;DHX34;TIMELESS;WNT4;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;CARD10;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CREB5;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;TP63;ZBTB12;PHACTR4;CCL5;FADS1;MAGOH;SH3BP4
663,GO:0001866,0.0272711001696578,0.998661081363902,2,4,NK T cell proliferation,BP,ELF4;IL15
2654,GO:0005997,0.0273188177834703,0.998657452496635,2,4,xylulose metabolic process,BP,DCXR;TKT
8355,GO:0033218,0.0273693397058979,0.984558020648242,23,198,amide binding,MF,CRYAB;INHBA;TAP1;HLA-B;PTGES;TGFB2;NUP153;BACE2;SLC7A5;C9ORF3;TYMS;ITGAV;ADRB2;HLA-F;NFKBIA;DHFR;OXTR;NUP214;TAPBP;TNPO3;IPO4;CLTA;HSP90AB1
15623,GO:0072109,0.0273951924708753,0.996701528357639,3,9,glomerular mesangium development,BP,EGR1;PDGFB;BMP7
10116,GO:0042634,0.0274271772284926,0.993563701428565,5,23,regulation of hair cycle,BP,TGFB2;FST;TNF;KRT17;FOXN1
3121,GO:0006700,0.0274297519737259,0.994950824198642,4,16,C21-steroid hormone biosynthetic process,BP,ADM;BMP2;EGR1;WNT4
9938,GO:0042288,0.0275020709031554,0.996683592826373,3,9,MHC class I protein binding,MF,TAP1;TAPBP;TUBB
4516,GO:0010566,0.0275212410526282,0.996680372801092,3,9,regulation of ketone biosynthetic process,BP,BMP2;EGR1;WNT4
6669,GO:0030029,0.0276220754781318,0.980910509897865,52,515,actin filament-based process,BP,PTGER4;CTGF;AMOT;ACTG1;SDC4;COBLL1;EDN1;DAPK3;EMP2;NEDD9;MYO1B;ARPC4;TNF;BAIAP2;CORO1C;PDPN;TPM4;FLNA;LCP1;ICAM1;KIF23;CDC42EP2;ARPC1B;AMOTL2;SFRP1;TPM1;WDR1;SRF;RHOB;SPTBN1;NEDD4L;DPYSL3;MYH9;PALM2;SPECC1;CLASP1;PPP1R9B;MICAL3;RHOG;ACTN4;SORBS2;KANK4;PHLDB2;ZYX;MYADM;CGNL1;WNT4;MYO1E;SWAP70;BIN3;PHACTR4;BAIAP2L2
359,GO:0000977,0.0276865126170522,0.981407742686058,45,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;GADD45A;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;SRF;ELF4;ZFP42;EGR1;ETS1;SFPQ;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;KLF6;ACTN4;ELK1;SMARCC2;PARP1
11403,GO:0045793,0.0277152964346707,0.99664772528386,3,9,positive regulation of cell size,BP,EDN1;CDK4;HSP90AB1
6949,GO:0030575,0.0277323107785493,0.99664485832579,3,9,nuclear body organization,BP,PML;SF1;ETS1
16174,GO:0090192,0.0277326765509114,0.996644796684312,3,9,regulation of glomerulus development,BP,EGR1;PDGFB;BMP7
18157,GO:1902903,0.0277435315901684,0.983382396326246,28,250,regulation of supramolecular fiber organization,BP,CRYAB;PTGER4;MAP2;CTGF;SDC4;EDN1;MID1;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;SPTBN1;DCTN1;COLGALT1;SLAIN2;CLASP1;HSPA8;RHOG;KANK4;PHLDB2;MYADM;WNT4;SWAP70;BAIAP2L2
7433,GO:0031536,0.0277652331130454,0.998623329565754,2,4,positive regulation of exit from mitosis,BP,UBE2C;CDCA5
17527,GO:1901017,0.027849014598946,0.996625173949512,3,9,negative regulation of potassium ion transmembrane transporter activity,BP,NEDD4L;CAB39;OXSR1
17645,GO:1901380,0.027849014598946,0.996625173949512,3,9,negative regulation of potassium ion transmembrane transport,BP,NEDD4L;CAB39;OXSR1
14706,GO:0070330,0.0278510297191793,0.99662483376147,3,9,aromatase activity,MF,CYP1B1;CYP1A1;CYP4B1
11735,GO:0046546,0.0279299791524337,0.987330014434612,13,95,development of primary male sexual characteristics,BP,INHBA;TGFB2;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1
18346,GO:1903313,0.0280158409666069,0.989563616874842,9,56,positive regulation of mRNA metabolic process,BP,ZC3H12A;PRPF19;ZFP36L1;SF3B4;ZFP36L2;SNRNP70;HSPA8;METTL16;POLR2G
633,GO:0001822,0.0280231016737882,0.984386112115727,22,184,kidney development,BP,ODC1;SDC4;IRX2;FBN1;TGFB2;EFNB2;FGFR2;PBX1;BMP2;LIF;OSR2;SFRP1;EGR1;PDGFB;NPNT;SMAD7;APH1A;FRAS1;BMP7;COL4A4;WNT4;MYO1E
17512,GO:1900744,0.0280376831125209,0.993381707381731,5,23,regulation of p38MAPK cascade,BP,GADD45A;ZC3H12A;GADD45B;BMP2;PHLPP1
13937,GO:0060601,0.0280412738688084,0.996592671590744,3,9,lateral sprouting from an epithelium,BP,FGFR2;BMP7;TP63
11604,GO:0046209,0.028158066108791,0.990247908759028,8,48,nitric oxide metabolic process,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;HSP90AB1
11288,GO:0045598,0.0282296678895018,0.987666709500842,12,84,regulation of fat cell differentiation,BP,NOCT;TNF;TRIO;ZC3H12A;CCDC85B;BMP2;SFRP1;GPER1;SNAI2;ZFP36L1;ZFP36L2;INSIG1
11318,GO:0045637,0.0283039340200505,0.984422203590162,21,185,regulation of myeloid cell differentiation,BP,MAFB;RUNX1;INHBA;CSF2;FBN1;TJP2;LYN;TNF;IL20;LIF;SFRP1;NFKBIA;ETS1;ZFP36L1;LGALS3;PRKCA;RBBP5;LILRB3;TRIB1;KLF10;JUN
6931,GO:0030532,0.0283928443512428,0.988681797019672,10,69,small nuclear ribonucleoprotein complex,CC,SART1;DDX23;ZMAT2;LUC7L;GEMIN4;CD2BP2;SNRNP70;TXNL4B;EFTUD2;PHF5A
12326,GO:0048678,0.0284322859181147,0.990118522658264,8,49,response to axon injury,BP,NEFL;LYN;TNC;TXN2;DHFR;DPYSL3;JUN;DAG1
15236,GO:0071392,0.0284988021483375,0.993243496585606,5,23,cellular response to estradiol stimulus,BP,SFRP1;GPER1;RUVBL2;ESR1;ZNF703
4623,GO:0010743,0.0285419829428069,0.994680051382497,4,16,regulation of macrophage derived foam cell differentiation,BP,CSF2;NFKB1;ITGAV;NFKBIA
301,GO:0000808,0.0285725596493811,0.996502378139285,3,9,origin recognition complex,CC,MCM2;ORC1;ORC4
2452,GO:0005664,0.0285725596493811,0.996502378139285,3,9,nuclear origin of replication recognition complex,CC,MCM2;ORC1;ORC4
10611,GO:0043589,0.0286161605750655,0.996494937080407,3,9,skin morphogenesis,BP,ERRFI1;SRF;TP63
7479,GO:0031643,0.0286185182342781,0.996494534582133,3,9,positive regulation of myelination,BP,NRG1;PARD3;DAG1
2410,GO:0005583,0.0286443522744003,0.99649012331286,3,9,fibrillar collagen trimer,CC,COL27A1;COL5A3;COL5A2
16801,GO:0098643,0.0286443522744003,0.99649012331286,3,9,banded collagen fibril,CC,COL27A1;COL5A3;COL5A2
10909,GO:0044454,0.028707589711901,0.980570736118989,46,464,nuclear chromosome part,CC,PML;TP53;JUNB;MCM5;RING1;ENC1;TELO2;DAXX;NAT10;MCM2;TOX4;APTX;IRF1;TFIP11;SRF;ZFP42;SNAI2;PRPF19;FEN1;CBX5;GINS2;BRMS1;ALYREF;POLA1;UHRF1;ORAOV1;MTA2;RUVBL2;ORC1;THOC1;CITED2;JUN;ESR1;RCC1;MCM7;XRCC6;MPHOSPH8;INCENP;IPO4;CHAF1A;TIMELESS;SMARCC2;CDCA5;PARP1;TP63;ORC4
3932,GO:0008612,0.0287251957217113,0.998548896651614,2,4,peptidyl-lysine modification to peptidyl-hypusine,BP,DOHH;EIF5A
6911,GO:0030501,0.0287370487898695,0.993171836781936,5,23,positive regulation of bone mineralization,BP,BMP2;ADRB2;OSR2;BMP7;WNT4
14610,GO:0070169,0.0287370487898695,0.993171836781936,5,23,positive regulation of biomineral tissue development,BP,BMP2;ADRB2;OSR2;BMP7;WNT4
11889,GO:0046903,0.0287398341301391,0.97819494328156,92,994,secretion,BP,KRT1;SAA1;TRIM16;FTL;FTH1;NRG1;MMP9;PTGER4;INHBA;S100P;FN1;CTGF;C1QTNF1;ADM;IL1R2;PML;PCDH7;SDC4;CSF2;TGFB2;EDN1;GBP1;B4GALT1;MGAM;RSAD2;HRNR;PANX1;NFKB1;GNPTAB;IRS1;LYN;PLEKHO2;LAMP1;TNF;VMP1;QPCT;SIRPA;ZC3H12A;FLNA;CYB5R1;ACAA1;CADPS2;CHP1;CD274;ITGAV;STAT5A;SERPINE1;LIF;SFRP1;WDR1;GPER1;SGK1;TXLNA;VCL;IRS2;LGALS3;TRAF2;PRKCA;SYK;PDGFB;OXTR;SPTBN1;IL1A;GLIPR1;TNFRSF21;LILRB3;DNAJC1;M6PR;CLASP1;TANGO2;MICAL3;CAB39;CD109;SOCS1;HSPA8;SLC22A4;CPT1A;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;CD38;PSMC3;MAPK11;BMP8A;PTPRB;SNF8;HSP90AB1;LAIR1;CCL5
3164,GO:0006775,0.0287909495539412,0.993116124740855,5,24,fat-soluble vitamin metabolic process,BP,CYP24A1;CYP1A1;NFKB1;TNF;SNAI2
7259,GO:0031226,0.0288267496887323,0.978793654086044,74,768,intrinsic component of plasma membrane,CC,NRG1;TENM3;C1QTNF1;SLC16A2;PCDH7;SDC4;TFRC;GPRC5A;CD83;TRAF3;STEAP4;IL27RA;IRS1;LYN;LAMP1;TNF;EFNB2;PDPN;FGFR2;SLC7A5;EPHB6;SLC16A9;EPHA2;ICAM1;BMP2;SLCO3A1;SLC7A5P2;ITGAV;EPGN;ADRB2;IFNGR1;SLC5A6;FXYD3;EBP;RELT;THBD;GPER1;KCNA7;ADAM17;TRAF2;IL15;SLC7A2;ROBO1;BCAM;OXTR;MYH9;COL17A1;NPNT;GPR75;TNFRSF21;LILRB3;ROR1;SLC43A2;TRIP6;M6PR;APH1A;SLC4A11;KCNIP3;SLC22A4;HCAR3;CCR6;GPNMB;GP6;SMPD2;CNTNAP1;EFNB1;TNFRSF10A;ZYX;SLC4A2;EFNA1;PTPRB;TBXA2R;IL6R;SLC2A6
12553,GO:0050705,0.0288338654774214,0.998540380478237,2,4,regulation of interleukin-1 alpha secretion,BP,IL1R2;PANX1
16108,GO:0090087,0.0290523696793163,0.980080725144394,49,488,regulation of peptide transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;TP53;IRS1;CDKN1A;LYN;TNF;PTPN14;ZC3H12A;LCP1;CYB5R1;CHP1;CD274;SFN;USP36;AKAP8L;SFRP1;PARL;GPER1;SNX12;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;WDR46;DNAJC1;UBE2J2;SOCS1;HSPA8;CPT1A;INSIG1;SNIP1;CD38;MAPK11;BMP8A;HSP90AB1;CCL5
2384,GO:0005520,0.0290698274164633,0.994550305697978,4,16,insulin-like growth factor binding,MF,IGFBP3;CYR61;CTGF;ITGAV
10597,GO:0043565,0.0291095928106815,0.978619755874712,73,754,sequence-specific DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;IRX2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;HNRNPAB;NFKB1;AHR;JUNB;MCM5;GADD45A;ZBED1;PBX1;NFKB2;TELO2;FOSL1;KLF7;FOXD2;MCM2;ELF3;GRWD1;OSR2;SAFB2;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;EDF1;ETS1;SNAI2;MAFK;ZNF778;UBTF;UHRF1;ZNF263;SFPQ;ZW10;MAFF;MTA2;HNRNPU;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;SAFB;ETS2;KLF10;JUN;ESR1;IKZF3;FOXN1;TFDP1;GTF2E1;XRCC6;KLF6;TEAD4;ACTN4;ELK1;SMARCC2;PARP1;TP63;ORC4
3336,GO:0007049,0.0292627923754925,0.976713760685132,138,1548,cell cycle,BP,INHBA;CTGF;CYP1A1;PML;CYLD;MYBL2;MAP3K14;TGFB2;EDN1;BIRC3;DAPK3;KLHL21;TP53;NEDD9;CDKN2B;LFNG;CDKN1A;AHR;JUNB;MCM5;GADD45A;TNF;CDKN2A;RING1;PKMYT1;FGFR2;PBX1;NUP153;PSMB9;FOSL1;UBE2C;TYMS;FLNA;SRSF2;ZNF503;GADD45B;BMP2;CDK4;KIF23;SFN;EPGN;SVIL;MCM2;CCDC124;AKAP8L;LIF;SFRP1;IRF1;PSME2;BANF1;GPER1;NSUN2;ZFP42;PARD3B;RRS1;ZFP36L1;AKAP8;RHOB;ADAM17;FEN1;DHFR;FGFR1OP;CBX5;PRKCA;GPR132;ZFP36L2;AJUBA;GINS2;CDKL1;PDGFB;POLA1;SPTBN1;DCTN1;UHRF1;MYH9;IL1A;ORAOV1;PRCC;SFPQ;ZW10;RCC2;NUP214;AFAP1L2;HNRNPU;CLASP1;PAGR1;CEP41;PPP1R9B;ORC1;MICAL3;THOC1;ANAPC15;RBM38;DUSP1;CAB39;TXNL4B;CITED2;OXSR1;HSPA8;JUN;CENPN;PES1;RCC1;MCM7;TFDP1;CHMP4B;SERTAD1;ZNF703;CENPO;CNTROB;PARD3;GPNMB;BMP7;URGCP;TPRA1;INCENP;CHAF1A;KIF22;TIMELESS;WNT4;RBM14;TUBB;CTDSP1;TNFAIP3;PSMC3;BRIP1;RRM2;CXCL8;CLTA;CDCA5;HSP90AB1;MKI67;BIN3;TP63;PHACTR4;TOP3A;ORC4;APEX2
4818,GO:0014012,0.0292672292010096,0.998506237532603,2,4,peripheral nervous system axon regeneration,BP,NEFL;TNC
10302,GO:0043065,0.0293176890045978,0.980049320694498,47,468,positive regulation of apoptotic process,BP,IGFBP3;MMP9;CYR61;INHBA;CYP1B1;CTGF;ADM;NQO1;PML;CYLD;MYBL2;TGFB2;DAPK3;B4GALT1;TP53;SQSTM1;LYN;GADD45A;TNF;CDKN2A;TRIO;FOSL1;ZC3H12A;GADD45B;CD274;BMP2;CDK4;SFN;TNFRSF12A;SFRP1;GPER1;RHOB;SHQ1;TRAF2;ROBO1;BRMS1;SFPQ;YWHAH;APH1A;DUSP1;JUN;TFDP1;BMP7;TNFRSF10A;PPP2R1B;TP63;CCL5
9852,GO:0042098,0.0293575402661196,0.986126882244457,14,106,T cell proliferation,BP,SDC4;TFRC;CD274;IRF1;ELF4;LGALS3;IL15;SYK;TNFRSF21;GPNMB;EFNB1;WNT4;CTPS1;CCL5
11802,GO:0046683,0.0293633401404397,0.987087937973747,12,85,response to organophosphorus,BP,TRIM16;PANX1;AHR;JUNB;FOSL1;TYMS;THBD;ZFP36L1;DUSP1;JUN;RAPGEF1;AKR1C1
9268,GO:0035690,0.029375448729407,0.982490533359508,27,241,cellular response to drug,BP,CYP1B1;NQO1;TFRC;EDN1;TP53;NFKB1;AHR;TNF;BAIAP2;ZC3H12A;ICAM1;CDK4;ERRFI1;DAXX;SFRP1;EGR1;ETS1;RHOB;TRAF2;PDGFB;PPP1R9B;QDPR;EFTUD2;TIMELESS;TNFAIP3;GCLC;HSP90AB1
224,GO:0000463,0.0294391939490328,0.99623719466761,3,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,FTSJ3;NOL9;PES1
8437,GO:0033554,0.0295677558456579,0.976377103605827,143,1619,cellular response to stress,BP,CRYAB;MMP9;PTGER4;NEFL;CYP1B1;CTGF;ADM;NQO1;PML;HSPB1;RELB;BAG1;SOD2;MAP3K14;TGFB2;EDN1;TXNRD1;IKBKE;MID1;G6PD;NUAK1;TP53;NFE2L1;SQSTM1;MARVELD3;NFKB1;CDKN1A;UBQLN2;LYN;JUNB;GADD45A;TNF;CDKN2A;TNC;ASCC2;NUP153;DNAJB1;PSMB9;ZC3H12A;CADPS2;EPHA2;GADD45B;ICAM1;FANCC;PITHD1;BMP2;UBE4B;ERRFI1;SFN;ANKS4B;DAXX;PGK1;AEN;SFRP1;TPM1;APTX;PSME2;TFIP11;SRF;TXN2;NFKBIA;EGR1;ETS1;SGK1;SNAI2;PRPF19;ZFP36L1;RHOB;FEN1;DHFR;IER3;NPAS2;TRAF2;SYK;AJUBA;GINS2;USP43;PTTG1IP;POLA1;DCTN1;UHRF1;IL1A;COPS3;ORAOV1;TNIP2;RBBP5;SFPQ;DDX39A;PXMP2;NUP214;ACKR3;TATDN2;PAGR1;UBE2J2;TRIB1;CREB3;RUVBL2;TUSC1;THOC1;KLF10;SUSD6;CAB39;CITED2;STAC;OXSR1;HSPA8;JUN;MCM7;TFDP1;RBM4;INSIG1;HERC2;BCL2L2;ZNF365;XRCC6;CHCHD6;BMP7;SMUG1;PHLPP1;RAPGEF1;CHAF1A;KIF22;DAG1;RNF185;TIMELESS;WNT4;RBM14;TRAF4;TNFAIP3;PSMC3;BRIP1;SUPT16H;CXCL8;MAPK11;POLR2G;NOL3;CDCA5;HSP90AB1;PARP1;TP63;TOP3A;FADS1;APEX2
12143,GO:0048245,0.0296255412152053,0.998477789437647,2,4,eosinophil chemotaxis,BP,LGALS3;CCL5
12417,GO:0048864,0.0297153614344087,0.988799319533122,9,57,stem cell development,BP,NRG1;EDN1;CORO1C;SNAI2;SEMA3C;TCOF1;EFNB1;BMP7;PHACTR4
8096,GO:0032781,0.0299890446215194,0.990381173139249,7,41,positive regulation of ATPase activity,BP,DNAJB1;TPM1;DNAJB2;UHRF1;DNAJC1;HNRNPU;DNAJC9
4474,GO:0010470,0.0299904148079622,0.99279207885788,5,23,regulation of gastrulation,BP,COL5A2;CLASP1;PHLDB2;MYADM;DAG1
19872,GO:2000351,0.0300569247800788,0.992771798270092,5,23,regulation of endothelial cell apoptotic process,BP,ICAM1;SERPINE1;GPER1;TNIP2;TNFAIP3
3658,GO:0008139,0.0302379123743558,0.992716545529033,5,23,nuclear localization sequence binding,MF,NUP153;NFKBIA;NUP214;TNPO3;IPO4
746,GO:0001976,0.030281933363746,0.998425166096464,2,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,SOD2;NAV2
6283,GO:0019887,0.0303114435088872,0.984097336874542,18,146,protein kinase regulator activity,MF,NRG1;HSPB1;CDKN2B;CDKN1A;CDKN2A;CHP1;CDK4;SFN;DAXX;FGFR1OP;RPLP1;AFAP1L2;TRIB1;CAB39;SOCS1;DUS2;HSP90AB1;CCL5
13917,GO:0060574,0.0303714379834402,0.998417939638938,2,4,intestinal epithelial cell maturation,BP,CDKN1A;TYMS
2575,GO:0005862,0.0304441746876181,0.998412058041548,2,4,muscle thin filament tropomyosin,CC,TPM4;TPM1
14195,GO:0061101,0.0305074248283131,0.998406937021167,2,4,neuroendocrine cell differentiation,BP,BMP2;WNT4
7496,GO:0031667,0.0306053689527825,0.980550697906351,34,318,response to nutrient levels,BP,CYP24A1;ADM;NQO1;CYP1A1;G6PD;PANX1;TP53;CDKN2B;CDKN1A;BAIAP2;TNC;TYMS;ZC3H12A;SRSF2;CADPS2;HMGCS1;ICAM1;ADRB2;SFRP1;SRF;TXN2;SNAI2;IL15;ACSL1;KLF10;HSPA8;JUN;BMP7;WNT4;BRIP1;BMP8A;GCLC;TBXA2R;FADS1
12666,GO:0050870,0.0306523652590201,0.984998034182053,15,116,positive regulation of T cell activation,BP,CYLD;TFRC;CD83;MAP3K14;LYN;EFNB2;SIRPA;SART1;CD274;IL7R;IL15;SYK;SOCS1;EFNB1;CCL5
380,GO:0001012,0.0307221551724111,0.979218223209032,45,436,RNA polymerase II regulatory region DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;GADD45A;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;SRF;ELF4;ZFP42;EGR1;ETS1;SFPQ;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;KLF6;ACTN4;ELK1;SMARCC2;PARP1
1258,GO:0003012,0.0308080039962979,0.981956537377328,25,221,muscle system process,BP,CRYAB;CTGF;EDN1;DAPK3;G6PD;TPM4;ZC3H12A;FLNA;ERRFI1;ADRB2;TPM1;GPER1;SRF;VCL;IL15;PRKCA;OXTR;NEDD4L;NPNT;SMAD7;STAC;SORBS2;NOL3;TBXA2R;PARP1
634,GO:0001823,0.0308554088299395,0.987562266406146,10,66,mesonephros development,BP,SDC4;FGFR2;PBX1;BMP2;OSR2;SFRP1;NPNT;SMAD7;BMP7;WNT4
10750,GO:0044130,0.0309406098651343,0.998371701713634,2,4,negative regulation of growth of symbiont in host,BP,SQSTM1;TNF
10753,GO:0044146,0.0309406098651343,0.998371701713634,2,4,negative regulation of growth of symbiont involved in interaction with host,BP,SQSTM1;TNF
8421,GO:0033489,0.0309554651642661,0.998370488357683,2,4,cholesterol biosynthetic process via desmosterol,BP,EBP;DHCR7
8422,GO:0033490,0.0309554651642661,0.998370488357683,2,4,cholesterol biosynthetic process via lathosterol,BP,EBP;DHCR7
8746,GO:0034394,0.0310149043594506,0.990002673662344,7,40,protein localization to cell surface,BP,NRG1;EMP2;TNF;FLNA;VCL;NEDD4L;HSP90AB1
3763,GO:0008307,0.0311204374807819,0.992402455501251,5,24,structural constituent of muscle,MF,TPM4;JPH1;TPM1;SORBS2;DAG1
14572,GO:0070100,0.0312226118667941,0.998348611544469,2,4,negative regulation of chemokine-mediated signaling pathway,BP,ROBO1;CCL5
11511,GO:0045995,0.0314324634227736,0.986036853198326,12,85,regulation of embryonic development,BP,AMOT;RBM19;NOCT;LFNG;SFRP1;COL5A2;CLASP1;BMP7;PHLDB2;MYADM;DAG1;WNT4
11273,GO:0045578,0.0315413833088481,0.998322366851993,2,4,negative regulation of B cell differentiation,BP,INHBA;SFRP1
1472,GO:0003729,0.031589614968184,0.982425851266988,21,180,mRNA binding,MF,TP53;HNRNPAB;NOCT;TYMS;ZC3H12A;GEMIN5;PABPC4;LUC7L;ZFP36L1;DHFR;ACO1;ZFP36L2;PUM3;RPS2;SNRNP70;SUPT5H;HNRNPU;RBM38;RBM4;SNIP1;CLUH
11881,GO:0046888,0.0316173338490121,0.990897159327171,6,32,negative regulation of hormone secretion,BP,INHBA;EDN1;IRS1;LIF;SFRP1;BMP8A
3765,GO:0008309,0.0316525231174253,0.998313180831556,2,4,double-stranded DNA exodeoxyribonuclease activity,MF,FEN1;APEX2
11455,GO:0045907,0.0316831163761633,0.993896496307283,4,16,positive regulation of vasoconstriction,BP,ICAM1;OXTR;CD38;TBXA2R
7498,GO:0031669,0.0317379719208438,0.982631195781126,20,166,cellular response to nutrient levels,BP,CYP24A1;TP53;CDKN2B;CDKN1A;BAIAP2;TNC;ZC3H12A;CADPS2;ICAM1;SFRP1;SRF;TXN2;SNAI2;IL15;KLF10;HSPA8;JUN;WNT4;BRIP1;FADS1
3442,GO:0007250,0.0317490285641244,0.993879764410931,4,16,activation of NF-kappaB-inducing kinase activity,BP,TRAF2;TNFRSF10A;TRAF4;CARD10
9896,GO:0042178,0.0318203765738487,0.995806257281825,3,10,xenobiotic catabolic process,BP,CYP1A1;ACAA1;ACSL1
664,GO:0001867,0.0318787423608107,0.998294426133144,2,4,complement activation, lectin pathway,BP,KRT1;C1S
9660,GO:0038003,0.0318854810034713,0.998293866294488,2,4,opioid receptor signaling pathway,BP,PPP1R9B;OGFR
15907,GO:0072676,0.031892378373816,0.989636188949376,7,41,lymphocyte migration,BP,SAA1;CCL20;CXCL16;ADAM17;CCR6;CCL22;CCL5
1322,GO:0003171,0.0319276801281982,0.993834354733403,4,16,atrioventricular valve development,BP,CYR61;TGFB2;BMP2;EFNA1
17799,GO:1901889,0.0319319978408562,0.993833256196075,4,16,negative regulation of cell junction assembly,BP,TNF;CORO1C;RCC2;PHLDB2
6591,GO:0022604,0.031933626471664,0.979362469292468,36,338,regulation of cell morphogenesis,BP,NRG1;MAP2;FN1;NEFL;GBP1;DAPK3;BAIAP2;CORO1C;PDPN;FLNA;ICAM1;L1CAM;MYO10;CDC42EP2;TNFRSF12A;TPM1;ZFYVE27;WDR1;SRF;RHOB;NTN1;ROBO1;NEDD4L;MYH9;SEMA3C;TBCCD1;RCC2;BAMBI;YWHAH;PALM2;PQBP1;ZSWIM6;ACTN4;MYADM;DAG1;EFNA1
15216,GO:0071362,0.0319682280467189,0.998286986245146,2,4,cellular response to ether,BP,ZC3H12A;CDK4
3122,GO:0006701,0.031981127017163,0.99828591283356,2,4,progesterone biosynthetic process,BP,ADM;EGR1
6951,GO:0030578,0.0319903605630428,0.998285144294792,2,4,PML body organization,BP,PML;ETS1
19545,GO:1990481,0.0320239845438546,0.998282344585582,2,4,mRNA pseudouridine synthesis,BP,PUS1;DKC1
6013,GO:0019062,0.0321088143103678,0.998275273733034,2,4,virion attachment to host cell,BP,ICAM1;HSP90AB1
10953,GO:0044650,0.0321088143103678,0.998275273733034,2,4,adhesion of symbiont to host cell,BP,ICAM1;HSP90AB1
2605,GO:0005903,0.0321651053842359,0.987687238611218,9,58,brush border,CC,B4GALT1;MYO1B;ANKS4B;SLC5A6;MYH9;DCXR;ACTN4;MYO1E;HSP90AB1
6663,GO:0030017,0.0322649959912314,0.984549682263872,14,107,sarcomere,CC,CRYAB;JPH2;HSPB1;PDLIM1;SQSTM1;DST;TPM4;JPH1;FLNA;TPM1;SPTBN1;FHL2;ACTN4;SORBS2
9996,GO:0042406,0.0323102362462233,0.998258441648412,2,4,extrinsic component of endoplasmic reticulum membrane,CC,PML;ZC3H12A
754,GO:0001993,0.0324086557048281,0.99825019518586,2,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,ADRB2;TPM1
19412,GO:1905953,0.0326371616724379,0.991929415323883,5,24,negative regulation of lipid localization,BP,NFKB1;TNF;ITGAV;NFKBIA;IRS2
12877,GO:0051205,0.0326687633403367,0.989329328930621,7,41,protein insertion into membrane,BP,TP53;SFN;REEP1;TRAM2;YWHAH;TFDP1;TP63
1368,GO:0003253,0.0327106052664934,0.998224805576386,2,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,SEMA3C;BMP7
4392,GO:0010046,0.0327320273612842,0.998222999161716,2,4,response to mycotoxin,BP,EGR1;PDGFB
4199,GO:0009306,0.0327868966650668,0.978900286093522,35,331,protein secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;TGFB2;GBP1;RSAD2;PANX1;GNPTAB;IRS1;LYN;TNF;ZC3H12A;CD274;ITGAV;SFRP1;GPER1;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;DNAJC1;M6PR;TANGO2;SOCS1;CPT1A;CD38;MAPK11;BMP8A;CCL5
13245,GO:0051918,0.0328334228162264,0.998214439807185,2,4,negative regulation of fibrinolysis,BP,SERPINE1;THBD
10767,GO:0044212,0.0328579230337078,0.976451266709495,60,608,transcription regulatory region DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;ELMSAN1;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;GADD45A;TNF;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;ETS1;NPAS2;MAFK;UBTF;UHRF1;RBBP5;SFPQ;SMAD7;MTA2;HNRNPU;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;SAFB;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;XRCC6;KLF6;TEAD4;ACTN4;ELK1;SMARCC2;PARP1;TP63
15630,GO:0072126,0.0328993581914651,0.998208865690571,2,4,positive regulation of glomerular mesangial cell proliferation,BP,EGR1;PDGFB
4557,GO:0010638,0.0329373527702651,0.977054861512613,51,513,positive regulation of organelle organization,BP,NRG1;MMP9;CTGF;PML;SDC4;CSF2;EDN1;TP53;ARPC4;TNF;BAIAP2;UBE2C;LCP1;CYB5R1;ICAM1;SFN;CDC42EP2;EPGN;ADRB2;ARPC1B;USP36;AKAP8L;LIF;SFRP1;TPM1;WDR1;GPER1;SNAI2;AKAP8;NELFE;DKC1;FEN1;PDGFB;DCTN1;SLAIN2;IL1A;SFPQ;WDR46;YWHAH;HNRNPU;CLASP1;UBE2J2;RUVBL2;TFDP1;RHOG;SNIP1;WNT4;CDCA5;SWAP70;TP63;BAIAP2L2
13783,GO:0060369,0.0329632503175381,0.998203458189966,2,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,LYN;RAPGEF1
11247,GO:0045446,0.033019160602425,0.986524568843148,10,67,endothelial cell differentiation,BP,NRG1;TJP2;TNF;PDPN;ICAM1;EDF1;TJP1;MARVELD2;RAPGEF1;MYADM
12632,GO:0050819,0.0330219789801148,0.990394277492971,6,32,negative regulation of coagulation,BP,KRT1;C1QTNF1;EDN1;SERPINE1;THBD;PDGFB
12657,GO:0050861,0.0332084335887724,0.99818265131816,2,4,positive regulation of B cell receptor signaling pathway,BP,LYN;CMTM3
8288,GO:0033093,0.0332663988712836,0.99817771931038,2,4,Weibel-Palade body,CC,EDN1;RAB27A
6642,GO:0023029,0.033351589642751,0.998170461847094,2,4,MHC class Ib protein binding,MF,TAP1;TAP2
9679,GO:0038044,0.0334480232623966,0.998162233740453,2,4,transforming growth factor-beta secretion,BP,FN1;ITGAV
16652,GO:0097524,0.0334769070037782,0.998159766607643,2,4,sperm plasma membrane,CC,CCR6;HSP90AB1
16534,GO:0097267,0.0334834083450199,0.998159211120596,2,4,omega-hydroxylase P450 pathway,BP,CYP1B1;CYP1A1
16112,GO:0090091,0.0334880015753143,0.998158818628845,2,4,positive regulation of extracellular matrix disassembly,BP,PDPN;CLASP1
8628,GO:0034144,0.0334884550571042,0.998158779877126,2,4,negative regulation of toll-like receptor 4 signaling pathway,BP,LYN;TNFAIP3
6569,GO:0022028,0.0334885032154769,0.998158775761795,2,4,tangential migration from the subventricular zone to the olfactory bulb,BP,SRF;ROBO1
8122,GO:0032808,0.0334885032154769,0.998158775761795,2,4,lacrimal gland development,BP,FGFR2;IGSF3
11209,GO:0045341,0.0334885032154769,0.998158775761795,2,4,MHC class I biosynthetic process,BP,PML;NLRC5
11211,GO:0045343,0.0334885032154769,0.998158775761795,2,4,regulation of MHC class I biosynthetic process,BP,PML;NLRC5
11212,GO:0045345,0.0334885032154769,0.998158775761795,2,4,positive regulation of MHC class I biosynthetic process,BP,PML;NLRC5
14022,GO:0060745,0.0334885032154769,0.998158775761795,2,4,mammary gland branching involved in pregnancy,BP,ESR1;WNT4
14105,GO:0060947,0.0334885032154769,0.998158775761795,2,4,cardiac vascular smooth muscle cell differentiation,BP,GPER1;SRF
14254,GO:0061304,0.0334885032154769,0.998158775761795,2,4,retinal blood vessel morphogenesis,BP,CYP1B1;COL4A1
14320,GO:0061476,0.0334885032154769,0.998158775761795,2,4,response to anticoagulant,BP,SFRP1;EGR1
15313,GO:0071503,0.0334885032154769,0.998158775761795,2,4,response to heparin,BP,SFRP1;EGR1
15314,GO:0071504,0.0334885032154769,0.998158775761795,2,4,cellular response to heparin,BP,SFRP1;EGR1
16066,GO:0090009,0.0334885032154769,0.998158775761795,2,4,primitive streak formation,BP,SRF;ETS2
9600,GO:0036457,0.0334885032154769,0.998158775761795,2,4,keratohyalin granule,CC,HRNR;RPTN
18518,GO:1903690,0.0334885032154913,0.998158775761795,2,4,negative regulation of wound healing, spreading of epidermal cells,BP,CLASP1;PHLDB2
4466,GO:0010460,0.0335731775589221,0.995480332535437,3,10,positive regulation of heart rate,BP,ADM;EDN1;TPM1
7801,GO:0032350,0.033598280931968,0.991626344609199,5,24,regulation of hormone metabolic process,BP,NFKB1;TNF;BMP2;EGR1;WNT4
11449,GO:0045899,0.0335985089277189,0.995475569299586,3,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;ESR1;PSMC3
3184,GO:0006807,0.033711568368188,0.971273685039522,587,7367,nitrogen compound metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;C1QTNF1;DTX2;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;P4HA2;PANK2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;HS3ST2;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;ADRB2;IL20;DAXX;FOXD2;NAT10;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;DKC1;FEN1;SNX12;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;COX5B;RNF115;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;ACSL1;NOP56;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;SLC22A4;PES1;USP31;FOXN1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;SMPD2;KBTBD12;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;DHX34;TIMELESS;DPM3;WNT4;MRPS2;RBM14;AKR1C1;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;XPNPEP3;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;C1S;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
396,GO:0001067,0.0338087652307143,0.975727679528155,60,609,regulatory region nucleic acid binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;ELMSAN1;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;GADD45A;TNF;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;ETS1;NPAS2;MAFK;UBTF;UHRF1;RBBP5;SFPQ;SMAD7;MTA2;HNRNPU;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;SAFB;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;XRCC6;KLF6;TEAD4;ACTN4;ELK1;SMARCC2;PARP1;TP63
14724,GO:0070373,0.0338147230164885,0.987845333648051,8,49,negative regulation of ERK1 and ERK2 cascade,BP,GBP1;LYN;ERRFI1;LIF;GPER1;SPRY4;DUSP1;RAPGEF1
979,GO:0002433,0.0340425130627773,0.986834118870511,9,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,ACTG1;LYN;ARPC4;BAIAP2;MYO10;ARPC1B;SYK;RAPGEF1;HSP90AB1
9700,GO:0038096,0.0340425130627773,0.986834118870511,9,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,ACTG1;LYN;ARPC4;BAIAP2;MYO10;ARPC1B;SYK;RAPGEF1;HSP90AB1
12256,GO:0048536,0.0344069196615888,0.99136940358439,5,24,spleen development,BP,CDKN2B;PBX1;NFKB2;ADAM17;CITED2
358,GO:0000976,0.0348289382893921,0.975742023939542,50,496,transcription regulatory region sequence-specific DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;RELB;ARID3B;IER2;NLRC5;TP53;NFE2L1;NFKB1;AHR;JUNB;GADD45A;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;PSPC1;SRF;ELF4;ZFP42;EGR1;ETS1;MAFK;UBTF;UHRF1;SFPQ;MTA2;CREB3;RUVBL2;MAZ;TUSC1;KCNIP3;ETS2;KLF10;JUN;ESR1;IKZF3;TFDP1;KLF6;ACTN4;ELK1;SMARCC2;PARP1
10574,GO:0043536,0.0348311277056874,0.988465874235224,7,41,positive regulation of blood vessel endothelial cell migration,BP,HDAC9;HSPB1;STAT5A;ETS1;ADAM17;PRKCA;PDGFB
8618,GO:0034134,0.0349480581895663,0.995219654212806,3,10,toll-like receptor 2 signaling pathway,BP,LYN;TNIP2;TNFAIP3
508,GO:0001570,0.0349834383355629,0.987341100555981,8,49,vasculogenesis,BP,ADM;AMOT;EMP2;JUNB;ITGAV;ZFP36L1;ACKR3;MYO1E
13467,GO:0055001,0.0350575473394373,0.984149116334973,12,87,muscle cell development,BP,HDAC9;ADM;ACTG1;EDN1;G6PD;TPM1;WDR1;SRF;FHL2;HNRNPU;SORBS2;BIN3
13705,GO:0060261,0.0351336390665438,0.992930149717262,4,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;SRF;ESR1;PSMC3
15467,GO:0071803,0.0351482506921573,0.995181334910583,3,10,positive regulation of podosome assembly,BP,CSF2;TNF;LCP1
10166,GO:0042752,0.0351790891216126,0.985474933789698,10,68,regulation of circadian rhythm,BP,PML;CSF2;TP53;NOCT;PSPC1;SFPQ;KLF10;RBM4;PHLPP1;TIMELESS
15691,GO:0072216,0.0352343818524952,0.995164820204815,3,10,positive regulation of metanephros development,BP,LIF;EGR1;PDGFB
3520,GO:0007492,0.0352976173004546,0.986258551845322,9,58,endoderm development,BP,MMP9;INHBA;FN1;COL12A1;ITGAV;ZFP36L1;COL5A2;DUSP1;LAMC1
16653,GO:0097525,0.0353812295921639,0.986160435253401,9,62,spliceosomal snRNP complex,CC,SART1;DDX23;ZMAT2;LUC7L;CD2BP2;SNRNP70;TXNL4B;EFTUD2;PHF5A
11420,GO:0045833,0.0354312620989185,0.987127443299723,8,50,negative regulation of lipid metabolic process,BP,NFKB1;TNF;BMP2;GPER1;SNAI2;PDGFB;INSIG1;WNT4
392,GO:0001047,0.0354611246105367,0.982309702982785,15,116,core promoter binding,MF,RUNX1;RELB;NLRC5;TP53;GADD45A;PSPC1;NPAS2;UBTF;SFPQ;HNRNPU;RUVBL2;MAZ;SAFB;KLF10;ESR1
1108,GO:0002697,0.035504920272848,0.979421707371203,23,202,regulation of immune effector process,BP,C1R;TFRC;TGFB2;BIRC3;RSAD2;TRAF3;IL27RA;LYN;LAMP1;TNF;ZC3H12A;IL7R;LGALS3;TRAF2;IL15;SYK;DNASE1;SMAD7;PQBP1;THOC1;RAPGEF1;TNFAIP3;C1S
12144,GO:0048246,0.0356920366728867,0.992714459778204,4,18,macrophage chemotaxis,BP,SAA1;MTUS1;LGALS3;CCL5
2811,GO:0006270,0.0357221434421974,0.988106406792468,7,41,DNA replication initiation,BP,MCM5;MCM2;GINS2;POLA1;ORC1;MCM7;ORC4
8156,GO:0032885,0.0358118030683576,0.990918844541045,5,24,regulation of polysaccharide biosynthetic process,BP,NFKB1;IRS1;PPP1R3B;IRS2;PDGFB
1450,GO:0003682,0.0358263549521925,0.975601204308291,44,436,chromatin binding,MF,FOSL2;RELB;TP53;NFKB1;MCM5;RING1;NFKB2;ZC3H12A;TOX4;GRWD1;APTX;GPER1;SRF;EGR1;SNAI2;NELFE;CBX5;POLR1A;AJUBA;UBTF;POLA1;UHRF1;SFPQ;SUPT5H;MTA2;HNRNPU;RUVBL2;ORC1;SAFB;DNTTIP1;CITED2;JUN;ESR1;RCC1;NOC2L;ACTN4;HMGN2;ELK1;CHAF1A;SMARCC2;BRIP1;SUPT16H;CDCA5;TP63
15909,GO:0072678,0.0361944678923641,0.990747950684655,5,25,T cell migration,BP,CCL20;CXCL16;ADAM17;CCR6;CCL5
3253,GO:0006913,0.0362099665989703,0.976997060222744,32,302,nucleocytoplasmic transport,BP,PML;TP53;CDKN1A;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;GEMIN5;CHP1;SFN;LSG1;AKAP8L;NFKBIA;GEMIN4;RRS1;U2AF2;PTTG1IP;ALYREF;PHAX;GEMIN8;DDX39A;NUP214;THOC1;TNPO3;RBM4;IPO4;EIF5A;DAG1;SRSF7;HSP90AB1;MAGOH
6063,GO:0019211,0.0362724795892721,0.994964452486968,3,10,phosphatase activator activity,MF,IGFBP3;BMP2;PHACTR4
11346,GO:0045669,0.0363744594016279,0.987841909915927,7,41,positive regulation of osteoblast differentiation,BP,CYR61;BMP2;NPNT;BMP7;WNT4;IL6R;TP63
483,GO:0001533,0.036458262933006,0.987716284929134,7,45,cornified envelope,CC,KRT1;SPRR3;SPRR2A;KRT2;KRT10;HRNR;RPTN
8125,GO:0032813,0.0365746288645943,0.989064208173208,6,33,tumor necrosis factor receptor superfamily binding,MF,TRAF1;TRAF3;TNF;TRAF2;TRAF4;NOL3
16873,GO:0098802,0.0367603114461833,0.983259081402611,12,87,plasma membrane receptor complex,CC,TFRC;TRAF3;IRS1;LYN;BMP2;ITGAV;TRAF2;SYK;MYH9;NPNT;TRIP6;IL6R
6677,GO:0030038,0.0368378826892017,0.984670102262267,10,68,contractile actin filament bundle assembly,BP,PTGER4;CTGF;SDC4;SFRP1;TPM1;SRF;CLASP1;PHLDB2;ZYX;WNT4
10348,GO:0043149,0.0368378826892017,0.984670102262267,10,68,stress fiber assembly,BP,PTGER4;CTGF;SDC4;SFRP1;TPM1;SRF;CLASP1;PHLDB2;ZYX;WNT4
11663,GO:0046425,0.0368562176889765,0.983877002405455,11,79,regulation of JAK-STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;IL20;LIF;IL15;PARP14;SOCS1;IL6R;CCL5
17746,GO:1901681,0.0369310198550703,0.980549696954924,17,140,sulfur compound binding,MF,SAA1;CYR61;FN1;CTGF;CCDC80;PTGES;FBN1;FST;NAV2;FGFR2;SFRP1;DPYSL3;COL5A3;RCC1;GPNMB;ACBD6;BMP7
478,GO:0001522,0.0369467409076386,0.992374655001283,4,18,pseudouridine synthesis,BP,PUS1;DKC1;TRUB2;RPUSD4
13468,GO:0055002,0.0369482837302086,0.983841339924576,11,78,striated muscle cell development,BP,HDAC9;ACTG1;EDN1;G6PD;TPM1;WDR1;SRF;FHL2;HNRNPU;SORBS2;BIN3
5632,GO:0016712,0.0369861048377423,0.994825306240982,3,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP1B1;CYP1A1;CYP4B1
17690,GO:1901568,0.0370015069828576,0.982492635208686,13,99,fatty acid derivative metabolic process,BP,CYP1B1;CYP1A1;PTGES;EDN1;SCD;AKR1C2;SYK;ACSL1;SCD5;THEM4;GPX4;AKR1C1;FADS1
11328,GO:0045651,0.0370866915334227,0.994805601955257,3,10,positive regulation of macrophage differentiation,BP,LIF;PRKCA;TRIB1
1167,GO:0002790,0.0371062303867757,0.975720016314514,36,346,peptide secretion,BP,SAA1;TRIM16;PTGER4;FN1;IL1R2;PML;TGFB2;EDN1;GBP1;RSAD2;PANX1;GNPTAB;IRS1;LYN;TNF;ZC3H12A;CD274;ITGAV;SFRP1;GPER1;IRS2;TRAF2;PRKCA;SYK;SPTBN1;IL1A;TNFRSF21;DNAJC1;M6PR;TANGO2;SOCS1;CPT1A;CD38;MAPK11;BMP8A;CCL5
7803,GO:0032352,0.0371422124606903,0.994794716128739,3,10,positive regulation of hormone metabolic process,BP,TNF;EGR1;WNT4
13522,GO:0055093,0.0372432270267458,0.992364499673772,4,17,response to hyperoxia,BP,CYP1A1;TP53;CDKN1A;CDK4
11391,GO:0045766,0.0373110139869623,0.982333159660353,13,98,positive regulation of angiogenesis,BP,RUNX1;HDAC9;CYP1B1;ADM;HSPB1;ZC3H12A;SERPINE1;ETS1;RHOB;PRKCA;IL1A;CXCL8;TBXA2R
1345,GO:0003208,0.037359410096734,0.987440440574196,7,41,cardiac ventricle morphogenesis,BP,NRG1;TGFB2;FGFR2;UBE4B;TPM1;SEMA3C;SMAD7
6754,GO:0030175,0.0373708296984742,0.984410068334768,10,68,filopodium,CC,B4GALT1;MYO1B;BAIAP2;PDPN;LCP1;ITGAV;MYO10;ENAH;PPP1R9B;DAG1
11377,GO:0045742,0.037374534572428,0.990362474990212,5,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;EPGN;GPER1;ADAM17;AFAP1L2
9698,GO:0038094,0.0374000384670106,0.985268638449589,9,59,Fc-gamma receptor signaling pathway,BP,ACTG1;LYN;ARPC4;BAIAP2;MYO10;ARPC1B;SYK;RAPGEF1;HSP90AB1
3431,GO:0007219,0.0374402854099449,0.980697648483857,16,128,Notch signaling pathway,BP,DTX2;TGFB2;LFNG;WWC1;PBX1;BMP2;ELF3;NFKBIA;SNAI2;ADAM17;SPEN;SLC35C2;APH1A;DTX4;BMP7;TP63
998,GO:0002467,0.0374689863509941,0.99473050794657,3,10,germinal center formation,BP,NFKB2;ADAM17;TNFAIP3
12995,GO:0051412,0.0375218252248697,0.99472010336577,3,10,response to corticosterone,BP,NEFL;CDKN1A;FOSL1
12733,GO:0050996,0.0375686334413159,0.994710881135688,3,10,positive regulation of lipid catabolic process,BP,IRS1;IRS2;CPT1A
20082,GO:2000738,0.0376718401260307,0.994690530092162,3,10,positive regulation of stem cell differentiation,BP,TGFB2;SEMA3C;BMP7
3310,GO:0007010,0.0376916933698108,0.971066848233901,91,982,cytoskeleton organization,BP,CRYAB;KRT2;PTGER4;MAP2;NEFL;CTGF;KRT15;AMOT;KRT4;NEFM;ACTG1;CYLD;MYBL2;SDC4;KRT13;COBLL1;EDN1;BIRC3;MID1;DAPK3;EMP2;SIPA1L3;KRT9;NEDD9;KRT6A;MYO1B;ARPC4;GADD45A;TNF;BAIAP2;KRT5;CORO1C;DST;TPM4;KRT17;FLNA;LCP1;CHP1;ICAM1;KIF23;CDC42EP2;SVIL;ARPC1B;AMOTL2;SFRP1;TPM1;CC2D2A;WDR1;EPPK1;SRF;PARD3B;RHOB;FGFR1OP;KRT14;AJUBA;SPTBN1;DCTN1;DPYSL3;SLAIN2;MYH9;ZW10;CCDC6;PALM2;SPECC1;HNRNPU;CLASP1;PPP1R9B;MICAL3;RCC1;CHMP4B;CNTROB;PARD3;RHOG;CNTNAP1;ACTN4;SORBS2;KIF24;KANK4;PHLDB2;ZYX;MYADM;DAG1;CGNL1;WNT4;RBM14;TUBB;SWAP70;TTLL5;BIN3;PHACTR4;BAIAP2L2
575,GO:0001726,0.0377785687942217,0.980058255162491,17,138,ruffle,CC,AMOT;BAIAP2;WWC1;PDPN;LAYN;LCP1;EPHA2;ITGAV;MYO10;TNFRSF12A;TPM1;ADAM17;MYH9;SPRY4;PPP1R9B;THEM4;MYADM
13915,GO:0060572,0.0377838687168022,0.994668412884702,3,10,morphogenesis of an epithelial bud,BP,FGFR2;BMP7;TP63
7337,GO:0031347,0.0379059775483833,0.973959577527127,45,453,regulation of defense response,BP,KRT1;SAA1;PTGER4;C1R;IL1R2;CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;NFKB1;LYN;LAMP1;TNF;PSMB9;ZC3H12A;IL20;IFNGR1;SERPINE1;IRF1;PSME2;PSPC1;GPER1;NFKBIA;ETS1;IL15;SYK;SLC7A2;DNASE1;TNIP2;SFPQ;PQBP1;PARP14;SOCS1;ESR1;XRCC6;ZYX;RBM14;TNFAIP3;PSMC3;HSP90AB1;C1S;CCL5
565,GO:0001706,0.0379430200090134,0.98720138343727,7,41,endoderm formation,BP,MMP9;INHBA;FN1;COL12A1;ITGAV;COL5A2;DUSP1
11894,GO:0046914,0.0379571672248703,0.971940301839662,69,729,transition metal ion binding,MF,HEPHL1;TRIM16;FTL;FTH1;MMP9;S100P;P3H2;CYP1B1;CYP24A1;DTX2;TRIM47;CYP1A1;PML;CYLD;TRAF1;SOD2;TRIM56;MID1;TET3;B4GALT1;TRAF3;HRNR;TP53;SQSTM1;P4HA2;CPA4;ADAMTS9;CSRP1;SCD;C9ORF3;QPCT;TK1;KLF7;ZMAT2;XAF1;TRIM22;DNPEP;NFX1;TRIM29;SF1;EGR1;CYP4B1;AKAP8;TRAF2;PRKCA;POLR1A;ZNF407;UHRF1;IL1A;ZNFX1;MTA2;GALNT2;DTX4;ESR1;SCD5;RBM4;RPTN;HERC2;ZSWIM6;RNF7;CYP20A1;TRAF4;TNFAIP3;XPNPEP3;ATAD3C;SRSF7;PARP1;TOP3A;APEX2
4413,GO:0010172,0.0379911736499014,0.994627412888559,3,10,embryonic body morphogenesis,BP,CLASP1;PHLDB2;DAG1
4492,GO:0010517,0.0380338175730396,0.988520634112017,6,33,regulation of phospholipase activity,BP,CYR61;FGFR2;ANXA8;RASGRP4;ESR1;CCL5
16105,GO:0090084,0.0381598840752878,0.99459397626617,3,10,negative regulation of inclusion body assembly,BP,SACS;DNAJB1;DNAJB2
6599,GO:0022616,0.0382486020811326,0.990074648244677,5,25,DNA strand elongation,BP,FEN1;GINS2;POLA1;GINS3;PARP1
10528,GO:0043462,0.0383555256190453,0.985805206419214,8,52,regulation of ATPase activity,BP,DNAJB1;TPM1;DNAJB2;SNRNP70;UHRF1;DNAJC1;HNRNPU;DNAJC9
12774,GO:0051049,0.0383569651434276,0.970151335317452,101,1111,regulation of transport,BP,SAA1;TRIM16;CRYAB;NRG1;MMP9;PTGER4;INHBA;FN1;C1QTNF1;JPH2;IL16;IL1R2;PML;SDC4;TGFB2;EDN1;GBP1;RSAD2;G6PD;PANX1;TP53;NFKB1;IRS1;CDKN1A;UBQLN2;LYN;LAMP1;EHD1;TNF;WWC1;PTPN14;NUP153;SIRPA;JPH1;ZC3H12A;FLNA;LCP1;CYB5R1;CADPS2;CHP1;ICAM1;CD274;GOSR1;ITGAV;SFN;ADRB2;SERPINE1;FXYD3;USP36;AKAP8L;LIF;SFRP1;PARL;WDR1;GPER1;NFKBIA;KCNA7;SGK1;SNX12;IRS2;LGALS3;TRAF2;REEP1;PRKCA;SYK;PDGFB;OXTR;SPTBN1;NEDD4L;IL1A;TNFRSF21;RUNDC1;WDR46;NUP214;DNAJC1;YWHAH;CLASP1;RRAD;UBE2J2;KCNIP3;CAB39;SOCS1;STAC;OXSR1;HSPA8;CPT1A;TFDP1;RBM4;INSIG1;ACTN4;SNIP1;SGSM1;RAPGEF1;RAB27A;CD38;MAPK11;BMP8A;SNF8;HSP90AB1;TP63;CCL5
11275,GO:0045580,0.0384110004020635,0.983084622480236,11,79,regulation of T cell differentiation,BP,RUNX1;CYLD;CD83;SART1;IRF1;IL7R;IL15;SYK;SMAD7;SOCS1;FOXN1
3113,GO:0006690,0.0384535038757401,0.984743748371386,9,61,icosanoid metabolic process,BP,CYP1B1;CYP1A1;PTGES;EDN1;AKR1C2;SYK;GPX4;AKR1C1;FADS1
3354,GO:0007088,0.0384765973554835,0.979632960993709,17,140,regulation of mitotic nuclear division,BP,EDN1;DAPK3;PKMYT1;UBE2C;EPGN;PDGFB;IL1A;ZW10;HNRNPU;PPP1R9B;ANAPC15;DUSP1;RCC1;CHMP4B;BMP7;CDCA5;MKI67
7586,GO:0031953,0.0385582200156991,0.994514782911352,3,10,negative regulation of protein autophosphorylation,BP,CHP1;ERRFI1;JUN
10289,GO:0043034,0.0387041418811972,0.991966288633902,4,17,costamere,CC,SDC4;SVIL;VCL;DAG1
2376,GO:0005506,0.0388649895679951,0.982129240721462,12,89,iron ion binding,MF,FTL;FTH1;P3H2;CYP1B1;CYP24A1;CYP1A1;TET3;P4HA2;SCD;CYP4B1;SCD5;CYP20A1
175,GO:0000381,0.0389995910457668,0.988157868731503,6,33,regulation of alternative mRNA splicing, via spliceosome,BP,SRSF2;DDX17;RBM15B;HNRNPU;RBM4;MAGOH
15687,GO:0072210,0.0390110145774552,0.989822008927972,5,25,metanephric nephron development,BP,IRX2;LIF;EGR1;PDGFB;WNT4
8148,GO:0032874,0.0390380896988101,0.980800925260239,14,108,positive regulation of stress-activated MAPK cascade,BP,CTGF;TGFB2;EDN1;MID1;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;TRAF2;SYK;IL1A;TRAF4
16067,GO:0090022,0.0391435486920281,0.99177024307234,4,18,regulation of neutrophil chemotaxis,BP,EDN1;CXCL5;CXCL8;CXCL3
20200,GO:2001057,0.0392057703169545,0.985447293940594,8,51,reactive nitrogen species metabolic process,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;HSP90AB1
6664,GO:0030018,0.0393937249163615,0.983388735756337,10,70,Z disc,CC,CRYAB;JPH2;HSPB1;PDLIM1;DST;JPH1;FLNA;FHL2;ACTN4;SORBS2
20124,GO:2000810,0.0394280864623564,0.991767030638025,4,17,regulation of bicellular tight junction assembly,BP,RUNX1;TNF;SNAI2;TJP1
15380,GO:0071622,0.0395882915164204,0.989581625714302,5,26,regulation of granulocyte chemotaxis,BP,EDN1;CXCL5;CXCL8;CXCL3;CCL5
4493,GO:0010518,0.0396113876423942,0.989622039879413,5,25,positive regulation of phospholipase activity,BP,CYR61;FGFR2;RASGRP4;ESR1;CCL5
7578,GO:0031941,0.0398480625195504,0.989494464312241,5,26,filamentous actin,CC,ACTG1;TPM4;FLNA;DPYSL3;SPECC1
3761,GO:0008305,0.039948796611153,0.991622930823895,4,17,integrin complex,CC,LYN;ITGAV;MYH9;NPNT
16797,GO:0098636,0.039948796611153,0.991622930823895,4,17,protein complex involved in cell adhesion,CC,LYN;ITGAV;MYH9;NPNT
6929,GO:0030522,0.0400373524066531,0.975937380255449,25,223,intracellular receptor signaling pathway,BP,TRIM16;RUNX1;CYP24A1;PML;CYLD;BIRC3;AHR;DAXX;SFRP1;SAFB2;GPER1;NFKBIA;SNAI2;DDX17;FHL2;YWHAH;PAGR1;SAFB;CITED2;ESR1;ACTN4;RBM14;TNFAIP3;PARP1;TP63
4410,GO:0010165,0.0400459355910194,0.987762194076369,6,33,response to X-ray,BP,TP53;CDKN1A;SFRP1;THBD;XRCC6;TP63
7255,GO:0031214,0.0402945679415189,0.982956740352188,10,69,biomineral tissue development,BP,TUFT1;FGFR2;BMP2;ADRB2;OSR2;TFIP11;KLF10;GPNMB;BMP7;WNT4
10544,GO:0043491,0.0404495006837362,0.978020351305299,18,150,protein kinase B signaling,BP,NRG1;C1QTNF1;IRS1;CDKN1A;TNF;FGFR2;EPHA2;GPER1;ZFP36L1;IRS2;AKR1C2;PDGFB;ESR1;THEM4;PHLPP1;RAPGEF1;DAG1;CCL5
18145,GO:1902882,0.0405195589965833,0.983768506135639,9,61,regulation of response to oxidative stress,BP,HSPB1;SOD2;TP53;TNF;DHFR;SFPQ;BMP7;NOL3;PARP1
15336,GO:0071556,0.0405927408692987,0.991365083727783,4,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-B;HLA-F;SPPL2A;TAPBP
16763,GO:0098553,0.0405927408692987,0.991365083727783,4,18,lumenal side of endoplasmic reticulum membrane,CC,HLA-B;HLA-F;SPPL2A;TAPBP
7585,GO:0031952,0.0410114612741258,0.987394677877726,6,33,regulation of protein autophosphorylation,BP,CHP1;ERRFI1;SYK;PDGFB;JUN;GPNMB
11353,GO:0045685,0.0410537390645018,0.985884609553986,7,42,regulation of glial cell differentiation,BP,BMP2;LIF;WDR1;PRPF19;TNFRSF21;ZNF365;DAG1
16319,GO:0090501,0.0412450324686058,0.978955986063868,15,123,RNA phosphodiester bond hydrolysis,BP,USB1;NOCT;ZC3H12A;RRP36;POP1;RRS1;FEN1;ISG20L2;TSR1;NOB1;UTP20;NOL9;ABT1;NOP14;POP4
9007,GO:0035150,0.0412583620615802,0.982463196126361,10,70,regulation of tube size,BP,ADM;SOD2;EDN1;ICAM1;ADRB2;GPER1;OXTR;CD38;GCLC;TBXA2R
12673,GO:0050880,0.0412583620615802,0.982463196126361,10,70,regulation of blood vessel size,BP,ADM;SOD2;EDN1;ICAM1;ADRB2;GPER1;OXTR;CD38;GCLC;TBXA2R
8293,GO:0033120,0.0412927327892477,0.98905729441106,5,25,positive regulation of RNA splicing,BP,PRPF19;U2AF2;SF3B4;SNRNP70;HSPA8
12551,GO:0050703,0.0413105756298214,0.997057208074504,2,5,interleukin-1 alpha secretion,BP,IL1R2;PANX1
11860,GO:0046849,0.0413479411334749,0.984488635054663,8,51,bone remodeling,BP,TFRC;EPHA2;ADRB2;SFRP1;PRKCA;SYK;CD38;TNFAIP3
15139,GO:0071230,0.0413767988135256,0.984475645652964,8,51,cellular response to amino acid stimulus,BP,TNF;BAIAP2;COL4A1;COL16A1;COL5A2;SOCS1;GCLC;SH3BP4
6683,GO:0030048,0.0415035685496837,0.982340886747638,10,70,actin filament-based movement,BP,EMP2;MYO1B;PDPN;TPM4;FLNA;TPM1;NEDD4L;MYH9;ACTN4;MYO1E
1778,GO:0004386,0.0415775724721276,0.977790255873837,17,138,helicase activity,MF,MCM5;NAV2;DDX23;MCM2;DHX37;DDX42;DDX17;GINS2;DDX47;DDX49;DDX39A;RUVBL2;MCM7;XRCC6;DHX34;BRIP1;DDX24
1327,GO:0003179,0.0418329784134989,0.988874371353168,5,25,heart valve morphogenesis,BP,CYR61;TGFB2;ADAMTS9;BMP2;EFNA1
7272,GO:0031252,0.0421090164664798,0.972902181023813,32,301,cell leading edge,CC,NRG1;AMOT;NEDD9;BAIAP2;CORO1C;WWC1;DST;PDPN;LAYN;LCP1;EPHA2;ITGAV;MYO10;TNFRSF12A;TPM1;GPER1;ADAM17;AJUBA;SPTBN1;DCTN1;DPYSL3;MYH9;SPRY4;ENAH;PPP1R9B;THEM4;SORBS2;PHLDB2;MYADM;DAG1;SWAP70;PHACTR4
14645,GO:0070229,0.0422632420560519,0.988676173894084,5,26,negative regulation of lymphocyte apoptotic process,BP,TSC22D3;IRS2;NOC2L;EFNA1;CCL5
4770,GO:0010955,0.0423275152153403,0.988654204542025,5,26,negative regulation of protein processing,BP,IL1R2;BIRC3;SERPINE1;SNX12;NOL3
18348,GO:1903318,0.0423275152153403,0.988654204542025,5,26,negative regulation of protein maturation,BP,IL1R2;BIRC3;SERPINE1;SNX12;NOL3
9891,GO:0042169,0.0424161820394818,0.988676116214696,5,25,SH2 domain binding,MF,SQSTM1;IRS1;SYK;AFAP1L2;DAG1
14854,GO:0070613,0.0424773047159041,0.983957037184927,8,52,regulation of protein processing,BP,C1R;IL1R2;BIRC3;SERPINE1;SNX12;MYH9;NOL3;C1S
19610,GO:1990752,0.0424800338468975,0.988654360987556,5,25,microtubule end,CC,DST;SVIL;DCTN1;SLAIN2;CLASP1
8056,GO:0032720,0.0425917167313096,0.988563793533042,5,26,negative regulation of tumor necrosis factor production,BP,ZC3H12A;ERRFI1;AKAP8;GPNMB;TNFAIP3
12285,GO:0048598,0.0428310964743936,0.97115810667631,39,380,embryonic morphogenesis,BP,MAFB;MMP9;CYR61;INHBA;FN1;ADM;AMOT;SDC4;IRX2;FBN1;TGFB2;EDN1;TXNRD1;COL12A1;FGFR2;PBX1;SLC39A1;ARFRP1;ITGAV;OSR2;SFRP1;CC2D2A;SRF;ZFP36L1;NTN1;COL5A2;CLASP1;ETS2;DUSP1;FRAS1;INSIG1;BMP7;PHLDB2;MYADM;DAG1;WNT4;EFNA1;TP63;PHACTR4
4483,GO:0010501,0.0429440163818288,0.985088640657696,7,42,RNA secondary structure unwinding,BP,DDX23;DDX42;DDX17;DDX47;DDX49;DDX39A;DDX24
1107,GO:0002696,0.0429643934278375,0.975640076658058,20,174,positive regulation of leukocyte activation,BP,CYLD;TFRC;CD83;MAP3K14;CDKN1A;LYN;LAMP1;EFNB2;SIRPA;SART1;CD274;IL7R;IRS2;IL15;SYK;TNIP2;SOCS1;EFNB1;CD38;CCL5
13978,GO:0060688,0.0430540867050328,0.986571399432164,6,34,regulation of morphogenesis of a branching structure,BP,TNF;FGFR2;SFRP1;SNAI2;ESR1;BMP7
12650,GO:0050854,0.0430660215093818,0.986566771588723,6,34,regulation of antigen receptor-mediated signaling pathway,BP,RUNX1;CYLD;GBP1;LYN;LGALS3;CMTM3
4604,GO:0010719,0.0431907080000486,0.990626297194621,4,18,negative regulation of epithelial to mesenchymal transition,BP,TGFB2;SFRP1;SMAD7;EFNA1
4424,GO:0010243,0.043267668689069,0.968288182360632,62,650,response to organonitrogen compound,BP,TRIM16;HDAC9;NEFL;CTGF;ADM;FBN1;EDN1;PANX1;TP53;NFKB1;IRS1;CDKN1A;UBQLN2;LYN;AHR;JUNB;TNF;BAIAP2;COL4A1;FOSL1;TYMS;HMGCS1;ICAM1;COL16A1;UBE4B;CDK4;ERRFI1;STAT5A;ADRB2;SFRP1;THBD;GPER1;NFKBIA;EGR1;ZFP36L1;DHFR;IRS2;SYK;OXTR;SDK1;COL5A2;UBE2J2;PPP1R9B;KLF10;DUSP1;SOCS1;JUN;QDPR;BMP7;EFTUD2;RAPGEF1;DAG1;RNF185;TIMELESS;TNFAIP3;PSMC3;BRIP1;GCLC;HSP90AB1;PARP1;BAIAP2L2;SH3BP4
1592,GO:0004004,0.043274283075622,0.982470714966821,9,60,ATP-dependent RNA helicase activity,MF,DDX23;DHX37;DDX42;DDX17;DDX47;DDX49;DDX39A;DHX34;DDX24
13235,GO:0051898,0.0432802782746628,0.98648363396443,6,34,negative regulation of protein kinase B signaling,BP,EPHA2;GPER1;THEM4;PHLPP1;RAPGEF1;DAG1
1005,GO:0002479,0.0434136806980351,0.982303423089967,9,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,TAP1;HLA-B;PSMB9;ITGAV;HLA-F;PSME2;TAPBP;TAP2;PSMC3
10030,GO:0042474,0.0434143894758101,0.993365736803739,3,11,middle ear morphogenesis,BP,EDN1;OSR2;INSIG1
364,GO:0000982,0.0434146132833477,0.972650491780387,29,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;MYBL2;ARID3B;TP53;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;NFX1;SRF;ELF4;ZFP42;EGR1;ETS1;SNAI2;CREB3;KCNIP3;ETS2;KLF10;JUN;ESR1;KLF6;ELK1;TP63
1609,GO:0004032,0.0434190628724156,0.996819937084288,2,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR1C2;AKR1C1
7202,GO:0031091,0.0435537703519999,0.983467734103112,8,52,platelet alpha granule,CC,FN1;PCDH7;TGFB2;CYB5R1;SERPINE1;PDGFB;CD109;ACTN4
11289,GO:0045599,0.0437601671962534,0.986297030692637,6,34,negative regulation of fat cell differentiation,BP,TNF;TRIO;CCDC85B;GPER1;ZFP36L2;INSIG1
3694,GO:0008199,0.0437978468234319,0.996776589397714,2,5,ferric iron binding,MF,FTL;FTH1
8604,GO:0034112,0.0438435858957032,0.996771340265107,2,5,positive regulation of homotypic cell-cell adhesion,BP,PDPN;CCL5
2094,GO:0004860,0.0438531112485293,0.981147066470294,10,71,protein kinase inhibitor activity,MF,HSPB1;CDKN2B;CDKN1A;CDKN2A;CHP1;SFN;FGFR1OP;TRIB1;SOCS1;DUS2
6856,GO:0030325,0.0439184338527084,0.993257414353243,3,11,adrenal gland development,BP,PBX1;CITED2;WNT4
6588,GO:0022600,0.0439824989287669,0.986210394327088,6,34,digestive system process,BP,TJP2;SGK1;ACO1;OXTR;VSIG1;AKR1C1
3543,GO:0007565,0.0440890076220593,0.977316230510137,15,121,female pregnancy,BP,MMP9;ADM;TFCP2L1;EMP2;JUNB;VMP1;FOSL1;COL16A1;LIF;THBD;ETS1;OXTR;ESR1;WNT4;CD38
2095,GO:0004861,0.0441119876664986,0.993215677125833,3,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN2B;CDKN1A;CDKN2A
15294,GO:0071478,0.0441736521283076,0.97619919431618,17,142,cellular response to radiation,BP,CRYAB;TP53;CDKN1A;GADD45A;NMT2;SFRP1;EGR1;SNAI2;RHOB;RUVBL2;NOC2L;XRCC6;ELK1;PDE6A;EEF1D;PARP1;TP63
3531,GO:0007517,0.044233084094343,0.973140219804702,25,226,muscle organ development,BP,CRYAB;NRG1;HDAC9;JPH2;TGFB2;EDN1;G6PD;EFNB2;FGFR2;JPH1;TSC22D3;BMP2;UBE4B;SVIL;LIF;TPM1;LUC7L;EGR1;GPCPD1;DDX17;MAFF;SMAD7;TEAD4;MAPK11;BIN3
8062,GO:0032730,0.0443936582378755,0.996707963448527,2,5,positive regulation of interleukin-1 alpha production,BP,CCL20;PANX1
8599,GO:0034104,0.0444547613106393,0.993141571091979,3,11,negative regulation of tissue remodeling,BP,SFRP1;CD38;TNFAIP3
4530,GO:0010595,0.0444765374426653,0.980831995522741,10,71,positive regulation of endothelial cell migration,BP,HDAC9;HSPB1;EDN1;ZC3H12A;STAT5A;ETS1;RHOB;ADAM17;PRKCA;PDGFB
4204,GO:0009312,0.0445286030593389,0.987895939135002,5,26,oligosaccharide biosynthetic process,BP,B4GALT1;GALNT18;ST6GALNAC5;GALNT2;MGAT2
14647,GO:0070231,0.0445492443021812,0.985951670744666,6,35,T cell apoptotic process,BP,TP53;TSC22D3;CD274;LGALS3;EFNA1;CCL5
16090,GO:0090066,0.0445648402030274,0.970768955168112,34,327,regulation of anatomical structure size,BP,NRG1;FN1;NEFL;ADM;SOD2;EDN1;ARPC4;BAIAP2;ICAM1;CDK4;L1CAM;CDC42EP2;ADRB2;TNFRSF12A;ARPC1B;ZFYVE27;WDR1;IL7R;GPER1;SRF;NTN1;OXTR;SPTBN1;SEMA3C;RHOG;KANK4;MYADM;CD38;SNF8;GCLC;HSP90AB1;SWAP70;TBXA2R;BAIAP2L2
11303,GO:0045620,0.0446512492581914,0.987853353992017,5,26,negative regulation of lymphocyte differentiation,BP,INHBA;CYLD;SFRP1;IRF1;SMAD7
5407,GO:0016247,0.0446549480880313,0.980726856669335,10,72,channel regulator activity,MF,ANKRD36C;FLNA;CHP1;ADRB2;FXYD3;SGK1;NEDD4L;YWHAH;KCNIP3;SNF8
362,GO:0000980,0.0446804552978323,0.982952758241894,8,52,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,ARID3B;NFE2L1;NFKB1;ZFP42;SFPQ;RUVBL2;JUN;SMARCC2
4753,GO:0010927,0.044688633233579,0.981770212229968,9,61,cellular component assembly involved in morphogenesis,BP,ACTG1;EDN1;TPM1;WDR1;SRF;CLASP1;CNTNAP1;PHLDB2;DAG1
8111,GO:0032797,0.0447464865539126,0.993078309132602,3,11,SMN complex,CC,GEMIN5;GEMIN4;GEMIN8
16645,GO:0097504,0.0450594172603765,0.993010252695876,3,11,Gemini of coiled bodies,CC,GEMIN5;GEMIN4;GEMIN8
6975,GO:0030638,0.0450743635447306,0.996628900924328,2,5,polyketide metabolic process,BP,AKR1C2;AKR1C1
6979,GO:0030647,0.0450743635447306,0.996628900924328,2,5,aminoglycoside antibiotic metabolic process,BP,AKR1C2;AKR1C1
10939,GO:0044597,0.0450743635447306,0.996628900924328,2,5,daunorubicin metabolic process,BP,AKR1C2;AKR1C1
10940,GO:0044598,0.0450743635447306,0.996628900924328,2,5,doxorubicin metabolic process,BP,AKR1C2;AKR1C1
14687,GO:0070302,0.0450859225436208,0.974720537517242,19,162,regulation of stress-activated protein kinase signaling cascade,BP,CTGF;TGFB2;EDN1;MID1;MARVELD3;LYN;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;SFRP1;TRAF2;SYK;IL1A;PHLPP1;RAPGEF1;TRAF4
618,GO:0001787,0.0451987278481901,0.996614380659781,2,5,natural killer cell proliferation,BP,ELF4;IL15
12827,GO:0051132,0.0451987278481901,0.996614380659781,2,5,NK T cell activation,BP,ELF4;IL15
11371,GO:0045736,0.0452156382537406,0.987656938355862,5,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2B;CDKN1A;CDKN2A;CDK4;TNFAIP3
16259,GO:0090312,0.0452476740192486,0.99003030402763,4,18,positive regulation of protein deacetylation,BP,TP53;AKAP8L;AKAP8;BRMS1
977,GO:0002431,0.0452705085127205,0.981488194912718,9,61,Fc receptor mediated stimulatory signaling pathway,BP,ACTG1;LYN;ARPC4;BAIAP2;MYO10;ARPC1B;SYK;RAPGEF1;HSP90AB1
6279,GO:0019883,0.0453846265088572,0.99293931165895,3,11,antigen processing and presentation of endogenous antigen,BP,TAP1;TAPBP;TAP2
324,GO:0000904,0.0456065936097792,0.96787519306087,48,483,cell morphogenesis involved in differentiation,BP,NRG1;MAP2;FN1;NEFL;GBP1;SIPA1L3;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;FLNA;KLF7;EPHA2;ITGAV;L1CAM;TNFRSF12A;ZFYVE27;WDR1;SRF;DOCK10;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;MYH9;SEMA3C;RCC2;YWHAH;ENAH;PQBP1;VSIG1;PARD3;LAMC1;ZNF365;ZSWIM6;ACTN4;EFNB1;LRFN4;BMP7;AKIP1;MYADM;DAG1;RILPL2;EFNA1
12840,GO:0051150,0.0456380425376786,0.989916117079035,4,18,regulation of smooth muscle cell differentiation,BP,FGFR2;GPER1;SRF;PDGFB
9477,GO:0036109,0.0456465957139957,0.992882007467906,3,11,alpha-linolenic acid metabolic process,BP,ACAA1;ACSL1;FADS1
719,GO:0001945,0.0457088075749444,0.989895381026172,4,18,lymph vessel development,BP,EFNB2;PDPN;PTPN14;SYK
18946,GO:1904707,0.0459486653307657,0.989825013105443,4,18,positive regulation of vascular smooth muscle cell proliferation,BP,MMP9;TNF;PDGFB;JUN
17280,GO:0140014,0.0460392124871727,0.971627852425286,26,239,mitotic nuclear division,BP,MYBL2;EDN1;BIRC3;DAPK3;PKMYT1;UBE2C;FLNA;KIF23;EPGN;AKAP8L;RRS1;AKAP8;PDGFB;IL1A;ZW10;HNRNPU;CLASP1;PPP1R9B;ANAPC15;DUSP1;RCC1;CHMP4B;BMP7;KIF22;CDCA5;MKI67
12653,GO:0050857,0.0461127619059985,0.992779688313821,3,11,positive regulation of antigen receptor-mediated signaling pathway,BP,CYLD;LYN;CMTM3
20234,GO:2001179,0.0461841736973768,0.996498501774891,2,5,regulation of interleukin-10 secretion,BP,CD274;TNFRSF21
9421,GO:0035987,0.0462327384668171,0.985327091419228,6,34,endodermal cell differentiation,BP,MMP9;INHBA;FN1;COL12A1;ITGAV;COL5A2
18447,GO:1903532,0.0462519164694335,0.972092033658011,24,218,positive regulation of secretion by cell,BP,SAA1;TRIM16;PTGER4;INHBA;C1QTNF1;SDC4;TGFB2;EDN1;PANX1;LAMP1;TNF;CADPS2;CD274;GPER1;IRS2;SYK;OXTR;SPTBN1;IL1A;CLASP1;RAB27A;CD38;MAPK11;SNF8
11060,GO:0045058,0.046376761392009,0.987250549537287,5,26,T cell selection,BP,CYLD;SRF;IL15;SYK;FOXN1
178,GO:0000387,0.0463791871272244,0.985193345112533,6,36,spliceosomal snRNP assembly,BP,SART1;GEMIN5;GEMIN4;CD2BP2;PRPF19;GEMIN8
16872,GO:0098801,0.0464417217289739,0.992707217396408,3,11,regulation of renal system process,BP,EDN1;EMP2;PDGFB
13821,GO:0060415,0.0464480742062598,0.983560405078255,7,43,muscle tissue morphogenesis,BP,NRG1;TGFB2;FGFR2;BMP2;UBE4B;TPM1;SMAD7
4702,GO:0010862,0.0464538711484787,0.98722345257644,5,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;TGFB2;BMP2;BMP7;BMP8A
5206,GO:0015804,0.0465358470227403,0.987194630840678,5,26,neutral amino acid transport,BP,NFKBIE;SLC7A5;SLC7A5P2;SLC43A2;SLC3A2
20077,GO:2000727,0.0465750449388923,0.99267778307377,3,11,positive regulation of cardiac muscle cell differentiation,BP,NRG1;EDN1;EFNB2
3945,GO:0008637,0.046729272255768,0.977069923326259,13,104,apoptotic mitochondrial changes,BP,MMP9;SOD2;TP53;SFN;GPER1;YWHAH;JUN;BLOC1S2;TFDP1;THEM4;NOL3;GCLC;TP63
7642,GO:0032052,0.0467977572357091,0.996425615640478,2,5,bile acid binding,MF,AKR1C2;AKR1C1
4600,GO:0010715,0.0468692397508455,0.992612704648516,3,11,regulation of extracellular matrix disassembly,BP,PDPN;ETS1;CLASP1
18347,GO:1903317,0.0469550660033321,0.981881118461955,8,53,regulation of protein maturation,BP,C1R;IL1R2;BIRC3;SERPINE1;SNX12;MYH9;NOL3;C1S
2814,GO:0006273,0.0469634676639356,0.99259182349507,3,11,lagging strand elongation,BP,FEN1;POLA1;PARP1
9413,GO:0035976,0.0469978936929291,0.996401720478198,2,5,transcription factor AP-1 complex,CC,JUNB;JUN
16092,GO:0090068,0.0471744523459994,0.971473647179416,24,219,positive regulation of cell cycle process,BP,CTGF;CYP1A1;PML;EDN1;TP53;CDKN1A;GADD45A;PBX1;UBE2C;CDK4;KIF23;SFN;EPGN;SVIL;FEN1;PDGFB;IL1A;SFPQ;RCC2;HNRNPU;PAGR1;TFDP1;WNT4;CDCA5
802,GO:0002070,0.0471934782411987,0.99254077704619,3,11,epithelial cell maturation,BP,TFCP2L1;CDKN1A;TYMS
8155,GO:0032881,0.0472660169096006,0.986937242042398,5,26,regulation of polysaccharide metabolic process,BP,NFKB1;IRS1;PPP1R3B;IRS2;PDGFB
11906,GO:0046934,0.0473347763459738,0.984890285871432,6,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,NRG1;IRS1;FGFR2;IRS2;PDGFB;ESR1
3524,GO:0007498,0.0473401717511969,0.979373994144163,10,71,mesoderm development,BP,INHBA;TXNRD1;FGFR2;SRF;ZFP36L1;ETS2;CITED2;IKZF3;BMP7;TP63
1468,GO:0003724,0.0474002485890832,0.98044967941838,9,61,RNA helicase activity,MF,DDX23;DHX37;DDX42;DDX17;DDX47;DDX49;DDX39A;DHX34;DDX24
3684,GO:0008186,0.0474002485890832,0.98044967941838,9,61,RNA-dependent ATPase activity,MF,DDX23;DHX37;DDX42;DDX17;DDX47;DDX49;DDX39A;DHX34;DDX24
12561,GO:0050713,0.0475100423467581,0.996340301659348,2,5,negative regulation of interleukin-1 beta secretion,BP,PML;ZC3H12A
9828,GO:0042045,0.0475543826610313,0.996334965890073,2,5,epithelial fluid transport,BP,CSF2;EDN1
8100,GO:0032785,0.0476282317326912,0.992443999966088,3,11,negative regulation of DNA-templated transcription, elongation,BP,NELFE;SUPT5H;HNRNPU
16265,GO:0090322,0.0476711759897166,0.989230903210879,4,19,regulation of superoxide metabolic process,BP,TNF;DHFR;SYK;BMP7
7203,GO:0031092,0.0476945271942689,0.992429208985797,3,11,platelet alpha granule membrane,CC,PCDH7;CYB5R1;CD109
3449,GO:0007259,0.0477104772973536,0.977318483547631,12,92,JAK-STAT cascade,BP,CYP1B1;CSF2;IL24;LYN;STAT5A;IL20;LIF;IL15;PARP14;SOCS1;IL6R;CCL5
2264,GO:0005179,0.0477399496710484,0.989210289088704,4,19,hormone activity,MF,INHBA;ADM;FBN1;EDN1
10847,GO:0044342,0.0477444319309922,0.992418069058804,3,11,type B pancreatic cell proliferation,BP,IGFBP3;ERRFI1;SFRP1
5741,GO:0016888,0.0477521059620724,0.992416355587915,3,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,FEN1;DNASE1;TATDN2
1341,GO:0003203,0.0478112126291785,0.989274255932799,4,18,endocardial cushion morphogenesis,BP,TGFB2;BMP2;SNAI2;BMP7
12852,GO:0051170,0.0478209265478885,0.974507212048529,16,134,import into nucleus,BP,PML;CDKN1A;TNF;NUP153;ZC3H12A;GEMIN5;CHP1;NFKBIA;GEMIN4;PTTG1IP;GEMIN8;NUP214;TNPO3;IPO4;DAG1;HSP90AB1
1026,GO:0002532,0.0478559495541133,0.984642217855541,6,35,production of molecular mediator involved in inflammatory response,BP,IL1R2;LYN;ZC3H12A;SERPINE1;SYK;SLC7A2
10682,GO:0043933,0.0479151363782382,0.960987409313029,142,1671,protein-containing complex subunit organization,BP,CRYAB;NRG1;PTGER4;MAP2;FN1;NEFL;CYP1B1;C1QTNF1;PML;CYLD;TRAF1;SOD2;CSF2;TGFB2;COBLL1;GBP1;MAT2A;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;PANX1;TP53;SQSTM1;NOCT;TAF4B;ARPC4;EHD1;TNF;COL12A1;BAIAP2;PPAN;NUP153;FOSL1;UBE2C;ZC3H12A;LCP1;SART1;TK1;GEMIN5;CADPS2;CHP1;ICAM1;FANCC;COL16A1;DDX23;CDC42EP2;ANKS4B;ADRB2;DAXX;ARPC1B;MCM2;GRWD1;TRIM22;WDR1;PWP2;PDE4DIP;LUC7L;TFIP11;SRF;SF1;KCNA7;GEMIN4;RRS1;CD2BP2;PRPF19;SHQ1;KCTD10;TRAF2;AJUBA;AASS;UBTF;GEMIN8;SPTBN1;SERPINH1;DCTN1;COLGALT1;DPYSL3;COL5A3;RRP7A;SLAIN2;RBBP5;ZW10;COL5A2;MRPS12;MRPS24;TAPBP;ERAL1;CLASP1;RUVBL2;ABT1;MICAL3;MRPL20;RRP7BP;CAB39;TXNL4B;HSPA8;JUN;MRPL33;ESR1;CENPN;RCC1;CPT1A;DCXR;BCS1L;GTF2E1;TRAPPC5;NOP2;CHMP4B;NACC1;INSIG1;CENPO;PARD3;LAMC1;RHOG;XRCC6;KIF24;KCTD1;KANK4;IPO4;CHAF1A;EIF5A;MYADM;GPX4;MRPS2;AKR1C1;TNFAIP3;PSMC3;SMARCC2;SUPT16H;CLDN7;HSD17B10;CARD10;CLTA;NOL3;HSP90AB1;SWAP70;PARP1;TP63;CCL5;BAIAP2L2
13850,GO:0060453,0.0480046025121418,0.996280623051056,2,5,regulation of gastric acid secretion,BP,SGK1;OXTR
9102,GO:0035371,0.0480130668813161,0.989214110082832,4,18,microtubule plus-end,CC,DST;DCTN1;SLAIN2;CLASP1
6834,GO:0030296,0.0481941753203794,0.992317450032759,3,11,protein tyrosine kinase activator activity,MF,NRG1;AFAP1L2;CCL5
1400,GO:0003334,0.0483021626802089,0.992293230173131,3,11,keratinocyte development,BP,KRT2;FOSL2;SFN
3942,GO:0008630,0.0483905804482582,0.976921612910022,12,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PML;IKBKE;TP53;CDKN1A;TNF;EPHA2;SFN;AEN;SNAI2;ACKR3;BCL2L2;TP63
10403,GO:0043235,0.0484481499136807,0.971741101923137,21,183,receptor complex,CC,TFRC;TRAF3;IRS1;LYN;AHR;FGFR2;EPHB6;EPHA2;BMP2;ITGAV;ADRB2;TRAF2;ABCG2;SYK;MYH9;NPNT;ROR1;TRIP6;PTPRB;HSP90AB1;IL6R
2234,GO:0005138,0.0484610576290981,0.996225221855498,2,5,interleukin-6 receptor binding,MF,ADAM17;IL6R
14227,GO:0061180,0.0485125916840305,0.981155885028174,8,53,mammary gland epithelium development,BP,PML;FGFR2;EPHA2;NTN1;ROBO1;ESR1;ZNF703;WNT4
6248,GO:0019825,0.0485398805378071,0.992239831681832,3,11,oxygen binding,MF,CYP1B1;CYP1A1;CYP4B1
4388,GO:0010041,0.0485934688661362,0.996209093274754,2,5,response to iron(III) ion,BP,CYP1A1;G6PD
11598,GO:0046184,0.0486164772508429,0.992222601756538,3,11,aldehyde biosynthetic process,BP,BMP2;TKT;WNT4
8486,GO:0033632,0.0486315416939722,0.9962044509704,2,5,regulation of cell-cell adhesion mediated by integrin,BP,SWAP70;CCL5
16550,GO:0097306,0.0487327415736687,0.98256743835059,7,43,cellular response to alcohol,BP,PTGER4;INHBA;HMGCS1;SFRP1;AKAP8;LANCL2;DAG1
13804,GO:0060393,0.0489444518624531,0.984205795443776,6,35,regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;TGFB2;BMP2;SMAD7;BMP7;BMP8A
17756,GO:1901722,0.0490552190284732,0.992123684560849,3,11,regulation of cell proliferation involved in kidney development,BP,EGR1;PDGFB;BMP7
3633,GO:0008093,0.0491013143586059,0.992113269854456,3,11,cytoskeletal adaptor activity,MF,BAIAP2;SORBS2;BIN3
20195,GO:2001046,0.0491097624884865,0.996145958979844,2,5,positive regulation of integrin-mediated signaling pathway,BP,EMP2;FLNA
10100,GO:0042609,0.0491165552846789,0.996145125722814,2,5,CD4 receptor binding,MF,IL16;SPG21
11398,GO:0045780,0.0491266423089748,0.992107545501982,3,11,positive regulation of bone resorption,BP,TFRC;PRKCA;SYK
11863,GO:0046852,0.0491266423089748,0.992107545501982,3,11,positive regulation of bone remodeling,BP,TFRC;PRKCA;SYK
7067,GO:0030854,0.0491472046382928,0.996141365193995,2,5,positive regulation of granulocyte differentiation,BP,RUNX1;TRIB1
10033,GO:0042481,0.0491986861022477,0.992091255975839,3,11,regulation of odontogenesis,BP,WNT10A;EDN1;BMP2
14117,GO:0060973,0.0492746841917022,0.99207406120589,3,11,cell migration involved in heart development,BP,SNAI2;SEMA3C;BMP7
9388,GO:0035925,0.0493371843725101,0.992059911797541,3,11,mRNA 3'-UTR AU-rich region binding,MF,ZC3H12A;ZFP36L1;ZFP36L2
14222,GO:0061158,0.0493372295292541,0.992059901571718,3,11,3'-UTR-mediated mRNA destabilization,BP,ZC3H12A;ZFP36L1;ZFP36L2
5286,GO:0015939,0.0493922394264268,0.996111251093022,2,5,pantothenate metabolic process,BP,PANK2;SLC5A6
10415,GO:0043252,0.0494015908478225,0.992045322730442,3,11,sodium-independent organic anion transport,BP,SLC16A2;SLCO3A1;SLC22A4
14312,GO:0061448,0.0495056578689496,0.972938661853806,17,142,connective tissue development,BP,RUNX1;CYR61;CTGF;EDN1;TYMS;BMP2;COL27A1;CDK4;OSR2;SRF;EGR1;SNAI2;PDGFB;SERPINH1;ARRDC3;BMP7;BMP8A
14880,GO:0070665,0.0495159041068566,0.978206631197438,10,74,positive regulation of leukocyte proliferation,BP,TFRC;CDKN1A;LYN;CD274;IRS2;IL15;SYK;EFNB1;CD38;CCL5
8477,GO:0033622,0.0496025886009174,0.99199974085106,3,11,integrin activation,BP,PTGER4;FN1;COL16A1
12784,GO:0051059,0.0496306151619702,0.986037740883681,5,27,NF-kappaB binding,MF,TAF4B;CDKN2A;NFKBIA;AKAP8;BRMS1
17874,GO:1902108,0.049740241789956,0.980556781349612,8,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;THEM4;NOL3;TP63
20014,GO:2000630,0.0497738093451185,0.996064182225342,2,5,positive regulation of miRNA metabolic process,BP,NFKB1;ZC3H12A
10748,GO:0044126,0.0497817709731128,0.99606319784572,2,5,regulation of growth of symbiont in host,BP,SQSTM1;TNF
10751,GO:0044144,0.0497817709731128,0.99606319784572,2,5,modulation of growth of symbiont involved in interaction with host,BP,SQSTM1;TNF
10087,GO:0042587,0.0497978498698748,0.996061209560718,2,5,glycogen granule,CC,PPP1R3B;PCYT1A
15241,GO:0071397,0.0498196153438003,0.991950434344312,3,11,cellular response to cholesterol,BP,INHBA;HMGCS1;DAG1
17579,GO:1901201,0.0498550516648341,0.991942374709861,3,11,regulation of extracellular matrix assembly,BP,CLASP1;PHLDB2;DAG1
7612,GO:0031998,0.0498938639760064,0.991933544400674,3,11,regulation of fatty acid beta-oxidation,BP,IRS1;IRS2;CPT1A
7426,GO:0031527,0.0498946143385312,0.991933373654126,3,11,filopodium membrane,CC,PDPN;ITGAV;MYO10
2873,GO:0006366,0.0499145210008936,0.959036160464652,153,1761,transcription by RNA polymerase II,BP,MAFB;NRG1;RUNX1;CYR61;INHBA;HDAC9;CTGF;FOSL2;PML;TFCP2L1;MYBL2;IRX2;RELB;SOD2;ARID3B;IER2;FBN1;TGFB2;EDN1;TET3;ELMSAN1;NLRC5;TP53;NFE2L1;SQSTM1;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;ZC3H12A;FLNA;SRSF2;KLF7;TSC22D3;BMP2;CDK4;STAT5A;ADRB2;FOXD2;SERPINE1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;SAFB2;MKL1;IRF1;PSME2;NFX1;GPER1;SRF;ELF4;MED22;TRIM29;NFKBIA;EGR1;ETS1;SNAI2;SRRT;ZFP36L1;NELFE;U2AF2;NPAS2;CBX5;PPRC1;MAFK;ZFP36L2;DDX17;AJUBA;PDGFB;BRMS1;UBTF;ALYREF;PHAX;NEDD4L;FHL2;UHRF1;NPNT;IL1A;ZNFX1;TNIP2;ZNF263;SFPQ;DDX39A;SPEN;MAFF;SMAD7;SUPT5H;MTA2;HNRNPU;PAGR1;CREB3;RUVBL2;ABT1;MAZ;KCNIP3;SAFB;THOC1;ETS2;KLF10;ZNF267;PRDM7;CITED2;JUN;ESR1;IKZF3;FOXN1;TFDP1;GTF2E1;NOP2;NOC2L;SERTAD1;INSIG1;XRCC6;KLF6;TEAD4;GLIS3;BMP7;KCTD1;ELK1;TIMELESS;RBM14;CTDSP1;PSMC3;SMARCC2;BRIP1;SUPT16H;EFNA1;BMP8A;HES4;POLR2G;SRSF7;CREB5;SNF8;PARP1;TP63;MAGOH
1354,GO:0003222,0.0499219702365954,0.991927148005385,3,11,ventricular trabecula myocardium morphogenesis,BP,NRG1;TGFB2;UBE4B
19413,GO:1905954,0.0499302539473322,0.981980735819737,7,45,positive regulation of lipid localization,BP,C1QTNF1;EDN1;IKBKE;NFKB1;EHD1;ZC3H12A;NFKBIA
10065,GO:0042555,0.0499727302620952,0.991915592146142,3,11,MCM complex,CC,MCM5;MCM2;MCM7
1984,GO:0004704,0.0500725664359828,0.996027180350617,2,5,NF-kappaB-inducing kinase activity,MF,MAP3K14;IKBKE
13907,GO:0060558,0.0501282216837633,0.996020272913437,2,5,regulation of calcidiol 1-monooxygenase activity,BP,NFKB1;TNF
12590,GO:0050766,0.0502635578208841,0.985809480757528,5,27,positive regulation of phagocytosis,BP,TNF;SIRPA;ITGAV;RAPGEF1;RAB27A
7973,GO:0032587,0.0504579970085849,0.97775024313595,10,72,ruffle membrane,CC,WWC1;PDPN;LCP1;EPHA2;ITGAV;TPM1;ADAM17;SPRY4;PPP1R9B;THEM4
2140,GO:0004953,0.050505466895836,0.995973333667228,2,5,icosanoid receptor activity,MF,PTGER4;TBXA2R
17574,GO:1901186,0.0505964617100063,0.985689074854569,5,27,positive regulation of ERBB signaling pathway,BP,MMP9;EPGN;GPER1;ADAM17;AFAP1L2
524,GO:0001618,0.050718007394873,0.981663211302733,7,44,virus receptor activity,MF,TFRC;LAMP1;EFNB2;EPHA2;ICAM1;ITGAV;DAG1
17188,GO:0104005,0.050718007394873,0.981663211302733,7,44,hijacked molecular function,MF,TFRC;LAMP1;EFNB2;EPHA2;ICAM1;ITGAV;DAG1
11249,GO:0045453,0.0508137491129851,0.98345026829683,6,35,bone resorption,BP,TFRC;ADRB2;PRKCA;SYK;CD38;TNFAIP3
17853,GO:1902042,0.0508299906154247,0.985604468032333,5,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,ICAM1;SERPINE1;TRAF2;TNFRSF10A;TNFAIP3
19280,GO:1905477,0.050844467285418,0.97557356526763,12,93,positive regulation of protein localization to membrane,BP,TP53;SQSTM1;EPHA2;CHP1;SFN;GPER1;SPTBN1;YWHAH;STAC;TFDP1;RHOG;TP63
8915,GO:0034754,0.0508647121223413,0.978679466642247,9,64,cellular hormone metabolic process,BP,CYP1B1;ADM;CYP1A1;BMP2;EGR1;AKR1C2;ESR1;WNT4;AKR1C1
16233,GO:0090280,0.0509060121415217,0.995923268844841,2,5,positive regulation of calcium ion import,BP,LGALS3;PDGFB
6553,GO:0021984,0.0509424453706309,0.99591870344245,2,5,adenohypophysis development,BP,BMP2;WNT4
8390,GO:0033299,0.0509722397021131,0.995914968521645,2,5,secretion of lysosomal enzymes,BP,GNPTAB;M6PR
10090,GO:0042590,0.051029312996667,0.97852569124322,9,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,TAP1;HLA-B;PSMB9;ITGAV;HLA-F;PSME2;TAPBP;TAP2;PSMC3
10017,GO:0042446,0.0510678760683641,0.981477569258069,7,45,hormone biosynthetic process,BP,ADM;NFKB1;TNF;BMP2;DHCR7;EGR1;WNT4
10874,GO:0044406,0.0512253092139216,0.99588319269094,2,5,adhesion of symbiont to host,BP,ICAM1;HSP90AB1
675,GO:0001885,0.051269679984942,0.981418998227993,7,44,endothelial cell development,BP,TJP2;TNF;ICAM1;TJP1;MARVELD2;RAPGEF1;MYADM
7186,GO:0031072,0.0513253149676704,0.97447970700721,13,102,heat shock protein binding,MF,SACS;GBP1;AHR;DNAJB1;TELO2;DAXX;DNAJB2;NFKBIA;NPAS2;HSPA8;DNAJC9;METTL21A;HSP90AB1
18637,GO:1903936,0.0514693862769019,0.995852458159489,2,5,cellular response to sodium arsenite,BP,ZC3H12A;DAXX
6062,GO:0019210,0.0517207317840773,0.97707662775049,10,73,kinase inhibitor activity,MF,HSPB1;CDKN2B;CDKN1A;CDKN2A;CHP1;SFN;FGFR1OP;TRIB1;SOCS1;DUS2
19478,GO:1990226,0.0517667571498573,0.995814896471179,2,5,histone methyltransferase binding,MF,NOP56;HSP90AB1
7071,GO:0030858,0.0518261092591737,0.982996242112646,6,36,positive regulation of epithelial cell differentiation,BP,TRIM16;SFN;IL20;SERPINE1;LIF;FOXN1
11268,GO:0045545,0.0518687299797248,0.99580198663599,2,5,syndecan binding,MF,TNC;GPNMB
13292,GO:0051987,0.0519462523163733,0.995792162221032,2,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,RCC2;HNRNPU
10036,GO:0042487,0.0520075067465498,0.995784393315271,2,5,regulation of odontogenesis of dentin-containing tooth,BP,WNT10A;BMP2
19120,GO:1905063,0.0520173376760506,0.995783145954116,2,5,regulation of vascular smooth muscle cell differentiation,BP,GPER1;PDGFB
770,GO:0002024,0.0520337742804225,0.9957810601454,2,5,diet induced thermogenesis,BP,ADRB2;BMP8A
11661,GO:0046415,0.0520406376068551,0.995780189072615,2,5,urate metabolic process,BP,SLC16A9;ABCG2
14646,GO:0070230,0.0520811708452981,0.991268644288187,3,12,positive regulation of lymphocyte apoptotic process,BP,TP53;CD274;CCL5
10034,GO:0042482,0.0524404428924652,0.995729330007788,2,5,positive regulation of odontogenesis,BP,EDN1;BMP2
1444,GO:0003433,0.0525852952393524,0.995710846700204,2,5,chondrocyte development involved in endochondral bone morphogenesis,BP,COL27A1;SERPINH1
7500,GO:0031672,0.0526168434949624,0.987722484432964,4,19,A band,CC,CRYAB;DST;SPTBN1;FHL2
8394,GO:0033313,0.0526869669431385,0.995697855296489,2,5,meiotic cell cycle checkpoint,BP,NSUN2;ORAOV1
3268,GO:0006939,0.0528811511837329,0.979068900157229,8,54,smooth muscle contraction,BP,EDN1;DAPK3;ADRB2;GPER1;SRF;OXTR;NPNT;TBXA2R
6825,GO:0030284,0.0528924946975702,0.995671548100022,2,5,estrogen receptor activity,MF,GPER1;ESR1
9845,GO:0042090,0.0528993921839763,0.995670664183635,2,5,interleukin-12 biosynthetic process,BP,NFKB1;IRF1
11075,GO:0045075,0.0528993921839763,0.995670664183635,2,5,regulation of interleukin-12 biosynthetic process,BP,NFKB1;IRF1
3126,GO:0006705,0.0529254959200213,0.995667318359505,2,5,mineralocorticoid biosynthetic process,BP,BMP2;WNT4
3705,GO:0008212,0.0529254959200213,0.995667318359505,2,5,mineralocorticoid metabolic process,BP,BMP2;WNT4
7793,GO:0032341,0.0529254959200213,0.995667318359505,2,5,aldosterone metabolic process,BP,BMP2;WNT4
7794,GO:0032342,0.0529254959200213,0.995667318359505,2,5,aldosterone biosynthetic process,BP,BMP2;WNT4
7795,GO:0032344,0.0529254959200213,0.995667318359505,2,5,regulation of aldosterone metabolic process,BP,BMP2;WNT4
7798,GO:0032347,0.0529254959200213,0.995667318359505,2,5,regulation of aldosterone biosynthetic process,BP,BMP2;WNT4
8856,GO:0034650,0.0529254959200213,0.995667318359505,2,5,cortisol metabolic process,BP,BMP2;WNT4
8857,GO:0034651,0.0529254959200213,0.995667318359505,2,5,cortisol biosynthetic process,BP,BMP2;WNT4
19718,GO:2000064,0.0529254959200213,0.995667318359505,2,5,regulation of cortisol biosynthetic process,BP,BMP2;WNT4
11136,GO:0045180,0.052925700733245,0.995667292103886,2,5,basal cortex,CC,CLASP1;PHLDB2
17353,GO:1900040,0.052925700733245,0.995667292103886,2,5,regulation of interleukin-2 secretion,BP,GBP1;SPTBN1
2413,GO:0005587,0.052925700733245,0.995667292103886,2,5,collagen type IV trimer,CC,COL4A1;COL4A4
4583,GO:0010668,0.0529257007332671,0.995667292103886,2,5,ectodermal cell differentiation,BP,ETS2;VPS52
13857,GO:0060462,0.0529257007332671,0.995667292103886,2,5,lung lobe development,BP,FGFR2;LIF
13858,GO:0060463,0.0529257007332671,0.995667292103886,2,5,lung lobe morphogenesis,BP,FGFR2;LIF
16346,GO:0090599,0.0529257007332671,0.995667292103886,2,5,alpha-glucosidase activity,MF,MGAM;GANC
3793,GO:0008360,0.0533428265009026,0.971811333214936,15,123,regulation of cell shape,BP,FN1;DAPK3;BAIAP2;PDPN;ICAM1;MYO10;CDC42EP2;TPM1;WDR1;RHOB;MYH9;TBCCD1;BAMBI;PALM2;DAG1
8211,GO:0032964,0.0534532671538777,0.98464604204383,5,27,collagen biosynthetic process,BP,CTGF;ERRFI1;SERPINH1;TRAM2;WNT4
11355,GO:0045687,0.0537037316650339,0.984553771880545,5,27,positive regulation of glial cell differentiation,BP,BMP2;LIF;PRPF19;ZNF365;DAG1
2465,GO:0005681,0.0537821525875823,0.968669014220601,20,181,spliceosomal complex,CC,SRSF2;SART1;DDX23;LUC7L;TFIP11;SF1;PRPF19;U2AF2;LGALS3;SF3B4;ALYREF;SNRNP70;DDX39A;HNRNPU;HNRNPF;TXNL4B;HSPA8;EFTUD2;PHF5A;MAGOH
4266,GO:0009612,0.0537958207832897,0.970870999538975,16,134,response to mechanical stimulus,BP,PTGER4;MAP3K14;EDN1;NFKB1;JUNB;GADD45A;TNC;FOSL1;IRF1;NFKBIA;ETS1;JUN;SMPD2;TNFRSF10A;DAG1;GCLC
17230,GO:0110020,0.0540384892956958,0.977108226616716,9,63,regulation of actomyosin structure organization,BP,PTGER4;CTGF;SDC4;EDN1;SFRP1;TPM1;CLASP1;PHLDB2;WNT4
13233,GO:0051896,0.0541832819167473,0.971296347697515,15,124,regulation of protein kinase B signaling,BP,NRG1;C1QTNF1;IRS1;TNF;FGFR2;EPHA2;GPER1;IRS2;AKR1C2;PDGFB;ESR1;THEM4;PHLPP1;RAPGEF1;DAG1
20273,GO:2001241,0.0541918983734137,0.990766168377631,3,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,INHBA;DAPK3;PPP2R1B
12601,GO:0050777,0.0542290480685834,0.974645980103368,11,84,negative regulation of immune response,BP,TGFB2;NLRC5;IL27RA;LYN;TNF;IL7R;LGALS3;SMAD7;THOC1;PARP14;TNFAIP3
687,GO:0001906,0.0542302908898483,0.976932370824266,9,67,cell killing,BP,EMP2;LAMP1;ICAM1;IL7R;DNASE1;HMGN2;RAB27A;TUBB;HSP90AB1
539,GO:0001657,0.054343805864665,0.976954153039534,9,63,ureteric bud development,BP,SDC4;FGFR2;PBX1;BMP2;SFRP1;NPNT;SMAD7;BMP7;WNT4
17852,GO:1902041,0.0544268728505182,0.979976068837453,7,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,ICAM1;SERPINE1;SFRP1;LGALS3;TRAF2;TNFRSF10A;TNFAIP3
18702,GO:1904062,0.0544753248118537,0.969253344275771,18,157,regulation of cation transmembrane transport,BP,MMP9;JPH2;G6PD;LYN;JPH1;FLNA;CHP1;ADRB2;FXYD3;GPER1;NEDD4L;YWHAH;RRAD;KCNIP3;CAB39;STAC;OXSR1;ACTN4
19820,GO:2000279,0.0546154323156395,0.984216798210116,5,27,negative regulation of DNA biosynthetic process,BP,TP53;GNL3L;NAT10;HNRNPU;DUSP1
11205,GO:0045335,0.0549774994873072,0.972344997019855,13,105,phagocytic vesicle,CC,ACTG1;TAP1;HLA-B;RAB32;LAMP1;ITGAV;CDC42EP2;HLA-F;SYK;TAPBP;TAP2;RAPGEF1;ZYX
724,GO:0001953,0.0553989066573212,0.983925840266231,5,27,negative regulation of cell-matrix adhesion,BP,CDKN2A;CORO1C;SERPINE1;RCC2;PHLDB2
9380,GO:0035909,0.0558495277949943,0.986708787527923,4,19,aorta morphogenesis,BP,TGFB2;ADAMTS9;EFNB2;SRF
8484,GO:0033630,0.0558635106434165,0.990362135025872,3,12,positive regulation of cell adhesion mediated by integrin,BP,TGFB2;SYK;CCL5
8229,GO:0032989,0.0559579848370704,0.957596282093189,70,749,cellular component morphogenesis,BP,NRG1;MAP2;FN1;NEFL;TENM3;ACTG1;TFCP2L1;TGFB2;EDN1;GBP1;DAPK3;SIPA1L3;PANK2;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;FLNA;KLF7;EPHA2;ICAM1;ITGAV;L1CAM;MYO10;CDC42EP2;TNFRSF12A;TPM1;ZFYVE27;WDR1;IL7R;SRF;DOCK10;SGK1;RHOB;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;MYH9;SEMA3C;TBCCD1;RCC2;BAMBI;YWHAH;PALM2;ENAH;CLASP1;PQBP1;VSIG1;PARD3;LAMC1;RHOG;ZNF365;ZSWIM6;CNTNAP1;ACTN4;EFNB1;LRFN4;BMP7;AKIP1;PHLDB2;MYADM;DAG1;RILPL2;EFNA1;BIN3
4467,GO:0010463,0.0560231232334321,0.983693121081172,5,27,mesenchymal cell proliferation,BP,FGFR2;BMP2;IRS2;BMP7;TP63
9553,GO:0036314,0.0560820388187808,0.9866350550266,4,19,response to sterol,BP,INHBA;HMGCS1;INSIG1;DAG1
8612,GO:0034121,0.0561115212646781,0.981223092057121,6,36,regulation of toll-like receptor signaling pathway,BP,BIRC3;RSAD2;LYN;IRF1;ESR1;TNFAIP3
13745,GO:0060317,0.0561810814310784,0.986603614082498,4,19,cardiac epithelial to mesenchymal transition,BP,TGFB2;BMP2;SNAI2;EFNA1
947,GO:0002366,0.0565247754524986,0.959998156803746,45,468,leukocyte activation involved in immune response,BP,KRT1;FTL;FTH1;MMP9;PTGER4;S100P;RELB;TFRC;B4GALT1;MGAM;HRNR;IL27RA;NFKB1;LFNG;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;LCP1;ACAA1;ICAM1;ITGAV;DOCK10;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;SMAD7;THOC1;CAB39;HSPA8;COMMD9;CCR6;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;SWAP70;LAIR1
17510,GO:1900739,0.0566340380873787,0.983402308037256,5,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;SFN;YWHAH;TFDP1;TP63
17511,GO:1900740,0.0566340380873787,0.983402308037256,5,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;SFN;YWHAH;TFDP1;TP63
20267,GO:2001235,0.0567369941353585,0.968379589418712,17,150,positive regulation of apoptotic signaling pathway,BP,MMP9;INHBA;PML;CYLD;DAPK3;TP53;SFN;TNFRSF12A;SFRP1;GPER1;TRAF2;SFPQ;YWHAH;TFDP1;TNFRSF10A;PPP2R1B;TP63
15218,GO:0071364,0.0570624145662329,0.980824534177407,6,36,cellular response to epidermal growth factor stimulus,BP,BAIAP2;ERRFI1;SNAI2;ZFP36L1;ZFP36L2;MCM7
13998,GO:0060712,0.0571369920411749,0.990050766485662,3,12,spongiotrophoblast layer development,BP,ADM;LIF;ZFP36L1
956,GO:0002377,0.0571630791791778,0.975500947286339,9,64,immunoglobulin production,BP,TFRC;IL27RA;TNF;IL7R;TRAF2;THOC1;GALNT2;CCR6;SWAP70
19437,GO:1990070,0.0572398409024473,1,1,1,TRAPPI protein complex,CC,TRAPPC5
13039,GO:0051495,0.0572760959367607,0.967462546336609,18,158,positive regulation of cytoskeleton organization,BP,CTGF;SDC4;EDN1;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;DCTN1;SLAIN2;CLASP1;RHOG;WNT4;SWAP70;BAIAP2L2
4664,GO:0010812,0.0572918360795643,0.978677236066723,7,45,negative regulation of cell-substrate adhesion,BP,GBP1;CDKN2A;CORO1C;SERPINE1;RCC2;ACTN4;PHLDB2
7063,GO:0030850,0.057297462356233,0.98072573535939,6,36,prostate gland development,BP,TNC;FGFR2;SFRP1;ESR1;BMP7;TP63
4765,GO:0010948,0.0573509261887455,0.96257116993591,30,295,negative regulation of cell cycle process,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;RING1;PSMB9;CDK4;SFN;LIF;PSME2;GPER1;ZFP36L1;CBX5;GPR132;ZFP36L2;ORAOV1;ZW10;ANAPC15;DUSP1;TFDP1;GPNMB;BMP7;TPRA1;RBM14;CTDSP1;PSMC3;RRM2;HSP90AB1;TP63
6926,GO:0030518,0.0574988064907621,0.970050787030738,14,114,intracellular steroid hormone receptor signaling pathway,BP,RUNX1;DAXX;SFRP1;SAFB2;GPER1;DDX17;FHL2;YWHAH;PAGR1;SAFB;ESR1;RBM14;PARP1;TP63
2226,GO:0005129,0.0575342762815851,1,1,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,CSF2
8564,GO:0034021,0.0575342762815851,1,1,1,response to silicon dioxide,BP,CSF2
19690,GO:2000010,0.0575440010071033,0.989950607719965,3,12,positive regulation of protein localization to cell surface,BP,NRG1;TNF;HSP90AB1
323,GO:0000902,0.0576189837690984,0.956710361694886,65,690,cell morphogenesis,BP,NRG1;MAP2;FN1;NEFL;TENM3;TFCP2L1;TGFB2;GBP1;DAPK3;SIPA1L3;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;FLNA;KLF7;EPHA2;ICAM1;ITGAV;L1CAM;MYO10;CDC42EP2;TNFRSF12A;TPM1;ZFYVE27;WDR1;IL7R;SRF;DOCK10;SGK1;RHOB;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;MYH9;SEMA3C;TBCCD1;RCC2;BAMBI;YWHAH;PALM2;ENAH;PQBP1;VSIG1;PARD3;LAMC1;RHOG;ZNF365;ZSWIM6;CNTNAP1;ACTN4;EFNB1;LRFN4;BMP7;AKIP1;MYADM;DAG1;RILPL2;EFNA1;BIN3
19909,GO:2000404,0.0577115334404631,0.986019296432806,4,20,regulation of T cell migration,BP,CCL20;ADAM17;CCR6;CCL5
4750,GO:0010921,0.0578226126443729,0.968377561165419,16,135,regulation of phosphatase activity,BP,IGFBP3;TGFB2;SH3RF2;NUAK1;TNF;PKMYT1;CHP1;BMP2;PPP1R3B;CD2BP2;NSFL1C;NPNT;PPP1R14C;PPP1R9B;HSP90AB1;PHACTR4
12349,GO:0048711,0.0580273143086817,0.989831268507772,3,12,positive regulation of astrocyte differentiation,BP,BMP2;LIF;PRPF19
7162,GO:0031032,0.0582825356976474,0.968808739960993,15,124,actomyosin structure organization,BP,PTGER4;CTGF;ACTG1;SDC4;EDN1;KIF23;SFRP1;TPM1;WDR1;SRF;MYH9;CLASP1;PHLDB2;ZYX;WNT4
775,GO:0002029,0.05831373898491,0.98976033891244,3,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADM;UBQLN2;ADRB2
6575,GO:0022401,0.05831373898491,0.98976033891244,3,12,negative adaptation of signaling pathway,BP,ADM;UBQLN2;ADRB2
13472,GO:0055007,0.0583971229977913,0.974869207622163,9,64,cardiac muscle cell differentiation,BP,NRG1;EDN1;G6PD;EFNB2;BMP2;SRF;FHL2;HNRNPU;SORBS2
7965,GO:0032570,0.0584632730635357,0.98271112307143,5,28,response to progesterone,BP,TGFB2;FOSL1;TYMS;OXTR;CD38
10547,GO:0043496,0.0586180838867893,0.985725953230145,4,20,regulation of protein homodimerization activity,BP,NRG1;GNL3L;TRAF2;TRAF4
12906,GO:0051252,0.0586428965100274,0.949912623773528,252,3021,regulation of RNA metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;SHQ1;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;NEDD4L;SNRNP70;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;RBM38;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;PARP1;CLK4;TP63;ZBTB12;CCL5;FADS1;MAGOH
15230,GO:0071384,0.058646696703434,0.978023098417552,7,46,cellular response to corticosteroid stimulus,BP,EDN1;ICAM1;ERRFI1;GPER1;ZFP36L1;ZFP36L2;HNRNPU
3538,GO:0007530,0.0586562909295766,0.989675309413099,3,12,sex determination,BP,SF1;CITED2;WNT4
12836,GO:0051146,0.0586733319618044,0.967186217964597,17,146,striated muscle cell differentiation,BP,NRG1;HDAC9;ACTG1;EDN1;G6PD;EHD1;EFNB2;BMP2;TPM1;WDR1;SRF;FHL2;MYH9;HNRNPU;RBM38;SORBS2;BIN3
9827,GO:0042044,0.0587159867488284,0.989660469172501,3,12,fluid transport,BP,CSF2;EDN1;SLC4A11
6996,GO:0030677,0.0587335281990104,0.989497634887435,3,13,ribonuclease P complex,CC,POP1;HSD17B10;POP4
10739,GO:0044105,0.0587940993026434,1,1,1,L-xylulose reductase (NAD+) activity,MF,DCXR
12436,GO:0050038,0.0587940993026434,1,1,1,L-xylulose reductase (NADP+) activity,MF,DCXR
11379,GO:0045744,0.0588091565374387,0.982579672981211,5,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,ADM;UBQLN2;ADRB2;CXCL8;CCL5
2866,GO:0006357,0.0588596348762852,0.951757903050124,139,1595,regulation of transcription by RNA polymerase II,BP,MAFB;NRG1;RUNX1;CYR61;INHBA;HDAC9;FOSL2;PML;TFCP2L1;MYBL2;IRX2;RELB;SOD2;ARID3B;IER2;FBN1;TGFB2;EDN1;TET3;ELMSAN1;NLRC5;TP53;NFE2L1;SQSTM1;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;TNF;ZBED1;WWC1;FGFR2;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;ZC3H12A;KLF7;TSC22D3;BMP2;STAT5A;ADRB2;FOXD2;SERPINE1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;SAFB2;MKL1;IRF1;PSME2;NFX1;GPER1;SRF;ELF4;MED22;TRIM29;NFKBIA;EGR1;ETS1;SNAI2;ZFP36L1;NELFE;NPAS2;CBX5;PPRC1;MAFK;ZFP36L2;DDX17;AJUBA;PDGFB;BRMS1;UBTF;NEDD4L;FHL2;UHRF1;NPNT;IL1A;ZNFX1;TNIP2;ZNF263;SFPQ;SPEN;MAFF;SMAD7;SUPT5H;MTA2;HNRNPU;PAGR1;CREB3;RUVBL2;ABT1;MAZ;KCNIP3;SAFB;ETS2;KLF10;ZNF267;PRDM7;CITED2;JUN;ESR1;IKZF3;FOXN1;TFDP1;GTF2E1;NOP2;NOC2L;SERTAD1;INSIG1;XRCC6;KLF6;TEAD4;GLIS3;BMP7;KCTD1;ELK1;TIMELESS;RBM14;CTDSP1;PSMC3;SMARCC2;BRIP1;SUPT16H;EFNA1;BMP8A;HES4;CREB5;SNF8;PARP1;TP63
10509,GO:0043412,0.0589094402719943,0.949511609143899,269,3237,macromolecule modification,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CTGF;C1QTNF1;DTX2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;TP53;SQSTM1;MARVELD3;IL24;P4HA2;NFKB1;CPA4;CDKN2B;LFNG;IRS1;GALNT18;CDKN1A;LYN;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;NUP153;PSMB9;EPHB6;TELO2;QPCT;UBE2C;ZC3H12A;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;NAT10;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;TRIM22;ZDHHC3;PUS1;PPP1R3B;METTL1;PSME2;DPH2;GPER1;NSUN2;DNAJB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;DKC1;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;METTL2B;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;BRMS1;OXTR;RPS2;PTTG1IP;NSUN5;NSFL1C;SPTBN1;NEDD4L;RNF115;UHRF1;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;FTSJ3;ROR1;ACSL1;NOP56;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MTA2;WDR4;KEAP1;ZDHHC6;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;TRUB2;PARP14;PRDM7;GALNT2;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;DTX4;ESR1;USP31;BRPF1;GLIPR2;NOP2;NOC2L;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;LAMC1;GPNMB;XRCC6;TRMT1;KBTBD12;BMP7;METTL16;SMUG1;PHLPP1;TNFRSF10A;RNF7;MPHOSPH8;INCENP;RAPGEF1;EIF5A;MYADM;DAG1;TMEM165;MGAT2;RNF185;ASB6;DPM3;RBM14;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;METTL21A;HSD17B10;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;DUSP8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;RPUSD4;PARP1;CLK4;OTUD6A;PHACTR4;CCL5
3664,GO:0008150,0.0589248418730025,0.95607767041679,867,11215,biological_process,BP,HEPHL1;IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;CCDC80;ADM;SLC16A2;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;WNT10A;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;IGFL3;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;ANKRD36C;TNC;ASCC2;DST;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;SLCO3A1;SLC7A5P2;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;LYPD6B;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;METTL13;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;GANC;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;NCKAP5;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;VPS13B;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;SLC43A3;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;BCAM;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;BCL7C;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;DDX39A;SPRY4;NOP16;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;CXCL5;RHBDL2;RBM38;SUSD6;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC27;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;BMP7;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;CXORF36;KANK4;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;CYP20A1;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;CYB561D2;SLC4A2;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;CXCL3;XPNPEP3;ATAD3C;BMP8A;HES4;TRIML2;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;TTLL5;HERC6;ADGRF3;IL6R;BIN3;LAIR1;POP4;RPUSD4;PARP1;SLC2A6;CLK4;TP63;ZBTB12;TXNDC15;OTUD6A;IL36G;C1S;PHACTR4;TOP3A;CCL5;TMEM51;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
11473,GO:0045927,0.0589256005584019,0.96583660136923,19,169,positive regulation of growth,BP,NRG1;FN1;TFCP2L1;TGFB2;EDN1;CXCL16;FGFR2;KRT17;L1CAM;SFN;TNFRSF12A;SFRP1;ZFYVE27;SRF;ADAM17;FGFR1OP;NTN1;NEDD4L;CD38
12567,GO:0050719,0.0589974838990169,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
12569,GO:0050721,0.0589974838990169,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
12572,GO:0050726,0.0589974838990169,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
7502,GO:0031674,0.0590022765649212,0.973189691993202,10,75,I band,CC,CRYAB;JPH2;HSPB1;PDLIM1;DST;JPH1;FLNA;FHL2;ACTN4;SORBS2
12255,GO:0048535,0.0591119074959852,0.989561876822295,3,12,lymph node development,BP,PDPN;IL7R;IL15
15652,GO:0072163,0.0591223029651887,0.974496639443135,9,64,mesonephric epithelium development,BP,SDC4;FGFR2;PBX1;BMP2;SFRP1;NPNT;SMAD7;BMP7;WNT4
15653,GO:0072164,0.0591223029651887,0.974496639443135,9,64,mesonephric tubule development,BP,SDC4;FGFR2;PBX1;BMP2;SFRP1;NPNT;SMAD7;BMP7;WNT4
2404,GO:0005575,0.0593533486092328,0.962506881897741,899,11683,cellular_component,CC,HEPHL1;IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;PLD5;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;CCDC80;ADM;SLC16A2;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;IGFL1;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;WNT10A;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;TMPPE;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CPA4;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;IGFL3;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;LAYN;QPCT;SLC16A9;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;SLCO3A1;SLC7A5P2;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;TMEM183B;COL9A2;GTPBP6;TRMT61A;STAT5A;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TMEM14EP;TNFRSF12A;FOXD2;NAT10;MTUS1;IQCJ-SCHIP1;IFNGR1;ANXA8L1;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;NCKAP5;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;C9ORF47;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;FAM74A7;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;SLC43A3;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;BCAM;PREP;IFFO2;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;TCP11L1;COL5A3;DCBLD1;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;TMEM159;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;ERVV-1;SPRY4;NOP16;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TMEM140;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;CXCL5;RHBDL2;RBM38;SUSD6;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC57;LRRC27;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NBPF1;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;SMIM17;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;OLFML3;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;BMP7;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;CXORF36;KANK4;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;CYP20A1;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;CCL22;CYB561D2;SLC4A2;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;CXCL3;XPNPEP3;ATAD3C;BMP8A;HES4;ZC3H18;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;TTLL5;HERC6;ADGRF3;IL6R;BIN3;LAIR1;POP4;RPUSD4;FAM74A3;PARP1;SLC2A6;CLK4;TP63;ZBTB12;TXNDC15;IL36G;C1S;PHACTR4;TOP3A;CCL5;ARIH2OS;TMEM51;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
13096,GO:0051607,0.059368481909622,0.96611459486515,18,159,defense response to virus,BP,PML;MAP3K14;GBP1;TRIM56;BIRC3;RSAD2;TRAF3;NLRC5;ZC3H12A;TRIM22;IRF1;IL15;DDX17;IFIT3;CRCP;PQBP1;POLR3H;TNFAIP3
15523,GO:0071901,0.0594918127623211,0.968837235009525,14,116,negative regulation of protein serine/threonine kinase activity,BP,DUSP14;HSPB1;CDKN2B;CDKN1A;LYN;CDKN2A;CDK4;SFN;SFRP1;SPRY4;DUSP1;BMP7;TNFAIP3;DUSP8
18684,GO:1904030,0.0595996820870779,0.982278345570172,5,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN2B;CDKN1A;CDKN2A;CDK4;TNFAIP3
15566,GO:0072012,0.0597371288427135,0.989405593117592,3,12,glomerulus vasculature development,BP,EGR1;PDGFB;BMP7
9804,GO:0040031,0.059758936635876,0.994328961927203,2,6,snRNA modification,BP,DKC1;METTL16
6300,GO:0019915,0.0597684409404619,0.97750643466699,7,46,lipid storage,BP,IKBKE;NFKB1;EHD1;TNF;ZC3H12A;ITGAV;NFKBIA
2247,GO:0005159,0.0597970478422203,0.989390577550723,3,12,insulin-like growth factor receptor binding,MF,IRS1;YWHAH;SOCS1
3513,GO:0007423,0.059903085987883,0.960195780114967,32,311,sensory organ development,BP,MAFB;CRYAB;INHBA;CYP1B1;TENM3;CYP1A1;SDC4;KRT13;WNT10A;FBN1;TGFB2;EDN1;SIPA1L3;RING1;FGFR2;COL4A1;EPHA2;BMP2;CDK4;MCM2;OSR2;CC2D2A;SRF;NTN1;SDK1;ROR1;COL5A2;JUN;INSIG1;BMP7;TTLL5;PHACTR4
1388,GO:0003298,0.0599150355728094,0.989360990754457,3,12,physiological muscle hypertrophy,BP,EDN1;G6PD;SORBS2
1391,GO:0003301,0.0599150355728094,0.989360990754457,3,12,physiological cardiac muscle hypertrophy,BP,EDN1;G6PD;SORBS2
14167,GO:0061049,0.0599150355728094,0.989360990754457,3,12,cell growth involved in cardiac muscle cell development,BP,EDN1;G6PD;SORBS2
13419,GO:0052813,0.0600961365427204,0.979540915527864,6,36,phosphatidylinositol bisphosphate kinase activity,MF,NRG1;IRS1;FGFR2;IRS2;PDGFB;ESR1
6798,GO:0030239,0.0601977031470225,0.98204957303086,5,28,myofibril assembly,BP,ACTG1;EDN1;TPM1;WDR1;SRF
17102,GO:0099640,0.0602838303365034,1,1,1,axo-dendritic protein transport,BP,HSPB1
17103,GO:0099641,0.0602838303365034,1,1,1,anterograde axonal protein transport,BP,HSPB1
12554,GO:0050706,0.0602899603814673,0.985180703522974,4,20,regulation of interleukin-1 beta secretion,BP,TRIM16;PML;PANX1;ZC3H12A
1112,GO:0002701,0.0605689832970642,0.985089171986478,4,20,negative regulation of production of molecular mediator of immune response,BP,TGFB2;TNF;SMAD7;THOC1
12649,GO:0050853,0.0606233169938663,0.981886325460743,5,28,B cell receptor signaling pathway,BP,RUNX1;LYN;SYK;CMTM3;CD38
5788,GO:0017017,0.0606467618402933,0.989176930409808,3,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP14;DUSP1;DUSP8
1015,GO:0002507,0.060849479030132,0.98912576473069,3,12,tolerance induction,BP,LYN;PHLPP1;TNFAIP3
11795,GO:0046661,0.0609023106299104,0.968870275309927,13,106,male sex differentiation,BP,INHBA;TGFB2;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1
463,GO:0001501,0.0611964087315734,0.959257029281834,32,311,skeletal system development,BP,MMP9;RUNX1;CYR61;PTGER4;CTGF;FBN1;TGFB2;EDN1;TJP2;COL12A1;FGFR2;PBX1;SLC39A1;TYMS;BMP2;COL27A1;COL9A2;EBP;OSR2;SFRP1;SRF;SNAI2;SERPINH1;COL5A2;ETS2;KLF10;TCOF1;INSIG1;TEAD4;BMP7;BMP8A;TP63
4622,GO:0010742,0.0612395018074618,0.98486859336905,4,20,macrophage derived foam cell differentiation,BP,CSF2;NFKB1;ITGAV;NFKBIA
16099,GO:0090077,0.0612395018074618,0.98486859336905,4,20,foam cell differentiation,BP,CSF2;NFKB1;ITGAV;NFKBIA
9870,GO:0042129,0.0613153329757061,0.970699377764351,11,86,regulation of T cell proliferation,BP,SDC4;TFRC;CD274;IRF1;LGALS3;IL15;SYK;TNFRSF21;GPNMB;EFNB1;CCL5
11954,GO:0047066,0.0613448267879562,1,1,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,GPX4
16717,GO:0097707,0.0613448267879562,1,1,1,ferroptosis,BP,GPX4
17241,GO:0110075,0.0613448267879562,1,1,1,regulation of ferroptosis,BP,GPX4
17242,GO:0110076,0.0613448267879562,1,1,1,negative regulation of ferroptosis,BP,GPX4
12681,GO:0050892,0.061461558418963,0.988970820779158,3,12,intestinal absorption,BP,TJP2;ACO1;AKR1C1
16506,GO:0097201,0.0614623008212153,0.988970632430052,3,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,DNAJB1;CITED2;JUN
19285,GO:1905517,0.0615607045291207,0.984669497603861,4,21,macrophage migration,BP,SAA1;MTUS1;LGALS3;CCL5
3959,GO:0008709,0.0615837222594752,1,1,1,cholate 7-alpha-dehydrogenase activity,MF,HSD17B10
6824,GO:0030283,0.0615837222594752,1,1,1,testosterone dehydrogenase [NAD(P)] activity,MF,HSD17B10
11944,GO:0047015,0.0615837222594752,1,1,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,HSD17B10
891,GO:0002263,0.0617072599292229,0.956035879721082,45,471,cell activation involved in immune response,BP,KRT1;FTL;FTH1;MMP9;PTGER4;S100P;RELB;TFRC;B4GALT1;MGAM;HRNR;IL27RA;NFKB1;LFNG;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;LCP1;ACAA1;ICAM1;ITGAV;DOCK10;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;SMAD7;THOC1;CAB39;HSPA8;COMMD9;CCR6;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;SWAP70;LAIR1
18930,GO:1904680,0.0617449206459975,0.984608283564456,4,21,peptide transmembrane transporter activity,MF,TAP1;TAPBP;TAP2;TOMM40
12651,GO:0050855,0.0621634822158163,0.988792293841087,3,12,regulation of B cell receptor signaling pathway,BP,RUNX1;LYN;CMTM3
12311,GO:0048661,0.0622302658810307,0.974467104727579,8,56,positive regulation of smooth muscle cell proliferation,BP,MMP9;EDN1;TNF;FGFR2;PDGFB;JUN;IL6R;CCL5
4821,GO:0014015,0.0623145339835855,0.978542469924164,6,37,positive regulation of gliogenesis,BP,LYN;BMP2;LIF;PRPF19;ZNF365;DAG1
13232,GO:0051895,0.0624227327169643,0.988726130240569,3,12,negative regulation of focal adhesion assembly,BP,CORO1C;RCC2;PHLDB2
15228,GO:0071380,0.0624377691509045,0.988722289044556,3,12,cellular response to prostaglandin E stimulus,BP,PTGER4;SFRP1;AKAP8
7805,GO:0032354,0.0625841728579007,0.988684867501218,3,12,response to follicle-stimulating hormone,BP,INHBA;HMGCS1;GCLC
7339,GO:0031349,0.0626475574931268,0.958766331121163,30,297,positive regulation of defense response,BP,PTGER4;CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;NFKB1;LYN;LAMP1;TNF;PSMB9;SERPINE1;IRF1;PSME2;PSPC1;NFKBIA;ETS1;IL15;SYK;TNIP2;SFPQ;PQBP1;ESR1;XRCC6;RBM14;TNFAIP3;PSMC3;CCL5
6923,GO:0030515,0.0627709834388442,0.980931876037374,5,30,snoRNA binding,MF,PWP2;DKC1;TSR1;NOP56;NOP14
731,GO:0001960,0.0627796457985678,0.978295657480757,6,38,negative regulation of cytokine-mediated signaling pathway,BP,IL1R2;NLRC5;ROBO1;PARP14;NOL3;CCL5
13997,GO:0060711,0.0627804365595732,0.978341333005578,6,37,labyrinthine layer development,BP,CYR61;ADM;JUNB;FGFR2;ZFP36L1;BMP7
646,GO:0001836,0.0627847089627449,0.97600428417604,7,49,release of cytochrome c from mitochondria,BP,MMP9;SOD2;TP53;SFN;GPER1;JUN;NOL3
405,GO:0001085,0.0631005291067358,0.967569954897084,13,106,RNA polymerase II transcription factor binding,MF,TP53;AHR;SRF;ZFP42;SPEN;MTA2;HNRNPU;RUVBL2;JUN;ESR1;GTF2E1;TEAD4;ELK1
6576,GO:0022402,0.0631520351093416,0.94963501427041,101,1140,cell cycle process,BP,INHBA;CTGF;CYP1A1;PML;MYBL2;TGFB2;EDN1;BIRC3;DAPK3;KLHL21;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;CDKN2A;RING1;PKMYT1;PBX1;NUP153;PSMB9;UBE2C;TYMS;FLNA;ZNF503;CDK4;KIF23;SFN;EPGN;SVIL;MCM2;AKAP8L;LIF;SFRP1;IRF1;PSME2;BANF1;GPER1;NSUN2;RRS1;ZFP36L1;AKAP8;RHOB;ADAM17;FEN1;DHFR;FGFR1OP;CBX5;PRKCA;GPR132;ZFP36L2;AJUBA;GINS2;PDGFB;POLA1;SPTBN1;DCTN1;MYH9;IL1A;ORAOV1;PRCC;SFPQ;ZW10;RCC2;NUP214;HNRNPU;CLASP1;PAGR1;CEP41;PPP1R9B;ORC1;ANAPC15;DUSP1;CAB39;CENPN;RCC1;MCM7;TFDP1;CHMP4B;CENPO;CNTROB;GPNMB;BMP7;TPRA1;INCENP;KIF22;TIMELESS;WNT4;RBM14;TUBB;CTDSP1;PSMC3;BRIP1;RRM2;CXCL8;CDCA5;HSP90AB1;MKI67;BIN3;TP63;ORC4
458,GO:0001306,0.0631985266192327,1,1,1,age-dependent response to oxidative stress,BP,SOD2
459,GO:0001315,0.0631985266192327,1,1,1,age-dependent response to reactive oxygen species,BP,SOD2
1274,GO:0003068,0.0631985266192327,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP,SOD2
1275,GO:0003069,0.0631985266192327,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,SOD2
1276,GO:0003070,0.0631985266192327,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,SOD2
3548,GO:0007571,0.0631985266192327,1,1,1,age-dependent general metabolic decline,BP,SOD2
2397,GO:0005542,0.0632201806199026,0.993805299571689,2,6,folic acid binding,MF,TYMS;DHFR
9875,GO:0042136,0.0632490377840761,0.973960881551622,8,56,neurotransmitter biosynthetic process,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;HSP90AB1
13841,GO:0060441,0.0633668134095258,0.984163033213446,4,20,epithelial tube branching involved in lung morphogenesis,BP,TNF;TNC;FGFR2;DAG1
19699,GO:2000027,0.0636803520092399,0.962135734507442,20,184,regulation of organ morphogenesis,BP,WNT10A;TGFB2;EDN1;B4GALT1;TNF;FGFR2;PSMB9;BMP2;LIF;SFRP1;PSME2;SNAI2;SEMA3C;ROR1;CITED2;ESR1;BMP7;WNT4;TNFAIP3;PSMC3
975,GO:0002429,0.0636934774298143,0.960201649201434,24,228,immune response-activating cell surface receptor signaling pathway,BP,RUNX1;ACTG1;CYLD;RELB;GBP1;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;PSME2;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;RAPGEF1;CD38;PSMC3;SPG21;HSP90AB1
1321,GO:0003170,0.0639322069625029,0.980605153552364,5,28,heart valve development,BP,CYR61;TGFB2;ADAMTS9;BMP2;EFNA1
85,GO:0000172,0.0640965335967448,0.993669939813126,2,6,ribonuclease MRP complex,CC,POP1;POP4
8231,GO:0032991,0.0641028827261803,0.944563552734294,310,3842,protein-containing complex,CC,IGFBP3;MAFB;SAA1;FTL;FTH1;INHBA;HDAC9;MAP2;FN1;NEFL;C1QTNF1;AMOT;JPH2;ACTG1;TAP1;HSPB1;MYBL2;PDLIM1;RELB;TFRC;ABCF1;CD3EAP;HLA-B;MAT2A;MID1;ELMSAN1;SPSB1;TRAF3;KLHL21;TP53;NFE2L1;SQSTM1;PDCD11;HNRNPAB;NOCT;NFKB1;TAF4B;IRS1;CDKN1A;HSPG2;LYN;MYO1B;AHR;JUNB;MCM5;ARPC4;COL12A1;GNL3L;RING1;CORO1C;PPAN;RRP1;ENC1;ASCC2;FGFR2;PBX1;NUP153;TPM4;NFKB2;COL4A1;PSMB9;EPHB6;TELO2;UBE2C;JPH1;ZC3H12A;FLNA;SRSF2;LCP1;SART1;GEMIN5;EPHA2;FANCC;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ITGAV;KIF23;MYO10;COL9A2;TRMT61A;RNF19B;ZMAT2;ADRB2;SVIL;DAXX;NAT10;FUS;PABPC4;ARPC1B;MCM2;TOX4;GRWD1;ABCF2;CC2D2A;HLA-F;WDR1;PPP1R3B;PWP2;METTL1;PSME2;LUC7L;TFIP11;NSUN2;RRP36;LARP4B;AP4S1;ABTB2;MED22;ZFP42;NFKBIA;SF1;PARD3B;EDF1;KCNA7;ETS1;GEMIN4;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;NELFE;DKC1;U2AF2;VCL;KCTD10;NPAS2;CBX5;LGALS3;TSR1;RPLP1;TRAF2;ABCG2;SF3B4;PRKCA;ZFC3H1;SYK;POLR1A;AJUBA;SENP3;GINS2;NOB1;BRMS1;RPS2;ALYREF;UTP14A;POLA1;UTP20;WDR34;RPS9;GEMIN8;NSFL1C;SNRNP70;DCTN1;COX5B;DPYSL3;COL5A3;RRP7A;MYH9;COL17A1;NPNT;COPS3;CAMK1G;ORAOV1;SNX8;RBBP5;SFPQ;BORCS7;DDX39A;FTSJ3;WDR46;SPEN;ZW10;ROR1;PXMP2;NOP56;COL5A2;NUP214;SMAD7;CRCP;MRPS12;MRPS24;SUPT5H;MTA2;TAPBP;TRIP6;WDR4;KEAP1;SPECC1;M6PR;HNRNPU;TJP1;CLASP1;HNRNPF;PQBP1;APH1A;PAGR1;UBE2J2;DCUN1D2;RUVBL2;ABT1;PPP1R9B;ORC1;KCNIP3;THOC1;DNTTIP1;ANAPC15;MRPL20;RRP7BP;CAB39;TGFBRAP1;TXNL4B;CITED2;RPL27A;SOCS1;HSPA8;JUN;MRPL33;ESR1;CENPN;BLOC1S2;PES1;RCC1;BRPF1;MCM7;TFDP1;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;ZNF703;INSIG1;CENPO;LAMC1;BCL2L2;XRCC6;EDC4;TAP2;CHCHD6;ZSWIM6;TEAD4;CNTNAP1;KBTBD12;ACTN4;KIF24;EFTUD2;RNF7;TOMM40;MPHOSPH8;INCENP;PHF5A;EIF3I;IPO4;CHAF1A;EIF5A;UBAP2L;KIF22;DAG1;CGNL1;POLR3H;RNF185;EEF1D;COL4A4;TIMELESS;GPX4;BLNK;DPM3;MRPS2;RBM14;VPS52;TUBB;PSMC3;SMARCC2;RRM2;SUPT16H;METTL21A;POLR1E;MYO1E;HSD17B10;SURF6;ZC3H18;CARD10;PTPRB;UTP4;RNF144B;POLR2G;CLTA;SNF8;CDCA5;GCLC;HSP90AB1;IL6R;POP4;PARP1;TP63;BAIAP2L2;ORC4;MAGOH
15561,GO:0072006,0.0642219568658785,0.969082809238128,11,85,nephron development,BP,IRX2;PBX1;BMP2;LIF;EGR1;PDGFB;NPNT;BMP7;COL4A4;WNT4;MYO1E
13231,GO:0051894,0.0644378445646233,0.98380453486331,4,20,positive regulation of focal adhesion assembly,BP,SDC4;COL16A1;SFRP1;WNT4
17723,GO:1901652,0.0645327283004487,0.956260431539552,34,338,response to peptide,BP,TRIM16;HDAC9;NEFL;CTGF;ADM;FBN1;EDN1;TP53;NFKB1;IRS1;LYN;BAIAP2;ICAM1;CDK4;ERRFI1;STAT5A;ADRB2;GPER1;NFKBIA;EGR1;ZFP36L1;IRS2;OXTR;KLF10;SOCS1;QDPR;BMP7;DAG1;TIMELESS;TNFAIP3;BRIP1;GCLC;PARP1;BAIAP2L2
13478,GO:0055013,0.0646194263019744,0.977543395357253,6,37,cardiac muscle cell development,BP,EDN1;G6PD;SRF;FHL2;HNRNPU;SORBS2
1448,GO:0003678,0.0646204397960431,0.975244109595848,7,46,DNA helicase activity,MF,MCM5;MCM2;GINS2;RUVBL2;MCM7;XRCC6;BRIP1
13761,GO:0060337,0.0646660365369437,0.971524609904713,9,68,type I interferon signaling pathway,BP,HLA-B;RSAD2;NLRC5;XAF1;HLA-F;IRF1;EGR1;IFIT3;HSP90AB1
15212,GO:0071357,0.0646660365369437,0.971524609904713,9,68,cellular response to type I interferon,BP,HLA-B;RSAD2;NLRC5;XAF1;HLA-F;IRF1;EGR1;IFIT3;HSP90AB1
5630,GO:0016709,0.0646902647835109,0.98371972787587,4,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP1A1;AKR1C2;MICAL3;AKR1C1
13844,GO:0060444,0.064930957415352,0.98363874916802,4,20,branching involved in mammary gland duct morphogenesis,BP,PML;EPHA2;ESR1;WNT4
9065,GO:0035296,0.0652137710293148,0.97128125821606,9,66,regulation of tube diameter,BP,ADM;SOD2;EDN1;ICAM1;ADRB2;GPER1;OXTR;CD38;TBXA2R
16734,GO:0097746,0.0652137710293148,0.97128125821606,9,66,regulation of blood vessel diameter,BP,ADM;SOD2;EDN1;ICAM1;ADRB2;GPER1;OXTR;CD38;TBXA2R
446,GO:0001205,0.0652187209765813,0.983541790811993,4,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,ARID3B;NFE2L1;NFKB1;SRF
16725,GO:0097726,0.065269339503063,1,1,1,LEM domain binding,MF,BANF1
12574,GO:0050728,0.0653049287142084,0.971210398856677,9,67,negative regulation of inflammatory response,BP,KRT1;SAA1;PTGER4;IL1R2;NFKB1;ZC3H12A;GPER1;ETS1;TNFAIP3
10849,GO:0044344,0.0656754350784264,0.966024405530806,13,107,cellular response to fibroblast growth factor stimulus,BP,CTGF;FGFR2;SFRP1;SNAI2;ZFP36L1;ZFP36L2;SPRY4;HNRNPF;WNT4;CXCL8;POLR2G;GCLC;CCL5
904,GO:0002286,0.0659373818155896,0.974585352399515,7,47,T cell activation involved in immune response,BP,PTGER4;RELB;LCP1;ICAM1;LGALS3;SMAD7;RAB27A
119,GO:0000247,0.065972771767082,1,1,1,C-8 sterol isomerase activity,MF,EBP
2030,GO:0004769,0.065972771767082,1,1,1,steroid delta-isomerase activity,MF,EBP
14512,GO:0065003,0.0660524226856441,0.946241020746033,121,1421,protein-containing complex assembly,BP,CRYAB;NRG1;PTGER4;MAP2;FN1;NEFL;C1QTNF1;PML;CYLD;TRAF1;SOD2;CSF2;COBLL1;GBP1;MAT2A;IKBKE;BIRC3;B4GALT1;PANX1;TP53;SQSTM1;NOCT;TAF4B;ARPC4;EHD1;TNF;BAIAP2;PPAN;NUP153;FOSL1;UBE2C;ZC3H12A;LCP1;SART1;TK1;GEMIN5;CADPS2;CHP1;ICAM1;FANCC;COL16A1;DDX23;CDC42EP2;ANKS4B;ADRB2;DAXX;ARPC1B;MCM2;GRWD1;TRIM22;PWP2;PDE4DIP;LUC7L;TFIP11;SRF;SF1;KCNA7;GEMIN4;RRS1;CD2BP2;PRPF19;SHQ1;KCTD10;TRAF2;AJUBA;AASS;UBTF;GEMIN8;SPTBN1;DCTN1;DPYSL3;RRP7A;SLAIN2;RBBP5;ZW10;TAPBP;ERAL1;CLASP1;RUVBL2;ABT1;MRPL20;RRP7BP;CAB39;TXNL4B;HSPA8;JUN;ESR1;CENPN;RCC1;CPT1A;DCXR;BCS1L;TRAPPC5;NOP2;CHMP4B;NACC1;INSIG1;CENPO;PARD3;LAMC1;RHOG;XRCC6;KCTD1;KANK4;IPO4;CHAF1A;MYADM;GPX4;AKR1C1;TNFAIP3;PSMC3;CLDN7;HSD17B10;CARD10;CLTA;NOL3;HSP90AB1;PARP1;TP63;CCL5;BAIAP2L2
895,GO:0002274,0.0661877838493636,0.953361663812924,41,427,myeloid leukocyte activation,BP,KRT1;FTL;FTH1;MMP9;S100P;RELB;CSF2;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;ZC3H12A;ACAA1;ITGAV;VCL;LGALS3;SYK;SLC7A2;DNASE1;GLIPR1;TNIP2;LILRB3;CAB39;HSPA8;JUN;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;CXCL8;PTPRB;HSP90AB1;LAIR1;CCL5
18540,GO:1903747,0.0662554424261619,0.966714456422564,12,98,regulation of establishment of protein localization to mitochondrion,BP,NRG1;TP53;CYB5R1;SFN;USP36;PARL;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;TP63
4508,GO:0010558,0.0663157211359915,0.946922339421661,102,1161,negative regulation of macromolecule biosynthetic process,BP,NRG1;INHBA;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;DAPK3;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;GNL3L;CDKN2A;RING1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;ITGAV;ERRFI1;DAXX;NAT10;ZC3H7B;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;SRF;TRIM29;SF1;EGR1;SNAI2;SRRT;ZFP36L1;NELFE;DHFR;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;NUP214;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;DUSP1;CITED2;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;POLR2G;GCLC;PARP1;TP63
17947,GO:1902292,0.0664526984250481,1,1,1,cell cycle DNA replication initiation,BP,GINS2
17960,GO:1902315,0.0664526984250481,1,1,1,nuclear cell cycle DNA replication initiation,BP,GINS2
18198,GO:1902975,0.0664526984250481,1,1,1,mitotic DNA replication initiation,BP,GINS2
7243,GO:0031167,0.0664680394394951,0.98301663821245,4,21,rRNA methylation,BP,NSUN5;FTSJ3;NOP2;METTL16
11807,GO:0046688,0.066469094237509,0.982924038678748,4,22,response to copper ion,BP,CYP1A1;ICAM1;DAXX;IL1A
2490,GO:0005737,0.0665158457009618,0.942673453200701,657,8359,cytoplasm,CC,IGFBP3;IL32;KRT1;SAA1;SPRR3;TRIM16;FTL;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;ADM;TNS3;KRT15;AMOT;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;IER2;HLA-B;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;MCM5;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;WWC1;ENC1;TNC;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;FANCC;ARFRP1;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;ANKS4B;RNF19B;ADRB2;SVIL;PLEKHA7;DAXX;MTUS1;IQCJ-SCHIP1;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;NMT2;ST6GALNAC5;XAF1;AKAP8L;AMOTL2;ELF3;GRWD1;RELT;LIF;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;TXN2;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;LGALS3;TSR1;ACO1;RPLP1;TRAF2;ABCG2;IL15;REEP1;AKR1C2;PRKCA;ZFP36L2;PUM3;NTN1;SYK;CMTM3;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;PDGFB;FILIP1;AASS;CEP95;BRMS1;PREP;RPS2;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;COLGALT1;COX5B;RNF115;DPYSL3;COL5A3;RRP7A;SLAIN2;MYH9;SPPL2A;TAPBPL;COL17A1;NPNT;IL1A;COPS3;CAMK1G;GLIPR1;TNIP2;LANCL2;DOHH;RASGRP4;SNX8;SFPQ;BORCS7;DDX39A;SPRY4;LILRB3;TBCCD1;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;CCDC6;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;CREB3;RUVBL2;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;THOC1;ETS2;TRUB2;PARP14;ANAPC15;MRPL20;RBM38;PCYT1A;GALNT2;ATG101;MARVELD2;DUSP1;CAB39;TGFBRAP1;TXNL4B;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;OGFR;EIF3B;BCS1L;GTF2E1;TRAPPC5;NBPF1;NOC2L;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;RPTN;ARRDC3;INSIG1;CENPO;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;SMPD2;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;SNIP1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;RNF7;KANK4;TOMM40;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;EIF3I;RAPGEF1;IPO4;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CYTH1;TNFAIP3;PSMC3;SPG21;DNAJC9;BRIP1;RRM2;MAPK11;AARSD1;METTL21A;CTPS1;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;CARD10;SLC25A22;PTPRB;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;TTLL5;HERC6;BIN3;LAIR1;RPUSD4;PARP1;TP63;PHACTR4;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
8325,GO:0033162,0.0667667791808888,0.99325066421968,2,6,melanosome membrane,CC,RAB32;RAB27A
11037,GO:0045009,0.0667667791808888,0.99325066421968,2,6,chitosome,CC,RAB32;RAB27A
16388,GO:0090741,0.0667667791808888,0.99325066421968,2,6,pigment granule membrane,CC,RAB32;RAB27A
12731,GO:0050994,0.0667854655474376,0.979413672084474,5,29,regulation of lipid catabolic process,BP,IRS1;TNF;CDK4;IRS2;CPT1A
4654,GO:0010797,0.0671384066275951,1,1,1,regulation of multivesicular body size involved in endosome transport,BP,SNF8
6303,GO:0019932,0.0672101854187263,0.961013526423794,18,161,second-messenger-mediated signaling,BP,CCL20;NRG1;PTGER4;ADM;JPH2;EDN1;GBP1;AHR;JPH1;CHP1;ADRB2;GPER1;PRKCA;SYK;PPP1R9B;CCR6;CXCL8;TBXA2R
12596,GO:0050772,0.0672494657849367,0.97020656259629,9,66,positive regulation of axonogenesis,BP,NRG1;FN1;NEFL;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1
9863,GO:0042116,0.0672575769430004,0.976337904527371,6,38,macrophage activation,BP,CSF2;ZC3H12A;SYK;SLC7A2;TNIP2;JUN
6836,GO:0030298,0.0673503779804078,1,1,1,receptor signaling protein tyrosine kinase activator activity,MF,CCL5
7524,GO:0031726,0.0673503779804078,1,1,1,CCR1 chemokine receptor binding,MF,CCL5
7525,GO:0031729,0.0673503779804078,1,1,1,CCR4 chemokine receptor binding,MF,CCL5
11843,GO:0046817,0.0673503779804078,1,1,1,chemokine receptor antagonist activity,MF,CCL5
7210,GO:0031102,0.0673694932611927,0.976288498026634,6,38,neuron projection regeneration,BP,NEFL;ADM;TNC;DHFR;JUN;DAG1
15882,GO:0072608,0.0674938785066388,0.993134725425353,2,6,interleukin-10 secretion,BP,CD274;TNFRSF21
11262,GO:0045517,0.067503462325038,1,1,1,interleukin-20 receptor binding,MF,IL20
11263,GO:0045518,0.067503462325038,1,1,1,interleukin-22 receptor binding,MF,IL20
725,GO:0001954,0.0677594992861571,0.976116147141098,6,38,positive regulation of cell-matrix adhesion,BP,SDC4;EMP2;COL16A1;SFRP1;DAG1;WNT4
8619,GO:0034135,0.0678824168424262,0.993072462357572,2,6,regulation of toll-like receptor 2 signaling pathway,BP,LYN;TNFAIP3
19736,GO:2000109,0.0680004868907574,0.993053499110595,2,6,regulation of macrophage apoptotic process,BP,CDKN2A;CCL5
3601,GO:0008033,0.0681943324549455,0.963505259243021,14,120,tRNA processing,BP,CDKAL1;TRMT61A;NAT10;PUS1;METTL1;NSUN2;POP1;METTL2B;WDR4;DUS2;TRMT1;HSD17B10;POP4;RPUSD4
12881,GO:0051216,0.0682196782739387,0.964511640303337,13,106,cartilage development,BP,RUNX1;CYR61;CTGF;EDN1;TYMS;BMP2;COL27A1;OSR2;SRF;SNAI2;SERPINH1;BMP7;BMP8A
10743,GO:0044110,0.0682384064217783,0.993015226588945,2,6,growth involved in symbiotic interaction,BP,SQSTM1;TNF
10746,GO:0044116,0.0682384064217783,0.993015226588945,2,6,growth of symbiont involved in interaction with host,BP,SQSTM1;TNF
10747,GO:0044117,0.0682384064217783,0.993015226588945,2,6,growth of symbiont in host,BP,SQSTM1;TNF
7736,GO:0032231,0.068249958885143,0.969675767486654,9,66,regulation of actin filament bundle assembly,BP,PTGER4;CTGF;SDC4;SFRP1;TPM1;CLASP1;PHLDB2;WNT4;SWAP70
11089,GO:0045089,0.0683186744600214,0.956534028110245,25,242,positive regulation of innate immune response,BP,CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;NFKB1;LYN;LAMP1;PSMB9;IRF1;PSME2;PSPC1;NFKBIA;SYK;TNIP2;SFPQ;PQBP1;ESR1;XRCC6;RBM14;TNFAIP3;PSMC3;CCL5
10892,GO:0044432,0.0684194689353871,0.94616221472094,86,962,endoplasmic reticulum part,CC,IGFBP3;CYR61;FN1;P3H2;CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;FBN1;EDN1;PRSS23;RSAD2;PANX1;NFE2L1;P4HA2;COL12A1;PKMYT1;SCD;TNC;DST;CDKAL1;COL4A1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;COL16A1;COL27A1;GGCX;COL9A2;ANKS4B;RNF19B;EBP;ZFYVE27;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;SGK1;CYP4B1;TRAF2;REEP1;PDGFB;SERPINH1;COLGALT1;COL5A3;SPPL2A;TAPBPL;COL17A1;ZW10;ACSL1;COL5A2;DNAJC1;TAPBP;ZDHHC6;APH1A;UBE2J2;CREB3;LPCAT3;PCYT1A;GALNT2;ATG101;PIGM;SCD5;INSIG1;LAMC1;RHOG;TAP2;EIF5A;DAG1;RNF185;COL4A4;DPM3;WNT4;LRRC59;FADS1
11088,GO:0045088,0.0685751307158876,0.954809094754926,29,287,regulation of innate immune response,BP,CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NLRC5;NFKB1;LYN;LAMP1;PSMB9;IFNGR1;IRF1;PSME2;PSPC1;NFKBIA;SYK;TNIP2;SFPQ;PQBP1;PARP14;SOCS1;ESR1;XRCC6;RBM14;TNFAIP3;PSMC3;HSP90AB1;CCL5
17584,GO:1901214,0.0686320535424288,0.957735084428062,22,205,regulation of neuron death,BP,NEFL;NQO1;MYBL2;SOD2;TGFB2;G6PD;TP53;EFNB2;CHP1;DAXX;EGR1;TRAF2;GPR75;JUN;CHMP4B;GPNMB;ELK1;GCLC;HSP90AB1;PARP1;TP63;CCL5
13800,GO:0060389,0.06911921086414,0.975513099852302,6,38,pathway-restricted SMAD protein phosphorylation,BP,INHBA;TGFB2;BMP2;SMAD7;BMP7;BMP8A
16669,GO:0097550,0.0691483234290788,0.992868112894201,2,6,transcriptional preinitiation complex,CC,ESR1;GTF2E1
2402,GO:0005547,0.0691524917139755,0.978468806903285,5,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,JPH2;MYO1B;MYO10;ANXA8;PARD3
989,GO:0002446,0.0691996341986167,0.952503644171434,35,359,neutrophil mediated immunity,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;WDR1;ADAM17;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CXCL5;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
19695,GO:2000018,0.0692388385960618,0.992853414396437,2,6,regulation of male gonad development,BP,CITED2;WNT4
7694,GO:0032147,0.0693206857258133,0.955849315552347,25,237,activation of protein kinase activity,BP,SAA1;NRG1;MAP3K14;TGFB2;EMP2;GADD45A;TNF;GADD45B;BMP2;EPGN;ADRB2;DAXX;RPLP1;TRAF2;SYK;PDGFB;CAB39;SOCS1;OXSR1;TNFRSF10A;RAPGEF1;TRAF4;MAPK11;CARD10;CCL5
3441,GO:0007249,0.0694149251626655,0.957191978107607,22,206,I-kappaB kinase/NF-kappaB signaling,BP,HSPB1;RELB;MAP3K14;IKBKE;BIRC3;SQSTM1;NFKB1;TNF;NFKB2;ZC3H12A;FLNA;TRIM22;NFKBIA;TRAF2;AJUBA;IL1A;TNIP2;ROR1;ESR1;SNIP1;EEF1D;TNFAIP3
133,GO:0000278,0.0694313147065731,0.945623367705356,82,913,mitotic cell cycle,BP,INHBA;CYP1A1;PML;CYLD;MYBL2;MAP3K14;EDN1;BIRC3;DAPK3;TP53;CDKN2B;CDKN1A;MCM5;GADD45A;TNF;CDKN2A;PKMYT1;PBX1;NUP153;PSMB9;UBE2C;TYMS;FLNA;SRSF2;CDK4;KIF23;SFN;EPGN;MCM2;AKAP8L;PSME2;BANF1;RRS1;ZFP36L1;AKAP8;RHOB;ADAM17;DHFR;FGFR1OP;PRKCA;GPR132;ZFP36L2;AJUBA;GINS2;PDGFB;POLA1;SPTBN1;DCTN1;IL1A;ORAOV1;PRCC;ZW10;RCC2;NUP214;AFAP1L2;HNRNPU;CLASP1;CEP41;PPP1R9B;ORC1;ANAPC15;DUSP1;OXSR1;RCC1;MCM7;TFDP1;CHMP4B;CNTROB;GPNMB;BMP7;TPRA1;INCENP;KIF22;TUBB;CTDSP1;PSMC3;RRM2;CDCA5;MKI67;BIN3;TP63;ORC4
15182,GO:0071316,0.0694526498649051,0.992818648164065,2,6,cellular response to nicotine,BP,NFKB1;TNF
560,GO:0001696,0.0696150306746694,0.992792201459265,2,6,gastric acid secretion,BP,SGK1;OXTR
3408,GO:0007189,0.069676448732537,0.975264992386971,6,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PTGER4;ADM;ADRB2;GPER1;PRKCA;TBXA2R
17589,GO:1901224,0.0696821613641078,0.975262445971438,6,38,positive regulation of NIK/NF-kappaB signaling,BP,TNF;TRAF2;ACTN4;TNFRSF10A;TRAF4;CARD10
541,GO:0001659,0.0697405456748783,0.981889314993416,4,21,temperature homeostasis,BP,TNF;ADRB2;IL1A;ARRDC3
11376,GO:0045741,0.0698319860400865,0.99275680814195,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,EPGN;ADAM17
11448,GO:0045898,0.069844643552347,0.986581424120654,3,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;ESR1;PSMC3
7378,GO:0031430,0.0698631003181591,0.986576396731298,3,13,M band,CC,CRYAB;SPTBN1;FHL2
3704,GO:0008211,0.0699664848075887,0.986548225133554,3,13,glucocorticoid metabolic process,BP,BMP2;YWHAH;WNT4
4925,GO:0014876,0.0701653432963518,1,1,1,response to injury involved in regulation of muscle adaptation,BP,NOL3
11942,GO:0047006,0.0701821904347659,1,1,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,AKR1C1
11951,GO:0047042,0.0701821904347659,1,1,1,androsterone dehydrogenase (B-specific) activity,MF,AKR1C1
12033,GO:0047718,0.0701821904347659,1,1,1,indanol dehydrogenase activity,MF,AKR1C1
4506,GO:0010556,0.0704641679071786,0.939241972375624,269,3254,regulation of macromolecule biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;TOX4;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EIF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;PARP1;TP63;ZBTB12;CCL5;FADS1;MAGOH
6269,GO:0019863,0.0705817583702525,1,1,1,IgE binding,MF,LGALS3
17831,GO:1901990,0.0706433115205724,0.951426287793756,35,358,regulation of mitotic cell cycle phase transition,BP,CYP1A1;PML;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;PBX1;PSMB9;UBE2C;CDK4;SFN;PSME2;ZFP36L1;ADAM17;FGFR1OP;GPR132;ZFP36L2;DCTN1;ORAOV1;ZW10;RCC2;CLASP1;CEP41;PPP1R9B;ANAPC15;DUSP1;TFDP1;GPNMB;TPRA1;TUBB;CTDSP1;PSMC3;CDCA5;TP63
15234,GO:0071389,0.0707318956607716,0.992609291303374,2,6,cellular response to mineralocorticoid stimulus,BP,EDN1;GPER1
801,GO:0002069,0.0708588352362582,0.992588391079497,2,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A;TYMS
12843,GO:0051153,0.070933870565321,0.970051674998702,8,57,regulation of striated muscle cell differentiation,BP,NRG1;HDAC9;EDN1;G6PD;EHD1;EFNB2;BMP2;RBM38
2119,GO:0004910,0.0710041888738576,1,1,1,interleukin-1, Type II, blocking receptor activity,MF,IL1R2
8041,GO:0032690,0.0710041888738576,1,1,1,negative regulation of interleukin-1 alpha production,BP,IL1R2
12560,GO:0050712,0.0710041888738576,1,1,1,negative regulation of interleukin-1 alpha secretion,BP,IL1R2
654,GO:0001844,0.0710441050920651,0.977636590220281,5,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;SFN;YWHAH;TFDP1;TP63
20275,GO:2001243,0.0711278383905941,0.966477902252876,10,79,negative regulation of intrinsic apoptotic signaling pathway,BP,MMP9;HSPB1;SOD2;SNAI2;PTTG1IP;ACKR3;CREB3;NOC2L;BCL2L2;NOL3
18915,GO:1904627,0.0711954479519927,1,1,1,response to phorbol 13-acetate 12-myristate,BP,CDK4
18916,GO:1904628,0.0711954479519927,1,1,1,cellular response to phorbol 13-acetate 12-myristate,BP,CDK4
15229,GO:0071383,0.0711995830911001,0.956519836463393,21,193,cellular response to steroid hormone stimulus,BP,RUNX1;EDN1;ICAM1;ERRFI1;DAXX;SFRP1;SAFB2;GPER1;ZFP36L1;ZFP36L2;DDX17;FHL2;YWHAH;HNRNPU;PAGR1;SAFB;ESR1;BMP7;RBM14;PARP1;TP63
7515,GO:0031700,0.0712586758117995,1,1,1,adrenomedullin receptor binding,MF,ADM
8063,GO:0032731,0.0713149971037752,0.981339956878651,4,21,positive regulation of interleukin-1 beta production,BP,TRIM16;HSPB1;PANX1;EGR1
6830,GO:0030291,0.0713763827021455,0.977501601872851,5,30,protein serine/threonine kinase inhibitor activity,MF,HSPB1;CDKN2B;CDKN1A;CDKN2A;SFN
11061,GO:0045059,0.0713774224272756,0.992502772029479,2,6,positive thymic T cell selection,BP,SRF;FOXN1
6059,GO:0019207,0.0714257108909873,0.958234287734685,18,162,kinase regulator activity,MF,NRG1;HSPB1;CDKN2B;CDKN1A;CDKN2A;CHP1;CDK4;SFN;DAXX;FGFR1OP;RPLP1;AFAP1L2;TRIB1;CAB39;SOCS1;DUS2;HSP90AB1;CCL5
279,GO:0000781,0.0714277169668936,0.959689880855062,16,146,chromosome, telomeric region,CC,PML;MCM5;TELO2;NAT10;MCM2;TOX4;TFIP11;FEN1;CBX5;ALYREF;ORC1;THOC1;MCM7;XRCC6;PARP1;ORC4
9949,GO:0042310,0.0714368512012827,0.974477527175738,6,38,vasoconstriction,BP,ADM;EDN1;ICAM1;OXTR;CD38;TBXA2R
7427,GO:0031528,0.0714605794385136,0.986139021859969,3,13,microvillus membrane,CC,S100P;PDPN;ITGAV
17708,GO:1901617,0.0715280133521459,0.958166710997108,18,162,organic hydroxy compound biosynthetic process,BP,TGFB2;G6PD;NFKB1;TNF;SCD;LSS;CYB5R1;HMGCS1;BMP2;EBP;DHCR7;GPER1;SNAI2;DHFR;PPIP5K1;INSIG1;QDPR;WNT4
4671,GO:0010819,0.0715773347724866,0.99246966557412,2,6,regulation of T cell chemotaxis,BP,ADAM17;CCL5
4672,GO:0010820,0.0715773347724866,0.99246966557412,2,6,positive regulation of T cell chemotaxis,BP,ADAM17;CCL5
745,GO:0001975,0.0716735732995467,0.986080372450276,3,13,response to amphetamine,BP,HDAC9;ICAM1;OXTR
2477,GO:0005697,0.0719285284382819,0.981022965570231,4,22,telomerase holoenzyme complex,CC,GNL3L;NAT10;DKC1;HNRNPU
10018,GO:0042447,0.0719293318693673,0.992411236989978,2,6,hormone catabolic process,BP,ACAA1;YWHAH
1554,GO:0003953,0.0719666775476891,1,1,1,NAD+ nucleosidase activity,MF,CD38
12444,GO:0050135,0.0719666775476891,1,1,1,NAD(P)+ nucleosidase activity,MF,CD38
14461,GO:0061809,0.0719666775476891,1,1,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,CD38
6650,GO:0023058,0.0720410005749642,0.985979014921215,3,13,adaptation of signaling pathway,BP,ADM;UBQLN2;ADRB2
16144,GO:0090153,0.0720659274049863,0.985972130253874,3,13,regulation of sphingolipid biosynthetic process,BP,CYR61;TNF;SMPD2
19107,GO:1905038,0.0720659274049863,0.985972130253874,3,13,regulation of membrane lipid metabolic process,BP,CYR61;TNF;SMPD2
19835,GO:2000303,0.0720659274049863,0.985972130253874,3,13,regulation of ceramide biosynthetic process,BP,CYR61;TNF;SMPD2
14257,GO:0061309,0.0720925407366513,0.992384086801037,2,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,SEMA3C;BMP7
11773,GO:0046631,0.0721166421101089,0.96758311326372,9,67,alpha-beta T cell activation,BP,PTGER4;RELB;CD83;RSAD2;IRF1;ELF4;IL15;SYK;SMAD7
5587,GO:0016605,0.0721195919479785,0.964541081150474,11,87,PML body,CC,TRIM16;PML;IKBKE;DAPK3;TP53;SQSTM1;DAXX;AKAP8L;ELF4;CBX5;TOP3A
15465,GO:0071801,0.0721487520326882,0.985949246827077,3,13,regulation of podosome assembly,BP,CSF2;TNF;LCP1
1132,GO:0002724,0.0722229737331629,0.985928730264306,3,13,regulation of T cell cytokine production,BP,RSAD2;TRAF2;SMAD7
3702,GO:0008209,0.0723295572543344,0.985899251603909,3,13,androgen metabolic process,BP,ADM;ESR1;WNT4
11334,GO:0045657,0.0724868480420318,0.992318339082655,2,6,positive regulation of monocyte differentiation,BP,ZFP36L1;JUN
1340,GO:0003199,0.0725029820622013,1,1,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,EFNA1
4825,GO:0014028,0.0725029820622013,1,1,1,notochord formation,BP,EFNA1
2488,GO:0005732,0.0725170488150551,0.980637182949324,4,24,small nucleolar ribonucleoprotein complex,CC,POP1;DKC1;NOP56;POP4
14443,GO:0061756,0.0725305549501273,0.985843606982957,3,13,leukocyte adhesion to vascular endothelial cell,BP,TNF;ICAM1;ETS1
4726,GO:0010888,0.0725462267335143,0.985839265460522,3,13,negative regulation of lipid storage,BP,TNF;ITGAV;NFKBIA
18192,GO:1902961,0.0725599419678706,0.992306127356881,2,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,LYN;EFNA1
19181,GO:1905247,0.0725599419678706,0.992306127356881,2,6,positive regulation of aspartic-type peptidase activity,BP,LYN;EFNA1
368,GO:0000989,0.0725647501688282,0.94691533042105,49,517,transcription factor activity, transcription factor binding,MF,NRG1;HDAC9;TFCP2L1;MYBL2;PDLIM1;RELB;TP53;NFE2L1;TAF4B;JUNB;WWC1;PTPN14;NFKB2;DNAJB1;SRSF2;KLF7;DAXX;FUS;ELF3;TRIM22;MKL1;SRF;MED22;ZFP42;SF1;EDF1;PPRC1;DDX17;NFKBIB;AJUBA;FHL2;SPEN;MTA2;HNRNPU;PQBP1;RUVBL2;ABT1;KCNIP3;CITED2;JUN;TFDP1;GTF2E1;NOC2L;ACTN4;KCTD1;WNT4;RBM14;SMARCC2;TP63
1102,GO:0002691,0.0725870500699246,0.985827954276502,3,13,regulation of cellular extravasation,BP,PTGER4;ICAM1;IL1A
357,GO:0000974,0.0726214029573052,0.985818433687143,3,13,Prp19 complex,CC,PRPF19;U2AF2;HSPA8
19246,GO:1905404,0.0726388012536298,1,1,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
10404,GO:0043236,0.0727753448349746,0.980826413554452,4,21,laminin binding,MF,LGALS3;BCAM;TINAGL1;DAG1
11397,GO:0045779,0.0728319390427568,0.992260619558805,2,6,negative regulation of bone resorption,BP,CD38;TNFAIP3
8146,GO:0032872,0.072882403351074,0.957278459083541,18,161,regulation of stress-activated MAPK cascade,BP,CTGF;TGFB2;EDN1;MID1;MARVELD3;GADD45A;TNF;ZC3H12A;GADD45B;BMP2;DAXX;SFRP1;TRAF2;SYK;IL1A;PHLPP1;RAPGEF1;TRAF4
5810,GO:0017065,0.0730436386537486,1,1,1,single-strand selective uracil DNA N-glycosylase activity,MF,SMUG1
2050,GO:0004799,0.0732606300434932,1,1,1,thymidylate synthase activity,MF,TYMS
6029,GO:0019088,0.0732606300434932,1,1,1,immortalization of host cell by virus,BP,TYMS
6329,GO:0020021,0.0732606300434932,1,1,1,immortalization of host cell,BP,TYMS
9841,GO:0042083,0.0732606300434932,1,1,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,TYMS
17587,GO:1901222,0.0733573008948204,0.97098081933204,7,48,regulation of NIK/NF-kappaB signaling,BP,TNF;TRAF2;ACTN4;TNFRSF10A;AKIP1;TRAF4;CARD10
17986,GO:1902410,0.0734320206132899,0.992159855065982,2,6,mitotic cytokinetic process,BP,CNTROB;BIN3
5136,GO:0015643,0.0735335537075388,0.992142756219076,2,6,toxic substance binding,MF,CYP4B1;PHAX
5453,GO:0016327,0.0735716041800055,0.985554293537237,3,13,apicolateral plasma membrane,CC,EPPK1;THBD;CLDN7
869,GO:0002218,0.0735729385081021,0.954300297425169,22,210,activation of innate immune response,BP,CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NFKB1;LYN;PSMB9;IRF1;PSME2;PSPC1;NFKBIA;SYK;TNIP2;SFPQ;PQBP1;ESR1;XRCC6;RBM14;TNFAIP3;PSMC3
5489,GO:0016423,0.0736112583956288,0.985543236800229,3,13,tRNA (guanine) methyltransferase activity,MF,METTL1;WDR4;TRMT1
17862,GO:1902075,0.0736176927308385,0.992128575779637,2,6,cellular response to salt,BP,ZC3H12A;DAXX
6644,GO:0023035,0.0736562094704734,0.99212208104318,2,6,CD40 signaling pathway,BP,TNIP2;TNFAIP3
13882,GO:0060513,0.0736946361122673,0.992115599442956,2,6,prostatic bud formation,BP,BMP7;TP63
13982,GO:0060693,0.0737007344590085,0.992114570617668,2,6,regulation of branching involved in salivary gland morphogenesis,BP,TNF;SNAI2
12588,GO:0050764,0.0737425013328216,0.973385724936776,6,39,regulation of phagocytosis,BP,TNF;SIRPA;ITGAV;SYK;RAPGEF1;RAB27A
16175,GO:0090193,0.0737974568131803,0.992098246099958,2,6,positive regulation of glomerulus development,BP,EGR1;PDGFB
4429,GO:0010259,0.0738292453757624,0.980453431979048,4,21,multicellular organism aging,BP,TFCP2L1;EDN1;TP53;TP63
10462,GO:0043320,0.0738484082444216,0.992089641435428,2,6,natural killer cell degranulation,BP,LAMP1;RAB27A
12772,GO:0051047,0.0738547379565837,0.953091156418574,24,230,positive regulation of secretion,BP,SAA1;TRIM16;PTGER4;INHBA;C1QTNF1;SDC4;TGFB2;EDN1;PANX1;LAMP1;TNF;CADPS2;CD274;GPER1;IRS2;SYK;OXTR;SPTBN1;IL1A;CLASP1;RAB27A;CD38;MAPK11;SNF8
11630,GO:0046332,0.0739208965833969,0.968515390761069,8,57,SMAD binding,MF,PML;FLNA;BMP2;COL5A2;SMAD7;TGFBRAP1;JUN;PARP1
16502,GO:0097197,0.0739916060017956,0.992065438917045,2,6,tetraspanin-enriched microdomain,CC,PDPN;GP6
16478,GO:0097158,0.0740085048520327,1,1,1,pre-mRNA intronic pyrimidine-rich binding,MF,RBM4
13244,GO:0051917,0.0740129195149546,0.992061834185422,2,6,regulation of fibrinolysis,BP,SERPINE1;THBD
9155,GO:0035507,0.0740153822425773,0.992061417626264,2,6,regulation of myosin-light-chain-phosphatase activity,BP,NUAK1;TNF
1686,GO:0004155,0.0741068219429302,1,1,1,6,7-dihydropteridine reductase activity,MF,QDPR
3402,GO:0007182,0.0741755054826063,0.992034315433272,2,6,common-partner SMAD protein phosphorylation,BP,PML;SPTBN1
16087,GO:0090051,0.0742483812703432,0.985365221450503,3,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,STARD13;CARD10;TBXA2R
11133,GO:0045177,0.0742544845780617,0.953323929096729,23,216,apical part of cell,CC,FN1;MGAM;EMP2;SIPA1L3;MYO1B;PDPN;SLC7A5;ADRB2;AMOTL2;PARD3B;ADAM17;ABCG2;OXTR;TJP1;MARVELD2;SLC22A4;PARD3;SORBS2;RAB27A;SLC4A2;SLC3A2;HSP90AB1;IL6R
19644,GO:1990845,0.0742812722190955,0.992016394010843,2,6,adaptive thermogenesis,BP,ADRB2;BMP8A
1210,GO:0002876,0.0742879568864367,1,1,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
1237,GO:0002925,0.0742879568864367,1,1,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
14166,GO:0061048,0.0742879568864367,1,1,1,negative regulation of branching involved in lung morphogenesis,BP,TNF
15852,GO:0072564,0.0742879568864367,1,1,1,blood microparticle formation,BP,TNF
19095,GO:1904999,0.0742879568864367,1,1,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
19859,GO:2000332,0.0742879568864367,1,1,1,regulation of blood microparticle formation,BP,TNF
19860,GO:2000334,0.0742879568864367,1,1,1,positive regulation of blood microparticle formation,BP,TNF
2006,GO:0004730,0.074299883032856,1,1,1,pseudouridylate synthase activity,MF,PUS1
14991,GO:0070902,0.074299883032856,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
13782,GO:0060368,0.0743515248213751,0.992004481626276,2,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,LYN;RAPGEF1
6125,GO:0019373,0.0743640134365535,0.99200236327706,2,6,epoxygenase P450 pathway,BP,CYP1B1;CYP1A1
17758,GO:1901724,0.074396188308605,0.991996904700494,2,6,positive regulation of cell proliferation involved in kidney development,BP,EGR1;PDGFB
9986,GO:0042382,0.0745607763215674,0.991968959327857,2,6,paraspeckles,CC,PSPC1;SFPQ
8434,GO:0033549,0.0746380259143265,0.985256012786226,3,13,MAP kinase phosphatase activity,MF,DUSP14;DUSP1;DUSP8
12170,GO:0048290,0.0746381662221423,0.991955806328013,2,6,isotype switching to IgA isotypes,BP,THOC1;CCR6
13476,GO:0055011,0.0746715637345464,1,1,1,atrial cardiac muscle cell differentiation,BP,FHL2
13479,GO:0055014,0.0746715637345464,1,1,1,atrial cardiac muscle cell development,BP,FHL2
8956,GO:0035019,0.0746850547597284,0.970293184320798,7,49,somatic stem cell population maintenance,BP,PBX1;SFRP1;ZFP36L2;KLF10;BMP7;POLR2G;TP63
11064,GO:0045062,0.0747837228446254,1,1,1,extrathymic T cell selection,BP,IL15
3393,GO:0007171,0.0748392236227471,0.991921596313975,2,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,NRG1;ADRB2
19885,GO:2000371,0.0748791686669556,0.991914792978468,2,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,UHRF1;HNRNPU
19886,GO:2000373,0.0748791686669556,0.991914792978468,2,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,UHRF1;HNRNPU
3224,GO:0006874,0.0749885531644507,0.953904210443818,21,196,cellular calcium ion homeostasis,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
19963,GO:2000535,0.0749905089705675,0.991895818128896,2,6,regulation of entry of bacterium into host cell,BP,ITGAV;CXCL8
10424,GO:0043267,0.0750072053765658,0.985152302600527,3,13,negative regulation of potassium ion transport,BP,NEDD4L;CAB39;OXSR1
14317,GO:0061469,0.0750257800357768,0.991889803580664,2,6,regulation of type B pancreatic cell proliferation,BP,ERRFI1;SFRP1
13055,GO:0051546,0.0750277598125607,0.985146521651773,3,13,keratinocyte migration,BP,MMP9;KRT2;EPPK1
667,GO:0001871,0.0751083998049988,0.991875708223007,2,6,pattern binding,MF,GPCPD1;TINAGL1
6803,GO:0030247,0.0751083998049988,0.991875708223007,2,6,polysaccharide binding,MF,GPCPD1;TINAGL1
17397,GO:1900125,0.0751126248790069,0.991874987149807,2,6,regulation of hyaluronan biosynthetic process,BP,NFKB1;PDGFB
6239,GO:0019798,0.0751410726974618,0.99187013145365,2,6,procollagen-proline dioxygenase activity,MF,P3H2;P4HA2
15681,GO:0072203,0.0752306942806211,0.991854826822794,2,6,cell proliferation involved in metanephros development,BP,EGR1;BMP7
14751,GO:0070424,0.0752363865752569,0.99185385437745,2,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,BIRC3;TNFAIP3
14249,GO:0061299,0.0752791131961084,0.991846553728476,2,6,retina vasculature morphogenesis in camera-type eye,BP,CYP1B1;COL4A1
1995,GO:0004716,0.0752957876183052,0.99184370390425,2,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,LYN;SYK
16800,GO:0098642,0.0753037540534313,0.991842342225733,2,6,network-forming collagen trimer,CC,COL4A1;COL4A4
16803,GO:0098645,0.0753037540534313,0.991842342225733,2,6,collagen network,CC,COL4A1;COL4A4
16807,GO:0098651,0.0753037540534313,0.991842342225733,2,6,basement membrane collagen trimer,CC,COL4A1;COL4A4
7582,GO:0031946,0.0753090166491919,0.991841442658123,2,6,regulation of glucocorticoid biosynthetic process,BP,BMP2;WNT4
16636,GO:0097493,0.075309252507053,0.991841402340605,2,6,structural molecule activity conferring elasticity,MF,FBN1;COL4A1
18517,GO:1903689,0.075309252507053,0.991841402340605,2,6,regulation of wound healing, spreading of epidermal cells,BP,CLASP1;PHLDB2
15697,GO:0072224,0.0753092525070563,0.991841402340601,2,6,metanephric glomerulus development,BP,EGR1;PDGFB
1000,GO:0002474,0.0753194451453168,0.964046417553825,10,83,antigen processing and presentation of peptide antigen via MHC class I,BP,TAP1;HLA-B;PSMB9;ITGAV;HLA-F;PSME2;TAPBPL;TAPBP;TAP2;PSMC3
12536,GO:0050685,0.0753788910871716,0.97990142844442,4,21,positive regulation of mRNA processing,BP,PRPF19;SF3B4;SNRNP70;HSPA8
4027,GO:0009059,0.0754150140092462,0.934272554572866,333,4111,macromolecule biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;B4GALT1;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;AHR;JUNB;MCM5;HS3ST2;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;PMM2;STAT5A;LYPD6B;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;MCM2;NMT2;TOX4;ST6GALNAC5;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;HS3ST1;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;U2AF2;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;AJUBA;GINS2;USP43;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;GALNT2;DUSP1;TGFBRAP1;CITED2;CD109;RPL27A;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;GINS3;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;DAG1;TMEM165;POLR3H;MGAT2;EEF1D;TIMELESS;DPM3;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH
12894,GO:0051235,0.0755412351168394,0.95240148128421,23,220,maintenance of location,BP,FTL;FTH1;JPH2;NFKBIE;PML;FBN1;IKBKE;NFKB1;LYN;EHD1;TNF;JPH1;ZC3H12A;FLNA;ITGAV;GPER1;NFKBIA;TBCCD1;KEAP1;HNRNPU;INSIG1;DAG1;NOL3
18510,GO:1903671,0.0755798474789725,0.979829535379596,4,21,negative regulation of sprouting angiogenesis,BP,STARD13;ADAMTS9;CARD10;TBXA2R
3131,GO:0006713,0.0756113822359215,1,1,1,glucocorticoid catabolic process,BP,YWHAH
1273,GO:0003065,0.0756209491563477,1,1,1,positive regulation of heart rate by epinephrine,BP,TPM1
2122,GO:0004917,0.0757622070421473,1,1,1,interleukin-7 receptor activity,MF,IL7R
3971,GO:0008775,0.0759440795094867,1,1,1,acetate CoA-transferase activity,MF,ACAA1
4328,GO:0009850,0.0759440795094867,1,1,1,auxin metabolic process,BP,ACAA1
4329,GO:0009852,0.0759440795094867,1,1,1,auxin catabolic process,BP,ACAA1
4400,GO:0010124,0.0759440795094867,1,1,1,phenylacetate catabolic process,BP,ACAA1
5332,GO:0016064,0.0759611683605292,0.967425384453982,8,58,immunoglobulin mediated immune response,BP,C1R;TFRC;IL27RA;TNF;THOC1;CCR6;SWAP70;C1S
6209,GO:0019724,0.0759611683605292,0.967425384453982,8,58,B cell mediated immunity,BP,C1R;TFRC;IL27RA;TNF;THOC1;CCR6;SWAP70;C1S
329,GO:0000917,0.0761527595121118,1,1,1,division septum assembly,BP,BIN3
16327,GO:0090529,0.0761527595121118,1,1,1,cell septum assembly,BP,BIN3
439,GO:0001179,0.0762532615734019,1,1,1,RNA polymerase I transcription factor binding,MF,POLR1E
6039,GO:0019135,0.0764585169774034,1,1,1,deoxyhypusine monooxygenase activity,MF,DOHH
863,GO:0002196,0.0765512660406425,1,1,1,Ser-tRNA(Ala) hydrolase activity,MF,AARSD1
18384,GO:1903392,0.0766043445706868,0.984700982425913,3,13,negative regulation of adherens junction organization,BP,CORO1C;RCC2;PHLDB2
10378,GO:0043198,0.0766970429534397,0.97942856441862,4,21,dendritic shaft,CC,MAP2;BAIAP2;FLNA;GPER1
18255,GO:1903078,0.0767720842084919,0.972003147754742,6,39,positive regulation of protein localization to plasma membrane,BP,SQSTM1;EPHA2;GPER1;SPTBN1;STAC;RHOG
2356,GO:0005452,0.0768182106298819,0.984640222461454,3,13,inorganic anion exchanger activity,MF,SLC4A11;SLC22A4;SLC4A2
8544,GO:0033871,0.0769018632327223,1,1,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,HS3ST2
15219,GO:0071371,0.0769360428662411,0.984606713236849,3,13,cellular response to gonadotropin stimulus,BP,INHBA;HMGCS1;GCLC
7704,GO:0032183,0.0770866557420219,0.984563847982349,3,13,SUMO binding,MF,PML;DAXX;HERC2
472,GO:0001515,0.0770999165137433,1,1,1,opioid peptide activity,MF,CDC42EP2
1525,GO:0003899,0.0772464380427095,0.971684079119602,6,41,DNA-directed 5'-3' RNA polymerase activity,MF,CD3EAP;POLR1A;CRCP;POLR3H;POLR1E;POLR2G
13817,GO:0060411,0.0772835881211737,0.969053815002946,7,48,cardiac septum morphogenesis,BP,CYR61;TGFB2;FGFR2;SEMA3C;SMAD7;CITED2;BMP7
8517,GO:0033699,0.0773656241086627,1,1,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,APTX
17274,GO:0120108,0.0773656241086627,1,1,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,APTX
19461,GO:1990165,0.0773656241086627,1,1,1,single-strand break-containing DNA binding,MF,APTX
14221,GO:0061157,0.0774001139069219,0.979175110602908,4,21,mRNA destabilization,BP,ZC3H12A;ZFP36L1;ZFP36L2;METTL16
6704,GO:0030104,0.0774382295521524,0.968977389400357,7,48,water homeostasis,BP,KRT1;HRNR;SFN;SRF;NEDD4L;RPTN;TP63
17045,GO:0099522,0.0774386908676266,1,1,1,region of cytosol,CC,HSPA8
17046,GO:0099523,0.0774386908676266,1,1,1,presynaptic cytosol,CC,HSPA8
17047,GO:0099524,0.0774386908676266,1,1,1,postsynaptic cytosol,CC,HSPA8
18978,GO:1904764,0.0774386908676266,1,1,1,chaperone-mediated autophagy translocation complex disassembly,BP,HSPA8
19638,GO:1990832,0.0774386908676266,1,1,1,slow axonal transport,BP,HSPA8
19639,GO:1990833,0.0774386908676266,1,1,1,clathrin-uncoating ATPase activity,MF,HSPA8
771,GO:0002025,0.0774552090845456,1,1,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,ADRB2
2133,GO:0004939,0.0774552090845456,1,1,1,beta-adrenergic receptor activity,MF,ADRB2
2134,GO:0004941,0.0774552090845456,1,1,1,beta2-adrenergic receptor activity,MF,ADRB2
12978,GO:0051380,0.0774552090845456,1,1,1,norepinephrine binding,MF,ADRB2
14482,GO:0061884,0.0774552090845456,1,1,1,regulation of mini excitatory postsynaptic potential,BP,ADRB2
14483,GO:0061885,0.0774552090845456,1,1,1,positive regulation of mini excitatory postsynaptic potential,BP,ADRB2
16882,GO:0098816,0.0774552090845456,1,1,1,mini excitatory postsynaptic potential,BP,ADRB2
12578,GO:0050732,0.0775261389795688,0.971656582731476,6,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,GPRC5A;ERRFI1;SFRP1;FGFR1OP;PARP14;SOCS1
18542,GO:1903749,0.0775709675267204,0.961315891747358,11,90,positive regulation of establishment of protein localization to mitochondrion,BP,NRG1;TP53;CYB5R1;SFN;USP36;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;TP63
10507,GO:0043409,0.0775990145330669,0.956663760854656,15,130,negative regulation of MAPK cascade,BP,DUSP14;GBP1;MARVELD3;LYN;ERRFI1;LIF;SFRP1;GPER1;SPRY4;DUSP1;BMP7;RAPGEF1;DAG1;EFNA1;DUSP8
13828,GO:0060425,0.0776368278621533,0.971605628624824,6,39,lung morphogenesis,BP,TNF;TNC;FGFR2;LIF;SRF;DAG1
9385,GO:0035921,0.0777547481413949,1,1,1,desmosome disassembly,BP,SNAI2
17484,GO:1900387,0.0777547481413949,1,1,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,SNAI2
4899,GO:0014826,0.077761753164911,1,1,1,vein smooth muscle contraction,BP,EDN1
6760,GO:0030185,0.077761753164911,1,1,1,nitric oxide transport,BP,EDN1
7448,GO:0031583,0.077761753164911,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
7519,GO:0031705,0.077761753164911,1,1,1,bombesin receptor binding,MF,EDN1
7520,GO:0031707,0.077761753164911,1,1,1,endothelin A receptor binding,MF,EDN1
7521,GO:0031708,0.077761753164911,1,1,1,endothelin B receptor binding,MF,EDN1
9336,GO:0035815,0.077761753164911,1,1,1,positive regulation of renal sodium excretion,BP,EDN1
9951,GO:0042313,0.077761753164911,1,1,1,protein kinase C deactivation,BP,EDN1
10366,GO:0043179,0.077761753164911,1,1,1,rhythmic excitation,BP,EDN1
7165,GO:0031038,0.077809968407004,1,1,1,myosin II filament organization,BP,DAPK3
10563,GO:0043519,0.077809968407004,1,1,1,regulation of myosin II filament organization,BP,DAPK3
2052,GO:0004802,0.0778189906561477,1,1,1,transketolase activity,MF,TKT
12176,GO:0048297,0.0779232939703401,1,1,1,negative regulation of isotype switching to IgA isotypes,BP,THOC1
16338,GO:0090560,0.0780145883987,1,1,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,DPH2
5978,GO:0018585,0.0780379004245657,1,1,1,fluorene oxygenase activity,MF,CYP4B1
5988,GO:0018917,0.0780379004245657,1,1,1,fluorene metabolic process,BP,CYP4B1
12527,GO:0050671,0.078059296835911,0.964278471349499,9,70,positive regulation of lymphocyte proliferation,BP,TFRC;CDKN1A;CD274;IRS2;IL15;SYK;EFNB1;CD38;CCL5
7761,GO:0032277,0.0780701951299951,1,1,1,negative regulation of gonadotropin secretion,BP,INHBA
10556,GO:0043509,0.0780701951299951,1,1,1,activin A complex,CC,INHBA
10557,GO:0043511,0.0780701951299951,1,1,1,inhibin complex,CC,INHBA
10558,GO:0043512,0.0780701951299951,1,1,1,inhibin A complex,CC,INHBA
11077,GO:0045077,0.0780701951299951,1,1,1,negative regulation of interferon-gamma biosynthetic process,BP,INHBA
11875,GO:0046882,0.0780701951299951,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBA
12121,GO:0048180,0.0780701951299951,1,1,1,activin complex,CC,INHBA
13714,GO:0060278,0.0780701951299951,1,1,1,regulation of ovulation,BP,INHBA
13715,GO:0060279,0.0780701951299951,1,1,1,positive regulation of ovulation,BP,INHBA
8885,GO:0034698,0.0781467588996162,0.978905009880993,4,21,response to gonadotropin,BP,INHBA;HMGCS1;ICAM1;GCLC
3882,GO:0008513,0.0781568481815995,1,1,1,secondary active organic cation transmembrane transporter activity,MF,SLC22A4
10137,GO:0042698,0.078210344156568,0.9713412861609,6,39,ovulation cycle,BP,INHBA;TGFB2;EGR1;ETS1;OXTR;ESR1
17557,GO:1901099,0.0783263726717723,0.978726890697021,4,22,negative regulation of signal transduction in absence of ligand,BP,CSF2;TNF;SNAI2;IL1A
20272,GO:2001240,0.0783263726717723,0.978726890697021,4,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,CSF2;TNF;SNAI2;IL1A
8783,GO:0034462,0.0783313473058891,1,1,1,small-subunit processome assembly,BP,ABT1
16828,GO:0098713,0.0783706865005511,1,1,1,leucine import across plasma membrane,BP,SLC3A2
18574,GO:1903801,0.0783706865005511,1,1,1,L-leucine import across plasma membrane,BP,SLC3A2
2144,GO:0004960,0.078385601751992,1,1,1,thromboxane receptor activity,MF,TBXA2R
2145,GO:0004961,0.078385601751992,1,1,1,thromboxane A2 receptor activity,MF,TBXA2R
9739,GO:0038193,0.078385601751992,1,1,1,thromboxane A2 signaling pathway,BP,TBXA2R
5195,GO:0015786,0.0783869427783264,1,1,1,UDP-glucose transmembrane transport,BP,SLC35C2
2260,GO:0005174,0.0784183903803868,1,1,1,CD40 receptor binding,MF,TRAF2
784,GO:0002041,0.0784410598393931,1,1,1,intussusceptive angiogenesis,BP,CYR61
4614,GO:0010731,0.078552327162138,1,1,1,protein glutathionylation,BP,G6PD
4615,GO:0010732,0.078552327162138,1,1,1,regulation of protein glutathionylation,BP,G6PD
4616,GO:0010734,0.078552327162138,1,1,1,negative regulation of protein glutathionylation,BP,G6PD
615,GO:0001783,0.0786228754181319,0.978618742463932,4,22,B cell apoptotic process,BP,LYN;IRS2;TNFRSF21;NOC2L
6488,GO:0021840,0.0786275796661935,1,1,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,NRG1
6489,GO:0021842,0.0786275796661935,1,1,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,NRG1
8223,GO:0032980,0.0786836029859887,1,1,1,keratinocyte activation,BP,KRT2
1924,GO:0004618,0.0786974710348651,1,1,1,phosphoglycerate kinase activity,MF,PGK1
5130,GO:0015578,0.0787326231489855,1,1,1,mannose transmembrane transporter activity,MF,M6PR
5188,GO:0015761,0.0787326231489855,1,1,1,mannose transmembrane transport,BP,M6PR
2628,GO:0005954,0.0787566407593387,1,1,1,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G
8349,GO:0033204,0.0787631621419755,1,1,1,ribonuclease P RNA binding,MF,POP4
1260,GO:0003014,0.0787644134622818,0.965959567860326,8,58,renal system process,BP,ADM;EDN1;EMP2;SGK1;PDGFB;MYO1E;XPNPEP3;MCAM
14958,GO:0070849,0.0787862645468506,0.971075276962358,6,39,response to epidermal growth factor,BP,BAIAP2;ERRFI1;SNAI2;ZFP36L1;ZFP36L2;MCM7
14319,GO:0061474,0.0788123833133591,1,1,1,phagolysosome membrane,CC,LAMP1
836,GO:0002135,0.0788130354684118,1,1,1,CTP binding,MF,HSP90AB1
5824,GO:0017098,0.0788130354684118,1,1,1,sulfonylurea receptor binding,MF,HSP90AB1
17651,GO:1901388,0.0788130354684118,1,1,1,regulation of transforming growth factor beta activation,BP,HSP90AB1
17652,GO:1901389,0.0788130354684118,1,1,1,negative regulation of transforming growth factor beta activation,BP,HSP90AB1
18507,GO:1903659,0.0788130354684118,1,1,1,regulation of complement-dependent cytotoxicity,BP,HSP90AB1
18508,GO:1903660,0.0788130354684118,1,1,1,negative regulation of complement-dependent cytotoxicity,BP,HSP90AB1
19661,GO:1990913,0.0788130354684118,1,1,1,sperm head plasma membrane,CC,HSP90AB1
19662,GO:1990917,0.0788130354684118,1,1,1,ooplasm,CC,HSP90AB1
238,GO:0000495,0.0788321831984216,1,1,1,box H/ACA snoRNA 3'-end processing,BP,DKC1
8558,GO:0033979,0.0788321831984216,1,1,1,box H/ACA snoRNA metabolic process,BP,DKC1
8936,GO:0034964,0.0788321831984216,1,1,1,box H/ACA snoRNA processing,BP,DKC1
10237,GO:0042942,0.0788338962044465,1,1,1,D-serine transport,BP,NFKBIE
398,GO:0001074,0.0788371688749534,1,1,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,TP53
404,GO:0001084,0.0788371688749534,1,1,1,transcription factor activity, TFIID-class binding,MF,TP53
8435,GO:0033552,0.0788371688749534,1,1,1,response to vitamin B3,BP,TP53
4270,GO:0009624,0.0788454428587604,1,1,1,response to nematode,BP,CYP1A1
4288,GO:0009692,0.0788454428587604,1,1,1,ethylene metabolic process,BP,CYP1A1
4289,GO:0009698,0.0788454428587604,1,1,1,phenylpropanoid metabolic process,BP,CYP1A1
4318,GO:0009804,0.0788454428587604,1,1,1,coumarin metabolic process,BP,CYP1A1
5631,GO:0016711,0.0788454428587604,1,1,1,flavonoid 3'-monooxygenase activity,MF,CYP1A1
6105,GO:0019341,0.0788454428587604,1,1,1,dibenzo-p-dioxin catabolic process,BP,CYP1A1
10523,GO:0043449,0.0788454428587604,1,1,1,cellular alkene metabolic process,BP,CYP1A1
3670,GO:0008160,0.0788479815184257,1,1,1,protein tyrosine phosphatase activator activity,MF,IGFBP3
10072,GO:0042567,0.0788479815184257,1,1,1,insulin-like growth factor ternary complex,CC,IGFBP3
4350,GO:0009918,0.0788592065279402,1,1,1,sterol delta7 reductase activity,MF,DHCR7
5359,GO:0016131,0.0788592065279402,1,1,1,brassinosteroid metabolic process,BP,DHCR7
5360,GO:0016132,0.0788592065279402,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
12018,GO:0047598,0.0788592065279402,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
16663,GO:0097536,0.0788663447364228,1,1,1,thymus epithelium morphogenesis,BP,FOXN1
4212,GO:0009360,0.0788665772409839,1,1,1,DNA polymerase III complex,CC,CRCP
3846,GO:0008455,0.0788672263518589,1,1,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,MGAT2
9555,GO:0036316,0.0788679843411293,1,1,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,INSIG1
17616,GO:1901303,0.0788679843411293,1,1,1,negative regulation of cargo loading into COPII-coated vesicle,BP,INSIG1
14478,GO:0061851,0.0788684773216047,1,1,1,leading edge of lamellipodium,CC,PDPN
18795,GO:1904328,0.0788684773216047,1,1,1,regulation of myofibroblast contraction,BP,PDPN
19616,GO:1990764,0.0788684773216047,1,1,1,myofibroblast contraction,BP,PDPN
18407,GO:1903435,0.0788708343293409,1,1,1,positive regulation of constitutive secretory pathway,BP,RAB27A
121,GO:0000250,0.0788708368543504,1,1,1,lanosterol synthase activity,MF,LSS
233,GO:0000481,0.0788708368543504,1,1,1,maturation of 5S rRNA,BP,SART1
297,GO:0000801,0.0788708368543504,1,1,1,central element,CC,INCENP
420,GO:0001112,0.0788708368543504,1,1,1,DNA-templated transcriptional open complex formation,BP,GTF2E1
421,GO:0001113,0.0788708368543504,1,1,1,transcriptional open complex formation at RNA polymerase II promoter,BP,GTF2E1
422,GO:0001120,0.0788708368543504,1,1,1,protein-DNA complex remodeling,BP,GTF2E1
437,GO:0001165,0.0788708368543504,1,1,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,UBTF
753,GO:0001992,0.0788708368543504,1,1,1,regulation of systemic arterial blood pressure by vasopressin,BP,OXTR
879,GO:0002238,0.0788708368543504,1,1,1,response to molecule of fungal origin,BP,SYK
940,GO:0002351,0.0788708368543504,1,1,1,serotonin production involved in inflammatory response,BP,SYK
957,GO:0002378,0.0788708368543504,1,1,1,immunoglobulin biosynthetic process,BP,GALNT2
960,GO:0002384,0.0788708368543504,1,1,1,hepatic immune response,BP,IL6R
985,GO:0002442,0.0788708368543504,1,1,1,serotonin secretion involved in inflammatory response,BP,SYK
1009,GO:0002488,0.0788708368543504,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,TAP2
1010,GO:0002489,0.0788708368543504,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,TAP2
1029,GO:0002537,0.0788708368543504,1,1,1,nitric oxide production involved in inflammatory response,BP,SLC7A2
1030,GO:0002538,0.0788708368543504,1,1,1,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1031,GO:0002540,0.0788708368543504,1,1,1,leukotriene production involved in inflammatory response,BP,SERPINE1
1040,GO:0002554,0.0788708368543504,1,1,1,serotonin secretion by platelet,BP,SYK
1160,GO:0002774,0.0788708368543504,1,1,1,Fc receptor mediated inhibitory signaling pathway,BP,LYN
1238,GO:0002930,0.0788708368543504,1,1,1,trabecular meshwork development,BP,CYP1B1
1371,GO:0003257,0.0788708368543504,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,SRF
1408,GO:0003342,0.0788708368543504,1,1,1,proepicardium development,BP,ZFP36L1
1409,GO:0003343,0.0788708368543504,1,1,1,septum transversum development,BP,ZFP36L1
1498,GO:0003844,0.0788708368543504,1,1,1,1,4-alpha-glucan branching enzyme activity,MF,GBE1
1654,GO:0004108,0.0788708368543504,1,1,1,citrate (Si)-synthase activity,MF,CS
1740,GO:0004339,0.0788708368543504,1,1,1,glucan 1,4-alpha-glucosidase activity,MF,MGAM
1792,GO:0004421,0.0788708368543504,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS1
1825,GO:0004478,0.0788708368543504,1,1,1,methionine adenosyltransferase activity,MF,MAT2A
1980,GO:0004698,0.0788708368543504,1,1,1,calcium-dependent protein kinase C activity,MF,PRKCA
2023,GO:0004753,0.0788708368543504,1,1,1,saccharopine dehydrogenase activity,MF,AASS
2143,GO:0004957,0.0788708368543504,1,1,1,prostaglandin E receptor activity,MF,PTGER4
2159,GO:0004990,0.0788708368543504,1,1,1,oxytocin receptor activity,MF,OXTR
2163,GO:0004998,0.0788708368543504,1,1,1,transferrin receptor activity,MF,TFRC
2422,GO:0005597,0.0788708368543504,1,1,1,collagen type XVI trimer,CC,COL16A1
2646,GO:0005982,0.0788708368543504,1,1,1,starch metabolic process,BP,MGAM
2647,GO:0005983,0.0788708368543504,1,1,1,starch catabolic process,BP,MGAM
3516,GO:0007439,0.0788708368543504,1,1,1,ectodermal digestive tract development,BP,VPS52
3525,GO:0007499,0.0788708368543504,1,1,1,ectoderm and mesoderm interaction,BP,TP63
3812,GO:0008403,0.0788708368543504,1,1,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,CYP24A1
3867,GO:0008488,0.0788708368543504,1,1,1,gamma-glutamyl carboxylase activity,MF,GGCX
3890,GO:0008523,0.0788708368543504,1,1,1,sodium-dependent multivitamin transmembrane transporter activity,MF,SLC5A6
3950,GO:0008650,0.0788708368543504,1,1,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,FTSJ3
4279,GO:0009645,0.0788708368543504,1,1,1,response to low light intensity stimulus,BP,HMGCS1
4296,GO:0009737,0.0788708368543504,1,1,1,response to abscisic acid,BP,LANCL2
4297,GO:0009738,0.0788708368543504,1,1,1,abscisic acid-activated signaling pathway,BP,LANCL2
4310,GO:0009787,0.0788708368543504,1,1,1,regulation of abscisic acid-activated signaling pathway,BP,LANCL2
4311,GO:0009789,0.0788708368543504,1,1,1,positive regulation of abscisic acid-activated signaling pathway,BP,LANCL2
4404,GO:0010142,0.0788708368543504,1,1,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,HMGCS1
4475,GO:0010477,0.0788708368543504,1,1,1,response to sulfur dioxide,BP,ICAM1
4594,GO:0010705,0.0788708368543504,1,1,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,BRIP1
4618,GO:0010736,0.0788708368543504,1,1,1,serum response element binding,MF,SRF
4975,GO:0015091,0.0788708368543504,1,1,1,ferric iron transmembrane transporter activity,MF,TFRC
5055,GO:0015252,0.0788708368543504,1,1,1,proton channel activity,MF,SLC4A11
5250,GO:0015878,0.0788708368543504,1,1,1,biotin transport,BP,SLC5A6
5257,GO:0015887,0.0788708368543504,1,1,1,pantothenate transmembrane transport,BP,SLC5A6
5457,GO:0016333,0.0788708368543504,1,1,1,morphogenesis of follicular epithelium,BP,WDR1
5458,GO:0016334,0.0788708368543504,1,1,1,establishment or maintenance of polarity of follicular epithelium,BP,WDR1
5817,GO:0017082,0.0788708368543504,1,1,1,mineralocorticoid receptor activity,MF,GPER1
5842,GO:0017130,0.0788708368543504,1,1,1,poly(C) RNA binding,MF,HNRNPU
6246,GO:0019814,0.0788708368543504,1,1,1,immunoglobulin complex,CC,SYK
6247,GO:0019815,0.0788708368543504,1,1,1,B cell receptor complex,CC,SYK
6383,GO:0021571,0.0788708368543504,1,1,1,rhombomere 5 development,BP,MAFB
6384,GO:0021572,0.0788708368543504,1,1,1,rhombomere 6 development,BP,MAFB
6419,GO:0021682,0.0788708368543504,1,1,1,nerve maturation,BP,DAG1
6666,GO:0030021,0.0788708368543504,1,1,1,extracellular matrix structural constituent conferring compression resistance,MF,TUFT1
6786,GO:0030222,0.0788708368543504,1,1,1,eosinophil differentiation,BP,TRIB1
6813,GO:0030264,0.0788708368543504,1,1,1,nuclear fragmentation involved in apoptotic nuclear change,BP,GPER1
6868,GO:0030342,0.0788708368543504,1,1,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,CYP24A1
6870,GO:0030345,0.0788708368543504,1,1,1,structural constituent of tooth enamel,MF,TUFT1
6878,GO:0030372,0.0788708368543504,1,1,1,high molecular weight B cell growth factor receptor binding,MF,TXLNA
6963,GO:0030617,0.0788708368543504,1,1,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,SMAD7
6974,GO:0030629,0.0788708368543504,1,1,1,U6 snRNA 3'-end binding,MF,METTL16
7006,GO:0030690,0.0788708368543504,1,1,1,Noc1p-Noc2p complex,CC,NOC2L
7007,GO:0030691,0.0788708368543504,1,1,1,Noc2p-Noc3p complex,CC,NOC2L
7439,GO:0031559,0.0788708368543504,1,1,1,oxidosqualene cyclase activity,MF,LSS
7456,GO:0031592,0.0788708368543504,1,1,1,centrosomal corona,CC,CLASP1
7487,GO:0031651,0.0788708368543504,1,1,1,negative regulation of heat generation,BP,ARRDC3
7514,GO:0031699,0.0788708368543504,1,1,1,beta-3 adrenergic receptor binding,MF,ARRDC3
7548,GO:0031849,0.0788708368543504,1,1,1,olfactory receptor binding,MF,REEP1
7581,GO:0031945,0.0788708368543504,1,1,1,positive regulation of glucocorticoid metabolic process,BP,WNT4
7584,GO:0031948,0.0788708368543504,1,1,1,positive regulation of glucocorticoid biosynthetic process,BP,WNT4
8073,GO:0032752,0.0788708368543504,1,1,1,positive regulation of interleukin-3 production,BP,SYK
8442,GO:0033560,0.0788708368543504,1,1,1,folate reductase activity,MF,DHFR
8448,GO:0033570,0.0788708368543504,1,1,1,transferrin transmembrane transporter activity,MF,TFRC
8487,GO:0033633,0.0788708368543504,1,1,1,negative regulation of cell-cell adhesion mediated by integrin,BP,SWAP70
8630,GO:0034146,0.0788708368543504,1,1,1,toll-like receptor 5 signaling pathway,BP,TNFAIP3
8631,GO:0034147,0.0788708368543504,1,1,1,regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8632,GO:0034148,0.0788708368543504,1,1,1,negative regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8635,GO:0034155,0.0788708368543504,1,1,1,regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
8636,GO:0034157,0.0788708368543504,1,1,1,positive regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
8794,GO:0034477,0.0788708368543504,1,1,1,U6 snRNA 3'-end processing,BP,USB1
8805,GO:0034506,0.0788708368543504,1,1,1,chromosome, centromeric core domain,CC,RCC2
8877,GO:0034683,0.0788708368543504,1,1,1,integrin alphav-beta3 complex,CC,ITGAV
8899,GO:0034718,0.0788708368543504,1,1,1,SMN-Gemin2 complex,CC,GEMIN5
8913,GO:0034752,0.0788708368543504,1,1,1,cytosolic aryl hydrocarbon receptor complex,CC,AHR
8914,GO:0034753,0.0788708368543504,1,1,1,nuclear aryl hydrocarbon receptor complex,CC,AHR
8972,GO:0035054,0.0788708368543504,1,1,1,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
9061,GO:0035283,0.0788708368543504,1,1,1,central nervous system segmentation,BP,MAFB
9062,GO:0035284,0.0788708368543504,1,1,1,brain segmentation,BP,MAFB
9114,GO:0035403,0.0788708368543504,1,1,1,histone kinase activity (H3-T6 specific),MF,PRKCA
9119,GO:0035408,0.0788708368543504,1,1,1,histone H3-T6 phosphorylation,BP,PRKCA
9131,GO:0035445,0.0788708368543504,1,1,1,borate transmembrane transport,BP,SLC4A11
9144,GO:0035490,0.0788708368543504,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9145,GO:0035491,0.0788708368543504,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9213,GO:0035598,0.0788708368543504,1,1,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,CDKAL1
9216,GO:0035602,0.0788708368543504,1,1,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,FGFR2
9217,GO:0035603,0.0788708368543504,1,1,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,FGFR2
9218,GO:0035604,0.0788708368543504,1,1,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,FGFR2
9237,GO:0035625,0.0788708368543504,1,1,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,ADAM17
9346,GO:0035853,0.0788708368543504,1,1,1,chromosome passenger complex localization to spindle midzone,BP,KLHL21
9590,GO:0036440,0.0788708368543504,1,1,1,citrate synthase activity,MF,CS
9905,GO:0042223,0.0788708368543504,1,1,1,interleukin-3 biosynthetic process,BP,SYK
9912,GO:0042247,0.0788708368543504,1,1,1,establishment of planar polarity of follicular epithelium,BP,WDR1
10122,GO:0042643,0.0788708368543504,1,1,1,actomyosin, actin portion,CC,WDR1
10570,GO:0043532,0.0788708368543504,1,1,1,angiostatin binding,MF,AMOT
10694,GO:0043972,0.0788708368543504,1,1,1,histone H3-K23 acetylation,BP,BRPF1
10705,GO:0043994,0.0788708368543504,1,1,1,histone acetyltransferase activity (H3-K23 specific),MF,BRPF1
10785,GO:0044245,0.0788708368543504,1,1,1,polysaccharide digestion,BP,MGAM
10848,GO:0044343,0.0788708368543504,1,1,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,SFRP1
10850,GO:0044345,0.0788708368543504,1,1,1,stromal-epithelial cell signaling involved in prostate gland development,BP,SFRP1
10974,GO:0044753,0.0788708368543504,1,1,1,amphisome,CC,SQSTM1
11083,GO:0045083,0.0788708368543504,1,1,1,negative regulation of interleukin-12 biosynthetic process,BP,NFKB1
11096,GO:0045105,0.0788708368543504,1,1,1,intermediate filament polymerization or depolymerization,BP,NEFL
11111,GO:0045131,0.0788708368543504,1,1,1,pre-mRNA branch point binding,MF,SF1
11230,GO:0045399,0.0788708368543504,1,1,1,regulation of interleukin-3 biosynthetic process,BP,SYK
11231,GO:0045401,0.0788708368543504,1,1,1,positive regulation of interleukin-3 biosynthetic process,BP,SYK
11241,GO:0045423,0.0788708368543504,1,1,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
11242,GO:0045425,0.0788708368543504,1,1,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
11254,GO:0045485,0.0788708368543504,1,1,1,omega-6 fatty acid desaturase activity,MF,FADS1
11283,GO:0045590,0.0788708368543504,1,1,1,negative regulation of regulatory T cell differentiation,BP,IRF1
11321,GO:0045643,0.0788708368543504,1,1,1,regulation of eosinophil differentiation,BP,TRIB1
11322,GO:0045645,0.0788708368543504,1,1,1,positive regulation of eosinophil differentiation,BP,TRIB1
11358,GO:0045715,0.0788708368543504,1,1,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
11367,GO:0045726,0.0788708368543504,1,1,1,positive regulation of integrin biosynthetic process,BP,TGFB2
11809,GO:0046690,0.0788708368543504,1,1,1,response to tellurium ion,BP,HMGCS1
11820,GO:0046713,0.0788708368543504,1,1,1,borate transport,BP,SLC4A11
11821,GO:0046715,0.0788708368543504,1,1,1,active borate transmembrane transporter activity,MF,SLC4A11
11925,GO:0046968,0.0788708368543504,1,1,1,peptide antigen transport,BP,TAP2
11935,GO:0046980,0.0788708368543504,1,1,1,tapasin binding,MF,TAP2
11959,GO:0047130,0.0788708368543504,1,1,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,AASS
11960,GO:0047131,0.0788708368543504,1,1,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,AASS
12289,GO:0048611,0.0788708368543504,1,1,1,embryonic ectodermal digestive tract development,BP,VPS52
12388,GO:0048807,0.0788708368543504,1,1,1,female genitalia morphogenesis,BP,TP63
12568,GO:0050720,0.0788708368543504,1,1,1,interleukin-1 beta biosynthetic process,BP,EGR1
12570,GO:0050722,0.0788708368543504,1,1,1,regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12571,GO:0050725,0.0788708368543504,1,1,1,positive regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12582,GO:0050748,0.0788708368543504,1,1,1,negative regulation of lipoprotein metabolic process,BP,ITGAV
12635,GO:0050822,0.0788708368543504,1,1,1,peptide stabilization,BP,TAPBP
12636,GO:0050823,0.0788708368543504,1,1,1,peptide antigen stabilization,BP,TAPBP
12766,GO:0051040,0.0788708368543504,1,1,1,regulation of calcium-independent cell-cell adhesion,BP,BMP2
12767,GO:0051042,0.0788708368543504,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
12812,GO:0051107,0.0788708368543504,1,1,1,negative regulation of DNA ligation,BP,TFIP11
12970,GO:0051352,0.0788708368543504,1,1,1,negative regulation of ligase activity,BP,TFIP11
12973,GO:0051365,0.0788708368543504,1,1,1,cellular response to potassium ion starvation,BP,JUN
12987,GO:0051391,0.0788708368543504,1,1,1,tRNA acetylation,BP,NAT10
12988,GO:0051392,0.0788708368543504,1,1,1,tRNA N-acetyltransferase activity,MF,NAT10
13215,GO:0051870,0.0788708368543504,1,1,1,methotrexate binding,MF,DHFR
13228,GO:0051891,0.0788708368543504,1,1,1,positive regulation of cardioblast differentiation,BP,TGFB2
13304,GO:0052047,0.0788708368543504,1,1,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,FN1
13308,GO:0052066,0.0788708368543504,1,1,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,ITGAV
13318,GO:0052190,0.0788708368543504,1,1,1,modulation by symbiont of host phagocytosis,BP,ITGAV
13319,GO:0052191,0.0788708368543504,1,1,1,positive regulation by symbiont of host phagocytosis,BP,ITGAV
13329,GO:0052231,0.0788708368543504,1,1,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13345,GO:0052370,0.0788708368543504,1,1,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13361,GO:0052522,0.0788708368543504,1,1,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13458,GO:0052907,0.0788708368543504,1,1,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,METTL16
13633,GO:0060128,0.0788708368543504,1,1,1,corticotropin hormone secreting cell differentiation,BP,BMP2
13932,GO:0060595,0.0788708368543504,1,1,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,FGFR2
13945,GO:0060615,0.0788708368543504,1,1,1,mammary gland bud formation,BP,FGFR2
13955,GO:0060648,0.0788708368543504,1,1,1,mammary gland bud morphogenesis,BP,FGFR2
13961,GO:0060667,0.0788708368543504,1,1,1,branch elongation involved in salivary gland morphogenesis,BP,FGFR2
14024,GO:0060748,0.0788708368543504,1,1,1,tertiary branching involved in mammary gland duct morphogenesis,BP,WNT4
14048,GO:0060804,0.0788708368543504,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
14090,GO:0060915,0.0788708368543504,1,1,1,mesenchymal cell differentiation involved in lung development,BP,FGFR2
14162,GO:0061044,0.0788708368543504,1,1,1,negative regulation of vascular wound healing,BP,SERPINE1
14172,GO:0061054,0.0788708368543504,1,1,1,dermatome development,BP,WNT4
14228,GO:0061183,0.0788708368543504,1,1,1,regulation of dermatome development,BP,WNT4
14229,GO:0061184,0.0788708368543504,1,1,1,positive regulation of dermatome development,BP,WNT4
14238,GO:0061205,0.0788708368543504,1,1,1,paramesonephric duct development,BP,WNT4
14286,GO:0061369,0.0788708368543504,1,1,1,negative regulation of testicular blood vessel morphogenesis,BP,WNT4
14315,GO:0061459,0.0788708368543504,1,1,1,L-arginine transmembrane transporter activity,MF,SLC7A2
14379,GO:0061618,0.0788708368543504,1,1,1,sublamina densa,CC,FRAS1
14421,GO:0061712,0.0788708368543504,1,1,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,CDKAL1
14473,GO:0061845,0.0788708368543504,1,1,1,neuron projection branch point,CC,BAIAP2
14474,GO:0061846,0.0788708368543504,1,1,1,dendritic spine cytoplasm,CC,BAIAP2
14579,GO:0070119,0.0788708368543504,1,1,1,ciliary neurotrophic factor binding,MF,IL6R
14639,GO:0070209,0.0788708368543504,1,1,1,ASTRA complex,CC,TELO2
14752,GO:0070425,0.0788708368543504,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
14755,GO:0070428,0.0788708368543504,1,1,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14756,GO:0070429,0.0788708368543504,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14759,GO:0070433,0.0788708368543504,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
14882,GO:0070667,0.0788708368543504,1,1,1,negative regulation of mast cell proliferation,BP,LYN
14905,GO:0070724,0.0788708368543504,1,1,1,BMP receptor complex,CC,BMP2
15126,GO:0071215,0.0788708368543504,1,1,1,cellular response to abscisic acid stimulus,BP,LANCL2
15136,GO:0071226,0.0788708368543504,1,1,1,cellular response to molecule of fungal origin,BP,SYK
15686,GO:0072209,0.0788708368543504,1,1,1,metanephric mesangial cell differentiation,BP,PDGFB
15709,GO:0072254,0.0788708368543504,1,1,1,metanephric glomerular mesangial cell differentiation,BP,PDGFB
15710,GO:0072255,0.0788708368543504,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
15732,GO:0072303,0.0788708368543504,1,1,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,EGR1
15763,GO:0072356,0.0788708368543504,1,1,1,chromosome passenger complex localization to kinetochore,BP,RCC2
15814,GO:0072510,0.0788708368543504,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TFRC
15857,GO:0072573,0.0788708368543504,1,1,1,tolerance induction to lipopolysaccharide,BP,TNFAIP3
15913,GO:0072682,0.0788708368543504,1,1,1,eosinophil extravasation,BP,PTGER4
16213,GO:0090246,0.0788708368543504,1,1,1,convergent extension involved in somitogenesis,BP,SFRP1
16243,GO:0090291,0.0788708368543504,1,1,1,negative regulation of osteoclast proliferation,BP,TNFAIP3
16270,GO:0090327,0.0788708368543504,1,1,1,negative regulation of locomotion involved in locomotory behavior,BP,ARRDC3
16373,GO:0090673,0.0788708368543504,1,1,1,endothelial cell-matrix adhesion,BP,ADAMTS9
16570,GO:0097356,0.0788708368543504,1,1,1,perinucleolar compartment,CC,EPPK1
16593,GO:0097403,0.0788708368543504,1,1,1,cellular response to raffinose,BP,ZFP36L1
16609,GO:0097442,0.0788708368543504,1,1,1,CA3 pyramidal cell dendrite,CC,MAP2
16683,GO:0097625,0.0788708368543504,1,1,1,low-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
16684,GO:0097626,0.0788708368543504,1,1,1,low-affinity L-arginine transmembrane transporter activity,MF,SLC7A2
16685,GO:0097627,0.0788708368543504,1,1,1,high-affinity L-ornithine transmembrane transporter activity,MF,SLC7A2
16694,GO:0097639,0.0788708368543504,1,1,1,L-lysine import across plasma membrane,BP,SLC7A2
16695,GO:0097640,0.0788708368543504,1,1,1,L-ornithine import across plasma membrane,BP,SLC7A2
16774,GO:0098577,0.0788708368543504,1,1,1,inactive sex chromosome,CC,HNRNPU
16790,GO:0098625,0.0788708368543504,1,1,1,methylselenol reductase activity,MF,TXNRD1
16791,GO:0098626,0.0788708368543504,1,1,1,methylseleninic acid reductase activity,MF,TXNRD1
17167,GO:0102752,0.0788708368543504,1,1,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,GBE1
17234,GO:0110025,0.0788708368543504,1,1,1,DNA strand resection involved in replication fork processing,BP,ZNF365
17235,GO:0110026,0.0788708368543504,1,1,1,regulation of DNA strand resection involved in replication fork processing,BP,ZNF365
17261,GO:0120048,0.0788708368543504,1,1,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,METTL16
17262,GO:0120049,0.0788708368543504,1,1,1,snRNA (adenine-N6)-methylation,BP,METTL16
17300,GO:0140074,0.0788708368543504,1,1,1,cardiac endothelial to mesenchymal transition,BP,SEMA3C
17454,GO:1900241,0.0788708368543504,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
17590,GO:1901228,0.0788708368543504,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,SRF
17626,GO:1901331,0.0788708368543504,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
17635,GO:1901350,0.0788708368543504,1,1,1,cell-cell signaling involved in cell-cell junction organization,BP,TJP1
17655,GO:1901419,0.0788708368543504,1,1,1,regulation of response to alcohol,BP,LANCL2
17656,GO:1901421,0.0788708368543504,1,1,1,positive regulation of response to alcohol,BP,LANCL2
17678,GO:1901545,0.0788708368543504,1,1,1,response to raffinose,BP,ZFP36L1
17742,GO:1901676,0.0788708368543504,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
17907,GO:1902216,0.0788708368543504,1,1,1,positive regulation of interleukin-4-mediated signaling pathway,BP,PARP14
17982,GO:1902396,0.0788708368543504,1,1,1,protein localization to bicellular tight junction,BP,ACTN4
18113,GO:1902767,0.0788708368543504,1,1,1,isoprenoid biosynthetic process via mevalonate,BP,HMGCS1
18148,GO:1902889,0.0788708368543504,1,1,1,protein localization to spindle microtubule,BP,HNRNPU
18164,GO:1902913,0.0788708368543504,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
18522,GO:1903701,0.0788708368543504,1,1,1,substantia propria of cornea development,BP,TGFB2
18628,GO:1903918,0.0788708368543504,1,1,1,regulation of actin filament severing,BP,MYH9
18629,GO:1903919,0.0788708368543504,1,1,1,negative regulation of actin filament severing,BP,MYH9
18638,GO:1903937,0.0788708368543504,1,1,1,response to acrylamide,BP,NEFL
18639,GO:1903939,0.0788708368543504,1,1,1,regulation of TORC2 signaling,BP,TELO2
18676,GO:1904021,0.0788708368543504,1,1,1,negative regulation of G-protein coupled receptor internalization,BP,UBQLN2
18682,GO:1904028,0.0788708368543504,1,1,1,positive regulation of collagen fibril organization,BP,COLGALT1
18708,GO:1904106,0.0788708368543504,1,1,1,protein localization to microvillus,BP,ANKS4B
18719,GO:1904155,0.0788708368543504,1,1,1,DN2 thymocyte differentiation,BP,CCR6
18720,GO:1904156,0.0788708368543504,1,1,1,DN3 thymocyte differentiation,BP,CCR6
18755,GO:1904235,0.0788708368543504,1,1,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
18756,GO:1904237,0.0788708368543504,1,1,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
18866,GO:1904515,0.0788708368543504,1,1,1,positive regulation of TORC2 signaling,BP,TELO2
18929,GO:1904674,0.0788708368543504,1,1,1,positive regulation of somatic stem cell population maintenance,BP,TP63
18970,GO:1904750,0.0788708368543504,1,1,1,negative regulation of protein localization to nucleolus,BP,POLR1A
18977,GO:1904762,0.0788708368543504,1,1,1,positive regulation of myofibroblast differentiation,BP,PARP1
19001,GO:1904812,0.0788708368543504,1,1,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,NAT10
19032,GO:1904876,0.0788708368543504,1,1,1,negative regulation of DNA ligase activity,BP,TFIP11
19078,GO:1904970,0.0788708368543504,1,1,1,brush border assembly,BP,ANKS4B
19126,GO:1905069,0.0788708368543504,1,1,1,allantois development,BP,BMP7
19161,GO:1905176,0.0788708368543504,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
19210,GO:1905319,0.0788708368543504,1,1,1,mesenchymal stem cell migration,BP,ACKR3
19211,GO:1905320,0.0788708368543504,1,1,1,regulation of mesenchymal stem cell migration,BP,ACKR3
19212,GO:1905322,0.0788708368543504,1,1,1,positive regulation of mesenchymal stem cell migration,BP,ACKR3
19414,GO:1905957,0.0788708368543504,1,1,1,regulation of cellular response to alcohol,BP,LANCL2
19415,GO:1905959,0.0788708368543504,1,1,1,positive regulation of cellular response to alcohol,BP,LANCL2
19494,GO:1990280,0.0788708368543504,1,1,1,RNA localization to chromatin,BP,HNRNPU
19650,GO:1990876,0.0788708368543504,1,1,1,cytoplasmic side of nuclear pore,CC,NUP214
19652,GO:1990882,0.0788708368543504,1,1,1,rRNA acetylation,BP,NAT10
19653,GO:1990883,0.0788708368543504,1,1,1,rRNA cytidine N-acetyltransferase activity,MF,NAT10
19654,GO:1990884,0.0788708368543504,1,1,1,RNA acetylation,BP,NAT10
19696,GO:2000019,0.0788708368543504,1,1,1,negative regulation of male gonad development,BP,WNT4
19702,GO:2000040,0.0788708368543504,1,1,1,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19703,GO:2000041,0.0788708368543504,1,1,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19713,GO:2000054,0.0788708368543504,1,1,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19720,GO:2000066,0.0788708368543504,1,1,1,positive regulation of cortisol biosynthetic process,BP,WNT4
19725,GO:2000079,0.0788708368543504,1,1,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19726,GO:2000080,0.0788708368543504,1,1,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19730,GO:2000098,0.0788708368543504,1,1,1,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
19789,GO:2000224,0.0788708368543504,1,1,1,regulation of testosterone biosynthetic process,BP,WNT4
19790,GO:2000225,0.0788708368543504,1,1,1,negative regulation of testosterone biosynthetic process,BP,WNT4
19871,GO:2000349,0.0788708368543504,1,1,1,negative regulation of CD40 signaling pathway,BP,TNFAIP3
19919,GO:2000417,0.0788708368543504,1,1,1,negative regulation of eosinophil migration,BP,PTGER4
19921,GO:2000419,0.0788708368543504,1,1,1,regulation of eosinophil extravasation,BP,PTGER4
19922,GO:2000420,0.0788708368543504,1,1,1,negative regulation of eosinophil extravasation,BP,PTGER4
19941,GO:2000474,0.0788708368543504,1,1,1,regulation of opioid receptor signaling pathway,BP,PPP1R9B
19964,GO:2000536,0.0788708368543504,1,1,1,negative regulation of entry of bacterium into host cell,BP,ITGAV
20040,GO:2000663,0.0788708368543504,1,1,1,negative regulation of interleukin-5 secretion,BP,TNFRSF21
20069,GO:2000707,0.0788708368543504,1,1,1,positive regulation of dense core granule biogenesis,BP,PRKCA
20072,GO:2000721,0.0788708368543504,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,NPNT
20073,GO:2000722,0.0788708368543504,1,1,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,GPER1
20074,GO:2000724,0.0788708368543504,1,1,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,GPER1
20250,GO:2001202,0.0788708368543504,1,1,1,negative regulation of transforming growth factor-beta secretion,BP,FN1
20300,GO:2001288,0.0788708368543504,1,1,1,positive regulation of caveolin-mediated endocytosis,BP,NEDD4L
2421,GO:0005595,0.0788708368543507,1,1,1,collagen type XII trimer,CC,COL12A1
8947,GO:0034987,0.0788708368543507,1,1,1,immunoglobulin receptor binding,MF,FLNA
8948,GO:0034988,0.0788708368543507,1,1,1,Fc-gamma receptor I complex binding,MF,FLNA
10965,GO:0044725,0.0788708368543507,1,1,1,chromatin reprogramming in the zygote,BP,TET3
10966,GO:0044727,0.0788708368543507,1,1,1,DNA demethylation of male pronucleus,BP,TET3
13786,GO:0060372,0.0788708368543507,1,1,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,FLNA
13846,GO:0060447,0.0788708368543507,1,1,1,bud outgrowth involved in lung branching,BP,TNC
14017,GO:0060739,0.0788708368543507,1,1,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,TNC
19096,GO:1905000,0.0788708368543507,1,1,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,FLNA
7501,GO:0031673,0.0788708368543509,1,1,1,H zone,CC,DST
12913,GO:0051259,0.0791136842174766,0.944727391386675,36,379,protein complex oligomerization,BP,CRYAB;C1QTNF1;SOD2;GBP1;MAT2A;IKBKE;BIRC3;B4GALT1;PANX1;TP53;SQSTM1;EHD1;ZC3H12A;TK1;CHP1;TRIM22;KCNA7;KCTD10;TRAF2;AASS;DPYSL3;CAB39;RCC1;CPT1A;DCXR;CHMP4B;NACC1;XRCC6;KCTD1;AKR1C1;TNFAIP3;CLDN7;HSD17B10;NOL3;TP63;CCL5
16908,GO:0098869,0.0794951722731555,0.965424062830044,8,63,cellular oxidant detoxification,BP,NQO1;SOD2;TXNRD1;TNF;FANCC;DHFR;BMP7;GPX4
6948,GO:0030574,0.0795134064259749,0.970738624598998,6,39,collagen catabolic process,BP,MMP9;COL12A1;COL4A1;COL5A3;COL5A2;COL4A4
16722,GO:0097718,0.0795753947829809,0.974108826124721,5,30,disordered domain specific binding,MF,FN1;TP53;KEAP1;BCL2L2;HSP90AB1
17832,GO:1901991,0.080041833110296,0.950374098693008,21,202,negative regulation of mitotic cell cycle phase transition,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;PSMB9;SFN;PSME2;ZFP36L1;GPR132;ZFP36L2;ORAOV1;ZW10;ANAPC15;DUSP1;TFDP1;GPNMB;TPRA1;CTDSP1;PSMC3;TP63
12775,GO:0051050,0.0801431404525955,0.939729143009191,56,606,positive regulation of transport,BP,SAA1;TRIM16;NRG1;PTGER4;INHBA;C1QTNF1;JPH2;SDC4;TGFB2;EDN1;G6PD;PANX1;TP53;IRS1;LAMP1;EHD1;TNF;SIRPA;ZC3H12A;FLNA;CYB5R1;CADPS2;CHP1;CD274;ITGAV;SFN;ADRB2;SERPINE1;USP36;GPER1;NFKBIA;SGK1;IRS2;LGALS3;SYK;PDGFB;OXTR;SPTBN1;NEDD4L;IL1A;WDR46;YWHAH;CLASP1;UBE2J2;STAC;TFDP1;ACTN4;SNIP1;RAPGEF1;RAB27A;CD38;MAPK11;SNF8;HSP90AB1;TP63;CCL5
1149,GO:0002757,0.0804211857261753,0.945027808831632,32,325,immune response-activating signal transduction,BP,RUNX1;ACTG1;CYLD;RELB;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;IRF1;PSME2;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;TNIP2;ESR1;RAPGEF1;CD38;TNFAIP3;PSMC3;SPG21;HSP90AB1
11590,GO:0046165,0.0805591948531623,0.956903326000479,13,111,alcohol biosynthetic process,BP,G6PD;NFKB1;TNF;SCD;LSS;HMGCS1;EBP;DHCR7;GPER1;DHFR;PPIP5K1;INSIG1;QDPR
12610,GO:0050790,0.0807544681335995,0.932908823677794,138,1614,regulation of catalytic activity,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;FN1;CTGF;AMOT;NQO1;DUSP14;PML;HSPB1;STARD13;SDC4;BAG1;GPRC5A;MAP3K14;TGFB2;EDN1;SH3RF2;BIRC3;DBNDD2;EMP2;NUAK1;NLRC5;TP53;SIPA1L3;NFKB1;CDKN2B;IRS1;CDKN1A;LYN;GADD45A;TNF;CDKN2A;RING1;CORO1C;PKMYT1;FGFR2;DNAJB1;PSMB9;EPHB6;TELO2;UBE2C;EPHA2;CHP1;GADD45B;ICAM1;BMP2;CDK4;ERRFI1;SFN;CDC42EP2;EPGN;ADRB2;DAXX;SERPINE1;SFRP1;TPM1;PPP1R3B;ANXA8;PSME2;TFIP11;GPER1;DNAJB2;EGR1;DOCK10;SGK1;CD2BP2;ADAM17;DKC1;DHFR;FGFR1OP;IRS2;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;RPS2;NSFL1C;SNRNP70;SERPINH1;UHRF1;NPNT;RASGRP4;RUNDC1;SPRY4;ROR1;ACSL1;RCC2;AFAP1L2;SMAD7;DNAJC1;HNRNPU;APH1A;PPP1R14C;TRIB1;DCUN1D2;PPP1R9B;A2ML1;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;JUN;ESR1;SERTAD1;ARRDC3;DUS2;RHOG;XRCC6;BMP7;TNFRSF10A;SGSM1;RAPGEF1;DAG1;WNT4;TRAF4;TNFAIP3;CCL22;DNAJC9;EFNA1;MAPK11;CARD10;DUSP8;NOL3;HSP90AB1;PARP1;TP63;PHACTR4;CCL5;SH3BP4
11395,GO:0045777,0.080804564316681,0.983289089082336,3,14,positive regulation of blood pressure,BP,TPM1;OXTR;TBXA2R
15152,GO:0071260,0.0811518344830431,0.964668055609333,8,59,cellular response to mechanical stimulus,BP,PTGER4;MAP3K14;NFKB1;GADD45A;IRF1;TNFRSF10A;DAG1;GCLC
17110,GO:0101002,0.0812983283102227,0.953280738892039,16,146,ficolin-1-rich granule,CC,KRT1;FTH1;MMP9;MGAM;PLEKHO2;LAMP1;QPCT;SIRPA;VCL;LGALS3;CAB39;HSPA8;COMMD9;XRCC6;PSMC3;HSP90AB1
4552,GO:0010633,0.0814863861470501,0.966919997240752,7,49,negative regulation of epithelial cell migration,BP,STARD13;MARVELD3;ADAMTS9;CORO1C;EPPK1;CARD10;TBXA2R
16780,GO:0098590,0.0816421274396889,0.938224928267879,58,622,plasma membrane region,CC,CRYAB;NRG1;S100P;FN1;TFRC;B4GALT1;MGAM;EMP2;SIPA1L3;IRS1;EHD1;BAIAP2;CORO1C;WWC1;DST;PDPN;SLC7A5;FOSL1;LCP1;CADPS2;EPHA2;ITGAV;MYO10;ADRB2;SVIL;SLC5A6;AMOTL2;TPM1;EPPK1;THBD;GPER1;PARD3B;RHOB;ADAM17;ABCG2;PDGFB;OXTR;SPTBN1;MYH9;SPRY4;TJP1;PPP1R9B;SLC4A11;MARVELD2;SLC22A4;PARD3;SMPD2;THEM4;SORBS2;PHLPP1;DAG1;PDE6A;RAB27A;SLC4A2;CLDN7;SLC3A2;HSP90AB1;IL6R
10211,GO:0042826,0.0817865798367936,0.958849861591188,11,89,histone deacetylase binding,MF,HDAC9;TP53;AKAP8L;SRF;AKAP8;CBX5;BRMS1;SFPQ;MTA2;HSP90AB1;PARP1
6294,GO:0019904,0.081881030794926,0.938992413562944,52,559,protein domain specific binding,MF,TRIM16;FN1;NEFL;DAPK3;TP53;NFE2L1;SQSTM1;IRS1;TJP2;LYN;LAMP1;BAIAP2;SIRPA;ERRFI1;L1CAM;SFN;MKL1;LUC7L;BANF1;ADAM17;U2AF2;IRS2;MAFK;SYK;ROBO1;DPYSL3;MYH9;RCC2;AFAP1L2;CCDC6;YWHAH;ENAH;KEAP1;ETS2;CITED2;HSPA8;JUN;SLC22A4;TFDP1;CNTROB;BCL2L2;CNTNAP1;RAPGEF1;CHAF1A;DAG1;RAB27A;TRAF4;TUBB;SRSF7;NOL3;HSP90AB1;TP63
5815,GO:0017080,0.0821659948022573,0.977314732947572,4,22,sodium channel regulator activity,MF,FXYD3;SGK1;NEDD4L;YWHAH
367,GO:0000988,0.0822446366209219,0.939255437386593,49,522,transcription factor activity, protein binding,MF,NRG1;HDAC9;TFCP2L1;MYBL2;PDLIM1;RELB;TP53;NFE2L1;TAF4B;JUNB;WWC1;PTPN14;NFKB2;DNAJB1;SRSF2;KLF7;DAXX;FUS;ELF3;TRIM22;MKL1;SRF;MED22;ZFP42;SF1;EDF1;PPRC1;DDX17;NFKBIB;AJUBA;FHL2;SPEN;MTA2;HNRNPU;PQBP1;RUVBL2;ABT1;KCNIP3;CITED2;JUN;TFDP1;GTF2E1;NOC2L;ACTN4;KCTD1;WNT4;RBM14;SMARCC2;TP63
3398,GO:0007176,0.0823988965713014,0.977228267307818,4,22,regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A;ERRFI1;EPGN;ADAM17
7325,GO:0031334,0.0824047961141239,0.948748112747558,21,199,positive regulation of protein complex assembly,BP,CSF2;TP53;ARPC4;TNF;BAIAP2;FOSL1;LCP1;ICAM1;CDC42EP2;ARPC1B;SRF;AJUBA;DCTN1;SLAIN2;CLASP1;JUN;ESR1;RHOG;PSMC3;PARP1;BAIAP2L2
5311,GO:0016020,0.0825125786783173,0.927445616547546,458,5731,membrane,CC,HEPHL1;IL32;KRT1;SPRR3;TRIM16;FTL;CRYAB;SPRR2A;NRG1;KRT2;PTGER4;S100P;FN1;PLD5;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;SLC16A2;AMOT;JPH2;ACTG1;IL16;CYP1A1;TAP1;IL1R2;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;KRT10;PCDH7;SDC4;FADS3;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD83;HLA-B;PTGES;TRIM16L;GBP1;TMPPE;IKBKE;BIRC3;DAPK3;B4GALT1;MGAM;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;HRNR;APOL6;PANX1;SIPA1L3;NFE2L1;MARVELD3;KRT9;STEAP4;NEDD9;IL27RA;GNPTAB;LFNG;IRS1;GALNT18;TJP2;HSPG2;UBQLN2;LYN;MYO1B;RAB32;STOML1;CDV3;MCM5;LAMP1;HS3ST2;EHD1;TNF;GNL3L;BAIAP2;EFNB2;KRT5;CORO1C;CXCL16;PKMYT1;SCD;WWC1;TNC;DST;VMP1;GPRIN1;PDPN;FGFR2;CDKAL1;NUP153;BACE2;TPM4;LSS;SLC7A5;CLN6;EPHB6;TELO2;FOSL1;LAYN;SLC16A9;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;LCP1;CYB5R1;TNK1;FAM69B;ACAA1;GEMIN5;CADPS2;EPHA2;CHP1;EIF5;ICAM1;ARFRP1;CD274;BMP2;GOSR1;SLCO3A1;SLC7A5P2;CDK4;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;MYO10;GGCX;SFN;CDC42EP2;TMEM183B;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ADRB2;SVIL;TMEM14EP;TNFRSF12A;NAT10;MTUS1;IFNGR1;SLC5A6;SERPINE1;FXYD3;PGK1;LSG1;CCDC124;EBP;NMT2;ST6GALNAC5;AMOTL2;AEN;RELT;SFRP1;PARL;ABCF2;TPM1;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;WDR1;ANXA8;PSME2;ABHD4;EPPK1;IL7R;DDX42;NFX1;THBD;GPER1;DNAJB2;HS3ST1;LARP4B;AP4S1;NFKBIA;PARD3B;IGSF3;KCNA7;DOCK10;GEMIN4;SGK1;FAM57A;PRPF19;CYP4B1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;FEN1;SNX12;UPK3B;TXLNA;VCL;RIPK4;IRS2;IER3;LGALS3;TRAF2;ABCG2;IL15;REEP1;PRKCA;GPR132;SYK;CMTM3;FAM74A7;SLC7A2;DDX17;ROBO1;AJUBA;DDX47;PPIP5K1;SLC43A3;PDGFB;FILIP1;BCAM;PREP;OXTR;RPS2;PTTG1IP;ALYREF;UTP20;RPS9;NSFL1C;SPTBN1;NEDD4L;SERPINH1;DCTN1;COLGALT1;COX5B;DCBLD1;MYH9;SPPL2A;TAPBPL;TMEM159;COL17A1;NPNT;SDK1;CAMK1G;GLIPR1;GPR75;TNFRSF21;LANCL2;RASGRP4;SNX8;BORCS7;DDX39A;ERVV-1;SPRY4;LILRB3;ZW10;ROR1;PXMP2;ACSL1;RCC2;NOP56;ACKR3;BAMBI;AFAP1L2;TMEM140;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;MRPS24;NOL9;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;ENAH;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;RRAD;APH1A;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TPST1;CREB3;RUVBL2;PPP1R9B;SLC4A11;MTFP1;ORC1;LPCAT3;MICAL3;KCNIP3;ETS2;PARP14;MRPL20;RHBDL2;SUSD6;PCYT1A;GALNT2;ATG101;MARVELD2;TGFBRAP1;CD109;RPL27A;STAC;FRAS1;HSPA8;PIGM;MRPL33;ESR1;MANEAL;IKZF3;BLOC1S2;SLC22A4;PES1;HCAR3;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;MCM7;LRRC57;LRRC27;SCD5;TNPO3;OGFR;BCS1L;TRAPPC5;NOP14;CHMP4B;CCR6;RPTN;ARRDC3;INSIG1;HERC2;PARD3;SMIM17;RHOG;GPNMB;BCL2L2;XRCC6;GP6;EDC4;TAP2;CHCHD6;SMPD2;CNTNAP1;EFNB1;THEM4;SORBS2;LRFN4;PHLPP1;EFTUD2;TNFRSF10A;TPRA1;TOMM40;MPHOSPH8;PHLDB2;CYP20A1;SGSM1;RAPGEF1;IPO4;ZYX;EIF5A;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;PDE6A;MGAT2;RNF185;RAB27A;DHX34;BLNK;DPM3;WNT4;RILPL2;MRPS2;VPS52;TRAF4;TUBB;CYTH1;CD38;PSMC3;SPG21;CYB561D2;SLC4A2;DNAJC9;BRIP1;PPP2R1B;EFNA1;CLDN7;CTPS1;DDX24;HSD17B10;SLC3A2;SLC25A22;PTPRB;RNF144B;SLC25A44;CLTA;NOL3;SNF8;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;ADGRF3;IL6R;LAIR1;FAM74A3;PARP1;SLC2A6;TXNDC15;ARIH2OS;TMEM51;BAIAP2L2;FADS1;SH3BP4
6652,GO:0030001,0.0826042334108743,0.940240720395415,43,451,metal ion transport,BP,HEPHL1;FTL;FTH1;CTGF;JPH2;IL16;PML;TFRC;G6PD;PANX1;STEAP4;LYN;JPH1;SLC39A1;FLNA;CHP1;ICAM1;ITGAV;ADRB2;SLC5A6;FXYD3;PARL;GPER1;KCNA7;SGK1;LGALS3;PDGFB;NEDD4L;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;SLC22A4;COMMD9;ACTN4;SLC41A2;TMEM165;SLC3A2;NOL3;CCL5
4958,GO:0015030,0.08272839603292,0.966214410504808,7,51,Cajal body,CC,SART1;LSG1;TRIM22;DDX42;DKC1;PHAX;EFTUD2
12907,GO:0051253,0.082768408824034,0.934075846203482,87,990,negative regulation of RNA metabolic process,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;TP53;SQSTM1;NOCT;FST;NFKB1;AHR;JUNB;TNF;CDKN2A;RING1;WWC1;FGFR2;NFKB2;DNAJB1;ZC3H12A;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;DAXX;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;SRF;TRIM29;SF1;EGR1;SNAI2;NELFE;DKC1;U2AF2;SHQ1;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;NOC2L;NACC1;ZNF703;XRCC6;GLIS3;BMP7;KCTD1;MPHOSPH8;DHX34;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;SRSF7;GCLC;PARP1;TP63
8186,GO:0032924,0.0833560479261572,0.976871960606928,4,22,activin receptor signaling pathway,BP,INHBA;FST;SMAD7;CITED2
5605,GO:0016646,0.0837366487183487,0.982419180578992,3,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,DHFR;AASS;QDPR
18400,GO:1903428,0.0839631024132719,0.972166825390089,5,31,positive regulation of reactive oxygen species biosynthetic process,BP,EDN1;TNF;ICAM1;RAB27A;HSP90AB1
13236,GO:0051899,0.0839931685333137,0.965615447935239,7,50,membrane depolarization,BP,EDN1;NEDD4L;SMAD7;YWHAH;JUN;GCLC;PARP1
8201,GO:0032946,0.0840093923463356,0.960959599733817,9,71,positive regulation of mononuclear cell proliferation,BP,TFRC;CDKN1A;CD274;IRS2;IL15;SYK;EFNB1;CD38;CCL5
16846,GO:0098754,0.0842449199541475,0.960730222829483,9,75,detoxification,BP,NQO1;SOD2;TXNRD1;TNF;ACAA1;FANCC;DHFR;BMP7;GPX4
11871,GO:0046875,0.0842718274876211,0.97652961384958,4,22,ephrin receptor binding,MF,LYN;EFNB2;EFNB1;EFNA1
6278,GO:0019882,0.0850686772654011,0.949026172592492,18,171,antigen processing and presentation,BP,TAP1;RELB;HLA-B;RAB32;PSMB9;ICAM1;ITGAV;KIF23;HLA-F;PSME2;DCTN1;TAPBPL;TAPBP;TAP2;KIF22;RAB27A;PSMC3;CLTA
8099,GO:0032784,0.0853494869085578,0.967946816229845,6,40,regulation of DNA-templated transcription, elongation,BP,NELFE;ALYREF;SUPT5H;HNRNPU;THOC1;SUPT16H
3137,GO:0006729,0.0853849284103865,0.98954282194614,2,7,tetrahydrobiopterin biosynthetic process,BP,DHFR;QDPR
11585,GO:0046146,0.0853849284103865,0.98954282194614,2,7,tetrahydrobiopterin metabolic process,BP,DHFR;QDPR
13036,GO:0051492,0.0853852804969806,0.962413010424378,8,59,regulation of stress fiber assembly,BP,PTGER4;CTGF;SDC4;SFRP1;TPM1;CLASP1;PHLDB2;WNT4
7816,GO:0032369,0.0855789884935977,0.981865394018843,3,14,negative regulation of lipid transport,BP,NFKB1;ITGAV;IRS2
19773,GO:2000191,0.0856538876282673,0.981842763693696,3,14,regulation of fatty acid transport,BP,EDN1;IRS2;SYK
13670,GO:0060193,0.0857493946770312,0.971397158634652,5,31,positive regulation of lipase activity,BP,CYR61;FGFR2;RASGRP4;ESR1;CCL5
6208,GO:0019722,0.0859839139209657,0.956311693527497,11,91,calcium-mediated signaling,BP,CCL20;NRG1;JPH2;EDN1;GBP1;JPH1;CHP1;SYK;PPP1R9B;CCR6;CXCL8
15491,GO:0071850,0.0860769049477808,0.981714781292033,3,14,mitotic cell cycle arrest,BP,CDKN1A;GADD45A;DUSP1
16779,GO:0098589,0.086087225730734,0.945545150549119,22,208,membrane region,CC,SDC4;BIRC3;DAPK3;EMP2;IRS1;LYN;STOML1;TNF;CORO1C;PDPN;ICAM1;PGK1;ADAM17;TRAF2;SERPINH1;SMPD2;EFNB1;EIF5A;MYADM;DAG1;TUBB;PPP2R1B
11251,GO:0045471,0.0861945684656046,0.959736226475513,9,71,response to ethanol,BP,NQO1;G6PD;TP53;TNC;FGFR2;TYMS;ICAM1;CLDN7;TBXA2R
18385,GO:1903393,0.0865389492501388,0.975676076698813,4,22,positive regulation of adherens junction organization,BP,SDC4;COL16A1;SFRP1;WNT4
4571,GO:0010656,0.0865812251572135,0.97566007952139,4,22,negative regulation of muscle cell apoptotic process,BP,EDN1;ZC3H12A;BMP7;NOL3
4945,GO:0014910,0.08671523502358,0.967298043772975,6,40,regulation of smooth muscle cell migration,BP,IGFBP3;SERPINE1;TPM1;PDGFB;TRIB1;CCL5
8626,GO:0034142,0.0867174320967591,0.981520442365021,3,14,toll-like receptor 4 signaling pathway,BP,LYN;NFKBIA;TNFAIP3
17238,GO:0110053,0.0868080138376337,0.946354961595497,20,188,regulation of actin filament organization,BP,PTGER4;CTGF;SDC4;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;SPTBN1;CLASP1;RHOG;KANK4;PHLDB2;MYADM;WNT4;SWAP70;BAIAP2L2
15325,GO:0071541,0.0872161907892102,0.989185835824664,2,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,EIF3B;EIF3I
16337,GO:0090559,0.0873015569688304,0.959113778425804,9,71,regulation of membrane permeability,BP,TP53;TJP2;SFN;YWHAH;BLOC1S2;TFDP1;THEM4;NOL3;TP63
15680,GO:0072202,0.0873755261119936,0.981320085753586,3,14,cell differentiation involved in metanephros development,BP,LIF;PDGFB;WNT4
17415,GO:1900151,0.0873876289965176,0.981316394517028,3,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36L2;POLR2G
17417,GO:1900153,0.0873876289965176,0.981316394517028,3,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36L2;POLR2G
16740,GO:0097756,0.0874887794896347,0.966929262368743,6,40,negative regulation of blood vessel diameter,BP,ADM;EDN1;ICAM1;OXTR;CD38;TBXA2R
11290,GO:0045600,0.0875435699956292,0.966903105265477,6,40,positive regulation of fat cell differentiation,BP,NOCT;ZC3H12A;BMP2;SFRP1;SNAI2;ZFP36L1
3484,GO:0007346,0.0877467934503908,0.934093495999717,53,577,regulation of mitotic cell cycle,BP,CYP1A1;PML;CYLD;MAP3K14;EDN1;DAPK3;TP53;CDKN2B;CDKN1A;GADD45A;TNF;CDKN2A;PKMYT1;PBX1;PSMB9;UBE2C;CDK4;SFN;EPGN;PSME2;ZFP36L1;ADAM17;FGFR1OP;PRKCA;GPR132;ZFP36L2;PDGFB;DCTN1;IL1A;ORAOV1;PRCC;ZW10;RCC2;AFAP1L2;HNRNPU;CLASP1;CEP41;PPP1R9B;ANAPC15;DUSP1;OXSR1;RCC1;TFDP1;CHMP4B;GPNMB;BMP7;TPRA1;TUBB;CTDSP1;PSMC3;CDCA5;MKI67;TP63
228,GO:0000470,0.0877631486480304,0.974986920816457,4,24,maturation of LSU-rRNA,BP,FTSJ3;NOL9;PES1;NOP2
917,GO:0002312,0.0878103259648344,0.96367222058145,7,50,B cell activation involved in immune response,BP,TFRC;IL27RA;LFNG;DOCK10;THOC1;CCR6;SWAP70
4505,GO:0010544,0.0878214268560944,0.981183936184004,3,14,negative regulation of platelet activation,BP,C1QTNF1;THBD;PDGFB
16905,GO:0098858,0.0878304673125306,0.951126344385419,14,122,actin-based cell projection,CC,S100P;B4GALT1;MYO1B;BAIAP2;PDPN;LCP1;ITGAV;MYO10;ANKS4B;OXTR;ENAH;PPP1R9B;DCXR;DAG1
8606,GO:0034114,0.0880163557128152,0.981124317295895,3,14,regulation of heterotypic cell-cell adhesion,BP,TNF;BMP7;MYADM
3668,GO:0008157,0.088054812837741,0.981112548020706,3,14,protein phosphatase 1 binding,MF,SH3RF2;PPP1R9B;PHACTR4
20274,GO:2001242,0.0882441687708133,0.950796332789607,14,127,regulation of intrinsic apoptotic signaling pathway,BP,MMP9;CYLD;HSPB1;SOD2;TP53;SNAI2;PTTG1IP;SFPQ;ACKR3;CREB3;NOC2L;BCL2L2;NOL3;PARP1
10244,GO:0042976,0.088247782374534,0.988982689582762,2,7,activation of Janus kinase activity,BP,SOCS1;CCL5
5637,GO:0016722,0.0883909260582242,0.981009584499411,3,14,oxidoreductase activity, oxidizing metal ions,MF,HEPHL1;FTH1;STEAP4
6785,GO:0030220,0.0885188840431776,0.980970338930155,3,14,platelet formation,BP,WDR1;SRF;MYH9
8091,GO:0032774,0.0885210497859951,0.923361503485184,247,2997,RNA biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;TTLL5;PARP1;TP63;ZBTB12;CCL5;FADS1;MAGOH
7482,GO:0031646,0.088558454338407,0.980958197162414,3,14,positive regulation of neurological system process,BP,NRG1;PARD3;DAG1
1114,GO:0002703,0.0885719598335278,0.953227290858559,12,102,regulation of leukocyte mediated immunity,BP,TFRC;RSAD2;IL27RA;LYN;LAMP1;TNF;IL7R;TRAF2;SYK;DNASE1;SMAD7;THOC1
16104,GO:0090083,0.0885976612088811,0.980946164442418,3,14,regulation of inclusion body assembly,BP,SACS;DNAJB1;DNAJB2
15981,GO:0080135,0.0886371867564626,0.933950924675419,50,537,regulation of cellular response to stress,BP,CRYAB;CTGF;PML;HSPB1;BAG1;SOD2;TGFB2;EDN1;MID1;NUAK1;TP53;MARVELD3;UBQLN2;LYN;GADD45A;TNF;CDKN2A;NUP153;DNAJB1;ZC3H12A;GADD45B;BMP2;DAXX;SFRP1;TFIP11;SNAI2;DHFR;IER3;NPAS2;TRAF2;SYK;AJUBA;PTTG1IP;IL1A;SFPQ;NUP214;ACKR3;CREB3;THOC1;HSPA8;INSIG1;ZNF365;BMP7;PHLPP1;RAPGEF1;TIMELESS;TRAF4;NOL3;HSP90AB1;PARP1
12876,GO:0051204,0.088692468046985,0.97003928182723,5,32,protein insertion into mitochondrial membrane,BP,TP53;SFN;YWHAH;TFDP1;TP63
14304,GO:0061437,0.0887877267291844,0.980887797922729,3,14,renal system vasculature development,BP,EGR1;PDGFB;BMP7
14307,GO:0061440,0.0887877267291844,0.980887797922729,3,14,kidney vasculature development,BP,EGR1;PDGFB;BMP7
11068,GO:0045066,0.0889697300094332,0.980831853200061,3,14,regulatory T cell differentiation,BP,RUNX1;IRF1;SOCS1
11282,GO:0045589,0.0889697300094332,0.980831853200061,3,14,regulation of regulatory T cell differentiation,BP,RUNX1;IRF1;SOCS1
11844,GO:0046822,0.088973858316782,0.954515197096454,11,91,regulation of nucleocytoplasmic transport,BP,TP53;CDKN1A;PTPN14;NUP153;ZC3H12A;CHP1;SFN;AKAP8L;NUP214;RBM4;HSP90AB1
682,GO:0001892,0.0889914761117796,0.958187997323638,9,70,embryonic placenta development,BP,CYR61;ADM;CSF2;JUNB;FGFR2;LIF;ZFP36L1;PDGFB;BMP7
6965,GO:0030619,0.0890178730932915,0.988830080730272,2,7,U1 snRNA binding,MF,GEMIN5;SNRNP70
12603,GO:0050779,0.0890406671481456,0.974724370127365,4,22,RNA destabilization,BP,ZC3H12A;ZFP36L1;ZFP36L2;METTL16
12664,GO:0050868,0.0891782702745832,0.960333916395092,8,60,negative regulation of T cell activation,BP,CYLD;SDC4;CD274;IRF1;LGALS3;TNFRSF21;SMAD7;GPNMB
9866,GO:0042119,0.0891790250435892,0.937683923161592,34,356,neutrophil activation,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;CXCL8;PTPRB;HSP90AB1;LAIR1;CCL5
4624,GO:0010744,0.0894700644538838,0.988740088905373,2,7,positive regulation of macrophage derived foam cell differentiation,BP,CSF2;NFKB1
6787,GO:0030223,0.0895413529102286,0.9887258758985,2,7,neutrophil differentiation,BP,CSF2;TRIB1
14516,GO:0065008,0.0896496906979197,0.923267478890946,198,2384,regulation of biological quality,BP,KRT1;MAFB;SAA1;FTL;CRYAB;FTH1;NRG1;PTGER4;INHBA;FN1;NEFL;CYP1B1;CTGF;C1QTNF1;ADM;SLC16A2;JPH2;ACTG1;NQO1;CYP1A1;NFKBIE;PML;CYLD;HSPB1;TFRC;SOD2;FBN1;EDN1;TXNRD1;IKBKE;DAPK3;G6PD;EMP2;HRNR;TP53;NFE2L1;SQSTM1;STEAP4;PANK2;NOCT;NFKB1;IRS1;CDKN1A;TJP2;LYN;ARPC4;LAMP1;CSRP1;EHD1;TNF;GNL3L;BAIAP2;NAV2;PDPN;BACE2;PSMB9;LSS;CLN6;TELO2;C9ORF3;UBE2C;JPH1;ZC3H12A;FLNA;ACAA1;CADPS2;CHP1;TSC22D3;ICAM1;FANCC;BMP2;CDK4;ITGAV;L1CAM;MYO10;GGCX;SFN;CDC42EP2;STAT5A;ADRB2;TNFRSF12A;NAT10;SERPINE1;PABPC4;ARPC1B;USP36;LIF;SFRP1;TPM1;ZFYVE27;APTX;DHCR7;WDR1;ANXA8;IRF1;PSME2;ABHD4;IL7R;TFIP11;THBD;GPER1;SRF;TXN2;NFKBIA;EGR1;DOCK10;ETS1;SGK1;ZFP36L1;RHOB;ADAM17;GPCPD1;DKC1;FEN1;VCL;IRS2;CBX5;ACO1;MAFK;ABCG2;AKR1C2;PRKCA;ZFP36L2;NTN1;SYK;SLC7A2;PDGFB;OXTR;POLA1;RPS9;SPTBN1;NEDD4L;MYH9;IL1A;TNIP2;SEMA3C;TBCCD1;NUP214;MAFF;BAMBI;SMAD7;YWHAH;TAPBP;PALM2;KEAP1;HNRNPU;VSIG1;SLC4A11;SAFB;HSPA8;JUN;ESR1;BLOC1S2;SLC22A4;FOXN1;CPT1A;COMMD9;TFDP1;CHMP4B;CCR6;RPTN;ARRDC3;INSIG1;RHOG;ZNF365;XRCC6;GP6;CNTNAP1;THEM4;METTL16;KANK4;UBAP2L;MYADM;DAG1;TMEM165;PDE6A;RAB27A;DPM3;WNT4;AKR1C1;CD38;TNFAIP3;PSMC3;SLC4A2;EFNA1;AARSD1;BMP8A;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;TBXA2R;PARP1;TP63;TXNDC15;CCL5;BAIAP2L2
7095,GO:0030890,0.0896700972125315,0.97436246207091,4,23,positive regulation of B cell proliferation,BP,TFRC;CDKN1A;IRS2;CD38
6991,GO:0030670,0.0897375564414408,0.95996296918468,8,62,phagocytic vesicle membrane,CC,TAP1;HLA-B;RAB32;LAMP1;HLA-F;TAPBP;TAP2;RAPGEF1
2476,GO:0005694,0.0898365658412252,0.929060497046724,77,882,chromosome,CC,PML;RBM19;MYBL2;CD3EAP;TET3;TP53;JUNB;MCM5;ZBED1;CDKN2A;RING1;ENC1;TELO2;FLNA;CDK4;DAXX;NAT10;MCM2;TOX4;AKAP8L;GRWD1;APTX;IRF1;BANF1;TFIP11;SRF;ZFP42;SNAI2;RRS1;PRPF19;AKAP8;FEN1;CBX5;PUM3;GINS2;BRMS1;ALYREF;POLA1;NSFL1C;DCTN1;UHRF1;ORAOV1;SFPQ;ZW10;RCC2;MTA2;HNRNPU;CLASP1;RUVBL2;ORC1;THOC1;PRDM7;CITED2;JUN;ESR1;CENPN;PES1;RCC1;MCM7;CENPO;XRCC6;HMGN2;MPHOSPH8;INCENP;IPO4;CHAF1A;KIF22;TIMELESS;SMARCC2;SUPT16H;UTP4;CDCA5;MKI67;PARP1;TP63;TOP3A;ORC4
7275,GO:0031256,0.0899637895695065,0.951008253905616,13,111,leading edge membrane,CC,NRG1;WWC1;PDPN;LCP1;EPHA2;ITGAV;TPM1;GPER1;ADAM17;SPTBN1;SPRY4;PPP1R9B;THEM4
15573,GO:0072028,0.0899718343847835,0.962561821723151,7,50,nephron morphogenesis,BP,IRX2;PBX1;BMP2;LIF;NPNT;BMP7;WNT4
3630,GO:0008090,0.0900363012580831,0.988627003657196,2,7,retrograde axonal transport,BP,NEFL;DST
8583,GO:0034062,0.0901432665764142,0.965489748886704,6,43,5'-3' RNA polymerase activity,MF,CD3EAP;POLR1A;CRCP;POLR3H;POLR1E;POLR2G
16735,GO:0097747,0.0901432665764142,0.965489748886704,6,43,RNA polymerase activity,MF,CD3EAP;POLR1A;CRCP;POLR3H;POLR1E;POLR2G
7225,GO:0031119,0.0902473140986769,0.988584748741187,2,7,tRNA pseudouridine synthesis,BP,PUS1;RPUSD4
10791,GO:0044260,0.0902551729883103,0.920426585537612,494,6220,cellular macromolecule metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CYP1B1;CTGF;C1QTNF1;DTX2;ADM;FOSL2;IL16;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;CD3EAP;ARID3B;IER2;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;HNRNPAB;IL24;P4HA2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;CLN6;EPHB6;TELO2;KRT17;FOSL1;QPCT;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;CDK4;ZNF142;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;MCM2;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;APTX;PPP1R3B;ANXA8;MKL1;IRF1;METTL1;PSME2;DPH2;IL7R;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;ZNF787;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;POP1;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;DKC1;FEN1;SNX12;DHFR;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;PRKCA;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;CDKL1;DNTTIP2;PDGFB;BRMS1;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;PHAX;POLA1;RPS9;NSUN5;NSFL1C;SPTBN1;NEDD4L;SERPINH1;FHL2;ZNF407;DNASE1;RNF115;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;SPEN;ROR1;ACSL1;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;APH1A;PAGR1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;PARP14;ANAPC15;PRDM7;MRPL20;GALNT2;DUSP1;CAB39;TGFBRAP1;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;USP31;FOXN1;BRPF1;GLIPR2;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;TEAD4;KBTBD12;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;EFTUD2;TNFRSF10A;RNF7;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;TINAGL1;KIF22;MYADM;DAG1;TMEM165;POLR3H;MGAT2;RNF185;EEF1D;ASB6;DHX34;TIMELESS;DPM3;WNT4;MRPS2;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;AARSD1;METTL21A;POLR1E;HSD17B10;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;TP63;ZBTB12;OTUD6A;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
8450,GO:0033574,0.0903533609745154,0.969309297371177,5,32,response to testosterone,BP,EDN1;CDK4;DUSP1;ELK1;TBXA2R
2860,GO:0006351,0.090652390868516,0.921478256136299,245,2973,transcription, DNA-templated,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;TTLL5;PARP1;TP63;ZBTB12;FADS1;MAGOH
1172,GO:0002819,0.0906930561771498,0.955216346055651,10,81,regulation of adaptive immune response,BP,TFRC;RSAD2;IL27RA;TNF;IRF1;IL7R;TRAF2;SMAD7;THOC1;TNFAIP3
9431,GO:0036002,0.090741344199485,0.969138135053223,5,32,pre-mRNA binding,MF,SRSF2;SF1;U2AF2;HNRNPU;RBM4
10546,GO:0043495,0.090859618355757,0.988461789841028,2,7,protein membrane anchor,MF,NUP153;MYH9
16396,GO:0097011,0.0910958129017846,0.988414221335168,2,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,CSF2;ZFP36L2
16397,GO:0097012,0.0910958129017846,0.988414221335168,2,7,response to granulocyte macrophage colony-stimulating factor,BP,CSF2;ZFP36L2
18353,GO:1903332,0.0911649537547691,0.988400282212771,2,7,regulation of protein folding,BP,DNAJB2;SNRNP70
16704,GO:0097659,0.0912774338584977,0.920901036642148,246,2987,nucleic acid-templated transcription,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;TTLL5;PARP1;TP63;ZBTB12;FADS1;MAGOH
8883,GO:0034695,0.0912796458358554,0.980117251191551,3,14,response to prostaglandin E,BP,PTGER4;SFRP1;AKAP8
13589,GO:0060056,0.0914072986559551,0.988351372624001,2,7,mammary gland involution,BP,B4GALT1;ELF3
2807,GO:0006266,0.0917074128403962,0.973574416257786,4,23,DNA ligation,BP,APTX;TFIP11;XRCC6;PARP1
1376,GO:0003272,0.0917113748886466,0.979982753802734,3,14,endocardial cushion formation,BP,TGFB2;SNAI2;BMP7
19734,GO:2000107,0.0918572699913155,0.968644493900876,5,32,negative regulation of leukocyte apoptotic process,BP,TSC22D3;IRS2;NOC2L;EFNA1;CCL5
11730,GO:0046540,0.0918937896906273,0.973388725018123,4,24,U4/U6 x U5 tri-snRNP complex,CC,SART1;ZMAT2;TXNL4B;EFTUD2
14127,GO:0060993,0.0920373232063098,0.95877802450193,8,60,kidney morphogenesis,BP,IRX2;PBX1;BMP2;LIF;NPNT;FRAS1;BMP7;WNT4
18122,GO:1902806,0.0922219318425903,0.946030066634024,16,147,regulation of cell cycle G1/S phase transition,BP,CYP1A1;PML;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;CDK4;SFN;PSME2;ADAM17;PAGR1;TFDP1;GPNMB;CTDSP1;TP63
3266,GO:0006936,0.0922509264188528,0.944137407307483,18,169,muscle contraction,BP,CRYAB;CTGF;EDN1;DAPK3;TPM4;ZC3H12A;FLNA;ADRB2;TPM1;GPER1;SRF;VCL;OXTR;NEDD4L;NPNT;SMAD7;STAC;TBXA2R
6319,GO:0019966,0.0922951072905199,0.988171510156753,2,7,interleukin-1 binding,MF,TRIM16;IL1R2
12914,GO:0051260,0.0925319578417447,0.94092184091541,22,214,protein homooligomerization,BP,CRYAB;C1QTNF1;SOD2;GBP1;IKBKE;B4GALT1;TP53;EHD1;TK1;KCNA7;KCTD10;TRAF2;DPYSL3;CPT1A;DCXR;CHMP4B;NACC1;KCTD1;AKR1C1;CLDN7;HSD17B10;TP63
5786,GO:0017015,0.0928065652226165,0.953970595924056,10,81,regulation of transforming growth factor beta receptor signaling pathway,BP,FBN1;CDKN2B;ADAM17;NPNT;BAMBI;SMAD7;CITED2;CD109;ZNF703;HSP90AB1
19705,GO:2000045,0.0928844398948776,0.946653175200306,15,136,regulation of G1/S transition of mitotic cell cycle,BP,CYP1A1;PML;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;CDK4;SFN;PSME2;ADAM17;TFDP1;GPNMB;CTDSP1;TP63
6795,GO:0030235,0.0931256149425612,0.988002281528685,2,7,nitric-oxide synthase regulator activity,MF,ESR1;HSP90AB1
15292,GO:0071476,0.0933440692102914,0.987957611865806,2,7,cellular hypotonic response,BP,CAB39;OXSR1
2883,GO:0006384,0.0935346985741227,0.987918578734157,2,7,transcription initiation from RNA polymerase III promoter,BP,CRCP;POLR3H
3303,GO:0007000,0.0938360660760268,0.987856770000517,2,7,nucleolus organization,BP,USP36;PES1
14032,GO:0060761,0.0939419399668623,0.963696614957655,6,42,negative regulation of response to cytokine stimulus,BP,IL1R2;NLRC5;ROBO1;PARP14;NOL3;CCL5
10906,GO:0044451,0.093999618541,0.92467216573171,86,977,nucleoplasm part,CC,TRIM16;HDAC9;S100P;IL16;PML;IKBKE;DAPK3;ELMSAN1;TP53;SQSTM1;TAF4B;CDKN1A;GADD45A;RING1;TELO2;SRSF2;SART1;GEMIN5;FANCC;DAXX;LSG1;USP36;AKAP8L;TRIM22;SAFB2;DDX42;PSPC1;TFIP11;ELF4;MED22;SF1;PARD3B;EDF1;GEMIN4;SGK1;CD2BP2;PRPF19;NELFE;DKC1;U2AF2;CBX5;IL15;DDX17;SENP3;GINS2;BRMS1;ALYREF;PHAX;GEMIN8;SNRNP70;PRCC;RBBP5;SFPQ;DDX39A;CRCP;TATDN2;SUPT5H;MTA2;HNRNPU;PQBP1;PAGR1;RUVBL2;THOC1;DNTTIP1;ARL6IP4;BRPF1;GTF2E1;RBM4;NACC1;TAP2;ACTN4;TKT;EFTUD2;INCENP;PHF5A;UBAP2L;KIF22;POLR3H;RBM14;SUPT16H;ZC3H18;POLR2G;TBXA2R;MKI67;TOP3A;MAGOH
13704,GO:0060260,0.0942899306957005,0.972565872164225,4,23,regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;SRF;ESR1;PSMC3
15839,GO:0072542,0.0943028282848863,0.987760795888364,2,7,protein phosphatase activator activity,MF,IGFBP3;PHACTR4
17345,GO:1900027,0.0943399425189077,0.972546235915049,4,23,regulation of ruffle assembly,BP,CORO1C;ICAM1;RCC2;RHOG
4924,GO:0014874,0.0945371659950856,0.987712500479511,2,7,response to stimulus involved in regulation of muscle adaptation,BP,DAG1;NOL3
11080,GO:0045080,0.0946266710426954,0.987694034411694,2,7,positive regulation of chemokine biosynthetic process,BP,TNF;EGR1
19030,GO:1904874,0.0948465674022778,0.978780818786216,3,15,positive regulation of telomerase RNA localization to Cajal body,BP,DKC1;SHQ1;RUVBL2
4932,GO:0014889,0.0948857667617163,0.987640518246722,2,7,muscle atrophy,BP,IL15;NOL3
8137,GO:0032836,0.0951124463269283,0.987593622918323,2,7,glomerular basement membrane development,BP,COL4A4;MYO1E
3223,GO:0006873,0.0951712256463891,0.933465092453747,33,343,cellular ion homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;LYN;CLN6;JPH1;CHP1;ITGAV;GPER1;GPCPD1;ACO1;ABCG2;OXTR;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;SWAP70;TBXA2R;CCL5
20028,GO:2000649,0.095211658117229,0.967148772540242,5,32,regulation of sodium ion transmembrane transporter activity,BP,CHP1;FXYD3;NEDD4L;YWHAH;ACTN4
7211,GO:0031103,0.0953875778793568,0.967069842135543,5,32,axon regeneration,BP,NEFL;TNC;DHFR;JUN;DAG1
1667,GO:0004128,0.0954779159293934,0.987517868063117,2,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,NQO1;CYB5R1
542,GO:0001660,0.0954782540620454,0.987517797890869,2,7,fever generation,BP,TNF;IL1A
19739,GO:2000112,0.095741158535258,0.916630904641517,263,3205,regulation of cellular macromolecule biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;TOX4;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EIF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;PARP1;TP63;ZBTB12;CCL5;FADS1;MAGOH
10551,GO:0043502,0.0959132455517457,0.959426374662094,7,51,regulation of muscle adaptation,BP,EDN1;G6PD;ERRFI1;PRKCA;DAG1;NOL3;PARP1
20013,GO:2000628,0.0960211599034111,0.987404929600077,2,7,regulation of miRNA metabolic process,BP,NFKB1;ZC3H12A
3300,GO:0006997,0.0961268110687792,0.945722567354361,14,124,nucleus organization,BP,PML;NUP153;USP36;AKAP8L;BANF1;GPER1;SF1;ETS1;PRKCA;NSFL1C;DCTN1;NUP214;PES1;CHMP4B
17828,GO:1901987,0.0964396516987776,0.931399962107772,36,380,regulation of cell cycle phase transition,BP,CYP1A1;PML;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;PBX1;PSMB9;UBE2C;CDK4;SFN;PSME2;ZFP36L1;ADAM17;FGFR1OP;GPR132;ZFP36L2;DCTN1;ORAOV1;ZW10;RCC2;CLASP1;PAGR1;CEP41;PPP1R9B;ANAPC15;DUSP1;TFDP1;GPNMB;TPRA1;TUBB;CTDSP1;PSMC3;CDCA5;TP63
10408,GO:0043243,0.0965131606119985,0.971689126916159,4,23,positive regulation of protein complex disassembly,BP,TNF;ADRB2;WDR1;EIF5A
11252,GO:0045472,0.0966957942892675,0.98726411974106,2,7,response to ether,BP,ZC3H12A;CDK4
20255,GO:2001212,0.0968716440330576,0.987227315283533,2,7,regulation of vasculogenesis,BP,ADM;EMP2
2446,GO:0005655,0.097104350514981,0.986729970347851,2,8,nucleolar ribonuclease P complex,CC,POP1;POP4
15289,GO:0071472,0.0971738403874153,0.987163969601838,2,7,cellular response to salt stress,BP,ZFP36L1;XRCC6
15290,GO:0071474,0.0971738403874536,0.987163969601838,2,7,cellular hyperosmotic response,BP,ERRFI1;XRCC6
8900,GO:0034719,0.0972040023467594,0.977829296866401,3,16,SMN-Sm protein complex,CC,GEMIN5;GEMIN4;GEMIN8
7295,GO:0031293,0.0972868668987818,0.971382179245009,4,23,membrane protein intracellular domain proteolysis,BP,NFKB1;ADAM17;SPPL2A;APH1A
11105,GO:0045121,0.0973052168658924,0.938225468377173,21,200,membrane raft,CC,SDC4;BIRC3;DAPK3;EMP2;IRS1;LYN;STOML1;TNF;CORO1C;PDPN;ICAM1;PGK1;ADAM17;TRAF2;SERPINH1;SMPD2;EFNB1;MYADM;DAG1;TUBB;PPP2R1B
7409,GO:0031491,0.0973661076589561,0.955639804927041,8,66,nucleosome binding,MF,UHRF1;MTA2;DNTTIP1;RCC1;NOC2L;HMGN2;SMARCC2;SUPT16H
13083,GO:0051591,0.0975063684730463,0.955731069714332,8,61,response to cAMP,BP,AHR;JUNB;FOSL1;THBD;ZFP36L1;DUSP1;JUN;RAPGEF1
11103,GO:0045117,0.0976115400719314,0.977890577081704,3,15,azole transport,BP,CSF2;EDN1;LYN
19911,GO:2000406,0.0976336283415825,0.977883417448384,3,15,positive regulation of T cell migration,BP,CCL20;ADAM17;CCL5
14959,GO:0070851,0.0976642633424531,0.95105902410057,10,82,growth factor receptor binding,MF,CSF2;LYN;EPGN;ADAM17;TXLNA;PDGFB;IL1A;TRIP6;IL6R;IL36G
1130,GO:0002719,0.0978305841760697,0.97781954330319,3,15,negative regulation of cytokine production involved in immune response,BP,TGFB2;TNF;SMAD7
11106,GO:0045123,0.0978419924380213,0.971161368224533,4,23,cellular extravasation,BP,PTGER4;TNF;ICAM1;IL1A
8829,GO:0034605,0.0980069664555767,0.945841785673404,13,113,cellular response to heat,BP,CRYAB;BAG1;TP53;CDKN1A;LYN;NUP153;DNAJB1;DAXX;IL1A;NUP214;STAC;HSPA8;HSP90AB1
11193,GO:0045296,0.0981570660008192,0.932879821909222,29,298,cadherin binding,MF,S100P;PDLIM1;GPRC5A;COBLL1;TJP2;MYO1B;EHD1;BAIAP2;DNAJB1;FLNA;EPHA2;EIF5;SFN;TRIM29;VCL;RPS2;SPTBN1;MYH9;NOP56;TJP1;HSPA8;CHMP4B;ARGLU1;PHLDB2;EEF1D;SLC3A2;LRRC59;HSP90AB1;SWAP70
17008,GO:0099106,0.0981614085958629,0.958196813824843,7,52,ion channel regulator activity,MF,ANKRD36C;FLNA;CHP1;ADRB2;SGK1;NEDD4L;KCNIP3
2214,GO:0005109,0.098211047005221,0.971014302957804,4,23,frizzled binding,MF,WNT10A;SFRP1;BAMBI;WNT4
3049,GO:0006606,0.0984656091844732,0.945530295792322,13,114,protein import into nucleus,BP,PML;CDKN1A;TNF;NUP153;ZC3H12A;CHP1;NFKBIA;PTTG1IP;NUP214;TNPO3;IPO4;DAG1;HSP90AB1
2217,GO:0005114,0.0986051654483962,0.98686226626685,2,7,type II transforming growth factor beta receptor binding,MF,TGFB2;BAMBI
7648,GO:0032059,0.0986668464564156,0.986849202791379,2,7,bleb,CC,PANX1;TPM1
2441,GO:0005641,0.0989380021216795,0.986791713835041,2,7,nuclear envelope lumen,CC,PTGES;TUBB
2195,GO:0005068,0.0990440521772402,0.98676920279993,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,IRS1;BLNK
689,GO:0001909,0.0990732474225308,0.957669638260117,7,53,leukocyte mediated cytotoxicity,BP,EMP2;LAMP1;ICAM1;IL7R;DNASE1;RAB27A;TUBB
5925,GO:0018200,0.0990803986215727,0.977412822428592,3,15,peptidyl-glutamic acid modification,BP,GGCX;CEP41;TTLL5
412,GO:0001098,0.0990934410620344,0.961158094199123,6,42,basal transcription machinery binding,MF,TP53;AHR;HNRNPU;RUVBL2;ESR1;GTF2E1
413,GO:0001099,0.0990934410620344,0.961158094199123,6,42,basal RNA polymerase II transcription machinery binding,MF,TP53;AHR;HNRNPU;RUVBL2;ESR1;GTF2E1
13505,GO:0055074,0.0991441718059502,0.936888706077605,21,203,calcium ion homeostasis,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
8314,GO:0033146,0.099171942934386,0.965360273753967,5,32,regulation of intracellular estrogen receptor signaling pathway,BP,RUNX1;PAGR1;ESR1;PARP1;TP63
16579,GO:0097371,0.0993022407337864,0.986714334474703,2,7,MDM2/MDM4 family protein binding,MF,TP53;TP63
2809,GO:0006268,0.0993132847255943,0.986711985491006,2,7,DNA unwinding involved in DNA replication,BP,MCM2;MCM7
7929,GO:0032506,0.0994047006742179,0.970537184472774,4,23,cytokinetic process,BP,KIF23;MYH9;CNTROB;BIN3
16299,GO:0090400,0.099405175484559,0.986692434588638,2,7,stress-induced premature senescence,BP,TP53;CDKN1A
8661,GO:0034214,0.0995106473712919,0.986669980163989,2,7,protein hexamerization,BP,MAT2A;PANX1
10494,GO:0043394,0.0995433243534269,0.970481630924573,4,23,proteoglycan binding,MF,FST;TNC;COL5A3;GPNMB
4743,GO:0010911,0.0995789573553579,0.986655429353932,2,7,regulation of isomerase activity,BP,UHRF1;HNRNPU
4744,GO:0010912,0.0995789573553579,0.986655429353932,2,7,positive regulation of isomerase activity,BP,UHRF1;HNRNPU
1435,GO:0003413,0.0996209386602193,0.986646483748683,2,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,COL27A1;SERPINH1
987,GO:0002444,0.0996371935432799,0.928902545441467,36,383,myeloid leukocyte mediated immunity,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;WDR1;ADAM17;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CXCL5;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
12168,GO:0048286,0.0996473203162948,0.970439934841585,4,23,lung alveolus development,BP,TNS3;FGFR2;ERRFI1;LIF
1159,GO:0002768,0.0996481511304897,0.9338668490162,25,251,immune response-regulating cell surface receptor signaling pathway,BP,RUNX1;ACTG1;CYLD;RELB;GBP1;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;PSME2;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;JUN;RAPGEF1;CD38;PSMC3;SPG21;HSP90AB1
20252,GO:2001204,0.0997163258502005,0.986626149338323,2,7,regulation of osteoclast development,BP,FBN1;TJP2
19813,GO:2000271,0.099834996331197,0.98660083441905,2,7,positive regulation of fibroblast apoptotic process,BP,SFRP1;TP63
11430,GO:0045843,0.0998563677035834,0.965048733469015,5,32,negative regulation of striated muscle tissue development,BP,G6PD;TSC22D3;BMP2;LUC7L;MAPK11
17791,GO:1901862,0.0998563677035834,0.965048733469015,5,32,negative regulation of muscle tissue development,BP,G6PD;TSC22D3;BMP2;LUC7L;MAPK11
7606,GO:0031987,0.0998789543037499,0.986591452462731,2,7,locomotion involved in locomotory behavior,BP,CLN6;ARRDC3
8710,GO:0034350,0.0998856047261795,0.986590032836513,2,7,regulation of glial cell apoptotic process,BP,TRAF2;PRKCA
8711,GO:0034351,0.0998856047261795,0.986590032836513,2,7,negative regulation of glial cell apoptotic process,BP,TRAF2;PRKCA
13792,GO:0060379,0.0998884046971091,0.986589435125597,2,7,cardiac muscle cell myoblast differentiation,BP,NRG1;SRF
2553,GO:0005828,0.0999839243789317,0.986569038206382,2,7,kinetochore microtubule,CC,ZW10;CLASP1
6833,GO:0030295,0.10001469528865,0.95721465341474,7,52,protein kinase activator activity,MF,NRG1;CDKN1A;DAXX;RPLP1;AFAP1L2;CAB39;CCL5
2589,GO:0005883,0.100021215494511,0.986561071880503,2,7,neurofilament,CC,NEFL;NEFM
1428,GO:0003401,0.100047656341838,0.970279267493044,4,23,axis elongation,BP,TNC;FGFR2;SFRP1;ESR1
5896,GO:0018095,0.100049073798395,0.986555119425714,2,7,protein polyglutamylation,BP,CEP41;TTLL5
9686,GO:0038063,0.100054535204763,0.986553952370764,2,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL4A1;SYK
14015,GO:0060736,0.100054535204763,0.986553952370764,2,7,prostate gland growth,BP,FGFR2;ESR1
8953,GO:0035004,0.100071659631033,0.960733957790188,6,41,phosphatidylinositol 3-kinase activity,MF,NRG1;IRS1;FGFR2;IRS2;PDGFB;ESR1
9525,GO:0036230,0.100097613664632,0.929271787949104,34,360,granulocyte activation,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;CXCL8;PTPRB;HSP90AB1;LAIR1;CCL5
18687,GO:1904036,0.100505714521924,0.970095129414899,4,23,negative regulation of epithelial cell apoptotic process,BP,ICAM1;SERPINE1;TNIP2;TNFAIP3
17010,GO:0099116,0.100517711169413,0.976740075769766,3,16,tRNA 5'-end processing,BP,POP1;HSD17B10;POP4
8776,GO:0034453,0.100696238166172,0.970018443738404,4,23,microtubule anchoring,BP,FGFR1OP;DCTN1;CLASP1;DAG1
11349,GO:0045672,0.100896938654787,0.976817387730231,3,15,positive regulation of osteoclast differentiation,BP,TNF;IL20;KLF10
10426,GO:0043269,0.10090959919599,0.93080692674528,29,296,regulation of ion transport,BP,MMP9;JPH2;IL16;PML;EDN1;G6PD;LYN;JPH1;FLNA;CHP1;ICAM1;ADRB2;FXYD3;WDR1;GPER1;KCNA7;IRS2;LGALS3;SYK;PDGFB;NEDD4L;YWHAH;RRAD;KCNIP3;CAB39;STAC;OXSR1;ACTN4;CCL5
14649,GO:0070233,0.100964090124197,0.976795279499263,3,15,negative regulation of T cell apoptotic process,BP,TSC22D3;EFNA1;CCL5
9605,GO:0036464,0.101048066338452,0.939000116410768,17,160,cytoplasmic ribonucleoprotein granule,CC,SQSTM1;NOCT;ZC3H12A;PABPC4;NSUN2;LARP4B;ZFP36L1;AJUBA;HNRNPU;PQBP1;SOCS1;RBM4;EDC4;BLNK;TUBB;PSMC3;POLR2G
16904,GO:0098857,0.10118535032519,0.935439957187975,21,201,membrane microdomain,CC,SDC4;BIRC3;DAPK3;EMP2;IRS1;LYN;STOML1;TNF;CORO1C;PDPN;ICAM1;PGK1;ADAM17;TRAF2;SERPINH1;SMPD2;EFNB1;MYADM;DAG1;TUBB;PPP2R1B
13765,GO:0060341,0.101555451479441,0.922295456039848,56,615,regulation of cellular localization,BP,CRYAB;NRG1;JPH2;PML;CYLD;GBP1;TP53;SQSTM1;CDKN1A;LYN;LAMP1;EHD1;TNF;GNL3L;WWC1;PTPN14;NUP153;JPH1;ZC3H12A;LCP1;CYB5R1;EPHA2;CHP1;GOSR1;SFN;USP36;AKAP8L;LIF;PARL;GPER1;TRIM29;ZFP36L1;DKC1;SNX12;REEP1;SYK;POLR1A;SPTBN1;NEDD4L;WDR46;NUP214;YWHAH;HNRNPU;UBE2J2;STAC;TFDP1;RBM4;INSIG1;PARD3;RHOG;SNIP1;CARD10;CDCA5;HSP90AB1;PARP1;TP63
14,GO:0000027,0.101948468783465,0.969159115551885,4,26,ribosomal large subunit assembly,BP,PPAN;RRS1;MRPL20;NOP2
4860,GO:0014074,0.102102483535253,0.946439785263071,11,93,response to purine-containing compound,BP,PANX1;TP53;AHR;JUNB;FOSL1;HMGCS1;THBD;ZFP36L1;DUSP1;JUN;RAPGEF1
8057,GO:0032722,0.102203565914342,0.9638885426461,5,33,positive regulation of chemokine production,BP,TNF;EGR1;ADAM17;IL1A;IL6R
8677,GO:0034248,0.102318642926485,0.925784059753735,39,424,regulation of cellular amide metabolic process,BP,CYR61;HSPB1;DAPK3;TNF;ENC1;NUP153;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;ZC3H7B;DPH2;CTIF;LARP4B;SRRT;ZFP36L1;DHFR;ACO1;ZFP36L2;PUM3;AJUBA;RPS9;SNRNP70;NUP214;DNAJC1;ESR1;TCOF1;EIF3B;RBM4;SMPD2;SNIP1;METTL16;EIF5A;EFNA1;POLR2G;CCL5;MAGOH
1445,GO:0003674,0.102761118156804,0.921496622215438,871,11298,molecular_function,MF,HEPHL1;IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;PLD5;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;CCDC80;ADM;SLC16A2;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;IGFL1;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;WNT10A;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;FBN1;FAM46B;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;TMPPE;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;NEDD9;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;IGFL3;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;GPATCH4;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;ANKRD36C;TNC;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;LAYN;QPCT;SLC16A9;PGD;SIRPA;UBE2C;MSANTD3;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;CD274;BMP2;COL16A1;UBE4B;GOSR1;SLCO3A1;SLC7A5P2;COL27A1;DDX23;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;METTL13;ADRB2;SVIL;IL20;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IFNGR1;ANXA8L1;GANC;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;ABHD16B;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;IER3;NPAS2;KRT14;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;PROSER2;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;SLC43A3;DDX49;DNTTIP2;PDGFB;AASS;CEP95;BRMS1;BCAM;PREP;IFFO2;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;COL5A3;DCBLD1;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;TMEM159;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;SPEN;ZW10;ROR1;PXMP2;C8ORF33;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TMEM140;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;A2ML1;ZNF267;TRUB2;PARP14;PRDM7;MRPL20;CXCL5;RHBDL2;RBM38;ANKRD52;SUSD6;PCYT1A;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;IKZF3;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;TPRA1;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;CYP20A1;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;SLC41A2;MYADM;DAG1;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SEC14L4;SMARCC2;SPG21;CCL22;CYB561D2;SLC4A2;FAM207A;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;PPP2R1B;EFNA1;MAPK11;RSRP1;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;CXCL3;XPNPEP3;ATAD3C;BMP8A;HES4;ZC3H18;TRIML2;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;TTLL5;HERC6;ADGRF3;IL6R;BIN3;LAIR1;IRGQ;POP4;RPUSD4;PARP1;SLC2A6;CLK4;TP63;ZBTB12;OTUD6A;IL36G;C1S;PHACTR4;TOP3A;CCL5;TMEM51;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
17769,GO:1901796,0.102822798458666,0.937765314536962,17,161,regulation of signal transduction by p53 class mediator,BP,PML;NUAK1;TP53;TAF4B;SNAI2;RRS1;PTTG1IP;MTA2;PAK1IP1;BRPF1;NOP2;NOC2L;BRIP1;SUPT16H;MAPK11;TP63;TOP3A
5208,GO:0015807,0.102984093361686,0.959214564606763,6,42,L-amino acid transport,BP,SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
1117,GO:0002706,0.103232190234146,0.94990086040146,9,73,regulation of lymphocyte mediated immunity,BP,TFRC;RSAD2;IL27RA;LAMP1;TNF;IL7R;TRAF2;SMAD7;THOC1
2862,GO:0006353,0.103278884282452,0.943905942439942,12,107,DNA-templated transcription, termination,BP,CD3EAP;SRSF2;U2AF2;POLR1A;UBTF;ALYREF;DDX39A;MAZ;THOC1;POLR1E;SRSF7;MAGOH
19800,GO:2000243,0.103833236754066,0.963136477129295,5,33,positive regulation of reproductive process,BP,INHBA;LFNG;OXTR;CITED2;WNT4
9564,GO:0036344,0.104222690515937,0.975714194973782,3,15,platelet morphogenesis,BP,WDR1;SRF;MYH9
12644,GO:0050848,0.104352105605355,0.958463796687722,6,43,regulation of calcium-mediated signaling,BP,NRG1;JPH2;GBP1;JPH1;CHP1;SYK
13914,GO:0060571,0.10437813516208,0.97566222139597,3,15,morphogenesis of an epithelial fold,BP,FGFR2;BMP7;TP63
7273,GO:0031253,0.104404853700381,0.933115269262404,21,202,cell projection membrane,CC,NRG1;S100P;B4GALT1;EHD1;WWC1;PDPN;LCP1;EPHA2;ITGAV;MYO10;SLC5A6;TPM1;GPER1;ADAM17;SPTBN1;SPRY4;PPP1R9B;THEM4;PHLPP1;PDE6A;HSP90AB1
12395,GO:0048820,0.104445212488453,0.975639782525746,3,15,hair follicle maturation,BP,TGFB2;NSUN2;NOM1
1342,GO:0003205,0.104652202080474,0.94310423545221,12,103,cardiac chamber development,BP,NRG1;CYR61;TGFB2;FGFR2;UBE4B;TPM1;SRF;FHL2;SEMA3C;SMAD7;CITED2;BMP7
13767,GO:0060343,0.104712513573181,0.975550296802523,3,15,trabecula formation,BP,SFRP1;SRF;FHL2
10152,GO:0042730,0.104778981809119,0.97552802814792,3,15,fibrinolysis,BP,KRT1;SERPINE1;THBD
7480,GO:0031644,0.104976665506127,0.962606423770533,5,33,regulation of neurological system process,BP,NRG1;EDN1;TNFRSF21;PARD3;DAG1
18589,GO:1903844,0.105112846501787,0.94654371797589,10,83,regulation of cellular response to transforming growth factor beta stimulus,BP,FBN1;CDKN2B;ADAM17;NPNT;BAMBI;SMAD7;CITED2;CD109;ZNF703;HSP90AB1
19608,GO:1990748,0.105181600210262,0.951216708939709,8,67,cellular detoxification,BP,NQO1;SOD2;TXNRD1;TNF;FANCC;DHFR;BMP7;GPX4
7527,GO:0031731,0.105391236610303,0.997069702327465,1,2,CCR6 chemokine receptor binding,MF,CCL20
6654,GO:0030003,0.105750574451961,0.925717326700869,32,335,cellular cation homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;LYN;CLN6;JPH1;CHP1;ITGAV;GPER1;ACO1;ABCG2;OXTR;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;SWAP70;TBXA2R;CCL5
13938,GO:0060602,0.105776455514626,0.975193047450021,3,15,branch elongation of an epithelium,BP,TNC;FGFR2;ESR1
17427,GO:1900181,0.10590315783344,0.975150389889014,3,15,negative regulation of protein localization to nucleus,BP,CHP1;TRIM29;POLR1A
7183,GO:0031065,0.105964012600816,0.975129893000912,3,15,positive regulation of histone deacetylation,BP,TP53;AKAP8L;AKAP8
1175,GO:0002822,0.105974912803242,0.948288663144459,9,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TFRC;RSAD2;IL27RA;TNF;IL7R;TRAF2;SMAD7;THOC1;TNFAIP3
13471,GO:0055006,0.106012788210802,0.957686249887701,6,42,cardiac cell development,BP,EDN1;G6PD;SRF;FHL2;HNRNPU;SORBS2
7908,GO:0032481,0.106180733710054,0.950789896760375,8,63,positive regulation of type I interferon production,BP,NFKB1;NFKB2;IRF1;SYK;CRCP;PQBP1;XRCC6;POLR3H
12550,GO:0050702,0.10626373755581,0.967617542493366,4,24,interleukin-1 beta secretion,BP,TRIM16;PML;PANX1;ZC3H12A
12883,GO:0051220,0.106268796791427,0.96761545441461,4,24,cytoplasmic sequestering of protein,BP,NFKBIE;FLNA;NFKBIA;KEAP1
7354,GO:0031396,0.106797087936315,0.934999807684786,17,162,regulation of protein ubiquitination,BP,BIRC3;GNL3L;UBE2C;CHP1;ADRB2;DAXX;DNAJB2;U2AF2;RPS2;PTTG1IP;SMAD7;DCUN1D2;HSPBP1;ARRDC3;TNFAIP3;GCLC;HSP90AB1
732,GO:0001961,0.106862166487602,0.96172811433062,5,33,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;NLRC5;ADAM17;TRAF2;PARP14
8527,GO:0033764,0.106959787204351,0.974574322310019,3,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,AKR1C2;AKR1C1;HSD17B10
7297,GO:0031295,0.107173789202855,0.961582445440181,5,33,T cell costimulation,BP,MAP3K14;LYN;EFNB2;CD274;EFNB1
9544,GO:0036296,0.107190576099009,0.967234365640002,4,24,response to increased oxygen levels,BP,CYP1A1;TP53;CDKN1A;CDK4
591,GO:0001755,0.107307008360725,0.96152012796762,5,33,neural crest cell migration,BP,CORO1C;SEMA3C;EFNB1;BMP7;PHACTR4
10469,GO:0043331,0.107309874580556,0.947500371000677,9,73,response to dsRNA,BP,NFKB1;ZC3H12A;ZC3H7B;NFKBIA;SRRT;PQBP1;ESR1;SNIP1;SLC3A2
6788,GO:0030224,0.107474668809487,0.967116655174222,4,24,monocyte differentiation,BP,CSF2;ZFP36L1;MYH9;JUN
18268,GO:1903131,0.107474668809487,0.967116655174222,4,24,mononuclear cell differentiation,BP,CSF2;ZFP36L1;MYH9;JUN
8101,GO:0032786,0.107679748650769,0.967031607122874,4,24,positive regulation of DNA-templated transcription, elongation,BP,ALYREF;SUPT5H;THOC1;SUPT16H
3189,GO:0006812,0.107823543196551,0.917947493167724,52,574,cation transport,BP,HEPHL1;FTL;FTH1;MMP9;CTGF;JPH2;IL16;NFKBIE;PML;TFRC;CSF2;EDN1;G6PD;PANX1;STEAP4;LYN;JPH1;SLC39A1;FLNA;CHP1;ICAM1;ITGAV;ADRB2;SLC5A6;FXYD3;PARL;GPER1;KCNA7;SGK1;LGALS3;SYK;SLC7A2;PDGFB;NEDD4L;COX5B;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;SLC22A4;COMMD9;ACTN4;SLC41A2;TMEM165;SLC3A2;SLC25A22;NOL3;SLC2A6;CCL5
15231,GO:0071385,0.108060140363587,0.9565810530954,6,43,cellular response to glucocorticoid stimulus,BP,EDN1;ICAM1;ERRFI1;ZFP36L1;ZFP36L2;HNRNPU
5451,GO:0016323,0.108101309999478,0.937798049920784,14,125,basolateral plasma membrane,CC,TFRC;B4GALT1;DST;PDPN;EPPK1;PDGFB;TJP1;SLC4A11;MARVELD2;DAG1;SLC4A2;CLDN7;HSP90AB1;IL6R
9505,GO:0036152,0.108227873586821,0.974363441176473,3,15,phosphatidylethanolamine acyl-chain remodeling,BP,PLBD1;ABHD4;LPCAT3
15433,GO:0071704,0.108255747848255,0.904672262829314,619,7898,organic substance metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;WNT10A;FADS3;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;P4HA2;PANK2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;HS3ST2;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TNK1;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;ADRB2;IL20;DAXX;FOXD2;NAT10;GANC;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;DHCR7;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;COX5B;RNF115;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;PRUNE2;ACSL1;NOP56;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;SLC22A4;PES1;USP31;FOXN1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;ZNF365;ACBD6;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TEAD4;SMPD2;KBTBD12;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;TPRA1;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;DPM3;WNT4;MRPS2;RBM14;AKR1C1;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;HSD17B10;SLC3A2;XPNPEP3;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;C1S;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
10782,GO:0044238,0.108412433613423,0.904379092601564,603,7685,primary metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;FADS3;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;P4HA2;PANK2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TNK1;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;ADRB2;IL20;DAXX;FOXD2;NAT10;GANC;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;DHCR7;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;ZNF787;RRP36;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;COX5B;RNF115;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;ACSL1;NOP56;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;SLC22A4;PES1;USP31;FOXN1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TEAD4;SMPD2;KBTBD12;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;TPRA1;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;DHX34;TIMELESS;GPX4;DPM3;WNT4;MRPS2;RBM14;AKR1C1;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;HSD17B10;SLC3A2;XPNPEP3;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;C1S;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2
16498,GO:0097193,0.109036872295259,0.927510163938319,24,244,intrinsic apoptotic signaling pathway,BP,MMP9;CYP1B1;PML;CYLD;HSPB1;SOD2;IKBKE;TP53;CDKN1A;TNF;EPHA2;SFN;AEN;SNAI2;TRAF2;PTTG1IP;SFPQ;ACKR3;CREB3;NOC2L;BCL2L2;NOL3;PARP1;TP63
12273,GO:0048568,0.109044160540245,0.925697781110444,27,272,embryonic organ development,BP,MAFB;CYR61;ADM;CSF2;FBN1;TGFB2;EDN1;JUNB;TNF;FGFR2;PBX1;SLC39A1;LIF;OSR2;CC2D2A;SRF;ZFP36L1;NTN1;PDGFB;CITED2;INSIG1;TEAD4;BMP7;VPS52;CXCL8;EFNA1;PHACTR4
15141,GO:0071236,0.10915081166885,0.940159860900151,12,106,cellular response to antibiotic,BP,CYP1B1;NQO1;TP53;AHR;ZC3H12A;DAXX;EGR1;ETS1;RHOB;PDGFB;TIMELESS;TNFAIP3
866,GO:0002204,0.109463556639803,0.960507697182617,5,33,somatic recombination of immunoglobulin genes involved in immune response,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
867,GO:0002208,0.109463556639803,0.960507697182617,5,33,somatic diversification of immunoglobulins involved in immune response,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
11144,GO:0045190,0.109463556639803,0.960507697182617,5,33,isotype switching,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
6854,GO:0030323,0.109723778542197,0.938182269565017,13,115,respiratory tube development,BP,CTGF;TNS3;TNF;TNC;PDPN;FGFR2;ERRFI1;LIF;DHCR7;SRF;DAG1;TIMELESS;TRAF4
20134,GO:2000826,0.109737456726476,0.966174762172189,4,24,regulation of heart morphogenesis,BP,TGFB2;BMP2;SEMA3C;BMP7
4282,GO:0009649,0.109833576475963,0.96613458209246,4,24,entrainment of circadian clock,BP,PML;TP53;RBM4;PHLPP1
9067,GO:0035303,0.10998317460192,0.932811600427549,17,159,regulation of dephosphorylation,BP,IGFBP3;TGFB2;SH3RF2;NUAK1;TNF;PKMYT1;CHP1;BMP2;PPP1R3B;CD2BP2;NSFL1C;NPNT;PPP1R14C;PPP1R9B;HSP90AB1;SWAP70;PHACTR4
6863,GO:0030332,0.109993786882122,0.966067580092522,4,24,cyclin binding,MF,CDKN1A;CDK4;RBM4;XRCC6
16576,GO:0097366,0.110032348721384,0.966051447324553,4,24,response to bronchodilator,BP,HDAC9;ICAM1;TRAF2;OXTR
5015,GO:0015175,0.110060893104747,0.966039504039108,4,24,neutral amino acid transmembrane transporter activity,MF,SLC7A5;SLC7A5P2;SLC43A2;SLC3A2
3352,GO:0007080,0.110131642997394,0.955520670600563,6,43,mitotic metaphase plate congression,BP,RRS1;ZW10;HNRNPU;CHMP4B;KIF22;CDCA5
17894,GO:1902176,0.11032392251379,0.973418404349927,3,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1;SOD2;NOL3
12351,GO:0048713,0.110403314907208,0.965896136198731,4,24,regulation of oligodendrocyte differentiation,BP,WDR1;TNFRSF21;ZNF365;DAG1
12298,GO:0048635,0.110659067310967,0.959943505768626,5,33,negative regulation of muscle organ development,BP,G6PD;TSC22D3;BMP2;LUC7L;MAPK11
6658,GO:0030010,0.110719427961363,0.93918702822367,12,104,establishment of cell polarity,BP,MAP2;AMOT;SIPA1L3;WWC1;AMOTL2;PARD3B;DCTN1;MYH9;ZW10;CLASP1;PARD3;CYTH1
3949,GO:0008649,0.110983792067907,0.973189689269784,3,16,rRNA methyltransferase activity,MF,FTSJ3;NOP2;METTL16
17307,GO:0140102,0.110983792067907,0.973189689269784,3,16,catalytic activity, acting on a rRNA,MF,FTSJ3;NOP2;METTL16
13488,GO:0055025,0.111100445666272,0.965603716063212,4,24,positive regulation of cardiac muscle tissue development,BP,NRG1;EDN1;EFNB2;FGFR2
7738,GO:0032233,0.111186245280185,0.954978490461943,6,43,positive regulation of actin filament bundle assembly,BP,CTGF;SDC4;SFRP1;TPM1;WNT4;SWAP70
18168,GO:1902930,0.111426742896465,0.95100874856928,7,53,regulation of alcohol biosynthetic process,BP,NFKB1;TNF;SCD;LSS;HMGCS1;DHCR7;GPER1
115,GO:0000243,0.111696890342815,0.983421252987719,2,8,commitment complex,CC,U2AF2;SNRNP70
9610,GO:0036473,0.112157380122495,0.947335698372767,8,64,cell death in response to oxidative stress,BP,CYP1B1;PML;HSPB1;SOD2;TP53;SFPQ;NOL3;PARP1
16996,GO:0099078,0.112276438942335,0.983283884069199,2,8,BORC complex,CC,BORCS7;BLOC1S2
8967,GO:0035035,0.112347316008464,0.965078899948729,4,24,histone acetyltransferase binding,MF,TP53;EGR1;ETS1;CITED2
19002,GO:1904813,0.112614560918199,0.937862650812246,12,109,ficolin-1-rich granule lumen,CC,KRT1;FTH1;MMP9;PLEKHO2;QPCT;VCL;CAB39;HSPA8;COMMD9;XRCC6;PSMC3;HSP90AB1
4639,GO:0010761,0.112970278552597,0.958846893578054,5,33,fibroblast migration,BP,PML;SDC4;CORO1C;RCC2;MTA2
1264,GO:0003018,0.113168632783115,0.941579003610182,10,84,vascular process in circulatory system,BP,ADM;SOD2;EDN1;ICAM1;ADRB2;GPER1;OXTR;CD38;GCLC;TBXA2R
4338,GO:0009890,0.113227092177384,0.906575010058305,104,1219,negative regulation of biosynthetic process,BP,NRG1;INHBA;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;DAPK3;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;GNL3L;CDKN2A;RING1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;ITGAV;ERRFI1;DAXX;NAT10;ZC3H7B;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;SRRT;ZFP36L1;NELFE;DHFR;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;NUP214;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;DUSP1;CITED2;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;INSIG1;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;POLR2G;GCLC;PARP1;TP63
2720,GO:0006098,0.113263819682267,0.972394442606801,3,16,pentose-phosphate shunt,BP,G6PD;PGD;TKT
7907,GO:0032480,0.11335712366384,0.953792745467473,6,44,negative regulation of type I interferon production,BP,CYLD;RELB;IKBKE;TRAF3;NLRC5;TNFAIP3
7493,GO:0031664,0.113458067419098,0.972326335784449,3,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,PRKCA;TRIB1;TNFAIP3
4891,GO:0014812,0.113632379450621,0.949797232363675,7,53,muscle cell migration,BP,IGFBP3;SERPINE1;TPM1;PDGFB;TRIB1;BIN3;CCL5
994,GO:0002456,0.114064771495298,0.949509148123316,7,54,T cell mediated immunity,BP,RSAD2;EMP2;ICAM1;IL7R;TRAF2;SMAD7;RAB27A
6817,GO:0030275,0.114413506856436,0.971990531505627,3,16,LRR domain binding,MF,DAPK3;MKL1;ROBO1
1338,GO:0003197,0.114560825163476,0.964141557239258,4,24,endocardial cushion development,BP,TGFB2;BMP2;SNAI2;BMP7
5355,GO:0016126,0.1145879816919,0.945932447726419,8,64,sterol biosynthetic process,BP,G6PD;SCD;LSS;CYB5R1;HMGCS1;EBP;DHCR7;INSIG1
5176,GO:0015732,0.114694705704041,0.982705831471149,2,8,prostaglandin transport,BP,EDN1;SLCO3A1
366,GO:0000987,0.114699440636474,0.920282899406291,29,295,proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;MYBL2;ARID3B;TP53;AHR;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;SRF;ELF4;ZFP42;ETS1;UBTF;UHRF1;CREB3;KCNIP3;ETS2;KLF10;JUN;ESR1;KLF6;ELK1;SMARCC2
4640,GO:0010762,0.114756028320365,0.964058549601772,4,24,regulation of fibroblast migration,BP,SDC4;CORO1C;RCC2;MTA2
7494,GO:0031665,0.115084862419682,0.982611837442773,2,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TRIB1;TNFAIP3
11304,GO:0045621,0.115088647676395,0.948943438021971,7,54,positive regulation of lymphocyte differentiation,BP,CYLD;CD83;SART1;IL7R;IL15;SYK;SOCS1
4304,GO:0009755,0.11557473234181,0.928877653201274,17,160,hormone-mediated signaling pathway,BP,RUNX1;DAXX;SFRP1;SAFB2;GPER1;DDX17;FHL2;LANCL2;ACSL1;YWHAH;PAGR1;SAFB;ESR1;BMP7;RBM14;PARP1;TP63
18686,GO:1904035,0.115623352551311,0.952680234660739,6,43,regulation of epithelial cell apoptotic process,BP,ICAM1;SERPINE1;GPER1;ZFP36L1;TNIP2;TNFAIP3
11277,GO:0045582,0.115961306868165,0.952437663988458,6,44,positive regulation of T cell differentiation,BP,CYLD;CD83;SART1;IL7R;SYK;SOCS1
15513,GO:0071888,0.116183292693084,0.982346120173077,2,8,macrophage apoptotic process,BP,CDKN2A;CCL5
16759,GO:0098542,0.116186285243058,0.921465637231484,25,260,defense response to other organism,BP,CCL20;PML;MAP3K14;GBP1;TRIM56;BIRC3;RSAD2;TRAF3;NLRC5;IL27RA;TNF;ZC3H12A;SERPINE1;TRIM22;IRF1;ADAM17;IL15;SYK;DDX17;IFIT3;CRCP;PQBP1;POLR3H;TNFAIP3;IL6R
12712,GO:0050930,0.116260879780441,0.982327290563846,2,8,induction of positive chemotaxis,BP,IL16;CXCL8
7296,GO:0031294,0.116618013210478,0.957006272683101,5,34,lymphocyte costimulation,BP,MAP3K14;LYN;EFNB2;CD274;EFNB1
1156,GO:0002764,0.116624403588814,0.91679902884115,33,349,immune response-regulating signaling pathway,BP,RUNX1;ACTG1;CYLD;RELB;GBP1;IKBKE;BIRC3;RSAD2;TRAF3;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;ZC3H12A;MYO10;ARPC1B;IRF1;PSME2;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;TNIP2;JUN;ESR1;RAPGEF1;CD38;TNFAIP3;PSMC3;SPG21;HSP90AB1
18234,GO:1903038,0.116841110562779,0.944624786554718,8,64,negative regulation of leukocyte cell-cell adhesion,BP,CYLD;SDC4;CD274;IRF1;LGALS3;TNFRSF21;SMAD7;GPNMB
11836,GO:0046784,0.117052227034055,0.982134780850544,2,8,viral mRNA export from host cell nucleus,BP,ALYREF;THOC1
5746,GO:0016893,0.117096463297485,0.956686547372559,5,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,POP1;FEN1;DNASE1;TATDN2;POP4
7208,GO:0031099,0.117196011254553,0.933179945839829,13,118,regeneration,BP,NEFL;ADM;CDKN1A;TNC;TYMS;LCP1;CDK4;EPPK1;NFKBIA;DHFR;JUN;DAG1;BIN3
16649,GO:0097512,0.117277711079287,0.996347790150361,1,2,cardiac myofibril,CC,CRYAB
18704,GO:1904064,0.117538342635747,0.944179027243407,8,65,positive regulation of cation transmembrane transport,BP,JPH2;G6PD;FLNA;CHP1;ADRB2;GPER1;STAC;ACTN4
1071,GO:0002637,0.117648748720597,0.95650838733046,5,34,regulation of immunoglobulin production,BP,TFRC;IL27RA;TNF;TRAF2;THOC1
7579,GO:0031943,0.117800555068929,0.981951970231948,2,8,regulation of glucocorticoid metabolic process,BP,BMP2;WNT4
8852,GO:0034645,0.11791964698444,0.895736360881176,324,4040,cellular macromolecule biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;B4GALT1;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;GALNT18;CDKN1A;AHR;JUNB;MCM5;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;LYPD6B;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;MCM2;NMT2;TOX4;ST6GALNAC5;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;U2AF2;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;AJUBA;GINS2;USP43;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;GALNT2;DUSP1;TGFBRAP1;CITED2;CD109;RPL27A;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;GINS3;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;DAG1;TMEM165;POLR3H;MGAT2;EEF1D;TIMELESS;DPM3;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH
10051,GO:0042533,0.117960853048675,0.981912713952271,2,8,tumor necrosis factor biosynthetic process,BP,HSPB1;ERRFI1
10052,GO:0042534,0.117960853048675,0.981912713952271,2,8,regulation of tumor necrosis factor biosynthetic process,BP,HSPB1;ERRFI1
18322,GO:1903265,0.117987044690523,0.981906296489953,2,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,ADAM17;TRAF2
5352,GO:0016114,0.11817571786868,0.981860040978703,2,8,terpenoid biosynthetic process,BP,CYP1A1;HMGCS1
15524,GO:0071902,0.118199803435813,0.919334588066,26,264,positive regulation of protein serine/threonine kinase activity,BP,SAA1;NRG1;MAP3K14;EDN1;GADD45A;TNF;TELO2;GADD45B;BMP2;EPGN;ADRB2;DAXX;ADAM17;TRAF2;SYK;ROBO1;AJUBA;PDGFB;ACSL1;CAB39;TNFRSF10A;RAPGEF1;TRAF4;MAPK11;CARD10;HSP90AB1
2852,GO:0006337,0.118313574878597,0.97060590252037,3,16,nucleosome disassembly,BP,GRWD1;SMARCC2;SUPT16H
7815,GO:0032368,0.118403227345079,0.947052645192137,7,55,regulation of lipid transport,BP,C1QTNF1;EDN1;NFKB1;ITGAV;NFKBIA;IRS2;SYK
11464,GO:0045918,0.118542925204426,0.996265967626283,1,2,negative regulation of cytolysis,BP,CSF2
751,GO:0001990,0.118661276892927,0.970481381226038,3,16,regulation of systemic arterial blood pressure by hormone,BP,EDN1;C9ORF3;OXTR
7228,GO:0031123,0.11875981123415,0.932118096309924,13,119,RNA 3'-end processing,BP,USB1;SRSF2;ZFP36L1;NELFE;DKC1;U2AF2;ALYREF;DDX39A;SUPT5H;THOC1;HSD17B10;SRSF7;MAGOH
1285,GO:0003093,0.11882288929607,0.981701020199871,2,8,regulation of glomerular filtration,BP,EMP2;PDGFB
18080,GO:1902679,0.118906953809216,0.904044556521885,80,925,negative regulation of RNA biosynthetic process,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;CDKN2A;RING1;WWC1;FGFR2;NFKB2;DNAJB1;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;DAXX;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;SRF;TRIM29;SF1;EGR1;SNAI2;NELFE;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;NOC2L;NACC1;ZNF703;XRCC6;GLIS3;BMP7;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;GCLC;PARP1;TP63
18427,GO:1903507,0.118906953809216,0.904044556521885,80,925,negative regulation of nucleic acid-templated transcription,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;CDKN2A;RING1;WWC1;FGFR2;NFKB2;DNAJB1;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;DAXX;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;SRF;TRIM29;SF1;EGR1;SNAI2;NELFE;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;NOC2L;NACC1;ZNF703;XRCC6;GLIS3;BMP7;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;GCLC;PARP1;TP63
13583,GO:0060050,0.119208802904157,0.981605930493917,2,8,positive regulation of protein glycosylation,BP,CHP1;IL15
9392,GO:0035929,0.119311453039488,0.981580604115195,2,8,steroid hormone secretion,BP,INHBA;C1QTNF1
11073,GO:0045073,0.119317802636154,0.981579037051038,2,8,regulation of chemokine biosynthetic process,BP,TNF;EGR1
7944,GO:0032535,0.11940881190517,0.918408680438789,26,265,regulation of cellular component size,BP,NRG1;FN1;NEFL;EDN1;ARPC4;BAIAP2;ICAM1;CDK4;L1CAM;CDC42EP2;TNFRSF12A;ARPC1B;ZFYVE27;WDR1;IL7R;SRF;NTN1;SPTBN1;SEMA3C;RHOG;KANK4;MYADM;SNF8;HSP90AB1;SWAP70;BAIAP2L2
3284,GO:0006971,0.119418720693036,0.981554123564282,2,8,hypotonic response,BP,CAB39;OXSR1
15963,GO:0075713,0.119507670566248,0.981532153460842,2,8,establishment of integrated proviral latency,BP,BANF1;XRCC6
12839,GO:0051149,0.119527199420661,0.946474868026239,7,54,positive regulation of muscle cell differentiation,BP,NRG1;EDN1;EHD1;EFNB2;GPER1;RBM4;MAPK11
1121,GO:0002710,0.119593374286986,0.981510975227474,2,8,negative regulation of T cell mediated immunity,BP,IL7R;SMAD7
13769,GO:0060347,0.119636244947643,0.98150037781587,2,8,heart trabecula formation,BP,SRF;FHL2
8136,GO:0032835,0.119845379319447,0.955442311315164,5,34,glomerulus development,BP,EGR1;PDGFB;BMP7;COL4A4;MYO1E
13249,GO:0051924,0.119921533479105,0.931358333293675,13,118,regulation of calcium ion transport,BP,JPH2;IL16;PML;G6PD;LYN;JPH1;ICAM1;GPER1;LGALS3;PDGFB;RRAD;STAC;CCL5
10399,GO:0043230,0.119933892603083,0.897206704521743,165,2042,extracellular organelle,CC,IGFBP3;KRT1;SAA1;SPRR3;FTL;CRYAB;FTH1;MMP9;KRT2;S100P;FN1;C1R;KRT34;KRT15;ACTG1;NQO1;HSPB1;KRT10;SDC4;KRT13;TFRC;SOD2;GPRC5A;UGT1A6;FBN1;COBLL1;TXNRD1;PRSS23;B4GALT1;MGAM;G6PD;HRNR;SQSTM1;KRT9;STEAP4;LFNG;KRT6A;HSPG2;LYN;MYO1B;ARPC4;LAMP1;CSRP1;EHD1;COL12A1;BAIAP2;KRT5;DST;TPM4;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;CHP1;ICAM1;CD274;DDX23;ITGAV;PMM2;SFN;PLEKHA7;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;SFRP1;SAFB2;WDR1;PSME2;BANF1;EDF1;DOCK10;GEMIN4;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;PRKCA;CDKL1;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;COL5A3;MYH9;SPPL2A;NPNT;SDK1;SEMA3C;SPEN;YWHAH;CLASP1;CAPNS1;RUVBL2;A2ML1;GALNT2;CAB39;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;LRRC57;EIF3B;CHMP4B;QDPR;LAMC1;RHOG;BCL2L2;OLFML3;GP6;CS;ACTN4;EFNB1;TKT;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;PPP2R1B;EFNA1;MYO1E;SLC3A2;XPNPEP3;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;LAIR1;C1S;SH3BP4
18465,GO:1903561,0.119933892603083,0.897206704521743,165,2042,extracellular vesicle,CC,IGFBP3;KRT1;SAA1;SPRR3;FTL;CRYAB;FTH1;MMP9;KRT2;S100P;FN1;C1R;KRT34;KRT15;ACTG1;NQO1;HSPB1;KRT10;SDC4;KRT13;TFRC;SOD2;GPRC5A;UGT1A6;FBN1;COBLL1;TXNRD1;PRSS23;B4GALT1;MGAM;G6PD;HRNR;SQSTM1;KRT9;STEAP4;LFNG;KRT6A;HSPG2;LYN;MYO1B;ARPC4;LAMP1;CSRP1;EHD1;COL12A1;BAIAP2;KRT5;DST;TPM4;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;CHP1;ICAM1;CD274;DDX23;ITGAV;PMM2;SFN;PLEKHA7;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;SFRP1;SAFB2;WDR1;PSME2;BANF1;EDF1;DOCK10;GEMIN4;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;PRKCA;CDKL1;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;COL5A3;MYH9;SPPL2A;NPNT;SDK1;SEMA3C;SPEN;YWHAH;CLASP1;CAPNS1;RUVBL2;A2ML1;GALNT2;CAB39;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;LRRC57;EIF3B;CHMP4B;QDPR;LAMC1;RHOG;BCL2L2;OLFML3;GP6;CS;ACTN4;EFNB1;TKT;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;PPP2R1B;EFNA1;MYO1E;SLC3A2;XPNPEP3;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;LAIR1;C1S;SH3BP4
17338,GO:1900016,0.12002891765415,0.981403197907032,2,8,negative regulation of cytokine production involved in inflammatory response,BP,IL1R2;ZC3H12A
8608,GO:0034116,0.120139774284433,0.981375725818033,2,8,positive regulation of heterotypic cell-cell adhesion,BP,TNF;BMP7
15690,GO:0072215,0.120181327785123,0.969934950464122,3,16,regulation of metanephros development,BP,LIF;EGR1;PDGFB
4819,GO:0014013,0.120295124680043,0.94260748167759,8,64,regulation of gliogenesis,BP,LYN;BMP2;LIF;WDR1;PRPF19;TNFRSF21;ZNF365;DAG1
8924,GO:0034765,0.120367478314298,0.921424626996932,21,208,regulation of ion transmembrane transport,BP,MMP9;JPH2;G6PD;LYN;JPH1;FLNA;CHP1;ADRB2;FXYD3;WDR1;GPER1;KCNA7;IRS2;NEDD4L;YWHAH;RRAD;KCNIP3;CAB39;STAC;OXSR1;ACTN4
10393,GO:0043224,0.120511490616948,0.996136736756053,1,2,nuclear SCF ubiquitin ligase complex,CC,RNF7
3281,GO:0006959,0.12065578020159,0.939212689346893,9,82,humoral immune response,BP,KRT1;C1R;CD83;TNF;TNFRSF21;CCR6;HMGN2;BLNK;C1S
1473,GO:0003730,0.120713288503268,0.945810792899967,7,54,mRNA 3'-UTR binding,MF,TP53;ZC3H12A;GEMIN5;ZFP36L1;ZFP36L2;HNRNPU;RBM4
9330,GO:0035809,0.120730029074389,0.98122917736919,2,8,regulation of urine volume,BP,ADM;EDN1
18505,GO:1903650,0.12095589276261,0.99610723855103,1,2,negative regulation of cytoplasmic transport,BP,SNX12
20021,GO:2000642,0.12095589276261,0.99610723855103,1,2,negative regulation of early endosome to late endosome transport,BP,SNX12
4203,GO:0009311,0.121237858549464,0.945516504703387,7,54,oligosaccharide metabolic process,BP,B4GALT1;MGAM;GALNT18;GANC;ST6GALNAC5;GALNT2;MGAT2
3528,GO:0007507,0.121398348750988,0.912608429442039,34,356,heart development,BP,NRG1;CYR61;HDAC9;ADM;JPH2;FBN1;TGFB2;EDN1;G6PD;ADAMTS9;EFNB2;FGFR2;BMP2;UBE4B;TPM1;CC2D2A;GPER1;SRF;SNAI2;ZFP36L1;ROBO1;CDKL1;PDGFB;OXTR;FHL2;SEMA3C;SMAD7;HNRNPU;CITED2;JUN;SORBS2;BMP7;EFNA1;MAPK11
17313,GO:0140131,0.121593211687004,0.981014037541835,2,8,positive regulation of lymphocyte chemotaxis,BP,ADAM17;CCL5
95,GO:0000185,0.121687119981683,0.969390349317079,3,16,activation of MAPKKK activity,BP,GADD45A;TNF;GADD45B
17535,GO:1901030,0.121712626326625,0.954437903730558,5,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;SFN;YWHAH;TFDP1;TP63
3225,GO:0006875,0.121783590932863,0.91593823140029,27,281,cellular metal ion homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;LYN;JPH1;ITGAV;GPER1;ACO1;ABCG2;OXTR;NEDD4L;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
8216,GO:0032970,0.121806424363718,0.916574373907143,26,266,regulation of actin filament-based process,BP,PTGER4;CTGF;SDC4;EDN1;DAPK3;ARPC4;BAIAP2;PDPN;FLNA;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;RHOB;SPTBN1;MYH9;CLASP1;RHOG;KANK4;PHLDB2;MYADM;WNT4;SWAP70;BAIAP2L2
11324,GO:0045647,0.121964998934016,0.980921070162949,2,8,negative regulation of erythrocyte differentiation,BP,MAFB;ZFP36L1
14255,GO:0061307,0.121990429832739,0.980914704368779,2,8,cardiac neural crest cell differentiation involved in heart development,BP,SEMA3C;BMP7
14256,GO:0061308,0.121990429832739,0.980914704368779,2,8,cardiac neural crest cell development involved in heart development,BP,SEMA3C;BMP7
15266,GO:0071439,0.122066038314345,0.980895773219605,2,8,clathrin complex,CC,CLTA;BAIAP2L2
3250,GO:0006909,0.122133235830635,0.925442620996218,16,151,phagocytosis,BP,ACTG1;LYN;ARPC4;TNF;BAIAP2;CORO1C;SIRPA;ITGAV;MYO10;ARPC1B;SYK;MYH9;RHOG;RAPGEF1;RAB27A;HSP90AB1
5519,GO:0016485,0.122406958041107,0.925224376711796,16,153,protein processing,BP,C1R;IL1R2;BIRC3;BACE2;C9ORF3;SERPINE1;PGK1;SNX12;MYH9;SPPL2A;APH1A;RHBDL2;XPNPEP3;NOL3;PARP1;C1S
13713,GO:0060272,0.122698334636542,0.980737161344095,2,8,embryonic skeletal joint morphogenesis,BP,OSR2;BMP7
10834,GO:0044327,0.122743515830169,0.980725807449534,2,8,dendritic spine head,CC,FUS;GPER1
19418,GO:1990001,0.122836792583737,0.980702358783282,2,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC3;NOL3
11937,GO:0046983,0.122868809735497,0.901572037704624,73,857,protein dimerization activity,MF,MAFB;CRYAB;INHBA;S100P;NEFL;ODC1;TENM3;TAP1;PML;HSPB1;TFRC;UGT1A6;TGFB2;GBP1;MID1;DAPK3;G6PD;PANX1;TP53;SQSTM1;NFKB1;TAF4B;AHR;GADD45A;ZBED1;FGFR2;PBX1;TPM4;CLN6;TYMS;FLNA;HMGCS1;BMP2;ADRB2;DAXX;TPM1;BANF1;SRF;ABTB2;FGFR1OP;NPAS2;CBX5;ABCG2;PDGFB;MYH9;SPPL2A;SFPQ;SUPT5H;YWHAH;KEAP1;TPST1;RUVBL2;SLC4A11;DNTTIP1;PCYT1A;JUN;IKZF3;TCOF1;RCC1;GLIPR2;CHMP4B;QDPR;BCL2L2;ACTN4;TKT;TIMELESS;RILPL2;HES4;SNF8;GCLC;HSP90AB1;IL6R;CCL5
18350,GO:1903320,0.122954708239112,0.921390078533584,19,188,regulation of protein modification by small protein conjugation or removal,BP,BIRC3;GNL3L;UBE2C;ZC3H12A;CHP1;ADRB2;DAXX;DNAJB2;EGR1;U2AF2;RPS2;PTTG1IP;SMAD7;DCUN1D2;HSPBP1;ARRDC3;TNFAIP3;GCLC;HSP90AB1
5491,GO:0016427,0.123073233462832,0.980642869025118,2,8,tRNA (cytosine) methyltransferase activity,MF,NSUN2;METTL2B
3125,GO:0006704,0.123074902792838,0.980642448751305,2,8,glucocorticoid biosynthetic process,BP,BMP2;WNT4
4649,GO:0010771,0.123144765073977,0.940931746516109,8,64,negative regulation of cell morphogenesis involved in differentiation,BP,GBP1;CORO1C;NTN1;SEMA3C;RCC2;YWHAH;ACTN4;EFNA1
18190,GO:1902959,0.123254229630506,0.980597279708084,2,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,LYN;EFNA1
19179,GO:1905245,0.123254229630506,0.980597279708084,2,8,regulation of aspartic-type peptidase activity,BP,LYN;EFNA1
13719,GO:0060284,0.123471815510187,0.905040120135539,52,571,regulation of cell development,BP,NRG1;HDAC9;MAP2;FN1;NEFL;TENM3;FBN1;EDN1;GBP1;G6PD;TJP2;LYN;TNF;BAIAP2;EFNB2;CORO1C;ENC1;PDPN;PBX1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;WDR1;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;TNFRSF21;SEMA3C;SPEN;RCC2;YWHAH;PQBP1;TRIB1;ZNF365;ZSWIM6;ACTN4;BMP7;RAPGEF1;MYADM;DAG1;CTDSP1;EFNA1
11888,GO:0046902,0.123665103160073,0.94054214575555,8,66,regulation of mitochondrial membrane permeability,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;THEM4;NOL3;TP63
10076,GO:0042574,0.123727288822256,0.980477921966051,2,8,retinal metabolic process,BP,CYP1B1;AKR1C1
10670,GO:0043900,0.123739388727959,0.91442384099625,27,283,regulation of multi-organism process,BP,INHBA;PML;BIRC3;B4GALT1;RSAD2;TRAF3;SQSTM1;TNF;ZC3H12A;ITGAV;BANF1;NELFE;IL15;PRKCA;OXTR;SUPT5H;PQBP1;TRIB1;HSPA8;JUN;CHMP4B;TNFAIP3;PSMC3;CXCL8;POLR2G;SNF8;CCL5
8316,GO:0033148,0.123814048474947,0.980455999659508,2,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PAGR1;PARP1
9902,GO:0042220,0.123968107261657,0.959929091755584,4,25,response to cocaine,BP,OXTR;SDK1;EFTUD2;HSP90AB1
12037,GO:0047750,0.124034910754295,0.995899569152317,1,2,cholestenol delta-isomerase activity,MF,EBP
2863,GO:0006354,0.1240586432854,0.928523372377116,13,121,DNA-templated transcription, elongation,BP,CD3EAP;TAF4B;NELFE;POLR1A;UBTF;ALYREF;SUPT5H;HNRNPU;THOC1;GTF2E1;SUPT16H;POLR1E;POLR2G
13861,GO:0060474,0.124285795713354,0.995882393709903,1,2,positive regulation of flagellated sperm motility involved in capacitation,BP,CCR6
17864,GO:1902093,0.124285795713354,0.995882393709903,1,2,positive regulation of flagellated sperm motility,BP,CCR6
13661,GO:0060174,0.124346174184313,0.9803213264004,2,8,limb bud formation,BP,FGFR2;SEMA3C
11244,GO:0045429,0.124377843417272,0.959748626171179,4,25,positive regulation of nitric oxide biosynthetic process,BP,EDN1;TNF;ICAM1;HSP90AB1
18826,GO:1904407,0.124377843417272,0.959748626171179,4,25,positive regulation of nitric oxide metabolic process,BP,EDN1;TNF;ICAM1;HSP90AB1
10733,GO:0044089,0.124416843693312,0.909334151314865,36,383,positive regulation of cellular component biogenesis,BP,CTGF;SDC4;CSF2;EDN1;TP53;ARPC4;TNF;BAIAP2;FOSL1;LCP1;ICAM1;COL16A1;CDC42EP2;ARPC1B;SFRP1;TPM1;SRF;PRKCA;AJUBA;OXTR;DCTN1;DPYSL3;SLAIN2;CLASP1;JUN;ESR1;RHOG;BMP7;PHLDB2;DAG1;WNT4;PSMC3;SNF8;SWAP70;PARP1;BAIAP2L2
5508,GO:0016459,0.124463038651975,0.953083923600881,5,35,myosin complex,CC,MYO1B;MYO10;MYH9;CGNL1;MYO1E
14757,GO:0070431,0.124575838487398,0.980263086754254,2,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,NFKBIA;TNFAIP3
1304,GO:0003148,0.124625721757157,0.968318145672807,3,16,outflow tract septum morphogenesis,BP,TGFB2;FGFR2;SEMA3C
7197,GO:0031086,0.124629824585212,0.980249386579318,2,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;EDC4
8012,GO:0032642,0.124716402990471,0.94774527260609,6,45,regulation of chemokine production,BP,TNF;EGR1;SNAI2;ADAM17;IL1A;IL6R
7590,GO:0031958,0.124795849895935,0.968255692273608,3,16,corticosteroid receptor signaling pathway,BP,GPER1;YWHAH;RBM14
8796,GO:0034483,0.124866865580723,0.980189186848666,2,8,heparan sulfate sulfotransferase activity,MF,HS3ST2;HS3ST1
11467,GO:0045921,0.124944759311294,0.943373927677123,7,55,positive regulation of exocytosis,BP,SDC4;LAMP1;CADPS2;SYK;CLASP1;RAB27A;SNF8
17800,GO:1901890,0.125037435445674,0.959457611579128,4,25,positive regulation of cell junction assembly,BP,SDC4;COL16A1;SFRP1;WNT4
3321,GO:0007028,0.125101146518224,0.980129615585324,2,8,cytoplasm organization,BP,TFCP2L1;FOSL1
920,GO:0002315,0.125113124216932,0.980126568046845,2,8,marginal zone B cell differentiation,BP,LFNG;DOCK10
13928,GO:0060590,0.125167600242891,0.952735392012545,5,35,ATPase regulator activity,MF,BAG1;DNAJB1;DNAJB2;DNAJC1;HSPBP1
9706,GO:0038110,0.125258512198457,0.980089561332331,2,8,interleukin-2-mediated signaling pathway,BP,STAT5A;SYK
1104,GO:0002693,0.125664879768654,0.979985978408672,2,8,positive regulation of cellular extravasation,BP,ICAM1;IL1A
6,GO:0000012,0.125795679717247,0.979952591482772,2,8,single strand break repair,BP,APTX;PARP1
17988,GO:1902414,0.125915123097456,0.979922083747959,2,8,protein localization to cell junction,BP,MARVELD3;ACTN4
16151,GO:0090162,0.125953852078274,0.959052259897977,4,25,establishment of epithelial cell polarity,BP,SIPA1L3;CLASP1;PARD3;CYTH1
12100,GO:0048103,0.126038387959019,0.96779830822707,3,16,somatic stem cell division,BP,TGFB2;FGFR2;ZFP36L2
11618,GO:0046320,0.126048336691548,0.967794637168225,3,16,regulation of fatty acid oxidation,BP,IRS1;IRS2;CPT1A
13105,GO:0051639,0.126060760921392,0.979884860234233,2,8,actin filament network formation,BP,COBLL1;LCP1
18572,GO:1903799,0.12607525857406,0.979881153263547,2,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A;ESR1
13735,GO:0060306,0.126249649040322,0.967720323101722,3,16,regulation of membrane repolarization,BP,FLNA;WDR1;NEDD4L
3349,GO:0007076,0.126282047628752,0.967708357834389,3,16,mitotic chromosome condensation,BP,AKAP8L;AKAP8;CDCA5
15053,GO:0071004,0.126289705295401,0.967467043064296,3,17,U2-type prespliceosome,CC,LUC7L;U2AF2;SNRNP70
11191,GO:0045294,0.126317040475964,0.979819290353482,2,8,alpha-catenin binding,MF,VCL;AJUBA
9081,GO:0035331,0.126422663685596,0.979792241303338,2,8,negative regulation of hippo signaling,BP,WWC1;AJUBA
13056,GO:0051547,0.126449127442287,0.979785461909947,2,8,regulation of keratinocyte migration,BP,MMP9;EPPK1
6777,GO:0030212,0.126548175256505,0.958788741576758,4,25,hyaluronan metabolic process,BP,NFKB1;CHP1;IL15;PDGFB
14019,GO:0060742,0.12656771259724,0.979755071912299,2,8,epithelial cell differentiation involved in prostate gland development,BP,FGFR2;TP63
15029,GO:0070970,0.126586070490505,0.979750365660965,2,8,interleukin-2 secretion,BP,GBP1;SPTBN1
17473,GO:1900364,0.126596946775412,0.979747577195439,2,8,negative regulation of mRNA polyadenylation,BP,NELFE;SUPT5H
16073,GO:0090030,0.126621880234548,0.979741184162372,2,8,regulation of steroid hormone biosynthetic process,BP,BMP2;WNT4
4503,GO:0010536,0.126641582534203,0.995719244066695,1,2,positive regulation of activation of Janus kinase activity,BP,CCL5
5276,GO:0015926,0.126650097082547,0.97973394827406,2,8,glucosidase activity,MF,MGAM;GANC
12217,GO:0048407,0.126650584894959,0.979733823170976,2,8,platelet-derived growth factor binding,MF,COL4A1;PDGFB
11366,GO:0045725,0.126650650015595,0.979733806470308,2,8,positive regulation of glycogen biosynthetic process,BP,IRS1;IRS2
9688,GO:0038065,0.126650650015605,0.979733806470298,2,8,collagen-activated signaling pathway,BP,COL4A1;SYK
18502,GO:1903644,0.126666805669064,0.995717478889042,1,2,regulation of chaperone-mediated protein folding,BP,DNAJB2
11101,GO:0045113,0.127079104317183,0.995688569989318,1,2,regulation of integrin biosynthetic process,BP,TGFB2
11243,GO:0045428,0.127194070055004,0.951729126949153,5,35,regulation of nitric oxide biosynthetic process,BP,EDN1;TNF;ZC3H12A;ICAM1;HSP90AB1
2861,GO:0006352,0.127208528250234,0.917220447588267,20,206,DNA-templated transcription, initiation,BP,CTGF;CD3EAP;TP53;TAF4B;CDKN1A;FOSL1;CDK4;SRF;POLR1A;UBTF;CRCP;MAZ;JUN;ESR1;GTF2E1;TEAD4;POLR3H;PSMC3;POLR1E;POLR2G
1225,GO:0002902,0.127220091289689,0.96712046890411,3,17,regulation of B cell apoptotic process,BP,LYN;IRS2;NOC2L
431,GO:0001158,0.127375165693531,0.938382049306629,8,65,enhancer sequence-specific DNA binding,MF,ARID3B;NFE2L1;NFKB1;ZFP42;SFPQ;RUVBL2;JUN;SMARCC2
17096,GO:0099631,0.127701087281751,0.995644761748431,1,2,postsynaptic endocytic zone cytoplasmic component,CC,CLTA
363,GO:0000981,0.127892274098545,0.898802694955081,64,715,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;IRX2;RELB;ARID3B;IER2;ELMSAN1;TP53;NFE2L1;NFKB1;TAF4B;AHR;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;TSC22D3;STAT5A;FOXD2;TOX4;VGLL3;ELF3;IRF1;NFX1;GPER1;SRF;ELF4;ZFP42;EGR1;ETS1;SNAI2;ZFP36L1;NPAS2;MAFK;ZFP36L2;UBTF;ZNFX1;ZNF263;MAFF;CREB3;MAZ;TUSC1;KCNIP3;ETS2;KLF10;ZNF267;PRDM7;JUN;ESR1;IKZF3;FOXN1;TFDP1;KLF6;TEAD4;ELK1;HES4;CREB5;PARP1;TP63
4405,GO:0010155,0.128254135761584,0.978801181226546,2,9,regulation of proton transport,BP,CHP1;ACTN4
19740,GO:2000113,0.128319931127728,0.894215491560287,95,1115,negative regulation of cellular macromolecule biosynthetic process,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;DAPK3;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;GNL3L;CDKN2A;RING1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;CCDC85B;TSC22D3;BMP2;DAXX;NAT10;ZC3H7B;ELF3;OSR2;SFRP1;IRF1;NFX1;PSPC1;SRF;TRIM29;EGR1;SNAI2;SRRT;ZFP36L1;NELFE;DHFR;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;NUP214;SMAD7;SUPT5H;MTA2;HNRNPU;KCNIP3;ETS2;KLF10;DUSP1;CITED2;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;POLR2G;GCLC;PARP1;TP63
18439,GO:1903522,0.128329065413999,0.923981819094986,14,130,regulation of blood circulation,BP,CTGF;ADM;TGFB2;EDN1;ZC3H12A;FLNA;ICAM1;FXYD3;TPM1;OXTR;SMAD7;KCNIP3;CD38;TBXA2R
4515,GO:0010565,0.128357040148794,0.92557719835757,13,123,regulation of cellular ketone metabolic process,BP,ODC1;NQO1;PANK2;IRS1;PSMB9;BMP2;PSME2;EGR1;IRS2;CPT1A;INSIG1;WNT4;PSMC3
1253,GO:0003007,0.128667294218741,0.920828686125714,16,151,heart morphogenesis,BP,NRG1;CYR61;TGFB2;FGFR2;BMP2;UBE4B;TPM1;SRF;SNAI2;FHL2;SEMA3C;SMAD7;CITED2;JUN;BMP7;EFNA1
448,GO:0001221,0.128824873036681,0.950915244879814,5,35,transcription cofactor binding,MF,TP53;AHR;BAIAP2;MAFK;ESR1
14879,GO:0070664,0.128884806953726,0.945505066460254,6,45,negative regulation of leukocyte proliferation,BP,SDC4;LYN;CD274;TNFRSF21;GPNMB;TNFAIP3
861,GO:0002192,0.129007836894153,0.995551950240196,1,2,IRES-dependent translational initiation of linear mRNA,BP,RBM4
17229,GO:0110017,0.129007836894153,0.995551950240196,1,2,cap-independent translational initiation of linear mRNA,BP,RBM4
11382,GO:0045747,0.12922132968257,0.950716837353398,5,35,positive regulation of Notch signaling pathway,BP,TGFB2;LFNG;ELF3;SLC35C2;TP63
15991,GO:0085029,0.129324956658784,0.95755093833758,4,25,extracellular matrix assembly,BP,CLASP1;PHLDB2;DAG1;FAM234A
7331,GO:0031341,0.129390216116763,0.950538607973261,5,36,regulation of cell killing,BP,LAMP1;ICAM1;IL7R;DNASE1;HSP90AB1
17829,GO:1901988,0.129981086229494,0.914236105500204,21,215,negative regulation of cell cycle phase transition,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;PSMB9;SFN;PSME2;ZFP36L1;GPR132;ZFP36L2;ORAOV1;ZW10;ANAPC15;DUSP1;TFDP1;GPNMB;TPRA1;CTDSP1;PSMC3;TP63
16450,GO:0097110,0.13004381164191,0.944878110700521,6,45,scaffold protein binding,MF,KRT15;PANX1;BAIAP2;KRT5;UBTF;TCOF1
8461,GO:0033598,0.130416266904774,0.956916007608122,4,26,mammary gland epithelial cell proliferation,BP,EPHA2;ROBO1;ESR1;ZNF703
11626,GO:0046328,0.130449856613491,0.922515862281425,14,130,regulation of JNK cascade,BP,CTGF;EDN1;MARVELD3;GADD45A;TNF;GADD45B;DAXX;SFRP1;TRAF2;SYK;IL1A;PHLPP1;RAPGEF1;TRAF4
16345,GO:0090596,0.130455932573762,0.920960172661864,15,141,sensory organ morphogenesis,BP,MAFB;TENM3;KRT13;FBN1;EDN1;RING1;FGFR2;EPHA2;OSR2;NTN1;SDK1;COL5A2;INSIG1;BMP7;PHACTR4
10648,GO:0043666,0.130522418038681,0.930580276469117,10,87,regulation of phosphoprotein phosphatase activity,BP,IGFBP3;SH3RF2;NUAK1;TNF;PPP1R3B;NSFL1C;PPP1R14C;PPP1R9B;HSP90AB1;PHACTR4
10103,GO:0042612,0.130637574302696,0.978166546998606,2,9,MHC class I protein complex,CC,HLA-B;HLA-F
7318,GO:0031327,0.130687075734032,0.891469611096362,102,1203,negative regulation of cellular biosynthetic process,BP,NRG1;INHBA;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;DAPK3;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;GNL3L;CDKN2A;RING1;WWC1;ENC1;FGFR2;NUP153;BACE2;NFKB2;DNAJB1;TYMS;ZC3H12A;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;ERRFI1;DAXX;NAT10;ZC3H7B;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;SRF;TRIM29;SF1;EGR1;SNAI2;SRRT;ZFP36L1;NELFE;DHFR;CBX5;MAFK;ZFP36L2;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;NUP214;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;ETS2;KLF10;DUSP1;CITED2;HSPA8;JUN;ESR1;NOC2L;RBM4;NACC1;ZNF703;INSIG1;XRCC6;GLIS3;SNIP1;BMP7;METTL16;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;POLR2G;GCLC;PARP1;TP63
10881,GO:0044419,0.130694402531525,0.89675243884248,62,726,interspecies interaction between organisms,BP,FN1;IL16;TAP1;PML;TFRC;HLA-B;RSAD2;TP53;SQSTM1;LYN;LAMP1;TNF;EFNB2;NUP153;PSMB9;TYMS;ZC3H12A;EPHA2;ICAM1;ITGAV;DAXX;NMT2;ZC3H7B;TRIM22;BANF1;NFX1;NFKBIA;RPLP2;NELFE;CBX5;RPLP1;SYK;RPS2;ALYREF;POLA1;RPS9;NEDD4L;RBM15B;SPEN;NUP214;ACKR3;SUPT5H;CREB3;THOC1;RPL27A;HSPA8;JUN;RCC1;EIF3B;GTF2E1;CHMP4B;XRCC6;TAP2;HMGN2;ZYX;DAG1;PSMC3;CXCL8;POLR2G;SNF8;HSP90AB1;CCL5
959,GO:0002381,0.130832553575383,0.949908298040493,5,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
17738,GO:1901671,0.130932196145551,0.995413362022413,1,2,positive regulation of superoxide dismutase activity,BP,TNF
19011,GO:1904833,0.130932196145551,0.995413362022413,1,2,positive regulation of removal of superoxide radicals,BP,TNF
15051,GO:0070997,0.130961553374815,0.911788400389198,23,234,neuron death,BP,NEFL;NQO1;MYBL2;SOD2;TGFB2;G6PD;TP53;EFNB2;CHP1;DAXX;EGR1;TRAF2;GPR75;TNFRSF21;JUN;CHMP4B;GPNMB;ELK1;GCLC;HSP90AB1;PARP1;TP63;CCL5
4538,GO:0010611,0.131045989374991,0.949800928248975,5,35,regulation of cardiac muscle hypertrophy,BP,EDN1;G6PD;ERRFI1;PRKCA;PARP1
4881,GO:0014743,0.131045989374991,0.949800928248975,5,35,regulation of muscle hypertrophy,BP,EDN1;G6PD;ERRFI1;PRKCA;PARP1
9898,GO:0042181,0.131048050763424,0.956631045336927,4,26,ketone biosynthetic process,BP,ADM;BMP2;EGR1;WNT4
6217,GO:0019748,0.131285073589717,0.949585362061109,5,36,secondary metabolic process,BP,CYP1B1;CYP1A1;ACAA1;AKR1C2;AKR1C1
4227,GO:0009404,0.131420054600879,0.965540636427118,3,17,toxin metabolic process,BP,CYP1B1;CYP1A1;ACAA1
12564,GO:0050716,0.131562348924548,0.965486674408455,3,17,positive regulation of interleukin-1 secretion,BP,SAA1;TRIM16;PANX1
19438,GO:1990071,0.131600758046195,0.995364679601087,1,2,TRAPPII protein complex,CC,TRAPPC5
19439,GO:1990072,0.131600758046195,0.995364679601087,1,2,TRAPPIII protein complex,CC,TRAPPC5
5672,GO:0016782,0.131796670382132,0.943857173771558,6,46,transferase activity, transferring sulfur-containing groups,MF,HS3ST2;CDKAL1;ACAA1;HS3ST1;CHST3;TPST1
32,GO:0000060,0.131845076455524,0.949302710148724,5,36,protein import into nucleus, translocation,BP,CDKN1A;TNF;NFKBIA;IPO4;HSP90AB1
11774,GO:0046632,0.131947717415214,0.939374624698454,7,55,alpha-beta T cell differentiation,BP,PTGER4;RELB;CD83;RSAD2;IRF1;SYK;SMAD7
18810,GO:1904377,0.13202445386708,0.943802624760369,6,45,positive regulation of protein localization to cell periphery,BP,SQSTM1;EPHA2;GPER1;SPTBN1;STAC;RHOG
19908,GO:2000403,0.132092402609163,0.965285411784683,3,17,positive regulation of lymphocyte migration,BP,CCL20;ADAM17;CCL5
10737,GO:0044093,0.132442421971977,0.889487393315253,107,1257,positive regulation of molecular function,BP,SAA1;CCL20;NRG1;MMP9;CYR61;FN1;CTGF;JPH2;PML;STARD13;TRAF1;SDC4;MAP3K14;TGFB2;EDN1;EMP2;SIPA1L3;NFKB1;LFNG;IRS1;CDKN1A;LYN;GADD45A;TNF;GNL3L;CORO1C;FGFR2;NFKB2;DNAJB1;EPHB6;TELO2;FOSL1;UBE2C;EPHA2;CHP1;GADD45B;ICAM1;BMP2;ERRFI1;CDC42EP2;EPGN;ADRB2;DAXX;SFRP1;TPM1;TRIM22;PSME2;GPER1;SRF;DNAJB2;NFKBIA;EGR1;EDF1;DOCK10;SGK1;ADAM17;DKC1;DHFR;RIPK4;PPRC1;RPLP1;TRAF2;SYK;NFKBIB;ROBO1;AJUBA;PDGFB;RPS2;UHRF1;NPNT;RASGRP4;RUNDC1;ROR1;ACSL1;RCC2;BAMBI;AFAP1L2;DNAJC1;HNRNPU;APH1A;DCUN1D2;CAB39;SOCS1;STAC;OXSR1;JUN;ESR1;ARRDC3;RHOG;XRCC6;ACTN4;TNFRSF10A;SGSM1;RAPGEF1;DAG1;WNT4;TRAF4;CCL22;DNAJC9;EFNA1;MAPK11;CARD10;CDCA5;HSP90AB1;PARP1;PHACTR4;CCL5
247,GO:0000703,0.132530426487671,0.995296525630707,1,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,SMUG1
13852,GO:0060455,0.1326558255319,0.995287291748856,1,2,negative regulation of gastric acid secretion,BP,OXTR
2907,GO:0006417,0.132692395572481,0.903083237424397,35,387,regulation of translation,BP,HSPB1;DAPK3;TNF;ENC1;NUP153;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;ZC3H7B;DPH2;CTIF;LARP4B;SRRT;ZFP36L1;DHFR;ACO1;ZFP36L2;PUM3;AJUBA;RPS9;NUP214;DNAJC1;ESR1;TCOF1;EIF3B;RBM4;SNIP1;METTL16;EIF5A;POLR2G;CCL5;MAGOH
9603,GO:0036461,0.132751377983835,0.995280249122246,1,2,BLOC-2 complex binding,MF,RAB32
3178,GO:0006793,0.132813042660611,0.884572137700374,194,2361,phosphorus metabolic process,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;ADM;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;IKBKE;PLBD1;MID1;DAPK3;DBNDD2;G6PD;EMP2;NUAK1;NLRC5;TP53;SQSTM1;MARVELD3;IL24;PANK2;NFKB1;CDKN2B;GNPTAB;IRS1;CDKN1A;TJP2;LYN;HMGXB3;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;SCD;WWC1;TRIO;FGFR2;PTPN14;NUP153;PSMB9;EPHB6;TELO2;PGD;TYMS;ZC3H12A;TNK1;TK1;EPHA2;CHP1;HMGCS1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;ADRB2;IL20;DAXX;PGK1;AKAP8L;LIF;SFRP1;APTX;PPP1R3B;PSME2;ABHD4;GPER1;EGR1;SGK1;CD2BP2;ZFP36L1;AKAP8;NELFE;ADAM17;GPCPD1;FGFR1OP;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;PPIP5K1;CDKL1;PDGFB;AASS;OXTR;NSFL1C;SPTBN1;COX5B;NPNT;IL1A;CAMK1G;TNIP2;RASGRP4;SPRY4;ROR1;PRUNE2;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;NOL9;HNRNPU;PPP1R14C;TRIB1;TPST1;PPP1R9B;LPCAT3;PARP14;PCYT1A;DUSP1;CAB39;CD109;SOCS1;OXSR1;HSPA8;JUN;PIGM;ESR1;GLIPR2;DCXR;MCM7;SCD5;SERTAD1;DUS2;PARD3;GPNMB;ACBD6;XRCC6;SMPD2;THEM4;BMP7;SMUG1;PHLPP1;TKT;TNFRSF10A;RAPGEF1;UAP1L1;MYADM;DAG1;PDE6A;GPX4;DPM3;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;CCL22;RRM2;EFNA1;MAPK11;CTPS1;BMP8A;CARD10;PTPRB;DUSP8;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;PHACTR4;CCL5;FADS1
9077,GO:0035326,0.132942443519596,0.931817154608872,9,76,enhancer binding,MF,ARID3B;NFE2L1;NFKB1;AHR;ZFP42;SFPQ;RUVBL2;JUN;SMARCC2
10154,GO:0042732,0.133032545930193,0.995259493075305,1,2,D-xylose metabolic process,BP,DCXR
7064,GO:0030851,0.133096436434597,0.964903093008359,3,17,granulocyte differentiation,BP,RUNX1;CSF2;TRIB1
7139,GO:0030971,0.133596459196265,0.942945391862143,6,45,receptor tyrosine kinase binding,MF,NRG1;TP53;SQSTM1;IRS1;PTPN14;BLNK
4944,GO:0014909,0.133732254261093,0.942871190861462,6,45,smooth muscle cell migration,BP,IGFBP3;SERPINE1;TPM1;PDGFB;TRIB1;CCL5
1006,GO:0002480,0.13432062422586,0.977171061356736,2,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-B;HLA-F
10873,GO:0044403,0.134395491021487,0.893810196795281,61,714,symbiont process,BP,FN1;IL16;TAP1;PML;TFRC;HLA-B;RSAD2;TP53;SQSTM1;LYN;LAMP1;TNF;EFNB2;NUP153;PSMB9;TYMS;ZC3H12A;EPHA2;ICAM1;ITGAV;DAXX;NMT2;ZC3H7B;TRIM22;BANF1;NFX1;NFKBIA;RPLP2;NELFE;CBX5;RPLP1;SYK;RPS2;ALYREF;POLA1;RPS9;NEDD4L;RBM15B;SPEN;NUP214;ACKR3;SUPT5H;CREB3;THOC1;RPL27A;HSPA8;JUN;RCC1;EIF3B;GTF2E1;CHMP4B;XRCC6;TAP2;ZYX;DAG1;PSMC3;CXCL8;POLR2G;SNF8;HSP90AB1;CCL5
16896,GO:0098840,0.134404890804561,0.995157482918348,1,2,protein transport along microtubule,BP,HSPB1
17011,GO:0099118,0.134404890804561,0.995157482918348,1,2,microtubule-based protein transport,BP,HSPB1
16407,GO:0097028,0.134526196820232,0.964356219871275,3,17,dendritic cell differentiation,BP,RELB;CSF2;LYN
11675,GO:0046456,0.134944075827886,0.954721971517682,4,27,icosanoid biosynthetic process,BP,PTGES;EDN1;SYK;FADS1
16731,GO:0097734,0.134971708864955,0.964185228975274,3,17,extracellular exosome biogenesis,BP,SDC4;RAB27A;SNF8
19473,GO:1990182,0.134971708864955,0.964185228975274,3,17,exosomal secretion,BP,SDC4;RAB27A;SNF8
11400,GO:0045786,0.135323736947113,0.896228968483361,48,536,negative regulation of cell cycle,BP,INHBA;PML;MAP3K14;TGFB2;TP53;CDKN2B;CDKN1A;GADD45A;TNF;CDKN2A;RING1;PSMB9;BMP2;CDK4;SFN;LIF;IRF1;PSME2;GPER1;NSUN2;PRPF19;ZFP36L1;RHOB;CBX5;GPR132;ZFP36L2;ORAOV1;PRCC;ZW10;PPP1R9B;THOC1;ANAPC15;DUSP1;CAB39;TFDP1;GPNMB;BMP7;TPRA1;TIMELESS;RBM14;CTDSP1;TNFAIP3;PSMC3;BRIP1;RRM2;CXCL8;HSP90AB1;TP63
16422,GO:0097057,0.135355144219468,0.995086163644111,1,2,TRAF2-GSTP1 complex,CC,TRAF2
12680,GO:0050891,0.135538156029102,0.941882147289716,6,45,multicellular organismal water homeostasis,BP,KRT1;HRNR;SFN;SRF;RPTN;TP63
5168,GO:0015718,0.135629625738885,0.927299971295522,10,87,monocarboxylic acid transport,BP,SLC16A2;EDN1;SLC16A9;SLCO3A1;SLC5A6;IRS2;SYK;ACSL1;CPT1A;AKR1C1
1307,GO:0003151,0.135865899591007,0.941702200523268,6,45,outflow tract morphogenesis,BP,TGFB2;FGFR2;SEMA3C;CITED2;JUN;BMP7
5768,GO:0016942,0.135882928832614,0.995046309601576,1,2,insulin-like growth factor binding protein complex,CC,IGFBP3
9598,GO:0036454,0.135882928832614,0.995046309601576,1,2,growth factor complex,CC,IGFBP3
18045,GO:1902570,0.135923942560821,0.976732106262616,2,9,protein localization to nucleolus,BP,RRS1;POLR1A
16100,GO:0090079,0.136031815501533,0.963777235529141,3,17,translation regulator activity, nucleic acid binding,MF,TYMS;CTIF;DHFR
1360,GO:0003231,0.136043839050612,0.929876834024275,9,76,cardiac ventricle development,BP,NRG1;CYR61;TGFB2;FGFR2;UBE4B;TPM1;SEMA3C;SMAD7;CITED2
3643,GO:0008113,0.136198088315624,0.995022428701893,1,2,peptide-methionine (S)-S-oxide reductase activity,MF,TXN2
13668,GO:0060191,0.136435150228639,0.941317241052225,6,46,regulation of lipase activity,BP,CYR61;FGFR2;ANXA8;RASGRP4;ESR1;CCL5
8040,GO:0032689,0.136439259253198,0.963620008756778,3,17,negative regulation of interferon-gamma production,BP,INHBA;ZC3H12A;CD274
15875,GO:0072594,0.136463378750381,0.897905031650388,40,460,establishment of protein localization to organelle,BP,NRG1;PML;TP53;GNPTAB;CDKN1A;LAMP1;TNF;NUP153;ZC3H12A;CYB5R1;CHP1;PMM2;SFN;USP36;PARL;NFKBIA;RPLP2;DKC1;RPLP1;RPS2;PTTG1IP;RPS9;WDR46;NUP214;YWHAH;UBE2J2;RUVBL2;RPL27A;HSPA8;TFDP1;TNPO3;CHMP4B;SNIP1;TOMM40;IPO4;DAG1;TNFAIP3;SNF8;HSP90AB1;TP63
7413,GO:0031498,0.136476490386933,0.963605630238658,3,17,chromatin disassembly,BP,GRWD1;SMARCC2;SUPT16H
7204,GO:0031093,0.13681346907224,0.946776538040695,5,36,platelet alpha granule lumen,CC,FN1;TGFB2;SERPINE1;PDGFB;ACTN4
9939,GO:0042289,0.137094765385812,0.994954145706722,1,2,MHC class II protein binding,MF,KRT17
16241,GO:0090289,0.137410457565025,0.994929986164493,1,2,regulation of osteoclast proliferation,BP,TNFAIP3
7477,GO:0031641,0.137587059734166,0.953649116972531,4,26,regulation of myelination,BP,NRG1;TNFRSF21;PARD3;DAG1
13290,GO:0051984,0.137588966756468,0.953648238729078,4,26,positive regulation of chromosome segregation,BP,FEN1;SFPQ;RCC2;HNRNPU
1865,GO:0004529,0.137734507515278,0.963118653517879,3,17,exodeoxyribonuclease activity,MF,APTX;FEN1;APEX2
5748,GO:0016895,0.137734507515278,0.963118653517879,3,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,APTX;FEN1;APEX2
7229,GO:0031124,0.137938338721701,0.925776977648962,10,88,mRNA 3'-end processing,BP,SRSF2;ZFP36L1;NELFE;U2AF2;ALYREF;DDX39A;SUPT5H;THOC1;SRSF7;MAGOH
7853,GO:0032413,0.1380202524641,0.946157977212414,5,36,negative regulation of ion transmembrane transporter activity,BP,MMP9;NEDD4L;RRAD;CAB39;OXSR1
3278,GO:0006956,0.138041576920247,0.962999452880622,3,17,complement activation,BP,KRT1;C1R;C1S
1681,GO:0004146,0.13806240682144,0.994879896556652,1,2,dihydrofolate reductase activity,MF,DHFR
10476,GO:0043368,0.138348661876569,0.962880115124297,3,17,positive T cell selection,BP,CYLD;SRF;FOXN1
3115,GO:0006692,0.138440823238139,0.95311152146555,4,27,prostanoid metabolic process,BP,PTGES;EDN1;AKR1C2;AKR1C1
3116,GO:0006693,0.138440823238139,0.95311152146555,4,27,prostaglandin metabolic process,BP,PTGES;EDN1;AKR1C2;AKR1C1
4061,GO:0009110,0.138459762441671,0.9628369075266,3,17,vitamin biosynthetic process,BP,NFKB1;TNF;SNAI2
8679,GO:0034250,0.138725381268604,0.918493510503237,13,122,positive regulation of cellular amide metabolic process,BP,CYR61;TNF;KRT17;ZC3H12A;CDK4;LARP4B;RPS9;ESR1;SMPD2;EIF5A;EFNA1;POLR2G;CCL5
2193,GO:0005055,0.138843045679296,0.994819570578398,1,2,laminin receptor activity,MF,BCAM
2194,GO:0005057,0.138980655104293,0.918376755122893,13,119,signal transducer activity, downstream of receptor,MF,BAG1;MAP3K14;IKBKE;LYN;FGFR2;EPHB6;EPHA2;DAXX;SYK;ROR1;SMAD7;OXSR1;MAPK11
17304,GO:0140097,0.139138608920127,0.910654931316442,18,178,catalytic activity, acting on DNA,MF,MCM5;ZBED1;MCM2;APTX;DKC1;FEN1;GINS2;POLA1;DNASE1;TATDN2;RUVBL2;MCM7;XRCC6;SMUG1;BRIP1;PARP1;TOP3A;APEX2
19951,GO:2000501,0.139220918100561,0.994790232675049,1,2,regulation of natural killer cell chemotaxis,BP,CCL5
19952,GO:2000503,0.139220918100561,0.994790232675049,1,2,positive regulation of natural killer cell chemotaxis,BP,CCL5
2262,GO:0005176,0.139315982047007,0.994782837879584,1,2,ErbB-2 class receptor binding,MF,NRG1
9914,GO:0042253,0.139477921292541,0.994770227996654,1,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,SYK
11421,GO:0045834,0.139491825973095,0.927669538336844,9,77,positive regulation of lipid metabolic process,BP,CYR61;IRS1;LYN;TNF;IRS2;PDGFB;CPT1A;SMPD2;WNT4
11478,GO:0045934,0.139542082464886,0.88459885924679,93,1095,negative regulation of nucleobase-containing compound metabolic process,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;TP53;SQSTM1;NOCT;FST;NFKB1;AHR;JUNB;TNF;GNL3L;CDKN2A;RING1;WWC1;FGFR2;NFKB2;DNAJB1;ZC3H12A;FLNA;SRSF2;CCDC85B;TSC22D3;BMP2;DAXX;NAT10;ELF3;OSR2;SFRP1;TRIM22;IRF1;NFX1;PSPC1;TFIP11;GPER1;SRF;TRIM29;SF1;EGR1;SNAI2;NELFE;DKC1;U2AF2;SHQ1;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;RUVBL2;KCNIP3;THOC1;ETS2;KLF10;DUSP1;CITED2;HSPA8;JUN;ESR1;NOC2L;NACC1;ZNF703;XRCC6;GLIS3;BMP7;KCTD1;MPHOSPH8;DHX34;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;SRSF7;GCLC;PARP1;TP63
19738,GO:2000111,0.139682676583463,0.994754260621247,1,2,positive regulation of macrophage apoptotic process,BP,CDKN2A
10031,GO:0042475,0.139804614060074,0.934757241712204,7,56,odontogenesis of dentin-containing tooth,BP,ADM;WNT10A;TNC;BMP2;SERPINE1;BMP7;TP63
5315,GO:0016032,0.139848394090075,0.88982135417621,58,679,viral process,BP,IL16;TAP1;PML;TFRC;HLA-B;RSAD2;TP53;LYN;LAMP1;TNF;EFNB2;NUP153;PSMB9;TYMS;ZC3H12A;EPHA2;ICAM1;ITGAV;DAXX;NMT2;ZC3H7B;TRIM22;BANF1;NFX1;NFKBIA;RPLP2;NELFE;CBX5;RPLP1;SYK;RPS2;ALYREF;POLA1;RPS9;NEDD4L;RBM15B;SPEN;NUP214;ACKR3;SUPT5H;CREB3;RPL27A;HSPA8;JUN;RCC1;EIF3B;GTF2E1;CHMP4B;XRCC6;TAP2;ZYX;DAG1;PSMC3;CXCL8;POLR2G;SNF8;HSP90AB1;CCL5
2656,GO:0005999,0.140284920931436,0.994707143808414,1,2,xylulose biosynthetic process,BP,TKT
5650,GO:0016744,0.140284920931436,0.994707143808414,1,2,transferase activity, transferring aldehyde or ketonic groups,MF,TKT
10540,GO:0043487,0.140445113555468,0.913788108716096,15,148,regulation of RNA stability,BP,HSPB1;NOCT;PSMB9;ZC3H12A;PABPC4;PSME2;ZFP36L1;DKC1;PRKCA;ZFP36L2;NUP214;HNRNPU;HSPA8;METTL16;PSMC3
180,GO:0000390,0.140450546485285,0.994694146191915,1,2,spliceosomal complex disassembly,BP,TFIP11
18806,GO:1904357,0.14066820038288,0.95222367085155,4,26,negative regulation of telomere maintenance via telomere lengthening,BP,GNL3L;NAT10;HNRNPU;PARP1
11469,GO:0045923,0.140792633971185,0.961925688679189,3,17,positive regulation of fatty acid metabolic process,BP,IRS1;IRS2;CPT1A
5459,GO:0016338,0.140996159618391,0.975321181108032,2,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,BMP2;CLDN7
11583,GO:0046136,0.140996853929712,0.994651152288823,1,2,positive regulation of vitamin metabolic process,BP,TNF
13906,GO:0060557,0.140996853929712,0.994651152288823,1,2,positive regulation of vitamin D biosynthetic process,BP,TNF
13908,GO:0060559,0.140996853929712,0.994651152288823,1,2,positive regulation of calcidiol 1-monooxygenase activity,BP,TNF
926,GO:0002323,0.141261395418993,0.97524647323286,2,9,natural killer cell activation involved in immune response,BP,LAMP1;RAB27A
5412,GO:0016256,0.141352509275673,0.994623061906905,1,2,N-glycan processing to lysosome,BP,GNPTAB
4906,GO:0014839,0.141380158196178,0.994620874812741,1,2,myoblast migration involved in skeletal muscle regeneration,BP,BIN3
2426,GO:0005605,0.141397506400214,0.961688196445868,3,17,basal lamina,CC,FN1;LAMC1;COL4A4
4856,GO:0014068,0.141425849936127,0.944401988047457,5,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;TGFB2;GPER1;PDGFB;CCL5
1921,GO:0004615,0.141641478116418,0.994600180087649,1,2,phosphomannomutase activity,MF,PMM2
234,GO:0000491,0.141799221465098,0.975094703550228,2,9,small nucleolar ribonucleoprotein complex assembly,BP,SHQ1;RUVBL2
2708,GO:0006081,0.141852863710525,0.933499186896879,7,57,cellular aldehyde metabolic process,BP,CYP1B1;G6PD;PGD;BMP2;TKT;WNT4;AKR1C1
10322,GO:0043111,0.141917780757004,0.994578252179765,1,2,replication fork arrest,BP,TIMELESS
4103,GO:0009157,0.141929118932374,0.975057990952752,2,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TYMS;TK1
3144,GO:0006739,0.14193541510076,0.951485338665252,4,27,NADP metabolic process,BP,G6PD;PGD;DCXR;TKT
7779,GO:0032303,0.142019959063764,0.975032303929027,2,9,regulation of icosanoid secretion,BP,EDN1;SYK
6887,GO:0030397,0.142075963552996,0.938191301953924,6,46,membrane disassembly,BP,NUP153;AKAP8L;BANF1;PRKCA;DCTN1;NUP214
12787,GO:0051081,0.142075963552996,0.938191301953924,6,46,nuclear envelope disassembly,BP,NUP153;AKAP8L;BANF1;PRKCA;DCTN1;NUP214
6552,GO:0021983,0.142142776875423,0.96139488518223,3,17,pituitary gland development,BP,BMP2;ETS1;WNT4
14823,GO:0070557,0.142178195467706,0.994557541249595,1,2,PCNA-p21 complex,CC,CDKN1A
9822,GO:0042033,0.142366263498018,0.974934279906872,2,9,chemokine biosynthetic process,BP,TNF;EGR1
12584,GO:0050755,0.142366263498018,0.974934279906872,2,9,chemokine metabolic process,BP,TNF;EGR1
2935,GO:0006452,0.142385793914425,0.99454100028401,1,2,translational frameshifting,BP,EIF5A
11453,GO:0045905,0.142385793914425,0.99454100028401,1,2,positive regulation of translational termination,BP,EIF5A
4648,GO:0010770,0.14240351644105,0.91800701524737,12,110,positive regulation of cell morphogenesis involved in differentiation,BP,NRG1;FN1;NEFL;BAIAP2;FLNA;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;MYADM
5288,GO:0015949,0.142594433662527,0.951039130221265,4,28,nucleobase-containing small molecule interconversion,BP,TXNRD1;TYMS;RRM2;CTPS1
13289,GO:0051983,0.142616619238231,0.922702791570214,10,89,regulation of chromosome segregation,BP,UBE2C;FEN1;SFPQ;ZW10;RCC2;HNRNPU;ANAPC15;DUSP1;CDCA5;MKI67
1144,GO:0002740,0.142642153987966,0.994520536698367,1,2,negative regulation of cytokine secretion involved in immune response,BP,TNF
1208,GO:0002874,0.142642153987966,0.994520536698367,1,2,regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
4337,GO:0009889,0.142660322767848,0.873658258142764,275,3399,regulation of biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;SCD;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;CHP1;HMGCS1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;TOX4;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;DHCR7;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EIF5A;EEF1D;RAB27A;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;PARP1;TP63;ZBTB12;CCL5;FADS1;MAGOH
14904,GO:0070723,0.142746610179956,0.961156677110466,3,17,response to cholesterol,BP,INHBA;HMGCS1;DAG1
15334,GO:0071550,0.143034520283423,0.974744682120974,2,9,death-inducing signaling complex assembly,BP,TNF;TRAF2
3767,GO:0008311,0.14348195066332,0.994453211371395,1,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,APEX2
1369,GO:0003254,0.143484700870207,0.95075908040454,4,27,regulation of membrane depolarization,BP,NEDD4L;SMAD7;GCLC;PARP1
4874,GO:0014735,0.143507766623516,0.994451134704067,1,2,regulation of muscle atrophy,BP,NOL3
4875,GO:0014736,0.143507766623516,0.994451134704067,1,2,negative regulation of muscle atrophy,BP,NOL3
7486,GO:0031650,0.14350781502618,0.974610046305812,2,9,regulation of heat generation,BP,TNF;ARRDC3
6837,GO:0030299,0.143523286244833,0.994449886084657,1,2,intestinal cholesterol absorption,BP,AKR1C1
10783,GO:0044241,0.143523286244833,0.994449886084657,1,2,lipid digestion,BP,AKR1C1
16903,GO:0098856,0.143523286244833,0.994449886084657,1,2,intestinal lipid absorption,BP,AKR1C1
10091,GO:0042592,0.143543927942063,0.881079373579069,93,1100,homeostatic process,BP,KRT1;MAFB;SAA1;FTL;FTH1;PTGER4;INHBA;CTGF;C1QTNF1;ADM;JPH2;ACTG1;PML;CYLD;HSPB1;TFRC;SOD2;EDN1;TXNRD1;G6PD;HRNR;TP53;NFE2L1;STEAP4;IRS1;LYN;EHD1;TNF;GNL3L;CLN6;TELO2;UBE2C;JPH1;CHP1;TSC22D3;ICAM1;FANCC;ITGAV;SFN;ADRB2;NAT10;ABHD4;IL7R;TFIP11;GPER1;SRF;TXN2;DOCK10;ETS1;ZFP36L1;ADAM17;GPCPD1;DKC1;FEN1;IRS2;ACO1;ABCG2;PRKCA;SYK;OXTR;POLA1;NEDD4L;IL1A;SMAD7;HNRNPU;VSIG1;SLC4A11;ESR1;FOXN1;COMMD9;CHMP4B;CCR6;RPTN;ARRDC3;INSIG1;ZNF365;XRCC6;UBAP2L;TMEM165;PDE6A;AKR1C1;CD38;TNFAIP3;SLC4A2;NOL3;GCLC;HSP90AB1;SWAP70;TBXA2R;PARP1;TP63;TXNDC15;CCL5
19959,GO:2000520,0.143559071557377,0.994447006425824,1,2,regulation of immunological synapse formation,BP,LGALS3
19960,GO:2000521,0.143559071557377,0.994447006425824,1,2,negative regulation of immunological synapse formation,BP,LGALS3
20243,GO:2001188,0.143559071557377,0.994447006425824,1,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
20244,GO:2001189,0.143559071557377,0.994447006425824,1,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
11591,GO:0046166,0.143711459248476,0.994434734688474,1,2,glyceraldehyde-3-phosphate biosynthetic process,BP,TKT
18582,GO:1903827,0.143883338805749,0.892717233563668,38,414,regulation of cellular protein localization,BP,NRG1;CYLD;GBP1;TP53;SQSTM1;CDKN1A;TNF;GNL3L;PTPN14;ZC3H12A;LCP1;CYB5R1;EPHA2;CHP1;SFN;USP36;AKAP8L;LIF;PARL;GPER1;TRIM29;DKC1;POLR1A;SPTBN1;NEDD4L;WDR46;YWHAH;UBE2J2;STAC;TFDP1;INSIG1;RHOG;SNIP1;CARD10;CDCA5;HSP90AB1;PARP1;TP63
17782,GO:1901842,0.14393093879026,0.994417034335394,1,2,negative regulation of high voltage-gated calcium channel activity,BP,RRAD
13919,GO:0060576,0.144107462229365,0.97443904796352,2,9,intestinal epithelial cell development,BP,CDKN1A;TYMS
19906,GO:2000401,0.144139281688835,0.950451257344646,4,27,regulation of lymphocyte migration,BP,CCL20;ADAM17;CCR6;CCL5
19243,GO:1905397,0.144167435140624,0.994397927623494,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
19244,GO:1905402,0.144167435140624,0.994397927623494,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
16165,GO:0090183,0.144199253316564,0.942960724210609,5,36,regulation of kidney development,BP,LIF;EGR1;PDGFB;BMP7;WNT4
12667,GO:0050871,0.144244454000055,0.936905789178842,6,47,positive regulation of B cell activation,BP,TFRC;CDKN1A;IRS2;SYK;TNIP2;CD38
10880,GO:0044417,0.14445192711904,0.974340606645745,2,9,translocation of molecules into host,BP,ALYREF;THOC1
13208,GO:0051836,0.14445192711904,0.974340606645745,2,9,translocation of molecules into other organism involved in symbiotic interaction,BP,ALYREF;THOC1
19520,GO:1990410,0.144514946914314,0.99436978786649,1,2,adrenomedullin receptor signaling pathway,BP,ADM
14989,GO:0070900,0.144527292998822,0.974319047933687,2,9,mitochondrial tRNA modification,BP,PUS1;HSD17B10
17522,GO:1900864,0.144527292998822,0.974319047933687,2,9,mitochondrial RNA modification,BP,PUS1;HSD17B10
12423,GO:0048871,0.144556895377629,0.904332926762336,20,201,multicellular organismal homeostasis,BP,KRT1;CTGF;ACTG1;HSPB1;TFRC;HRNR;TNF;SFN;ADRB2;SRF;PRKCA;SYK;IL1A;VSIG1;CHMP4B;RPTN;ARRDC3;CD38;TNFAIP3;TP63
14143,GO:0061013,0.144574377924193,0.909293616357237,16,160,regulation of mRNA catabolic process,BP,HSPB1;NOCT;PSMB9;ZC3H12A;PABPC4;PSME2;ZFP36L1;PRKCA;ZFP36L2;NUP214;HNRNPU;HSPA8;METTL16;DHX34;PSMC3;POLR2G
14548,GO:0070062,0.144587062538164,0.875081265560947,163,2033,extracellular exosome,CC,IGFBP3;KRT1;SAA1;SPRR3;FTL;CRYAB;FTH1;MMP9;KRT2;S100P;FN1;C1R;KRT34;KRT15;ACTG1;NQO1;HSPB1;KRT10;SDC4;KRT13;TFRC;SOD2;GPRC5A;UGT1A6;FBN1;COBLL1;TXNRD1;PRSS23;B4GALT1;MGAM;G6PD;HRNR;SQSTM1;KRT9;STEAP4;KRT6A;HSPG2;LYN;MYO1B;ARPC4;LAMP1;CSRP1;EHD1;COL12A1;BAIAP2;KRT5;DST;TPM4;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;CHP1;ICAM1;CD274;DDX23;ITGAV;PMM2;SFN;PLEKHA7;ANXA8L1;SERPINE1;FXYD3;PGK1;ARPC1B;RELT;SFRP1;SAFB2;WDR1;PSME2;BANF1;EDF1;DOCK10;GEMIN4;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;PRKCA;CDKL1;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;COL5A3;MYH9;SPPL2A;NPNT;SDK1;SEMA3C;SPEN;YWHAH;CLASP1;CAPNS1;RUVBL2;A2ML1;GALNT2;CAB39;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;LRRC57;EIF3B;CHMP4B;QDPR;LAMC1;RHOG;BCL2L2;GP6;CS;ACTN4;EFNB1;TKT;TOMM40;MPHOSPH8;EIF3I;EIF5A;TINAGL1;MYADM;DAG1;FAM234A;RAB27A;GPX4;WNT4;RILPL2;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;PPP2R1B;EFNA1;MYO1E;SLC3A2;XPNPEP3;SRSF7;CREB5;SNF8;HSP90AB1;FBLN2;LAIR1;C1S;SH3BP4
14792,GO:0070498,0.14474106514801,0.921194673454625,10,93,interleukin-1-mediated signaling pathway,BP,IL1R2;SQSTM1;NFKB1;PSMB9;PSME2;NFKBIA;EGR1;IL1A;TNIP2;PSMC3
12755,GO:0051023,0.144846286748852,0.974227716533707,2,9,regulation of immunoglobulin secretion,BP,TNF;TRAF2
2876,GO:0006369,0.144923076934149,0.927564816774574,8,69,termination of RNA polymerase II transcription,BP,SRSF2;U2AF2;ALYREF;DDX39A;MAZ;THOC1;SRSF7;MAGOH
5811,GO:0017069,0.145025348154472,0.942334204065203,5,38,snRNA binding,MF,GEMIN5;SNRNP70;HNRNPU;METTL16;EIF5A
7636,GO:0032044,0.145097851328265,0.99432241597604,1,2,DSIF complex,CC,SUPT5H
10589,GO:0043552,0.145100037308408,0.960223482992341,3,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,IRS1;LYN;PDGFB
7300,GO:0031298,0.145113253455943,0.974151179153045,2,9,replication fork protection complex,CC,GINS2;TIMELESS
5844,GO:0017134,0.145164646373161,0.959945622234439,3,18,fibroblast growth factor binding,MF,FGFR2;ITGAV;RPS2
12138,GO:0048237,0.14518153871829,0.994315597187572,1,2,rough endoplasmic reticulum lumen,CC,EDN1
9537,GO:0036284,0.145290929656744,0.994306677417436,1,2,tubulobulbar complex,CC,ARPC1B
684,GO:0001894,0.145329003753102,0.91391343670067,13,122,tissue homeostasis,BP,KRT1;CTGF;ACTG1;HSPB1;TFRC;ADRB2;SRF;PRKCA;SYK;VSIG1;CHMP4B;CD38;TNFAIP3
12785,GO:0051066,0.145356311019153,0.994301342589574,1,2,dihydrobiopterin metabolic process,BP,QDPR
11134,GO:0045178,0.145399223551216,0.942334024728989,5,36,basal part of cell,CC,EDN1;DST;KRT14;CLASP1;PHLDB2
2527,GO:0005783,0.145445452301779,0.877619169925545,111,1323,endoplasmic reticulum,CC,IGFBP3;CYR61;FN1;P3H2;CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;FBN1;EDN1;PRSS23;RSAD2;PANX1;TP53;NFE2L1;SQSTM1;P4HA2;ADAMTS9;RAB32;COL12A1;BAIAP2;PKMYT1;SCD;TNC;DST;VMP1;CDKAL1;BACE2;COL4A1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;CHP1;COL16A1;COL27A1;GGCX;COL9A2;ANKS4B;RNF19B;LSG1;EBP;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;SGK1;RRS1;CYP4B1;ACO1;TRAF2;REEP1;PRKCA;PUM3;PDGFB;SERPINH1;COLGALT1;COL5A3;SPPL2A;TAPBPL;COL17A1;ZW10;ACSL1;COL5A2;TRAM2;DNAJC1;TAPBP;KEAP1;ZDHHC6;APH1A;UBE2J2;CREB3;TUSC1;LPCAT3;KCNIP3;PCYT1A;GALNT2;ATG101;RPL27A;PIGM;SCD5;TRAPPC5;INSIG1;DUS2;LAMC1;RHOG;TAP2;SMPD2;EIF5A;DAG1;RNF185;EEF1D;COL4A4;DPM3;WNT4;NOL3;LRRC59;TP63;FADS1
9313,GO:0035770,0.145515431073408,0.907226143451538,17,169,ribonucleoprotein granule,CC,SQSTM1;NOCT;ZC3H12A;PABPC4;NSUN2;LARP4B;ZFP36L1;AJUBA;HNRNPU;PQBP1;SOCS1;RBM4;EDC4;BLNK;TUBB;PSMC3;POLR2G
747,GO:0001977,0.145528754891617,0.974031873330047,2,9,renal system process involved in regulation of blood volume,BP,EMP2;PDGFB
14144,GO:0061014,0.145585400359328,0.942236624045578,5,36,positive regulation of mRNA catabolic process,BP,ZC3H12A;ZFP36L1;ZFP36L2;METTL16;POLR2G
16318,GO:0090500,0.145661204414336,0.994276428952953,1,2,endocardial cushion to mesenchymal transition,BP,EFNA1
14467,GO:0061827,0.145693357792478,0.994273798189117,1,2,sperm head,CC,HSP90AB1
7608,GO:0031994,0.145706925453263,0.973980645124952,2,9,insulin-like growth factor I binding,MF,IGFBP3;ITGAV
10598,GO:0043567,0.145706925453263,0.973980645124952,2,9,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3;BMP2
6379,GO:0021564,0.145746966898817,0.994269410480334,1,2,vagus nerve development,BP,NAV2
2460,GO:0005673,0.145760101083492,0.99426833521817,1,2,transcription factor TFIIE complex,CC,GTF2E1
10271,GO:0043011,0.145926160364724,0.973917553264527,2,9,myeloid dendritic cell differentiation,BP,RELB;CSF2
16654,GO:0097526,0.146090770836681,0.949257097193302,4,29,spliceosomal tri-snRNP complex,CC,SART1;ZMAT2;TXNL4B;EFTUD2
6905,GO:0030485,0.146197057961954,0.994232500441652,1,2,smooth muscle contractile fiber,CC,NPNT
17446,GO:1900222,0.14620962512042,0.99423146802255,1,2,negative regulation of amyloid-beta clearance,BP,SRF
635,GO:0001824,0.146257325466056,0.935774004534608,6,47,blastocyst development,BP,JUNB;ELF3;SRF;PRPF19;RRP7A;PSMC3
1158,GO:0002767,0.14630957217872,0.994223253596181,1,2,immune response-inhibiting cell surface receptor signaling pathway,BP,LYN
1653,GO:0004105,0.146334394646306,0.994221212512118,1,2,choline-phosphate cytidylyltransferase activity,MF,PCYT1A
12598,GO:0050774,0.146339455005127,0.973798444445678,2,9,negative regulation of dendrite morphogenesis,BP,YWHAH;EFNA1
11157,GO:0045213,0.14635358933005,0.994219633917876,1,2,neurotransmitter receptor metabolic process,BP,NRG1
6267,GO:0019860,0.146359151242383,0.994219176455805,1,2,uracil metabolic process,BP,TYMS
12594,GO:0050770,0.146379018106891,0.913201625250411,13,121,regulation of axonogenesis,BP,NRG1;MAP2;FN1;NEFL;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;SEMA3C;ZSWIM6;EFNA1
6003,GO:0019043,0.146494701610856,0.973753645984553,2,9,establishment of viral latency,BP,BANF1;XRCC6
2048,GO:0004797,0.146506303240108,0.994207066224865,1,2,thymidine kinase activity,MF,TK1
6365,GO:0021546,0.146506303240108,0.994207066224865,1,2,rhombomere development,BP,MAFB
3682,GO:0008180,0.146742305702674,0.949221449402017,4,27,COP9 signalosome,CC,AMOT;MYH9;COPS3;HSP90AB1
1235,GO:0002923,0.146824517406206,0.994180831103842,1,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
8110,GO:0032796,0.146840332496429,0.99417952555698,1,2,uropod organization,BP,MYH9
1089,GO:0002677,0.146886976231516,0.99417567416032,1,2,negative regulation of chronic inflammatory response,BP,TNFAIP3
5585,GO:0016603,0.146943593451532,0.994170997394808,1,2,glutaminyl-peptide cyclotransferase activity,MF,QPCT
5873,GO:0017186,0.146943593451532,0.994170997394808,1,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,QPCT
1061,GO:0002589,0.146947249090482,0.99417069535736,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,TAPBPL
1062,GO:0002590,0.146947249090482,0.99417069535736,1,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,TAPBPL
11327,GO:0045650,0.146969920353688,0.994168822015298,1,2,negative regulation of macrophage differentiation,BP,INHBA
13481,GO:0055017,0.147034082053436,0.93541055579299,6,46,cardiac muscle tissue growth,BP,TGFB2;EDN1;G6PD;FGFR2;SORBS2;MAPK11
7008,GO:0030692,0.147036696933539,0.994163302326953,1,2,Noc4p-Nop14p complex,CC,NOP14
2901,GO:0006408,0.147116176443262,0.994156728940864,1,2,snRNA export from nucleus,BP,PHAX
2238,GO:0005146,0.14723369484902,0.99414700219048,1,2,leukemia inhibitory factor receptor binding,MF,LIF
11067,GO:0045065,0.147272463999986,0.994143791427981,1,2,cytotoxic T cell differentiation,BP,SART1
11278,GO:0045583,0.147272463999986,0.994143791427981,1,2,regulation of cytotoxic T cell differentiation,BP,SART1
11279,GO:0045585,0.147272463999986,0.994143791427981,1,2,positive regulation of cytotoxic T cell differentiation,BP,SART1
11510,GO:0045994,0.147305526696253,0.994141052506228,1,2,positive regulation of translational initiation by iron,BP,TNF
14444,GO:0061757,0.147305526696253,0.994141052506228,1,2,leukocyte adhesion to arterial endothelial cell,BP,TNF
19093,GO:1904997,0.147305526696253,0.994141052506228,1,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
1002,GO:0002476,0.147446999853766,0.994129325002475,1,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,TAP2
9298,GO:0035740,0.147446999853766,0.994129325002475,1,2,CD8-positive, alpha-beta T cell proliferation,BP,IRF1
19977,GO:2000564,0.147446999853766,0.994129325002475,1,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,IRF1
8185,GO:0032922,0.147499638718401,0.935147875439421,6,46,circadian regulation of gene expression,BP,PML;RELB;NOCT;AHR;NPAS2;HNRNPU
4320,GO:0009812,0.147587661606884,0.973437371216441,2,9,flavonoid metabolic process,BP,CYP1A1;UGT1A6
5325,GO:0016051,0.147652190891558,0.907113298994884,16,156,carbohydrate biosynthetic process,BP,B4GALT1;G6PD;NFKB1;IRS1;GALNT18;PGD;PGK1;ST6GALNAC5;PPP1R3B;GPER1;IRS2;PDGFB;GALNT2;GBE1;TKT;MGAT2
17920,GO:1902232,0.147706630210093,0.99410776974088,1,2,regulation of positive thymic T cell selection,BP,FOXN1
17905,GO:1902214,0.14771078695074,0.994107424288256,1,2,regulation of interleukin-4-mediated signaling pathway,BP,PARP14
8276,GO:0033078,0.147762227213561,0.994103148354521,1,2,extrathymic T cell differentiation,BP,IL15
1240,GO:0002933,0.147789730341228,0.994100861488136,1,2,lipid hydroxylation,BP,CYP1A1
17114,GO:0101020,0.147789730341228,0.994100861488136,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP1A1
7234,GO:0031133,0.147803061347526,0.994099752851192,1,2,regulation of axon diameter,BP,NEFL
3264,GO:0006933,0.147972606338909,0.994085643257357,1,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,SNAI2
15108,GO:0071157,0.148023631674008,0.958794963758553,3,18,negative regulation of cell cycle arrest,BP,CDK4;GPER1;HSP90AB1
19029,GO:1904872,0.148031183178434,0.958791909682705,3,18,regulation of telomerase RNA localization to Cajal body,BP,DKC1;SHQ1;RUVBL2
1283,GO:0003085,0.148079642048794,0.97329449810803,2,9,negative regulation of systemic arterial blood pressure,BP,SOD2;ADRB2
6312,GO:0019957,0.148090595038141,0.994075813422264,1,2,C-C chemokine binding,MF,CCR6
18895,GO:1904580,0.148090595038141,0.994075813422264,1,2,regulation of intracellular mRNA localization,BP,ZFP36L1
18896,GO:1904582,0.148090595038141,0.994075813422264,1,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1
777,GO:0002032,0.148128551195213,0.994072649351468,1,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,ADRB2
14168,GO:0061050,0.148182105149284,0.97326470286857,2,9,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1;G6PD
3289,GO:0006978,0.148190112840702,0.95872761524626,3,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,TP53;CDKN1A;TP63
1134,GO:0002726,0.14832888323802,0.973221997532782,2,9,positive regulation of T cell cytokine production,BP,RSAD2;TRAF2
236,GO:0000493,0.148372179252373,0.994052318428661,1,2,box H/ACA snoRNP assembly,BP,SHQ1
9658,GO:0038001,0.148426576571239,0.994047773784657,1,2,paracrine signaling,BP,PDGFB
1297,GO:0003130,0.148471425400516,0.994044025458002,1,2,BMP signaling pathway involved in heart induction,BP,BMP2
1299,GO:0003133,0.148471425400516,0.994044025458002,1,2,endodermal-mesodermal cell signaling,BP,BMP2
1300,GO:0003134,0.148471425400516,0.994044025458002,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP2
13671,GO:0060197,0.148471425400516,0.994044025458002,1,2,cloacal septation,BP,TP63
15642,GO:0072138,0.148471425400516,0.994044025458002,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP2
2950,GO:0006478,0.148482509567489,0.99404309888049,1,2,peptidyl-tyrosine sulfation,BP,TPST1
3859,GO:0008476,0.148482509567489,0.99404309888049,1,2,protein-tyrosine sulfotransferase activity,MF,TPST1
19589,GO:1990698,0.148498125228345,0.994041793361618,1,2,palmitoleoyltransferase activity,MF,CPT1A
9327,GO:0035801,0.148524668528307,0.994039573901664,1,2,adrenal cortex development,BP,CITED2
9328,GO:0035802,0.148524668528307,0.994039573901664,1,2,adrenal cortex formation,BP,CITED2
1394,GO:0003308,0.148646481416821,0.994029382579341,1,2,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2
1305,GO:0003149,0.148821874984047,0.973078356091625,2,9,membranous septum morphogenesis,BP,TGFB2;FGFR2
5468,GO:0016401,0.14883114983655,0.994013914531331,1,2,palmitoyl-CoA oxidase activity,MF,ACAA1
9445,GO:0036022,0.148847533950441,0.994012541130695,1,2,limb joint morphogenesis,BP,OSR2
9446,GO:0036023,0.148847533950441,0.994012541130695,1,2,embryonic skeletal limb joint morphogenesis,BP,OSR2
17625,GO:1901329,0.148896286530156,0.994008453428793,1,2,regulation of odontoblast differentiation,BP,SERPINE1
6924,GO:0030516,0.148968638825701,0.925147132741629,8,67,regulation of axon extension,BP,NRG1;FN1;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;SEMA3C
17957,GO:1902309,0.148976216606442,0.994001748350966,1,2,negative regulation of peptidyl-serine dephosphorylation,BP,SWAP70
4325,GO:0009826,0.149023386213832,0.993997789536493,1,2,unidimensional cell growth,BP,BIN3
15717,GO:0072272,0.149070857663419,0.993993803959758,1,2,proximal/distal pattern formation involved in metanephric nephron development,BP,IRX2
2142,GO:0004955,0.149089206293429,0.993992263073261,1,2,prostaglandin receptor activity,MF,PTGER4
16374,GO:0090677,0.149115968884189,0.993990015212585,1,2,reversible differentiation,BP,PDGFB
16375,GO:0090678,0.149115968884189,0.993990015212585,1,2,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
19160,GO:1905174,0.149115968884189,0.993990015212585,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
19670,GO:1990936,0.149115968884189,0.993990015212585,1,2,vascular smooth muscle cell dedifferentiation,BP,PDGFB
4625,GO:0010745,0.149116663715188,0.97299231379894,2,9,negative regulation of macrophage derived foam cell differentiation,BP,ITGAV;NFKBIA
19265,GO:1905449,0.149119776002761,0.993989695405607,1,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,RAPGEF1
19266,GO:1905451,0.149119776002761,0.993989695405607,1,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,RAPGEF1
7065,GO:0030852,0.149156256446455,0.972980748973679,2,9,regulation of granulocyte differentiation,BP,RUNX1;TRIB1
893,GO:0002266,0.149161389416612,0.993986199178765,1,2,follicular dendritic cell activation,BP,NFKB2
894,GO:0002268,0.149161389416612,0.993986199178765,1,2,follicular dendritic cell differentiation,BP,NFKB2
8367,GO:0033257,0.149161389416612,0.993986199178765,1,2,Bcl3/NF-kappaB2 complex,CC,NFKB2
8227,GO:0032986,0.149171275386341,0.958329925886411,3,18,protein-DNA complex disassembly,BP,GRWD1;SMARCC2;SUPT16H
2063,GO:0004817,0.149187102522197,0.993984038294368,1,2,cysteine-tRNA ligase activity,MF,CARS2
2913,GO:0006423,0.149187102522197,0.993984038294368,1,2,cysteinyl-tRNA aminoacylation,BP,CARS2
5952,GO:0018312,0.149239492653665,0.993979634217078,1,2,peptidyl-serine ADP-ribosylation,BP,PARP1
19514,GO:1990404,0.149239492653665,0.993979634217078,1,2,protein ADP-ribosylase activity,MF,PARP1
15809,GO:0072503,0.149259117221633,0.899680264757724,21,216,cellular divalent inorganic cation homeostasis,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
902,GO:0002283,0.149299752262052,0.891244363857573,32,351,neutrophil activation involved in immune response,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
20235,GO:2001180,0.149301441781704,0.993974424326247,1,2,negative regulation of interleukin-10 secretion,BP,TNFRSF21
19098,GO:1905006,0.149315853226446,0.993973211980614,1,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
17713,GO:1901623,0.149319962380154,0.972932909766918,2,9,regulation of lymphocyte chemotaxis,BP,ADAM17;CCL5
983,GO:0002440,0.149369445005781,0.913185409913679,12,112,production of molecular mediator of immune response,BP,TFRC;TGFB2;RSAD2;IL27RA;TNF;IL7R;TRAF2;SMAD7;THOC1;GALNT2;CCR6;SWAP70
19660,GO:1990911,0.149442226273345,0.993962575334412,1,2,response to psychosocial stress,BP,ADRB2
2130,GO:0004935,0.149523590722178,0.993955721618457,1,2,adrenergic receptor activity,MF,ADRB2
10474,GO:0043366,0.149531323449338,0.993955070034537,1,2,beta selection,BP,SYK
16639,GO:0097498,0.149531323449338,0.993955070034537,1,2,endothelial tube lumen extension,BP,STARD13
6166,GO:0019520,0.149694501540694,0.993941311252813,1,2,aldonic acid metabolic process,BP,PGD
6167,GO:0019521,0.149694501540694,0.993941311252813,1,2,D-gluconate metabolic process,BP,PGD
16772,GO:0098575,0.149704902221254,0.993940433717557,1,2,lumenal side of lysosomal membrane,CC,HSPA8
19949,GO:2000490,0.149732290602506,0.993938122551556,1,2,negative regulation of hepatic stellate cell activation,BP,GCLC
10503,GO:0043405,0.149741172259031,0.895673459446831,25,260,regulation of MAP kinase activity,BP,SAA1;NRG1;DUSP14;MAP3K14;EDN1;LYN;GADD45A;TNF;GADD45B;BMP2;EPGN;DAXX;SFRP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;SPRY4;TRIB1;DUSP1;BMP7;RAPGEF1;MAPK11;DUSP8
9855,GO:0042102,0.149754654605885,0.933722831817664,6,48,positive regulation of T cell proliferation,BP,TFRC;CD274;IL15;SYK;EFNB1;CCL5
7904,GO:0032472,0.149830509111954,0.993929830461396,1,2,Golgi calcium ion transport,BP,TMEM165
12977,GO:0051379,0.149844679914475,0.993928633585036,1,2,epinephrine binding,MF,ADRB2
8615,GO:0034124,0.149895908825724,0.9939243056861,1,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,IRF1
20043,GO:2000666,0.149919266455816,0.993922331841641,1,2,negative regulation of interleukin-13 secretion,BP,TNFRSF21
8256,GO:0033032,0.149936204383147,0.958018970798856,3,18,regulation of myeloid cell apoptotic process,BP,CDKN2A;ADAM17;CCL5
2116,GO:0004906,0.150031513814241,0.993912841489548,1,2,interferon-gamma receptor activity,MF,IFNGR1
9333,GO:0035812,0.150058056790899,0.993910596145036,1,2,renal sodium excretion,BP,EDN1
9334,GO:0035813,0.150058056790899,0.993910596145036,1,2,regulation of renal sodium excretion,BP,EDN1
6659,GO:0030011,0.150132717623103,0.972694886795143,2,9,maintenance of cell polarity,BP,DST;WDR1
4007,GO:0008967,0.150140679092164,0.993903604018739,1,2,phosphoglycolate phosphatase activity,MF,APTX
4417,GO:0010193,0.15014462977234,0.993903269573162,1,2,response to ozone,BP,EDN1
9211,GO:0035596,0.150161628065043,0.993901830465949,1,2,methylthiotransferase activity,MF,CDKAL1
9214,GO:0035600,0.150161628065043,0.993901830465949,1,2,tRNA methylthiolation,BP,CDKAL1
12490,GO:0050497,0.150161628065043,0.993901830465949,1,2,transferase activity, transferring alkylthio groups,MF,CDKAL1
873,GO:0002224,0.150179991603779,0.917698938458993,10,90,toll-like receptor signaling pathway,BP,IKBKE;BIRC3;RSAD2;TRAF3;LYN;IRF1;NFKBIA;TNIP2;ESR1;TNFAIP3
14436,GO:0061741,0.150207988307721,0.993897904584726,1,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,HSPA8
6234,GO:0019785,0.150233283939434,0.993895761920401,1,2,ISG15-specific protease activity,MF,USP43
3011,GO:0006556,0.150453206149866,0.99387711623083,1,2,S-adenosylmethionine biosynthetic process,BP,MAT2A
12161,GO:0048269,0.150453206149866,0.99387711623083,1,2,methionine adenosyltransferase complex,CC,MAT2A
8884,GO:0034696,0.150475778523755,0.993875200728918,1,2,response to prostaglandin F,BP,EDN1
14827,GO:0070563,0.150499140769956,0.993873217855759,1,2,negative regulation of vitamin D receptor signaling pathway,BP,SNAI2
13561,GO:0060024,0.150505593808646,0.993872670092031,1,2,rhythmic synaptic transmission,BP,EDN1
13730,GO:0060298,0.150505593808646,0.993872670092031,1,2,positive regulation of sarcomere organization,BP,EDN1
13924,GO:0060584,0.150505593808646,0.993872670092031,1,2,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
13925,GO:0060585,0.150505593808646,0.993872670092031,1,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
14573,GO:0070101,0.150505593808646,0.993872670092031,1,2,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
1811,GO:0004461,0.150529023614594,0.99387068103853,1,2,lactose synthase activity,MF,B4GALT1
4593,GO:0010701,0.150545836326456,0.993869253521773,1,2,positive regulation of norepinephrine secretion,BP,OXTR
18436,GO:1903518,0.150574801900082,0.993866793719066,1,2,positive regulation of single strand break repair,BP,PARP1
19031,GO:1904875,0.150574801900082,0.993866793719066,1,2,regulation of DNA ligase activity,BP,TFIP11
6299,GO:0019912,0.150579567739216,0.993866388945118,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
10984,GO:0044778,0.150633765193411,0.993861784808002,1,2,meiotic DNA integrity checkpoint,BP,ORAOV1
10596,GO:0043564,0.150681180553449,0.993857755280384,1,2,Ku70:Ku80 complex,CC,XRCC6
15938,GO:0072737,0.150713218303986,0.993855031784976,1,2,response to diamide,BP,DAXX
15939,GO:0072738,0.150713218303986,0.993855031784976,1,2,cellular response to diamide,BP,DAXX
17991,GO:1902423,0.150714792814862,0.993854897920577,1,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
17992,GO:1902425,0.150714792814862,0.993854897920577,1,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
1239,GO:0002931,0.150730010895721,0.947319849387646,4,27,response to ischemia,BP,PANX1;SQSTM1;EGR1;NOL3
17968,GO:1902359,0.150751574155335,0.99385177033283,1,2,Notch signaling pathway involved in somitogenesis,BP,LFNG
17972,GO:1902366,0.150751574155335,0.99385177033283,1,2,regulation of Notch signaling pathway involved in somitogenesis,BP,LFNG
17973,GO:1902367,0.150751574155335,0.99385177033283,1,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,LFNG
6998,GO:0030681,0.15076184647896,0.971989045940902,2,10,multimeric ribonuclease P complex,CC,POP1;POP4
12132,GO:0048209,0.15077932062496,0.993849410426029,1,2,regulation of vesicle targeting, to, from or within Golgi,BP,GOSR1
10140,GO:0042701,0.150789731028003,0.993848524868372,1,2,progesterone secretion,BP,INHBA
14898,GO:0070697,0.150789731028003,0.993848524868372,1,2,activin receptor binding,MF,INHBA
14899,GO:0070699,0.150789731028003,0.993848524868372,1,2,type II activin receptor binding,MF,INHBA
17751,GO:1901699,0.150798509265365,0.885779895701889,41,450,cellular response to nitrogen compound,BP,HDAC9;FBN1;EDN1;TP53;NFKB1;IRS1;LYN;AHR;TNF;BAIAP2;COL4A1;ZC3H12A;ICAM1;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;DAXX;ZC3H7B;SFRP1;GPER1;EGR1;SRRT;ZFP36L1;IRS2;TRAF2;COL5A2;PQBP1;PPP1R9B;KLF10;SOCS1;ESR1;SNIP1;RAPGEF1;TIMELESS;BRIP1;GCLC;PARP1;BAIAP2L2;SH3BP4
1265,GO:0003025,0.150828741761845,0.993845205817226,1,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,NAV2
16500,GO:0097195,0.150828741761845,0.993845205817226,1,2,pilomotor reflex,BP,NPNT
5367,GO:0016160,0.150833726242063,0.993844781665366,1,2,amylase activity,MF,MGAM
1242,GO:0002940,0.150846902051503,0.99384366040005,1,2,tRNA N2-guanine methylation,BP,TRMT1
7405,GO:0031468,0.150865888850773,0.957639967965526,3,18,nuclear envelope reassembly,BP,BANF1;NSFL1C;CHMP4B
17507,GO:1900673,0.15088687175189,0.993840258288554,1,2,olefin metabolic process,BP,CYP1A1
5203,GO:0015801,0.150953564444195,0.993834579318258,1,2,aromatic amino acid transport,BP,SLC3A2
5224,GO:0015827,0.150953564444195,0.993834579318258,1,2,tryptophan transport,BP,SLC3A2
1413,GO:0003350,0.150989419192558,0.993831525065522,1,2,pulmonary myocardium development,BP,SEMA3C
13631,GO:0060126,0.150989419192558,0.993831525065522,1,2,somatotropin secreting cell differentiation,BP,WNT4
14766,GO:0070447,0.150997769251944,0.993830813655783,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,LYN
19110,GO:1905041,0.151008767528135,0.993829876554887,1,2,regulation of epithelium regeneration,BP,EPPK1
19510,GO:1990399,0.151008767528135,0.993829876554887,1,2,epithelium regeneration,BP,EPPK1
17283,GO:0140031,0.151048653234932,0.993826477471417,1,2,phosphorylation-dependent protein binding,MF,LYN
8374,GO:0033269,0.15106401608752,0.993825167969029,1,2,internode region of axon,CC,PARD3
5218,GO:0015820,0.151066544139436,0.993824952467911,1,2,leucine transport,BP,SLC3A2
10256,GO:0042994,0.151084606514402,0.957550632986823,3,18,cytoplasmic sequestering of transcription factor,BP,NFKBIE;NFKBIA;KEAP1
9715,GO:0038129,0.151162554133035,0.993816765176143,1,2,ERBB3 signaling pathway,BP,NRG1
3850,GO:0008459,0.151166753056072,0.993816406976873,1,2,chondroitin 6-sulfotransferase activity,MF,CHST3
8004,GO:0032632,0.15119794675492,0.993813745570443,1,2,interleukin-3 production,BP,SYK
8028,GO:0032672,0.15119794675492,0.993813745570443,1,2,regulation of interleukin-3 production,BP,SYK
1570,GO:0003977,0.151215769439044,0.993812224682836,1,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,UAP1L1
19208,GO:1905314,0.15123114903978,0.972371841180598,2,9,semi-lunar valve development,BP,TGFB2;EFNA1
1745,GO:0004345,0.151233871791729,0.993810679722165,1,2,glucose-6-phosphate dehydrogenase activity,MF,G6PD
19035,GO:1904879,0.151233871791729,0.993810679722165,1,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
14672,GO:0070278,0.151234804601331,0.993810600105066,1,2,extracellular matrix constituent secretion,BP,CTGF
1459,GO:0003705,0.151241918289712,0.927919854592611,7,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,ARID3B;NFE2L1;NFKB1;VGLL3;SRF;SNAI2;JUN
168,GO:0000349,0.151242911112857,0.993809908175256,1,2,generation of catalytic spliceosome for first transesterification step,BP,PRPF19
2303,GO:0005287,0.151280631864263,0.993806687975235,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
2304,GO:0005289,0.151280631864263,0.993806687975235,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC7A2
2306,GO:0005292,0.151280631864263,0.993806687975235,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC7A2
6483,GO:0021826,0.151303194511515,0.993804761379824,1,2,substrate-independent telencephalic tangential migration,BP,NRG1
6486,GO:0021830,0.151303194511515,0.993804761379824,1,2,interneuron migration from the subpallium to the cortex,BP,NRG1
6490,GO:0021843,0.151303194511515,0.993804761379824,1,2,substrate-independent telencephalic tangential interneuron migration,BP,NRG1
215,GO:0000448,0.151307843037715,0.993804364407746,1,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,NOL9
14525,GO:0070012,0.151312426812384,0.993803972951761,1,2,oligopeptidase activity,MF,PREP
20239,GO:2001184,0.151322873030001,0.993803080790908,1,2,positive regulation of interleukin-12 secretion,BP,MAPK11
8879,GO:0034685,0.151341364125716,0.993801501385035,1,2,integrin alphav-beta6 complex,CC,ITGAV
8627,GO:0034143,0.151380774513537,0.972327715877405,2,9,regulation of toll-like receptor 4 signaling pathway,BP,LYN;TNFAIP3
3413,GO:0007195,0.151382639689532,0.993797975069318,1,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,FLNA
6375,GO:0021560,0.151384380648084,0.993797826309215,1,2,abducens nerve development,BP,MAFB
6394,GO:0021598,0.151384380648084,0.993797826309215,1,2,abducens nerve morphogenesis,BP,MAFB
6395,GO:0021599,0.151384380648084,0.993797826309215,1,2,abducens nerve formation,BP,MAFB
20202,GO:2001070,0.151393430222755,0.993797053016839,1,2,starch binding,MF,GPCPD1
9683,GO:0038052,0.151403144759339,0.993796222844769,1,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,ESR1
19036,GO:1904880,0.151422681582354,0.993794553110086,1,2,response to hydrogen sulfide,BP,NQO1
16849,GO:0098758,0.151425810561659,0.993794285665989,1,2,response to interleukin-8,BP,EGR1
16850,GO:0098759,0.151425810561659,0.993794285665989,1,2,cellular response to interleukin-8,BP,EGR1
4771,GO:0010956,0.151434735540516,0.993793522784474,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,NFKB1
9979,GO:0042369,0.151434735540516,0.993793522784474,1,2,vitamin D catabolic process,BP,CYP24A1
2420,GO:0005594,0.151450984260299,0.993792133759954,1,2,collagen type IX trimer,CC,COL9A2
19729,GO:2000097,0.15145975391076,0.993791384014813,1,2,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
18680,GO:1904026,0.151466526633272,0.993790804959718,1,2,regulation of collagen fibril organization,BP,COLGALT1
10463,GO:0043321,0.151473435906807,0.993790214199559,1,2,regulation of natural killer cell degranulation,BP,LAMP1
10464,GO:0043323,0.151473435906807,0.993790214199559,1,2,positive regulation of natural killer cell degranulation,BP,LAMP1
674,GO:0001884,0.151474036673002,0.993790162831105,1,2,pyrimidine nucleoside binding,MF,HSP90AB1
835,GO:0002134,0.151474036673002,0.993790162831105,1,2,UTP binding,MF,HSP90AB1
7952,GO:0032551,0.151474036673002,0.993790162831105,1,2,pyrimidine ribonucleoside binding,MF,HSP90AB1
9569,GO:0036363,0.151474036673002,0.993790162831105,1,2,transforming growth factor beta activation,BP,HSP90AB1
5847,GO:0017143,0.151495972768878,0.993788287029446,1,2,insecticide metabolic process,BP,CYP1A1
10226,GO:0042904,0.151503890409011,0.993787609899862,1,2,9-cis-retinoic acid biosynthetic process,BP,CYP1A1
10227,GO:0042905,0.151503890409011,0.993787609899862,1,2,9-cis-retinoic acid metabolic process,BP,CYP1A1
14542,GO:0070053,0.151504234591336,0.993787580463916,1,2,thrombospondin receptor activity,MF,SDC4
14287,GO:0061370,0.15151936597324,0.993786286288507,1,2,testosterone biosynthetic process,BP,WNT4
16661,GO:0097534,0.151523145249641,0.993785963027076,1,2,lymphoid lineage cell migration,BP,FOXN1
16662,GO:0097535,0.151523145249641,0.993785963027076,1,2,lymphoid lineage cell migration into thymus,BP,FOXN1
4217,GO:0009383,0.151523957395073,0.993785893558804,1,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,NOP2
9394,GO:0035931,0.151524655655915,0.993785833831512,1,2,mineralocorticoid secretion,BP,C1QTNF1
9395,GO:0035932,0.151524655655915,0.993785833831512,1,2,aldosterone secretion,BP,C1QTNF1
17615,GO:1901301,0.151524655655915,0.993785833831512,1,2,regulation of cargo loading into COPII-coated vesicle,BP,INSIG1
20018,GO:2000638,0.151524655655915,0.993785833831512,1,2,regulation of SREBP signaling pathway,BP,INSIG1
20019,GO:2000639,0.151524655655915,0.993785833831512,1,2,negative regulation of SREBP signaling pathway,BP,INSIG1
20151,GO:2000855,0.151524655655915,0.993785833831512,1,2,regulation of mineralocorticoid secretion,BP,C1QTNF1
20152,GO:2000857,0.151524655655915,0.993785833831512,1,2,positive regulation of mineralocorticoid secretion,BP,C1QTNF1
20153,GO:2000858,0.151524655655915,0.993785833831512,1,2,regulation of aldosterone secretion,BP,C1QTNF1
20154,GO:2000860,0.151524655655915,0.993785833831512,1,2,positive regulation of aldosterone secretion,BP,C1QTNF1
143,GO:0000294,0.151524735359503,0.993785827013869,1,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,ZC3H12A
18091,GO:1902714,0.151524735359503,0.993785827013869,1,2,negative regulation of interferon-gamma secretion,BP,ZC3H12A
20011,GO:2000625,0.151524735359503,0.993785827013869,1,2,regulation of miRNA catabolic process,BP,ZC3H12A
20012,GO:2000627,0.151524735359503,0.993785827013869,1,2,positive regulation of miRNA catabolic process,BP,ZC3H12A
4519,GO:0010572,0.151525109790261,0.993785794985955,1,2,positive regulation of platelet activation,BP,PDPN
14060,GO:0060838,0.151525109790261,0.993785794985955,1,2,lymphatic endothelial cell fate commitment,BP,PDPN
17762,GO:1901731,0.151525109790261,0.993785794985955,1,2,positive regulation of platelet aggregation,BP,PDPN
19380,GO:1905863,0.151525109790262,0.993785794985955,1,2,invadopodium organization,BP,PDPN
17519,GO:1900756,0.151526034534775,0.99378571588513,1,2,protein processing in phagocytic vesicle,BP,MYH9
18630,GO:1903921,0.151526034534775,0.99378571588513,1,2,regulation of protein processing in phagocytic vesicle,BP,MYH9
18631,GO:1903923,0.151526034534775,0.99378571588513,1,2,positive regulation of protein processing in phagocytic vesicle,BP,MYH9
1583,GO:0003994,0.151526711153511,0.99378565800815,1,2,aconitate hydratase activity,MF,ACO1
2314,GO:0005314,0.151526844864655,0.993785646570659,1,2,high-affinity glutamate transmembrane transporter activity,MF,SLC25A22
5125,GO:0015501,0.151526844864655,0.993785646570659,1,2,glutamate:sodium symporter activity,MF,SLC25A22
13508,GO:0055077,0.151527012580965,0.993785632224391,1,2,gap junction hemi-channel activity,MF,PANX1
4490,GO:0010512,0.151527105505008,0.993785624275763,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
9318,GO:0035788,0.151527105505008,0.993785624275763,1,2,cell migration involved in metanephros development,BP,PDGFB
9319,GO:0035789,0.151527105505008,0.993785624275763,1,2,metanephric mesenchymal cell migration,BP,PDGFB
9322,GO:0035793,0.151527105505008,0.993785624275763,1,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
17452,GO:1900238,0.151527105505008,0.993785624275763,1,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
19993,GO:2000589,0.151527105505008,0.993785624275763,1,2,regulation of metanephric mesenchymal cell migration,BP,PDGFB
19994,GO:2000591,0.151527105505008,0.993785624275763,1,2,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
19350,GO:1905719,0.151527200770784,0.99378561612682,1,2,protein localization to perinuclear region of cytoplasm,BP,SQSTM1
5089,GO:0015349,0.151527215798362,0.993785614841375,1,2,thyroid hormone transmembrane transporter activity,MF,SLC16A2
10354,GO:0043163,0.151527228883519,0.993785613722082,1,2,cell envelope organization,BP,HRNR
11168,GO:0045229,0.151527228883519,0.993785613722082,1,2,external encapsulating structure organization,BP,HRNR
10459,GO:0043316,0.151527281069268,0.99378560925816,1,2,cytotoxic T cell degranulation,BP,RAB27A
18405,GO:1903433,0.151527281069268,0.99378560925816,1,2,regulation of constitutive secretory pathway,BP,RAB27A
120,GO:0000248,0.151527283395309,0.993785609059193,1,2,C-5 sterol desaturase activity,MF,FADS1
170,GO:0000354,0.151527283395309,0.993785609059193,1,2,cis assembly of pre-catalytic spliceosome,BP,DDX23
248,GO:0000706,0.151527283395309,0.993785609059193,1,2,meiotic DNA double-strand break processing,BP,BRIP1
456,GO:0001300,0.151527283395309,0.993785609059193,1,2,chronological cell aging,BP,SERPINE1
503,GO:0001560,0.151527283395309,0.993785609059193,1,2,regulation of cell growth by extracellular stimulus,BP,PPP1R9B
564,GO:0001705,0.151527283395309,0.993785609059193,1,2,ectoderm formation,BP,ETS2
571,GO:0001712,0.151527283395309,0.993785609059193,1,2,ectodermal cell fate commitment,BP,ETS2
883,GO:0002249,0.151527283395309,0.993785609059193,1,2,lymphocyte anergy,BP,PHLPP1
1083,GO:0002667,0.151527283395309,0.993785609059193,1,2,regulation of T cell anergy,BP,PHLPP1
1207,GO:0002870,0.151527283395309,0.993785609059193,1,2,T cell anergy,BP,PHLPP1
1230,GO:0002911,0.151527283395309,0.993785609059193,1,2,regulation of lymphocyte anergy,BP,PHLPP1
1379,GO:0003275,0.151527283395309,0.993785609059193,1,2,apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
1521,GO:0003883,0.151527283395309,0.993785609059193,1,2,CTP synthase activity,MF,CTPS1
1755,GO:0004357,0.151527283395309,0.993785609059193,1,2,glutamate-cysteine ligase activity,MF,GCLC
1774,GO:0004379,0.151527283395309,0.993785609059193,1,2,glycylpeptide N-tetradecanoyltransferase activity,MF,NMT2
1866,GO:0004530,0.151527283395309,0.993785609059193,1,2,deoxyribonuclease I activity,MF,DNASE1
2053,GO:0004803,0.151527283395309,0.993785609059193,1,2,transposase activity,MF,ZBED1
2103,GO:0004874,0.151527283395309,0.993785609059193,1,2,aryl hydrocarbon receptor activity,MF,AHR
2121,GO:0004915,0.151527283395309,0.993785609059193,1,2,interleukin-6 receptor activity,MF,IL6R
2165,GO:0005000,0.151527283395309,0.993785609059193,1,2,vasopressin receptor activity,MF,OXTR
2243,GO:0005153,0.151527283395309,0.993785609059193,1,2,interleukin-8 receptor binding,MF,CXCL8
2599,GO:0005896,0.151527283395309,0.993785609059193,1,2,interleukin-6 receptor complex,CC,IL6R
2650,GO:0005988,0.151527283395309,0.993785609059193,1,2,lactose metabolic process,BP,B4GALT1
2651,GO:0005989,0.151527283395309,0.993785609059193,1,2,lactose biosynthetic process,BP,B4GALT1
3466,GO:0007284,0.151527283395309,0.993785609059193,1,2,spermatogonial cell division,BP,BRIP1
4010,GO:0008988,0.151527283395309,0.993785609059193,1,2,rRNA (adenine-N6-)-methyltransferase activity,MF,METTL16
4048,GO:0009085,0.151527283395309,0.993785609059193,1,2,lysine biosynthetic process,BP,AASS
4830,GO:0014034,0.151527283395309,0.993785609059193,1,2,neural crest cell fate commitment,BP,SFRP1
5461,GO:0016340,0.151527283395309,0.993785609059193,1,2,calcium-dependent cell-matrix adhesion,BP,DAG1
5498,GO:0016436,0.151527283395309,0.993785609059193,1,2,rRNA (uridine) methyltransferase activity,MF,FTSJ3
5829,GO:0017109,0.151527283395309,0.993785609059193,1,2,glutamate-cysteine ligase complex,CC,GCLC
5878,GO:0018008,0.151527283395309,0.993785609059193,1,2,N-terminal peptidyl-glycine N-myristoylation,BP,NMT2
6036,GO:0019107,0.151527283395309,0.993785609059193,1,2,myristoyltransferase activity,MF,NMT2
6277,GO:0019878,0.151527283395309,0.993785609059193,1,2,lysine biosynthetic process via aminoadipic acid,BP,AASS
6321,GO:0019981,0.151527283395309,0.993785609059193,1,2,interleukin-6 binding,MF,IL6R
6333,GO:0021502,0.151527283395309,0.993785609059193,1,2,neural fold elevation formation,BP,BMP7
6378,GO:0021563,0.151527283395309,0.993785609059193,1,2,glossopharyngeal nerve development,BP,NAV2
6416,GO:0021679,0.151527283395309,0.993785609059193,1,2,cerebellar molecular layer development,BP,ZNF365
6423,GO:0021687,0.151527283395309,0.993785609059193,1,2,cerebellar molecular layer morphogenesis,BP,ZNF365
6480,GO:0021823,0.151527283395309,0.993785609059193,1,2,cerebral cortex tangential migration using cell-cell interactions,BP,ROBO1
6484,GO:0021827,0.151527283395309,0.993785609059193,1,2,postnatal olfactory bulb interneuron migration,BP,ROBO1
6487,GO:0021836,0.151527283395309,0.993785609059193,1,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,ROBO1
6492,GO:0021847,0.151527283395309,0.993785609059193,1,2,ventricular zone neuroblast division,BP,FGFR2
6796,GO:0030237,0.151527283395309,0.993785609059193,1,2,female sex determination,BP,WNT4
6873,GO:0030350,0.151527283395309,0.993785609059193,1,2,iron-responsive element binding,MF,ACO1
7591,GO:0031959,0.151527283395309,0.993785609059193,1,2,mineralocorticoid receptor signaling pathway,BP,GPER1
7660,GO:0032089,0.151527283395309,0.993785609059193,1,2,NACHT domain binding,MF,TRIM16
7741,GO:0032240,0.151527283395309,0.993785609059193,1,2,negative regulation of nucleobase-containing compound transport,BP,NUP153
7797,GO:0032346,0.151527283395309,0.993785609059193,1,2,positive regulation of aldosterone metabolic process,BP,WNT4
7800,GO:0032349,0.151527283395309,0.993785609059193,1,2,positive regulation of aldosterone biosynthetic process,BP,WNT4
8053,GO:0032714,0.151527283395309,0.993785609059193,1,2,negative regulation of interleukin-5 production,BP,TNFRSF21
8248,GO:0033023,0.151527283395309,0.993785609059193,1,2,mast cell homeostasis,BP,ADAM17
8249,GO:0033024,0.151527283395309,0.993785609059193,1,2,mast cell apoptotic process,BP,ADAM17
8250,GO:0033025,0.151527283395309,0.993785609059193,1,2,regulation of mast cell apoptotic process,BP,ADAM17
8444,GO:0033564,0.151527283395309,0.993785609059193,1,2,anterior/posterior axon guidance,BP,NTN1
8479,GO:0033624,0.151527283395309,0.993785609059193,1,2,negative regulation of integrin activation,BP,PTGER4
8535,GO:0033857,0.151527283395309,0.993785609059193,1,2,diphosphoinositol-pentakisphosphate kinase activity,MF,PPIP5K1
8640,GO:0034165,0.151527283395309,0.993785609059193,1,2,positive regulation of toll-like receptor 9 signaling pathway,BP,RSAD2
8874,GO:0034678,0.151527283395309,0.993785609059193,1,2,integrin alpha8-beta1 complex,CC,NPNT
8878,GO:0034684,0.151527283395309,0.993785609059193,1,2,integrin alphav-beta5 complex,CC,ITGAV
8880,GO:0034686,0.151527283395309,0.993785609059193,1,2,integrin alphav-beta8 complex,CC,ITGAV
8963,GO:0035026,0.151527283395309,0.993785609059193,1,2,leading edge cell differentiation,BP,JUN
9221,GO:0035607,0.151527283395309,0.993785609059193,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR2
9236,GO:0035624,0.151527283395309,0.993785609059193,1,2,receptor transactivation,BP,ADAM17
9239,GO:0035630,0.151527283395309,0.993785609059193,1,2,bone mineralization involved in bone maturation,BP,BMP2
9357,GO:0035868,0.151527283395309,0.993785609059193,1,2,alphav-beta3 integrin-HMGB1 complex,CC,ITGAV
10141,GO:0042704,0.151527283395309,0.993785609059193,1,2,uterine wall breakdown,BP,TGFB2
10765,GO:0044210,0.151527283395309,0.993785609059193,1,2,'de novo' CTP biosynthetic process,BP,CTPS1
11261,GO:0045509,0.151527283395309,0.993785609059193,1,2,interleukin-27 receptor activity,MF,IL27RA
11281,GO:0045588,0.151527283395309,0.993785609059193,1,2,positive regulation of gamma-delta T cell differentiation,BP,SYK
11336,GO:0045659,0.151527283395309,0.993785609059193,1,2,negative regulation of neutrophil differentiation,BP,TRIB1
11639,GO:0046351,0.151527283395309,0.993785609059193,1,2,disaccharide biosynthetic process,BP,B4GALT1
11851,GO:0046832,0.151527283395309,0.993785609059193,1,2,negative regulation of RNA export from nucleus,BP,NUP153
11996,GO:0047389,0.151527283395309,0.993785609059193,1,2,glycerophosphocholine phosphodiesterase activity,MF,GPCPD1
12205,GO:0048382,0.151527283395309,0.993785609059193,1,2,mesendoderm development,BP,ZFP36L1
12453,GO:0050211,0.151527283395309,0.993785609059193,1,2,procollagen galactosyltransferase activity,MF,COLGALT1
12707,GO:0050925,0.151527283395309,0.993785609059193,1,2,negative regulation of negative chemotaxis,BP,ROBO1
13057,GO:0051548,0.151527283395309,0.993785609059193,1,2,negative regulation of keratinocyte migration,BP,EPPK1
13227,GO:0051890,0.151527283395309,0.993785609059193,1,2,regulation of cardioblast differentiation,BP,TGFB2
13542,GO:0060002,0.151527283395309,0.993785609059193,1,2,plus-end directed microfilament motor activity,MF,MYO10
13650,GO:0060157,0.151527283395309,0.993785609059193,1,2,urinary bladder development,BP,TP63
13815,GO:0060406,0.151527283395309,0.993785609059193,1,2,positive regulation of penile erection,BP,OXTR
13891,GO:0060532,0.151527283395309,0.993785609059193,1,2,bronchus cartilage development,BP,SRF
13931,GO:0060594,0.151527283395309,0.993785609059193,1,2,mammary gland specification,BP,FGFR2
14201,GO:0061110,0.151527283395309,0.993785609059193,1,2,dense core granule biogenesis,BP,PRKCA
14211,GO:0061145,0.151527283395309,0.993785609059193,1,2,lung smooth muscle development,BP,SRF
14292,GO:0061386,0.151527283395309,0.993785609059193,1,2,closure of optic fissure,BP,PHACTR4
14569,GO:0070097,0.151527283395309,0.993785609059193,1,2,delta-catenin binding,MF,PLEKHA7
14578,GO:0070110,0.151527283395309,0.993785609059193,1,2,ciliary neurotrophic factor receptor complex,CC,IL6R
14693,GO:0070309,0.151527283395309,0.993785609059193,1,2,lens fiber cell morphogenesis,BP,EPHA2
14695,GO:0070315,0.151527283395309,0.993785609059193,1,2,G1 to G0 transition involved in cell differentiation,BP,ZNF503
14877,GO:0070662,0.151527283395309,0.993785609059193,1,2,mast cell proliferation,BP,LYN
14881,GO:0070666,0.151527283395309,0.993785609059193,1,2,regulation of mast cell proliferation,BP,LYN
14883,GO:0070668,0.151527283395309,0.993785609059193,1,2,positive regulation of mast cell proliferation,BP,LYN
14901,GO:0070704,0.151527283395309,0.993785609059193,1,2,sterol desaturase activity,MF,FADS1
15246,GO:0071403,0.151527283395309,0.993785609059193,1,2,cellular response to high density lipoprotein particle stimulus,BP,ADAM17
15366,GO:0071603,0.151527283395309,0.993785609059193,1,2,endothelial cell-cell adhesion,BP,CYP1B1
15489,GO:0071847,0.151527283395309,0.993785609059193,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
15575,GO:0072034,0.151527283395309,0.993785609059193,1,2,renal vesicle induction,BP,WNT4
15577,GO:0072038,0.151527283395309,0.993785609059193,1,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
15578,GO:0072039,0.151527283395309,0.993785609059193,1,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
15579,GO:0072040,0.151527283395309,0.993785609059193,1,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
15638,GO:0072134,0.151527283395309,0.993785609059193,1,2,nephrogenic mesenchyme morphogenesis,BP,BMP7
15639,GO:0072135,0.151527283395309,0.993785609059193,1,2,kidney mesenchymal cell proliferation,BP,BMP7
15640,GO:0072136,0.151527283395309,0.993785609059193,1,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
15651,GO:0072162,0.151527283395309,0.993785609059193,1,2,metanephric mesenchymal cell differentiation,BP,WNT4
15712,GO:0072262,0.151527283395309,0.993785609059193,1,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,EGR1
15729,GO:0072300,0.151527283395309,0.993785609059193,1,2,positive regulation of metanephric glomerulus development,BP,EGR1
15730,GO:0072301,0.151527283395309,0.993785609059193,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,EGR1
15964,GO:0075732,0.151527283395309,0.993785609059193,1,2,viral penetration into host nucleus,BP,NUP153
16080,GO:0090038,0.151527283395309,0.993785609059193,1,2,negative regulation of protein kinase C signaling,BP,MYADM
16268,GO:0090325,0.151527283395309,0.993785609059193,1,2,regulation of locomotion involved in locomotory behavior,BP,ARRDC3
16433,GO:0097069,0.151527283395309,0.993785609059193,1,2,cellular response to thyroxine stimulus,BP,GCLC
16693,GO:0097638,0.151527283395309,0.993785609059193,1,2,L-arginine import across plasma membrane,BP,SLC7A2
16936,GO:0098914,0.151527283395309,0.993785609059193,1,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,FLNA
17091,GO:0099624,0.151527283395309,0.993785609059193,1,2,atrial cardiac muscle cell membrane repolarization,BP,FLNA
17124,GO:0102092,0.151527283395309,0.993785609059193,1,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,PPIP5K1
17355,GO:1900042,0.151527283395309,0.993785609059193,1,2,positive regulation of interleukin-2 secretion,BP,SPTBN1
17563,GO:1901145,0.151527283395309,0.993785609059193,1,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
17930,GO:1902256,0.151527283395309,0.993785609059193,1,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
18052,GO:1902594,0.151527283395309,0.993785609059193,1,2,multi-organism nuclear import,BP,NUP153
18592,GO:1903847,0.151527283395309,0.993785609059193,1,2,regulation of aorta morphogenesis,BP,EFNB2
18593,GO:1903849,0.151527283395309,0.993785609059193,1,2,positive regulation of aorta morphogenesis,BP,EFNB2
18675,GO:1904020,0.151527283395309,0.993785609059193,1,2,regulation of G-protein coupled receptor internalization,BP,UBQLN2
18819,GO:1904387,0.151527283395309,0.993785609059193,1,2,cellular response to L-phenylalanine derivative,BP,GCLC
18910,GO:1904612,0.151527283395309,0.993785609059193,1,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
18911,GO:1904613,0.151527283395309,0.993785609059193,1,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
18928,GO:1904673,0.151527283395309,0.993785609059193,1,2,negative regulation of somatic stem cell population maintenance,BP,BMP7
19081,GO:1904975,0.151527283395309,0.993785609059193,1,2,response to bleomycin,BP,TIMELESS
19082,GO:1904976,0.151527283395309,0.993785609059193,1,2,cellular response to bleomycin,BP,TIMELESS
19121,GO:1905064,0.151527283395309,0.993785609059193,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
19445,GO:1990108,0.151527283395309,0.993785609059193,1,2,protein linear deubiquitination,BP,CYLD
19459,GO:1990145,0.151527283395309,0.993785609059193,1,2,maintenance of translational fidelity,BP,CDKAL1
19531,GO:1990430,0.151527283395309,0.993785609059193,1,2,extracellular matrix protein binding,MF,ITGAV
19546,GO:1990498,0.151527283395309,0.993785609059193,1,2,mitotic spindle microtubule,CC,HNRNPU
19599,GO:1990730,0.151527283395309,0.993785609059193,1,2,VCP-NSFL1C complex,CC,NSFL1C
19663,GO:1990918,0.151527283395309,0.993785609059193,1,2,double-strand break repair involved in meiotic recombination,BP,BRIP1
19712,GO:2000053,0.151527283395309,0.993785609059193,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19772,GO:2000182,0.151527283395309,0.993785609059193,1,2,regulation of progesterone biosynthetic process,BP,EGR1
19796,GO:2000233,0.151527283395309,0.993785609059193,1,2,negative regulation of rRNA processing,BP,SHQ1
20047,GO:2000670,0.151527283395309,0.993785609059193,1,2,positive regulation of dendritic cell apoptotic process,BP,LYN
20067,GO:2000705,0.151527283395309,0.993785609059193,1,2,regulation of dense core granule biogenesis,BP,PRKCA
20194,GO:2001045,0.151527283395309,0.993785609059193,1,2,negative regulation of integrin-mediated signaling pathway,BP,PHACTR4
20249,GO:2001201,0.151527283395309,0.993785609059193,1,2,regulation of transforming growth factor-beta secretion,BP,FN1
2601,GO:0005899,0.15152728339531,0.993785609059193,1,2,insulin receptor complex,CC,IRS1
7119,GO:0030934,0.15152728339531,0.993785609059193,1,2,anchoring collagen complex,CC,COL12A1
9356,GO:0035867,0.15152728339531,0.993785609059193,1,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,ITGAV
18308,GO:1903225,0.15152728339531,0.993785609059193,1,2,negative regulation of endodermal cell differentiation,BP,COL5A2
4883,GO:0014745,0.151537225478122,0.972281546722475,2,9,negative regulation of muscle adaptation,BP,ERRFI1;NOL3
9286,GO:0035723,0.151833255275823,0.97219410078805,2,9,interleukin-15-mediated signaling pathway,BP,STAT5A;IL15
15205,GO:0071350,0.151833255275823,0.97219410078805,2,9,cellular response to interleukin-15,BP,STAT5A;IL15
1123,GO:0002712,0.152045233874599,0.946688024725775,4,27,regulation of B cell mediated immunity,BP,TFRC;IL27RA;TNF;THOC1
1219,GO:0002889,0.152045233874599,0.946688024725775,4,27,regulation of immunoglobulin mediated immune response,BP,TFRC;IL27RA;TNF;THOC1
6855,GO:0030324,0.152227566070873,0.911235105888759,12,111,lung development,BP,CTGF;TNS3;TNF;TNC;PDPN;FGFR2;ERRFI1;LIF;DHCR7;SRF;DAG1;TIMELESS
16166,GO:0090184,0.152330745513584,0.946550564044647,4,27,positive regulation of kidney development,BP,LIF;EGR1;PDGFB;WNT4
4536,GO:0010608,0.152488155296754,0.883175637655786,44,506,posttranscriptional regulation of gene expression,BP,HSPB1;DAPK3;NOCT;TNF;ENC1;NUP153;PSMB9;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;PABPC4;ZC3H7B;PSME2;DPH2;CTIF;LARP4B;SRRT;ZFP36L1;DKC1;DHFR;ACO1;PRKCA;ZFP36L2;PUM3;AJUBA;RPS9;NUP214;DNAJC1;HNRNPU;HSPA8;ESR1;TCOF1;EIF3B;RBM4;SNIP1;METTL16;EIF5A;PSMC3;POLR2G;CCL5;MAGOH
12647,GO:0050851,0.152554822037867,0.903461929730698,16,161,antigen receptor-mediated signaling pathway,BP,RUNX1;CYLD;GBP1;NFKB1;LYN;PSMB9;ZC3H12A;PSME2;NFKBIA;LGALS3;SYK;CMTM3;TNFRSF21;CD38;PSMC3;SPG21
5546,GO:0016538,0.15259892832202,0.946271929903188,4,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN2B;CDKN1A;CDKN2A;CDK4
14031,GO:0060760,0.152604653877315,0.938425343559377,5,37,positive regulation of response to cytokine stimulus,BP,EDN1;NLRC5;ADAM17;TRAF2;PARP14
3677,GO:0008174,0.152634319991963,0.971956901464501,2,9,mRNA methyltransferase activity,MF,TRMT61A;METTL16
993,GO:0002455,0.152849034892791,0.956827580060746,3,18,humoral immune response mediated by circulating immunoglobulin,BP,C1R;TNF;C1S
18295,GO:1903201,0.15285949197858,0.931952159709396,6,48,regulation of oxidative stress-induced cell death,BP,HSPB1;SOD2;TP53;SFPQ;NOL3;PARP1
10950,GO:0044615,0.152901847162909,0.971877500552238,2,9,nuclear pore nuclear basket,CC,NUP153;NUP214
9360,GO:0035871,0.153109777833712,0.971815723756232,2,9,protein K11-linked deubiquitination,BP,TNFAIP3;OTUD6A
14884,GO:0070669,0.153186162588953,0.971793015599626,2,9,response to interleukin-2,BP,STAT5A;SYK
15207,GO:0071352,0.153186162588953,0.971793015599626,2,9,cellular response to interleukin-2,BP,STAT5A;SYK
3297,GO:0006991,0.153354391833695,0.971742976739339,2,9,response to sterol depletion,BP,LYN;INSIG1
15596,GO:0072075,0.153389755056754,0.971732453494481,2,9,metanephric mesenchyme development,BP,BMP7;WNT4
13013,GO:0051446,0.153415379563739,0.971724827248197,2,9,positive regulation of meiotic cell cycle,BP,LFNG;WNT4
11323,GO:0045646,0.153484952142175,0.937955571923434,5,37,regulation of erythrocyte differentiation,BP,MAFB;INHBA;LYN;ETS1;ZFP36L1
13558,GO:0060021,0.153733570400226,0.926421646032651,7,57,roof of mouth development,BP,INHBA;TGFB2;OSR2;SNAI2;FRAS1;PAK1IP1;INSIG1
19901,GO:2000392,0.153868032225145,0.971589971100216,2,9,regulation of lamellipodium morphogenesis,BP,CORO1C;PDPN
14825,GO:0070561,0.153880689601069,0.971586196360651,2,9,vitamin D receptor signaling pathway,BP,CYP24A1;SNAI2
5088,GO:0015347,0.154107381056661,0.971518556397849,2,9,sodium-independent organic anion transmembrane transporter activity,MF,SLCO3A1;SLC22A4
9897,GO:0042180,0.154229660277659,0.90221954400522,16,162,cellular ketone metabolic process,BP,ODC1;ADM;NQO1;PANK2;IRS1;PSMB9;BMP2;PSME2;EGR1;IRS2;AKR1C2;CPT1A;INSIG1;WNT4;AKR1C1;PSMC3
720,GO:0001946,0.154230282482972,0.971481857470552,2,9,lymphangiogenesis,BP,PDPN;PTPN14
1241,GO:0002934,0.1542565251801,0.971474018755903,2,9,desmosome organization,BP,SNAI2;PRKCA
2181,GO:0005031,0.154494572420664,0.956149449116853,3,18,tumor necrosis factor-activated receptor activity,MF,RELT;TNFRSF21;TNFRSF10A
2183,GO:0005035,0.154494572420664,0.956149449116853,3,18,death receptor activity,MF,RELT;TNFRSF21;TNFRSF10A
17644,GO:1901379,0.154544595952203,0.937388787285434,5,37,regulation of potassium ion transmembrane transport,BP,FLNA;NEDD4L;KCNIP3;CAB39;OXSR1
7389,GO:0031441,0.154585639487563,0.971375636595768,2,9,negative regulation of mRNA 3'-end processing,BP,NELFE;SUPT5H
14248,GO:0061298,0.154614745479732,0.97136692921393,2,9,retina vasculature development in camera-type eye,BP,CYP1B1;COL4A1
3445,GO:0007254,0.154621499612013,0.902003946376167,16,157,JNK cascade,BP,PTGER4;CTGF;EDN1;MARVELD3;GADD45A;TNF;GADD45B;DAXX;SFRP1;TRAF2;SYK;IL1A;TRIB1;PHLPP1;RAPGEF1;TRAF4
12348,GO:0048710,0.15462335729682,0.956096222114492,3,18,regulation of astrocyte differentiation,BP,BMP2;LIF;PRPF19
3781,GO:0008340,0.154640497065276,0.971359224429071,2,9,determination of adult lifespan,BP,TFCP2L1;TP53
14971,GO:0070875,0.154652450456644,0.971355647725245,2,9,positive regulation of glycogen metabolic process,BP,IRS1;IRS2
6061,GO:0019209,0.154871166715322,0.925676183828358,7,58,kinase activator activity,MF,NRG1;CDKN1A;DAXX;RPLP1;AFAP1L2;CAB39;CCL5
15464,GO:0071800,0.154912738934333,0.955976538556324,3,18,podosome assembly,BP,CSF2;TNF;LCP1
11446,GO:0045892,0.15497247322422,0.873363034862899,76,892,negative regulation of transcription, DNA-templated,BP,NRG1;HDAC9;PML;TFCP2L1;IRX2;RELB;CSF2;EDN1;TP53;SQSTM1;FST;NFKB1;AHR;JUNB;TNF;CDKN2A;RING1;WWC1;FGFR2;NFKB2;DNAJB1;FLNA;CCDC85B;TSC22D3;BMP2;DAXX;ELF3;OSR2;SFRP1;IRF1;NFX1;PSPC1;SRF;TRIM29;EGR1;SNAI2;NELFE;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;LANCL2;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;KCNIP3;ETS2;KLF10;CITED2;HSPA8;JUN;ESR1;NOC2L;NACC1;ZNF703;XRCC6;GLIS3;BMP7;KCTD1;MPHOSPH8;TIMELESS;WNT4;CD38;SMARCC2;EFNA1;GCLC;PARP1;TP63
17572,GO:1901184,0.155126978457954,0.917577528624124,9,79,regulation of ERBB signaling pathway,BP,NRG1;MMP9;GPRC5A;ERRFI1;EPGN;GPER1;ADAM17;RNF115;AFAP1L2
10520,GO:0043434,0.155259955329008,0.88903063627162,28,297,response to peptide hormone,BP,TRIM16;HDAC9;NEFL;CTGF;ADM;FBN1;EDN1;NFKB1;IRS1;LYN;BAIAP2;ICAM1;CDK4;ERRFI1;STAT5A;GPER1;EGR1;ZFP36L1;IRS2;OXTR;SOCS1;QDPR;BMP7;DAG1;BRIP1;GCLC;PARP1;BAIAP2L2
10549,GO:0043500,0.155409348115163,0.925350693355448,7,58,muscle adaptation,BP,EDN1;G6PD;ERRFI1;IL15;PRKCA;NOL3;PARP1
1399,GO:0003333,0.155598936118717,0.93045592808893,6,47,amino acid transmembrane transport,BP,SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
12537,GO:0050686,0.155632874171355,0.944952923383785,4,27,negative regulation of mRNA processing,BP,NELFE;U2AF2;SUPT5H;SRSF7
4575,GO:0010660,0.155794382149928,0.936718471203059,5,37,regulation of muscle cell apoptotic process,BP,EDN1;CDKN2A;ZC3H12A;BMP7;NOL3
17692,GO:1901570,0.155825658335126,0.925041445229291,7,59,fatty acid derivative biosynthetic process,BP,PTGES;EDN1;SCD;SYK;ACSL1;SCD5;FADS1
5504,GO:0016447,0.155884944537129,0.936669821844696,5,37,somatic recombination of immunoglobulin gene segments,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
10475,GO:0043367,0.155922339077525,0.936649730789282,5,37,CD4-positive, alpha-beta T cell differentiation,BP,PTGER4;RELB;CD83;RSAD2;SMAD7
15277,GO:0071456,0.155940842055193,0.902583586688912,15,151,cellular response to hypoxia,BP,EDN1;TP53;PSMB9;ICAM1;PGK1;SFRP1;PSME2;EGR1;ZFP36L1;AJUBA;CITED2;BMP7;PSMC3;BRIP1;NOL3
13012,GO:0051445,0.155949491205742,0.94479898335137,4,27,regulation of meiotic cell cycle,BP,LFNG;LIF;DUSP1;WNT4
2929,GO:0006446,0.156219953239959,0.920468089303283,8,70,regulation of translational initiation,BP,HSPB1;TNF;EIF5;CTIF;EIF3B;RBM4;POLR2G;CCL5
10567,GO:0043525,0.156424459783304,0.936276469144105,5,38,positive regulation of neuron apoptotic process,BP,NQO1;MYBL2;TGFB2;TP53;JUN
5016,GO:0015179,0.156849489004265,0.936151034679808,5,37,L-amino acid transmembrane transporter activity,MF,SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC25A22
12818,GO:0051123,0.156886094808265,0.944188347318846,4,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;TAF4B;ESR1;PSMC3
15245,GO:0071402,0.156940424204847,0.955134755267381,3,18,cellular response to lipoprotein particle stimulus,BP,HMGCS1;ADAM17;SYK
19799,GO:2000242,0.156993188707775,0.944135989840517,4,28,negative regulation of reproductive process,BP,LIF;DUSP1;BMP7;WNT4
15213,GO:0071359,0.157151348214252,0.924294825783352,7,58,cellular response to dsRNA,BP,NFKB1;ZC3H12A;ZC3H7B;SRRT;PQBP1;ESR1;SNIP1
2604,GO:0005902,0.157299456642197,0.9293996397572,6,48,microvillus,CC,S100P;PDPN;ITGAV;ANKS4B;OXTR;DCXR
15636,GO:0072132,0.157652952071648,0.94396850072875,4,27,mesenchyme morphogenesis,BP,TGFB2;BMP2;SNAI2;BMP7
5682,GO:0016796,0.157680121852789,0.929179685375564,6,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,USB1;NOCT;APTX;FEN1;ISG20L2;APEX2
13040,GO:0051496,0.157875085777341,0.935598124827374,5,37,positive regulation of stress fiber assembly,BP,CTGF;SDC4;SFRP1;TPM1;WNT4
9824,GO:0042036,0.15790776562635,0.954731220074389,3,18,negative regulation of cytokine biosynthetic process,BP,INHBA;NFKB1;ERRFI1
10270,GO:0043010,0.158069479091347,0.895267043503732,19,191,camera-type eye development,BP,CRYAB;INHBA;CYP1B1;TENM3;CYP1A1;FBN1;TGFB2;RING1;COL4A1;EPHA2;CDK4;OSR2;CC2D2A;SRF;SDK1;JUN;BMP7;TTLL5;PHACTR4
12403,GO:0048844,0.1581030343127,0.935475055799027,5,37,artery morphogenesis,BP,TGFB2;ADAMTS9;EFNB2;SRF;SMAD7
1992,GO:0004713,0.158123504859171,0.907138252714645,12,111,protein tyrosine kinase activity,MF,NRG1;CSF2;LYN;FGFR2;EPHB6;TNK1;EPHA2;STAT5A;FGFR1OP;SYK;ROR1;CLK4
20214,GO:2001141,0.159116331088301,0.859440701972164,231,2846,regulation of RNA biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;CREB5;SNF8;GCLC;PARP1;TP63;ZBTB12;CCL5;FADS1
3179,GO:0006796,0.159160771019134,0.860813335209557,187,2289,phosphate-containing compound metabolic process,BP,IGFBP3;SAA1;CCL20;CRYAB;NRG1;MMP9;CYR61;PTGER4;INHBA;FN1;NEFL;CTGF;C1QTNF1;ADM;DUSP14;PML;HSPB1;SDC4;GPRC5A;CSF2;MAP3K14;TGFB2;EDN1;SH3RF2;GBP1;IKBKE;PLBD1;MID1;DAPK3;DBNDD2;G6PD;EMP2;NUAK1;NLRC5;TP53;SQSTM1;MARVELD3;IL24;PANK2;NFKB1;CDKN2B;GNPTAB;IRS1;CDKN1A;TJP2;LYN;HMGXB3;GADD45A;TNF;CDKN2A;CORO1C;PKMYT1;WWC1;TRIO;FGFR2;PTPN14;NUP153;PSMB9;EPHB6;TELO2;PGD;TYMS;ZC3H12A;TNK1;TK1;EPHA2;CHP1;HMGCS1;GADD45B;ICAM1;BMP2;CDK4;ITGAV;ERRFI1;SFN;STAT5A;EPGN;ADRB2;IL20;DAXX;PGK1;AKAP8L;LIF;SFRP1;APTX;PPP1R3B;PSME2;ABHD4;GPER1;EGR1;SGK1;CD2BP2;ZFP36L1;AKAP8;NELFE;ADAM17;GPCPD1;FGFR1OP;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;SYK;ROBO1;AJUBA;PPIP5K1;CDKL1;PDGFB;OXTR;NSFL1C;SPTBN1;COX5B;NPNT;IL1A;CAMK1G;TNIP2;RASGRP4;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;NOL9;HNRNPU;PPP1R14C;TRIB1;TPST1;PPP1R9B;LPCAT3;PARP14;PCYT1A;DUSP1;CAB39;CD109;SOCS1;OXSR1;HSPA8;JUN;PIGM;ESR1;GLIPR2;DCXR;MCM7;SERTAD1;DUS2;PARD3;GPNMB;XRCC6;SMPD2;BMP7;SMUG1;PHLPP1;TKT;TNFRSF10A;RAPGEF1;MYADM;DAG1;PDE6A;GPX4;DPM3;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;CCL22;RRM2;EFNA1;MAPK11;CTPS1;BMP8A;CARD10;PTPRB;DUSP8;HSP90AB1;SWAP70;IL6R;PARP1;CLK4;PHACTR4;CCL5;FADS1
12542,GO:0050691,0.159174232369173,0.943066427527953,4,28,regulation of defense response to virus by host,BP,ZC3H12A;IL15;PQBP1;TNFAIP3
1863,GO:0004527,0.159352454882389,0.918532803113009,8,69,exonuclease activity,MF,USB1;NOCT;ZC3H12A;AEN;APTX;FEN1;ISG20L2;APEX2
1176,GO:0002823,0.159363243865839,0.954121688872071,3,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL7R;SMAD7;THOC1
2905,GO:0006414,0.159390821039849,0.905944804476477,12,125,translational elongation,BP,DPH2;RPLP2;RPLP1;MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;EFTUD2;EIF5A;EEF1D;MRPS2
14950,GO:0070841,0.160002957917375,0.953852889290366,3,18,inclusion body assembly,BP,SACS;DNAJB1;DNAJB2
19688,GO:2000008,0.160388960385046,0.942468044963469,4,28,regulation of protein localization to cell surface,BP,NRG1;TNF;NEDD4L;HSP90AB1
9833,GO:0042058,0.160465869011309,0.917826146821845,8,69,regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;GPRC5A;ERRFI1;EPGN;GPER1;ADAM17;RNF115;AFAP1L2
2620,GO:0005938,0.160634798432087,0.889908505553474,22,226,cell cortex,CC,CTGF;NEDD9;DST;FGFR2;TPM4;FLNA;MYO10;WDR1;PARD3B;RHOB;TRAF2;SPTBN1;DCTN1;MYH9;LANCL2;CLASP1;MICAL3;PARD3;ACTN4;PHLDB2;MYADM;CLTA
2591,GO:0005885,0.160754987960841,0.96893170169009,2,10,Arp2/3 protein complex,CC,ARPC4;ARPC1B
561,GO:0001701,0.160922407773164,0.887750049110884,24,250,in utero embryonic development,BP,CYR61;ADM;AMOT;CSF2;EDN1;JUNB;FGFR2;FOSL1;SLC39A1;BMP2;ELF3;LIF;SRF;PRPF19;ZFP36L1;PDGFB;RRP7A;MYH9;COPS3;MAFF;KEAP1;BMP7;PSMC3;MYO1E
9068,GO:0035304,0.160956688649288,0.907625853302026,11,102,regulation of protein dephosphorylation,BP,IGFBP3;SH3RF2;NUAK1;TNF;PPP1R3B;NSFL1C;PPP1R14C;PPP1R9B;HSP90AB1;SWAP70;PHACTR4
8803,GO:0034504,0.161019923007821,0.891782008338738,20,205,protein localization to nucleus,BP,PML;CDKN1A;TNF;NUP153;ZC3H12A;CHP1;LIF;TRIM29;NFKBIA;RRS1;POLR1A;PTTG1IP;NUP214;HNRNPU;TNPO3;BMP7;IPO4;DAG1;CARD10;HSP90AB1
19278,GO:1905475,0.161167935291853,0.902688996419135,13,125,regulation of protein localization to membrane,BP,GBP1;TP53;SQSTM1;EPHA2;CHP1;SFN;GPER1;SPTBN1;YWHAH;STAC;TFDP1;RHOG;TP63
8926,GO:0034767,0.161188174424946,0.917320063618429,8,70,positive regulation of ion transmembrane transport,BP,JPH2;G6PD;FLNA;CHP1;ADRB2;GPER1;STAC;ACTN4
1462,GO:0003712,0.161411792484889,0.876930536923295,41,456,transcription cofactor activity,MF,NRG1;HDAC9;TFCP2L1;PDLIM1;RELB;NFE2L1;TAF4B;JUNB;WWC1;PTPN14;NFKB2;DNAJB1;SRSF2;KLF7;DAXX;FUS;ELF3;TRIM22;MKL1;MED22;SF1;EDF1;PPRC1;DDX17;NFKBIB;AJUBA;FHL2;HNRNPU;PQBP1;RUVBL2;ABT1;KCNIP3;CITED2;JUN;TFDP1;NOC2L;ACTN4;KCTD1;WNT4;RBM14;SMARCC2
18580,GO:1903825,0.161560839652733,0.913376331583849,9,79,organic acid transmembrane transport,BP,SLC7A5;SLC7A5P2;SLC5A6;IRS2;SLC7A2;SLC43A2;CPT1A;SLC3A2;SLC25A22
19108,GO:1905039,0.161560839652733,0.913376331583849,9,79,carboxylic acid transmembrane transport,BP,SLC7A5;SLC7A5P2;SLC5A6;IRS2;SLC7A2;SLC43A2;CPT1A;SLC3A2;SLC25A22
3301,GO:0006998,0.161815478936699,0.913169508248891,9,80,nuclear envelope organization,BP,NUP153;AKAP8L;BANF1;GPER1;PRKCA;NSFL1C;DCTN1;NUP214;CHMP4B
5392,GO:0016229,0.16193900416202,0.952778036413318,3,19,steroid dehydrogenase activity,MF,AKR1C2;AKR1C1;HSD17B10
14350,GO:0061564,0.162108563684782,0.8815139949571,31,332,axon development,BP,NRG1;MAP2;FN1;NEFL;NEFM;BAIAP2;EFNB2;TNC;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;SEMA3C;ENAH;JUN;PARD3;ZSWIM6;EFNB1;LRFN4;BMP7;DAG1;EFNA1
2870,GO:0006362,0.16234127718166,0.941353276077814,4,29,transcription elongation from RNA polymerase I promoter,BP,CD3EAP;POLR1A;UBTF;POLR1E
7075,GO:0030863,0.162408613785271,0.912819452536963,9,79,cortical cytoskeleton,CC,TPM4;FLNA;WDR1;SPTBN1;MYH9;LANCL2;CLASP1;ACTN4;MYADM
16194,GO:0090218,0.162867186896233,0.952642675474714,3,18,positive regulation of lipid kinase activity,BP,IRS1;LYN;PDGFB
8265,GO:0033045,0.163003367809498,0.916163087965191,8,70,regulation of sister chromatid segregation,BP,UBE2C;FEN1;SFPQ;ZW10;HNRNPU;ANAPC15;DUSP1;CDCA5
2643,GO:0005979,0.163079291140885,0.952552620881373,3,18,regulation of glycogen biosynthetic process,BP,IRS1;PPP1R3B;IRS2
4777,GO:0010962,0.163079291140885,0.952552620881373,3,18,regulation of glucan biosynthetic process,BP,IRS1;PPP1R3B;IRS2
790,GO:0002053,0.163271593182235,0.952470922113388,3,18,positive regulation of mesenchymal cell proliferation,BP,FGFR2;IRS2;TP63
2539,GO:0005796,0.163447633833209,0.925825847661928,6,48,Golgi lumen,CC,SDC4;HSPG2;HS3ST1;PDGFB;DAG1;WNT4
7852,GO:0032412,0.163488281690565,0.901033203720073,13,125,regulation of ion transmembrane transporter activity,BP,MMP9;JPH2;JPH1;CHP1;ADRB2;FXYD3;NEDD4L;YWHAH;RRAD;CAB39;STAC;OXSR1;ACTN4
9069,GO:0035305,0.163499939712191,0.912061421839409,9,80,negative regulation of dephosphorylation,BP,TGFB2;SH3RF2;TNF;PKMYT1;CHP1;CD2BP2;PPP1R14C;PPP1R9B;SWAP70
9198,GO:0035580,0.163839484966507,0.932144810195178,5,39,specific granule lumen,CC,NFKB1;QPCT;ACAA1;VCL;RAB27A
3118,GO:0006695,0.163984340055044,0.920059000390911,7,59,cholesterol biosynthetic process,BP,G6PD;SCD;LSS;HMGCS1;EBP;DHCR7;INSIG1
11475,GO:0045931,0.16404794686171,0.902912501646407,12,114,positive regulation of mitotic cell cycle,BP,CYP1A1;EDN1;PBX1;UBE2C;CDK4;EPGN;PRKCA;PDGFB;IL1A;RCC2;HNRNPU;CDCA5
13174,GO:0051775,0.164049702728665,0.967895191422999,2,10,response to redox state,BP,NPAS2;RNF7
10181,GO:0042772,0.164436073569606,0.951711912998495,3,19,DNA damage response, signal transduction resulting in transcription,BP,TP53;CDKN1A;TP63
16565,GO:0097345,0.164539021493771,0.925109697230776,6,49,mitochondrial outer membrane permeabilization,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;TP63
8204,GO:0032956,0.164727418243064,0.885681185556961,23,241,regulation of actin cytoskeleton organization,BP,PTGER4;CTGF;SDC4;EDN1;DAPK3;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;RHOB;SPTBN1;CLASP1;RHOG;KANK4;PHLDB2;MYADM;WNT4;SWAP70;BAIAP2L2
3591,GO:0008015,0.164760761266497,0.884710303496289,24,252,blood circulation,BP,CTGF;ADM;SOD2;TGFB2;EDN1;EMP2;NAV2;C9ORF3;ZC3H12A;FLNA;ICAM1;ADRB2;FXYD3;TPM1;GPER1;SGK1;PDGFB;OXTR;NEDD4L;SMAD7;KCNIP3;CD38;GCLC;TBXA2R
562,GO:0001702,0.164871461885851,0.951789318744962,3,18,gastrulation with mouth forming second,BP,AMOT;SRF;ETS2
17106,GO:0099738,0.16497201944639,0.940193156855734,4,28,cell cortex region,CC,DCTN1;CLASP1;PHLDB2;CLTA
16518,GO:0097225,0.16497952322144,0.967600124018271,2,10,sperm midpiece,CC,SQSTM1;CCR6
15092,GO:0071103,0.165108640778789,0.886260455650444,22,245,DNA conformation change,BP,TP53;MCM5;CDKN2A;DAXX;MCM2;AKAP8L;GRWD1;GPER1;AKAP8;GINS2;RUVBL2;CENPN;MCM7;NOC2L;CENPO;XRCC6;IPO4;CHAF1A;BRIP1;CDCA5;PARP1;TOP3A
10222,GO:0042887,0.165290652571144,0.939881708556683,4,29,amide transmembrane transporter activity,MF,TAP1;TAPBP;TAP2;TOMM40
3663,GO:0008146,0.165440335754828,0.939959170417235,4,28,sulfotransferase activity,MF,HS3ST2;HS3ST1;CHST3;TPST1
16085,GO:0090049,0.165995362851362,0.939681494690241,4,28,regulation of cell migration involved in sprouting angiogenesis,BP,HDAC9;STARD13;CARD10;TBXA2R
10541,GO:0043488,0.166133254617631,0.896974756643724,14,141,regulation of mRNA stability,BP,HSPB1;NOCT;PSMB9;ZC3H12A;PABPC4;PSME2;ZFP36L1;PRKCA;ZFP36L2;NUP214;HNRNPU;HSPA8;METTL16;PSMC3
2899,GO:0006406,0.166196009440107,0.903979602939631,11,103,mRNA export from nucleus,BP,NUP153;SRSF2;AKAP8L;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
15260,GO:0071427,0.166196009440107,0.903979602939631,11,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153;SRSF2;AKAP8L;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
2939,GO:0006464,0.166211481657097,0.852444827484579,249,3079,cellular protein modification process,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CTGF;C1QTNF1;DTX2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;TP53;SQSTM1;MARVELD3;IL24;P4HA2;NFKB1;CPA4;CDKN2B;LFNG;IRS1;GALNT18;CDKN1A;LYN;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;FGFR2;PTPN14;NUP153;PSMB9;EPHB6;TELO2;QPCT;UBE2C;ZC3H12A;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;TRIM22;ZDHHC3;PPP1R3B;PSME2;DPH2;GPER1;DNAJB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;BRMS1;OXTR;RPS2;PTTG1IP;NSFL1C;SPTBN1;NEDD4L;RNF115;UHRF1;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MTA2;KEAP1;ZDHHC6;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;PARP14;PRDM7;GALNT2;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;DTX4;ESR1;USP31;BRPF1;GLIPR2;NOC2L;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;LAMC1;GPNMB;XRCC6;KBTBD12;BMP7;PHLPP1;TNFRSF10A;RNF7;MPHOSPH8;INCENP;RAPGEF1;EIF5A;MYADM;DAG1;TMEM165;MGAT2;RNF185;ASB6;DPM3;RBM14;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;METTL21A;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;DUSP8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;OTUD6A;PHACTR4;CCL5
9517,GO:0036211,0.166211481657097,0.852444827484579,249,3079,protein modification process,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CTGF;C1QTNF1;DTX2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;TP53;SQSTM1;MARVELD3;IL24;P4HA2;NFKB1;CPA4;CDKN2B;LFNG;IRS1;GALNT18;CDKN1A;LYN;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;FGFR2;PTPN14;NUP153;PSMB9;EPHB6;TELO2;QPCT;UBE2C;ZC3H12A;TNK1;EPHA2;CHP1;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;TRIM22;ZDHHC3;PPP1R3B;PSME2;DPH2;GPER1;DNAJB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;AKAP8;NELFE;ADAM17;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;BRMS1;OXTR;RPS2;PTTG1IP;NSFL1C;SPTBN1;NEDD4L;RNF115;UHRF1;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MTA2;KEAP1;ZDHHC6;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;PARP14;PRDM7;GALNT2;DUSP1;CAB39;CD109;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;DTX4;ESR1;USP31;BRPF1;GLIPR2;NOC2L;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;LAMC1;GPNMB;XRCC6;KBTBD12;BMP7;PHLPP1;TNFRSF10A;RNF7;MPHOSPH8;INCENP;RAPGEF1;EIF5A;MYADM;DAG1;TMEM165;MGAT2;RNF185;ASB6;DPM3;RBM14;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;METTL21A;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;DUSP8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;OTUD6A;PHACTR4;CCL5
7428,GO:0031529,0.166599969812334,0.930730373676922,5,38,ruffle organization,BP,CORO1C;ICAM1;TPM1;RCC2;RHOG
15757,GO:0072347,0.166720511756586,0.930663902954214,5,38,response to anesthetic,BP,OXTR;SDK1;PPP1R9B;EFTUD2;HSP90AB1
10059,GO:0042542,0.166777312846658,0.903520996773491,11,105,response to hydrogen peroxide,BP,CRYAB;CYP1B1;NQO1;TP53;FOSL1;APTX;ETS1;RHOB;DUSP1;JUN;TNFAIP3
16370,GO:0090670,0.166872087051337,0.950663859098689,3,19,RNA localization to Cajal body,BP,DKC1;SHQ1;RUVBL2
16371,GO:0090671,0.166872087051337,0.950663859098689,3,19,telomerase RNA localization to Cajal body,BP,DKC1;SHQ1;RUVBL2
16372,GO:0090672,0.166872087051337,0.950663859098689,3,19,telomerase RNA localization,BP,DKC1;SHQ1;RUVBL2
16376,GO:0090685,0.166872087051337,0.950663859098689,3,19,RNA localization to nucleus,BP,DKC1;SHQ1;RUVBL2
12424,GO:0048872,0.167171746858494,0.891085451111813,17,172,homeostasis of number of cells,BP,MAFB;INHBA;CYLD;G6PD;NFE2L1;LYN;TSC22D3;FANCC;IL7R;SRF;DOCK10;ETS1;ZFP36L1;ADAM17;FOXN1;UBAP2L;TNFAIP3
16799,GO:0098641,0.16717661220089,0.950532288314198,3,19,cadherin binding involved in cell-cell adhesion,MF,PDLIM1;BAIAP2;TRIM29
12347,GO:0048709,0.167272322982655,0.918029539753373,7,59,oligodendrocyte differentiation,BP,NRG1;LYN;WDR1;TNFRSF21;ZNF365;CNTNAP1;DAG1
17350,GO:1900037,0.167467713384061,0.966805019872528,2,10,regulation of cellular response to hypoxia,BP,AJUBA;NOL3
5011,GO:0015171,0.167591393694082,0.923391796270413,6,48,amino acid transmembrane transporter activity,MF,SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
1390,GO:0003300,0.167608473257607,0.923381721767734,6,48,cardiac muscle hypertrophy,BP,EDN1;G6PD;ERRFI1;PRKCA;SORBS2;PARP1
4937,GO:0014897,0.167608473257607,0.923381721767734,6,48,striated muscle hypertrophy,BP,EDN1;G6PD;ERRFI1;PRKCA;SORBS2;PARP1
16906,GO:0098862,0.168589458486124,0.908655043499511,9,81,cluster of actin-based cell projections,CC,B4GALT1;MYO1B;ANKS4B;SLC5A6;MYH9;DCXR;ACTN4;MYO1E;HSP90AB1
10564,GO:0043522,0.168939740453741,0.96633086179977,2,10,leucine zipper domain binding,MF,DAPK3;MKL1
10047,GO:0042501,0.169374605055374,0.966190250834525,2,10,serine phosphorylation of STAT protein,BP,IL24;LIF
8044,GO:0032693,0.16937488578958,0.966190159981869,2,10,negative regulation of interleukin-10 production,BP,CD274;TNFRSF21
7986,GO:0032602,0.169410772345076,0.922161102188333,6,50,chemokine production,BP,TNF;EGR1;SNAI2;ADAM17;IL1A;IL6R
13170,GO:0051767,0.169879258160494,0.966026768029029,2,10,nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1
13171,GO:0051769,0.169879258160494,0.966026768029029,2,10,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1
11245,GO:0045444,0.169952061160533,0.892354836323781,15,148,fat cell differentiation,BP,STEAP4;NOCT;TNF;TRIO;ZC3H12A;CCDC85B;BMP2;ADRB2;SFRP1;GPER1;SNAI2;ZFP36L1;ZFP36L2;SOCS1;INSIG1
7838,GO:0032392,0.170007523932321,0.907711981102971,9,81,DNA geometric change,BP,TP53;MCM5;MCM2;GINS2;RUVBL2;MCM7;XRCC6;BRIP1;PARP1
10416,GO:0043254,0.170305517796257,0.874803404789166,31,338,regulation of protein complex assembly,BP,CRYAB;PTGER4;MAP2;CSF2;TP53;ARPC4;TNF;BAIAP2;FOSL1;LCP1;ICAM1;CDC42EP2;ARPC1B;TFIP11;SRF;AJUBA;SPTBN1;DCTN1;SLAIN2;CLASP1;HSPA8;JUN;ESR1;INSIG1;RHOG;KANK4;MYADM;PSMC3;CLDN7;PARP1;BAIAP2L2
6910,GO:0030500,0.170990016821522,0.928298054948168,5,38,regulation of bone mineralization,BP,BMP2;ADRB2;OSR2;BMP7;WNT4
19747,GO:2000134,0.171110844896019,0.90351879372097,10,93,negative regulation of G1/S transition of mitotic cell cycle,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;SFN;TFDP1;GPNMB;CTDSP1;TP63
9133,GO:0035456,0.17114824049749,0.948557528647532,3,20,response to interferon-beta,BP,IKBKE;XAF1;IRF1
4385,GO:0010038,0.171341083085821,0.882593303757958,21,221,response to metal ion,BP,MMP9;NQO1;CYP1A1;PTGES;EDN1;G6PD;TP53;JUNB;ICAM1;CDK4;DAXX;FUS;KRT14;ACO1;NEDD4L;IL1A;DUSP1;JUN;QDPR;GCLC;PARP1
14986,GO:0070897,0.171381968267953,0.927971507976951,5,39,DNA-templated transcriptional preinitiation complex assembly,BP,TP53;TAF4B;UBTF;ESR1;PSMC3
9072,GO:0035308,0.171463626740847,0.927925944264923,5,39,negative regulation of protein dephosphorylation,BP,SH3RF2;TNF;PPP1R14C;PPP1R9B;SWAP70
769,GO:0002021,0.171689336627903,0.965437688029256,2,10,response to dietary excess,BP,ADRB2;BMP8A
6641,GO:0023026,0.171878282654314,0.965375953011517,2,10,MHC class II protein complex binding,MF,HSPA8;HSP90AB1
5604,GO:0016645,0.171946592568998,0.948455401635695,3,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,DHFR;AASS;QDPR
17311,GO:0140112,0.172328828918444,0.948287674189981,3,19,extracellular vesicle biogenesis,BP,SDC4;RAB27A;SNF8
9019,GO:0035196,0.172550135290565,0.927427992189134,5,38,production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A;ZC3H7B;SRRT;ESR1;SNIP1
6810,GO:0030261,0.172999999691461,0.936143211432517,4,28,chromosome condensation,BP,AKAP8L;GPER1;AKAP8;CDCA5
286,GO:0000790,0.17334411294422,0.875157430287219,27,304,nuclear chromatin,CC,TP53;JUNB;RING1;ENC1;TELO2;DAXX;APTX;IRF1;SRF;ZFP42;SNAI2;CBX5;BRMS1;UHRF1;MTA2;RUVBL2;CITED2;JUN;ESR1;RCC1;MPHOSPH8;IPO4;CHAF1A;TIMELESS;SMARCC2;CDCA5;TP63
950,GO:0002369,0.173384402685178,0.947823484608708,3,19,T cell cytokine production,BP,RSAD2;TRAF2;SMAD7
11628,GO:0046330,0.173991121670077,0.901579049370866,10,92,positive regulation of JNK cascade,BP,CTGF;EDN1;GADD45A;TNF;GADD45B;DAXX;TRAF2;SYK;IL1A;TRAF4
15441,GO:0071715,0.174009725712776,0.947547807762531,3,19,icosanoid transport,BP,EDN1;SLCO3A1;SYK
17693,GO:1901571,0.174009725712776,0.947547807762531,3,19,fatty acid derivative transport,BP,EDN1;SLCO3A1;SYK
776,GO:0002031,0.174308784407417,0.964577724623277,2,10,G-protein coupled receptor internalization,BP,ADM;UBQLN2
1898,GO:0004582,0.174344644905389,0.989004315305632,1,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
8340,GO:0033185,0.174344644905389,0.989004315305632,1,3,dolichol-phosphate-mannose synthase complex,CC,DPM3
16313,GO:0090481,0.174359431219987,0.964561010220765,2,10,pyrimidine nucleotide-sugar transmembrane transport,BP,SLC35A4;SLC35C2
18073,GO:1902653,0.174400533358475,0.913525902216665,7,60,secondary alcohol biosynthetic process,BP,G6PD;SCD;LSS;HMGCS1;EBP;DHCR7;INSIG1
1259,GO:0003013,0.174633906539208,0.876865981818774,24,254,circulatory system process,BP,CTGF;ADM;SOD2;TGFB2;EDN1;EMP2;NAV2;C9ORF3;ZC3H12A;FLNA;ICAM1;ADRB2;FXYD3;TPM1;GPER1;SGK1;PDGFB;OXTR;NEDD4L;SMAD7;KCNIP3;CD38;GCLC;TBXA2R
8114,GO:0032800,0.174636930248313,0.947270785965084,3,19,receptor biosynthetic process,BP,EDN1;TNF;ITGAV
6743,GO:0030162,0.17468786260245,0.8640899891413,45,518,regulation of proteolysis,BP,CRYAB;MMP9;CYR61;FN1;C1R;CTGF;IL1R2;PML;BIRC3;TRAF3;UBQLN2;LYN;TNF;PSMB9;CLN6;ZC3H12A;SFN;RNF19B;SERPINE1;PARL;ANXA8;PSME2;GPER1;ABTB2;SNX12;TRAF2;ROBO1;SERPINH1;MYH9;SMAD7;DNAJC1;KEAP1;TRIB1;A2ML1;CD109;HSPBP1;TNFRSF10A;PSMC3;EFNA1;RNF144B;NOL3;GCLC;HSP90AB1;TP63;C1S
12701,GO:0050919,0.174932952529367,0.935155809772501,4,28,negative chemotaxis,BP,NRG1;ITGAV;ROBO1;SEMA3C
17953,GO:1902305,0.175028474021909,0.925928929734928,5,39,regulation of sodium ion transmembrane transport,BP,CHP1;FXYD3;NEDD4L;YWHAH;ACTN4
6070,GO:0019219,0.175192559126539,0.843805653769962,263,3265,regulation of nucleobase-containing compound metabolic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;TFRC;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;IL27RA;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;TOX4;USP36;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;IL7R;NFX1;PSPC1;TFIP11;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;SHQ1;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;SF3B4;PRKCA;ZNF778;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;NEDD4L;SNRNP70;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;HNRNPF;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;RBM38;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EEF1D;DHX34;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;PARP1;CLK4;TP63;ZBTB12;CCL5;FADS1;MAGOH
4826,GO:0014029,0.175217473463952,0.964277338418468,2,10,neural crest formation,BP,SFRP1;TCOF1
15806,GO:0072498,0.175258184213376,0.964263855762148,2,10,embryonic skeletal joint development,BP,OSR2;BMP7
6935,GO:0030540,0.175757956078611,0.964098166728939,2,10,female genitalia development,BP,ESR1;TP63
4784,GO:0010971,0.175810988301724,0.946750845461603,3,19,positive regulation of G2/M transition of mitotic cell cycle,BP,PBX1;CDK4;RCC2
4936,GO:0014896,0.175968608323753,0.918326680806999,6,49,muscle hypertrophy,BP,EDN1;G6PD;ERRFI1;PRKCA;SORBS2;PARP1
17536,GO:1901031,0.176132207936278,0.934376513331817,4,29,regulation of response to reactive oxygen species,BP,TP53;TNF;DHFR;BMP7
18426,GO:1903506,0.176133848241188,0.843750358941957,230,2844,regulation of nucleic acid-templated transcription,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;CREB5;SNF8;GCLC;PARP1;TP63;ZBTB12;FADS1
10832,GO:0044325,0.176152752411897,0.903560296255334,9,82,ion channel binding,MF,PANX1;LYN;FLNA;NEDD4L;YWHAH;KCNIP3;STAC;ACTN4;HSP90AB1
19635,GO:1990825,0.176164479357972,0.963963155430409,2,10,sequence-specific mRNA binding,MF,TYMS;DHFR
4439,GO:0010314,0.176506783764483,0.963849307214881,2,10,phosphatidylinositol-5-phosphate binding,MF,JPH2;LANCL2
14665,GO:0070265,0.176670374476345,0.924897972950365,5,40,necrotic cell death,BP,CYLD;BIRC3;TNF;TRAF2;NOL3
640,GO:0001829,0.176678294257286,0.963792207301158,2,10,trophectodermal cell differentiation,BP,JUNB;SRF
7467,GO:0031625,0.176973272853973,0.874038635679008,25,268,ubiquitin protein ligase binding,MF,ACTG1;PML;TRAF1;IKBKE;MID1;TRAF3;TP53;SQSTM1;CDKN1A;LYN;UBE2C;DAXX;ABTB2;NFKBIA;VCL;TRAF2;SMAD7;UBE2J2;TRIB1;HSPA8;JUN;HERC2;MPHOSPH8;TRAF4;TUBB
3636,GO:0008104,0.177089524985092,0.845277679837488,167,2056,protein localization,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;AMOT;TAP1;IL1R2;NFKBIE;PML;CYLD;HSPB1;TFRC;FBN1;TGFB2;GBP1;MID1;RSAD2;EMP2;KLHL21;PANX1;TP53;SQSTM1;MARVELD3;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;LAMP1;EHD1;TNF;GNL3L;BAIAP2;CORO1C;PTPN14;NUP153;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;CADPS2;EPHA2;CHP1;ARFRP1;CD274;GOSR1;ITGAV;PMM2;SFN;ANKS4B;LSG1;USP36;AKAP8L;LIF;SFRP1;PARL;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;DDX42;GPER1;AP4S1;TRIM29;NFKBIA;RRS1;PRPF19;RPLP2;AKAP8;RHOB;DKC1;SNX12;U2AF2;VCL;VPS13B;IRS2;RPLP1;TRAF2;REEP1;PRKCA;SYK;POLR1A;AJUBA;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;NEDD4L;MYH9;NPNT;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;RCC2;NUP214;TRAM2;SMAD7;DNAJC1;YWHAH;KEAP1;M6PR;ZDHHC6;HNRNPU;UBE2J2;CEP41;RUVBL2;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;STAC;FRAS1;HSPA8;ESR1;PES1;CPT1A;TFDP1;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;RHOG;TAP2;CNTNAP1;ACTN4;SNIP1;BMP7;TOMM40;PHLDB2;SGSM1;IPO4;EIF5A;MYADM;DAG1;RAB27A;WNT4;RILPL2;VPS52;CD38;TNFAIP3;MAPK11;BMP8A;CARD10;SRSF7;CLTA;SNF8;CDCA5;HSP90AB1;SWAP70;BIN3;PARP1;TP63;CCL5;MAGOH;SH3BP4
14268,GO:0061333,0.177358792038367,0.917491296931381,6,49,renal tubule morphogenesis,BP,IRX2;PBX1;COL4A1;BMP2;NPNT;WNT4
15605,GO:0072088,0.177358792038367,0.917491296931381,6,49,nephron epithelium morphogenesis,BP,IRX2;PBX1;BMP2;LIF;NPNT;WNT4
7931,GO:0032508,0.177366611299052,0.906831923674036,8,71,DNA duplex unwinding,BP,MCM5;MCM2;GINS2;RUVBL2;MCM7;XRCC6;BRIP1;PARP1
13964,GO:0060670,0.177520323303134,0.963511327460041,2,10,branching involved in labyrinthine layer morphogenesis,BP,ADM;FGFR2
2804,GO:0006261,0.177543599928726,0.888672115808693,14,138,DNA-dependent DNA replication,BP,MCM5;MCM2;FEN1;GINS2;ALYREF;POLA1;ORC1;THOC1;MCM7;GINS3;ZNF365;TIMELESS;PARP1;ORC4
8674,GO:0034244,0.177599506602027,0.96348486702893,2,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,NELFE;HNRNPU
16250,GO:0090303,0.177819136196276,0.933506489730564,4,29,positive regulation of wound healing,BP,PDPN;SERPINE1;THBD;TBXA2R
2871,GO:0006363,0.178134640108444,0.933188754167425,4,30,termination of RNA polymerase I transcription,BP,CD3EAP;POLR1A;UBTF;POLR1E
11442,GO:0045876,0.17840756022253,0.963214381892507,2,10,positive regulation of sister chromatid cohesion,BP,FEN1;SFPQ
135,GO:0000281,0.178566163681683,0.910902606521053,7,60,mitotic cytokinesis,BP,KIF23;RHOB;SPTBN1;CHMP4B;CNTROB;INCENP;BIN3
10677,GO:0043922,0.178729101423633,0.963106517070743,2,10,negative regulation by host of viral transcription,BP,JUN;CCL5
361,GO:0000979,0.178903706064075,0.932945235122742,4,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,NLRC5;GADD45A;RUVBL2;MAZ
7875,GO:0032436,0.179078807482897,0.905710357769677,8,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;RNF144B;GCLC
4482,GO:0010499,0.179121245624294,0.944563507529807,3,22,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1;PSMB9;KEAP1
393,GO:0001054,0.179153276112731,0.962419808833205,2,11,RNA polymerase I activity,MF,POLR1A;POLR1E
12896,GO:0051238,0.179300464131739,0.962369637239801,2,11,sequestering of metal ion,BP,FTL;FTH1
1173,GO:0002820,0.17931928912565,0.945186426764575,3,19,negative regulation of adaptive immune response,BP,IL7R;SMAD7;THOC1
20030,GO:2000651,0.179455290576185,0.962862419929032,2,10,positive regulation of sodium ion transmembrane transporter activity,BP,CHP1;ACTN4
1862,GO:0004526,0.179475467991475,0.962309947603677,2,11,ribonuclease P activity,MF,POP1;POP4
13903,GO:0060547,0.179480923120259,0.962853791583033,2,10,negative regulation of necrotic cell death,BP,BIRC3;NOL3
11246,GO:0045445,0.179627719920508,0.916042050785919,6,50,myoblast differentiation,BP,IGFBP3;NRG1;TNF;SRF;ZFP36L1;DDX17
18205,GO:1902993,0.179818007482602,0.962740244865036,2,10,positive regulation of amyloid precursor protein catabolic process,BP,LYN;EFNA1
7276,GO:0031258,0.179964600838016,0.944896921413229,3,19,lamellipodium membrane,CC,PDPN;EPHA2;ITGAV
7721,GO:0032211,0.179980735910509,0.944889675807403,3,19,negative regulation of telomere maintenance via telomerase,BP,GNL3L;NAT10;HNRNPU
15061,GO:0071013,0.179985859350884,0.897310155697753,10,96,catalytic step 2 spliceosome,CC,SART1;DDX23;TFIP11;PRPF19;ALYREF;HNRNPU;HNRNPF;EFTUD2;PHF5A;MAGOH
17306,GO:0140101,0.179986702470205,0.891495949722344,12,117,catalytic activity, acting on a tRNA,MF,CARS2;CDKAL1;TRMT61A;METTL1;NSUN2;POP1;METTL2B;WDR4;DUS2;TRMT1;AARSD1;POP4
15967,GO:0080009,0.180016606871249,0.962673278499338,2,10,mRNA methylation,BP,TRMT61A;METTL16
5162,GO:0015701,0.18035231965001,0.944722718871938,3,19,bicarbonate transport,BP,CYB5R1;SLC4A11;SLC4A2
4540,GO:0010613,0.180368748123343,0.94471533321796,3,19,positive regulation of cardiac muscle hypertrophy,BP,EDN1;PRKCA;PARP1
4880,GO:0014742,0.180368748123343,0.94471533321796,3,19,positive regulation of muscle hypertrophy,BP,EDN1;PRKCA;PARP1
8054,GO:0032715,0.180586969194563,0.944617195516825,3,19,negative regulation of interleukin-6 production,BP,TNF;ZC3H12A;TNFAIP3
14887,GO:0070672,0.180749797209601,0.962425613517814,2,10,response to interleukin-15,BP,STAT5A;IL15
12850,GO:0051168,0.180788119907222,0.879165376094465,18,187,nuclear export,BP,TP53;PTPN14;NUP153;SRSF2;CHP1;SFN;LSG1;AKAP8L;RRS1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
360,GO:0000978,0.181045602550614,0.869027380873127,27,288,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;FOSL2;MYBL2;ARID3B;TP53;AHR;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;ELF3;IRF1;SRF;ELF4;ZFP42;ETS1;CREB3;KCNIP3;ETS2;KLF10;JUN;ESR1;KLF6;ELK1;SMARCC2
7094,GO:0030889,0.181101579323173,0.962306540000276,2,10,negative regulation of B cell proliferation,BP,LYN;TNFRSF21
322,GO:0000900,0.181558548516524,0.962151625151824,2,10,translation repressor activity, mRNA regulatory element binding,MF,TYMS;DHFR
7849,GO:0032409,0.181710199651773,0.885571675075812,14,139,regulation of transporter activity,BP,MMP9;JPH2;JPH1;CHP1;ADRB2;FXYD3;SGK1;NEDD4L;YWHAH;RRAD;CAB39;STAC;OXSR1;ACTN4
10500,GO:0043401,0.181792539928306,0.883519127114161,15,149,steroid hormone mediated signaling pathway,BP,RUNX1;DAXX;SFRP1;SAFB2;GPER1;DDX17;FHL2;YWHAH;PAGR1;SAFB;ESR1;BMP7;RBM14;PARP1;TP63
1111,GO:0002700,0.181793513906455,0.903875919737327,8,72,regulation of production of molecular mediator of immune response,BP,TFRC;TGFB2;RSAD2;IL27RA;TNF;TRAF2;SMAD7;THOC1
5004,GO:0015149,0.181894923835235,0.962037421192554,2,10,hexose transmembrane transporter activity,MF,M6PR;SLC2A6
14409,GO:0061684,0.182073609728871,0.961976695943344,2,10,chaperone-mediated autophagy,BP,SNRNP70;HSPA8
11508,GO:0045992,0.182161703094108,0.943907175650115,3,19,negative regulation of embryonic development,BP,LFNG;COL5A2;BMP7
14804,GO:0070528,0.18246926554155,0.94376812513084,3,19,protein kinase C signaling,BP,PDGFB;PHLPP1;MYADM
693,GO:0001913,0.182513930102045,0.943478730569726,3,20,T cell mediated cytotoxicity,BP,EMP2;IL7R;RAB27A
13808,GO:0060397,0.18276547408809,0.961741184412559,2,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,LYN;STAT5A
13014,GO:0051447,0.182825756791119,0.961720635056632,2,10,negative regulation of meiotic cell cycle,BP,LIF;DUSP1
7434,GO:0031543,0.183079151926503,0.9616342060242,2,10,peptidyl-proline dioxygenase activity,MF,P3H2;P4HA2
283,GO:0000785,0.18333077031343,0.859343265171891,39,457,chromatin,CC,PML;TP53;JUNB;CDKN2A;RING1;ENC1;TELO2;CDK4;DAXX;MCM2;TOX4;AKAP8L;APTX;IRF1;SRF;ZFP42;SNAI2;CBX5;BRMS1;POLA1;UHRF1;SFPQ;MTA2;RUVBL2;CITED2;JUN;ESR1;RCC1;MCM7;HMGN2;MPHOSPH8;INCENP;IPO4;CHAF1A;KIF22;TIMELESS;SMARCC2;CDCA5;TP63
18345,GO:1903312,0.183352782018513,0.907864706636535,7,60,negative regulation of mRNA metabolic process,BP,NOCT;NELFE;U2AF2;SUPT5H;HNRNPU;DHX34;SRSF7
6631,GO:0022898,0.183396805985,0.886554229857895,13,128,regulation of transmembrane transporter activity,BP,MMP9;JPH2;JPH1;CHP1;ADRB2;FXYD3;NEDD4L;YWHAH;RRAD;CAB39;STAC;OXSR1;ACTN4
6993,GO:0030673,0.183502823633508,0.961489514672479,2,10,axolemma,CC,NRG1;SPTBN1
13819,GO:0060413,0.183514154409038,0.961485641856911,2,10,atrial septum morphogenesis,BP,CYR61;TGFB2
18152,GO:1902894,0.18366147109163,0.961435274616572,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,SRF;PDGFB
391,GO:0001046,0.183667819520969,0.902689142723964,8,71,core promoter sequence-specific DNA binding,MF,NLRC5;TP53;GADD45A;UBTF;RUVBL2;MAZ;KLF10;ESR1
2249,GO:0005161,0.18367329491023,0.961431230875016,2,10,platelet-derived growth factor receptor binding,MF,LYN;PDGFB
14805,GO:0070530,0.184054625037419,0.943049429851332,3,19,K63-linked polyubiquitin modification-dependent protein binding,MF,SQSTM1;TNIP2;TNFAIP3
799,GO:0002067,0.184141770604505,0.930213813290583,4,29,glandular epithelial cell differentiation,BP,FGFR2;BMP2;WNT4;TP63
10569,GO:0043531,0.184188677337144,0.930189198527672,4,29,ADP binding,MF,TAP1;MYH9;RUVBL2;GCLC
13677,GO:0060205,0.184451054133066,0.87222738107666,21,228,cytoplasmic vesicle lumen,CC,SAA1;FTL;S100P;FN1;TGFB2;HRNR;NFKB1;QPCT;ACAA1;SERPINE1;VCL;PDGFB;CAB39;HSPA8;COMMD9;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;HSP90AB1
14608,GO:0070167,0.184596934487827,0.920492966805638,5,39,regulation of biomineral tissue development,BP,BMP2;ADRB2;OSR2;BMP7;WNT4
13698,GO:0060249,0.185250991809735,0.866407111970791,26,286,anatomical structure homeostasis,BP,KRT1;CTGF;ACTG1;PML;HSPB1;TFRC;GNL3L;TELO2;ADRB2;NAT10;TFIP11;SRF;DKC1;FEN1;PRKCA;SYK;POLA1;HNRNPU;VSIG1;CHMP4B;ZNF365;XRCC6;CD38;TNFAIP3;HSP90AB1;PARP1
9697,GO:0038093,0.18528523178179,0.880805507283824,15,154,Fc receptor signaling pathway,BP,ACTG1;NFKB1;LYN;ARPC4;BAIAP2;PSMB9;MYO10;ARPC1B;PSME2;NFKBIA;SYK;JUN;RAPGEF1;PSMC3;HSP90AB1
3665,GO:0008152,0.185873638988707,0.833369200812119,641,8255,metabolic process,BP,HEPHL1;IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;DTX2;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;WNT10A;FADS3;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;GFOD1;NUAK1;KLHL21;NLRC5;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;STEAP4;IL24;P4HA2;PANK2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;MPND;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;HMGXB3;HS3ST2;COMMD4;GADD45A;TNF;COL12A1;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;VMP1;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TNK1;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;METTL13;ADRB2;IL20;DAXX;FOXD2;NAT10;GANC;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;DHCR7;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;PREP;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;COX5B;RNF115;COL5A3;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;PRUNE2;ACSL1;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;TRAM2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;ZNF365;ACBD6;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TEAD4;SMPD2;KBTBD12;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;OVCH2;TRA2A;RNF7;TPRA1;TOMM40;MPHOSPH8;ELK1;CYP20A1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;DPM3;WNT4;MRPS2;RBM14;AKR1C1;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;CYB561D2;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SLC3A2;XPNPEP3;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;C1S;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2;SH3BP4
10673,GO:0043903,0.186118882783863,0.876586064629837,17,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,PML;RSAD2;SQSTM1;TNF;ZC3H12A;ITGAV;BANF1;NELFE;SUPT5H;HSPA8;JUN;CHMP4B;PSMC3;CXCL8;POLR2G;SNF8;CCL5
18703,GO:1904063,0.1861495477045,0.91948821036207,5,40,negative regulation of cation transmembrane transport,BP,MMP9;NEDD4L;RRAD;CAB39;OXSR1
3192,GO:0006816,0.186181671341888,0.872196914758639,20,209,calcium ion transport,BP,CTGF;JPH2;IL16;PML;G6PD;PANX1;LYN;JPH1;ICAM1;ITGAV;PARL;GPER1;LGALS3;PDGFB;RRAD;STAC;TMEM165;SLC3A2;NOL3;CCL5
20287,GO:2001267,0.18634533874411,0.94172866737901,3,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9;TRAF2;TNFRSF10A
10816,GO:0044304,0.186574941564654,0.919355602298064,5,39,main axon,CC,NRG1;SPTBN1;PARD3;CNTNAP1;DAG1
4230,GO:0009408,0.18682225372013,0.881771464408371,14,139,response to heat,BP,CRYAB;BAG1;TP53;CDKN1A;LYN;NUP153;DNAJB1;DAXX;IL1A;NUP214;STAC;HSPA8;GCLC;HSP90AB1
4349,GO:0009914,0.186915349632621,0.876017044218234,17,175,hormone transport,BP,INHBA;C1QTNF1;ADM;SLC16A2;EDN1;IRS1;LYN;TNF;LIF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
566,GO:0001707,0.186945874833639,0.919141797387653,5,39,mesoderm formation,BP,INHBA;TXNRD1;FGFR2;SRF;BMP7
5812,GO:0017070,0.187175500667303,0.959644422881515,2,11,U6 snRNA binding,MF,METTL16;EIF5A
1480,GO:0003774,0.18731495943401,0.89227297812849,10,94,motor activity,MF,MYO1B;KIF23;MYO10;WDR34;DCTN1;MYH9;KIF24;KIF22;CGNL1;MYO1E
7757,GO:0032273,0.187707710929495,0.891963111559462,10,95,positive regulation of protein polymerization,BP,ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;DCTN1;SLAIN2;CLASP1;RHOG;BAIAP2L2
11452,GO:0045903,0.187761875895455,0.987158647217693,1,3,positive regulation of translational fidelity,BP,RPS9
690,GO:0001910,0.18799680242012,0.928016852686448,4,30,regulation of leukocyte mediated cytotoxicity,BP,LAMP1;ICAM1;IL7R;DNASE1
13010,GO:0051443,0.188096570586869,0.927963913122712,4,30,positive regulation of ubiquitin-protein transferase activity,BP,UBE2C;RPS2;DCUN1D2;ARRDC3
4206,GO:0009314,0.188111469689761,0.860128138731481,31,341,response to radiation,BP,CRYAB;PML;KRT13;TP53;CDKN1A;JUNB;GADD45A;HMGCS1;ICAM1;UBE4B;NMT2;AEN;SFRP1;THBD;EGR1;SNAI2;RHOB;FEN1;KRT14;COPS3;RUVBL2;DUSP1;JUN;NOC2L;RBM4;XRCC6;ELK1;PDE6A;EEF1D;PARP1;TP63
17876,GO:1902110,0.188209466244989,0.910728227672774,6,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;TP63
536,GO:0001654,0.188402448607316,0.869181510731705,21,220,eye development,BP,CRYAB;INHBA;CYP1B1;TENM3;CYP1A1;FBN1;TGFB2;SIPA1L3;RING1;COL4A1;EPHA2;CDK4;OSR2;CC2D2A;SRF;SDK1;COL5A2;JUN;BMP7;TTLL5;PHACTR4
11296,GO:0045606,0.188463383086594,0.940753052439975,3,20,positive regulation of epidermal cell differentiation,BP,TRIM16;SFN;IL20
3900,GO:0008537,0.18908427528111,0.986968228911479,1,3,proteasome activator complex,CC,PSME2
8409,GO:0033365,0.189390447271681,0.846293825487591,61,730,protein localization to organelle,BP,NRG1;PML;MID1;KLHL21;TP53;GNPTAB;CDKN1A;LAMP1;EHD1;TNF;GNL3L;NUP153;ZC3H12A;CYB5R1;CHP1;ARFRP1;PMM2;SFN;USP36;LIF;PARL;CC2D2A;TRIM29;NFKBIA;RRS1;RPLP2;DKC1;RPLP1;POLR1A;RPS2;PTTG1IP;RPS9;WDR46;ZW10;RCC2;NUP214;TRAM2;YWHAH;HNRNPU;UBE2J2;RUVBL2;RPL27A;HSPA8;ESR1;PES1;TFDP1;TNPO3;CHMP4B;INSIG1;SNIP1;BMP7;TOMM40;IPO4;DAG1;TNFAIP3;CARD10;SNF8;CDCA5;HSP90AB1;TP63;SH3BP4
6200,GO:0019682,0.189422581772141,0.940309319312697,3,20,glyceraldehyde-3-phosphate metabolic process,BP,G6PD;PGD;TKT
1308,GO:0003156,0.189428833754749,0.94030642320073,3,20,regulation of animal organ formation,BP,BMP2;CITED2;BMP7
1085,GO:0002673,0.189614354919403,0.927157016985774,4,30,regulation of acute inflammatory response,BP,C1R;TNF;DNASE1;C1S
134,GO:0000280,0.189809631709295,0.860205770722422,29,317,nuclear division,BP,MYBL2;EDN1;BIRC3;DAPK3;PKMYT1;UBE2C;FLNA;KIF23;EPGN;AKAP8L;LIF;RRS1;AKAP8;PDGFB;IL1A;ZW10;HNRNPU;CLASP1;PPP1R9B;ANAPC15;DUSP1;RCC1;CHMP4B;BMP7;KIF22;WNT4;BRIP1;CDCA5;MKI67
7603,GO:0031983,0.190051790175914,0.86777887268955,21,229,vesicle lumen,CC,SAA1;FTL;S100P;FN1;TGFB2;HRNR;NFKB1;QPCT;ACAA1;SERPINE1;VCL;PDGFB;CAB39;HSPA8;COMMD9;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;HSP90AB1
2864,GO:0006355,0.190805336803527,0.830193712308423,228,2827,regulation of transcription, DNA-templated,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;ZNF142;STAT5A;ADRB2;DAXX;FOXD2;SERPINE1;FUS;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DHFR;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;GLIS3;SNIP1;BMP7;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;CREB5;SNF8;GCLC;PARP1;TP63;ZBTB12;FADS1
18398,GO:1903426,0.190977761915779,0.909021383349446,6,51,regulation of reactive oxygen species biosynthetic process,BP,EDN1;TNF;ZC3H12A;ICAM1;RAB27A;HSP90AB1
13049,GO:0051539,0.192129954048219,0.915909954663153,5,41,4 iron, 4 sulfur cluster binding,MF,RSAD2;CDKAL1;ACO1;POLA1;BRIP1
11408,GO:0045807,0.192603394460424,0.892277774003007,9,84,positive regulation of endocytosis,BP,TNF;SIRPA;ITGAV;SERPINE1;SYK;NEDD4L;ACTN4;RAPGEF1;RAB27A
19214,GO:1905330,0.192705619072025,0.877268938396577,14,144,regulation of morphogenesis of an epithelium,BP,TNF;FGFR2;PSMB9;LIF;SFRP1;PSME2;SNAI2;ROR1;CLASP1;ESR1;BMP7;PHLDB2;WNT4;PSMC3
14657,GO:0070252,0.192816666051149,0.907882825679785,6,51,actin-mediated cell contraction,BP,EMP2;PDPN;TPM4;FLNA;TPM1;NEDD4L
17621,GO:1901317,0.193363744622379,0.986341433271807,1,3,regulation of flagellated sperm motility,BP,CCR6
14267,GO:0061326,0.193389940840248,0.901347215853722,7,61,renal tubule development,BP,IRX2;PBX1;COL4A1;BMP2;LIF;NPNT;WNT4
13823,GO:0060419,0.193479979727423,0.907555245193974,6,50,heart growth,BP,TGFB2;EDN1;G6PD;FGFR2;SORBS2;MAPK11
6304,GO:0019933,0.193493017949007,0.901216013178357,7,62,cAMP-mediated signaling,BP,PTGER4;ADM;AHR;ADRB2;GPER1;PRKCA;TBXA2R
1404,GO:0003338,0.193511608487296,0.938404406121261,3,20,metanephros morphogenesis,BP,LIF;FRAS1;WNT4
18123,GO:1902807,0.193673151176037,0.887732585052652,10,96,negative regulation of cell cycle G1/S phase transition,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;SFN;TFDP1;GPNMB;CTDSP1;TP63
4107,GO:0009162,0.19374313293955,0.957310430325582,2,11,deoxyribonucleoside monophosphate metabolic process,BP,TYMS;TK1
16254,GO:0090307,0.194264722396256,0.900779568861776,7,61,mitotic spindle assembly,BP,MYBL2;BIRC3;FLNA;KIF23;HNRNPU;CLASP1;CHMP4B
8925,GO:0034766,0.194536375642867,0.906814651723199,6,51,negative regulation of ion transmembrane transport,BP,MMP9;IRS2;NEDD4L;RRAD;CAB39;OXSR1
9306,GO:0035751,0.194551735416269,0.957019230446071,2,11,regulation of lysosomal lumen pH,BP,CLN6;TMEM165
555,GO:0001676,0.194606327666324,0.900492941812039,7,62,long-chain fatty acid metabolic process,BP,CYP1B1;CYP1A1;PTGES;ACAA1;ACSL1;CPT1A;FADS1
10455,GO:0043312,0.194739390463424,0.854569466907756,31,350,neutrophil degranulation,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
16700,GO:0097647,0.194746648002937,0.986135417683334,1,3,amylin receptor signaling pathway,BP,ADM
1118,GO:0002707,0.194783436320182,0.937807531213246,3,20,negative regulation of lymphocyte mediated immunity,BP,IL7R;SMAD7;THOC1
1707,GO:0004252,0.195059718342663,0.894989297811447,8,73,serine-type endopeptidase activity,MF,MMP9;C1R;PRSS23;PARL;PREP;RHBDL2;OVCH2;C1S
19802,GO:2000251,0.195384853466598,0.95671832217488,2,11,positive regulation of actin cytoskeleton reorganization,BP,BAIAP2;BAIAP2L2
2189,GO:0005048,0.195511754262926,0.914040656011897,5,40,signal sequence binding,MF,NUP153;NFKBIA;NUP214;TNPO3;IPO4
2569,GO:0005853,0.195577587107241,0.986010812452678,1,3,eukaryotic translation elongation factor 1 complex,CC,EEF1D
10427,GO:0043270,0.195731305721483,0.879980699653903,12,120,positive regulation of ion transport,BP,JPH2;EDN1;G6PD;FLNA;CHP1;ADRB2;GPER1;LGALS3;PDGFB;STAC;ACTN4;CCL5
12300,GO:0048638,0.195856677526052,0.865955161782464,19,198,regulation of developmental growth,BP,NRG1;FN1;EDN1;G6PD;WWC1;FGFR2;CDK4;L1CAM;STAT5A;ADRB2;TNFRSF12A;SFRP1;ZFYVE27;EPPK1;SRF;NTN1;NEDD4L;SEMA3C;MAPK11
14666,GO:0070266,0.195864429159971,0.923804351467502,4,30,necroptotic process,BP,CYLD;BIRC3;TNF;TRAF2
6284,GO:0019888,0.195875236404146,0.89966720580749,7,62,protein phosphatase regulator activity,MF,IGFBP3;SH3RF2;PPP1R3B;NSFL1C;PPP1R14C;PPP1R9B;PHACTR4
11100,GO:0045112,0.195936932414256,0.985956735707039,1,3,integrin biosynthetic process,BP,TGFB2
15932,GO:0072717,0.195974227187906,0.985951116745803,1,3,cellular response to actinomycin D,BP,TP53
7840,GO:0032395,0.19609457132055,0.985932976825982,1,3,MHC class II receptor activity,MF,KRT17
5616,GO:0016668,0.196095043385476,0.95646110877694,2,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD1;PGK1
3632,GO:0008092,0.196174576833642,0.841207960236336,58,671,cytoskeletal protein binding,MF,CRYAB;KRT2;MAP2;NEFM;COBLL1;GBP1;MID1;B4GALT1;KLHL21;PANX1;NFKB1;LYN;MYO1B;ARPC4;BAIAP2;CORO1C;ENC1;DST;TPM4;FLNA;LCP1;CHP1;KIF23;MYO10;SVIL;MTUS1;FUS;ARPC1B;TPM1;WDR1;ANXA8;MKL1;EPPK1;VCL;REEP1;AJUBA;SPTBN1;DCTN1;DNASE1;DPYSL3;MYH9;RCC2;YWHAH;ENAH;HNRNPU;CLASP1;PPP1R9B;MICAL3;BLOC1S2;ACTN4;SORBS2;KIF24;KIF22;DAG1;RAB27A;MYO1E;BIN3;PHACTR4
1129,GO:0002718,0.196351952975947,0.913433710626911,5,41,regulation of cytokine production involved in immune response,BP,TGFB2;RSAD2;TNF;TRAF2;SMAD7
20236,GO:2001181,0.196419742620409,0.985883897989499,1,3,positive regulation of interleukin-10 secretion,BP,CD274
4572,GO:0010657,0.196436913739542,0.913496760606802,5,40,muscle cell apoptotic process,BP,EDN1;CDKN2A;ZC3H12A;BMP7;NOL3
305,GO:0000814,0.196465414440804,0.985876997089535,1,3,ESCRT II complex,CC,SNF8
4194,GO:0009299,0.196656379581997,0.936924774720076,3,20,mRNA transcription,BP,TP53;FLNA;SRF
783,GO:0002040,0.196703621670414,0.893933871012648,8,72,sprouting angiogenesis,BP,HDAC9;STARD13;ADAMTS9;EFNB2;SRF;ROBO1;CARD10;TBXA2R
11276,GO:0045581,0.197108798657815,0.936710866882124,3,20,negative regulation of T cell differentiation,BP,CYLD;IRF1;SMAD7
8753,GO:0034405,0.197124762293606,0.923122468917838,4,30,response to fluid shear stress,BP,CSF2;ETS1;SMAD7;CITED2
17334,GO:1900003,0.197153777865307,0.98577276171642,1,3,regulation of serine-type endopeptidase activity,BP,ANXA8
17335,GO:1900004,0.197153777865307,0.98577276171642,1,3,negative regulation of serine-type endopeptidase activity,BP,ANXA8
18046,GO:1902571,0.197153777865307,0.98577276171642,1,3,regulation of serine-type peptidase activity,BP,ANXA8
18047,GO:1902572,0.197153777865307,0.98577276171642,1,3,negative regulation of serine-type peptidase activity,BP,ANXA8
7108,GO:0030904,0.197484838344953,0.936532872666311,3,20,retromer complex,CC,DCTN1;SNX8;M6PR
18691,GO:1904044,0.197855165128634,0.985666119137262,1,3,response to aldosterone,BP,PARP1
604,GO:0001772,0.197866120723525,0.936352212280835,3,20,immunological synapse,CC,ICAM1;LGALS3;MYH9
4189,GO:0009266,0.19795746724593,0.867461733922907,17,176,response to temperature stimulus,BP,CRYAB;ADM;BAG1;TP53;CDKN1A;LYN;NUP153;DNAJB1;ADRB2;DAXX;NFKBIA;IL1A;NUP214;STAC;HSPA8;GCLC;HSP90AB1
8212,GO:0032965,0.198103131023769,0.936239817681307,3,20,regulation of collagen biosynthetic process,BP,CTGF;ERRFI1;WNT4
15622,GO:0072108,0.198214379962659,0.985611332025918,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
794,GO:0002062,0.198479518560419,0.898033195890752,7,61,chondrocyte differentiation,BP,RUNX1;CTGF;BMP2;COL27A1;OSR2;SNAI2;SERPINH1
6060,GO:0019208,0.198529560830146,0.892647856559726,8,73,phosphatase regulator activity,MF,IGFBP3;SH3RF2;BMP2;PPP1R3B;NSFL1C;PPP1R14C;PPP1R9B;PHACTR4
10349,GO:0043153,0.1985523005384,0.93602661641743,3,20,entrainment of circadian clock by photoperiod,BP,PML;TP53;RBM4
5233,GO:0015849,0.198988277748063,0.866675086944958,17,175,organic acid transport,BP,SLC16A2;NFKBIE;EDN1;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;SLC5A6;IRS2;SYK;SLC7A2;ACSL1;SLC43A2;CPT1A;AKR1C1;SLC3A2;SLC25A22
11910,GO:0046942,0.198988277748063,0.866675086944958,17,175,carboxylic acid transport,BP,SLC16A2;NFKBIE;EDN1;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;SLC5A6;IRS2;SYK;SLC7A2;ACSL1;SLC43A2;CPT1A;AKR1C1;SLC3A2;SLC25A22
337,GO:0000932,0.199112091110555,0.892202116776233,8,74,P-body,CC,SQSTM1;NOCT;ZC3H12A;ZFP36L1;AJUBA;EDC4;PSMC3;POLR2G
19237,GO:1905383,0.199185519213998,0.985462636908758,1,3,protein localization to presynapse,BP,HSPB1
14969,GO:0070873,0.199196971149401,0.935720168973744,3,20,regulation of glycogen metabolic process,BP,IRS1;PPP1R3B;IRS2
17737,GO:1901668,0.199486388282477,0.985416398278786,1,3,regulation of superoxide dismutase activity,BP,TNF
13189,GO:0051795,0.19973816308448,0.985377642286353,1,3,positive regulation of timing of catagen,BP,TGFB2
5074,GO:0015297,0.199995159281177,0.903402250460825,6,51,antiporter activity,MF,SLC7A5;SLC7A5P2;SLC4A11;SLC22A4;SLC4A2;SLC3A2
14738,GO:0070404,0.200127606993131,0.985317582777726,1,3,NADH binding,MF,QDPR
7959,GO:0032558,0.200322710769259,0.985287442988471,1,3,adenyl deoxyribonucleotide binding,MF,HSP90AB1
7963,GO:0032564,0.200322710769259,0.985287442988471,1,3,dATP binding,MF,HSP90AB1
20147,GO:2000848,0.200328871550184,0.985286490709743,1,3,positive regulation of corticosteroid hormone secretion,BP,C1QTNF1
8072,GO:0032747,0.200349414417067,0.985283315129914,1,3,positive regulation of interleukin-23 production,BP,CSF2
8346,GO:0033197,0.200467643360581,0.954863180556003,2,11,response to vitamin E,BP,SRSF2;HMGCS1
11782,GO:0046640,0.200477855212225,0.95485941998513,2,11,regulation of alpha-beta T cell proliferation,BP,IRF1;SYK
18945,GO:1904706,0.200569835725151,0.954825541619327,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,TPM1;GPER1
272,GO:0000774,0.200595846431845,0.954815959356868,2,11,adenyl-nucleotide exchange factor activity,MF,BAG1;HSPBP1
974,GO:0002428,0.200621064037043,0.985241287070742,1,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,TAP2
16560,GO:0097340,0.200706930045147,0.954775026729787,2,11,inhibition of cysteine-type endopeptidase activity,BP,BIRC3;NOL3
16561,GO:0097341,0.200706930045147,0.954775026729787,2,11,zymogen inhibition,BP,BIRC3;NOL3
7895,GO:0032463,0.200743337641895,0.954761607636262,2,11,negative regulation of protein homooligomerization,BP,CRYAB;CLDN7
8605,GO:0034113,0.200840605517146,0.921100773673087,4,30,heterotypic cell-cell adhesion,BP,TNF;ITGAV;BMP7;MYADM
13550,GO:0060011,0.20099218089133,0.985183762923157,1,3,Sertoli cell proliferation,BP,BCL2L2
13590,GO:0060057,0.20099218089133,0.985183762923157,1,3,apoptotic process involved in mammary gland involution,BP,B4GALT1
13591,GO:0060058,0.20099218089133,0.985183762923157,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,B4GALT1
17965,GO:1902339,0.20099218089133,0.985183762923157,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18437,GO:1903519,0.20099218089133,0.985183762923157,1,3,regulation of mammary gland involution,BP,B4GALT1
18438,GO:1903521,0.20099218089133,0.985183762923157,1,3,positive regulation of mammary gland involution,BP,B4GALT1
18967,GO:1904747,0.20099218089133,0.985183762923157,1,3,positive regulation of apoptotic process involved in development,BP,B4GALT1
7400,GO:0031463,0.201141750987967,0.902681307769434,6,51,Cul3-RING ubiquitin ligase complex,CC,KLHL21;ENC1;KCTD10;KEAP1;KBTBD12;RNF7
9252,GO:0035651,0.201162212304629,0.985157366252397,1,3,AP-3 adaptor complex binding,MF,RAB32
5597,GO:0016628,0.201167735752105,0.934505839729292,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DHCR7;AKR1C2;AKR1C1
4957,GO:0015026,0.201179032488161,0.934774664819041,3,20,coreceptor activity,MF,ITGAV;ROR1;ACKR3
12936,GO:0051293,0.201190858642996,0.920909341710244,4,30,establishment of spindle localization,BP,DCTN1;MYH9;ZW10;CLASP1
8311,GO:0033143,0.201683271372967,0.895865925561277,7,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,RUNX1;SFRP1;SAFB2;PAGR1;ESR1;PARP1;TP63
16297,GO:0090398,0.202150242252903,0.901961594770752,6,52,cellular senescence,BP,PML;NUAK1;TP53;CDKN1A;CDKN2A;SRF
965,GO:0002407,0.202185391020669,0.954228728270206,2,11,dendritic cell chemotaxis,BP,CCR6;CCL5
9542,GO:0036294,0.202362394767606,0.867751411674914,15,158,cellular response to decreased oxygen levels,BP,EDN1;TP53;PSMB9;ICAM1;PGK1;SFRP1;PSME2;EGR1;ZFP36L1;AJUBA;CITED2;BMP7;PSMC3;BRIP1;NOL3
13137,GO:0051702,0.202432382346716,0.901783534355121,6,52,interaction with symbiont,BP,FN1;ZC3H12A;HSPA8;JUN;PSMC3;CCL5
11058,GO:0045055,0.202445588650566,0.840712051249258,44,510,regulated exocytosis,BP,KRT1;FTL;FTH1;MMP9;S100P;FN1;PCDH7;TGFB2;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;FLNA;CYB5R1;ACAA1;CADPS2;CHP1;ITGAV;SERPINE1;WDR1;VCL;LGALS3;SYK;PDGFB;GLIPR1;LILRB3;CAB39;CD109;HSPA8;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
13818,GO:0060412,0.202512238100865,0.920185794181915,4,30,ventricular septum morphogenesis,BP,TGFB2;FGFR2;SMAD7;CITED2
15163,GO:0071280,0.202524394172301,0.953565144161137,2,12,cellular response to copper ion,BP,CYP1A1;DAXX
9673,GO:0038033,0.202685422338893,0.984919734452637,1,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,HSPB1
16463,GO:0097129,0.202790149499274,0.984903319516444,1,3,cyclin D2-CDK4 complex,CC,CDK4
7587,GO:0031954,0.202816770435244,0.933989636939693,3,20,positive regulation of protein autophosphorylation,BP,SYK;PDGFB;GPNMB
1277,GO:0003071,0.202853618516136,0.953980894716903,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,EMP2;PDGFB
527,GO:0001635,0.202898826857684,0.984886274976777,1,3,calcitonin gene-related peptide receptor activity,MF,CRCP
16696,GO:0097642,0.202898826857684,0.984886274976777,1,3,calcitonin family receptor activity,MF,CRCP
12180,GO:0048305,0.20293150080012,0.953951972308469,2,11,immunoglobulin secretion,BP,TNF;TRAF2
13173,GO:0051771,0.202991788165953,0.984871686835156,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
3685,GO:0008187,0.203035585949759,0.933884492159636,3,20,poly-pyrimidine tract binding,MF,PABPC4;U2AF2;HNRNPU
14863,GO:0070633,0.203075293622098,0.953898552882865,2,11,transepithelial transport,BP,CSF2;EDN1
6290,GO:0019900,0.203127324941358,0.837369969555458,51,585,kinase binding,MF,NRG1;HDAC9;CYLD;HSPB1;SDC4;RELB;TRAF3;EMP2;TP53;SQSTM1;MARVELD3;CDKN2B;IRS1;CDKN1A;GADD45A;CDKN2A;WWC1;FGFR2;PTPN14;EPHB6;TELO2;FLNA;SRSF2;EPHA2;CHP1;ITGAV;ERRFI1;SFN;DAXX;TRIM22;RHOB;FGFR1OP;IRS2;TRAF2;SYK;POLA1;DCTN1;TNIP2;ROR1;RCC2;TRIP6;TRIB1;CAB39;SOCS1;ESR1;RHOG;BLNK;TRAF4;TNFAIP3;HSP90AB1;PARP1
19795,GO:2000232,0.203225980718348,0.9538425437574,2,11,regulation of rRNA processing,BP,USP36;SHQ1
16544,GO:0097286,0.203249490250457,0.953833802835842,2,11,iron ion import,BP,TFRC;STEAP4
15598,GO:0072077,0.203285376812951,0.953820458726678,2,11,renal vesicle morphogenesis,BP,LIF;WNT4
15604,GO:0072087,0.203285376812951,0.953820458726678,2,11,renal vesicle development,BP,LIF;WNT4
7317,GO:0031326,0.203320881020381,0.817455464444085,268,3349,regulation of cellular biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;NOCT;FST;NFKB1;CDKN2B;TAF4B;IRS1;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ENC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ERRFI1;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;TOX4;AKAP8L;ZC3H7B;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;AJUBA;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;POLA1;RPS9;NEDD4L;FHL2;ZNF407;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;SFPQ;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;ZNF34;MPHOSPH8;ELK1;PHF5A;EIF5A;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;BMP8A;HES4;UTP4;POLR2G;CREB5;SNF8;GCLC;HSP90AB1;PARP1;TP63;ZBTB12;CCL5;FADS1;MAGOH
19472,GO:1990180,0.203383932373068,0.984810063058197,1,3,mitochondrial tRNA 3'-end processing,BP,HSD17B10
6271,GO:0019865,0.203390168974743,0.984809081882751,1,3,immunoglobulin binding,MF,LGALS3
13582,GO:0060049,0.203443483398479,0.953761648485818,2,11,regulation of protein glycosylation,BP,CHP1;IL15
3407,GO:0007188,0.203525899161949,0.889254976637517,8,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PTGER4;ADM;EDN1;FLNA;ADRB2;GPER1;PRKCA;TBXA2R
6997,GO:0030678,0.203767211248569,0.984749698391133,1,3,mitochondrial ribonuclease P complex,CC,HSD17B10
16733,GO:0097745,0.203767211248569,0.984749698391133,1,3,mitochondrial tRNA 5'-end processing,BP,HSD17B10
12122,GO:0048185,0.203836734635071,0.953615233444311,2,11,activin binding,MF,FST;SMAD7
17875,GO:1902109,0.203919583002868,0.984725663708995,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,NOL3
6075,GO:0019227,0.204171733351645,0.984685844192083,1,3,neuronal action potential propagation,BP,CNTNAP1
16909,GO:0098870,0.204171733351645,0.984685844192083,1,3,action potential propagation,BP,CNTNAP1
18415,GO:1903445,0.204241493643833,0.984674817524714,1,3,protein transport from ciliary membrane to plasma membrane,BP,RILPL2
14654,GO:0070243,0.2043574727741,0.953421047396143,2,11,regulation of thymocyte apoptotic process,BP,TP53;EFNA1
6066,GO:0019215,0.204501671288824,0.953367213523897,2,11,intermediate filament binding,MF,EPPK1;KRT14
7332,GO:0031342,0.204583641040309,0.95333659973497,2,11,negative regulation of cell killing,BP,IL7R;HSP90AB1
12418,GO:0048865,0.204617000213196,0.984615387512958,1,3,stem cell fate commitment,BP,SFRP1
19819,GO:2000278,0.204636322552495,0.883913396629556,9,84,regulation of DNA biosynthetic process,BP,TP53;CDKN1A;GNL3L;NAT10;DKC1;PDGFB;HNRNPU;DUSP1;HSP90AB1
6002,GO:0019042,0.20469657554353,0.953294407223498,2,11,viral latency,BP,BANF1;XRCC6
12565,GO:0050717,0.204719009960969,0.98459922080298,1,3,positive regulation of interleukin-1 alpha secretion,BP,PANX1
7834,GO:0032387,0.204770416656534,0.908321969505116,5,42,negative regulation of intracellular transport,BP,CRYAB;NUP153;CHP1;SNX12;INSIG1
3191,GO:0006814,0.204836941314575,0.873317352935969,12,118,sodium ion transport,BP,CHP1;ADRB2;SLC5A6;FXYD3;SGK1;NEDD4L;YWHAH;SLC4A11;SLC22A4;COMMD9;ACTN4;SLC3A2
1311,GO:0003159,0.205038343777419,0.953166622447046,2,11,morphogenesis of an endothelium,BP,STARD13;RHOB
14218,GO:0061154,0.205038343777419,0.953166622447046,2,11,endothelial tube morphogenesis,BP,STARD13;RHOB
11674,GO:0046452,0.205100621960062,0.984538658731083,1,3,dihydrofolate metabolic process,BP,DHFR
844,GO:0002158,0.205306893780221,0.984505868416698,1,3,osteoclast proliferation,BP,TNFAIP3
4653,GO:0010796,0.205531568150501,0.984470108904085,1,3,regulation of multivesicular body size,BP,SNF8
16479,GO:0097159,0.205571824806231,0.81386192474706,364,4608,organic cyclic compound binding,MF,MAFB;TRIM16;RUNX1;CYP1B1;CYP24A1;FOSL2;ACTG1;NQO1;CYP1A1;TAP1;DUSP14;PML;TFCP2L1;RBM19;HSPB1;MYBL2;IRX2;RELB;TFRC;BAG1;ABCF1;CD3EAP;ARID3B;IER2;MAP3K14;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;DAPK3;TET3;ELMSAN1;G6PD;NUAK1;NLRC5;TP53;NFE2L1;PDCD11;HNRNPAB;PANK2;NOCT;NFKB1;TAF4B;LYN;MYO1B;RAB32;AHR;JUNB;MCM5;HMGXB3;CSRP1;EHD1;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;GPATCH4;CARS2;PKMYT1;PPAN;RRP1;NAV2;TRIO;FGFR2;PBX1;NUP153;NFKB2;EPHB6;TELO2;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TNK1;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;ZNF142;KIF23;MYO10;GTPBP6;STAT5A;RRP12;ZMAT2;ADRB2;FOXD2;NAT10;FUS;PABPC4;PGK1;MCM2;LSG1;CCDC124;TOX4;USP36;AKAP8L;ZC3H7B;AEN;ELF3;GRWD1;OSR2;ABCF2;SAFB2;APTX;DHCR7;PUS1;DHX37;PWP2;IRF1;METTL1;LUC7L;BANF1;EPPK1;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;ZNF787;RRP36;ELF4;LARP4B;ZFP42;SF1;EGR1;JRK;EDF1;ETS1;SGK1;SNAI2;POP1;RRS1;SRRT;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;RIPK4;NPAS2;PPRC1;LGALS3;TSR1;ACO1;MAFK;ABCG2;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;DDX17;IFIT3;DDX47;PPIP5K1;CDKL1;DDX49;DNTTIP2;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;SPTBN1;SNRNP70;SERPINH1;ZNF407;RRP7A;UHRF1;MYH9;ZNF234;NOM1;ZNFX1;CAMK1G;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;BRD9;ZNF697;FTSJ3;WDR46;SPEN;ZW10;ROR1;ACSL1;RCC2;NOP56;MAFF;GPN1;SMAD7;CRCP;MRPS12;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;TRIP6;ERAL1;HNRNPU;HNRNPF;PQBP1;RRAD;UBE2J2;CREB3;RUVBL2;ABT1;MAZ;TUSC1;ORC1;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PRDM7;MRPL20;RBM38;ARL6IP4;RPL27A;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;SLC22A4;PES1;FOXN1;RCC1;BRPF1;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;BCS1L;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;ZNF703;DUS2;QDPR;RHOG;XRCC6;ZNF132;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;HMGN2;SORBS2;KIF24;GLIS3;SNIP1;METTL16;SMUG1;CLUH;ZNF34;URGCP;EFTUD2;TRA2A;ELK1;CYP20A1;PHF5A;EIF3I;ZYX;EIF5A;UBAP2L;KIF22;POLR3H;EEF1D;RAB27A;DHX34;TIMELESS;RBM14;AKR1C1;TRAF4;TUBB;TNFAIP3;PSMC3;SMARCC2;BRIP1;SUPT16H;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;ATAD3C;HES4;ZC3H18;UTP4;POLR2G;SRSF7;CREB5;NOL3;GCLC;LRRC59;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;ORC4;MAGOH;APEX2
10955,GO:0044666,0.205629477929456,0.952945248009041,2,11,MLL3/4 complex,CC,RBBP5;PAGR1
7663,GO:0032092,0.205812611093922,0.887640611340796,8,74,positive regulation of protein binding,BP,MMP9;LFNG;GNL3L;BMP2;TRAF2;BAMBI;TRAF4;HSP90AB1
10102,GO:0042611,0.205921353329723,0.952284318746719,2,12,MHC protein complex,CC,HLA-B;HLA-F
9420,GO:0035986,0.206020782405407,0.984392086721045,1,3,senescence-associated heterochromatin focus assembly,BP,CDKN2A
18584,GO:1903829,0.2062009062258,0.84926484214622,26,285,positive regulation of cellular protein localization,BP,NRG1;CYLD;TP53;SQSTM1;TNF;GNL3L;ZC3H12A;CYB5R1;EPHA2;CHP1;SFN;USP36;LIF;GPER1;DKC1;SPTBN1;WDR46;YWHAH;UBE2J2;STAC;TFDP1;RHOG;SNIP1;CARD10;HSP90AB1;TP63
2803,GO:0006260,0.206223016169908,0.851305407698824,24,260,DNA replication,BP,CSF2;MCM5;MCM2;GRWD1;FEN1;GINS2;PDGFB;ALYREF;POLA1;ORC1;THOC1;JUN;MCM7;GINS3;ZNF365;CHAF1A;TIMELESS;RBM14;BRIP1;RRM2;SUPT16H;PARP1;TOP3A;ORC4
12824,GO:0051129,0.206340223673529,0.837826246610028,43,491,negative regulation of cellular component organization,BP,CRYAB;PTGER4;SACS;GBP1;MID1;UBQLN2;TNF;GNL3L;EFNB2;CORO1C;DNAJB1;NAT10;LIF;TFIP11;DNAJB2;LGALS3;NTN1;SPTBN1;DPYSL3;SEMA3C;ZW10;RCC2;YWHAH;HNRNPU;CLASP1;ANAPC15;DUSP1;HSPA8;NOC2L;CHMP4B;INSIG1;ZNF365;ACTN4;BMP7;KANK4;PHLDB2;MYADM;RBM14;EFNA1;CLDN7;NOL3;SWAP70;PARP1
7307,GO:0031307,0.206621154558709,0.931869030296934,3,21,integral component of mitochondrial outer membrane,CC,CPT1A;TOMM40;SLC25A44
1056,GO:0002584,0.20668204037983,0.984286281539567,1,3,negative regulation of antigen processing and presentation of peptide antigen,BP,TAPBPL
12678,GO:0050886,0.206702954193134,0.907275174654196,5,41,endocrine process,BP,INHBA;C1QTNF1;EDN1;C9ORF3;OXTR
2167,GO:0005003,0.206926933535805,0.952457792235641,2,11,ephrin receptor activity,MF,EPHB6;EPHA2
2169,GO:0005005,0.206926933535805,0.952457792235641,2,11,transmembrane-ephrin receptor activity,MF,EPHB6;EPHA2
8343,GO:0033189,0.207065861348495,0.952405469014248,2,11,response to vitamin A,BP,CYP1A1;TYMS
18674,GO:1904019,0.207081598565387,0.892301051178848,7,62,epithelial cell apoptotic process,BP,TNF;ICAM1;SERPINE1;GPER1;ZFP36L1;TNIP2;TNFAIP3
9302,GO:0035747,0.207121927854144,0.98421567730299,1,3,natural killer cell chemotaxis,BP,CCL5
559,GO:0001682,0.207125436176868,0.951826742356993,2,12,tRNA 5'-leader removal,BP,POP1;POP4
19737,GO:2000110,0.207160559824582,0.984209468282088,1,3,negative regulation of macrophage apoptotic process,BP,CCL5
1556,GO:0003955,0.207183566028997,0.984205770027342,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,NQO1
10050,GO:0042532,0.207327560543396,0.952306840265747,2,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,PARP14;SOCS1
13048,GO:0051538,0.207358143504693,0.984177690984399,1,3,3 iron, 4 sulfur cluster binding,MF,ACO1
1090,GO:0002678,0.207534260835111,0.984149336229133,1,3,positive regulation of chronic inflammatory response,BP,TNF
3968,GO:0008757,0.207603798129031,0.86848112760152,13,131,S-adenosylmethionine-dependent methyltransferase activity,MF,TRMT61A;METTL1;NSUN2;METTL2B;NSUN5;RBBP5;FTSJ3;WDR4;PRDM7;NOP2;TRMT1;METTL16;METTL21A
631,GO:0001820,0.207751486689529,0.984114324226867,1,3,serotonin secretion,BP,SYK
302,GO:0000811,0.207920375478966,0.984087073464273,1,3,GINS complex,CC,GINS2
81,GO:0000164,0.207945609564494,0.952073562693613,2,11,protein phosphatase type 1 complex,CC,PPP1R3B;PPP1R9B
14696,GO:0070316,0.207977378462568,0.906508398799632,5,41,regulation of G0 to G1 transition,BP,CTGF;RING1;CBX5;TFDP1;RRM2
11063,GO:0045061,0.208122437082503,0.95200673055513,2,11,thymic T cell selection,BP,SRF;FOXN1
15812,GO:0072507,0.208147100105074,0.853306779906472,21,227,divalent inorganic cation homeostasis,BP,SAA1;PTGER4;C1QTNF1;ADM;JPH2;PML;EDN1;LYN;JPH1;ITGAV;GPER1;OXTR;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
1569,GO:0003976,0.208310808053718,0.984023976627305,1,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,GNPTAB
7170,GO:0031050,0.208403582762889,0.906251551877999,5,41,dsRNA fragmentation,BP,ZC3H12A;ZC3H7B;SRRT;ESR1;SNIP1
14998,GO:0070918,0.208403582762889,0.906251551877999,5,41,production of small RNA involved in gene silencing by RNA,BP,ZC3H12A;ZC3H7B;SRRT;ESR1;SNIP1
8929,GO:0034774,0.208424614959701,0.854395861864256,20,220,secretory granule lumen,CC,FTL;S100P;FN1;TGFB2;HRNR;NFKB1;QPCT;ACAA1;SERPINE1;VCL;PDGFB;CAB39;HSPA8;COMMD9;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;HSP90AB1
3493,GO:0007379,0.208462977037139,0.951877910294003,2,11,segment specification,BP,MAFB;IRX2
8603,GO:0034111,0.208541213417816,0.95184829386709,2,11,negative regulation of homotypic cell-cell adhesion,BP,C1QTNF1;ZNF703
2489,GO:0005736,0.208620550200115,0.951255964457115,2,12,DNA-directed RNA polymerase I complex,CC,POLR1A;POLR1E
8488,GO:0033634,0.208682153376456,0.983963835793309,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,CCL5
18531,GO:1903719,0.208728949560301,0.983956248065184,1,3,regulation of I-kappaB phosphorylation,BP,TRAF2
18532,GO:1903721,0.208728949560301,0.983956248065184,1,3,positive regulation of I-kappaB phosphorylation,BP,TRAF2
5837,GO:0017124,0.208792857307233,0.87694670017264,10,96,SH3 domain binding,MF,LYN;SIRPA;ERRFI1;ADAM17;DPYSL3;AFAP1L2;CCDC6;ENAH;CNTNAP1;RAPGEF1
15505,GO:0071875,0.20881569025868,0.951744328501217,2,11,adrenergic receptor signaling pathway,BP,ADRB2;ARRDC3
12846,GO:0051156,0.208977741730743,0.930717891093725,3,21,glucose 6-phosphate metabolic process,BP,G6PD;PGD;TKT
19005,GO:1904816,0.209057335686992,0.951652719033231,2,11,positive regulation of protein localization to chromosome, telomeric region,BP,GNL3L;DKC1
8252,GO:0033028,0.209241929554175,0.930588402497049,3,21,myeloid cell apoptotic process,BP,CDKN2A;ADAM17;CCL5
3672,GO:0008169,0.209336599533556,0.983857540139906,1,3,C-methyltransferase activity,MF,NOP2
13994,GO:0060708,0.209542487510031,0.983824018984118,1,3,spongiotrophoblast differentiation,BP,LIF
15259,GO:0071426,0.209705522894734,0.869614585365339,12,121,ribonucleoprotein complex export from nucleus,BP,NUP153;SRSF2;AKAP8L;RRS1;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
9588,GO:0036435,0.209730458302957,0.983793381234636,1,3,K48-linked polyubiquitin modification-dependent protein binding,MF,IKBKE
11768,GO:0046625,0.209841918790421,0.951354762537159,2,11,sphingolipid binding,MF,LYN;TRAF2
982,GO:0002439,0.209907147501928,0.983764552925063,1,3,chronic inflammatory response to antigenic stimulus,BP,TNF
6778,GO:0030213,0.209917314771947,0.951326088335265,2,11,hyaluronan biosynthetic process,BP,NFKB1;PDGFB
11451,GO:0045901,0.210037397921438,0.983743283258727,1,3,positive regulation of translational elongation,BP,EIF5A
3234,GO:0006887,0.210181983113621,0.831164978472194,51,598,exocytosis,BP,KRT1;FTL;FTH1;MMP9;S100P;FN1;PCDH7;SDC4;TGFB2;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;VMP1;QPCT;SIRPA;FLNA;CYB5R1;ACAA1;CADPS2;CHP1;ITGAV;SERPINE1;WDR1;TXLNA;VCL;LGALS3;SYK;PDGFB;GLIPR1;LILRB3;CLASP1;MICAL3;CAB39;CD109;HSPA8;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;PTPRB;SNF8;HSP90AB1;LAIR1;CCL5
17405,GO:1900138,0.210267971047765,0.983705593123066,1,3,negative regulation of phospholipase A2 activity,BP,ANXA8
1133,GO:0002725,0.210335029202189,0.983694622501966,1,3,negative regulation of T cell cytokine production,BP,SMAD7
2813,GO:0006272,0.2104362041414,0.983678062655192,1,3,leading strand elongation,BP,POLA1
9148,GO:0035497,0.210571141507049,0.951077123159044,2,11,cAMP response element binding,MF,CREB3;JUN
15291,GO:0071475,0.210595893593261,0.983651906410743,1,3,cellular hyperosmotic salinity response,BP,XRCC6
9240,GO:0035631,0.21067236504753,0.951038530171993,2,11,CD40 receptor complex,CC,TRAF3;TRAF2
14363,GO:0061578,0.210861888356486,0.95096623630575,2,11,Lys63-specific deubiquitinase activity,MF,CYLD;TNFAIP3
16078,GO:0090036,0.211005623246406,0.950911377818408,2,11,regulation of protein kinase C signaling,BP,PHLPP1;MYADM
9809,GO:0040037,0.211167340891287,0.95084962433554,2,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4;WNT4
6574,GO:0022400,0.21117844896469,0.950845381379,2,11,regulation of rhodopsin mediated signaling pathway,BP,NMT2;PDE6A
11515,GO:0046016,0.211208302999882,0.983551381242616,1,3,positive regulation of transcription by glucose,BP,SRF
117,GO:0000245,0.211553339731056,0.895895423548615,6,53,spliceosomal complex assembly,BP,DDX23;LUC7L;SF1;PRPF19;TXNL4B;NOL3
5003,GO:0015145,0.211558006945676,0.950700306513559,2,11,monosaccharide transmembrane transporter activity,MF,M6PR;SLC2A6
2158,GO:0004985,0.211583049195701,0.983489698747368,1,3,opioid receptor activity,MF,OGFR
15010,GO:0070938,0.211651407743199,0.950664578534824,2,11,contractile ring,CC,MYH9;DAG1
11876,GO:0046883,0.211669446292124,0.862878252386043,14,144,regulation of hormone secretion,BP,INHBA;C1QTNF1;EDN1;IRS1;TNF;LIF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
1339,GO:0003198,0.211692534341022,0.950648843113051,2,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2;SNAI2
16064,GO:0089718,0.211791597919399,0.950610931571407,2,11,amino acid import across plasma membrane,BP,SLC7A2;SLC3A2
20076,GO:2000726,0.211801603261827,0.950607101837453,2,11,negative regulation of cardiac muscle cell differentiation,BP,G6PD;BMP2
826,GO:0002101,0.211807136371434,0.983452753077156,1,3,tRNA wobble cytosine modification,BP,NAT10
10054,GO:0042536,0.211992508458143,0.983422155715259,1,3,negative regulation of tumor necrosis factor biosynthetic process,BP,ERRFI1
15018,GO:0070948,0.212025507972149,0.983416705545833,1,3,regulation of neutrophil mediated cytotoxicity,BP,DNASE1
9378,GO:0035905,0.212052195890742,0.983412297064762,1,3,ascending aorta development,BP,TGFB2
9381,GO:0035910,0.212052195890742,0.983412297064762,1,3,ascending aorta morphogenesis,BP,TGFB2
14063,GO:0060841,0.212088713978725,0.950497150191245,2,11,venous blood vessel development,BP,EFNB2;SEMA3C
12617,GO:0050801,0.212327586685189,0.835792047079583,37,424,ion homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;STEAP4;LYN;CLN6;JPH1;CHP1;ITGAV;GPER1;GPCPD1;ACO1;ABCG2;OXTR;NEDD4L;SMAD7;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;GCLC;SWAP70;TBXA2R;PARP1;CCL5
2793,GO:0006231,0.21234406239375,0.98336404213383,1,3,dTMP biosynthetic process,BP,TYMS
11544,GO:0046073,0.21234406239375,0.98336404213383,1,3,dTMP metabolic process,BP,TYMS
15235,GO:0071391,0.212382352935287,0.950384589364445,2,11,cellular response to estrogen stimulus,BP,SFRP1;ESR1
9703,GO:0038107,0.212398007506838,0.9833551147294,1,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,CITED2
17373,GO:1900094,0.212398007506838,0.9833551147294,1,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,CITED2
17420,GO:1900164,0.212398007506838,0.9833551147294,1,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,CITED2
12056,GO:0048002,0.212430576365142,0.862191911394742,14,149,antigen processing and presentation of peptide antigen,BP,TAP1;HLA-B;PSMB9;ITGAV;KIF23;HLA-F;PSME2;DCTN1;TAPBPL;TAPBP;TAP2;KIF22;PSMC3;CLTA
1157,GO:0002765,0.212466537294472,0.983343769856385,1,3,immune response-inhibiting signal transduction,BP,LYN
11206,GO:0045337,0.212510093822134,0.983336556985765,1,3,farnesyl diphosphate biosynthetic process,BP,HMGCS1
11842,GO:0046813,0.212602052657814,0.983321323085771,1,3,receptor-mediated virion attachment to host cell,BP,ICAM1
5822,GO:0017091,0.212604637836729,0.928932492855346,3,21,AU-rich element binding,MF,ZC3H12A;ZFP36L1;ZFP36L2
15520,GO:0071898,0.21265039755664,0.983313311163256,1,3,regulation of estrogen receptor binding,BP,RUVBL2
15521,GO:0071899,0.21265039755664,0.983313311163256,1,3,negative regulation of estrogen receptor binding,BP,RUVBL2
15449,GO:0071733,0.212650397556641,0.983313311163256,1,3,transcriptional activation by promoter-enhancer looping,BP,RUVBL2
16184,GO:0090202,0.212650397556641,0.983313311163256,1,3,gene looping,BP,RUVBL2
16343,GO:0090579,0.212650397556641,0.983313311163256,1,3,dsDNA loop formation,BP,RUVBL2
10379,GO:0043199,0.212675695591708,0.983309117811711,1,3,sulfate binding,MF,RCC1
6162,GO:0019511,0.212770656732738,0.950235571147173,2,11,peptidyl-proline hydroxylation,BP,P3H2;P4HA2
2898,GO:0006405,0.212826578032548,0.864482663206178,13,133,RNA export from nucleus,BP,NUP153;SRSF2;AKAP8L;RRS1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
17429,GO:1900186,0.212888622938893,0.983273800161242,1,3,negative regulation of clathrin-dependent endocytosis,BP,UBQLN2
18218,GO:1903010,0.212940982087877,0.950170144997636,2,11,regulation of bone development,BP,FBN1;TJP2
19634,GO:1990823,0.212943276364569,0.882737111028038,8,74,response to leukemia inhibitory factor,BP,PML;MYBL2;TFRC;MAT2A;ICAM1;SMAD7;HNRNPU;SRSF7
19637,GO:1990830,0.212943276364569,0.882737111028038,8,74,cellular response to leukemia inhibitory factor,BP,PML;MYBL2;TFRC;MAT2A;ICAM1;SMAD7;HNRNPU;SRSF7
116,GO:0000244,0.212948825729213,0.950167131168288,2,11,spliceosomal tri-snRNP complex assembly,BP,CD2BP2;PRPF19
1296,GO:0003129,0.212980123991649,0.983258610378228,1,3,heart induction,BP,BMP2
15297,GO:0071481,0.213033206446649,0.950134703864564,2,11,cellular response to X-ray,BP,SFRP1;XRCC6
10180,GO:0042771,0.2130401356614,0.903215000018964,5,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,PML;TP53;CDKN1A;AEN;TP63
14136,GO:0061002,0.21305469109729,0.983246226067116,1,3,negative regulation of dendritic spine morphogenesis,BP,EFNA1
9080,GO:0035330,0.213124270605997,0.950099697907834,2,11,regulation of hippo signaling,BP,WWC1;AJUBA
6028,GO:0019087,0.213127218533471,0.983234175619399,1,3,transformation of host cell by virus,BP,TYMS
13814,GO:0060405,0.21314579424132,0.983231088486055,1,3,regulation of penile erection,BP,OXTR
18084,GO:1902686,0.213152421289949,0.894868037789027,6,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;TP63
17090,GO:0099623,0.213260904047273,0.950047154765917,2,11,regulation of cardiac muscle cell membrane repolarization,BP,FLNA;WDR1
7876,GO:0032437,0.213265971668847,0.983211108317805,1,3,cuticular plate,CC,SPTBN1
4983,GO:0015106,0.213374566368017,0.950003427092426,2,11,bicarbonate transmembrane transporter activity,MF,SLC4A11;SLC4A2
4871,GO:0014732,0.21338647408267,0.983191060818807,1,3,skeletal muscle atrophy,BP,IL15
5263,GO:0015908,0.213503806696923,0.894727709155962,6,52,fatty acid transport,BP,EDN1;SLCO3A1;IRS2;SYK;ACSL1;CPT1A
3296,GO:0006990,0.213553880380366,0.983163188002823,1,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,CREB3
15562,GO:0072007,0.213657686669261,0.983145891545449,1,3,mesangial cell differentiation,BP,PDGFB
15563,GO:0072008,0.213657686669261,0.983145891545449,1,3,glomerular mesangial cell differentiation,BP,PDGFB
15645,GO:0072143,0.213657686669261,0.983145891545449,1,3,mesangial cell development,BP,PDGFB
15646,GO:0072144,0.213657686669261,0.983145891545449,1,3,glomerular mesangial cell development,BP,PDGFB
18757,GO:1904238,0.213657686669261,0.983145891545449,1,3,pericyte cell differentiation,BP,PDGFB
14293,GO:0061387,0.213664592961641,0.882238288446734,8,74,regulation of extent of cell growth,BP,NRG1;FN1;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;SEMA3C
11563,GO:0046104,0.213833192110576,0.983116625904413,1,3,thymidine metabolic process,BP,TK1
11573,GO:0046125,0.213833192110576,0.983116625904413,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK1
9200,GO:0035582,0.213966918006963,0.983094308047252,1,3,sequestering of BMP in extracellular matrix,BP,FBN1
1464,GO:0003714,0.214038026838375,0.85482461513471,17,178,transcription corepressor activity,MF,HDAC9;TFCP2L1;RELB;JUNB;DNAJB1;SRSF2;DAXX;TRIM22;SF1;AJUBA;HNRNPU;RUVBL2;KCNIP3;CITED2;NOC2L;KCTD1;WNT4
11057,GO:0045054,0.214151661425325,0.983063448731762,1,3,constitutive secretory pathway,BP,RAB27A
4853,GO:0014065,0.214181240300105,0.877133702328194,9,85,phosphatidylinositol 3-kinase signaling,BP,NRG1;TGFB2;EDN1;IRS1;GPER1;ZFP36L1;IER3;PDGFB;CCL5
11214,GO:0045347,0.2141838662356,0.983058066070957,1,3,negative regulation of MHC class II biosynthetic process,BP,NFX1
8533,GO:0033829,0.214306961081588,0.983037483413437,1,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,LFNG
4606,GO:0010721,0.214468431627159,0.851106620261334,19,202,negative regulation of cell development,BP,NRG1;FBN1;GBP1;G6PD;TJP2;EFNB2;CORO1C;PBX1;PRPF19;NTN1;DPYSL3;SEMA3C;RCC2;YWHAH;ZNF365;ACTN4;BMP7;CTDSP1;EFNA1
2930,GO:0006447,0.214569432891045,0.982993549075517,1,3,regulation of translational initiation by iron,BP,TNF
11240,GO:0045416,0.214569432891045,0.982993549075517,1,3,positive regulation of interleukin-8 biosynthetic process,BP,TNF
3547,GO:0007569,0.214595226622706,0.876751378396276,9,87,cell aging,BP,PML;NUAK1;TP53;CDKN1A;CDKN2A;ICAM1;SERPINE1;SRF;TP63
19463,GO:1990167,0.21475899524567,0.982961779443412,1,3,protein K27-linked deubiquitination,BP,OTUD6A
19464,GO:1990168,0.21475899524567,0.982961779443412,1,3,protein K33-linked deubiquitination,BP,OTUD6A
10899,GO:0044444,0.214783590063752,0.80511244698832,557,7171,cytoplasmic part,CC,IGFBP3;IL32;KRT1;SAA1;SPRR3;TRIM16;FTL;CRYAB;SPRR2A;FTH1;MMP9;KRT2;RUNX1;CYR61;INHBA;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;TNS3;KRT15;AMOT;JPH2;KRT4;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;STARD13;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;HLA-B;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;PRSS23;B4GALT1;KRTAP2-3;MGAM;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;HRNR;KLHL21;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;MCM5;PLEKHO2;ARPC4;LAMP1;HS3ST2;EHD1;TNF;COL12A1;GNL3L;BAIAP2;KRT5;CDKN2A;RING1;CARS2;PKMYT1;SCD;WWC1;TNC;DST;TRIO;VMP1;PDPN;FGFR2;CDKAL1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;CHP1;HMGCS1;EIF5;TSC22D3;FANCC;ARFRP1;COL16A1;GOSR1;COL27A1;CDK4;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;ANKS4B;RNF19B;ADRB2;SVIL;PLEKHA7;DAXX;MTUS1;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;LSG1;CCDC124;EBP;NMT2;ST6GALNAC5;XAF1;AMOTL2;ELF3;GRWD1;LIF;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;DHCR7;HLA-F;PTGFRN;PUS1;WDR1;PPP1R3B;ANXA8;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;DNPEP;BANF1;DPH2;IL7R;DDX42;CTIF;NFX1;LRRC75A-AS1;THBD;GPER1;NSUN2;DNAJB2;HS3ST1;TXN2;LARP4B;AP4S1;ABTB2;TRIM29;NFKBIA;SF1;PARD3B;EDF1;DOCK10;GEMIN4;SGK1;RRS1;CD2BP2;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;ADAM17;GPCPD1;FEN1;SNX12;TXLNA;DHFR;FGFR1OP;VCL;SHQ1;KCTD10;IRS2;IER3;NPAS2;KRT14;LGALS3;TSR1;ACO1;RPLP1;TRAF2;ABCG2;IL15;REEP1;AKR1C2;PRKCA;ZFP36L2;PUM3;SYK;DDX17;NFKBIB;AJUBA;C9ORF78;IFIT3;NOB1;PPIP5K1;PDGFB;AASS;PREP;RPS2;ALYREF;UTP14A;PHAX;POLA1;WDR34;RPS9;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SERPINH1;FHL2;DCTN1;COLGALT1;COX5B;RNF115;DPYSL3;COL5A3;SLAIN2;MYH9;SPPL2A;TAPBPL;COL17A1;NPNT;IL1A;COPS3;CAMK1G;GLIPR1;TNIP2;LANCL2;DOHH;RASGRP4;SNX8;BORCS7;SPRY4;LILRB3;ZW10;PXMP2;ACSL1;RCC2;COL5A2;NUP214;MAFF;ACKR3;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;CCDC6;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;CAPNS1;UBE2J2;CEP41;TPST1;CREB3;RUVBL2;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;THOC1;ETS2;TRUB2;PARP14;ANAPC15;MRPL20;RBM38;PCYT1A;GALNT2;ATG101;MARVELD2;CAB39;TGFBRAP1;TXNL4B;CD109;RPL27A;SOCS1;STAC;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOC2L;CHMP4B;RBM4;RPTN;ARRDC3;INSIG1;CENPO;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;ACBD6;XRCC6;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;SMPD2;ACTN4;THEM4;SORBS2;KIF24;SNIP1;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;RNF7;KANK4;TOMM40;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;EIF3I;RAPGEF1;ZYX;EIF5A;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;AKR1C1;VPS52;TRAF4;TUBB;CYTH1;TNFAIP3;PSMC3;SPG21;DNAJC9;RRM2;MAPK11;CTPS1;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;CARD10;SLC25A22;PTPRB;RNF144B;POLR2G;SLC25A44;CLTA;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;TBXA2R;TTLL5;HERC6;LAIR1;RPUSD4;PARP1;TP63;BAIAP2L2;ORC4;FADS1;APEX2;SH3BP4
3481,GO:0007341,0.214840851086992,0.98294805063064,1,3,penetration of zona pellucida,BP,B4GALT1
8895,GO:0034711,0.214978006330861,0.982925033222749,1,3,inhibin binding,MF,INHBA
17628,GO:1901338,0.21498443163621,0.982923954503045,1,3,catecholamine binding,MF,ADRB2
18706,GO:1904098,0.214990143171094,0.982922995583629,1,3,regulation of protein O-linked glycosylation,BP,IL15
18707,GO:1904100,0.214990143171094,0.982922995583629,1,3,positive regulation of protein O-linked glycosylation,BP,IL15
7411,GO:0031493,0.214999571666012,0.982921412551744,1,3,nucleosomal histone binding,MF,UHRF1
13587,GO:0060054,0.2150277593744,0.982916679384934,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,B4GALT1
5305,GO:0016011,0.215037122655568,0.982915106978636,1,3,dystroglycan complex,CC,DAG1
756,GO:0001996,0.21505485753815,0.982912128481005,1,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,TPM1
1397,GO:0003321,0.21505485753815,0.982912128481005,1,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,TPM1
1922,GO:0004616,0.215274895232381,0.982875150023755,1,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,PGD
19122,GO:1905065,0.215314818505624,0.982868435938831,1,3,positive regulation of vascular smooth muscle cell differentiation,BP,GPER1
14750,GO:0070423,0.215323016899288,0.912881401502233,4,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,CYLD;BIRC3;NFKBIA;TNFAIP3
11199,GO:0045323,0.215363259158659,0.982860287476263,1,3,interleukin-1 receptor complex,CC,TRIP6
12189,GO:0048332,0.215422278196873,0.901992027603545,5,41,mesoderm morphogenesis,BP,INHBA;TXNRD1;FGFR2;SRF;BMP7
1393,GO:0003307,0.21556340839003,0.98282659639837,1,3,regulation of Wnt signaling pathway involved in heart development,BP,BMP2
8744,GO:0034392,0.215588374836347,0.982822391214533,1,3,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
15629,GO:0072125,0.215643453029611,0.982813112176519,1,3,negative regulation of glomerular mesangial cell proliferation,BP,BMP7
16176,GO:0090194,0.215643453029611,0.982813112176519,1,3,negative regulation of glomerulus development,BP,BMP7
8278,GO:0033080,0.215643453029611,0.982813112176519,1,3,immature T cell proliferation in thymus,BP,WNT4
9342,GO:0035844,0.215643453029611,0.982813112176519,1,3,cloaca development,BP,TP63
13975,GO:0060685,0.215643453029611,0.982813112176519,1,3,regulation of prostatic bud formation,BP,BMP7
13976,GO:0060686,0.215643453029611,0.982813112176519,1,3,negative regulation of prostatic bud formation,BP,BMP7
14239,GO:0061209,0.215643453029611,0.982813112176519,1,3,cell proliferation involved in mesonephros development,BP,BMP2
6831,GO:0030292,0.215672135498249,0.982808278927159,1,3,protein tyrosine kinase inhibitor activity,MF,FGFR1OP
14115,GO:0060971,0.215692500333449,0.982804846812595,1,3,embryonic heart tube left/right pattern formation,BP,CITED2
18055,GO:1902603,0.215699082128082,0.982803737491739,1,3,carnitine transmembrane transport,BP,SLC22A4
18973,GO:1904753,0.215699615895006,0.982803647526871,1,3,negative regulation of vascular associated smooth muscle cell migration,BP,TPM1
10726,GO:0044062,0.215741138466095,0.982796648213642,1,3,regulation of excretion,BP,EDN1
15716,GO:0072268,0.21576530913435,0.982792573118204,1,3,pattern specification involved in metanephros development,BP,IRX2
7422,GO:0031515,0.215794755311293,0.982787607862199,1,3,tRNA (m1A) methyltransferase complex,CC,TRMT61A
16211,GO:0090244,0.21580471375793,0.982785928474117,1,3,Wnt signaling pathway involved in somitogenesis,BP,SFRP1
408,GO:0001093,0.215816552766102,0.982783931830108,1,3,TFIIB-class transcription factor binding,MF,ESR1
695,GO:0001915,0.215820491236957,0.98278326757995,1,3,negative regulation of T cell mediated cytotoxicity,BP,IL7R
17956,GO:1902308,0.215899969512203,0.982769859969319,1,3,regulation of peptidyl-serine dephosphorylation,BP,SWAP70
5488,GO:0016422,0.215971297856601,0.982757822258678,1,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,METTL16
1586,GO:0003997,0.215974829381219,0.982757226139999,1,3,acyl-CoA oxidase activity,MF,ACAA1
3818,GO:0008410,0.215974829381219,0.982757226139999,1,3,CoA-transferase activity,MF,ACAA1
5516,GO:0016479,0.215991788867852,0.982754363231408,1,3,negative regulation of transcription by RNA polymerase I,BP,FLNA
5493,GO:0016429,0.216108464160814,0.982734660245217,1,3,tRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
14501,GO:0061953,0.216108464160814,0.982734660245217,1,3,mRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
12803,GO:0051097,0.216166174932626,0.982724909975284,1,3,negative regulation of helicase activity,BP,TP53
17844,GO:1902022,0.216193529948585,0.982720287256373,1,3,L-lysine transport,BP,SLC7A2
18388,GO:1903401,0.216193529948585,0.982720287256373,1,3,L-lysine transmembrane transport,BP,SLC7A2
18951,GO:1904715,0.216205081302215,0.982718334988212,1,3,negative regulation of chaperone-mediated autophagy,BP,SNRNP70
2056,GO:0004809,0.216216902224499,0.982716337033531,1,3,tRNA (guanine-N2-)-methyltransferase activity,MF,TRMT1
9513,GO:0036166,0.216237203255103,0.98271290548302,1,3,phenotypic switching,BP,PDGFB
17453,GO:1900239,0.216237203255103,0.98271290548302,1,3,regulation of phenotypic switching,BP,PDGFB
15181,GO:0071315,0.216265156446354,0.98270817984073,1,3,cellular response to morphine,BP,PPP1R9B
15183,GO:0071317,0.216265156446354,0.98270817984073,1,3,cellular response to isoquinoline alkaloid,BP,PPP1R9B
16854,GO:0098771,0.216284698236284,0.834302103898886,34,388,inorganic ion homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;STEAP4;LYN;CLN6;JPH1;CHP1;ITGAV;GPER1;GPCPD1;ACO1;ABCG2;OXTR;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;SWAP70;TBXA2R;CCL5
14055,GO:0060828,0.216315304081341,0.851185413372142,18,195,regulation of canonical Wnt signaling pathway,BP,CYLD;DAPK3;NFKB1;FGFR2;PSMB9;BMP2;KREMEN2;SFRP1;PSME2;EGR1;JRK;SNAI2;BAMBI;RUVBL2;ZNF703;RAPGEF1;WNT4;PSMC3
2059,GO:0004813,0.216490091734814,0.982670127058567,1,3,alanine-tRNA ligase activity,MF,AARSD1
2909,GO:0006419,0.216490091734814,0.982670127058567,1,3,alanyl-tRNA aminoacylation,BP,AARSD1
14433,GO:0061738,0.216594052628101,0.982652524007661,1,3,late endosomal microautophagy,BP,HSPA8
13219,GO:0051879,0.216600239014973,0.912159055060191,4,31,Hsp90 protein binding,MF,GBP1;AHR;TELO2;NPAS2
19407,GO:1905940,0.216752556934281,0.982625666273559,1,3,negative regulation of gonad development,BP,WNT4
5357,GO:0016128,0.216761018169221,0.982624231909457,1,3,phytosteroid metabolic process,BP,DHCR7
5358,GO:0016129,0.216761018169221,0.982624231909457,1,3,phytosteroid biosynthetic process,BP,DHCR7
19948,GO:2000489,0.216804955695767,0.982616782477078,1,3,regulation of hepatic stellate cell activation,BP,GCLC
6451,GO:0021769,0.21697183708687,0.982588472170685,1,3,orbitofrontal cortex development,BP,FGFR2
18852,GO:1904468,0.216974845214907,0.982587961626165,1,3,negative regulation of tumor necrosis factor secretion,BP,ZC3H12A
8046,GO:0032696,0.216977196896434,0.982587562489026,1,3,negative regulation of interleukin-13 production,BP,TNFRSF21
9484,GO:0036118,0.217001348642724,0.982583463059122,1,3,hyaluranon cable assembly,BP,BMP7
17380,GO:1900104,0.217001348642724,0.982583463059122,1,3,regulation of hyaluranon cable assembly,BP,BMP7
17381,GO:1900106,0.217001348642724,0.982583463059122,1,3,positive regulation of hyaluranon cable assembly,BP,BMP7
11335,GO:0045658,0.21703530540447,0.982577698450792,1,3,regulation of neutrophil differentiation,BP,TRIB1
4524,GO:0010586,0.217057738145879,0.926717664087516,3,21,miRNA metabolic process,BP,NFKB1;ZC3H12A;DDX17
11504,GO:0045988,0.217094586572708,0.982567632139307,1,3,negative regulation of striated muscle contraction,BP,ZC3H12A
13535,GO:0055118,0.217094586572708,0.982567632139307,1,3,negative regulation of cardiac muscle contraction,BP,ZC3H12A
16985,GO:0099053,0.217243148540799,0.982542391139031,1,3,activating signal cointegrator 1 complex,CC,ASCC2
14435,GO:0061740,0.217243165984753,0.98254238817407,1,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,HSPA8
20159,GO:2000969,0.217257183445593,0.98254000552478,1,3,positive regulation of AMPA receptor activity,BP,ADRB2
5665,GO:0016774,0.217269746691325,0.982537869904779,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,PGK1
14682,GO:0070294,0.21734801257315,0.982524562243425,1,3,renal sodium ion absorption,BP,SGK1
1901,GO:0004586,0.217400045354868,0.982515711903418,1,3,ornithine decarboxylase activity,MF,ODC1
8414,GO:0033387,0.217400045354868,0.982515711903418,1,3,putrescine biosynthetic process from ornithine,BP,ODC1
5984,GO:0018879,0.217501252367609,0.982498490276438,1,3,biphenyl metabolic process,BP,CYP4B1
13729,GO:0060297,0.217517318636829,0.982495755531464,1,3,regulation of sarcomere organization,BP,EDN1
4849,GO:0014061,0.217554389836001,0.982489444489797,1,3,regulation of norepinephrine secretion,BP,OXTR
7181,GO:0031063,0.21755721865103,0.926467680245662,3,21,regulation of histone deacetylation,BP,TP53;AKAP8L;AKAP8
18434,GO:1903516,0.217581072772437,0.98248490117157,1,3,regulation of single strand break repair,BP,PARP1
19973,GO:2000553,0.217610917894116,0.982479818646961,1,3,positive regulation of T-helper 2 cell cytokine production,BP,RSAD2
16494,GO:0097187,0.217617820669813,0.982478643010112,1,3,dentinogenesis,BP,SERPINE1
7958,GO:0032557,0.217640383699837,0.982474799911213,1,3,pyrimidine ribonucleotide binding,MF,HSP90AB1
11418,GO:0045829,0.217654403151499,0.982472411779591,1,3,negative regulation of isotype switching,BP,THOC1
16707,GO:0097680,0.217679068236402,0.982468209785751,1,3,double-strand break repair via classical nonhomologous end joining,BP,XRCC6
17012,GO:0099122,0.217716799071678,0.98246178079645,1,3,RNA polymerase II C-terminal domain binding,MF,HNRNPU
3345,GO:0007063,0.217719165243667,0.926386560581769,3,21,regulation of sister chromatid cohesion,BP,FEN1;SFPQ;CDCA5
2577,GO:0005865,0.217721343624957,0.947719469547959,2,12,striated muscle thin filament,CC,TPM4;TPM1
13402,GO:0052735,0.217760383106982,0.982454352837807,1,3,tRNA (cytosine-3-)-methyltransferase activity,MF,METTL2B
6454,GO:0021773,0.217779064369739,0.982451168482051,1,3,striatal medium spiny neuron differentiation,BP,INHBA
7760,GO:0032276,0.217779064369739,0.982451168482051,1,3,regulation of gonadotropin secretion,BP,INHBA
7762,GO:0032278,0.217779064369739,0.982451168482051,1,3,positive regulation of gonadotropin secretion,BP,INHBA
11873,GO:0046880,0.217779064369739,0.982451168482051,1,3,regulation of follicle-stimulating hormone secretion,BP,INHBA
11874,GO:0046881,0.217779064369739,0.982451168482051,1,3,positive regulation of follicle-stimulating hormone secretion,BP,INHBA
15508,GO:0071879,0.217822641473279,0.982443739197206,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ARRDC3
17213,GO:0106071,0.217822641473279,0.982443739197206,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PRKCA
19241,GO:1905394,0.217840479319643,0.982440697588356,1,3,retromer complex binding,MF,M6PR
6968,GO:0030622,0.217843712681498,0.98244014622226,1,3,U4atac snRNA binding,MF,GEMIN5
1016,GO:0002513,0.217870112765397,0.982435644010343,1,3,tolerance induction to self antigen,BP,LYN
8897,GO:0034714,0.217870112765397,0.982435644010343,1,3,type III transforming growth factor beta receptor binding,MF,TGFB2
3145,GO:0006740,0.217904707716034,0.982429743288707,1,3,NADPH regeneration,BP,G6PD
15113,GO:0071166,0.217913827427147,0.863434739573028,12,122,ribonucleoprotein complex localization,BP,NUP153;SRSF2;AKAP8L;RRS1;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
6155,GO:0019474,0.217935457302936,0.982424497526569,1,3,L-lysine catabolic process to acetyl-CoA,BP,AASS
6156,GO:0019477,0.217935457302936,0.982424497526569,1,3,L-lysine catabolic process,BP,AASS
8428,GO:0033512,0.217935457302936,0.982424497526569,1,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,AASS
11669,GO:0046440,0.217935457302936,0.982424497526569,1,3,L-lysine metabolic process,BP,AASS
15055,GO:0071006,0.21795151475258,0.982421757839542,1,3,U2-type catalytic step 1 spliceosome,CC,PRPF19
1952,GO:0004656,0.217955296904716,0.982421112502312,1,3,procollagen-proline 4-dioxygenase activity,MF,P4HA2
14960,GO:0070852,0.218029397000859,0.982408466358207,1,3,cell body fiber,CC,SACS
15597,GO:0072076,0.218029397000859,0.982408466358207,1,3,nephrogenic mesenchyme development,BP,BMP7
5205,GO:0015803,0.218033979375081,0.982407684149829,1,3,branched-chain amino acid transport,BP,SLC3A2
2353,GO:0005432,0.218034063165162,0.982407669846735,1,3,calcium:sodium antiporter activity,MF,SLC3A2
19571,GO:1990597,0.218074544964965,0.982400758782618,1,3,AIP1-IRE1 complex,CC,TRAF2
19574,GO:1990604,0.218074544964965,0.982400758782618,1,3,IRE1-TRAF2-ASK1 complex,CC,TRAF2
8341,GO:0033186,0.21808531382805,0.982398920064147,1,3,CAF-1 complex,CC,CHAF1A
13929,GO:0060591,0.218093782404311,0.982397474030464,1,3,chondroblast differentiation,BP,CYR61
7620,GO:0032010,0.218129009536188,0.982391458184957,1,3,phagolysosome,CC,LAMP1
10973,GO:0044752,0.218164306947838,0.98238542918651,1,3,response to human chorionic gonadotropin,BP,GCLC
7375,GO:0031427,0.218166123623716,0.982385118856773,1,3,response to methotrexate,BP,DHFR
1370,GO:0003256,0.218218004161044,0.982376255187615,1,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,SRF
15635,GO:0072131,0.218223531453449,0.98237531071582,1,3,kidney mesenchyme morphogenesis,BP,BMP7
15637,GO:0072133,0.218223531453449,0.98237531071582,1,3,metanephric mesenchyme morphogenesis,BP,BMP7
18387,GO:1903400,0.218231279656519,0.982373986700073,1,3,L-arginine transmembrane transport,BP,SLC7A2
14758,GO:0070432,0.218240561737681,0.982372400501576,1,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
6835,GO:0030297,0.218252064248804,0.982370434747148,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,NRG1
12206,GO:0048384,0.218270224827991,0.926110285630147,3,21,retinoic acid receptor signaling pathway,BP,TRIM16;PML;ACTN4
8578,GO:0034056,0.21834413789218,0.982354695148608,1,3,estrogen response element binding,MF,ESR1
8778,GO:0034455,0.218352642997287,0.982353240841317,1,3,t-UTP complex,CC,UTP4
5524,GO:0016494,0.218365017510122,0.982351124775675,1,3,C-X-C chemokine receptor activity,MF,ACKR3
6313,GO:0019958,0.218365017510122,0.982351124775675,1,3,C-X-C chemokine binding,MF,ACKR3
11084,GO:0045084,0.218367895138184,0.982350632675403,1,3,positive regulation of interleukin-12 biosynthetic process,BP,IRF1
17421,GO:1900165,0.218383019326983,0.982348046177197,1,3,negative regulation of interleukin-6 secretion,BP,ZC3H12A
16074,GO:0090031,0.218386796465408,0.982347400188089,1,3,positive regulation of steroid hormone biosynthetic process,BP,WNT4
6668,GO:0030027,0.218396072017901,0.855403945917263,15,155,lamellipodium,CC,AMOT;NEDD9;CORO1C;PDPN;EPHA2;ITGAV;MYO10;AJUBA;DPYSL3;ENAH;PPP1R9B;SORBS2;DAG1;SWAP70;PHACTR4
14252,GO:0061302,0.218396285944768,0.982345777181572,1,3,smooth muscle cell-matrix adhesion,BP,SERPINE1
5514,GO:0016476,0.218397249929132,0.982345612304543,1,3,regulation of embryonic cell shape,BP,DAG1
8195,GO:0032937,0.218425132236456,0.98234084302531,1,3,SREBP-SCAP-Insig complex,CC,INSIG1
10236,GO:0042940,0.218427145695038,0.982340498594611,1,3,D-amino acid transport,BP,NFKBIE
2406,GO:0005577,0.218427755310539,0.982340394310476,1,3,fibrinogen complex,CC,FN1
5985,GO:0018894,0.218429650566215,0.982340070095566,1,3,dibenzo-p-dioxin metabolic process,BP,CYP1A1
16301,GO:0090403,0.21842992274968,0.9823400235338,1,3,oxidative stress-induced premature senescence,BP,TP53
7142,GO:0030981,0.218441379019254,0.982338063675277,1,3,cortical microtubule cytoskeleton,CC,CLASP1
19918,GO:2000416,0.218443968726131,0.982337620629496,1,3,regulation of eosinophil migration,BP,PTGER4
14323,GO:0061484,0.218447341786917,0.982337043558612,1,3,hematopoietic stem cell homeostasis,BP,UBAP2L
19331,GO:1905651,0.218448337481293,0.982336873210948,1,3,regulation of artery morphogenesis,BP,EFNB2
19332,GO:1905653,0.218448337481293,0.982336873210948,1,3,positive regulation of artery morphogenesis,BP,EFNB2
4724,GO:0010886,0.218453096182393,0.982336059059288,1,3,positive regulation of cholesterol storage,BP,EHD1
5496,GO:0016434,0.218455429856498,0.982335659790445,1,3,rRNA (cytosine) methyltransferase activity,MF,NOP2
14977,GO:0070885,0.218457127812556,0.982335369283582,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,CHP1
17209,GO:0106057,0.218457127812556,0.982335369283582,1,3,negative regulation of calcineurin-mediated signaling,BP,CHP1
7796,GO:0032345,0.218457788539068,0.982335256237777,1,3,negative regulation of aldosterone metabolic process,BP,BMP2
7799,GO:0032348,0.218457788539068,0.982335256237777,1,3,negative regulation of aldosterone biosynthetic process,BP,BMP2
19719,GO:2000065,0.218457788539068,0.982335256237777,1,3,negative regulation of cortisol biosynthetic process,BP,BMP2
2301,GO:0005280,0.218458089778258,0.982335204697669,1,3,amino acid:proton symporter activity,MF,SLC25A22
9317,GO:0035787,0.218458329878786,0.982335163617939,1,3,cell migration involved in kidney development,BP,PDGFB
14703,GO:0070327,0.218458431480446,0.9823351462345,1,3,thyroid hormone transport,BP,SLC16A2
125,GO:0000255,0.218458493750398,0.982335135580478,1,3,allantoin metabolic process,BP,STAT5A
702,GO:0001922,0.218458493750398,0.982335135580478,1,3,B-1 B cell homeostasis,BP,TNFAIP3
1378,GO:0003274,0.218458493750398,0.982335135580478,1,3,endocardial cushion fusion,BP,TGFB2
1385,GO:0003289,0.218458493750398,0.982335135580478,1,3,atrial septum primum morphogenesis,BP,TGFB2
2019,GO:0004748,0.218458493750398,0.982335135580478,1,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,RRM2
2638,GO:0005971,0.218458493750398,0.982335135580478,1,3,ribonucleoside-diphosphate reductase complex,CC,RRM2
3804,GO:0008384,0.218458493750398,0.982335135580478,1,3,IkappaB kinase activity,MF,IKBKE
3992,GO:0008889,0.218458493750398,0.982335135580478,1,3,glycerophosphodiester phosphodiesterase activity,MF,GPCPD1
4798,GO:0010990,0.218458493750398,0.982335135580478,1,3,regulation of SMAD protein complex assembly,BP,PARP1
5643,GO:0016728,0.218458493750398,0.982335135580478,1,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,RRM2
5926,GO:0018201,0.218458493750398,0.982335135580478,1,3,peptidyl-glycine modification,BP,NMT2
6238,GO:0019797,0.218458493750398,0.982335135580478,1,3,procollagen-proline 3-dioxygenase activity,MF,P3H2
6315,GO:0019960,0.218458493750398,0.982335135580478,1,3,C-X3-C chemokine binding,MF,ITGAV
6327,GO:0020016,0.218458493750398,0.982335135580478,1,3,ciliary pocket,CC,EHD1
6328,GO:0020018,0.218458493750398,0.982335135580478,1,3,ciliary pocket membrane,CC,EHD1
6500,GO:0021869,0.218458493750398,0.982335135580478,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR2
7971,GO:0032584,0.218458493750398,0.982335135580478,1,3,growth cone membrane,CC,ZFYVE27
8209,GO:0032962,0.218458493750398,0.982335135580478,1,3,positive regulation of inositol trisphosphate biosynthetic process,BP,GPER1
8624,GO:0034140,0.218458493750398,0.982335135580478,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
8638,GO:0034163,0.218458493750398,0.982335135580478,1,3,regulation of toll-like receptor 9 signaling pathway,BP,RSAD2
8867,GO:0034666,0.218458493750398,0.982335135580478,1,3,integrin alpha2-beta1 complex,CC,LYN
8992,GO:0035101,0.218458493750398,0.982335135580478,1,3,FACT complex,CC,SUPT16H
9009,GO:0035166,0.218458493750398,0.982335135580478,1,3,post-embryonic hemopoiesis,BP,MYO1E
9594,GO:0036446,0.218458493750398,0.982335135580478,1,3,myofibroblast differentiation,BP,PARP1
10144,GO:0042713,0.218458493750398,0.982335135580478,1,3,sperm ejaculation,BP,OXTR
10552,GO:0043504,0.218458493750398,0.982335135580478,1,3,mitochondrial DNA repair,BP,PARP1
10600,GO:0043569,0.218458493750398,0.982335135580478,1,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
10696,GO:0043974,0.218458493750398,0.982335135580478,1,3,histone H3-K27 acetylation,BP,LIF
10925,GO:0044539,0.218458493750398,0.982335135580478,1,3,long-chain fatty acid import,BP,ACSL1
11161,GO:0045218,0.218458493750398,0.982335135580478,1,3,zonula adherens maintenance,BP,PLEKHA7
11280,GO:0045586,0.218458493750398,0.982335135580478,1,3,regulation of gamma-delta T cell differentiation,BP,SYK
11786,GO:0046645,0.218458493750398,0.982335135580478,1,3,positive regulation of gamma-delta T cell activation,BP,SYK
12705,GO:0050923,0.218458493750398,0.982335135580478,1,3,regulation of negative chemotaxis,BP,ROBO1
12794,GO:0051088,0.218458493750398,0.982335135580478,1,3,PMA-inducible membrane protein ectodomain proteolysis,BP,ADAM17
12938,GO:0051295,0.218458493750398,0.982335135580478,1,3,establishment of meiotic spindle localization,BP,MYH9
13130,GO:0051684,0.218458493750398,0.982335135580478,1,3,maintenance of Golgi location,BP,TBCCD1
14427,GO:0061731,0.218458493750398,0.982335135580478,1,3,ribonucleoside-diphosphate reductase activity,MF,RRM2
15011,GO:0070939,0.218458493750398,0.982335135580478,1,3,Dsl1/NZR complex,CC,ZW10
15544,GO:0071947,0.218458493750398,0.982335135580478,1,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,TNFAIP3
15659,GO:0072174,0.218458493750398,0.982335135580478,1,3,metanephric tubule formation,BP,WNT4
15727,GO:0072298,0.218458493750398,0.982335135580478,1,3,regulation of metanephric glomerulus development,BP,EGR1
16432,GO:0097068,0.218458493750398,0.982335135580478,1,3,response to thyroxine,BP,GCLC
16469,GO:0097149,0.218458493750398,0.982335135580478,1,3,centralspindlin complex,CC,KIF23
16563,GO:0097343,0.218458493750398,0.982335135580478,1,3,ripoptosome assembly,BP,CYLD
17354,GO:1900041,0.218458493750398,0.982335135580478,1,3,negative regulation of interleukin-2 secretion,BP,GBP1
17371,GO:1900086,0.218458493750398,0.982335135580478,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,SYK
17532,GO:1901026,0.218458493750398,0.982335135580478,1,3,ripoptosome assembly involved in necroptotic process,BP,CYLD
17740,GO:1901674,0.218458493750398,0.982335135580478,1,3,regulation of histone H3-K27 acetylation,BP,LIF
17964,GO:1902338,0.218458493750398,0.982335135580478,1,3,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
18818,GO:1904386,0.218458493750398,0.982335135580478,1,3,response to L-phenylalanine derivative,BP,GCLC
18966,GO:1904746,0.218458493750398,0.982335135580478,1,3,negative regulation of apoptotic process involved in development,BP,BMP7
18975,GO:1904760,0.218458493750398,0.982335135580478,1,3,regulation of myofibroblast differentiation,BP,PARP1
19526,GO:1990423,0.218458493750398,0.982335135580478,1,3,RZZ complex,CC,ZW10
19548,GO:1990504,0.218458493750398,0.982335135580478,1,3,dense core granule exocytosis,BP,CADPS2
19845,GO:2000317,0.218458493750398,0.982335135580478,1,3,negative regulation of T-helper 17 type immune response,BP,SMAD7
19848,GO:2000320,0.218458493750398,0.982335135580478,1,3,negative regulation of T-helper 17 cell differentiation,BP,SMAD7
19899,GO:2000389,0.218458493750398,0.982335135580478,1,3,regulation of neutrophil extravasation,BP,IL1A
19900,GO:2000391,0.218458493750398,0.982335135580478,1,3,positive regulation of neutrophil extravasation,BP,IL1A
2112,GO:0004897,0.218458493750398,0.982335135580478,1,3,ciliary neurotrophic factor receptor activity,MF,IL6R
2427,GO:0005606,0.218458493750398,0.982335135580478,1,3,laminin-1 complex,CC,LAMC1
7116,GO:0030916,0.218458493750398,0.982335135580478,1,3,otic vesicle formation,BP,FGFR2
8459,GO:0033596,0.218458493750398,0.982335135580478,1,3,TSC1-TSC2 complex,CC,NEFL
11317,GO:0045636,0.218458493750398,0.982335135580478,1,3,positive regulation of melanocyte differentiation,BP,ADAMTS9
13756,GO:0060332,0.218458493750398,0.982335135580478,1,3,positive regulation of response to interferon-gamma,BP,NLRC5
13759,GO:0060335,0.218458493750398,0.982335135580478,1,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,NLRC5
14580,GO:0070120,0.218458493750398,0.982335135580478,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6R
15364,GO:0071600,0.218458493750398,0.982335135580478,1,3,otic vesicle morphogenesis,BP,FGFR2
16650,GO:0097513,0.218458493750398,0.982335135580478,1,3,myosin II filament,CC,MYH9
17516,GO:1900748,0.218458493750398,0.982335135580478,1,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,ROBO1
19102,GO:1905031,0.218458493750398,0.982335135580478,1,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,FLNA
20211,GO:2001137,0.218458493750398,0.982335135580478,1,3,positive regulation of endocytic recycling,BP,EHD1
2781,GO:0006211,0.218458493750398,0.982335135580478,1,3,5-methylcytosine catabolic process,BP,TET3
6264,GO:0019857,0.218458493750398,0.982335135580478,1,3,5-methylcytosine metabolic process,BP,TET3
9201,GO:0035583,0.218458493750398,0.982335135580478,1,3,sequestering of TGFbeta in extracellular matrix,BP,FBN1
10420,GO:0043259,0.218458493750398,0.982335135580478,1,3,laminin-10 complex,CC,LAMC1
10421,GO:0043260,0.218458493750398,0.982335135580478,1,3,laminin-11 complex,CC,LAMC1
3138,GO:0006730,0.218620262896299,0.925934594941519,3,21,one-carbon metabolic process,BP,MAT2A;TYMS;DHFR
2186,GO:0005044,0.219076693906277,0.925705272268043,3,21,scavenger receptor activity,MF,CXCL16;ACKR3;TINAGL1
15058,GO:0071010,0.21910277082146,0.925415782530391,3,22,prespliceosome,CC,LUC7L;U2AF2;SNRNP70
7850,GO:0032410,0.219131526524882,0.899597255466259,5,42,negative regulation of transporter activity,BP,MMP9;NEDD4L;RRAD;CAB39;OXSR1
8988,GO:0035094,0.219360808346348,0.925562393658637,3,21,response to nicotine,BP,EDN1;NFKB1;TNF
12539,GO:0050688,0.219628209140364,0.890679298226291,6,53,regulation of defense response to virus,BP,BIRC3;TRAF3;ZC3H12A;IL15;PQBP1;TNFAIP3
3637,GO:0008106,0.219650723914304,0.946956021991884,2,12,alcohol dehydrogenase (NADP+) activity,MF,AKR1C2;AKR1C1
13484,GO:0055021,0.21986800426474,0.910302067807082,4,31,regulation of cardiac muscle tissue growth,BP,EDN1;G6PD;FGFR2;MAPK11
10505,GO:0043407,0.219928588929537,0.883556756332583,7,64,negative regulation of MAP kinase activity,BP,DUSP14;LYN;SFRP1;SPRY4;DUSP1;BMP7;DUSP8
5354,GO:0016125,0.220315782645992,0.864848283638017,11,110,sterol metabolic process,BP,CYP1B1;G6PD;NFE2L1;SCD;LSS;CLN6;CYB5R1;HMGCS1;EBP;DHCR7;INSIG1
12061,GO:0048009,0.220419957060782,0.925028863638643,3,21,insulin-like growth factor receptor signaling pathway,BP,IGFBP3;IRS1;BMP2
2466,GO:0005682,0.22060406369568,0.924657164505795,3,22,U5 snRNP,CC,DDX23;CD2BP2;TXNL4B
3815,GO:0008406,0.220607596136799,0.855972622644046,14,145,gonad development,BP,INHBA;TGFB2;LFNG;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1
4752,GO:0010923,0.220831758240235,0.877198822035038,8,75,negative regulation of phosphatase activity,BP,TGFB2;SH3RF2;TNF;PKMYT1;CHP1;CD2BP2;PPP1R14C;PPP1R9B
896,GO:0002275,0.221180808272887,0.830799186332122,33,380,myeloid cell activation involved in immune response,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;DNASE1;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
9044,GO:0035258,0.221327437998545,0.876852146699768,8,75,steroid hormone receptor binding,MF,DAXX;FUS;FHL2;YWHAH;PAGR1;ETS2;ESR1;PARP1
6565,GO:0022011,0.221332693771306,0.92456795658564,3,21,myelination in peripheral nervous system,BP,PARD3;CNTNAP1;DAG1
7772,GO:0032292,0.221332693771306,0.92456795658564,3,21,peripheral nervous system axon ensheathment,BP,PARD3;CNTNAP1;DAG1
9808,GO:0040036,0.22154037391086,0.924462937804459,3,21,regulation of fibroblast growth factor receptor signaling pathway,BP,FGFR2;SPRY4;WNT4
3052,GO:0006611,0.22154727692568,0.850755429300039,16,170,protein export from nucleus,BP,TP53;PTPN14;NUP153;SRSF2;CHP1;SFN;AKAP8L;RRS1;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
7399,GO:0031462,0.221699897413414,0.946139925852563,2,12,Cul2-RING ubiquitin ligase complex,CC,ZSWIM6;RNF7
10330,GO:0043122,0.221962773173625,0.848492209584635,17,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,HSPB1;MAP3K14;IKBKE;BIRC3;SQSTM1;TNF;ZC3H12A;FLNA;TRIM22;TRAF2;AJUBA;IL1A;TNIP2;ROR1;ESR1;EEF1D;TNFAIP3
4358,GO:0009954,0.222154858240164,0.924151891213857,3,21,proximal/distal pattern formation,BP,IRX2;PBX1;TP63
17393,GO:1900119,0.222176658579721,0.945949277851242,2,12,positive regulation of execution phase of apoptosis,BP,TP53;ZC3H12A
2892,GO:0006399,0.222358027054904,0.84814606265176,17,183,tRNA metabolic process,BP,CARS2;CDKAL1;TRMT61A;NAT10;PUS1;METTL1;NSUN2;POP1;METTL2B;WDR4;GTF3C2;DUS2;TRMT1;AARSD1;HSD17B10;POP4;RPUSD4
59,GO:0000122,0.222382029858654,0.820086259062038,52,603,negative regulation of transcription by RNA polymerase II,BP,HDAC9;TFCP2L1;IRX2;RELB;EDN1;TP53;SQSTM1;FST;NFKB1;JUNB;TNF;WWC1;FGFR2;NFKB2;DNAJB1;TSC22D3;BMP2;OSR2;NFX1;SRF;TRIM29;EGR1;SNAI2;NELFE;CBX5;MAFK;AJUBA;PDGFB;BRMS1;NEDD4L;FHL2;UHRF1;ZNF263;SFPQ;SPEN;SMAD7;SUPT5H;MTA2;HNRNPU;KCNIP3;ETS2;KLF10;CITED2;JUN;ESR1;NOC2L;GLIS3;KCTD1;TIMELESS;EFNA1;PARP1;TP63
11043,GO:0045023,0.222532984029206,0.897496565638699,5,42,G0 to G1 transition,BP,CTGF;RING1;CBX5;TFDP1;RRM2
19406,GO:1905939,0.222582495079881,0.945786760863944,2,12,regulation of gonad development,BP,CITED2;WNT4
9021,GO:0035198,0.222680343734772,0.923885519472654,3,21,miRNA binding,MF,ZC3H12A;ZC3H7B;RBM4
1226,GO:0002903,0.22288789242043,0.945664324937111,2,12,negative regulation of B cell apoptotic process,BP,IRS2;NOC2L
17489,GO:1900409,0.22293822182497,0.945644136009385,2,12,positive regulation of cellular response to oxidative stress,BP,TNF;SFPQ
18147,GO:1902884,0.22293822182497,0.945644136009385,2,12,positive regulation of response to oxidative stress,BP,TNF;SFPQ
17533,GO:1901028,0.223003418883523,0.897087684668424,5,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;SFN;YWHAH;TFDP1;TP63
2842,GO:0006310,0.223007123520363,0.842675106524594,20,215,DNA recombination,BP,TFRC;IL27RA;IL7R;FEN1;GINS2;ALYREF;ORAOV1;SFPQ;PAGR1;RUVBL2;THOC1;CCR6;ZNF365;XRCC6;RBM14;BRIP1;SWAP70;PARP1;TOP3A;APEX2
1120,GO:0002709,0.223059372437537,0.908301026303023,4,32,regulation of T cell mediated immunity,BP,RSAD2;IL7R;TRAF2;SMAD7
10423,GO:0043266,0.223150826897981,0.897113599417325,5,42,regulation of potassium ion transport,BP,FLNA;NEDD4L;KCNIP3;CAB39;OXSR1
12813,GO:0051117,0.223211555761878,0.888255857725285,6,54,ATPase binding,MF,DNAJB1;UBE4B;NSFL1C;RUVBL2;ESR1;METTL21A
8773,GO:0034450,0.223599033095333,0.945378758616769,2,12,ubiquitin-ubiquitin ligase activity,MF,UBE4B;PRPF19
12646,GO:0050850,0.224435089950978,0.922708478228864,3,22,positive regulation of calcium-mediated signaling,BP,NRG1;JPH2;SYK
16001,GO:0086009,0.224967119035813,0.922722310493739,3,21,membrane repolarization,BP,FLNA;WDR1;NEDD4L
8128,GO:0032816,0.225352728218098,0.944671762603098,2,12,positive regulation of natural killer cell activation,BP,LAMP1;IL15
13489,GO:0055026,0.225396765624346,0.92250303247805,3,21,negative regulation of cardiac muscle tissue development,BP,G6PD;BMP2;MAPK11
19815,GO:2000273,0.226336451302884,0.921734499198283,3,22,positive regulation of signaling receptor activity,BP,EPGN;ADRB2;ADAM17
10562,GO:0043518,0.226394116490587,0.944250058395378,2,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;PTTG1IP
7043,GO:0030816,0.226876657480474,0.944054183250922,2,12,positive regulation of cAMP metabolic process,BP,ADM;GPER1
13094,GO:0051604,0.227319777206202,0.840650152590845,19,209,protein maturation,BP,C1R;IL1R2;BIRC3;BACE2;C9ORF3;SERPINE1;PGK1;SNX12;SERPINH1;MYH9;SPPL2A;DOHH;APH1A;RHBDL2;EIF5A;XPNPEP3;NOL3;PARP1;C1S
889,GO:0002260,0.227634203056312,0.894201801440285,5,43,lymphocyte homeostasis,BP,LYN;TSC22D3;DOCK10;FOXN1;TNFAIP3
7306,GO:0031306,0.227839755812924,0.920961222086872,3,22,intrinsic component of mitochondrial outer membrane,CC,CPT1A;TOMM40;SLC25A44
10948,GO:0044613,0.227876111405038,0.943647527997726,2,12,nuclear pore central transport channel,CC,NUP153;NUP214
13234,GO:0051897,0.228181391332059,0.867004973858105,9,87,positive regulation of protein kinase B signaling,BP,NRG1;C1QTNF1;IRS1;TNF;FGFR2;IRS2;AKR1C2;PDGFB;ESR1
17640,GO:1901363,0.228277660793464,0.792461900525127,360,4570,heterocyclic compound binding,MF,MAFB;TRIM16;RUNX1;CYP1B1;CYP24A1;FOSL2;ACTG1;NQO1;CYP1A1;TAP1;DUSP14;PML;TFCP2L1;RBM19;HSPB1;MYBL2;IRX2;RELB;TFRC;BAG1;ABCF1;CD3EAP;ARID3B;IER2;MAP3K14;GBP1;TXNRD1;MAT2A;TRIM56;IKBKE;DAPK3;TET3;ELMSAN1;G6PD;NUAK1;NLRC5;TP53;NFE2L1;PDCD11;HNRNPAB;PANK2;NOCT;NFKB1;TAF4B;LYN;MYO1B;RAB32;AHR;JUNB;MCM5;HMGXB3;CSRP1;EHD1;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;GPATCH4;CARS2;PKMYT1;PPAN;RRP1;NAV2;TRIO;FGFR2;PBX1;NUP153;NFKB2;EPHB6;TELO2;FOSL1;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TNK1;SART1;TK1;GEMIN5;KLF7;ZNF503;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;ZNF142;KIF23;MYO10;GTPBP6;STAT5A;RRP12;ZMAT2;FOXD2;NAT10;FUS;PABPC4;PGK1;MCM2;LSG1;CCDC124;TOX4;USP36;AKAP8L;ZC3H7B;AEN;ELF3;GRWD1;OSR2;ABCF2;SAFB2;APTX;DHCR7;PUS1;DHX37;PWP2;IRF1;METTL1;LUC7L;BANF1;EPPK1;DDX42;CTIF;NFX1;PSPC1;TFIP11;SRF;NSUN2;ZNF787;RRP36;ELF4;LARP4B;ZFP42;SF1;EGR1;JRK;EDF1;ETS1;SGK1;SNAI2;POP1;RRS1;SRRT;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;RHOB;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;RIPK4;NPAS2;PPRC1;LGALS3;TSR1;ACO1;MAFK;ABCG2;SF3B4;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;DDX17;IFIT3;DDX47;PPIP5K1;CDKL1;DDX49;DNTTIP2;RPS2;UBTF;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;SPTBN1;SNRNP70;SERPINH1;ZNF407;RRP7A;UHRF1;MYH9;ZNF234;NOM1;ZNFX1;CAMK1G;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;NOP16;BRD9;ZNF697;FTSJ3;WDR46;SPEN;ZW10;ROR1;ACSL1;RCC2;NOP56;MAFF;GPN1;SMAD7;CRCP;MRPS12;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;TRIP6;ERAL1;HNRNPU;HNRNPF;PQBP1;RRAD;UBE2J2;CREB3;RUVBL2;ABT1;MAZ;TUSC1;ORC1;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PRDM7;MRPL20;RBM38;ARL6IP4;RPL27A;HSPBP1;OXSR1;HSPA8;JUN;ESR1;IKZF3;TCOF1;SLC22A4;PES1;FOXN1;RCC1;BRPF1;MCM7;TFDP1;ZNF772;ZNF512;EIF3B;BCS1L;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;RBM4;ZNF703;DUS2;QDPR;RHOG;XRCC6;ZNF132;TRMT1;KLF6;CS;TAP2;TEAD4;ACTN4;HMGN2;SORBS2;KIF24;GLIS3;SNIP1;METTL16;SMUG1;CLUH;ZNF34;URGCP;EFTUD2;TRA2A;ELK1;CYP20A1;PHF5A;EIF3I;ZYX;EIF5A;UBAP2L;KIF22;POLR3H;EEF1D;RAB27A;DHX34;TIMELESS;RBM14;TRAF4;TUBB;TNFAIP3;PSMC3;SMARCC2;BRIP1;SUPT16H;MAPK11;AARSD1;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;ATAD3C;HES4;ZC3H18;UTP4;POLR2G;SRSF7;CREB5;NOL3;GCLC;LRRC59;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;ORC4;MAGOH;APEX2
12845,GO:0051155,0.228284517212574,0.905280723459857,4,32,positive regulation of striated muscle cell differentiation,BP,NRG1;EDN1;EHD1;EFNB2
12287,GO:0048608,0.228922589057948,0.829305888427689,27,301,reproductive structure development,BP,CYR61;INHBA;ADM;CSF2;TGFB2;LFNG;JUNB;TNC;FGFR2;FOSL1;HMGCS1;ICAM1;LIF;SFRP1;SAFB2;ZFP42;SF1;ZFP36L1;PDGFB;CITED2;ESR1;BCL2L2;BMP7;WNT4;BRIP1;HSP90AB1;TP63
12915,GO:0051261,0.228970790450521,0.871476328940379,8,75,protein depolymerization,BP,MID1;WDR1;SPTBN1;CLASP1;MICAL3;HSPA8;KIF24;SWAP70
16546,GO:0097296,0.229087668447183,0.943152850142996,2,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TRAF2;TNFRSF10A
19624,GO:1990782,0.229119500958933,0.884459144335088,6,53,protein tyrosine kinase binding,MF,NRG1;TP53;SQSTM1;IRS1;PTPN14;BLNK
16258,GO:0090311,0.229409260440393,0.904626361600489,4,32,regulation of protein deacetylation,BP,TP53;AKAP8L;AKAP8;BRMS1
2698,GO:0006063,0.229680252312889,0.942910211110925,2,12,uronic acid metabolic process,BP,UGT1A6;DCXR
6184,GO:0019585,0.229680252312889,0.942910211110925,2,12,glucuronate metabolic process,BP,UGT1A6;DCXR
768,GO:0002020,0.229846081859117,0.865709355928809,9,89,protease binding,MF,FN1;PANX1;TP53;TNF;ITGAV;SERPINE1;TNFRSF10A;TNFAIP3;NOL3
9086,GO:0035337,0.230040586389049,0.904258409660508,4,32,fatty-acyl-CoA metabolic process,BP,SCD;ACSL1;SCD5;THEM4
8020,GO:0032653,0.230506149571543,0.919582718541495,3,22,regulation of interleukin-10 production,BP,CD83;CD274;TNFRSF21
18253,GO:1903076,0.230533937577344,0.876250260232457,7,65,regulation of protein localization to plasma membrane,BP,GBP1;SQSTM1;EPHA2;GPER1;SPTBN1;STAC;RHOG
614,GO:0001782,0.230731716906998,0.919465694638049,3,22,B cell homeostasis,BP,LYN;DOCK10;TNFAIP3
15870,GO:0072589,0.230781710450619,0.977836162911646,1,4,box H/ACA scaRNP complex,CC,DKC1
16490,GO:0097178,0.230799684816761,0.90381536649383,4,32,ruffle assembly,BP,CORO1C;ICAM1;RCC2;RHOG
7382,GO:0031434,0.230856855929992,0.892301182142327,5,42,mitogen-activated protein kinase kinase binding,MF,FGFR2;EPHB6;EPHA2;ROR1;TRIB1
6638,GO:0023023,0.230940319173529,0.942392763816792,2,12,MHC protein complex binding,MF,HSPA8;HSP90AB1
7974,GO:0032588,0.231205878923987,0.875787708090421,7,65,trans-Golgi network membrane,CC,MYO1B;ARFRP1;AP4S1;M6PR;TMEM165;VPS52;CLTA
10724,GO:0044058,0.231237809979922,0.942270301083703,2,12,regulation of digestive system process,BP,SGK1;OXTR
5070,GO:0015293,0.231400981405813,0.869755312179987,8,75,symporter activity,MF,SLC16A2;SLC16A9;SLC5A6;SLC4A11;SLC22A4;SLC4A2;SLC25A22;SLC2A6
12547,GO:0050699,0.231465138142972,0.919084758111235,3,22,WW domain binding,MF,ENAH;TRAF4;TP63
13918,GO:0060575,0.232046920224951,0.941936653406854,2,12,intestinal epithelial cell differentiation,BP,CDKN1A;TYMS
9361,GO:0035872,0.232254953817563,0.90296410912716,4,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,CYLD;BIRC3;NFKBIA;TNFAIP3
17726,GO:1901655,0.232287048356745,0.875042501823212,7,65,cellular response to ketone,BP,PTGER4;AHR;ICAM1;ERRFI1;SFRP1;AKAP8;ELK1
12562,GO:0050714,0.232325501893174,0.846828872218559,14,146,positive regulation of protein secretion,BP,SAA1;TRIM16;PTGER4;TGFB2;PANX1;TNF;CD274;GPER1;IRS2;SYK;SPTBN1;IL1A;CD38;MAPK11
16356,GO:0090646,0.232347818869507,0.94181235898322,2,12,mitochondrial tRNA processing,BP,PUS1;HSD17B10
10185,GO:0042776,0.232804379755239,0.977423064048884,1,4,mitochondrial ATP synthesis coupled proton transport,BP,COX5B
13909,GO:0060560,0.23290303605895,0.843990844631146,15,156,developmental growth involved in morphogenesis,BP,NRG1;FN1;TNC;FGFR2;L1CAM;TNFRSF12A;SFRP1;ZFYVE27;SRF;VCL;NTN1;NEDD4L;SEMA3C;ESR1;BIN3
13176,GO:0051781,0.233350326886308,0.881565331001011,6,54,positive regulation of cell division,BP,TGFB2;FGFR2;KIF23;SVIL;PDGFB;IL1A
12788,GO:0051082,0.233430594481436,0.858727577200144,10,101,unfolded protein binding,MF,CRYAB;DNAJB1;DNAJB2;SHQ1;SERPINH1;TAPBP;RUVBL2;HSPA8;CHAF1A;HSP90AB1
479,GO:0001523,0.23344898949296,0.890544178056245,5,43,retinoid metabolic process,BP,CYP1B1;CYP1A1;SDC4;HSPG2;AKR1C1
10310,GO:0043085,0.233569211698818,0.801564201756045,85,1024,positive regulation of catalytic activity,BP,SAA1;CCL20;NRG1;CYR61;FN1;CTGF;PML;STARD13;SDC4;MAP3K14;TGFB2;EDN1;EMP2;SIPA1L3;IRS1;CDKN1A;LYN;GADD45A;TNF;CORO1C;FGFR2;DNAJB1;EPHB6;TELO2;UBE2C;EPHA2;GADD45B;ICAM1;BMP2;ERRFI1;CDC42EP2;EPGN;ADRB2;DAXX;SFRP1;TPM1;PSME2;GPER1;DNAJB2;EGR1;DOCK10;ADAM17;DKC1;DHFR;RPLP1;TRAF2;SYK;ROBO1;AJUBA;PDGFB;RPS2;UHRF1;NPNT;RASGRP4;RUNDC1;ROR1;ACSL1;RCC2;AFAP1L2;DNAJC1;HNRNPU;APH1A;DCUN1D2;CAB39;SOCS1;OXSR1;JUN;ESR1;ARRDC3;RHOG;XRCC6;TNFRSF10A;SGSM1;RAPGEF1;DAG1;WNT4;TRAF4;CCL22;DNAJC9;EFNA1;MAPK11;CARD10;HSP90AB1;PHACTR4;CCL5
636,GO:0001825,0.23360579177242,0.917969072196213,3,22,blastocyst formation,BP,JUNB;SRF;RRP7A
5192,GO:0015780,0.233791497102963,0.941214388797701,2,12,nucleotide-sugar transmembrane transport,BP,SLC35A4;SLC35C2
13136,GO:0051701,0.234153746364238,0.842940382800397,15,159,interaction with host,BP,PML;TFRC;LAMP1;EFNB2;NUP153;TYMS;ZC3H12A;EPHA2;ICAM1;ITGAV;ALYREF;THOC1;CHMP4B;DAG1;CXCL8
7226,GO:0031120,0.234274164789376,0.977120205295002,1,4,snRNA pseudouridine synthesis,BP,DKC1
1232,GO:0002920,0.23444770373463,0.917528711484738,3,22,regulation of humoral immune response,BP,C1R;TNF;C1S
11033,GO:0045005,0.234621911579362,0.901574238179156,4,32,DNA-dependent DNA replication maintenance of fidelity,BP,ALYREF;THOC1;ZNF365;TIMELESS
550,GO:0001671,0.234867350869469,0.917308885953702,3,22,ATPase activator activity,MF,DNAJB1;DNAJB2;DNAJC1
16868,GO:0098797,0.234897351483535,0.826376681938076,25,277,plasma membrane protein complex,CC,TFRC;HLA-B;TRAF3;IRS1;HSPG2;LYN;CORO1C;BMP2;ITGAV;ABCF2;HLA-F;KCNA7;TRAF2;PRKCA;SYK;MYH9;NPNT;SMAD7;TRIP6;APH1A;KCNIP3;CNTNAP1;DAG1;CLTA;IL6R
3280,GO:0006958,0.234954171922615,0.940730861593998,2,12,complement activation, classical pathway,BP,C1R;C1S
10417,GO:0043255,0.234998722153765,0.880558403518635,6,53,regulation of carbohydrate biosynthetic process,BP,NFKB1;IRS1;PPP1R3B;GPER1;IRS2;PDGFB
3133,GO:0006721,0.235154323414097,0.880363533392629,6,54,terpenoid metabolic process,BP,CYP1B1;CYP1A1;SDC4;HSPG2;HMGCS1;AKR1C1
7222,GO:0031116,0.235255983517504,0.917105111268036,3,22,positive regulation of microtubule polymerization,BP,DCTN1;SLAIN2;CLASP1
10434,GO:0043279,0.235363230492701,0.872915824707698,7,65,response to alkaloid,BP,TP53;ICAM1;OXTR;SDK1;PPP1R9B;EFTUD2;HSP90AB1
13510,GO:0055080,0.235474093910637,0.818545075069118,33,380,cation homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;STEAP4;LYN;CLN6;JPH1;CHP1;ITGAV;GPER1;ACO1;ABCG2;OXTR;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;SWAP70;TBXA2R;CCL5
15247,GO:0071404,0.235582037057156,0.940469025461869,2,12,cellular response to low-density lipoprotein particle stimulus,BP,HMGCS1;SYK
4281,GO:0009648,0.235603351815031,0.916922813864021,3,22,photoperiodism,BP,PML;TP53;RBM4
1646,GO:0004090,0.235667262285963,0.976831062310903,1,4,carbonyl reductase (NADPH) activity,MF,DCXR
11140,GO:0045185,0.235871687826441,0.861320616134948,9,89,maintenance of protein location,BP,NFKBIE;PML;FBN1;FLNA;NFKBIA;KEAP1;HNRNPU;INSIG1;DAG1
8200,GO:0032945,0.235890896360445,0.888996976055777,5,43,negative regulation of mononuclear cell proliferation,BP,SDC4;LYN;CD274;TNFRSF21;GPNMB
12528,GO:0050672,0.235890896360445,0.888996976055777,5,43,negative regulation of lymphocyte proliferation,BP,SDC4;LYN;CD274;TNFRSF21;GPNMB
15114,GO:0071168,0.236401755809614,0.916503245495291,3,22,protein localization to chromatin,BP,RUVBL2;ESR1;CDCA5
14110,GO:0060965,0.236583989567482,0.940050135187859,2,12,negative regulation of gene silencing by miRNA,BP,ZC3H12A;ESR1
17830,GO:1901989,0.23673973848019,0.871892195718083,7,66,positive regulation of cell cycle phase transition,BP,CYP1A1;PBX1;UBE2C;CDK4;RCC2;PAGR1;CDCA5
11008,GO:0044827,0.236858137146949,0.939935296283236,2,12,modulation by host of viral genome replication,BP,ZC3H12A;HSPA8
12950,GO:0051310,0.237134045890254,0.879040746116686,6,54,metaphase plate congression,BP,RRS1;ZW10;HNRNPU;CHMP4B;KIF22;CDCA5
9323,GO:0035794,0.237534095775162,0.878684435946537,6,55,positive regulation of mitochondrial membrane permeability,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;TP63
19346,GO:1905710,0.237534095775162,0.878684435946537,6,55,positive regulation of membrane permeability,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;TP63
13199,GO:0051817,0.237572879288378,0.865245272768241,8,77,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TYMS;ZC3H12A;ITGAV;HSPA8;JUN;DAG1;PSMC3;CCL5
11071,GO:0045071,0.237675220197129,0.887628602271332,5,45,negative regulation of viral genome replication,BP,RSAD2;TNF;ZC3H12A;BANF1;CCL5
5610,GO:0016653,0.237831465463681,0.939526793731748,2,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NQO1;CYB5R1
1425,GO:0003382,0.237928697609018,0.915698615261608,3,22,epithelial cell morphogenesis,BP,SIPA1L3;VSIG1;RILPL2
12324,GO:0048675,0.238262849615198,0.859662536731592,9,87,axon extension,BP,NRG1;FN1;L1CAM;TNFRSF12A;ZFYVE27;SRF;VCL;NTN1;SEMA3C
9045,GO:0035259,0.238266001071493,0.93934402727226,2,12,glucocorticoid receptor binding,MF,YWHAH;ETS2
8297,GO:0033127,0.238266781943953,0.939343698617289,2,12,regulation of histone phosphorylation,BP,AKAP8L;AKAP8
8842,GO:0034629,0.23859592052179,0.915346108310755,3,22,cellular protein-containing complex localization,BP,KLHL21;RCC2;SMAD7
4730,GO:0010893,0.238921380129418,0.93906791436017,2,12,positive regulation of steroid biosynthetic process,BP,TNF;WNT4
7475,GO:0031639,0.238976676754293,0.939044592478456,2,12,plasminogen activation,BP,SERPINE1;PGK1
10625,GO:0043621,0.239049440984401,0.886985930712983,5,43,protein self-association,MF,RSAD2;TP53;ZFYVE27;TNFAIP3;CCL5
7414,GO:0031501,0.239250785149083,0.976077926301289,1,4,mannosyltransferase complex,CC,DPM3
15776,GO:0072376,0.239384212481416,0.91492892521404,3,22,protein activation cascade,BP,KRT1;C1R;C1S
17833,GO:1901992,0.239511479774166,0.877357534730008,6,55,positive regulation of mitotic cell cycle phase transition,BP,CYP1A1;PBX1;UBE2C;CDK4;RCC2;CDCA5
9788,GO:0040001,0.239534590103573,0.914849254062229,3,22,establishment of mitotic spindle localization,BP,DCTN1;ZW10;CLASP1
9337,GO:0035821,0.239560434832944,0.858528770624825,9,91,modification of morphology or physiology of other organism,BP,TYMS;ZC3H12A;ITGAV;HSPA8;JUN;HMGN2;DAG1;PSMC3;CCL5
11824,GO:0046718,0.239889985237377,0.863529305397439,8,78,viral entry into host cell,BP,TFRC;LAMP1;EFNB2;NUP153;EPHA2;ICAM1;ITGAV;DAG1
15748,GO:0072331,0.240146533540252,0.825638703094849,22,246,signal transduction by p53 class mediator,BP,PML;NUAK1;TP53;TAF4B;CDKN1A;GADD45A;SFN;AEN;SNAI2;RRS1;PTTG1IP;MTA2;PAK1IP1;BRPF1;TFDP1;NOP2;NOC2L;BRIP1;SUPT16H;MAPK11;TP63;TOP3A
8893,GO:0034708,0.240370139468253,0.85797751596087,9,90,methyltransferase complex,CC,HDAC9;TRMT61A;METTL1;CBX5;SENP3;RBBP5;WDR4;PAGR1;RUVBL2
2977,GO:0006518,0.240550813627585,0.800459566282816,62,783,peptide metabolic process,BP,HSPB1;ABCF1;PTGES;DAPK3;G6PD;TNF;CARS2;ENC1;CDKAL1;NUP153;BACE2;KRT17;C9ORF3;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;PABPC4;DNPEP;DPH2;CTIF;LARP4B;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;ZFP36L2;PUM3;AJUBA;RPS2;RPS9;SNRNP70;SPPL2A;NUP214;MRPS12;MRPS24;DNAJC1;TAPBP;ERAL1;APH1A;MRPL20;RPL27A;HSPA8;MRPL33;ESR1;TCOF1;EIF3B;RBM4;METTL16;EFTUD2;EIF3I;EIF5A;EEF1D;MRPS2;EFNA1;AARSD1;POLR2G;GCLC;CCL5;MAGOH
13251,GO:0051928,0.240615930480469,0.876614631354796,6,55,positive regulation of calcium ion transport,BP,JPH2;G6PD;GPER1;LGALS3;PDGFB;CCL5
15595,GO:0072074,0.240666525530243,0.938329986236004,2,12,kidney mesenchyme development,BP,BMP7;WNT4
8922,GO:0034763,0.240893923936529,0.868998425185476,7,66,negative regulation of transmembrane transport,BP,MMP9;TNF;IRS2;NEDD4L;RRAD;CAB39;OXSR1
12302,GO:0048640,0.240932953489452,0.869041312716833,7,65,negative regulation of developmental growth,BP,G6PD;WWC1;ADRB2;SFRP1;NTN1;SEMA3C;MAPK11
12798,GO:0051092,0.241037880231435,0.849146167643238,11,113,positive regulation of NF-kappaB transcription factor activity,BP,TRAF1;NFKB1;TNF;NFKB2;ICAM1;TRIM22;NFKBIA;RIPK4;TRAF2;NFKBIB;ROR1
17472,GO:1900363,0.241063559438795,0.938161555023163,2,12,regulation of mRNA polyadenylation,BP,NELFE;SUPT5H
16111,GO:0090090,0.241144448022103,0.845544723053835,12,128,negative regulation of canonical Wnt signaling pathway,BP,CYLD;PSMB9;BMP2;KREMEN2;SFRP1;PSME2;EGR1;SNAI2;RUVBL2;RAPGEF1;WNT4;PSMC3
8049,GO:0032703,0.241157008205586,0.938121882361544,2,12,negative regulation of interleukin-2 production,BP,GBP1;TNFAIP3
7920,GO:0032495,0.24122659228591,0.938092333898512,2,12,response to muramyl dipeptide,BP,NFKBIA;TNFAIP3
13293,GO:0051988,0.241286785879458,0.938066768025809,2,12,regulation of attachment of spindle microtubules to kinetochore,BP,RCC2;HNRNPU
11104,GO:0045120,0.241350310738532,0.938039782218997,2,12,pronucleus,CC,TET3;AKAP8
10313,GO:0043090,0.241497884227966,0.937977071928941,2,12,amino acid import,BP,SLC7A2;SLC3A2
12352,GO:0048714,0.241535469690615,0.937961095782082,2,12,positive regulation of oligodendrocyte differentiation,BP,ZNF365;DAG1
2482,GO:0005720,0.241704366141767,0.897196291277955,4,33,nuclear heterochromatin,CC,RING1;CBX5;UHRF1;MPHOSPH8
1350,GO:0003215,0.241842066630141,0.937830705251782,2,12,cardiac right ventricle morphogenesis,BP,TGFB2;SEMA3C
400,GO:0001076,0.241853344869352,0.839310092161975,14,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,MYBL2;TP53;NFE2L1;DNAJB1;MKL1;SRF;MED22;ZFP42;PPRC1;SPEN;CITED2;JUN;GTF2E1;RBM14
4239,GO:0009437,0.242174202250163,0.937689317115558,2,12,carnitine metabolic process,BP,SLC22A4;CPT1A
18962,GO:1904738,0.242185711546776,0.937684415133519,2,12,vascular associated smooth muscle cell migration,BP,TPM1;PDGFB
18972,GO:1904752,0.242185711546776,0.937684415133519,2,12,regulation of vascular associated smooth muscle cell migration,BP,TPM1;PDGFB
12793,GO:0051087,0.242415770781299,0.861658369125938,8,79,chaperone binding,MF,FN1;SACS;BAG1;TP53;PDPN;DNAJB1;DNAJB2;DNAJC1
18304,GO:1903214,0.242471505086596,0.867826671368374,7,67,regulation of protein targeting to mitochondrion,BP,NRG1;CYB5R1;USP36;PARL;WDR46;UBE2J2;SNIP1
9548,GO:0036303,0.243027134278551,0.937325579009714,2,12,lymph vessel morphogenesis,BP,PDPN;PTPN14
16557,GO:0097329,0.243133134876827,0.937280309027978,2,12,response to antimetabolite,BP,DHFR;TIMELESS
10867,GO:0044389,0.24339196368855,0.819182682399612,25,281,ubiquitin-like protein ligase binding,MF,ACTG1;PML;TRAF1;IKBKE;MID1;TRAF3;TP53;SQSTM1;CDKN1A;LYN;UBE2C;DAXX;ABTB2;NFKBIA;VCL;TRAF2;SMAD7;UBE2J2;TRIB1;HSPA8;JUN;HERC2;MPHOSPH8;TRAF4;TUBB
14314,GO:0061458,0.243427984373841,0.816997754014557,27,304,reproductive system development,BP,CYR61;INHBA;ADM;CSF2;TGFB2;LFNG;JUNB;TNC;FGFR2;FOSL1;HMGCS1;ICAM1;LIF;SFRP1;SAFB2;ZFP42;SF1;ZFP36L1;PDGFB;CITED2;ESR1;BCL2L2;BMP7;WNT4;BRIP1;HSP90AB1;TP63
1949,GO:0004653,0.243479528742016,0.937132272809252,2,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT18;GALNT2
5941,GO:0018243,0.243479528742016,0.937132272809252,2,12,protein O-linked glycosylation via threonine,BP,GALNT18;GALNT2
288,GO:0000792,0.243627367810575,0.867085015469425,7,66,heterochromatin,CC,PML;CDKN2A;RING1;CBX5;UHRF1;MPHOSPH8;INCENP
11115,GO:0045137,0.243768082827325,0.837772392480599,14,148,development of primary sexual characteristics,BP,INHBA;TGFB2;LFNG;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1
1004,GO:0002478,0.243784461375523,0.84040516806986,13,141,antigen processing and presentation of exogenous peptide antigen,BP,TAP1;HLA-B;PSMB9;ITGAV;KIF23;HLA-F;PSME2;DCTN1;TAPBP;TAP2;KIF22;PSMC3;CLTA
12089,GO:0048048,0.244399678005203,0.91225655141815,3,22,embryonic eye morphogenesis,BP,FBN1;BMP7;PHACTR4
13512,GO:0055082,0.244716879738125,0.807730780499002,37,432,cellular chemical homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TP53;LYN;CLN6;JPH1;CHP1;ICAM1;ITGAV;GPER1;SRF;GPCPD1;IRS2;ACO1;ABCG2;OXTR;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;GCLC;SWAP70;TBXA2R;CCL5
11872,GO:0046879,0.245495667567587,0.831601162494846,16,172,hormone secretion,BP,INHBA;C1QTNF1;ADM;EDN1;IRS1;LYN;TNF;LIF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
12611,GO:0050792,0.246008960471642,0.833417460151658,15,163,regulation of viral process,BP,PML;RSAD2;TNF;ZC3H12A;BANF1;NELFE;SUPT5H;HSPA8;JUN;CHMP4B;PSMC3;CXCL8;POLR2G;SNF8;CCL5
7388,GO:0031440,0.246009119116764,0.911392387774777,3,22,regulation of mRNA 3'-end processing,BP,ZFP36L1;NELFE;SUPT5H
14914,GO:0070741,0.246631276545792,0.911057470489626,3,22,response to interleukin-6,BP,NFKB1;ICAM1;IL6R
15209,GO:0071354,0.246631276545792,0.911057470489626,3,22,cellular response to interleukin-6,BP,NFKB1;ICAM1;IL6R
10467,GO:0043328,0.246986172572898,0.97440592584037,1,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,SNF8
19446,GO:1990111,0.247275623371872,0.974342125486222,1,4,spermatoproteasome complex,CC,PSMB9
5669,GO:0016779,0.24735559989652,0.840755968476999,12,127,nucleotidyltransferase activity,MF,CD3EAP;FAM46B;APTX;DKC1;POLR1A;POLA1;CRCP;PCYT1A;UAP1L1;POLR3H;POLR1E;POLR2G
3794,GO:0008361,0.247486363057515,0.840770128376728,12,123,regulation of cell size,BP,NRG1;FN1;EDN1;CDK4;L1CAM;TNFRSF12A;ZFYVE27;IL7R;SRF;NTN1;SEMA3C;HSP90AB1
19070,GO:1904951,0.247624084829326,0.811442429514077,29,330,positive regulation of establishment of protein localization,BP,SAA1;TRIM16;NRG1;PTGER4;TGFB2;PANX1;TP53;TNF;ZC3H12A;CYB5R1;CHP1;CD274;SFN;USP36;GPER1;DKC1;IRS2;SYK;SPTBN1;IL1A;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;CD38;MAPK11;HSP90AB1;TP63
9577,GO:0036379,0.247763987408772,0.934680886737033,2,13,myofilament,CC,TPM4;TPM1
11764,GO:0046621,0.247862656347578,0.910393186345898,3,22,negative regulation of organ growth,BP,G6PD;WWC1;MAPK11
7833,GO:0032386,0.248136667614799,0.811959144994485,28,318,regulation of intracellular transport,BP,CRYAB;NRG1;TP53;CDKN1A;LYN;LAMP1;EHD1;WWC1;PTPN14;NUP153;ZC3H12A;LCP1;CYB5R1;CHP1;SFN;USP36;AKAP8L;PARL;SNX12;REEP1;SYK;WDR46;NUP214;UBE2J2;RBM4;INSIG1;SNIP1;HSP90AB1
36,GO:0000075,0.248143811998187,0.823625504066104,19,208,cell cycle checkpoint,BP,PML;MAP3K14;TP53;CDKN2B;CDKN1A;GADD45A;SFN;NSUN2;PRPF19;ORAOV1;PRCC;ZW10;THOC1;ANAPC15;DUSP1;TFDP1;TIMELESS;BRIP1;TP63
6769,GO:0030203,0.24830375373685,0.843655454455699,11,111,glycosaminoglycan metabolic process,BP,SDC4;B4GALT1;NFKB1;HSPG2;HS3ST2;CLN6;CHP1;HS3ST1;IL15;PDGFB;CHST3
15172,GO:0071300,0.248327552574031,0.880889597877519,5,44,cellular response to retinoic acid,BP,KRT13;LYN;TNC;FGFR2;SNRNP70
3541,GO:0007548,0.248610178548016,0.82908393130417,16,172,sex differentiation,BP,INHBA;TGFB2;LFNG;PBX1;HMGCS1;ICAM1;SFRP1;SAFB2;ZFP42;SF1;CITED2;ESR1;BCL2L2;WNT4;BRIP1;TP63
13237,GO:0051900,0.248624184019634,0.934304732226072,2,13,regulation of mitochondrial depolarization,BP,GCLC;PARP1
16239,GO:0090287,0.248716175287275,0.829016811865772,16,171,regulation of cellular response to growth factor stimulus,BP,CYR61;FBN1;CDKN2B;FGFR2;SFRP1;ADAM17;ROBO1;NPNT;SPRY4;BAMBI;SMAD7;CITED2;CD109;ZNF703;WNT4;HSP90AB1
6862,GO:0030331,0.249085761531801,0.892752343568114,4,33,estrogen receptor binding,MF,FUS;PAGR1;ESR1;PARP1
14948,GO:0070838,0.249204545115791,0.818102283483522,22,243,divalent metal ion transport,BP,CTGF;JPH2;IL16;PML;G6PD;PANX1;LYN;JPH1;SLC39A1;ICAM1;ITGAV;PARL;GPER1;LGALS3;PDGFB;RRAD;STAC;SLC41A2;TMEM165;SLC3A2;NOL3;CCL5
15251,GO:0071417,0.249687334343082,0.806268065425089,33,377,cellular response to organonitrogen compound,BP,HDAC9;FBN1;EDN1;TP53;NFKB1;IRS1;LYN;AHR;TNF;BAIAP2;COL4A1;ICAM1;COL16A1;CDK4;ERRFI1;STAT5A;ADRB2;SFRP1;GPER1;EGR1;ZFP36L1;IRS2;COL5A2;PPP1R9B;KLF10;SOCS1;RAPGEF1;TIMELESS;BRIP1;GCLC;PARP1;BAIAP2L2;SH3BP4
11799,GO:0046676,0.249833958948595,0.909029318790197,3,23,negative regulation of insulin secretion,BP,IRS1;SFRP1;BMP8A
16231,GO:0090278,0.249833958948595,0.909029318790197,3,23,negative regulation of peptide hormone secretion,BP,IRS1;SFRP1;BMP8A
1252,GO:0003006,0.250063219739354,0.803746588274688,36,415,developmental process involved in reproduction,BP,CYR61;INHBA;ADM;CSF2;TGFB2;B4GALT1;PANK2;TAF4B;LFNG;JUNB;TNC;FGFR2;PBX1;FOSL1;HMGCS1;ICAM1;FANCC;LIF;SFRP1;SAFB2;NSUN2;ZFP42;SF1;ZFP36L1;PDGFB;IL1A;CITED2;ESR1;CCR6;BCL2L2;BMP7;WNT4;BRIP1;HSP90AB1;TTLL5;TP63
3013,GO:0006558,0.250168528618092,0.973699547970065,1,4,L-phenylalanine metabolic process,BP,QDPR
3014,GO:0006559,0.250168528618092,0.973699547970065,1,4,L-phenylalanine catabolic process,BP,QDPR
17911,GO:1902221,0.250168528618092,0.973699547970065,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,QDPR
17912,GO:1902222,0.250168528618092,0.973699547970065,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,QDPR
56,GO:0000118,0.250196797259776,0.870116992719933,6,55,histone deacetylase complex,CC,HDAC9;ELMSAN1;CBX5;BRMS1;MTA2;DNTTIP1
6306,GO:0019935,0.250258905681881,0.862341861566015,7,67,cyclic-nucleotide-mediated signaling,BP,PTGER4;ADM;AHR;ADRB2;GPER1;PRKCA;TBXA2R
14139,GO:0061005,0.250799205221912,0.89171170778056,4,33,cell differentiation involved in kidney development,BP,LIF;PDGFB;WNT4;MYO1E
7851,GO:0032411,0.250921849016952,0.869531332497046,6,56,positive regulation of transporter activity,BP,JPH2;CHP1;ADRB2;SGK1;STAC;ACTN4
10868,GO:0044390,0.25100404431979,0.891587073661363,4,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF19B;DCUN1D2;RNF185;RNF144B
8263,GO:0033043,0.25116545881288,0.785657196651167,84,1016,regulation of organelle organization,BP,NRG1;MMP9;PTGER4;MAP2;CTGF;PML;CYLD;SDC4;CSF2;EDN1;MID1;DAPK3;TP53;SQSTM1;UBQLN2;ARPC4;TNF;GNL3L;BAIAP2;PKMYT1;UBE2C;LCP1;CYB5R1;ICAM1;SFN;CDC42EP2;EPGN;ADRB2;NAT10;ARPC1B;USP36;AKAP8L;LIF;SFRP1;PARL;TPM1;WDR1;PDE4DIP;GPER1;SNAI2;AKAP8;RHOB;NELFE;DKC1;FEN1;PDGFB;SPTBN1;DCTN1;UHRF1;SLAIN2;IL1A;RUNDC1;SFPQ;WDR46;ZW10;YWHAH;HNRNPU;CLASP1;UBE2J2;RUVBL2;PPP1R9B;ANAPC15;DUSP1;RCC1;TFDP1;NOC2L;CHMP4B;INSIG1;RHOG;SNIP1;BMP7;KANK4;PHLDB2;SGSM1;MYADM;WNT4;RBM14;NOL3;CDCA5;SWAP70;MKI67;PARP1;TP63;BAIAP2L2
3666,GO:0008154,0.251183649738881,0.831855397562956,14,149,actin polymerization or depolymerization,BP,COBLL1;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;WDR1;SPTBN1;MICAL3;RHOG;KANK4;MYADM;SWAP70;BAIAP2L2
9279,GO:0035710,0.251433818426547,0.878867836204233,5,44,CD4-positive, alpha-beta T cell activation,BP,PTGER4;RELB;CD83;RSAD2;SMAD7
6584,GO:0022411,0.25164481827513,0.799766128796717,40,477,cellular component disassembly,BP,MMP9;FN1;FBN1;MID1;SQSTM1;HSPG2;TNF;PDPN;NUP153;LCP1;ADRB2;USP36;AKAP8L;GRWD1;WDR1;BANF1;TFIP11;GPER1;ETS1;SNAI2;PRKCA;SPTBN1;DCTN1;NUP214;MRPS12;MRPS24;ERAL1;CLASP1;CAPNS1;MICAL3;MRPL20;HSPA8;MRPL33;LAMC1;KIF24;EIF5A;MRPS2;SMARCC2;SUPT16H;SWAP70
5918,GO:0018193,0.251716581915491,0.786371471632204,78,941,peptidyl-amino acid modification,BP,TRIM16;NRG1;HDAC9;P3H2;GPRC5A;CSF2;IKBKE;DAPK3;TET3;TP53;IL24;P4HA2;CPA4;GALNT18;LYN;TNF;GNL3L;ZBED1;FGFR2;NUP153;QPCT;TNK1;EPHA2;ICAM1;ERRFI1;GGCX;STAT5A;EPGN;IL20;NMT2;ST6GALNAC5;LIF;SFRP1;ZDHHC3;DPH2;EGR1;SGK1;SNAI2;NELFE;ADAM17;FGFR1OP;IL15;PRKCA;SYK;SENP3;PDGFB;CAMK1G;DOHH;RBBP5;ROR1;NUP214;AFAP1L2;SMAD7;ZDHHC6;CEP41;TPST1;RUVBL2;PARP14;PRDM7;GALNT2;CAB39;SOCS1;OXSR1;BRPF1;NOC2L;PARD3;BMP7;INCENP;EIF5A;MGAT2;DPM3;EFNA1;METTL21A;TTLL5;IL6R;PARP1;CLK4;CCL5
4861,GO:0014075,0.251813737803501,0.907949555533767,3,23,response to amine,BP,HDAC9;ICAM1;OXTR
4186,GO:0009263,0.252497833357468,0.932598967104666,2,13,deoxyribonucleotide biosynthetic process,BP,TYMS;RRM2
8313,GO:0033145,0.252773773156432,0.932476715979383,2,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PAGR1;PARP1
18509,GO:1903670,0.253331719716528,0.877627381783511,5,44,regulation of sprouting angiogenesis,BP,HDAC9;STARD13;ADAMTS9;CARD10;TBXA2R
4674,GO:0010822,0.253563246088021,0.832748014170799,13,139,positive regulation of mitochondrion organization,BP,NRG1;MMP9;TP53;CYB5R1;SFN;USP36;GPER1;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;TP63
4605,GO:0010720,0.253674714967882,0.805326819391072,30,340,positive regulation of cell development,BP,NRG1;FN1;NEFL;TENM3;EDN1;LYN;BAIAP2;ENC1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;ZFYVE27;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;NEDD4L;DPYSL3;SEMA3C;SPEN;TRIB1;ZNF365;BMP7;RAPGEF1;MYADM;DAG1
10285,GO:0043030,0.253698177997822,0.906917287696695,3,23,regulation of macrophage activation,BP,ZC3H12A;SLC7A2;TNIP2
7403,GO:0031466,0.253795275513668,0.972881265138226,1,4,Cul5-RING ubiquitin ligase complex,CC,RNF7
18158,GO:1902904,0.253931004167468,0.84792258315377,9,90,negative regulation of supramolecular fiber organization,BP,CRYAB;MID1;SPTBN1;CLASP1;HSPA8;KANK4;PHLDB2;MYADM;SWAP70
7441,GO:0031571,0.254078134898009,0.859560872259146,7,68,mitotic G1 DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1;TP63
11006,GO:0044819,0.254078134898009,0.859560872259146,7,68,mitotic G1/S transition checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1;TP63
7338,GO:0031348,0.254222272552591,0.838992611849518,11,114,negative regulation of defense response,BP,KRT1;SAA1;PTGER4;IL1R2;NLRC5;NFKB1;ZC3H12A;GPER1;ETS1;PARP14;TNFAIP3
8129,GO:0032817,0.254463722578473,0.972728898471379,1,4,regulation of natural killer cell proliferation,BP,IL15
8130,GO:0032819,0.254463722578473,0.972728898471379,1,4,positive regulation of natural killer cell proliferation,BP,IL15
5158,GO:0015696,0.254485368009816,0.876748724390365,5,45,ammonium transport,BP,CSF2;EDN1;LYN;SYK;SLC22A4
1055,GO:0002583,0.254518110616541,0.972716479936399,1,4,regulation of antigen processing and presentation of peptide antigen,BP,TAPBPL
11474,GO:0045930,0.25456538268684,0.810856107841689,24,275,negative regulation of mitotic cell cycle,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;TNF;PSMB9;SFN;PSME2;ZFP36L1;GPR132;ZFP36L2;ORAOV1;PRCC;ZW10;ANAPC15;DUSP1;TFDP1;GPNMB;BMP7;TPRA1;CTDSP1;PSMC3;TP63
14736,GO:0070402,0.254765069135207,0.931591579615588,2,13,NADPH binding,MF,DHFR;QDPR
1868,GO:0004532,0.254780240817969,0.889101561770441,4,34,exoribonuclease activity,MF,USB1;NOCT;ZC3H12A;ISG20L2
16819,GO:0098687,0.254862472131019,0.807162668256482,27,312,chromosomal region,CC,PML;MCM5;TELO2;DAXX;NAT10;MCM2;TOX4;TFIP11;FEN1;CBX5;ALYREF;DCTN1;ZW10;RCC2;HNRNPU;CLASP1;ORC1;THOC1;CENPN;MCM7;CENPO;XRCC6;INCENP;KIF22;CDCA5;PARP1;ORC4
17773,GO:1901800,0.255106599333338,0.847043169792503,9,90,positive regulation of proteasomal protein catabolic process,BP,UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;PSMC3;RNF144B;GCLC
10055,GO:0042537,0.255153012038106,0.931418540591899,2,13,benzene-containing compound metabolic process,BP,ACAA1;CYP4B1
15160,GO:0071276,0.255163746039627,0.905833909235854,3,24,cellular response to cadmium ion,BP,MMP9;DAXX;JUN
15815,GO:0072511,0.255484890787796,0.812812526816383,22,244,divalent inorganic cation transport,BP,CTGF;JPH2;IL16;PML;G6PD;PANX1;LYN;JPH1;SLC39A1;ICAM1;ITGAV;PARL;GPER1;LGALS3;PDGFB;RRAD;STAC;SLC41A2;TMEM165;SLC3A2;NOL3;CCL5
4229,GO:0009407,0.255624345338631,0.972463196106607,1,4,toxin catabolic process,BP,ACAA1
514,GO:0001578,0.255790193605827,0.876014717055819,5,44,microtubule bundle formation,BP,MAP2;CHP1;CC2D2A;CLASP1;TTLL5
1203,GO:0002863,0.255802224745882,0.97242234505946,1,4,positive regulation of inflammatory response to antigenic stimulus,BP,TNF
4655,GO:0010799,0.25589341001645,0.888597715112102,4,33,regulation of peptidyl-threonine phosphorylation,BP,SMAD7;CAB39;PARD3;BMP7
5874,GO:0017187,0.255937613938787,0.972391229146827,1,4,peptidyl-glutamic acid carboxylation,BP,GGCX
5935,GO:0018214,0.255937613938787,0.972391229146827,1,4,protein carboxylation,BP,GGCX
3386,GO:0007163,0.25600412121178,0.825456393180203,15,159,establishment or maintenance of cell polarity,BP,MAP2;AMOT;SIPA1L3;WWC1;DST;AMOTL2;WDR1;PARD3B;RHOB;DCTN1;MYH9;ZW10;CLASP1;PARD3;CYTH1
16252,GO:0090305,0.2560561543478,0.812274914886426,22,249,nucleic acid phosphodiester bond hydrolysis,BP,USB1;NOCT;ZC3H12A;AEN;APTX;RRP36;POP1;RRS1;FEN1;ISG20L2;TSR1;NOB1;UTP20;DNASE1;TATDN2;NOL9;ABT1;NOP14;EDC4;POP4;PARP1;APEX2
3406,GO:0007187,0.256286481238622,0.851628718854441,8,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,PTGER4;ADM;EDN1;FLNA;ADRB2;GPER1;PRKCA;TBXA2R
5361,GO:0016137,0.256309090865947,0.930901724834777,2,13,glycoside metabolic process,BP,AKR1C2;AKR1C1
2468,GO:0005684,0.2563514944544,0.865626937926152,6,58,U2-type spliceosomal complex,CC,LUC7L;TFIP11;PRPF19;U2AF2;SNRNP70;EFTUD2
4597,GO:0010712,0.256595723965686,0.90532149712137,3,23,regulation of collagen metabolic process,BP,CTGF;ERRFI1;WNT4
608,GO:0001776,0.256679403053851,0.865574664338445,6,56,leukocyte homeostasis,BP,LYN;TSC22D3;DOCK10;ADAM17;FOXN1;TNFAIP3
7819,GO:0032372,0.256998144900117,0.972146803829433,1,4,negative regulation of sterol transport,BP,NFKB1
7822,GO:0032375,0.256998144900117,0.972146803829433,1,4,negative regulation of cholesterol transport,BP,NFKB1
11488,GO:0045948,0.257003417532442,0.905096132697933,3,23,positive regulation of translational initiation,BP,TNF;POLR2G;CCL5
1591,GO:0004003,0.257104644499646,0.887852891405609,4,33,ATP-dependent DNA helicase activity,MF,RUVBL2;MCM7;XRCC6;BRIP1
12454,GO:0050220,0.257118589194086,0.972118967269077,1,4,prostaglandin-E synthase activity,MF,PTGES
5497,GO:0016435,0.257126178987482,0.972117212621171,1,4,rRNA (guanine) methyltransferase activity,MF,FTSJ3
8923,GO:0034764,0.257185856872837,0.840785032254517,10,102,positive regulation of transmembrane transport,BP,JPH2;G6PD;IRS1;FLNA;CHP1;ADRB2;GPER1;IRS2;STAC;ACTN4
2795,GO:0006235,0.257495450167923,0.972031766964124,1,4,dTTP biosynthetic process,BP,TYMS
4150,GO:0009212,0.257495450167923,0.972031766964124,1,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,TYMS
11545,GO:0046075,0.257495450167923,0.972031766964124,1,4,dTTP metabolic process,BP,TYMS
3127,GO:0006706,0.257545938480475,0.930346885911336,2,13,steroid catabolic process,BP,CYP24A1;YWHAH
14788,GO:0070492,0.25759894711581,0.972007792208671,1,4,oligosaccharide binding,MF,DCBLD1
18111,GO:1902751,0.257644485462791,0.904741349011538,3,23,positive regulation of cell cycle G2/M phase transition,BP,PBX1;CDK4;RCC2
166,GO:0000346,0.257786812569697,0.930238601445341,2,13,transcription export complex,CC,ALYREF;THOC1
7356,GO:0031398,0.257812177442852,0.844967612853228,9,91,positive regulation of protein ubiquitination,BP,BIRC3;UBE2C;ADRB2;RPS2;PTTG1IP;SMAD7;DCUN1D2;HSPBP1;ARRDC3
12932,GO:0051289,0.257831287347529,0.864689852141955,6,57,protein homotetramerization,BP,SOD2;TP53;TK1;DCXR;HSD17B10;TP63
10396,GO:0043227,0.258052799010449,0.76759021163384,711,9229,membrane-bounded organelle,CC,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;C1R;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;SACS;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;HSPB1;STARD13;MYBL2;KRT10;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;IKBKE;BIRC3;PLBD1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;ANXA8L1;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;OSR2;SFRP1;PARL;ABCF2;TRIM22;ZFYVE27;ZDHHC3;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;EPPK1;IL7R;DDX42;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;RHOB;NELFE;DKC1;FEN1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;BRMS1;BCAM;PREP;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;DPYSL3;COL5A3;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;SNX8;RBBP5;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;SPEN;ZW10;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC57;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;ARGLU1;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;SMPD2;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;TRA2A;RNF7;TOMM40;AKIP1;MPHOSPH8;ELK1;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;MYADM;DAG1;TMEM165;FAM234A;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;PPP2R1B;EFNA1;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;TTLL5;HERC6;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;C1S;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
9678,GO:0038042,0.258272062237779,0.971851582787699,1,4,dimeric G-protein coupled receptor signaling pathway,BP,ADM
16699,GO:0097646,0.258272062237779,0.971851582787699,1,4,calcitonin family receptor signaling pathway,BP,ADM
10575,GO:0043537,0.258348945231307,0.904350897913461,3,23,negative regulation of blood vessel endothelial cell migration,BP,STARD13;CARD10;TBXA2R
11102,GO:0045116,0.258519137625367,0.929359765360976,2,14,protein neddylation,BP,DCUN1D2;RNF7
3259,GO:0006925,0.258539871732093,0.929899580489422,2,13,inflammatory cell apoptotic process,BP,CDKN2A;CCL5
10890,GO:0044430,0.258612360840687,0.776394067229784,98,1192,cytoskeletal part,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;KRT4;NEFM;ACTG1;TAP1;CYLD;HSPB1;KRT10;KRT13;RELB;MID1;DAPK3;KRTAP2-3;KLHL21;NLRC5;SIPA1L3;KRT9;NEDD9;KRT6A;MYO1B;ARPC4;BAIAP2;KRT5;DST;TPM4;KRT17;FLNA;LCP1;CCDC85B;KIF23;MYO10;SVIL;PLEKHA7;MTUS1;ARPC1B;CCDC124;TPM1;WDR1;PDE4DIP;EPPK1;GPER1;NSUN2;PRPF19;FGFR1OP;VCL;KRT14;AJUBA;CEP95;IFFO2;PHAX;WDR34;SPTBN1;DCTN1;DPYSL3;TCP11L1;SLAIN2;MYH9;LANCL2;TBCCD1;ZW10;ROR1;RCC2;SMAD7;KEAP1;SPECC1;HNRNPU;TJP1;CLASP1;CEP41;RUVBL2;MICAL3;BLOC1S2;DCXR;HERC2;CNTROB;ZNF365;ACTN4;KIF24;INCENP;ZYX;KIF22;MYADM;CGNL1;POLR3H;RILPL2;TUBB;MYO1E;CLTA;TTLL5;BIN3
13363,GO:0052548,0.258708696465258,0.808591838603225,23,267,regulation of endopeptidase activity,BP,CRYAB;MMP9;CYR61;CTGF;PML;BIRC3;LYN;TNF;PSMB9;SFN;SERPINE1;ANXA8;PSME2;GPER1;TRAF2;ROBO1;SERPINH1;A2ML1;CD109;TNFRSF10A;EFNA1;NOL3;TP63
2202,GO:0005087,0.258796048363144,0.971729640209834,1,4,Ran guanyl-nucleotide exchange factor activity,MF,RCC1
7407,GO:0031489,0.258991535283658,0.929695892923658,2,13,myosin V binding,MF,FUS;RAB27A
12713,GO:0050931,0.259050853879775,0.903961251987573,3,23,pigment cell differentiation,BP,ADAMTS9;RAB32;RAB27A
3159,GO:0006766,0.259096458633477,0.843956112396708,9,92,vitamin metabolic process,BP,CYP24A1;CYP1A1;PANK2;NFKB1;TNF;SLC5A6;SNAI2;DHFR;GCLC
12247,GO:0048521,0.259098175482878,0.971659192910406,1,4,negative regulation of behavior,BP,ARRDC3
14802,GO:0070525,0.259177174700191,0.929612098137119,2,13,tRNA threonylcarbamoyladenosine metabolic process,BP,PUS1;HSD17B10
9053,GO:0035270,0.259250561383001,0.855935110002895,7,67,endocrine system development,BP,PBX1;BMP2;SRF;ETS1;CITED2;WNT4;IL6R
18232,GO:1903036,0.259377061559173,0.886268042679978,4,34,positive regulation of response to wounding,BP,PDPN;SERPINE1;THBD;TBXA2R
15931,GO:0072716,0.259402896258186,0.971588040041111,1,4,response to actinomycin D,BP,TP53
2869,GO:0006361,0.259444297449303,0.886054611970108,4,35,transcription initiation from RNA polymerase I promoter,BP,CD3EAP;POLR1A;UBTF;POLR1E
98,GO:0000188,0.259846131208411,0.903519040773139,3,23,inactivation of MAPK activity,BP,DUSP14;DUSP1;DUSP8
18900,GO:1904589,0.260080807118802,0.873058902390932,5,45,regulation of protein import,BP,CDKN1A;ZC3H12A;CHP1;HSPA8;HSP90AB1
4895,GO:0014821,0.260093478831068,0.971426412761387,1,4,phasic smooth muscle contraction,BP,EDN1
2271,GO:0005212,0.260193340143286,0.971402997650196,1,4,structural constituent of eye lens,MF,CRYAB
19397,GO:1905907,0.260244090652176,0.971391093684204,1,4,negative regulation of amyloid fibril formation,BP,CRYAB
2518,GO:0005771,0.260247413511263,0.903011067851348,3,24,multivesicular body,CC,LAMP1;NEDD4L;RAB27A
10443,GO:0043299,0.260490167462566,0.797598407437386,32,376,leukocyte degranulation,BP,KRT1;FTL;FTH1;MMP9;S100P;B4GALT1;MGAM;HRNR;NFKB1;LYN;PLEKHO2;LAMP1;QPCT;SIRPA;ACAA1;ITGAV;VCL;LGALS3;SYK;GLIPR1;LILRB3;CAB39;HSPA8;COMMD9;RHOG;XRCC6;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;LAIR1
7355,GO:0031397,0.260490313905238,0.862760236240923,6,58,negative regulation of protein ubiquitination,BP,GNL3L;CHP1;U2AF2;SMAD7;TNFAIP3;GCLC
2377,GO:0005507,0.260615754306033,0.885165152648931,4,36,copper ion binding,MF,HEPHL1;TP53;IL1A;RNF7
14507,GO:0062012,0.260757118778304,0.800078923089865,29,335,regulation of small molecule metabolic process,BP,IGFBP3;ODC1;C1QTNF1;ADM;NQO1;PANK2;NFKB1;IRS1;TNF;SCD;NUP153;PSMB9;LSS;HMGCS1;BMP2;DHCR7;PPP1R3B;PSME2;GPER1;EGR1;SNAI2;IRS2;PDGFB;NUP214;CPT1A;INSIG1;WNT4;PSMC3;PARP1
7892,GO:0032460,0.260822197959583,0.928867609056885,2,13,negative regulation of protein oligomerization,BP,CRYAB;CLDN7
20062,GO:2000698,0.260839340610685,0.971251262625271,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF
3397,GO:0007175,0.260922939890913,0.928821902284241,2,13,negative regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A;ERRFI1
10446,GO:0043302,0.260923983332056,0.92882142880447,2,13,positive regulation of leukocyte degranulation,BP,LAMP1;SYK
11145,GO:0045191,0.261174565546273,0.902778630475186,3,23,regulation of isotype switching,BP,TFRC;IL27RA;THOC1
12937,GO:0051294,0.261383716320048,0.902661860949931,3,23,establishment of spindle orientation,BP,DCTN1;ZW10;CLASP1
12761,GO:0051030,0.261526539891282,0.971089349752988,1,4,snRNA transport,BP,PHAX
774,GO:0002028,0.261639503431603,0.862138799752112,6,56,regulation of sodium ion transport,BP,CHP1;ADRB2;FXYD3;NEDD4L;YWHAH;ACTN4
13689,GO:0060231,0.262167180437099,0.928256303985984,2,13,mesenchymal to epithelial transition,BP,LIF;WNT4
2846,GO:0006323,0.262379776889847,0.822518280571818,14,166,DNA packaging,BP,TP53;CDKN2A;DAXX;MCM2;AKAP8L;GRWD1;GPER1;AKAP8;CENPN;NOC2L;CENPO;IPO4;CHAF1A;CDCA5
3443,GO:0007252,0.262545197141085,0.928084070333969,2,13,I-kappaB phosphorylation,BP,IKBKE;TRAF2
19423,GO:1990023,0.262674758561843,0.928024996359388,2,13,mitotic spindle midzone,CC,RCC2;HNRNPU
10511,GO:0043414,0.262679367862746,0.808207920246946,21,234,macromolecule methylation,BP,TET3;TRMT61A;METTL1;NSUN2;NELFE;METTL2B;RPS2;NSUN5;RBBP5;FTSJ3;MTA2;WDR4;PRDM7;HSPA8;NOP2;TRMT1;METTL16;MPHOSPH8;METTL21A;HSD17B10;PARP1
10119,GO:0042637,0.262870196519048,0.97077127299411,1,4,catagen,BP,TGFB2
12393,GO:0048818,0.262870196519048,0.97077127299411,1,4,positive regulation of hair follicle maturation,BP,TGFB2
13188,GO:0051794,0.262870196519048,0.97077127299411,1,4,regulation of timing of catagen,BP,TGFB2
11794,GO:0046660,0.263024009136864,0.846607593051575,8,79,female sex differentiation,BP,INHBA;LFNG;ICAM1;SFRP1;ZFP42;ESR1;WNT4;TP63
19536,GO:1990446,0.263143078602355,0.970706433192485,1,4,U1 snRNP binding,MF,SNRNP70
6040,GO:0019136,0.263302123089507,0.97066860476026,1,4,deoxynucleoside kinase activity,MF,TK1
2457,GO:0005669,0.263317665008499,0.88364486261257,4,35,transcription factor TFIID complex,CC,TP53;TAF4B;EDF1;GTF2E1
16093,GO:0090069,0.26336576151487,0.927709563652197,2,13,regulation of ribosome biogenesis,BP,USP36;SHQ1
13041,GO:0051497,0.263394941727729,0.927696229690399,2,13,negative regulation of stress fiber assembly,BP,CLASP1;PHLDB2
7955,GO:0032554,0.26340867589913,0.970643245837916,1,4,purine deoxyribonucleotide binding,MF,HSP90AB1
20140,GO:2000833,0.263414351147646,0.970641894813466,1,4,positive regulation of steroid hormone secretion,BP,C1QTNF1
8309,GO:0033141,0.263926163282678,0.970519909609157,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
16223,GO:0090266,0.263934757922212,0.927449360377906,2,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,ANAPC15;DUSP1
18425,GO:1903504,0.263934757922212,0.927449360377906,2,13,regulation of mitotic spindle checkpoint,BP,ANAPC15;DUSP1
1103,GO:0002692,0.264082055761921,0.970482697029271,1,4,negative regulation of cellular extravasation,BP,PTGER4
17255,GO:0120035,0.264137863170818,0.790684985432781,37,429,regulation of plasma membrane bounded cell projection organization,BP,NRG1;MAP2;FN1;NEFL;TENM3;CYLD;LYN;BAIAP2;EFNB2;CORO1C;ENC1;PDPN;EPHA2;ICAM1;L1CAM;MYO10;CDC42EP2;TNFRSF12A;SFRP1;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;SEMA3C;RCC2;YWHAH;PQBP1;RHOG;ZNF365;ZSWIM6;BMP7;RAPGEF1;EFNA1;BIN3
9251,GO:0035650,0.264182016113435,0.970458821763756,1,4,AP-1 adaptor complex binding,MF,RAB32
4447,GO:0010369,0.264238137596607,0.927310452613575,2,13,chromocenter,CC,CBX5;INCENP
14990,GO:0070901,0.264395928788067,0.970407692367691,1,4,mitochondrial tRNA methylation,BP,HSD17B10
6611,GO:0022829,0.264398803873108,0.927236840367828,2,13,wide pore channel activity,MF,PANX1;TOMM40
4510,GO:0010560,0.264460386896905,0.927208616084268,2,13,positive regulation of glycoprotein biosynthetic process,BP,CHP1;IL15
14787,GO:0070491,0.264485157122972,0.860156288153624,6,56,repressing transcription factor binding,MF,HDAC9;ZFP42;CBX5;MTA2;NOC2L;ZNF703
11936,GO:0046982,0.264641092638333,0.796585654550501,29,353,protein heterodimerization activity,MF,MAFB;INHBA;NEFL;TENM3;UGT1A6;TGFB2;MID1;PANX1;TP53;NFKB1;TAF4B;AHR;GADD45A;PBX1;TPM4;BMP2;DAXX;TPM1;ABTB2;PDGFB;SUPT5H;YWHAH;JUN;IKZF3;TCOF1;RCC1;BCL2L2;TIMELESS;GCLC
4760,GO:0010939,0.264641185090818,0.900545622775009,3,24,regulation of necrotic cell death,BP,BIRC3;TRAF2;NOL3
4193,GO:0009298,0.264790262262151,0.970313306859383,1,4,GDP-mannose biosynthetic process,BP,PMM2
9872,GO:0042133,0.264878044461896,0.845234249014883,8,79,neurotransmitter metabolic process,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;ICAM1;SLC7A2;HSP90AB1
13500,GO:0055065,0.264995421291464,0.797391414855989,28,324,metal ion homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;STEAP4;LYN;JPH1;ITGAV;GPER1;ACO1;ABCG2;OXTR;NEDD4L;ESR1;CCR6;TMEM165;PDE6A;CD38;NOL3;SWAP70;TBXA2R;CCL5
15660,GO:0072175,0.265402840004628,0.834478736146565,10,102,epithelial tube formation,BP,ADM;SDC4;IRX2;TGFB2;FGFR2;SFRP1;CC2D2A;BMP7;WNT4;PHACTR4
4531,GO:0010596,0.265496406957268,0.88245821006029,4,34,negative regulation of endothelial cell migration,BP,STARD13;ADAMTS9;CARD10;TBXA2R
10341,GO:0043137,0.265503970976902,0.970142042080654,1,4,DNA replication, removal of RNA primer,BP,FEN1
10053,GO:0042535,0.265585181414843,0.970122518893091,1,4,positive regulation of tumor necrosis factor biosynthetic process,BP,HSPB1
4387,GO:0010040,0.265827844239284,0.970064138837011,1,4,response to iron(II) ion,BP,ACO1
3544,GO:0007566,0.26601363403815,0.881957416209197,4,35,embryo implantation,BP,MMP9;EMP2;VMP1;LIF
12108,GO:0048147,0.266165033642655,0.899685000700005,3,24,negative regulation of fibroblast proliferation,BP,FTH1;TP53;SFRP1
18969,GO:1904749,0.266174082956712,0.969980727958307,1,4,regulation of protein localization to nucleolus,BP,POLR1A
8742,GO:0034390,0.266261149878221,0.92638112861053,2,13,smooth muscle cell apoptotic process,BP,EDN1;CDKN2A
8743,GO:0034391,0.266261149878221,0.92638112861053,2,13,regulation of smooth muscle cell apoptotic process,BP,EDN1;CDKN2A
507,GO:0001569,0.266325877604166,0.899886958743695,3,23,branching involved in blood vessel morphogenesis,BP,EDN1;COL4A1;SRF
9419,GO:0035985,0.266368584137147,0.969933813495333,1,4,senescence-associated heterochromatin focus,CC,CDKN2A
945,GO:0002360,0.266422479684558,0.92630678894517,2,13,T cell lineage commitment,BP,CYLD;FOXN1
10987,GO:0044783,0.266436878364965,0.850615358842943,7,69,G1 DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1;TP63
351,GO:0000964,0.266581714010286,0.969882357768934,1,4,mitochondrial RNA 5'-end processing,BP,HSD17B10
4751,GO:0010922,0.266617611333153,0.899722217593137,3,23,positive regulation of phosphatase activity,BP,BMP2;NPNT;HSP90AB1
12362,GO:0048741,0.266714361930248,0.926172205796823,2,13,skeletal muscle fiber development,BP,HDAC9;BIN3
16474,GO:0097154,0.267161509799205,0.969742124396579,1,4,GABAergic neuron differentiation,BP,INHBA
8259,GO:0033036,0.267406919730042,0.760429148015226,180,2265,macromolecule localization,BP,SAA1;TRIM16;NRG1;PTGER4;INHBA;FN1;C1QTNF1;AMOT;TAP1;IL1R2;NFKBIE;PML;CYLD;HSPB1;TFRC;FBN1;TGFB2;EDN1;GBP1;IKBKE;MID1;RSAD2;EMP2;KLHL21;APOL6;PANX1;TP53;SQSTM1;MARVELD3;NFKB1;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;STOML1;LAMP1;EHD1;TNF;GNL3L;BAIAP2;CORO1C;PTPN14;NUP153;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;CADPS2;EPHA2;CHP1;ARFRP1;CD274;GOSR1;SLCO3A1;ITGAV;PMM2;SFN;ANKS4B;LSG1;USP36;AKAP8L;LIF;SFRP1;PARL;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;DDX42;GPER1;AP4S1;TRIM29;NFKBIA;RRS1;PRPF19;ZFP36L1;RPLP2;AKAP8;RHOB;DKC1;SNX12;U2AF2;VCL;VPS13B;SHQ1;IRS2;RPLP1;TRAF2;ABCG2;REEP1;PRKCA;SYK;POLR1A;AJUBA;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;NEDD4L;MYH9;NPNT;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;ACSL1;RCC2;NUP214;TRAM2;SMAD7;DNAJC1;YWHAH;KEAP1;M6PR;ZDHHC6;HNRNPU;UBE2J2;CEP41;RUVBL2;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;STAC;FRAS1;HSPA8;ESR1;PES1;CPT1A;TFDP1;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;RHOG;TAP2;CNTNAP1;ACTN4;SNIP1;BMP7;TOMM40;PHLDB2;SGSM1;IPO4;EIF5A;MYADM;DAG1;RAB27A;WNT4;RILPL2;AKR1C1;VPS52;CD38;TNFAIP3;MAPK11;BMP8A;CARD10;SRSF7;CLTA;SNF8;CDCA5;HSP90AB1;SWAP70;BIN3;PARP1;TP63;CCL5;MAGOH;SH3BP4
10710,GO:0044003,0.267501208755032,0.88120067451616,4,34,modification by symbiont of host morphology or physiology,BP,TYMS;ZC3H12A;ITGAV;DAG1
17955,GO:1902307,0.267629443258105,0.925749556989574,2,13,positive regulation of sodium ion transmembrane transport,BP,CHP1;ACTN4
7209,GO:0031100,0.26768100399661,0.857827389846491,6,57,animal organ regeneration,BP,ADM;CDKN1A;TYMS;LCP1;CDK4;NFKBIA
4468,GO:0010464,0.267891998513164,0.899001347288712,3,23,regulation of mesenchymal cell proliferation,BP,FGFR2;IRS2;TP63
6680,GO:0030043,0.268031371750526,0.969531036641781,1,4,actin filament fragmentation,BP,WDR1
19801,GO:2000249,0.268119138850282,0.898577198835549,3,24,regulation of actin cytoskeleton reorganization,BP,DAPK3;BAIAP2;BAIAP2L2
15495,GO:0071865,0.26813567482904,0.969505669398892,1,4,regulation of apoptotic process in bone marrow,BP,FGFR2
15496,GO:0071866,0.26813567482904,0.969505669398892,1,4,negative regulation of apoptotic process in bone marrow,BP,FGFR2
19954,GO:2000508,0.268365007939457,0.969449851613955,1,4,regulation of dendritic cell chemotaxis,BP,CCR6
19955,GO:2000510,0.268365007939457,0.969449851613955,1,4,positive regulation of dendritic cell chemotaxis,BP,CCR6
16363,GO:0090661,0.268444285676613,0.967559632172557,1,5,box H/ACA telomerase RNP complex,CC,DKC1
11547,GO:0046078,0.268493522017999,0.969418546882703,1,4,dUMP metabolic process,BP,TYMS
19003,GO:1904814,0.268504838473921,0.925344220930255,2,13,regulation of protein localization to chromosome, telomeric region,BP,GNL3L;DKC1
11332,GO:0045655,0.268508092072652,0.925342712554341,2,13,regulation of monocyte differentiation,BP,ZFP36L1;JUN
6280,GO:0019884,0.269228631622762,0.820123627586469,13,144,antigen processing and presentation of exogenous antigen,BP,TAP1;HLA-B;PSMB9;ITGAV;KIF23;HLA-F;PSME2;DCTN1;TAPBP;TAP2;KIF22;PSMC3;CLTA
1050,GO:0002578,0.269266823450567,0.969229792046596,1,4,negative regulation of antigen processing and presentation,BP,TAPBPL
18170,GO:1902932,0.269342119870532,0.924955602055715,2,13,positive regulation of alcohol biosynthetic process,BP,TNF;GPER1
1043,GO:0002562,0.269498386891744,0.866772233483872,5,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
5501,GO:0016444,0.269498386891744,0.866772233483872,5,45,somatic cell DNA recombination,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
10605,GO:0043583,0.269500922918124,0.827084615215507,11,114,ear development,BP,MAFB;SDC4;TGFB2;EDN1;FGFR2;BMP2;MCM2;OSR2;NTN1;ROR1;INSIG1
5563,GO:0016575,0.269552375346775,0.841757821385415,8,79,histone deacetylation,BP,HDAC9;TP53;AKAP8L;AKAP8;BRMS1;SFPQ;MTA2;RBM14
534,GO:0001652,0.269737341512216,0.969114618943634,1,4,granular component,CC,SURF6
10333,GO:0043125,0.26975271386405,0.969110851964435,1,4,ErbB-3 class receptor binding,MF,NRG1
4584,GO:0010669,0.269793334478213,0.924745796223095,2,13,epithelial structure maintenance,BP,SRF;VSIG1
15581,GO:0072047,0.269827751421568,0.969092460321221,1,4,proximal/distal pattern formation involved in nephron development,BP,IRX2
15602,GO:0072081,0.269827751421568,0.969092460321221,1,4,specification of nephron tubule identity,BP,IRX2
15603,GO:0072086,0.269827751421568,0.969092460321221,1,4,specification of loop of Henle identity,BP,IRX2
11514,GO:0046015,0.26989546625119,0.969075858106061,1,4,regulation of transcription by glucose,BP,SRF
16578,GO:0097368,0.270048145862068,0.969038405675468,1,4,establishment of Sertoli cell barrier,BP,ICAM1
11139,GO:0045184,0.270243655828084,0.761973438420049,126,1582,establishment of protein localization,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;TAP1;IL1R2;PML;HSPB1;TFRC;TGFB2;GBP1;RSAD2;PANX1;TP53;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;LAMP1;EHD1;TNF;CORO1C;PTPN14;NUP153;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;ITGAV;PMM2;SFN;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;RPLP2;AKAP8;RHOB;DKC1;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;REEP1;PRKCA;SYK;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;NPNT;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;RCC2;NUP214;TRAM2;DNAJC1;YWHAH;M6PR;ZDHHC6;UBE2J2;CEP41;RUVBL2;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;CPT1A;TFDP1;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;PHLDB2;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;VPS52;CD38;TNFAIP3;MAPK11;BMP8A;SRSF7;CLTA;SNF8;HSP90AB1;TP63;CCL5;MAGOH
8520,GO:0033743,0.270272137333148,0.9689834135288,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,TXN2
8833,GO:0034616,0.270395236930726,0.924465511974332,2,13,response to laminar fluid shear stress,BP,ETS1;SMAD7
5502,GO:0016445,0.270458172368954,0.866126171549207,5,45,somatic diversification of immunoglobulins,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
11269,GO:0045569,0.270516899317964,0.968923258267835,1,4,TRAIL binding,MF,TNFRSF10A
15013,GO:0070942,0.270707395750676,0.968876393790689,1,4,neutrophil mediated cytotoxicity,BP,DNASE1
15057,GO:0071008,0.270715500144034,0.968874399114928,1,4,U2-type post-mRNA release spliceosomal complex,CC,TFIP11
15321,GO:0071535,0.270746055617912,0.968866878060165,1,4,RING-like zinc finger domain binding,MF,MAFK
15264,GO:0071437,0.270769451960874,0.924291016343723,2,13,invadopodium,CC,PDPN;SVIL
16321,GO:0090503,0.270804927445215,0.878937867910017,4,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,USB1;NOCT;ZC3H12A;ISG20L2
20037,GO:2000660,0.27081003676643,0.968851126103852,1,4,negative regulation of interleukin-1-mediated signaling pathway,BP,IL1R2
19675,GO:1990966,0.270852656373758,0.968840630764877,1,4,ATP generation from poly-ADP-D-ribose,BP,PARP1
16548,GO:0097300,0.270853867489091,0.878906889229286,4,35,programmed necrotic cell death,BP,CYLD;BIRC3;TNF;TRAF2
13117,GO:0051653,0.270887407849211,0.87906616163967,4,34,spindle localization,BP,DCTN1;MYH9;ZW10;CLASP1
18858,GO:1904491,0.270921878698479,0.968823580038325,1,4,protein localization to ciliary transition zone,BP,CC2D2A
19480,GO:1990239,0.271139289914328,0.968769993008935,1,4,steroid hormone binding,MF,GPER1
13509,GO:0055078,0.271154391135675,0.924111330283948,2,13,sodium ion homeostasis,BP,EDN1;NEDD4L
1119,GO:0002708,0.271169121439628,0.865521713460901,5,46,positive regulation of lymphocyte mediated immunity,BP,TFRC;RSAD2;LAMP1;TNF;TRAF2
9363,GO:0035877,0.27117135284643,0.968762085759015,1,4,death effector domain binding,MF,NOL3
7463,GO:0031620,0.271179094106789,0.96876017646458,1,4,regulation of fever generation,BP,TNF
7464,GO:0031622,0.271179094106789,0.96876017646458,1,4,positive regulation of fever generation,BP,TNF
14026,GO:0060750,0.271273668677501,0.968736845330069,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,ESR1
6850,GO:0030318,0.271332327222582,0.924028206307534,2,13,melanocyte differentiation,BP,ADAMTS9;RAB27A
9449,GO:0036035,0.271432511286589,0.923981386585806,2,13,osteoclast development,BP,FBN1;TJP2
5330,GO:0016056,0.271473159627503,0.92396238639301,2,13,rhodopsin mediated signaling pathway,BP,NMT2;PDE6A
13596,GO:0060065,0.271581026407368,0.92391195598032,2,13,uterus development,BP,TGFB2;ESR1
10409,GO:0043244,0.271621584088208,0.84021251085469,8,79,regulation of protein complex disassembly,BP,MID1;TNF;ADRB2;WDR1;SPTBN1;CLASP1;EIF5A;SWAP70
13894,GO:0060536,0.271726626071939,0.968624964657768,1,4,cartilage morphogenesis,BP,SNAI2
18105,GO:1902743,0.271760866339108,0.878513437721813,4,34,regulation of lamellipodium organization,BP,CORO1C;PDPN;EPHA2;BIN3
6897,GO:0030431,0.271846821352669,0.923196229724667,2,14,sleep,BP,CSF2;OXTR
19168,GO:1905208,0.272107517326439,0.923665591372784,2,13,negative regulation of cardiocyte differentiation,BP,G6PD;BMP2
2097,GO:0004864,0.2721724618451,0.896264347574229,3,24,protein phosphatase inhibitor activity,MF,SH3RF2;PPP1R14C;PPP1R9B
10067,GO:0042559,0.27235974209565,0.922954399188924,2,14,pteridine-containing compound biosynthetic process,BP,DHFR;QDPR
3031,GO:0006577,0.272419142687326,0.923519600642532,2,13,amino-acid betaine metabolic process,BP,SLC22A4;CPT1A
5932,GO:0018210,0.272420555459828,0.829047710499454,10,102,peptidyl-threonine modification,BP,DAPK3;GALNT18;PRKCA;CAMK1G;SMAD7;GALNT2;CAB39;OXSR1;PARD3;BMP7
12365,GO:0048745,0.272462541913806,0.92349925889516,2,13,smooth muscle tissue development,BP,SRF;TP63
1325,GO:0003176,0.272526142675415,0.968426925854989,1,4,aortic valve development,BP,EFNA1
1328,GO:0003180,0.272526142675415,0.968426925854989,1,4,aortic valve morphogenesis,BP,EFNA1
315,GO:0000827,0.272670200691448,0.968391167161804,1,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,PPIP5K1
316,GO:0000828,0.272670200691448,0.968391167161804,1,4,inositol hexakisphosphate kinase activity,MF,PPIP5K1
317,GO:0000829,0.272670200691448,0.968391167161804,1,4,inositol heptakisphosphate kinase activity,MF,PPIP5K1
318,GO:0000832,0.272670200691448,0.968391167161804,1,4,inositol hexakisphosphate 5-kinase activity,MF,PPIP5K1
13398,GO:0052723,0.272670200691448,0.968391167161804,1,4,inositol hexakisphosphate 1-kinase activity,MF,PPIP5K1
13399,GO:0052724,0.272670200691448,0.968391167161804,1,4,inositol hexakisphosphate 3-kinase activity,MF,PPIP5K1
6714,GO:0030124,0.272708187370028,0.96838173408926,1,4,AP-4 adaptor complex,CC,AP4S1
3227,GO:0006879,0.272874496585498,0.864248819097944,5,47,cellular iron ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;ABCG2
9103,GO:0035372,0.272889247187755,0.923299126582771,2,13,protein localization to microtubule,BP,MID1;HNRNPU
4489,GO:0010511,0.272965648612467,0.968317757374591,1,4,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
3232,GO:0006885,0.273086917143678,0.845777162139523,7,69,regulation of pH,BP,EDN1;TP53;CLN6;CHP1;SLC4A11;TMEM165;SLC4A2
13773,GO:0060351,0.273169884499104,0.923167373733604,2,13,cartilage development involved in endochondral bone morphogenesis,BP,COL27A1;SERPINH1
1437,GO:0003416,0.273172478523126,0.923166155420731,2,13,endochondral bone growth,BP,FGFR2;COL27A1
14698,GO:0070318,0.273190489934917,0.968261825877974,1,4,positive regulation of G0 to G1 transition,BP,CTGF
1864,GO:0004528,0.273287935026641,0.968237567915388,1,4,phosphodiesterase I activity,MF,APEX2
13606,GO:0060076,0.273330320548644,0.923092006662002,2,13,excitatory synapse,CC,BAIAP2;FGFR2
3735,GO:0008270,0.273368812637119,0.77621221882246,48,570,zinc ion binding,MF,TRIM16;MMP9;DTX2;TRIM47;PML;CYLD;TRAF1;TRIM56;MID1;TRAF3;TP53;SQSTM1;CPA4;ADAMTS9;CSRP1;C9ORF3;QPCT;TK1;KLF7;ZMAT2;XAF1;TRIM22;DNPEP;NFX1;TRIM29;SF1;EGR1;AKAP8;TRAF2;PRKCA;POLR1A;ZNF407;UHRF1;ZNFX1;MTA2;DTX4;ESR1;RBM4;HERC2;ZSWIM6;RNF7;TRAF4;TNFAIP3;ATAD3C;SRSF7;PARP1;TOP3A;APEX2
19971,GO:2000551,0.273401968986899,0.968209166854766,1,4,regulation of T-helper 2 cell cytokine production,BP,RSAD2
11506,GO:0045990,0.273436366518596,0.968200597025333,1,4,carbon catabolite regulation of transcription,BP,SRF
11507,GO:0045991,0.273436366518596,0.968200597025333,1,4,carbon catabolite activation of transcription,BP,SRF
11459,GO:0045913,0.273461688460326,0.864098022499202,5,45,positive regulation of carbohydrate metabolic process,BP,NFKB1;IRS1;GPER1;IRS2;PDGFB
761,GO:0002002,0.27368929620873,0.96813754131154,1,4,regulation of angiotensin levels in blood,BP,C9ORF3
762,GO:0002003,0.27368929620873,0.96813754131154,1,4,angiotensin maturation,BP,C9ORF3
4787,GO:0010976,0.273690286471796,0.806274406106881,17,186,positive regulation of neuron projection development,BP,NRG1;FN1;NEFL;TENM3;LYN;BAIAP2;ENC1;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;BMP7;RAPGEF1
12742,GO:0051010,0.273724946570442,0.922906483226011,2,13,microtubule plus-end binding,MF,DST;CLASP1
5940,GO:0018242,0.273731142064479,0.922903568957317,2,13,protein O-linked glycosylation via serine,BP,GALNT18;GALNT2
11207,GO:0045338,0.273799947158827,0.968109933398482,1,4,farnesyl diphosphate metabolic process,BP,HMGCS1
5492,GO:0016428,0.273884219331566,0.968088897927971,1,4,tRNA (cytosine-5-)-methyltransferase activity,MF,NSUN2
8463,GO:0033600,0.273971857344537,0.968067013875744,1,4,negative regulation of mammary gland epithelial cell proliferation,BP,ROBO1
16509,GO:0097208,0.273975876548409,0.968066010036022,1,4,alveolar lamellar body,CC,LAMP1
17845,GO:1902023,0.273978138338447,0.96806544512151,1,4,L-arginine transport,BP,SLC7A2
7995,GO:0032613,0.2740887167236,0.895163886945663,3,24,interleukin-10 production,BP,CD83;CD274;TNFRSF21
13158,GO:0051731,0.274186478530922,0.968013384632938,1,4,polynucleotide 5'-hydroxyl-kinase activity,MF,NOL9
546,GO:0001665,0.274207463546111,0.968008138161405,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC5
1177,GO:0002824,0.274387928957703,0.863343781034725,5,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TFRC;RSAD2;IL27RA;TNF;TRAF2
4635,GO:0010757,0.274400496124249,0.967959854903116,1,4,negative regulation of plasminogen activation,BP,SERPINE1
2645,GO:0005981,0.27445674510513,0.967945777494548,1,4,regulation of glycogen catabolic process,BP,PPP1R3B
1302,GO:0003140,0.274532308812939,0.967926860623614,1,4,determination of left/right asymmetry in lateral mesoderm,BP,CITED2
19892,GO:2000381,0.274636112308271,0.967900863689213,1,4,negative regulation of mesoderm development,BP,TP63
1858,GO:0004521,0.274671266081073,0.863030319884091,5,47,endoribonuclease activity,MF,ZC3H12A;POP1;FEN1;NOB1;POP4
14784,GO:0070487,0.274788134537786,0.967862768904247,1,4,monocyte aggregation,BP,BMP7
1243,GO:0002943,0.274886059758483,0.967838216418702,1,4,tRNA dihydrouridine synthesis,BP,DUS2
5853,GO:0017150,0.274886059758483,0.967838216418702,1,4,tRNA dihydrouridine synthase activity,MF,DUS2
20298,GO:2001286,0.274984258141468,0.967813584658627,1,4,regulation of caveolin-mediated endocytosis,BP,NEDD4L
3776,GO:0008330,0.27499073433175,0.967811959812636,1,4,protein tyrosine/threonine phosphatase activity,MF,DUSP1
9377,GO:0035904,0.275078783422979,0.876405897165638,4,34,aorta development,BP,TGFB2;ADAMTS9;EFNB2;SRF
20240,GO:2001185,0.275100684400183,0.967784366681805,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,IRF1
10309,GO:0043084,0.275221161396282,0.96775411615469,1,4,penile erection,BP,OXTR
10286,GO:0043031,0.275295985511359,0.967735320405416,1,4,negative regulation of macrophage activation,BP,ZC3H12A
15006,GO:0070934,0.275309835520043,0.967731840607661,1,4,CRD-mediated mRNA stabilization,BP,HNRNPU
1463,GO:0003713,0.275310686630889,0.794489880380795,23,261,transcription coactivator activity,MF,PDLIM1;TAF4B;JUNB;WWC1;NFKB2;KLF7;DAXX;FUS;ELF3;MKL1;EDF1;PPRC1;DDX17;NFKBIB;FHL2;PQBP1;ABT1;CITED2;JUN;TFDP1;ACTN4;RBM14;SMARCC2
2848,GO:0006333,0.27532130662651,0.81493476921183,13,156,chromatin assembly or disassembly,BP,TP53;CDKN2A;DAXX;MCM2;GRWD1;MTA2;CENPN;NOC2L;CENPO;IPO4;CHAF1A;SMARCC2;SUPT16H
1271,GO:0003062,0.27540218479956,0.967708632467436,1,4,regulation of heart rate by chemical signal,BP,TPM1
12758,GO:0051026,0.27541596515766,0.967705168529375,1,4,chiasma assembly,BP,BRIP1
4933,GO:0014891,0.275441806253948,0.967698672336398,1,4,striated muscle atrophy,BP,IL15
5924,GO:0018199,0.275470813464714,0.967691379322077,1,4,peptidyl-glutamine modification,BP,QPCT
12544,GO:0050693,0.27549090501255,0.967686327337313,1,4,LBD domain binding,MF,CITED2
19484,GO:1990254,0.27553405264393,0.967675476410737,1,4,keratin filament binding,MF,KRT14
16485,GO:0097167,0.27564587531245,0.967647345114867,1,4,circadian regulation of translation,BP,RBM4
4391,GO:0010044,0.275697965328016,0.967634236010702,1,4,response to aluminum ion,BP,QDPR
19717,GO:2000060,0.275835106148122,0.836994191968369,8,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;RNF144B;GCLC
16739,GO:0097755,0.27586372560013,0.875721170779518,4,35,positive regulation of blood vessel diameter,BP,ADM;SOD2;ADRB2;GPER1
14300,GO:0061428,0.276022517532176,0.967552489824278,1,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,CITED2
19869,GO:2000347,0.276220225663522,0.967502634398238,1,4,positive regulation of hepatocyte proliferation,BP,TNFAIP3
14652,GO:0070236,0.276235176307419,0.967498862557833,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
12652,GO:0050856,0.276247042292774,0.893919006573106,3,24,regulation of T cell receptor signaling pathway,BP,CYLD;GBP1;LGALS3
9260,GO:0035666,0.276267802566109,0.893907004657839,3,24,TRIF-dependent toll-like receptor signaling pathway,BP,IKBKE;BIRC3;TRAF3
11368,GO:0045727,0.276310415187089,0.82589644192896,10,105,positive regulation of translation,BP,TNF;KRT17;ZC3H12A;CDK4;LARP4B;RPS9;ESR1;EIF5A;POLR2G;CCL5
9589,GO:0036438,0.276352690272216,0.967469206673608,1,4,maintenance of lens transparency,BP,CHMP4B
12307,GO:0048645,0.276388818489459,0.875385606316562,4,35,animal organ formation,BP,FGFR2;CITED2;BMP7;TP63
18462,GO:1903555,0.27640564825921,0.843276119293581,7,70,regulation of tumor necrosis factor superfamily cytokine production,BP,HSPB1;ZC3H12A;CD274;ERRFI1;AKAP8;GPNMB;TNFAIP3
15564,GO:0072009,0.276437077707601,0.843396654847512,7,68,nephron epithelium development,BP,IRX2;PBX1;BMP2;LIF;NPNT;WNT4;MYO1E
19074,GO:1904956,0.276463312841123,0.967441275736569,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP1
12415,GO:0048861,0.276471644783006,0.967439171459738,1,4,leukemia inhibitory factor signaling pathway,BP,LIF
9157,GO:0035509,0.276532600875354,0.967423774298255,1,4,negative regulation of myosin-light-chain-phosphatase activity,BP,TNF
18358,GO:1903347,0.276532600875354,0.967423774298255,1,4,negative regulation of bicellular tight junction assembly,BP,TNF
3472,GO:0007296,0.276541923861261,0.967421418997191,1,4,vitellogenesis,BP,FOSL1
9170,GO:0035523,0.276707223511351,0.967379642510908,1,4,protein K29-linked deubiquitination,BP,OTUD6A
6618,GO:0022840,0.276793506166414,0.96735782394174,1,4,leak channel activity,MF,PANX1
6620,GO:0022842,0.276793506166414,0.96735782394174,1,4,narrow pore channel activity,MF,PANX1
9014,GO:0035184,0.276923961774848,0.967324819330437,1,4,histone threonine kinase activity,MF,PRKCA
9116,GO:0035405,0.276923961774848,0.967324819330437,1,4,histone-threonine phosphorylation,BP,PRKCA
4636,GO:0010758,0.276999906526853,0.920751066224083,2,14,regulation of macrophage chemotaxis,BP,MTUS1;CCL5
13637,GO:0060136,0.277064407055564,0.967289266000238,1,4,embryonic process involved in female pregnancy,BP,JUNB
16793,GO:0098631,0.277262566735592,0.874826532347314,4,35,cell adhesion mediator activity,MF,PDLIM1;BAIAP2;TRIM29;BCAM
1906,GO:0004594,0.277363333241487,0.967213519835136,1,4,pantothenate kinase activity,MF,PANK2
5068,GO:0015291,0.277371279976801,0.817081495988854,12,126,secondary active transmembrane transporter activity,MF,SLC16A2;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;SLC5A6;SLC4A11;SLC22A4;SLC4A2;SLC3A2;SLC25A22;SLC2A6
16369,GO:0090669,0.27740742717346,0.967202338182585,1,4,telomerase RNA stabilization,BP,DKC1
12579,GO:0050733,0.277426131627384,0.9671975943136,1,4,RS domain binding,MF,LUC7L
1549,GO:0003945,0.277431860923244,0.967196141156946,1,4,N-acetyllactosamine synthase activity,MF,B4GALT1
1290,GO:0003100,0.277452794110119,0.967190831429663,1,4,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
13930,GO:0060592,0.277521975685649,0.967173279935352,1,4,mammary gland formation,BP,FGFR2
15650,GO:0072161,0.277521975685649,0.967173279935352,1,4,mesenchymal cell differentiation involved in kidney development,BP,WNT4
20169,GO:2001012,0.277521975685649,0.967173279935352,1,4,mesenchymal cell differentiation involved in renal system development,BP,WNT4
5043,GO:0015226,0.277573220558432,0.967160275544119,1,4,carnitine transmembrane transporter activity,MF,SLC22A4
5251,GO:0015879,0.277573220558432,0.967160275544119,1,4,carnitine transport,BP,SLC22A4
18307,GO:1903224,0.277646695842393,0.967141624594285,1,4,regulation of endodermal cell differentiation,BP,COL5A2
18180,GO:1902949,0.277668149780979,0.9671361775853,1,4,positive regulation of tau-protein kinase activity,BP,EGR1
19967,GO:2000542,0.277670527175518,0.967135573949124,1,4,negative regulation of gastrulation,BP,COL5A2
19870,GO:2000348,0.277778126012186,0.967108247234663,1,4,regulation of CD40 signaling pathway,BP,TNFAIP3
1287,GO:0003096,0.277836166299933,0.96709350141951,1,4,renal sodium ion transport,BP,SGK1
5490,GO:0016426,0.277950338473758,0.967064483573324,1,4,tRNA (adenine) methyltransferase activity,MF,TRMT61A
18581,GO:1903826,0.278028700075182,0.967044558800213,1,4,arginine transmembrane transport,BP,SLC7A2
4709,GO:0010871,0.278046032668148,0.967040150759067,1,4,negative regulation of receptor biosynthetic process,BP,ITGAV
15883,GO:0072610,0.278052406597223,0.967038529650417,1,4,interleukin-12 secretion,BP,MAPK11
20237,GO:2001182,0.278052406597223,0.967038529650417,1,4,regulation of interleukin-12 secretion,BP,MAPK11
19534,GO:1990441,0.278063455987129,0.96703571930341,1,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,JUN
7470,GO:0031628,0.278125180307246,0.967020017557961,1,4,opioid receptor binding,MF,FLNA
7549,GO:0031852,0.278125180307246,0.967020017557961,1,4,mu-type opioid receptor binding,MF,FLNA
14763,GO:0070444,0.278125658183603,0.967019895976613,1,4,oligodendrocyte progenitor proliferation,BP,LYN
14764,GO:0070445,0.278125658183603,0.967019895976613,1,4,regulation of oligodendrocyte progenitor proliferation,BP,LYN
34,GO:0000064,0.278132899185973,0.967018053688601,1,4,L-ornithine transmembrane transporter activity,MF,SLC7A2
16773,GO:0098576,0.278146058753327,0.967014705421789,1,4,lumenal side of membrane,CC,HSPA8
443,GO:0001191,0.278162795646905,0.874249601869092,4,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,DNAJB1;ZFP42;SPEN;CITED2
10386,GO:0043208,0.278392751173459,0.966951901898426,1,4,glycosphingolipid binding,MF,LYN
1532,GO:0003917,0.278398506391339,0.966950435903344,1,4,DNA topoisomerase type I activity,MF,TOP3A
9669,GO:0038027,0.278421398759116,0.966944604286573,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ITGAV
14184,GO:0061083,0.278465756212226,0.966933302959077,1,4,regulation of protein refolding,BP,SNRNP70
14185,GO:0061084,0.278465756212226,0.966933302959077,1,4,negative regulation of protein refolding,BP,SNRNP70
10518,GO:0043426,0.278549082113932,0.966912067311458,1,4,MRF binding,MF,TSC22D3
995,GO:0002457,0.278570609484551,0.966906579778248,1,4,T cell antigen processing and presentation,BP,ICAM1
9295,GO:0035733,0.278591938248078,0.966901142356717,1,4,hepatic stellate cell activation,BP,GCLC
9820,GO:0042026,0.27864328461639,0.892530196590745,3,24,protein refolding,BP,DNAJB2;SNRNP70;HSPA8
8795,GO:0034481,0.27881392822765,0.966844519173108,1,4,chondroitin sulfotransferase activity,MF,CHST3
680,GO:0001890,0.27885974638541,0.819625489750447,11,116,placenta development,BP,CYR61;ADM;CSF2;JUNB;FGFR2;FOSL1;LIF;ZFP36L1;PDGFB;BMP7;HSP90AB1
6977,GO:0030643,0.278860908786221,0.966832528675658,1,4,cellular phosphate ion homeostasis,BP,GPCPD1
15807,GO:0072501,0.278860908786221,0.966832528675658,1,4,cellular divalent inorganic anion homeostasis,BP,GPCPD1
15808,GO:0072502,0.278860908786221,0.966832528675658,1,4,cellular trivalent inorganic anion homeostasis,BP,GPCPD1
1124,GO:0002713,0.278967859174562,0.966805223242466,1,4,negative regulation of B cell mediated immunity,BP,THOC1
1220,GO:0002890,0.278967859174562,0.966805223242466,1,4,negative regulation of immunoglobulin mediated immune response,BP,THOC1
7218,GO:0031112,0.278973020016337,0.892338537161751,3,24,positive regulation of microtubule polymerization or depolymerization,BP,DCTN1;SLAIN2;CLASP1
15124,GO:0071211,0.278995612364601,0.966798135485453,1,4,protein targeting to vacuole involved in autophagy,BP,HSPA8
19944,GO:2000481,0.279008525082821,0.966794837470755,1,4,positive regulation of cAMP-dependent protein kinase activity,BP,ADRB2
19176,GO:1905232,0.279171309339251,0.96675324489652,1,4,cellular response to L-glutamate,BP,BAIAP2
14816,GO:0070545,0.279214629289242,0.966742171293877,1,4,PeBoW complex,CC,PES1
4897,GO:0014824,0.279225197599798,0.966739469462693,1,4,artery smooth muscle contraction,BP,EDN1
5455,GO:0016331,0.279233592264294,0.819364269665152,11,115,morphogenesis of embryonic epithelium,BP,ADM;SDC4;IRX2;TGFB2;FGFR2;SFRP1;CC2D2A;BMP7;WNT4;TP63;PHACTR4
1377,GO:0003273,0.27924268251564,0.966734999096735,1,4,cell migration involved in endocardial cushion formation,BP,SNAI2
3918,GO:0008585,0.279258056306746,0.841249549711859,7,69,female gonad development,BP,INHBA;LFNG;ICAM1;SFRP1;ZFP42;ESR1;WNT4
3504,GO:0007409,0.279279217903473,0.7860907575571,27,307,axonogenesis,BP,NRG1;MAP2;FN1;NEFL;BAIAP2;EFNB2;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;SEMA3C;ENAH;PARD3;ZSWIM6;EFNB1;LRFN4;BMP7;DAG1;EFNA1
14170,GO:0061052,0.279280228697023,0.966725398503969,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,G6PD
12141,GO:0048243,0.279282308070293,0.966724866759837,1,4,norepinephrine secretion,BP,OXTR
12208,GO:0048386,0.279327567272028,0.966713291719709,1,4,positive regulation of retinoic acid receptor signaling pathway,BP,TRIM16
15879,GO:0072603,0.279334381043248,0.966711548897598,1,4,interleukin-5 secretion,BP,TNFRSF21
20039,GO:2000662,0.279334381043248,0.966711548897598,1,4,regulation of interleukin-5 secretion,BP,TNFRSF21
15905,GO:0072674,0.279406753835162,0.966693034196077,1,4,multinuclear osteoclast differentiation,BP,CD109
15906,GO:0072675,0.279406753835162,0.966693034196077,1,4,osteoclast fusion,BP,CD109
18461,GO:1903553,0.279457901875711,0.96667994573078,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
605,GO:0001773,0.279475985193356,0.919563822119746,2,14,myeloid dendritic cell activation,BP,RELB;CSF2
13876,GO:0060501,0.279480441367371,0.966674177077623,1,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
11877,GO:0046884,0.279489275569247,0.966671915936435,1,4,follicle-stimulating hormone secretion,BP,INHBA
10671,GO:0043901,0.279494263561006,0.819052929069588,11,118,negative regulation of multi-organism process,BP,PML;RSAD2;SQSTM1;TNF;ZC3H12A;ITGAV;BANF1;TRIB1;JUN;TNFAIP3;CCL5
8634,GO:0034154,0.27955438758744,0.966655247596741,1,4,toll-like receptor 7 signaling pathway,BP,RSAD2
1439,GO:0003418,0.279573148263185,0.966650444072521,1,4,growth plate cartilage chondrocyte differentiation,BP,COL27A1
1443,GO:0003431,0.279573148263185,0.966650444072521,1,4,growth plate cartilage chondrocyte development,BP,COL27A1
15457,GO:0071787,0.279585719038805,0.966647225201427,1,4,endoplasmic reticulum tubular network formation,BP,ZFYVE27
677,GO:0001887,0.279599157600027,0.966643783927925,1,4,selenium compound metabolic process,BP,TXNRD1
10599,GO:0043568,0.279638473301979,0.966633715006244,1,4,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3
3477,GO:0007320,0.279718799488766,0.966613137695043,1,4,insemination,BP,OXTR
1717,GO:0004309,0.279720053535175,0.966612816385833,1,4,exopolyphosphatase activity,MF,PRUNE2
3181,GO:0006798,0.279720053535175,0.966612816385833,1,4,polyphosphate catabolic process,BP,PRUNE2
10994,GO:0044793,0.279742006145003,0.966607191445232,1,4,negative regulation by host of viral process,BP,ZC3H12A
11009,GO:0044828,0.279742006145003,0.966607191445232,1,4,negative regulation by host of viral genome replication,BP,ZC3H12A
14640,GO:0070212,0.279847496516162,0.966580153942244,1,4,protein poly-ADP-ribosylation,BP,PARP1
12264,GO:0048549,0.27988395494504,0.966570806612917,1,4,positive regulation of pinocytosis,BP,ACTN4
9382,GO:0035912,0.279893621651483,0.966568327979747,1,4,dorsal aorta morphogenesis,BP,SRF
5220,GO:0015822,0.279905850878716,0.966565192141215,1,4,ornithine transport,BP,SLC7A2
18363,GO:1903352,0.279905850878716,0.966565192141215,1,4,L-ornithine transmembrane transport,BP,SLC7A2
16088,GO:0090063,0.279914401420563,0.966562999496861,1,4,positive regulation of microtubule nucleation,BP,DCTN1
1412,GO:0003348,0.279924997395862,0.966560282220487,1,4,cardiac endothelial cell differentiation,BP,NRG1
14107,GO:0060956,0.279924997395862,0.966560282220487,1,4,endocardial cell differentiation,BP,NRG1
6397,GO:0021603,0.279993891427738,0.966542611651947,1,4,cranial nerve formation,BP,MAFB
14392,GO:0061640,0.280018574032974,0.84068906520454,7,69,cytoskeleton-dependent cytokinesis,BP,KIF23;RHOB;SPTBN1;CHMP4B;CNTROB;INCENP;BIN3
8052,GO:0032713,0.280023059377973,0.966535128774512,1,4,negative regulation of interleukin-4 production,BP,CD83
6482,GO:0021825,0.280032133893007,0.96653280056144,1,4,substrate-dependent cerebral cortex tangential migration,BP,ROBO1
17293,GO:0140059,0.280032133893007,0.96653280056144,1,4,dendrite arborization,BP,ZNF365
9975,GO:0042363,0.280036622264099,0.966531648963109,1,4,fat-soluble vitamin catabolic process,BP,CYP24A1
3616,GO:0008063,0.280039098678593,0.966531013570341,1,4,Toll signaling pathway,BP,TRAF3
1291,GO:0003104,0.280047794091103,0.966528782466385,1,4,positive regulation of glomerular filtration,BP,PDGFB
16415,GO:0097048,0.280047794091103,0.966528782466385,1,4,dendritic cell apoptotic process,BP,LYN
20045,GO:2000668,0.280047794091103,0.966528782466385,1,4,regulation of dendritic cell apoptotic process,BP,LYN
14715,GO:0070345,0.280062004359275,0.966525136154637,1,4,negative regulation of fat cell proliferation,BP,TFDP1
14841,GO:0070579,0.280087761582473,0.966518526347519,1,4,methylcytosine dioxygenase activity,MF,TET3
16212,GO:0090245,0.280089540783233,0.96651806974213,1,4,axis elongation involved in somitogenesis,BP,SFRP1
2964,GO:0006499,0.28009888307228,0.966515672124003,1,4,N-terminal protein myristoylation,BP,NMT2
5964,GO:0018377,0.28009888307228,0.966515672124003,1,4,protein myristoylation,BP,NMT2
17369,GO:1900084,0.280108580642558,0.966513183221664,1,4,regulation of peptidyl-tyrosine autophosphorylation,BP,SYK
1648,GO:0004095,0.280111174510899,0.966512517481739,1,4,carnitine O-palmitoyltransferase activity,MF,CPT1A
5482,GO:0016416,0.280111174510899,0.966512517481739,1,4,O-palmitoyltransferase activity,MF,CPT1A
6169,GO:0019530,0.28011233535235,0.966512219538751,1,4,taurine metabolic process,BP,STAT5A
6203,GO:0019694,0.28011233535235,0.966512219538751,1,4,alkanesulfonate metabolic process,BP,STAT5A
18090,GO:1902713,0.280112995527907,0.966512050096602,1,4,regulation of interferon-gamma secretion,BP,ZC3H12A
14058,GO:0060836,0.280113313267426,0.966511968544686,1,4,lymphatic endothelial cell differentiation,BP,PDPN
17998,GO:1902455,0.280114346131625,0.966511703446073,1,4,negative regulation of stem cell population maintenance,BP,BMP7
7580,GO:0031944,0.280114508142395,0.966511661863703,1,4,negative regulation of glucocorticoid metabolic process,BP,BMP2
7583,GO:0031947,0.280114508142395,0.966511661863703,1,4,negative regulation of glucocorticoid biosynthetic process,BP,BMP2
16075,GO:0090032,0.280114508142395,0.966511661863703,1,4,negative regulation of steroid hormone biosynthetic process,BP,BMP2
5855,GO:0017153,0.280114785640327,0.966511590639836,1,4,sodium:dicarboxylate symporter activity,MF,SLC25A22
15088,GO:0071072,0.280115006818044,0.966511533871309,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
338,GO:0000938,0.280115157774593,0.966511495126047,1,4,GARP complex,CC,VPS52
845,GO:0002159,0.280115157774593,0.966511495126047,1,4,desmosome assembly,BP,PRKCA
849,GO:0002175,0.280115157774593,0.966511495126047,1,4,protein localization to paranode region of axon,BP,CNTNAP1
1384,GO:0003284,0.280115157774593,0.966511495126047,1,4,septum primum development,BP,TGFB2
1429,GO:0003402,0.280115157774593,0.966511495126047,1,4,planar cell polarity pathway involved in axis elongation,BP,SFRP1
3384,GO:0007161,0.280115157774593,0.966511495126047,1,4,calcium-independent cell-matrix adhesion,BP,FN1
3404,GO:0007185,0.280115157774593,0.966511495126047,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,TRIO
3607,GO:0008046,0.280115157774593,0.966511495126047,1,4,axon guidance receptor activity,MF,ROBO1
3910,GO:0008559,0.280115157774593,0.966511495126047,1,4,xenobiotic transmembrane transporting ATPase activity,MF,ABCG2
4478,GO:0010484,0.280115157774593,0.966511495126047,1,4,H3 histone acetyltransferase activity,MF,BRPF1
4626,GO:0010746,0.280115157774593,0.966511495126047,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
4627,GO:0010748,0.280115157774593,0.966511495126047,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
5381,GO:0016199,0.280115157774593,0.966511495126047,1,4,axon midline choice point recognition,BP,ROBO1
6539,GO:0021943,0.280115157774593,0.966511495126047,1,4,formation of radial glial scaffolds,BP,FLNA
6597,GO:0022614,0.280115157774593,0.966511495126047,1,4,membrane to membrane docking,BP,ICAM1
6812,GO:0030263,0.280115157774593,0.966511495126047,1,4,apoptotic chromosome condensation,BP,GPER1
7435,GO:0031544,0.280115157774593,0.966511495126047,1,4,peptidyl-proline 3-dioxygenase activity,MF,P3H2
7588,GO:0031956,0.280115157774593,0.966511495126047,1,4,medium-chain fatty acid-CoA ligase activity,MF,ACSL1
7624,GO:0032021,0.280115157774593,0.966511495126047,1,4,NELF complex,CC,NELFE
8208,GO:0032960,0.280115157774593,0.966511495126047,1,4,regulation of inositol trisphosphate biosynthetic process,BP,GPER1
8370,GO:0033263,0.280115157774593,0.966511495126047,1,4,CORVET complex,CC,TGFBRAP1
8701,GO:0034334,0.280115157774593,0.966511495126047,1,4,adherens junction maintenance,BP,PLEKHA7
8973,GO:0035061,0.280115157774593,0.966511495126047,1,4,interchromatin granule,CC,SRSF2
9717,GO:0038132,0.280115157774593,0.966511495126047,1,4,neuregulin binding,MF,ITGAV
10405,GO:0043237,0.280115157774593,0.966511495126047,1,4,laminin-1 binding,MF,DAG1
10456,GO:0043313,0.280115157774593,0.966511495126047,1,4,regulation of neutrophil degranulation,BP,SYK
11673,GO:0046449,0.280115157774593,0.966511495126047,1,4,creatinine metabolic process,BP,STAT5A
11785,GO:0046643,0.280115157774593,0.966511495126047,1,4,regulation of gamma-delta T cell activation,BP,SYK
12015,GO:0047555,0.280115157774593,0.966511495126047,1,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE6A
13787,GO:0060373,0.280115157774593,0.966511495126047,1,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,SMAD7
14091,GO:0060916,0.280115157774593,0.966511495126047,1,4,mesenchymal cell proliferation involved in lung development,BP,FGFR2
14272,GO:0061343,0.280115157774593,0.966511495126047,1,4,cell adhesion involved in heart morphogenesis,BP,TGFB2
15120,GO:0071205,0.280115157774593,0.966511495126047,1,4,protein localization to juxtaparanode region of axon,BP,CNTNAP1
15903,GO:0072672,0.280115157774593,0.966511495126047,1,4,neutrophil extravasation,BP,IL1A
16095,GO:0090071,0.280115157774593,0.966511495126047,1,4,negative regulation of ribosome biogenesis,BP,SHQ1
16825,GO:0098706,0.280115157774593,0.966511495126047,1,4,ferric iron import across plasma membrane,BP,STEAP4
17147,GO:0102391,0.280115157774593,0.966511495126047,1,4,decanoate-CoA ligase activity,MF,ACSL1
18040,GO:1902563,0.280115157774593,0.966511495126047,1,4,regulation of neutrophil activation,BP,SYK
19607,GO:1990745,0.280115157774593,0.966511495126047,1,4,EARP complex,CC,VPS52
19710,GO:2000051,0.280115157774593,0.966511495126047,1,4,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP1
20009,GO:2000622,0.280115157774593,0.966511495126047,1,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,DHX34
20010,GO:2000623,0.280115157774593,0.966511495126047,1,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,DHX34
2802,GO:0006259,0.280372010929669,0.762256635740991,69,844,DNA metabolic process,BP,CTGF;PML;TFRC;CSF2;TET3;TP53;IL27RA;CDKN1A;MCM5;GADD45A;GNL3L;ASCC2;TELO2;TYMS;TK1;FANCC;NAT10;MCM2;GRWD1;APTX;IL7R;TFIP11;GPER1;PRPF19;DKC1;FEN1;NPAS2;GINS2;USP43;PDGFB;ALYREF;POLA1;DNASE1;UHRF1;COPS3;ORAOV1;SFPQ;TATDN2;MTA2;HNRNPU;PAGR1;RUVBL2;ORC1;THOC1;DUSP1;JUN;MCM7;CCR6;GINS3;HERC2;ZNF365;XRCC6;SMUG1;MPHOSPH8;CHAF1A;KIF22;TIMELESS;RBM14;BRIP1;RRM2;SUPT16H;POLR2G;CDCA5;HSP90AB1;SWAP70;PARP1;TOP3A;ORC4;APEX2
12226,GO:0048483,0.280927661270048,0.89119965643887,3,24,autonomic nervous system development,BP,NAV2;TP63;PHACTR4
8016,GO:0032649,0.281082046534476,0.858654646226756,5,47,regulation of interferon-gamma production,BP,INHBA;IL27RA;TNF;ZC3H12A;CD274
5795,GO:0017038,0.281130377814385,0.804768434007745,15,166,protein import,BP,PML;CDKN1A;TNF;NUP153;ZC3H12A;CHP1;NFKBIA;PTTG1IP;NUP214;HSPA8;TNPO3;TOMM40;IPO4;DAG1;HSP90AB1
14194,GO:0061099,0.281417566626908,0.89091347572148,3,24,negative regulation of protein tyrosine kinase activity,BP,GPRC5A;ERRFI1;FGFR1OP
2092,GO:0004857,0.282340686471975,0.793065779013835,20,231,enzyme inhibitor activity,MF,HSPB1;SH3RF2;BIRC3;CDKN2B;CDKN1A;CDKN2A;CHP1;SFN;SERPINE1;FGFR1OP;SERPINH1;PPP1R14C;TRIB1;PPP1R9B;A2ML1;CD109;SOCS1;HSPBP1;DUS2;NOL3
13009,GO:0051438,0.282439801922803,0.857602976981541,5,48,regulation of ubiquitin-protein transferase activity,BP,UBE2C;RPS2;SMAD7;DCUN1D2;ARRDC3
797,GO:0002065,0.282478059732031,0.838872715868989,7,69,columnar/cuboidal epithelial cell differentiation,BP,CDKN1A;FGFR2;TYMS;BMP2;SERPINE1;WNT4;TP63
18368,GO:1903364,0.282753573984449,0.816530206079061,11,116,positive regulation of cellular protein catabolic process,BP,UBQLN2;RNF19B;PTTG1IP;SMAD7;KEAP1;TRIB1;HSPBP1;TNFAIP3;PSMC3;RNF144B;GCLC
7602,GO:0031982,0.282984544588385,0.743039327328533,237,3048,vesicle,CC,IGFBP3;KRT1;SAA1;SPRR3;FTL;CRYAB;FTH1;MMP9;KRT2;S100P;FN1;C1R;KRT34;KRT15;AMOT;ACTG1;NQO1;TAP1;PML;HSPB1;KRT10;PCDH7;SDC4;KRT13;TFRC;SOD2;GPRC5A;UGT1A6;HLA-B;FBN1;TGFB2;COBLL1;EDN1;TXNRD1;IKBKE;PRSS23;B4GALT1;MGAM;DBNDD2;G6PD;TRAF3;EMP2;HRNR;SQSTM1;MARVELD3;KRT9;STEAP4;NFKB1;LFNG;KRT6A;HSPG2;UBQLN2;LYN;MYO1B;RAB32;STOML1;PLEKHO2;ARPC4;LAMP1;CSRP1;EHD1;TNF;COL12A1;BAIAP2;KRT5;CORO1C;DST;PDPN;FGFR2;BACE2;TPM4;DNAJB1;PSMB9;SLC7A5;KRT17;QPCT;PGD;SIRPA;FLNA;SRSF2;LCP1;CYB5R1;ACAA1;CADPS2;CHP1;ICAM1;CD274;GOSR1;DDX23;KREMEN2;ITGAV;PMM2;SFN;CDC42EP2;ADRB2;PLEKHA7;ANXA8L1;SLC5A6;SERPINE1;FXYD3;PGK1;ARPC1B;EBP;AMOTL2;RELT;SFRP1;ZFYVE27;SAFB2;HLA-F;WDR1;ANXA8;PSME2;BANF1;IL7R;GPER1;AP4S1;EDF1;DOCK10;GEMIN4;RPLP2;RHOB;SNX12;UPK3B;VCL;KRT14;LGALS3;ACO1;RPLP1;TRAF2;IL15;PRKCA;SYK;CDKL1;PDGFB;BCAM;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SERPINH1;DNASE1;COX5B;DPYSL3;COL5A3;MYH9;SPPL2A;NPNT;SDK1;GLIPR1;SNX8;SEMA3C;LILRB3;SPEN;RCC2;ACKR3;CRCP;YWHAH;TAPBP;M6PR;CLASP1;CAPNS1;RUVBL2;A2ML1;GALNT2;MARVELD2;CAB39;TGFBRAP1;CD109;SOCS1;OXSR1;HSPA8;GBE1;GLIPR2;DCXR;COMMD9;LRRC57;EIF3B;TRAPPC5;CHMP4B;ARRDC3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;XRCC6;GP6;CS;TAP2;ACTN4;EFNB1;BMP7;TKT;TOMM40;MPHOSPH8;SGSM1;EIF3I;RAPGEF1;ZYX;EIF5A;TINAGL1;MYADM;DAG1;TMEM165;FAM234A;RAB27A;GPX4;WNT4;RILPL2;AKR1C1;VPS52;TUBB;CTDSP1;CD38;TNFAIP3;PSMC3;SPG21;PPP2R1B;EFNA1;MYO1E;SLC3A2;XPNPEP3;PTPRB;SRSF7;CLTA;CREB5;SNF8;HSP90AB1;TBXA2R;FBLN2;LAIR1;C1S;BAIAP2L2;SH3BP4
10676,GO:0043921,0.28301207163853,0.889979997792179,3,24,modulation by host of viral transcription,BP,JUN;PSMC3;CCL5
13337,GO:0052312,0.28301207163853,0.889979997792179,3,24,modulation of transcription in other organism involved in symbiotic interaction,BP,JUN;PSMC3;CCL5
13355,GO:0052472,0.28301207163853,0.889979997792179,3,24,modulation by host of symbiont transcription,BP,JUN;PSMC3;CCL5
4838,GO:0014044,0.283168188228717,0.889888434078904,3,24,Schwann cell development,BP,PARD3;CNTNAP1;DAG1
10169,GO:0042755,0.283266500535597,0.917730798616883,2,14,eating behavior,BP,OXTR;CPT1A
13644,GO:0060149,0.283790769949604,0.917475791918716,2,14,negative regulation of posttranscriptional gene silencing,BP,ZC3H12A;ESR1
14112,GO:0060967,0.283790769949604,0.917475791918716,2,14,negative regulation of gene silencing by RNA,BP,ZC3H12A;ESR1
10903,GO:0044448,0.28419269058369,0.81156476655315,12,127,cell cortex part,CC,TPM4;FLNA;WDR1;SPTBN1;DCTN1;MYH9;LANCL2;CLASP1;ACTN4;PHLDB2;MYADM;CLTA
18538,GO:1903727,0.284254513586134,0.889250466868827,3,24,positive regulation of phospholipid metabolic process,BP,IRS1;LYN;PDGFB
13179,GO:0051784,0.28433118010311,0.856420209902743,5,47,negative regulation of nuclear division,BP,LIF;ZW10;ANAPC15;DUSP1;BMP7
7377,GO:0031429,0.284533822987421,0.963259863783351,1,5,box H/ACA snoRNP complex,CC,DKC1
8809,GO:0034513,0.284533822987421,0.963259863783351,1,5,box H/ACA snoRNA binding,MF,DKC1
2642,GO:0005978,0.284770788418731,0.869986410868802,4,35,glycogen biosynthetic process,BP,IRS1;PPP1R3B;IRS2;GBE1
4176,GO:0009250,0.284770788418731,0.869986410868802,4,35,glucan biosynthetic process,BP,IRS1;PPP1R3B;IRS2;GBE1
8065,GO:0032733,0.28488248273589,0.916943623877833,2,14,positive regulation of interleukin-10 production,BP,CD83;CD274
12301,GO:0048639,0.285304562522145,0.818884298214595,10,104,positive regulation of developmental growth,BP,NRG1;FN1;EDN1;FGFR2;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;NEDD4L
3288,GO:0006977,0.285507182036368,0.844971154202075,6,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
6809,GO:0030260,0.285635399813812,0.823581166866374,9,94,entry into host cell,BP,TFRC;LAMP1;EFNB2;NUP153;EPHA2;ICAM1;ITGAV;DAG1;CXCL8
10875,GO:0044409,0.285635399813812,0.823581166866374,9,94,entry into host,BP,TFRC;LAMP1;EFNB2;NUP153;EPHA2;ICAM1;ITGAV;DAG1;CXCL8
13196,GO:0051806,0.285635399813812,0.823581166866374,9,94,entry into cell of other organism involved in symbiotic interaction,BP,TFRC;LAMP1;EFNB2;NUP153;EPHA2;ICAM1;ITGAV;DAG1;CXCL8
13203,GO:0051828,0.285635399813812,0.823581166866374,9,94,entry into other organism involved in symbiotic interaction,BP,TFRC;LAMP1;EFNB2;NUP153;EPHA2;ICAM1;ITGAV;DAG1;CXCL8
3213,GO:0006855,0.285672435538956,0.855620901502472,5,46,drug transmembrane transport,BP,EBP;ABCG2;SLC7A2;SLC4A11;SLC25A22
11476,GO:0045932,0.285747471426963,0.916520867046135,2,14,negative regulation of muscle contraction,BP,ZC3H12A;ADRB2
7244,GO:0031175,0.286073073761555,0.762071904605595,54,644,neuron projection development,BP,NRG1;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;DBNDD2;LYN;EHD1;BAIAP2;EFNB2;ENC1;TNC;GPRIN1;FGFR2;KLF7;UBE4B;L1CAM;TNFRSF12A;SFRP1;ZFYVE27;SRF;DOCK10;SGK1;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;DPYSL3;SDK1;SEMA3C;YWHAH;ENAH;PQBP1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;EFNA1
12274,GO:0048569,0.286134909456047,0.916331191804851,2,14,post-embryonic animal organ development,BP,FBN1;MYO1E
13362,GO:0052547,0.287001864864105,0.78291951105478,24,284,regulation of peptidase activity,BP,CRYAB;MMP9;CYR61;FN1;CTGF;PML;BIRC3;LYN;TNF;PSMB9;SFN;SERPINE1;ANXA8;PSME2;GPER1;TRAF2;ROBO1;SERPINH1;A2ML1;CD109;TNFRSF10A;EFNA1;NOL3;TP63
2944,GO:0006471,0.287250755982423,0.887483357133537,3,24,protein ADP-ribosylation,BP,PUM3;PARP14;PARP1
7755,GO:0032271,0.287798221391537,0.802028636962509,14,154,regulation of protein polymerization,BP,MAP2;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SPTBN1;DCTN1;SLAIN2;CLASP1;RHOG;KANK4;MYADM;BAIAP2L2
4370,GO:0009988,0.287917006483273,0.886793327125812,3,25,cell-cell recognition,BP,B4GALT1;LGALS3;UBAP2L
18817,GO:1904385,0.288191159110942,0.91532123657925,2,14,cellular response to angiotensin,BP,NFKB1;BRIP1
6917,GO:0030509,0.288291713549642,0.821615151799963,9,92,BMP signaling pathway,BP,CYR61;FBN1;TGFB2;BMP2;SFRP1;EGR1;SMAD7;BMP7;BMP8A
156,GO:0000314,0.288754788744079,0.885539868060237,3,28,organellar small ribosomal subunit,CC,MRPS12;MRPS24;MRPS2
2510,GO:0005763,0.288754788744079,0.885539868060237,3,28,mitochondrial small ribosomal subunit,CC,MRPS12;MRPS24;MRPS2
6679,GO:0030042,0.288781618420825,0.867374522181611,4,35,actin filament depolymerization,BP,WDR1;SPTBN1;MICAL3;SWAP70
7975,GO:0032589,0.289060345939406,0.88641077191745,3,24,neuron projection membrane,CC,NRG1;GPER1;SPTBN1
15519,GO:0071897,0.289163753265866,0.795563493045682,16,178,DNA biosynthetic process,BP,CTGF;TP53;CDKN1A;GNL3L;TYMS;TK1;NAT10;DKC1;USP43;PDGFB;POLA1;HNRNPU;DUSP1;BRIP1;HSP90AB1;TOP3A
18453,GO:1903541,0.289245150824931,0.9148014055467,2,14,regulation of exosomal secretion,BP,SDC4;SNF8
18455,GO:1903543,0.289245150824931,0.9148014055467,2,14,positive regulation of exosomal secretion,BP,SDC4;SNF8
2979,GO:0006521,0.28937105816279,0.852473059790202,5,51,regulation of cellular amino acid metabolic process,BP,ODC1;NQO1;PSMB9;PSME2;PSMC3
890,GO:0002262,0.289826538245849,0.815230335591194,10,106,myeloid cell homeostasis,BP,MAFB;INHBA;G6PD;NFE2L1;LYN;FANCC;SRF;ETS1;ZFP36L1;ADAM17
7935,GO:0032515,0.289994911460767,0.866397332590658,4,36,negative regulation of phosphoprotein phosphatase activity,BP,SH3RF2;TNF;PPP1R14C;PPP1R9B
10642,GO:0043651,0.290016233693384,0.914420182985084,2,14,linoleic acid metabolic process,BP,ACSL1;FADS1
13824,GO:0060420,0.290065577649003,0.866534527230781,4,35,regulation of heart growth,BP,EDN1;G6PD;FGFR2;MAPK11
19042,GO:1904888,0.290275077442398,0.852432009125395,5,46,cranial skeletal system development,BP,TGFB2;FGFR2;SLC39A1;INSIG1;TP63
12067,GO:0048015,0.290410058256448,0.814851267095966,10,104,phosphatidylinositol-mediated signaling,BP,NRG1;TGFB2;EDN1;IRS1;GPER1;ZFP36L1;IRS2;IER3;PDGFB;CCL5
10190,GO:0042789,0.290620211258655,0.914121032356737,2,14,mRNA transcription by RNA polymerase II,BP,FLNA;SRF
12566,GO:0050718,0.290758660998372,0.914052390641412,2,14,positive regulation of interleukin-1 beta secretion,BP,TRIM16;PANX1
13547,GO:0060008,0.290876319878738,0.913994037012498,2,14,Sertoli cell differentiation,BP,ICAM1;SAFB2
12656,GO:0050860,0.291015371933981,0.913925049887423,2,14,negative regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
1116,GO:0002705,0.291183338778203,0.84086639270556,6,59,positive regulation of leukocyte mediated immunity,BP,TFRC;RSAD2;LAMP1;TNF;TRAF2;SYK
7703,GO:0032182,0.291296397089666,0.825142009251606,8,82,ubiquitin-like protein binding,MF,PML;HSPB1;SQSTM1;DAXX;NSFL1C;DCUN1D2;HERC2;TNFAIP3
17275,GO:0120111,0.291380354746799,0.84072334170789,6,59,neuron projection cytoplasm,CC,NEFL;HSPB1;BAIAP2;DST;PQBP1;BLOC1S2
7716,GO:0032205,0.291614468611408,0.865518712697547,4,35,negative regulation of telomere maintenance,BP,GNL3L;NAT10;HNRNPU;PARP1
1170,GO:0002793,0.29176595793944,0.798749801183566,14,154,positive regulation of peptide secretion,BP,SAA1;TRIM16;PTGER4;TGFB2;PANX1;TNF;CD274;GPER1;IRS2;SYK;SPTBN1;IL1A;CD38;MAPK11
12709,GO:0050927,0.291876604945828,0.913497205774962,2,14,positive regulation of positive chemotaxis,BP,IL16;CXCL8
13822,GO:0060416,0.291911985880508,0.884712389521391,3,24,response to growth hormone,BP,TRIM16;LYN;STAT5A
12615,GO:0050796,0.291953943716102,0.813543970930969,10,106,regulation of insulin secretion,BP,IRS1;TNF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
6684,GO:0030049,0.292268721044954,0.912736989151499,2,15,muscle filament sliding,BP,TPM4;TPM1
8378,GO:0033275,0.292268721044954,0.912736989151499,2,15,actin-myosin filament sliding,BP,TPM4;TPM1
12518,GO:0050661,0.292351877876938,0.864848979861648,4,36,NADP binding,MF,G6PD;DHCR7;DHFR;QDPR
9049,GO:0035265,0.292565609463422,0.818282721577231,9,92,organ growth,BP,TGFB2;EDN1;G6PD;WWC1;FGFR2;COL27A1;ESR1;SORBS2;MAPK11
308,GO:0000819,0.292841572680637,0.785965167814009,19,216,sister chromatid segregation,BP,UBE2C;KIF23;AKAP8L;RRS1;AKAP8;FEN1;SFPQ;ZW10;RCC2;HNRNPU;CLASP1;ANAPC15;DUSP1;CENPN;CHMP4B;CENPO;INCENP;KIF22;CDCA5
10608,GO:0043586,0.293124332594395,0.912875631106947,2,14,tongue development,BP,KRT13;WNT10A
7737,GO:0032232,0.293595703184092,0.912640278486906,2,14,negative regulation of actin filament bundle assembly,BP,CLASP1;PHLDB2
9,GO:0000018,0.293660052913065,0.839159590431763,6,58,regulation of DNA recombination,BP,TFRC;IL27RA;IL7R;ALYREF;THOC1;ZNF365
8921,GO:0034762,0.29377854013726,0.778521281219533,23,263,regulation of transmembrane transport,BP,MMP9;JPH2;G6PD;IRS1;LYN;TNF;JPH1;FLNA;CHP1;ADRB2;FXYD3;WDR1;GPER1;KCNA7;IRS2;NEDD4L;YWHAH;RRAD;KCNIP3;CAB39;STAC;OXSR1;ACTN4
6900,GO:0030449,0.293788317708595,0.912544023157731,2,14,regulation of complement activation,BP,C1R;C1S
19808,GO:2000257,0.293788317708595,0.912544023157731,2,14,regulation of protein activation cascade,BP,C1R;C1S
131,GO:0000271,0.293906040444802,0.838980447309718,6,58,polysaccharide biosynthetic process,BP,NFKB1;IRS1;PPP1R3B;IRS2;PDGFB;GBE1
16201,GO:0090231,0.294135524079979,0.912370390456377,2,14,regulation of spindle checkpoint,BP,ANAPC15;DUSP1
14976,GO:0070884,0.294243879148589,0.912316171279848,2,14,regulation of calcineurin-NFAT signaling cascade,BP,NRG1;CHP1
17208,GO:0106056,0.294243879148589,0.912316171279848,2,14,regulation of calcineurin-mediated signaling,BP,NRG1;CHP1
6064,GO:0019212,0.294272393654392,0.882995275046768,3,25,phosphatase inhibitor activity,MF,SH3RF2;PPP1R14C;PPP1R9B
1022,GO:0002523,0.294787525907348,0.960358821776872,1,5,leukocyte migration involved in inflammatory response,BP,CCR6
6936,GO:0030544,0.29514942420718,0.863003005023632,4,36,Hsp70 protein binding,MF,SACS;DNAJB1;DNAJB2;METTL21A
4541,GO:0010614,0.295228404694986,0.911822823090179,2,14,negative regulation of cardiac muscle hypertrophy,BP,G6PD;ERRFI1
4879,GO:0014741,0.295228404694986,0.911822823090179,2,14,negative regulation of muscle hypertrophy,BP,G6PD;ERRFI1
6994,GO:0030674,0.295418939461079,0.802395070559582,12,129,protein binding, bridging,MF,NEFL;IRS1;TJP2;ARPC4;BAIAP2;TRIM22;CBX5;CNTNAP1;SORBS2;BLNK;RBM14;BIN3
12593,GO:0050769,0.296154779511578,0.772466490457159,26,298,positive regulation of neurogenesis,BP,NRG1;FN1;NEFL;TENM3;LYN;BAIAP2;ENC1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;ZFYVE27;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;NEDD4L;DPYSL3;SPEN;ZNF365;BMP7;RAPGEF1;DAG1
6783,GO:0030218,0.296425821471469,0.821200416881855,8,82,erythrocyte differentiation,BP,MAFB;INHBA;G6PD;NFE2L1;LYN;SRF;ETS1;ZFP36L1
19811,GO:2000269,0.296893872761407,0.910985351573695,2,14,regulation of fibroblast apoptotic process,BP,SFRP1;TP63
12955,GO:0051336,0.296987093693674,0.745823505498084,73,897,regulation of hydrolase activity,BP,IGFBP3;CCL20;CRYAB;MMP9;CYR61;FN1;CTGF;AMOT;PML;STARD13;TGFB2;SH3RF2;BIRC3;NUAK1;TP53;SIPA1L3;LYN;TNF;CORO1C;PKMYT1;FGFR2;DNAJB1;PSMB9;EPHA2;CHP1;ICAM1;BMP2;ERRFI1;SFN;CDC42EP2;SERPINE1;SFRP1;TPM1;PPP1R3B;ANXA8;PSME2;GPER1;DNAJB2;DOCK10;CD2BP2;TRAF2;ROBO1;AJUBA;NSFL1C;SNRNP70;SERPINH1;UHRF1;NPNT;RASGRP4;RUNDC1;RCC2;DNAJC1;HNRNPU;PPP1R14C;PPP1R9B;A2ML1;CD109;JUN;ESR1;RHOG;TNFRSF10A;SGSM1;RAPGEF1;WNT4;CCL22;DNAJC9;EFNA1;NOL3;HSP90AB1;TP63;PHACTR4;CCL5;SH3BP4
10114,GO:0042632,0.297239602357913,0.861617989785706,4,36,cholesterol homeostasis,BP,EHD1;COMMD9;INSIG1;AKR1C1
13521,GO:0055092,0.297239602357913,0.861617989785706,4,36,sterol homeostasis,BP,EHD1;COMMD9;INSIG1;AKR1C1
7219,GO:0031113,0.297520413719392,0.86143153782887,4,36,regulation of microtubule polymerization,BP,MAP2;DCTN1;SLAIN2;CLASP1
395,GO:0001056,0.297603736770026,0.910047050160513,2,15,RNA polymerase III activity,MF,CRCP;POLR3H
4420,GO:0010224,0.297721126031996,0.910568015525039,2,14,response to UV-B,BP,TP53;CDKN1A
2083,GO:0004843,0.298328401783122,0.826953819365643,7,70,thiol-dependent ubiquitin-specific protease activity,MF,CYLD;ZC3H12A;USP36;USP43;USP31;TNFAIP3;OTUD6A
7334,GO:0031344,0.29836896667814,0.760129887224778,37,436,regulation of cell projection organization,BP,NRG1;MAP2;FN1;NEFL;TENM3;CYLD;LYN;BAIAP2;EFNB2;CORO1C;ENC1;PDPN;EPHA2;ICAM1;L1CAM;MYO10;CDC42EP2;TNFRSF12A;SFRP1;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;SEMA3C;RCC2;YWHAH;PQBP1;RHOG;ZNF365;ZSWIM6;BMP7;RAPGEF1;EFNA1;BIN3
11835,GO:0046782,0.298495944838036,0.835438451638969,6,60,regulation of viral transcription,BP,NELFE;SUPT5H;JUN;PSMC3;POLR2G;CCL5
3661,GO:0008143,0.29860950976369,0.910118837211882,2,14,poly(A) binding,MF,PABPC4;HNRNPU
5540,GO:0016529,0.298712419463367,0.860639078795885,4,36,sarcoplasmic reticulum,CC,P3H2;JPH2;JPH1;NOL3
3241,GO:0006896,0.298924594224342,0.909959276837489,2,14,Golgi to vacuole transport,BP,LAMP1;VPS52
17648,GO:1901385,0.299097751447972,0.909871533479491,2,14,regulation of voltage-gated calcium channel activity,BP,RRAD;STAC
15599,GO:0072078,0.299444961782034,0.845879037138978,5,47,nephron tubule morphogenesis,BP,IRX2;PBX1;BMP2;NPNT;WNT4
15799,GO:0072431,0.299506683477418,0.834696499539906,6,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
17983,GO:1902400,0.299506683477418,0.834696499539906,6,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
16232,GO:0090279,0.299710790383987,0.90956057303359,2,14,regulation of calcium ion import,BP,LGALS3;PDGFB
4386,GO:0010039,0.299749881235457,0.879682117276325,3,25,response to iron ion,BP,CYP1A1;G6PD;ACO1
18352,GO:1903322,0.299803544824062,0.807248143438083,10,107,positive regulation of protein modification by small protein conjugation or removal,BP,BIRC3;UBE2C;ZC3H12A;ADRB2;RPS2;PTTG1IP;SMAD7;DCUN1D2;HSPBP1;ARRDC3
1703,GO:0004190,0.299840155356393,0.909494890153697,2,14,aspartic-type endopeptidase activity,MF,BACE2;SPPL2A
14519,GO:0070001,0.299840155356393,0.909494890153697,2,14,aspartic-type peptidase activity,MF,BACE2;SPPL2A
10230,GO:0042921,0.300248994652308,0.9092871639747,2,14,glucocorticoid receptor signaling pathway,BP,YWHAH;RBM14
3285,GO:0006972,0.300392685477379,0.909214104148622,2,14,hyperosmotic response,BP,ERRFI1;XRCC6
744,GO:0001974,0.300419200557876,0.879274744676917,3,25,blood vessel remodeling,BP,LIF;SEMA3C;NOL3
13046,GO:0051536,0.300427254893304,0.83393006003903,6,61,iron-sulfur cluster binding,MF,RSAD2;CDKAL1;ACO1;POLA1;CISD3;BRIP1
13050,GO:0051540,0.300427254893304,0.83393006003903,6,61,metal cluster binding,MF,RSAD2;CDKAL1;ACO1;POLA1;CISD3;BRIP1
18571,GO:1903798,0.300496351871108,0.909161377914413,2,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A;ESR1
11914,GO:0046949,0.300966998363511,0.878940925784077,3,25,fatty-acyl-CoA biosynthetic process,BP,SCD;ACSL1;SCD5
9095,GO:0035357,0.30100919832577,0.908900328436526,2,14,peroxisome proliferator activated receptor signaling pathway,BP,CITED2;ACTN4
12251,GO:0048525,0.301228154741639,0.824614307701053,7,72,negative regulation of viral process,BP,PML;RSAD2;TNF;ZC3H12A;BANF1;JUN;CCL5
16222,GO:0090263,0.301229260540105,0.805986615837519,10,110,positive regulation of canonical Wnt signaling pathway,BP,DAPK3;NFKB1;FGFR2;PSMB9;SFRP1;PSME2;JRK;BAMBI;WNT4;PSMC3
12916,GO:0051262,0.301513910035931,0.805503631929259,10,117,protein tetramerization,BP,SOD2;TP53;TK1;AASS;RCC1;DCXR;XRCC6;HSD17B10;TP63;CCL5
10165,GO:0042749,0.301739147366971,0.958319462551577,1,5,regulation of circadian sleep/wake cycle,BP,CSF2
11142,GO:0045187,0.301739147366971,0.958319462551577,1,5,regulation of circadian sleep/wake cycle, sleep,BP,CSF2
9464,GO:0036066,0.30186977856758,0.908461496330312,2,14,protein O-linked fucosylation,BP,LFNG;SLC35C2
12814,GO:0051119,0.301949025373658,0.90842103724257,2,14,sugar transmembrane transporter activity,MF,M6PR;SLC2A6
7465,GO:0031623,0.302113616633274,0.832871710737519,6,59,receptor internalization,BP,ADM;TFRC;UBQLN2;SYK;ACKR3;CXCL8
1383,GO:0003283,0.302279491211581,0.908252230182429,2,14,atrial septum development,BP,CYR61;TGFB2
13485,GO:0055022,0.302511669120385,0.908133543982253,2,14,negative regulation of cardiac muscle tissue growth,BP,G6PD;MAPK11
14203,GO:0061117,0.302511669120385,0.908133543982253,2,14,negative regulation of heart growth,BP,G6PD;MAPK11
8637,GO:0034162,0.302526292884173,0.908126066132521,2,14,toll-like receptor 9 signaling pathway,BP,RSAD2;TNIP2
18709,GO:1904115,0.30274403181557,0.857765391795812,4,37,axon cytoplasm,CC,NEFL;HSPB1;DST;BLOC1S2
14204,GO:0061133,0.302819408397394,0.957997233367358,1,5,endopeptidase activator activity,MF,PSME2
13572,GO:0060039,0.302834831010342,0.907968229656689,2,14,pericardium development,BP,BMP2;BMP7
13209,GO:0051851,0.30311260766946,0.843156100338239,5,48,modification by host of symbiont morphology or physiology,BP,ZC3H12A;HSPA8;JUN;PSMC3;CCL5
10716,GO:0044030,0.30315125784976,0.907806227185168,2,14,regulation of DNA methylation,BP,MPHOSPH8;PARP1
13222,GO:0051882,0.303325017507688,0.907120611838444,2,15,mitochondrial depolarization,BP,GCLC;PARP1
16907,GO:0098868,0.303364107591368,0.907697179235232,2,14,bone growth,BP,FGFR2;COL27A1
16061,GO:0089701,0.303464042366478,0.957804261594647,1,5,U2AF,CC,U2AF2
3628,GO:0008088,0.303504102415424,0.842878148069231,5,48,axo-dendritic transport,BP,NEFL;HSPB1;DST;HSPA8;BLOC1S2
1150,GO:0002758,0.303561051708327,0.780944041122678,17,195,innate immune response-activating signal transduction,BP,CYLD;RELB;IKBKE;BIRC3;RSAD2;TRAF3;NFKB1;LYN;PSMB9;IRF1;PSME2;NFKBIA;SYK;TNIP2;ESR1;TNFAIP3;PSMC3
246,GO:0000702,0.303701224152846,0.957733132011062,1,5,oxidized base lesion DNA N-glycosylase activity,MF,SMUG1
9871,GO:0042130,0.303833406253617,0.857216257079229,4,36,negative regulation of T cell proliferation,BP,SDC4;CD274;TNFRSF21;GPNMB
8692,GO:0034312,0.30416536414366,0.90668712912403,2,15,diol biosynthetic process,BP,DHFR;QDPR
11734,GO:0046545,0.304199544118247,0.822430584545367,7,71,development of primary female sexual characteristics,BP,INHBA;LFNG;ICAM1;SFRP1;ZFP42;ESR1;WNT4
11437,GO:0045862,0.304257938875384,0.767884791603515,24,281,positive regulation of proteolysis,BP,CYR61;FN1;CTGF;PML;UBQLN2;LYN;TNF;CLN6;ZC3H12A;RNF19B;PSME2;GPER1;TRAF2;ROBO1;MYH9;SMAD7;KEAP1;TRIB1;HSPBP1;TNFRSF10A;PSMC3;EFNA1;RNF144B;GCLC
8673,GO:0034243,0.304453165375239,0.876807890762679,3,25,regulation of transcription elongation from RNA polymerase II promoter,BP,NELFE;HNRNPU;SUPT16H
13238,GO:0051901,0.305283695018124,0.957256778702938,1,5,positive regulation of mitochondrial depolarization,BP,PARP1
10428,GO:0043271,0.305674095028491,0.821308013890367,7,71,negative regulation of ion transport,BP,MMP9;ICAM1;IRS2;NEDD4L;RRAD;CAB39;OXSR1
2878,GO:0006376,0.30570444062467,0.87603865476791,3,25,mRNA splice site selection,BP,LUC7L;SF1;NOL3
540,GO:0001658,0.305947942652,0.855794250294853,4,36,branching involved in ureteric bud morphogenesis,BP,PBX1;BMP2;NPNT;WNT4
10027,GO:0042471,0.306093347409528,0.829931407120249,6,59,ear morphogenesis,BP,MAFB;EDN1;FGFR2;OSR2;NTN1;INSIG1
2535,GO:0005791,0.306286214541765,0.82951380593305,6,62,rough endoplasmic reticulum,CC,EDN1;BAIAP2;CDKAL1;ZC3H12A;TRAM2;TP63
18310,GO:1903232,0.30681227573219,0.956793704473358,1,5,melanosome assembly,BP,RAB32
14131,GO:0060997,0.306993155473294,0.855089483743102,4,36,dendritic spine morphogenesis,BP,BAIAP2;DOCK10;ZNF365;EFNA1
713,GO:0001938,0.307064779459642,0.829116256112333,6,60,positive regulation of endothelial cell proliferation,BP,BMP2;STAT5A;ADAM17;PRKCA;PDGFB;JUN
19286,GO:1905521,0.307100424859341,0.905165777904469,2,15,regulation of macrophage migration,BP,MTUS1;CCL5
15790,GO:0072401,0.307194947784803,0.820074518535238,7,72,signal transduction involved in DNA integrity checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;PRPF19;TFDP1
15794,GO:0072422,0.307194947784803,0.820074518535238,7,72,signal transduction involved in DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;PRPF19;TFDP1
1481,GO:0003777,0.307221955345663,0.812827651430733,8,82,microtubule motor activity,MF,MYO1B;KIF23;MYO10;WDR34;MYH9;KIF24;KIF22;MYO1E
6010,GO:0019058,0.30738017252306,0.768140459276758,22,255,viral life cycle,BP,PML;TFRC;RSAD2;LAMP1;TNF;EFNB2;NUP153;ZC3H12A;EPHA2;ICAM1;ITGAV;NMT2;BANF1;NEDD4L;NUP214;HSPA8;CHMP4B;DAG1;CXCL8;SNF8;HSP90AB1;CCL5
9324,GO:0035795,0.307392595650873,0.956617141117033,1,5,negative regulation of mitochondrial membrane permeability,BP,NOL3
19345,GO:1905709,0.307392595650873,0.956617141117033,1,5,negative regulation of membrane permeability,BP,NOL3
7425,GO:0031526,0.307510560762388,0.874924935350427,3,25,brush border membrane,CC,B4GALT1;SLC5A6;HSP90AB1
16839,GO:0098742,0.307829193064021,0.800842889179512,10,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM3;PCDH7;TGFB2;ICAM1;BMP2;ROBO1;AJUBA;SDK1;MYADM;CLDN7
18618,GO:1903901,0.307880165065721,0.828418890771099,6,61,negative regulation of viral life cycle,BP,PML;RSAD2;TNF;ZC3H12A;BANF1;CCL5
15274,GO:0071453,0.308348283348156,0.781881012268366,15,172,cellular response to oxygen levels,BP,EDN1;TP53;PSMB9;ICAM1;PGK1;SFRP1;PSME2;EGR1;ZFP36L1;AJUBA;CITED2;BMP7;PSMC3;BRIP1;NOL3
12783,GO:0051058,0.308389427748668,0.839526877158681,5,47,negative regulation of small GTPase mediated signal transduction,BP,TGFB2;TNK1;SPRY4;RAPGEF1;CGNL1
12797,GO:0051091,0.308610529120551,0.779080796563405,16,181,positive regulation of DNA binding transcription factor activity,BP,TRAF1;EDN1;NFKB1;TNF;NFKB2;FOSL1;ICAM1;TRIM22;SRF;NFKBIA;RIPK4;PPRC1;TRAF2;NFKBIB;ROR1;ESR1
10064,GO:0042554,0.308661033690046,0.904352207934628,2,15,superoxide anion generation,BP,EDN1;SYK
7060,GO:0030838,0.308749690724501,0.818886142774836,7,72,positive regulation of actin filament polymerization,BP,ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;RHOG;BAIAP2L2
11961,GO:0047134,0.308996077262044,0.95612710276905,1,5,protein-disulfide reductase activity,MF,PGK1
17426,GO:1900180,0.309109647330256,0.811291990524386,8,83,regulation of protein localization to nucleus,BP,CDKN1A;ZC3H12A;CHP1;LIF;TRIM29;POLR1A;CARD10;HSP90AB1
3617,GO:0008064,0.309193457209233,0.790993359665504,12,132,regulation of actin polymerization or depolymerization,BP,ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;WDR1;SPTBN1;RHOG;KANK4;MYADM;SWAP70;BAIAP2L2
17041,GO:0099516,0.30987846434685,0.853137556602447,4,36,ion antiporter activity,MF,SLC4A11;SLC22A4;SLC4A2;SLC3A2
20288,GO:2001268,0.310066004994677,0.955798342246616,1,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9
7526,GO:0031730,0.31012049219666,0.955781561560913,1,5,CCR5 chemokine receptor binding,MF,CCL5
5349,GO:0016101,0.31012445829892,0.838153385033773,5,48,diterpenoid metabolic process,BP,CYP1B1;CYP1A1;SDC4;HSPG2;AKR1C1
2673,GO:0006024,0.31031100939977,0.810412926516707,8,82,glycosaminoglycan biosynthetic process,BP,SDC4;B4GALT1;NFKB1;HSPG2;HS3ST2;HS3ST1;PDGFB;CHST3
7782,GO:0032306,0.310564127367704,0.955644795162423,1,5,regulation of prostaglandin secretion,BP,EDN1
7783,GO:0032308,0.310564127367704,0.955644795162423,1,5,positive regulation of prostaglandin secretion,BP,EDN1
12279,GO:0048588,0.310696223554385,0.786194586514443,13,142,developmental cell growth,BP,NRG1;FN1;EDN1;G6PD;L1CAM;TNFRSF12A;ZFYVE27;SRF;VCL;NTN1;NEDD4L;SEMA3C;SORBS2
3479,GO:0007339,0.311341520704054,0.902947287296287,2,15,binding of sperm to zona pellucida,BP,B4GALT1;UBAP2L
17895,GO:1902177,0.311696624049898,0.95529454733279,1,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SFPQ
17724,GO:1901653,0.311832343192563,0.76425624433562,22,254,cellular response to peptide,BP,HDAC9;FBN1;EDN1;TP53;NFKB1;IRS1;LYN;BAIAP2;CDK4;ERRFI1;STAT5A;ADRB2;GPER1;ZFP36L1;IRS2;KLF10;SOCS1;TIMELESS;BRIP1;GCLC;PARP1;BAIAP2L2
12912,GO:0051258,0.311996203632297,0.771513487245048,18,206,protein polymerization,BP,MAP2;NEFL;COBLL1;ARPC4;BAIAP2;UBE2C;ICAM1;CDC42EP2;ARPC1B;SPTBN1;DCTN1;SLAIN2;CLASP1;RHOG;KANK4;MYADM;GPX4;BAIAP2L2
2699,GO:0006064,0.31206369917725,0.95518067750586,1,5,glucuronate catabolic process,BP,DCXR
6190,GO:0019640,0.31206369917725,0.95518067750586,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,DCXR
12849,GO:0051167,0.31206369917725,0.95518067750586,1,5,xylulose 5-phosphate metabolic process,BP,DCXR
17565,GO:1901159,0.31206369917725,0.95518067750586,1,5,xylulose 5-phosphate biosynthetic process,BP,DCXR
14870,GO:0070646,0.312416681673081,0.763695933266768,22,258,protein modification by small protein removal,BP,CYLD;BIRC3;TRAF3;TP53;PSMB9;ZC3H12A;ADRB2;USP36;PSME2;NFKBIA;TRAF2;SENP3;USP43;COPS3;TNIP2;SMAD7;KEAP1;ESR1;USP31;TNFAIP3;PSMC3;OTUD6A
7404,GO:0031467,0.312449925289665,0.95506068469269,1,5,Cul7-RING ubiquitin ligase complex,CC,RNF7
10886,GO:0044425,0.312552232535178,0.7131716129071,290,3690,membrane part,CC,HEPHL1;CRYAB;NRG1;PTGER4;S100P;FN1;PLD5;CYP1B1;TENM3;C1QTNF1;SLC16A2;AMOT;JPH2;CYP1A1;TAP1;IL1R2;PML;CYLD;PCDH7;SDC4;FADS3;TFRC;GPRC5A;UGT1A6;CD83;HLA-B;PTGES;TMPPE;BIRC3;DAPK3;B4GALT1;MGAM;RSAD2;G6PD;TRAF3;EMP2;PANX1;SIPA1L3;NFE2L1;MARVELD3;STEAP4;IL27RA;GNPTAB;LFNG;IRS1;GALNT18;HSPG2;LYN;STOML1;LAMP1;HS3ST2;EHD1;TNF;BAIAP2;EFNB2;CORO1C;CXCL16;PKMYT1;SCD;WWC1;DST;VMP1;PDPN;FGFR2;CDKAL1;BACE2;LSS;SLC7A5;CLN6;EPHB6;FOSL1;LAYN;SLC16A9;SIRPA;JPH1;SLC39A1;ZC3H12A;LCP1;CYB5R1;TNK1;FAM69B;CADPS2;EPHA2;ICAM1;CD274;BMP2;GOSR1;SLCO3A1;SLC7A5P2;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;MYO10;GGCX;TMEM183B;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ADRB2;SVIL;TMEM14EP;TNFRSF12A;IFNGR1;SLC5A6;FXYD3;PGK1;EBP;NMT2;ST6GALNAC5;AMOTL2;RELT;SFRP1;PARL;ABCF2;TPM1;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;ABHD4;EPPK1;IL7R;THBD;GPER1;DNAJB2;HS3ST1;AP4S1;PARD3B;IGSF3;KCNA7;SGK1;FAM57A;CYP4B1;RHOB;ADAM17;SNX12;UPK3B;IER3;LGALS3;TRAF2;ABCG2;IL15;REEP1;PRKCA;GPR132;SYK;CMTM3;FAM74A7;SLC7A2;ROBO1;SLC43A3;PDGFB;BCAM;OXTR;PTTG1IP;SPTBN1;SERPINH1;DCTN1;COX5B;DCBLD1;MYH9;SPPL2A;TAPBPL;TMEM159;COL17A1;NPNT;SDK1;GLIPR1;GPR75;TNFRSF21;SNX8;ERVV-1;SPRY4;LILRB3;ZW10;ROR1;PXMP2;ACSL1;ACKR3;BAMBI;TMEM140;TRAM2;SMAD7;SLC35A4;SLC35C2;SLC43A2;DNAJC1;TAPBP;TRIP6;M6PR;ZDHHC6;TJP1;CHST3;APH1A;UBE2J2;VSIG1;TPST1;CREB3;PPP1R9B;SLC4A11;MTFP1;LPCAT3;KCNIP3;RHBDL2;SUSD6;PCYT1A;GALNT2;ATG101;MARVELD2;CD109;STAC;FRAS1;HSPA8;PIGM;ESR1;MANEAL;SLC22A4;HCAR3;CPT1A;SCD5;BCS1L;CHMP4B;CCR6;INSIG1;PARD3;SMIM17;RHOG;GPNMB;GP6;TAP2;CHCHD6;SMPD2;CNTNAP1;EFNB1;THEM4;SORBS2;LRFN4;PHLPP1;TNFRSF10A;TPRA1;TOMM40;CYP20A1;ZYX;EIF5A;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;PDE6A;MGAT2;RNF185;RAB27A;DPM3;TUBB;CYTH1;CD38;CYB561D2;SLC4A2;PPP2R1B;EFNA1;CLDN7;SLC3A2;SLC25A22;PTPRB;RNF144B;SLC25A44;CLTA;SNF8;LRRC59;HSP90AB1;TBXA2R;MCAM;ADGRF3;IL6R;LAIR1;FAM74A3;SLC2A6;TXNDC15;ARIH2OS;TMEM51;BAIAP2L2;FADS1;SH3BP4
4801,GO:0010994,0.312604354163428,0.955012654386086,1,5,free ubiquitin chain polymerization,BP,UBE2C
17111,GO:0101003,0.312785671029572,0.850973078203986,4,37,ficolin-1-rich granule membrane,CC,MGAM;LAMP1;SIRPA;LGALS3
3551,GO:0007585,0.31313629006967,0.85073385265054,4,37,respiratory gaseous exchange,BP,MAFB;EDN1;COX5B;TRAF4
16845,GO:0098751,0.313245026844999,0.871362335628984,3,25,bone cell development,BP,FBN1;TJP2;SRF
11483,GO:0045940,0.313507611961458,0.901805005510799,2,15,positive regulation of steroid metabolic process,BP,TNF;WNT4
15107,GO:0071156,0.313545484306128,0.801443146652673,9,97,regulation of cell cycle arrest,BP,PML;TP53;CDKN1A;GADD45A;CDK4;SFN;GPER1;TFDP1;HSP90AB1
15792,GO:0072413,0.313632570661,0.824127672196746,6,61,signal transduction involved in mitotic cell cycle checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
17984,GO:1902402,0.313632570661,0.824127672196746,6,61,signal transduction involved in mitotic DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
17985,GO:1902403,0.313632570661,0.824127672196746,6,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
6289,GO:0019899,0.313710712258809,0.718986700860564,146,1825,enzyme binding,MF,NRG1;HDAC9;FN1;NEFL;ACTG1;CYP1A1;PML;CYLD;HSPB1;TRAF1;SDC4;RELB;CSF2;SH3RF2;GBP1;IKBKE;MID1;DAPK3;TRAF3;EMP2;PANX1;TP53;SQSTM1;MARVELD3;CDKN2B;IRS1;CDKN1A;LYN;ARPC4;LAMP1;EHD1;GADD45A;TNF;CDKN2A;CORO1C;WWC1;TRIO;FGFR2;PTPN14;DNAJB1;EPHB6;TELO2;UBE2C;FLNA;SRSF2;LCP1;EPHA2;CHP1;UBE4B;ITGAV;ERRFI1;SFN;CDC42EP2;RNF19B;ADRB2;DAXX;NAT10;SERPINE1;MCM2;AKAP8L;TRIM22;PPP1R3B;PDE4DIP;BANF1;SRF;ABTB2;NFKBIA;EGR1;DOCK10;ETS1;ARHGEF28;AKAP8;RHOB;SNX12;U2AF2;FGFR1OP;VCL;IRS2;CBX5;TRAF2;PRKCA;SYK;PDGFB;BRMS1;RPS2;POLA1;NSFL1C;SPTBN1;DCTN1;TNIP2;RASGRP4;RUNDC1;SFPQ;ROR1;RCC2;NOP56;SMAD7;SUPT5H;MTA2;YWHAH;TRIP6;HNRNPU;UBE2J2;TRIB1;DCUN1D2;RUVBL2;PPP1R9B;PARP14;CAB39;CITED2;SOCS1;HSPA8;JUN;ESR1;TCOF1;RCC1;GTF2E1;TRAPPC5;NOP14;HERC2;PARD3;RHOG;TNFRSF10A;MPHOSPH8;SGSM1;RAPGEF1;IPO4;RNF185;BLNK;RILPL2;VPS52;TRAF4;TUBB;CYTH1;TNFAIP3;SLC4A2;METTL21A;RNF144B;CLTA;NOL3;HSP90AB1;TBXA2R;IL6R;PARP1;PHACTR4;SH3BP4
6291,GO:0019901,0.31383506949244,0.741538376001141,44,525,protein kinase binding,MF,NRG1;HDAC9;CYLD;HSPB1;SDC4;RELB;TRAF3;EMP2;TP53;SQSTM1;MARVELD3;CDKN2B;IRS1;CDKN1A;CDKN2A;FGFR2;PTPN14;EPHB6;TELO2;SRSF2;EPHA2;ITGAV;ERRFI1;SFN;DAXX;TRIM22;RHOB;FGFR1OP;IRS2;TRAF2;SYK;POLA1;DCTN1;TNIP2;ROR1;RCC2;TRIB1;SOCS1;ESR1;RHOG;BLNK;TRAF4;HSP90AB1;PARP1
5596,GO:0016627,0.314679637295935,0.83474795450035,5,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,ACAA1;DHCR7;AKR1C2;DUS2;AKR1C1
14524,GO:0070011,0.314700859294384,0.751460365223908,30,356,peptidase activity, acting on L-amino acid peptides,MF,MMP9;C1R;CYLD;PRSS23;CPA4;MPND;ADAMTS9;BACE2;PSMB9;C9ORF3;ZC3H12A;USP36;SFRP1;PARL;DNPEP;ADAM17;SENP3;USP43;PREP;SPPL2A;APH1A;CAPNS1;RHBDL2;USP31;OVCH2;TINAGL1;TNFAIP3;XPNPEP3;OTUD6A;C1S
10631,GO:0043628,0.314706080060434,0.869865726491414,3,27,ncRNA 3'-end processing,BP,USB1;DKC1;HSD17B10
2671,GO:0006022,0.314940894221783,0.790408038973147,11,118,aminoglycan metabolic process,BP,SDC4;B4GALT1;NFKB1;HSPG2;HS3ST2;CLN6;CHP1;HS3ST1;IL15;PDGFB;CHST3
7854,GO:0032414,0.315089540232596,0.83445176637182,5,49,positive regulation of ion transmembrane transporter activity,BP,JPH2;CHP1;ADRB2;STAC;ACTN4
4621,GO:0010739,0.315134717962527,0.954221399359623,1,5,positive regulation of protein kinase A signaling,BP,ADRB2
918,GO:0002313,0.315726260269695,0.900628540573921,2,15,mature B cell differentiation involved in immune response,BP,LFNG;DOCK10
10493,GO:0043393,0.315949409562021,0.775475184139505,15,170,regulation of protein binding,BP,NRG1;MMP9;CYLD;LFNG;GNL3L;BMP2;ADRB2;TFIP11;DNAJB2;TRAF2;PDGFB;BAMBI;RUVBL2;TRAF4;HSP90AB1
18354,GO:1903333,0.31595366096966,0.95396358746364,1,5,negative regulation of protein folding,BP,SNRNP70
859,GO:0002190,0.316275057129957,0.953862177563335,1,5,cap-independent translational initiation,BP,RBM4
2571,GO:0005856,0.316426678263809,0.718435545643723,126,1566,cytoskeleton,CC,KRT1;SAA1;CRYAB;KRT2;MAP2;NEFL;KRT34;KRT15;AMOT;KRT4;NEFM;ACTG1;TAP1;CYLD;HSPB1;PDLIM1;KRT10;KRT13;RELB;MID1;DAPK3;KRTAP2-3;NUAK1;KLHL21;NLRC5;SIPA1L3;KRT9;NEDD9;KRT6A;MYO1B;ARPC4;BAIAP2;KRT5;CORO1C;ENC1;DST;PTPN14;TPM4;KRT17;ZC3H12A;FLNA;LCP1;CHP1;CCDC85B;KIF23;MYO10;CDC42EP2;SVIL;PLEKHA7;MTUS1;ARPC1B;MCM2;CCDC124;TPM1;CC2D2A;WDR1;PDE4DIP;EPPK1;GPER1;NSUN2;PRPF19;ADAM17;FGFR1OP;VCL;KRT14;AJUBA;FILIP1;CEP95;IFFO2;PHAX;WDR34;NSFL1C;SPTBN1;DCTN1;DPYSL3;TCP11L1;SLAIN2;MYH9;LANCL2;SAP30BP;TBCCD1;ZW10;ROR1;RCC2;SMAD7;NOL9;CCDC6;TRIP6;ENAH;KEAP1;SPECC1;HNRNPU;TJP1;CLASP1;CEP41;RUVBL2;PPP1R9B;MICAL3;BLOC1S2;DCXR;HERC2;CNTROB;PARD3;RHOG;ZNF365;ACTN4;SORBS2;KIF24;KANK4;PHLDB2;INCENP;ZYX;KIF22;MYADM;DAG1;CGNL1;POLR3H;RILPL2;TRAF4;TUBB;MYO1E;CLTA;SWAP70;TTLL5;BIN3;BAIAP2L2
10627,GO:0043624,0.316860521453906,0.774512804458101,15,179,cellular protein complex disassembly,BP,MID1;WDR1;SPTBN1;MRPS12;MRPS24;ERAL1;CLASP1;MICAL3;MRPL20;HSPA8;MRPL33;KIF24;EIF5A;MRPS2;SWAP70
11789,GO:0046653,0.317353885072242,0.899761306716938,2,15,tetrahydrofolate metabolic process,BP,TYMS;DHFR
14999,GO:0070920,0.317359261564604,0.899758436157989,2,15,regulation of production of small RNA involved in gene silencing by RNA,BP,ZC3H12A;ESR1
7495,GO:0031666,0.317466979098532,0.953484952845972,1,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,PRKCA
16206,GO:0090237,0.317517455427948,0.953468938258316,1,5,regulation of arachidonic acid secretion,BP,SYK
8279,GO:0033081,0.317536095793052,0.899664001265302,2,15,regulation of T cell differentiation in thymus,BP,IL7R;FOXN1
18050,GO:1902581,0.317636980409895,0.953431003809323,1,5,multi-organism cellular localization,BP,NUP153
18051,GO:1902583,0.317636980409895,0.953431003809323,1,5,multi-organism intracellular transport,BP,NUP153
11301,GO:0045618,0.317639153159115,0.899608946259451,2,15,positive regulation of keratinocyte differentiation,BP,TRIM16;IL20
12167,GO:0048285,0.318182277666647,0.74835083319648,30,354,organelle fission,BP,MYBL2;EDN1;BIRC3;DAPK3;PKMYT1;UBE2C;FLNA;KIF23;EPGN;AKAP8L;LIF;RRS1;AKAP8;PDGFB;IL1A;ZW10;HNRNPU;CLASP1;PPP1R9B;MTFP1;ANAPC15;DUSP1;RCC1;CHMP4B;BMP7;KIF22;WNT4;BRIP1;CDCA5;MKI67
16182,GO:0090200,0.318437625125243,0.86751058804571,3,27,positive regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;GPER1
4375,GO:0010001,0.31845106005061,0.783312069848986,12,132,glial cell differentiation,BP,NRG1;LYN;BMP2;LIF;WDR1;PRPF19;TNFRSF21;ROR1;PARD3;ZNF365;CNTNAP1;DAG1
10407,GO:0043242,0.318550967349764,0.832072919064188,5,48,negative regulation of protein complex disassembly,BP,MID1;TNF;SPTBN1;CLASP1;SWAP70
7054,GO:0030832,0.318658414471373,0.783107687901526,12,133,regulation of actin filament length,BP,ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;WDR1;SPTBN1;RHOG;KANK4;MYADM;SWAP70;BAIAP2L2
13898,GO:0060541,0.318712204769843,0.783126577991045,12,131,respiratory system development,BP,CTGF;TNS3;TNF;TNC;PDPN;FGFR2;ERRFI1;LIF;DHCR7;SRF;DAG1;TIMELESS
1115,GO:0002704,0.318729162109458,0.867609592960659,3,26,negative regulation of leukocyte mediated immunity,BP,IL7R;SMAD7;THOC1
7410,GO:0031492,0.318778350608813,0.846049251411297,4,42,nucleosomal DNA binding,MF,MTA2;RCC1;HMGN2;SMARCC2
8468,GO:0033605,0.318939077843562,0.953016577048024,1,5,positive regulation of catecholamine secretion,BP,OXTR
20289,GO:2001269,0.319061070313476,0.898847888775532,2,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TRAF2;TNFRSF10A
1872,GO:0004540,0.319076595829704,0.803272970381479,8,86,ribonuclease activity,MF,USB1;NOCT;ZC3H12A;POP1;FEN1;ISG20L2;NOB1;POP4
13018,GO:0051453,0.319212294460934,0.819934130144071,6,61,regulation of intracellular pH,BP,TP53;CLN6;CHP1;SLC4A11;TMEM165;SLC4A2
3306,GO:0007006,0.319638880682688,0.796456260750624,9,99,mitochondrial membrane organization,BP,TP53;SFN;YWHAH;BLOC1S2;TFDP1;CHCHD6;THEM4;NOL3;TP63
1405,GO:0003339,0.319733712701292,0.952762607937532,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
12227,GO:0048484,0.319733712701293,0.952762607937532,1,5,enteric nervous system development,BP,PHACTR4
656,GO:0001846,0.319905984786042,0.952707443273033,1,5,opsonin binding,MF,ITGAV
10468,GO:0043330,0.320079649785835,0.866754022360435,3,26,response to exogenous dsRNA,BP,NFKBIA;PQBP1;SLC3A2
15788,GO:0072395,0.320119907379296,0.810052662933622,7,73,signal transduction involved in cell cycle checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;PRPF19;TFDP1
12006,GO:0047485,0.320321899709578,0.7960020698795,9,97,protein N-terminus binding,MF,TP53;GADD45A;DAXX;APTX;BANF1;ACTN4;EIF5A;SNF8;PARP1
939,GO:0002349,0.320323218091011,0.952573681380547,1,5,histamine production involved in inflammatory response,BP,LYN
984,GO:0002441,0.320323218091011,0.952573681380547,1,5,histamine secretion involved in inflammatory response,BP,LYN
1039,GO:0002553,0.320323218091011,0.952573681380547,1,5,histamine secretion by mast cell,BP,LYN
5264,GO:0015909,0.320368386235914,0.845768431247219,4,37,long-chain fatty acid transport,BP,IRS2;SYK;ACSL1;CPT1A
1148,GO:0002756,0.320626443259204,0.866406976808547,3,26,MyD88-independent toll-like receptor signaling pathway,BP,IKBKE;BIRC3;TRAF3
8003,GO:0032627,0.320841167402429,0.952407322923944,1,5,interleukin-23 production,BP,CSF2
8027,GO:0032667,0.320841167402429,0.952407322923944,1,5,regulation of interleukin-23 production,BP,CSF2
16532,GO:0097255,0.320898448933633,0.952388903907054,1,5,R2TP complex,CC,RUVBL2
2084,GO:0004844,0.320904818684758,0.952386855440106,1,5,uracil DNA N-glycosylase activity,MF,SMUG1
16647,GO:0097506,0.320904818684758,0.952386855440106,1,5,deaminated base DNA N-glycosylase activity,MF,SMUG1
8161,GO:0032890,0.320922492336154,0.866218923530981,3,26,regulation of organic acid transport,BP,EDN1;IRS2;SYK
1382,GO:0003281,0.320929001528347,0.830343465322051,5,48,ventricular septum development,BP,CYR61;TGFB2;FGFR2;SMAD7;CITED2
7376,GO:0031428,0.321018417715555,0.952350314126497,1,5,box C/D snoRNP complex,CC,NOP56
8802,GO:0034502,0.321079675841144,0.809381973892195,7,72,protein localization to chromosome,BP,GNL3L;DKC1;ZW10;RCC2;RUVBL2;ESR1;CDCA5
19697,GO:2000020,0.32111641524762,0.952318778144655,1,5,positive regulation of male gonad development,BP,CITED2
14697,GO:0070317,0.321138949346616,0.845235892397769,4,37,negative regulation of G0 to G1 transition,BP,RING1;CBX5;TFDP1;RRM2
8977,GO:0035066,0.321183814951582,0.866052839388372,3,26,positive regulation of histone acetylation,BP,LIF;SNAI2;RUVBL2
15142,GO:0071241,0.321260348462329,0.785086756192493,11,121,cellular response to inorganic substance,BP,MMP9;NQO1;CYP1A1;EDN1;JUNB;DAXX;FUS;TRAF2;JUN;TIMELESS;PARP1
13530,GO:0055106,0.321263054420452,0.897100878134742,2,16,ubiquitin-protein transferase regulator activity,MF,RING1;TRIB1
9393,GO:0035930,0.321528037736258,0.952186182960885,1,5,corticosteroid hormone secretion,BP,C1QTNF1
20145,GO:2000846,0.321528037736258,0.952186182960885,1,5,regulation of corticosteroid hormone secretion,BP,C1QTNF1
9253,GO:0035655,0.321594903935858,0.952164623110131,1,5,interleukin-18-mediated signaling pathway,BP,PDGFB
15206,GO:0071351,0.321594903935858,0.952164623110131,1,5,cellular response to interleukin-18,BP,PDGFB
12069,GO:0048017,0.321655602575417,0.789570219004917,10,107,inositol lipid-mediated signaling,BP,NRG1;TGFB2;EDN1;IRS1;GPER1;ZFP36L1;IRS2;IER3;PDGFB;CCL5
17178,GO:0102991,0.321657016459403,0.952144590898813,1,5,myristoyl-CoA hydrolase activity,MF,THEM4
3432,GO:0007220,0.321719692508068,0.897417670284627,2,15,Notch receptor processing,BP,ADAM17;APH1A
12708,GO:0050926,0.32191072409803,0.897314540584395,2,15,regulation of positive chemotaxis,BP,IL16;CXCL8
9227,GO:0035613,0.322072706266965,0.897227055223214,2,15,RNA stem-loop binding,MF,ZC3H12A;METTL16
9560,GO:0036336,0.322221426708044,0.897146701560337,2,15,dendritic cell migration,BP,CCR6;CCL5
15601,GO:0072080,0.322378305249417,0.817637227189898,6,60,nephron tubule development,BP,IRX2;PBX1;BMP2;LIF;NPNT;WNT4
14508,GO:0062013,0.322587209503112,0.794224528531397,9,96,positive regulation of small molecule metabolic process,BP,ADM;NFKB1;IRS1;TNF;GPER1;IRS2;PDGFB;CPT1A;WNT4
16181,GO:0090199,0.322824623594517,0.843710596458515,4,39,regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;GPER1;NOL3
12258,GO:0048538,0.323126945392191,0.843858883475322,4,37,thymus development,BP,MAFB;PBX1;SRF;FOXN1
18557,GO:1903772,0.323326350353088,0.951604363479131,1,5,regulation of viral budding via host ESCRT complex,BP,SNF8
14029,GO:0060754,0.323404860355281,0.951578868619939,1,5,positive regulation of mast cell chemotaxis,BP,SWAP70
8447,GO:0033567,0.323452959866603,0.951563245187812,1,5,DNA replication, Okazaki fragment processing,BP,FEN1
9694,GO:0038089,0.323527769526824,0.951538940030207,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,HSPB1
837,GO:0002138,0.323559450629118,0.951528644896614,1,5,retinoic acid biosynthetic process,BP,CYP1A1
5350,GO:0016102,0.323559450629118,0.951528644896614,1,5,diterpenoid biosynthetic process,BP,CYP1A1
19593,GO:1990712,0.323574420680134,0.951523779762466,1,5,HFE-transferrin receptor complex,CC,TFRC
13579,GO:0060046,0.323631807186823,0.951505127002037,1,5,regulation of acrosome reaction,BP,B4GALT1
18223,GO:1903020,0.323919952790409,0.896226891428756,2,15,positive regulation of glycoprotein metabolic process,BP,CHP1;IL15
5744,GO:0016891,0.323968589121928,0.863988296476765,3,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,POP1;FEN1;POP4
352,GO:0000965,0.32404184232426,0.951371727740544,1,5,mitochondrial RNA 3'-end processing,BP,HSD17B10
3700,GO:0008206,0.324145393024019,0.86416473915636,3,26,bile acid metabolic process,BP,PANK2;ACAA1;AKR1C1
6655,GO:0030004,0.324154371168291,0.806914912009133,7,73,cellular monovalent inorganic cation homeostasis,BP,TP53;CLN6;CHP1;NEDD4L;SLC4A11;TMEM165;SLC4A2
14169,GO:0061051,0.324386059609949,0.951259575371754,1,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
15960,GO:0075525,0.324507008104167,0.951220132113125,1,5,viral translational termination-reinitiation,BP,EIF3B
10630,GO:0043627,0.324548651055452,0.827567800780719,5,49,response to estrogen,BP,ARPC1B;SFRP1;RBBP5;CITED2;ESR1
652,GO:0001842,0.324615558774529,0.951184716039754,1,5,neural fold formation,BP,BMP7
4942,GO:0014904,0.324635307678899,0.895838347900908,2,15,myotube cell development,BP,HDAC9;BIN3
19847,GO:2000319,0.324640205781579,0.951176672530331,1,5,regulation of T-helper 17 cell differentiation,BP,SMAD7
16777,GO:0098586,0.324652666783649,0.842799046477052,4,37,cellular response to virus,BP,IKBKE;BIRC3;ZC3H12A;MAPK11
7811,GO:0032364,0.324805882190696,0.951122584122836,1,5,oxygen homeostasis,BP,SOD2
15362,GO:0071598,0.324909932572648,0.951088596803122,1,5,neuronal ribonucleoprotein granule,CC,PQBP1
8354,GO:0033216,0.325022716212017,0.951051741162381,1,5,ferric iron import,BP,STEAP4
4703,GO:0010863,0.32513392045668,0.895567122543133,2,15,positive regulation of phospholipase C activity,BP,RASGRP4;ESR1
7449,GO:0031584,0.325142240438782,0.951012665031552,1,5,activation of phospholipase D activity,BP,CCL5
4599,GO:0010714,0.32518910907006,0.895537081702824,2,15,positive regulation of collagen metabolic process,BP,CTGF;WNT4
8214,GO:0032967,0.32518910907006,0.895537081702824,2,15,positive regulation of collagen biosynthetic process,BP,CTGF;WNT4
15392,GO:0071639,0.325191916071477,0.950996419159916,1,5,positive regulation of monocyte chemotactic protein-1 production,BP,IL1A
10277,GO:0043021,0.32527372199995,0.786478032375283,10,110,ribonucleoprotein complex binding,MF,ZC3H12A;GEMIN5;GTPBP6;CD2BP2;CBX5;SNRNP70;ERAL1;HNRNPU;PQBP1;EIF5A
6727,GO:0030139,0.325281396196684,0.759965846237475,18,208,endocytic vesicle,CC,SAA1;AMOT;ACTG1;TAP1;HLA-B;RAB32;LAMP1;ITGAV;CDC42EP2;HLA-F;SYK;TAPBP;TAP2;RAPGEF1;ZYX;WNT4;MYO1E;CLTA
7457,GO:0031593,0.325392808801903,0.842283962255628,4,37,polyubiquitin modification-dependent protein binding,MF,IKBKE;SQSTM1;TNIP2;TNFAIP3
17348,GO:1900034,0.32540695729718,0.806012975364179,7,72,regulation of cellular response to heat,BP,CRYAB;BAG1;NUP153;DNAJB1;NUP214;HSPA8;HSP90AB1
13116,GO:0051651,0.325508089390512,0.805785532086394,7,74,maintenance of location in cell,BP,FTL;FTH1;PML;TBCCD1;HNRNPU;INSIG1;DAG1
4022,GO:0009052,0.325765564373094,0.950808584546446,1,5,pentose-phosphate shunt, non-oxidative branch,BP,TKT
15493,GO:0071863,0.325877257419233,0.950771962836213,1,5,regulation of cell proliferation in bone marrow,BP,FGFR2
15494,GO:0071864,0.325877257419233,0.950771962836213,1,5,positive regulation of cell proliferation in bone marrow,BP,FGFR2
12765,GO:0051036,0.325891500066903,0.950767291832333,1,5,regulation of endosome size,BP,SNF8
4118,GO:0009176,0.326109110669187,0.950695892108568,1,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,TYMS
4119,GO:0009177,0.326109110669187,0.950695892108568,1,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,TYMS
5797,GO:0017046,0.326119146177819,0.895030221024548,2,15,peptide hormone binding,MF,INHBA;OXTR
12791,GO:0051085,0.326263242409184,0.862807933170697,3,26,chaperone cofactor-dependent protein refolding,BP,BAG1;DNAJB1;HSPA8
261,GO:0000727,0.326264508497724,0.950644867671626,1,5,double-strand break repair via break-induced replication,BP,GINS2
365,GO:0000983,0.326368372392031,0.894894198562933,2,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,TAF4B;SRF
15435,GO:0071706,0.326405996143262,0.805083836714726,7,74,tumor necrosis factor superfamily cytokine production,BP,HSPB1;ZC3H12A;CD274;ERRFI1;AKAP8;GPNMB;TNFAIP3
7278,GO:0031261,0.326409965609057,0.950597079143044,1,5,DNA replication preinitiation complex,CC,GINS2
13724,GO:0060292,0.326560043210537,0.89478953205159,2,15,long term synaptic depression,BP,SRF;CD38
8353,GO:0033211,0.326561660415654,0.950547212329899,1,5,adiponectin-activated signaling pathway,BP,ACSL1
8655,GO:0034201,0.326627672692016,0.950525502804328,1,5,response to oleic acid,BP,ACSL1
57,GO:0000120,0.32664661446537,0.950519272369892,1,5,RNA polymerase I transcription factor complex,CC,CD3EAP
15655,GO:0072170,0.326854579474847,0.89462859746343,2,15,metanephric tubule development,BP,LIF;WNT4
1873,GO:0004549,0.327024008070095,0.893958173580799,2,16,tRNA-specific ribonuclease activity,MF,POP1;POP4
8859,GO:0034654,0.327116256363011,0.699814175120676,265,3382,nucleobase-containing compound biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PGK1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;USP43;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;SMUG1;ZNF34;MPHOSPH8;ELK1;PHF5A;UAP1L1;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;FADS1;MAGOH
9344,GO:0035850,0.32711635488817,0.862259826539789,3,26,epithelial cell differentiation involved in kidney development,BP,LIF;PDGFB;MYO1E
2274,GO:0005217,0.327122900886065,0.894481885517191,2,15,intracellular ligand-gated ion channel activity,MF,JPH2;JPH1
5064,GO:0015278,0.327122900886065,0.894481885517191,2,15,calcium-release channel activity,MF,JPH2;JPH1
5371,GO:0016176,0.327310921083908,0.950300473167438,1,5,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
4657,GO:0010801,0.327330580422585,0.894368264926965,2,15,negative regulation of peptidyl-threonine phosphorylation,BP,SMAD7;PARD3
15456,GO:0071786,0.327331879579363,0.894367553981991,2,15,endoplasmic reticulum tubular network organization,BP,ZFYVE27;REEP1
4759,GO:0010936,0.327762016456224,0.950151574615403,1,5,negative regulation of macrophage cytokine production,BP,TGFB2
7882,GO:0032449,0.328041353047722,0.950059239235404,1,5,CBM complex,CC,CARD10
18617,GO:1903900,0.328076834376751,0.784132078708828,10,111,regulation of viral life cycle,BP,PML;RSAD2;TNF;ZC3H12A;BANF1;HSPA8;CHMP4B;CXCL8;SNF8;CCL5
14027,GO:0060751,0.328262488977605,0.949986070940308,1,5,branch elongation involved in mammary gland duct branching,BP,ESR1
4579,GO:0010664,0.32833912911341,0.893815670320555,2,15,negative regulation of striated muscle cell apoptotic process,BP,BMP7;NOL3
18336,GO:1903297,0.328469524517035,0.949917510987567,1,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,NOL3
18337,GO:1903298,0.328469524517035,0.949917510987567,1,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,NOL3
5735,GO:0016881,0.328490431562199,0.893732652471979,2,15,acid-amino acid ligase activity,MF,GCLC;TTLL5
1018,GO:0002517,0.328641501167145,0.949860518793185,1,5,T cell tolerance induction,BP,PHLPP1
1081,GO:0002664,0.328641501167145,0.949860518793185,1,5,regulation of T cell tolerance induction,BP,PHLPP1
8984,GO:0035090,0.328931656675915,0.94976427625279,1,5,maintenance of apical/basal cell polarity,BP,WDR1
11149,GO:0045199,0.328931656675915,0.94976427625279,1,5,maintenance of epithelial cell apical/basal polarity,BP,WDR1
6275,GO:0019870,0.329054103968118,0.949723628756995,1,5,potassium channel inhibitor activity,MF,NEDD4L
6121,GO:0019369,0.329142438438135,0.860954524503255,3,26,arachidonic acid metabolic process,BP,CYP1B1;CYP1A1;PTGES
20186,GO:2001033,0.329163330770051,0.949687353594788,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,TFIP11
1610,GO:0004033,0.329323137968639,0.892691526527424,2,16,aldo-keto reductase (NADP) activity,MF,AKR1C2;AKR1C1
13967,GO:0060674,0.32940483017915,0.860785109676246,3,26,placenta blood vessel development,BP,CYR61;JUNB;FOSL1
13849,GO:0060452,0.329466753712266,0.949586503401467,1,5,positive regulation of cardiac muscle contraction,BP,CTGF
6460,GO:0021781,0.329485779926392,0.949580175602932,1,5,glial cell fate commitment,BP,NRG1
10345,GO:0043141,0.329499205415133,0.949575710230029,1,5,ATP-dependent 5'-3' DNA helicase activity,MF,RUVBL2
20257,GO:2001214,0.329533402632946,0.949564335042664,1,5,positive regulation of vasculogenesis,BP,ADM
4786,GO:0010975,0.329583584642372,0.741476936376573,27,317,regulation of neuron projection development,BP,NRG1;MAP2;FN1;NEFL;TENM3;LYN;BAIAP2;EFNB2;ENC1;L1CAM;TNFRSF12A;SFRP1;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;SEMA3C;YWHAH;PQBP1;ZNF365;ZSWIM6;BMP7;RAPGEF1;EFNA1
13953,GO:0060638,0.329588768205679,0.949545915319593,1,5,mesenchymal-epithelial cell signaling,BP,TNC
18646,GO:1903955,0.329589043655933,0.8119590920827,6,62,positive regulation of protein targeting to mitochondrion,BP,NRG1;CYB5R1;USP36;WDR46;UBE2J2;SNIP1
882,GO:0002248,0.329644696886318,0.949527304234182,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,IL1A
3317,GO:0007020,0.32972877372392,0.860575836735224,3,26,microtubule nucleation,BP,DCTN1;SLAIN2;CLASP1
2442,GO:0005642,0.329766533392763,0.949486747365967,1,5,annulate lamellae,CC,EIF5A
3984,GO:0008823,0.329779443154455,0.949482448847852,1,5,cupric reductase activity,MF,STEAP4
13445,GO:0052851,0.329779443154455,0.949482448847852,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP4
17781,GO:1901841,0.329808662086159,0.949472719127182,1,5,regulation of high voltage-gated calcium channel activity,BP,RRAD
2114,GO:0004904,0.329858286292747,0.949456192050052,1,5,interferon receptor activity,MF,IFNGR1
2117,GO:0004908,0.32992885750939,0.949432683201559,1,5,interleukin-1 receptor activity,MF,IL1R2
13867,GO:0060484,0.329997241989766,0.949409896662408,1,5,lung-associated mesenchyme development,BP,FGFR2
3592,GO:0008016,0.330090582633711,0.782556197901436,10,109,regulation of heart contraction,BP,CTGF;ADM;TGFB2;EDN1;ZC3H12A;FLNA;FXYD3;TPM1;SMAD7;KCNIP3
8286,GO:0033089,0.330150499621108,0.949358807401469,1,5,positive regulation of T cell differentiation in thymus,BP,IL7R
12838,GO:0051148,0.330178287752479,0.860285229319462,3,26,negative regulation of muscle cell differentiation,BP,G6PD;BMP2;PDGFB
10056,GO:0042538,0.330240463099618,0.949328803442287,1,5,hyperosmotic salinity response,BP,XRCC6
2896,GO:0006403,0.330332504496434,0.755542012051013,18,209,RNA localization,BP,NUP153;SRSF2;AKAP8L;RRS1;ZFP36L1;DKC1;U2AF2;SHQ1;ALYREF;PHAX;DDX39A;NUP214;HNRNPU;RUVBL2;THOC1;EIF5A;SRSF7;MAGOH
4926,GO:0014877,0.330355235792701,0.949290510100484,1,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,DAG1
4934,GO:0014894,0.330355235792701,0.949290510100484,1,5,response to denervation involved in regulation of muscle adaptation,BP,DAG1
181,GO:0000393,0.330515870089066,0.949236886646776,1,5,spliceosomal conformational changes to generate catalytic conformation,BP,PRPF19
15904,GO:0072673,0.330558208815286,0.892595010300102,2,15,lamellipodium morphogenesis,BP,CORO1C;PDPN
12275,GO:0048570,0.330586318311531,0.94921335886443,1,5,notochord morphogenesis,BP,EFNA1
2215,GO:0005112,0.330637611508468,0.892551210415796,2,15,Notch binding,MF,ADAM17;KCTD10
2028,GO:0004767,0.330758770645175,0.949155737388614,1,5,sphingomyelin phosphodiesterase activity,MF,SMPD2
495,GO:0001547,0.330764396808989,0.949153856870805,1,5,antral ovarian follicle growth,BP,ESR1
10559,GO:0043515,0.330774404318066,0.949150511808459,1,5,kinetochore binding,MF,CLASP1
14164,GO:0061046,0.330803935512028,0.949140640096334,1,5,regulation of branching involved in lung morphogenesis,BP,TNF
16349,GO:0090611,0.330887499486253,0.949112700143684,1,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,CHMP4B
17649,GO:1901386,0.330974389213696,0.949083638623442,1,5,negative regulation of voltage-gated calcium channel activity,BP,RRAD
18808,GO:1904375,0.331020223123781,0.801540459555434,7,73,regulation of protein localization to cell periphery,BP,GBP1;SQSTM1;EPHA2;GPER1;SPTBN1;STAC;RHOG
11210,GO:0045342,0.331044420675201,0.949060208477268,1,5,MHC class II biosynthetic process,BP,NFX1
11213,GO:0045346,0.331044420675201,0.949060208477268,1,5,regulation of MHC class II biosynthetic process,BP,NFX1
14656,GO:0070245,0.331048785935206,0.949058747799368,1,5,positive regulation of thymocyte apoptotic process,BP,TP53
11055,GO:0045048,0.331070235109486,0.949051570242931,1,5,protein insertion into ER membrane,BP,TRAM2
12190,GO:0048333,0.331125716485577,0.8922817773891,2,15,mesodermal cell differentiation,BP,INHBA;FGFR2
13540,GO:0055131,0.33121305751241,0.949003762258725,1,5,C3HC4-type RING finger domain binding,MF,HSPA8
7299,GO:0031297,0.331278225402482,0.859573079576746,3,26,replication fork processing,BP,ALYREF;THOC1;ZNF365
2810,GO:0006269,0.331299176488698,0.94897492225448,1,5,DNA replication, synthesis of RNA primer,BP,POLA1
16542,GO:0097283,0.331520100502444,0.948900894033892,1,5,keratinocyte apoptotic process,BP,ZFP36L1
17890,GO:1902172,0.331520100502444,0.948900894033892,1,5,regulation of keratinocyte apoptotic process,BP,ZFP36L1
8277,GO:0033079,0.331569897362097,0.94888419913953,1,5,immature T cell proliferation,BP,WNT4
8077,GO:0032757,0.331611367935385,0.859059252784302,3,27,positive regulation of interleukin-8 production,BP,TNF;SERPINE1;AFAP1L2
16655,GO:0097527,0.331624606633816,0.948865853603913,1,5,necroptotic signaling pathway,BP,TNF
287,GO:0000791,0.331628491889458,0.859048128385528,3,27,euchromatin,CC,UHRF1;RUVBL2;JUN
8213,GO:0032966,0.331708103060119,0.948837847456323,1,5,negative regulation of collagen biosynthetic process,BP,ERRFI1
14651,GO:0070235,0.331801141689286,0.948806630039475,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D3
10845,GO:0044340,0.331962341641931,0.948752515754901,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,SFRP1
12262,GO:0048546,0.332086011878298,0.859049133712663,3,26,digestive tract morphogenesis,BP,FGFR2;SFRP1;TP63
17837,GO:1902001,0.332201760624719,0.891686672710535,2,15,fatty acid transmembrane transport,BP,IRS2;CPT1A
20197,GO:2001054,0.332393996557985,0.948607444619873,1,5,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
11316,GO:0045634,0.332401835806565,0.948604807759211,1,5,regulation of melanocyte differentiation,BP,ADAMTS9
1068,GO:0002634,0.33240426367873,0.948603991088146,1,5,regulation of germinal center formation,BP,TNFAIP3
4246,GO:0009446,0.332460272403145,0.948585149131061,1,5,putrescine biosynthetic process,BP,ODC1
15009,GO:0070937,0.332485948664746,0.948576509989755,1,5,CRD-mediated mRNA stability complex,CC,HNRNPU
11069,GO:0045069,0.332500199404253,0.800229173666433,7,75,regulation of viral genome replication,BP,RSAD2;TNF;ZC3H12A;BANF1;HSPA8;CXCL8;CCL5
3004,GO:0006549,0.332536352605316,0.948559548381366,1,5,isoleucine metabolic process,BP,STAT5A
6589,GO:0022602,0.332606645977869,0.858711014827126,3,26,ovulation cycle process,BP,INHBA;TGFB2;ESR1
10200,GO:0042805,0.33263456058769,0.891446874560369,2,15,actinin binding,MF,NFKB1;DAG1
10040,GO:0042492,0.332641915661089,0.948524014292811,1,5,gamma-delta T cell differentiation,BP,SYK
10482,GO:0043374,0.332641915661089,0.948524014292811,1,5,CD8-positive, alpha-beta T cell differentiation,BP,IRF1
6497,GO:0021859,0.332853194540064,0.948452851213485,1,5,pyramidal neuron differentiation,BP,FGFR2
6498,GO:0021860,0.332853194540064,0.948452851213485,1,5,pyramidal neuron development,BP,FGFR2
14333,GO:0061515,0.333012093116703,0.821328952446448,5,49,myeloid cell development,BP,FBN1;G6PD;TJP2;PABPC4;SRF
12283,GO:0048596,0.333015848698817,0.891235408555221,2,15,embryonic camera-type eye morphogenesis,BP,BMP7;PHACTR4
11850,GO:0046831,0.333059266807629,0.891211316063676,2,15,regulation of RNA export from nucleus,BP,NUP153;AKAP8L
15424,GO:0071692,0.333101054523749,0.948369292925583,1,5,protein localization to extracellular region,BP,FBN1
15425,GO:0071694,0.333101054523749,0.948369292925583,1,5,maintenance of protein location in extracellular region,BP,FBN1
16605,GO:0097433,0.333140381213129,0.94835602781474,1,5,dense body,CC,ACTG1
6259,GO:0019843,0.333159939955055,0.82041458944605,5,56,rRNA binding,MF,PPAN;RRS1;RPS9;ERAL1;MRPL20
14522,GO:0070006,0.333169400642828,0.891150191979167,2,15,metalloaminopeptidase activity,MF,C9ORF3;DNPEP
11967,GO:0047184,0.333176520982706,0.948343835896784,1,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT3
9098,GO:0035360,0.333326112898386,0.948293352311087,1,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
8668,GO:0034237,0.333347624526824,0.891051243482705,2,15,protein kinase A regulatory subunit binding,MF,AKAP8L;AKAP8
15278,GO:0071458,0.33335190519918,0.948284645103834,1,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,SPPL2A
12575,GO:0050729,0.333375605454448,0.808963548352052,6,63,positive regulation of inflammatory response,BP,PTGER4;TNF;SERPINE1;NFKBIA;ETS1;IL15
3883,GO:0008514,0.333409369185387,0.770765520496514,12,132,organic anion transmembrane transporter activity,MF,SLC16A2;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;SLC7A2;SLC43A2;SLC4A11;SLC22A4;SLC4A2;SLC3A2;SLC25A22
6691,GO:0030061,0.333528217332109,0.948225100823359,1,5,mitochondrial crista,CC,LYN
14745,GO:0070412,0.333546923812799,0.890940543494217,2,15,R-SMAD binding,MF,JUN;PARP1
12480,GO:0050431,0.333620620301806,0.890899595545119,2,15,transforming growth factor beta binding,MF,ITGAV;CD109
3498,GO:0007398,0.333703033539639,0.890853795659801,2,15,ectoderm development,BP,ETS2;VPS52
9314,GO:0035771,0.333762794801938,0.948145816424765,1,5,interleukin-4-mediated signaling pathway,BP,PARP14
7100,GO:0030896,0.333788499875481,0.94813712406177,1,5,checkpoint clamp complex,CC,ORAOV1
1174,GO:0002821,0.333877845459767,0.820556610895433,5,50,positive regulation of adaptive immune response,BP,TFRC;RSAD2;IL27RA;TNF;TRAF2
19991,GO:2000587,0.3339289937859,0.94808959979741,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
18862,GO:1904502,0.334113472750841,0.948027157873322,1,5,regulation of lipophagy,BP,ADRB2
18863,GO:1904504,0.334113472750841,0.948027157873322,1,5,positive regulation of lipophagy,BP,ADRB2
19682,GO:2000002,0.334352841021724,0.947946071102751,1,5,negative regulation of DNA damage checkpoint,BP,THOC1
10654,GO:0043696,0.334413469875278,0.947925521036117,1,5,dedifferentiation,BP,PDGFB
10655,GO:0043697,0.334413469875278,0.947925521036117,1,5,cell dedifferentiation,BP,PDGFB
715,GO:0001940,0.334418579366002,0.947923788962416,1,5,male pronucleus,CC,TET3
17212,GO:0106070,0.334510212363752,0.947892720383102,1,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PRKCA
17757,GO:1901723,0.334521912560396,0.94788875259109,1,5,negative regulation of cell proliferation involved in kidney development,BP,BMP7
6550,GO:0021978,0.334523727871399,0.947888136963528,1,5,telencephalon regionalization,BP,BMP2
15663,GO:0072178,0.334523731573742,0.947888135707941,1,5,nephric duct morphogenesis,BP,EFNB2
2949,GO:0006477,0.334532396168498,0.947885197219248,1,5,protein sulfation,BP,TPST1
5608,GO:0016651,0.334584242947295,0.798069208632226,7,83,oxidoreductase activity, acting on NAD(P)H,MF,NQO1;TXNRD1;CYB5R1;PGK1;AKR1C2;DCXR;AKR1C1
403,GO:0001083,0.33464629425409,0.947846561013603,1,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TP53
18178,GO:1902947,0.334658384447985,0.947842458817408,1,5,regulation of tau-protein kinase activity,BP,EGR1
19633,GO:1990822,0.334716186912963,0.947822843839167,1,5,basic amino acid transmembrane transport,BP,SLC7A2
5018,GO:0015181,0.33479909834404,0.947794700652963,1,5,arginine transmembrane transporter activity,MF,SLC7A2
5025,GO:0015189,0.33479909834404,0.947794700652963,1,5,L-lysine transmembrane transporter activity,MF,SLC7A2
15517,GO:0071895,0.334832431929729,0.947783383482898,1,5,odontoblast differentiation,BP,SERPINE1
15884,GO:0072611,0.334934922946998,0.947748577421109,1,5,interleukin-13 secretion,BP,TNFRSF21
20042,GO:2000665,0.334934922946998,0.947748577421109,1,5,regulation of interleukin-13 secretion,BP,TNFRSF21
6276,GO:0019871,0.334955204356071,0.947741688208607,1,5,sodium channel inhibitor activity,MF,NEDD4L
5794,GO:0017034,0.335030553122369,0.947716088953052,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF1
14236,GO:0061200,0.335070009043592,0.947702681104775,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,HSPA8
14237,GO:0061202,0.335070009043592,0.947702681104775,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,HSPA8
15533,GO:0071922,0.335118585671568,0.947686171082992,1,5,regulation of cohesin loading,BP,CDCA5
12175,GO:0048296,0.335205173550636,0.947656734320525,1,5,regulation of isotype switching to IgA isotypes,BP,THOC1
13394,GO:0052696,0.335240988517572,0.947644555660591,1,5,flavonoid glucuronidation,BP,UGT1A6
13395,GO:0052697,0.335240988517572,0.947644555660591,1,5,xenobiotic glucuronidation,BP,UGT1A6
19903,GO:2000394,0.335320560355987,0.947617491753608,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1C
10686,GO:0043950,0.335336818998551,0.947611960860971,1,5,positive regulation of cAMP-mediated signaling,BP,PRKCA
19647,GO:1990868,0.33535026694087,0.947607385856408,1,5,response to chemokine,BP,ZC3H12A
19648,GO:1990869,0.33535026694087,0.947607385856408,1,5,cellular response to chemokine,BP,ZC3H12A
4449,GO:0010385,0.335367955544314,0.947601367814876,1,5,double-stranded methylated DNA binding,MF,EGR1
2552,GO:0005827,0.335502612302425,0.947555541313627,1,5,polar microtubule,CC,KLHL21
15835,GO:0072537,0.335509361251399,0.947553243882671,1,5,fibroblast activation,BP,GCLC
9331,GO:0035810,0.33563216223527,0.947511430427077,1,5,positive regulation of urine volume,BP,EDN1
2551,GO:0005826,0.335715759363713,0.947482954528865,1,5,actomyosin contractile ring,CC,MYH9
15144,GO:0071243,0.33576103962742,0.889106891143352,2,16,cellular response to arsenic-containing substance,BP,ZC3H12A;DAXX
15742,GO:0072318,0.335774679241188,0.947462879020396,1,5,clathrin coat disassembly,BP,HSPA8
782,GO:0002039,0.335794242979457,0.807291279606066,6,61,p53 binding,MF,NUAK1;TP53;DAXX;TRIM29;PTTG1IP;TP63
3494,GO:0007386,0.335860997373992,0.947433460037673,1,5,compartment pattern specification,BP,LFNG
17495,GO:1900451,0.335885728259205,0.947425029452917,1,5,positive regulation of glutamate receptor signaling pathway,BP,ADRB2
13495,GO:0055056,0.336079137252631,0.947359070123759,1,5,D-glucose transmembrane transporter activity,MF,SLC2A6
5248,GO:0015874,0.336145317067107,0.947336489233013,1,5,norepinephrine transport,BP,OXTR
7163,GO:0031033,0.336148579480459,0.94733537593285,1,5,myosin filament organization,BP,DAPK3
4651,GO:0010793,0.336196410440521,0.947319051996938,1,5,regulation of mRNA export from nucleus,BP,AKAP8L
2963,GO:0006498,0.336221203795235,0.947310589247581,1,5,N-terminal protein lipidation,BP,NMT2
13072,GO:0051575,0.336229368423033,0.947307802228215,1,5,5'-deoxyribose-5-phosphate lyase activity,MF,XRCC6
1072,GO:0002638,0.336230186491007,0.947307522973543,1,5,negative regulation of immunoglobulin production,BP,THOC1
498,GO:0001553,0.336335971660297,0.94727140490634,1,5,luteinization,BP,INHBA
12371,GO:0048755,0.33651056437215,0.947211761980016,1,5,branching morphogenesis of a nerve,BP,FGFR2
12358,GO:0048733,0.336524541313172,0.94720698556883,1,5,sebaceous gland development,BP,WNT10A
3123,GO:0006702,0.336536139368277,0.947203021912441,1,5,androgen biosynthetic process,BP,WNT4
6514,GO:0021891,0.336540393084342,0.947201568153152,1,5,olfactory bulb interneuron development,BP,ROBO1
3180,GO:0006797,0.336548560005223,0.947198776942094,1,5,polyphosphate metabolic process,BP,PRUNE2
13275,GO:0051962,0.336558253598422,0.733993648292699,28,329,positive regulation of nervous system development,BP,NRG1;FN1;NEFL;TENM3;LYN;BAIAP2;ENC1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;ZFYVE27;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;OXTR;NEDD4L;DPYSL3;SPEN;PARD3;ZNF365;BMP7;RAPGEF1;DAG1
16583,GO:0097381,0.336560191708399,0.947194801420712,1,5,photoreceptor disc membrane,CC,PDE6A
4590,GO:0010694,0.336600353499021,0.947181073432591,1,5,positive regulation of alkaline phosphatase activity,BP,NPNT
474,GO:0001517,0.336630693005864,0.947170701470233,1,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,CHST3
901,GO:0002281,0.336651925796418,0.94716344204318,1,5,macrophage activation involved in immune response,BP,SYK
12363,GO:0048742,0.336652704897857,0.947163175659529,1,5,regulation of skeletal muscle fiber development,BP,HDAC9
9379,GO:0035907,0.336708447703119,0.947144114498718,1,5,dorsal aorta development,BP,SRF
5266,GO:0015911,0.336723587744033,0.947138936684469,1,5,plasma membrane long-chain fatty acid transport,BP,IRS2
10588,GO:0043551,0.336824471037768,0.855959501313033,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,IRS1;LYN;PDGFB
14694,GO:0070314,0.336827745951293,0.947103306996061,1,5,G1 to G0 transition,BP,ZNF503
6471,GO:0021800,0.336836042583375,0.947100468333496,1,5,cerebral cortex tangential migration,BP,ROBO1
13960,GO:0060666,0.336836042583375,0.947100468333496,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,SEMA3C
7491,GO:0031659,0.336878357086072,0.947085989178434,1,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,ADAM17
13565,GO:0060028,0.336888924733808,0.947082372780373,1,5,convergent extension involved in axis elongation,BP,SFRP1
601,GO:0001768,0.336899833809827,0.947078639387413,1,5,establishment of T cell polarity,BP,MYH9
14912,GO:0070739,0.336899987939587,0.94707858663875,1,5,protein-glutamic acid ligase activity,MF,TTLL5
14913,GO:0070740,0.336899987939587,0.94707858663875,1,5,tubulin-glutamic acid ligase activity,MF,TTLL5
4525,GO:0010587,0.336910530804573,0.947074978423369,1,5,miRNA catabolic process,BP,ZC3H12A
4689,GO:0010838,0.336912480013325,0.947074311305559,1,5,positive regulation of keratinocyte proliferation,BP,TP63
2171,GO:0005007,0.336912522625653,0.947074296721412,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR2
7066,GO:0030853,0.336912522625653,0.947074296721412,1,5,negative regulation of granulocyte differentiation,BP,TRIB1
15752,GO:0072338,0.336912522625653,0.947074296721412,1,5,cellular lactam metabolic process,BP,STAT5A
16598,GO:0097418,0.336912522625653,0.947074296721412,1,5,neurofibrillary tangle,CC,NEFM
17999,GO:1902459,0.336912522625653,0.947074296721412,1,5,positive regulation of stem cell population maintenance,BP,TP63
19099,GO:1905007,0.336912522625653,0.947074296721412,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
19774,GO:2000192,0.336912522625653,0.947074296721412,1,5,negative regulation of fatty acid transport,BP,IRS2
3880,GO:0008510,0.336912522625653,0.947074296721412,1,5,sodium:bicarbonate symporter activity,MF,SLC4A2
4543,GO:0010616,0.336912522625653,0.947074296721412,1,5,negative regulation of cardiac muscle adaptation,BP,ERRFI1
5380,GO:0016198,0.336912522625653,0.947074296721412,1,5,axon choice point recognition,BP,ROBO1
7977,GO:0032591,0.336912522625653,0.947074296721412,1,5,dendritic spine membrane,CC,GPER1
12715,GO:0050942,0.336912522625653,0.947074296721412,1,5,positive regulation of pigment cell differentiation,BP,ADAMTS9
13122,GO:0051661,0.336912522625653,0.947074296721412,1,5,maintenance of centrosome location,BP,TBCCD1
16933,GO:0098910,0.336912522625653,0.947074296721412,1,5,regulation of atrial cardiac muscle cell action potential,BP,FLNA
18316,GO:1903243,0.336912522625653,0.947074296721412,1,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1
10839,GO:0044332,0.336912522625653,0.947074296721412,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
2903,GO:0006412,0.337359738068888,0.716446363246007,50,654,translation,BP,HSPB1;ABCF1;DAPK3;TNF;CARS2;ENC1;CDKAL1;NUP153;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;PABPC4;DPH2;CTIF;LARP4B;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;ZFP36L2;PUM3;AJUBA;RPS2;RPS9;NUP214;MRPS12;MRPS24;DNAJC1;ERAL1;MRPL20;RPL27A;MRPL33;ESR1;TCOF1;EIF3B;RBM4;METTL16;EFTUD2;EIF3I;EIF5A;EEF1D;MRPS2;AARSD1;POLR2G;CCL5;MAGOH
11127,GO:0045165,0.337379058614313,0.771653354932113,11,121,cell fate commitment,BP,NRG1;PML;CYLD;WNT10A;PDPN;FGFR2;BMP2;SFRP1;ETS2;FOXN1;WNT4
11845,GO:0046823,0.337380161783571,0.888196566886659,2,16,negative regulation of nucleocytoplasmic transport,BP,NUP153;CHP1
5439,GO:0016303,0.337445076381572,0.855552797936749,3,26,1-phosphatidylinositol-3-kinase activity,MF,IRS1;FGFR2;IRS2
871,GO:0002221,0.337746209731559,0.771307822872762,11,122,pattern recognition receptor signaling pathway,BP,CYLD;IKBKE;BIRC3;RSAD2;TRAF3;LYN;IRF1;NFKBIA;TNIP2;ESR1;TNFAIP3
15753,GO:0072341,0.337889287915279,0.817442149060208,5,51,modified amino acid binding,MF,JPH2;PTGES;TYMS;DHFR;HSPA8
11345,GO:0045668,0.338481843184034,0.854566930573107,3,27,negative regulation of osteoblast differentiation,BP,NOCT;TNF;SFRP1
17394,GO:1900120,0.339023002783887,0.887269287186457,2,16,regulation of receptor binding,BP,MMP9;RUVBL2
13501,GO:0055067,0.339781124666243,0.786697386463253,8,86,monovalent inorganic cation homeostasis,BP,EDN1;TP53;CLN6;CHP1;NEDD4L;SLC4A11;TMEM165;SLC4A2
9285,GO:0035722,0.34000041246589,0.831438251549857,4,40,interleukin-12-mediated signaling pathway,BP,SOD2;LCP1;PSME2;HNRNPF
15204,GO:0071349,0.34000041246589,0.831438251549857,4,40,cellular response to interleukin-12,BP,SOD2;LCP1;PSME2;HNRNPF
12778,GO:0051053,0.34030137633878,0.77409265117898,10,109,negative regulation of DNA metabolic process,BP,TP53;GNL3L;NAT10;TFIP11;GPER1;HNRNPU;THOC1;DUSP1;TIMELESS;PARP1
6506,GO:0021879,0.341089822097545,0.852846449830446,3,27,forebrain neuron differentiation,BP,INHBA;FGFR2;ROBO1
11847,GO:0046825,0.341125565745815,0.830808499903252,4,39,regulation of protein export from nucleus,BP,TP53;PTPN14;SFN;AKAP8L
17974,GO:1902369,0.341643342559036,0.830623091413621,4,38,negative regulation of RNA catabolic process,BP,NOCT;DKC1;HNRNPU;DHX34
12607,GO:0050786,0.34190231439204,0.941900673788373,1,7,RAGE receptor binding,MF,S100P
18343,GO:1903307,0.342136606276771,0.852153528332589,3,27,positive regulation of regulated secretory pathway,BP,LAMP1;SYK;RAB27A
4094,GO:0009148,0.342751427127015,0.884609518314334,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,TYMS;CTPS1
10887,GO:0044427,0.343074845945695,0.706489077859604,61,772,chromosomal part,CC,PML;MYBL2;TP53;JUNB;MCM5;CDKN2A;RING1;ENC1;TELO2;FLNA;CDK4;DAXX;NAT10;MCM2;TOX4;AKAP8L;APTX;IRF1;TFIP11;SRF;ZFP42;SNAI2;PRPF19;FEN1;CBX5;GINS2;BRMS1;ALYREF;POLA1;DCTN1;UHRF1;ORAOV1;SFPQ;ZW10;RCC2;MTA2;HNRNPU;CLASP1;RUVBL2;ORC1;THOC1;CITED2;JUN;ESR1;CENPN;RCC1;MCM7;CENPO;XRCC6;HMGN2;MPHOSPH8;INCENP;IPO4;CHAF1A;KIF22;TIMELESS;SMARCC2;CDCA5;PARP1;TP63;ORC4
257,GO:0000723,0.34318288382688,0.758386375082657,13,153,telomere maintenance,BP,PML;GNL3L;TELO2;NAT10;TFIP11;DKC1;FEN1;POLA1;HNRNPU;ZNF365;XRCC6;HSP90AB1;PARP1
7746,GO:0032259,0.343255917218525,0.733195353301784,24,284,methylation,BP,MAT2A;TET3;TYMS;TRMT61A;METTL13;METTL1;NSUN2;NELFE;METTL2B;RPS2;NSUN5;RBBP5;FTSJ3;MTA2;WDR4;PRDM7;HSPA8;NOP2;TRMT1;METTL16;MPHOSPH8;METTL21A;HSD17B10;PARP1
20094,GO:2000758,0.343422049704875,0.851300776225144,3,27,positive regulation of peptidyl-lysine acetylation,BP,LIF;SNAI2;RUVBL2
15452,GO:0071772,0.343533755120403,0.777072710717782,9,97,response to BMP,BP,CYR61;FBN1;TGFB2;BMP2;SFRP1;EGR1;SMAD7;BMP7;BMP8A
15453,GO:0071773,0.343533755120403,0.777072710717782,9,97,cellular response to BMP stimulus,BP,CYR61;FBN1;TGFB2;BMP2;SFRP1;EGR1;SMAD7;BMP7;BMP8A
1216,GO:0002886,0.343713284178076,0.851107290433457,3,27,regulation of myeloid leukocyte mediated immunity,BP,LYN;SYK;DNASE1
7322,GO:0031331,0.344101552683946,0.732456603458275,24,282,positive regulation of cellular catabolic process,BP,IRS1;UBQLN2;TNF;ZC3H12A;RNF19B;ADRB2;TRIM22;ZFP36L1;IRS2;ZFP36L2;PTTG1IP;SMAD7;SUPT5H;KEAP1;TRIB1;HSPBP1;CPT1A;METTL16;TNFAIP3;PSMC3;RNF144B;POLR2G;GCLC;SH3BP4
3922,GO:0008593,0.344134377103547,0.79107711598728,7,74,regulation of Notch signaling pathway,BP,TGFB2;LFNG;ELF3;NFKBIA;SLC35C2;BMP7;TP63
16118,GO:0090101,0.344330551424968,0.7909205046351,7,74,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FBN1;FST;SFRP1;ADAM17;BAMBI;SMAD7;CD109
4509,GO:0010559,0.345095957339028,0.850187263138122,3,27,regulation of glycoprotein biosynthetic process,BP,BACE2;CHP1;IL15
1476,GO:0003746,0.34539190340899,0.883639905563093,2,16,translation elongation factor activity,MF,EIF5A;EEF1D
10444,GO:0043300,0.345829945096557,0.849697910332819,3,27,regulation of leukocyte degranulation,BP,LYN;LAMP1;SYK
2100,GO:0004867,0.346146063546895,0.827025173739499,4,40,serine-type endopeptidase inhibitor activity,MF,SERPINE1;SERPINH1;A2ML1;CD109
12759,GO:0051028,0.346166085324033,0.759835036883548,12,135,mRNA transport,BP,NUP153;SRSF2;AKAP8L;ZFP36L1;U2AF2;ALYREF;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
17258,GO:0120039,0.346379971063996,0.716363788762984,37,443,plasma membrane bounded cell projection morphogenesis,BP,NRG1;MAP2;FN1;NEFL;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DOCK10;SGK1;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;SEMA3C;YWHAH;ENAH;PQBP1;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;DAG1;EFNA1
14653,GO:0070242,0.346456702797043,0.883027750023931,2,16,thymocyte apoptotic process,BP,TP53;EFNA1
10565,GO:0043523,0.346836123323519,0.759230496068881,12,136,regulation of neuron apoptotic process,BP,NEFL;NQO1;MYBL2;SOD2;TGFB2;G6PD;TP53;JUN;GCLC;HSP90AB1;PARP1;TP63
15895,GO:0072659,0.347032570564998,0.745826945541775,16,184,protein localization to plasma membrane,BP,GBP1;EMP2;SQSTM1;TNF;FLNA;EPHA2;ARFRP1;ZFYVE27;GPER1;SPTBN1;KCNIP3;STAC;RHOG;MYADM;WNT4;RILPL2
10504,GO:0043406,0.347085423482075,0.743198926038057,17,196,positive regulation of MAP kinase activity,BP,SAA1;NRG1;MAP3K14;EDN1;GADD45A;TNF;GADD45B;BMP2;EPGN;DAXX;TRAF2;SYK;ROBO1;AJUBA;PDGFB;RAPGEF1;MAPK11
8187,GO:0032925,0.347409996773432,0.88247839176949,2,16,regulation of activin receptor signaling pathway,BP,FST;SMAD7
7177,GO:0031058,0.347802896608334,0.788142581442375,7,74,positive regulation of histone modification,BP,TP53;AKAP8L;LIF;SNAI2;AKAP8;NELFE;RUVBL2
5261,GO:0015893,0.347822840481544,0.773422719930092,9,99,drug transport,BP,INHBA;NFKBIE;EDN1;SLC5A6;EBP;ABCG2;SLC7A2;SLC4A11;SLC25A22
1993,GO:0004714,0.3478855838237,0.826135888414812,4,38,transmembrane receptor protein tyrosine kinase activity,MF,FGFR2;EPHB6;EPHA2;ROR1
19621,GO:1990776,0.347991875481492,0.882142462933218,2,16,response to angiotensin,BP,NFKB1;BRIP1
2894,GO:0006401,0.3480784124416,0.724520270770348,27,346,RNA catabolic process,BP,HSPB1;NOCT;PSMB9;ZC3H12A;PABPC4;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;NUP214;HNRNPU;RPL27A;HSPA8;EDC4;METTL16;DHX34;PSMC3;POLR2G;MAGOH
12884,GO:0051222,0.348190305205676,0.727279724277942,25,298,positive regulation of protein transport,BP,SAA1;TRIM16;NRG1;PTGER4;TGFB2;PANX1;TP53;TNF;ZC3H12A;CYB5R1;CHP1;CD274;SFN;USP36;GPER1;IRS2;SYK;SPTBN1;IL1A;WDR46;UBE2J2;SNIP1;CD38;MAPK11;HSP90AB1
8322,GO:0033158,0.348813116460072,0.881667562040034,2,16,regulation of protein import into nucleus, translocation,BP,CDKN1A;HSP90AB1
6509,GO:0021884,0.348911100848011,0.881610839081573,2,16,forebrain neuron development,BP,FGFR2;ROBO1
6725,GO:0030136,0.349260819090989,0.761547634774265,11,123,clathrin-coated vesicle,CC,TFRC;EDN1;ADRB2;IL7R;M6PR;HSPA8;RAB27A;SPG21;MYO1E;CLTA;SH3BP4
17252,GO:0120032,0.34932222468514,0.761495508890611,11,123,regulation of plasma membrane bounded cell projection assembly,BP,CYLD;CORO1C;EPHA2;ICAM1;MYO10;CDC42EP2;SRF;DPYSL3;RCC2;RHOG;BIN3
13618,GO:0060090,0.349365090904507,0.753230162438755,13,147,molecular adaptor activity,MF,NEFL;IRS1;TJP2;ARPC4;BAIAP2;TRIM22;CBX5;AFAP1L2;CNTNAP1;SORBS2;BLNK;RBM14;BIN3
11189,GO:0045292,0.349564796995593,0.881232081181842,2,16,mRNA cis splicing, via spliceosome,BP,SART1;DDX23
7408,GO:0031490,0.349661707923087,0.778307428649062,8,92,chromatin DNA binding,MF,SRF;MTA2;HNRNPU;RUVBL2;RCC1;ACTN4;HMGN2;SMARCC2
12654,GO:0050858,0.349859224213089,0.881061297077108,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
4854,GO:0014066,0.349879986513383,0.796239913380964,6,62,regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;TGFB2;GPER1;IER3;PDGFB;CCL5
15298,GO:0071482,0.350706603003895,0.777738007741917,8,87,cellular response to light stimulus,BP,TP53;CDKN1A;NMT2;RUVBL2;NOC2L;PDE6A;PARP1;TP63
12281,GO:0048592,0.350833478709717,0.77769571971498,8,86,eye morphogenesis,BP,TENM3;FBN1;RING1;EPHA2;SDK1;COL5A2;BMP7;PHACTR4
15426,GO:0071695,0.350847512971522,0.770962846868944,9,98,anatomical structure maturation,BP,TFCP2L1;TGFB2;G6PD;CDKN1A;TYMS;BMP2;NSUN2;NOM1;DAG1
13523,GO:0055094,0.350995186123151,0.88040126906409,2,16,response to lipoprotein particle,BP,HMGCS1;SYK
75,GO:0000152,0.351188119397323,0.823372726374932,4,40,nuclear ubiquitin ligase complex,CC,RING1;UBE2C;ANAPC15;RNF7
9922,GO:0042268,0.351189211140808,0.939921814546495,1,6,regulation of cytolysis,BP,CSF2
5849,GO:0017145,0.351263753247653,0.846054460000634,3,27,stem cell division,BP,TGFB2;FGFR2;ZFP36L2
350,GO:0000963,0.351601970331162,0.880047988316207,2,16,mitochondrial RNA processing,BP,PUS1;HSD17B10
12413,GO:0048858,0.351650042814314,0.711494479292171,37,444,cell projection morphogenesis,BP,NRG1;MAP2;FN1;NEFL;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DOCK10;SGK1;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;SEMA3C;YWHAH;ENAH;PQBP1;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;DAG1;EFNA1
4673,GO:0010821,0.351729030712254,0.741621155596117,16,188,regulation of mitochondrion organization,BP,NRG1;MMP9;TP53;SQSTM1;CYB5R1;SFN;USP36;PARL;GPER1;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;NOL3;TP63
11013,GO:0044839,0.351809247112376,0.732298704977491,20,239,cell cycle G2/M phase transition,BP,TP53;CDKN2B;CDKN1A;PKMYT1;PBX1;PSMB9;CDK4;AKAP8L;PSME2;AKAP8;FGFR1OP;GPR132;AJUBA;DCTN1;ORAOV1;RCC2;CLASP1;CEP41;TUBB;PSMC3
2454,GO:0005666,0.352379039350579,0.879031097925525,2,17,DNA-directed RNA polymerase III complex,CC,CRCP;POLR3H
6702,GO:0030101,0.352453160878157,0.822451829508358,4,40,natural killer cell activation,BP,LAMP1;ELF4;IL15;RAB27A
450,GO:0001223,0.352509128110404,0.879518887797135,2,16,transcription coactivator binding,MF,AHR;ESR1
12398,GO:0048839,0.352975370208443,0.769191918764985,9,98,inner ear development,BP,MAFB;SDC4;TGFB2;FGFR2;BMP2;MCM2;NTN1;ROR1;INSIG1
2434,GO:0005623,0.353748698373254,0.692662902347118,849,11084,cell,CC,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;ADM;SLC16A2;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;IL27RA;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;LAYN;QPCT;SLC16A9;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;SLCO3A1;SLC7A5P2;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IQCJ-SCHIP1;IFNGR1;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;BCAM;PREP;IFFO2;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC27;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NBPF1;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;SLC4A2;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;IL6R;BIN3;LAIR1;POP4;RPUSD4;PARP1;SLC2A6;CLK4;TP63;ZBTB12;TXNDC15;PHACTR4;TOP3A;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
18242,GO:1903052,0.353819987788857,0.768436238412524,9,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;PSMC3;RNF144B;GCLC
12428,GO:0048878,0.353882271692623,0.700159315784791,52,645,chemical homeostasis,BP,KRT1;SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;SOD2;EDN1;HRNR;TP53;STEAP4;IRS1;LYN;EHD1;CLN6;JPH1;CHP1;ICAM1;ITGAV;SFN;ABHD4;GPER1;SRF;GPCPD1;IRS2;ACO1;ABCG2;OXTR;NEDD4L;SMAD7;SLC4A11;ESR1;COMMD9;CCR6;RPTN;INSIG1;TMEM165;PDE6A;AKR1C1;CD38;SLC4A2;NOL3;GCLC;SWAP70;TBXA2R;PARP1;TP63;CCL5
37,GO:0000076,0.354228712065458,0.878512855466839,2,16,DNA replication checkpoint,BP,ORAOV1;TIMELESS
12483,GO:0050434,0.354304884271061,0.821100593079378,4,40,positive regulation of viral transcription,BP,NELFE;SUPT5H;JUN;POLR2G
14001,GO:0060716,0.354527766538745,0.878337483018708,2,16,labyrinthine layer blood vessel development,BP,CYR61;JUNB
10066,GO:0042558,0.354681840667015,0.843445164801528,3,28,pteridine-containing compound metabolic process,BP,TYMS;DHFR;QDPR
8801,GO:0034501,0.355248611862194,0.877914260085418,2,16,protein localization to kinetochore,BP,ZW10;RCC2
6604,GO:0022625,0.355274553652212,0.803044372971472,5,63,cytosolic large ribosomal subunit,CC,GEMIN5;RPLP2;RPLP1;RPL27A;SURF6
6236,GO:0019788,0.355336087450606,0.938361091796135,1,6,NEDD8 transferase activity,MF,RNF7
681,GO:0001891,0.35534177089292,0.877859512671439,2,16,phagocytic cup,CC,TNF;LCP1
6922,GO:0030514,0.35535472810091,0.843287298575852,3,27,negative regulation of BMP signaling pathway,BP,FBN1;SFRP1;SMAD7
20081,GO:2000737,0.356848150545996,0.876972599493608,2,16,negative regulation of stem cell differentiation,BP,ZFP36L2;HNRNPU
11137,GO:0045182,0.357249422674763,0.81894393047329,4,40,translation regulator activity,MF,TYMS;CTIF;DHFR;RPS9
3505,GO:0007411,0.357597415561904,0.739426778184567,15,171,axon guidance,BP,EFNB2;KLF7;L1CAM;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;SEMA3C;ENAH;ZSWIM6;EFNB1;BMP7;DAG1;EFNA1
2612,GO:0005921,0.358016806154316,0.876282388128282,2,16,gap junction,CC,PANX1;TJP1
14886,GO:0070671,0.358384850971661,0.817934639214906,4,41,response to interleukin-12,BP,SOD2;LCP1;PSME2;HNRNPF
6973,GO:0030628,0.358421221710141,0.937184471279014,1,6,pre-mRNA 3'-splice site binding,MF,U2AF2
12090,GO:0048050,0.358482744173151,0.9371608725551,1,6,post-embryonic eye morphogenesis,BP,FBN1
1381,GO:0003279,0.35880187734073,0.779270168388049,7,74,cardiac septum development,BP,CYR61;TGFB2;FGFR2;SEMA3C;SMAD7;CITED2;BMP7
3563,GO:0007603,0.358882198951522,0.875770078380063,2,16,phototransduction, visible light,BP,NMT2;PDE6A
4149,GO:0009211,0.358919920815517,0.936993028362382,1,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,TYMS
648,GO:0001838,0.359017701419224,0.764090372027828,9,99,embryonic epithelial tube formation,BP,ADM;SDC4;IRX2;TGFB2;SFRP1;CC2D2A;BMP7;WNT4;PHACTR4
8691,GO:0034311,0.35905185344668,0.875090449466302,2,17,diol metabolic process,BP,DHFR;QDPR
9801,GO:0040020,0.359245766029844,0.875554541464084,2,16,regulation of meiotic nuclear division,BP,LIF;WNT4
2568,GO:0005852,0.359274796795572,0.874957735411549,2,17,eukaryotic translation initiation factor 3 complex,CC,EIF3B;EIF3I
11812,GO:0046697,0.359365192738036,0.875483701030689,2,16,decidualization,BP,JUNB;LIF
6861,GO:0030330,0.359569184728304,0.763526499311085,9,101,DNA damage response, signal transduction by p53 class mediator,BP,PML;TP53;CDKN1A;GADD45A;SFN;SNAI2;PTTG1IP;TFDP1;TP63
948,GO:0002367,0.359585965506972,0.800850450901157,5,52,cytokine production involved in immune response,BP,TGFB2;RSAD2;TNF;TRAF2;SMAD7
8968,GO:0035036,0.360098562731171,0.874466770360466,2,17,sperm-egg recognition,BP,B4GALT1;UBAP2L
19935,GO:2000463,0.36043770573196,0.874846640437647,2,16,positive regulation of excitatory postsynaptic potential,BP,BAIAP2;ADRB2
473,GO:0001516,0.360535332273266,0.874206077003505,2,17,prostaglandin biosynthetic process,BP,PTGES;EDN1
11676,GO:0046457,0.360535332273266,0.874206077003505,2,17,prostanoid biosynthetic process,BP,PTGES;EDN1
17089,GO:0099622,0.361286899846781,0.874341108326631,2,16,cardiac muscle cell membrane repolarization,BP,FLNA;WDR1
3698,GO:0008203,0.361512761083139,0.761944791918167,9,100,cholesterol metabolic process,BP,G6PD;NFE2L1;SCD;LSS;CLN6;HMGCS1;EBP;DHCR7;INSIG1
9584,GO:0036402,0.361515369509161,0.93599105081312,1,6,proteasome-activating ATPase activity,MF,PSMC3
11338,GO:0045661,0.361645424254217,0.83868599890774,3,28,regulation of myoblast differentiation,BP,IGFBP3;TNF;ZFP36L1
6976,GO:0030641,0.361768128681484,0.786646808767673,6,64,regulation of cellular pH,BP,TP53;CLN6;CHP1;SLC4A11;TMEM165;SLC4A2
12887,GO:0051225,0.361802764355314,0.761752555256035,9,99,spindle assembly,BP,MYBL2;BIRC3;FLNA;KIF23;HNRNPU;CLASP1;RCC1;CHMP4B;TUBB
5340,GO:0016078,0.362143155900498,0.935747272291121,1,6,tRNA catabolic process,BP,POP1
13807,GO:0060396,0.362259454743328,0.873760921217251,2,16,growth hormone receptor signaling pathway,BP,LYN;STAT5A
7383,GO:0031435,0.362350960154621,0.873706265839729,2,16,mitogen-activated protein kinase kinase kinase binding,MF,MARVELD3;TRAF2
3817,GO:0008409,0.36238001856969,0.873688907095007,2,16,5'-3' exonuclease activity,MF,APTX;FEN1
7740,GO:0032239,0.362631479062148,0.873538642599094,2,16,regulation of nucleobase-containing compound transport,BP,NUP153;AKAP8L
10203,GO:0042813,0.362777427751034,0.873451388585956,2,16,Wnt-activated receptor activity,MF,SFRP1;ROR1
12964,GO:0051346,0.362866624498852,0.716944753771856,23,279,negative regulation of hydrolase activity,BP,CRYAB;MMP9;AMOT;TGFB2;SH3RF2;BIRC3;TP53;TNF;PKMYT1;CHP1;SFN;SERPINE1;ANXA8;CD2BP2;SERPINH1;RCC2;PPP1R14C;PPP1R9B;A2ML1;CD109;TNFRSF10A;NOL3;SH3BP4
3433,GO:0007221,0.362971539030529,0.873335295628241,2,16,positive regulation of transcription of Notch receptor target,BP,WWC1;PBX1
2044,GO:0004791,0.363261769540069,0.935311523457072,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD1
3596,GO:0008022,0.363438355446363,0.737397971513575,14,162,protein C-terminus binding,MF,FN1;NEFL;CTGF;DAPK3;TP53;TJP2;HSPG2;BAIAP2;DST;BANF1;BCAM;XRCC6;SNF8;MKI67
9287,GO:0035725,0.363611882454652,0.775276754112669,7,75,sodium ion transmembrane transport,BP,CHP1;FXYD3;NEDD4L;YWHAH;SLC4A11;ACTN4;SLC3A2
7953,GO:0032552,0.364026196878964,0.935012730935482,1,6,deoxyribonucleotide binding,MF,HSP90AB1
2436,GO:0005635,0.364029843369401,0.70549093569779,31,376,nuclear envelope,CC,DTX2;ABCF1;PTGES;DST;NUP153;CDK4;RRP12;EBP;AEN;DHCR7;BANF1;GPER1;DNAJB2;CBX5;CMTM3;POLA1;DCTN1;DNASE1;NUP214;DNAJC1;PCYT1A;RCC1;TNPO3;CHMP4B;PHLPP1;IPO4;EIF5A;TUBB;BRIP1;LRRC59;PARP1
10294,GO:0043043,0.364178731412057,0.69084831402569,51,673,peptide biosynthetic process,BP,HSPB1;ABCF1;DAPK3;TNF;CARS2;ENC1;CDKAL1;NUP153;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;PABPC4;DPH2;CTIF;LARP4B;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;ZFP36L2;PUM3;AJUBA;RPS2;RPS9;NUP214;MRPS12;MRPS24;DNAJC1;ERAL1;MRPL20;RPL27A;MRPL33;ESR1;TCOF1;EIF3B;RBM4;METTL16;EFTUD2;EIF3I;EIF5A;EEF1D;MRPS2;AARSD1;POLR2G;GCLC;CCL5;MAGOH
14154,GO:0061035,0.364405856230061,0.813849413743413,4,39,regulation of cartilage development,BP,CYR61;CTGF;BMP2;SNAI2
6940,GO:0030548,0.364559716176832,0.934803704812233,1,6,acetylcholine receptor regulator activity,MF,LYPD6B
17082,GO:0099602,0.364559716176832,0.934803704812233,1,6,neurotransmitter receptor regulator activity,MF,LYPD6B
15147,GO:0071248,0.364785056369939,0.75913942446303,9,101,cellular response to metal ion,BP,MMP9;NQO1;CYP1A1;EDN1;JUNB;DAXX;FUS;JUN;PARP1
19786,GO:2000210,0.364841349220416,0.934693202312799,1,6,positive regulation of anoikis,BP,BRMS1
7785,GO:0032310,0.364961663476658,0.934645961208332,1,6,prostaglandin secretion,BP,EDN1
7894,GO:0032462,0.365177698391597,0.871418970571979,2,17,regulation of protein homooligomerization,BP,CRYAB;CLDN7
6034,GO:0019103,0.365958748290697,0.934253669802976,1,6,pyrimidine nucleotide binding,MF,HSP90AB1
18280,GO:1903169,0.365987394861029,0.773258284533882,7,76,regulation of calcium ion transmembrane transport,BP,JPH2;G6PD;LYN;JPH1;GPER1;RRAD;STAC
16630,GO:0097485,0.366232193253971,0.731788440850868,15,172,neuron projection guidance,BP,EFNB2;KLF7;L1CAM;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;SEMA3C;ENAH;ZSWIM6;EFNB1;BMP7;DAG1;EFNA1
16065,GO:0089720,0.366394932446859,0.934081615393828,1,6,caspase binding,MF,NOL3
13742,GO:0060314,0.366489060833515,0.870626293414025,2,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2;JPH1
15046,GO:0070990,0.366615045338555,0.933994688641381,1,6,snRNP binding,MF,SNRNP70
3286,GO:0006974,0.36677817033293,0.684940362466967,59,740,cellular response to DNA damage stimulus,BP,PML;MAP3K14;IKBKE;NUAK1;TP53;CDKN1A;LYN;GADD45A;TNF;ASCC2;ZC3H12A;EPHA2;FANCC;PITHD1;SFN;AEN;APTX;TFIP11;SGK1;SNAI2;PRPF19;FEN1;IER3;NPAS2;GINS2;USP43;PTTG1IP;POLA1;UHRF1;COPS3;ORAOV1;RBBP5;SFPQ;DDX39A;ACKR3;PAGR1;RUVBL2;THOC1;SUSD6;MCM7;TFDP1;HERC2;BCL2L2;ZNF365;XRCC6;CHCHD6;SMUG1;CHAF1A;KIF22;TIMELESS;RBM14;BRIP1;SUPT16H;POLR2G;CDCA5;PARP1;TP63;TOP3A;APEX2
2961,GO:0006493,0.367012187279515,0.764200671752694,8,88,protein O-linked glycosylation,BP,TET3;LFNG;GALNT18;IL15;SLC35C2;GALNT2;DAG1;DPM3
4764,GO:0010944,0.367419319661405,0.933676480756538,1,6,negative regulation of transcription by competitive promoter binding,BP,SMAD7
18036,GO:1902555,0.36748768653099,0.834357801585985,3,29,endoribonuclease complex,CC,POP1;HSD17B10;POP4
19224,GO:1905348,0.36748768653099,0.834357801585985,3,29,endonuclease complex,CC,POP1;HSD17B10;POP4
457,GO:0001302,0.367828126471255,0.933514385733482,1,6,replicative cell aging,BP,TP63
11743,GO:0046579,0.367951088077818,0.834324530860919,3,28,positive regulation of Ras protein signal transduction,BP,NRG1;ROBO1;RASGRP4
14509,GO:0062014,0.368032422395148,0.781637026072207,6,64,negative regulation of small molecule metabolic process,BP,NFKB1;BMP2;SNAI2;INSIG1;WNT4;PARP1
4069,GO:0009120,0.368076181619796,0.933415914129198,1,6,deoxyribonucleoside metabolic process,BP,TK1
1860,GO:0004523,0.36821355810041,0.933361341486334,1,6,RNA-DNA hybrid ribonuclease activity,MF,FEN1
4714,GO:0010876,0.368271768201117,0.719630382773,19,224,lipid localization,BP,INHBA;C1QTNF1;EDN1;IKBKE;APOL6;NFKB1;STOML1;EHD1;TNF;ZC3H12A;SLCO3A1;ITGAV;NFKBIA;IRS2;ABCG2;SYK;ACSL1;CPT1A;AKR1C1
12484,GO:0050435,0.368717930119563,0.833790752114485,3,28,amyloid-beta metabolic process,BP,BACE2;APH1A;EFNA1
270,GO:0000768,0.368851523823368,0.833697686121578,3,28,syncytium formation by plasma membrane fusion,BP,EHD1;MYH9;CD109
4141,GO:0009202,0.36913619767311,0.932994127785154,1,6,deoxyribonucleoside triphosphate biosynthetic process,BP,TYMS
5611,GO:0016655,0.369349711027987,0.808630318225375,4,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,NQO1;AKR1C2;DCXR;AKR1C1
5898,GO:0018103,0.369356926486081,0.932906097160232,1,6,protein C-linked glycosylation,BP,DPM3
5933,GO:0018211,0.369356926486081,0.932906097160232,1,6,peptidyl-tryptophan modification,BP,DPM3
5954,GO:0018317,0.369356926486081,0.932906097160232,1,6,protein C-linked glycosylation via tryptophan,BP,DPM3
5970,GO:0018406,0.369356926486081,0.932906097160232,1,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
13874,GO:0060491,0.369740157866277,0.743927698108179,11,125,regulation of cell projection assembly,BP,CYLD;CORO1C;EPHA2;ICAM1;MYO10;CDC42EP2;SRF;DPYSL3;RCC2;RHOG;BIN3
2672,GO:0006023,0.369802598382051,0.761934089505661,8,87,aminoglycan biosynthetic process,BP,SDC4;B4GALT1;NFKB1;HSPG2;HS3ST2;HS3ST1;PDGFB;CHST3
16678,GO:0097602,0.369836961051425,0.868591812039062,2,17,cullin family protein binding,MF,DCUN1D2;RNF7
167,GO:0000347,0.369871609446234,0.93270056238848,1,6,THO complex,CC,THOC1
213,GO:0000445,0.369871609446234,0.93270056238848,1,6,THO complex part of transcription export complex,CC,THOC1
8597,GO:0034101,0.369930713754577,0.761702642042904,8,89,erythrocyte homeostasis,BP,MAFB;INHBA;G6PD;NFE2L1;LYN;SRF;ETS1;ZFP36L1
4598,GO:0010713,0.370076067870326,0.93261880853103,1,6,negative regulation of collagen metabolic process,BP,ERRFI1
1469,GO:0003725,0.370346031942655,0.779875947811713,6,63,double-stranded RNA binding,MF,TFRC;APTX;HNRNPU;DUS2;SLC3A2;HSP90AB1
15900,GO:0072666,0.370658154765342,0.808998991207525,4,40,establishment of protein localization to vacuole,BP,GNPTAB;HSPA8;TNFAIP3;SNF8
2587,GO:0005881,0.370790137518625,0.792152515423624,5,52,cytoplasmic microtubule,CC,SAA1;CYLD;MID1;CLASP1;DCXR
9025,GO:0035234,0.370958576430222,0.932265247296012,1,6,ectopic germ cell programmed cell death,BP,IL1A
14807,GO:0070534,0.371123245363335,0.808650391488553,4,40,protein K63-linked ubiquitination,BP,TRIM56;PRPF19;TRAF2;RNF115
10491,GO:0043388,0.371360858806997,0.808290375647641,4,41,positive regulation of DNA binding,BP,MMP9;EDF1;CDCA5;PARP1
13854,GO:0060457,0.371608474386524,0.932004165190435,1,6,negative regulation of digestive system process,BP,OXTR
877,GO:0002230,0.371664565405677,0.867474648379466,2,17,positive regulation of defense response to virus by host,BP,ZC3H12A;PQBP1
14918,GO:0070761,0.371672698371794,0.931978331799223,1,6,pre-snoRNP complex,CC,NOP56
67,GO:0000138,0.371748122804902,0.931947985608283,1,6,Golgi trans cisterna,CC,B4GALT1
1234,GO:0002922,0.371761681215948,0.931942529666702,1,6,positive regulation of humoral immune response,BP,TNF
14028,GO:0060753,0.371849255160212,0.931907283328957,1,6,regulation of mast cell chemotaxis,BP,SWAP70
16898,GO:0098843,0.372076089543694,0.931815937029162,1,6,postsynaptic endocytic zone,CC,CLTA
14920,GO:0070765,0.372149405564351,0.931786396868317,1,6,gamma-secretase complex,CC,APH1A
7609,GO:0031995,0.372188182249819,0.93177077002553,1,6,insulin-like growth factor II binding,MF,IGFBP3
8462,GO:0033599,0.372370362275306,0.867041974423851,2,17,regulation of mammary gland epithelial cell proliferation,BP,ROBO1;ZNF703
3512,GO:0007422,0.372645635393868,0.790699417213363,5,52,peripheral nervous system development,BP,NRG1;RUNX1;PARD3;CNTNAP1;DAG1
17396,GO:1900122,0.373324471136187,0.931311892595591,1,6,positive regulation of receptor binding,BP,MMP9
15899,GO:0072665,0.37341780334293,0.790093648545549,5,52,protein localization to vacuole,BP,GNPTAB;HSPA8;TNFAIP3;SNF8;SH3BP4
8307,GO:0033139,0.373731449366056,0.931147088078261,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
8807,GO:0034511,0.373746190038386,0.931141114423009,1,6,U3 snoRNA binding,MF,TSR1
14734,GO:0070391,0.373759906451919,0.93113555556787,1,6,response to lipoteichoic acid,BP,CCL20
15133,GO:0071223,0.373759906451919,0.93113555556787,1,6,cellular response to lipoteichoic acid,BP,CCL20
15869,GO:0072588,0.374351469423293,0.927898133868405,1,8,box H/ACA RNP complex,CC,DKC1
14503,GO:0061980,0.374399723404447,0.829812971827008,3,28,regulatory RNA binding,MF,ZC3H12A;ZC3H7B;RBM4
1982,GO:0004702,0.37455424130847,0.757952466518415,8,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAP3K14;IKBKE;FGFR2;EPHB6;EPHA2;ROR1;OXSR1;MAPK11
5067,GO:0015288,0.374672903518562,0.930764936368918,1,6,porin activity,MF,TOMM40
13755,GO:0060331,0.37480715207526,0.930710338730819,1,6,negative regulation of response to interferon-gamma,BP,PARP14
13760,GO:0060336,0.37480715207526,0.930710338730819,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,PARP14
8230,GO:0032990,0.374812913197242,0.689138943347982,38,462,cell part morphogenesis,BP,NRG1;MAP2;FN1;NEFL;PANK2;BAIAP2;EFNB2;CORO1C;PDPN;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DOCK10;SGK1;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;SEMA3C;YWHAH;ENAH;PQBP1;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;DAG1;EFNA1
4894,GO:0014820,0.374871998766212,0.930683956886074,1,6,tonic smooth muscle contraction,BP,EDN1
16466,GO:0097136,0.375001410522,0.930631289660594,1,6,Bcl-2 family protein complex,CC,BCL2L2
7991,GO:0032609,0.375030352521375,0.788697930568204,5,53,interferon-gamma production,BP,INHBA;IL27RA;TNF;ZC3H12A;CD274
20138,GO:2000831,0.375061364608278,0.93060688172318,1,6,regulation of steroid hormone secretion,BP,C1QTNF1
13599,GO:0060068,0.375090944520728,0.93059483752202,1,6,vagina development,BP,ESR1
8258,GO:0033034,0.37513977486738,0.930574952265611,1,6,positive regulation of myeloid cell apoptotic process,BP,CDKN2A
1001,GO:0002475,0.375289770250131,0.930513847921153,1,6,antigen processing and presentation via MHC class Ib,BP,TAP2
4782,GO:0010968,0.375346833795069,0.930490593150821,1,6,regulation of microtubule nucleation,BP,DCTN1
7478,GO:0031642,0.375443299317314,0.93045127044577,1,6,negative regulation of myelination,BP,TNFRSF21
1989,GO:0004709,0.375560162703486,0.788543909825502,5,51,MAP kinase kinase kinase activity,MF,MAP3K14;FGFR2;EPHB6;EPHA2;ROR1
6025,GO:0019083,0.375594465296971,0.729734738692379,13,171,viral transcription,BP,NUP153;RPLP2;NELFE;RPLP1;RPS2;RPS9;NUP214;SUPT5H;RPL27A;JUN;PSMC3;POLR2G;CCL5
6370,GO:0021554,0.375691987302353,0.930349834657838,1,6,optic nerve development,BP,NAV2
15718,GO:0072273,0.376036507691174,0.864783386876414,2,17,metanephric nephron morphogenesis,BP,LIF;WNT4
7784,GO:0032309,0.376124973371643,0.864728655160484,2,17,icosanoid secretion,BP,EDN1;SYK
8031,GO:0032675,0.376538434031645,0.774773306483252,6,64,regulation of interleukin-6 production,BP,TNF;ZC3H12A;IL1A;AFAP1L2;TNFAIP3;IL6R
4494,GO:0010519,0.376628536277793,0.929967030312271,1,6,negative regulation of phospholipase activity,BP,ANXA8
11284,GO:0045591,0.376783091225556,0.929903735810238,1,6,positive regulation of regulatory T cell differentiation,BP,SOCS1
15985,GO:0080154,0.376999306866118,0.929815131597686,1,6,regulation of fertilization,BP,B4GALT1
19458,GO:1990144,0.377221201884284,0.929724129688376,1,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,NOL3
8400,GO:0033327,0.377226685853056,0.929721879742371,1,6,Leydig cell differentiation,BP,SF1
9691,GO:0038084,0.377274578081331,0.864016429446216,2,17,vascular endothelial growth factor signaling pathway,BP,HSPB1;ROBO1
6678,GO:0030041,0.377442596776717,0.73717091165552,11,127,actin filament polymerization,BP,COBLL1;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SPTBN1;RHOG;KANK4;MYADM;BAIAP2L2
64,GO:0000127,0.377633161416248,0.92955499099193,1,6,transcription factor TFIIIC complex,CC,GTF3C2
10192,GO:0042791,0.377633161416248,0.92955499099193,1,6,5S class rRNA transcription by RNA polymerase III,BP,GTF3C2
10195,GO:0042797,0.377633161416248,0.92955499099193,1,6,tRNA transcription by RNA polymerase III,BP,GTF3C2
13968,GO:0060675,0.377782301361594,0.803632324596783,4,40,ureteric bud morphogenesis,BP,PBX1;BMP2;NPNT;WNT4
15656,GO:0072171,0.377782301361594,0.803632324596783,4,40,mesonephric tubule morphogenesis,BP,PBX1;BMP2;NPNT;WNT4
13504,GO:0055072,0.377799061448073,0.773558456270858,6,66,iron ion homeostasis,BP,FTL;FTH1;TFRC;STEAP4;ACO1;ABCG2
13944,GO:0060613,0.377858610696105,0.929462323974898,1,6,fat pad development,BP,ARRDC3
7233,GO:0031128,0.378033588326292,0.863545182982454,2,17,developmental induction,BP,BMP2;WNT4
10282,GO:0043027,0.378119483070809,0.863491802936457,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,BIRC3;NOL3
12317,GO:0048667,0.378176765868868,0.691368333552264,32,386,cell morphogenesis involved in neuron differentiation,BP,NRG1;MAP2;FN1;NEFL;BAIAP2;EFNB2;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DOCK10;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;SEMA3C;YWHAH;ENAH;PQBP1;PARD3;ZNF365;ZSWIM6;EFNB1;LRFN4;BMP7;DAG1;EFNA1
5495,GO:0016433,0.378266812623084,0.929294352247935,1,6,rRNA (adenine) methyltransferase activity,MF,METTL16
881,GO:0002246,0.378453688291833,0.929217373838883,1,6,wound healing involved in inflammatory response,BP,IL1A
3197,GO:0006825,0.378569975003083,0.862660197310305,2,18,copper ion transport,BP,HEPHL1;STEAP4
14655,GO:0070244,0.378596730065389,0.929158417399777,1,6,negative regulation of thymocyte apoptotic process,BP,EFNA1
13213,GO:0051865,0.37873562508765,0.785904874540553,5,52,protein autoubiquitination,BP,UBE4B;TRAF2;RNF115;UHRF1;RNF185
19457,GO:1990138,0.379029648268629,0.741099745957048,10,112,neuron projection extension,BP,NRG1;FN1;L1CAM;TNFRSF12A;ZFYVE27;SRF;VCL;NTN1;NEDD4L;SEMA3C
9006,GO:0035148,0.379034011113347,0.741051369935777,10,113,tube formation,BP,ADM;SDC4;IRX2;TGFB2;FGFR2;SFRP1;CC2D2A;BMP7;WNT4;PHACTR4
5520,GO:0016486,0.37910632718535,0.862877781448656,2,17,peptide hormone processing,BP,BACE2;C9ORF3
13581,GO:0060048,0.379119690829584,0.772578805433768,6,65,cardiac muscle contraction,BP,CTGF;ZC3H12A;FLNA;TPM1;NEDD4L;SMAD7
16435,GO:0097084,0.379134541988531,0.928936485850019,1,6,vascular smooth muscle cell development,BP,ADM
18921,GO:1904646,0.379178254066087,0.862832974883817,2,17,cellular response to amyloid-beta,BP,ADRB2;PARP1
3204,GO:0006837,0.379336941117696,0.928852855775504,1,6,serotonin transport,BP,SYK
3671,GO:0008168,0.379689795592776,0.719726993390499,15,176,methyltransferase activity,MF,TYMS;TRMT61A;METTL13;METTL1;NSUN2;METTL2B;NSUN5;RBBP5;FTSJ3;WDR4;PRDM7;NOP2;TRMT1;METTL16;METTL21A
11431,GO:0045844,0.379915599352196,0.80201409047628,4,40,positive regulation of striated muscle tissue development,BP,NRG1;EDN1;EFNB2;FGFR2
12299,GO:0048636,0.379915599352196,0.80201409047628,4,40,positive regulation of muscle organ development,BP,NRG1;EDN1;EFNB2;FGFR2
17792,GO:1901863,0.379915599352196,0.80201409047628,4,40,positive regulation of muscle tissue development,BP,NRG1;EDN1;EFNB2;FGFR2
7466,GO:0031624,0.380099309964572,0.825782236637175,3,28,ubiquitin conjugating enzyme binding,MF,RNF19B;DCUN1D2;RNF144B
20036,GO:2000659,0.380108286787787,0.9285335946608,1,6,regulation of interleukin-1-mediated signaling pathway,BP,IL1R2
14385,GO:0061626,0.380395652729105,0.928414432203201,1,6,pharyngeal arch artery morphogenesis,BP,TGFB2
2536,GO:0005793,0.380415598594262,0.745806750552618,9,102,endoplasmic reticulum-Golgi intermediate compartment,CC,FN1;TAP1;VMP1;CHP1;SERPINH1;SLC35C2;TAPBP;TRAPPC5;TAP2
6938,GO:0030546,0.380439917586237,0.92839606614607,1,6,receptor activator activity,MF,NRG1
16948,GO:0098930,0.380446194163096,0.801424273775885,4,41,axonal transport,BP,NEFL;HSPB1;DST;BLOC1S2
3533,GO:0007519,0.380523511313962,0.752795537406365,8,89,skeletal muscle tissue development,BP,HDAC9;TSC22D3;SVIL;EGR1;GPCPD1;DDX17;MAFF;BIN3
1483,GO:0003785,0.380561182501513,0.861414493533917,2,18,actin monomer binding,MF,COBLL1;MKL1
4707,GO:0010869,0.380621936174995,0.86193211082683,2,17,regulation of receptor biosynthetic process,BP,EDN1;ITGAV
10915,GO:0044464,0.380666602982896,0.666867240877301,848,11078,cell part,CC,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;TENM3;CYP24A1;C1QTNF1;KRT34;DTX2;ADM;SLC16A2;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CD83;HLA-B;CSF2;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;IL27RA;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;EFNB2;KRT5;CDKN2A;RING1;CARS2;CORO1C;CXCL16;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;TRIO;VMP1;GPRIN1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;LAYN;QPCT;SLC16A9;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;SLCO3A1;SLC7A5P2;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;L1CAM;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;LYPD6B;RRP12;EPGN;ANKS4B;GPR146;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;TNFRSF12A;FOXD2;NAT10;MTUS1;IQCJ-SCHIP1;IFNGR1;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;IGSF3;KCNA7;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;FAM57A;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;UPK3B;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;GPR132;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;BCAM;PREP;IFFO2;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;IL1A;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;GPR75;TNFRSF21;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;SLC43A2;DNAJC1;YWHAH;TAPBP;TRIP6;PALM2;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;VSIG1;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;SLC4A11;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;FRAS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;HCAR3;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC27;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NBPF1;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;CNTNAP1;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;LRFN4;SNIP1;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;SLC4A2;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;CLDN7;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;IL6R;BIN3;LAIR1;POP4;RPUSD4;PARP1;SLC2A6;CLK4;TP63;ZBTB12;PHACTR4;TOP3A;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
1578,GO:0003988,0.380811128615503,0.928241933630701,1,6,acetyl-CoA C-acyltransferase activity,MF,ACAA1
5210,GO:0015809,0.38089415956166,0.928207430437481,1,6,arginine transport,BP,SLC7A2
5567,GO:0016579,0.381011403208107,0.705884796633295,20,243,protein deubiquitination,BP,CYLD;BIRC3;TRAF3;TP53;PSMB9;ZC3H12A;ADRB2;USP36;PSME2;NFKBIA;TRAF2;USP43;TNIP2;SMAD7;KEAP1;ESR1;USP31;TNFAIP3;PSMC3;OTUD6A
488,GO:0001540,0.381027072571681,0.800982097425479,4,41,amyloid-beta binding,MF,CRYAB;TGFB2;BACE2;ADRB2
4480,GO:0010494,0.381129383605483,0.801091054892468,4,40,cytoplasmic stress granule,CC,PABPC4;LARP4B;PQBP1;RBM4
399,GO:0001075,0.381292088311326,0.928041933191457,1,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,TAF4B
11357,GO:0045714,0.3813990581996,0.927997405397264,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
13580,GO:0060047,0.381448228729921,0.733677770207493,11,127,heart contraction,BP,CTGF;ADM;TGFB2;EDN1;ZC3H12A;FLNA;FXYD3;TPM1;NEDD4L;SMAD7;KCNIP3
17351,GO:1900038,0.381455694760244,0.927973822835947,1,6,negative regulation of cellular response to hypoxia,BP,NOL3
17072,GO:0099568,0.381464441689653,0.692795656244969,28,339,cytoplasmic region,CC,NEFL;CTGF;HSPB1;NEDD9;BAIAP2;DST;FGFR2;TPM4;FLNA;MYO10;WDR1;PARD3B;RHOB;TRAF2;WDR34;SPTBN1;DCTN1;MYH9;LANCL2;CLASP1;PQBP1;MICAL3;BLOC1S2;PARD3;ACTN4;PHLDB2;MYADM;CLTA
12882,GO:0051219,0.381956260351576,0.770364798860218,6,64,phosphoprotein binding,MF,MID1;IRS1;LYN;SFN;APTX;SYK
19812,GO:2000270,0.382219074559592,0.927655506879448,1,6,negative regulation of fibroblast apoptotic process,BP,SFRP1
9696,GO:0038092,0.3822911244556,0.927625419392969,1,6,nodal signaling pathway,BP,CITED2
2933,GO:0006450,0.382364132426182,0.860281778528186,2,18,regulation of translational fidelity,BP,RPS9;AARSD1
8242,GO:0033010,0.382383890407891,0.927586669870341,1,6,paranodal junction,CC,CNTNAP1
18440,GO:1903523,0.382489095853952,0.860762673601816,2,17,negative regulation of blood circulation,BP,ADM;ZC3H12A
16719,GO:0097709,0.382538234634797,0.927522170448366,1,6,connective tissue replacement,BP,IL1A
2343,GO:0005381,0.382771397823057,0.927424667070845,1,6,iron ion transmembrane transporter activity,MF,TFRC
10058,GO:0042541,0.382953393443089,0.927348505526504,1,6,hemoglobin biosynthetic process,BP,INHBA
6653,GO:0030002,0.38296272996989,0.927344597069424,1,6,cellular anion homeostasis,BP,GPCPD1
6851,GO:0030320,0.38296272996989,0.927344597069424,1,6,cellular monovalent inorganic anion homeostasis,BP,GPCPD1
12346,GO:0048708,0.38312644569992,0.799380815450851,4,41,astrocyte differentiation,BP,BMP2;LIF;PRPF19;ROR1
7945,GO:0032536,0.383186883230039,0.927250723738798,1,6,regulation of cell projection size,BP,NEFL
4923,GO:0014870,0.383192765515331,0.927248259301608,1,6,response to muscle inactivity,BP,DAG1
603,GO:0001771,0.383223829093355,0.927235244091864,1,6,immunological synapse formation,BP,LGALS3
7644,GO:0032055,0.383344836853534,0.927184530045915,1,6,negative regulation of translation in response to stress,BP,RBM4
9301,GO:0035745,0.383350763999423,0.927182045443408,1,6,T-helper 2 cell cytokine production,BP,RSAD2
2931,GO:0006448,0.383451890132707,0.860157750468109,2,17,regulation of translational elongation,BP,DPH2;EIF5A
18213,GO:1903003,0.383456539214193,0.927137696842362,1,6,positive regulation of protein deubiquitination,BP,ZC3H12A
10251,GO:0042985,0.383523261447001,0.927109713642636,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,BACE2
6513,GO:0021889,0.383540615556967,0.927102434287808,1,6,olfactory bulb interneuron differentiation,BP,ROBO1
13534,GO:0055117,0.383582949612398,0.799031957226215,4,41,regulation of cardiac muscle contraction,BP,CTGF;ZC3H12A;FLNA;SMAD7
5312,GO:0016021,0.383590909315527,0.647244853895534,211,2694,integral component of membrane,CC,HEPHL1;NRG1;PTGER4;PLD5;TENM3;C1QTNF1;SLC16A2;JPH2;TAP1;IL1R2;PCDH7;SDC4;FADS3;TFRC;GPRC5A;UGT1A6;CD83;HLA-B;PTGES;TMPPE;B4GALT1;MGAM;TRAF3;EMP2;PANX1;NFE2L1;MARVELD3;STEAP4;IL27RA;GNPTAB;LFNG;IRS1;GALNT18;LYN;STOML1;LAMP1;HS3ST2;TNF;EFNB2;CXCL16;SCD;DST;VMP1;PDPN;FGFR2;CDKAL1;BACE2;SLC7A5;CLN6;EPHB6;LAYN;SLC16A9;SIRPA;JPH1;SLC39A1;CYB5R1;FAM69B;EPHA2;ICAM1;CD274;BMP2;GOSR1;SLCO3A1;SLC7A5P2;KREMEN2;DRAM1;ITGAV;L1CAM;GGCX;TMEM183B;RRP12;EPGN;GPR146;RNF19B;ADRB2;TMEM14EP;TNFRSF12A;IFNGR1;SLC5A6;FXYD3;EBP;ST6GALNAC5;RELT;SFRP1;PARL;ABCF2;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;IL7R;THBD;GPER1;HS3ST1;IGSF3;KCNA7;FAM57A;ADAM17;UPK3B;IER3;TRAF2;ABCG2;IL15;REEP1;GPR132;CMTM3;FAM74A7;SLC7A2;ROBO1;SLC43A3;BCAM;OXTR;PTTG1IP;DCBLD1;MYH9;SPPL2A;TAPBPL;TMEM159;COL17A1;NPNT;SDK1;GLIPR1;GPR75;TNFRSF21;ERVV-1;LILRB3;ROR1;PXMP2;ACSL1;ACKR3;BAMBI;TMEM140;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;TAPBP;TRIP6;M6PR;ZDHHC6;CHST3;APH1A;UBE2J2;VSIG1;TPST1;CREB3;SLC4A11;MTFP1;LPCAT3;KCNIP3;RHBDL2;SUSD6;GALNT2;MARVELD2;FRAS1;PIGM;ESR1;MANEAL;SLC22A4;HCAR3;CPT1A;SCD5;BCS1L;CCR6;INSIG1;SMIM17;GPNMB;GP6;TAP2;CHCHD6;SMPD2;CNTNAP1;EFNB1;LRFN4;TNFRSF10A;TPRA1;TOMM40;CYP20A1;ZYX;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;MGAT2;RNF185;DPM3;CD38;CYB561D2;SLC4A2;EFNA1;CLDN7;SLC3A2;SLC25A22;PTPRB;RNF144B;SLC25A44;LRRC59;TBXA2R;MCAM;ADGRF3;IL6R;LAIR1;FAM74A3;SLC2A6;TXNDC15;ARIH2OS;TMEM51;FADS1
9785,GO:0039706,0.383630383628332,0.927064773131695,1,6,co-receptor binding,MF,BMP2
16794,GO:0098632,0.383708640150089,0.822904558329351,3,29,cell-cell adhesion mediator activity,MF,PDLIM1;BAIAP2;TRIM29
179,GO:0000389,0.383752297071617,0.927013606856114,1,6,mRNA 3'-splice site recognition,BP,SF1
19763,GO:2000171,0.383785744186393,0.859947686886737,2,17,negative regulation of dendrite development,BP,YWHAH;EFNA1
2449,GO:0005658,0.383993829346011,0.926912173028814,1,6,alpha DNA polymerase:primase complex,CC,POLA1
17469,GO:1900274,0.383996160402228,0.859815211094942,2,17,regulation of phospholipase C activity,BP,RASGRP4;ESR1
11454,GO:0045906,0.384183653852112,0.926832394374372,1,6,negative regulation of vasoconstriction,BP,ADM
13486,GO:0055023,0.384234699863221,0.859664954136093,2,17,positive regulation of cardiac muscle tissue growth,BP,EDN1;FGFR2
3198,GO:0006826,0.384251149009366,0.798341918477692,4,42,iron ion transport,BP,FTL;FTH1;TFRC;STEAP4
11238,GO:0045414,0.384298971593653,0.926783903316624,1,6,regulation of interleukin-8 biosynthetic process,BP,TNF
3242,GO:0006897,0.384392982340241,0.680948037320837,37,453,endocytosis,BP,SAA1;ADM;ACTG1;TFRC;HSPG2;UBQLN2;LYN;ARPC4;EHD1;TNF;BAIAP2;CORO1C;CXCL16;SIRPA;ITGAV;MYO10;ADRB2;SERPINE1;ARPC1B;SNX12;LGALS3;SYK;NEDD4L;MYH9;SNX8;ACKR3;M6PR;RHOG;ACTN4;RAPGEF1;TINAGL1;RAB27A;CXCL8;MYO1E;CLTA;HSP90AB1;SH3BP4
15552,GO:0071971,0.3845092973746,0.926695411194159,1,6,extracellular exosome assembly,BP,SDC4
18460,GO:1903551,0.3845092973746,0.926695411194159,1,6,regulation of extracellular exosome assembly,BP,SDC4
3074,GO:0006641,0.384586174565808,0.781130489116635,5,53,triglyceride metabolic process,BP,PANK2;ACSL1;SLC22A4;CPT1A;INSIG1
20196,GO:2001053,0.384614548740917,0.926651103543244,1,6,regulation of mesenchymal cell apoptotic process,BP,BMP7
10954,GO:0044665,0.384679656634125,0.82220850403524,3,29,MLL1/2 complex,CC,SENP3;RBBP5;RUVBL2
15197,GO:0071339,0.384679656634125,0.82220850403524,3,29,MLL1 complex,CC,SENP3;RBBP5;RUVBL2
5598,GO:0016634,0.38477137833537,0.926585052854729,1,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,ACAA1
15934,GO:0072719,0.384814048036575,0.92656707574446,1,6,cellular response to cisplatin,BP,TIMELESS
12077,GO:0048025,0.38481551737809,0.859298761155196,2,17,negative regulation of mRNA splicing, via spliceosome,BP,U2AF2;SRSF7
585,GO:0001739,0.384836094643048,0.926557786273177,1,6,sex chromatin,CC,RING1
4272,GO:0009629,0.384915400571531,0.92652436433922,1,6,response to gravity,BP,FOSL1
5740,GO:0016887,0.384989914910611,0.688319131847095,29,350,ATPase activity,MF,TAP1;ABCF1;MYO1B;DDX23;KIF23;MYO10;ABCF2;DHX37;DDX42;ABCG2;DDX17;DDX47;DDX49;WDR34;MYH9;DDX39A;TAPBP;RUVBL2;HSPA8;MCM7;XRCC6;TAP2;KIF24;KIF22;DHX34;PSMC3;BRIP1;DDX24;MYO1E
10612,GO:0043596,0.385125381381806,0.797851484830996,4,41,nuclear replication fork,CC,PRPF19;GINS2;POLA1;TIMELESS
3593,GO:0008017,0.385142309748404,0.706633874940622,18,213,microtubule binding,MF,CRYAB;MAP2;NEFM;MID1;MYO1B;DST;CHP1;KIF23;MYO10;MTUS1;REEP1;DCTN1;MYH9;RCC2;CLASP1;KIF24;KIF22;MYO1E
13570,GO:0060037,0.3852888150248,0.859000007163877,2,17,pharyngeal system development,BP,TGFB2;BMP7
10851,GO:0044346,0.385340172039791,0.858967570784172,2,17,fibroblast apoptotic process,BP,SFRP1;TP63
17083,GO:0099604,0.385397727562245,0.858931215113595,2,17,ligand-gated calcium channel activity,MF,JPH2;JPH1
3071,GO:0006637,0.38541955664869,0.757023211469795,7,78,acyl-CoA metabolic process,BP,SCD;HMGCS1;AASS;ACSL1;SCD5;ACBD6;THEM4
9108,GO:0035383,0.38541955664869,0.757023211469795,7,78,thioester metabolic process,BP,SCD;HMGCS1;AASS;ACSL1;SCD5;ACBD6;THEM4
19213,GO:1905323,0.385470298164917,0.926290255150414,1,6,telomerase holoenzyme complex assembly,BP,HSP90AB1
15684,GO:0072207,0.385668689940906,0.858759995832555,2,17,metanephric epithelium development,BP,LIF;WNT4
4887,GO:0014807,0.385668989386163,0.92620631806087,1,6,regulation of somitogenesis,BP,LFNG
10046,GO:0042500,0.385688318442785,0.926198149404619,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2A
9199,GO:0035581,0.385722145310432,0.926183852503716,1,6,sequestering of extracellular ligand from receptor,BP,FBN1
4157,GO:0009219,0.385772414686265,0.858128051880593,2,18,pyrimidine deoxyribonucleotide metabolic process,BP,TYMS;SMUG1
390,GO:0001042,0.385781861968401,0.926158609194436,1,6,RNA polymerase I core binding,MF,TCOF1
12430,GO:0048934,0.385816744178559,0.926143861427997,1,6,peripheral nervous system neuron differentiation,BP,RUNX1
12431,GO:0048935,0.385816744178559,0.926143861427997,1,6,peripheral nervous system neuron development,BP,RUNX1
6453,GO:0021772,0.385850640566269,0.858644964619723,2,17,olfactory bulb development,BP,SRF;ROBO1
15304,GO:0071493,0.385858413636305,0.926126241751471,1,6,cellular response to UV-B,BP,CDKN1A
15286,GO:0071468,0.385866559513183,0.926122797018571,1,6,cellular response to acidic pH,BP,CHP1
16470,GO:0097150,0.38601147388147,0.858543245294985,2,17,neuronal stem cell population maintenance,BP,FANCC;SRRT
13672,GO:0060198,0.386025688559562,0.926055484860776,1,6,clathrin-sculpted vesicle,CC,HSPA8
18796,GO:1904338,0.386134330856377,0.926009507377317,1,6,regulation of dopaminergic neuron differentiation,BP,SFRP1
13848,GO:0060449,0.386188238867356,0.92598668702764,1,6,bud elongation involved in lung branching,BP,FGFR2
14424,GO:0061724,0.386261754992549,0.925955559273164,1,6,lipophagy,BP,ADRB2
12316,GO:0048666,0.386265784165407,0.667305392106777,57,705,neuron development,BP,NRG1;RUNX1;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;TGFB2;DBNDD2;LYN;EHD1;BAIAP2;EFNB2;ENC1;TNC;GPRIN1;FGFR2;KLF7;UBE4B;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;SRF;DOCK10;SGK1;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;DPYSL3;SDK1;SEMA3C;YWHAH;ENAH;PQBP1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;EFNA1
12746,GO:0051014,0.386290217307843,0.925943505794938,1,6,actin filament severing,BP,MYH9
20259,GO:2001223,0.386381990942825,0.925904632544829,1,6,negative regulation of neuron migration,BP,NRG1
10253,GO:0042987,0.386394420213293,0.820976419362651,3,29,amyloid precursor protein catabolic process,BP,LYN;APH1A;EFNA1
18020,GO:1902513,0.386431094990568,0.925883828080668,1,6,regulation of organelle transport along microtubule,BP,LAMP1
15060,GO:0071012,0.386504429852305,0.925852750863843,1,6,catalytic step 1 spliceosome,CC,PRPF19
18763,GO:1904251,0.38657117315452,0.92582446007685,1,6,regulation of bile acid metabolic process,BP,PANK2
18351,GO:1903321,0.386584926054818,0.766286979495547,6,67,negative regulation of protein modification by small protein conjugation or removal,BP,GNL3L;CHP1;U2AF2;SMAD7;TNFAIP3;GCLC
8740,GO:0034388,0.3868401002599,0.925710402231511,1,6,Pwp2p-containing subcomplex of 90S preribosome,CC,PWP2
10296,GO:0043045,0.386847631993838,0.925707206325007,1,6,DNA methylation involved in embryo development,BP,TET3
17677,GO:1901538,0.386847631993838,0.925707206325007,1,6,changes to DNA methylation involved in embryo development,BP,TET3
17820,GO:1901977,0.386870507630064,0.925697499097485,1,6,negative regulation of cell cycle checkpoint,BP,THOC1
5138,GO:0015651,0.386897926526072,0.925685862931192,1,6,quaternary ammonium group transmembrane transporter activity,MF,SLC22A4
714,GO:0001939,0.386935816048133,0.925669781365366,1,6,female pronucleus,CC,AKAP8
1392,GO:0003306,0.386970109356031,0.925655224327434,1,6,Wnt signaling pathway involved in heart development,BP,BMP2
3358,GO:0007094,0.387014640917612,0.820529871796801,3,29,mitotic spindle assembly checkpoint,BP,ZW10;ANAPC15;DUSP1
15116,GO:0071173,0.387014640917612,0.820529871796801,3,29,spindle assembly checkpoint,BP,ZW10;ANAPC15;DUSP1
15117,GO:0071174,0.387014640917612,0.820529871796801,3,29,mitotic spindle checkpoint,BP,ZW10;ANAPC15;DUSP1
1326,GO:0003177,0.387032679607524,0.925628659648501,1,6,pulmonary valve development,BP,TGFB2
1331,GO:0003184,0.387032679607524,0.925628659648501,1,6,pulmonary valve morphogenesis,BP,TGFB2
5227,GO:0015838,0.387076164425761,0.925610194436856,1,6,amino-acid betaine transport,BP,SLC22A4
10105,GO:0042622,0.387177217074304,0.925567273094604,1,6,photoreceptor outer segment membrane,CC,PHLPP1
18950,GO:1904714,0.387293576874967,0.925517831503143,1,6,regulation of chaperone-mediated autophagy,BP,SNRNP70
1530,GO:0003910,0.387400979962057,0.925472177919603,1,6,DNA ligase (ATP) activity,MF,PARP1
10797,GO:0044271,0.387440623935088,0.640214871180281,304,3948,cellular nitrogen compound biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;ODC1;CYP1B1;CTGF;ADM;FOSL2;NQO1;IL16;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;GEMIN5;KLF7;ZNF503;CHP1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;AJUBA;USP43;DNTTIP2;PDGFB;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ERAL1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;DUSP1;TGFBRAP1;CITED2;RPL27A;HSPA8;JUN;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;QDPR;RHOG;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;EIF5A;UAP1L1;POLR3H;EEF1D;TIMELESS;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;FADS1;MAGOH
11423,GO:0045836,0.387460930395335,0.925446687526197,1,6,positive regulation of meiotic nuclear division,BP,WNT4
4870,GO:0014731,0.387463685297956,0.925445516038569,1,6,spectrin-associated cytoskeleton,CC,SPTBN1
10143,GO:0042711,0.387475864374908,0.925440336905318,1,6,maternal behavior,BP,OXTR
15532,GO:0071921,0.387580644161726,0.925395770425047,1,6,cohesin loading,BP,CDCA5
19326,GO:1905634,0.387580644161726,0.925395770425047,1,6,regulation of protein localization to chromatin,BP,CDCA5
11858,GO:0046847,0.387594445054112,0.796146401000434,4,40,filopodium assembly,BP,MYO10;SRF;DPYSL3;PPP1R9B
19097,GO:1905005,0.387640744154923,0.925370200500095,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
15743,GO:0072319,0.387677533120668,0.92535454576986,1,6,vesicle uncoating,BP,HSPA8
11300,GO:0045617,0.387699148727475,0.925345346795,1,6,negative regulation of keratinocyte differentiation,BP,TP63
9105,GO:0035374,0.387771592753277,0.925314511691076,1,6,chondroitin sulfate binding,MF,DPYSL3
1531,GO:0003916,0.387776476452673,0.925312432712565,1,6,DNA topoisomerase activity,MF,TOP3A
14826,GO:0070562,0.387791124277676,0.92530619695926,1,6,regulation of vitamin D receptor signaling pathway,BP,SNAI2
8206,GO:0032958,0.387805031661973,0.857406443553592,2,17,inositol phosphate biosynthetic process,BP,GPER1;PPIP5K1
6821,GO:0030279,0.387862983971295,0.795749644646193,4,41,negative regulation of ossification,BP,NOCT;TNF;KREMEN2;SFRP1
8622,GO:0034138,0.387900257855717,0.85734596036365,2,17,toll-like receptor 3 signaling pathway,BP,TNIP2;TNFAIP3
16826,GO:0098711,0.387922517796104,0.925250247009895,1,6,iron ion import across plasma membrane,BP,STEAP4
8945,GO:0034983,0.387927058296658,0.925248313119567,1,6,peptidyl-lysine deacetylation,BP,HDAC9
12810,GO:0051105,0.387985942330364,0.925223230470242,1,6,regulation of DNA ligation,BP,TFIP11
711,GO:0001936,0.388052246585654,0.754817054003172,7,78,regulation of endothelial cell proliferation,BP,TNF;BMP2;STAT5A;ADAM17;PRKCA;PDGFB;JUN
12638,GO:0050830,0.388150010117411,0.818674502532082,3,33,defense response to Gram-positive bacterium,BP,IL27RA;TNF;ADAM17
7436,GO:0031545,0.388160764562515,0.925148731812469,1,6,peptidyl-proline 4-dioxygenase activity,MF,P4HA2
13498,GO:0055062,0.388168856760067,0.9251452823142,1,6,phosphate ion homeostasis,BP,GPCPD1
15810,GO:0072505,0.388168856760067,0.9251452823142,1,6,divalent inorganic anion homeostasis,BP,GPCPD1
15811,GO:0072506,0.388168856760067,0.9251452823142,1,6,trivalent inorganic anion homeostasis,BP,GPCPD1
15891,GO:0072655,0.388174028669893,0.718924999492101,13,157,establishment of protein localization to mitochondrion,BP,NRG1;TP53;CYB5R1;SFN;USP36;PARL;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;TOMM40;TP63
679,GO:0001889,0.388222332120949,0.739097186765795,9,102,liver development,BP,CYP1A1;TYMS;HMGCS1;NFKBIA;CITED2;JUN;QDPR;WNT4;TNFAIP3
9073,GO:0035312,0.388234693314966,0.925117214267376,1,6,5'-3' exodeoxyribonuclease activity,MF,APTX
17556,GO:1901098,0.388294119354534,0.925091873710977,1,6,positive regulation of autophagosome maturation,BP,ADRB2
15388,GO:0071635,0.388296379928746,0.925090909649913,1,6,negative regulation of transforming growth factor beta production,BP,HSP90AB1
12390,GO:0048813,0.388513113509242,0.738898567659769,9,101,dendrite morphogenesis,BP,MAP2;BAIAP2;KLF7;DOCK10;NEDD4L;YWHAH;PQBP1;ZNF365;EFNA1
15450,GO:0071763,0.388520247482603,0.924995400039786,1,6,nuclear membrane organization,BP,GPER1
6022,GO:0019080,0.38853363338319,0.714609615100414,14,185,viral gene expression,BP,NUP153;RPLP2;NELFE;RPLP1;RPS2;RPS9;NUP214;SUPT5H;RPL27A;JUN;EIF3B;PSMC3;POLR2G;CCL5
8170,GO:0032906,0.388559033078179,0.924978845239078,1,6,transforming growth factor beta2 production,BP,TGFB2
8173,GO:0032909,0.388559033078179,0.924978845239078,1,6,regulation of transforming growth factor beta2 production,BP,TGFB2
19779,GO:2000197,0.388573508979355,0.924972665940728,1,6,regulation of ribonucleoprotein complex localization,BP,AKAP8L
20115,GO:2000794,0.388694572794562,0.924920975545734,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
11072,GO:0045072,0.388702069222306,0.924917774097151,1,6,regulation of interferon-gamma biosynthetic process,BP,INHBA
11422,GO:0045835,0.388702069222306,0.924917774097151,1,6,negative regulation of meiotic nuclear division,BP,LIF
6967,GO:0030621,0.388751914975252,0.924896484695602,1,6,U4 snRNA binding,MF,GEMIN5
326,GO:0000912,0.388770977785609,0.9248883418906,1,6,assembly of actomyosin apparatus involved in cytokinesis,BP,KIF23
327,GO:0000915,0.388770977785609,0.9248883418906,1,6,actomyosin contractile ring assembly,BP,KIF23
13058,GO:0051549,0.388836559363179,0.924860324182238,1,6,positive regulation of keratinocyte migration,BP,MMP9
5828,GO:0017108,0.388861757862808,0.92484955720776,1,6,5'-flap endonuclease activity,MF,FEN1
3337,GO:0007050,0.388864276453725,0.703197854467844,18,216,cell cycle arrest,BP,INHBA;PML;TGFB2;TP53;CDKN2B;CDKN1A;GADD45A;CDKN2A;CDK4;SFN;IRF1;GPER1;PPP1R9B;DUSP1;CAB39;TFDP1;CXCL8;HSP90AB1
5094,GO:0015368,0.388901399580574,0.924832616942213,1,6,calcium:cation antiporter activity,MF,SLC3A2
9911,GO:0042246,0.388921791807379,0.819153729617977,3,29,tissue regeneration,BP,EPPK1;DAG1;BIN3
14061,GO:0060839,0.388973145681994,0.924801951460551,1,6,endothelial cell fate commitment,BP,PDPN
11265,GO:0045540,0.389025378213135,0.794854616647164,4,41,regulation of cholesterol biosynthetic process,BP,SCD;LSS;HMGCS1;DHCR7
5578,GO:0016595,0.389059131279132,0.924765189746235,1,6,glutamate binding,MF,GCLC
7431,GO:0031532,0.38912694158413,0.75391465268003,7,78,actin cytoskeleton reorganization,BP,DAPK3;NEDD9;BAIAP2;FLNA;MYH9;RHOG;BAIAP2L2
6876,GO:0030368,0.389134715085297,0.924732866108401,1,6,interleukin-17 receptor activity,MF,IL27RA
5763,GO:0016929,0.389165276599329,0.924719793985968,1,6,SUMO-specific protease activity,MF,SENP3
14712,GO:0070341,0.389186176600642,0.924710853600896,1,6,fat cell proliferation,BP,TFDP1
14714,GO:0070344,0.389186176600642,0.924710853600896,1,6,regulation of fat cell proliferation,BP,TFDP1
9671,GO:0038030,0.389211435494552,0.924700047751125,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT4
600,GO:0001767,0.389221484656828,0.924695748419134,1,6,establishment of lymphocyte polarity,BP,MYH9
16926,GO:0098903,0.389225197081126,0.924694160095252,1,6,regulation of membrane repolarization during action potential,BP,FLNA
5473,GO:0016406,0.389229793197327,0.924692193664246,1,6,carnitine O-acyltransferase activity,MF,CPT1A
9839,GO:0042074,0.389230496480253,0.924691892764533,1,6,cell migration involved in gastrulation,BP,AMOT
8511,GO:0033689,0.389230911399768,0.924691715240819,1,6,negative regulation of osteoblast proliferation,BP,SFRP1
2313,GO:0005313,0.38923279202601,0.924690910609842,1,6,L-glutamate transmembrane transporter activity,MF,SLC25A22
5012,GO:0015172,0.38923279202601,0.924690910609842,1,6,acidic amino acid transmembrane transporter activity,MF,SLC25A22
8478,GO:0033623,0.389233101456161,0.924690778218819,1,6,regulation of integrin activation,BP,PTGER4
8416,GO:0033391,0.389233173150341,0.924690747544141,1,6,chromatoid body,CC,NSUN2
3631,GO:0008091,0.389233173269983,0.924690747492947,1,6,spectrin,CC,SPTBN1
15711,GO:0072257,0.389233173269983,0.924690747492947,1,6,metanephric nephron tubule epithelial cell differentiation,BP,LIF
15735,GO:0072307,0.389233173269983,0.924690747492947,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
2610,GO:0005915,0.389233173269986,0.924690747492944,1,6,zonula adherens,CC,PLEKHA7
4419,GO:0010216,0.389233173269986,0.924690747492944,1,6,maintenance of DNA methylation,BP,UHRF1
5640,GO:0016725,0.389233173269986,0.924690747492944,1,6,oxidoreductase activity, acting on CH or CH2 groups,MF,RRM2
6081,GO:0019237,0.389233173269986,0.924690747492944,1,6,centromeric DNA binding,MF,ZW10
8207,GO:0032959,0.389233173269986,0.924690747492944,1,6,inositol trisphosphate biosynthetic process,BP,GPER1
11160,GO:0045217,0.389233173269986,0.924690747492944,1,6,cell-cell junction maintenance,BP,PLEKHA7
14011,GO:0060732,0.389233173269986,0.924690747492944,1,6,positive regulation of inositol phosphate biosynthetic process,BP,GPER1
16533,GO:0097264,0.389233173269986,0.924690747492944,1,6,self proteolysis,BP,TENM3
19062,GO:1904929,0.389233173269986,0.924690747492944,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,ROR1
804,GO:0002072,0.389233173269987,0.924690747492944,1,6,optic cup morphogenesis involved in camera-type eye development,BP,PHACTR4
1410,GO:0003344,0.389233173269987,0.924690747492944,1,6,pericardium morphogenesis,BP,BMP7
2611,GO:0005916,0.389233173269987,0.924690747492944,1,6,fascia adherens,CC,VCL
6504,GO:0021873,0.389233173269987,0.924690747492944,1,6,forebrain neuroblast division,BP,FGFR2
8996,GO:0035112,0.389233173269987,0.924690747492944,1,6,genitalia morphogenesis,BP,TP63
10228,GO:0042908,0.389233173269987,0.924690747492944,1,6,xenobiotic transport,BP,ABCG2
10229,GO:0042910,0.389233173269987,0.924690747492944,1,6,xenobiotic transmembrane transporter activity,MF,ABCG2
10373,GO:0043190,0.389233173269987,0.924690747492944,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCF2
12184,GO:0048312,0.389233173269987,0.924690747492944,1,6,intracellular distribution of mitochondria,BP,CLUH
15363,GO:0071599,0.389233173269987,0.924690747492944,1,6,otic vesicle development,BP,FGFR2
4539,GO:0010612,0.389233173270017,0.924690747492913,1,6,regulation of cardiac muscle adaptation,BP,ERRFI1
6685,GO:0030050,0.389233173270017,0.924690747492913,1,6,vesicle transport along actin filament,BP,ACTN4
14563,GO:0070087,0.389233173270017,0.924690747492913,1,6,chromo shadow domain binding,MF,CHAF1A
15574,GO:0072033,0.389233173270017,0.924690747492913,1,6,renal vesicle formation,BP,WNT4
17087,GO:0099612,0.389233173270017,0.924690747492913,1,6,protein localization to axon,BP,CNTNAP1
18315,GO:1903242,0.389233173270017,0.924690747492913,1,6,regulation of cardiac muscle hypertrophy in response to stress,BP,ERRFI1
2904,GO:0006413,0.38943825406551,0.713778485730498,14,186,translational initiation,BP,HSPB1;TNF;EIF5;CTIF;RPLP2;RPLP1;RPS2;RPS9;RPL27A;EIF3B;RBM4;EIF3I;POLR2G;CCL5
1551,GO:0003950,0.389500124237088,0.856327892072133,2,17,NAD+ ADP-ribosyltransferase activity,MF,PARP14;PARP1
10248,GO:0042982,0.38981200004978,0.794248055238209,4,41,amyloid precursor protein metabolic process,BP,LYN;BACE2;APH1A;EFNA1
6173,GO:0019538,0.389830623060288,0.637476621978361,323,4202,protein metabolic process,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CTGF;TENM3;C1QTNF1;DTX2;IL1R2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;ABCF1;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;APOL6;TP53;SQSTM1;MARVELD3;IL24;P4HA2;NFKB1;CPA4;CDKN2B;MPND;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;UBQLN2;ADAMTS9;LYN;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;FGFR2;PTPN14;CDKAL1;NUP153;BACE2;PSMB9;CLN6;EPHB6;TELO2;KRT17;C9ORF3;QPCT;UBE2C;TYMS;ZC3H12A;FLNA;TNK1;GEMIN5;EPHA2;CHP1;EIF5;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;SERPINE1;PABPC4;PGK1;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;PARL;TRIM22;ZDHHC3;PPP1R3B;ANXA8;IRF1;PSME2;DNPEP;DPH2;CTIF;GPER1;DNAJB2;LARP4B;ABTB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;SNX12;DHFR;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;ACO1;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;BRMS1;PREP;OXTR;RPS2;PTTG1IP;RPS9;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;RNF115;UHRF1;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MRPS12;MRPS24;MTA2;DNAJC1;KEAP1;ZDHHC6;ERAL1;CHST3;APH1A;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;A2ML1;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;GALNT2;DUSP1;CAB39;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;MRPL33;DTX4;ESR1;TCOF1;USP31;BRPF1;GLIPR2;EIF3B;NOC2L;CHMP4B;RBM4;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;LAMC1;GPNMB;XRCC6;KBTBD12;BMP7;METTL16;PHLPP1;EFTUD2;TNFRSF10A;OVCH2;RNF7;MPHOSPH8;INCENP;EIF3I;RAPGEF1;EIF5A;TINAGL1;MYADM;DAG1;TMEM165;MGAT2;RNF185;EEF1D;ASB6;DPM3;MRPS2;RBM14;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;AARSD1;METTL21A;XPNPEP3;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;POLR2G;DUSP8;CLTA;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;TP63;OTUD6A;C1S;PHACTR4;CCL5;MAGOH
9946,GO:0042306,0.389893836498737,0.794184910947051,4,41,regulation of protein import into nucleus,BP,CDKN1A;ZC3H12A;CHP1;HSP90AB1
6916,GO:0030507,0.390274795918016,0.855833637435626,2,17,spectrin binding,MF,GBP1;MYO10
11776,GO:0046634,0.390419202726794,0.793779361194806,4,41,regulation of alpha-beta T cell activation,BP,CD83;IRF1;SYK;SMAD7
15387,GO:0071634,0.390676461334751,0.855577034529412,2,17,regulation of transforming growth factor beta production,BP,TGFB2;HSP90AB1
3318,GO:0007021,0.390727789100991,0.92217724133188,1,7,tubulin complex assembly,BP,CRYAB
4682,GO:0010830,0.390763157207954,0.817820716121934,3,29,regulation of myotube differentiation,BP,HDAC9;EHD1;RBM38
14619,GO:0070182,0.390764329943656,0.854944128099547,2,18,DNA polymerase binding,MF,NAT10;HSP90AB1
3272,GO:0006949,0.390879131801921,0.817736616185666,3,29,syncytium formation,BP,EHD1;MYH9;CD109
1346,GO:0003209,0.391225499247752,0.855225914959378,2,17,cardiac atrium morphogenesis,BP,CYR61;TGFB2
15226,GO:0071378,0.391324109834875,0.855162806668192,2,17,cellular response to growth hormone stimulus,BP,LYN;STAT5A
4941,GO:0014902,0.391446331639326,0.775638887897355,5,53,myotube differentiation,BP,HDAC9;EHD1;MYH9;RBM38;BIN3
3219,GO:0006865,0.391505538410113,0.751990554068798,7,77,amino acid transport,BP,NFKBIE;SLC7A5;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
4190,GO:0009267,0.391596670226576,0.730090324109748,10,114,cellular response to starvation,BP,TP53;CDKN1A;ZC3H12A;CADPS2;SFRP1;KLF10;HSPA8;JUN;WNT4;FADS1
795,GO:0002063,0.391722377785595,0.854907785559479,2,17,chondrocyte development,BP,COL27A1;SERPINH1
10331,GO:0043123,0.391844989527186,0.719860299078297,12,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,MAP3K14;IKBKE;BIRC3;TNF;FLNA;TRIM22;TRAF2;AJUBA;IL1A;TNIP2;ROR1;EEF1D
2246,GO:0005158,0.39187759541478,0.854808335118799,2,17,insulin receptor binding,MF,IRS1;IRS2
7055,GO:0030833,0.391884534404104,0.729751398141295,10,116,regulation of actin filament polymerization,BP,ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SPTBN1;RHOG;KANK4;MYADM;BAIAP2L2
3243,GO:0006898,0.39195982673403,0.711993367996805,14,165,receptor-mediated endocytosis,BP,SAA1;ADM;TFRC;HSPG2;UBQLN2;CXCL16;ADRB2;SERPINE1;SYK;ACKR3;M6PR;TINAGL1;CXCL8;CLTA
2834,GO:0006302,0.392051948380949,0.705498518825966,16,194,double-strand break repair,BP,PML;APTX;TFIP11;PRPF19;FEN1;GINS2;POLA1;ORAOV1;SFPQ;HERC2;ZNF365;XRCC6;TIMELESS;BRIP1;CDCA5;PARP1
10542,GO:0043489,0.392263426358311,0.816731475931079,3,29,RNA stabilization,BP,NOCT;DKC1;HNRNPU
11257,GO:0045499,0.392393782132455,0.854477361246382,2,17,chemorepellent activity,MF,NRG1;SEMA3C
10269,GO:0043009,0.392456444275844,0.676028055116341,34,415,chordate embryonic development,BP,CYR61;ADM;AMOT;SDC4;CSF2;TGFB2;EDN1;LFNG;JUNB;FGFR2;PBX1;FOSL1;SLC39A1;BMP2;ELF3;LIF;OSR2;SFRP1;CC2D2A;SRF;PRPF19;ZFP36L1;PDGFB;RRP7A;MYH9;COPS3;SEMA3C;MAFF;KEAP1;TCOF1;BMP7;PSMC3;MYO1E;PHACTR4
11147,GO:0045197,0.392554472902556,0.816519839092146,3,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,WDR1;PARD3B;PARD3
6731,GO:0030145,0.392659392161842,0.792046544652903,4,41,manganese ion binding,MF,SOD2;B4GALT1;GALNT2;XPNPEP3
3188,GO:0006811,0.393087698442637,0.656602720923397,68,858,ion transport,BP,HEPHL1;FTL;FTH1;MMP9;CTGF;SLC16A2;JPH2;IL16;NFKBIE;PML;TFRC;CSF2;EDN1;G6PD;PANX1;STEAP4;LYN;SLC7A5;SLC16A9;JPH1;SLC39A1;FLNA;CYB5R1;CHP1;TSC22D3;ICAM1;SLCO3A1;SLC7A5P2;ITGAV;ADRB2;SLC5A6;FXYD3;PARL;WDR1;GPER1;KCNA7;SGK1;IRS2;LGALS3;SYK;SLC7A2;PDGFB;NEDD4L;COX5B;ACSL1;SLC35C2;SLC43A2;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;SLC22A4;CPT1A;COMMD9;ACTN4;TOMM40;SLC41A2;TMEM165;AKR1C1;SLC4A2;SLC3A2;SLC25A22;NOL3;SLC2A6;CCL5
3718,GO:0008236,0.393311088125935,0.741788918053355,8,91,serine-type peptidase activity,MF,MMP9;C1R;PRSS23;PARL;PREP;RHBDL2;OVCH2;C1S
4619,GO:0010737,0.393450754404366,0.853216131901862,2,18,protein kinase A signaling,BP,LCP1;ADRB2
9950,GO:0042311,0.393526107797246,0.853167514975978,2,18,vasodilation,BP,SOD2;ADRB2
14206,GO:0061135,0.393600753734843,0.749857623657908,7,82,endopeptidase regulator activity,MF,BIRC3;SERPINE1;PSME2;SERPINH1;A2ML1;CD109;NOL3
11426,GO:0045839,0.393857768370689,0.790933587908099,4,42,negative regulation of mitotic nuclear division,BP,ZW10;ANAPC15;DUSP1;BMP7
5560,GO:0016572,0.394310664643406,0.815240544197663,3,29,histone phosphorylation,BP,AKAP8L;AKAP8;PRKCA
8126,GO:0032814,0.394320086758318,0.85265476256397,2,18,regulation of natural killer cell activation,BP,LAMP1;IL15
7891,GO:0032459,0.394561265742979,0.814765548897956,3,30,regulation of protein oligomerization,BP,CRYAB;TP53;CLDN7
8034,GO:0032680,0.39468638423558,0.759599503785617,6,67,regulation of tumor necrosis factor production,BP,HSPB1;ZC3H12A;ERRFI1;AKAP8;GPNMB;TNFAIP3
3357,GO:0007093,0.394757573887644,0.713130222896668,13,154,mitotic cell cycle checkpoint,BP,PML;TP53;CDKN2B;CDKN1A;GADD45A;SFN;ORAOV1;PRCC;ZW10;ANAPC15;DUSP1;TFDP1;TP63
1254,GO:0003008,0.39516094175749,0.656018692775753,64,801,system process,BP,CRYAB;NRG1;INHBA;NEFL;CYP1B1;CTGF;C1QTNF1;ADM;SOD2;TGFB2;EDN1;DAPK3;G6PD;EMP2;TJP2;NAV2;TPM4;CLN6;FOSL1;C9ORF3;ZC3H12A;FLNA;ICAM1;ERRFI1;ADRB2;FXYD3;TPM1;WDR1;GPER1;SRF;SGK1;SNAI2;FEN1;VCL;ACO1;IL15;PRKCA;NOB1;PDGFB;OXTR;NEDD4L;NPNT;TNFRSF21;ROR1;SMAD7;VSIG1;KCNIP3;MARVELD2;STAC;JUN;PARD3;CNTNAP1;SORBS2;DAG1;PDE6A;AKR1C1;CD38;MYO1E;XPNPEP3;NOL3;GCLC;TBXA2R;MCAM;PARP1
7231,GO:0031126,0.396135985488432,0.919776996894762,1,7,snoRNA 3'-end processing,BP,DKC1
8088,GO:0032770,0.396364312824827,0.851330488551403,2,18,positive regulation of monooxygenase activity,BP,TNF;DHFR
16676,GO:0097581,0.396373025241981,0.758392851486791,6,65,lamellipodium organization,BP,CORO1C;PDPN;EPHA2;VCL;AJUBA;BIN3
4497,GO:0010522,0.396483753552278,0.771444618040312,5,54,regulation of calcium ion transport into cytosol,BP,JPH2;PML;LYN;JPH1;GPER1
2970,GO:0006508,0.39674387174597,0.64560551354732,98,1251,proteolysis,BP,CRYAB;MMP9;CYR61;FN1;C1R;CTGF;TENM3;IL1R2;PML;CYLD;BIRC3;PRSS23;SPSB1;TRAF3;TP53;SQSTM1;NFKB1;CPA4;MPND;UBQLN2;ADAMTS9;LYN;TNF;ENC1;BACE2;PSMB9;CLN6;C9ORF3;UBE2C;ZC3H12A;UBE4B;SFN;RNF19B;ADRB2;SERPINE1;PGK1;USP36;SFRP1;PARL;ANXA8;PSME2;DNPEP;GPER1;ABTB2;NFKBIA;PRPF19;ADAM17;SNX12;KCTD10;TRAF2;ROBO1;SENP3;USP43;PREP;NSFL1C;NEDD4L;SERPINH1;RNF115;UHRF1;MYH9;SPPL2A;COPS3;TNIP2;SMAD7;DNAJC1;KEAP1;APH1A;CAPNS1;UBE2J2;TRIB1;A2ML1;ANAPC15;RHBDL2;CD109;HSPBP1;ESR1;USP31;CHMP4B;HERC2;TNFRSF10A;OVCH2;RNF7;TINAGL1;DAG1;RNF185;TNFAIP3;PSMC3;EFNA1;XPNPEP3;RNF144B;NOL3;SNF8;GCLC;HSP90AB1;PARP1;TP63;OTUD6A;C1S
17282,GO:0140030,0.39724273983659,0.72514332421559,10,114,modification-dependent protein binding,MF,IKBKE;SQSTM1;LYN;CBX5;UHRF1;TNIP2;RBBP5;BRD9;MPHOSPH8;TNFAIP3
6148,GO:0019438,0.397549876125487,0.631376106332084,266,3428,aromatic compound biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PGK1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;USP43;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;QDPR;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;SMUG1;ZNF34;MPHOSPH8;ELK1;PHF5A;UAP1L1;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;FADS1;MAGOH
5521,GO:0016491,0.397645863662739,0.665249304353885,41,529,oxidoreductase activity,MF,HEPHL1;FTH1;P3H2;CYP1B1;CYP24A1;NQO1;CYP1A1;FADS3;SOD2;TXNRD1;TET3;G6PD;GFOD1;STEAP4;P4HA2;SCD;PGD;CYB5R1;ACAA1;BMP2;PGK1;DHCR7;TXN2;CYP4B1;DHFR;AKR1C2;AASS;COX5B;DOHH;MICAL3;BLOC1S2;DCXR;SCD5;DUS2;QDPR;CYP20A1;GPX4;AKR1C1;RRM2;HSD17B10;FADS1
87,GO:0000175,0.398122745373988,0.81215503430815,3,30,3'-5'-exoribonuclease activity,MF,USB1;NOCT;ISG20L2
5166,GO:0015711,0.398140569354907,0.686348860617338,22,265,organic anion transport,BP,SLC16A2;NFKBIE;EDN1;SLC7A5;SLC16A9;CYB5R1;SLCO3A1;SLC7A5P2;SLC5A6;IRS2;SYK;SLC7A2;ACSL1;SLC35C2;SLC43A2;SLC4A11;SLC22A4;CPT1A;AKR1C1;SLC4A2;SLC3A2;SLC25A22
11594,GO:0046173,0.398825476446086,0.787061374403971,4,42,polyol biosynthetic process,BP,GPER1;DHFR;PPIP5K1;QDPR
2948,GO:0006476,0.399200496626737,0.73679037428268,8,90,protein deacetylation,BP,HDAC9;TP53;AKAP8L;AKAP8;BRMS1;SFPQ;MTA2;RBM14
2098,GO:0004865,0.399445951567208,0.918286011298196,1,7,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14C
12303,GO:0048641,0.399467548010296,0.811461522063776,3,29,regulation of skeletal muscle tissue development,BP,HDAC9;TSC22D3;DDX17
9529,GO:0036257,0.399767011930908,0.810944402599954,3,30,multivesicular body organization,BP,CHMP4B;RAB27A;SNF8
10353,GO:0043162,0.399808191925314,0.849086085157845,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,RNF115;SNF8
25,GO:0000049,0.400317677161574,0.768332607191167,5,54,tRNA binding,MF,NAT10;METTL1;NSUN2;TRMT1;HSD17B10
13771,GO:0060349,0.400552515015165,0.768273134592969,5,53,bone morphogenesis,BP,FGFR2;COL27A1;OSR2;SERPINH1;INSIG1
3331,GO:0007041,0.400745468083638,0.735457981094966,8,90,lysosomal transport,BP,GNPTAB;LAMP1;ADRB2;RHOB;M6PR;TGFBRAP1;HSPA8;VPS52
14062,GO:0060840,0.400796107741145,0.768074903625493,5,53,artery development,BP,TGFB2;ADAMTS9;EFNB2;SRF;SMAD7
11436,GO:0045861,0.400826558312064,0.694691388290017,17,210,negative regulation of proteolysis,BP,CRYAB;MMP9;IL1R2;PML;BIRC3;SFN;SERPINE1;ANXA8;SNX12;SERPINH1;DNAJC1;A2ML1;CD109;TNFRSF10A;EFNA1;NOL3;HSP90AB1
12359,GO:0048736,0.40085688002002,0.71658086692098,11,127,appendage development,BP,TGFB2;FGFR2;PBX1;SLC39A1;KREMEN2;OSR2;SEMA3C;FRAS1;FOXN1;BMP7;TP63
13660,GO:0060173,0.40085688002002,0.71658086692098,11,127,limb development,BP,TGFB2;FGFR2;PBX1;SLC39A1;KREMEN2;OSR2;SEMA3C;FRAS1;FOXN1;BMP7;TP63
6920,GO:0030512,0.401559957849563,0.7673209334554,5,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,FBN1;ADAM17;BAMBI;SMAD7;CD109
1261,GO:0003015,0.402049537006101,0.715445034042185,11,129,heart process,BP,CTGF;ADM;TGFB2;EDN1;ZC3H12A;FLNA;FXYD3;TPM1;NEDD4L;SMAD7;KCNIP3
13033,GO:0051489,0.402320545813772,0.809356362982388,3,29,regulation of filopodium assembly,BP,MYO10;SRF;DPYSL3
16810,GO:0098656,0.402622730601448,0.706127188374338,13,152,anion transmembrane transport,BP,SLC7A5;SLC7A5P2;SLC5A6;FXYD3;IRS2;SLC7A2;SLC35C2;SLC43A2;SLC4A11;CPT1A;SLC4A2;SLC3A2;SLC25A22
489,GO:0001541,0.402649035536994,0.78406179343456,4,42,ovarian follicle development,BP,INHBA;LFNG;ICAM1;ESR1
18685,GO:1904031,0.402956502375224,0.80858630592637,3,30,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A;ADAM17;PDGFB
5901,GO:0018107,0.403272653087398,0.733274067467282,8,90,peptidyl-threonine phosphorylation,BP,DAPK3;PRKCA;CAMK1G;SMAD7;CAB39;OXSR1;PARD3;BMP7
11744,GO:0046580,0.403526772970419,0.783559156454213,4,41,negative regulation of Ras protein signal transduction,BP,TGFB2;TNK1;SPRY4;RAPGEF1
870,GO:0002220,0.40405519349379,0.732296192596867,8,95,innate immune response activating cell surface receptor signaling pathway,BP,RELB;NFKB1;LYN;PSMB9;PSME2;NFKBIA;SYK;PSMC3
872,GO:0002223,0.40405519349379,0.732296192596867,8,95,stimulatory C-type lectin receptor signaling pathway,BP,RELB;NFKB1;LYN;PSMB9;PSME2;NFKBIA;SYK;PSMC3
2327,GO:0005342,0.404101642482236,0.732556476835493,8,90,organic acid transmembrane transporter activity,MF,SLC16A2;SLC7A5;SLC16A9;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
11911,GO:0046943,0.404101642482236,0.732556476835493,8,90,carboxylic acid transmembrane transporter activity,MF,SLC16A2;SLC7A5;SLC16A9;SLC7A5P2;SLC7A2;SLC43A2;SLC3A2;SLC25A22
8066,GO:0032735,0.404388535576432,0.846074863914937,2,18,positive regulation of interleukin-12 production,BP,IRF1;MAPK11
5908,GO:0018130,0.404405677828733,0.624665779476812,266,3431,heterocycle biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;KLF7;ZNF503;CHP1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PGK1;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;USP43;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;QDPR;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;SMUG1;ZNF34;MPHOSPH8;ELK1;PHF5A;UAP1L1;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;FADS1;MAGOH
18221,GO:1903018,0.404694436649963,0.807295966954964,3,30,regulation of glycoprotein metabolic process,BP,BACE2;CHP1;IL15
12282,GO:0048593,0.404786115506349,0.75126998116477,6,66,camera-type eye morphogenesis,BP,TENM3;RING1;EPHA2;SDK1;BMP7;PHACTR4
15492,GO:0071855,0.404800604881854,0.915838350573259,1,7,neuropeptide receptor binding,MF,EDN1
5938,GO:0018230,0.405435635884332,0.845382267856448,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC3;ZDHHC6
5939,GO:0018231,0.405435635884332,0.845382267856448,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC3;ZDHHC6
10026,GO:0042470,0.405436244177866,0.731275267541915,8,92,melanosome,CC,TFRC;RAB32;LAMP1;HSPA8;GPNMB;RAB27A;SLC3A2;HSP90AB1
12379,GO:0048770,0.405436244177866,0.731275267541915,8,92,pigment granule,CC,TFRC;RAB32;LAMP1;HSPA8;GPNMB;RAB27A;SLC3A2;HSP90AB1
10106,GO:0042623,0.405835462159917,0.675773050369857,24,291,ATPase activity, coupled,MF,TAP1;MYO1B;DDX23;MYO10;DHX37;DDX42;ABCG2;DDX17;DDX47;DDX49;WDR34;MYH9;DDX39A;TAPBP;RUVBL2;HSPA8;MCM7;XRCC6;TAP2;DHX34;PSMC3;BRIP1;DDX24;MYO1E
10991,GO:0044788,0.406177476883471,0.844890633258876,2,18,modulation by host of viral process,BP,ZC3H12A;HSPA8
9243,GO:0035635,0.406232387195282,0.844854211637043,2,18,entry of bacterium into host cell,BP,ITGAV;CXCL8
16229,GO:0090276,0.406308701252621,0.717014179213133,10,117,regulation of peptide hormone secretion,BP,IRS1;TNF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
12944,GO:0051303,0.406418643906769,0.74989890057116,6,66,establishment of chromosome localization,BP,RRS1;ZW10;HNRNPU;CHMP4B;KIF22;CDCA5
18072,GO:1902652,0.406526464418052,0.723064027555237,9,104,secondary alcohol metabolic process,BP,G6PD;NFE2L1;SCD;LSS;CLN6;HMGCS1;EBP;DHCR7;INSIG1
17639,GO:1901362,0.406601011595714,0.622294993828913,273,3524,organic cyclic compound biosynthetic process,BP,MAFB;TRIM16;NRG1;RUNX1;CYR61;INHBA;HDAC9;CYP1B1;CTGF;ADM;FOSL2;IL16;NFKBIE;PML;TFCP2L1;CYLD;MYBL2;PDLIM1;TRAF1;IRX2;RELB;SOD2;CD3EAP;ARID3B;IER2;CSF2;FBN1;TGFB2;EDN1;DAPK3;TET3;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;CDKN1A;AHR;JUNB;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;SCD;WWC1;ASCC2;FGFR2;PTPN14;PBX1;NUP153;NFKB2;DNAJB1;PSMB9;LSS;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TK1;KLF7;ZNF503;CHP1;HMGCS1;CCDC85B;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;PMM2;STAT5A;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PGK1;EBP;TOX4;AKAP8L;VGLL3;ELF3;LIF;OSR2;SFRP1;TRIM22;SAFB2;DHCR7;MKL1;IRF1;PSME2;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;AKAP8;NELFE;DKC1;DHFR;U2AF2;RIPK4;NPAS2;CBX5;PPRC1;MAFK;TRAF2;ZNF778;ZFP36L2;SYK;POLR1A;DDX17;NFKBIB;AJUBA;USP43;DNTTIP2;PDGFB;BRMS1;UBTF;ALYREF;PHAX;POLA1;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SUPT5H;MTA2;YWHAH;TRIP6;KEAP1;HNRNPU;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;DUSP1;TGFBRAP1;CITED2;HSPA8;JUN;ESR1;IKZF3;FOXN1;BRPF1;COMMD9;TFDP1;ZNF772;ZNF512;GTF2E1;NOP2;NOC2L;GTF3C2;SERTAD1;NACC1;ZNF703;INSIG1;ARGLU1;QDPR;RHOG;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;GLIS3;SNIP1;BMP7;KCTD1;SMUG1;ZNF34;MPHOSPH8;ELK1;PHF5A;UAP1L1;POLR3H;EEF1D;TIMELESS;WNT4;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;FADS1;MAGOH
6196,GO:0019673,0.406647589874124,0.914983788575221,1,7,GDP-mannose metabolic process,BP,PMM2
6987,GO:0030665,0.406662151485087,0.749596731171506,6,67,clathrin-coated vesicle membrane,CC,TFRC;ADRB2;IL7R;M6PR;HSPA8;CLTA
5539,GO:0016528,0.407109807671643,0.780541166431886,4,42,sarcoplasm,CC,P3H2;JPH2;JPH1;NOL3
11805,GO:0046686,0.407398240359251,0.779959833781685,4,44,response to cadmium ion,BP,MMP9;DAXX;JUN;GCLC
7266,GO:0031234,0.407432595146184,0.749046021605553,6,66,extrinsic component of cytoplasmic side of plasma membrane,CC,CYLD;LYN;TNK1;ERRFI1;SYK;CYTH1
18920,GO:1904645,0.407440766237279,0.844051608393765,2,18,response to amyloid-beta,BP,ADRB2;PARP1
7665,GO:0032094,0.407498215966083,0.844013398247161,2,18,response to food,BP,CYP1A1;G6PD
12092,GO:0048066,0.407668962832804,0.805078616860617,3,30,developmental pigmentation,BP,ADAMTS9;RAB32;RAB27A
16809,GO:0098655,0.407984284677592,0.662303374871376,33,412,cation transmembrane transport,BP,MMP9;JPH2;G6PD;PANX1;STEAP4;LYN;JPH1;SLC39A1;FLNA;CHP1;ITGAV;ADRB2;FXYD3;PARL;GPER1;KCNA7;SLC7A2;NEDD4L;COX5B;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;SLC22A4;ACTN4;SLC41A2;SLC3A2;SLC25A22;NOL3;SLC2A6
1977,GO:0004693,0.408187678385612,0.80469079084767,3,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDKN1A;CDK4;CDKL1
10398,GO:0043229,0.408448001407019,0.623002431366644,711,9289,intracellular organelle,CC,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;NEFL;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;SACS;NEFM;ACTG1;TRIM47;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;FANCC;ARFRP1;PITHD1;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;SERPINE1;FUS;PABPC4;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;OSR2;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;EPPK1;IL7R;DDX42;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;PREP;IFFO2;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;SNX8;RBBP5;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;UBE2J2;CEP41;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPA8;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;SMPD2;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;SNIP1;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;MYADM;DAG1;TMEM165;CGNL1;POLR3H;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;BIN3;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
6122,GO:0019370,0.408490217004744,0.914125957331761,1,7,leukotriene biosynthetic process,BP,SYK
65,GO:0000132,0.408609175598917,0.843273561207906,2,18,establishment of mitotic spindle orientation,BP,DCTN1;ZW10
8264,GO:0033044,0.408748320329371,0.67470992318166,23,279,regulation of chromosome organization,BP,PML;TP53;GNL3L;UBE2C;NAT10;AKAP8L;LIF;SNAI2;AKAP8;NELFE;DKC1;FEN1;UHRF1;SFPQ;ZW10;HNRNPU;RUVBL2;ANAPC15;DUSP1;NOC2L;CDCA5;MKI67;PARP1
35,GO:0000070,0.408821081869692,0.704653406201159,12,142,mitotic sister chromatid segregation,BP,UBE2C;KIF23;AKAP8L;RRS1;AKAP8;ZW10;HNRNPU;ANAPC15;DUSP1;CHMP4B;KIF22;CDCA5
11428,GO:0045841,0.40887844848586,0.804173794157184,3,30,negative regulation of mitotic metaphase/anaphase transition,BP,ZW10;ANAPC15;DUSP1
17867,GO:1902100,0.40887844848586,0.804173794157184,3,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,ZW10;ANAPC15;DUSP1
5716,GO:0016853,0.408984307237938,0.71451460491495,10,120,isomerase activity,MF,PTGES;LSS;HMGCS1;PMM2;EBP;PUS1;DKC1;TRUB2;RPUSD4;TOP3A
12270,GO:0048563,0.409103254176578,0.913839384996298,1,7,post-embryonic animal organ morphogenesis,BP,FBN1
2707,GO:0006073,0.409380751990188,0.760914680141395,5,54,cellular glucan metabolic process,BP,MGAM;IRS1;PPP1R3B;IRS2;GBE1
10721,GO:0044042,0.409380751990188,0.760914680141395,5,54,glucan metabolic process,BP,MGAM;IRS1;PPP1R3B;IRS2;GBE1
15437,GO:0071709,0.409668457875848,0.84256648769479,2,18,membrane assembly,BP,EMP2;SPTBN1
9504,GO:0036151,0.409872057666374,0.842430399565255,2,18,phosphatidylcholine acyl-chain remodeling,BP,PLBD1;LPCAT3
13648,GO:0060155,0.409965665301233,0.913435244924518,1,7,platelet dense granule organization,BP,BLOC1S2
3350,GO:0007077,0.410020550119351,0.778231585524724,4,42,mitotic nuclear envelope disassembly,BP,NUP153;BANF1;PRKCA;NUP214
18728,GO:1904181,0.410590671701587,0.913141629011475,1,7,positive regulation of membrane depolarization,BP,PARP1
8999,GO:0035116,0.41069548995201,0.841879401069282,2,18,embryonic hindlimb morphogenesis,BP,OSR2;TP63
3444,GO:0007253,0.410893719190253,0.912999042783676,1,7,cytoplasmic sequestering of NF-kappaB,BP,NFKBIA
14140,GO:0061008,0.411205258620194,0.718947393588479,9,104,hepaticobiliary system development,BP,CYP1A1;TYMS;HMGCS1;NFKBIA;CITED2;JUN;QDPR;WNT4;TNFAIP3
12934,GO:0051291,0.411384374496791,0.725598425407478,8,101,protein heterooligomerization,BP,C1QTNF1;MAT2A;BIRC3;SQSTM1;TRAF2;CAB39;RCC1;XRCC6
13744,GO:0060316,0.411890092333929,0.912529225595014,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2
7873,GO:0032434,0.412307567044297,0.717923511907608,9,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;RNF144B;GCLC;HSP90AB1
865,GO:0002200,0.412392333092624,0.758430635529933,5,54,somatic diversification of immune receptors,BP,TFRC;IL27RA;THOC1;CCR6;SWAP70
10795,GO:0044267,0.412902602654787,0.615371571206793,300,3914,cellular protein metabolic process,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;P3H2;CTGF;C1QTNF1;DTX2;IL1R2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;ABCF1;CSF2;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;TP53;SQSTM1;MARVELD3;IL24;P4HA2;NFKB1;CPA4;CDKN2B;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;UBQLN2;LYN;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;FGFR2;PTPN14;CDKAL1;NUP153;PSMB9;CLN6;EPHB6;TELO2;KRT17;QPCT;UBE2C;TYMS;ZC3H12A;TNK1;GEMIN5;EPHA2;CHP1;EIF5;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;SERPINE1;PABPC4;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;TRIM22;ZDHHC3;PPP1R3B;ANXA8;PSME2;DPH2;CTIF;GPER1;DNAJB2;LARP4B;ABTB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;SNX12;DHFR;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;ACO1;RPLP1;TRAF2;IL15;PRKCA;ZFP36L2;PUM3;SYK;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;BRMS1;OXTR;RPS2;PTTG1IP;RPS9;NSFL1C;SPTBN1;NEDD4L;SERPINH1;RNF115;UHRF1;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MRPS12;MRPS24;MTA2;DNAJC1;KEAP1;ZDHHC6;ERAL1;APH1A;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;A2ML1;PARP14;ANAPC15;PRDM7;MRPL20;GALNT2;DUSP1;CAB39;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;MRPL33;DTX4;ESR1;TCOF1;USP31;BRPF1;GLIPR2;EIF3B;NOC2L;CHMP4B;RBM4;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;LAMC1;GPNMB;XRCC6;KBTBD12;BMP7;METTL16;PHLPP1;EFTUD2;TNFRSF10A;RNF7;MPHOSPH8;INCENP;EIF3I;RAPGEF1;EIF5A;TINAGL1;MYADM;DAG1;TMEM165;MGAT2;RNF185;EEF1D;ASB6;DPM3;MRPS2;RBM14;TRAF4;CTDSP1;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;AARSD1;METTL21A;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;POLR2G;DUSP8;CLTA;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;OTUD6A;PHACTR4;CCL5;MAGOH
9666,GO:0038024,0.41307041390583,0.775801176869725,4,42,cargo receptor activity,MF,TFRC;CXCL16;ACKR3;TINAGL1
11864,GO:0046854,0.413208541101947,0.74416844562177,6,66,phosphatidylinositol phosphorylation,BP,NRG1;IRS1;FGFR2;IRS2;PDGFB;ESR1
17819,GO:1901976,0.413270804322159,0.800872183686233,3,30,regulation of cell cycle checkpoint,BP,THOC1;ANAPC15;DUSP1
12140,GO:0048240,0.413281728006486,0.91187041945579,1,7,sperm capacitation,BP,CCR6
5077,GO:0015301,0.413433649001859,0.840040144144886,2,18,anion:anion antiporter activity,MF,SLC4A11;SLC4A2
3715,GO:0008233,0.413494869621225,0.660335155419815,30,373,peptidase activity,MF,MMP9;C1R;CYLD;PRSS23;CPA4;MPND;ADAMTS9;BACE2;PSMB9;C9ORF3;ZC3H12A;USP36;SFRP1;PARL;DNPEP;ADAM17;SENP3;USP43;PREP;SPPL2A;APH1A;CAPNS1;RHBDL2;USP31;OVCH2;TINAGL1;TNFAIP3;XPNPEP3;OTUD6A;C1S
3320,GO:0007026,0.413685111460754,0.839870691552389,2,18,negative regulation of microtubule depolymerization,BP,MID1;CLASP1
3058,GO:0006620,0.41369060260581,0.911676276872538,1,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,CHMP4B
8291,GO:0033116,0.413710099543424,0.757210239351253,5,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,TAP1;VMP1;SLC35C2;TAPBP;TAP2
3205,GO:0006839,0.413807388218863,0.675605987015198,20,249,mitochondrial transport,BP,NRG1;TP53;CYB5R1;SFN;USP36;PARL;COX5B;WDR46;YWHAH;UBE2J2;BLOC1S2;CPT1A;TFDP1;THEM4;SNIP1;TOMM40;SLC25A22;SLC25A44;NOL3;TP63
19396,GO:1905906,0.414086922615415,0.911487843866072,1,7,regulation of amyloid fibril formation,BP,CRYAB
17538,GO:1901033,0.414298303799215,0.911387239900787,1,7,positive regulation of response to reactive oxygen species,BP,TNF
6556,GO:0021988,0.414419380877906,0.839375368144964,2,18,olfactory lobe development,BP,SRF;ROBO1
15455,GO:0071782,0.414455900817811,0.839350712199406,2,18,endoplasmic reticulum tubular network,CC,ZFYVE27;REEP1
6006,GO:0019048,0.414578784578692,0.799884257390261,3,30,modulation by virus of host morphology or physiology,BP,TYMS;ZC3H12A;DAG1
4245,GO:0009445,0.414658086935443,0.911215843840154,1,7,putrescine metabolic process,BP,ODC1
17526,GO:1901016,0.414779884811662,0.799732171259781,3,30,regulation of potassium ion transmembrane transporter activity,BP,NEDD4L;CAB39;OXSR1
6758,GO:0030182,0.414895847429116,0.63563749984018,68,851,neuron differentiation,BP,NRG1;RUNX1;INHBA;HDAC9;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;WNT10A;IER2;TGFB2;DAPK3;DBNDD2;LYN;EHD1;BAIAP2;EFNB2;ENC1;TNC;GPRIN1;FGFR2;PBX1;KLF7;BMP2;UBE4B;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;SRF;DOCK10;SGK1;PRPF19;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;DPYSL3;SDK1;SEMA3C;YWHAH;ENAH;PQBP1;ABT1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;WNT4;CTDSP1;EFNA1
5072,GO:0015295,0.415237301303489,0.838822698413938,2,18,solute:proton symporter activity,MF,SLC25A22;SLC2A6
12844,GO:0051154,0.415384539340634,0.838723106803022,2,18,negative regulation of striated muscle cell differentiation,BP,G6PD;BMP2
3870,GO:0008494,0.415561911814424,0.91078437074297,1,7,translation activator activity,MF,CTIF
2483,GO:0005721,0.415635270187291,0.838553440647108,2,18,pericentric heterochromatin,CC,CBX5;INCENP
8058,GO:0032725,0.415658276836174,0.910738291218563,1,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,SYK
15170,GO:0071294,0.415725513125632,0.909127120297375,1,8,cellular response to zinc ion,BP,PARP1
16482,GO:0097164,0.415728146290204,0.703135763530302,11,131,ammonium ion metabolic process,BP,ODC1;TGFB2;PLBD1;ABHD4;AKR1C2;LPCAT3;PCYT1A;SLC22A4;CPT1A;SMPD2;AKR1C1
7412,GO:0031497,0.415834728510063,0.707893686726176,10,134,chromatin assembly,BP,TP53;CDKN2A;DAXX;MCM2;GRWD1;CENPN;NOC2L;CENPO;IPO4;CHAF1A
16341,GO:0090575,0.415908648344107,0.702973359406714,11,131,RNA polymerase II transcription factor complex,CC,TP53;HNRNPAB;TAF4B;JUNB;PBX1;EDF1;SFPQ;HNRNPU;JUN;TFDP1;GTF2E1
7371,GO:0031418,0.415927353966329,0.838355676860208,2,18,L-ascorbic acid binding,MF,P3H2;P4HA2
4960,GO:0015035,0.41600506045769,0.837241737380896,2,20,protein disulfide oxidoreductase activity,MF,TXNRD1;TXN2
5852,GO:0017148,0.416074580560537,0.680564169745033,17,216,negative regulation of translation,BP,DAPK3;ENC1;NUP153;TYMS;ZC3H12A;ZC3H7B;SRRT;ZFP36L1;DHFR;ZFP36L2;AJUBA;NUP214;ESR1;RBM4;SNIP1;METTL16;POLR2G
14843,GO:0070585,0.416435282770319,0.693391766773073,13,160,protein localization to mitochondrion,BP,NRG1;TP53;CYB5R1;SFN;USP36;PARL;WDR46;YWHAH;UBE2J2;TFDP1;SNIP1;TOMM40;TP63
17796,GO:1901880,0.416534633417989,0.773027593492654,4,42,negative regulation of protein depolymerization,BP,MID1;SPTBN1;CLASP1;SWAP70
10323,GO:0043112,0.416704265146625,0.702294595428092,11,130,receptor metabolic process,BP,NRG1;ADM;TFRC;EDN1;UBQLN2;TNF;ITGAV;SYK;ACKR3;CXCL8;CLTA
4800,GO:0010992,0.41680270656263,0.910189926671995,1,7,ubiquitin recycling,BP,UBE2C
235,GO:0000492,0.416838698936791,0.910172646895981,1,7,box C/D snoRNP assembly,BP,RUVBL2
15368,GO:0071605,0.416853721761494,0.910165433900089,1,7,monocyte chemotactic protein-1 production,BP,IL1A
15390,GO:0071637,0.416853721761494,0.910165433900089,1,7,regulation of monocyte chemotactic protein-1 production,BP,IL1A
8069,GO:0032740,0.416937727939526,0.910125092916568,1,7,positive regulation of interleukin-17 production,BP,IL15
10615,GO:0043603,0.416941241854931,0.63354518311011,68,905,cellular amide metabolic process,BP,CYR61;HSPB1;ABCF1;PTGES;DAPK3;G6PD;PANK2;TNF;CARS2;ENC1;CDKAL1;NUP153;BACE2;CLN6;KRT17;C9ORF3;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;STAT5A;SLC5A6;PABPC4;DNPEP;DPH2;CTIF;LARP4B;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;ZFP36L2;PUM3;AJUBA;RPS2;RPS9;SNRNP70;SPPL2A;NUP214;MRPS12;MRPS24;DNAJC1;TAPBP;ERAL1;APH1A;MRPL20;RPL27A;HSPA8;MRPL33;ESR1;TCOF1;EIF3B;RBM4;SMPD2;METTL16;EFTUD2;EIF3I;EIF5A;EEF1D;MRPS2;EFNA1;AARSD1;POLR2G;GCLC;CCL5;MAGOH
18169,GO:1902931,0.416947284232983,0.910120503138468,1,7,negative regulation of alcohol biosynthetic process,BP,NFKB1
11783,GO:0046641,0.417141850727525,0.910027023534167,1,7,positive regulation of alpha-beta T cell proliferation,BP,SYK
2640,GO:0005976,0.417343589519578,0.729764422916788,7,79,polysaccharide metabolic process,BP,MGAM;NFKB1;IRS1;PPP1R3B;IRS2;PDGFB;GBE1
12389,GO:0048812,0.417480176345518,0.651412452153748,35,431,neuron projection morphogenesis,BP,NRG1;MAP2;FN1;NEFL;BAIAP2;EFNB2;FGFR2;KLF7;L1CAM;TNFRSF12A;ZFYVE27;SRF;DOCK10;SGK1;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;SEMA3C;YWHAH;ENAH;PQBP1;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;DAG1;EFNA1
12068,GO:0048016,0.417950054134699,0.79732783506575,3,30,inositol phosphate-mediated signaling,BP,NRG1;EDN1;CHP1
11505,GO:0045989,0.41797265229145,0.909627187799893,1,7,positive regulation of striated muscle contraction,BP,CTGF
7751,GO:0032266,0.418373810020662,0.797005473626886,3,30,phosphatidylinositol-3-phosphate binding,MF,JPH2;LANCL2;PARD3
15161,GO:0071277,0.418581277492,0.771382477934835,4,42,cellular response to calcium ion,BP,EDN1;JUNB;FUS;JUN
19408,GO:1905941,0.41868449601706,0.909283729234072,1,7,positive regulation of gonad development,BP,CITED2
7324,GO:0031333,0.418806964653238,0.719538677298189,8,93,negative regulation of protein complex assembly,BP,CRYAB;PTGER4;TFIP11;SPTBN1;INSIG1;KANK4;MYADM;CLDN7
15367,GO:0071604,0.419145125093139,0.836168813085903,2,18,transforming growth factor beta production,BP,TGFB2;HSP90AB1
15813,GO:0072509,0.419245782605194,0.836100161968612,2,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A1;SLC41A2
3622,GO:0008076,0.419578106861748,0.796088079891793,3,30,voltage-gated potassium channel complex,CC,KCNA7;KCNIP3;CNTNAP1
16142,GO:0090150,0.419813275411524,0.669781081786043,20,266,establishment of protein localization to membrane,BP,TP53;CHP1;ARFRP1;SFN;ZDHHC3;RPLP2;RPLP1;REEP1;RPS2;RPS9;SPTBN1;TRAM2;YWHAH;ZDHHC6;RPL27A;TFDP1;CHMP4B;PARD3;RILPL2;TP63
14937,GO:0070820,0.420010012939634,0.710998479679458,9,107,tertiary granule,CC,FTH1;MMP9;MGAM;LAMP1;QPCT;SIRPA;LGALS3;PTPRB;LAIR1
4807,GO:0012505,0.420055392435834,0.610066111637972,245,3159,endomembrane system,CC,IGFBP3;KRT1;SPRR3;FTL;CRYAB;FTH1;MMP9;CYR61;S100P;FN1;P3H2;CYP1B1;CTGF;DTX2;JPH2;CYP1A1;TAP1;NFKBIE;PML;PCDH7;SDC4;FADS3;TFRC;ABCF1;UGT1A6;HLA-B;PTGES;FBN1;TGFB2;EDN1;GBP1;IKBKE;PRSS23;B4GALT1;MGAM;DBNDD2;RSAD2;TRAF3;EMP2;HRNR;PANX1;TP53;NFE2L1;SQSTM1;STEAP4;P4HA2;NEDD9;NFKB1;GNPTAB;LFNG;GALNT18;HSPG2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;PLEKHO2;LAMP1;HS3ST2;EHD1;TNF;COL12A1;BAIAP2;PKMYT1;SCD;TNC;DST;VMP1;FGFR2;CDKAL1;NUP153;BACE2;COL4A1;LSS;CLN6;QPCT;SIRPA;JPH1;SLC39A1;ZC3H12A;CYB5R1;SART1;FAM69B;ACAA1;CHP1;ARFRP1;CD274;COL16A1;GOSR1;COL27A1;CDK4;KREMEN2;ITGAV;GGCX;CDC42EP2;COL9A2;RRP12;ANKS4B;RNF19B;ADRB2;MTUS1;SERPINE1;LSG1;EBP;NMT2;ST6GALNAC5;AMOTL2;AEN;ELF3;TRIM22;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;ANXA8;ABHD4;PDE4DIP;BANF1;GPER1;DNAJB2;HS3ST1;AP4S1;PARD3B;SGK1;RRS1;CYP4B1;AKAP8;RHOB;SNX12;VCL;CBX5;LGALS3;ACO1;TRAF2;IL15;REEP1;PRKCA;PUM3;CMTM3;AJUBA;PDGFB;POLA1;NSFL1C;NEDD4L;SERPINH1;DCTN1;DNASE1;COLGALT1;DPYSL3;COL5A3;SPPL2A;TAPBPL;COL17A1;CAMK1G;GLIPR1;SNX8;RUNDC1;LILRB3;ZW10;ACSL1;RCC2;COL5A2;NUP214;ACKR3;TRAM2;CRCP;SLC35A4;SLC35C2;DNAJC1;TAPBP;KEAP1;M6PR;ZDHHC6;CLASP1;CHST3;APH1A;UBE2J2;TPST1;CREB3;TUSC1;TANGO2;LPCAT3;KCNIP3;PCYT1A;GALNT2;ATG101;CAB39;TGFBRAP1;CD109;RPL27A;HSPA8;PIGM;ESR1;MANEAL;RCC1;GLIPR2;COMMD9;SCD5;TNPO3;TRAPPC5;CHMP4B;ARRDC3;INSIG1;DUS2;PARD3;LAMC1;RHOG;XRCC6;TAP2;SMPD2;ACTN4;PHLPP1;SGSM1;RAPGEF1;IPO4;EIF5A;DAG1;TMEM165;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;DPM3;WNT4;VPS52;TUBB;CYTH1;PSMC3;SPG21;BRIP1;PTPRB;CLTA;NOL3;SNF8;LRRC59;HSP90AB1;TBXA2R;LAIR1;PARP1;TP63;FADS1;SH3BP4
5123,GO:0015491,0.420239552686208,0.835421594391264,2,18,cation:cation antiporter activity,MF,SLC22A4;SLC3A2
4545,GO:0010623,0.420595627371302,0.908357629904872,1,7,programmed cell death involved in cell development,BP,IL1A
1403,GO:0003337,0.42077290555566,0.908271428557725,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
11054,GO:0045047,0.420813471752673,0.725422994391342,7,101,protein targeting to ER,BP,PMM2;RPLP2;RPLP1;RPS2;RPS9;RPL27A;CHMP4B
5145,GO:0015672,0.420826210622414,0.669063467284188,20,249,monovalent inorganic cation transport,BP,FLNA;CHP1;ADRB2;SLC5A6;FXYD3;KCNA7;SGK1;NEDD4L;COX5B;YWHAH;SLC4A11;KCNIP3;CAB39;OXSR1;SLC22A4;COMMD9;ACTN4;SLC3A2;SLC25A22;SLC2A6
12433,GO:0050000,0.420830479447123,0.737581647555074,6,67,chromosome localization,BP,RRS1;ZW10;HNRNPU;CHMP4B;KIF22;CDCA5
1180,GO:0002827,0.420886828488387,0.908216007139142,1,7,positive regulation of T-helper 1 type immune response,BP,IL27RA
19701,GO:2000036,0.420913454905612,0.834960622858682,2,18,regulation of stem cell population maintenance,BP,BMP7;TP63
7868,GO:0032429,0.421196829958489,0.90806509194497,1,7,regulation of phospholipase A2 activity,BP,ANXA8
2540,GO:0005797,0.421322900630337,0.908003674127518,1,7,Golgi medial cisterna,CC,GOSR1
12658,GO:0050862,0.421350670571145,0.907990142030231,1,7,positive regulation of T cell receptor signaling pathway,BP,CYLD
7481,GO:0031645,0.421579359123991,0.90787865676701,1,7,negative regulation of neurological system process,BP,TNFRSF21
4185,GO:0009262,0.421588989031965,0.793983627674557,3,32,deoxyribonucleotide metabolic process,BP,TYMS;SMUG1;RRM2
7640,GO:0032050,0.421625046930352,0.907856374013833,1,7,clathrin heavy chain binding,MF,CLTA
9604,GO:0036462,0.421821748110196,0.907760401131125,1,7,TRAIL-activated apoptotic signaling pathway,BP,TNFRSF10A
2381,GO:0005516,0.422182055693777,0.697389739381852,11,129,calmodulin binding,MF,MAP2;MYO1B;MYO10;EDF1;SPTBN1;MYH9;CAMK1G;TJP1;RRAD;PCYT1A;MYO1E
4767,GO:0010951,0.422277650530628,0.697082305737492,11,135,negative regulation of endopeptidase activity,BP,CRYAB;MMP9;BIRC3;SFN;SERPINE1;ANXA8;SERPINH1;A2ML1;CD109;TNFRSF10A;NOL3
15185,GO:0071320,0.422356028929243,0.793964857639799,3,30,cellular response to cAMP,BP,AHR;ZFP36L1;RAPGEF1
12637,GO:0050829,0.42303465585549,0.831957095872657,2,21,defense response to Gram-negative bacterium,BP,SERPINE1;IL6R
10187,GO:0042780,0.423180903785041,0.907095557145763,1,7,tRNA 3'-end processing,BP,HSD17B10
2017,GO:0004745,0.423213762507329,0.907079447276911,1,7,retinol dehydrogenase activity,MF,BMP2
4093,GO:0009147,0.423239935211365,0.832277166651346,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,TYMS;CTPS1
6797,GO:0030238,0.42353048969438,0.90692407429061,1,7,male sex determination,BP,SF1
18448,GO:1903533,0.423601724281449,0.715252902870554,8,94,regulation of protein targeting,BP,NRG1;CYB5R1;CHP1;USP36;PARL;WDR46;UBE2J2;SNIP1
2401,GO:0005546,0.42362074244959,0.767122988965813,4,43,phosphatidylinositol-4,5-bisphosphate binding,MF,JPH2;MYO1B;ANXA8;PARD3
6123,GO:0019371,0.423734705606996,0.906823809067118,1,7,cyclooxygenase pathway,BP,PTGES
8087,GO:0032769,0.423802893579876,0.906790315439217,1,7,negative regulation of monooxygenase activity,BP,NFKB1
16596,GO:0097413,0.423896154632138,0.906744493920077,1,7,Lewy body,CC,SQSTM1
19370,GO:1905819,0.424249409342944,0.792215977188851,3,31,negative regulation of chromosome separation,BP,ZW10;ANAPC15;DUSP1
20127,GO:2000816,0.424249409342944,0.792215977188851,3,31,negative regulation of mitotic sister chromatid separation,BP,ZW10;ANAPC15;DUSP1
10998,GO:0044798,0.424299435056014,0.686294202005762,13,157,nuclear transcription factor complex,CC,CD3EAP;TP53;HNRNPAB;TAF4B;JUNB;PBX1;EDF1;SFPQ;HNRNPU;JUN;TFDP1;GTF2E1;GTF3C2
5282,GO:0015935,0.424454726576491,0.746890198400233,5,68,small ribosomal subunit,CC,RPS2;RPS9;MRPS12;MRPS24;MRPS2
2448,GO:0005657,0.424646115257058,0.734214306286923,6,68,replication fork,CC,TP53;PRPF19;GINS2;POLA1;UHRF1;TIMELESS
12097,GO:0048087,0.424852624066056,0.906273747934353,1,7,positive regulation of developmental pigmentation,BP,ADAMTS9
12893,GO:0051234,0.424973715782319,0.60454317619218,264,3428,establishment of localization,BP,HEPHL1;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;PTGER4;INHBA;S100P;FN1;NEFL;CTGF;C1QTNF1;ADM;SLC16A2;JPH2;ACTG1;IL16;TAP1;IL1R2;NFKBIE;PML;HSPB1;PCDH7;SDC4;TFRC;ABCF1;CSF2;TGFB2;EDN1;GBP1;B4GALT1;MGAM;RSAD2;G6PD;EMP2;HRNR;APOL6;PANX1;TP53;SQSTM1;STEAP4;NFKB1;GNPTAB;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;PLEKHO2;ARPC4;LAMP1;EHD1;TNF;BAIAP2;CORO1C;CXCL16;WWC1;DST;VMP1;PTPN14;NUP153;PSMB9;SLC7A5;QPCT;SLC16A9;SIRPA;JPH1;SLC39A1;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;ACAA1;GEMIN5;CADPS2;CHP1;TSC22D3;ICAM1;ARFRP1;CD274;GOSR1;SLCO3A1;SLC7A5P2;ITGAV;KIF23;MYO10;PMM2;SFN;STAT5A;ADRB2;SLC5A6;SERPINE1;FXYD3;ARPC1B;LSG1;EBP;NMT2;USP36;AKAP8L;LIF;SFRP1;PARL;ZFYVE27;ZDHHC3;WDR1;ANXA8;PSME2;BANF1;GPER1;AP4S1;NFKBIA;KCNA7;GEMIN4;SGK1;RRS1;ZFP36L1;RPLP2;AKAP8;RHOB;DKC1;SNX12;TXLNA;U2AF2;VCL;VPS13B;IRS2;LGALS3;ACO1;RPLP1;TRAF2;ABCG2;REEP1;PRKCA;NTN1;SYK;SLC7A2;SLC43A3;PDGFB;OXTR;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;NEDD4L;DCTN1;COX5B;MYH9;NPNT;IL1A;GLIPR1;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;LILRB3;ZW10;ACSL1;RCC2;NUP214;ACKR3;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;HNRNPU;CLASP1;RRAD;UBE2J2;CEP41;RUVBL2;SLC4A11;TANGO2;MICAL3;KCNIP3;THOC1;CAB39;TGFBRAP1;CD109;RPL27A;SOCS1;STAC;FRAS1;OXSR1;HSPA8;BLOC1S2;SLC22A4;CPT1A;COMMD9;TFDP1;TNPO3;TRAPPC5;CHMP4B;RBM4;INSIG1;HERC2;PARD3;RHOG;XRCC6;TAP2;ACTN4;THEM4;SNIP1;TOMM40;PHLDB2;SGSM1;RAPGEF1;IPO4;EIF5A;TINAGL1;KIF22;SLC41A2;DAG1;TMEM165;RNF185;RAB27A;RILPL2;AKR1C1;VPS52;TUBB;CYTH1;CD38;TNFAIP3;PSMC3;SLC4A2;CXCL8;MAPK11;MYO1E;SLC3A2;BMP8A;SLC25A22;PTPRB;SLC25A44;SRSF7;CLTA;NOL3;SNF8;CDCA5;HSP90AB1;LAIR1;SLC2A6;TP63;CCL5;MAGOH;SH3BP4
8113,GO:0032799,0.425089854789074,0.831512047067265,2,19,low-density lipoprotein receptor particle metabolic process,BP,ITGAV;CLTA
3626,GO:0008081,0.425096581516772,0.747712667142008,5,55,phosphoric diester hydrolase activity,MF,GPCPD1;SMPD2;PDE6A;CCL5;APEX2
16406,GO:0097027,0.425109004777655,0.906147314414874,1,7,ubiquitin-protein transferase activator activity,MF,RING1
13172,GO:0051770,0.425285846836469,0.906060043391906,1,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
8133,GO:0032825,0.425472811445581,0.905967722062699,1,7,positive regulation of natural killer cell differentiation,BP,IL15
7474,GO:0031638,0.425828297775316,0.790999682169104,3,31,zymogen activation,BP,C1R;SERPINE1;PGK1
2469,GO:0005685,0.426052219751753,0.830326790482646,2,20,U1 snRNP,CC,LUC7L;SNRNP70
19844,GO:2000316,0.426064777564191,0.905675042650924,1,7,regulation of T-helper 17 type immune response,BP,SMAD7
19187,GO:1905269,0.426230051039733,0.721952771060405,7,80,positive regulation of chromatin organization,BP,TP53;AKAP8L;LIF;SNAI2;AKAP8;NELFE;RUVBL2
12109,GO:0048148,0.426294625662088,0.905561248746839,1,7,behavioral response to cocaine,BP,SDK1
1710,GO:0004301,0.426382585277338,0.905517678843401,1,7,epoxide hydrolase activity,MF,C9ORF3
15658,GO:0072173,0.426614497042983,0.905402743712408,1,7,metanephric tubule morphogenesis,BP,WNT4
11790,GO:0046654,0.426614713933167,0.905402636174323,1,7,tetrahydrofolate biosynthetic process,BP,DHFR
9616,GO:0036480,0.42661609955362,0.905401949202573,1,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PARP1
18374,GO:1903376,0.42661609955362,0.905401949202573,1,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,PARP1
8021,GO:0032655,0.426741802999884,0.79029449920601,3,31,regulation of interleukin-12 production,BP,NFKB1;IRF1;MAPK11
4197,GO:0009304,0.426744052569629,0.905338498306852,1,7,tRNA transcription,BP,GTF3C2
15434,GO:0071705,0.426758724307993,0.611425141338368,131,1701,nitrogen compound transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;TAP1;IL1R2;NFKBIE;PML;HSPB1;TFRC;CSF2;TGFB2;EDN1;GBP1;RSAD2;PANX1;TP53;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;EHD1;TNF;PTPN14;NUP153;SLC7A5;ZC3H12A;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;SLC7A5P2;ITGAV;PMM2;SFN;SLC5A6;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;ZFP36L1;RPLP2;AKAP8;RHOB;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;ABCG2;PRKCA;SYK;SLC7A2;OXTR;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;UBE2J2;CEP41;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;SLC22A4;CPT1A;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;VPS52;CD38;MAPK11;SLC3A2;BMP8A;SLC25A22;SRSF7;CLTA;SNF8;HSP90AB1;CCL5;MAGOH
12099,GO:0048102,0.42683712677149,0.905292326883701,1,7,autophagic cell death,BP,LAMP1
13585,GO:0060052,0.426893837087374,0.905264187666406,1,7,neurofilament cytoskeleton organization,BP,NEFL
880,GO:0002244,0.426954936410144,0.687757642317943,12,157,hematopoietic progenitor cell differentiation,BP,RUNX1;INHBA;SIPA1L3;FST;PSMB9;ARMC6;SFRP1;PSME2;SRF;RRS1;PSMC3;HERC6
3084,GO:0006657,0.426976856608325,0.905222984638383,1,7,CDP-choline pathway,BP,PCYT1A
7058,GO:0030836,0.426979728826457,0.905221558940688,1,7,positive regulation of actin filament depolymerization,BP,WDR1
15837,GO:0072539,0.427015850937356,0.905203627693706,1,7,T-helper 17 cell differentiation,BP,SMAD7
11010,GO:0044829,0.427016353602814,0.905203378156702,1,7,positive regulation by host of viral genome replication,BP,HSPA8
14138,GO:0061004,0.427017716131994,0.905202701745721,1,7,pattern specification involved in kidney development,BP,IRX2
15582,GO:0072048,0.427017716131994,0.905202701745721,1,7,renal system pattern specification,BP,IRX2
4766,GO:0010950,0.427197878470568,0.692621206712821,11,135,positive regulation of endopeptidase activity,BP,CYR61;CTGF;PML;LYN;TNF;PSME2;GPER1;TRAF2;ROBO1;TNFRSF10A;EFNA1
16344,GO:0090594,0.427499896659131,0.904963140412099,1,7,inflammatory response to wounding,BP,IL1A
12225,GO:0048478,0.427620988339283,0.904902919359972,1,7,replication fork protection,BP,TIMELESS
8188,GO:0032926,0.428050699627727,0.904689024400988,1,7,negative regulation of activin receptor signaling pathway,BP,FST
4637,GO:0010759,0.428103724972187,0.904662609516976,1,7,positive regulation of macrophage chemotaxis,BP,CCL5
935,GO:0002335,0.428164394889265,0.829376043258008,2,19,mature B cell differentiation,BP,LFNG;DOCK10
17795,GO:1901879,0.428525580394716,0.744825636652063,5,55,regulation of protein depolymerization,BP,MID1;WDR1;SPTBN1;CLASP1;SWAP70
11356,GO:0045713,0.428575120454181,0.904427580494131,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
12280,GO:0048589,0.428839881490706,0.643561387187665,32,395,developmental growth,BP,NRG1;FN1;ADM;TGFB2;EDN1;G6PD;WWC1;TNC;FGFR2;TYMS;COL27A1;CDK4;L1CAM;STAT5A;ADRB2;TNFRSF12A;SFRP1;ZFYVE27;DHCR7;EPPK1;SRF;PRPF19;ZFP36L1;VCL;NTN1;NEDD4L;SEMA3C;ESR1;SORBS2;DAG1;MAPK11;BIN3
9850,GO:0042095,0.428940788626015,0.904245016614044,1,7,interferon-gamma biosynthetic process,BP,INHBA
13896,GO:0060538,0.42910409244851,0.710440800236324,8,93,skeletal muscle organ development,BP,HDAC9;TSC22D3;SVIL;EGR1;GPCPD1;DDX17;MAFF;BIN3
4823,GO:0014020,0.429140402256472,0.719403795919379,7,80,primary neural tube formation,BP,ADM;SDC4;TGFB2;SFRP1;CC2D2A;BMP7;PHACTR4
737,GO:0001967,0.429187498605568,0.904121721155558,1,7,suckling behavior,BP,OXTR
5591,GO:0016616,0.429344930768323,0.719000688719954,7,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,G6PD;PGD;BMP2;AKR1C2;DCXR;AKR1C1;HSD17B10
20286,GO:2001259,0.429511428879585,0.7881499054374,3,31,positive regulation of cation channel activity,BP,JPH2;ADRB2;STAC
15238,GO:0071394,0.429540410213914,0.903945178462003,1,7,cellular response to testosterone stimulus,BP,ELK1
13900,GO:0060544,0.429617610978985,0.828361614955698,2,19,regulation of necroptotic process,BP,BIRC3;TRAF2
7711,GO:0032200,0.42973517164483,0.68105957561475,13,166,telomere organization,BP,PML;GNL3L;TELO2;NAT10;TFIP11;DKC1;FEN1;POLA1;HNRNPU;ZNF365;XRCC6;HSP90AB1;PARP1
7990,GO:0032608,0.429805642702201,0.762083303721039,4,43,interferon-beta production,BP,RELB;TRIM56;TRAF3;IRF1
16624,GO:0097472,0.429816628279748,0.78791297624772,3,31,cyclin-dependent protein kinase activity,MF,CDKN1A;CDK4;CDKL1
9450,GO:0036037,0.429860855204235,0.903784701511863,1,7,CD8-positive, alpha-beta T cell activation,BP,IRF1
3040,GO:0006591,0.429919339476231,0.903755394898288,1,7,ornithine metabolic process,BP,ODC1
9412,GO:0035973,0.429986259810781,0.903721854113352,1,7,aggrephagy,BP,SQSTM1
12971,GO:0051353,0.430084271930328,0.787424239063995,3,32,positive regulation of oxidoreductase activity,BP,EDN1;TNF;DHFR
5866,GO:0017171,0.430116449304484,0.709479792680732,8,94,serine hydrolase activity,MF,MMP9;C1R;PRSS23;PARL;PREP;RHBDL2;OVCH2;C1S
10865,GO:0044387,0.43014434247061,0.903642593393426,1,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,CORO1C
8361,GO:0033238,0.430245163763052,0.742768391526874,5,60,regulation of cellular amine metabolic process,BP,ODC1;NQO1;PSMB9;PSME2;PSMC3
8270,GO:0033059,0.43026278126818,0.76152718175341,4,44,cellular pigmentation,BP,RAB32;DCTN1;BLOC1S2;RAB27A
4633,GO:0010755,0.430321429078346,0.90355375596191,1,7,regulation of plasminogen activation,BP,SERPINE1
3339,GO:0007052,0.430409285935395,0.701808876851592,9,105,mitotic spindle organization,BP,MYBL2;BIRC3;FLNA;KIF23;DCTN1;HNRNPU;CLASP1;RCC1;CHMP4B
8007,GO:0032635,0.430452694017201,0.729210461059557,6,68,interleukin-6 production,BP,TNF;ZC3H12A;IL1A;AFAP1L2;TNFAIP3;IL6R
7113,GO:0030913,0.430491756772452,0.90346826100594,1,7,paranodal junction assembly,BP,CNTNAP1
10343,GO:0043139,0.430625528788008,0.903401081788341,1,7,5'-3' DNA helicase activity,MF,RUVBL2
9854,GO:0042101,0.430678095676416,0.903374675136358,1,7,T cell receptor complex,CC,SYK
9948,GO:0042308,0.430856529447394,0.903285006420852,1,7,negative regulation of protein import into nucleus,BP,CHP1
18901,GO:1904590,0.430856529447394,0.903285006420852,1,7,negative regulation of protein import,BP,CHP1
2932,GO:0006449,0.430887368414037,0.903269503588011,1,7,regulation of translational termination,BP,EIF5A
14832,GO:0070569,0.430889989758091,0.903268185759591,1,7,uridylyltransferase activity,MF,UAP1L1
12841,GO:0051151,0.431021709013141,0.903201952066476,1,7,negative regulation of smooth muscle cell differentiation,BP,PDGFB
6210,GO:0019725,0.431138239977664,0.631891472366457,43,548,cellular homeostasis,BP,SAA1;FTL;FTH1;PTGER4;C1QTNF1;ADM;JPH2;PML;TFRC;EDN1;TXNRD1;TP53;LYN;CLN6;UBE2C;JPH1;CHP1;ICAM1;ITGAV;GPER1;SRF;TXN2;GPCPD1;FEN1;IRS2;ACO1;ABCG2;OXTR;POLA1;NEDD4L;SLC4A11;ESR1;CCR6;TMEM165;PDE6A;CD38;SLC4A2;NOL3;GCLC;SWAP70;TBXA2R;TXNDC15;CCL5
1181,GO:0002828,0.431184456849195,0.827264391034077,2,19,regulation of type 2 immune response,BP,RSAD2;IL27RA
13805,GO:0060394,0.431265881252533,0.903079097655606,1,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,SMAD7
13480,GO:0055015,0.431542988935166,0.902939553943111,1,7,ventricular cardiac muscle cell development,BP,FHL2
13892,GO:0060534,0.43156160851853,0.902930173138601,1,7,trachea cartilage development,BP,SRF
8851,GO:0034644,0.431603417145846,0.728118611897792,6,69,cellular response to UV,BP,TP53;CDKN1A;RUVBL2;NOC2L;PARP1;TP63
4231,GO:0009409,0.43164729820225,0.78648928458062,3,31,response to cold,BP,ADM;ADRB2;NFKBIA
8607,GO:0034115,0.431829446926532,0.902795169796647,1,7,negative regulation of heterotypic cell-cell adhesion,BP,MYADM
14845,GO:0070587,0.431829446926532,0.902795169796647,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,MYADM
12634,GO:0050821,0.431911621936313,0.688402610803002,11,133,protein stabilization,BP,CRYAB;CDKN1A;LAMP1;TELO2;FLNA;CHP1;USP36;TNIP2;SMAD7;EFNA1;HSP90AB1
3271,GO:0006942,0.432008039234162,0.760095399105143,4,44,regulation of striated muscle contraction,BP,CTGF;ZC3H12A;FLNA;SMAD7
3344,GO:0007062,0.432063823882614,0.693808680449657,10,120,sister chromatid cohesion,BP,FEN1;SFPQ;ZW10;RCC2;CLASP1;CENPN;CENPO;INCENP;KIF22;CDCA5
11779,GO:0046637,0.432064356423309,0.786164337213578,3,31,regulation of alpha-beta T cell differentiation,BP,CD83;SYK;SMAD7
7619,GO:0032009,0.432217927005007,0.902599148873993,1,7,early phagosome,CC,SYK
3294,GO:0006986,0.432340660118295,0.678906748765667,13,157,response to unfolded protein,BP,HSPB1;DNAJB1;DAXX;DNAJB2;SERPINH1;DCTN1;TATDN2;UBE2J2;CREB3;TUSC1;HSPA8;CXCL8;HSP90AB1
11086,GO:0045086,0.432415937397387,0.902499140966183,1,7,positive regulation of interleukin-2 biosynthetic process,BP,IL1A
16811,GO:0098657,0.432474968290612,0.632826377990453,40,500,import into cell,BP,SAA1;ADM;ACTG1;TFRC;STEAP4;HSPG2;UBQLN2;LYN;ARPC4;EHD1;TNF;BAIAP2;CORO1C;CXCL16;SIRPA;ITGAV;MYO10;ADRB2;SERPINE1;ARPC1B;SNX12;LGALS3;SYK;SLC7A2;NEDD4L;MYH9;SNX8;ACKR3;M6PR;RHOG;ACTN4;RAPGEF1;TINAGL1;RAB27A;CXCL8;MYO1E;SLC3A2;CLTA;HSP90AB1;SH3BP4
15803,GO:0072488,0.432575846382061,0.902418329869632,1,7,ammonium transmembrane transport,BP,SLC22A4
10326,GO:0043116,0.432778162004266,0.902316028306693,1,7,negative regulation of vascular permeability,BP,ADM
18250,GO:1903071,0.432835668128473,0.902286937909118,1,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2
9907,GO:0042228,0.43288438905811,0.902262287407119,1,7,interleukin-8 biosynthetic process,BP,TNF
15764,GO:0072357,0.43294117187926,0.902233553058211,1,7,PTW/PP1 phosphatase complex,CC,TOX4
14747,GO:0070417,0.433003323792391,0.902202095665729,1,7,cellular response to cold,BP,NFKBIA
18590,GO:1903845,0.433016886325252,0.740894465942445,5,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,FBN1;ADAM17;BAMBI;SMAD7;CD109
10364,GO:0043177,0.433025403444055,0.699304095086747,9,108,organic acid binding,MF,P3H2;P4HA2;LAYN;TYMS;HMGCS1;DHFR;AKR1C2;AKR1C1;GCLC
6756,GO:0030177,0.433065344900113,0.687277420889075,11,135,positive regulation of Wnt signaling pathway,BP,DAPK3;NFKB1;FGFR2;PSMB9;BMP2;SFRP1;PSME2;JRK;BAMBI;WNT4;PSMC3
3322,GO:0007029,0.433134355573393,0.759352586830974,4,43,endoplasmic reticulum organization,BP,VMP1;ZFYVE27;REEP1;TRAM2
19891,GO:2000380,0.433146786206567,0.90212945987518,1,7,regulation of mesoderm development,BP,TP63
16472,GO:0097152,0.433175088773997,0.902115126142105,1,7,mesenchymal cell apoptotic process,BP,BMP7
7445,GO:0031579,0.433246578484131,0.825814830974006,2,19,membrane raft organization,BP,EMP2;MYADM
10893,GO:0044433,0.433292759139875,0.613899728949579,81,1037,cytoplasmic vesicle part,CC,KRT1;SAA1;FTL;FTH1;MMP9;S100P;FN1;TAP1;PML;PCDH7;TFRC;GPRC5A;HLA-B;TGFB2;IKBKE;B4GALT1;MGAM;DBNDD2;HRNR;STEAP4;NFKB1;MYO1B;RAB32;STOML1;PLEKHO2;LAMP1;EHD1;QPCT;SIRPA;CYB5R1;ACAA1;CADPS2;KREMEN2;ITGAV;SFN;ADRB2;SERPINE1;ZFYVE27;HLA-F;ANXA8;IL7R;GPER1;AP4S1;RHOB;VCL;LGALS3;PDGFB;SPPL2A;GLIPR1;SNX8;LILRB3;RCC2;YWHAH;TAPBP;M6PR;CAB39;TGFBRAP1;CD109;HSPA8;COMMD9;TRAPPC5;CHMP4B;RHOG;XRCC6;TAP2;ACTN4;SGSM1;RAPGEF1;TMEM165;RAB27A;WNT4;VPS52;TUBB;PSMC3;SPG21;PTPRB;CLTA;SNF8;HSP90AB1;LAIR1;BAIAP2L2
14749,GO:0070419,0.433334570569007,0.902034332658803,1,7,nonhomologous end joining complex,CC,XRCC6
12790,GO:0051084,0.433388864251959,0.785130866090868,3,31,'de novo' posttranslational protein folding,BP,BAG1;DNAJB1;HSPA8
819,GO:0002091,0.433400705660981,0.902000816384962,1,7,negative regulation of receptor internalization,BP,UBQLN2
4686,GO:0010835,0.43346535785031,0.901968044685761,1,7,regulation of protein ADP-ribosylation,BP,PUM3
7570,GO:0031931,0.433516181377961,0.901942277821052,1,7,TORC1 complex,CC,TELO2
12714,GO:0050932,0.433602044554058,0.901898736689858,1,7,regulation of pigment cell differentiation,BP,ADAMTS9
7198,GO:0031087,0.433748832365827,0.901824272711947,1,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,EDC4
12304,GO:0048642,0.433864361301419,0.901765641184679,1,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3
12178,GO:0048302,0.43395474893908,0.90171975370984,1,7,regulation of isotype switching to IgG isotypes,BP,IL27RA
14550,GO:0070064,0.433975136870175,0.825301195289284,2,19,proline-rich region binding,MF,CYLD;BAIAP2
10502,GO:0043403,0.434173472065283,0.825161232782559,2,19,skeletal muscle tissue regeneration,BP,DAG1;BIN3
7735,GO:0032230,0.434178136742839,0.901606287950181,1,7,positive regulation of synaptic transmission, GABAergic,BP,OXTR
9422,GO:0035988,0.434225502990342,0.90158221859952,1,7,chondrocyte proliferation,BP,CTGF
8678,GO:0034249,0.434297508091966,0.66096221912227,18,231,negative regulation of cellular amide metabolic process,BP,DAPK3;ENC1;NUP153;TYMS;ZC3H12A;ZC3H7B;SRRT;ZFP36L1;DHFR;ZFP36L2;AJUBA;SNRNP70;NUP214;ESR1;RBM4;SNIP1;METTL16;POLR2G
5854,GO:0017151,0.434297928793753,0.901545408007397,1,7,DEAD/H-box RNA helicase binding,MF,AKAP8L
8239,GO:0033006,0.434306807257636,0.825067107269381,2,19,regulation of mast cell activation involved in immune response,BP,LYN;SYK
10448,GO:0043304,0.434306807257636,0.825067107269381,2,19,regulation of mast cell degranulation,BP,LYN;SYK
19867,GO:2000345,0.43438504860516,0.901501117729099,1,7,regulation of hepatocyte proliferation,BP,TNFAIP3
9096,GO:0035358,0.434386346457883,0.901500457827894,1,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
5336,GO:0016073,0.434473229180647,0.714415652926671,7,84,snRNA metabolic process,BP,USB1;SRRT;DKC1;PHAX;GTF2E1;METTL16;POLR2G
13778,GO:0060363,0.434533969832103,0.901425379750212,1,7,cranial suture morphogenesis,BP,INSIG1
13763,GO:0060339,0.434556150950182,0.901414095816611,1,7,negative regulation of type I interferon-mediated signaling pathway,BP,NLRC5
6729,GO:0030141,0.434578028450883,0.629269367478247,42,537,secretory granule,CC,KRT1;FTL;FTH1;MMP9;S100P;FN1;PCDH7;TGFB2;EDN1;B4GALT1;MGAM;HRNR;NFKB1;PLEKHO2;LAMP1;BAIAP2;QPCT;SIRPA;CYB5R1;ACAA1;ITGAV;SERPINE1;VCL;LGALS3;PDGFB;GLIPR1;LILRB3;CRCP;CAB39;CD109;HSPA8;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;PTPRB;HSP90AB1;TBXA2R;LAIR1
5762,GO:0016926,0.43463873647138,0.901372075958667,1,7,protein desumoylation,BP,SENP3
9797,GO:0040016,0.434647929239139,0.901367397954312,1,7,embryonic cleavage,BP,TPRA1
10478,GO:0043370,0.434661786285646,0.824816388405418,2,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83;SMAD7
9744,GO:0038203,0.434870887642386,0.90125389641232,1,7,TORC2 signaling,BP,TELO2
19990,GO:2000586,0.43489792520023,0.90124012683258,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
1529,GO:0003909,0.435108163399124,0.901133016520412,1,7,DNA ligase activity,MF,PARP1
15661,GO:0072176,0.435402594001767,0.900982890340639,1,7,nephric duct development,BP,EFNB2
8577,GO:0034046,0.435432253996492,0.900967759194183,1,7,poly(G) binding,MF,HNRNPU
7440,GO:0031570,0.435432713109835,0.676054050635827,13,157,DNA integrity checkpoint,BP,PML;MAP3K14;TP53;CDKN1A;GADD45A;SFN;PRPF19;ORAOV1;THOC1;TFDP1;TIMELESS;BRIP1;TP63
19785,GO:2000209,0.435485774876721,0.824233694207186,2,19,regulation of anoikis,BP,SNAI2;BRMS1
18021,GO:1902514,0.435531702546676,0.900917014628379,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
14023,GO:0060746,0.435810841626884,0.900774494213753,1,7,parental behavior,BP,OXTR
2285,GO:0005243,0.435815798888594,0.900771962013845,1,7,gap junction channel activity,MF,PANX1
4353,GO:0009931,0.435903149095798,0.900727336412432,1,7,calcium-dependent protein serine/threonine kinase activity,MF,PRKCA
8588,GO:0034085,0.435907361418368,0.900725184098486,1,7,establishment of sister chromatid cohesion,BP,CDCA5
8982,GO:0035088,0.435926442345455,0.783144528505325,3,31,establishment or maintenance of apical/basal cell polarity,BP,WDR1;PARD3B;PARD3
14245,GO:0061245,0.435926442345455,0.783144528505325,3,31,establishment or maintenance of bipolar cell polarity,BP,WDR1;PARD3B;PARD3
13393,GO:0052695,0.436002093707142,0.900676772255605,1,7,cellular glucuronidation,BP,UGT1A6
9502,GO:0036149,0.436047228245425,0.900653701567846,1,7,phosphatidylinositol acyl-chain remodeling,BP,PLBD1
9110,GO:0035385,0.436105650227416,0.900623833968414,1,7,Roundabout signaling pathway,BP,ROBO1
7224,GO:0031118,0.436261657165712,0.898805317168997,1,8,rRNA pseudouridine synthesis,BP,DKC1
4832,GO:0014037,0.436324661912351,0.782832056619866,3,31,Schwann cell differentiation,BP,PARD3;CNTNAP1;DAG1
11523,GO:0046037,0.436346237718746,0.823624135278272,2,19,GMP metabolic process,BP,TJP2;PDE6A
2302,GO:0005283,0.436426886791161,0.900459504700277,1,7,amino acid:sodium symporter activity,MF,SLC25A22
4277,GO:0009642,0.436451510132629,0.90044690155464,1,7,response to light intensity,BP,HMGCS1
8010,GO:0032640,0.436452158563786,0.723814148051383,6,70,tumor necrosis factor production,BP,HSPB1;ZC3H12A;ERRFI1;AKAP8;GPNMB;TNFAIP3
11012,GO:0044837,0.43653682436796,0.900403226796159,1,7,actomyosin contractile ring organization,BP,KIF23
7758,GO:0032274,0.436631134557291,0.90035493277922,1,7,gonadotropin secretion,BP,INHBA
12862,GO:0051182,0.436714057129995,0.900312457955981,1,7,coenzyme transport,BP,SLC5A6
9364,GO:0035878,0.436743683351455,0.900297279981546,1,7,nail development,BP,FOXN1
17739,GO:1901673,0.436755306334373,0.823333963498474,2,19,regulation of mitotic spindle assembly,BP,HNRNPU;CHMP4B
296,GO:0000800,0.43682468673699,0.900255773285272,1,7,lateral element,CC,INCENP
1125,GO:0002714,0.436857355942525,0.823261536259254,2,19,positive regulation of B cell mediated immunity,BP,TFRC;TNF
1221,GO:0002891,0.436857355942525,0.823261536259254,2,19,positive regulation of immunoglobulin mediated immune response,BP,TFRC;TNF
16205,GO:0090235,0.436888982097904,0.900222820190941,1,7,regulation of metaphase plate congression,BP,HNRNPU
14924,GO:0070775,0.436890673899583,0.900221952999122,1,7,H3 histone acetyltransferase complex,CC,BRPF1
14925,GO:0070776,0.436890673899583,0.900221952999122,1,7,MOZ/MORF histone acetyltransferase complex,CC,BRPF1
6530,GO:0021932,0.436905204493444,0.900214504692534,1,7,hindbrain radial glia guided cell migration,BP,FLNA
5622,GO:0016679,0.436925317718821,0.898460178320959,1,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,CYP1A1
13768,GO:0060346,0.437012156743093,0.900159670808902,1,7,bone trabecula formation,BP,SFRP1
734,GO:0001964,0.437280974693835,0.900021765728261,1,7,startle response,BP,NRG1
7130,GO:0030953,0.437292071599458,0.900016070394832,1,7,astral microtubule organization,BP,CLASP1
5048,GO:0015232,0.43729596557579,0.900014071812695,1,7,heme transporter activity,MF,ABCG2
5256,GO:0015886,0.43729596557579,0.900014071812695,1,7,heme transport,BP,ABCG2
13564,GO:0060027,0.437411691729057,0.899954664025054,1,7,convergent extension involved in gastrulation,BP,SFRP1
428,GO:0001135,0.437428268416374,0.899946152602341,1,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL2
4749,GO:0010919,0.437429618122375,0.89994545956489,1,7,regulation of inositol phosphate biosynthetic process,BP,GPER1
7206,GO:0031095,0.437429618122375,0.89994545956489,1,7,platelet dense tubular network membrane,CC,EHD1
8225,GO:0032982,0.437429618122375,0.89994545956489,1,7,myosin filament,CC,MYH9
8698,GO:0034331,0.437429618122375,0.89994545956489,1,7,cell junction maintenance,BP,PLEKHA7
9595,GO:0036449,0.437429618122375,0.89994545956489,1,7,microtubule minus-end,CC,SVIL
14081,GO:0060900,0.437429618122375,0.89994545956489,1,7,embryonic camera-type eye formation,BP,PHACTR4
15780,GO:0072383,0.437429618122375,0.89994545956489,1,7,plus-end-directed vesicle transport along microtubule,BP,KIF23
10347,GO:0043144,0.437574565563961,0.898121823587012,1,8,snoRNA processing,BP,DKC1
14938,GO:0070821,0.437621387782275,0.755466296066462,4,44,tertiary granule membrane,CC,MGAM;SIRPA;PTPRB;LAIR1
3327,GO:0007034,0.437756839260211,0.688680276854054,10,119,vacuolar transport,BP,GNPTAB;LAMP1;ADRB2;RHOB;M6PR;TGFBRAP1;HSPA8;CHMP4B;VPS52;SNF8
2494,GO:0005742,0.438279038416299,0.8977538915807,1,8,mitochondrial outer membrane translocase complex,CC,TOMM40
9085,GO:0035336,0.438655140049602,0.821983072053817,2,19,long-chain fatty-acyl-CoA metabolic process,BP,ACSL1;THEM4
14686,GO:0070301,0.438855228840658,0.721718511703703,6,70,cellular response to hydrogen peroxide,BP,CYP1B1;NQO1;TP53;ETS1;RHOB;TNFAIP3
7845,GO:0032402,0.438863519188563,0.821834576736982,2,19,melanosome transport,BP,DCTN1;RAB27A
13241,GO:0051904,0.438863519188563,0.821834576736982,2,19,pigment granule transport,BP,DCTN1;RAB27A
2895,GO:0006402,0.438990848971431,0.644213492291632,24,322,mRNA catabolic process,BP,HSPB1;NOCT;PSMB9;ZC3H12A;PABPC4;PSME2;CTIF;ZFP36L1;RPLP2;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;NUP214;HNRNPU;RPL27A;HSPA8;EDC4;METTL16;DHX34;PSMC3;POLR2G;MAGOH
20080,GO:2000736,0.439993143350752,0.692433468136237,9,121,regulation of stem cell differentiation,BP,RUNX1;TGFB2;PSMB9;PSME2;ZFP36L2;SEMA3C;HNRNPU;BMP7;PSMC3
7483,GO:0031647,0.440769258817563,0.657641865359152,17,211,regulation of protein stability,BP,CRYAB;CDKN1A;LAMP1;GNL3L;LSS;TELO2;FLNA;CHP1;BMP2;USP36;APTX;TNIP2;SMAD7;HSPA8;DPM3;EFNA1;HSP90AB1
1201,GO:0002861,0.44096737896123,0.896342183738782,1,8,regulation of inflammatory response to antigenic stimulus,BP,TNF
6250,GO:0019827,0.440989093867109,0.685688974664307,10,120,stem cell population maintenance,BP,PBX1;FANCC;LIF;SFRP1;SRRT;ZFP36L2;KLF10;BMP7;POLR2G;TP63
8890,GO:0034705,0.44107292127376,0.779090353378243,3,31,potassium channel complex,CC,KCNA7;KCNIP3;CNTNAP1
8321,GO:0033157,0.441159163819693,0.657294476939376,17,210,regulation of intracellular protein transport,BP,NRG1;TP53;CDKN1A;PTPN14;ZC3H12A;LCP1;CYB5R1;CHP1;SFN;USP36;AKAP8L;PARL;WDR46;UBE2J2;INSIG1;SNIP1;HSP90AB1
4470,GO:0010466,0.441302271180991,0.679660712668464,11,137,negative regulation of peptidase activity,BP,CRYAB;MMP9;BIRC3;SFN;SERPINE1;ANXA8;SERPINH1;A2ML1;CD109;TNFRSF10A;NOL3
5749,GO:0016896,0.441326458206143,0.778600569883231,3,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,USB1;NOCT;ISG20L2
2104,GO:0004879,0.442061248784165,0.778307846274932,3,31,nuclear receptor activity,MF,AHR;GPER1;ESR1
16753,GO:0098531,0.442061248784165,0.778307846274932,3,31,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,AHR;GPER1;ESR1
9795,GO:0040014,0.442103541432647,0.75174369039361,4,44,regulation of multicellular organism growth,BP,FGFR2;CDK4;STAT5A;ADRB2
5684,GO:0016799,0.442436457682314,0.818732650381032,2,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,SMUG1;CD38
4522,GO:0010575,0.4425064360849,0.81922813299217,2,19,positive regulation of vascular endothelial growth factor production,BP,CYP1B1;IL1A
13770,GO:0060348,0.442897103846553,0.684033562183566,10,118,bone development,BP,PTGER4;FBN1;TJP2;FGFR2;BMP2;COL27A1;OSR2;SRF;SERPINH1;INSIG1
3282,GO:0006968,0.442909694876835,0.818938393910941,2,19,cellular defense response,BP,FOSL1;CCR6
12991,GO:0051402,0.443080219332978,0.668911540893028,13,159,neuron apoptotic process,BP,NEFL;NQO1;MYBL2;SOD2;TGFB2;G6PD;TP53;TNFRSF21;JUN;GCLC;HSP90AB1;PARP1;TP63
13600,GO:0060070,0.443106067893293,0.65033640141776,19,238,canonical Wnt signaling pathway,BP,CYLD;WNT10A;DAPK3;NFKB1;FGFR2;PSMB9;BMP2;KREMEN2;SFRP1;PSME2;EGR1;JRK;SNAI2;BAMBI;RUVBL2;ZNF703;RAPGEF1;WNT4;PSMC3
10436,GO:0043281,0.443361688816071,0.664665207879356,14,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CRYAB;MMP9;CYR61;CTGF;PML;BIRC3;TNF;SFN;GPER1;TRAF2;ROBO1;TNFRSF10A;NOL3;TP63
5096,GO:0015370,0.443442727099101,0.777211927899823,3,31,solute:sodium symporter activity,MF,SLC5A6;SLC4A2;SLC25A22
10179,GO:0042770,0.443811700798136,0.683064893980497,10,121,signal transduction in response to DNA damage,BP,PML;TP53;CDKN1A;GADD45A;SFN;SNAI2;PRPF19;PTTG1IP;TFDP1;TP63
2722,GO:0006101,0.444047745297567,0.776440018175275,3,32,citrate metabolic process,BP,STAT5A;ACO1;CS
13571,GO:0060038,0.444741167248067,0.776179612028815,3,31,cardiac muscle cell proliferation,BP,TGFB2;FGFR2;MAPK11
3717,GO:0008235,0.445165627052317,0.775841670463253,3,31,metalloexopeptidase activity,MF,CPA4;C9ORF3;DNPEP
9690,GO:0038083,0.445774260702728,0.775356684439727,3,31,peptidyl-tyrosine autophosphorylation,BP,LYN;TNK1;SYK
5002,GO:0015144,0.445787121958594,0.816863934480888,2,19,carbohydrate transmembrane transporter activity,MF,M6PR;SLC2A6
1994,GO:0004715,0.446088828596699,0.775105833014794,3,31,non-membrane spanning protein tyrosine kinase activity,MF,LYN;TNK1;SYK
11763,GO:0046620,0.44614178646163,0.729662281357889,5,56,regulation of organ growth,BP,EDN1;G6PD;WWC1;FGFR2;MAPK11
3564,GO:0007605,0.446156561927123,0.715316296109683,6,70,sensory perception of sound,BP,NAV2;ICAM1;WDR1;SNAI2;ROR1;MARVELD2
9076,GO:0035325,0.446703011338169,0.893289545650607,1,8,Toll-like receptor binding,MF,SYK
11381,GO:0045746,0.447736779107007,0.773495687815159,3,32,negative regulation of Notch signaling pathway,BP,LFNG;NFKBIA;BMP7
5297,GO:0015985,0.447738209066361,0.892732642912295,1,8,energy coupled proton transport, down electrochemical gradient,BP,COX5B
5298,GO:0015986,0.447738209066361,0.892732642912295,1,8,ATP synthesis coupled proton transport,BP,COX5B
7996,GO:0032615,0.448121550638984,0.773187564443596,3,32,interleukin-12 production,BP,NFKB1;IRF1;MAPK11
7559,GO:0031901,0.448604972813693,0.685232084776472,9,107,early endosome membrane,CC,PML;HLA-B;STEAP4;EHD1;KREMEN2;HLA-F;SNX8;RCC2;TMEM165
7444,GO:0031577,0.448795762841841,0.7726471905036,3,32,spindle checkpoint,BP,ZW10;ANAPC15;DUSP1
15749,GO:0072332,0.449154788571561,0.712487563927798,6,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PML;TP53;CDKN1A;AEN;PTTG1IP;TP63
2653,GO:0005996,0.449181267909577,0.652644096180752,16,197,monosaccharide metabolic process,BP,IGFBP3;C1QTNF1;UGT1A6;B4GALT1;G6PD;IRS1;TNF;PGD;PMM2;PGK1;PPP1R3B;IRS2;CPT1A;DCXR;TKT;GCLC
10350,GO:0043154,0.449339362276989,0.712415306440828,6,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CRYAB;MMP9;BIRC3;SFN;TNFRSF10A;NOL3
14378,GO:0061617,0.449417515371265,0.891825341297866,1,8,MICOS complex,CC,CHCHD6
5647,GO:0016741,0.449482160265461,0.655550188384721,15,184,transferase activity, transferring one-carbon groups,MF,TYMS;TRMT61A;METTL13;METTL1;NSUN2;METTL2B;NSUN5;RBBP5;FTSJ3;WDR4;PRDM7;NOP2;TRMT1;METTL16;METTL21A
20285,GO:2001258,0.449513800652575,0.813601099498664,2,20,negative regulation of cation channel activity,BP,MMP9;RRAD
14551,GO:0070069,0.449816039289445,0.812009399644842,2,23,cytochrome complex,CC,COX5B;BCS1L
4314,GO:0009792,0.449955809242242,0.621204975158925,34,425,embryo development ending in birth or egg hatching,BP,CYR61;ADM;AMOT;SDC4;CSF2;TGFB2;EDN1;LFNG;JUNB;FGFR2;PBX1;FOSL1;SLC39A1;BMP2;ELF3;LIF;OSR2;SFRP1;CC2D2A;SRF;PRPF19;ZFP36L1;PDGFB;RRP7A;MYH9;COPS3;SEMA3C;MAFF;KEAP1;TCOF1;BMP7;PSMC3;MYO1E;PHACTR4
2533,GO:0005789,0.450254053565879,0.603461770851834,62,795,endoplasmic reticulum membrane,CC,CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;RSAD2;PANX1;NFE2L1;PKMYT1;SCD;DST;CDKAL1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;GGCX;ANKS4B;RNF19B;EBP;ZFYVE27;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;SGK1;CYP4B1;TRAF2;REEP1;SPPL2A;TAPBPL;ZW10;ACSL1;DNAJC1;TAPBP;ZDHHC6;APH1A;UBE2J2;CREB3;LPCAT3;PCYT1A;GALNT2;ATG101;PIGM;SCD5;INSIG1;RHOG;TAP2;EIF5A;RNF185;DPM3;LRRC59;FADS1
13636,GO:0060135,0.450658201309016,0.744573493164182,4,44,maternal process involved in female pregnancy,BP,JUNB;LIF;ESR1;WNT4
9784,GO:0039702,0.450673406974764,0.812753145722302,2,20,viral budding via host ESCRT complex,BP,CHMP4B;SNF8
10400,GO:0043231,0.450784907980199,0.578379621306105,633,8289,intracellular membrane-bounded organelle,CC,IGFBP3;KRT1;MAFB;SPRR3;TRIM16;FTL;CRYAB;FTH1;NRG1;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;P3H2;CYP1B1;CTGF;CYP24A1;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;SACS;ACTG1;TRIM47;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;HSPB1;STARD13;MYBL2;KRT10;SDC4;KRT13;FADS3;IRX2;RELB;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;FBN1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;IKBKE;BIRC3;PLBD1;DAPK3;TET3;PRSS23;B4GALT1;ELMSAN1;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;NLRC5;PANX1;TP53;NFE2L1;SQSTM1;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;AHR;JUNB;MCM5;HMGXB3;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;TELO2;FOSL1;C9ORF3;PGD;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;FANCC;ARFRP1;PITHD1;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;DRAM1;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;FUS;PABPC4;MCM2;LSG1;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;OSR2;PARL;ABCF2;TRIM22;ZFYVE27;ZDHHC3;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;PPP1R3B;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;EPPK1;DDX42;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;AKAP8;RHOB;NELFE;DKC1;FEN1;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;BRMS1;PREP;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;COL5A3;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;SNX8;RBBP5;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ZW10;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;UBE2J2;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;DUSP1;ARL6IP4;TGFBRAP1;TXNL4B;CITED2;RPL27A;SOCS1;HSPA8;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;ARGLU1;QDPR;LAMC1;RHOG;BCL2L2;ZNF365;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;SMPD2;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;GLIS3;SNIP1;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;TRA2A;RNF7;TOMM40;AKIP1;MPHOSPH8;ELK1;SGSM1;INCENP;PHF5A;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;DAG1;TMEM165;POLR3H;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;DPM3;WNT4;MRPS2;RBM14;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;SLC25A22;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
2502,GO:0005751,0.451495844131221,0.888111507052765,1,10,mitochondrial respiratory chain complex IV,CC,COX5B
30,GO:0000055,0.45156358146964,0.890658829273609,1,8,ribosomal large subunit export from nucleus,BP,RRS1
16832,GO:0098727,0.451819187256588,0.675708300629329,10,121,maintenance of cell number,BP,PBX1;FANCC;LIF;SFRP1;SRRT;ZFP36L2;KLF10;BMP7;POLR2G;TP63
7216,GO:0031110,0.45181989097399,0.724615116340573,5,57,regulation of microtubule polymerization or depolymerization,BP,MAP2;MID1;DCTN1;SLAIN2;CLASP1
4041,GO:0009074,0.452121513813389,0.890354265178332,1,8,aromatic amino acid family catabolic process,BP,QDPR
12514,GO:0050657,0.452148114096779,0.656517258965606,14,173,nucleic acid transport,BP,NUP153;SRSF2;AKAP8L;RRS1;ZFP36L1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
12515,GO:0050658,0.452148114096779,0.656517258965606,14,173,RNA transport,BP,NUP153;SRSF2;AKAP8L;RRS1;ZFP36L1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
13517,GO:0055088,0.45325669389504,0.709039908939242,6,70,lipid homeostasis,BP,EHD1;ABHD4;IRS2;COMMD9;INSIG1;AKR1C1
10781,GO:0044237,0.453290763653776,0.575153123486812,602,7882,cellular metabolic process,BP,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;CYP24A1;C1QTNF1;DTX2;ADM;FOSL2;NQO1;IL16;CYP1A1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;KRT10;TRAF1;SDC4;FADS3;IRX2;RELB;TFRC;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;ELMSAN1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;NLRC5;TP53;NFE2L1;SQSTM1;MARVELD3;PDCD11;HNRNPAB;IL24;P4HA2;PANK2;NOCT;IL27RA;FST;NFKB1;CPA4;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;AHR;JUNB;MCM5;HMGXB3;COMMD4;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;WWC1;RRP1;ENC1;TNC;ASCC2;TRIO;VMP1;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;SLC16A9;PGD;UBE2C;TYMS;ZC3H12A;FLNA;SRSF2;TNK1;SART1;TK1;ACAA1;GEMIN5;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;ICAM1;FANCC;BMP2;UBE4B;DDX23;CDK4;ZNF142;DRAM1;ITGAV;ERRFI1;GGCX;PMM2;SFN;TRMT61A;STAT5A;LYPD6B;EPGN;RNF19B;ZMAT2;ADRB2;IL20;DAXX;FOXD2;NAT10;GANC;SLC5A6;SERPINE1;FUS;PABPC4;PGK1;MCM2;NMT2;TOX4;ST6GALNAC5;USP36;AKAP8L;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;PARL;TRIM22;ZDHHC3;SAFB2;APTX;PUS1;DHX37;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;LUC7L;DNPEP;DPH2;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;GPER1;SRF;NSUN2;DNAJB2;ZNF787;RRP36;ELF4;LARP4B;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;DHFR;ISG20L2;U2AF2;FGFR1OP;SHQ1;KCTD10;RIPK4;IRS2;METTL2B;NPAS2;CBX5;PPRC1;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;ROBO1;AJUBA;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;AASS;BRMS1;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;ZNF407;DNASE1;COX5B;RNF115;RRP7A;UHRF1;MYH9;ZNF234;SPPL2A;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;RBBP5;RBM15B;SFPQ;DDX39A;SPRY4;BRD9;ZNF697;SAP30BP;FTSJ3;WDR46;SPEN;ROR1;PRUNE2;ACSL1;NOP56;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;IKZF3;TCOF1;SLC22A4;PES1;USP31;FOXN1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;GINS3;HERC2;DUS2;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;ZNF365;ACBD6;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TEAD4;SMPD2;KBTBD12;ACTN4;THEM4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;TKT;EFTUD2;TNFRSF10A;TRA2A;RNF7;TOMM40;MPHOSPH8;ELK1;INCENP;PHF5A;EIF3I;RAPGEF1;CHAF1A;EIF5A;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;ASB6;RAB27A;DHX34;TIMELESS;GPX4;DPM3;WNT4;MRPS2;RBM14;AKR1C1;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;CCL22;BRIP1;RRM2;SUPT16H;CXCL8;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;HSD17B10;BMP8A;HES4;TRIML2;CARD10;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;OTUD6A;PHACTR4;TOP3A;CCL5;ORC4;FADS1;MAGOH;APEX2;SH3BP4
4961,GO:0015036,0.453549341879226,0.768279452314314,3,34,disulfide oxidoreductase activity,MF,TXNRD1;PGK1;TXN2
7021,GO:0030742,0.453654699391814,0.810563799097553,2,20,GTP-dependent protein binding,MF,RAB32;RASGRP4
6757,GO:0030178,0.454205469134958,0.662762627595818,12,151,negative regulation of Wnt signaling pathway,BP,CYLD;PSMB9;BMP2;KREMEN2;SFRP1;PSME2;EGR1;SNAI2;RUVBL2;RAPGEF1;WNT4;PSMC3
12782,GO:0051057,0.454698921712939,0.767890383268438,3,32,positive regulation of small GTPase mediated signal transduction,BP,NRG1;ROBO1;RASGRP4
16240,GO:0090288,0.454793183631482,0.687214515389548,8,95,negative regulation of cellular response to growth factor stimulus,BP,FBN1;SFRP1;ADAM17;SPRY4;BAMBI;SMAD7;CD109;WNT4
6068,GO:0019217,0.455268925883955,0.72161106029256,5,57,regulation of fatty acid metabolic process,BP,PANK2;IRS1;IRS2;CPT1A;INSIG1
1184,GO:0002831,0.455340684773978,0.686654447842478,8,96,regulation of response to biotic stimulus,BP,BIRC3;TRAF3;ZC3H12A;IL15;PRKCA;PQBP1;TRIB1;TNFAIP3
19865,GO:2000343,0.455362703022262,0.888574348950892,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
7934,GO:0032511,0.455446486477371,0.888528098017257,1,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,SNF8
1122,GO:0002711,0.455472388001893,0.80922237275254,2,20,positive regulation of T cell mediated immunity,BP,RSAD2;TRAF2
2837,GO:0006305,0.455522077684258,0.740458453979295,4,44,DNA alkylation,BP,TET3;MTA2;MPHOSPH8;PARP1
2838,GO:0006306,0.455522077684258,0.740458453979295,4,44,DNA methylation,BP,TET3;MTA2;MPHOSPH8;PARP1
7817,GO:0032370,0.455535592813674,0.766932052024296,3,33,positive regulation of lipid transport,BP,C1QTNF1;EDN1;NFKBIA
3299,GO:0006996,0.455720507740877,0.575242459686113,237,3094,organelle organization,BP,TRIM16;CRYAB;NRG1;MMP9;KRT2;PTGER4;HDAC9;MAP2;NEFL;CTGF;KRT15;AMOT;KRT4;NEFM;ACTG1;TAP1;PML;CYLD;MYBL2;SDC4;KRT13;SOD2;CSF2;COBLL1;EDN1;BIRC3;MID1;DAPK3;TET3;EMP2;TP53;SIPA1L3;SQSTM1;KRT9;PANK2;NOCT;NEDD9;CPA4;GNPTAB;KRT6A;UBQLN2;MYO1B;RAB32;MCM5;ARPC4;EHD1;GADD45A;TNF;GNL3L;BAIAP2;KRT5;CDKN2A;RING1;CORO1C;PKMYT1;PPAN;DST;VMP1;NUP153;TPM4;CLN6;TELO2;KRT17;UBE2C;FLNA;LCP1;CYB5R1;CHP1;ICAM1;GOSR1;KIF23;SFN;CDC42EP2;EPGN;ADRB2;SVIL;DAXX;NAT10;ARPC1B;MCM2;TOX4;USP36;AKAP8L;AMOTL2;GRWD1;LIF;SFRP1;PARL;TPM1;ZFYVE27;CC2D2A;PTGFRN;WDR1;ANXA8;PWP2;PDE4DIP;BANF1;EPPK1;TFIP11;GPER1;SRF;SF1;PARD3B;ETS1;SNAI2;RRS1;AKAP8;RHOB;NELFE;DKC1;FEN1;SNX12;FGFR1OP;KRT14;PPRC1;REEP1;PRKCA;AJUBA;GINS2;PDGFB;BRMS1;UBTF;POLA1;WDR34;NSFL1C;SPTBN1;DCTN1;DPYSL3;RRP7A;UHRF1;SLAIN2;MYH9;IL1A;COPS3;SNX8;RBBP5;RUNDC1;SFPQ;BRD9;WDR46;ZW10;RCC2;NUP214;TRAM2;CCDC6;MTA2;YWHAH;TAPBP;PALM2;SPECC1;ERAL1;HNRNPU;CLASP1;UBE2J2;CEP41;RUVBL2;ABT1;PPP1R9B;MTFP1;TANGO2;MICAL3;SAFB;ANAPC15;PRDM7;MRPL20;RRP7BP;ATG101;DUSP1;TGFBRAP1;JUN;ESR1;CENPN;BLOC1S2;PES1;RCC1;BRPF1;MCM7;TFDP1;BCS1L;TRAPPC5;NOP2;NOC2L;CHMP4B;INSIG1;CENPO;CNTROB;PARD3;RHOG;ZNF365;XRCC6;TAP2;CHCHD6;CNTNAP1;ACTN4;THEM4;SORBS2;KIF24;SNIP1;BMP7;CLUH;KANK4;TOMM40;PHLDB2;SGSM1;INCENP;IPO4;CHAF1A;ZYX;KIF22;MYADM;DAG1;TMEM165;CGNL1;RAB27A;WNT4;RILPL2;RBM14;TUBB;SMARCC2;BRIP1;SUPT16H;HSD17B10;ATAD3C;NOL3;SNF8;CDCA5;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;BIN3;PARP1;TP63;PHACTR4;TOP3A;BAIAP2L2
3332,GO:0007042,0.455878269584294,0.888289548078744,1,8,lysosomal lumen acidification,BP,CLN6
7459,GO:0031595,0.456288566237345,0.888062569274415,1,8,nuclear proteasome complex,CC,PSMC3
6877,GO:0030371,0.456523987394243,0.808444025107459,2,20,translation repressor activity,MF,TYMS;DHFR
8990,GO:0035097,0.457025362936653,0.705688145828791,6,70,histone methyltransferase complex,CC,HDAC9;CBX5;SENP3;RBBP5;PAGR1;RUVBL2
17975,GO:1902373,0.457034228797306,0.765995913358574,3,32,negative regulation of mRNA catabolic process,BP,NOCT;HNRNPU;DHX34
15223,GO:0071375,0.457064839101543,0.639588106167801,18,223,cellular response to peptide hormone stimulus,BP,HDAC9;FBN1;EDN1;NFKB1;IRS1;LYN;BAIAP2;CDK4;ERRFI1;STAT5A;GPER1;ZFP36L1;IRS2;SOCS1;BRIP1;GCLC;PARP1;BAIAP2L2
1857,GO:0004520,0.457184802927694,0.738861377535402,4,45,endodeoxyribonuclease activity,MF,FEN1;DNASE1;TATDN2;APEX2
8358,GO:0033233,0.457272558199847,0.807888944619452,2,20,regulation of protein sumoylation,BP,GNL3L;EGR1
17706,GO:1901615,0.457424608118683,0.623657713802854,26,327,organic hydroxy compound metabolic process,BP,CYP1B1;CYP24A1;CYP1A1;TGFB2;G6PD;NFE2L1;PANK2;NFKB1;TNF;SCD;LSS;CLN6;CYB5R1;ACAA1;HMGCS1;BMP2;EBP;DHCR7;GPER1;SNAI2;DHFR;PPIP5K1;INSIG1;QDPR;WNT4;AKR1C1
15115,GO:0071169,0.457446009414493,0.887420688306466,1,8,establishment of protein localization to chromatin,BP,RUVBL2
17488,GO:1900408,0.457457185242279,0.765370295349072,3,33,negative regulation of cellular response to oxidative stress,BP,HSPB1;SOD2;NOL3
18296,GO:1903202,0.457457185242279,0.765370295349072,3,33,negative regulation of oxidative stress-induced cell death,BP,HSPB1;SOD2;NOL3
1049,GO:0002577,0.457632102687987,0.887317269539335,1,8,regulation of antigen processing and presentation,BP,TAPBPL
17529,GO:1901019,0.457792106533572,0.73834418950065,4,45,regulation of calcium ion transmembrane transporter activity,BP,JPH2;JPH1;RRAD;STAC
19742,GO:2000116,0.457923535588232,0.647433715788243,15,191,regulation of cysteine-type endopeptidase activity,BP,CRYAB;MMP9;CYR61;CTGF;PML;BIRC3;TNF;PSMB9;SFN;GPER1;TRAF2;ROBO1;TNFRSF10A;NOL3;TP63
14316,GO:0061462,0.458231680782494,0.765021712823507,3,32,protein localization to lysosome,BP,GNPTAB;HSPA8;SH3BP4
8257,GO:0033033,0.458386515359085,0.88689739731439,1,8,negative regulation of myeloid cell apoptotic process,BP,CCL5
8905,GO:0034724,0.458456026404397,0.736831247776097,4,51,DNA replication-independent nucleosome organization,BP,CENPN;CENPO;IPO4;SUPT16H
7056,GO:0030834,0.458555558221967,0.764757893083998,3,32,regulation of actin filament depolymerization,BP,WDR1;SPTBN1;SWAP70
5225,GO:0015833,0.458665855040216,0.582107891035253,116,1518,peptide transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;TAP1;IL1R2;PML;HSPB1;TFRC;TGFB2;EDN1;GBP1;RSAD2;PANX1;TP53;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;EHD1;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;ITGAV;PMM2;SFN;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;RPLP2;AKAP8;RHOB;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;PRKCA;SYK;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;TRAM2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;UBE2J2;CEP41;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;CPT1A;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;VPS52;CD38;MAPK11;BMP8A;SRSF7;CLTA;SNF8;HSP90AB1;CCL5;MAGOH
15420,GO:0071682,0.459398054552786,0.886332862495683,1,8,endocytic vesicle lumen,CC,SAA1
4768,GO:0010952,0.459474806251696,0.657834202922553,12,151,positive regulation of peptidase activity,BP,CYR61;FN1;CTGF;PML;LYN;TNF;PSME2;GPER1;TRAF2;ROBO1;TNFRSF10A;EFNA1
4346,GO:0009898,0.459558132224902,0.668594378089444,10,120,cytoplasmic side of plasma membrane,CC,CYLD;G6PD;TRAF3;LYN;TNK1;ERRFI1;TRAF2;SYK;CHMP4B;CYTH1
2579,GO:0005869,0.45959766232364,0.886221251353936,1,8,dynactin complex,CC,DCTN1
38,GO:0000077,0.459725050153514,0.657727342841364,12,147,DNA damage checkpoint,BP,PML;MAP3K14;TP53;CDKN1A;GADD45A;SFN;PRPF19;ORAOV1;THOC1;TFDP1;BRIP1;TP63
15877,GO:0072599,0.459993239628633,0.690413205441734,7,104,establishment of protein localization to endoplasmic reticulum,BP,PMM2;RPLP2;RPLP1;RPS2;RPS9;RPL27A;CHMP4B
4159,GO:0009221,0.460119551138345,0.885929106863356,1,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,TYMS
1465,GO:0003720,0.460744136437692,0.885578848086613,1,8,telomerase activity,MF,DKC1
1563,GO:0003964,0.460744136437692,0.885578848086613,1,8,RNA-directed DNA polymerase activity,MF,DKC1
20281,GO:2001252,0.460908298590462,0.656650980163583,12,146,positive regulation of chromosome organization,BP,PML;TP53;AKAP8L;LIF;SNAI2;AKAP8;NELFE;DKC1;FEN1;SFPQ;HNRNPU;RUVBL2
3316,GO:0007019,0.46104266929256,0.762727349820264,3,32,microtubule depolymerization,BP,MID1;CLASP1;KIF24
4436,GO:0010288,0.46119331535761,0.804967716039395,2,20,response to lead ion,BP,CDK4;QDPR
7781,GO:0032305,0.461231105771468,0.885305288286739,1,8,positive regulation of icosanoid secretion,BP,EDN1
19775,GO:2000193,0.461231105771468,0.885305288286739,1,8,positive regulation of fatty acid transport,BP,EDN1
11849,GO:0046827,0.461325381649585,0.804868910333141,2,20,positive regulation of protein export from nucleus,BP,TP53;SFN
7987,GO:0032604,0.46177167111029,0.885001133291469,1,8,granulocyte macrophage colony-stimulating factor production,BP,SYK
8013,GO:0032645,0.46177167111029,0.885001133291469,1,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,SYK
1109,GO:0002698,0.461812321226204,0.701314649095037,6,71,negative regulation of immune effector process,BP,TGFB2;TNF;IL7R;LGALS3;SMAD7;THOC1
3420,GO:0007205,0.461853769769043,0.804473329381941,2,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;PARD3
10221,GO:0042886,0.46200859305409,0.578663920567895,117,1532,amide transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;TAP1;IL1R2;PML;HSPB1;TFRC;TGFB2;EDN1;GBP1;RSAD2;PANX1;TP53;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;EHD1;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;ITGAV;PMM2;SFN;SLC5A6;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;RPLP2;AKAP8;RHOB;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;PRKCA;SYK;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;TRAM2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;UBE2J2;CEP41;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;CPT1A;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;VPS52;CD38;MAPK11;BMP8A;SRSF7;CLTA;SNF8;HSP90AB1;CCL5;MAGOH
4062,GO:0009111,0.462243846251186,0.884735038999854,1,8,vitamin catabolic process,BP,CYP24A1
2464,GO:0005680,0.462273686257961,0.803637181751546,2,21,anaphase-promoting complex,CC,UBE2C;ANAPC15
5432,GO:0016290,0.462333911585562,0.884684238186587,1,8,palmitoyl-CoA hydrolase activity,MF,THEM4
10643,GO:0043652,0.462443046170263,0.884622662374799,1,8,engulfment of apoptotic cell,BP,RHOG
3534,GO:0007520,0.462470535632849,0.804011044979452,2,20,myoblast fusion,BP,EHD1;MYH9
8418,GO:0033483,0.462560615137745,0.884556304289355,1,8,gas homeostasis,BP,SOD2
3576,GO:0007620,0.462624133488065,0.884520443251072,1,8,copulation,BP,OXTR
7676,GO:0032105,0.463070746066922,0.884268095361648,1,8,negative regulation of response to extracellular stimulus,BP,SNAI2
7679,GO:0032108,0.463070746066922,0.884268095361648,1,8,negative regulation of response to nutrient levels,BP,SNAI2
10554,GO:0043507,0.463306072048298,0.714561162322778,5,57,positive regulation of JUN kinase activity,BP,EDN1;TNF;DAXX;TRAF2;SYK
8246,GO:0033017,0.463367671216626,0.803337577899335,2,20,sarcoplasmic reticulum membrane,CC,JPH2;JPH1
7488,GO:0031652,0.463718118160782,0.88390168949598,1,8,positive regulation of heat generation,BP,TNF
14719,GO:0070365,0.463735286996848,0.883891962066327,1,8,hepatocyte differentiation,BP,CYP1A1
3190,GO:0006813,0.463840725825137,0.678939843954387,8,95,potassium ion transport,BP,FLNA;CHP1;FXYD3;KCNA7;NEDD4L;KCNIP3;CAB39;OXSR1
2522,GO:0005776,0.463865338141383,0.688149286958067,7,83,autophagosome,CC,FTL;FTH1;SQSTM1;UBQLN2;LAMP1;VMP1;HSPA8
18203,GO:1902991,0.463918666331145,0.802923343725671,2,20,regulation of amyloid precursor protein catabolic process,BP,LYN;EFNA1
12963,GO:0051345,0.464068633784821,0.599291553006842,44,561,positive regulation of hydrolase activity,BP,CCL20;CYR61;FN1;CTGF;PML;STARD13;SIPA1L3;LYN;TNF;CORO1C;FGFR2;DNAJB1;EPHA2;ICAM1;BMP2;ERRFI1;CDC42EP2;SFRP1;TPM1;PSME2;GPER1;DNAJB2;DOCK10;TRAF2;ROBO1;UHRF1;NPNT;RASGRP4;RUNDC1;RCC2;DNAJC1;HNRNPU;JUN;ESR1;RHOG;TNFRSF10A;SGSM1;RAPGEF1;WNT4;CCL22;DNAJC9;EFNA1;HSP90AB1;CCL5
15279,GO:0071459,0.464183756527359,0.802723885344609,2,20,protein localization to chromosome, centromeric region,BP,ZW10;RCC2
3755,GO:0008296,0.464391865451093,0.883519570912078,1,8,3'-5'-exodeoxyribonuclease activity,MF,APEX2
190,GO:0000407,0.464460041808692,0.759923933309456,3,32,phagophore assembly site,CC,SQSTM1;VMP1;ATG101
3046,GO:0006600,0.46446954122712,0.883475465262867,1,8,creatine metabolic process,BP,STAT5A
981,GO:0002438,0.464549139667611,0.88343025684227,1,8,acute inflammatory response to antigenic stimulus,BP,ICAM1
10587,GO:0043550,0.464895345975135,0.759565721599313,3,32,regulation of lipid kinase activity,BP,IRS1;LYN;PDGFB
18537,GO:1903726,0.465084982108803,0.883125630547407,1,8,negative regulation of phospholipid metabolic process,BP,PDGFB
11880,GO:0046887,0.465115133976755,0.698349279066861,6,71,positive regulation of hormone secretion,BP,INHBA;C1QTNF1;EDN1;GPER1;IRS2;CD38
685,GO:0001895,0.465134157630522,0.759082160447095,3,33,retina homeostasis,BP,KRT1;ACTG1;HSPB1
10553,GO:0043506,0.465143907463093,0.698419652450883,6,70,regulation of JUN kinase activity,BP,EDN1;TNF;DAXX;SFRP1;TRAF2;SYK
15893,GO:0072657,0.465434272232612,0.60603741225021,34,452,protein localization to membrane,BP,GBP1;EMP2;TP53;SQSTM1;RAB32;TNF;FLNA;EPHA2;CHP1;ARFRP1;SFN;ZFYVE27;ZDHHC3;GPER1;RPLP2;RPLP1;REEP1;RPS2;RPS9;SPTBN1;TRAM2;YWHAH;ZDHHC6;KCNIP3;RPL27A;STAC;TFDP1;CHMP4B;PARD3;RHOG;MYADM;WNT4;RILPL2;TP63
14130,GO:0060996,0.465580083351688,0.698027283974653,6,70,dendritic spine development,BP,NRG1;BAIAP2;DOCK10;SDK1;ZNF365;EFNA1
6928,GO:0030521,0.465809993990776,0.712221114617518,5,58,androgen receptor signaling pathway,BP,DAXX;SFRP1;SAFB2;DDX17;FHL2
17337,GO:1900015,0.465847686694628,0.801469458226224,2,20,regulation of cytokine production involved in inflammatory response,BP,IL1R2;ZC3H12A
2868,GO:0006360,0.46604773158594,0.711885952792269,5,59,transcription by RNA polymerase I,BP,CD3EAP;FLNA;POLR1A;UBTF;POLR1E
7844,GO:0032401,0.46609253449483,0.801284510730715,2,20,establishment of melanosome localization,BP,DCTN1;RAB27A
13242,GO:0051905,0.46609253449483,0.801284510730715,2,20,establishment of pigment granule localization,BP,DCTN1;RAB27A
11882,GO:0046889,0.466123802298133,0.73120474907291,4,45,positive regulation of lipid biosynthetic process,BP,CYR61;TNF;SMPD2;WNT4
14533,GO:0070034,0.466178139972325,0.800692414482656,2,21,telomerase RNA binding,MF,DKC1;HNRNPU
11036,GO:0045008,0.466202556672842,0.882488655439708,1,8,depyrimidination,BP,SMUG1
3258,GO:0006924,0.466423081184924,0.882362703508003,1,8,activation-induced cell death of T cells,BP,TSC22D3
8226,GO:0032984,0.466663602944199,0.623333090559851,21,275,protein-containing complex disassembly,BP,MID1;TNF;ADRB2;GRWD1;WDR1;TFIP11;SPTBN1;MRPS12;MRPS24;ERAL1;CLASP1;MICAL3;MRPL20;HSPA8;MRPL33;KIF24;EIF5A;MRPS2;SMARCC2;SUPT16H;SWAP70
13825,GO:0060421,0.466807401463071,0.800744004584334,2,20,positive regulation of heart growth,BP,EDN1;FGFR2
10809,GO:0044295,0.466883760155633,0.800686223909884,2,20,axonal growth cone,CC,L1CAM;PARD3
1038,GO:0002551,0.46692368048167,0.882076467591393,1,8,mast cell chemotaxis,BP,SWAP70
3051,GO:0006610,0.466932221156815,0.882071580291926,1,8,ribosomal protein import into nucleus,BP,IPO4
16886,GO:0098827,0.467059390161887,0.587001361482394,62,799,endoplasmic reticulum subcompartment,CC,CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;RSAD2;PANX1;NFE2L1;PKMYT1;SCD;DST;CDKAL1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;GGCX;ANKS4B;RNF19B;EBP;ZFYVE27;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;SGK1;CYP4B1;TRAF2;REEP1;SPPL2A;TAPBPL;ZW10;ACSL1;DNAJC1;TAPBP;ZDHHC6;APH1A;UBE2J2;CREB3;LPCAT3;PCYT1A;GALNT2;ATG101;PIGM;SCD5;INSIG1;RHOG;TAP2;EIF5A;RNF185;DPM3;LRRC59;FADS1
6694,GO:0030071,0.467187488612615,0.730108184536713,4,46,regulation of mitotic metaphase/anaphase transition,BP,UBE2C;ZW10;ANAPC15;DUSP1
17866,GO:1902099,0.467187488612615,0.730108184536713,4,46,regulation of metaphase/anaphase transition of cell cycle,BP,UBE2C;ZW10;ANAPC15;DUSP1
12924,GO:0051279,0.467213975304082,0.730085313682495,4,46,regulation of release of sequestered calcium ion into cytosol,BP,JPH2;LYN;JPH1;GPER1
9430,GO:0035999,0.467417307012118,0.881793783048035,1,8,tetrahydrofolate interconversion,BP,TYMS
12580,GO:0050746,0.467494941309979,0.881749284915236,1,8,regulation of lipoprotein metabolic process,BP,ITGAV
8241,GO:0033008,0.467660663829537,0.881654260867432,1,8,positive regulation of mast cell activation involved in immune response,BP,SYK
10450,GO:0043306,0.467660663829537,0.881654260867432,1,8,positive regulation of mast cell degranulation,BP,SYK
18768,GO:1904263,0.468158674162402,0.881368411599971,1,8,positive regulation of TORC1 signaling,BP,TELO2
9730,GO:0038180,0.46822561652746,0.881329954208487,1,8,nerve growth factor signaling pathway,BP,RAPGEF1
2481,GO:0005719,0.468451659753121,0.798966940461946,2,21,nuclear euchromatin,CC,RUVBL2;JUN
4577,GO:0010662,0.468453611719236,0.79949633046829,2,20,regulation of striated muscle cell apoptotic process,BP,BMP7;NOL3
15332,GO:0071548,0.468769886313942,0.756076855959152,3,33,response to dexamethasone,BP,EDN1;ICAM1;ERRFI1
4758,GO:0010935,0.469031754047963,0.880866213493603,1,8,regulation of macrophage cytokine production,BP,TGFB2
12958,GO:0051340,0.469226368927984,0.880754085290527,1,8,regulation of ligase activity,BP,TFIP11
3659,GO:0008140,0.469342365041366,0.880687221513404,1,8,cAMP response element binding protein binding,MF,DAPK3
17665,GO:1901522,0.469399471965224,0.798777570581898,2,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,BMP2;CREB3
9299,GO:0035743,0.469401756458046,0.880652977147638,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,RSAD2
11015,GO:0044848,0.469409369658259,0.880648587017103,1,8,biological phase,BP,TGFB2
11017,GO:0044851,0.469409369658259,0.880648587017103,1,8,hair cycle phase,BP,TGFB2
12394,GO:0048819,0.469409369658259,0.880648587017103,1,8,regulation of hair follicle maturation,BP,TGFB2
5302,GO:0016004,0.469442034962224,0.880629749477869,1,8,phospholipase activator activity,MF,CCL5
13688,GO:0060229,0.469442034962224,0.880629749477869,1,8,lipase activator activity,MF,CCL5
9408,GO:0035966,0.469445732502495,0.640150960734472,14,174,response to topologically incorrect protein,BP,HSPB1;DNAJB1;DAXX;DNAJB2;SERPINH1;DCTN1;TATDN2;UBE2J2;CREB3;TUSC1;HSPA8;RNF185;CXCL8;HSP90AB1
10001,GO:0042416,0.469466365204281,0.88061571739297,1,8,dopamine biosynthetic process,BP,TGFB2
13700,GO:0060252,0.469526080482613,0.880581273065904,1,8,positive regulation of glial cell proliferation,BP,LYN
3187,GO:0006810,0.469642877172946,0.560709436176775,256,3344,transport,BP,HEPHL1;KRT1;SAA1;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;PTGER4;INHBA;S100P;FN1;NEFL;CTGF;C1QTNF1;ADM;SLC16A2;JPH2;ACTG1;IL16;TAP1;IL1R2;NFKBIE;PML;HSPB1;PCDH7;SDC4;TFRC;ABCF1;CSF2;TGFB2;EDN1;GBP1;B4GALT1;MGAM;RSAD2;G6PD;EMP2;HRNR;APOL6;PANX1;TP53;SQSTM1;STEAP4;NFKB1;GNPTAB;IRS1;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;PLEKHO2;ARPC4;LAMP1;EHD1;TNF;BAIAP2;CORO1C;CXCL16;WWC1;DST;VMP1;PTPN14;NUP153;PSMB9;SLC7A5;QPCT;SLC16A9;SIRPA;JPH1;SLC39A1;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;ACAA1;GEMIN5;CADPS2;CHP1;TSC22D3;ICAM1;ARFRP1;CD274;GOSR1;SLCO3A1;SLC7A5P2;ITGAV;KIF23;MYO10;PMM2;SFN;STAT5A;ADRB2;SLC5A6;SERPINE1;FXYD3;ARPC1B;LSG1;EBP;NMT2;USP36;AKAP8L;LIF;SFRP1;PARL;ZFYVE27;ZDHHC3;WDR1;ANXA8;PSME2;BANF1;GPER1;AP4S1;NFKBIA;KCNA7;GEMIN4;SGK1;RRS1;ZFP36L1;RPLP2;AKAP8;RHOB;SNX12;TXLNA;U2AF2;VCL;VPS13B;IRS2;LGALS3;ACO1;RPLP1;TRAF2;ABCG2;REEP1;PRKCA;NTN1;SYK;SLC7A2;SLC43A3;PDGFB;OXTR;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;NEDD4L;DCTN1;COX5B;MYH9;IL1A;GLIPR1;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;LILRB3;ZW10;ACSL1;NUP214;ACKR3;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;CLASP1;RRAD;UBE2J2;CEP41;SLC4A11;TANGO2;MICAL3;KCNIP3;THOC1;CAB39;TGFBRAP1;CD109;RPL27A;SOCS1;STAC;FRAS1;OXSR1;HSPA8;BLOC1S2;SLC22A4;CPT1A;COMMD9;TFDP1;TNPO3;TRAPPC5;CHMP4B;RBM4;INSIG1;HERC2;PARD3;RHOG;XRCC6;TAP2;ACTN4;THEM4;SNIP1;TOMM40;SGSM1;RAPGEF1;IPO4;EIF5A;TINAGL1;KIF22;SLC41A2;DAG1;TMEM165;RNF185;RAB27A;RILPL2;AKR1C1;VPS52;TUBB;CYTH1;CD38;PSMC3;SLC4A2;CXCL8;MAPK11;MYO1E;SLC3A2;BMP8A;SLC25A22;PTPRB;SLC25A44;SRSF7;CLTA;NOL3;SNF8;HSP90AB1;LAIR1;SLC2A6;TP63;CCL5;MAGOH;SH3BP4
12990,GO:0051400,0.469733418638764,0.880461629073547,1,8,BH domain binding,MF,BCL2L2
16355,GO:0090630,0.469773661540375,0.694245174421242,6,70,activation of GTPase activity,BP,CORO1C;EPHA2;RUNDC1;RCC2;RHOG;SGSM1
14888,GO:0070673,0.46982558931601,0.880408417561669,1,8,response to interleukin-18,BP,PDGFB
14978,GO:0070886,0.469965473826004,0.880327631139845,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,NRG1
17210,GO:0106058,0.469965473826004,0.880327631139845,1,8,positive regulation of calcineurin-mediated signaling,BP,NRG1
15004,GO:0070932,0.470009868327077,0.798312998248148,2,20,histone H3 deacetylation,BP,HDAC9;SFPQ
672,GO:0001882,0.470314695567114,0.616100647577697,23,291,nucleoside binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;POLA1;LANCL2;GPN1;ERAL1;RRAD;RHOG;ACTN4;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
3816,GO:0008408,0.470588531609635,0.727164601915779,4,46,3'-5' exonuclease activity,MF,USB1;NOCT;ISG20L2;APEX2
13016,GO:0051451,0.47102712443119,0.879713364159434,1,8,myoblast migration,BP,BIN3
17827,GO:1901985,0.471123559575777,0.754121898618443,3,33,positive regulation of protein acetylation,BP,LIF;SNAI2;RUVBL2
11491,GO:0045954,0.471189844569582,0.879619036662054,1,8,positive regulation of natural killer cell mediated cytotoxicity,BP,LAMP1
13085,GO:0051593,0.471192088562254,0.879617735508861,1,8,response to folic acid,BP,TYMS
5727,GO:0016868,0.471366128400112,0.879516792891472,1,8,intramolecular transferase activity, phosphotransferases,MF,PMM2
11754,GO:0046600,0.47148473593619,0.879447969759836,1,8,negative regulation of centriole replication,BP,RBM14
13912,GO:0060563,0.471608607746013,0.753718097918118,3,33,neuroepithelial cell differentiation,BP,BMP2;SERPINE1;WNT4
1697,GO:0004175,0.471702779298922,0.625506915961817,18,228,endopeptidase activity,MF,MMP9;C1R;PRSS23;ADAMTS9;BACE2;PSMB9;SFRP1;PARL;ADAM17;SENP3;PREP;SPPL2A;APH1A;CAPNS1;RHBDL2;OVCH2;TINAGL1;C1S
13286,GO:0051974,0.471783101382552,0.879274728911405,1,8,negative regulation of telomerase activity,BP,TP53
1182,GO:0002829,0.471865278977804,0.879226985839407,1,8,negative regulation of type 2 immune response,BP,IL27RA
6706,GO:0030111,0.471880423384315,0.620533483872666,20,255,regulation of Wnt signaling pathway,BP,RUNX1;CYLD;DAPK3;NFKB1;FGFR2;PSMB9;BMP2;KREMEN2;SFRP1;PSME2;EGR1;JRK;SNAI2;BAMBI;RUVBL2;ESR1;ZNF703;RAPGEF1;WNT4;PSMC3
16342,GO:0090576,0.471983480114684,0.879158292778133,1,8,RNA polymerase III transcription factor complex,CC,GTF3C2
4177,GO:0009251,0.471991310386294,0.796800962003424,2,20,glucan catabolic process,BP,MGAM;PPP1R3B
16815,GO:0098662,0.472083054166793,0.605295451765498,29,372,inorganic cation transmembrane transport,BP,JPH2;G6PD;PANX1;STEAP4;LYN;JPH1;SLC39A1;FLNA;CHP1;ITGAV;FXYD3;PARL;GPER1;KCNA7;NEDD4L;COX5B;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;ACTN4;SLC41A2;SLC3A2;SLC25A22;NOL3;SLC2A6
6755,GO:0030176,0.47217418300969,0.656691721714794,10,123,integral component of endoplasmic reticulum membrane,CC,TAP1;HLA-B;ZFYVE27;DHCR7;HLA-F;SPPL2A;TAPBP;INSIG1;TAP2;DPM3
2396,GO:0005540,0.47221695503921,0.87902253423855,1,8,hyaluronic acid binding,MF,LAYN
980,GO:0002437,0.472223530703458,0.796086745109144,2,21,inflammatory response to antigenic stimulus,BP,TNF;ICAM1
8837,GO:0034622,0.472239514375987,0.580306434143914,66,883,cellular protein-containing complex assembly,BP,CRYAB;NRG1;MAP2;NEFL;COBLL1;TP53;NOCT;TAF4B;ARPC4;BAIAP2;PPAN;NUP153;UBE2C;SART1;GEMIN5;CADPS2;ICAM1;DDX23;CDC42EP2;ANKS4B;ADRB2;DAXX;ARPC1B;MCM2;GRWD1;PWP2;PDE4DIP;LUC7L;SF1;GEMIN4;RRS1;CD2BP2;PRPF19;SHQ1;TRAF2;UBTF;GEMIN8;SPTBN1;DCTN1;RRP7A;SLAIN2;ERAL1;CLASP1;RUVBL2;ABT1;MRPL20;RRP7BP;TXNL4B;ESR1;CENPN;BCS1L;NOP2;INSIG1;CENPO;RHOG;KANK4;IPO4;CHAF1A;MYADM;GPX4;PSMC3;CLTA;NOL3;HSP90AB1;PARP1;BAIAP2L2
18224,GO:1903025,0.472450415878653,0.877312544482635,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
3823,GO:0008420,0.472621121956604,0.878787292186559,1,8,CTD phosphatase activity,MF,CTDSP1
10242,GO:0042974,0.472760073687948,0.796212686174905,2,20,retinoic acid receptor binding,MF,FUS;ACTN4
9041,GO:0035255,0.472770648839951,0.796204587445229,2,20,ionotropic glutamate receptor binding,MF,SQSTM1;FUS
5075,GO:0015298,0.472866858940688,0.796130899257143,2,20,solute:cation antiporter activity,MF,SLC22A4;SLC3A2
381,GO:0001013,0.472951426338156,0.87859482329394,1,8,RNA polymerase I regulatory region DNA binding,MF,UBTF
435,GO:0001163,0.472951426338156,0.87859482329394,1,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,UBTF
436,GO:0001164,0.472951426338156,0.87859482329394,1,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,UBTF
441,GO:0001188,0.472951426338156,0.87859482329394,1,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,UBTF
3050,GO:0006607,0.472953568659348,0.796064475223949,2,20,NLS-bearing protein import into nucleus,BP,IPO4;DAG1
12266,GO:0048557,0.472960959829457,0.878589265203455,1,8,embryonic digestive tract morphogenesis,BP,FGFR2
6988,GO:0030666,0.473114167089518,0.662351689144455,9,112,endocytic vesicle membrane,CC,TAP1;HLA-B;RAB32;LAMP1;HLA-F;TAPBP;TAP2;RAPGEF1;WNT4
481,GO:0001527,0.473130022361514,0.878490673422655,1,8,microfibril,CC,FBN1
3713,GO:0008227,0.473138531200398,0.878485709978619,1,8,G-protein coupled amine receptor activity,MF,ADRB2
19288,GO:1905523,0.473235959153508,0.878428868324018,1,8,positive regulation of macrophage migration,BP,CCL5
6355,GO:0021536,0.473236146945059,0.752360876063756,3,33,diencephalon development,BP,BMP2;ETS1;WNT4
12391,GO:0048814,0.473383838347562,0.705491382574573,5,58,regulation of dendrite morphogenesis,BP,BAIAP2;NEDD4L;YWHAH;PQBP1;EFNA1
9921,GO:0042267,0.47345912715384,0.751900246047674,3,34,natural killer cell mediated cytotoxicity,BP,LAMP1;RAB27A;TUBB
4916,GO:0014854,0.473613993903199,0.878208152633333,1,8,response to inactivity,BP,DAG1
2666,GO:0006013,0.473847037473808,0.878071961899171,1,8,mannose metabolic process,BP,PMM2
11513,GO:0046007,0.473897600949177,0.878042399678871,1,8,negative regulation of activated T cell proliferation,BP,CD274
10532,GO:0043471,0.473916774896805,0.878031188314632,1,8,regulation of cellular carbohydrate catabolic process,BP,PPP1R3B
19715,GO:2000058,0.474222458581508,0.65472572028906,10,124,regulation of ubiquitin-dependent protein catabolic process,BP,PML;UBQLN2;RNF19B;SMAD7;KEAP1;TRIB1;HSPBP1;RNF144B;GCLC;HSP90AB1
6224,GO:0019774,0.474427069793996,0.874882475385242,1,10,proteasome core complex, beta-subunit complex,CC,PSMB9
13834,GO:0060433,0.474506819422803,0.877685854420772,1,8,bronchus development,BP,SRF
5204,GO:0015802,0.474533844408644,0.877670022542307,1,8,basic amino acid transport,BP,SLC7A2
6324,GO:0019992,0.474605984620024,0.877627754630841,1,8,diacylglycerol binding,MF,RASGRP4
18805,GO:1904356,0.474775578219578,0.704247979276047,5,58,regulation of telomere maintenance via telomere lengthening,BP,GNL3L;NAT10;DKC1;HNRNPU;PARP1
3808,GO:0008395,0.474972235855613,0.877413018294608,1,8,steroid hydroxylase activity,MF,CYP1A1
5907,GO:0018126,0.475051072234853,0.794454132443557,2,20,protein hydroxylation,BP,P3H2;P4HA2
11076,GO:0045076,0.475089593771074,0.877344159075193,1,8,regulation of interleukin-2 biosynthetic process,BP,IL1A
12842,GO:0051152,0.47517867219877,0.877291876110903,1,8,positive regulation of smooth muscle cell differentiation,BP,GPER1
2002,GO:0004726,0.475194148024635,0.87728279139981,1,8,non-membrane spanning protein tyrosine phosphatase activity,MF,DUSP1
10609,GO:0043587,0.475196948311481,0.877281147508879,1,8,tongue morphogenesis,BP,KRT13
7462,GO:0031618,0.475345606845722,0.877193858259843,1,8,nuclear pericentric heterochromatin,CC,CBX5
8896,GO:0034713,0.475351812200003,0.87719021373257,1,8,type I transforming growth factor beta receptor binding,MF,SMAD7
12910,GO:0051256,0.47546094201593,0.877126108294158,1,8,mitotic spindle midzone assembly,BP,KIF23
8799,GO:0034498,0.475481286762529,0.877114154921198,1,8,early endosome to Golgi transport,BP,SNX8
6564,GO:0022010,0.475686990936145,0.876993253316418,1,8,central nervous system myelination,BP,CNTNAP1
7771,GO:0032291,0.475686990936145,0.876993253316418,1,8,axon ensheathment in central nervous system,BP,CNTNAP1
5476,GO:0016409,0.475705259165729,0.750295075616801,3,33,palmitoyltransferase activity,MF,ZDHHC3;ZDHHC6;CPT1A
15866,GO:0072584,0.47613600497826,0.876729081675465,1,8,caveolin-mediated endocytosis,BP,NEDD4L
16879,GO:0098813,0.476199506938335,0.616395799569778,20,253,nuclear chromosome segregation,BP,UBE2C;KIF23;AKAP8L;RRS1;AKAP8;FEN1;SFPQ;ZW10;RCC2;HNRNPU;CLASP1;ANAPC15;DUSP1;CENPN;CHMP4B;CENPO;INCENP;KIF22;BRIP1;CDCA5
5146,GO:0015677,0.47625098582489,0.876661375489813,1,8,copper ion import,BP,STEAP4
6330,GO:0020027,0.476275384052409,0.876647005578365,1,8,hemoglobin metabolic process,BP,INHBA
15485,GO:0071837,0.476294923771944,0.876635496416411,1,8,HMG box domain binding,MF,JUN
18135,GO:1902850,0.476397544653424,0.652766057775447,10,122,microtubule cytoskeleton organization involved in mitosis,BP,MYBL2;BIRC3;FLNA;KIF23;DCTN1;ZW10;HNRNPU;CLASP1;RCC1;CHMP4B
15087,GO:0071071,0.476488774187587,0.876521278461545,1,8,regulation of phospholipid biosynthetic process,BP,PDGFB
2874,GO:0006367,0.476528305990077,0.641745135980826,12,151,transcription initiation from RNA polymerase II promoter,BP,CTGF;TP53;TAF4B;CDKN1A;CDK4;SRF;MAZ;ESR1;GTF2E1;TEAD4;PSMC3;POLR2G
905,GO:0002287,0.476567861236013,0.749571443236826,3,33,alpha-beta T cell activation involved in immune response,BP,PTGER4;RELB;SMAD7
908,GO:0002293,0.476567861236013,0.749571443236826,3,33,alpha-beta T cell differentiation involved in immune response,BP,PTGER4;RELB;SMAD7
909,GO:0002294,0.476567861236013,0.749571443236826,3,33,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,PTGER4;RELB;SMAD7
9848,GO:0042093,0.476567861236013,0.749571443236826,3,33,T-helper cell differentiation,BP,PTGER4;RELB;SMAD7
6819,GO:0030277,0.476585462638744,0.876464283538086,1,8,maintenance of gastrointestinal epithelium,BP,VSIG1
2203,GO:0005088,0.476602049485388,0.633357090069853,14,173,Ras guanyl-nucleotide exchange factor activity,MF,NRG1;NEFL;CSF2;IRS1;TRIO;FGFR2;ARHGEF28;IRS2;PDGFB;SPTBN1;RASGRP4;RCC1;TRAPPC5;RAPGEF1
14844,GO:0070586,0.476665658790439,0.876416997476141,1,8,cell-cell adhesion involved in gastrulation,BP,MYADM
16477,GO:0097157,0.476846455932125,0.876310351286994,1,8,pre-mRNA intronic binding,MF,RBM4
8395,GO:0033314,0.476948655505521,0.876250040963723,1,8,mitotic DNA replication checkpoint,BP,ORAOV1
19496,GO:1990314,0.477050948851664,0.876189656328645,1,8,cellular response to insulin-like growth factor stimulus,BP,FBN1
6331,GO:0020037,0.477161235936378,0.701984307934466,5,59,heme binding,MF,CYP1B1;CYP24A1;CYP1A1;CYP4B1;CYP20A1
752,GO:0001991,0.47719968056891,0.876101824870969,1,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,C9ORF3
2394,GO:0005537,0.477331421568134,0.876023993531027,1,8,mannose binding,MF,M6PR
12198,GO:0048368,0.477341816503164,0.876017850962438,1,8,lateral mesoderm development,BP,CITED2
6696,GO:0030073,0.477466453587424,0.651672689005247,10,124,insulin secretion,BP,IRS1;TNF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
12339,GO:0048699,0.477592690958644,0.572452161610807,74,943,generation of neurons,BP,NRG1;RUNX1;INHBA;HDAC9;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;WNT10A;IER2;TGFB2;DAPK3;DBNDD2;LYN;EHD1;BAIAP2;EFNB2;ENC1;TNC;GPRIN1;FGFR2;PBX1;FLNA;KLF7;BMP2;UBE4B;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;WDR1;GPER1;SRF;DOCK10;SGK1;SRRT;PRPF19;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;DPYSL3;SDK1;TNFRSF21;SEMA3C;SPEN;YWHAH;ENAH;PQBP1;ABT1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;WNT4;CTDSP1;EFNA1
1492,GO:0003831,0.477690619184205,0.875811622918264,1,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT1
17839,GO:1902004,0.477817595727632,0.875736493752759,1,8,positive regulation of amyloid-beta formation,BP,EFNA1
17391,GO:1900117,0.477922217299238,0.791693470459021,2,21,regulation of execution phase of apoptosis,BP,TP53;ZC3H12A
17583,GO:1901213,0.478055722219511,0.875595520664433,1,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,SRF
7789,GO:0032329,0.478103598301855,0.875567165140097,1,8,serine transport,BP,NFKBIE
14692,GO:0070307,0.478112506834359,0.875561888433269,1,8,lens fiber cell development,BP,EPHA2
1309,GO:0003157,0.47813134392084,0.875550730354907,1,8,endocardium development,BP,NRG1
14134,GO:0061000,0.478242257056531,0.875485018328292,1,8,negative regulation of dendritic spine development,BP,EFNA1
1330,GO:0003183,0.478242270616869,0.875485010300256,1,8,mitral valve morphogenesis,BP,EFNA1
1333,GO:0003188,0.478242270616869,0.875485010300256,1,8,heart valve formation,BP,EFNA1
8623,GO:0034139,0.478361506705626,0.875414342252932,1,8,regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
7257,GO:0031224,0.478399964670625,0.553919619536855,213,2759,intrinsic component of membrane,CC,HEPHL1;NRG1;PTGER4;PLD5;TENM3;C1QTNF1;SLC16A2;JPH2;TAP1;IL1R2;PCDH7;SDC4;FADS3;TFRC;GPRC5A;UGT1A6;CD83;HLA-B;PTGES;TMPPE;B4GALT1;MGAM;TRAF3;EMP2;PANX1;NFE2L1;MARVELD3;STEAP4;IL27RA;GNPTAB;LFNG;IRS1;GALNT18;LYN;STOML1;LAMP1;HS3ST2;TNF;EFNB2;CXCL16;SCD;DST;VMP1;PDPN;FGFR2;CDKAL1;BACE2;SLC7A5;CLN6;EPHB6;LAYN;SLC16A9;SIRPA;JPH1;SLC39A1;CYB5R1;FAM69B;EPHA2;ICAM1;CD274;BMP2;GOSR1;SLCO3A1;SLC7A5P2;KREMEN2;DRAM1;ITGAV;L1CAM;GGCX;TMEM183B;LYPD6B;RRP12;EPGN;GPR146;RNF19B;ADRB2;TMEM14EP;TNFRSF12A;IFNGR1;SLC5A6;FXYD3;EBP;ST6GALNAC5;RELT;SFRP1;PARL;ABCF2;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;IL7R;THBD;GPER1;HS3ST1;IGSF3;KCNA7;FAM57A;ADAM17;UPK3B;IER3;TRAF2;ABCG2;IL15;REEP1;GPR132;CMTM3;FAM74A7;SLC7A2;ROBO1;SLC43A3;BCAM;OXTR;PTTG1IP;DCBLD1;MYH9;SPPL2A;TAPBPL;TMEM159;COL17A1;NPNT;SDK1;GLIPR1;GPR75;TNFRSF21;ERVV-1;LILRB3;ROR1;PXMP2;ACSL1;ACKR3;BAMBI;TMEM140;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;TAPBP;TRIP6;M6PR;ZDHHC6;CHST3;APH1A;UBE2J2;VSIG1;TPST1;CREB3;SLC4A11;MTFP1;LPCAT3;KCNIP3;RHBDL2;SUSD6;GALNT2;MARVELD2;CD109;FRAS1;PIGM;ESR1;MANEAL;SLC22A4;HCAR3;CPT1A;SCD5;BCS1L;CCR6;INSIG1;SMIM17;GPNMB;GP6;TAP2;CHCHD6;SMPD2;CNTNAP1;EFNB1;LRFN4;TNFRSF10A;TPRA1;TOMM40;CYP20A1;ZYX;SLC41A2;MYADM;DAG1;TMEM165;FAM234A;MGAT2;RNF185;DPM3;CD38;CYB561D2;SLC4A2;EFNA1;CLDN7;SLC3A2;SLC25A22;PTPRB;RNF144B;SLC25A44;LRRC59;TBXA2R;MCAM;ADGRF3;IL6R;LAIR1;FAM74A3;SLC2A6;TXNDC15;ARIH2OS;TMEM51;FADS1
12171,GO:0048291,0.478415691293773,0.875382219963171,1,8,isotype switching to IgG isotypes,BP,IL27RA
11185,GO:0045277,0.478465628256126,0.871408458957154,1,11,respiratory chain complex IV,CC,COX5B
13037,GO:0051493,0.478585774352793,0.596558347708156,31,395,regulation of cytoskeleton organization,BP,PTGER4;MAP2;CTGF;CYLD;SDC4;EDN1;MID1;DAPK3;ARPC4;BAIAP2;ICAM1;CDC42EP2;ARPC1B;SFRP1;TPM1;WDR1;RHOB;SPTBN1;DCTN1;SLAIN2;HNRNPU;CLASP1;CHMP4B;RHOG;KANK4;PHLDB2;MYADM;WNT4;RBM14;SWAP70;BAIAP2L2
19874,GO:2000353,0.478695112241935,0.875216485789093,1,8,positive regulation of endothelial cell apoptotic process,BP,GPER1
706,GO:0001931,0.478765241893378,0.875174867177407,1,8,uropod,CC,MYH9
7274,GO:0031254,0.478765241893378,0.875174867177407,1,8,cell trailing edge,CC,MYH9
16005,GO:0086013,0.478768740795194,0.875172790507578,1,8,membrane repolarization during cardiac muscle cell action potential,BP,FLNA
7112,GO:0030911,0.478770336271638,0.875171843557804,1,8,TPR domain binding,MF,HSP90AB1
19513,GO:1990403,0.478806330784767,0.875150478713356,1,8,embryonic brain development,BP,CC2D2A
3230,GO:0006883,0.478932169545479,0.875075767530201,1,8,cellular sodium ion homeostasis,BP,NEDD4L
20209,GO:2001135,0.478969893588469,0.875053364935423,1,8,regulation of endocytic recycling,BP,EHD1
14037,GO:0060766,0.479050614604409,0.875005419685115,1,8,negative regulation of androgen receptor signaling pathway,BP,SFRP1
9137,GO:0035461,0.479093056996366,0.874980205734552,1,8,vitamin transmembrane transport,BP,SLC5A6
3009,GO:0006554,0.479196331073075,0.874918839522158,1,8,lysine catabolic process,BP,AASS
6232,GO:0019783,0.479222452369158,0.664580947616504,8,97,ubiquitin-like protein-specific protease activity,MF,CYLD;ZC3H12A;USP36;SENP3;USP43;USP31;TNFAIP3;OTUD6A
12895,GO:0051236,0.479288309918106,0.630710366321342,14,176,establishment of RNA localization,BP,NUP153;SRSF2;AKAP8L;RRS1;ZFP36L1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;THOC1;EIF5A;SRSF7;MAGOH
13877,GO:0060502,0.479482198829465,0.87474887343392,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,FGFR2
2334,GO:0005351,0.47973234620587,0.874600023093487,1,8,carbohydrate:proton symporter activity,MF,SLC2A6
8193,GO:0032933,0.47976293116054,0.874581815671966,1,8,SREBP signaling pathway,BP,INSIG1
15311,GO:0071501,0.47976293116054,0.874581815671966,1,8,cellular response to sterol depletion,BP,INSIG1
5159,GO:0015697,0.479845054376916,0.874532918733597,1,8,quaternary ammonium group transport,BP,SLC22A4
12404,GO:0048845,0.47989426459948,0.874503612609089,1,8,venous blood vessel morphogenesis,BP,EFNB2
15568,GO:0072015,0.479959047424848,0.874465025803783,1,8,glomerular visceral epithelial cell development,BP,MYO1E
15738,GO:0072310,0.479959047424848,0.874465025803783,1,8,glomerular epithelial cell development,BP,MYO1E
5014,GO:0015174,0.479960077955783,0.874464411925231,1,8,basic amino acid transmembrane transporter activity,MF,SLC7A2
10278,GO:0043022,0.479983420704127,0.718786121321726,4,47,ribosome binding,MF,ZC3H12A;GEMIN5;GTPBP6;EIF5A
2190,GO:0005049,0.480040016601283,0.874416787103319,1,8,nuclear export signal receptor activity,MF,NUP214
3262,GO:0006930,0.480057839875874,0.874406166993512,1,8,substrate-dependent cell migration, cell extension,BP,NTN1
14362,GO:0061577,0.48007628898767,0.874395173361834,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
16149,GO:0090160,0.480214263634214,0.874312936005081,1,8,Golgi to lysosome transport,BP,LAMP1
5582,GO:0016600,0.480224575147421,0.874306788618581,1,8,flotillin complex,CC,CORO1C
3553,GO:0007588,0.480281219316274,0.789860064531945,2,21,excretion,BP,EDN1;NEDD4L
8375,GO:0033270,0.48039407896428,0.874205708081095,1,8,paranode region of axon,CC,CNTNAP1
1701,GO:0004181,0.480410965375757,0.874195635293295,1,8,metallocarboxypeptidase activity,MF,CPA4
4699,GO:0010857,0.480414710945719,0.874193400986276,1,8,calcium-dependent protein kinase activity,MF,PRKCA
18600,GO:1903867,0.480419520065197,0.87419053220479,1,8,extraembryonic membrane development,BP,BMP7
18792,GO:1904321,0.480446609071584,0.874174372045228,1,8,response to forskolin,BP,AHR
18793,GO:1904322,0.480446609071584,0.874174372045228,1,8,cellular response to forskolin,BP,AHR
7028,GO:0030801,0.480470465901335,0.789712606415724,2,21,positive regulation of cyclic nucleotide metabolic process,BP,ADM;GPER1
15509,GO:0071880,0.480602301544223,0.874081466461898,1,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ADRB2
10680,GO:0043931,0.480607026467875,0.874078646286667,1,8,ossification involved in bone maturation,BP,BMP2
11771,GO:0046628,0.480726932721741,0.874007063996202,1,8,positive regulation of insulin receptor signaling pathway,BP,IRS1
12676,GO:0050884,0.480743144362262,0.873997383865568,1,8,neuromuscular process controlling posture,BP,CNTNAP1
7889,GO:0032456,0.480838993617625,0.74597364808004,3,33,endocytic recycling,BP,EHD1;VPS52;SNF8
20029,GO:2000650,0.480923494855407,0.873889662397622,1,8,negative regulation of sodium ion transmembrane transporter activity,BP,NEDD4L
8464,GO:0033601,0.481113334483795,0.873776208905223,1,8,positive regulation of mammary gland epithelial cell proliferation,BP,ZNF703
10268,GO:0043008,0.481121282170529,0.873771457704502,1,8,ATP-dependent protein binding,MF,HSP90AB1
3380,GO:0007157,0.481219220213982,0.789128639074328,2,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM3;ICAM1
8006,GO:0032634,0.481264417599837,0.873685870264126,1,8,interleukin-5 production,BP,TNFRSF21
8030,GO:0032674,0.481264417599837,0.873685870264126,1,8,regulation of interleukin-5 production,BP,TNFRSF21
8162,GO:0032891,0.48126929542694,0.873682952922029,1,8,negative regulation of organic acid transport,BP,IRS2
2293,GO:0005251,0.48127095093666,0.873681962780023,1,8,delayed rectifier potassium channel activity,MF,KCNA7
1438,GO:0003417,0.481388748888745,0.873611496277262,1,8,growth plate cartilage development,BP,COL27A1
12150,GO:0048256,0.481399457329282,0.873605089250479,1,8,flap endonuclease activity,MF,FEN1
10622,GO:0043618,0.48147351114669,0.662187567376803,8,102,regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;DNAJB1;PSMB9;PSME2;EGR1;CITED2;JUN;PSMC3
15928,GO:0072711,0.481507277433855,0.87354056709481,1,8,cellular response to hydroxyurea,BP,TIMELESS
3743,GO:0008278,0.48156666829354,0.873505017074087,1,8,cohesin complex,CC,CDCA5
22,GO:0000041,0.481610604431827,0.683095826701147,6,74,transition metal ion transport,BP,HEPHL1;FTL;FTH1;TFRC;STEAP4;SLC39A1
3930,GO:0008610,0.481659877160186,0.584976907401025,40,512,lipid biosynthetic process,BP,CYR61;ADM;CYP1A1;TFCP2L1;FADS3;PTGES;EDN1;G6PD;NFKB1;IRS1;TNF;SCD;FGFR2;PBX1;LSS;CYB5R1;HMGCS1;BMP2;CDK4;EBP;ST6GALNAC5;DHCR7;GPER1;SF1;EGR1;SNAI2;PRPF19;IRS2;AJUBA;PDGFB;ACSL1;LPCAT3;PCYT1A;PIGM;SCD5;INSIG1;SMPD2;DPM3;WNT4;FADS1
2197,GO:0005072,0.481716346329514,0.873415394544347,1,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,SMAD7
18598,GO:1903861,0.481748816467941,0.87339594702269,1,8,positive regulation of dendrite extension,BP,NEDD4L
15417,GO:0071679,0.481766833009284,0.873385155440452,1,8,commissural neuron axon guidance,BP,DAG1
14974,GO:0070878,0.481816898276148,0.873355164125513,1,8,primary miRNA binding,MF,SRF
16255,GO:0090308,0.481826604359498,0.873349349222544,1,8,regulation of methylation-dependent chromatin silencing,BP,UHRF1
3313,GO:0007016,0.481826614162038,0.873349343354445,1,8,cytoskeletal anchoring at plasma membrane,BP,DAG1
7205,GO:0031094,0.481826614162038,0.873349343354445,1,8,platelet dense tubular network,CC,EHD1
8205,GO:0032957,0.481826614162038,0.873349343354445,1,8,inositol trisphosphate metabolic process,BP,GPER1
10418,GO:0043256,0.481826614162038,0.873349343354445,1,8,laminin complex,CC,LAMC1
13120,GO:0051657,0.481826614162038,0.873349343354445,1,8,maintenance of organelle location,BP,TBCCD1
13469,GO:0055003,0.481826614162038,0.873349343354445,1,8,cardiac myofibril assembly,BP,SRF
14577,GO:0070106,0.481826614162038,0.873349343354445,1,8,interleukin-27-mediated signaling pathway,BP,IL27RA
14917,GO:0070757,0.481826614162038,0.873349343354445,1,8,interleukin-35-mediated signaling pathway,BP,IL27RA
15540,GO:0071936,0.481826614162038,0.873349343354445,1,8,coreceptor activity involved in Wnt signaling pathway,MF,ROR1
15783,GO:0072386,0.481826614162038,0.873349343354445,1,8,plus-end-directed organelle transport along microtubule,BP,KIF23
4164,GO:0009226,0.481925377860062,0.788577089756195,2,21,nucleotide-sugar biosynthetic process,BP,PMM2;UAP1L1
8268,GO:0033048,0.482566303304203,0.744231552402286,3,34,negative regulation of mitotic sister chromatid segregation,BP,ZW10;ANAPC15;DUSP1
8976,GO:0035065,0.482656667822389,0.716608192680996,4,46,regulation of histone acetylation,BP,LIF;SNAI2;RUVBL2;NOC2L
3629,GO:0008089,0.482691333303926,0.744125492563146,3,34,anterograde axonal transport,BP,NEFL;HSPB1;BLOC1S2
6434,GO:0021700,0.4829661272326,0.635680751563062,12,149,developmental maturation,BP,TFCP2L1;TGFB2;G6PD;CDKN1A;RAB32;TYMS;BMP2;NSUN2;IL15;NOM1;CCR6;DAG1
4344,GO:0009896,0.483149581390233,0.598708064014764,26,329,positive regulation of catabolic process,BP,IRS1;UBQLN2;TNF;ZC3H12A;RNF19B;ADRB2;TRIM22;ZFP36L1;IRS2;ZFP36L2;PTTG1IP;NEDD4L;SMAD7;SUPT5H;KEAP1;TRIB1;HSPBP1;CPT1A;METTL16;TNFAIP3;PSMC3;RNF144B;POLR2G;SNF8;GCLC;SH3BP4
9018,GO:0035195,0.483534974359949,0.645543925873241,10,134,gene silencing by miRNA,BP,NUP153;ZC3H12A;ZC3H7B;SRRT;AJUBA;NUP214;ESR1;RBM4;SNIP1;POLR2G
1699,GO:0004177,0.483599195177615,0.74363548393137,3,33,aminopeptidase activity,MF,C9ORF3;DNPEP;XPNPEP3
8998,GO:0035115,0.483994956012838,0.786956129302805,2,21,embryonic forelimb morphogenesis,BP,OSR2;TP63
13038,GO:0051494,0.484054405186346,0.660004531376914,8,98,negative regulation of cytoskeleton organization,BP,MID1;SPTBN1;CLASP1;KANK4;PHLDB2;MYADM;RBM14;SWAP70
12080,GO:0048029,0.484351921087716,0.71511128984857,4,46,monosaccharide binding,MF,P3H2;G6PD;P4HA2;M6PR
15760,GO:0072350,0.48514798787034,0.74203727939358,3,34,tricarboxylic acid metabolic process,BP,STAT5A;ACO1;CS
4959,GO:0015031,0.485160475204432,0.556214495423428,114,1500,protein transport,BP,SAA1;TRIM16;NRG1;PTGER4;FN1;TAP1;IL1R2;PML;HSPB1;TFRC;TGFB2;GBP1;RSAD2;PANX1;TP53;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;EHD1;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;ITGAV;PMM2;SFN;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;RPLP2;AKAP8;RHOB;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;PRKCA;SYK;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;TRAM2;DNAJC1;YWHAH;M6PR;ZDHHC6;UBE2J2;CEP41;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;CPT1A;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;VPS52;CD38;MAPK11;BMP8A;SRSF7;CLTA;SNF8;HSP90AB1;CCL5;MAGOH
6583,GO:0022410,0.485380283390621,0.869548407942013,1,9,circadian sleep/wake cycle process,BP,CSF2
12618,GO:0050802,0.485380283390621,0.869548407942013,1,9,circadian sleep/wake cycle, sleep,BP,CSF2
19814,GO:2000272,0.485941279671924,0.785425566945275,2,21,negative regulation of signaling receptor activity,BP,GPRC5A;ERRFI1
10533,GO:0043473,0.486532416822781,0.678664031226473,6,73,pigmentation,BP,ADAMTS9;RAB32;SNAI2;DCTN1;BLOC1S2;RAB27A
8658,GO:0034205,0.486621268958099,0.784889427049914,2,21,amyloid-beta formation,BP,APH1A;EFNA1
10982,GO:0044773,0.486916146407627,0.657260232074011,8,99,mitotic DNA damage checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;ORAOV1;TFDP1;TP63
8164,GO:0032897,0.487318311166081,0.784339085096894,2,21,negative regulation of viral transcription,BP,JUN;CCL5
6608,GO:0022804,0.487649167991238,0.615836560292314,16,201,active transmembrane transporter activity,MF,SLC16A2;TAP1;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;SLC5A6;ABCG2;TAPBP;SLC4A11;SLC22A4;TAP2;SLC4A2;SLC3A2;SLC25A22;SLC2A6
8236,GO:0033003,0.487989821728202,0.78380817627104,2,21,regulation of mast cell activation,BP,LYN;SYK
13405,GO:0052742,0.488469150231676,0.739484955551313,3,33,phosphatidylinositol kinase activity,MF,IRS1;FGFR2;IRS2
9473,GO:0036092,0.488656958639293,0.739324245786026,3,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,IRS1;FGFR2;IRS2
1474,GO:0003735,0.488767618492073,0.639941190337067,10,154,structural constituent of ribosome,MF,RPLP2;RPLP1;RPS2;RPS9;MRPS12;MRPS24;MRPL20;RPL27A;MRPL33;MRPS2
13491,GO:0055029,0.489013867320789,0.640610537881732,10,127,nuclear DNA-directed RNA polymerase complex,CC,TP53;TAF4B;EDF1;POLR1A;POLA1;CRCP;GTF2E1;POLR3H;POLR1E;POLR2G
3132,GO:0006720,0.48921863619081,0.676185506367271,6,73,isoprenoid metabolic process,BP,CYP1B1;CYP1A1;SDC4;HSPG2;HMGCS1;AKR1C1
17879,GO:1902117,0.489349667822451,0.690970109157104,5,59,positive regulation of organelle assembly,BP,SDC4;CSF2;EDN1;TNF;LCP1
12396,GO:0048821,0.489624491187528,0.782512797404881,2,21,erythrocyte development,BP,G6PD;SRF
9005,GO:0035145,0.489833575103804,0.782346805825864,2,21,exon-exon junction complex,CC,ALYREF;MAGOH
19216,GO:1905332,0.489920100924963,0.782278092784641,2,21,positive regulation of morphogenesis of an epithelium,BP,LIF;WNT4
15545,GO:0071949,0.490172368499692,0.782077691003386,2,21,FAD binding,MF,CYB5R1;MICAL3
3719,GO:0008237,0.490193606362476,0.654299135368023,8,97,metallopeptidase activity,MF,MMP9;CPA4;MPND;ADAMTS9;C9ORF3;DNPEP;ADAM17;XPNPEP3
19770,GO:2000179,0.490284303897777,0.781988737045847,2,21,positive regulation of neural precursor cell proliferation,BP,LYN;FLNA
11417,GO:0045824,0.4903113127186,0.737621621489091,3,34,negative regulation of innate immune response,BP,NLRC5;PARP14;TNFAIP3
15178,GO:0071312,0.490453340577926,0.781854367630027,2,21,cellular response to alkaloid,BP,ICAM1;PPP1R9B
10869,GO:0044391,0.490952539783869,0.627150789639704,12,182,ribosomal subunit,CC,GEMIN5;RPLP2;RPLP1;RPS2;RPS9;MRPS12;MRPS24;MRPL20;RPL27A;MRPL33;MRPS2;SURF6
11370,GO:0045732,0.49128094544483,0.619180139256197,14,176,positive regulation of protein catabolic process,BP,UBQLN2;TNF;RNF19B;PTTG1IP;NEDD4L;SMAD7;KEAP1;TRIB1;HSPBP1;TNFAIP3;PSMC3;RNF144B;SNF8;GCLC
10725,GO:0044060,0.491384078919551,0.781113700380336,2,21,regulation of endocrine process,BP,INHBA;C1QTNF1
419,GO:0001106,0.491582344073139,0.780955746464316,2,21,RNA polymerase II transcription corepressor activity,MF,DNAJB1;CITED2
7076,GO:0030864,0.492116087595857,0.688447500293998,5,59,cortical actin cytoskeleton,CC,WDR1;SPTBN1;MYH9;LANCL2;MYADM
3089,GO:0006662,0.492389658112099,0.86521005353731,1,9,glycerol ether metabolic process,BP,TXN2
6260,GO:0019852,0.493233658064095,0.864681444197171,1,9,L-ascorbic acid metabolic process,BP,GCLC
4643,GO:0010765,0.495785586773303,0.777592394350327,2,21,positive regulation of sodium ion transport,BP,CHP1;ACTN4
14903,GO:0070717,0.496051469932172,0.777378692864189,2,21,poly-purine tract binding,MF,PABPC4;HNRNPU
3060,GO:0006622,0.496106689964127,0.777334296038989,2,21,protein targeting to lysosome,BP,GNPTAB;HSPA8
3455,GO:0007267,0.496756670606514,0.554738631137597,70,906,cell-cell signaling,BP,CCL20;RUNX1;CYR61;INHBA;CTGF;C1QTNF1;ADM;NQO1;CYLD;WNT10A;TGFB2;EDN1;DAPK3;PANX1;SQSTM1;NFKB1;IRS1;LYN;TNF;BAIAP2;EFNB2;TNC;FGFR2;PSMB9;FLNA;CADPS2;BMP2;KREMEN2;ADRB2;AMOTL2;LIF;SFRP1;PSME2;GPER1;SRF;EGR1;JRK;SNAI2;IRS2;IL15;PRKCA;PDGFB;OXTR;ROR1;BAMBI;YWHAH;TJP1;RUVBL2;PPP1R9B;KLF10;CXCL5;HSPA8;ESR1;CPT1A;ZNF703;GPNMB;EFNB1;RAPGEF1;ZYX;PDE6A;WNT4;CD38;PSMC3;CCL22;EFNA1;BMP8A;TP63;IL36G;CCL5;FADS1
4656,GO:0010800,0.496889846784467,0.776704114418759,2,21,positive regulation of peptidyl-threonine phosphorylation,BP,CAB39;BMP7
7877,GO:0032438,0.496900615352998,0.776175958419432,2,22,melanosome organization,BP,RAB32;BLOC1S2
20103,GO:2000774,0.496905339360976,0.862366108358026,1,9,positive regulation of cellular senescence,BP,CDKN2A
8613,GO:0034122,0.497130290560767,0.776510440112849,2,21,negative regulation of toll-like receptor signaling pathway,BP,LYN;TNFAIP3
6838,GO:0030301,0.497600298832274,0.702938387972308,4,48,cholesterol transport,BP,NFKB1;NFKBIA;ABCG2;AKR1C1
4946,GO:0014911,0.497733249591562,0.776024357629247,2,21,positive regulation of smooth muscle cell migration,BP,PDGFB;CCL5
132,GO:0000272,0.498245408125635,0.775611017761797,2,21,polysaccharide catabolic process,BP,MGAM;PPP1R3B
10786,GO:0044247,0.498245408125635,0.775611017761797,2,21,cellular polysaccharide catabolic process,BP,MGAM;PPP1R3B
8267,GO:0033047,0.498453311249921,0.682386633527595,5,61,regulation of mitotic sister chromatid segregation,BP,UBE2C;ZW10;HNRNPU;ANAPC15;DUSP1
15828,GO:0072528,0.498807473798663,0.72974709303339,3,36,pyrimidine-containing compound biosynthetic process,BP,TYMS;TK1;CTPS1
18146,GO:1902883,0.498837908805858,0.729977315292892,3,35,negative regulation of response to oxidative stress,BP,HSPB1;SOD2;NOL3
20182,GO:2001028,0.498981778843639,0.861045357186802,1,9,positive regulation of endothelial cell chemotaxis,BP,HSPB1
10585,GO:0043548,0.499281919343872,0.774773210137948,2,21,phosphatidylinositol 3-kinase binding,MF,IRS1;IRS2
1359,GO:0003230,0.499337200585436,0.774728478131967,2,21,cardiac atrium development,BP,CYR61;TGFB2
10159,GO:0042742,0.499524741268446,0.6544007698546,7,93,defense response to bacterium,BP,CCL20;IL27RA;TNF;SERPINE1;ADAM17;SYK;IL6R
203,GO:0000428,0.49965958625967,0.630390952945394,10,128,DNA-directed RNA polymerase complex,CC,TP53;TAF4B;EDF1;POLR1A;POLA1;CRCP;GTF2E1;POLR3H;POLR1E;POLR2G
1503,GO:0003857,0.499866423160941,0.86048015947909,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HSD17B10
442,GO:0001190,0.499963902419908,0.700980154267815,4,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,NFE2L1;MKL1;CITED2;JUN
5851,GO:0017147,0.500004546888109,0.774188093398141,2,21,Wnt-protein binding,MF,SFRP1;ROR1
14155,GO:0061036,0.500355569777278,0.773903564934065,2,21,positive regulation of cartilage development,BP,CYR61;BMP2
12993,GO:0051409,0.500535268066338,0.860051838883436,1,9,response to nitrosative stress,BP,GCLC
4586,GO:0010676,0.500750437163397,0.728582805652144,3,34,positive regulation of cellular carbohydrate metabolic process,BP,IRS1;GPER1;IRS2
7013,GO:0030705,0.501031222632431,0.618221874906633,12,152,cytoskeleton-dependent intracellular transport,BP,NEFL;HSPB1;LAMP1;DST;KIF23;MYO10;WDR34;DCTN1;HSPA8;BLOC1S2;ACTN4;TUBB
13022,GO:0051457,0.501288763188585,0.772620684982365,2,22,maintenance of protein location in nucleus,BP,PML;HNRNPU
11114,GO:0045136,0.501463972928343,0.859455681090848,1,9,development of secondary sexual characteristics,BP,B4GALT1
2099,GO:0004866,0.501470478362621,0.664430159952287,6,77,endopeptidase inhibitor activity,MF,BIRC3;SERPINE1;SERPINH1;A2ML1;CD109;NOL3
6888,GO:0030414,0.501470478362621,0.664430159952287,6,77,peptidase inhibitor activity,MF,BIRC3;SERPINE1;SERPINH1;A2ML1;CD109;NOL3
8405,GO:0033344,0.50183243946582,0.772178045424578,2,22,cholesterol efflux,BP,NFKBIA;ABCG2
12718,GO:0050954,0.502168427721097,0.664040643789772,6,74,sensory perception of mechanical stimulus,BP,NAV2;ICAM1;WDR1;SNAI2;ROR1;MARVELD2
7215,GO:0031109,0.502180155222143,0.652370559864852,7,86,microtubule polymerization or depolymerization,BP,CRYAB;MAP2;MID1;DCTN1;SLAIN2;CLASP1;KIF24
7461,GO:0031616,0.502224451011594,0.858966275341883,1,9,spindle pole centrosome,CC,TBCCD1
6124,GO:0019372,0.502667518025258,0.858680625325054,1,9,lipoxygenase pathway,BP,GPX4
1871,GO:0004536,0.503025091352578,0.678165337609926,5,61,deoxyribonuclease activity,MF,APTX;FEN1;DNASE1;TATDN2;APEX2
4222,GO:0009396,0.503521618802012,0.8581289074873,1,9,folic acid-containing compound biosynthetic process,BP,DHFR
8292,GO:0033119,0.503707988605465,0.770647391834822,2,22,negative regulation of RNA splicing,BP,U2AF2;SRSF7
3635,GO:0008097,0.504199734120704,0.856266828214328,1,10,5S rRNA binding,MF,RRS1
7260,GO:0031227,0.504218027796646,0.626087934515344,10,126,intrinsic component of endoplasmic reticulum membrane,CC,TAP1;HLA-B;ZFYVE27;DHCR7;HLA-F;SPPL2A;TAPBP;INSIG1;TAP2;DPM3
6570,GO:0022029,0.50438049645674,0.725404528661029,3,34,telencephalon cell migration,BP,NRG1;SRF;ROBO1
11684,GO:0046466,0.504412771122378,0.770070744446008,2,22,membrane lipid catabolic process,BP,CYP1B1;SMPD2
7046,GO:0030819,0.504654517819128,0.857394918269929,1,9,positive regulation of cAMP biosynthetic process,BP,GPER1
3657,GO:0008138,0.504776356239992,0.724780770524378,3,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP14;DUSP1;DUSP8
12591,GO:0050767,0.504886272705452,0.562869107518146,39,499,regulation of neurogenesis,BP,NRG1;MAP2;FN1;NEFL;TENM3;LYN;BAIAP2;EFNB2;ENC1;PBX1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;WDR1;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;TNFRSF21;SEMA3C;SPEN;YWHAH;PQBP1;ZNF365;ZSWIM6;BMP7;RAPGEF1;DAG1;CTDSP1;EFNA1
10028,GO:0042472,0.505617953272138,0.69585319881276,4,47,inner ear morphogenesis,BP,MAFB;FGFR2;NTN1;INSIG1
8131,GO:0032823,0.50596001900437,0.856546015064012,1,9,regulation of natural killer cell differentiation,BP,IL15
4685,GO:0010833,0.506370660110765,0.66009251313501,6,74,telomere maintenance via telomere lengthening,BP,GNL3L;NAT10;DKC1;HNRNPU;HSP90AB1;PARP1
94,GO:0000184,0.506474414577706,0.637713502811509,8,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,CTIF;RPLP2;RPLP1;RPS2;RPS9;RPL27A;DHX34;MAGOH
1110,GO:0002699,0.50651174615499,0.638563397998453,8,101,positive regulation of immune effector process,BP,TFRC;RSAD2;LYN;LAMP1;TNF;TRAF2;SYK;RAPGEF1
5808,GO:0017062,0.506597645605607,0.856130193385375,1,9,respiratory chain complex III assembly,BP,BCS1L
8813,GO:0034551,0.506597645605607,0.856130193385375,1,9,mitochondrial respiratory chain complex III assembly,BP,BCS1L
17765,GO:1901741,0.506784406933054,0.856008248980036,1,9,positive regulation of myoblast fusion,BP,EHD1
9215,GO:0035601,0.506836365860232,0.638372226857599,8,99,protein deacylation,BP,HDAC9;TP53;AKAP8L;AKAP8;BRMS1;SFPQ;MTA2;RBM14
3758,GO:0008299,0.507261920351477,0.767731400046003,2,22,isoprenoid biosynthetic process,BP,CYP1A1;HMGCS1
12805,GO:0051099,0.50745035078091,0.617077689631038,11,140,positive regulation of binding,BP,MMP9;LFNG;GNL3L;BMP2;EDF1;TRAF2;BAMBI;TRAF4;CDCA5;HSP90AB1;PARP1
9713,GO:0038127,0.507564924886077,0.622899834869576,10,125,ERBB signaling pathway,BP,NRG1;MMP9;GPRC5A;ERRFI1;EPGN;GPER1;ADAM17;PRKCA;RNF115;AFAP1L2
16768,GO:0098562,0.508175224426313,0.616411012139166,11,139,cytoplasmic side of membrane,CC,CYLD;G6PD;TRAF3;LYN;TNK1;ERRFI1;TRAF2;SYK;SPPL2A;CHMP4B;CYTH1
12801,GO:0051095,0.508278642674535,0.855030149012427,1,9,regulation of helicase activity,BP,TP53
15722,GO:0072283,0.508589607008008,0.854826048970216,1,9,metanephric renal vesicle morphogenesis,BP,LIF
140,GO:0000290,0.508762582629119,0.854712435301515,1,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,NOCT
19533,GO:1990440,0.508816227594784,0.854677188374266,1,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,TP53
12597,GO:0050773,0.508886426292126,0.63640819186346,8,99,regulation of dendrite development,BP,NRG1;BAIAP2;NEDD4L;SDK1;YWHAH;PQBP1;BMP7;EFNA1
18539,GO:1903729,0.508961850634921,0.854581479702794,1,9,regulation of plasma membrane organization,BP,TGFB2
16658,GO:0097531,0.508995468003896,0.854559379260773,1,9,mast cell migration,BP,SWAP70
14636,GO:0070206,0.509064953885278,0.720997581074697,3,35,protein trimerization,BP,C1QTNF1;TRIM22;TRAF2
10548,GO:0043497,0.509320369603475,0.854345671174336,1,9,regulation of protein heterodimerization activity,BP,NRG1
14114,GO:0060969,0.509403074554524,0.765964697216478,2,22,negative regulation of gene silencing,BP,ZC3H12A;ESR1
5724,GO:0016863,0.509409163433384,0.852835340552456,1,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,EBP
11780,GO:0046638,0.509474451653244,0.765905674286974,2,22,positive regulation of alpha-beta T cell differentiation,BP,CD83;SYK
5008,GO:0015165,0.509622269018432,0.85414690761003,1,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,SLC35A4
8238,GO:0033005,0.509665681269984,0.85411831129057,1,9,positive regulation of mast cell activation,BP,SYK
14036,GO:0060765,0.509887793011028,0.765563712139781,2,22,regulation of androgen receptor signaling pathway,BP,SFRP1;SAFB2
17954,GO:1902306,0.509920350232907,0.85395048247114,1,9,negative regulation of sodium ion transmembrane transport,BP,NEDD4L
13248,GO:0051923,0.510019118224791,0.853885359344426,1,9,sulfation,BP,TPST1
10081,GO:0042581,0.510047384144908,0.635174284112205,8,101,specific granule,CC,NFKB1;QPCT;ACAA1;ITGAV;VCL;RAB27A;PTPRB;LAIR1
598,GO:0001765,0.510260657498842,0.853726018632796,1,9,membrane raft assembly,BP,EMP2
9060,GO:0035282,0.510282723879762,0.67154155777171,5,60,segmentation,BP,MAFB;IRX2;LFNG;SFRP1;SEMA3C
14830,GO:0070567,0.510572963778772,0.853519823841967,1,9,cytidylyltransferase activity,MF,PCYT1A
3158,GO:0006760,0.510706639366642,0.764885448574338,2,22,folic acid-containing compound metabolic process,BP,TYMS;DHFR
17573,GO:1901185,0.510735908385856,0.691000967335366,4,48,negative regulation of ERBB signaling pathway,BP,NRG1;GPRC5A;ERRFI1;RNF115
6503,GO:0021872,0.510803004395737,0.719457070103816,3,35,forebrain generation of neurons,BP,INHBA;FGFR2;ROBO1
6293,GO:0019903,0.510866511193127,0.634507596357029,8,99,protein phosphatase binding,MF,SH3RF2;TRAF3;TP53;IRS2;TRAF2;PPP1R9B;PARD3;PHACTR4
17514,GO:1900746,0.510880486040137,0.853316600277117,1,9,regulation of vascular endothelial growth factor signaling pathway,BP,ROBO1
18033,GO:1902547,0.510880486040137,0.853316600277117,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,ROBO1
7285,GO:0031272,0.510954340784524,0.853267766281437,1,9,regulation of pseudopodium assembly,BP,CDC42EP2
7286,GO:0031274,0.510954340784524,0.853267766281437,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP2
17743,GO:1901678,0.511698942379273,0.852774823410999,1,9,iron coordination entity transport,BP,ABCG2
9202,GO:0035584,0.511879931126441,0.851189181753177,1,10,calcium-mediated signaling using intracellular calcium source,BP,CCL20
15062,GO:0071014,0.512019730737741,0.852562117724947,1,9,post-mRNA release spliceosomal complex,CC,TFIP11
20175,GO:2001021,0.512220787705703,0.669482768299875,5,62,negative regulation of response to DNA damage stimulus,BP,TFIP11;SNAI2;PTTG1IP;ACKR3;THOC1
8719,GO:0034364,0.512937165384477,0.85048110597501,1,10,high-density lipoprotein particle,CC,SAA1
15836,GO:0072538,0.513079945233102,0.851857674884084,1,9,T-helper 17 type immune response,BP,SMAD7
17445,GO:1900221,0.513240819824033,0.851750590256611,1,9,regulation of amyloid-beta clearance,BP,SRF
18262,GO:1903115,0.513364163101176,0.762676634306978,2,22,regulation of actin filament-based movement,BP,PDPN;FLNA
18197,GO:1902969,0.513513172351362,0.851569184728249,1,9,mitotic DNA replication,BP,GINS2
9893,GO:0042175,0.513604036555905,0.540910323000992,62,810,nuclear outer membrane-endoplasmic reticulum membrane network,CC,CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;RSAD2;PANX1;NFE2L1;PKMYT1;SCD;DST;CDKAL1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;GGCX;ANKS4B;RNF19B;EBP;ZFYVE27;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;SGK1;CYP4B1;TRAF2;REEP1;SPPL2A;TAPBPL;ZW10;ACSL1;DNAJC1;TAPBP;ZDHHC6;APH1A;UBE2J2;CREB3;LPCAT3;PCYT1A;GALNT2;ATG101;PIGM;SCD5;INSIG1;RHOG;TAP2;EIF5A;RNF185;DPM3;LRRC59;FADS1
252,GO:0000715,0.513731833421247,0.761876960764926,2,23,nucleotide-excision repair, DNA damage recognition,BP,COPS3;PARP1
17797,GO:1901881,0.513850795848165,0.85134410046502,1,9,positive regulation of protein depolymerization,BP,WDR1
8980,GO:0035082,0.514165737858107,0.762008132145793,2,22,axoneme assembly,BP,CC2D2A;TTLL5
876,GO:0002228,0.514231474710437,0.716140936753396,3,36,natural killer cell mediated immunity,BP,LAMP1;RAB27A;TUBB
4521,GO:0010574,0.514238736748299,0.761947199747299,2,22,regulation of vascular endothelial growth factor production,BP,CYP1B1;IL1A
8745,GO:0034393,0.514302309124655,0.851042736188263,1,9,positive regulation of smooth muscle cell apoptotic process,BP,CDKN2A
18248,GO:1903069,0.51431858897292,0.851031862594389,1,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2
5547,GO:0016540,0.514340137810265,0.85101746894363,1,9,protein autoprocessing,BP,PARP1
17732,GO:1901661,0.514689173948956,0.761076667520149,2,23,quinone metabolic process,BP,AKR1C2;AKR1C1
11772,GO:0046629,0.514886852357582,0.85065198019761,1,9,gamma-delta T cell activation,BP,SYK
10362,GO:0043175,0.514930960025713,0.715781362720825,3,35,RNA polymerase core enzyme binding,MF,HNRNPU;TCOF1;GTF2E1
9121,GO:0035418,0.515200600516131,0.761143512219219,2,22,protein localization to synapse,BP,HSPB1;BAIAP2
11090,GO:0045091,0.515468094863152,0.850262758126818,1,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
2686,GO:0006048,0.515893360312731,0.849977558860713,1,9,UDP-N-acetylglucosamine biosynthetic process,BP,UAP1L1
15592,GO:0072070,0.515899985548272,0.849973112879715,1,9,loop of Henle development,BP,IRX2
9602,GO:0036459,0.515926950467593,0.639197701565617,7,87,thiol-dependent ubiquitinyl hydrolase activity,MF,CYLD;ZC3H12A;USP36;USP43;USP31;TNFAIP3;OTUD6A
17112,GO:0101005,0.515926950467593,0.639197701565617,7,87,ubiquitinyl hydrolase activity,MF,CYLD;ZC3H12A;USP36;USP43;USP31;TNFAIP3;OTUD6A
8845,GO:0034637,0.51600467619629,0.666053789346216,5,61,cellular carbohydrate biosynthetic process,BP,B4GALT1;IRS1;PPP1R3B;IRS2;GBE1
3459,GO:0007271,0.516047465707661,0.84987412108921,1,9,synaptic transmission, cholinergic,BP,NQO1
369,GO:0000990,0.516088002639169,0.849846904266013,1,9,transcription factor activity, core RNA polymerase binding,MF,TP53
7086,GO:0030880,0.516156620181651,0.614354593826526,10,130,RNA polymerase complex,CC,TP53;TAF4B;EDF1;POLR1A;POLA1;CRCP;GTF2E1;POLR3H;POLR1E;POLR2G
18959,GO:1904724,0.516281838422306,0.714056331338684,3,37,tertiary granule lumen,CC,FTH1;MMP9;QPCT
10249,GO:0042983,0.516372568822967,0.84965575211203,1,9,amyloid precursor protein biosynthetic process,BP,BACE2
10250,GO:0042984,0.516372568822967,0.84965575211203,1,9,regulation of amyloid precursor protein biosynthetic process,BP,BACE2
16273,GO:0090331,0.516430064450313,0.849617110882894,1,9,negative regulation of platelet aggregation,BP,C1QTNF1
10332,GO:0043124,0.516430724842739,0.714439993680324,3,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,ZC3H12A;ESR1;TNFAIP3
17679,GO:1901550,0.516444714067228,0.849607264226132,1,9,regulation of endothelial cell development,BP,TNF
18271,GO:1903140,0.516444714067228,0.849607264226132,1,9,regulation of establishment of endothelial barrier,BP,TNF
14585,GO:0070125,0.516577498756083,0.649465535074855,6,86,mitochondrial translational elongation,BP,MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;MRPS2
1074,GO:0002643,0.516580339463312,0.849516084090516,1,9,regulation of tolerance induction,BP,PHLPP1
9796,GO:0040015,0.51659319636241,0.849507438572092,1,9,negative regulation of multicellular organism growth,BP,ADRB2
6636,GO:0023019,0.516663686737058,0.849460032032642,1,9,signal transduction involved in regulation of gene expression,BP,PARP1
10093,GO:0042594,0.516702834173455,0.60810720622186,11,139,response to starvation,BP,ADM;TP53;CDKN1A;ZC3H12A;CADPS2;SFRP1;KLF10;HSPA8;JUN;WNT4;FADS1
17858,GO:1902065,0.516843200766209,0.849339259641094,1,9,response to L-glutamate,BP,BAIAP2
3778,GO:0008333,0.516903426425076,0.68532263008346,4,48,endosome to lysosome transport,BP,ADRB2;RHOB;M6PR;TGFBRAP1
3572,GO:0007616,0.517087301043107,0.75956265813782,2,22,long-term memory,BP,SRF;SGK1
11623,GO:0046325,0.517129088974293,0.849146788774972,1,9,negative regulation of glucose import,BP,TNF
907,GO:0002292,0.517256313085094,0.713700250017706,3,35,T cell differentiation involved in immune response,BP,PTGER4;RELB;SMAD7
3027,GO:0006573,0.517298004684317,0.849032991636265,1,9,valine metabolic process,BP,STAT5A
10158,GO:0042738,0.517419582100613,0.848951050669355,1,9,exogenous drug catabolic process,BP,CYP4B1
19021,GO:1904851,0.517436334591601,0.848939757478669,1,9,positive regulation of establishment of protein localization to telomere,BP,DKC1
4723,GO:0010885,0.517605689809473,0.848825560285648,1,9,regulation of cholesterol storage,BP,EHD1
13764,GO:0060340,0.517686717960487,0.848770902283434,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,NLRC5
13477,GO:0055012,0.517728391383948,0.848742786125396,1,9,ventricular cardiac muscle cell differentiation,BP,FHL2
19840,GO:2000311,0.517769931967786,0.848714756135667,1,9,regulation of AMPA receptor activity,BP,ADRB2
2806,GO:0006265,0.517782451223326,0.848706307949562,1,9,DNA topological change,BP,TOP3A
13692,GO:0060236,0.517921207600273,0.713103793992123,3,35,regulation of mitotic spindle organization,BP,DCTN1;HNRNPU;CHMP4B
9004,GO:0035137,0.517933320990847,0.75885187984253,2,22,hindlimb morphogenesis,BP,OSR2;TP63
343,GO:0000956,0.517957034267789,0.592624156011707,14,200,nuclear-transcribed mRNA catabolic process,BP,NOCT;ZC3H12A;CTIF;ZFP36L1;RPLP2;RPLP1;ZFP36L2;RPS2;RPS9;RPL27A;EDC4;DHX34;POLR2G;MAGOH
8143,GO:0032868,0.517975548172435,0.589432839440257,15,192,response to insulin,BP,HDAC9;ADM;IRS1;LYN;BAIAP2;ICAM1;CDK4;ERRFI1;EGR1;ZFP36L1;IRS2;SOCS1;GCLC;PARP1;BAIAP2L2
7843,GO:0032400,0.518096885954802,0.758714325599209,2,22,melanosome localization,BP,DCTN1;RAB27A
13217,GO:0051875,0.518096885954802,0.758714325599209,2,22,pigment granule localization,BP,DCTN1;RAB27A
16834,GO:0098732,0.518133675826241,0.627440569835208,8,100,macromolecule deacylation,BP,HDAC9;TP53;AKAP8L;AKAP8;BRMS1;SFPQ;MTA2;RBM14
5385,GO:0016209,0.51814718217319,0.683380007776569,4,53,antioxidant activity,MF,NQO1;SOD2;TXNRD1;GPX4
727,GO:0001956,0.518170220301261,0.848444480224895,1,9,positive regulation of neurotransmitter secretion,BP,GPER1
20229,GO:2001170,0.518265983286875,0.848379773264747,1,9,negative regulation of ATP biosynthetic process,BP,PARP1
11306,GO:0045623,0.518313719093237,0.848347511377743,1,9,negative regulation of T-helper cell differentiation,BP,SMAD7
266,GO:0000733,0.518416408368029,0.848278094143117,1,9,DNA strand renaturation,BP,TP53
165,GO:0000340,0.518426679396255,0.848271149836793,1,9,RNA 7-methylguanosine cap binding,MF,GEMIN5
1455,GO:0003691,0.518463169131546,0.8482464771961,1,9,double-stranded telomeric DNA binding,MF,XRCC6
8324,GO:0033160,0.51854644399479,0.848190160679196,1,9,positive regulation of protein import into nucleus, translocation,BP,HSP90AB1
15858,GO:0072574,0.518651103673563,0.848119362505183,1,9,hepatocyte proliferation,BP,TNFAIP3
15859,GO:0072575,0.518651103673563,0.848119362505183,1,9,epithelial cell proliferation involved in liver morphogenesis,BP,TNFAIP3
589,GO:0001750,0.518755530772129,0.712354468024254,3,35,photoreceptor outer segment,CC,PHLPP1;PDE6A;RAB27A
651,GO:0001841,0.518820678904024,0.636417133605457,7,87,neural tube formation,BP,ADM;SDC4;TGFB2;SFRP1;CC2D2A;BMP7;PHACTR4
12263,GO:0048548,0.518833068898234,0.847996217932129,1,9,regulation of pinocytosis,BP,ACTN4
2560,GO:0005840,0.518973795694981,0.587807826393417,15,225,ribosome,CC,ABCF1;GEMIN5;LARP4B;SF1;RPLP2;RPLP1;RPS2;RPS9;MRPS12;MRPS24;MRPL20;RPL27A;MRPL33;MRPS2;SURF6
15933,GO:0072718,0.518987470997955,0.847891674623787,1,9,response to cisplatin,BP,TIMELESS
8022,GO:0032656,0.518996021145762,0.847885884056601,1,9,regulation of interleukin-13 production,BP,TNFRSF21
9291,GO:0035729,0.519009403674307,0.847876820470642,1,9,cellular response to hepatocyte growth factor stimulus,BP,GCLC
15005,GO:0070933,0.519057652803578,0.847844139806469,1,9,histone H4 deacetylation,BP,HDAC9
10412,GO:0043249,0.519112457110865,0.84780701345209,1,9,erythrocyte maturation,BP,G6PD
5715,GO:0016849,0.519143576307842,0.84778592953632,1,9,phosphorus-oxygen lyase activity,MF,CD38
3356,GO:0007091,0.519232915184883,0.682993302558863,4,49,metaphase/anaphase transition of mitotic cell cycle,BP,UBE2C;ZW10;ANAPC15;DUSP1
10988,GO:0044784,0.519232915184883,0.682993302558863,4,49,metaphase/anaphase transition of cell cycle,BP,UBE2C;ZW10;ANAPC15;DUSP1
6695,GO:0030072,0.519309517752856,0.605484197446545,11,141,peptide hormone secretion,BP,EDN1;IRS1;TNF;SFRP1;GPER1;IRS2;PRKCA;CPT1A;CD38;BMP8A;CCL5
1323,GO:0003174,0.519421651026496,0.847597441853747,1,9,mitral valve development,BP,EFNA1
10168,GO:0042754,0.519476378074664,0.847560327897239,1,9,negative regulation of circadian rhythm,BP,SFPQ
5656,GO:0016755,0.519638145388617,0.847450587862131,1,9,transferase activity, transferring amino-acyl groups,MF,QPCT
14321,GO:0061478,0.51985529151197,0.847303197277408,1,9,response to platelet aggregation inhibitor,BP,AHR
4931,GO:0014888,0.520002864799977,0.7571081850483,2,22,striated muscle adaptation,BP,ERRFI1;IL15
3468,GO:0007288,0.520100782489299,0.847136453242649,1,9,sperm axoneme assembly,BP,TTLL5
5870,GO:0017182,0.520243364372487,0.847039552243311,1,9,peptidyl-diphthamide metabolic process,BP,DPH2
5871,GO:0017183,0.520243364372487,0.847039552243311,1,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,DPH2
2335,GO:0005355,0.520281037431305,0.847013942189205,1,9,glucose transmembrane transporter activity,MF,SLC2A6
4257,GO:0009584,0.520285571521695,0.756869440580377,2,22,detection of visible light,BP,NMT2;PDE6A
3008,GO:0006553,0.520300488281159,0.847000718429583,1,9,lysine metabolic process,BP,AASS
4573,GO:0010658,0.520326550349578,0.756834823176719,2,22,striated muscle cell apoptotic process,BP,BMP7;NOL3
16167,GO:0090185,0.520345138100257,0.846970360146903,1,9,negative regulation of kidney development,BP,BMP7
9321,GO:0035791,0.520575163605994,0.84681389780834,1,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
7220,GO:0031114,0.520601492922723,0.756602489892756,2,22,regulation of microtubule depolymerization,BP,MID1;CLASP1
12668,GO:0050872,0.52063339129191,0.846774274722,1,9,white fat cell differentiation,BP,SNAI2
3067,GO:0006631,0.52096285488664,0.572467072550161,20,260,fatty acid metabolic process,BP,CYP1B1;CYP1A1;FADS3;PTGES;EDN1;PANK2;IRS1;SCD;ACAA1;STAT5A;IRS2;AKR1C2;ACSL1;CPT1A;SCD5;INSIG1;THEM4;GPX4;AKR1C1;FADS1
19727,GO:2000095,0.520978697876859,0.846539158436606,1,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1
14744,GO:0070411,0.521130726861159,0.846435567114962,1,9,I-SMAD binding,MF,SMAD7
11962,GO:0047144,0.52129553462288,0.846323215854115,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT3
13902,GO:0060546,0.521296233924917,0.846322739013871,1,9,negative regulation of necroptotic process,BP,BIRC3
2184,GO:0005041,0.521472598638215,0.846202448392166,1,9,low-density lipoprotein particle receptor activity,MF,CXCL16
9894,GO:0042176,0.521480881277356,0.565842367003929,23,300,regulation of protein catabolic process,BP,NRG1;ODC1;PML;UBQLN2;TNF;FLNA;RNF19B;PSME2;SNX12;PTTG1IP;NEDD4L;SNRNP70;SMAD7;KEAP1;TRIB1;HSPBP1;TNFAIP3;PSMC3;EFNA1;RNF144B;SNF8;GCLC;HSP90AB1
2393,GO:0005536,0.52155828796481,0.846143980841738,1,9,glucose binding,MF,G6PD
325,GO:0000910,0.521576691037962,0.603298720209617,11,140,cytokinesis,BP,BIRC3;KLHL21;KIF23;SVIL;RHOB;SPTBN1;MYH9;CHMP4B;CNTROB;INCENP;BIN3
15035,GO:0070977,0.521599956735487,0.846115544050613,1,9,bone maturation,BP,BMP2
3578,GO:0007622,0.521646342766492,0.755215467469348,2,23,rhythmic behavior,BP,CSF2;TP53
12240,GO:0048512,0.521646342766492,0.755215467469348,2,23,circadian behavior,BP,CSF2;TP53
5279,GO:0015931,0.521691017190835,0.582416191309879,16,207,nucleobase-containing compound transport,BP,NUP153;SRSF2;AKAP8L;RRS1;ZFP36L1;U2AF2;ALYREF;PHAX;DDX39A;NUP214;SLC35A4;SLC35C2;THOC1;EIF5A;SRSF7;MAGOH
2351,GO:0005416,0.521872536099006,0.845929436316851,1,9,amino acid:cation symporter activity,MF,SLC25A22
12942,GO:0051301,0.521943699018373,0.545849213773591,39,508,cell division,BP,TGFB2;BIRC3;KLHL21;NEDD9;FGFR2;UBE2C;CDK4;KIF23;SFN;SVIL;CCDC124;NSUN2;PARD3B;RHOB;ZFP36L2;PDGFB;SPTBN1;DCTN1;MYH9;IL1A;ZW10;RCC2;HNRNPU;CLASP1;MICAL3;ANAPC15;RCC1;CHMP4B;CNTROB;PARD3;TPRA1;INCENP;TIMELESS;TUBB;BRIP1;CLTA;CDCA5;BIN3;TP63
15665,GO:0072182,0.52231789763184,0.845625036337391,1,9,regulation of nephron tubule epithelial cell differentiation,BP,LIF
12369,GO:0048753,0.522320198761812,0.754643513319102,2,23,pigment granule organization,BP,RAB32;BLOC1S2
15927,GO:0072710,0.522429226842139,0.845548881414841,1,9,response to hydroxyurea,BP,TIMELESS
1817,GO:0004467,0.522489419231896,0.845507696294224,1,9,long-chain fatty acid-CoA ligase activity,MF,ACSL1
8373,GO:0033268,0.522536880111629,0.845475217221779,1,9,node of Ranvier,CC,DAG1
9134,GO:0035457,0.522623599367825,0.845415860572413,1,9,cellular response to interferon-alpha,BP,IFIT3
18974,GO:1904754,0.522646161758802,0.845400414820867,1,9,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB
8777,GO:0034454,0.522676470078633,0.845379664746112,1,9,microtubule anchoring at centrosome,BP,DCTN1
19503,GO:1990380,0.522720732646898,0.845349357796466,1,9,Lys48-specific deubiquitinase activity,MF,CYLD
15890,GO:0072643,0.522721951050245,0.845348523488642,1,9,interferon-gamma secretion,BP,ZC3H12A
16326,GO:0090527,0.522722682279672,0.845348022778663,1,9,actin filament reorganization,BP,NEDD9
17040,GO:0099515,0.522723385212873,0.84534754143626,1,9,actin filament-based transport,BP,ACTN4
17273,GO:0120103,0.522723385212873,0.84534754143626,1,9,centriolar subdistal appendage,CC,DCTN1
15745,GO:0072321,0.522869981520237,0.843719589838619,1,10,chaperone-mediated protein transport,BP,HSPA8
12084,GO:0048037,0.522919716701883,0.557899982883177,27,354,cofactor binding,MF,P3H2;CYP1B1;CYP24A1;CYP1A1;PTGES;TXNRD1;RSAD2;G6PD;P4HA2;CDKAL1;TYMS;CYB5R1;DHCR7;CYP4B1;DHFR;ACO1;POLA1;MICAL3;DUS2;QDPR;ACBD6;CISD3;TKT;CYP20A1;BRIP1;GCLC;PARP1
8266,GO:0033046,0.522988361369351,0.708268173197219,3,36,negative regulation of sister chromatid segregation,BP,ZW10;ANAPC15;DUSP1
13291,GO:0051985,0.522988361369351,0.708268173197219,3,36,negative regulation of chromosome segregation,BP,ZW10;ANAPC15;DUSP1
2200,GO:0005085,0.52393512174103,0.574472477472429,18,230,guanyl-nucleotide exchange factor activity,MF,NRG1;NEFL;CSF2;IRS1;TRIO;FGFR2;DOCK10;ARHGEF28;IRS2;PDGFB;SPTBN1;RASGRP4;RCC1;TRAPPC5;HERC2;RAPGEF1;CYTH1;TBXA2R
19743,GO:2000117,0.524081990703046,0.642979202176507,6,77,negative regulation of cysteine-type endopeptidase activity,BP,CRYAB;MMP9;BIRC3;SFN;TNFRSF10A;NOL3
7695,GO:0032148,0.524178916005463,0.75306196411869,2,23,activation of protein kinase B activity,BP,NRG1;PDGFB
10616,GO:0043604,0.524377553740865,0.534142752496711,53,734,amide biosynthetic process,BP,CYR61;HSPB1;ABCF1;DAPK3;TNF;CARS2;ENC1;CDKAL1;NUP153;KRT17;TYMS;ZC3H12A;GEMIN5;EIF5;CDK4;PABPC4;DPH2;CTIF;LARP4B;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;ZFP36L2;PUM3;AJUBA;RPS2;RPS9;NUP214;MRPS12;MRPS24;DNAJC1;ERAL1;MRPL20;RPL27A;MRPL33;ESR1;TCOF1;EIF3B;RBM4;SMPD2;METTL16;EFTUD2;EIF3I;EIF5A;EEF1D;MRPS2;AARSD1;POLR2G;GCLC;CCL5;MAGOH
13576,GO:0060043,0.524561758366354,0.753242047241379,2,22,regulation of cardiac muscle cell proliferation,BP,FGFR2;MAPK11
4740,GO:0010907,0.524866411450106,0.752982456062806,2,22,positive regulation of glucose metabolic process,BP,IRS1;IRS2
14783,GO:0070486,0.52525910813938,0.842063534445746,1,10,leukocyte aggregation,BP,BMP7
6605,GO:0022626,0.525460989034813,0.628659448929053,7,110,cytosolic ribosome,CC,GEMIN5;RPLP2;RPLP1;RPS2;RPS9;RPL27A;SURF6
2906,GO:0006415,0.525502752871784,0.629124340311355,7,100,translational termination,BP,MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;EIF5A;MRPS2
8864,GO:0034661,0.525810961441128,0.75166854242613,2,23,ncRNA catabolic process,BP,ZC3H12A;POP1
15008,GO:0070936,0.525991168805214,0.676695125976091,4,49,protein K48-linked ubiquitination,BP,UBE2C;NEDD4L;RNF115;TNFAIP3
11832,GO:0046755,0.526718542007627,0.750891736997409,2,23,viral budding,BP,CHMP4B;SNF8
13035,GO:0051491,0.526745669988089,0.751377737424832,2,22,positive regulation of filopodium assembly,BP,SRF;DPYSL3
14906,GO:0070727,0.527141557818045,0.514814620621526,111,1469,cellular macromolecule localization,BP,NRG1;AMOT;PML;CYLD;HSPB1;GBP1;MID1;EMP2;KLHL21;TP53;SQSTM1;GNPTAB;CDKN1A;RAB32;LAMP1;EHD1;TNF;GNL3L;PTPN14;NUP153;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;EPHA2;CHP1;ARFRP1;PMM2;SFN;USP36;AKAP8L;LIF;PARL;ZFYVE27;ZDHHC3;CC2D2A;GPER1;AP4S1;TRIM29;NFKBIA;RRS1;PRPF19;ZFP36L1;RPLP2;RHOB;DKC1;U2AF2;VCL;RPLP1;REEP1;POLR1A;AJUBA;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SNX8;RUNDC1;DDX39A;WDR46;ZW10;RCC2;NUP214;TRAM2;SMAD7;YWHAH;ZDHHC6;HNRNPU;UBE2J2;RUVBL2;KCNIP3;THOC1;TGFBRAP1;RPL27A;STAC;HSPA8;ESR1;PES1;TFDP1;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;RHOG;CNTNAP1;SNIP1;BMP7;TOMM40;SGSM1;IPO4;EIF5A;MYADM;DAG1;RAB27A;WNT4;RILPL2;TNFAIP3;CARD10;SRSF7;CLTA;SNF8;CDCA5;HSP90AB1;PARP1;TP63;MAGOH;SH3BP4
2835,GO:0006303,0.528346444666885,0.653674725022037,5,67,double-strand break repair via nonhomologous end joining,BP,TFIP11;PRPF19;POLA1;HERC2;XRCC6
12807,GO:0051101,0.528652748456879,0.626622043148506,7,91,regulation of DNA binding,BP,MMP9;LIF;NFKBIA;EDF1;JUN;CDCA5;PARP1
16163,GO:0090181,0.528732290275774,0.674124281709112,4,49,regulation of cholesterol metabolic process,BP,SCD;LSS;HMGCS1;DHCR7
1131,GO:0002720,0.528914279113644,0.749006687293933,2,23,positive regulation of cytokine production involved in immune response,BP,RSAD2;TRAF2
5840,GO:0017127,0.529405157592438,0.839161944588856,1,10,cholesterol transporter activity,MF,ABCG2
710,GO:0001935,0.529792369314262,0.625653709076615,7,89,endothelial cell proliferation,BP,TNF;BMP2;STAT5A;ADAM17;PRKCA;PDGFB;JUN
2516,GO:0005769,0.529891391412457,0.563614537003636,20,258,early endosome,CC,PML;TFRC;HLA-B;STEAP4;MYO1B;RAB32;EHD1;KREMEN2;ADRB2;HLA-F;GPER1;RHOB;SNX12;SNX8;RCC2;ACKR3;TGFBRAP1;ARRDC3;RAPGEF1;TMEM165
4779,GO:0010965,0.531181681886448,0.671650763806969,4,50,regulation of mitotic sister chromatid separation,BP,UBE2C;ZW10;ANAPC15;DUSP1
9843,GO:0042088,0.531239974577879,0.747001244813585,2,23,T-helper 1 type immune response,BP,RELB;IL27RA
8680,GO:0034260,0.531373504134748,0.700627830285841,3,36,negative regulation of GTPase activity,BP,AMOT;RCC2;SH3BP4
8722,GO:0034367,0.53172047723728,0.837526181532806,1,10,protein-containing complex remodeling,BP,GTF2E1
6752,GO:0030173,0.532376945066411,0.699706794897257,3,36,integral component of Golgi membrane,CC,LFNG;TPST1;GALNT2
6603,GO:0022624,0.532541732014564,0.745403361015229,2,24,proteasome accessory complex,CC,PSME2;PSMC3
11581,GO:0046134,0.533082387583875,0.744934059447321,2,24,pyrimidine nucleoside biosynthetic process,BP,TK1;CTPS1
4188,GO:0009265,0.533147953642261,0.83651214220679,1,10,2'-deoxyribonucleotide biosynthetic process,BP,TYMS
11652,GO:0046385,0.533147953642261,0.83651214220679,1,10,deoxyribose phosphate biosynthetic process,BP,TYMS
10900,GO:0044445,0.533380884002312,0.577297166278262,14,203,cytosolic part,CC,NEFL;AHR;GEMIN5;RPLP2;RPLP1;RPS2;RPS9;BORCS7;RPL27A;HSPA8;BLOC1S2;PSMC3;RRM2;SURF6
653,GO:0001843,0.533442978223456,0.634124675732437,6,75,neural tube closure,BP,ADM;SDC4;TGFB2;SFRP1;CC2D2A;PHACTR4
13941,GO:0060606,0.533442978223456,0.634124675732437,6,75,tube closure,BP,ADM;SDC4;TGFB2;SFRP1;CC2D2A;PHACTR4
9847,GO:0042092,0.533533678514629,0.745014465928352,2,23,type 2 immune response,BP,RSAD2;IL27RA
13812,GO:0060401,0.534315531954649,0.621242110063534,7,89,cytosolic calcium ion transport,BP,CTGF;JPH2;PML;LYN;JPH1;GPER1;NOL3
14631,GO:0070199,0.534598543220643,0.744089071879323,2,23,establishment of protein localization to chromosome,BP,DKC1;RUVBL2
20107,GO:2000779,0.534889671430567,0.668314830717719,4,49,regulation of double-strand break repair,BP,PML;TFIP11;ZNF365;TIMELESS
18054,GO:1902600,0.534920035269357,0.632095620901382,6,82,proton transmembrane transport,BP,CHP1;COX5B;SLC4A11;ACTN4;SLC25A22;SLC2A6
5050,GO:0015238,0.535309139444507,0.647563369107373,5,62,drug transmembrane transporter activity,MF,EBP;ABCG2;SLC7A2;SLC4A11;SLC25A22
13669,GO:0060192,0.535488341653789,0.834840419059057,1,10,negative regulation of lipase activity,BP,ANXA8
42,GO:0000086,0.535618503280544,0.56545979270289,17,225,G2/M transition of mitotic cell cycle,BP,CDKN2B;CDKN1A;PKMYT1;PBX1;PSMB9;CDK4;PSME2;FGFR1OP;GPR132;AJUBA;DCTN1;ORAOV1;RCC2;CLASP1;CEP41;TUBB;PSMC3
2839,GO:0006307,0.536273491768406,0.834277028692655,1,10,DNA dealkylation involved in DNA repair,BP,ASCC2
17301,GO:0140078,0.536528485343545,0.834093778385545,1,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX2
17302,GO:0140080,0.536528485343545,0.834093778385545,1,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX2
16279,GO:0090343,0.536613328101996,0.834032776193487,1,10,positive regulation of cell aging,BP,CDKN2A
10735,GO:0044091,0.5368696619904,0.742108993529132,2,23,membrane biogenesis,BP,EMP2;SPTBN1
6205,GO:0019706,0.536886691243169,0.742094113474275,2,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC3;ZDHHC6
6206,GO:0019707,0.536886691243169,0.742094113474275,2,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC3;ZDHHC6
6672,GO:0030032,0.536998640980648,0.666313986343285,4,49,lamellipodium assembly,BP,EPHA2;VCL;AJUBA;BIN3
8831,GO:0034613,0.537013212716266,0.505062944864851,110,1459,cellular protein localization,BP,NRG1;AMOT;PML;CYLD;HSPB1;GBP1;MID1;EMP2;KLHL21;TP53;SQSTM1;GNPTAB;CDKN1A;RAB32;LAMP1;EHD1;TNF;GNL3L;PTPN14;NUP153;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;EPHA2;CHP1;ARFRP1;PMM2;SFN;USP36;AKAP8L;LIF;PARL;ZFYVE27;ZDHHC3;CC2D2A;GPER1;AP4S1;TRIM29;NFKBIA;RRS1;PRPF19;RPLP2;RHOB;DKC1;U2AF2;VCL;RPLP1;REEP1;POLR1A;AJUBA;RPS2;PTTG1IP;ALYREF;RPS9;SPTBN1;NEDD4L;SNX8;RUNDC1;DDX39A;WDR46;ZW10;RCC2;NUP214;TRAM2;SMAD7;YWHAH;ZDHHC6;HNRNPU;UBE2J2;RUVBL2;KCNIP3;THOC1;TGFBRAP1;RPL27A;STAC;HSPA8;ESR1;PES1;TFDP1;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;RHOG;CNTNAP1;SNIP1;BMP7;TOMM40;SGSM1;IPO4;EIF5A;MYADM;DAG1;RAB27A;WNT4;RILPL2;TNFAIP3;CARD10;SRSF7;CLTA;SNF8;CDCA5;HSP90AB1;PARP1;TP63;MAGOH;SH3BP4
4334,GO:0009886,0.537068233742329,0.833705440176279,1,10,post-embryonic animal morphogenesis,BP,FBN1
12777,GO:0051052,0.537260112866472,0.546656108005003,25,324,regulation of DNA metabolic process,BP,PML;TFRC;CSF2;TP53;IL27RA;CDKN1A;GNL3L;NAT10;IL7R;TFIP11;GPER1;DKC1;NPAS2;PDGFB;ALYREF;UHRF1;HNRNPU;THOC1;DUSP1;JUN;ZNF365;MPHOSPH8;TIMELESS;HSP90AB1;PARP1
4044,GO:0009081,0.53733020763815,0.741706397965045,2,23,branched-chain amino acid metabolic process,BP,STAT5A;HSD17B10
15827,GO:0072527,0.537716031574764,0.644890367886464,5,65,pyrimidine-containing compound metabolic process,BP,TET3;TYMS;TK1;SMUG1;CTPS1
19863,GO:2000341,0.53780369917975,0.833175302889801,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
6701,GO:0030100,0.538441830461589,0.581364245800006,12,156,regulation of endocytosis,BP,UBQLN2;TNF;SIRPA;ITGAV;SERPINE1;SNX12;LGALS3;SYK;NEDD4L;ACTN4;RAPGEF1;RAB27A
2821,GO:0006285,0.538710962874893,0.832519762890704,1,10,base-excision repair, AP site formation,BP,SMUG1
4520,GO:0010573,0.539083014708327,0.740170843143797,2,23,vascular endothelial growth factor production,BP,CYP1B1;IL1A
10112,GO:0042629,0.539122764076065,0.832221645308031,1,10,mast cell granule,CC,LYN
2850,GO:0006335,0.539607252474115,0.736511400902929,2,32,DNA replication-dependent nucleosome assembly,BP,IPO4;CHAF1A
8904,GO:0034723,0.539607252474115,0.736511400902929,2,32,DNA replication-dependent nucleosome organization,BP,IPO4;CHAF1A
12522,GO:0050665,0.539804520621445,0.831727310873027,1,10,hydrogen peroxide biosynthetic process,BP,CYP1A1
12943,GO:0051302,0.540049084142765,0.597756714872557,9,116,regulation of cell division,BP,TGFB2;KLHL21;FGFR2;KIF23;SFN;SVIL;PDGFB;IL1A;TP63
10624,GO:0043620,0.540512888512461,0.605157953837452,8,107,regulation of DNA-templated transcription in response to stress,BP,TP53;DNAJB1;PSMB9;PSME2;EGR1;CITED2;JUN;PSMC3
11041,GO:0045019,0.540725093928516,0.831058254233354,1,10,negative regulation of nitric oxide biosynthetic process,BP,ZC3H12A
18825,GO:1904406,0.540725093928516,0.831058254233354,1,10,negative regulation of nitric oxide metabolic process,BP,ZC3H12A
1027,GO:0002534,0.540785846736783,0.738674049972888,2,23,cytokine production involved in inflammatory response,BP,IL1R2;ZC3H12A
2730,GO:0006109,0.540844707735893,0.590144311882376,10,128,regulation of carbohydrate metabolic process,BP,IGFBP3;C1QTNF1;NFKB1;IRS1;NUP153;PPP1R3B;GPER1;IRS2;PDGFB;NUP214
9017,GO:0035194,0.541478842230728,0.589049258960525,10,140,posttranscriptional gene silencing by RNA,BP,NUP153;ZC3H12A;ZC3H7B;SRRT;AJUBA;NUP214;ESR1;RBM4;SNIP1;POLR2G
13830,GO:0060428,0.541905289454258,0.737687355606604,2,23,lung epithelium development,BP,FGFR2;ERRFI1
11325,GO:0045648,0.542102121871238,0.737513642500674,2,23,positive regulation of erythrocyte differentiation,BP,INHBA;ETS1
12387,GO:0048806,0.54220197206226,0.73742549500119,2,23,genitalia development,BP,ESR1;TP63
19889,GO:2000378,0.542407265810829,0.690156914408957,3,37,negative regulation of reactive oxygen species metabolic process,BP,CRYAB;G6PD;ZC3H12A
1128,GO:0002717,0.542412891660791,0.829826927988914,1,10,positive regulation of natural killer cell mediated immunity,BP,LAMP1
17941,GO:1902275,0.54244693807104,0.582618009099894,11,141,regulation of chromatin organization,BP,TP53;AKAP8L;LIF;SNAI2;AKAP8;NELFE;UHRF1;HNRNPU;RUVBL2;NOC2L;MKI67
14586,GO:0070126,0.542561846325437,0.624200098755556,6,88,mitochondrial translational termination,BP,MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;MRPS2
3695,GO:0008200,0.542664597815513,0.736534177330443,2,24,ion channel inhibitor activity,MF,ANKRD36C;NEDD4L
9250,GO:0035646,0.542798661595486,0.829544641505008,1,10,endosome to melanosome transport,BP,RAB32
10538,GO:0043485,0.542798661595486,0.829544641505008,1,10,endosome to pigment granule transport,BP,RAB32
12372,GO:0048757,0.542798661595486,0.829544641505008,1,10,pigment granule maturation,BP,RAB32
303,GO:0000812,0.543032934073287,0.829373058469062,1,10,Swr1 complex,CC,RUVBL2
11709,GO:0046500,0.543182286689399,0.829263610415958,1,10,S-adenosylmethionine metabolic process,BP,MAT2A
13492,GO:0055037,0.543262088893957,0.581731961901353,11,143,recycling endosome,CC,TFRC;HLA-B;EHD1;TNF;AMOTL2;ZFYVE27;HLA-F;GPER1;ACKR3;VPS52;SNF8
8330,GO:0033173,0.543357564124355,0.7364040965092,2,23,calcineurin-NFAT signaling cascade,BP,NRG1;CHP1
7972,GO:0032585,0.543367841231737,0.829127566810133,1,10,multivesicular body membrane,CC,RAB27A
19689,GO:2000009,0.543382060100503,0.829117138890798,1,10,negative regulation of protein localization to cell surface,BP,NEDD4L
7662,GO:0032091,0.543382279151545,0.624160128376253,6,78,negative regulation of protein binding,BP,GNL3L;ADRB2;TFIP11;DNAJB2;PDGFB;RUVBL2
2956,GO:0006487,0.543713925351202,0.623834792889474,6,78,protein N-linked glycosylation,BP,B4GALT1;PMM2;ST6GALNAC5;TMEM165;MGAT2;DPM3
13548,GO:0060009,0.543837858865418,0.828782634093394,1,10,Sertoli cell development,BP,ICAM1
2728,GO:0006107,0.543868548810863,0.828760095214756,1,10,oxaloacetate metabolic process,BP,STAT5A
4313,GO:0009791,0.54393287812721,0.623798624675723,6,76,post-embryonic development,BP,FBN1;FGFR2;DHCR7;ACO1;SEMA3C;MYO1E
8663,GO:0034220,0.543954157026414,0.51996312306756,44,579,ion transmembrane transport,BP,MMP9;JPH2;G6PD;PANX1;STEAP4;LYN;SLC7A5;JPH1;SLC39A1;FLNA;CHP1;TSC22D3;SLC7A5P2;ITGAV;ADRB2;SLC5A6;FXYD3;PARL;WDR1;GPER1;KCNA7;SGK1;IRS2;SLC7A2;NEDD4L;COX5B;SLC35C2;SLC43A2;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;SLC22A4;CPT1A;ACTN4;SLC41A2;SLC4A2;SLC3A2;SLC25A22;NOL3;SLC2A6
1280,GO:0003081,0.544025298126385,0.828644946259188,1,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,C9ORF3
17310,GO:0140110,0.544037311059349,0.498361949845683,108,1402,transcription regulator activity,MF,MAFB;NRG1;RUNX1;HDAC9;FOSL2;TFCP2L1;MYBL2;PDLIM1;IRX2;RELB;ARID3B;IER2;ELMSAN1;TP53;NFE2L1;HNRNPAB;NOCT;NFKB1;TAF4B;AHR;JUNB;ZBED1;WWC1;PTPN14;PBX1;NFKB2;DNAJB1;FOSL1;SRSF2;KLF7;TSC22D3;STAT5A;DAXX;FOXD2;FUS;TOX4;VGLL3;ELF3;TRIM22;MKL1;IRF1;NFX1;GPER1;SRF;ELF4;MED22;ZFP42;TRIM29;SF1;EGR1;EDF1;ETS1;SNAI2;ZFP36L1;NPAS2;PPRC1;MAFK;ZNF778;ZFP36L2;DDX17;NFKBIB;AJUBA;UBTF;FHL2;UHRF1;ZNF234;ZNFX1;ZNF263;SPEN;MAFF;SMAD7;MTA2;HNRNPU;PQBP1;CREB3;RUVBL2;ABT1;MAZ;TUSC1;KCNIP3;ETS2;KLF10;ZNF267;PRDM7;CITED2;JUN;ESR1;IKZF3;FOXN1;TFDP1;ZNF772;GTF2E1;NOC2L;ZNF132;KLF6;TEAD4;ACTN4;KCTD1;ZNF34;ELK1;PHF5A;WNT4;RBM14;SMARCC2;HES4;CREB5;PARP1;TP63
14670,GO:0070273,0.544410432615283,0.735471495262663,2,23,phosphatidylinositol-4-phosphate binding,MF,JPH2;LANCL2
9036,GO:0035250,0.544518930149965,0.735375282815743,2,23,UDP-galactosyltransferase activity,MF,B4GALT1;COLGALT1
17395,GO:1900121,0.544557226502436,0.828253797485524,1,10,negative regulation of receptor binding,BP,RUVBL2
12071,GO:0048019,0.544653941945643,0.828182613699649,1,10,receptor antagonist activity,MF,CCL5
11823,GO:0046717,0.544759593130281,0.658730269006361,4,50,acid secretion,BP,EDN1;SGK1;SYK;OXTR
3353,GO:0007084,0.544778567470934,0.828090858256546,1,10,mitotic nuclear envelope reassembly,BP,BANF1
17763,GO:1901739,0.544784861560833,0.828086223354857,1,10,regulation of myoblast fusion,BP,EHD1
7417,GO:0031507,0.544792671831524,0.828080471838077,1,10,heterochromatin assembly,BP,CDKN2A
3562,GO:0007602,0.54500068529482,0.734947831587884,2,23,phototransduction,BP,NMT2;PDE6A
5946,GO:0018279,0.54500132094769,0.687480142910274,3,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC5;MGAT2;DPM3
20092,GO:2000756,0.545268107132559,0.658241803033254,4,50,regulation of peptidyl-lysine acetylation,BP,LIF;SNAI2;RUVBL2;NOC2L
15820,GO:0072520,0.545417614567687,0.82761983831493,1,10,seminiferous tubule development,BP,BRIP1
11343,GO:0045666,0.545450125043096,0.552923009069596,18,233,positive regulation of neuron differentiation,BP,NRG1;FN1;NEFL;TENM3;LYN;BAIAP2;ENC1;BMP2;L1CAM;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;BMP7;RAPGEF1
19623,GO:1990778,0.545565732802465,0.558591194893048,16,208,protein localization to cell periphery,BP,GBP1;EMP2;SQSTM1;TNF;FLNA;EPHA2;ARFRP1;ZFYVE27;GPER1;SPTBN1;KCNIP3;STAC;RHOG;MYADM;WNT4;RILPL2
7560,GO:0031902,0.545808775137871,0.600077904974293,8,104,late endosome membrane,CC,STOML1;ANXA8;RHOB;SPPL2A;CHMP4B;TMEM165;RAB27A;SNF8
163,GO:0000338,0.545829533550623,0.827315763295021,1,10,protein deneddylation,BP,COPS3
11502,GO:0045986,0.545873182286053,0.827283520869912,1,10,negative regulation of smooth muscle contraction,BP,ADRB2
1183,GO:0002830,0.54591914514698,0.827249564628919,1,10,positive regulation of type 2 immune response,BP,RSAD2
6989,GO:0030667,0.546062185579542,0.561394483191253,15,196,secretory granule membrane,CC,PCDH7;B4GALT1;MGAM;LAMP1;SIRPA;CYB5R1;ITGAV;LGALS3;GLIPR1;LILRB3;CD109;RHOG;RAB27A;PTPRB;LAIR1
4708,GO:0010870,0.546114643926539,0.827105084283118,1,10,positive regulation of receptor biosynthetic process,BP,EDN1
97,GO:0000187,0.546609521635707,0.599340398646706,8,103,activation of MAPK activity,BP,SAA1;NRG1;TNF;BMP2;EPGN;DAXX;SYK;MAPK11
15109,GO:0071158,0.546739143011473,0.62086173932261,6,78,positive regulation of cell cycle arrest,BP,PML;TP53;CDKN1A;GADD45A;SFN;TFDP1
3304,GO:0007004,0.546970931984128,0.636018222319011,5,64,telomere maintenance via telomerase,BP,GNL3L;NAT10;DKC1;HNRNPU;HSP90AB1
12614,GO:0050795,0.547016315881869,0.732667548113718,2,24,regulation of behavior,BP,CSF2;ARRDC3
1178,GO:0002825,0.547176475404506,0.826318921058809,1,10,regulation of T-helper 1 type immune response,BP,IL27RA
7649,GO:0032060,0.547287026373659,0.826236931594228,1,10,bleb assembly,BP,EMP2
16881,GO:0098815,0.547755791135264,0.732495591327354,2,23,modulation of excitatory postsynaptic potential,BP,BAIAP2;ADRB2
12972,GO:0051354,0.547825845532211,0.825836943040897,1,10,negative regulation of oxidoreductase activity,BP,NFKB1
14205,GO:0061134,0.547929065398842,0.597749338832191,8,108,peptidase regulator activity,MF,FN1;BIRC3;SERPINE1;PSME2;SERPINH1;A2ML1;CD109;NOL3
12686,GO:0050901,0.547970975936956,0.825729099640466,1,10,leukocyte tethering or rolling,BP,TNF
10395,GO:0043226,0.548087328136351,0.486619319057822,743,9764,organelle,CC,IGFBP3;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CRYAB;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;HDAC9;MAP2;S100P;FN1;NEFL;C1R;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;KRT15;AMOT;FOSL2;JPH2;KRT4;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;FBN1;TGFB2;COBLL1;EDN1;SH3RF2;GBP1;USB1;TXNRD1;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;STOML1;AHR;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;SART1;FAM69B;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;CHP1;CCDC85B;GADD45B;TSC22D3;ICAM1;FANCC;ARFRP1;PITHD1;CD274;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;ANXA8L1;SLC5A6;SERPINE1;FUS;FXYD3;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;EPPK1;IL7R;DDX42;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;RPLP2;AKAP8;RHOB;NELFE;ADAM17;DKC1;FEN1;SNX12;UPK3B;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;PRKCA;ZNF778;ZFP36L2;PUM3;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;BCAM;PREP;IFFO2;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;SDK1;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;PRCC;SNX8;RBBP5;SEMA3C;RBM15B;SFPQ;BORCS7;DDX39A;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;CEP41;TRIB1;TPST1;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;A2ML1;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;MANEAL;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;LRRC57;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;BCL2L2;OLFML3;ZNF365;XRCC6;GP6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;TEAD4;SMPD2;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;MYADM;DAG1;TMEM165;FAM234A;CGNL1;POLR3H;PDE6A;MGAT2;RNF185;EEF1D;RAB27A;COL4A4;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;SUPT16H;PPP2R1B;EFNA1;MAPK11;AARSD1;METTL21A;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;LRRC59;HSP90AB1;SWAP70;TBXA2R;FBLN2;MKI67;MCAM;TTLL5;HERC6;BIN3;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;C1S;TOP3A;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
18583,GO:1903828,0.548255787878174,0.619456128898953,6,77,negative regulation of cellular protein localization,BP,GBP1;CHP1;TRIM29;POLR1A;NEDD4L;INSIG1
7715,GO:0032204,0.548315561673748,0.619488220846079,6,76,regulation of telomere maintenance,BP,PML;GNL3L;NAT10;DKC1;HNRNPU;PARP1
4644,GO:0010766,0.548353458569368,0.825444667209268,1,10,negative regulation of sodium ion transport,BP,NEDD4L
5284,GO:0015937,0.548810051001356,0.825104709948573,1,10,coenzyme A biosynthetic process,BP,PANK2
11274,GO:0045579,0.548811499052726,0.825103631079358,1,10,positive regulation of B cell differentiation,BP,SYK
691,GO:0001911,0.549104349751937,0.824885350354713,1,10,negative regulation of leukocyte mediated cytotoxicity,BP,IL7R
1146,GO:0002753,0.54911150021327,0.654539177005971,4,50,cytoplasmic pattern recognition receptor signaling pathway,BP,CYLD;BIRC3;NFKBIA;TNFAIP3
9463,GO:0036065,0.549163470550515,0.731237588327777,2,23,fucosylation,BP,LFNG;SLC35C2
8359,GO:0033234,0.549211646241303,0.824805328900795,1,10,negative regulation of protein sumoylation,BP,GNL3L
3418,GO:0007202,0.549285081319278,0.824750546856806,1,10,activation of phospholipase C activity,BP,RASGRP4
16428,GO:0097064,0.54939734144317,0.683595706629968,3,37,ncRNA export from nucleus,BP,NUP153;PHAX;NUP214
2473,GO:0005689,0.549458952511206,0.729620304776221,2,26,U12-type spliceosomal complex,CC,SF3B4;PHF5A
4757,GO:0010934,0.549496733847223,0.824592590348793,1,10,macrophage cytokine production,BP,TGFB2
14967,GO:0070862,0.549770740863091,0.824387954684252,1,10,negative regulation of protein exit from endoplasmic reticulum,BP,INSIG1
5687,GO:0016803,0.549842858838234,0.824334068069382,1,10,ether hydrolase activity,MF,C9ORF3
4291,GO:0009713,0.549907684032723,0.824285621017363,1,10,catechol-containing compound biosynthetic process,BP,TGFB2
10006,GO:0042423,0.549907684032723,0.824285621017363,1,10,catecholamine biosynthetic process,BP,TGFB2
7997,GO:0032616,0.550666167126845,0.823718092879091,1,10,interleukin-13 production,BP,TNFRSF21
9043,GO:0035257,0.550693669505486,0.580228062775007,10,130,nuclear hormone receptor binding,MF,DAXX;FUS;FHL2;YWHAH;TRIP6;PAGR1;ETS2;ESR1;ACTN4;PARP1
11415,GO:0045822,0.551003520941566,0.823465270083123,1,10,negative regulation of heart contraction,BP,ZC3H12A
6462,GO:0021783,0.551074296903617,0.82341219716116,1,10,preganglionic parasympathetic fiber development,BP,NAV2
13936,GO:0060600,0.551214484707939,0.823307042123151,1,10,dichotomous subdivision of an epithelial terminal unit,BP,SEMA3C
3292,GO:0006983,0.551517711321688,0.823079445422909,1,10,ER overload response,BP,TP53
11340,GO:0045663,0.551546852573889,0.823057561972417,1,10,positive regulation of myoblast differentiation,BP,IGFBP3
9781,GO:0039692,0.551640472660362,0.822987246032056,1,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
5499,GO:0016441,0.55174882998988,0.578750679249808,10,141,posttranscriptional gene silencing,BP,NUP153;ZC3H12A;ZC3H7B;SRRT;AJUBA;NUP214;ESR1;RBM4;SNIP1;POLR2G
15959,GO:0075522,0.551918741534874,0.822778132015798,1,10,IRES-dependent viral translational initiation,BP,EIF3B
6908,GO:0030496,0.551997605708421,0.567792962135226,12,156,midbody,CC,CYLD;KIF23;SVIL;NAT10;CCDC124;URB2;RCC2;KEAP1;HNRNPU;MICAL3;CHMP4B;INCENP
10477,GO:0043369,0.552255956084231,0.822524495567253,1,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,CYLD
5589,GO:0016614,0.552326503884394,0.603194884482531,7,93,oxidoreductase activity, acting on CH-OH group of donors,MF,G6PD;PGD;BMP2;AKR1C2;DCXR;AKR1C1;HSD17B10
11853,GO:0046834,0.552382091281497,0.615470396100573,6,76,lipid phosphorylation,BP,NRG1;IRS1;FGFR2;IRS2;PDGFB;ESR1
12926,GO:0051281,0.552667546980192,0.727597383000233,2,24,positive regulation of release of sequestered calcium ion into cytosol,BP,JPH2;GPER1
16426,GO:0097061,0.552810801613065,0.650957357766596,4,50,dendritic spine organization,BP,BAIAP2;DOCK10;ZNF365;EFNA1
5230,GO:0015844,0.552840813411382,0.727441054299842,2,24,monoamine transport,BP,SYK;OXTR
13993,GO:0060707,0.552864166199443,0.822066403109477,1,10,trophoblast giant cell differentiation,BP,LIF
12935,GO:0051292,0.553135976486969,0.821861419915375,1,10,nuclear pore complex assembly,BP,NUP153
9383,GO:0035914,0.553578382309772,0.679636967497263,3,37,skeletal muscle cell differentiation,BP,EGR1;DDX17;MAFF
1659,GO:0004114,0.553872919506538,0.821304849663287,1,10,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE6A
4972,GO:0015085,0.553968078053229,0.629278531393725,5,63,calcium ion transmembrane transporter activity,MF,JPH2;PANX1;JPH1;ITGAV;SLC3A2
2501,GO:0005750,0.553975548650804,0.819837301820423,1,11,mitochondrial respiratory chain complex III,CC,BCS1L
11184,GO:0045275,0.553975548650804,0.819837301820423,1,11,respiratory chain complex III,CC,BCS1L
1143,GO:0002739,0.554088227518015,0.821142015979502,1,10,regulation of cytokine secretion involved in immune response,BP,TNF
17468,GO:1900273,0.554580136092709,0.820769613522589,1,10,positive regulation of long-term synaptic potentiation,BP,SQSTM1
9645,GO:0036513,0.554650499980696,0.820716300785833,1,10,Derlin-1 retrotranslocation complex,CC,RNF185
3681,GO:0008179,0.554655122942647,0.820712797719122,1,10,adenylate cyclase binding,MF,ADRB2
16431,GO:0097067,0.554859739218335,0.820557702023906,1,10,cellular response to thyroid hormone stimulus,BP,GCLC
11259,GO:0045504,0.554913479918537,0.820516952261861,1,10,dynein heavy chain binding,MF,WDR34
12909,GO:0051255,0.554934948078084,0.820500671913077,1,10,spindle midzone assembly,BP,KIF23
10495,GO:0043395,0.554944605058241,0.820493348220761,1,10,heparan sulfate proteoglycan binding,MF,FST
11,GO:0000022,0.554994211354962,0.820455724439816,1,10,mitotic spindle elongation,BP,KIF23
2544,GO:0005811,0.555065028179937,0.628077829516902,5,64,lipid droplet,CC,STARD13;RSAD2;EHD1;LSS;PRPF19
14635,GO:0070203,0.555525454476536,0.820052465856786,1,10,regulation of establishment of protein localization to telomere,BP,DKC1
1313,GO:0003161,0.55555797910383,0.820027756786434,1,10,cardiac conduction system development,BP,NRG1
5638,GO:0016723,0.555661921414717,0.819948775885111,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP4
11295,GO:0045605,0.55566810724882,0.819944074811779,1,10,negative regulation of epidermal cell differentiation,BP,TP63
4020,GO:0009048,0.555766743418257,0.81986910251642,1,10,dosage compensation by inactivation of X chromosome,BP,HNRNPU
15031,GO:0070972,0.555841107989331,0.589066616395593,8,125,protein localization to endoplasmic reticulum,BP,PMM2;RPLP2;RPLP1;RPS2;RPS9;RPL27A;CHMP4B;INSIG1
510,GO:0001573,0.556064979260361,0.819642286624059,1,10,ganglioside metabolic process,BP,CLN6
10479,GO:0043371,0.556333655706053,0.819437783982811,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,SMAD7
8315,GO:0033147,0.556535387636038,0.819284131677207,1,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,TP63
20026,GO:2000647,0.556625595156114,0.819215394720642,1,10,negative regulation of stem cell proliferation,BP,SNAI2
15860,GO:0072576,0.556644436904916,0.819201035290422,1,10,liver morphogenesis,BP,TNFAIP3
10983,GO:0044774,0.55675717361827,0.589092157552794,8,105,mitotic DNA integrity checkpoint,BP,PML;TP53;CDKN1A;GADD45A;SFN;ORAOV1;TFDP1;TP63
2669,GO:0006020,0.556920293892156,0.818990713232259,1,10,inositol metabolic process,BP,PPIP5K1
14523,GO:0070008,0.556962205370511,0.818958743932552,1,10,serine-type exopeptidase activity,MF,PREP
101,GO:0000212,0.557286297723012,0.818711401593207,1,10,meiotic spindle organization,BP,MYH9
10613,GO:0043601,0.557461779331822,0.72325242819102,2,24,nuclear replisome,CC,PRPF19;POLA1
7059,GO:0030837,0.557537710245329,0.675608662038165,3,38,negative regulation of actin filament polymerization,BP,SPTBN1;KANK4;MYADM
643,GO:0001833,0.557586539253027,0.818482055164729,1,10,inner cell mass cell proliferation,BP,PRPF19
15876,GO:0072595,0.557639001765797,0.675511798807823,3,38,maintenance of protein localization in organelle,BP,PML;HNRNPU;INSIG1
7172,GO:0031053,0.557726563904936,0.818375026090715,1,10,primary miRNA processing,BP,SRRT
11342,GO:0045665,0.557751073045666,0.567150202775124,11,144,negative regulation of neuron differentiation,BP,EFNB2;PBX1;PRPF19;NTN1;DPYSL3;SEMA3C;YWHAH;ZNF365;BMP7;CTDSP1;EFNA1
2386,GO:0005522,0.557866596539869,0.818267947627598,1,10,profilin binding,MF,ACTG1
19301,GO:1905564,0.558037904654067,0.818136894923699,1,10,positive regulation of vascular endothelial cell proliferation,BP,ADAM17
15448,GO:0071732,0.558101098566183,0.818088534475202,1,10,cellular response to nitric oxide,BP,TRAF2
280,GO:0000782,0.558110258567636,0.818081523862064,1,10,telomere cap complex,CC,XRCC6
281,GO:0000783,0.558110258567636,0.818081523862064,1,10,nuclear telomere cap complex,CC,XRCC6
19711,GO:2000052,0.55814869409201,0.818052105190978,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,SFRP1
5739,GO:0016886,0.558200718297723,0.818012280497804,1,10,ligase activity, forming phosphoric ester bonds,MF,PARP1
3212,GO:0006853,0.558413687477121,0.817849189548941,1,10,carnitine shuttle,BP,CPT1A
12750,GO:0051018,0.558550859071115,0.67489526335543,3,37,protein kinase A binding,MF,AKAP8L;AKAP8;PALM2
7547,GO:0031848,0.558795742466442,0.81755636198099,1,10,protection from non-homologous end joining at telomere,BP,TFIP11
17554,GO:1901096,0.559039696035007,0.817369213809402,1,10,regulation of autophagosome maturation,BP,ADRB2
13577,GO:0060044,0.559142754561664,0.817290113207861,1,10,negative regulation of cardiac muscle cell proliferation,BP,MAPK11
7150,GO:0031005,0.559160175973759,0.817276739410248,1,10,filamin binding,MF,DPYSL3
6052,GO:0019199,0.559234704983167,0.64469524234801,4,50,transmembrane receptor protein kinase activity,MF,FGFR2;EPHB6;EPHA2;ROR1
6791,GO:0030228,0.559240405274616,0.817215141557109,1,10,lipoprotein particle receptor activity,MF,CXCL16
18851,GO:1904467,0.559389504959844,0.817100629028909,1,10,regulation of tumor necrosis factor secretion,BP,ZC3H12A
10440,GO:0043295,0.559596791975621,0.815524309777261,1,11,glutathione binding,MF,PTGES
17517,GO:1900750,0.559596791975621,0.815524309777261,1,11,oligopeptide binding,MF,PTGES
2320,GO:0005328,0.559611852565065,0.816929768610739,1,10,neurotransmitter:sodium symporter activity,MF,SLC25A22
18648,GO:1903960,0.559922714611216,0.816690706477469,1,10,negative regulation of anion transmembrane transport,BP,IRS2
5137,GO:0015645,0.559972349654474,0.816652515803278,1,10,fatty acid ligase activity,MF,ACSL1
6354,GO:0021535,0.559985716571294,0.816642229964854,1,10,cell migration in hindbrain,BP,FLNA
15649,GO:0072160,0.560022096252888,0.816614233807205,1,10,nephron tubule epithelial cell differentiation,BP,LIF
8580,GO:0034058,0.560030841459259,0.816607503452435,1,10,endosomal vesicle fusion,BP,TGFBRAP1
13544,GO:0060004,0.560033438128111,0.816605505008764,1,10,reflex,BP,NPNT
14638,GO:0070208,0.560056672042685,0.81658762311665,1,10,protein heterotrimerization,BP,C1QTNF1
14301,GO:0061430,0.560069312888923,0.816577893634646,1,10,bone trabecula morphogenesis,BP,SFRP1
2166,GO:0005001,0.560147455370764,0.816517740585932,1,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRB
6051,GO:0019198,0.560147455370764,0.816517740585932,1,10,transmembrane receptor protein phosphatase activity,MF,PTPRB
13736,GO:0060307,0.560245893320086,0.816441945051559,1,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,WDR1
18596,GO:1903859,0.560256688004461,0.816433632018116,1,10,regulation of dendrite extension,BP,NEDD4L
5135,GO:0015631,0.560365736155311,0.53068140135888,21,276,tubulin binding,MF,CRYAB;MAP2;NEFM;MID1;LYN;MYO1B;DST;CHP1;KIF23;MYO10;MTUS1;REEP1;DCTN1;MYH9;RCC2;CLASP1;BLOC1S2;KIF24;KIF22;DAG1;MYO1E
5863,GO:0017166,0.560379958812455,0.81633868229924,1,10,vinculin binding,MF,DAG1
9593,GO:0036445,0.560395610137251,0.816326624400357,1,10,neuronal stem cell division,BP,FGFR2
13496,GO:0055057,0.560395610137251,0.816326624400357,1,10,neuroblast division,BP,FGFR2
16006,GO:0086014,0.560395610137251,0.816326624400357,1,10,atrial cardiac muscle cell action potential,BP,FLNA
16016,GO:0086026,0.560395610137251,0.816326624400357,1,10,atrial cardiac muscle cell to AV node cell signaling,BP,FLNA
16038,GO:0086066,0.560395610137251,0.816326624400357,1,10,atrial cardiac muscle cell to AV node cell communication,BP,FLNA
2389,GO:0005525,0.560478932160783,0.530539734052504,21,278,GTP binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
12879,GO:0051209,0.56105356540955,0.622036395208277,5,65,release of sequestered calcium ion into cytosol,BP,JPH2;LYN;JPH1;GPER1;NOL3
12928,GO:0051283,0.56105356540955,0.622036395208277,5,65,negative regulation of sequestering of calcium ion,BP,JPH2;LYN;JPH1;GPER1;NOL3
4025,GO:0009057,0.561367270219221,0.48577841293001,84,1127,macromolecule catabolic process,BP,NRG1;ODC1;PML;CYLD;HSPB1;SDC4;MGAM;SPSB1;TP53;SQSTM1;NOCT;HSPG2;UBQLN2;ADAMTS9;TNF;ENC1;BACE2;PSMB9;CLN6;UBE2C;ZC3H12A;FLNA;CHP1;UBE4B;RNF19B;PABPC4;USP36;PPP1R3B;PSME2;CTIF;ABTB2;POP1;PRPF19;ZFP36L1;RPLP2;DKC1;FEN1;SNX12;KCTD10;RPLP1;TRAF2;PRKCA;ZFP36L2;USP43;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;SNRNP70;DNASE1;RNF115;UHRF1;COPS3;NUP214;SMAD7;TATDN2;KEAP1;HNRNPU;UBE2J2;TRIB1;ANAPC15;RPL27A;HSPBP1;HSPA8;USP31;CHMP4B;HERC2;EDC4;METTL16;RNF7;TINAGL1;RNF185;DHX34;TNFAIP3;PSMC3;EFNA1;RNF144B;POLR2G;CLTA;SNF8;GCLC;HSP90AB1;MAGOH
2639,GO:0005975,0.561785342042772,0.510287038543695,34,447,carbohydrate metabolic process,BP,IGFBP3;C1QTNF1;UGT1A6;B4GALT1;MGAM;G6PD;NFKB1;GNPTAB;IRS1;GALNT18;TNF;NUP153;PGD;PMM2;GANC;PGK1;ST6GALNAC5;PPP1R3B;GPER1;IRS2;PPIP5K1;PDGFB;NUP214;CHST3;GALNT2;GBE1;CPT1A;DCXR;CS;TKT;MGAT2;DPM3;SLC3A2;GCLC
10162,GO:0042745,0.56213466142562,0.813554124231211,1,11,circadian sleep/wake cycle,BP,CSF2
7167,GO:0031047,0.562200427193429,0.562285227709614,11,155,gene silencing by RNA,BP,NUP153;ZC3H12A;ZC3H7B;SRRT;DDX17;AJUBA;NUP214;ESR1;RBM4;SNIP1;POLR2G
6510,GO:0021885,0.562965842157191,0.670654370524958,3,37,forebrain cell migration,BP,NRG1;SRF;ROBO1
10728,GO:0044068,0.563517782401512,0.717706089290081,2,24,modulation by symbiont of host cellular process,BP,ZC3H12A;ITGAV
4331,GO:0009880,0.563772658829832,0.669876220148149,3,37,embryonic pattern specification,BP,FGFR2;EFNB1;BMP7
5921,GO:0018196,0.564009033125705,0.669144991401892,3,39,peptidyl-asparagine modification,BP,ST6GALNAC5;MGAT2;DPM3
12947,GO:0051306,0.564020203928858,0.639663427676838,4,52,mitotic sister chromatid separation,BP,UBE2C;ZW10;ANAPC15;DUSP1
11394,GO:0045776,0.564504339874728,0.716796398385906,2,24,negative regulation of blood pressure,BP,SOD2;ADRB2
11890,GO:0046906,0.564725343420909,0.618382603350097,5,65,tetrapyrrole binding,MF,CYP1B1;CYP24A1;CYP1A1;CYP4B1;CYP20A1
11846,GO:0046824,0.564943029553771,0.638915869841939,4,51,positive regulation of nucleocytoplasmic transport,BP,TP53;ZC3H12A;SFN;HSP90AB1
4917,GO:0014855,0.564948478559487,0.668740429960499,3,37,striated muscle cell proliferation,BP,TGFB2;FGFR2;MAPK11
3068,GO:0006633,0.565125520629373,0.590369731684881,7,93,fatty acid biosynthetic process,BP,FADS3;PTGES;EDN1;SCD;SCD5;INSIG1;FADS1
16723,GO:0097720,0.565130519377451,0.716218107430697,2,24,calcineurin-mediated signaling,BP,NRG1;CHP1
3720,GO:0008238,0.565381665998797,0.617845615805933,5,64,exopeptidase activity,MF,CPA4;C9ORF3;DNPEP;PREP;XPNPEP3
14123,GO:0060986,0.565459380113999,0.715914116993223,2,24,endocrine hormone secretion,BP,INHBA;C1QTNF1
18834,GO:1904427,0.565695637627613,0.667758417294104,3,38,positive regulation of calcium ion transmembrane transport,BP,JPH2;G6PD;GPER1
8190,GO:0032928,0.565769518988533,0.810707204586189,1,11,regulation of superoxide anion generation,BP,SYK
8514,GO:0033692,0.565952857836376,0.63791876954804,4,51,cellular polysaccharide biosynthetic process,BP,IRS1;PPP1R3B;IRS2;GBE1
5408,GO:0016248,0.566466630912432,0.714515480639848,2,25,channel inhibitor activity,MF,ANKRD36C;NEDD4L
14132,GO:0060998,0.56658606282509,0.637292859384185,4,51,regulation of dendritic spine development,BP,NRG1;BAIAP2;SDK1;EFNA1
17770,GO:1901797,0.566796607677491,0.714209342026571,2,25,negative regulation of signal transduction by p53 class mediator,BP,SNAI2;PTTG1IP
15514,GO:0071889,0.567035716661579,0.714454309444265,2,24,14-3-3 protein binding,MF,ZFP36L1;IRS2
7364,GO:0031406,0.567186680476216,0.578464159775143,8,107,carboxylic acid binding,MF,P3H2;P4HA2;LAYN;TYMS;DHFR;AKR1C2;AKR1C1;GCLC
7720,GO:0032210,0.567226494776104,0.6366592669825,4,51,regulation of telomere maintenance via telomerase,BP,GNL3L;NAT10;DKC1;HNRNPU
4161,GO:0009223,0.567437053630669,0.809391179361706,1,11,pyrimidine deoxyribonucleotide catabolic process,BP,SMUG1
17081,GO:0099601,0.567896800581154,0.713655002445641,2,24,regulation of neurotransmitter receptor activity,BP,LYPD6B;ADRB2
13777,GO:0060359,0.568003776861326,0.615106715574158,5,65,response to ammonium ion,BP,OXTR;SDK1;PPP1R9B;EFTUD2;HSP90AB1
10435,GO:0043280,0.568370312478379,0.577156088450436,8,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CYR61;CTGF;PML;TNF;GPER1;TRAF2;ROBO1;TNFRSF10A
18240,GO:1903050,0.568406355160772,0.546441259613284,13,174,regulation of proteolysis involved in cellular protein catabolic process,BP,PML;UBQLN2;RNF19B;PSME2;SMAD7;KEAP1;TRIB1;HSPBP1;PSMC3;EFNA1;RNF144B;GCLC;HSP90AB1
11042,GO:0045022,0.568453101766072,0.665082405372411,3,38,early endosome to late endosome transport,BP,EMP2;SNX12;SNF8
4040,GO:0009072,0.568936602036279,0.808202345668316,1,11,aromatic amino acid family metabolic process,BP,QDPR
10560,GO:0043516,0.569029245732374,0.712132872157834,2,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;PTTG1IP
7057,GO:0030835,0.569572547908545,0.71209566566298,2,24,negative regulation of actin filament depolymerization,BP,SPTBN1;SWAP70
12732,GO:0050995,0.570111378074589,0.807267415056896,1,11,negative regulation of lipid catabolic process,BP,TNF
4390,GO:0010043,0.570190581873616,0.710616883865245,2,26,response to zinc ion,BP,KRT14;PARP1
8032,GO:0032677,0.570527683046943,0.662814354454685,3,39,regulation of interleukin-8 production,BP,TNF;SERPINE1;AFAP1L2
2836,GO:0006304,0.570594733336711,0.59698473653685,6,79,DNA modification,BP,TET3;ASCC2;MTA2;SMUG1;MPHOSPH8;PARP1
2297,GO:0005262,0.571288062314281,0.632628435223647,4,51,calcium channel activity,MF,JPH2;PANX1;JPH1;ITGAV
10794,GO:0044265,0.571449294865159,0.479274659164828,71,960,cellular macromolecule catabolic process,BP,PML;CYLD;HSPB1;SPSB1;TP53;SQSTM1;NOCT;UBQLN2;ADAMTS9;ENC1;PSMB9;CLN6;UBE2C;ZC3H12A;UBE4B;RNF19B;PABPC4;USP36;PSME2;CTIF;ABTB2;POP1;PRPF19;ZFP36L1;RPLP2;DKC1;FEN1;KCTD10;RPLP1;PRKCA;ZFP36L2;USP43;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;DNASE1;RNF115;UHRF1;COPS3;NUP214;SMAD7;TATDN2;KEAP1;HNRNPU;UBE2J2;TRIB1;ANAPC15;RPL27A;HSPBP1;HSPA8;USP31;CHMP4B;HERC2;EDC4;METTL16;RNF7;TINAGL1;RNF185;DHX34;TNFAIP3;PSMC3;EFNA1;RNF144B;POLR2G;CLTA;SNF8;GCLC;HSP90AB1;MAGOH
11534,GO:0046058,0.571461634379792,0.662149652911814,3,38,cAMP metabolic process,BP,ADM;EPHA2;GPER1
1447,GO:0003677,0.571592877013009,0.465560028817339,145,1912,DNA binding,MF,MAFB;TRIM16;RUNX1;FOSL2;PML;TFCP2L1;MYBL2;IRX2;RELB;ARID3B;IER2;TET3;ELMSAN1;NLRC5;TP53;NFE2L1;HNRNPAB;NFKB1;TAF4B;AHR;JUNB;MCM5;HMGXB3;GADD45A;TNF;ZBED1;PBX1;NUP153;NFKB2;TELO2;FOSL1;ZC3H12A;KLF7;ZNF142;STAT5A;ZMAT2;FOXD2;FUS;MCM2;TOX4;AKAP8L;ELF3;GRWD1;OSR2;SAFB2;APTX;IRF1;BANF1;NFX1;PSPC1;SRF;ZNF787;ELF4;ZFP42;EGR1;JRK;EDF1;ETS1;SNAI2;SRRT;ZFP36L1;AKAP8;FEN1;NPAS2;MAFK;ZNF778;ZFP36L2;PUM3;POLR1A;UBTF;POLA1;ZNF407;UHRF1;ZNF234;ZNF101;ZNF263;RBBP5;SFPQ;ZNF697;SPEN;ZW10;MAFF;SMAD7;SUPT5H;MTA2;DNAJC1;HNRNPU;PQBP1;CREB3;RUVBL2;ABT1;MAZ;TUSC1;ORC1;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;JUN;ESR1;IKZF3;FOXN1;RCC1;BRPF1;MCM7;TFDP1;ZNF772;ZNF512;GTF2E1;GTF3C2;XRCC6;ZNF132;KLF6;TEAD4;ACTN4;HMGN2;GLIS3;SMUG1;ZNF34;ELK1;PHF5A;KIF22;POLR3H;EEF1D;TIMELESS;TRAF4;TNFAIP3;SMARCC2;BRIP1;POLR1E;SURF6;HES4;POLR2G;CREB5;SWAP70;MKI67;PARP1;TP63;ZBTB12;TOP3A;ORC4;APEX2
3554,GO:0007589,0.571623971845108,0.63212996131144,4,52,body fluid secretion,BP,EDN1;STAT5A;OXTR;SLC22A4
5816,GO:0017081,0.572013480864854,0.805746965831788,1,11,chloride channel regulator activity,MF,SGK1
9699,GO:0038095,0.572015800378289,0.573451409243181,8,109,Fc-epsilon receptor signaling pathway,BP,NFKB1;LYN;PSMB9;PSME2;NFKBIA;SYK;JUN;PSMC3
11621,GO:0046323,0.57210996731322,0.631810086481014,4,51,glucose import,BP,IRS1;TNF;IRS2;SLC2A6
13813,GO:0060402,0.572467029168346,0.595091357687022,6,79,calcium ion transport into cytosol,BP,JPH2;PML;LYN;JPH1;GPER1;NOL3
18303,GO:1903209,0.572781717783643,0.805130523439729,1,11,positive regulation of oxidative stress-induced cell death,BP,SFPQ
10096,GO:0042599,0.57318182738525,0.804808933671108,1,11,lamellar body,CC,LAMP1
18366,GO:1903362,0.573585248166425,0.533370573317006,15,201,regulation of cellular protein catabolic process,BP,PML;UBQLN2;RNF19B;PSME2;PTTG1IP;SMAD7;KEAP1;TRIB1;HSPBP1;TNFAIP3;PSMC3;EFNA1;RNF144B;GCLC;HSP90AB1
20258,GO:2001222,0.573664752671524,0.708266480228983,2,24,regulation of neuron migration,BP,NRG1;FLNA
2742,GO:0006123,0.573694639910454,0.801238343125146,1,14,mitochondrial electron transport, cytochrome c to oxygen,BP,COX5B
6191,GO:0019646,0.573694639910454,0.801238343125146,1,14,aerobic electron transport chain,BP,COX5B
11200,GO:0045324,0.57407052526268,0.804093320772071,1,11,late endosome to vacuole transport,BP,SNF8
17256,GO:0120036,0.574123467142103,0.474476268824451,78,1023,plasma membrane bounded cell projection organization,BP,NRG1;MAP2;FN1;NEFL;TENM3;ADM;NEFM;CYLD;SDC4;DBNDD2;EMP2;LYN;EHD1;BAIAP2;EFNB2;CORO1C;ENC1;TNC;GPRIN1;PDPN;FGFR2;FLNA;KLF7;EPHA2;ICAM1;UBE4B;L1CAM;MYO10;CDC42EP2;TNFRSF12A;SFRP1;TPM1;ZFYVE27;CC2D2A;SRF;DOCK10;SGK1;DHFR;FGFR1OP;VCL;IRS2;PRKCA;NTN1;ROBO1;AJUBA;WDR34;SPTBN1;NEDD4L;DCTN1;DPYSL3;MYH9;SDK1;SEMA3C;RCC2;YWHAH;ENAH;CLASP1;PQBP1;CEP41;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;KIF24;LRFN4;BMP7;RAPGEF1;DAG1;RILPL2;TUBB;EFNA1;TTLL5;BIN3
10818,GO:0044306,0.574367373479569,0.593165678455475,6,79,neuron projection terminus,CC,BAIAP2;GPER1;ROR1;KCNIP3;HSPA8;ELK1
10317,GO:0043097,0.57479733352247,0.803506713730393,1,11,pyrimidine nucleoside salvage,BP,TK1
7018,GO:0030730,0.574834971371545,0.803476302998072,1,11,sequestering of triglyceride,BP,TNF
9158,GO:0035510,0.574841051196472,0.706685521239992,2,25,DNA dealkylation,BP,TET3;ASCC2
15994,GO:0086002,0.574847890758177,0.707153741049662,2,24,cardiac muscle cell action potential involved in contraction,BP,FLNA;NEDD4L
8994,GO:0035107,0.57490005469864,0.570732915620646,8,105,appendage morphogenesis,BP,TGFB2;FGFR2;PBX1;OSR2;SEMA3C;FRAS1;BMP7;TP63
8995,GO:0035108,0.57490005469864,0.570732915620646,8,105,limb morphogenesis,BP,TGFB2;FGFR2;PBX1;OSR2;SEMA3C;FRAS1;BMP7;TP63
6494,GO:0021854,0.575301042750775,0.803099454033527,1,11,hypothalamus development,BP,ETS1
8736,GO:0034383,0.575350984479675,0.706204649522245,2,25,low-density lipoprotein particle clearance,BP,EHD1;CLTA
12927,GO:0051282,0.575358347007102,0.607595858203641,5,66,regulation of sequestering of calcium ion,BP,JPH2;LYN;JPH1;GPER1;NOL3
5337,GO:0016074,0.575463976857103,0.801728157504257,1,12,snoRNA metabolic process,BP,DKC1
11903,GO:0046930,0.575508021020418,0.802931937559166,1,11,pore complex,CC,TOMM40
5706,GO:0016835,0.57552740426105,0.628074409216866,4,53,carbon-oxygen lyase activity,MF,PUS1;ACO1;XRCC6;APEX2
16198,GO:0090224,0.575540546216347,0.65815155803398,3,38,regulation of spindle organization,BP,DCTN1;HNRNPU;CHMP4B
2816,GO:0006278,0.57571809635061,0.607232395961741,5,66,RNA-dependent DNA biosynthetic process,BP,GNL3L;NAT10;DKC1;HNRNPU;HSP90AB1
12229,GO:0048486,0.575793279256025,0.802700903196587,1,11,parasympathetic nervous system development,BP,NAV2
3139,GO:0006732,0.576741436043331,0.511858949673471,22,295,coenzyme metabolic process,BP,MAT2A;G6PD;PANK2;SCD;NUP153;PGD;TYMS;HMGCS1;SLC5A6;PGK1;DHFR;AASS;ACSL1;NUP214;DCXR;SCD5;QDPR;ACBD6;THEM4;TKT;CD38;GCLC
10480,GO:0043372,0.577344816851721,0.801440988354711,1,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83
8024,GO:0032660,0.577528592156807,0.801291384543376,1,11,regulation of interleukin-17 production,BP,IL15
15600,GO:0072079,0.577563269777027,0.801263146127886,1,11,nephron tubule formation,BP,IRX2
1087,GO:0002675,0.577717517907212,0.801137506054532,1,11,positive regulation of acute inflammatory response,BP,TNF
16106,GO:0090085,0.577803905306852,0.801067116535688,1,11,regulation of protein deubiquitination,BP,ZC3H12A
14025,GO:0060749,0.577888225674394,0.80099839450119,1,11,mammary gland alveolus development,BP,ESR1
14289,GO:0061377,0.577888225674394,0.80099839450119,1,11,mammary gland lobule development,BP,ESR1
10075,GO:0042573,0.578126758264379,0.800803898110403,1,11,retinoic acid metabolic process,BP,CYP1A1
6058,GO:0019206,0.57827870561874,0.800679933071421,1,11,nucleoside kinase activity,MF,TK1
8086,GO:0032768,0.578461961199132,0.655022117582209,3,39,regulation of monooxygenase activity,BP,NFKB1;TNF;DHFR
20284,GO:2001257,0.578914347644923,0.588541934054543,6,79,regulation of cation channel activity,BP,MMP9;JPH2;JPH1;ADRB2;RRAD;STAC
12804,GO:0051098,0.579033975645832,0.51152447905488,21,283,regulation of binding,BP,NRG1;MMP9;CYLD;LFNG;GNL3L;BMP2;ADRB2;LIF;TFIP11;DNAJB2;NFKBIA;EDF1;TRAF2;PDGFB;BAMBI;RUVBL2;JUN;TRAF4;CDCA5;HSP90AB1;PARP1
19369,GO:1905818,0.579095503187787,0.624493524871092,4,53,regulation of chromosome separation,BP,UBE2C;ZW10;ANAPC15;DUSP1
6719,GO:0030130,0.579107331580272,0.80000295748685,1,11,clathrin coat of trans-Golgi network vesicle,CC,CLTA
15439,GO:0071712,0.579628360141507,0.799576463338104,1,11,ER-associated misfolded protein catabolic process,BP,RNF185
3073,GO:0006639,0.579816114444324,0.603081077030569,5,66,acylglycerol metabolic process,BP,PANK2;ACSL1;SLC22A4;CPT1A;INSIG1
2760,GO:0006171,0.580527123848789,0.701296688313087,2,25,cAMP biosynthetic process,BP,ADM;GPER1
10649,GO:0043679,0.580678939297639,0.602204444824684,5,66,axon terminus,CC,GPER1;ROR1;KCNIP3;HSPA8;ELK1
595,GO:0001759,0.580688372443015,0.798706816271809,1,11,organ induction,BP,BMP2
74,GO:0000151,0.5808035659758,0.511942353888272,20,266,ubiquitin ligase complex,CC,SPSB1;KLHL21;RING1;ENC1;UBE2C;UBE4B;RNF19B;ABTB2;KCTD10;TRAF2;KEAP1;UBE2J2;DCUN1D2;ANAPC15;HSPA8;ZSWIM6;KBTBD12;RNF7;MPHOSPH8;RNF144B
885,GO:0002251,0.581011140120974,0.795207445140184,1,14,organ or tissue specific immune response,BP,IL6R
17918,GO:1902230,0.58123328890469,0.700180969628898,2,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;ACKR3
3270,GO:0006941,0.581288408331137,0.586031897980521,6,80,striated muscle contraction,BP,CTGF;ZC3H12A;FLNA;TPM1;NEDD4L;SMAD7
7951,GO:0032550,0.581473220955119,0.509043891152849,21,281,purine ribonucleoside binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
14180,GO:0061077,0.581824181242261,0.600926998263981,5,67,chaperone-mediated protein folding,BP,HSPB1;BAG1;DNAJB1;DNAJB2;HSPA8
1856,GO:0004519,0.582202452012152,0.563086049381202,8,108,endonuclease activity,MF,ZC3H12A;POP1;FEN1;NOB1;DNASE1;TATDN2;POP4;APEX2
2797,GO:0006241,0.582288593296899,0.796121696365614,1,12,CTP biosynthetic process,BP,CTPS1
11522,GO:0046036,0.582288593296899,0.796121696365614,1,12,CTP metabolic process,BP,CTPS1
1451,GO:0003684,0.582591962761164,0.600257591078883,5,66,damaged DNA binding,MF,TP53;APTX;FEN1;XRCC6;TP63
8045,GO:0032695,0.582604210383661,0.797128346907705,1,11,negative regulation of interleukin-12 production,BP,NFKB1
2665,GO:0006012,0.582675550956326,0.797069402164263,1,11,galactose metabolic process,BP,B4GALT1
13032,GO:0051482,0.582783075860458,0.796980537645393,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
19956,GO:2000514,0.58285108136726,0.699077175525513,2,25,regulation of CD4-positive, alpha-beta T cell activation,BP,CD83;SMAD7
15045,GO:0070989,0.583000531613117,0.796800736842413,1,11,oxidative demethylation,BP,TET3
5927,GO:0018202,0.583021693869261,0.796783233114859,1,11,peptidyl-histidine modification,BP,DPH2
16521,GO:0097228,0.583038095942826,0.796769665902494,1,11,sperm principal piece,CC,CCR6
9834,GO:0042059,0.583079101079567,0.650443322516483,3,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,GPRC5A;ERRFI1;RNF115
9849,GO:0042094,0.583124560042904,0.796698135377607,1,11,interleukin-2 biosynthetic process,BP,IL1A
13678,GO:0060211,0.583133238531802,0.796690954812327,1,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,POLR2G
13680,GO:0060213,0.583133238531802,0.796690954812327,1,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,POLR2G
12250,GO:0048524,0.583181670385782,0.571859941116956,7,95,positive regulation of viral process,BP,NELFE;SUPT5H;HSPA8;JUN;CHMP4B;POLR2G;CCL5
12809,GO:0051103,0.58331833719547,0.796537762169672,1,11,DNA ligation involved in DNA repair,BP,PARP1
17646,GO:1901381,0.583384627594835,0.796482878769888,1,11,positive regulation of potassium ion transmembrane transport,BP,FLNA
7899,GO:0032467,0.583425858913712,0.698526696456538,2,25,positive regulation of cytokinesis,BP,KIF23;SVIL
4511,GO:0010561,0.583580052704189,0.796321021244698,1,11,negative regulation of glycoprotein biosynthetic process,BP,BACE2
3655,GO:0008135,0.583727859187566,0.583450477265976,6,81,translation factor activity, RNA binding,MF,ABCF1;EIF5;EIF3B;EIF3I;EIF5A;EEF1D
274,GO:0000776,0.58380277774758,0.553307186687242,9,121,kinetochore,CC,CBX5;DCTN1;ZW10;HNRNPU;CLASP1;CENPN;CENPO;INCENP;KIF22
3151,GO:0006749,0.583919004208648,0.648925070103978,3,42,glutathione metabolic process,BP,PTGES;G6PD;GCLC
2326,GO:0005338,0.583980869411527,0.795988769113053,1,11,nucleotide-sugar transmembrane transporter activity,MF,SLC35A4
20060,GO:2000696,0.584248894235764,0.795766381127222,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,LIF
12207,GO:0048385,0.584327056809541,0.795701495337006,1,11,regulation of retinoic acid receptor signaling pathway,BP,TRIM16
18156,GO:1902902,0.584762243438226,0.795339965366909,1,11,negative regulation of autophagosome assembly,BP,CHMP4B
17200,GO:0106027,0.584885916026201,0.618806231620379,4,52,neuron projection organization,BP,BAIAP2;DOCK10;ZNF365;EFNA1
17389,GO:1900115,0.584900666088154,0.795224877061352,1,11,extracellular regulation of signal transduction,BP,FBN1
17390,GO:1900116,0.584900666088154,0.795224877061352,1,11,extracellular negative regulation of signal transduction,BP,FBN1
5831,GO:0017111,0.585039394807385,0.475028733501869,49,648,nucleoside-triphosphatase activity,MF,TAP1;ABCF1;GBP1;MYO1B;RAB32;MCM5;GNL3L;NAV2;EIF5;ARFRP1;DDX23;KIF23;MYO10;MCM2;LSG1;ABCF2;DHX37;DDX42;RHOB;TSR1;ABCG2;DDX17;GINS2;DDX47;DDX49;WDR34;DCTN1;MYH9;DDX39A;GPN1;TAPBP;RRAD;RUVBL2;HSPA8;MCM7;RHOG;XRCC6;TAP2;KIF24;EFTUD2;KIF22;CGNL1;RAB27A;DHX34;TUBB;PSMC3;BRIP1;DDX24;MYO1E
7284,GO:0031269,0.585111145897031,0.795049791398178,1,11,pseudopodium assembly,BP,CDC42EP2
2726,GO:0006105,0.585327862999595,0.794869407440262,1,11,succinate metabolic process,BP,STAT5A
10550,GO:0043501,0.585382237057251,0.794824131824777,1,11,skeletal muscle adaptation,BP,IL15
16381,GO:0090723,0.585472105167489,0.794749286004909,1,11,growth cone part,CC,ZFYVE27
10273,GO:0043015,0.585533919089798,0.696502531383754,2,25,gamma-tubulin binding,MF,LYN;BLOC1S2
3252,GO:0006911,0.586086658724679,0.695970428414079,2,25,phagocytosis, engulfment,BP,MYH9;RHOG
6918,GO:0030510,0.586189373128916,0.617483913675717,4,52,regulation of BMP signaling pathway,BP,CYR61;FBN1;SFRP1;SMAD7
3403,GO:0007183,0.58619616486836,0.794145559224456,1,11,SMAD protein complex assembly,BP,PARP1
19368,GO:1905809,0.586242983877845,0.794106478233764,1,11,negative regulation of synapse organization,BP,EFNA1
7107,GO:0030903,0.586247366960818,0.794102819298339,1,11,notochord development,BP,EFNA1
10287,GO:0043032,0.586545563776797,0.793853781416953,1,11,positive regulation of macrophage activation,BP,TNIP2
12149,GO:0048255,0.586653754114161,0.695423916815382,2,25,mRNA stabilization,BP,NOCT;HNRNPU
17035,GO:0099503,0.586864030559677,0.475590003631711,45,607,secretory vesicle,CC,KRT1;FTL;FTH1;MMP9;S100P;FN1;PCDH7;TGFB2;EDN1;B4GALT1;MGAM;DBNDD2;HRNR;NFKB1;PLEKHO2;LAMP1;BAIAP2;QPCT;SIRPA;CYB5R1;ACAA1;ITGAV;SERPINE1;VCL;LGALS3;PDGFB;DPYSL3;GLIPR1;LILRB3;CRCP;CAB39;CD109;HSPA8;COMMD9;RHOG;XRCC6;ACTN4;RAB27A;TUBB;PSMC3;PTPRB;CLTA;HSP90AB1;TBXA2R;LAIR1
15647,GO:0072148,0.587134763555873,0.793361090618652,1,11,epithelial cell fate commitment,BP,PDPN
1777,GO:0004385,0.58722718351203,0.793283733625889,1,11,guanylate kinase activity,MF,TJP2
2787,GO:0006220,0.587264473439435,0.645795776392677,3,41,pyrimidine nucleotide metabolic process,BP,TYMS;SMUG1;CTPS1
6286,GO:0019896,0.587312730284316,0.793212111431476,1,11,axonal transport of mitochondrion,BP,NEFL
7915,GO:0032488,0.587351523809801,0.7931796266306,1,11,Cdc42 protein signal transduction,BP,NTN1
9126,GO:0035437,0.587542811435068,0.793019394252197,1,11,maintenance of protein localization in endoplasmic reticulum,BP,INSIG1
818,GO:0002090,0.587721062480047,0.694393728609153,2,25,regulation of receptor internalization,BP,UBQLN2;SYK
16155,GO:0090169,0.587819525644802,0.694298583211068,2,25,regulation of spindle assembly,BP,HNRNPU;CHMP4B
4458,GO:0010447,0.587986997387959,0.792646984008466,1,11,response to acidic pH,BP,CHP1
3161,GO:0006768,0.588264166397956,0.792414363523889,1,11,biotin metabolic process,BP,SLC5A6
298,GO:0000803,0.588300371252092,0.69383368071242,2,25,sex chromosome,CC,RING1;HNRNPU
3222,GO:0006869,0.588351656795115,0.518197188234447,15,200,lipid transport,BP,INHBA;C1QTNF1;EDN1;APOL6;NFKB1;STOML1;SLCO3A1;ITGAV;NFKBIA;IRS2;ABCG2;SYK;ACSL1;CPT1A;AKR1C1
4739,GO:0010906,0.588424726159944,0.594294199036405,5,66,regulation of glucose metabolic process,BP,IGFBP3;C1QTNF1;IRS1;PPP1R3B;IRS2
14135,GO:0061001,0.588822766039433,0.693328118581178,2,25,regulation of dendritic spine morphogenesis,BP,BAIAP2;EFNA1
1657,GO:0004112,0.589088957238384,0.791721050710561,1,11,cyclic-nucleotide phosphodiesterase activity,MF,PDE6A
11638,GO:0046349,0.589301949708506,0.791541745957129,1,11,amino sugar biosynthetic process,BP,UAP1L1
4526,GO:0010591,0.589431355220524,0.692738497737154,2,25,regulation of lamellipodium assembly,BP,EPHA2;BIN3
15097,GO:0071108,0.589463847627604,0.692706998609994,2,25,protein K48-linked deubiquitination,BP,CYLD;TNFAIP3
4558,GO:0010639,0.589614597610963,0.500652364056049,21,281,negative regulation of organelle organization,BP,MID1;GNL3L;NAT10;LIF;SPTBN1;ZW10;HNRNPU;CLASP1;ANAPC15;DUSP1;NOC2L;CHMP4B;INSIG1;BMP7;KANK4;PHLDB2;MYADM;RBM14;NOL3;SWAP70;PARP1
4355,GO:0009950,0.589766889043526,0.791149964950199,1,11,dorsal/ventral axis specification,BP,SFRP1
18430,GO:1903510,0.5898202084376,0.577358396528995,6,79,mucopolysaccharide metabolic process,BP,B4GALT1;NFKB1;CHP1;IL15;PDGFB;CHST3
7818,GO:0032371,0.589856342481571,0.691876297616938,2,26,regulation of sterol transport,BP,NFKB1;NFKBIA
7821,GO:0032374,0.589856342481571,0.691876297616938,2,26,regulation of cholesterol transport,BP,NFKB1;NFKBIA
2990,GO:0006534,0.589963891818177,0.790983803992711,1,11,cysteine metabolic process,BP,GCLC
20185,GO:2001032,0.589978308089413,0.79097164100062,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,TFIP11
19067,GO:1904948,0.590002400510041,0.790951313136553,1,11,midbrain dopaminergic neuron differentiation,BP,SFRP1
12890,GO:0051231,0.590008901905323,0.79094582737777,1,11,spindle elongation,BP,KIF23
846,GO:0002161,0.590018763961411,0.790937505758286,1,11,aminoacyl-tRNA editing activity,MF,AARSD1
17216,GO:0106074,0.590018763961411,0.790937505758286,1,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,AARSD1
4036,GO:0009068,0.590062587819302,0.790900524288827,1,11,aspartate family amino acid catabolic process,BP,AASS
11765,GO:0046622,0.590147242598036,0.692044037911973,2,25,positive regulation of organ growth,BP,EDN1;FGFR2
14298,GO:0061418,0.590301078430352,0.591833231820166,5,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB9;PSME2;EGR1;CITED2;PSMC3
11341,GO:0045664,0.590331195892138,0.484328655014124,31,411,regulation of neuron differentiation,BP,NRG1;MAP2;FN1;NEFL;TENM3;LYN;BAIAP2;EFNB2;ENC1;PBX1;BMP2;L1CAM;TNFRSF12A;SFRP1;ZFYVE27;SRF;PRPF19;NTN1;ROBO1;NEDD4L;DPYSL3;SDK1;SEMA3C;YWHAH;PQBP1;ZNF365;ZSWIM6;BMP7;RAPGEF1;CTDSP1;EFNA1
4716,GO:0010878,0.590533692737571,0.79050268303045,1,11,cholesterol storage,BP,EHD1
14634,GO:0070202,0.590611176177413,0.790437198237755,1,11,regulation of establishment of protein localization to chromosome,BP,DKC1
5803,GO:0017056,0.590720025755387,0.691487709162184,2,25,structural constituent of nuclear pore,MF,NUP153;NUP214
14681,GO:0070293,0.590847821285409,0.790237109136572,1,11,renal absorption,BP,SGK1
11781,GO:0046639,0.59135564387206,0.789807277386146,1,11,negative regulation of alpha-beta T cell differentiation,BP,SMAD7
9052,GO:0035269,0.591419300070019,0.788448524462482,1,12,protein O-linked mannosylation,BP,DPM3
464,GO:0001502,0.591552670310959,0.789640342549904,1,11,cartilage condensation,BP,CTGF
16840,GO:0098743,0.591552670310959,0.789640342549904,1,11,cell aggregation,BP,CTGF
17115,GO:0101023,0.591754874493657,0.789468923315172,1,11,vascular endothelial cell proliferation,BP,ADAM17
19299,GO:1905562,0.591754874493657,0.789468923315172,1,11,regulation of vascular endothelial cell proliferation,BP,ADAM17
9290,GO:0035728,0.591773445023233,0.789453175141731,1,11,response to hepatocyte growth factor,BP,GCLC
14263,GO:0061318,0.591839160627975,0.789397440321017,1,11,renal filtration cell differentiation,BP,MYO1E
15626,GO:0072112,0.591839160627975,0.789397440321017,1,11,glomerular visceral epithelial cell differentiation,BP,MYO1E
15739,GO:0072311,0.591839160627975,0.789397440321017,1,11,glomerular epithelial cell differentiation,BP,MYO1E
14390,GO:0061631,0.591939514920837,0.689849308848224,2,26,ubiquitin conjugating enzyme activity,MF,UBE2C;UBE2J2
14171,GO:0061053,0.591984487378802,0.611576951611889,4,52,somite development,BP,LFNG;SFRP1;SEMA3C;WNT4
265,GO:0000732,0.591993270129435,0.690248841073674,2,25,strand displacement,BP,BRIP1;TOP3A
16720,GO:0097711,0.592022084003646,0.562807192927685,7,94,ciliary basal body-plasma membrane docking,BP,CC2D2A;FGFR1OP;DCTN1;CLASP1;CEP41;KIF24;TUBB
20171,GO:2001014,0.592336691381347,0.788975135106274,1,11,regulation of skeletal muscle cell differentiation,BP,DDX17
14500,GO:0061951,0.592427387357678,0.641071643607297,3,39,establishment of protein localization to plasma membrane,BP,ARFRP1;SPTBN1;RILPL2
8312,GO:0033144,0.592548332632411,0.689707813156059,2,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;TP63
4561,GO:0010642,0.592565438858616,0.788780772824299,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
9562,GO:0036342,0.592670897882043,0.788691123687952,1,11,post-anal tail morphogenesis,BP,TP63
7190,GO:0031078,0.59268635285855,0.788677983382547,1,11,histone deacetylase activity (H3-K14 specific),MF,HDAC9
7634,GO:0032041,0.59268635285855,0.788677983382547,1,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC9
16003,GO:0086011,0.592701903893802,0.788664760821013,1,11,membrane repolarization during action potential,BP,FLNA
15447,GO:0071731,0.592983708486502,0.788425049639126,1,11,response to nitric oxide,BP,TRAF2
854,GO:0002182,0.59299296238649,0.788417174738996,1,11,cytoplasmic translational elongation,BP,DPH2
17460,GO:1900247,0.59299296238649,0.788417174738996,1,11,regulation of cytoplasmic translational elongation,BP,DPH2
16440,GO:0097094,0.593012449348546,0.788400591013337,1,11,craniofacial suture morphogenesis,BP,INSIG1
2348,GO:0005402,0.59302492825336,0.788389970775639,1,11,carbohydrate:cation symporter activity,MF,SLC2A6
5344,GO:0016082,0.593044555048569,0.788373266526409,1,11,synaptic vesicle priming,BP,CADPS2
289,GO:0000793,0.593103513238862,0.521002301289285,13,175,condensed chromosome,CC,RRS1;AKAP8;ORAOV1;ZW10;HNRNPU;CLASP1;CENPN;PES1;RCC1;CENPO;INCENP;CDCA5;MKI67
6892,GO:0030424,0.593335487127627,0.486393460800008,27,360,axon,CC,CRYAB;NRG1;NEFL;TENM3;SACS;NEFM;HSPB1;TGFB2;DST;GPRIN1;L1CAM;IQCJ-SCHIP1;ZFYVE27;GPER1;KCNA7;ROBO1;SPTBN1;DPYSL3;TNFRSF21;ROR1;KCNIP3;HSPA8;BLOC1S2;PARD3;CNTNAP1;ELK1;DAG1
10406,GO:0043240,0.593378790669437,0.788088657165965,1,11,Fanconi anaemia nuclear complex,CC,FANCC
6502,GO:0021871,0.59338997615142,0.78807912778411,1,11,forebrain regionalization,BP,BMP2
12989,GO:0051393,0.593675949508328,0.787835391958564,1,11,alpha-actinin binding,MF,DAG1
3072,GO:0006638,0.593793707509151,0.588654302423198,5,67,neutral lipid metabolic process,BP,PANK2;ACSL1;SLC22A4;CPT1A;INSIG1
9070,GO:0035306,0.593898430109824,0.639584496385143,3,39,positive regulation of dephosphorylation,BP,BMP2;NPNT;HSP90AB1
16870,GO:0098799,0.5941501508069,0.78611467234825,1,12,outer mitochondrial membrane protein complex,CC,TOMM40
19620,GO:1990774,0.594170512449533,0.787413405981324,1,11,tumor necrosis factor secretion,BP,ZC3H12A
10430,GO:0043274,0.594657861121398,0.786996993875527,1,11,phospholipase binding,MF,NEFL
4463,GO:0010457,0.594678557035385,0.786979297586305,1,11,centriole-centriole cohesion,BP,DCTN1
673,GO:0001883,0.594724862232065,0.495338691502564,21,283,purine nucleoside binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
16607,GO:0097440,0.594767505627324,0.786903229147189,1,11,apical dendrite,CC,FLNA
17092,GO:0099625,0.594959366744081,0.786739084776153,1,11,ventricular cardiac muscle cell membrane repolarization,BP,WDR1
15787,GO:0072393,0.595057469210883,0.78665511979209,1,11,microtubule anchoring at microtubule organizing center,BP,DCTN1
9597,GO:0036452,0.595057729337616,0.686799980119706,2,26,ESCRT complex,CC,CHMP4B;SNF8
13563,GO:0060026,0.59506995274573,0.786644433570536,1,11,convergent extension,BP,SFRP1
20295,GO:2001275,0.595097276996633,0.786621041991555,1,11,positive regulation of glucose import in response to insulin stimulus,BP,IRS1
11624,GO:0046326,0.595405698640268,0.68691352383922,2,25,positive regulation of glucose import,BP,IRS1;IRS2
4585,GO:0010675,0.595440070961593,0.571455524039271,6,80,regulation of cellular carbohydrate metabolic process,BP,IGFBP3;C1QTNF1;IRS1;PPP1R3B;GPER1;IRS2
14809,GO:0070536,0.595444582795987,0.686875391888018,2,25,protein K63-linked deubiquitination,BP,CYLD;TNFAIP3
417,GO:0001104,0.595724328785754,0.571074812700992,6,81,RNA polymerase II transcription cofactor activity,MF,DNAJB1;MKL1;MED22;PPRC1;CITED2;RBM14
5628,GO:0016706,0.595947072956137,0.637507755851832,3,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,P3H2;TET3;P4HA2
6651,GO:0023061,0.596254190175701,0.500843599380021,18,242,signal release,BP,INHBA;C1QTNF1;ADM;EDN1;IRS1;LYN;TNF;CADPS2;LIF;SFRP1;GPER1;IRS2;PRKCA;HSPA8;CPT1A;CD38;BMP8A;CCL5
2641,GO:0005977,0.5966223803259,0.606653872536949,4,53,glycogen metabolic process,BP,IRS1;PPP1R3B;IRS2;GBE1
7188,GO:0031076,0.5967033429061,0.685639438030124,2,25,embryonic camera-type eye development,BP,BMP7;PHACTR4
17344,GO:1900026,0.597682165449612,0.684219311039142,2,26,positive regulation of substrate adhesion-dependent cell spreading,BP,FLNA;MYADM
1855,GO:0004518,0.59826987485358,0.515574538450377,13,177,nuclease activity,MF,USB1;NOCT;ZC3H12A;AEN;APTX;POP1;FEN1;ISG20L2;NOB1;DNASE1;TATDN2;POP4;APEX2
6849,GO:0030317,0.598759848916989,0.683155820756718,2,26,flagellated sperm motility,BP,CCR6;TTLL5
9836,GO:0042063,0.599097639432986,0.514764262470624,13,175,gliogenesis,BP,NRG1;TGFB2;LYN;BMP2;LIF;WDR1;PRPF19;TNFRSF21;ROR1;PARD3;ZNF365;CNTNAP1;DAG1
10977,GO:0044766,0.599204244241378,0.582938010446097,5,68,multi-organism transport,BP,NUP153;NMT2;ALYREF;NUP214;THOC1
18049,GO:1902579,0.599204244241378,0.582938010446097,5,68,multi-organism localization,BP,NUP153;NMT2;ALYREF;NUP214;THOC1
4451,GO:0010389,0.599395013572356,0.514324279812664,13,180,regulation of G2/M transition of mitotic cell cycle,BP,PBX1;PSMB9;CDK4;PSME2;FGFR1OP;GPR132;DCTN1;ORAOV1;RCC2;CLASP1;CEP41;TUBB;PSMC3
2853,GO:0006338,0.599746659521993,0.52365188900981,11,155,chromatin remodeling,BP,CDKN2A;DAXX;TOX4;UBTF;MTA2;RUVBL2;ESR1;CENPN;CENPO;SMARCC2;TP63
8372,GO:0033267,0.599759278372283,0.497199319664574,18,242,axon part,CC,NRG1;NEFL;HSPB1;DST;GPRIN1;L1CAM;ZFYVE27;GPER1;SPTBN1;DPYSL3;ROR1;KCNIP3;HSPA8;BLOC1S2;PARD3;CNTNAP1;ELK1;DAG1
8907,GO:0034728,0.599998614714935,0.53577509220893,9,139,nucleosome organization,BP,DAXX;MCM2;GRWD1;CENPN;CENPO;IPO4;CHAF1A;SMARCC2;SUPT16H
5777,GO:0016999,0.60002049898709,0.554288243615736,7,97,antibiotic metabolic process,BP,CYP1A1;STAT5A;CYP4B1;ACO1;AKR1C2;CS;AKR1C1
7098,GO:0030894,0.600162618434402,0.68176821867523,2,26,replisome,CC,PRPF19;POLA1
4971,GO:0015081,0.600257456057475,0.582068127238258,5,66,sodium ion transmembrane transporter activity,MF,SLC5A6;SLC4A11;SLC4A2;SLC3A2;SLC25A22
900,GO:0002279,0.600324615995657,0.681607731346641,2,26,mast cell activation involved in immune response,BP,LYN;SYK
10447,GO:0043303,0.600324615995657,0.681607731346641,2,26,mast cell degranulation,BP,LYN;SYK
5618,GO:0016671,0.60039370802357,0.780710350091768,1,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,TXN2
9895,GO:0042177,0.600409285328841,0.553882006616744,7,97,negative regulation of protein catabolic process,BP,NRG1;PML;FLNA;SNX12;SNRNP70;EFNA1;HSP90AB1
592,GO:0001756,0.600571339257524,0.632795687487168,3,39,somitogenesis,BP,LFNG;SFRP1;SEMA3C
15333,GO:0071549,0.601228188030092,0.68071166460911,2,26,cellular response to dexamethasone stimulus,BP,ICAM1;ERRFI1
2798,GO:0006244,0.601583543721253,0.779669548010205,1,12,pyrimidine nucleotide catabolic process,BP,SMUG1
6461,GO:0021782,0.601677940019032,0.580362868359906,5,68,glial cell development,BP,LYN;ROR1;PARD3;CNTNAP1;DAG1
2662,GO:0006006,0.601788646734028,0.527687703292326,10,135,glucose metabolic process,BP,IGFBP3;C1QTNF1;G6PD;IRS1;TNF;PGK1;PPP1R3B;IRS2;CPT1A;DCXR
10156,GO:0042734,0.601968715784259,0.631365099140746,3,39,presynaptic membrane,CC,FOSL1;CADPS2;GPER1
6562,GO:0022008,0.602089853073792,0.446174390212023,77,1015,neurogenesis,BP,NRG1;RUNX1;INHBA;HDAC9;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;WNT10A;IER2;TGFB2;DAPK3;DBNDD2;LYN;EHD1;BAIAP2;EFNB2;ENC1;TNC;GPRIN1;FGFR2;PBX1;FLNA;KLF7;BMP2;UBE4B;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;WDR1;GPER1;SRF;ABTB2;DOCK10;SGK1;SRRT;PRPF19;DHFR;VCL;IRS2;PRKCA;NTN1;ROBO1;SPTBN1;NEDD4L;DPYSL3;NOM1;SDK1;TNFRSF21;SEMA3C;SPEN;ROR1;YWHAH;ENAH;PQBP1;ABT1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;WNT4;CTDSP1;EFNA1
12645,GO:0050849,0.602299272298134,0.779041775311043,1,12,negative regulation of calcium-mediated signaling,BP,CHP1
2875,GO:0006368,0.602491734143425,0.551703371041298,7,97,transcription elongation from RNA polymerase II promoter,BP,TAF4B;NELFE;SUPT5H;HNRNPU;GTF2E1;SUPT16H;POLR2G
18926,GO:1904668,0.602692113660973,0.778696668453526,1,12,positive regulation of ubiquitin protein ligase activity,BP,UBE2C
7252,GO:0031210,0.602720228720874,0.778671954943131,1,12,phosphatidylcholine binding,MF,PCYT1A
12734,GO:0050997,0.602720228720874,0.778671954943131,1,12,quaternary ammonium group binding,MF,PCYT1A
11777,GO:0046635,0.6028586939342,0.679090754007842,2,26,positive regulation of alpha-beta T cell activation,BP,CD83;SYK
3467,GO:0007286,0.603026362188762,0.578955934933825,5,68,spermatid development,BP,PANK2;NSUN2;CCR6;BRIP1;TTLL5
3114,GO:0006691,0.603063117615745,0.77837039250359,1,12,leukotriene metabolic process,BP,SYK
3901,GO:0008540,0.603087451711986,0.778348980117329,1,12,proteasome regulatory particle, base subcomplex,CC,PSMC3
6074,GO:0019226,0.603128349337525,0.678822194945573,2,26,transmission of nerve impulse,BP,GPER1;CNTNAP1
12959,GO:0051341,0.603689297052877,0.599032723612549,4,55,regulation of oxidoreductase activity,BP,EDN1;NFKB1;TNF;DHFR
468,GO:0001508,0.604154697241016,0.577888311584249,5,67,action potential,BP,FLNA;GPER1;NEDD4L;YWHAH;CNTNAP1
9003,GO:0035136,0.604337753300962,0.677615991891025,2,26,forelimb morphogenesis,BP,OSR2;TP63
5071,GO:0015294,0.60496210545853,0.59801725055544,4,53,solute:cation symporter activity,MF,SLC5A6;SLC4A2;SLC25A22;SLC2A6
3480,GO:0007340,0.605064279642516,0.776604560924135,1,12,acrosome reaction,BP,B4GALT1
3770,GO:0008320,0.605198064350645,0.775338660105783,1,13,protein transmembrane transporter activity,MF,TOMM40
3395,GO:0007173,0.605240505207991,0.539150932857876,8,108,epidermal growth factor receptor signaling pathway,BP,MMP9;GPRC5A;ERRFI1;EPGN;GPER1;ADAM17;RNF115;AFAP1L2
13011,GO:0051444,0.605484849866926,0.775083676803304,1,13,negative regulation of ubiquitin-protein transferase activity,BP,SMAD7
11374,GO:0045739,0.6056945256159,0.627288643133923,3,40,positive regulation of DNA repair,BP,NPAS2;TIMELESS;PARP1
3043,GO:0006596,0.605862678446367,0.775897251869624,1,12,polyamine biosynthetic process,BP,ODC1
16764,GO:0098554,0.605911330552003,0.774704107117681,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,SPPL2A
3953,GO:0008655,0.606149292118267,0.775642947511601,1,12,pyrimidine-containing compound salvage,BP,TK1
7261,GO:0031228,0.606258929222814,0.626706384870104,3,40,intrinsic component of Golgi membrane,CC,LFNG;TPST1;GALNT2
6899,GO:0030433,0.606440082930508,0.575383914194416,5,68,ubiquitin-dependent ERAD pathway,BP,UBQLN2;UBE4B;UBE2J2;RNF185;PSMC3
8008,GO:0032637,0.606691356493441,0.626025386680192,3,41,interleukin-8 production,BP,TNF;SERPINE1;AFAP1L2
7460,GO:0031597,0.606714335931464,0.775140994480139,1,12,cytosolic proteasome complex,CC,PSMC3
18222,GO:1903019,0.60749966955698,0.774442012390413,1,12,negative regulation of glycoprotein metabolic process,BP,BACE2
12648,GO:0050852,0.607673626171379,0.521322520699124,10,140,T cell receptor signaling pathway,BP,CYLD;GBP1;NFKB1;PSMB9;ZC3H12A;PSME2;NFKBIA;LGALS3;TNFRSF21;PSMC3
15854,GO:0072567,0.607893203825005,0.774091163878628,1,12,chemokine (C-X-C motif) ligand 2 production,BP,TNF
12123,GO:0048188,0.608083303270567,0.773921543907549,1,12,Set1C/COMPASS complex,CC,RBBP5
6364,GO:0021545,0.608187732599728,0.673757445303887,2,26,cranial nerve development,BP,MAFB;NAV2
4808,GO:0012506,0.608255820689742,0.457955105260901,39,524,vesicle membrane,CC,TAP1;PCDH7;TFRC;GPRC5A;HLA-B;B4GALT1;MGAM;DBNDD2;RAB32;LAMP1;SIRPA;CYB5R1;CADPS2;ITGAV;SFN;ADRB2;SLC5A6;HLA-F;IL7R;GPER1;LGALS3;TRAF2;GLIPR1;LILRB3;YWHAH;TAPBP;M6PR;CD109;HSPA8;RHOG;TAP2;SGSM1;RAPGEF1;RAB27A;WNT4;PTPRB;CLTA;LAIR1;BAIAP2L2
13943,GO:0060612,0.60837624686056,0.673567775757251,2,26,adipose tissue development,BP,CDK4;ARRDC3
12482,GO:0050433,0.608443889562557,0.773599552598631,1,12,regulation of catecholamine secretion,BP,OXTR
13267,GO:0051954,0.6084538453615,0.773590657740581,1,12,positive regulation of amine transport,BP,OXTR
20180,GO:2001026,0.60850611373912,0.773543955235798,1,12,regulation of endothelial cell chemotaxis,BP,HSPB1
7962,GO:0032561,0.608513323816662,0.480966280508703,21,285,guanyl ribonucleotide binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
7950,GO:0032549,0.60888323115445,0.480579785386969,21,285,ribonucleoside binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
4233,GO:0009411,0.608955988201843,0.527009733930586,9,123,response to UV,BP,PML;TP53;CDKN1A;UBE4B;FEN1;RUVBL2;NOC2L;PARP1;TP63
3716,GO:0008234,0.609078370349685,0.514030287381295,11,150,cysteine-type peptidase activity,MF,CYLD;ZC3H12A;USP36;SFRP1;SENP3;USP43;CAPNS1;USP31;TINAGL1;TNFAIP3;OTUD6A
9880,GO:0042147,0.609658430131133,0.572002918007246,5,68,retrograde transport, endosome to Golgi,BP,ARFRP1;GOSR1;DCTN1;SNX8;VPS52
4316,GO:0009798,0.60983816128947,0.592764126305804,4,54,axis specification,BP,SFRP1;SRF;ETS2;CITED2
4620,GO:0010738,0.609898943960493,0.772296891571212,1,12,regulation of protein kinase A signaling,BP,ADRB2
14630,GO:0070198,0.610203937443465,0.671725308323174,2,26,protein localization to chromosome, telomeric region,BP,GNL3L;DKC1
9135,GO:0035458,0.610431736376592,0.771818555858636,1,12,cellular response to interferon-beta,BP,IRF1
14400,GO:0061650,0.610501864231602,0.670992415894981,2,27,ubiquitin-like protein conjugating enzyme activity,MF,UBE2C;UBE2J2
6021,GO:0019079,0.610653421030881,0.543120352676417,7,97,viral genome replication,BP,RSAD2;TNF;ZC3H12A;BANF1;HSPA8;CXCL8;CCL5
15829,GO:0072529,0.610737379011693,0.670754201552453,2,27,pyrimidine-containing compound catabolic process,BP,TET3;SMUG1
4678,GO:0010826,0.611208524948106,0.771119867976779,1,12,negative regulation of centrosome duplication,BP,RBM14
9947,GO:0042307,0.611223396562278,0.670694784110677,2,26,positive regulation of protein import into nucleus,BP,ZC3H12A;HSP90AB1
306,GO:0000815,0.611283170833471,0.771052646213201,1,12,ESCRT III complex,CC,CHMP4B
12019,GO:0047617,0.611340074238328,0.771001392751477,1,12,acyl-CoA hydrolase activity,MF,THEM4
5270,GO:0015918,0.611356823017256,0.591017610140163,4,55,sterol transport,BP,NFKB1;NFKBIA;ABCG2;AKR1C1
2820,GO:0006284,0.611619568048343,0.620914473449954,3,41,base-excision repair,BP,TP53;SMUG1;APEX2
683,GO:0001893,0.611671816266547,0.67024085568432,2,26,maternal placenta development,BP,JUNB;LIF
13641,GO:0060143,0.611675482073878,0.770699119665152,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,EHD1
7283,GO:0031268,0.61189108549569,0.770504663891251,1,12,pseudopodium organization,BP,CDC42EP2
15468,GO:0071804,0.611943025850606,0.554084018869201,6,81,cellular potassium ion transport,BP,FLNA;KCNA7;NEDD4L;KCNIP3;CAB39;OXSR1
15469,GO:0071805,0.611943025850606,0.554084018869201,6,81,potassium ion transmembrane transport,BP,FLNA;KCNA7;NEDD4L;KCNIP3;CAB39;OXSR1
3293,GO:0006984,0.611959560934238,0.620796650044493,3,40,ER-nucleus signaling pathway,BP,TP53;INSIG1;CXCL8
15432,GO:0071702,0.612125164470424,0.424362617254247,144,1931,organic substance transport,BP,SAA1;TRIM16;NRG1;PTGER4;INHBA;FN1;C1QTNF1;SLC16A2;TAP1;IL1R2;NFKBIE;PML;HSPB1;TFRC;CSF2;TGFB2;EDN1;GBP1;RSAD2;APOL6;PANX1;TP53;NFKB1;GNPTAB;IRS1;CDKN1A;ADAMTS9;LYN;RAB32;STOML1;EHD1;TNF;PTPN14;NUP153;SLC7A5;SLC16A9;ZC3H12A;SRSF2;LCP1;CYB5R1;CADPS2;CHP1;ARFRP1;CD274;GOSR1;SLCO3A1;SLC7A5P2;ITGAV;PMM2;SFN;SLC5A6;LSG1;USP36;AKAP8L;SFRP1;PARL;ZDHHC3;GPER1;AP4S1;NFKBIA;RRS1;ZFP36L1;RPLP2;AKAP8;RHOB;SNX12;U2AF2;VPS13B;IRS2;RPLP1;TRAF2;ABCG2;PRKCA;SYK;SLC7A2;OXTR;RPS2;PTTG1IP;ALYREF;PHAX;RPS9;SPTBN1;MYH9;IL1A;TNFRSF21;SNX8;RUNDC1;DDX39A;WDR46;ZW10;ACSL1;NUP214;TRAM2;SLC35A4;SLC35C2;SLC43A2;DNAJC1;YWHAH;TAPBP;M6PR;ZDHHC6;UBE2J2;CEP41;SLC4A11;TANGO2;KCNIP3;THOC1;TGFBRAP1;RPL27A;SOCS1;FRAS1;HSPA8;SLC22A4;CPT1A;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;AKR1C1;VPS52;CD38;SLC4A2;MAPK11;SLC3A2;BMP8A;SLC25A22;SRSF7;CLTA;SNF8;HSP90AB1;SLC2A6;CCL5;MAGOH
10535,GO:0043476,0.612131432019567,0.770287751933644,1,12,pigment accumulation,BP,RAB32
10536,GO:0043482,0.612131432019567,0.770287751933644,1,12,cellular pigment accumulation,BP,RAB32
6657,GO:0030008,0.612310613118366,0.76895346522909,1,13,TRAPP complex,CC,TRAPPC5
8614,GO:0034123,0.612448638675987,0.77000124780102,1,12,positive regulation of toll-like receptor signaling pathway,BP,RSAD2
11250,GO:0045454,0.612592914535476,0.589428848051209,4,57,cell redox homeostasis,BP,TXNRD1;TXN2;GCLC;TXNDC15
3600,GO:0008028,0.612630134468906,0.669269448422069,2,26,monocarboxylic acid transmembrane transporter activity,MF,SLC16A2;SLC16A9
12489,GO:0050482,0.612680109465694,0.769792018613504,1,12,arachidonic acid secretion,BP,SYK
18650,GO:1903963,0.612680109465694,0.769792018613504,1,12,arachidonate transport,BP,SYK
5281,GO:0015934,0.612720659267259,0.53996668115565,7,115,large ribosomal subunit,CC,GEMIN5;RPLP2;RPLP1;MRPL20;RPL27A;MRPL33;SURF6
9443,GO:0036020,0.612785375097586,0.769696822375247,1,12,endolysosome membrane,CC,CLTA
13954,GO:0060644,0.613146200308163,0.769370297132762,1,12,mammary gland epithelial cell differentiation,BP,ZNF703
11360,GO:0045717,0.613278803068983,0.769250215681016,1,12,negative regulation of fatty acid biosynthetic process,BP,INSIG1
15607,GO:0072091,0.61353339849898,0.619155817137883,3,40,regulation of stem cell proliferation,BP,SNAI2;ZFP36L1;HNRNPU
11687,GO:0046470,0.613699999397068,0.58855170647614,4,55,phosphatidylcholine metabolic process,BP,PLBD1;ABHD4;LPCAT3;PCYT1A
18109,GO:1902749,0.613766518895062,0.495149322496398,14,195,regulation of cell cycle G2/M phase transition,BP,TP53;PBX1;PSMB9;CDK4;PSME2;FGFR1OP;GPR132;DCTN1;ORAOV1;RCC2;CLASP1;CEP41;TUBB;PSMC3
7415,GO:0031503,0.613803756026892,0.488214738041913,16,219,protein-containing complex localization,BP,KLHL21;NUP153;SRSF2;AKAP8L;RRS1;U2AF2;ALYREF;WDR34;DDX39A;RCC2;NUP214;SMAD7;THOC1;EIF5A;SRSF7;MAGOH
12677,GO:0050885,0.613882766032281,0.667996998541278,2,26,neuromuscular process controlling balance,BP,NEFL;CNTNAP1
9083,GO:0035333,0.613898149892227,0.768688754381281,1,12,Notch receptor processing, ligand-dependent,BP,APH1A
10912,GO:0044458,0.613980447941124,0.768614073926422,1,12,motile cilium assembly,BP,CC2D2A
2369,GO:0005496,0.614154585919289,0.588072410092544,4,55,steroid binding,MF,GPER1;AKR1C2;ESR1;AKR1C1
15042,GO:0070986,0.61436692432848,0.768263137282851,1,12,left/right axis specification,BP,CITED2
4713,GO:0010875,0.614790214189279,0.767878331428072,1,12,positive regulation of cholesterol efflux,BP,NFKBIA
7712,GO:0032201,0.615174547834454,0.666245928894475,2,27,telomere maintenance via semi-conservative replication,BP,FEN1;POLA1
5995,GO:0019001,0.615249537039534,0.473902076629409,21,286,guanyl nucleotide binding,MF,GBP1;RAB32;EHD1;GNL3L;EIF5;ARFRP1;GTPBP6;LSG1;RHOB;TSR1;LANCL2;GPN1;ERAL1;RRAD;RHOG;URGCP;EFTUD2;RAB27A;TUBB;HSP90AB1;IRGQ
4148,GO:0009209,0.615263965635282,0.766264213116483,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,CTPS1
2788,GO:0006221,0.615413265583499,0.665598908928269,2,28,pyrimidine nucleotide biosynthetic process,BP,TYMS;CTPS1
10555,GO:0043508,0.615659549828429,0.767086584486052,1,12,negative regulation of JUN kinase activity,BP,SFRP1
4220,GO:0009394,0.615837485040867,0.665165364090928,2,28,2'-deoxyribonucleotide metabolic process,BP,TYMS;SMUG1
15214,GO:0071360,0.615974172508609,0.766799561272732,1,12,cellular response to exogenous dsRNA,BP,PQBP1
12769,GO:0051044,0.615983658851618,0.766790903120945,1,12,positive regulation of membrane protein ectodomain proteolysis,BP,TNF
12094,GO:0048070,0.616115492534366,0.766670554915018,1,12,regulation of developmental pigmentation,BP,ADAMTS9
14915,GO:0070742,0.616159670162011,0.76663021603091,1,12,C2H2 zinc finger domain binding,MF,U2AF2
12878,GO:0051208,0.61636495667567,0.564806177012393,5,69,sequestering of calcium ion,BP,JPH2;LYN;JPH1;GPER1;NOL3
3757,GO:0008298,0.616417877460777,0.766394344246247,1,12,intracellular mRNA localization,BP,ZFP36L1
7127,GO:0030950,0.616603505776559,0.766224666584805,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOB
15480,GO:0071824,0.616726579500902,0.484824318994763,16,237,protein-DNA complex subunit organization,BP,TP53;TAF4B;DAXX;MCM2;GRWD1;UBTF;ESR1;CENPN;GTF2E1;CENPO;IPO4;CHAF1A;PSMC3;SMARCC2;SUPT16H;PARP1
7149,GO:0031000,0.616756585451556,0.766084673592977,1,12,response to caffeine,BP,TP53
9536,GO:0036270,0.616756585451556,0.766084673592977,1,12,response to diuretic,BP,TP53
11817,GO:0046710,0.617113473354498,0.765758060002422,1,12,GDP metabolic process,BP,TJP2
16599,GO:0097421,0.617152317432788,0.66422402028301,2,27,liver regeneration,BP,TYMS;NFKBIA
10780,GO:0044233,0.617200024861002,0.765678800786336,1,12,ER-mitochondrion membrane contact site,CC,RAB32
4283,GO:0009650,0.617295720015113,0.765591145690256,1,12,UV protection,BP,FEN1
4196,GO:0009303,0.617454125639383,0.663914798285104,2,27,rRNA transcription,BP,CD3EAP;GTF3C2
11822,GO:0046716,0.617581463812215,0.765329267913667,1,12,muscle cell cellular homeostasis,BP,SRF
9056,GO:0035278,0.61771433974927,0.76520741788691,1,12,miRNA mediated inhibition of translation,BP,RBM4
9806,GO:0040033,0.61771433974927,0.76520741788691,1,12,negative regulation of translation, ncRNA-mediated,BP,RBM4
11497,GO:0045974,0.61771433974927,0.76520741788691,1,12,regulation of translation, ncRNA-mediated,BP,RBM4
10352,GO:0043161,0.618314073321736,0.460328750746375,27,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PML;SPSB1;TP53;UBQLN2;PSMB9;UBE2C;UBE4B;RNF19B;PSME2;ABTB2;KCTD10;NSFL1C;NEDD4L;RNF115;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;HERC2;RNF7;RNF185;PSMC3;RNF144B;GCLC;HSP90AB1
7791,GO:0032331,0.618371593538493,0.764604027475188,1,12,negative regulation of chondrocyte differentiation,BP,SNAI2
15751,GO:0072337,0.618397604518991,0.764580125037085,1,12,modified amino acid transport,BP,SLC5A6
29,GO:0000054,0.618429520830415,0.763356722313101,1,13,ribosomal subunit export from nucleus,BP,RRS1
8524,GO:0033750,0.618429520830415,0.763356722313101,1,13,ribosome localization,BP,RRS1
7336,GO:0031346,0.618434790096013,0.475088518767126,19,257,positive regulation of cell projection organization,BP,NRG1;FN1;NEFL;TENM3;LYN;BAIAP2;CORO1C;ENC1;L1CAM;CDC42EP2;TNFRSF12A;ZFYVE27;SRF;NTN1;ROBO1;NEDD4L;DPYSL3;BMP7;RAPGEF1
6057,GO:0019205,0.618599189568881,0.613382269212168,3,42,nucleobase-containing compound kinase activity,MF,TJP2;TK1;NOL9
4681,GO:0010829,0.618773368974754,0.764234624838953,1,12,negative regulation of glucose transmembrane transport,BP,TNF
4499,GO:0010524,0.619645982003913,0.661663694823481,2,27,positive regulation of calcium ion transport into cytosol,BP,JPH2;GPER1
5397,GO:0016234,0.619658101729676,0.561414112866377,5,68,inclusion body,CC,NEFM;SQSTM1;NUP153;URB2;HSP90AB1
4896,GO:0014823,0.619864262165981,0.612275937560654,3,41,response to activity,BP,EDN1;MTFP1;GCLC
7236,GO:0031143,0.61991921086694,0.763178796485454,1,12,pseudopodium,CC,ACTN4
11923,GO:0046966,0.61996446790278,0.661335807828682,2,27,thyroid hormone receptor binding,MF,FUS;TRIP6
7872,GO:0032433,0.620204287704277,0.762915581589731,1,12,filopodium tip,CC,MYO10
1987,GO:0004707,0.620273094804382,0.762852019315036,1,12,MAP kinase activity,MF,MAPK11
16724,GO:0097722,0.620367818146847,0.660920262336316,2,27,sperm motility,BP,CCR6;TTLL5
15342,GO:0071564,0.620604358296959,0.762545832959893,1,12,npBAF complex,CC,SMARCC2
19942,GO:2000479,0.620876878005943,0.762293727917297,1,12,regulation of cAMP-dependent protein kinase activity,BP,ADRB2
12737,GO:0051000,0.620980730700805,0.762197603688701,1,12,positive regulation of nitric-oxide synthase activity,BP,DHFR
16946,GO:0098927,0.62102569205819,0.611050076328214,3,41,vesicle-mediated transport between endosomal compartments,BP,EMP2;SNX12;SNF8
5304,GO:0016010,0.621048763891556,0.762134618032492,1,12,dystrophin-associated glycoprotein complex,CC,DAG1
16365,GO:0090665,0.621048763891556,0.762134618032492,1,12,glycoprotein complex,CC,DAG1
4582,GO:0010667,0.621134230354305,0.762055475313894,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,NOL3
10342,GO:0043138,0.621151722115604,0.762039275422119,1,12,3'-5' DNA helicase activity,MF,GINS2
13110,GO:0051645,0.621521355155742,0.761696754210675,1,12,Golgi localization,BP,TBCCD1
2287,GO:0005245,0.621533587594463,0.761685412865205,1,12,voltage-gated calcium channel activity,MF,ITGAV
3325,GO:0007032,0.621617252006332,0.559214932222739,5,69,endosome organization,BP,SQSTM1;ANXA8;CHMP4B;RAB27A;SNF8
954,GO:0002374,0.621710605101577,0.761521246503691,1,12,cytokine secretion involved in immune response,BP,TNF
991,GO:0002448,0.621868953303259,0.659370897002093,2,27,mast cell mediated immunity,BP,LYN;SYK
3542,GO:0007549,0.621944446604777,0.761304255233513,1,12,dosage compensation,BP,HNRNPU
5464,GO:0016358,0.622135353814037,0.495055736131075,12,163,dendrite development,BP,NRG1;MAP2;BAIAP2;KLF7;DOCK10;NEDD4L;SDK1;YWHAH;PQBP1;ZNF365;BMP7;EFNA1
4769,GO:0010954,0.622232238309205,0.76103700395526,1,12,positive regulation of protein processing,BP,MYH9
8916,GO:0034755,0.622305573842189,0.760968867727021,1,12,iron ion transmembrane transport,BP,STEAP4
6076,GO:0019228,0.622440848309435,0.760843146739592,1,12,neuronal action potential,BP,GPER1
8993,GO:0035102,0.622458570106718,0.76082667293845,1,12,PRC1 complex,CC,RING1
4812,GO:0014003,0.622747047888754,0.658462507796422,2,27,oligodendrocyte development,BP,LYN;CNTNAP1
19957,GO:2000515,0.622901915042955,0.760414279789147,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,SMAD7
15343,GO:0071565,0.623350101664614,0.75999685621995,1,12,nBAF complex,CC,SMARCC2
11065,GO:0045063,0.623406522664573,0.759944270330346,1,12,T-helper 1 cell differentiation,BP,RELB
3342,GO:0007059,0.623439466941851,0.463262450403843,22,301,chromosome segregation,BP,UBE2C;KIF23;AKAP8L;RRS1;AKAP8;FEN1;SFPQ;ZW10;RCC2;HNRNPU;CLASP1;ANAPC15;DUSP1;CENPN;RCC1;CHMP4B;CENPO;INCENP;KIF22;BRIP1;CDCA5;MKI67
13211,GO:0051861,0.623608545392928,0.759755910775461,1,12,glycolipid binding,MF,LYN
7016,GO:0030728,0.623947670697568,0.759439478694037,1,12,ovulation,BP,INHBA
15565,GO:0072010,0.624061225325823,0.759333454837648,1,12,glomerular epithelium development,BP,MYO1E
11922,GO:0046965,0.624365078893826,0.759049584590462,1,12,retinoid X receptor binding,MF,FUS
13273,GO:0051960,0.62462300333387,0.439380605053508,41,548,regulation of nervous system development,BP,NRG1;MAP2;FN1;NEFL;TENM3;LYN;BAIAP2;EFNB2;ENC1;PBX1;FLNA;BMP2;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;WDR1;GPER1;SRF;SRRT;PRPF19;NTN1;ROBO1;OXTR;NEDD4L;DPYSL3;SDK1;TNFRSF21;SEMA3C;SPEN;YWHAH;PQBP1;PARD3;ZNF365;ZSWIM6;BMP7;RAPGEF1;DAG1;CTDSP1;EFNA1
9995,GO:0042405,0.624885538952355,0.758562785173724,1,12,nuclear inclusion body,CC,NUP153
16140,GO:0090148,0.624970668716607,0.758483092835208,1,12,membrane fission,BP,CHMP4B
13578,GO:0060045,0.624991136691159,0.758463929329096,1,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR2
17889,GO:1902170,0.625115507826516,0.758347460743192,1,12,cellular response to reactive nitrogen species,BP,TRAF2
14207,GO:0061136,0.62520120884576,0.496852330727701,11,153,regulation of proteasomal protein catabolic process,BP,UBQLN2;RNF19B;PSME2;SMAD7;KEAP1;TRIB1;HSPBP1;PSMC3;RNF144B;GCLC;HSP90AB1
13949,GO:0060628,0.62530034389176,0.758174293340891,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,INSIG1
13802,GO:0060391,0.625435813792519,0.758047318030147,1,12,positive regulation of SMAD protein signal transduction,BP,PARP1
817,GO:0002089,0.625718060506324,0.757782612903939,1,12,lens morphogenesis in camera-type eye,BP,EPHA2
4901,GO:0014829,0.625721477331777,0.757779407137134,1,12,vascular smooth muscle contraction,BP,EDN1
11769,GO:0046626,0.62585839966045,0.605925318669664,3,41,regulation of insulin receptor signaling pathway,BP,IRS1;CDK4;SOCS1
9503,GO:0036150,0.625986783617985,0.757530394116617,1,12,phosphatidylserine acyl-chain remodeling,BP,LPCAT3
8015,GO:0032648,0.626116690447111,0.605650327201658,3,41,regulation of interferon-beta production,BP,RELB;TRAF3;IRF1
12386,GO:0048799,0.626184329401422,0.757344858612829,1,12,animal organ maturation,BP,BMP2
16162,GO:0090179,0.626348561241264,0.757190532579739,1,12,planar cell polarity pathway involved in neural tube closure,BP,SFRP1
260,GO:0000726,0.626468194163633,0.553516006760769,5,74,non-recombinational repair,BP,TFIP11;PRPF19;POLA1;HERC2;XRCC6
1979,GO:0004697,0.626657615015178,0.756899924907865,1,12,protein kinase C activity,MF,PRKCA
9347,GO:0035855,0.626716860353659,0.756844186598731,1,12,megakaryocyte development,BP,SRF
1870,GO:0004535,0.626759264449294,0.756804286869881,1,12,poly(A)-specific ribonuclease activity,MF,NOCT
17292,GO:0140058,0.627019347783617,0.756559459041203,1,12,neuron projection arborization,BP,ZNF365
5483,GO:0016417,0.627029033427384,0.654010662216364,2,27,S-acyltransferase activity,MF,ZDHHC3;ZDHHC6
1389,GO:0003299,0.627055392915252,0.756525513944422,1,12,muscle hypertrophy in response to stress,BP,ERRFI1
4930,GO:0014887,0.627055392915252,0.756525513944422,1,12,cardiac muscle adaptation,BP,ERRFI1
4938,GO:0014898,0.627055392915252,0.756525513944422,1,12,cardiac muscle hypertrophy in response to stress,BP,ERRFI1
14137,GO:0061003,0.627062388013038,0.756518925987732,1,12,positive regulation of dendritic spine morphogenesis,BP,BAIAP2
5961,GO:0018345,0.627374716114517,0.653649658061785,2,27,protein palmitoylation,BP,ZDHHC3;ZDHHC6
372,GO:0000993,0.6276223261508,0.653390925095529,2,27,RNA polymerase II core binding,MF,HNRNPU;GTF2E1
11716,GO:0046513,0.628037271536231,0.603602074267333,3,41,ceramide biosynthetic process,BP,CYR61;TNF;SMPD2
11770,GO:0046627,0.628323780414682,0.652657288118602,2,27,negative regulation of insulin receptor signaling pathway,BP,IRS1;SOCS1
10432,GO:0043277,0.628675979854846,0.65228855449318,2,27,apoptotic cell clearance,BP,ITGAV;RHOG
3904,GO:0008543,0.629216190401489,0.535403265866439,6,84,fibroblast growth factor receptor signaling pathway,BP,CTGF;FGFR2;SPRY4;HNRNPF;WNT4;POLR2G
7342,GO:0031369,0.629581389880171,0.650925977674032,2,28,translation initiation factor binding,MF,EIF3B;POLR2G
10431,GO:0043276,0.629764002136741,0.651147867230596,2,27,anoikis,BP,SNAI2;BRMS1
2943,GO:0006470,0.629923773742176,0.465433916977511,18,246,protein dephosphorylation,BP,IGFBP3;DUSP14;SH3RF2;NUAK1;TNF;PTPN14;PPP1R3B;NSFL1C;PPP1R14C;PPP1R9B;DUSP1;PHLPP1;CTDSP1;PTPRB;DUSP8;HSP90AB1;SWAP70;PHACTR4
2818,GO:0006282,0.630080497683822,0.534552856300449,6,83,regulation of DNA repair,BP,PML;TFIP11;NPAS2;ZNF365;TIMELESS;PARP1
2675,GO:0006027,0.630274489363468,0.601208355473266,3,41,glycosaminoglycan catabolic process,BP,SDC4;HSPG2;CHP1
12366,GO:0048747,0.63031009925024,0.65057443140178,2,27,muscle fiber development,BP,HDAC9;BIN3
9729,GO:0038179,0.63126725196828,0.64956789925681,2,27,neurotrophin signaling pathway,BP,ZFYVE27;RAPGEF1
5986,GO:0018904,0.631551968940172,0.751022979115804,1,13,ether metabolic process,BP,TXN2
7194,GO:0031083,0.632439319391965,0.750172342898765,1,13,BLOC-1 complex,CC,BLOC1S2
10885,GO:0044424,0.632699931801616,0.405095191601026,789,10389,intracellular part,CC,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;FANCC;ARFRP1;PITHD1;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;RRP12;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;IQCJ-SCHIP1;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;PREP;IFFO2;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NBPF1;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;SNIP1;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;CGNL1;POLR3H;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;RRM2;SUPT16H;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;BIN3;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;PHACTR4;TOP3A;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
3800,GO:0008378,0.632703670171898,0.648053873989462,2,27,galactosyltransferase activity,MF,B4GALT1;COLGALT1
1527,GO:0003906,0.632932027507229,0.749699098846924,1,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,APEX2
7217,GO:0031111,0.633007817086846,0.647732754189691,2,27,negative regulation of microtubule polymerization or depolymerization,BP,MID1;CLASP1
12269,GO:0048562,0.633256087321162,0.483131112287516,12,165,embryonic organ morphogenesis,BP,MAFB;FBN1;EDN1;FGFR2;SLC39A1;OSR2;SRF;NTN1;INSIG1;BMP7;EFNA1;PHACTR4
2101,GO:0004869,0.633612651842813,0.646290832378495,2,29,cysteine-type endopeptidase inhibitor activity,MF,BIRC3;NOL3
6925,GO:0030517,0.63401087809904,0.646672376228702,2,27,negative regulation of axon extension,BP,NTN1;SEMA3C
16183,GO:0090201,0.634094672673478,0.748579767533369,1,13,negative regulation of release of cytochrome c from mitochondria,BP,NOL3
7790,GO:0032330,0.634145245693885,0.64653017408966,2,27,regulation of chondrocyte differentiation,BP,CTGF;SNAI2
694,GO:0001914,0.635101458216231,0.747607513275372,1,13,regulation of T cell mediated cytotoxicity,BP,IL7R
3948,GO:0008645,0.635191215719409,0.54459973676835,5,69,hexose transmembrane transport,BP,IRS1;TNF;IRS2;M6PR;SLC2A6
6527,GO:0021915,0.635234478797107,0.498947943942621,9,124,neural tube development,BP,ADM;SDC4;TGFB2;SFRP1;CC2D2A;ZFP36L1;SEMA3C;BMP7;PHACTR4
9451,GO:0036038,0.635265533333809,0.747448803331417,1,13,MKS complex,CC,CC2D2A
6542,GO:0021954,0.63563301878523,0.595209523972544,3,42,central nervous system neuron development,BP,MAP2;FGFR2;ROBO1
5683,GO:0016798,0.635807007171718,0.528276608114836,6,84,hydrolase activity, acting on glycosyl bonds,MF,MGAM;GANC;GBE1;MANEAL;SMUG1;CD38
617,GO:0001786,0.635854192480795,0.644718351205395,2,27,phosphatidylserine binding,MF,JPH2;HSPA8
8345,GO:0033194,0.636105263079533,0.746635378853617,1,13,response to hydroperoxide,BP,CD38
6628,GO:0022884,0.636366758713906,0.745307936928178,1,14,macromolecule transmembrane transporter activity,MF,TOMM40
8116,GO:0032802,0.636598242371364,0.746156942193799,1,13,low-density lipoprotein particle receptor catabolic process,BP,CLTA
12060,GO:0048008,0.636619700107279,0.594373404338225,3,41,platelet-derived growth factor receptor signaling pathway,BP,PDGFB;RAPGEF1;MYO1E
9209,GO:0035591,0.636625067072178,0.564010413256808,4,55,signaling adaptor activity,MF,IRS1;AFAP1L2;CNTNAP1;BLNK
2721,GO:0006099,0.636966710626181,0.643116969561621,2,28,tricarboxylic acid cycle,BP,ACO1;CS
4201,GO:0009309,0.636978854588725,0.745787101396264,1,13,amine biosynthetic process,BP,ODC1
9992,GO:0042401,0.636978854588725,0.745787101396264,1,13,cellular biogenic amine biosynthetic process,BP,ODC1
4810,GO:0012510,0.637132334661062,0.745637852205529,1,13,trans-Golgi network transport vesicle membrane,CC,CLTA
19417,GO:1990000,0.637211487615466,0.745560855888239,1,13,amyloid fibril formation,BP,CRYAB
616,GO:0001784,0.637279847849577,0.643202275647262,2,27,phosphotyrosine residue binding,MF,IRS1;SYK
20280,GO:2001251,0.637339890787029,0.504753265615791,8,111,negative regulation of chromosome organization,BP,GNL3L;NAT10;ZW10;HNRNPU;ANAPC15;DUSP1;NOC2L;PARP1
8163,GO:0032892,0.637344957096291,0.745430983943162,1,13,positive regulation of organic acid transport,BP,EDN1
138,GO:0000288,0.63738348861333,0.541903360220492,5,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,NOCT;ZFP36L1;ZFP36L2;EDC4;POLR2G
7999,GO:0032620,0.637400127141637,0.74537728663206,1,13,interleukin-17 production,BP,IL15
5509,GO:0016460,0.637597746365157,0.745184873987579,1,13,myosin II complex,CC,MYH9
6728,GO:0030140,0.637613529339016,0.642427715373888,2,28,trans-Golgi network transport vesicle,CC,SPG21;CLTA
15056,GO:0071007,0.638314753487123,0.641290051654335,2,29,U2-type catalytic step 2 spliceosome,CC,PRPF19;EFTUD2
5733,GO:0016879,0.638502408708796,0.592100275986611,3,42,ligase activity, forming carbon-nitrogen bonds,MF,CTPS1;GCLC;TTLL5
4200,GO:0009308,0.638750478357462,0.524697863656387,6,89,amine metabolic process,BP,ODC1;NQO1;CYP1A1;PSMB9;PSME2;PSMC3
9988,GO:0042391,0.639020695683016,0.468319254952758,14,194,regulation of membrane potential,BP,EDN1;PANK2;BAIAP2;FLNA;ADRB2;WDR1;GPER1;NEDD4L;SMAD7;YWHAH;JUN;CNTNAP1;GCLC;PARP1
16263,GO:0090316,0.639129333214421,0.481883667174165,11,154,positive regulation of intracellular protein transport,BP,NRG1;TP53;ZC3H12A;CYB5R1;CHP1;SFN;USP36;WDR46;UBE2J2;SNIP1;HSP90AB1
11372,GO:0045737,0.63918363932893,0.640750999745296,2,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,ADAM17;PDGFB
1912,GO:0004602,0.639247795708141,0.741556744796509,1,15,glutathione peroxidase activity,MF,GPX4
13514,GO:0055085,0.63956704749241,0.41162345974699,64,869,transmembrane transport,BP,MMP9;SLC16A2;JPH2;TAP1;ABCF1;G6PD;PANX1;STEAP4;IRS1;LYN;TNF;PSMB9;SLC7A5;SLC16A9;JPH1;SLC39A1;FLNA;CHP1;TSC22D3;SLCO3A1;SLC7A5P2;ITGAV;ADRB2;SLC5A6;FXYD3;EBP;PARL;WDR1;PSME2;GPER1;KCNA7;SGK1;IRS2;ABCG2;SLC7A2;SLC43A3;NEDD4L;COX5B;SLC35A4;SLC35C2;SLC43A2;YWHAH;M6PR;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;HSPA8;SLC22A4;CPT1A;TAP2;ACTN4;TOMM40;SLC41A2;RNF185;PSMC3;SLC4A2;SLC3A2;SLC25A22;SLC25A44;NOL3;SLC2A6
17428,GO:1900182,0.64013312237385,0.560036295805229,4,56,positive regulation of protein localization to nucleus,BP,ZC3H12A;LIF;CARD10;HSP90AB1
17043,GO:0099518,0.640700260552062,0.589709199310627,3,42,vesicle cytoskeletal trafficking,BP,KIF23;BLOC1S2;ACTN4
3055,GO:0006614,0.640786525105116,0.536702326160734,5,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPLP2;RPLP1;RPS2;RPS9;RPL27A
1218,GO:0002888,0.640903749923942,0.741949973025524,1,13,positive regulation of myeloid leukocyte mediated immunity,BP,SYK
10995,GO:0044794,0.641189167628375,0.741669272612168,1,13,positive regulation by host of viral process,BP,HSPA8
11759,GO:0046606,0.641532714632775,0.741331102872474,1,13,negative regulation of centrosome cycle,BP,RBM14
13640,GO:0060142,0.641601941256173,0.741262919995242,1,13,regulation of syncytium formation by plasma membrane fusion,BP,EHD1
10284,GO:0043029,0.641702212516032,0.638050744590745,2,28,T cell homeostasis,BP,TSC22D3;FOXN1
15553,GO:0071985,0.642339317179578,0.637365588604623,2,28,multivesicular body sorting pathway,BP,RAB27A;SNF8
8975,GO:0035064,0.642361652692132,0.557597874871444,4,56,methylated histone binding,MF,CBX5;UHRF1;RBBP5;MPHOSPH8
17285,GO:0140034,0.642361652692132,0.557597874871444,4,56,methylation-dependent protein binding,MF,CBX5;UHRF1;RBBP5;MPHOSPH8
2206,GO:0005092,0.64255460676282,0.740323260163887,1,13,GDP-dissociation inhibitor activity,MF,SH3BP4
19768,GO:2000177,0.642694301679755,0.587532684833379,3,42,regulation of neural precursor cell proliferation,BP,LYN;FLNA;RAPGEF1
3107,GO:0006684,0.642733378749474,0.740146646281043,1,13,sphingomyelin metabolic process,BP,SMPD2
16670,GO:0097553,0.642771081057844,0.536120411361568,5,71,calcium ion transmembrane import into cytosol,BP,JPH2;LYN;JPH1;GPER1;NOL3
4412,GO:0010171,0.643161722426641,0.587021501079236,3,42,body morphogenesis,BP,CLASP1;PHLDB2;DAG1
13284,GO:0051972,0.643200793540914,0.586978754818264,3,42,regulation of telomerase activity,BP,TP53;DKC1;HSP90AB1
1785,GO:0004407,0.643905168848177,0.586207672233017,3,42,histone deacetylase activity,MF,HDAC9;BRMS1;MTA2
7508,GO:0031690,0.643937748092027,0.738954484085596,1,13,adrenergic receptor binding,MF,ARRDC3
8039,GO:0032688,0.644103497104839,0.738790096675336,1,13,negative regulation of interferon-beta production,BP,RELB
2584,GO:0005876,0.64420113097618,0.555579564440202,4,56,spindle microtubule,CC,KLHL21;ZW10;HNRNPU;CLASP1
7041,GO:0030814,0.644384101413998,0.635160852680824,2,28,regulation of cAMP metabolic process,BP,ADM;GPER1
17923,GO:1902236,0.644404462675464,0.738491406229774,1,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,CREB3
8433,GO:0033540,0.644718027841634,0.738179940611081,1,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,ACAA1
8228,GO:0032988,0.64498707978408,0.737912469660857,1,13,ribonucleoprotein complex disassembly,BP,TFIP11
7077,GO:0030865,0.645611486821948,0.584336205248632,3,42,cortical cytoskeleton organization,BP,TNF;KIF23;WDR1
5475,GO:0016408,0.645628492308065,0.737274003669986,1,13,C-acyltransferase activity,MF,ACAA1
4147,GO:0009208,0.64563302531923,0.736167608585167,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,CTPS1
10672,GO:0043902,0.64587572765066,0.48036695967802,10,143,positive regulation of multi-organism process,BP,INHBA;NELFE;PRKCA;OXTR;SUPT5H;HSPA8;JUN;CHMP4B;POLR2G;CCL5
5169,GO:0015721,0.645922625398617,0.736980833731092,1,13,bile acid and bile salt transport,BP,AKR1C1
9387,GO:0035924,0.646328850655336,0.633055838572449,2,28,cellular response to vascular endothelial growth factor stimulus,BP,HSPB1;ROBO1
5703,GO:0016831,0.646453550659216,0.632920590587859,2,28,carboxy-lyase activity,MF,ODC1;GGCX
7571,GO:0031932,0.646760772567125,0.736144090428389,1,13,TORC2 complex,CC,TELO2
10069,GO:0042562,0.646996183966604,0.582591003834782,3,43,hormone binding,MF,INHBA;GPER1;OXTR
12228,GO:0048485,0.647560672869111,0.735343675256665,1,13,sympathetic nervous system development,BP,TP63
4460,GO:0010453,0.647570214343223,0.735334116690497,1,13,regulation of cell fate commitment,BP,FGFR2
17825,GO:1901983,0.647720363680417,0.551557639997047,4,57,regulation of protein acetylation,BP,LIF;SNAI2;RUVBL2;NOC2L
11895,GO:0046915,0.648053496693788,0.631182397753008,2,28,transition metal ion transmembrane transporter activity,MF,TFRC;SLC39A1
5186,GO:0015749,0.648058157778887,0.530413351849076,5,70,monosaccharide transmembrane transport,BP,IRS1;TNF;IRS2;M6PR;SLC2A6
5685,GO:0016801,0.648095446941668,0.734807544429068,1,13,hydrolase activity, acting on ether bonds,MF,C9ORF3
20125,GO:2000811,0.648249072544963,0.734653378812947,1,13,negative regulation of anoikis,BP,SNAI2
2849,GO:0006334,0.648629068702464,0.501201691237927,7,116,nucleosome assembly,BP,DAXX;MCM2;GRWD1;CENPN;CENPO;IPO4;CHAF1A
11627,GO:0046329,0.648644320745054,0.630539153571474,2,28,negative regulation of JNK cascade,BP,MARVELD3;SFRP1
17365,GO:1900077,0.648686103243054,0.63049363597293,2,28,negative regulation of cellular response to insulin stimulus,BP,IRS1;SOCS1
12954,GO:0051321,0.648750744553145,0.471497482732519,11,153,meiotic cell cycle,BP,LFNG;LIF;NSUN2;ZFP42;MYH9;ORAOV1;ZW10;DUSP1;WNT4;BRIP1;TOP3A
7237,GO:0031145,0.64892802807102,0.528777517373909,5,77,anaphase-promoting complex-dependent catabolic process,BP,PSMB9;UBE2C;PSME2;ANAPC15;PSMC3
9087,GO:0035338,0.648951670649283,0.733947455064152,1,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL1
6670,GO:0030030,0.649086222154519,0.397265041220365,78,1044,cell projection organization,BP,NRG1;MAP2;FN1;NEFL;TENM3;ADM;NEFM;CYLD;SDC4;DBNDD2;EMP2;LYN;EHD1;BAIAP2;EFNB2;CORO1C;ENC1;TNC;GPRIN1;PDPN;FGFR2;FLNA;KLF7;EPHA2;ICAM1;UBE4B;L1CAM;MYO10;CDC42EP2;TNFRSF12A;SFRP1;TPM1;ZFYVE27;CC2D2A;SRF;DOCK10;SGK1;DHFR;FGFR1OP;VCL;IRS2;PRKCA;NTN1;ROBO1;AJUBA;WDR34;SPTBN1;NEDD4L;DCTN1;DPYSL3;MYH9;SDK1;SEMA3C;RCC2;YWHAH;ENAH;CLASP1;PQBP1;CEP41;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;ZSWIM6;CNTNAP1;EFNB1;KIF24;LRFN4;BMP7;RAPGEF1;DAG1;RILPL2;TUBB;EFNA1;TTLL5;BIN3
11375,GO:0045740,0.649359619718998,0.579984215226126,3,43,positive regulation of DNA replication,BP,CSF2;PDGFB;JUN
4354,GO:0009948,0.649723937980969,0.629361836591989,2,28,anterior/posterior axis specification,BP,SRF;ETS2
11622,GO:0046324,0.649736304238822,0.579791284318638,3,42,regulation of glucose import,BP,IRS1;TNF;IRS2
5761,GO:0016925,0.650049763058428,0.512616592693111,6,85,protein sumoylation,BP,GNL3L;ZBED1;NUP153;EGR1;NUP214;INCENP
2685,GO:0006047,0.650916470777006,0.731965876537314,1,13,UDP-N-acetylglucosamine metabolic process,BP,UAP1L1
3111,GO:0006688,0.651055266016652,0.73182547824133,1,13,glycosphingolipid biosynthetic process,BP,ST6GALNAC5
7143,GO:0030983,0.651311149328548,0.731566494657612,1,13,mismatched DNA binding,MF,APTX
15285,GO:0071467,0.651361179453757,0.731515836404394,1,13,cellular response to pH,BP,CHP1
9771,GO:0039535,0.65138693277819,0.731489756945324,1,13,regulation of RIG-I signaling pathway,BP,BIRC3
13084,GO:0051592,0.651550492955012,0.510960443646369,6,85,response to calcium ion,BP,PTGES;EDN1;JUNB;FUS;DUSP1;JUN
8962,GO:0035025,0.651702965269674,0.731169567149373,1,13,positive regulation of Rho protein signal transduction,BP,ROBO1
5214,GO:0015813,0.651884287215874,0.730985730381105,1,13,L-glutamate transmembrane transport,BP,SLC25A22
7309,GO:0031312,0.651960999616358,0.626914441139743,2,28,extrinsic component of organelle membrane,CC,PML;ZC3H12A
18349,GO:1903319,0.652057345859209,0.730810183332407,1,13,positive regulation of protein maturation,BP,MYH9
14846,GO:0070588,0.652193489350823,0.467717005127734,11,154,calcium ion transmembrane transport,BP,JPH2;G6PD;PANX1;LYN;JPH1;ITGAV;PARL;GPER1;RRAD;STAC;NOL3
12243,GO:0048515,0.6521938481276,0.525633264155843,5,72,spermatid differentiation,BP,PANK2;NSUN2;CCR6;BRIP1;TTLL5
5533,GO:0016514,0.652249162012222,0.730615508359618,1,13,SWI/SNF complex,CC,SMARCC2
4256,GO:0009583,0.652328052921016,0.62651185694425,2,28,detection of light stimulus,BP,NMT2;PDE6A
4659,GO:0010804,0.6523490527709,0.729391778726933,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,NOL3
2328,GO:0005343,0.652463918860021,0.730397425080809,1,13,organic acid:sodium symporter activity,MF,SLC25A22
10410,GO:0043247,0.652652595724402,0.730205716092646,1,13,telomere maintenance in response to DNA damage,BP,TFIP11
11351,GO:0045683,0.652811646778396,0.730044029296952,1,13,negative regulation of epidermis development,BP,TP63
18781,GO:1904294,0.652884705738836,0.729969735174013,1,13,positive regulation of ERAD pathway,BP,UBQLN2
606,GO:0001774,0.653000499168761,0.729851952551133,1,13,microglial cell activation,BP,JUN
6442,GO:0021756,0.653132842063432,0.729717288776041,1,13,striatum development,BP,INHBA
6915,GO:0030506,0.653155840242557,0.729693882123807,1,13,ankyrin binding,MF,SPTBN1
1471,GO:0003727,0.653332497247288,0.52447251987594,5,71,single-stranded RNA binding,MF,PABPC4;U2AF2;HNRNPU;HNRNPF;POLR2G
13281,GO:0051968,0.653455558558498,0.729388700802187,1,13,positive regulation of synaptic transmission, glutamatergic,BP,OXTR
6779,GO:0030214,0.653554463416406,0.72928793623199,1,13,hyaluronan catabolic process,BP,CHP1
3928,GO:0008608,0.653586032545779,0.625129916797482,2,28,attachment of spindle microtubules to kinetochore,BP,RCC2;HNRNPU
6983,GO:0030659,0.653645920686189,0.412038189594543,37,507,cytoplasmic vesicle membrane,CC,TAP1;PCDH7;TFRC;GPRC5A;HLA-B;B4GALT1;MGAM;DBNDD2;RAB32;LAMP1;SIRPA;CYB5R1;CADPS2;ITGAV;SFN;ADRB2;HLA-F;IL7R;GPER1;LGALS3;GLIPR1;LILRB3;YWHAH;TAPBP;M6PR;CD109;HSPA8;RHOG;TAP2;SGSM1;RAPGEF1;RAB27A;WNT4;PTPRB;CLTA;LAIR1;BAIAP2L2
16124,GO:0090110,0.653728259245246,0.729110804000306,1,13,cargo loading into COPII-coated vesicle,BP,INSIG1
12952,GO:0051315,0.653992227279874,0.728841601363716,1,13,attachment of mitotic spindle microtubules to kinetochore,BP,HNRNPU
2433,GO:0005622,0.654572035814753,0.383716504649684,798,10512,intracellular,CC,IGFBP3;IL32;KRT1;MAFB;SAA1;SPRR3;TRIM16;FTL;CCL20;CRYAB;SPRR2A;FTH1;NRG1;MMP9;KRT2;RUNX1;CYR61;PTGER4;INHBA;HDAC9;MAP2;S100P;FN1;NEFL;ODC1;P3H2;CYP1B1;CTGF;CYP24A1;KRT34;DTX2;ADM;TNS3;KRT15;AMOT;FOSL2;JPH2;KRT4;TUFT1;SACS;NEFM;ACTG1;TRIM47;NQO1;IL16;CYP1A1;TAP1;IL1R2;DUSP14;NFKBIE;PML;TFCP2L1;RBM19;CYLD;HSPB1;STARD13;MYBL2;PDLIM1;KRT10;TRAF1;PCDH7;SDC4;KRT13;FADS3;IRX2;RELB;TFRC;BAG1;SOD2;GPRC5A;ABCF1;UGT1A6;CD3EAP;ARID3B;IER2;HLA-B;CSF2;PTGES;MAP3K14;TRIM16L;FBN1;TGFB2;EDN1;SH3RF2;GBP1;USB1;TXNRD1;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;KRTAP2-3;MGAM;ELMSAN1;SPSB1;DBNDD2;RSAD2;G6PD;TRAF3;EMP2;NUAK1;HRNR;KLHL21;NLRC5;APOL6;PANX1;TP53;SIPA1L3;NFE2L1;SQSTM1;MARVELD3;PDCD11;KRT9;HNRNPAB;STEAP4;P4HA2;PANK2;NOCT;NEDD9;NFKB1;CDKN2B;TAF4B;GNPTAB;LFNG;IRS1;GALNT18;KRT6A;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;C15ORF39;STOML1;AHR;CDV3;JUNB;MCM5;HMGXB3;PLEKHO2;ARPC4;LAMP1;HS3ST2;COMMD4;CSRP1;EHD1;GADD45A;TNF;COL12A1;GNL3L;BAIAP2;ZBED1;KRT5;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;SCD;PPAN;WWC1;RRP1;NAV2;ENC1;TNC;ASCC2;DST;TRIO;VMP1;PDPN;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;TPM4;NFKB2;COL4A1;DNAJB1;PSMB9;LSS;SLC7A5;CLN6;EPHB6;TELO2;KRT17;FOSL1;C9ORF3;QPCT;PGD;SIRPA;UBE2C;JPH1;SLC39A1;TYMS;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;TNK1;ARMC6;SART1;FAM69B;TK1;ACAA1;GEMIN5;CADPS2;KLF7;ZNF503;EPHA2;CHP1;HMGCS1;CCDC85B;EIF5;GADD45B;TSC22D3;FANCC;ARFRP1;PITHD1;BMP2;COL16A1;UBE4B;GOSR1;COL27A1;DDX23;CDK4;ZNF142;KREMEN2;DRAM1;ITGAV;ERRFI1;KIF23;MYO10;GGCX;PMM2;SFN;CDC42EP2;COL9A2;GTPBP6;TRMT61A;STAT5A;RRP12;EPGN;ANKS4B;RNF19B;ZMAT2;ADRB2;SVIL;PLEKHA7;DAXX;FOXD2;NAT10;MTUS1;IQCJ-SCHIP1;SERPINE1;FUS;PABPC4;PGK1;ARPC1B;MCM2;LSG1;CCDC124;EBP;CSRP2;NMT2;TOX4;ST6GALNAC5;USP36;XAF1;AKAP8L;AMOTL2;ZC3H7B;AEN;VGLL3;ELF3;GRWD1;RELT;LIF;OSR2;SFRP1;PARL;ABCF2;TPM1;TRIM22;ZFYVE27;ZDHHC3;CC2D2A;SAFB2;APTX;DHCR7;HLA-F;PTGFRN;PUS1;DHX37;WDR1;PPP1R3B;ANXA8;PWP2;MKL1;IRF1;METTL1;PSME2;ABHD4;PDE4DIP;LUC7L;DNPEP;BANF1;DPH2;EPPK1;IL7R;DDX42;CTIF;NFX1;PSPC1;TFIP11;LRRC75A-AS1;THBD;GPER1;SRF;NSUN2;DNAJB2;HS3ST1;ZNF787;RRP36;TXN2;ELF4;LARP4B;AP4S1;ABTB2;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;PARD3B;JRK;EDF1;DOCK10;ETS1;GEMIN4;SGK1;SNAI2;POP1;RRS1;CD2BP2;SRRT;PRPF19;CYP4B1;ZFP36L1;ARHGEF28;RPLP2;AKAP8;RHOB;NELFE;ADAM17;GPCPD1;DKC1;FEN1;SNX12;TXLNA;DHFR;ISG20L2;U2AF2;FGFR1OP;VCL;SHQ1;KCTD10;RIPK4;IRS2;IER3;NPAS2;KRT14;CBX5;PPRC1;URB2;LGALS3;TSR1;ACO1;RPLP1;MAFK;TRAF2;ABCG2;IL15;SF3B4;REEP1;AKR1C2;PRKCA;ZNF778;ZFP36L2;PUM3;NTN1;ZFC3H1;SYK;CMTM3;POLR1A;DDX17;NFKBIB;ROBO1;AJUBA;C9ORF78;SENP3;GINS2;USP43;IFIT3;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;DNTTIP2;PDGFB;FILIP1;AASS;CEP95;BRMS1;PREP;IFFO2;OXTR;RPS2;UBTF;PTTG1IP;ALYREF;UTP14A;PHAX;POLA1;UTP20;WDR34;RPS9;NSUN5;GEMIN8;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;FHL2;DCTN1;ZNF407;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;TCP11L1;COL5A3;RRP7A;UHRF1;SLAIN2;MYH9;ZNF234;SPPL2A;TAPBPL;NOM1;COL17A1;NPNT;IL1A;ZNFX1;COPS3;CAMK1G;GLIPR1;ORAOV1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;PRCC;RASGRP4;SNX8;RBBP5;RUNDC1;RBM15B;SFPQ;BORCS7;DDX39A;SPRY4;NOP16;ZNF697;SAP30BP;FTSJ3;WDR46;LILRB3;TBCCD1;SPEN;ZW10;ROR1;PXMP2;PRUNE2;ACSL1;RCC2;NOP56;COL5A2;NUP214;MAFF;ACKR3;BAMBI;AFAP1L2;GPN1;TRAM2;SMAD7;CRCP;SLC35A4;SLC35C2;MRPS12;TATDN2;MRPS24;NOL9;CCDC6;SUPT5H;MTA2;DNAJC1;YWHAH;TAPBP;TRIP6;WDR4;ENAH;KEAP1;SPECC1;M6PR;ZDHHC6;ERAL1;HNRNPU;TJP1;CLASP1;CHST3;HNRNPF;PQBP1;RRAD;APH1A;PAGR1;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;CREB3;RUVBL2;ABT1;MAZ;PPP1R9B;TUSC1;MTFP1;TANGO2;ORC1;LPCAT3;MICAL3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;RPP25L;ZNF267;TRUB2;PARP14;ANAPC15;PRDM7;MRPL20;RBM38;PCYT1A;RRP7BP;GALNT2;ATG101;MARVELD2;DUSP1;ARL6IP4;CAB39;TGFBRAP1;TXNL4B;CITED2;CD109;RPL27A;SOCS1;HSPBP1;STAC;OXSR1;HSPA8;GBE1;JUN;PIGM;MRPL33;DTX4;ESR1;MANEAL;C6ORF47;IKZF3;CENPN;TCOF1;BLOC1S2;SLC22A4;PES1;USP31;FOXN1;PAK1IP1;RCC1;BRPF1;GLIPR2;CPT1A;DCXR;COMMD9;MCM7;SCD5;TFDP1;TNPO3;ZNF772;OGFR;ZNF512;EIF3B;BCS1L;GTF2E1;TRAPPC5;NOP2;NBPF1;NOP14;NOC2L;GTF3C2;CHMP4B;RBM4;SERTAD1;NACC1;ZNF703;CCR6;RPTN;ARRDC3;INSIG1;CENPO;GINS3;HERC2;DUS2;CNTROB;ARGLU1;PARD3;QDPR;LAMC1;RHOG;GPNMB;SCHIP1;BCL2L2;ZNF365;ACBD6;XRCC6;ZNF132;EDC4;TRMT1;KLF6;CS;TAP2;CHCHD6;ZSWIM6;TEAD4;SMPD2;KBTBD12;ACTN4;HMGN2;EFNB1;THEM4;SORBS2;KIF24;GLIS3;SNIP1;METTL16;KCTD1;SMUG1;TTC31;PHLPP1;CLUH;ZNF34;URGCP;CISD3;TKT;EFTUD2;TNFRSF10A;TRA2A;RNF7;KANK4;TOMM40;AKIP1;MPHOSPH8;ELK1;PHLDB2;SGSM1;INCENP;PHF5A;EIF3I;RAPGEF1;IPO4;CHAF1A;ZYX;EIF5A;UBAP2L;TINAGL1;KIF22;UAP1L1;MYADM;DAG1;TMEM165;CGNL1;POLR3H;MGAT2;RNF185;EEF1D;ASB6;RAB27A;COL4A4;DHX34;TIMELESS;GPX4;BLNK;DPM3;WNT4;RILPL2;MRPS2;RBM14;AKR1C1;VPS52;TRAF4;TUBB;CTDSP1;CYTH1;CD38;TNFAIP3;PSMC3;SMARCC2;SPG21;DNAJC9;BRIP1;RRM2;SUPT16H;CXCL8;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SURF6;SLC3A2;XPNPEP3;ATAD3C;HES4;ZC3H18;CARD10;SLC25A22;PTPRB;UTP4;RNF144B;POLR2G;DUSP8;SLC25A44;SRSF7;CLTA;CREB5;NOL3;SNF8;CDCA5;GCLC;LRRC59;HSP90AB1;SWAP70;TBXA2R;MKI67;MCAM;TTLL5;HERC6;BIN3;LAIR1;POP4;RPUSD4;PARP1;CLK4;TP63;ZBTB12;PHACTR4;TOP3A;CCL5;BAIAP2L2;ORC4;FADS1;MAGOH;APEX2;SH3BP4
16755,GO:0098533,0.654586997241211,0.728234297308714,1,13,ATPase dependent transmembrane transport complex,CC,ABCF2
16314,GO:0090482,0.654678910906694,0.72814035518926,1,13,vitamin transmembrane transporter activity,MF,SLC5A6
3042,GO:0006595,0.654933050705158,0.726750305564146,1,14,polyamine metabolic process,BP,ODC1
14574,GO:0070102,0.65495940316256,0.727853521165372,1,13,interleukin-6-mediated signaling pathway,BP,IL6R
10793,GO:0044264,0.655113753942476,0.522493135045083,5,71,cellular polysaccharide metabolic process,BP,MGAM;IRS1;PPP1R3B;IRS2;GBE1
7913,GO:0032486,0.655134661788892,0.727674184091239,1,13,Rap protein signal transduction,BP,RAPGEF1
8789,GO:0034472,0.655241421150066,0.726433784226721,1,14,snRNA 3'-end processing,BP,USB1
16264,GO:0090317,0.655385084799707,0.622747572786323,2,29,negative regulation of intracellular protein transport,BP,CHP1;INSIG1
8076,GO:0032755,0.655593051226349,0.573062051110337,3,43,positive regulation of interleukin-6 production,BP,TNF;IL1A;IL6R
6201,GO:0019692,0.655706379337161,0.622020103012491,2,30,deoxyribose phosphate metabolic process,BP,TYMS;SMUG1
2606,GO:0005905,0.655749546009577,0.542644531448357,4,57,clathrin-coated pit,CC,TFRC;ACKR3;CLTA;SH3BP4
16160,GO:0090177,0.655849005322155,0.72694229341639,1,13,establishment of planar polarity involved in neural tube closure,BP,SFRP1
16161,GO:0090178,0.655849005322155,0.72694229341639,1,13,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP1
9530,GO:0036258,0.655906734192703,0.622171188650881,2,29,multivesicular body assembly,BP,CHMP4B;SNF8
5462,GO:0016342,0.65613692919971,0.726646877028409,1,13,catenin complex,CC,SMAD7
18566,GO:1903792,0.65613692919971,0.726646877028409,1,13,negative regulation of anion transport,BP,IRS2
13684,GO:0060218,0.656542478799866,0.504429056869776,6,100,hematopoietic stem cell differentiation,BP,RUNX1;PSMB9;SFRP1;PSME2;SRF;PSMC3
8061,GO:0032729,0.657123882762188,0.620824046588414,2,29,positive regulation of interferon-gamma production,BP,IL27RA;TNF
4680,GO:0010828,0.657959773975764,0.620298699713431,2,28,positive regulation of glucose transmembrane transport,BP,IRS1;IRS2
6414,GO:0021675,0.6580731984475,0.57028880341588,3,43,nerve development,BP,MAFB;NAV2;DAG1
9109,GO:0035384,0.658391245036016,0.569932379988092,3,43,thioester biosynthetic process,BP,SCD;ACSL1;SCD5
15376,GO:0071616,0.658391245036016,0.569932379988092,3,43,acyl-CoA biosynthetic process,BP,SCD;ACSL1;SCD5
4427,GO:0010256,0.659406825102432,0.418267033885007,26,357,endomembrane system organization,BP,TGFB2;SQSTM1;BAIAP2;VMP1;NUP153;AKAP8L;ZFYVE27;ANXA8;PDE4DIP;BANF1;GPER1;REEP1;PRKCA;NSFL1C;SPTBN1;DCTN1;ZW10;NUP214;TRAM2;CLASP1;TANGO2;BLOC1S2;CHMP4B;RAB27A;SNF8;BAIAP2L2
3447,GO:0007257,0.659610337708621,0.61846473531052,2,28,activation of JUN kinase activity,BP,DAXX;SYK
8440,GO:0033558,0.660065504171906,0.568053124839319,3,43,protein deacetylase activity,MF,HDAC9;BRMS1;MTA2
15606,GO:0072089,0.660581101513737,0.516390512296422,5,71,stem cell proliferation,BP,RUNX1;FGFR2;SNAI2;ZFP36L1;HNRNPU
12861,GO:0051181,0.660934830233889,0.616585321170343,2,29,cofactor transport,BP,SLC5A6;ABCG2
4236,GO:0009416,0.661370756156566,0.437267914262478,16,224,response to light stimulus,BP,PML;TP53;CDKN1A;HMGCS1;UBE4B;NMT2;FEN1;COPS3;RUVBL2;DUSP1;NOC2L;RBM4;ELK1;PDE6A;PARP1;TP63
12062,GO:0048010,0.661536059518805,0.515217558237195,5,72,vascular endothelial growth factor receptor signaling pathway,BP,ACTG1;HSPB1;BAIAP2;ITGAV;MAPK11
11271,GO:0045576,0.662075175249486,0.615310823228131,2,29,mast cell activation,BP,LYN;SYK
8693,GO:0034314,0.662100583397922,0.615282393608581,2,29,Arp2/3 complex-mediated actin nucleation,BP,ARPC4;ARPC1B
3066,GO:0006629,0.662234641863641,0.385233643582645,72,976,lipid metabolic process,BP,NRG1;CYR61;CYP1B1;CTGF;CYP24A1;ADM;CYP1A1;TFCP2L1;SDC4;FADS3;PTGES;EDN1;TXNRD1;PLBD1;G6PD;NFE2L1;PANK2;NFKB1;IRS1;HSPG2;LYN;TNF;SCD;FGFR2;PBX1;LSS;CLN6;C9ORF3;CYB5R1;ACAA1;HMGCS1;BMP2;CDK4;STAT5A;EBP;ST6GALNAC5;DHCR7;ABHD4;GPER1;SF1;EGR1;EDF1;SNAI2;PRPF19;GPCPD1;IRS2;NPAS2;AKR1C2;AJUBA;PDGFB;FHL2;GLIPR1;TNFRSF21;ACSL1;YWHAH;LPCAT3;PCYT1A;PIGM;ESR1;SLC22A4;CPT1A;SCD5;INSIG1;SMPD2;THEM4;TPRA1;GPX4;DPM3;WNT4;AKR1C1;HSD17B10;FADS1
241,GO:0000502,0.66235451391169,0.534453521227137,4,63,proteasome complex,CC,HSPB1;PSMB9;PSME2;PSMC3
3152,GO:0006750,0.662591537513897,0.71880698090118,1,14,glutathione biosynthetic process,BP,GCLC
2674,GO:0006026,0.662939745986389,0.564815266845696,3,43,aminoglycan catabolic process,BP,SDC4;HSPG2;CHP1
5431,GO:0016289,0.663816010762474,0.717520899131131,1,14,CoA hydrolase activity,MF,THEM4
3338,GO:0007051,0.663978855780749,0.45477234503416,11,155,spindle organization,BP,MYBL2;BIRC3;FLNA;KIF23;DCTN1;MYH9;HNRNPU;CLASP1;RCC1;CHMP4B;TUBB
1668,GO:0004129,0.664048310486166,0.713957327057425,1,18,cytochrome-c oxidase activity,MF,COX5B
4949,GO:0015002,0.664048310486166,0.713957327057425,1,18,heme-copper terminal oxidase activity,MF,COX5B
5621,GO:0016676,0.664048310486166,0.713957327057425,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,COX5B
14183,GO:0061082,0.664082570333039,0.717240335004023,1,14,myeloid leukocyte cytokine production,BP,TGFB2
16813,GO:0098660,0.664199140359767,0.409021843336376,29,405,inorganic ion transmembrane transport,BP,JPH2;G6PD;PANX1;STEAP4;LYN;JPH1;SLC39A1;FLNA;CHP1;ITGAV;FXYD3;PARL;GPER1;KCNA7;NEDD4L;COX5B;YWHAH;RRAD;SLC4A11;KCNIP3;CAB39;STAC;OXSR1;ACTN4;SLC41A2;SLC3A2;SLC25A22;NOL3;SLC2A6
155,GO:0000313,0.664570457541181,0.510772803714704,5,84,organellar ribosome,CC,MRPS12;MRPS24;MRPL20;MRPL33;MRPS2
2508,GO:0005761,0.664570457541181,0.510772803714704,5,84,mitochondrial ribosome,CC,MRPS12;MRPS24;MRPL20;MRPL33;MRPS2
12343,GO:0048704,0.664577119441639,0.532588154877393,4,58,embryonic skeletal system morphogenesis,BP,FGFR2;SLC39A1;OSR2;BMP7
3691,GO:0008194,0.66496019247397,0.483958752434758,7,100,UDP-glycosyltransferase activity,MF,UGT1A6;B4GALT1;LFNG;GALNT18;COLGALT1;GALNT2;MGAT2
18902,GO:1904591,0.665258232950351,0.611738211389312,2,29,positive regulation of protein import,BP,ZC3H12A;HSP90AB1
11339,GO:0045662,0.665307551696111,0.715948262311845,1,14,negative regulation of myoblast differentiation,BP,TNF
6744,GO:0030163,0.665544936645657,0.388584823529422,54,741,protein catabolic process,BP,NRG1;ODC1;PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;ADAMTS9;TNF;ENC1;BACE2;PSMB9;CLN6;UBE2C;FLNA;UBE4B;RNF19B;USP36;PSME2;ABTB2;PRPF19;SNX12;KCTD10;TRAF2;USP43;PTTG1IP;NSFL1C;NEDD4L;SNRNP70;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;HSPA8;USP31;CHMP4B;HERC2;RNF7;TINAGL1;RNF185;TNFAIP3;PSMC3;EFNA1;RNF144B;CLTA;SNF8;GCLC;HSP90AB1
2851,GO:0006336,0.66656394412412,0.559385560937489,3,50,DNA replication-independent nucleosome assembly,BP,CENPN;CENPO;IPO4
773,GO:0002027,0.666691418095481,0.560350111327011,3,44,regulation of heart rate,BP,ADM;EDN1;TPM1
6287,GO:0019897,0.666841641659088,0.481855563087352,7,100,extrinsic component of plasma membrane,CC,CYLD;LYN;TNK1;ERRFI1;SYK;SMAD7;CYTH1
416,GO:0001103,0.667278529291051,0.609459073108972,2,29,RNA polymerase II repressing transcription factor binding,MF,ZFP42;MTA2
10280,GO:0043024,0.667448891218072,0.713678818745634,1,14,ribosomal small subunit binding,MF,ERAL1
16838,GO:0098739,0.667620133607408,0.559510918157801,3,43,import across plasma membrane,BP,STEAP4;SLC7A2;SLC3A2
13533,GO:0055114,0.667686675795799,0.387764080157738,51,717,oxidation-reduction process,BP,HEPHL1;FTH1;P3H2;CYP1B1;CYP24A1;NQO1;CYP1A1;FADS3;SOD2;PTGES;TXNRD1;TET3;G6PD;GFOD1;STEAP4;P4HA2;PANK2;IRS1;SCD;PGD;CYB5R1;ACAA1;BMP2;PGK1;DHCR7;PPP1R3B;TXN2;CYP4B1;DHFR;IRS2;ACO1;AKR1C2;AASS;COX5B;DOHH;MICAL3;GBE1;BLOC1S2;CPT1A;DCXR;SCD5;DUS2;QDPR;CS;CYP20A1;GPX4;AKR1C1;CYB561D2;RRM2;HSD17B10;FADS1
12481,GO:0050432,0.667831037804802,0.713272356609116,1,14,catecholamine secretion,BP,OXTR
9883,GO:0042157,0.668102065983354,0.462651533831069,9,131,lipoprotein metabolic process,BP,APOL6;ITGAV;LYPD6B;NMT2;ZDHHC3;ZDHHC6;CD109;PIGM;DPM3
15059,GO:0071011,0.668468047284781,0.607379205080383,2,31,precatalytic spliceosome,CC,SNRNP70;PHF5A
13252,GO:0051930,0.668480616415108,0.712580432182994,1,14,regulation of sensory perception of pain,BP,EDN1
13253,GO:0051931,0.668480616415108,0.712580432182994,1,14,regulation of sensory perception,BP,EDN1
3363,GO:0007099,0.668512552776384,0.608062493158971,2,29,centriole replication,BP,CNTROB;RBM14
12154,GO:0048261,0.668679779138539,0.712368030044373,1,14,negative regulation of receptor-mediated endocytosis,BP,UBQLN2
2733,GO:0006112,0.668770668102378,0.527835850312166,4,58,energy reserve metabolic process,BP,IRS1;PPP1R3B;IRS2;GBE1
5778,GO:0017000,0.668804251010215,0.712235222772825,1,14,antibiotic biosynthetic process,BP,CYP1A1
5625,GO:0016701,0.66911449699885,0.71190399614984,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,P4HA2
5626,GO:0016702,0.66911449699885,0.71190399614984,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,P4HA2
2711,GO:0006084,0.669233618038746,0.607244874458981,2,29,acetyl-CoA metabolic process,BP,HMGCS1;AASS
7398,GO:0031461,0.669347099471043,0.448785660961214,11,157,cullin-RING ubiquitin ligase complex,CC,SPSB1;KLHL21;ENC1;UBE2C;ABTB2;KCTD10;KEAP1;ANAPC15;ZSWIM6;KBTBD12;RNF7
19958,GO:2000516,0.669753746801848,0.711220594454376,1,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,CD83
4913,GO:0014850,0.669839552385803,0.711128767802867,1,14,response to muscle activity,BP,MTFP1
5234,GO:0015850,0.670008106172703,0.478185591425176,7,102,organic hydroxy compound transport,BP,C1QTNF1;NFKB1;NFKBIA;ABCG2;SYK;OXTR;AKR1C1
4452,GO:0010390,0.670067559950564,0.606297818305579,2,29,histone monoubiquitination,BP,RING1;UHRF1
17897,GO:1902186,0.670327270879005,0.606002563439921,2,29,regulation of viral release from host cell,BP,PML;CHMP4B
3566,GO:0007608,0.670597290246639,0.710316884972095,1,14,sensory perception of smell,BP,NAV2
3497,GO:0007389,0.670780489345595,0.421420421283494,18,251,pattern specification process,BP,MAFB;IRX2;EDN1;MID1;LFNG;RING1;FGFR2;PBX1;BMP2;SFRP1;CC2D2A;SRF;SEMA3C;ETS2;CITED2;EFNB1;BMP7;TP63
7675,GO:0032104,0.670872541741788,0.710021531420376,1,14,regulation of response to extracellular stimulus,BP,SNAI2
7678,GO:0032107,0.670872541741788,0.710021531420376,1,14,regulation of response to nutrient levels,BP,SNAI2
13002,GO:0051427,0.671172019589972,0.452566291654357,10,143,hormone receptor binding,MF,DAXX;FUS;FHL2;YWHAH;TRIP6;PAGR1;ETS2;ESR1;ACTN4;PARP1
15261,GO:0071428,0.671515123657795,0.708311801478868,1,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,RRS1
7105,GO:0030901,0.671601339543745,0.524473941582697,4,59,midbrain development,BP,G6PD;FGFR2;SFRP1;YWHAH
4076,GO:0009129,0.67169582396906,0.709136741382564,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,TYMS
4077,GO:0009130,0.67169582396906,0.709136741382564,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,TYMS
13762,GO:0060338,0.671780800043648,0.604347317112589,2,29,regulation of type I interferon-mediated signaling pathway,BP,NLRC5;HSP90AB1
7476,GO:0031640,0.671880756422599,0.707027668782419,1,16,killing of cells of other organism,BP,HMGN2
10860,GO:0044364,0.671880756422599,0.707027668782419,1,16,disruption of cells of other organism,BP,HMGN2
6023,GO:0019081,0.672163033211457,0.708633703691409,1,14,viral translation,BP,EIF3B
13951,GO:0060632,0.672199183257018,0.708594753543212,1,14,regulation of microtubule-based movement,BP,LAMP1
5660,GO:0016765,0.672207019093785,0.55346151880815,3,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,PTGES;MAT2A;DPH2
8662,GO:0034219,0.672918244875662,0.502364053339859,5,72,carbohydrate transmembrane transport,BP,IRS1;TNF;IRS2;M6PR;SLC2A6
20199,GO:2001056,0.673176988974285,0.464859801543908,8,119,positive regulation of cysteine-type endopeptidase activity,BP,CYR61;CTGF;PML;TNF;GPER1;TRAF2;ROBO1;TNFRSF10A
4712,GO:0010874,0.673215735706955,0.707497817837949,1,14,regulation of cholesterol efflux,BP,NFKBIA
2385,GO:0005521,0.673252277519604,0.707458327338805,1,14,lamin binding,MF,AKAP8L
2450,GO:0005662,0.673651876659263,0.707026214767398,1,14,DNA replication factor A complex,CC,PRPF19
2458,GO:0005671,0.673686441175651,0.70698881478434,1,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,UBAP2L
5860,GO:0017160,0.67369109234749,0.706983781776993,1,14,Ral GTPase binding,MF,FLNA
7443,GO:0031573,0.673778873421787,0.706888781850875,1,14,intra-S DNA damage checkpoint,BP,ORAOV1
3053,GO:0006612,0.67381430128247,0.448980706623798,10,164,protein targeting to membrane,BP,CHP1;ZDHHC3;RPLP2;RPLP1;RPS2;RPS9;ZDHHC6;RPL27A;CHMP4B;PARD3
11645,GO:0046364,0.673912548537031,0.521832403659879,4,59,monosaccharide biosynthetic process,BP,G6PD;PGD;PGK1;TKT
8202,GO:0032947,0.673993074311842,0.501140870907781,5,72,protein-containing complex scaffold activity,MF,WWC1;TELO2;PDE4DIP;EIF3B;CARD10
13065,GO:0051568,0.674158529594424,0.551608230014339,3,45,histone H3-K4 methylation,BP,TET3;NELFE;RBBP5
4298,GO:0009743,0.674354374653283,0.44895481707894,10,145,response to carbohydrate,BP,CTGF;LYN;ICAM1;GPER1;SRF;TXN2;EGR1;ZFP36L1;IRS2;GCLC
9040,GO:0035254,0.67455854484752,0.601170874343505,2,29,glutamate receptor binding,MF,SQSTM1;FUS
14939,GO:0070822,0.674733838433214,0.705853746443426,1,14,Sin3-type complex,CC,BRMS1
8144,GO:0032869,0.674800203051497,0.442740191351372,11,157,cellular response to insulin stimulus,BP,HDAC9;IRS1;BAIAP2;CDK4;ERRFI1;ZFP36L1;IRS2;SOCS1;GCLC;PARP1;BAIAP2L2
14156,GO:0061037,0.675409788983654,0.705119415122205,1,14,negative regulation of cartilage development,BP,SNAI2
2840,GO:0006308,0.675611051165451,0.599579339060223,2,30,DNA catabolic process,BP,DNASE1;TATDN2
3064,GO:0006626,0.675746980173166,0.461927836800474,8,120,protein targeting to mitochondrion,BP,NRG1;CYB5R1;USP36;PARL;WDR46;UBE2J2;SNIP1;TOMM40
3791,GO:0008356,0.675781362876641,0.704715145761818,1,14,asymmetric cell division,BP,PARD3
19233,GO:1905369,0.67587449956264,0.518957458585186,4,64,endopeptidase complex,CC,HSPB1;PSMB9;PSME2;PSMC3
12979,GO:0051382,0.676071983211525,0.704398654523343,1,14,kinetochore assembly,BP,CENPN
9010,GO:0035173,0.676200382316572,0.704258741805683,1,14,histone kinase activity,MF,PRKCA
17877,GO:1902115,0.676476100109368,0.446658109080474,10,143,regulation of organelle assembly,BP,CYLD;SDC4;CSF2;EDN1;UBQLN2;TNF;LCP1;HNRNPU;CHMP4B;RBM14
14664,GO:0070262,0.676482175983463,0.703951499861556,1,14,peptidyl-serine dephosphorylation,BP,SWAP70
15995,GO:0086003,0.676519838228793,0.598917567291887,2,29,cardiac muscle cell contraction,BP,FLNA;NEDD4L
12940,GO:0051299,0.676542823313943,0.703885343276016,1,14,centrosome separation,BP,CNTROB
3536,GO:0007528,0.67662718154924,0.598793989790356,2,29,neuromuscular junction development,BP,TNC;COL4A1
18077,GO:1902667,0.676756143620572,0.598645489349498,2,29,regulation of axon guidance,BP,SEMA3C;ZSWIM6
772,GO:0002026,0.676868140660648,0.70353027838555,1,14,regulation of the force of heart contraction,BP,ADM
19769,GO:2000178,0.677040666849565,0.703341842345152,1,14,negative regulation of neural precursor cell proliferation,BP,RAPGEF1
8029,GO:0032673,0.677156459917362,0.703215319151133,1,14,regulation of interleukin-4 production,BP,CD83
816,GO:0002088,0.677173218857478,0.54834157644855,3,44,lens development in camera-type eye,BP,CRYAB;EPHA2;CDK4
15699,GO:0072234,0.677217781166145,0.703148298549065,1,14,metanephric nephron tubule development,BP,LIF
16530,GO:0097242,0.677339903349762,0.703014791076163,1,14,amyloid-beta clearance,BP,SRF
7598,GO:0031970,0.677690897033833,0.496357241191918,5,78,organelle envelope lumen,CC,PTGES;PANK2;LYN;THEM4;TUBB
8108,GO:0032794,0.677929713471567,0.702369338248681,1,14,GTPase activating protein binding,MF,TUBB
4783,GO:0010970,0.678054597006068,0.451533395584396,9,131,transport along microtubule,BP,NEFL;HSPB1;LAMP1;DST;KIF23;WDR34;DCTN1;HSPA8;BLOC1S2
17009,GO:0099111,0.678054597006068,0.451533395584396,9,131,microtubule-based transport,BP,NEFL;HSPB1;LAMP1;DST;KIF23;WDR34;DCTN1;HSPA8;BLOC1S2
15318,GO:0071526,0.678077226471274,0.597122074729537,2,29,semaphorin-plexin signaling pathway,BP,FLNA;SEMA3C
7635,GO:0032042,0.678100123443846,0.702182649364032,1,14,mitochondrial DNA metabolic process,BP,PARP1
3315,GO:0007018,0.678295848274493,0.41871133335851,16,227,microtubule-based movement,BP,NEFL;HSPB1;MYO1B;LAMP1;DST;KIF23;MYO10;WDR34;DCTN1;MYH9;HSPA8;BLOC1S2;KIF24;KIF22;MYO1E;CLTA
9008,GO:0035162,0.67834366556964,0.701915684455189,1,14,embryonic hemopoiesis,BP,PBX1
2220,GO:0005123,0.678663880127752,0.701564390481304,1,14,death receptor binding,MF,NOL3
8978,GO:0035067,0.678746881010597,0.701473281255586,1,14,negative regulation of histone acetylation,BP,NOC2L
7976,GO:0032590,0.678925150746749,0.701277523359968,1,14,dendrite membrane,CC,GPER1
3796,GO:0008373,0.679020550776857,0.701172723694075,1,14,sialyltransferase activity,MF,ST6GALNAC5
16644,GO:0097503,0.679020550776857,0.701172723694075,1,14,sialylation,BP,ST6GALNAC5
13068,GO:0051571,0.679127123198989,0.701055617063643,1,14,positive regulation of histone H3-K4 methylation,BP,NELFE
6035,GO:0019104,0.679226141023949,0.699907313750161,1,15,DNA N-glycosylase activity,MF,SMUG1
1251,GO:0003002,0.679304538994377,0.42435059974223,14,198,regionalization,BP,MAFB;IRX2;EDN1;LFNG;RING1;FGFR2;PBX1;BMP2;SFRP1;SRF;SEMA3C;ETS2;CITED2;TP63
7936,GO:0032516,0.679385425744916,0.700771634509162,1,14,positive regulation of phosphoprotein phosphatase activity,BP,HSP90AB1
20109,GO:2000781,0.679626492441389,0.700506412257577,1,14,positive regulation of double-strand break repair,BP,TIMELESS
15001,GO:0070925,0.679644858157185,0.377903150681378,46,636,organelle assembly,BP,ACTG1;CYLD;MYBL2;SDC4;CSF2;EDN1;BIRC3;NOCT;UBQLN2;RAB32;EHD1;TNF;PPAN;FLNA;LCP1;KIF23;TPM1;CC2D2A;WDR1;PWP2;SRF;RRS1;FGFR1OP;WDR34;NSFL1C;DCTN1;RRP7A;ERAL1;HNRNPU;CLASP1;CEP41;ABT1;MRPL20;RRP7BP;ATG101;CENPN;RCC1;NOP2;CHMP4B;CNTROB;KIF24;RILPL2;RBM14;TUBB;SNF8;TTLL5
1797,GO:0004435,0.679666706641843,0.700462150701998,1,14,phosphatidylinositol phospholipase C activity,MF,CCL5
14632,GO:0070200,0.679677974504773,0.700449747874333,1,14,establishment of protein localization to telomere,BP,DKC1
15258,GO:0071425,0.67992848675917,0.700173899410779,1,14,hematopoietic stem cell proliferation,BP,RUNX1
642,GO:0001832,0.67995746920041,0.700141973008695,1,14,blastocyst growth,BP,PRPF19
4956,GO:0015020,0.680167977986859,0.699910001930198,1,14,glucuronosyltransferase activity,MF,UGT1A6
11837,GO:0046785,0.680350850705292,0.514428935184244,4,59,microtubule polymerization,BP,MAP2;DCTN1;SLAIN2;CLASP1
2865,GO:0006356,0.680661706270173,0.593744188386499,2,30,regulation of transcription by RNA polymerase I,BP,FLNA;UBTF
18124,GO:1902808,0.680739641669638,0.593653690619165,2,30,positive regulation of cell cycle G1/S phase transition,BP,CYP1A1;PAGR1
3409,GO:0007190,0.681176419811478,0.69879680721098,1,14,activation of adenylate cyclase activity,BP,ADRB2
6491,GO:0021846,0.682238230497198,0.697621225645391,1,14,cell proliferation in forebrain,BP,FGFR2
15187,GO:0071322,0.682857987547503,0.475387064889063,6,90,cellular response to carbohydrate stimulus,BP,ICAM1;GPER1;SRF;ZFP36L1;IRS2;GCLC
10828,GO:0044321,0.68287327925219,0.696916424405503,1,14,response to leptin,BP,EDN1
17898,GO:1902187,0.682910776775506,0.69687476817163,1,14,negative regulation of viral release from host cell,BP,PML
9913,GO:0042249,0.683022665129256,0.696750444126707,1,14,establishment of planar polarity of embryonic epithelium,BP,SFRP1
5472,GO:0016405,0.68313793208074,0.696622324335196,1,14,CoA-ligase activity,MF,ACSL1
13683,GO:0060216,0.683171123538056,0.696585424025149,1,14,definitive hemopoiesis,BP,ZFP36L2
2299,GO:0005272,0.683337266662388,0.696400663176409,1,14,sodium channel activity,MF,SLC4A11
17878,GO:1902116,0.68353995327619,0.590392716122059,2,30,negative regulation of organelle assembly,BP,CHMP4B;RBM14
12183,GO:0048311,0.683577949441387,0.696132853991458,1,14,mitochondrion distribution,BP,CLUH
10864,GO:0044381,0.683627344366058,0.696077869135379,1,14,glucose import in response to insulin stimulus,BP,IRS1
20293,GO:2001273,0.683627344366058,0.696077869135379,1,14,regulation of glucose import in response to insulin stimulus,BP,IRS1
20260,GO:2001224,0.683628325187088,0.696076777237998,1,14,positive regulation of neuron migration,BP,FLNA
7625,GO:0032024,0.683834587214255,0.540394530033859,3,45,positive regulation of insulin secretion,BP,GPER1;IRS2;CD38
2580,GO:0005871,0.683991355348753,0.540421007695864,3,44,kinesin complex,CC,KIF23;KIF24;KIF22
9997,GO:0042407,0.684685600473611,0.693844283588384,1,15,cristae formation,BP,CHCHD6
3256,GO:0006919,0.684799232770338,0.488274758167468,5,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PML;TNF;TRAF2;ROBO1;TNFRSF10A
7152,GO:0031011,0.685303200821867,0.693152436878864,1,15,Ino80 complex,CC,RUVBL2
8348,GO:0033202,0.685303200821867,0.693152436878864,1,15,DNA helicase complex,CC,RUVBL2
5511,GO:0016462,0.685568493013021,0.369351527380983,50,686,pyrophosphatase activity,MF,TAP1;ABCF1;GBP1;MYO1B;RAB32;MCM5;GNL3L;NAV2;EIF5;ARFRP1;DDX23;KIF23;MYO10;MCM2;LSG1;ABCF2;DHX37;DDX42;RHOB;TSR1;ABCG2;DDX17;GINS2;DDX47;DDX49;WDR34;DCTN1;MYH9;DDX39A;PRUNE2;GPN1;TAPBP;RRAD;RUVBL2;HSPA8;MCM7;RHOG;XRCC6;TAP2;KIF24;EFTUD2;KIF22;CGNL1;RAB27A;DHX34;TUBB;PSMC3;BRIP1;DDX24;MYO1E
14331,GO:0061512,0.685887856019187,0.587644586649035,2,30,protein localization to cilium,BP,EHD1;CC2D2A
4026,GO:0009058,0.686126999979483,0.339081506821433,369,4935,biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;ODC1;CYP1B1;CTGF;ADM;FOSL2;NQO1;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;FADS3;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;PTGES;FBN1;TGFB2;EDN1;MAT2A;DAPK3;TET3;B4GALT1;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;AHR;JUNB;MCM5;HS3ST2;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;SCD;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;KRT17;FOSL1;PGD;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TK1;GEMIN5;KLF7;ZNF503;CHP1;HMGCS1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;PMM2;STAT5A;LYPD6B;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;NMT2;TOX4;ST6GALNAC5;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;DHCR7;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;HS3ST1;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;U2AF2;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;AJUBA;GINS2;USP43;PPIP5K1;DNTTIP2;PDGFB;AASS;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;SERPINH1;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;BAMBI;AFAP1L2;TRAM2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;PCYT1A;GALNT2;DUSP1;TGFBRAP1;CITED2;CD109;RPL27A;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;GINS3;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;UAP1L1;DAG1;TMEM165;POLR3H;MGAT2;EEF1D;RAB27A;TIMELESS;DPM3;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH
6098,GO:0019318,0.686139312806551,0.425050504991752,12,172,hexose metabolic process,BP,IGFBP3;C1QTNF1;B4GALT1;G6PD;IRS1;TNF;PMM2;PGK1;PPP1R3B;IRS2;CPT1A;DCXR
16756,GO:0098534,0.686827249019341,0.586541470037806,2,30,centriole assembly,BP,CNTROB;RBM14
7930,GO:0032507,0.686996366703204,0.50645206295714,4,61,maintenance of protein location in cell,BP,PML;HNRNPU;INSIG1;DAG1
2525,GO:0005779,0.687985385095286,0.690133595205827,1,15,integral component of peroxisomal membrane,CC,PXMP2
7263,GO:0031231,0.687985385095286,0.690133595205827,1,15,intrinsic component of peroxisomal membrane,CC,PXMP2
273,GO:0000775,0.688231874959187,0.422682185995498,12,173,chromosome, centromeric region,CC,DAXX;CBX5;DCTN1;ZW10;RCC2;HNRNPU;CLASP1;CENPN;CENPO;INCENP;KIF22;CDCA5
3167,GO:0006778,0.688287606731484,0.584458769194083,2,31,porphyrin-containing compound metabolic process,BP,CYP1A1;NFE2L1
12233,GO:0048490,0.688555341785918,0.689489110248985,1,15,anterograde synaptic vesicle transport,BP,BLOC1S2
17039,GO:0099514,0.688555341785918,0.689489110248985,1,15,synaptic vesicle cytoskeletal transport,BP,BLOC1S2
17042,GO:0099517,0.688555341785918,0.689489110248985,1,15,synaptic vesicle transport along microtubule,BP,BLOC1S2
4788,GO:0010977,0.68867462850286,0.456961108245831,7,103,negative regulation of neuron projection development,BP,EFNB2;NTN1;DPYSL3;SEMA3C;YWHAH;ZNF365;EFNA1
3029,GO:0006575,0.688725247330241,0.439379168475054,9,134,cellular modified amino acid metabolic process,BP,PTGES;G6PD;PANK2;TYMS;STAT5A;SLC5A6;DHFR;LPCAT3;GCLC
14133,GO:0060999,0.689252765610738,0.583683670742088,2,30,positive regulation of dendritic spine development,BP,NRG1;BAIAP2
10263,GO:0043001,0.689462621775863,0.583435764263761,2,30,Golgi to plasma membrane protein transport,BP,ARFRP1;SPTBN1
2955,GO:0006486,0.689669301640892,0.41278035059224,14,201,protein glycosylation,BP,TET3;B4GALT1;LFNG;GALNT18;CHP1;PMM2;ST6GALNAC5;IL15;SLC35C2;GALNT2;DAG1;TMEM165;MGAT2;DPM3
10510,GO:0043413,0.689669301640892,0.41278035059224,14,201,macromolecule glycosylation,BP,TET3;B4GALT1;LFNG;GALNT18;CHP1;PMM2;ST6GALNAC5;IL15;SLC35C2;GALNT2;DAG1;TMEM165;MGAT2;DPM3
6446,GO:0021762,0.690426007758294,0.581931655341849,2,31,substantia nigra development,BP,G6PD;YWHAH
5620,GO:0016675,0.690547223190015,0.684101142088053,1,19,oxidoreductase activity, acting on a heme group of donors,MF,COX5B
1113,GO:0002702,0.690668765822526,0.532166892068516,3,46,positive regulation of production of molecular mediator of immune response,BP,TFRC;RSAD2;TRAF2
10897,GO:0044440,0.691106333955008,0.381234672705545,28,393,endosomal part,CC,PML;TFRC;HLA-B;IKBKE;STEAP4;MYO1B;STOML1;LAMP1;EHD1;KREMEN2;ADRB2;ZFYVE27;HLA-F;ANXA8;AP4S1;RHOB;SPPL2A;SNX8;RCC2;TGFBRAP1;TRAPPC5;CHMP4B;TMEM165;RAB27A;VPS52;SPG21;CLTA;SNF8
11896,GO:0046916,0.691197303171904,0.480770760925911,5,78,cellular transition metal ion homeostasis,BP,FTL;FTH1;TFRC;ACO1;ABCG2
14118,GO:0060976,0.691222435429296,0.581352782718526,2,30,coronary vasculature development,BP,GPER1;SRF
5696,GO:0016817,0.691831662623454,0.362659507133022,50,688,hydrolase activity, acting on acid anhydrides,MF,TAP1;ABCF1;GBP1;MYO1B;RAB32;MCM5;GNL3L;NAV2;EIF5;ARFRP1;DDX23;KIF23;MYO10;MCM2;LSG1;ABCF2;DHX37;DDX42;RHOB;TSR1;ABCG2;DDX17;GINS2;DDX47;DDX49;WDR34;DCTN1;MYH9;DDX39A;PRUNE2;GPN1;TAPBP;RRAD;RUVBL2;HSPA8;MCM7;RHOG;XRCC6;TAP2;KIF24;EFTUD2;KIF22;CGNL1;RAB27A;DHX34;TUBB;PSMC3;BRIP1;DDX24;MYO1E
5697,GO:0016818,0.691831662623454,0.362659507133022,50,688,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TAP1;ABCF1;GBP1;MYO1B;RAB32;MCM5;GNL3L;NAV2;EIF5;ARFRP1;DDX23;KIF23;MYO10;MCM2;LSG1;ABCF2;DHX37;DDX42;RHOB;TSR1;ABCG2;DDX17;GINS2;DDX47;DDX49;WDR34;DCTN1;MYH9;DDX39A;PRUNE2;GPN1;TAPBP;RRAD;RUVBL2;HSPA8;MCM7;RHOG;XRCC6;TAP2;KIF24;EFTUD2;KIF22;CGNL1;RAB27A;DHX34;TUBB;PSMC3;BRIP1;DDX24;MYO1E
11691,GO:0046475,0.692055336667554,0.685508299157641,1,15,glycerophospholipid catabolic process,BP,GPCPD1
5518,GO:0016482,0.692103051075617,0.435661511042518,9,131,cytosolic transport,BP,EMP2;LAMP1;ARFRP1;GOSR1;SNX12;DCTN1;SNX8;VPS52;SNF8
20101,GO:2000772,0.692796658832835,0.579117468369352,2,31,regulation of cellular senescence,BP,NUAK1;CDKN2A
6939,GO:0030547,0.69321785265455,0.684177218260433,1,15,receptor inhibitor activity,MF,CCL5
12688,GO:0050905,0.693233772651256,0.529332429839577,3,45,neuromuscular process,BP,NRG1;NEFL;CNTNAP1
3069,GO:0006635,0.693544482984255,0.4987814092567,4,61,fatty acid beta-oxidation,BP,IRS1;ACAA1;IRS2;CPT1A
13658,GO:0060170,0.693840311703481,0.528612756108039,3,45,ciliary membrane,CC,EHD1;PHLPP1;PDE6A
12160,GO:0048268,0.693893250546369,0.683401845349103,1,15,clathrin coat assembly,BP,CLTA
611,GO:0001779,0.693937228330695,0.68335130563971,1,15,natural killer cell differentiation,BP,IL15
5801,GO:0017053,0.693984484357369,0.477887674836491,5,74,transcriptional repressor complex,CC,CBX5;SPEN;MTA2;JUN;SMARCC2
3309,GO:0007009,0.694278677289135,0.498047502398152,4,60,plasma membrane organization,BP,TGFB2;BAIAP2;SPTBN1;BAIAP2L2
2542,GO:0005801,0.694301279009538,0.52786365198953,3,46,cis-Golgi network,CC,CTGF;GOSR1;SLC35C2
6541,GO:0021953,0.694417806659686,0.462140218203953,6,89,central nervous system neuron differentiation,BP,INHBA;MAP2;FGFR2;SFRP1;ROBO1;ABT1
10806,GO:0044291,0.694636751519558,0.527666677887786,3,45,cell-cell contact zone,CC,VCL;YWHAH;BAIAP2L2
853,GO:0002181,0.695155098821095,0.475598236065675,5,85,cytoplasmic translation,BP,DPH2;RPLP2;RPLP1;RPL27A;RBM4
2877,GO:0006370,0.695193128873998,0.575916039032153,2,32,7-methylguanosine mRNA capping,BP,SUPT5H;POLR2G
5283,GO:0015936,0.695747980642637,0.681264817070941,1,15,coenzyme A metabolic process,BP,PANK2
2975,GO:0006516,0.695849562438982,0.681147444706179,1,15,glycoprotein catabolic process,BP,ADAMTS9
12517,GO:0050660,0.696240927190223,0.495732723920332,4,60,flavin adenine dinucleotide binding,MF,TXNRD1;CYB5R1;MICAL3;DUS2
6857,GO:0030326,0.696548859438463,0.459665417050629,6,89,embryonic limb morphogenesis,BP,TGFB2;PBX1;OSR2;FRAS1;BMP7;TP63
8997,GO:0035113,0.696548859438463,0.459665417050629,6,89,embryonic appendage morphogenesis,BP,TGFB2;PBX1;OSR2;FRAS1;BMP7;TP63
13221,GO:0051881,0.696895723475006,0.524396783831487,3,48,regulation of mitochondrial membrane potential,BP,PANK2;GCLC;PARP1
8741,GO:0034389,0.696969627879933,0.679850992627501,1,15,lipid particle organization,BP,PTGFRN
9084,GO:0035335,0.697009575893778,0.474252452733952,5,75,peptidyl-tyrosine dephosphorylation,BP,DUSP14;PTPN14;DUSP1;PTPRB;DUSP8
11070,GO:0045070,0.697107772288596,0.573965515110378,2,31,positive regulation of viral genome replication,BP,HSPA8;CCL5
96,GO:0000186,0.697143400516004,0.524681020818264,3,45,activation of MAPKK activity,BP,MAP3K14;GADD45B;RAPGEF1
1708,GO:0004298,0.697216589096236,0.67704615162246,1,18,threonine-type endopeptidase activity,MF,PSMB9
14520,GO:0070003,0.697216589096236,0.67704615162246,1,18,threonine-type peptidase activity,MF,PSMB9
13250,GO:0051926,0.697284608537993,0.573753238771593,2,31,negative regulation of calcium ion transport,BP,ICAM1;RRAD
11869,GO:0046873,0.697381571845051,0.404200778445415,14,199,metal ion transmembrane transporter activity,MF,JPH2;TFRC;PANX1;JPH1;SLC39A1;ITGAV;SLC5A6;KCNA7;SLC4A11;KCNIP3;SLC41A2;SLC4A2;SLC3A2;SLC25A22
7175,GO:0031056,0.697479405967086,0.437363052596899,8,117,regulation of histone modification,BP,TP53;AKAP8L;LIF;SNAI2;AKAP8;NELFE;RUVBL2;NOC2L
20055,GO:2000679,0.697629639729648,0.679085084302261,1,15,positive regulation of transcription regulatory region DNA binding,BP,PARP1
2517,GO:0005770,0.697661139120481,0.40767515582568,13,189,late endosome,CC,SQSTM1;STOML1;LAMP1;ANXA8;RHOB;NEDD4L;SPPL2A;M6PR;HSPA8;CHMP4B;TMEM165;RAB27A;SNF8
11904,GO:0046931,0.697684636592012,0.679021197701289,1,15,pore complex assembly,BP,NUP153
11468,GO:0045922,0.697792941724326,0.678895356459454,1,15,negative regulation of fatty acid metabolic process,BP,INSIG1
18478,GO:1903579,0.697959955312723,0.678701224121493,1,15,negative regulation of ATP metabolic process,BP,PARP1
17899,GO:1902188,0.698042851960892,0.678604832499773,1,15,positive regulation of viral release from host cell,BP,CHMP4B
4139,GO:0009200,0.698057683794577,0.677638657139928,1,16,deoxyribonucleoside triphosphate metabolic process,BP,TYMS
14942,GO:0070828,0.698263919453295,0.6783476642958,1,15,heterochromatin organization,BP,CDKN2A
3673,GO:0008170,0.698265142522802,0.472779268367379,5,75,N-methyltransferase activity,MF,RBBP5;PRDM7;TRMT1;METTL16;METTL21A
16086,GO:0090050,0.698408935137464,0.67817887835131,1,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,HDAC9
8215,GO:0032968,0.698722405464118,0.677813784514469,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,SUPT16H
2937,GO:0006458,0.698819963905411,0.522474892426995,3,46,'de novo' protein folding,BP,BAG1;DNAJB1;HSPA8
2201,GO:0005086,0.698846727626419,0.6776688971709,1,15,ARF guanyl-nucleotide exchange factor activity,MF,CYTH1
3054,GO:0006613,0.699195664468726,0.470156998338515,5,96,cotranslational protein targeting to membrane,BP,RPLP2;RPLP1;RPS2;RPS9;RPL27A
13838,GO:0060438,0.699732742360938,0.676634814853171,1,15,trachea development,BP,SRF
11018,GO:0044853,0.699777707656609,0.491544214689571,4,60,plasma membrane raft,CC,IRS1;CORO1C;SMPD2;DAG1
9714,GO:0038128,0.699798985678395,0.570726796205737,2,31,ERBB2 signaling pathway,BP,NRG1;PRKCA
10425,GO:0043268,0.700129044729698,0.676171428409179,1,15,positive regulation of potassium ion transport,BP,FLNA
16430,GO:0097066,0.700602794934224,0.675616788843282,1,15,response to thyroid hormone,BP,GCLC
5149,GO:0015682,0.70064241347343,0.569362893828457,2,32,ferric iron transport,BP,TFRC;STEAP4
15816,GO:0072512,0.70064241347343,0.569362893828457,2,32,trivalent inorganic cation transport,BP,TFRC;STEAP4
2378,GO:0005509,0.700694467184422,0.373436050835348,26,368,calcium ion binding,MF,S100P;C1R;PCDH7;FBN1;HRNR;GNPTAB;HSPG2;EHD1;DST;TPM4;LCP1;CHP1;ANXA8L1;ANXA8;THBD;NPNT;RASGRP4;CAPNS1;KCNIP3;RPTN;ACTN4;DAG1;NOL3;SWAP70;FBLN2;C1S
3603,GO:0008037,0.700738123235141,0.4902722424589,4,61,cell recognition,BP,B4GALT1;LGALS3;ROBO1;UBAP2L
9195,GO:0035577,0.700823546267988,0.519879135137453,3,47,azurophil granule membrane,CC,B4GALT1;LAMP1;GLIPR1
2968,GO:0006506,0.700836541833216,0.569128118727784,2,32,GPI anchor biosynthetic process,BP,PIGM;DPM3
8715,GO:0034358,0.701410654127671,0.673712809063057,1,16,plasma lipoprotein particle,CC,SAA1
19622,GO:1990777,0.701410654127671,0.673712809063057,1,16,lipoprotein particle,CC,SAA1
4576,GO:0010661,0.701435206261002,0.674640411629179,1,15,positive regulation of muscle cell apoptotic process,BP,CDKN2A
3597,GO:0008023,0.701547675436004,0.519202606038421,3,46,transcription elongation factor complex,CC,NELFE;SUPT5H;SUPT16H
2817,GO:0006281,0.701877572813748,0.362917882815937,34,484,DNA repair,BP,PML;TP53;GADD45A;ASCC2;FANCC;APTX;TFIP11;PRPF19;FEN1;NPAS2;GINS2;USP43;POLA1;UHRF1;COPS3;ORAOV1;SFPQ;PAGR1;RUVBL2;HERC2;ZNF365;XRCC6;SMUG1;CHAF1A;KIF22;TIMELESS;RBM14;BRIP1;SUPT16H;POLR2G;CDCA5;PARP1;TOP3A;APEX2
5528,GO:0016504,0.701936738824811,0.567795831733606,2,32,peptidase activator activity,MF,FN1;PSME2
3302,GO:0006999,0.702110887607039,0.67384614446514,1,15,nuclear pore organization,BP,NUP153
16011,GO:0086019,0.702190546478195,0.673752402886749,1,15,cell-cell signaling involved in cardiac conduction,BP,FLNA
820,GO:0002092,0.702313452236693,0.673607726592695,1,15,positive regulation of receptor internalization,BP,SYK
12892,GO:0051233,0.702612523343233,0.5673221061626,2,31,spindle midzone,CC,RCC2;HNRNPU
7084,GO:0030878,0.702695372987896,0.673157827631244,1,15,thyroid gland development,BP,SRF
15705,GO:0072243,0.70270591399595,0.673145403388079,1,15,metanephric nephron epithelium development,BP,LIF
7733,GO:0032228,0.702906234391399,0.672909222201528,1,15,regulation of synaptic transmission, GABAergic,BP,OXTR
18536,GO:1903725,0.702997332273808,0.517457556845259,3,46,regulation of phospholipid metabolic process,BP,IRS1;LYN;PDGFB
3417,GO:0007200,0.703280318266265,0.566511167632712,2,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;ESR1
10077,GO:0042575,0.703466900711265,0.671286431713271,1,16,DNA polymerase complex,CC,CRCP
3879,GO:0008509,0.704140525812253,0.40041245996559,13,187,anion transmembrane transporter activity,MF,SLC16A2;SLC7A5;SLC16A9;SLCO3A1;SLC7A5P2;FXYD3;SLC7A2;SLC43A2;SLC4A11;SLC22A4;SLC4A2;SLC3A2;SLC25A22
9410,GO:0035970,0.704175293374079,0.671409799144789,1,15,peptidyl-threonine dephosphorylation,BP,DUSP1
13801,GO:0060390,0.704186802179237,0.671396176036788,1,15,regulation of SMAD protein signal transduction,BP,PARP1
9765,GO:0039529,0.704266996548124,0.671301236436277,1,15,RIG-I signaling pathway,BP,BIRC3
11778,GO:0046636,0.704726435293103,0.670756896665998,1,15,negative regulation of alpha-beta T cell activation,BP,SMAD7
20174,GO:2001020,0.704780046918948,0.408846508958904,11,162,regulation of response to DNA damage stimulus,BP,PML;TFIP11;SNAI2;IER3;NPAS2;PTTG1IP;ACKR3;THOC1;ZNF365;TIMELESS;PARP1
6396,GO:0021602,0.704801540945914,0.670667843209812,1,15,cranial nerve morphogenesis,BP,MAFB
1930,GO:0004629,0.704961655927224,0.670477928811926,1,15,phospholipase C activity,MF,CCL5
18364,GO:1903358,0.705314753844139,0.670058803844891,1,15,regulation of Golgi organization,BP,PDE4DIP
4691,GO:0010842,0.705441818702474,0.669907873857061,1,15,retina layer formation,BP,SDK1
13513,GO:0055083,0.705616883054061,0.66969983824669,1,15,monovalent inorganic anion homeostasis,BP,GPCPD1
12344,GO:0048705,0.705759239671184,0.419987950119871,9,132,skeletal system morphogenesis,BP,CTGF;FGFR2;SLC39A1;COL27A1;OSR2;SFRP1;SERPINH1;INSIG1;BMP7
2550,GO:0005819,0.706452726620684,0.375388834181877,21,299,spindle,CC,CYLD;HSPB1;MID1;KLHL21;NEDD9;KIF23;MTUS1;NSUN2;PRPF19;CEP95;DCTN1;MYH9;TBCCD1;ZW10;RCC2;HNRNPU;CLASP1;MICAL3;INCENP;KIF22;CLTA
3750,GO:0008287,0.70647622844683,0.513252741284569,3,46,protein serine/threonine phosphatase complex,CC,TOX4;PPP1R3B;PPP1R9B
18333,GO:1903293,0.70647622844683,0.513252741284569,3,46,phosphatase complex,CC,TOX4;PPP1R3B;PPP1R9B
19883,GO:2000369,0.706531944226476,0.668610718740114,1,15,regulation of clathrin-dependent endocytosis,BP,UBQLN2
17854,GO:1902043,0.706609623592624,0.668518130626034,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1
7072,GO:0030859,0.707115871014537,0.667914210146533,1,15,polarized epithelial cell differentiation,BP,TP63
2345,GO:0005385,0.707142516656201,0.667882399071815,1,15,zinc ion transmembrane transporter activity,MF,SLC39A1
15349,GO:0071577,0.707142516656201,0.667882399071815,1,15,zinc ion transmembrane transport,BP,SLC39A1
11258,GO:0045503,0.70715241513444,0.667870581082156,1,15,dynein light chain binding,MF,WDR34
10967,GO:0044728,0.707240931241221,0.482504810306095,4,61,DNA methylation or demethylation,BP,TET3;MTA2;MPHOSPH8;PARP1
17917,GO:1902229,0.707287100652387,0.56094857403683,2,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;ACKR3
5569,GO:0016581,0.707393322732619,0.667582852168076,1,15,NuRD complex,CC,MTA2
16332,GO:0090545,0.707393322732619,0.667582852168076,1,15,CHD-type complex,CC,MTA2
10283,GO:0043028,0.707444584937925,0.561081575001245,2,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,BIRC3;NOL3
2857,GO:0006346,0.707672936821351,0.667248641987507,1,15,methylation-dependent chromatin silencing,BP,UHRF1
10361,GO:0043174,0.707691010937435,0.666256593065297,1,16,nucleoside salvage,BP,TK1
15988,GO:0080182,0.708281006339908,0.665549160533967,1,16,histone H3-K4 trimethylation,BP,TET3
3411,GO:0007193,0.70833089441141,0.560342490983624,2,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDN1;FLNA
583,GO:0001736,0.708337623862838,0.433873785104193,7,109,establishment of planar polarity,BP,PSMB9;SFRP1;WDR1;PSME2;ROR1;PSMC3;TP63
3387,GO:0007164,0.708337623862838,0.433873785104193,7,109,establishment of tissue polarity,BP,PSMB9;SFRP1;WDR1;PSME2;ROR1;PSMC3;TP63
2001,GO:0004725,0.708373968836974,0.460738618271605,5,76,protein tyrosine phosphatase activity,MF,DUSP14;PTPN14;DUSP1;PTPRB;DUSP8
2940,GO:0006465,0.708452968443343,0.665342742463487,1,16,signal peptide processing,BP,SPPL2A
15997,GO:0086005,0.708508811716758,0.666247941051452,1,15,ventricular cardiac muscle cell action potential,BP,NEDD4L
9013,GO:0035176,0.708876383506693,0.559672465717229,2,31,social behavior,BP,OXTR;DNAJC9
13138,GO:0051703,0.708876383506693,0.559672465717229,2,31,intraspecies interaction between organisms,BP,OXTR;DNAJC9
14796,GO:0070509,0.708876658738924,0.559672127462038,2,31,calcium ion import,BP,LGALS3;PDGFB
13772,GO:0060350,0.709264813204664,0.559194905434857,2,31,endochondral bone morphogenesis,BP,COL27A1;SERPINH1
14502,GO:0061971,0.709264813204664,0.559194905434857,2,31,replacement bone morphogenesis,BP,COL27A1;SERPINH1
10729,GO:0044070,0.70940392682866,0.509500693576389,3,47,regulation of anion transport,BP,EDN1;IRS2;SYK
17005,GO:0099094,0.709661759395889,0.558706486011652,2,31,ligand-gated cation channel activity,MF,JPH2;JPH1
1432,GO:0003407,0.709913123143119,0.5583969941475,2,31,neural retina development,BP,TGFB2;SDK1
17530,GO:1901020,0.710361764333869,0.663044568498381,1,16,negative regulation of calcium ion transmembrane transporter activity,BP,RRAD
2701,GO:0006066,0.710613886496649,0.382666834352644,16,232,alcohol metabolic process,BP,CYP1B1;G6PD;NFE2L1;NFKB1;TNF;SCD;LSS;CLN6;HMGCS1;EBP;DHCR7;GPER1;DHFR;PPIP5K1;INSIG1;QDPR
4888,GO:0014808,0.71107561600158,0.662181827188411,1,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,NOL3
18432,GO:1903514,0.71107561600158,0.662181827188411,1,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,NOL3
12345,GO:0048706,0.71172839671407,0.456739523467868,5,76,embryonic skeletal system development,BP,FGFR2;PBX1;SLC39A1;OSR2;BMP7
7893,GO:0032461,0.711917141174204,0.661162487374974,1,16,positive regulation of protein oligomerization,BP,TP53
1761,GO:0004364,0.711955081610825,0.659490879764223,1,18,glutathione transferase activity,MF,PTGES
275,GO:0000777,0.712268841865782,0.441007017340662,6,92,condensed chromosome kinetochore,CC,ZW10;HNRNPU;CLASP1;CENPN;CENPO;INCENP
4252,GO:0009452,0.712502377551558,0.554521932181812,2,33,7-methylguanosine RNA capping,BP,SUPT5H;POLR2G
9531,GO:0036260,0.712502377551558,0.554521932181812,2,33,RNA capping,BP,SUPT5H;POLR2G
7562,GO:0031904,0.713448617178736,0.659301011023282,1,16,endosome lumen,CC,AP4S1
6048,GO:0019184,0.713773775078105,0.658904722059548,1,16,nonribosomal peptide biosynthetic process,BP,GCLC
11891,GO:0046907,0.713817645227305,0.323626665968612,105,1457,intracellular transport,BP,CRYAB;NRG1;NEFL;TAP1;PML;HSPB1;EMP2;TP53;SQSTM1;GNPTAB;CDKN1A;LYN;RAB32;LAMP1;EHD1;TNF;WWC1;DST;PTPN14;NUP153;ZC3H12A;SRSF2;LCP1;CYB5R1;GEMIN5;CADPS2;CHP1;ARFRP1;GOSR1;KIF23;MYO10;PMM2;SFN;ADRB2;LSG1;USP36;AKAP8L;PARL;ZDHHC3;ANXA8;BANF1;AP4S1;NFKBIA;GEMIN4;RRS1;RPLP2;RHOB;SNX12;U2AF2;RPLP1;REEP1;NTN1;SYK;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;DCTN1;COX5B;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;YWHAH;M6PR;ZDHHC6;UBE2J2;KCNIP3;THOC1;TGFBRAP1;RPL27A;HSPA8;BLOC1S2;CPT1A;TNPO3;TRAPPC5;CHMP4B;RBM4;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;TINAGL1;DAG1;RAB27A;RILPL2;VPS52;TUBB;SRSF7;CLTA;SNF8;HSP90AB1;MAGOH
3899,GO:0008536,0.71396533188507,0.553035358669614,2,32,Ran GTPase binding,MF,RCC1;IPO4
10792,GO:0044262,0.714160008241681,0.38898928939393,13,189,cellular carbohydrate metabolic process,BP,IGFBP3;C1QTNF1;B4GALT1;MGAM;GNPTAB;IRS1;PGD;GANC;PPP1R3B;GPER1;IRS2;PPIP5K1;GBE1
4481,GO:0010498,0.714273054497456,0.354608337409344,29,415,proteasomal protein catabolic process,BP,PML;SPSB1;TP53;UBQLN2;ENC1;PSMB9;UBE2C;UBE4B;RNF19B;PSME2;ABTB2;PRPF19;KCTD10;NSFL1C;NEDD4L;RNF115;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;HERC2;RNF7;RNF185;PSMC3;RNF144B;GCLC;HSP90AB1
2296,GO:0005261,0.714595769240481,0.426798059796075,7,104,cation channel activity,MF,JPH2;PANX1;JPH1;ITGAV;KCNA7;SLC4A11;KCNIP3
13274,GO:0051961,0.714812134322396,0.388223182583517,13,190,negative regulation of nervous system development,BP,NRG1;EFNB2;PBX1;PRPF19;NTN1;DPYSL3;TNFRSF21;SEMA3C;YWHAH;ZNF365;BMP7;CTDSP1;EFNA1
13627,GO:0060122,0.715769577007956,0.656464099163855,1,16,inner ear receptor cell stereocilium organization,BP,SDC4
7031,GO:0030804,0.715948411366584,0.656244714043682,1,16,positive regulation of cyclic nucleotide biosynthetic process,BP,GPER1
14116,GO:0060972,0.716193863016459,0.655943420149956,1,16,left/right pattern formation,BP,CITED2
7423,GO:0031519,0.71628066773776,0.50107585620126,3,47,PcG protein complex,CC,RING1;ZFP42;UBAP2L
5667,GO:0016776,0.716940096113435,0.548999693113143,2,33,phosphotransferase activity, phosphate group as acceptor,MF,TJP2;PPIP5K1
2453,GO:0005665,0.717109321316407,0.653946050010725,1,17,DNA-directed RNA polymerase II, core complex,CC,POLR2G
1705,GO:0004198,0.717281106657911,0.654606227101591,1,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPNS1
2967,GO:0006505,0.717785405150417,0.547942136105232,2,33,GPI anchor metabolic process,BP,PIGM;DPM3
5426,GO:0016279,0.718172342007428,0.498741350444339,3,47,protein-lysine N-methyltransferase activity,MF,RBBP5;PRDM7;METTL21A
14794,GO:0070507,0.718339338993896,0.398850483482063,10,148,regulation of microtubule cytoskeleton organization,BP,MAP2;CYLD;MID1;DCTN1;SLAIN2;HNRNPU;CLASP1;CHMP4B;PHLDB2;RBM14
7604,GO:0031984,0.718412019632162,0.320854420574424,93,1274,organelle subcompartment,CC,CYP1B1;JPH2;CYP1A1;TAP1;PML;FADS3;UGT1A6;HLA-B;PTGES;GBP1;B4GALT1;RSAD2;EMP2;PANX1;NFE2L1;STEAP4;GNPTAB;LFNG;GALNT18;MYO1B;RAB32;HS3ST2;PKMYT1;SCD;DST;CDKAL1;LSS;CLN6;JPH1;SLC39A1;ZC3H12A;CYB5R1;FAM69B;CHP1;ARFRP1;GOSR1;GGCX;ANKS4B;RNF19B;EBP;ST6GALNAC5;ZFYVE27;ZDHHC3;DHCR7;HLA-F;PTGFRN;ABHD4;GPER1;DNAJB2;AP4S1;SGK1;CYP4B1;TRAF2;REEP1;PDGFB;NSFL1C;SPPL2A;TAPBPL;CAMK1G;ZW10;ACSL1;SLC35A4;DNAJC1;TAPBP;M6PR;ZDHHC6;CHST3;APH1A;UBE2J2;TPST1;CREB3;LPCAT3;PCYT1A;GALNT2;ATG101;PIGM;MANEAL;GLIPR2;SCD5;TRAPPC5;INSIG1;RHOG;TAP2;EIF5A;TMEM165;MGAT2;RNF185;DPM3;VPS52;CYTH1;CLTA;LRRC59;FADS1
10197,GO:0042800,0.718446383702005,0.653168350019564,1,16,histone methyltransferase activity (H3-K4 specific),MF,RBBP5
6254,GO:0019835,0.718544625708273,0.652172405738755,1,17,cytolysis,BP,CSF2
7756,GO:0032272,0.718671476102102,0.497936956773672,3,48,negative regulation of protein polymerization,BP,SPTBN1;KANK4;MYADM
7820,GO:0032373,0.718865291596973,0.652650249402986,1,16,positive regulation of sterol transport,BP,NFKBIA
7823,GO:0032376,0.718865291596973,0.652650249402986,1,16,positive regulation of cholesterol transport,BP,NFKBIA
20053,GO:2000677,0.719009877677157,0.546406974644008,2,33,regulation of transcription regulatory region DNA binding,BP,LIF;PARP1
2966,GO:0006501,0.719193151149189,0.546176868346624,2,33,C-terminal protein lipidation,BP,LYPD6B;CD109
9991,GO:0042398,0.719340159141334,0.545992232371079,2,33,cellular modified amino acid biosynthetic process,BP,DHFR;GCLC
9442,GO:0036019,0.719738403699303,0.651568356176684,1,16,endolysosome,CC,CLTA
3555,GO:0007595,0.719874475704125,0.545651123147503,2,32,lactation,BP,STAT5A;OXTR
2962,GO:0006497,0.719885341121942,0.420330503417577,7,108,protein lipidation,BP,LYPD6B;NMT2;ZDHHC3;ZDHHC6;CD109;PIGM;DPM3
11305,GO:0045622,0.719886437763627,0.651384650194719,1,16,regulation of T-helper cell differentiation,BP,SMAD7
9923,GO:0042269,0.720017133622963,0.651222394393402,1,16,regulation of natural killer cell mediated cytotoxicity,BP,LAMP1
3430,GO:0007218,0.720346820023281,0.649934867067422,1,17,neuropeptide signaling pathway,BP,CRCP
7858,GO:0032418,0.720352881827994,0.495853826544418,3,48,lysosome localization,BP,LYN;SYK;BLOC1S2
5378,GO:0016192,0.720540864183552,0.316528472186197,105,1436,vesicle-mediated transport,BP,KRT1;SAA1;FTL;FTH1;MMP9;S100P;FN1;ADM;ACTG1;TAP1;PCDH7;SDC4;TFRC;TGFB2;B4GALT1;MGAM;EMP2;HRNR;SQSTM1;NFKB1;HSPG2;UBQLN2;ADAMTS9;LYN;MYO1B;RAB32;PLEKHO2;ARPC4;LAMP1;EHD1;TNF;BAIAP2;CORO1C;CXCL16;VMP1;QPCT;SIRPA;FLNA;CYB5R1;ACAA1;CADPS2;CHP1;ARFRP1;GOSR1;ITGAV;KIF23;MYO10;ADRB2;SERPINE1;ARPC1B;ZFYVE27;WDR1;ANXA8;RHOB;SNX12;TXLNA;VCL;LGALS3;SYK;PDGFB;SPTBN1;NEDD4L;DCTN1;MYH9;GLIPR1;SNX8;RUNDC1;LILRB3;ZW10;ACKR3;TAPBP;M6PR;CLASP1;MICAL3;CAB39;TGFBRAP1;CD109;HSPA8;BLOC1S2;COMMD9;TRAPPC5;CHMP4B;INSIG1;RHOG;XRCC6;TAP2;ACTN4;SGSM1;RAPGEF1;TINAGL1;KIF22;RAB27A;VPS52;TUBB;CYTH1;PSMC3;CXCL8;MYO1E;PTPRB;CLTA;SNF8;HSP90AB1;LAIR1;CCL5;SH3BP4
4396,GO:0010092,0.720681166929259,0.650397055220538,1,16,specification of animal organ identity,BP,FGFR2
10691,GO:0043968,0.720760243329586,0.65029866296155,1,16,histone H2A acetylation,BP,RUVBL2
2902,GO:0006409,0.720797224059733,0.544489962787858,2,32,tRNA export from nucleus,BP,NUP153;NUP214
15262,GO:0071431,0.720797224059733,0.544489962787858,2,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153;NUP214
6237,GO:0019789,0.720811208367429,0.650235236731282,1,16,SUMO transferase activity,MF,ZBED1
4028,GO:0009060,0.721200678165157,0.464773580827977,4,68,aerobic respiration,BP,PANK2;ACO1;COX5B;CS
8389,GO:0033293,0.721232218146905,0.543300253858786,2,34,monocarboxylic acid binding,MF,AKR1C2;AKR1C1
16859,GO:0098781,0.721326949181714,0.430087770139106,6,94,ncRNA transcription,BP,CD3EAP;SRRT;PHAX;GTF2E1;GTF3C2;POLR2G
7835,GO:0032388,0.721357831037882,0.380691921787308,13,192,positive regulation of intracellular transport,BP,NRG1;TP53;EHD1;ZC3H12A;CYB5R1;CHP1;SFN;USP36;SYK;WDR46;UBE2J2;SNIP1;HSP90AB1
12806,GO:0051100,0.721857612379097,0.40872274873632,8,123,negative regulation of binding,BP,GNL3L;ADRB2;TFIP11;DNAJB2;NFKBIA;PDGFB;RUVBL2;JUN
1475,GO:0003743,0.722126917148487,0.493470042990508,3,49,translation initiation factor activity,MF,EIF5;EIF3B;EIF3I
3773,GO:0008327,0.722298913939426,0.648379608844981,1,16,methyl-CpG binding,MF,UHRF1
11419,GO:0045830,0.723106068215029,0.647369453017738,1,16,positive regulation of isotype switching,BP,TFRC
14109,GO:0060964,0.723417379355832,0.427052710259943,6,103,regulation of gene silencing by miRNA,BP,NUP153;ZC3H12A;AJUBA;NUP214;ESR1;POLR2G
9742,GO:0038201,0.723545694075387,0.646818254750576,1,16,TOR complex,CC,TELO2
823,GO:0002097,0.723618616203864,0.64672675708718,1,16,tRNA wobble base modification,BP,NAT10
3249,GO:0006907,0.723627116132314,0.646716090689476,1,16,pinocytosis,BP,ACTN4
8541,GO:0033866,0.72373272924322,0.646583536666465,1,16,nucleoside bisphosphate biosynthetic process,BP,PANK2
8565,GO:0034030,0.72373272924322,0.646583536666465,1,16,ribonucleoside bisphosphate biosynthetic process,BP,PANK2
8568,GO:0034033,0.72373272924322,0.646583536666465,1,16,purine nucleoside bisphosphate biosynthetic process,BP,PANK2
13493,GO:0055038,0.723866238975736,0.462061498027641,4,63,recycling endosome membrane,CC,HLA-B;EHD1;ZFYVE27;HLA-F
11664,GO:0046426,0.724013471251056,0.540425510718498,2,32,negative regulation of JAK-STAT cascade,BP,PARP14;SOCS1
19046,GO:1904893,0.724013471251056,0.540425510718498,2,32,negative regulation of STAT cascade,BP,PARP14;SOCS1
7129,GO:0030952,0.724093252894031,0.646130737607848,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOB
19191,GO:1905276,0.724135636938005,0.646077474002697,1,16,regulation of epithelial tube formation,BP,SFRP1
10295,GO:0043044,0.724440401912456,0.460694804409805,4,69,ATP-dependent chromatin remodeling,BP,MTA2;CENPN;CENPO;SMARCC2
13574,GO:0060041,0.724972867315716,0.440687447164342,5,77,retina development in camera-type eye,BP,CYP1B1;TGFB2;COL4A1;SDK1;TTLL5
4863,GO:0014704,0.725170195675004,0.538957149444071,2,32,intercalated disc,CC,VCL;YWHAH
12340,GO:0048701,0.725188540712572,0.538933833837958,2,32,embryonic cranial skeleton morphogenesis,BP,FGFR2;SLC39A1
10685,GO:0043949,0.725236066454204,0.64469225524589,1,16,regulation of cAMP-mediated signaling,BP,PRKCA
11130,GO:0045171,0.725354688952507,0.489622108779184,3,48,intercellular bridge,CC,USB1;KIF23;THOC1
141,GO:0000291,0.725521636586034,0.537572569050745,2,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,EDC4;POLR2G
1097,GO:0002686,0.725575634243798,0.643375970493963,1,17,negative regulation of leukocyte migration,BP,PTGER4
2724,GO:0006103,0.725701744108754,0.644104712884356,1,16,2-oxoglutarate metabolic process,BP,STAT5A
17838,GO:1902003,0.725780272474693,0.644005555006725,1,16,regulation of amyloid-beta formation,BP,EFNA1
5615,GO:0016667,0.72611344051117,0.488319981854677,3,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD1;PGK1;TXN2
5858,GO:0017157,0.726144487995783,0.403746594714007,8,121,regulation of exocytosis,BP,SDC4;LYN;LAMP1;CADPS2;SYK;CLASP1;RAB27A;SNF8
16577,GO:0097367,0.726160955332816,0.308882454004781,117,1579,carbohydrate derivative binding,MF,SAA1;RUNX1;CYR61;FN1;CTGF;CCDC80;ACTG1;TAP1;ABCF1;MAP3K14;FBN1;GBP1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;FST;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TNC;TRIO;FGFR2;EPHB6;LAYN;UBE2C;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;SFRP1;ABCF2;DHX37;DDX42;SGK1;RHOB;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;POLA1;DPYSL3;COL5A3;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;RHOG;GPNMB;XRCC6;TAP2;ACTN4;KIF24;BMP7;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;ORC4
19681,GO:2000001,0.726186159993045,0.643492675597148,1,16,regulation of DNA damage checkpoint,BP,THOC1
10863,GO:0044380,0.726460887902763,0.488424705467132,3,47,protein localization to cytoskeleton,BP,MID1;KLHL21;HNRNPU
10678,GO:0043923,0.726527184052439,0.643061284710057,1,16,positive regulation by host of viral transcription,BP,JUN
18924,GO:1904666,0.726671809990174,0.641199452302221,1,18,regulation of ubiquitin protein ligase activity,BP,UBE2C
5845,GO:0017136,0.726818562208229,0.642692352632308,1,16,NAD-dependent histone deacetylase activity,MF,HDAC9
12592,GO:0050768,0.726823339919326,0.37862205635952,12,178,negative regulation of neurogenesis,BP,NRG1;EFNB2;PBX1;PRPF19;NTN1;DPYSL3;SEMA3C;YWHAH;ZNF365;BMP7;CTDSP1;EFNA1
2972,GO:0006511,0.727006604632495,0.333694671657968,36,513,ubiquitin-dependent protein catabolic process,BP,PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;PSMB9;UBE2C;UBE4B;RNF19B;USP36;PSME2;ABTB2;KCTD10;USP43;NSFL1C;NEDD4L;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;USP31;HERC2;RNF7;RNF185;TNFAIP3;PSMC3;RNF144B;SNF8;GCLC;HSP90AB1
10757,GO:0044183,0.727255451782359,0.535968392073116,2,33,protein binding involved in protein folding,MF,HSPB1;HSPA8
9767,GO:0039531,0.727256510243074,0.642137244605037,1,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,BIRC3
3570,GO:0007613,0.727267580262817,0.457869476102042,4,63,memory,BP,SRF;SGK1;FEN1;OXTR
12704,GO:0050922,0.727344147086531,0.535855142805953,2,33,negative regulation of chemotaxis,BP,ROBO1;SEMA3C
9350,GO:0035861,0.727377063888654,0.536145997382904,2,32,site of double-strand break,CC,PRPF19;ORAOV1
2960,GO:0006491,0.727613345689453,0.641684419660814,1,16,N-glycan processing,BP,GNPTAB
3732,GO:0008266,0.728341487925531,0.640758929751238,1,16,poly(U) RNA binding,MF,PABPC4
1928,GO:0004622,0.728354741776454,0.640742065339237,1,16,lysophospholipase activity,MF,PLBD1
4163,GO:0009225,0.728394611574507,0.534512295909016,2,33,nucleotide-sugar metabolic process,BP,PMM2;UAP1L1
6346,GO:0021522,0.728496205886741,0.640562023143539,1,16,spinal cord motor neuron differentiation,BP,ABT1
8540,GO:0033865,0.728529628128149,0.534339488103722,2,33,nucleoside bisphosphate metabolic process,BP,PANK2;TPST1
8546,GO:0033875,0.728529628128149,0.534339488103722,2,33,ribonucleoside bisphosphate metabolic process,BP,PANK2;TPST1
8567,GO:0034032,0.728529628128149,0.534339488103722,2,33,purine nucleoside bisphosphate metabolic process,BP,PANK2;TPST1
14258,GO:0061311,0.728544109663592,0.640501038734119,1,16,cell surface receptor signaling pathway involved in heart development,BP,BMP2
6363,GO:0021544,0.728729578336203,0.640264844750432,1,16,subpallium development,BP,INHBA
8368,GO:0033260,0.729454511821332,0.484294696696185,3,49,nuclear DNA replication,BP,FEN1;GINS2;POLA1
5556,GO:0016567,0.729715671728567,0.321779535386813,50,707,protein ubiquitination,BP,DTX2;SH3RF2;TRIM56;BIRC3;SPSB1;TRAF3;KLHL21;GNL3L;RING1;ENC1;PSMB9;UBE2C;CHP1;UBE4B;RNF19B;ADRB2;DAXX;TRIM22;PSME2;DNAJB2;PRPF19;U2AF2;KCTD10;TRAF2;RPS2;PTTG1IP;NEDD4L;RNF115;UHRF1;SMAD7;KEAP1;UBE2J2;DCUN1D2;SOCS1;HSPBP1;DTX4;ARRDC3;HERC2;KBTBD12;RNF7;MPHOSPH8;RNF185;ASB6;TNFAIP3;PSMC3;TRIML2;RNF144B;GCLC;HSP90AB1;HERC6
4559,GO:0010640,0.729856717279032,0.638826657487773,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
9486,GO:0036120,0.730123354394448,0.638485739206073,1,16,cellular response to platelet-derived growth factor stimulus,BP,ERRFI1
19709,GO:2000050,0.730190129258158,0.638400319879795,1,16,regulation of non-canonical Wnt signaling pathway,BP,SFRP1
7978,GO:0032592,0.730364099351389,0.453800278389659,4,65,integral component of mitochondrial membrane,CC,CPT1A;CHCHD6;TOMM40;SLC25A44
3361,GO:0007097,0.730917057701445,0.637469333767555,1,16,nuclear migration,BP,NTN1
12220,GO:0048469,0.730953191826665,0.418560529952708,6,93,cell maturation,BP,TFCP2L1;G6PD;CDKN1A;TYMS;IL15;CCR6
7697,GO:0032154,0.731054404893606,0.482456459139292,3,48,cleavage furrow,CC,SVIL;RHOB;MYH9
12863,GO:0051184,0.731216898228546,0.637084742309457,1,16,cofactor transmembrane transporter activity,MF,ABCG2
5410,GO:0016254,0.731294817767325,0.636085991406762,1,17,preassembly of GPI anchor in ER membrane,BP,PIGM
14561,GO:0070085,0.731397795355308,0.365385106183728,14,207,glycosylation,BP,TET3;B4GALT1;LFNG;GALNT18;CHP1;PMM2;ST6GALNAC5;IL15;SLC35C2;GALNT2;DAG1;TMEM165;MGAT2;DPM3
14839,GO:0070577,0.731439647993373,0.636798811141171,1,16,lysine-acetylated histone binding,MF,BRD9
17284,GO:0140033,0.731439647993373,0.636798811141171,1,16,acetylation-dependent protein binding,MF,BRD9
5425,GO:0016278,0.731715437707891,0.481620921427734,3,48,lysine N-methyltransferase activity,MF,RBBP5;PRDM7;METTL21A
4255,GO:0009582,0.732763917943392,0.480293725725646,3,48,detection of abiotic stimulus,BP,NMT2;PDE6A;TIMELESS
12153,GO:0048260,0.733146776290145,0.528400852578571,2,33,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;SYK
14684,GO:0070296,0.733892885539248,0.63273362046913,1,17,sarcoplasmic reticulum calcium ion transport,BP,NOL3
692,GO:0001912,0.734052644242815,0.632526638818165,1,17,positive regulation of leukocyte mediated cytotoxicity,BP,LAMP1
2882,GO:0006383,0.734198988099319,0.47811991117492,3,50,transcription by RNA polymerase III,BP,CRCP;GTF3C2;POLR3H
14545,GO:0070059,0.734362862453401,0.478084677161418,3,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PML;TRAF2;CREB3
418,GO:0001105,0.734650852273407,0.526453976523644,2,33,RNA polymerase II transcription coactivator activity,MF,MKL1;CITED2
3590,GO:0008013,0.73469663216083,0.448640033987923,4,63,beta-catenin binding,MF,VCL;SMAD7;RUVBL2;ESR1
330,GO:0000920,0.735393665498243,0.630785368999034,1,17,cell separation after cytokinesis,BP,CHMP4B
6445,GO:0021761,0.735433731192668,0.447599481465329,4,64,limbic system development,BP,NEFL;FGFR2;SRF;ETS1
8734,GO:0034381,0.735563490791517,0.52495479925431,2,34,plasma lipoprotein particle clearance,BP,EHD1;CLTA
9884,GO:0042158,0.735708326479357,0.401312900776617,7,110,lipoprotein biosynthetic process,BP,LYPD6B;NMT2;ZDHHC3;ZDHHC6;CD109;PIGM;DPM3
17560,GO:1901137,0.736620259990541,0.320806772324771,39,554,carbohydrate derivative biosynthetic process,BP,ADM;SDC4;TET3;B4GALT1;G6PD;PANK2;NFKB1;LFNG;GALNT18;HSPG2;HS3ST2;NUP153;BACE2;TYMS;TK1;CHP1;PMM2;PGK1;ST6GALNAC5;GPER1;HS3ST1;IL15;PDGFB;COX5B;NUP214;SLC35C2;CHST3;GALNT2;PIGM;DCXR;TKT;UAP1L1;DAG1;TMEM165;MGAT2;DPM3;RRM2;CTPS1;PARP1
6827,GO:0030286,0.736769577023752,0.523385922239888,2,34,dynein complex,CC,WDR34;DCTN1
12762,GO:0051031,0.736881461666325,0.523555428610901,2,33,tRNA transport,BP,NUP153;NUP214
3703,GO:0008210,0.736909547822248,0.628808714642598,1,17,estrogen metabolic process,BP,CYP1B1
110,GO:0000226,0.737063334464498,0.328277213558705,30,426,microtubule cytoskeleton organization,BP,CRYAB;MAP2;NEFL;CYLD;MYBL2;BIRC3;MID1;GADD45A;FLNA;CHP1;KIF23;CC2D2A;PARD3B;FGFR1OP;DCTN1;SLAIN2;MYH9;ZW10;HNRNPU;CLASP1;RCC1;CHMP4B;CNTROB;PARD3;KIF24;PHLDB2;DAG1;RBM14;TUBB;TTLL5
33,GO:0000062,0.737325605982145,0.628264636717898,1,17,fatty-acyl-CoA binding,MF,ACBD6
2399,GO:0005544,0.737495175095043,0.522755575186945,2,33,calcium-dependent phospholipid binding,MF,ANXA8L1;ANXA8
6020,GO:0019076,0.738404417524495,0.521568671714034,2,33,viral release from host cell,BP,PML;CHMP4B
9371,GO:0035890,0.738404417524495,0.521568671714034,2,33,exit from host,BP,PML;CHMP4B
9372,GO:0035891,0.738404417524495,0.521568671714034,2,33,exit from host cell,BP,PML;CHMP4B
13311,GO:0052126,0.738404417524495,0.521568671714034,2,33,movement in host environment,BP,PML;CHMP4B
13320,GO:0052192,0.738404417524495,0.521568671714034,2,33,movement in environment of other organism involved in symbiotic interaction,BP,PML;CHMP4B
10337,GO:0043130,0.738653730257775,0.443447511426308,4,65,ubiquitin binding,MF,HSPB1;SQSTM1;NSFL1C;TNFAIP3
164,GO:0000339,0.738798722974839,0.626332842998253,1,17,RNA cap binding,MF,GEMIN5
13285,GO:0051973,0.739077155607194,0.52068904165626,2,33,positive regulation of telomerase activity,BP,DKC1;HSP90AB1
6721,GO:0030132,0.739753799176514,0.625075869684996,1,17,clathrin coat of coated pit,CC,CLTA
10740,GO:0044106,0.74030946927163,0.4212825070124,5,84,cellular amine metabolic process,BP,ODC1;NQO1;PSMB9;PSME2;PSMC3
2777,GO:0006206,0.740676094911869,0.623858648564987,1,17,pyrimidine nucleobase metabolic process,BP,TYMS
12826,GO:0051131,0.740774547722798,0.623728515904345,1,17,chaperone-mediated protein complex assembly,BP,HSP90AB1
8582,GO:0034061,0.741025965310954,0.517817542377504,2,34,DNA polymerase activity,MF,DKC1;POLA1
6606,GO:0022627,0.741619541775108,0.514871697256123,2,43,cytosolic small ribosomal subunit,CC,RPS2;RPS9
3233,GO:0006886,0.7416457538635,0.303140028522364,64,917,intracellular protein transport,BP,NRG1;PML;HSPB1;TP53;GNPTAB;CDKN1A;RAB32;EHD1;TNF;PTPN14;NUP153;ZC3H12A;SRSF2;LCP1;CYB5R1;CHP1;PMM2;SFN;USP36;AKAP8L;PARL;ZDHHC3;AP4S1;NFKBIA;RRS1;RPLP2;RHOB;U2AF2;RPLP1;RPS2;PTTG1IP;ALYREF;RPS9;SNX8;RUNDC1;DDX39A;WDR46;NUP214;YWHAH;ZDHHC6;UBE2J2;KCNIP3;THOC1;TGFBRAP1;RPL27A;HSPA8;TNPO3;CHMP4B;INSIG1;HERC2;PARD3;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;DAG1;RAB27A;RILPL2;SRSF7;CLTA;SNF8;HSP90AB1;MAGOH
14860,GO:0070628,0.741682584624652,0.621712976436087,1,18,proteasome binding,MF,SACS
2582,GO:0005874,0.741684149232562,0.33231982360347,23,332,microtubule,CC,SAA1;MAP2;CYLD;MID1;KLHL21;BAIAP2;DST;KIF23;SVIL;MTUS1;DCTN1;TCP11L1;SLAIN2;ZW10;RCC2;HNRNPU;CLASP1;DCXR;KIF24;INCENP;KIF22;TUBB;TTLL5
14146,GO:0061024,0.741807448723526,0.310142318210927,47,664,membrane organization,BP,ACTG1;TAP1;TFRC;TGFB2;EMP2;TP53;ARPC4;BAIAP2;NUP153;CHP1;GOSR1;SFN;ADRB2;AKAP8L;BANF1;IL7R;GPER1;REEP1;PRKCA;NSFL1C;SPTBN1;DCTN1;MYH9;RUNDC1;NUP214;TRAM2;YWHAH;TAPBP;M6PR;TGFBRAP1;HSPA8;BLOC1S2;TFDP1;TRAPPC5;CHMP4B;INSIG1;RHOG;TAP2;CHCHD6;THEM4;SGSM1;MYADM;RILPL2;CLTA;NOL3;TP63;BAIAP2L2
16770,GO:0098573,0.741889393237061,0.439259928939727,4,66,intrinsic component of mitochondrial membrane,CC,CPT1A;CHCHD6;TOMM40;SLC25A44
20093,GO:2000757,0.741992119222306,0.622116002585515,1,17,negative regulation of peptidyl-lysine acetylation,BP,NOC2L
20020,GO:2000641,0.742121238394099,0.621944658144206,1,17,regulation of early endosome to late endosome transport,BP,SNX12
14278,GO:0061351,0.742128875661361,0.419418851098119,5,79,neural precursor cell proliferation,BP,LYN;FGFR2;FLNA;ZNF503;RAPGEF1
3142,GO:0006735,0.742243392879342,0.621782495334574,1,17,NADH regeneration,BP,PGK1
14381,GO:0061621,0.742243392879342,0.621782495334574,1,17,canonical glycolysis,BP,PGK1
14422,GO:0061718,0.742243392879342,0.621782495334574,1,17,glucose catabolic process to pyruvate,BP,PGK1
5658,GO:0016758,0.742328727586999,0.370579860432632,10,152,transferase activity, transferring hexosyl groups,MF,UGT1A6;B4GALT1;LFNG;GALNT18;COLGALT1;GALNT2;GBE1;PIGM;MGAT2;DPM3
10466,GO:0043325,0.742372373233156,0.621611206961143,1,17,phosphatidylinositol-3,4-bisphosphate binding,MF,ANXA8
13082,GO:0051590,0.742532449327922,0.621398531270149,1,17,positive regulation of neurotransmitter transport,BP,GPER1
4023,GO:0009055,0.742627381555292,0.418119204476668,5,88,electron transfer activity,MF,NQO1;TXNRD1;P4HA2;COX5B;QDPR
3947,GO:0008643,0.742676181164034,0.40425783710104,6,93,carbohydrate transport,BP,IRS1;TNF;IRS2;SLC35A4;M6PR;SLC2A6
14513,GO:0065004,0.742695824897625,0.355596642833891,13,213,protein-DNA complex assembly,BP,TP53;TAF4B;DAXX;MCM2;GRWD1;UBTF;ESR1;CENPN;CENPO;IPO4;CHAF1A;PSMC3;PARP1
2559,GO:0005839,0.743230670874119,0.618271985476936,1,20,proteasome core complex,CC,PSMB9
11791,GO:0046655,0.743278452673491,0.620406058096458,1,17,folic acid metabolic process,BP,DHFR
2440,GO:0005640,0.7436268032833,0.619941860091,1,17,nuclear outer membrane,CC,DHCR7
6586,GO:0022414,0.743779675217777,0.302632045534733,59,824,reproductive process,BP,MMP9;CYR61;INHBA;ADM;CYP1A1;TFCP2L1;CSF2;TGFB2;EDN1;BIRC3;B4GALT1;EMP2;PANK2;TAF4B;LFNG;JUNB;TNC;VMP1;FGFR2;PBX1;FOSL1;HMGCS1;ICAM1;FANCC;COL16A1;LIF;SFRP1;SAFB2;THBD;NSUN2;ZFP42;SF1;EGR1;ETS1;ZFP36L1;PDGFB;OXTR;MYH9;IL1A;ORAOV1;ZW10;MAFF;DUSP1;CITED2;ESR1;CCR6;HERC2;BCL2L2;BMP7;UBAP2L;GPX4;WNT4;CD38;SLC4A2;BRIP1;HSP90AB1;TTLL5;TP63;TOP3A
4158,GO:0009220,0.743782400344078,0.618917439778166,1,18,pyrimidine ribonucleotide biosynthetic process,BP,CTPS1
11579,GO:0046132,0.743782400344078,0.618917439778166,1,18,pyrimidine ribonucleoside biosynthetic process,BP,CTPS1
13699,GO:0060251,0.743814446208191,0.619691614644394,1,17,regulation of glial cell proliferation,BP,LYN
12583,GO:0050750,0.744046335492806,0.619382167413525,1,17,low-density lipoprotein particle receptor binding,MF,HSPG2
4859,GO:0014072,0.744154720791323,0.61923745796611,1,17,response to isoquinoline alkaloid,BP,PPP1R9B
10433,GO:0043278,0.744154720791323,0.61923745796611,1,17,response to morphine,BP,PPP1R9B
12933,GO:0051290,0.74415861610378,0.51151771172619,2,43,protein heterotetramerization,BP,RCC1;XRCC6
6734,GO:0030150,0.744279104945776,0.61825360546994,1,18,protein import into mitochondrial matrix,BP,TOMM40
19643,GO:1990841,0.74455943016579,0.51347429361367,2,33,promoter-specific chromatin binding,MF,EGR1;HNRNPU
4301,GO:0009749,0.744607890604909,0.381504986228984,8,125,response to glucose,BP,CTGF;ICAM1;GPER1;SRF;TXN2;EGR1;IRS2;GCLC
467,GO:0001505,0.744735413751826,0.36235226001212,11,166,regulation of neurotransmitter levels,BP,CYP1B1;NQO1;EDN1;TNF;ZC3H12A;CADPS2;ICAM1;GPER1;SLC7A2;HSPA8;HSP90AB1
15326,GO:0071542,0.744850728372554,0.618307073935328,1,17,dopaminergic neuron differentiation,BP,SFRP1
9376,GO:0035902,0.744970145464497,0.618147249298389,1,17,response to immobilization stress,BP,CYP1A1
16858,GO:0098780,0.745085325982333,0.617993040723066,1,17,response to mitochondrial depolarisation,BP,SQSTM1
11753,GO:0046599,0.745425646767744,0.617537094436512,1,17,regulation of centriole replication,BP,RBM14
9165,GO:0035518,0.745636182227324,0.617254796217921,1,17,histone H2A monoubiquitination,BP,RING1
4187,GO:0009264,0.745740924626909,0.61629420410863,1,18,deoxyribonucleotide catabolic process,BP,SMUG1
2973,GO:0006513,0.74577832527652,0.434446748560234,4,65,protein monoubiquitination,BP,RING1;UBE4B;NEDD4L;UHRF1
7036,GO:0030809,0.74594343419439,0.616842495687075,1,17,negative regulation of nucleotide biosynthetic process,BP,PARP1
17479,GO:1900372,0.74594343419439,0.616842495687075,1,17,negative regulation of purine nucleotide biosynthetic process,BP,PARP1
8157,GO:0032886,0.746361497381096,0.36042849322938,11,166,regulation of microtubule-based process,BP,MAP2;CYLD;MID1;LAMP1;DCTN1;SLAIN2;HNRNPU;CLASP1;CHMP4B;PHLDB2;RBM14
8587,GO:0034080,0.746544169785339,0.508962472882833,2,40,CENP-A containing nucleosome assembly,BP,CENPN;CENPO
14393,GO:0061641,0.746544169785339,0.508962472882833,2,40,CENP-A containing chromatin organization,BP,CENPN;CENPO
8233,GO:0032994,0.746610857704661,0.615124095256473,1,18,protein-lipid complex,CC,SAA1
2,GO:0000003,0.747160517584306,0.298952632418169,59,825,reproduction,BP,MMP9;CYR61;INHBA;ADM;CYP1A1;TFCP2L1;CSF2;TGFB2;EDN1;BIRC3;B4GALT1;EMP2;PANK2;TAF4B;LFNG;JUNB;TNC;VMP1;FGFR2;PBX1;FOSL1;HMGCS1;ICAM1;FANCC;COL16A1;LIF;SFRP1;SAFB2;THBD;NSUN2;ZFP42;SF1;EGR1;ETS1;ZFP36L1;PDGFB;OXTR;MYH9;IL1A;ORAOV1;ZW10;MAFF;DUSP1;CITED2;ESR1;CCR6;HERC2;BCL2L2;BMP7;UBAP2L;GPX4;WNT4;CD38;SLC4A2;BRIP1;HSP90AB1;TTLL5;TP63;TOP3A
291,GO:0000795,0.747445047377351,0.614822020437556,1,17,synaptonemal complex,CC,INCENP
17002,GO:0099086,0.747445047377351,0.614822020437556,1,17,synaptonemal structure,CC,INCENP
16980,GO:0099023,0.747642654731531,0.4320754784708,4,65,tethering complex,CC,ZW10;TGFBRAP1;TRAPPC5;VPS52
8005,GO:0032633,0.747683108163572,0.614500865359429,1,17,interleukin-4 production,BP,CD83
17928,GO:1902254,0.74769211719062,0.61366549416099,1,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,PTTG1IP
5460,GO:0016339,0.747898896497824,0.614209558711767,1,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,AJUBA
13642,GO:0060147,0.747974404278589,0.396980755118835,6,106,regulation of posttranscriptional gene silencing,BP,NUP153;ZC3H12A;AJUBA;NUP214;ESR1;POLR2G
14111,GO:0060966,0.747974404278589,0.396980755118835,6,106,regulation of gene silencing by RNA,BP,NUP153;ZC3H12A;AJUBA;NUP214;ESR1;POLR2G
14046,GO:0060795,0.748009657497347,0.614059962031056,1,17,cell fate commitment involved in formation of primary germ layer,BP,ETS2
1700,GO:0004180,0.7483567792294,0.613590808281865,1,17,carboxypeptidase activity,MF,CPA4
8943,GO:0034979,0.748393773208015,0.613540780103588,1,17,NAD-dependent protein deacetylase activity,MF,HDAC9
4978,GO:0015095,0.748864439477328,0.612903797401162,1,17,magnesium ion transmembrane transporter activity,MF,SLC41A2
5155,GO:0015693,0.748864439477328,0.612903797401162,1,17,magnesium ion transport,BP,SLC41A2
18585,GO:1903830,0.748864439477328,0.612903797401162,1,17,magnesium ion transmembrane transport,BP,SLC41A2
18688,GO:1904037,0.748978638333611,0.612749109061314,1,17,positive regulation of epithelial cell apoptotic process,BP,GPER1
16629,GO:0097484,0.749586741740137,0.611924506924556,1,17,dendrite extension,BP,NEDD4L
2996,GO:0006541,0.749810422504152,0.611620811425957,1,17,glutamine metabolic process,BP,CTPS1
3887,GO:0008519,0.749924970130642,0.611465208919229,1,17,ammonium transmembrane transporter activity,MF,SLC22A4
17638,GO:1901361,0.749932236406433,0.306719054813186,38,568,organic cyclic compound catabolic process,BP,CYP24A1;CYP1A1;HSPB1;TET3;NOCT;NUP153;PSMB9;ZC3H12A;ACAA1;PABPC4;PGK1;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;DNASE1;NUP214;TATDN2;YWHAH;HNRNPU;RPL27A;HSPA8;QDPR;EDC4;METTL16;SMUG1;DHX34;PSMC3;POLR2G;MAGOH
6341,GO:0021515,0.749939053032065,0.611446074881055,1,17,cell differentiation in spinal cord,BP,ABT1
6343,GO:0021517,0.749939053032065,0.611446074881055,1,17,ventral spinal cord development,BP,ABT1
16981,GO:0099024,0.750269616908678,0.505551718640066,2,34,plasma membrane invagination,BP,MYH9;RHOG
14491,GO:0061900,0.750281879639956,0.610980036085838,1,17,glial cell activation,BP,JUN
4980,GO:0015101,0.750330619576976,0.610913739947632,1,17,organic cation transmembrane transporter activity,MF,SLC22A4
9051,GO:0035268,0.750572561796878,0.609756698431217,1,18,protein mannosylation,BP,DPM3
10325,GO:0043114,0.750585238408663,0.610567248939026,1,17,regulation of vascular permeability,BP,ADM
6031,GO:0019098,0.750591776625385,0.610558348091811,1,17,reproductive behavior,BP,OXTR
18254,GO:1903077,0.750803763178041,0.610269663778994,1,17,negative regulation of protein localization to plasma membrane,BP,GBP1
5575,GO:0016592,0.751005932897381,0.50426443224819,2,35,mediator complex,CC,MED22;RBM14
7238,GO:0031146,0.751258721401054,0.42693161946455,4,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB9;PSME2;RNF7;PSMC3
9485,GO:0036119,0.751437820894855,0.609405100477811,1,17,response to platelet-derived growth factor,BP,ERRFI1
3160,GO:0006767,0.751534449265966,0.426992034219023,4,66,water-soluble vitamin metabolic process,BP,PANK2;SLC5A6;DHFR;GCLC
3200,GO:0006829,0.751572902585733,0.609220697713347,1,17,zinc ion transport,BP,SLC39A1
11487,GO:0045947,0.752128369045586,0.607631355798565,1,18,negative regulation of translational initiation,BP,RBM4
17024,GO:0099175,0.752198223061308,0.50296216058901,2,34,regulation of postsynapse organization,BP,BAIAP2;EFNA1
4195,GO:0009301,0.752306837253883,0.425893581001994,4,67,snRNA transcription,BP,SRRT;PHAX;GTF2E1;POLR2G
10193,GO:0042795,0.752306837253883,0.425893581001994,4,67,snRNA transcription by RNA polymerase II,BP,SRRT;PHAX;GTF2E1;POLR2G
18647,GO:1903959,0.75241830585576,0.608064913836793,1,17,regulation of anion transmembrane transport,BP,IRS2
6780,GO:0030215,0.752809437089871,0.607529185281779,1,17,semaphorin receptor binding,MF,SEMA3C
9737,GO:0038191,0.75281860650053,0.60751661844667,1,17,neuropilin binding,MF,SEMA3C
20110,GO:2000785,0.752917506189223,0.501993646299396,2,34,regulation of autophagosome assembly,BP,UBQLN2;CHMP4B
3584,GO:0007631,0.752959966770165,0.50163612583919,2,35,feeding behavior,BP,OXTR;CPT1A
2783,GO:0006213,0.753043129893809,0.501241026968294,2,36,pyrimidine nucleoside metabolic process,BP,TK1;CTPS1
10063,GO:0042552,0.753109359507591,0.405576227377903,5,80,myelination,BP,NRG1;TNFRSF21;PARD3;CNTNAP1;DAG1
2825,GO:0006289,0.753234125953858,0.379815425974437,7,113,nucleotide-excision repair,BP,TP53;FANCC;PRPF19;COPS3;ORAOV1;POLR2G;PARP1
9990,GO:0042393,0.753779644848321,0.351462904695252,11,172,histone binding,MF,DAXX;MCM2;GRWD1;CBX5;UHRF1;RBBP5;BRD9;RCC1;NOC2L;MPHOSPH8;SUPT16H
10257,GO:0042995,0.754043667529446,0.282421661209643,95,1306,cell projection,CC,CRYAB;NRG1;MAP2;S100P;NEFL;TENM3;AMOT;SACS;NEFM;NQO1;CYLD;HSPB1;TGFB2;B4GALT1;PANX1;SQSTM1;NEDD9;MYO1B;ARPC4;LAMP1;EHD1;BAIAP2;CORO1C;WWC1;DST;GPRIN1;PDPN;EPHB6;FOSL1;LAYN;FLNA;LCP1;EPHA2;ITGAV;L1CAM;MYO10;ANKS4B;SVIL;TNFRSF12A;IQCJ-SCHIP1;SLC5A6;FUS;TPM1;ZFYVE27;CC2D2A;WDR1;EPPK1;GPER1;TXN2;KCNA7;DOCK10;ADAM17;FGFR1OP;ROBO1;AJUBA;OXTR;WDR34;SPTBN1;DCTN1;DPYSL3;MYH9;CAMK1G;TNFRSF21;SPRY4;ROR1;ENAH;TJP1;PQBP1;CEP41;PPP1R9B;MICAL3;KCNIP3;HSPA8;BLOC1S2;DCXR;CCR6;PARD3;QDPR;CNTNAP1;ACTN4;THEM4;SORBS2;PHLPP1;ELK1;KIF22;MYADM;DAG1;PDE6A;RAB27A;RILPL2;HSP90AB1;SWAP70;TTLL5;TP63;PHACTR4
7078,GO:0030866,0.754540157809263,0.499803279571854,2,34,cortical actin cytoskeleton organization,BP,TNF;KIF23
3172,GO:0006783,0.754567472633907,0.604279274798238,1,18,heme biosynthetic process,BP,NFE2L1
18619,GO:1903902,0.755050900926437,0.450985762088154,3,51,positive regulation of viral life cycle,BP,HSPA8;CHMP4B;CCL5
3194,GO:0006820,0.755556972335783,0.316539962321054,23,335,anion transport,BP,SLC16A2;NFKBIE;EDN1;SLC7A5;SLC16A9;CYB5R1;SLCO3A1;SLC7A5P2;SLC5A6;FXYD3;IRS2;SYK;SLC7A2;ACSL1;SLC35C2;SLC43A2;SLC4A11;SLC22A4;CPT1A;AKR1C1;SLC4A2;SLC3A2;SLC25A22
18399,GO:1903427,0.755675829806988,0.602747882858417,1,18,negative regulation of reactive oxygen species biosynthetic process,BP,ZC3H12A
3061,GO:0006623,0.755681968303284,0.498257424507301,2,34,protein targeting to vacuole,BP,GNPTAB;HSPA8
17695,GO:1901576,0.755732102361125,0.266787905659412,363,4895,organic substance biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;ODC1;CYP1B1;CTGF;ADM;FOSL2;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;SDC4;FADS3;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;PTGES;FBN1;TGFB2;EDN1;MAT2A;DAPK3;TET3;B4GALT1;ELMSAN1;G6PD;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;GALNT18;CDKN1A;HSPG2;AHR;JUNB;MCM5;HS3ST2;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;SCD;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;LSS;KRT17;FOSL1;PGD;TYMS;ZC3H12A;FLNA;SRSF2;CYB5R1;TK1;GEMIN5;KLF7;ZNF503;CHP1;HMGCS1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ITGAV;ERRFI1;PMM2;STAT5A;LYPD6B;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;EBP;NMT2;TOX4;ST6GALNAC5;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;DHCR7;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;HS3ST1;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;U2AF2;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;DDX17;NFKBIB;AJUBA;GINS2;USP43;PPIP5K1;DNTTIP2;PDGFB;AASS;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;PCYT1A;GALNT2;DUSP1;TGFBRAP1;CITED2;CD109;RPL27A;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;DCXR;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;GINS3;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;UAP1L1;DAG1;TMEM165;POLR3H;MGAT2;EEF1D;TIMELESS;DPM3;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH
10800,GO:0044275,0.75579819824846,0.498099853052405,2,34,cellular carbohydrate catabolic process,BP,MGAM;PPP1R3B
14637,GO:0070207,0.755804274033358,0.60257008266349,1,18,protein homotrimerization,BP,TRAF2
7193,GO:0031082,0.756378280540109,0.601774664292509,1,18,BLOC complex,CC,BLOC1S2
19716,GO:2000059,0.756760008443177,0.496209631545347,2,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,PML;HSP90AB1
2298,GO:0005267,0.756924275754372,0.496571209650034,2,34,potassium channel activity,MF,KCNA7;KCNIP3
9311,GO:0035767,0.757044268722741,0.600850051727552,1,18,endothelial cell chemotaxis,BP,HSPB1
10109,GO:0042626,0.757486777645782,0.419330721401674,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,TAP1;ABCG2;TAPBP;TAP2
5398,GO:0016235,0.757492711038528,0.495798158216384,2,34,aggresome,CC,SQSTM1;URB2
17826,GO:1901984,0.757801095709648,0.599797059308771,1,18,negative regulation of protein acetylation,BP,NOC2L
18923,GO:1904659,0.757849564323141,0.418973152769693,4,65,glucose transmembrane transport,BP,IRS1;TNF;IRS2;SLC2A6
3799,GO:0008376,0.758014426006663,0.495087813433505,2,34,acetylgalactosaminyltransferase activity,MF,GALNT18;GALNT2
2288,GO:0005246,0.758339527996658,0.599046453516274,1,18,calcium channel regulator activity,MF,SGK1
855,GO:0002183,0.758390522035492,0.598975301331336,1,18,cytoplasmic translational initiation,BP,RBM4
4356,GO:0009952,0.758588606223388,0.364537833003028,8,124,anterior/posterior pattern specification,BP,LFNG;RING1;PBX1;BMP2;SFRP1;SRF;SEMA3C;ETS2
19068,GO:1904949,0.758671854636978,0.398445741471218,5,81,ATPase complex,CC,DAXX;ABCF2;MTA2;RUVBL2;SMARCC2
1126,GO:0002715,0.758912041333333,0.59824699119557,1,18,regulation of natural killer cell mediated immunity,BP,LAMP1
6307,GO:0019941,0.758937224762452,0.298288650889048,36,521,modification-dependent protein catabolic process,BP,PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;PSMB9;UBE2C;UBE4B;RNF19B;USP36;PSME2;ABTB2;KCTD10;USP43;NSFL1C;NEDD4L;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;USP31;HERC2;RNF7;RNF185;TNFAIP3;PSMC3;RNF144B;SNF8;GCLC;HSP90AB1
13047,GO:0051537,0.759235073855273,0.597044687706693,1,19,2 iron, 2 sulfur cluster binding,MF,CISD3
5444,GO:0016311,0.759533663699527,0.30905314711589,25,363,dephosphorylation,BP,IGFBP3;DUSP14;TGFB2;SH3RF2;NUAK1;TNF;PKMYT1;PTPN14;CHP1;BMP2;APTX;PPP1R3B;CD2BP2;NSFL1C;NPNT;PPP1R14C;PPP1R9B;DUSP1;PHLPP1;CTDSP1;PTPRB;DUSP8;HSP90AB1;SWAP70;PHACTR4
11407,GO:0045806,0.760074306755543,0.491973630814427,2,35,negative regulation of endocytosis,BP,UBQLN2;LGALS3
14377,GO:0061615,0.760275853391683,0.596336945849812,1,18,glycolytic process through fructose-6-phosphate,BP,PGK1
14380,GO:0061620,0.760275853391683,0.596336945849812,1,18,glycolytic process through glucose-6-phosphate,BP,PGK1
8570,GO:0034035,0.760443324362385,0.596101853320863,1,18,purine ribonucleoside bisphosphate metabolic process,BP,TPST1
12478,GO:0050427,0.760443324362385,0.596101853320863,1,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,TPST1
13507,GO:0055076,0.760480133870405,0.381709276437616,6,100,transition metal ion homeostasis,BP,FTL;FTH1;TFRC;STEAP4;ACO1;ABCG2
11600,GO:0046189,0.760635310687713,0.595832199260677,1,18,phenol-containing compound biosynthetic process,BP,TGFB2
4300,GO:0009746,0.760786938678649,0.361719091181604,8,127,response to hexose,BP,CTGF;ICAM1;GPER1;SRF;TXN2;EGR1;IRS2;GCLC
17315,GO:0140142,0.760833221326206,0.595554059315166,1,18,nucleocytoplasmic carrier activity,MF,NUP214
8232,GO:0032993,0.761119973990787,0.353451731961027,9,163,protein-DNA complex,CC,PRPF19;GINS2;POLA1;KCNIP3;ESR1;GTF2E1;XRCC6;MPHOSPH8;PARP1
4679,GO:0010827,0.761146976691974,0.443081360937151,3,50,regulation of glucose transmembrane transport,BP,IRS1;TNF;IRS2
13093,GO:0051603,0.761464792701246,0.291933402548163,41,590,proteolysis involved in cellular protein catabolic process,BP,PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;ENC1;PSMB9;UBE2C;UBE4B;RNF19B;USP36;PSME2;ABTB2;PRPF19;KCTD10;USP43;NSFL1C;NEDD4L;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;USP31;CHMP4B;HERC2;RNF7;TINAGL1;RNF185;TNFAIP3;PSMC3;EFNA1;RNF144B;SNF8;GCLC;HSP90AB1
5670,GO:0016780,0.761528738227993,0.594575262758633,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,GNPTAB
14685,GO:0070300,0.761554152967784,0.594539457486852,1,18,phosphatidic acid binding,MF,JPH2
6985,GO:0030662,0.761559619682203,0.360769148011613,8,127,coated vesicle membrane,CC,TFRC;HLA-B;ADRB2;HLA-F;IL7R;M6PR;HSPA8;CLTA
12860,GO:0051180,0.761580908205563,0.594501760672725,1,18,vitamin transport,BP,SLC5A6
415,GO:0001102,0.76165590791115,0.489805405311938,2,35,RNA polymerase II activating transcription factor binding,MF,SRF;JUN
4683,GO:0010831,0.762017559329804,0.593886106262078,1,18,positive regulation of myotube differentiation,BP,EHD1
3574,GO:0007618,0.76258638743742,0.593082859530305,1,18,mating,BP,OXTR
10002,GO:0042417,0.76300992584913,0.592483871786836,1,18,dopamine metabolic process,BP,TGFB2
3330,GO:0007040,0.763063150641715,0.440359265725412,3,51,lysosome organization,BP,GNPTAB;CLN6;TMEM165
15987,GO:0080171,0.763063150641715,0.440359265725412,3,51,lytic vacuole organization,BP,GNPTAB;CLN6;TMEM165
8556,GO:0033962,0.763115416052393,0.592334562166307,1,18,cytoplasmic mRNA processing body assembly,BP,NOCT
3099,GO:0006672,0.763478582661311,0.411547314268988,4,66,ceramide metabolic process,BP,CYR61;TNF;CLN6;SMPD2
17022,GO:0099173,0.763530033389908,0.411480165454321,4,66,postsynapse organization,BP,BAIAP2;DOCK10;ZNF365;EFNA1
14701,GO:0070325,0.764262324037034,0.590708133605634,1,18,lipoprotein particle receptor binding,MF,HSPG2
13111,GO:0051646,0.764306083754667,0.486155606435965,2,35,mitochondrion localization,BP,NEFL;CLUH
6065,GO:0019213,0.764381596743497,0.438596099452568,3,51,deacetylase activity,MF,HDAC9;BRMS1;MTA2
9632,GO:0036499,0.764386524321016,0.590531663036612,1,18,PERK-mediated unfolded protein response,BP,CXCL8
3203,GO:0006836,0.764812293243446,0.356800564145836,8,126,neurotransmitter transport,BP,CSF2;EDN1;LYN;CADPS2;GPER1;SYK;HSPA8;SLC25A22
13092,GO:0051602,0.764814541067246,0.589922999592024,1,18,response to electrical stimulus,BP,NQO1
6016,GO:0019068,0.764907294240893,0.485039549566633,2,36,virion assembly,BP,CHMP4B;SNF8
10779,GO:0044232,0.765010067892394,0.589644684318124,1,18,organelle membrane contact site,CC,RAB32
18297,GO:1903203,0.765196819586764,0.58937870411516,1,18,regulation of oxidative stress-induced neuron death,BP,PARP1
7366,GO:0031410,0.76523522621978,0.267343665407775,116,1602,cytoplasmic vesicle,CC,KRT1;SAA1;FTL;FTH1;MMP9;S100P;FN1;AMOT;ACTG1;TAP1;PML;PCDH7;TFRC;GPRC5A;HLA-B;TGFB2;EDN1;IKBKE;B4GALT1;MGAM;DBNDD2;TRAF3;EMP2;HRNR;SQSTM1;MARVELD3;STEAP4;NFKB1;UBQLN2;MYO1B;RAB32;STOML1;PLEKHO2;LAMP1;EHD1;TNF;BAIAP2;DST;PDPN;FGFR2;BACE2;QPCT;SIRPA;CYB5R1;ACAA1;CADPS2;CHP1;GOSR1;KREMEN2;ITGAV;SFN;CDC42EP2;ADRB2;SERPINE1;EBP;AMOTL2;ZFYVE27;HLA-F;ANXA8;IL7R;GPER1;AP4S1;RHOB;SNX12;VCL;LGALS3;IL15;SYK;PDGFB;NEDD4L;DPYSL3;SPPL2A;GLIPR1;SNX8;LILRB3;RCC2;ACKR3;CRCP;YWHAH;TAPBP;M6PR;MARVELD2;CAB39;TGFBRAP1;CD109;SOCS1;HSPA8;COMMD9;TRAPPC5;CHMP4B;ARRDC3;RHOG;GPNMB;XRCC6;TAP2;ACTN4;SGSM1;RAPGEF1;ZYX;TMEM165;RAB27A;WNT4;VPS52;TUBB;PSMC3;SPG21;MYO1E;SLC3A2;PTPRB;CLTA;SNF8;HSP90AB1;TBXA2R;LAIR1;BAIAP2L2;SH3BP4
4342,GO:0009894,0.765269660874575,0.281065093358766,54,768,regulation of catabolic process,BP,NRG1;ODC1;PML;HSPB1;DAPK3;NOCT;IRS1;UBQLN2;TNF;NUP153;PSMB9;ZC3H12A;FLNA;CDK4;DRAM1;RNF19B;ADRB2;PABPC4;USP36;TRIM22;PPP1R3B;PSME2;ZFP36L1;DKC1;SNX12;IRS2;PRKCA;ZFP36L2;PTTG1IP;NEDD4L;SNRNP70;NUP214;SMAD7;SUPT5H;KEAP1;HNRNPU;CAPNS1;TRIB1;ATG101;HSPBP1;HSPA8;CPT1A;CHMP4B;METTL16;DHX34;TNFAIP3;PSMC3;EFNA1;RNF144B;POLR2G;SNF8;GCLC;HSP90AB1;SH3BP4
10591,GO:0043555,0.765348922081667,0.58916196047488,1,18,regulation of translation in response to stress,BP,RBM4
14472,GO:0061844,0.765654046398518,0.585604419448027,1,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,HMGN2
4377,GO:0010008,0.765755445332325,0.3019246332534,25,367,endosome membrane,CC,PML;TFRC;HLA-B;IKBKE;STEAP4;MYO1B;STOML1;LAMP1;EHD1;KREMEN2;ADRB2;ZFYVE27;HLA-F;ANXA8;RHOB;SPPL2A;SNX8;RCC2;CHMP4B;TMEM165;RAB27A;VPS52;SPG21;CLTA;SNF8
11653,GO:0046386,0.765823268395647,0.587725817542212,1,19,deoxyribose phosphate catabolic process,BP,SMUG1
10074,GO:0042572,0.766353836753233,0.587727432415083,1,18,retinol metabolic process,BP,CYP1B1
290,GO:0000794,0.766698436734389,0.407334646655863,4,66,condensed nuclear chromosome,CC,RRS1;ORAOV1;RCC1;INCENP
16393,GO:0097006,0.766810960375478,0.435176068583697,3,52,regulation of plasma lipoprotein particle levels,BP,EHD1;LPCAT3;CLTA
4580,GO:0010665,0.767136785103633,0.586606696360643,1,18,regulation of cardiac muscle cell apoptotic process,BP,NOL3
14871,GO:0070647,0.767169162788862,0.274464192778194,67,947,protein modification by small protein conjugation or removal,BP,DTX2;CYLD;SH3RF2;TRIM56;BIRC3;SPSB1;TRAF3;KLHL21;TP53;GNL3L;ZBED1;RING1;ENC1;NUP153;PSMB9;UBE2C;ZC3H12A;CHP1;UBE4B;RNF19B;ADRB2;DAXX;USP36;TRIM22;PSME2;DNAJB2;NFKBIA;EGR1;PRPF19;U2AF2;KCTD10;TRAF2;SENP3;USP43;RPS2;PTTG1IP;NEDD4L;RNF115;UHRF1;COPS3;TNIP2;NUP214;SMAD7;KEAP1;UBE2J2;DCUN1D2;SOCS1;HSPBP1;DTX4;ESR1;USP31;ARRDC3;HERC2;KBTBD12;RNF7;MPHOSPH8;INCENP;RNF185;ASB6;TNFAIP3;PSMC3;TRIML2;RNF144B;GCLC;HSP90AB1;HERC6;OTUD6A
14851,GO:0070603,0.767255215202291,0.406496107458564,4,67,SWI/SNF superfamily-type complex,CC,DAXX;MTA2;RUVBL2;SMARCC2
15965,GO:0075733,0.767381883626848,0.434407939518014,3,52,intracellular transport of virus,BP,NUP153;NMT2;NUP214
9132,GO:0035455,0.76759585475853,0.585186385658786,1,19,response to interferon-alpha,BP,IFIT3
15193,GO:0071333,0.7678486462238,0.38646626108898,5,84,cellular response to glucose stimulus,BP,ICAM1;GPER1;SRF;IRS2;GCLC
5998,GO:0019005,0.768438675743555,0.432984034432014,3,52,SCF ubiquitin ligase complex,CC,SPSB1;ABTB2;RNF7
16875,GO:0098805,0.768455433975258,0.268521484197671,86,1195,whole membrane,CC,CYP24A1;TAP1;PML;PCDH7;SDC4;TFRC;HLA-B;IKBKE;BIRC3;DAPK3;B4GALT1;MGAM;DBNDD2;RSAD2;EMP2;STEAP4;IRS1;LYN;MYO1B;RAB32;STOML1;LAMP1;EHD1;TNF;CORO1C;VMP1;PDPN;SIRPA;CYB5R1;ICAM1;KREMEN2;DRAM1;ITGAV;ADRB2;PGK1;ZFYVE27;DHCR7;HLA-F;ANXA8;IL7R;THBD;RHOB;ADAM17;LGALS3;TRAF2;SERPINH1;SPPL2A;GLIPR1;SNX8;BORCS7;LILRB3;PXMP2;ACSL1;RCC2;TAPBP;M6PR;TGFBRAP1;CD109;HSPA8;BLOC1S2;CPT1A;CHMP4B;RHOG;BCL2L2;TAP2;SMPD2;EFNB1;TOMM40;RAPGEF1;EIF5A;MYADM;DAG1;TMEM165;RNF185;RAB27A;WNT4;VPS52;TUBB;SPG21;PPP2R1B;PTPRB;SLC25A44;CLTA;SNF8;HSP90AB1;LAIR1
2546,GO:0005814,0.76862925371329,0.360789981592912,7,111,centriole,CC,FGFR1OP;WDR34;DCTN1;CEP41;HERC2;CNTROB;KIF24
3367,GO:0007129,0.769468540207536,0.583252935646188,1,18,synapsis,BP,BRIP1
5707,GO:0016836,0.769560087639258,0.478571508116334,2,36,hydro-lyase activity,MF,PUS1;ACO1
5732,GO:0016878,0.769878863349914,0.582660273879442,1,18,acid-thiol ligase activity,MF,ACSL1
3328,GO:0007035,0.769936636260414,0.581811729014749,1,19,vacuolar acidification,BP,CLN6
4785,GO:0010972,0.769986187577286,0.383494998709463,5,87,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB9;PSME2;GPR132;ORAOV1;PSMC3
16718,GO:0097708,0.770049746807616,0.262175004995694,116,1604,intracellular vesicle,CC,KRT1;SAA1;FTL;FTH1;MMP9;S100P;FN1;AMOT;ACTG1;TAP1;PML;PCDH7;TFRC;GPRC5A;HLA-B;TGFB2;EDN1;IKBKE;B4GALT1;MGAM;DBNDD2;TRAF3;EMP2;HRNR;SQSTM1;MARVELD3;STEAP4;NFKB1;UBQLN2;MYO1B;RAB32;STOML1;PLEKHO2;LAMP1;EHD1;TNF;BAIAP2;DST;PDPN;FGFR2;BACE2;QPCT;SIRPA;CYB5R1;ACAA1;CADPS2;CHP1;GOSR1;KREMEN2;ITGAV;SFN;CDC42EP2;ADRB2;SERPINE1;EBP;AMOTL2;ZFYVE27;HLA-F;ANXA8;IL7R;GPER1;AP4S1;RHOB;SNX12;VCL;LGALS3;IL15;SYK;PDGFB;NEDD4L;DPYSL3;SPPL2A;GLIPR1;SNX8;LILRB3;RCC2;ACKR3;CRCP;YWHAH;TAPBP;M6PR;MARVELD2;CAB39;TGFBRAP1;CD109;SOCS1;HSPA8;COMMD9;TRAPPC5;CHMP4B;ARRDC3;RHOG;GPNMB;XRCC6;TAP2;ACTN4;SGSM1;RAPGEF1;ZYX;TMEM165;RAB27A;WNT4;VPS52;TUBB;PSMC3;SPG21;MYO1E;SLC3A2;PTPRB;CLTA;SNF8;HSP90AB1;TBXA2R;LAIR1;BAIAP2L2;SH3BP4
4174,GO:0009247,0.770114898932034,0.430565940648703,3,53,glycolipid biosynthetic process,BP,ST6GALNAC5;PIGM;DPM3
2470,GO:0005686,0.77012374097947,0.5808540629714,1,20,U2 snRNP,CC,PHF5A
6772,GO:0030206,0.770220306148294,0.582166529615425,1,18,chondroitin sulfate biosynthetic process,BP,CHST3
14691,GO:0070306,0.770487516177839,0.581779767004987,1,18,lens fiber cell differentiation,BP,EPHA2
12402,GO:0048843,0.770614483683803,0.581595881120709,1,18,negative regulation of axon extension involved in axon guidance,BP,SEMA3C
5997,GO:0019003,0.77116382797137,0.429299675361936,3,52,GDP binding,MF,GBP1;RHOB;RAB27A
13112,GO:0051647,0.771424647291949,0.580420829677283,1,18,nucleus localization,BP,NTN1
9886,GO:0042162,0.771486882357497,0.476159856843701,2,35,telomeric DNA binding,MF,TELO2;XRCC6
2196,GO:0005070,0.77182468025869,0.475685758744637,2,35,SH3/SH2 adaptor activity,MF,CNTNAP1;BLNK
11204,GO:0045334,0.771837584545529,0.475381420399668,2,36,clathrin-coated endocytic vesicle,CC,MYO1E;CLTA
264,GO:0000731,0.772127546659511,0.399970925057009,4,68,DNA synthesis involved in DNA repair,BP,USP43;POLA1;BRIP1;TOP3A
7227,GO:0031122,0.772185943350475,0.428073428855874,3,51,cytoplasmic microtubule organization,BP,CHP1;SLAIN2;CLASP1
16385,GO:0090734,0.772330070054642,0.474975788133798,2,35,site of DNA damage,CC,PRPF19;ORAOV1
14949,GO:0070840,0.772339831655713,0.579089914113918,1,18,dynein complex binding,MF,DCTN1
3460,GO:0007272,0.772405012941647,0.380726877274759,5,82,ensheathment of neurons,BP,NRG1;TNFRSF21;PARD3;CNTNAP1;DAG1
3795,GO:0008366,0.772405012941647,0.380726877274759,5,82,axon ensheathment,BP,NRG1;TNFRSF21;PARD3;CNTNAP1;DAG1
7880,GO:0032446,0.772614274110367,0.272552837632453,55,787,protein modification by small protein conjugation,BP,DTX2;SH3RF2;TRIM56;BIRC3;SPSB1;TRAF3;KLHL21;GNL3L;ZBED1;RING1;ENC1;NUP153;PSMB9;UBE2C;CHP1;UBE4B;RNF19B;ADRB2;DAXX;TRIM22;PSME2;DNAJB2;EGR1;PRPF19;U2AF2;KCTD10;TRAF2;RPS2;PTTG1IP;NEDD4L;RNF115;UHRF1;NUP214;SMAD7;KEAP1;UBE2J2;DCUN1D2;SOCS1;HSPBP1;DTX4;ARRDC3;HERC2;KBTBD12;RNF7;MPHOSPH8;INCENP;RNF185;ASB6;TNFAIP3;PSMC3;TRIML2;RNF144B;GCLC;HSP90AB1;HERC6
7174,GO:0031055,0.773070249593459,0.472225799128648,2,42,chromatin remodeling at centromere,BP,CENPN;CENPO
18281,GO:1903170,0.773540407236112,0.57656847385542,1,19,negative regulation of calcium ion transmembrane transport,BP,RRAD
4811,GO:0014002,0.774474913519586,0.575199269361753,1,19,astrocyte development,BP,ROR1
4131,GO:0009190,0.775005207826563,0.470917904332798,2,36,cyclic nucleotide biosynthetic process,BP,ADM;GPER1
13383,GO:0052652,0.775005207826563,0.470917904332798,2,36,cyclic purine nucleotide metabolic process,BP,ADM;GPER1
1185,GO:0002832,0.776214784903814,0.469205234735209,2,36,negative regulation of response to biotic stimulus,BP,TRIB1;TNFAIP3
8850,GO:0034643,0.776485961478104,0.572239269122632,1,19,establishment of mitochondrion localization, microtubule-mediated,BP,NEFL
12009,GO:0047497,0.776485961478104,0.572239269122632,1,19,mitochondrion transport along microtubule,BP,NEFL
12008,GO:0047496,0.777179739389749,0.467835639785482,2,36,vesicle transport along microtubule,BP,KIF23;BLOC1S2
15189,GO:0071326,0.777188605053354,0.374278665487516,5,85,cellular response to monosaccharide stimulus,BP,ICAM1;GPER1;SRF;IRS2;GCLC
15191,GO:0071331,0.777188605053354,0.374278665487516,5,85,cellular response to hexose stimulus,BP,ICAM1;GPER1;SRF;IRS2;GCLC
18813,GO:1904380,0.777427645991154,0.570846863380154,1,19,endoplasmic reticulum mannose trimming,BP,RNF185
5931,GO:0018209,0.777460198385987,0.308097988271436,15,227,peptidyl-serine modification,BP,IKBKE;DAPK3;IL24;GALNT18;TNF;LIF;SGK1;PRKCA;SYK;PDGFB;CAMK1G;SMAD7;GALNT2;CAB39;PARP1
6784,GO:0030219,0.777876630976687,0.391441810366138,4,78,megakaryocyte differentiation,BP,RUNX1;CDKN2B;SRF;RBBP5
15975,GO:0080111,0.778244096338304,0.569636325529172,1,19,DNA demethylation,BP,TET3
15781,GO:0072384,0.778271234401441,0.391804081353137,4,68,organelle transport along microtubule,BP,NEFL;LAMP1;KIF23;BLOC1S2
3048,GO:0006605,0.778386667176744,0.290053119064282,23,366,protein targeting,BP,NRG1;GNPTAB;CYB5R1;CHP1;PMM2;USP36;PARL;ZDHHC3;AP4S1;RPLP2;RPLP1;RPS2;RPS9;WDR46;ZDHHC6;UBE2J2;RPL27A;HSPA8;CHMP4B;PARD3;SNIP1;TOMM40;RAB27A
7044,GO:0030817,0.778398284053899,0.569407367990235,1,19,regulation of cAMP biosynthetic process,BP,GPER1
6115,GO:0019362,0.778516464995645,0.339673703005163,8,128,pyridine nucleotide metabolic process,BP,G6PD;NUP153;PGD;PGK1;NUP214;DCXR;TKT;CD38
11705,GO:0046496,0.778516464995645,0.339673703005163,8,128,nicotinamide nucleotide metabolic process,BP,G6PD;NUP153;PGD;PGK1;NUP214;DCXR;TKT;CD38
12768,GO:0051043,0.778643876147721,0.569042454244902,1,19,regulation of membrane protein ectodomain proteolysis,BP,TNF
8347,GO:0033198,0.778787383607817,0.568829093847238,1,19,response to ATP,BP,PANX1
15865,GO:0072583,0.779113638740193,0.465081940199439,2,36,clathrin-dependent endocytosis,BP,UBQLN2;CLTA
6733,GO:0030149,0.779135460723333,0.568311191518479,1,19,sphingolipid catabolic process,BP,SMPD2
13107,GO:0051641,0.779383430157709,0.248292433649511,158,2184,cellular localization,BP,FTL;CRYAB;FTH1;NRG1;NEFL;AMOT;JPH2;TAP1;PML;CYLD;HSPB1;GBP1;MID1;EMP2;KLHL21;TP53;SQSTM1;GNPTAB;CDKN1A;LYN;RAB32;LAMP1;EHD1;TNF;GNL3L;WWC1;DST;PTPN14;NUP153;JPH1;ZC3H12A;FLNA;SRSF2;LCP1;CYB5R1;GEMIN5;CADPS2;EPHA2;CHP1;ARFRP1;GOSR1;KIF23;MYO10;PMM2;SFN;ADRB2;LSG1;USP36;AKAP8L;LIF;PARL;ZFYVE27;ZDHHC3;CC2D2A;ANXA8;BANF1;GPER1;AP4S1;TRIM29;NFKBIA;GEMIN4;RRS1;PRPF19;ZFP36L1;RPLP2;RHOB;DKC1;SNX12;U2AF2;FGFR1OP;VCL;RPLP1;REEP1;NTN1;SYK;POLR1A;AJUBA;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;NEDD4L;DCTN1;COX5B;MYH9;SNX8;RUNDC1;DDX39A;WDR46;TBCCD1;ZW10;RCC2;NUP214;TRAM2;SMAD7;YWHAH;M6PR;ZDHHC6;HNRNPU;CLASP1;UBE2J2;CEP41;RUVBL2;KCNIP3;THOC1;TGFBRAP1;RPL27A;STAC;HSPA8;ESR1;BLOC1S2;PES1;CPT1A;TFDP1;TNPO3;TRAPPC5;CHMP4B;RBM4;INSIG1;HERC2;PARD3;RHOG;TAP2;CNTNAP1;ACTN4;KIF24;SNIP1;BMP7;CLUH;TOMM40;SGSM1;IPO4;EIF5A;TINAGL1;KIF22;MYADM;DAG1;RAB27A;WNT4;RILPL2;VPS52;TUBB;TNFAIP3;CARD10;SRSF7;CLTA;NOL3;SNF8;CDCA5;HSP90AB1;PARP1;TP63;MAGOH;SH3BP4
16728,GO:0097731,0.779474338359276,0.41795079695721,3,52,9+0 non-motile cilium,CC,PHLPP1;PDE6A;RAB27A
16730,GO:0097733,0.779474338359276,0.41795079695721,3,52,photoreceptor cell cilium,CC,PHLPP1;PDE6A;RAB27A
18241,GO:1903051,0.780120970138397,0.41675862363295,3,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,PML;EFNA1;HSP90AB1
12621,GO:0050805,0.780251245766503,0.463456545321512,2,36,negative regulation of synaptic transmission,BP,SRF;CD38
16188,GO:0090207,0.780561535335565,0.566183453219413,1,19,regulation of triglyceride metabolic process,BP,PANK2
9612,GO:0036475,0.780649316633861,0.566052171168958,1,19,neuron death in response to oxidative stress,BP,PARP1
16278,GO:0090342,0.78074495884679,0.46247862123692,2,37,regulation of cell aging,BP,NUAK1;CDKN2A
17466,GO:1900271,0.780835588280954,0.565773471564121,1,19,regulation of long-term synaptic potentiation,BP,SQSTM1
9050,GO:0035267,0.780960772994674,0.565586078899331,1,19,NuA4 histone acetyltransferase complex,CC,RUVBL2
10372,GO:0043189,0.780960772994674,0.565586078899331,1,19,H4/H2A histone acetyltransferase complex,CC,RUVBL2
18171,GO:1902936,0.781195490811752,0.387888587476075,4,68,phosphatidylinositol bisphosphate binding,MF,JPH2;MYO1B;ANXA8;PARD3
18504,GO:1903649,0.781249912759664,0.56515297625934,1,19,regulation of cytoplasmic transport,BP,SNX12
4269,GO:0009620,0.781849785118239,0.563552825287997,1,20,response to fungus,BP,SYK
8475,GO:0033617,0.781991074322536,0.563340489026264,1,20,mitochondrial respiratory chain complex IV assembly,BP,BCS1L
2578,GO:0005868,0.782104037001496,0.563170655675696,1,20,cytoplasmic dynein complex,CC,WDR34
4156,GO:0009218,0.782655861346732,0.562340153141618,1,20,pyrimidine ribonucleotide metabolic process,BP,CTPS1
13254,GO:0051932,0.782762461980795,0.56288091910731,1,19,synaptic transmission, GABAergic,BP,OXTR
3379,GO:0007156,0.78291265281936,0.385684732780645,4,67,homophilic cell adhesion via plasma membrane adhesion molecules,BP,TENM3;PCDH7;ROBO1;SDK1
15880,GO:0072604,0.783087766686138,0.562390855843186,1,19,interleukin-6 secretion,BP,ZC3H12A
335,GO:0000930,0.783150233266746,0.562296694190121,1,19,gamma-tubulin complex,CC,BLOC1S2
11196,GO:0045309,0.783160531757179,0.45928096616939,2,36,protein phosphorylated amino acid binding,MF,IRS1;SYK
14966,GO:0070861,0.78325950153429,0.562131939580685,1,19,regulation of protein exit from endoplasmic reticulum,BP,INSIG1
12181,GO:0048306,0.783328979526006,0.458510206889408,2,38,calcium-dependent protein binding,MF,S100P;CHP1
19731,GO:2000104,0.783347118631774,0.561999789700154,1,19,negative regulation of DNA-dependent DNA replication,BP,TIMELESS
12945,GO:0051304,0.783367076433516,0.384868132139763,4,69,chromosome separation,BP,UBE2C;ZW10;ANAPC15;DUSP1
152,GO:0000307,0.783519394984956,0.45849250401158,2,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A;CDK4
9882,GO:0042149,0.783637882612765,0.458593241017553,2,36,cellular response to glucose starvation,BP,TP53;ZC3H12A
11457,GO:0045911,0.783666156254888,0.561518288417808,1,19,positive regulation of DNA recombination,BP,TFRC
17336,GO:1900006,0.783736742048586,0.412062580761718,3,52,positive regulation of dendrite development,BP,NRG1;BAIAP2;BMP7
202,GO:0000423,0.783845665008231,0.561247155878706,1,19,mitophagy,BP,SQSTM1
1991,GO:0004712,0.783864187162223,0.458266943605286,2,36,protein serine/threonine/tyrosine kinase activity,MF,SGK1;CLK4
15993,GO:0086001,0.783996821055562,0.458075628173184,2,36,cardiac muscle cell action potential,BP,FLNA;NEDD4L
3305,GO:0007005,0.78429664468727,0.272926205886644,32,485,mitochondrion organization,BP,NRG1;MMP9;SOD2;TP53;SQSTM1;PANK2;RAB32;CYB5R1;SFN;USP36;PARL;GPER1;PPRC1;WDR46;YWHAH;UBE2J2;MTFP1;JUN;BLOC1S2;TFDP1;BCS1L;CHCHD6;THEM4;SNIP1;CLUH;TOMM40;HSD17B10;ATAD3C;NOL3;GCLC;PARP1;TP63
16230,GO:0090277,0.784502270084128,0.41084632565013,3,53,positive regulation of peptide hormone secretion,BP,GPER1;IRS2;CD38
12980,GO:0051383,0.784641272402199,0.5600436135278,1,19,kinetochore organization,BP,CENPN
12197,GO:0048365,0.784678417274116,0.410755444142402,3,52,Rac GTPase binding,MF,CORO1C;FLNA;RCC2
18107,GO:1902745,0.784922821836364,0.559616981113729,1,19,positive regulation of lamellipodium organization,BP,CORO1C
16002,GO:0086010,0.784972740661747,0.55954129949801,1,19,membrane depolarization during action potential,BP,YWHAH
14549,GO:0070063,0.785316383104868,0.409714807275588,3,53,RNA polymerase binding,MF,HNRNPU;TCOF1;GTF2E1
5319,GO:0016042,0.785388438830093,0.304978632356408,13,203,lipid catabolic process,BP,CYP1B1;CYP24A1;PLBD1;IRS1;TNF;ACAA1;CDK4;ABHD4;GPCPD1;IRS2;YWHAH;CPT1A;SMPD2
6430,GO:0021696,0.785680387426257,0.558467158149181,1,19,cerebellar cortex morphogenesis,BP,ZNF365
16924,GO:0098901,0.785702321337791,0.558433826196254,1,19,regulation of cardiac muscle cell action potential,BP,FLNA
20108,GO:2000780,0.78628600037133,0.557545987506982,1,19,negative regulation of double-strand break repair,BP,TFIP11
9078,GO:0035327,0.786708277681056,0.556196928819051,1,20,transcriptionally active chromatin,CC,ESR1
14980,GO:0070888,0.786815374583721,0.556739335117493,1,19,E-box binding,MF,AHR
1496,GO:0003841,0.787304203035773,0.555993265475213,1,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,LPCAT3
20017,GO:2000637,0.787494846430001,0.555701984853334,1,19,positive regulation of gene silencing by miRNA,BP,AJUBA
3613,GO:0008053,0.787839061964942,0.554468684147009,1,20,mitochondrial fusion,BP,CHCHD6
5923,GO:0018198,0.787901716023869,0.451888424459779,2,38,peptidyl-cysteine modification,BP,ZDHHC3;ZDHHC6
2644,GO:0005980,0.787905368067817,0.555074158804523,1,19,glycogen catabolic process,BP,PPP1R3B
6292,GO:0019902,0.787917689850244,0.32092305901501,9,142,phosphatase binding,MF,SH3RF2;TRAF3;TP53;IRS2;TRAF2;SYK;PPP1R9B;PARD3;PHACTR4
2388,GO:0005524,0.787990706343092,0.247864005294681,83,1147,ATP binding,MF,RUNX1;ACTG1;TAP1;ABCF1;MAP3K14;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;MCM5;EHD1;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;UBE4B;DDX23;CDK4;KIF23;MYO10;NAT10;PGK1;MCM2;ABCF2;DHX37;DDX42;SGK1;RIPK4;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;NOL9;HNRNPU;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;XRCC6;TAP2;KIF24;KIF22;DHX34;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;CLK4;ORC4
17308,GO:0140103,0.78816914815909,0.554670318901292,1,19,catalytic activity, acting on a glycoprotein,MF,MGAT2
6741,GO:0030159,0.788577321536741,0.554044750856792,1,19,receptor signaling complex scaffold activity,MF,CARD10
18809,GO:1904376,0.788616258123735,0.553985034173388,1,19,negative regulation of protein localization to cell periphery,BP,GBP1
18078,GO:1902668,0.788734089199058,0.553804272781432,1,19,negative regulation of axon guidance,BP,SEMA3C
8686,GO:0034284,0.789323902029376,0.325927163549905,8,131,response to monosaccharide,BP,CTGF;ICAM1;GPER1;SRF;TXN2;EGR1;IRS2;GCLC
5053,GO:0015248,0.789693880063611,0.551620433823435,1,20,sterol transporter activity,MF,ABCG2
17366,GO:1900078,0.789738373519959,0.552260880149463,1,19,positive regulation of cellular response to insulin stimulus,BP,IRS1
13948,GO:0060627,0.78975990544658,0.276993348412123,23,343,regulation of vesicle-mediated transport,BP,SDC4;UBQLN2;LYN;LAMP1;EHD1;TNF;SIRPA;CADPS2;GOSR1;ITGAV;SERPINE1;SNX12;LGALS3;SYK;NEDD4L;RUNDC1;CLASP1;INSIG1;ACTN4;SGSM1;RAPGEF1;RAB27A;SNF8
5742,GO:0016889,0.789876815512151,0.55133861071615,1,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,APEX2
6288,GO:0019898,0.790017420562193,0.303168989398878,12,187,extrinsic component of membrane,CC,PML;CYLD;LYN;ZC3H12A;TNK1;ERRFI1;NMT2;SNX12;SYK;SNX8;SMAD7;CYTH1
12381,GO:0048786,0.790022892526385,0.551822732717531,1,19,presynaptic active zone,CC,GPER1
5971,GO:0018410,0.79053895165227,0.44803823964285,2,38,C-terminal protein amino acid modification,BP,LYPD6B;CD109
12923,GO:0051276,0.790776120703482,0.246958157411509,73,1048,chromosome organization,BP,TRIM16;HDAC9;PML;DAPK3;TET3;TP53;CPA4;MCM5;GNL3L;CDKN2A;RING1;TELO2;UBE2C;KIF23;DAXX;NAT10;MCM2;TOX4;USP36;AKAP8L;GRWD1;LIF;TFIP11;GPER1;SNAI2;RRS1;AKAP8;NELFE;DKC1;FEN1;PRKCA;GINS2;BRMS1;UBTF;POLA1;UHRF1;COPS3;RBBP5;SFPQ;BRD9;ZW10;RCC2;MTA2;HNRNPU;CLASP1;RUVBL2;SAFB;ANAPC15;PRDM7;DUSP1;ESR1;CENPN;BRPF1;MCM7;NOC2L;CHMP4B;CENPO;ZNF365;XRCC6;INCENP;IPO4;CHAF1A;KIF22;RBM14;SMARCC2;BRIP1;SUPT16H;CDCA5;HSP90AB1;MKI67;PARP1;TP63;TOP3A
13258,GO:0051937,0.791207640250358,0.549283458882774,1,20,catecholamine transport,BP,OXTR
3110,GO:0006687,0.791298038050427,0.401348075037533,3,53,glycosphingolipid metabolic process,BP,CLN6;ST6GALNAC5;SMPD2
3749,GO:0008286,0.791620314181496,0.341775584015597,6,100,insulin receptor signaling pathway,BP,IRS1;BAIAP2;CDK4;IRS2;SOCS1;BAIAP2L2
1458,GO:0003700,0.791877493325549,0.244641165171194,78,1085,DNA binding transcription factor activity,MF,MAFB;RUNX1;FOSL2;TFCP2L1;MYBL2;IRX2;RELB;ARID3B;IER2;ELMSAN1;TP53;NFE2L1;HNRNPAB;NOCT;NFKB1;TAF4B;AHR;JUNB;ZBED1;PBX1;NFKB2;FOSL1;KLF7;TSC22D3;STAT5A;FOXD2;TOX4;VGLL3;ELF3;TRIM22;IRF1;NFX1;GPER1;SRF;ELF4;ZFP42;TRIM29;EGR1;ETS1;SNAI2;ZFP36L1;NPAS2;MAFK;ZNF778;ZFP36L2;UBTF;UHRF1;ZNF234;ZNFX1;ZNF263;MAFF;SMAD7;MTA2;CREB3;MAZ;TUSC1;KCNIP3;ETS2;KLF10;ZNF267;PRDM7;CITED2;JUN;ESR1;IKZF3;FOXN1;TFDP1;ZNF772;ZNF132;KLF6;TEAD4;ZNF34;ELK1;PHF5A;HES4;CREB5;PARP1;TP63
10635,GO:0043632,0.791938441096688,0.26103770079275,36,530,modification-dependent macromolecule catabolic process,BP,PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;PSMB9;UBE2C;UBE4B;RNF19B;USP36;PSME2;ABTB2;KCTD10;USP43;NSFL1C;NEDD4L;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;USP31;HERC2;RNF7;RNF185;TNFAIP3;PSMC3;RNF144B;SNF8;GCLC;HSP90AB1
18299,GO:1903205,0.792018982291642,0.548026253189358,1,20,regulation of hydrogen peroxide-induced cell death,BP,TP53
4676,GO:0010824,0.792259973902179,0.445770547970073,2,37,regulation of centrosome duplication,BP,CHMP4B;RBM14
8147,GO:0032873,0.792617269337579,0.445245111304788,2,37,negative regulation of stress-activated MAPK cascade,BP,MARVELD3;SFRP1
14688,GO:0070303,0.792617269337579,0.445245111304788,2,37,negative regulation of stress-activated protein kinase signaling cascade,BP,MARVELD3;SFRP1
2603,GO:0005901,0.793435298204469,0.398335737934202,3,53,caveola,CC,IRS1;CORO1C;SMPD2
6149,GO:0019439,0.7935642512595,0.259103248460012,36,552,aromatic compound catabolic process,BP,CYP1A1;HSPB1;TET3;NOCT;NUP153;PSMB9;ZC3H12A;ACAA1;PABPC4;PGK1;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;DNASE1;NUP214;TATDN2;HNRNPU;RPL27A;HSPA8;QDPR;EDC4;METTL16;SMUG1;DHX34;PSMC3;POLR2G;MAGOH
13118,GO:0051654,0.794142283874727,0.544720678482541,1,20,establishment of mitochondrion localization,BP,NEFL
7901,GO:0032469,0.794595481122828,0.544012227545447,1,20,endoplasmic reticulum calcium ion homeostasis,BP,PML
7458,GO:0031594,0.794816741168872,0.442001097591625,2,37,neuromuscular junction,CC,NRG1;MYH9
11833,GO:0046777,0.79529238572533,0.300981928557642,11,171,protein autophosphorylation,BP,DAPK3;LYN;FGFR2;TNK1;CHP1;ERRFI1;SYK;PDGFB;JUN;GPNMB;CLK4
9491,GO:0036126,0.79559701482125,0.440588786695973,2,38,sperm flagellum,CC,SQSTM1;CCR6
16726,GO:0097729,0.79559701482125,0.440588786695973,2,38,9+2 motile cilium,CC,SQSTM1;CCR6
7932,GO:0032509,0.795637514663894,0.542379384618027,1,20,endosome transport via multivesicular body sorting pathway,BP,SNF8
15970,GO:0080025,0.796013238883043,0.541789293531503,1,20,phosphatidylinositol-3,5-bisphosphate binding,MF,JPH2
17585,GO:1901215,0.797160964189594,0.315929431433422,8,131,negative regulation of neuron death,BP,NEFL;SOD2;TRAF2;JUN;CHMP4B;GPNMB;GCLC;HSP90AB1
4046,GO:0009083,0.797178728011942,0.539954304729331,1,20,branched-chain amino acid catabolic process,BP,HSD17B10
15128,GO:0071218,0.797259859569182,0.539826312008761,1,20,cellular response to misfolded protein,BP,RNF185
1460,GO:0003707,0.797744159197692,0.437657914560982,2,37,steroid hormone receptor activity,MF,GPER1;ESR1
6946,GO:0030554,0.798069241130481,0.236437540065831,85,1178,adenyl nucleotide binding,MF,RUNX1;ACTG1;TAP1;BAG1;ABCF1;MAP3K14;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;MCM5;EHD1;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;UBE4B;DDX23;CDK4;KIF23;MYO10;NAT10;PGK1;MCM2;ABCF2;DHX37;DDX42;SGK1;RIPK4;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;NOL9;HNRNPU;UBE2J2;RUVBL2;ORC1;HSPBP1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;XRCC6;TAP2;KIF24;KIF22;DHX34;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;CLK4;ORC4
12622,GO:0050806,0.798227818901881,0.346379583606857,5,85,positive regulation of synaptic transmission,BP,SQSTM1;BAIAP2;ADRB2;GPER1;OXTR
9636,GO:0036503,0.798335231569908,0.346165449905476,5,86,ERAD pathway,BP,UBQLN2;UBE4B;UBE2J2;RNF185;PSMC3
17689,GO:1901567,0.798393100548422,0.53738716912592,1,21,fatty acid derivative binding,MF,ACBD6
5379,GO:0016197,0.79871627312424,0.296629817308568,11,175,endosomal transport,BP,SQSTM1;EHD1;ARFRP1;GOSR1;ANXA8;DCTN1;SNX8;CHMP4B;TINAGL1;VPS52;SNF8
1929,GO:0004623,0.798837879080903,0.537330171487756,1,20,phospholipase A2 activity,MF,PLBD1
4969,GO:0015078,0.799001074876976,0.362999718367357,4,75,proton transmembrane transporter activity,MF,COX5B;SLC4A11;SLC25A22;SLC2A6
6054,GO:0019201,0.799244469373916,0.53668495782646,1,20,nucleotide kinase activity,MF,TJP2
10377,GO:0043197,0.799403924102806,0.331530621349762,6,100,dendritic spine,CC,CRYAB;BAIAP2;FUS;GPER1;DOCK10;PPP1R9B
3211,GO:0006851,0.799451547802251,0.536356021439294,1,20,mitochondrial calcium ion transmembrane transport,BP,PARL
14842,GO:0070584,0.799751447042172,0.535230181725256,1,21,mitochondrion morphogenesis,BP,PANK2
712,GO:0001937,0.800512883537403,0.534666666382738,1,20,negative regulation of endothelial cell proliferation,BP,TNF
15996,GO:0086004,0.800686480989106,0.534389794088662,1,20,regulation of cardiac muscle cell contraction,BP,FLNA
11840,GO:0046794,0.800749124145395,0.387645532251796,3,55,transport of virus,BP,NUP153;NMT2;NUP214
14113,GO:0060968,0.800758344711467,0.319055390429655,7,127,regulation of gene silencing,BP,NUP153;ZC3H12A;AJUBA;UHRF1;NUP214;ESR1;POLR2G
6009,GO:0019054,0.800884383289568,0.534073967688961,1,20,modulation by virus of host process,BP,ZC3H12A
2558,GO:0005838,0.800954268151252,0.53331224906033,1,21,proteasome regulatory particle,CC,PSMC3
11038,GO:0045010,0.801182049347387,0.432261925187379,2,38,actin nucleation,BP,ARPC4;ARPC1B
17364,GO:1900076,0.802345246411359,0.385497753294277,3,54,regulation of cellular response to insulin stimulus,BP,IRS1;CDK4;SOCS1
2493,GO:0005741,0.802354827813513,0.302484711421963,9,148,mitochondrial outer membrane,CC,CYP24A1;RSAD2;RAB32;ACSL1;CPT1A;BCL2L2;TOMM40;RNF185;SLC25A44
4574,GO:0010659,0.802473355155736,0.531530809262205,1,20,cardiac muscle cell apoptotic process,BP,NOL3
4108,GO:0009163,0.803086191616067,0.428922691339222,2,40,nucleoside biosynthetic process,BP,TK1;CTPS1
12507,GO:0050650,0.803452558778621,0.529957032766357,1,20,chondroitin sulfate proteoglycan biosynthetic process,BP,CHST3
7768,GO:0032288,0.803663562385448,0.529617249763733,1,20,myelin assembly,BP,CNTNAP1
7597,GO:0031968,0.80374028527225,0.295097334139057,10,163,organelle outer membrane,CC,CYP24A1;RSAD2;RAB32;DHCR7;ACSL1;CPT1A;BCL2L2;TOMM40;RNF185;SLC25A44
9892,GO:0042171,0.804106782063094,0.528902763093424,1,20,lysophosphatidic acid acyltransferase activity,MF,LPCAT3
15377,GO:0071617,0.804106782063094,0.528902763093424,1,20,lysophospholipid acyltransferase activity,MF,LPCAT3
17493,GO:1900449,0.804262514064553,0.52865147187388,1,20,regulation of glutamate receptor signaling pathway,BP,ADRB2
13643,GO:0060148,0.804282380083931,0.528619406608092,1,20,positive regulation of posttranscriptional gene silencing,BP,AJUBA
18567,GO:1903793,0.804544963875773,0.527542095979914,1,21,positive regulation of anion transport,BP,EDN1
10689,GO:0043966,0.804564133518156,0.382162122254399,3,55,histone H3 acetylation,BP,TRIM16;LIF;BRPF1
7573,GO:0031935,0.805010404781618,0.527442883026709,1,20,regulation of chromatin silencing,BP,UHRF1
12063,GO:0048011,0.80501243217324,0.527439602750013,1,20,neurotrophin TRK receptor signaling pathway,BP,ZFYVE27
9136,GO:0035459,0.805107237237227,0.527286185981561,1,20,cargo loading into vesicle,BP,INSIG1
17927,GO:1902253,0.805150400534156,0.52596962866858,1,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,PTTG1IP
10732,GO:0044088,0.805604373012374,0.425591407713929,2,38,regulation of vacuole organization,BP,UBQLN2;CHMP4B
2312,GO:0005310,0.805681862675664,0.52635528860978,1,20,dicarboxylic acid transmembrane transporter activity,MF,SLC25A22
3464,GO:0007281,0.805766276161843,0.304807137897672,8,132,germ cell development,BP,PANK2;TAF4B;FANCC;NSUN2;CCR6;WNT4;BRIP1;TTLL5
4088,GO:0009142,0.806043763221988,0.312438183389506,7,119,nucleoside triphosphate biosynthetic process,BP,NUP153;TYMS;PGK1;COX5B;NUP214;CTPS1;PARP1
2936,GO:0006457,0.806663981842699,0.278788034732342,13,210,protein folding,BP,CRYAB;SACS;HSPB1;BAG1;DNAJB1;DNAJB2;SNRNP70;DNAJC1;RUVBL2;HSPBP1;HSPA8;TTC31;HSP90AB1
258,GO:0000724,0.807092046785662,0.321248528325992,6,101,double-strand break repair via homologous recombination,BP,FEN1;GINS2;ORAOV1;SFPQ;ZNF365;PARP1
13140,GO:0051705,0.807261527340113,0.423073909313226,2,38,multi-organism behavior,BP,OXTR;DNAJC9
7596,GO:0031967,0.807472826898204,0.230248042015604,66,974,organelle envelope,CC,CYP24A1;DTX2;STARD13;SOD2;ABCF1;PTGES;IKBKE;RSAD2;PANK2;LYN;RAB32;DST;NUP153;TYMS;CDK4;RRP12;EBP;AEN;PARL;ABCF2;DHCR7;BANF1;GPER1;DNAJB2;CBX5;LGALS3;ABCG2;REEP1;PRKCA;CMTM3;POLA1;DCTN1;DNASE1;COX5B;ACSL1;NUP214;MRPS12;MRPS24;DNAJC1;ERAL1;MTFP1;MRPL20;PCYT1A;MRPL33;RCC1;CPT1A;TNPO3;BCS1L;CHMP4B;HERC2;BCL2L2;CHCHD6;THEM4;PHLPP1;TOMM40;IPO4;EIF5A;RNF185;MRPS2;TUBB;BRIP1;SLC25A22;RNF144B;SLC25A44;LRRC59;PARP1
7600,GO:0031975,0.807472826898204,0.230248042015604,66,974,envelope,CC,CYP24A1;DTX2;STARD13;SOD2;ABCF1;PTGES;IKBKE;RSAD2;PANK2;LYN;RAB32;DST;NUP153;TYMS;CDK4;RRP12;EBP;AEN;PARL;ABCF2;DHCR7;BANF1;GPER1;DNAJB2;CBX5;LGALS3;ABCG2;REEP1;PRKCA;CMTM3;POLA1;DCTN1;DNASE1;COX5B;ACSL1;NUP214;MRPS12;MRPS24;DNAJC1;ERAL1;MTFP1;MRPL20;PCYT1A;MRPL33;RCC1;CPT1A;TNPO3;BCS1L;CHMP4B;HERC2;BCL2L2;CHCHD6;THEM4;PHLPP1;TOMM40;IPO4;EIF5A;RNF185;MRPS2;TUBB;BRIP1;SLC25A22;RNF144B;SLC25A44;LRRC59;PARP1
3168,GO:0006779,0.808069398673102,0.521812347145443,1,21,porphyrin-containing compound biosynthetic process,BP,NFE2L1
584,GO:0001738,0.808324634247358,0.309358944761393,7,121,morphogenesis of a polarized epithelium,BP,PSMB9;SFRP1;WDR1;PSME2;ROR1;PSMC3;TP63
3307,GO:0007007,0.808408491372423,0.520662207920579,1,22,inner mitochondrial membrane organization,BP,CHCHD6
5721,GO:0016860,0.808459592904382,0.420772051196136,2,40,intramolecular oxidoreductase activity,MF,PTGES;EBP
9197,GO:0035579,0.808932852730679,0.375832703537126,3,55,specific granule membrane,CC,ITGAV;PTPRB;LAIR1
3797,GO:0008374,0.809300414207806,0.41996293858231,2,38,O-acyltransferase activity,MF,LPCAT3;CPT1A
6724,GO:0030135,0.809943234923607,0.274770792588751,13,207,coated vesicle,CC,TFRC;HLA-B;EDN1;ADRB2;HLA-F;IL7R;M6PR;HSPA8;RAB27A;SPG21;MYO1E;CLTA;SH3BP4
2827,GO:0006293,0.810475673005989,0.517862162510123,1,21,nucleotide-excision repair, preincision complex stabilization,BP,PARP1
2829,GO:0006295,0.810475673005989,0.517862162510123,1,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,PARP1
6621,GO:0022843,0.810620709510803,0.417940364902639,2,38,voltage-gated cation channel activity,MF,ITGAV;KCNA7
8407,GO:0033363,0.811288928312874,0.516520002283363,1,21,secretory granule organization,BP,BLOC1S2
4343,GO:0009895,0.811380345426606,0.27296792044762,13,208,negative regulation of catabolic process,BP,NRG1;PML;NOCT;TNF;FLNA;DKC1;SNX12;SNRNP70;HNRNPU;CHMP4B;DHX34;EFNA1;HSP90AB1
2663,GO:0006007,0.811682636401261,0.515868945920652,1,21,glucose catabolic process,BP,PGK1
5566,GO:0016578,0.811773978947597,0.515717775764378,1,21,histone deubiquitination,BP,USP36
3674,GO:0008171,0.812697970588969,0.514186011620436,1,21,O-methyltransferase activity,MF,FTSJ3
19443,GO:1990089,0.812707865503842,0.414485890598033,2,39,response to nerve growth factor,BP,EHD1;RAPGEF1
19444,GO:1990090,0.812707865503842,0.414485890598033,2,39,cellular response to nerve growth factor stimulus,BP,EHD1;RAPGEF1
9246,GO:0035639,0.812927748505979,0.217591504374791,101,1401,purine ribonucleoside triphosphate binding,MF,RUNX1;ACTG1;TAP1;ABCF1;MAP3K14;GBP1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHX37;DDX42;SGK1;RHOB;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;ORC4
1073,GO:0002639,0.812997347299681,0.513688706352386,1,21,positive regulation of immunoglobulin production,BP,TFRC
15824,GO:0072524,0.81341670652084,0.294816840078442,8,133,pyridine-containing compound metabolic process,BP,G6PD;NUP153;PGD;PGK1;NUP214;DCXR;TKT;CD38
90,GO:0000178,0.813836566287743,0.511692669929636,1,22,exosome (RNase complex),CC,ZFC3H1
19226,GO:1905354,0.813836566287743,0.511692669929636,1,22,exoribonuclease complex,CC,ZFC3H1
5848,GO:0017144,0.813925595977835,0.236477012106942,35,534,drug metabolic process,BP,CYP1B1;ADM;NQO1;CYP1A1;TGFB2;EDN1;MAT2A;TNF;NUP153;TYMS;ZC3H12A;ACAA1;ICAM1;BMP2;STAT5A;SLC5A6;PGK1;EGR1;CYP4B1;DHFR;ACO1;AKR1C2;SLC7A2;AASS;COX5B;ACSL1;NUP214;HSPA8;QDPR;CS;WNT4;AKR1C1;HSP90AB1;PARP1;FADS1
3452,GO:0007264,0.813930735452374,0.239719715579488,31,457,small GTPase mediated signal transduction,BP,NRG1;AMOT;STARD13;TGFB2;TP53;SIPA1L3;SQSTM1;CDKN1A;RAB32;CDKN2A;TRIO;PDPN;TNK1;CHP1;CDC42EP2;DOCK10;ARHGEF28;RHOB;NTN1;ROBO1;RASGRP4;SPRY4;RRAD;JUN;RHOG;RAPGEF1;CGNL1;RAB27A;CYTH1;MAPK11;PHACTR4
10790,GO:0044257,0.814059096825254,0.231473790933147,43,633,cellular protein catabolic process,BP,PML;CYLD;SPSB1;TP53;SQSTM1;UBQLN2;ENC1;PSMB9;UBE2C;UBE4B;RNF19B;USP36;PSME2;ABTB2;PRPF19;KCTD10;USP43;PTTG1IP;NSFL1C;NEDD4L;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;USP31;CHMP4B;HERC2;RNF7;TINAGL1;RNF185;TNFAIP3;PSMC3;EFNA1;RNF144B;CLTA;SNF8;GCLC;HSP90AB1
798,GO:0002066,0.814362510889685,0.411929413791212,2,39,columnar/cuboidal epithelial cell development,BP,CDKN1A;TYMS
4055,GO:0009100,0.814468974560373,0.252431221311381,20,307,glycoprotein metabolic process,BP,TET3;B4GALT1;GNPTAB;LFNG;GALNT18;ADAMTS9;BACE2;CHP1;BMP2;PMM2;ST6GALNAC5;IL15;SLC35C2;CHST3;GALNT2;DAG1;TMEM165;MGAT2;RNF185;DPM3
259,GO:0000725,0.814595733875078,0.311105610235894,6,102,recombinational repair,BP,FEN1;GINS2;ORAOV1;SFPQ;ZNF365;PARP1
5107,GO:0015399,0.814612846698656,0.341310963225625,4,73,primary active transmembrane transporter activity,MF,TAP1;ABCG2;TAPBP;TAP2
5108,GO:0015405,0.814612846698656,0.341310963225625,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,TAP1;ABCG2;TAPBP;TAP2
10821,GO:0044309,0.814642810865704,0.311041957310635,6,102,neuron spine,CC,CRYAB;BAIAP2;FUS;GPER1;DOCK10;PPP1R9B
11373,GO:0045738,0.814803994884369,0.510677088477832,1,21,negative regulation of DNA repair,BP,TFIP11
5657,GO:0016757,0.814820042459419,0.268698215551691,13,207,transferase activity, transferring glycosyl groups,MF,UGT1A6;B4GALT1;LFNG;GALNT18;ST6GALNAC5;COLGALT1;PARP14;GALNT2;GBE1;PIGM;MGAT2;DPM3;PARP1
285,GO:0000788,0.814833520132104,0.506400952015671,1,31,nuclear nucleosome,CC,MPHOSPH8
12152,GO:0048259,0.814961597219252,0.366873164178889,3,56,regulation of receptor-mediated endocytosis,BP,UBQLN2;SERPINE1;SYK
18561,GO:1903779,0.815190175951555,0.410646830979419,2,39,regulation of cardiac conduction,BP,FLNA;FXYD3
277,GO:0000779,0.815548409774012,0.309716676914575,6,104,condensed chromosome, centromeric region,CC,ZW10;HNRNPU;CLASP1;CENPN;CENPO;INCENP
10905,GO:0044450,0.815686502929519,0.285381609990745,9,147,microtubule organizing center part,CC,FGFR1OP;WDR34;DCTN1;CLASP1;CEP41;BLOC1S2;HERC2;CNTROB;KIF24
6273,GO:0019867,0.815881172158229,0.279596286085317,10,165,outer membrane,CC,CYP24A1;RSAD2;RAB32;DHCR7;ACSL1;CPT1A;BCL2L2;TOMM40;RNF185;SLC25A44
13992,GO:0060706,0.815945207573003,0.508765358391035,1,21,cell differentiation involved in embryonic placenta development,BP,LIF
12533,GO:0050681,0.815971562488596,0.40943361551981,2,39,androgen receptor binding,MF,DAXX;FHL2
7333,GO:0031343,0.816104418928909,0.50789713835731,1,22,positive regulation of cell killing,BP,LAMP1
7980,GO:0032594,0.816189113496093,0.508355826948741,1,21,protein transport within lipid bilayer,BP,RILPL2
17281,GO:0140029,0.816388326035643,0.364769456909343,3,56,exocytic process,BP,LYN;CADPS2;SYK
11291,GO:0045601,0.816391765684326,0.508015308478481,1,21,regulation of endothelial cell differentiation,BP,TNF
5799,GO:0017049,0.816596184108868,0.507671588058225,1,21,GTP-Rho binding,MF,CDC42EP2
12865,GO:0051186,0.816620745124861,0.239309505070874,28,430,cofactor metabolic process,BP,CYP1A1;PTGES;MAT2A;G6PD;NFE2L1;PANK2;SCD;NUP153;PGD;TYMS;HMGCS1;STAT5A;SLC5A6;PGK1;DHFR;AKR1C2;AASS;ACSL1;NUP214;DCXR;SCD5;QDPR;ACBD6;THEM4;TKT;AKR1C1;CD38;GCLC
253,GO:0000717,0.816824542309154,0.506685904690101,1,22,nucleotide-excision repair, DNA duplex unwinding,BP,PARP1
2879,GO:0006378,0.816960292628607,0.407895186805487,2,39,mRNA polyadenylation,BP,NELFE;SUPT5H
13066,GO:0051569,0.817022233560113,0.50695444801237,1,21,regulation of histone H3-K4 methylation,BP,NELFE
11484,GO:0045943,0.817137203491331,0.506760751413427,1,21,positive regulation of transcription by RNA polymerase I,BP,UBTF
4035,GO:0009067,0.817233955153247,0.506597690325229,1,21,aspartate family amino acid biosynthetic process,BP,AASS
9764,GO:0039528,0.817879412739786,0.505508508003491,1,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,BIRC3
16,GO:0000030,0.818207715202873,0.504351229786109,1,22,mannosyltransferase activity,MF,DPM3
8586,GO:0034067,0.81859834950914,0.504292548693506,1,21,protein localization to Golgi apparatus,BP,ARFRP1
13133,GO:0051693,0.81864173176848,0.504219080859585,1,21,actin filament capping,BP,SPTBN1
4352,GO:0009925,0.818734607530062,0.504061759743687,1,21,basal plasma membrane,CC,DST
5928,GO:0018205,0.818780721908389,0.24407293245381,22,337,peptidyl-lysine modification,BP,TRIM16;HDAC9;TET3;CPA4;GNL3L;ZBED1;NUP153;LIF;EGR1;SNAI2;NELFE;SENP3;DOHH;RBBP5;NUP214;RUVBL2;PRDM7;BRPF1;NOC2L;INCENP;EIF5A;METTL21A
2583,GO:0005875,0.819163293710464,0.295052553270028,7,119,microtubule associated complex,CC,MAP2;MID1;KIF23;WDR34;DCTN1;KIF24;KIF22
10517,GO:0043425,0.819201573422518,0.503270025825673,1,21,bHLH transcription factor binding,MF,TSC22D3
18341,GO:1903305,0.819597855828151,0.334293055718,4,72,regulation of regulated secretory pathway,BP,LYN;LAMP1;SYK;RAB27A
15758,GO:0072348,0.819789865102578,0.502270810183852,1,21,sulfur compound transport,BP,SLC5A6
1970,GO:0004683,0.819947827869957,0.502002171877282,1,21,calmodulin-dependent protein kinase activity,MF,CAMK1G
3085,GO:0006658,0.819948346814857,0.50200128910352,1,21,phosphatidylserine metabolic process,BP,LPCAT3
10990,GO:0044786,0.820589224074549,0.358410358072987,3,57,cell cycle DNA replication,BP,FEN1;GINS2;POLA1
5372,GO:0016180,0.820600514480632,0.500286691856538,1,22,snRNA processing,BP,USB1
19983,GO:2000573,0.820827165632893,0.358185703281686,3,56,positive regulation of DNA biosynthetic process,BP,DKC1;PDGFB;HSP90AB1
11456,GO:0045910,0.820876265650474,0.500420329308373,1,21,negative regulation of DNA recombination,BP,THOC1
5063,GO:0015276,0.821366779523519,0.40099379181611,2,39,ligand-gated ion channel activity,MF,JPH2;JPH1
6613,GO:0022834,0.821366779523519,0.40099379181611,2,39,ligand-gated channel activity,MF,JPH2;JPH1
9611,GO:0036474,0.821429637064671,0.498870632533733,1,22,cell death in response to hydrogen peroxide,BP,TP53
7320,GO:0031329,0.821468215844802,0.221089291216981,47,690,regulation of cellular catabolic process,BP,PML;HSPB1;DAPK3;NOCT;IRS1;UBQLN2;TNF;NUP153;PSMB9;ZC3H12A;DRAM1;RNF19B;ADRB2;PABPC4;USP36;TRIM22;PPP1R3B;PSME2;ZFP36L1;DKC1;IRS2;PRKCA;ZFP36L2;PTTG1IP;SNRNP70;NUP214;SMAD7;SUPT5H;KEAP1;HNRNPU;CAPNS1;TRIB1;ATG101;HSPBP1;HSPA8;CPT1A;CHMP4B;METTL16;DHX34;TNFAIP3;PSMC3;EFNA1;RNF144B;POLR2G;GCLC;HSP90AB1;SH3BP4
5659,GO:0016763,0.82229286385902,0.399302763867655,2,40,transferase activity, transferring pentosyl groups,MF,PARP14;PARP1
5663,GO:0016772,0.82252212445442,0.217130531917243,54,777,transferase activity, transferring phosphorus-containing groups,MF,NRG1;CD3EAP;CSF2;MAP3K14;FAM46B;IKBKE;DAPK3;NUAK1;SQSTM1;PANK2;GNPTAB;IRS1;CDKN1A;TJP2;LYN;HMGXB3;PKMYT1;TRIO;FGFR2;EPHB6;TNK1;TK1;EPHA2;CDK4;STAT5A;PGK1;APTX;SGK1;DKC1;FGFR1OP;RIPK4;IRS2;PRKCA;SYK;POLR1A;PPIP5K1;CDKL1;PDGFB;POLA1;CAMK1G;ROR1;CRCP;NOL9;PCYT1A;CAB39;OXSR1;ESR1;UAP1L1;POLR3H;MAPK11;POLR1E;POLR2G;CLK4;CCL5
9048,GO:0035264,0.823660462991539,0.298669155035283,6,104,multicellular organism growth,BP,FGFR2;CDK4;STAT5A;ADRB2;DHCR7;ZFP36L1
10492,GO:0043392,0.825142090383326,0.394571194267565,2,41,negative regulation of DNA binding,BP,NFKBIA;JUN
267,GO:0000737,0.825545917883299,0.491781163053724,1,22,DNA catabolic process, endonucleolytic,BP,DNASE1
16261,GO:0090314,0.825719321084105,0.491480323039165,1,22,positive regulation of protein targeting to membrane,BP,CHP1
17332,GO:0150034,0.825806272034731,0.262281732566954,11,179,distal axon,CC,NEFL;GPRIN1;L1CAM;ZFYVE27;GPER1;DPYSL3;ROR1;KCNIP3;HSPA8;PARD3;ELK1
9639,GO:0036507,0.826120573409402,0.490783499373691,1,22,protein demannosylation,BP,RNF185
9640,GO:0036508,0.826120573409402,0.490783499373691,1,22,protein alpha-1,2-demannosylation,BP,RNF185
17730,GO:1901659,0.826128588960752,0.392793138876871,2,42,glycosyl compound biosynthetic process,BP,TK1;CTPS1
5814,GO:0017076,0.826248458598432,0.202691217131985,103,1434,purine nucleotide binding,MF,RUNX1;ACTG1;TAP1;BAG1;ABCF1;MAP3K14;GBP1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHX37;DDX42;SGK1;RHOB;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;HSPBP1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;ORC4
6282,GO:0019886,0.826812595024146,0.323727242241828,4,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KIF23;DCTN1;KIF22;CLTA
17531,GO:1901021,0.82688108785907,0.489460143214216,1,22,positive regulation of calcium ion transmembrane transporter activity,BP,JPH2
16516,GO:0097223,0.827087663569129,0.306306355643814,5,90,sperm part,CC,SQSTM1;CRCP;CCR6;HSP90AB1;TBXA2R
5886,GO:0018024,0.827389082086508,0.391209480649432,2,40,histone-lysine N-methyltransferase activity,MF,RBBP5;PRDM7
6879,GO:0030374,0.827571877226892,0.347938382562949,3,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,PPRC1;ACTN4;RBM14
6794,GO:0030234,0.827708313485732,0.212709323552199,50,734,enzyme regulator activity,MF,IGFBP3;NRG1;FN1;HSPB1;STARD13;BAG1;SH3RF2;BIRC3;SIPA1L3;CDKN2B;CDKN1A;CDKN2A;RING1;DNAJB1;CHP1;BMP2;CDK4;ERRFI1;SFN;CDC42EP2;DAXX;SERPINE1;PPP1R3B;PSME2;DNAJB2;FGFR1OP;RPLP1;PDGFB;NSFL1C;SERPINH1;RUNDC1;AFAP1L2;DNAJC1;PPP1R14C;TRIB1;PPP1R9B;A2ML1;CAB39;CD109;SOCS1;HSPBP1;JUN;ESR1;DUS2;SGSM1;NOL3;HSP90AB1;PHACTR4;CCL5;SH3BP4
13183,GO:0051788,0.827785801885602,0.487881365113766,1,22,response to misfolded protein,BP,RNF185
3346,GO:0007064,0.828882691490757,0.485960630336121,1,22,mitotic sister chromatid cohesion,BP,CDCA5
17250,GO:0120025,0.828930567788358,0.201689047556462,89,1257,plasma membrane bounded cell projection,CC,CRYAB;NRG1;MAP2;S100P;NEFL;TENM3;AMOT;SACS;NEFM;NQO1;CYLD;HSPB1;TGFB2;B4GALT1;PANX1;SQSTM1;NEDD9;MYO1B;LAMP1;EHD1;BAIAP2;CORO1C;WWC1;DST;GPRIN1;PDPN;EPHB6;FOSL1;LAYN;FLNA;LCP1;EPHA2;ITGAV;L1CAM;MYO10;ANKS4B;SVIL;TNFRSF12A;IQCJ-SCHIP1;SLC5A6;FUS;TPM1;ZFYVE27;CC2D2A;GPER1;TXN2;KCNA7;DOCK10;ADAM17;ROBO1;AJUBA;OXTR;WDR34;SPTBN1;DCTN1;DPYSL3;MYH9;CAMK1G;TNFRSF21;SPRY4;ROR1;ENAH;PQBP1;CEP41;PPP1R9B;KCNIP3;HSPA8;BLOC1S2;DCXR;CCR6;PARD3;QDPR;CNTNAP1;ACTN4;THEM4;SORBS2;PHLPP1;ELK1;KIF22;MYADM;DAG1;PDE6A;RAB27A;RILPL2;HSP90AB1;SWAP70;TTLL5;TP63;PHACTR4
5930,GO:0018208,0.829388819376887,0.387578479045771,2,42,peptidyl-proline modification,BP,P3H2;P4HA2
16666,GO:0097542,0.829870230703896,0.387013019695563,2,41,ciliary tip,CC,CYLD;WDR34
10531,GO:0043470,0.82993307662187,0.344363058037395,3,57,regulation of carbohydrate catabolic process,BP,NUP153;PPP1R3B;NUP214
8305,GO:0033137,0.830097815709041,0.483824358309212,1,22,negative regulation of peptidyl-serine phosphorylation,BP,SMAD7
12412,GO:0048857,0.830297234860192,0.386326034207132,2,41,neural nucleus development,BP,G6PD;YWHAH
8139,GO:0032839,0.830434533109945,0.48323079646361,1,22,dendrite cytoplasm,CC,BAIAP2
6921,GO:0030513,0.830843623450846,0.48250872453216,1,22,positive regulation of BMP signaling pathway,BP,CYR61
4191,GO:0009268,0.830878033654553,0.482447941527384,1,22,response to pH,BP,CHP1
3314,GO:0007017,0.830975276182911,0.213093218561647,41,604,microtubule-based process,BP,CRYAB;MAP2;NEFL;CYLD;HSPB1;MYBL2;BIRC3;MID1;MYO1B;LAMP1;GADD45A;DST;FLNA;CHP1;KIF23;MYO10;CC2D2A;PARD3B;FGFR1OP;WDR34;DCTN1;SLAIN2;MYH9;ZW10;HNRNPU;CLASP1;HSPA8;BLOC1S2;RCC1;CHMP4B;CNTROB;PARD3;KIF24;PHLDB2;KIF22;DAG1;RBM14;TUBB;MYO1E;CLTA;TTLL5
13108,GO:0051642,0.831023976982604,0.482190063134517,1,22,centrosome localization,BP,TBCCD1
3453,GO:0007265,0.831223942569302,0.226459388645843,24,365,Ras protein signal transduction,BP,NRG1;TGFB2;TP53;SQSTM1;CDKN1A;RAB32;CDKN2A;TRIO;PDPN;TNK1;CDC42EP2;ARHGEF28;RHOB;NTN1;ROBO1;RASGRP4;SPRY4;JUN;RHOG;RAPGEF1;RAB27A;CYTH1;MAPK11;PHACTR4
8138,GO:0032838,0.832422232362937,0.277049577494933,7,122,plasma membrane bounded cell projection cytoplasm,CC,NEFL;HSPB1;BAIAP2;DST;WDR34;PQBP1;BLOC1S2
5909,GO:0018146,0.832479903057363,0.479610309116557,1,22,keratan sulfate biosynthetic process,BP,B4GALT1
11444,GO:0045880,0.832489732061156,0.479592848689513,1,22,positive regulation of smoothened signaling pathway,BP,SFRP1
16566,GO:0097346,0.832499026307558,0.479019696299768,1,23,INO80-type complex,CC,RUVBL2
3662,GO:0008144,0.83284015657669,0.197202413921307,90,1262,drug binding,MF,RUNX1;CYP1B1;ACTG1;CYP1A1;TAP1;ABCF1;MAP3K14;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;MCM5;EHD1;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TYMS;TNK1;TK1;EPHA2;HMGCS1;UBE4B;DDX23;CDK4;KIF23;MYO10;NAT10;PGK1;MCM2;SFRP1;ABCF2;DHX37;DDX42;SGK1;CYP4B1;DHFR;RIPK4;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;NOL9;HNRNPU;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;XRCC6;TAP2;KIF24;KIF22;DHX34;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;CLK4;ORC4
7960,GO:0032559,0.833180881388591,0.197966321486504,83,1166,adenyl ribonucleotide binding,MF,RUNX1;ACTG1;TAP1;ABCF1;MAP3K14;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;MCM5;EHD1;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;UBE4B;DDX23;CDK4;KIF23;MYO10;NAT10;PGK1;MCM2;ABCF2;DHX37;DDX42;SGK1;RIPK4;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;NOL9;HNRNPU;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;XRCC6;TAP2;KIF24;KIF22;DHX34;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;CLK4;ORC4
1706,GO:0004222,0.833476314245854,0.338964734504222,3,57,metalloendopeptidase activity,MF,MMP9;ADAMTS9;ADAM17
3471,GO:0007292,0.8338887602988,0.31340001591402,4,74,female gamete generation,BP,INHBA;TAF4B;FOSL1;WNT4
5702,GO:0016830,0.834129597775346,0.380127187066974,2,41,carbon-carbon lyase activity,MF,ODC1;GGCX
19279,GO:1905476,0.834352498626692,0.476272964898315,1,22,negative regulation of protein localization to membrane,BP,GBP1
262,GO:0000729,0.83458649674691,0.475854395629378,1,22,DNA double-strand break processing,BP,BRIP1
556,GO:0001678,0.834646115080294,0.295474195606276,5,92,cellular glucose homeostasis,BP,ICAM1;GPER1;SRF;IRS2;GCLC
3454,GO:0007266,0.834833353945054,0.260205627987972,9,150,Rho protein signal transduction,BP,TRIO;PDPN;CDC42EP2;ARHGEF28;RHOB;NTN1;ROBO1;RHOG;PHACTR4
3248,GO:0006906,0.835114016573285,0.273413518914157,7,121,vesicle fusion,BP,TAP1;GOSR1;RUNDC1;TAPBP;TGFBRAP1;TAP2;SGSM1
3238,GO:0006892,0.835534835215443,0.294321742815241,5,90,post-Golgi vesicle-mediated transport,BP,MYO1B;LAMP1;ARFRP1;SPTBN1;VPS52
1539,GO:0003924,0.835597785825515,0.239426855698074,14,227,GTPase activity,MF,GBP1;RAB32;GNL3L;EIF5;ARFRP1;LSG1;RHOB;TSR1;GPN1;RRAD;RHOG;EFTUD2;RAB27A;TUBB
3604,GO:0008038,0.835721291194962,0.473819629934037,1,22,neuron recognition,BP,ROBO1
18039,GO:1902562,0.835726772886758,0.377525950708299,2,41,H4 histone acetyltransferase complex,CC,RUVBL2;UBAP2L
346,GO:0000959,0.836344947154189,0.376516318235421,2,41,mitochondrial RNA metabolic process,BP,PUS1;HSD17B10
3751,GO:0008289,0.836698655747632,0.213761560398761,30,455,lipid binding,MF,JPH2;STARD13;APOL6;NFE2L1;LYN;MYO1B;CADPS2;MYO10;ANXA8L1;ANXA8;GPER1;PARD3B;SNX12;TRAF2;AKR1C2;NSFL1C;SPTBN1;LANCL2;RASGRP4;SNX8;PCYT1A;HSPA8;ESR1;PARD3;ACBD6;AKR1C1;CYTH1;SEC14L4;MYO1E;BAIAP2L2
12669,GO:0050873,0.837010235886947,0.470939813038261,1,23,brown fat cell differentiation,BP,ADRB2
20190,GO:2001038,0.837522690108119,0.470013860331697,1,23,regulation of cellular response to drug,BP,TP53
4128,GO:0009187,0.837584453697663,0.332531918767072,3,58,cyclic nucleotide metabolic process,BP,ADM;EPHA2;GPER1
9244,GO:0035637,0.837936984560535,0.290882629701516,5,90,multicellular organismal signaling,BP,FLNA;FXYD3;GPER1;KCNIP3;CNTNAP1
20276,GO:2001244,0.837962038677638,0.373274790963365,2,44,positive regulation of intrinsic apoptotic signaling pathway,BP,TP53;SFPQ
10634,GO:0043631,0.838544794746951,0.372910435995159,2,41,RNA polyadenylation,BP,NELFE;SUPT5H
14492,GO:0061912,0.838956719095369,0.37223296251214,2,41,selective autophagy,BP,SQSTM1;ADRB2
5418,GO:0016266,0.838969473065532,0.372211975156897,2,41,O-glycan processing,BP,GALNT18;GALNT2
10189,GO:0042788,0.839264635626534,0.464322888002875,1,29,polysomal ribosome,CC,LARP4B
7698,GO:0032155,0.839704105524105,0.329254967275404,3,58,cell division site part,CC,SVIL;RHOB;MYH9
12781,GO:0051056,0.839793404819858,0.227024333988418,17,266,regulation of small GTPase mediated signal transduction,BP,NRG1;AMOT;STARD13;TGFB2;SIPA1L3;SQSTM1;TRIO;TNK1;ARHGEF28;RHOB;ROBO1;RASGRP4;SPRY4;RHOG;RAPGEF1;CGNL1;CYTH1
11501,GO:0045981,0.839804593758798,0.370629069352557,2,42,positive regulation of nucleotide metabolic process,BP,ADM;GPER1
17504,GO:1900544,0.839804593758798,0.370629069352557,2,42,positive regulation of purine nucleotide metabolic process,BP,ADM;GPER1
7079,GO:0030867,0.839862086168187,0.464783084661767,1,25,rough endoplasmic reticulum membrane,CC,ZC3H12A
10539,GO:0043486,0.840151113020211,0.369001790673787,2,48,histone exchange,BP,CENPN;CENPO
3898,GO:0008535,0.840800919011115,0.463538042912596,1,24,respiratory chain complex IV assembly,BP,BCS1L
1011,GO:0002495,0.840846276813077,0.302955444944955,4,76,antigen processing and presentation of peptide antigen via MHC class II,BP,KIF23;DCTN1;KIF22;CLTA
17372,GO:1900087,0.840873905775066,0.463917016964861,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,CYP1A1
9432,GO:0036003,0.840932770491924,0.463809275358626,1,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53
13272,GO:0051959,0.840988595616723,0.463707076321242,1,23,dynein light intermediate chain binding,MF,RILPL2
4815,GO:0014009,0.841721210182926,0.462363992633664,1,23,glial cell proliferation,BP,LYN
17686,GO:1901564,0.841981450704001,0.175561504496304,357,4898,organonitrogen compound metabolic process,BP,IGFBP3;KRT1;SAA1;SPRR3;TRIM16;CCL20;CRYAB;SPRR2A;NRG1;MMP9;KRT2;CYR61;PTGER4;INHBA;HDAC9;FN1;NEFL;C1R;ODC1;P3H2;CTGF;TENM3;C1QTNF1;DTX2;ADM;NQO1;CYP1A1;IL1R2;DUSP14;PML;CYLD;HSPB1;KRT10;SDC4;GPRC5A;ABCF1;CSF2;PTGES;MAP3K14;FBN1;TGFB2;EDN1;SH3RF2;GBP1;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;SPSB1;DBNDD2;G6PD;TRAF3;EMP2;NUAK1;KLHL21;APOL6;TP53;NFE2L1;SQSTM1;MARVELD3;IL24;P4HA2;PANK2;NFKB1;CPA4;CDKN2B;MPND;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;HSPG2;UBQLN2;ADAMTS9;LYN;HS3ST2;GADD45A;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;CORO1C;PKMYT1;WWC1;ENC1;TNC;TRIO;FGFR2;PTPN14;CDKAL1;NUP153;BACE2;PSMB9;SLC7A5;CLN6;EPHB6;TELO2;KRT17;C9ORF3;QPCT;SLC16A9;PGD;UBE2C;TYMS;ZC3H12A;FLNA;TNK1;TK1;GEMIN5;EPHA2;CHP1;EIF5;GADD45B;ICAM1;BMP2;UBE4B;CDK4;ITGAV;ERRFI1;GGCX;PMM2;SFN;STAT5A;LYPD6B;EPGN;RNF19B;ADRB2;IL20;DAXX;SLC5A6;SERPINE1;PABPC4;PGK1;NMT2;ST6GALNAC5;USP36;AKAP8L;LIF;SFRP1;PARL;TRIM22;ZDHHC3;PPP1R3B;ANXA8;IRF1;PSME2;ABHD4;DNPEP;DPH2;CTIF;GPER1;DNAJB2;HS3ST1;LARP4B;ABTB2;NFKBIA;EGR1;SGK1;SNAI2;PRPF19;ZFP36L1;RPLP2;AKAP8;NELFE;ADAM17;SNX12;DHFR;U2AF2;FGFR1OP;KCTD10;RIPK4;IRS2;ACO1;RPLP1;TRAF2;ABCG2;IL15;PRKCA;ZFP36L2;PUM3;SYK;SLC7A2;ROBO1;AJUBA;SENP3;USP43;CDKL1;PDGFB;AASS;BRMS1;PREP;OXTR;RPS2;PTTG1IP;RPS9;NSFL1C;SPTBN1;NEDD4L;SNRNP70;SERPINH1;COX5B;RNF115;UHRF1;MYH9;SPPL2A;NPNT;IL1A;COPS3;CAMK1G;TNIP2;DOHH;RASGRP4;RBBP5;SFPQ;SPRY4;ROR1;ACSL1;NUP214;ACKR3;AFAP1L2;SMAD7;SLC35C2;MRPS12;MRPS24;MTA2;DNAJC1;TAPBP;KEAP1;ZDHHC6;ERAL1;CHST3;APH1A;CAPNS1;UBE2J2;PPP1R14C;CEP41;TRIB1;TPST1;DCUN1D2;RUVBL2;PPP1R9B;LPCAT3;A2ML1;PARP14;ANAPC15;PRDM7;MRPL20;RHBDL2;PCYT1A;GALNT2;DUSP1;CAB39;CD109;RPL27A;SOCS1;HSPBP1;OXSR1;HSPA8;JUN;PIGM;MRPL33;DTX4;ESR1;TCOF1;SLC22A4;USP31;BRPF1;GLIPR2;CPT1A;DCXR;EIF3B;NOC2L;CHMP4B;RBM4;SERTAD1;ARRDC3;HERC2;DUS2;PARD3;QDPR;LAMC1;GPNMB;XRCC6;SMPD2;KBTBD12;BMP7;METTL16;SMUG1;PHLPP1;TKT;EFTUD2;TNFRSF10A;OVCH2;RNF7;MPHOSPH8;INCENP;EIF3I;RAPGEF1;EIF5A;TINAGL1;MYADM;DAG1;TMEM165;PDE6A;MGAT2;RNF185;EEF1D;ASB6;DPM3;MRPS2;RBM14;TRAF4;CTDSP1;CD38;TNFAIP3;PSMC3;CCL22;EFNA1;MAPK11;AARSD1;METTL21A;CTPS1;HSD17B10;XPNPEP3;BMP8A;TRIML2;CARD10;PTPRB;RNF144B;POLR2G;DUSP8;CLTA;NOL3;SNF8;GCLC;HSP90AB1;SWAP70;TTLL5;HERC6;IL6R;PARP1;CLK4;TP63;OTUD6A;C1S;PHACTR4;CCL5;MAGOH
2709,GO:0006082,0.842020113867391,0.194242629191189,56,824,organic acid metabolic process,BP,ODC1;CYP1B1;NQO1;CYP1A1;FADS3;UGT1A6;PTGES;EDN1;B4GALT1;PANK2;NFKB1;IRS1;CARS2;SCD;NUP153;PSMB9;SLC7A5;SLC16A9;PGD;TYMS;ACAA1;CHP1;STAT5A;SLC5A6;PGK1;PSME2;DHFR;IRS2;ACO1;ABCG2;IL15;AKR1C2;SYK;SLC7A2;PDGFB;AASS;PRUNE2;ACSL1;NUP214;CHST3;TPST1;CPT1A;DCXR;SCD5;INSIG1;QDPR;CS;THEM4;GPX4;AKR1C1;PSMC3;AARSD1;CTPS1;HSD17B10;GCLC;FADS1
3914,GO:0008574,0.842658713951456,0.460640157838855,1,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,WDR34
10566,GO:0043524,0.8429241433172,0.28358284601859,5,92,negative regulation of neuron apoptotic process,BP,NEFL;SOD2;JUN;GCLC;HSP90AB1
18511,GO:1903672,0.843002019917818,0.460007456182271,1,23,positive regulation of sprouting angiogenesis,BP,HDAC9
8942,GO:0034976,0.843050549627168,0.227355654287704,15,242,response to endoplasmic reticulum stress,BP,PML;TP53;UBQLN2;UBE4B;ANKS4B;TRAF2;DCTN1;TATDN2;UBE2J2;CREB3;TUSC1;JUN;RNF185;PSMC3;CXCL8
4440,GO:0010324,0.843517463667186,0.364476949910281,2,42,membrane invagination,BP,MYH9;RHOG
16119,GO:0090102,0.84375368888967,0.458619432435448,1,23,cochlea development,BP,MCM2
4056,GO:0009101,0.843767255710392,0.224123185335993,16,256,glycoprotein biosynthetic process,BP,TET3;B4GALT1;LFNG;GALNT18;BACE2;CHP1;PMM2;ST6GALNAC5;IL15;SLC35C2;CHST3;GALNT2;DAG1;TMEM165;MGAT2;DPM3
13182,GO:0051787,0.843859450814961,0.458423832859776,1,23,misfolded protein binding,MF,HSPA8
7026,GO:0030799,0.844674624726315,0.362547368372167,2,42,regulation of cyclic nucleotide metabolic process,BP,ADM;GPER1
10359,GO:0043171,0.844733275974252,0.456804902007301,1,23,peptide catabolic process,BP,C9ORF3
14389,GO:0061630,0.844967564629419,0.233627320082808,12,198,ubiquitin protein ligase activity,MF,UBE2C;UBE4B;RNF19B;PRPF19;NEDD4L;RNF115;UHRF1;UBE2J2;HERC2;RNF7;RNF144B;HERC6
2992,GO:0006536,0.845044056578317,0.45622789130096,1,23,glutamate metabolic process,BP,GCLC
20228,GO:2001169,0.845118759067587,0.32069790433781,3,59,regulation of ATP biosynthetic process,BP,NUP153;NUP214;PARP1
20097,GO:2000765,0.845395773617513,0.45557409526937,1,23,regulation of cytoplasmic translation,BP,DPH2
697,GO:0001917,0.845761309778644,0.454893730810985,1,23,photoreceptor inner segment,CC,PHLPP1
2443,GO:0005643,0.845935459243234,0.295346030168408,4,76,nuclear pore,CC,NUP153;NUP214;IPO4;EIF5A
20027,GO:2000648,0.846026151263563,0.454400225241132,1,23,positive regulation of stem cell proliferation,BP,HNRNPU
17251,GO:0120031,0.846561568362818,0.203748038269556,28,427,plasma membrane bounded cell projection assembly,BP,CYLD;EMP2;EHD1;CORO1C;FLNA;EPHA2;ICAM1;MYO10;CDC42EP2;CC2D2A;SRF;FGFR1OP;VCL;NTN1;AJUBA;WDR34;DCTN1;DPYSL3;RCC2;CLASP1;CEP41;PPP1R9B;RHOG;KIF24;RILPL2;TUBB;TTLL5;BIN3
10530,GO:0043467,0.846624673615742,0.278212157569283,5,92,regulation of generation of precursor metabolites and energy,BP,IRS1;NUP153;PPP1R3B;IRS2;NUP214
5478,GO:0016411,0.846743366288694,0.453061389042179,1,23,acylglycerol O-acyltransferase activity,MF,LPCAT3
7302,GO:0031301,0.847314007408186,0.249282891057947,8,140,integral component of organelle membrane,CC,LFNG;PXMP2;TPST1;GALNT2;CPT1A;CHCHD6;TOMM40;SLC25A44
8102,GO:0032787,0.847339500951992,0.20373083415262,27,417,monocarboxylic acid metabolic process,BP,CYP1B1;CYP1A1;FADS3;UGT1A6;PTGES;EDN1;PANK2;IRS1;SCD;NUP153;PGD;ACAA1;STAT5A;SLC5A6;PGK1;IRS2;AKR1C2;ACSL1;NUP214;CPT1A;DCXR;SCD5;INSIG1;THEM4;GPX4;AKR1C1;FADS1
427,GO:0001134,0.847357755742473,0.451911726888028,1,23,transcription factor activity, transcription factor recruiting,MF,MYBL2
10545,GO:0043492,0.847963022182137,0.292293590315786,4,76,ATPase activity, coupled to movement of substances,MF,TAP1;ABCG2;TAPBP;TAP2
2319,GO:0005326,0.848026800799848,0.450656869015172,1,23,neurotransmitter transporter activity,MF,SLC25A22
12409,GO:0048854,0.84831293578927,0.450119261916261,1,23,brain morphogenesis,BP,FANCC
1014,GO:0002504,0.848379019971977,0.291591115890738,4,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KIF23;DCTN1;KIF22;CLTA
4140,GO:0009201,0.849338979782109,0.262525917722901,6,110,ribonucleoside triphosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;CTPS1;PARP1
18110,GO:1902750,0.849823758141866,0.273279537294357,5,97,negative regulation of cell cycle G2/M phase transition,BP,PSMB9;PSME2;GPR132;ORAOV1;PSMC3
6083,GO:0019239,0.849962661263709,0.446493114378021,1,24,deaminase activity,MF,RPUSD4
11793,GO:0046658,0.85003947929797,0.446347793383789,1,24,anchored component of plasma membrane,CC,EFNA1
8244,GO:0033014,0.850064703228813,0.446300066950509,1,24,tetrapyrrole biosynthetic process,BP,NFE2L1
13609,GO:0060079,0.850671897411888,0.352451890337943,2,42,excitatory postsynaptic potential,BP,BAIAP2;ADRB2
6745,GO:0030165,0.850697090281209,0.311898914135316,3,59,PDZ domain binding,MF,BAIAP2;ADAM17;SLC22A4
6811,GO:0030262,0.850743145892498,0.445014723878574,1,24,apoptotic nuclear changes,BP,GPER1
7335,GO:0031345,0.851358384600346,0.250834492194723,7,124,negative regulation of cell projection organization,BP,EFNB2;NTN1;DPYSL3;SEMA3C;YWHAH;ZNF365;EFNA1
12115,GO:0048167,0.851628409617614,0.270894466602692,5,92,regulation of synaptic plasticity,BP,SQSTM1;BAIAP2;SRF;YWHAH;CD38
5791,GO:0017022,0.851649848021874,0.350594796252285,2,43,myosin binding,MF,FUS;RAB27A
7956,GO:0032555,0.851771133679959,0.174655665435351,101,1420,purine ribonucleotide binding,MF,RUNX1;ACTG1;TAP1;ABCF1;MAP3K14;GBP1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHX37;DDX42;SGK1;RHOB;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;ORC4
6715,GO:0030125,0.851828973858652,0.442950899068041,1,24,clathrin vesicle coat,CC,CLTA
6585,GO:0022412,0.852616158369672,0.227208886172166,11,185,cellular process involved in reproduction in multicellular organism,BP,INHBA;PANK2;TAF4B;FOSL1;FANCC;SFRP1;NSUN2;CCR6;WNT4;BRIP1;TTLL5
7341,GO:0031365,0.853314559236763,0.440113855893099,1,24,N-terminal protein amino acid modification,BP,NMT2
15920,GO:0072698,0.853595129710011,0.347472160541236,2,42,protein localization to microtubule cytoskeleton,BP,MID1;HNRNPU
2974,GO:0006515,0.853771856622325,0.439237409190598,1,24,protein quality control for misfolded or incompletely synthesized proteins,BP,RNF185
3236,GO:0006890,0.853930944699855,0.2831645749374,4,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF23;ZW10;TAPBP;KIF22
8243,GO:0033013,0.853965361748171,0.346457623413119,2,44,tetrapyrrole metabolic process,BP,CYP1A1;NFE2L1
1147,GO:0002755,0.854112886334468,0.438582831458788,1,24,MyD88-dependent toll-like receptor signaling pathway,BP,IRF1
1,GO:0000002,0.854238603129845,0.438341319756491,1,24,mitochondrial genome maintenance,BP,PARP1
18404,GO:1903432,0.854596165171973,0.437653798915467,1,24,regulation of TORC1 signaling,BP,TELO2
11854,GO:0046835,0.854823976263831,0.437215286839188,1,24,carbohydrate phosphorylation,BP,GNPTAB
1926,GO:0004620,0.855005498871509,0.304915629526663,3,60,phospholipase activity,MF,PLBD1;SMPD2;CCL5
21,GO:0000038,0.855269178903373,0.436357245804429,1,24,very long-chain fatty acid metabolic process,BP,ACAA1
9890,GO:0042168,0.855290184650974,0.435842217516861,1,25,heme metabolic process,BP,NFE2L1
13279,GO:0051966,0.855324828458074,0.436249892145917,1,24,regulation of synaptic transmission, glutamatergic,BP,OXTR
83,GO:0000166,0.855326825761152,0.169132835301032,116,1626,nucleotide binding,MF,RUNX1;ACTG1;TAP1;BAG1;ABCF1;MAP3K14;GBP1;TXNRD1;MAT2A;IKBKE;DAPK3;G6PD;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TYMS;CYB5R1;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHCR7;DHX37;DDX42;SGK1;RHOB;DHFR;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;POLA1;UHRF1;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;CRCP;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;MICAL3;HSPBP1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;DUS2;QDPR;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;PARP1;CLK4;ORC4
12313,GO:0048663,0.855335103879144,0.436230067376049,1,24,neuron fate commitment,BP,NRG1
11813,GO:0046700,0.855830099563598,0.187920390157763,34,543,heterocycle catabolic process,BP,CYP1A1;HSPB1;TET3;NOCT;NUP153;PSMB9;ZC3H12A;PABPC4;PGK1;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;DNASE1;NUP214;TATDN2;HNRNPU;RPL27A;HSPA8;EDC4;METTL16;SMUG1;DHX34;PSMC3;POLR2G;MAGOH
11512,GO:0046006,0.855873639155982,0.434715361297463,1,25,regulation of activated T cell proliferation,BP,CD274
14471,GO:0061842,0.856400885320738,0.434169681986576,1,24,microtubule organizing center localization,BP,TBCCD1
5994,GO:0018995,0.856605505763683,0.302239101096637,3,61,host,CC,NUP153;NMT2;NUP214
10647,GO:0043657,0.856605505763683,0.302239101096637,3,61,host cell,CC,NUP153;NMT2;NUP214
10770,GO:0044215,0.856605505763683,0.302239101096637,3,61,other organism,CC,NUP153;NMT2;NUP214
10771,GO:0044216,0.856605505763683,0.302239101096637,3,61,other organism cell,CC,NUP153;NMT2;NUP214
10772,GO:0044217,0.856605505763683,0.302239101096637,3,61,other organism part,CC,NUP153;NMT2;NUP214
17603,GO:1901265,0.856734559647647,0.167569918716673,116,1627,nucleoside phosphate binding,MF,RUNX1;ACTG1;TAP1;BAG1;ABCF1;MAP3K14;GBP1;TXNRD1;MAT2A;IKBKE;DAPK3;G6PD;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TYMS;CYB5R1;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHCR7;DHX37;DDX42;SGK1;RHOB;DHFR;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;POLA1;UHRF1;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;CRCP;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;MICAL3;HSPBP1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;DUS2;QDPR;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;PARP1;CLK4;ORC4
6732,GO:0030148,0.856901317157395,0.278618006467171,4,77,sphingolipid biosynthetic process,BP,CYR61;TNF;ST6GALNAC5;SMPD2
9782,GO:0039694,0.857452822970505,0.432127992006679,1,24,viral RNA genome replication,BP,CXCL8
9987,GO:0042383,0.857749538532738,0.27731470181143,4,77,sarcolemma,CC,LAMP1;VCL;STAC;DAG1
6389,GO:0021587,0.857824545248616,0.431404593707058,1,24,cerebellum morphogenesis,BP,ZNF365
6133,GO:0019395,0.858079355984852,0.276735938083522,4,78,fatty acid oxidation,BP,IRS1;ACAA1;IRS2;CPT1A
17290,GO:0140053,0.858173136543835,0.233990387229452,8,153,mitochondrial gene expression,BP,PUS1;MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;MRPS2;HSD17B10
4981,GO:0015103,0.858474759621175,0.276198616799244,4,77,inorganic anion transmembrane transporter activity,MF,FXYD3;SLC4A11;SLC22A4;SLC4A2
10688,GO:0043954,0.858825892013609,0.429450861693259,1,24,cellular component maintenance,BP,PLEKHA7
13575,GO:0060042,0.859319544586628,0.428484976749964,1,24,retina morphogenesis in camera-type eye,BP,SDK1
17824,GO:1901981,0.859753561477989,0.247593658253319,6,109,phosphatidylinositol phosphate binding,MF,JPH2;MYO1B;MYO10;ANXA8;LANCL2;PARD3
5646,GO:0016740,0.859784164942177,0.162659014130258,135,1892,transferase activity,MF,NRG1;DTX2;UGT1A6;CD3EAP;CSF2;PTGES;MAP3K14;FAM46B;SH3RF2;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;B4GALT1;SPSB1;TRAF3;NUAK1;KLHL21;SQSTM1;PANK2;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;LYN;HMGXB3;HS3ST2;ZBED1;RING1;PKMYT1;TRIO;FGFR2;CDKAL1;EPHB6;QPCT;UBE2C;TYMS;TNK1;TK1;ACAA1;EPHA2;HMGCS1;UBE4B;CDK4;TRMT61A;STAT5A;RNF19B;METTL13;NAT10;PGK1;NMT2;ST6GALNAC5;TRIM22;ZDHHC3;APTX;METTL1;DPH2;NFX1;NSUN2;HS3ST1;SGK1;PRPF19;DKC1;FGFR1OP;KCTD10;RIPK4;IRS2;METTL2B;TRAF2;PRKCA;SYK;POLR1A;PPIP5K1;CDKL1;PDGFB;POLA1;NSUN5;NEDD4L;COLGALT1;RNF115;UHRF1;CAMK1G;RBBP5;FTSJ3;ROR1;CRCP;NOL9;WDR4;KEAP1;ZDHHC6;CHST3;UBE2J2;TPST1;LPCAT3;PARP14;PRDM7;PCYT1A;GALNT2;CAB39;OXSR1;GBE1;PIGM;DTX4;ESR1;BRPF1;CPT1A;NOP2;HERC2;TRMT1;CS;KBTBD12;METTL16;TKT;RNF7;MPHOSPH8;UAP1L1;POLR3H;MGAT2;DPM3;CD38;TNFAIP3;MAPK11;METTL21A;POLR1E;TRIML2;RNF144B;POLR2G;HERC6;PARP1;CLK4;CCL5
12400,GO:0048841,0.860009460884181,0.427132057766951,1,24,regulation of axon extension involved in axon guidance,BP,SEMA3C
13114,GO:0051649,0.860580250091128,0.163274787492198,116,1670,establishment of localization in cell,BP,CRYAB;NRG1;NEFL;JPH2;TAP1;PML;HSPB1;EMP2;TP53;SQSTM1;GNPTAB;CDKN1A;LYN;RAB32;LAMP1;EHD1;TNF;WWC1;DST;PTPN14;NUP153;JPH1;ZC3H12A;SRSF2;LCP1;CYB5R1;GEMIN5;CADPS2;CHP1;ARFRP1;GOSR1;KIF23;MYO10;PMM2;SFN;ADRB2;LSG1;USP36;AKAP8L;PARL;ZDHHC3;ANXA8;BANF1;GPER1;AP4S1;NFKBIA;GEMIN4;RRS1;RPLP2;RHOB;SNX12;U2AF2;RPLP1;REEP1;NTN1;SYK;RPS2;PTTG1IP;ALYREF;PHAX;WDR34;RPS9;GEMIN8;SPTBN1;DCTN1;COX5B;MYH9;SNX8;RUNDC1;DDX39A;WDR46;ZW10;NUP214;YWHAH;M6PR;ZDHHC6;HNRNPU;CLASP1;UBE2J2;KCNIP3;THOC1;TGFBRAP1;RPL27A;HSPA8;BLOC1S2;CPT1A;TFDP1;TNPO3;TRAPPC5;CHMP4B;RBM4;INSIG1;HERC2;PARD3;TAP2;ACTN4;SNIP1;TOMM40;SGSM1;IPO4;EIF5A;TINAGL1;KIF22;DAG1;RAB27A;RILPL2;VPS52;TUBB;SRSF7;CLTA;NOL3;SNF8;CDCA5;HSP90AB1;TP63;MAGOH
6689,GO:0030057,0.861055601446593,0.425073826285504,1,24,desmosome,CC,B4GALT1
3155,GO:0006754,0.86105730675337,0.256768836838904,5,95,ATP biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
13265,GO:0051952,0.861223771536171,0.424266672567189,1,25,regulation of amine transport,BP,OXTR
157,GO:0000315,0.861319469751855,0.332660292197667,2,51,organellar large ribosomal subunit,CC,MRPL20;MRPL33
2509,GO:0005762,0.861319469751855,0.332660292197667,2,51,mitochondrial large ribosomal subunit,CC,MRPL20;MRPL33
11578,GO:0046131,0.86169729556346,0.422893610800408,1,26,pyrimidine ribonucleoside metabolic process,BP,CTPS1
5701,GO:0016829,0.861751341536236,0.236036525306129,7,128,lyase activity,MF,ODC1;GGCX;PUS1;ACO1;XRCC6;CD38;APEX2
200,GO:0000421,0.861773892861032,0.423180278563841,1,25,autophagosome membrane,CC,VMP1
6219,GO:0019752,0.861922398516581,0.173245753577792,50,750,carboxylic acid metabolic process,BP,ODC1;CYP1B1;NQO1;CYP1A1;FADS3;UGT1A6;PTGES;EDN1;PANK2;NFKB1;IRS1;CARS2;SCD;NUP153;PSMB9;SLC7A5;PGD;TYMS;ACAA1;CHP1;STAT5A;SLC5A6;PGK1;PSME2;DHFR;IRS2;ACO1;IL15;AKR1C2;SYK;SLC7A2;PDGFB;AASS;ACSL1;NUP214;CPT1A;DCXR;SCD5;INSIG1;QDPR;CS;THEM4;GPX4;AKR1C1;PSMC3;AARSD1;CTPS1;HSD17B10;GCLC;FADS1
17922,GO:1902235,0.862225785110577,0.422286166607181,1,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,CREB3
8806,GO:0034508,0.862246045724673,0.331176417059251,2,50,centromere complex assembly,BP,CENPN;CENPO
12939,GO:0051298,0.863245100632126,0.291479585519163,3,61,centrosome duplication,BP,CHMP4B;CNTROB;RBM14
16157,GO:0090174,0.863629624645118,0.233422259615294,7,126,organelle membrane fusion,BP,TAP1;GOSR1;RUNDC1;TAPBP;TGFBRAP1;TAP2;SGSM1
13625,GO:0060119,0.86422162919644,0.418318681947932,1,25,inner ear receptor cell development,BP,SDC4
8768,GO:0034440,0.864638582125585,0.266506802181955,4,79,lipid oxidation,BP,IRS1;ACAA1;IRS2;CPT1A
16271,GO:0090329,0.864798229359607,0.327637524703876,2,44,regulation of DNA-dependent DNA replication,BP,ZNF365;TIMELESS
17503,GO:1900543,0.864935428305624,0.416892349948705,1,25,negative regulation of purine nucleotide metabolic process,BP,PARP1
10584,GO:0043547,0.864940623037065,0.191774312199621,19,302,positive regulation of GTPase activity,BP,CCL20;STARD13;SIPA1L3;CORO1C;EPHA2;ICAM1;ERRFI1;CDC42EP2;SFRP1;DOCK10;RUNDC1;RCC2;JUN;RHOG;SGSM1;RAPGEF1;WNT4;CCL22;CCL5
1911,GO:0004601,0.864982874686869,0.415578397901532,1,28,peroxidase activity,MF,GPX4
5884,GO:0018022,0.865414871585334,0.250232208522268,5,95,peptidyl-lysine methylation,BP,TET3;NELFE;RBBP5;PRDM7;METTL21A
13601,GO:0060071,0.865486494462348,0.249933216069112,5,99,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB9;SFRP1;PSME2;ROR1;PSMC3
8860,GO:0034655,0.866102822161473,0.176913638931566,32,518,nucleobase-containing compound catabolic process,BP,HSPB1;NOCT;NUP153;PSMB9;ZC3H12A;PABPC4;PGK1;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;DNASE1;NUP214;TATDN2;HNRNPU;RPL27A;HSPA8;EDC4;METTL16;SMUG1;DHX34;PSMC3;POLR2G;MAGOH
3140,GO:0006733,0.866713991108202,0.222290508246145,8,143,oxidoreduction coenzyme metabolic process,BP,G6PD;NUP153;PGD;PGK1;NUP214;DCXR;TKT;CD38
17309,GO:0140104,0.866996788669504,0.411907376830758,1,27,molecular carrier activity,MF,NUP214
14402,GO:0061659,0.867360035955305,0.204044463249697,12,203,ubiquitin-like protein ligase activity,MF,UBE2C;UBE4B;RNF19B;PRPF19;NEDD4L;RNF115;UHRF1;UBE2J2;HERC2;RNF7;RNF144B;HERC6
4517,GO:0010569,0.867469837594607,0.411796147057118,1,25,regulation of double-strand break repair via homologous recombination,BP,ZNF365
2058,GO:0004812,0.867479206798172,0.322891149985565,2,44,aminoacyl-tRNA ligase activity,MF,CARS2;AARSD1
5730,GO:0016875,0.867479206798172,0.322891149985565,2,44,ligase activity, forming carbon-oxygen bonds,MF,CARS2;AARSD1
8429,GO:0033522,0.867832478611662,0.41106283995455,1,25,histone H2A ubiquitination,BP,RING1
14739,GO:0070405,0.867979495124149,0.410326666097292,1,26,ammonium ion binding,MF,PCYT1A
19232,GO:1905368,0.868454344957168,0.260160104963623,4,85,peptidase complex,CC,HSPB1;PSMB9;PSME2;PSMC3
7070,GO:0030857,0.868582517458364,0.409542870799637,1,25,negative regulation of epithelial cell differentiation,BP,TP63
5747,GO:0016894,0.868642069304698,0.408983376304908,1,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,APEX2
12595,GO:0050771,0.868876067518516,0.320403731993735,2,44,negative regulation of axonogenesis,BP,NTN1;SEMA3C
7874,GO:0032435,0.868936432343903,0.408385475642919,1,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HSP90AB1
13150,GO:0051721,0.869039847137696,0.408613894716377,1,25,protein phosphatase 2A binding,MF,TP53
14829,GO:0070566,0.869194997980451,0.408298358109625,1,25,adenylyltransferase activity,MF,APTX
2286,GO:0005244,0.869500131463538,0.281086783958783,3,62,voltage-gated ion channel activity,MF,ITGAV;KCNA7;KCNIP3
6612,GO:0022832,0.869500131463538,0.281086783958783,3,62,voltage-gated channel activity,MF,ITGAV;KCNA7;KCNIP3
17539,GO:1901068,0.869602673660909,0.318765295509856,2,46,guanosine-containing compound metabolic process,BP,TJP2;PDE6A
18367,GO:1903363,0.869617111254447,0.280699107913221,3,64,negative regulation of cellular protein catabolic process,BP,PML;EFNA1;HSP90AB1
2082,GO:0004842,0.869776619916844,0.179284278850714,24,377,ubiquitin-protein transferase activity,MF,TRIM56;BIRC3;SPSB1;TRAF3;KLHL21;UBE2C;UBE4B;RNF19B;PRPF19;KCTD10;TRAF2;NEDD4L;RNF115;UHRF1;KEAP1;UBE2J2;DTX4;HERC2;KBTBD12;RNF7;MPHOSPH8;TNFAIP3;RNF144B;HERC6
7954,GO:0032553,0.871467793047885,0.152595315411246,101,1431,ribonucleotide binding,MF,RUNX1;ACTG1;TAP1;ABCF1;MAP3K14;GBP1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;UBE2C;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHX37;DDX42;SGK1;RHOB;RIPK4;TSR1;ABCG2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;RHOG;XRCC6;TAP2;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;ORC4
12599,GO:0050775,0.871602292939773,0.403377813304114,1,25,positive regulation of dendrite morphogenesis,BP,BAIAP2
17728,GO:1901657,0.871723931144308,0.229828024934379,6,115,glycosyl compound metabolic process,BP,TJP2;TK1;AKR1C2;PDE6A;AKR1C1;CTPS1
2291,GO:0005249,0.871761662222388,0.403050408324231,1,25,voltage-gated potassium channel activity,MF,KCNA7
3634,GO:0008094,0.872045841941463,0.254865600026836,4,79,DNA-dependent ATPase activity,MF,RUVBL2;MCM7;XRCC6;BRIP1
1876,GO:0004553,0.872722140751457,0.275725851636402,3,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,MGAM;GANC;GBE1
3257,GO:0006921,0.872873952843148,0.40032089719265,1,26,cellular component disassembly involved in execution phase of apoptosis,BP,GPER1
12224,GO:0048477,0.873012536260651,0.312805320324414,2,45,oogenesis,BP,TAF4B;WNT4
6708,GO:0030118,0.873217323673423,0.312435446372842,2,45,clathrin coat,CC,CLTA;BAIAP2L2
10804,GO:0044283,0.873271083179143,0.166446334755001,35,542,small molecule biosynthetic process,BP,ADM;CYP1A1;FADS3;PTGES;EDN1;G6PD;NFKB1;TNF;SCD;NUP153;LSS;PGD;TK1;HMGCS1;BMP2;PGK1;EBP;DHCR7;GPER1;EGR1;SNAI2;DHFR;SYK;PPIP5K1;PDGFB;AASS;NUP214;SCD5;INSIG1;QDPR;SMUG1;TKT;WNT4;CTPS1;FADS1
11500,GO:0045980,0.873287817730445,0.399465933824208,1,26,negative regulation of nucleotide metabolic process,BP,PARP1
1523,GO:0003887,0.873402436531571,0.399228905033154,1,26,DNA-directed DNA polymerase activity,MF,POLA1
5454,GO:0016328,0.873506043418395,0.311913601881809,2,45,lateral plasma membrane,CC,CORO1C;CLDN7
15036,GO:0070979,0.873642462817823,0.398326853618813,1,27,protein K11-linked ubiquitination,BP,UBE2C
3035,GO:0006584,0.873768824239329,0.398470498487237,1,26,catecholamine metabolic process,BP,TGFB2
4290,GO:0009712,0.873768824239329,0.398470498487237,1,26,catechol-containing compound metabolic process,BP,TGFB2
10829,GO:0044322,0.873771583770058,0.398464782177604,1,26,endoplasmic reticulum quality control compartment,CC,RNF185
11646,GO:0046365,0.873989802132832,0.310872926305315,2,46,monosaccharide catabolic process,BP,PGK1;DCXR
16814,GO:0098661,0.874001479733841,0.311017097619793,2,45,inorganic anion transmembrane transport,BP,FXYD3;SLC4A11
12519,GO:0050662,0.874076251155816,0.192119540220176,13,220,coenzyme binding,MF,P3H2;TXNRD1;G6PD;P4HA2;CYB5R1;DHCR7;DHFR;MICAL3;DUS2;QDPR;ACBD6;GCLC;PARP1
3141,GO:0006734,0.87408907337867,0.397806688929879,1,26,NADH metabolic process,BP,PGK1
4809,GO:0012507,0.874201974992754,0.310488661726366,2,46,ER to Golgi transport vesicle membrane,CC,HLA-B;HLA-F
16260,GO:0090313,0.874597652404082,0.396750764874703,1,26,regulation of protein targeting to membrane,BP,CHP1
19479,GO:1990234,0.874708371011388,0.159304437171889,47,712,transferase complex,CC,HDAC9;MAT2A;SPSB1;KLHL21;TP53;TAF4B;IRS1;CDKN1A;RING1;ENC1;UBE2C;UBE4B;CDK4;TRMT61A;RNF19B;METTL1;ABTB2;EDF1;KCTD10;CBX5;TRAF2;POLR1A;SENP3;POLA1;RBBP5;CRCP;WDR4;KEAP1;PAGR1;UBE2J2;DCUN1D2;RUVBL2;ANAPC15;CAB39;HSPA8;BRPF1;GTF2E1;ZSWIM6;KBTBD12;RNF7;MPHOSPH8;UBAP2L;POLR3H;DPM3;POLR1E;RNF144B;POLR2G
5651,GO:0016746,0.874936441066923,0.1971202732799,11,190,transferase activity, transferring acyl groups,MF,QPCT;ACAA1;HMGCS1;NAT10;NMT2;ZDHHC3;ZDHHC6;LPCAT3;BRPF1;CPT1A;CS
3424,GO:0007212,0.87507981156008,0.395747708577168,1,26,dopamine receptor signaling pathway,BP,FLNA
5562,GO:0016574,0.875285959136272,0.308686699294476,2,45,histone ubiquitination,BP,RING1;UHRF1
2537,GO:0005794,0.875295693134061,0.151102138009153,79,1144,Golgi apparatus,CC,SPRR3;CRYAB;P3H2;CTGF;NFKBIE;SDC4;HLA-B;GBP1;B4GALT1;RSAD2;EMP2;STEAP4;NEDD9;GNPTAB;LFNG;GALNT18;HSPG2;LYN;MYO1B;RAB32;HS3ST2;BAIAP2;PKMYT1;FGFR2;BACE2;SART1;CHP1;ARFRP1;GOSR1;MTUS1;NMT2;ST6GALNAC5;ELF3;TRIM22;ZDHHC3;HLA-F;PTGFRN;PDE4DIP;GPER1;HS3ST1;AP4S1;AKAP8;ACO1;IL15;AJUBA;PDGFB;NSFL1C;NEDD4L;TAPBPL;CAMK1G;SLC35A4;SLC35C2;TAPBP;M6PR;ZDHHC6;CLASP1;CHST3;APH1A;TPST1;CREB3;TANGO2;KCNIP3;GALNT2;ESR1;MANEAL;GLIPR2;COMMD9;TRAPPC5;SGSM1;DAG1;TMEM165;MGAT2;RAB27A;WNT4;VPS52;CYTH1;SPG21;CLTA;TP63
2244,GO:0005154,0.875843032611501,0.394155976642812,1,26,epidermal growth factor receptor binding,MF,EPGN
9188,GO:0035567,0.875940014785398,0.215498363034836,7,132,non-canonical Wnt signaling pathway,BP,PSMB9;SFRP1;PSME2;ROR1;PDE6A;WNT4;PSMC3
6671,GO:0030031,0.87664659477115,0.167087445762285,28,437,cell projection assembly,BP,CYLD;EMP2;EHD1;CORO1C;FLNA;EPHA2;ICAM1;MYO10;CDC42EP2;CC2D2A;SRF;FGFR1OP;VCL;NTN1;AJUBA;WDR34;DCTN1;DPYSL3;RCC2;CLASP1;CEP41;PPP1R9B;RHOG;KIF24;RILPL2;TUBB;TTLL5;BIN3
18779,GO:1904292,0.876668125983566,0.392429701103248,1,26,regulation of ERAD pathway,BP,UBQLN2
14413,GO:0061695,0.876681052352728,0.186069988359022,14,239,transferase complex, transferring phosphorus-containing groups,CC,TP53;TAF4B;IRS1;CDKN1A;CDK4;EDF1;POLR1A;POLA1;CRCP;CAB39;GTF2E1;POLR3H;POLR1E;POLR2G
17849,GO:1902036,0.877099849411134,0.245950118772097,4,95,regulation of hematopoietic stem cell differentiation,BP,RUNX1;PSMB9;PSME2;PSMC3
16158,GO:0090175,0.877252937315091,0.231925235648528,5,101,regulation of establishment of planar polarity,BP,PSMB9;SFRP1;PSME2;ROR1;PSMC3
7158,GO:0031018,0.877290500385504,0.391123749438579,1,26,endocrine pancreas development,BP,IL6R
16331,GO:0090543,0.877473589212903,0.390738940941344,1,26,Flemming body,CC,KIF23
6385,GO:0021575,0.878419632320318,0.38874602760088,1,26,hindbrain morphogenesis,BP,ZNF365
6630,GO:0022890,0.878982023484557,0.178788153042827,16,268,inorganic cation transmembrane transporter activity,MF,JPH2;TFRC;PANX1;JPH1;SLC39A1;ITGAV;SLC5A6;KCNA7;COX5B;SLC4A11;KCNIP3;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC2A6
8060,GO:0032728,0.879053213334322,0.387407046895607,1,26,positive regulation of interferon-beta production,BP,IRF1
2880,GO:0006379,0.879164058255615,0.386767432368656,1,27,mRNA cleavage,BP,POP4
5157,GO:0015695,0.879572639357078,0.386306731607091,1,26,organic cation transport,BP,SLC22A4
11005,GO:0044818,0.879611241687834,0.386224865889494,1,26,mitotic G2/M transition checkpoint,BP,ORAOV1
10160,GO:0042743,0.880411564434834,0.383744569838513,1,28,hydrogen peroxide metabolic process,BP,CYP1A1
4486,GO:0010508,0.880525095255627,0.227043548300371,5,97,positive regulation of autophagy,BP,ZC3H12A;ADRB2;TRIM22;SUPT5H;SH3BP4
3239,GO:0006893,0.880773348274276,0.298466562504934,2,46,Golgi to plasma membrane transport,BP,ARFRP1;SPTBN1
12166,GO:0048284,0.881673455907514,0.200915860203788,8,146,organelle fusion,BP,TAP1;GOSR1;RUNDC1;TAPBP;TGFBRAP1;TAP2;CHCHD6;SGSM1
11700,GO:0046488,0.881773212019092,0.195689778566521,9,160,phosphatidylinositol metabolic process,BP,NRG1;PLBD1;IRS1;FGFR2;IRS2;PDGFB;PIGM;ESR1;DPM3
1998,GO:0004721,0.881917247898292,0.200587685186123,8,145,phosphoprotein phosphatase activity,MF,DUSP14;PTPN14;PPP1R3B;DUSP1;PHLPP1;CTDSP1;PTPRB;DUSP8
10577,GO:0043539,0.882146038174873,0.380416046376738,1,27,protein serine/threonine kinase activator activity,MF,CAB39
10788,GO:0044249,0.882220166190896,0.132263007026176,351,4830,cellular biosynthetic process,BP,MAFB;TRIM16;CCL20;NRG1;RUNX1;CYR61;INHBA;HDAC9;ODC1;CYP1B1;CTGF;ADM;FOSL2;NQO1;IL16;CYP1A1;NFKBIE;PML;TFCP2L1;CYLD;HSPB1;MYBL2;PDLIM1;TRAF1;FADS3;IRX2;RELB;SOD2;ABCF1;CD3EAP;ARID3B;IER2;CSF2;PTGES;FBN1;TGFB2;EDN1;MAT2A;DAPK3;TET3;B4GALT1;ELMSAN1;TRAF3;NLRC5;TP53;NFE2L1;SQSTM1;HNRNPAB;PANK2;NOCT;FST;NFKB1;CDKN2B;TAF4B;LFNG;IRS1;GALNT18;CDKN1A;AHR;JUNB;MCM5;COMMD4;TNF;GNL3L;ZBED1;CDKN2A;RING1;CARS2;SCD;WWC1;ENC1;ASCC2;FGFR2;PTPN14;CDKAL1;PBX1;NUP153;BACE2;NFKB2;DNAJB1;PSMB9;KRT17;FOSL1;TYMS;ZC3H12A;FLNA;SRSF2;TK1;GEMIN5;KLF7;ZNF503;CHP1;HMGCS1;CCDC85B;EIF5;TSC22D3;ICAM1;BMP2;CDK4;ZNF142;ERRFI1;PMM2;STAT5A;LYPD6B;ADRB2;DAXX;FOXD2;NAT10;SERPINE1;FUS;PABPC4;PGK1;MCM2;NMT2;TOX4;ST6GALNAC5;AKAP8L;VGLL3;ELF3;GRWD1;LIF;OSR2;SFRP1;TRIM22;ZDHHC3;SAFB2;PPP1R3B;MKL1;IRF1;PSME2;DPH2;CTIF;NFX1;PSPC1;GPER1;SRF;ZNF787;ELF4;LARP4B;MED22;ZFP42;TRIM29;NFKBIA;SF1;EGR1;EDF1;ETS1;SGK1;SNAI2;SRRT;ZFP36L1;RPLP2;AKAP8;NELFE;DKC1;FEN1;DHFR;U2AF2;RIPK4;IRS2;NPAS2;CBX5;PPRC1;ACO1;RPLP1;MAFK;TRAF2;IL15;ZNF778;ZFP36L2;PUM3;SYK;POLR1A;SLC7A2;DDX17;NFKBIB;AJUBA;GINS2;USP43;DNTTIP2;PDGFB;AASS;BRMS1;RPS2;UBTF;ALYREF;PHAX;POLA1;RPS9;NEDD4L;FHL2;ZNF407;COX5B;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;LANCL2;ZNF263;RBBP5;RBM15B;SFPQ;DDX39A;BRD9;ZNF697;SAP30BP;SPEN;ROR1;ACSL1;NUP214;MAFF;BAMBI;AFAP1L2;SMAD7;CRCP;SLC35C2;MRPS12;MRPS24;SUPT5H;MTA2;DNAJC1;YWHAH;TRIP6;KEAP1;ZDHHC6;ERAL1;HNRNPU;CHST3;PQBP1;PAGR1;TRIB1;CREB3;RUVBL2;ABT1;MAZ;ORC1;LPCAT3;KCNIP3;SAFB;THOC1;ETS2;DNTTIP1;KLF10;ZNF267;PARP14;PRDM7;MRPL20;PCYT1A;GALNT2;DUSP1;TGFBRAP1;CITED2;CD109;RPL27A;HSPA8;GBE1;JUN;PIGM;MRPL33;ESR1;IKZF3;TCOF1;FOXN1;BRPF1;COMMD9;MCM7;SCD5;TFDP1;ZNF772;ZNF512;EIF3B;GTF2E1;NOP2;NOC2L;GTF3C2;RBM4;SERTAD1;NACC1;ZNF703;INSIG1;GINS3;ARGLU1;QDPR;RHOG;ZNF365;XRCC6;ZNF132;KLF6;TEAD4;SMPD2;ACTN4;GLIS3;SNIP1;BMP7;METTL16;KCTD1;SMUG1;ZNF34;TKT;EFTUD2;MPHOSPH8;ELK1;PHF5A;EIF3I;CHAF1A;EIF5A;UAP1L1;DAG1;TMEM165;POLR3H;MGAT2;EEF1D;TIMELESS;DPM3;WNT4;MRPS2;RBM14;CTDSP1;CD38;TNFAIP3;PSMC3;SMARCC2;BRIP1;RRM2;SUPT16H;EFNA1;MAPK11;AARSD1;CTPS1;POLR1E;BMP8A;HES4;UTP4;POLR2G;SRSF7;CREB5;SNF8;GCLC;HSP90AB1;TTLL5;PARP1;TP63;ZBTB12;TOP3A;CCL5;ORC4;FADS1;MAGOH
1186,GO:0002833,0.8825961137663,0.379450631206499,1,27,positive regulation of response to biotic stimulus,BP,PRKCA
15746,GO:0072329,0.882630009641203,0.223682480038301,5,99,monocarboxylic acid catabolic process,BP,IRS1;ACAA1;IRS2;CPT1A;DCXR
14147,GO:0061025,0.882930515749496,0.189755140024063,10,177,membrane fusion,BP,TAP1;CHP1;GOSR1;NSFL1C;RUNDC1;TAPBP;TGFBRAP1;TAP2;CHCHD6;SGSM1
7029,GO:0030802,0.883025559719891,0.378527787856402,1,27,regulation of cyclic nucleotide biosynthetic process,BP,GPER1
10810,GO:0044297,0.883249968079068,0.168301857010279,19,312,cell body,CC,CRYAB;NRG1;MAP2;NQO1;TGFB2;LAMP1;BAIAP2;ENC1;FLNA;L1CAM;MYO10;PMM2;FUS;TXN2;PHAX;DPYSL3;PARD3;ELK1;TUBB
9409,GO:0035967,0.883547890002185,0.198210289223763,8,146,cellular response to topologically incorrect protein,BP,DAXX;DCTN1;TATDN2;CREB3;TUSC1;HSPA8;RNF185;CXCL8
3323,GO:0007030,0.883574396936573,0.212163442272634,6,113,Golgi organization,BP,VMP1;PDE4DIP;NSFL1C;ZW10;CLASP1;TANGO2
12624,GO:0050808,0.883668016771755,0.188757326869752,10,175,synapse organization,BP,NRG1;BAIAP2;TNC;COL4A1;L1CAM;DOCK10;OXTR;SDK1;ZNF365;EFNA1
19555,GO:1990542,0.884171662075785,0.255878254654638,3,67,mitochondrial transmembrane transport,BP,COX5B;CPT1A;TOMM40
16727,GO:0097730,0.884324576836854,0.25587461558668,3,64,non-motile cilium,CC,PHLPP1;PDE6A;RAB27A
10281,GO:0043025,0.88468871263352,0.171288714707433,16,268,neuronal cell body,CC,CRYAB;MAP2;NQO1;TGFB2;LAMP1;BAIAP2;ENC1;FLNA;L1CAM;MYO10;PMM2;FUS;TXN2;PHAX;PARD3;ELK1
2679,GO:0006040,0.885610615447506,0.372937723397859,1,27,amino sugar metabolic process,BP,UAP1L1
4253,GO:0009566,0.886687624777262,0.251624528649008,3,66,fertilization,BP,B4GALT1;UBAP2L;TTLL5
2815,GO:0006275,0.88699974416878,0.216845442850228,5,99,regulation of DNA replication,BP,CSF2;PDGFB;JUN;ZNF365;TIMELESS
5329,GO:0016055,0.887178043992233,0.157416959332866,24,388,Wnt signaling pathway,BP,RUNX1;CYLD;WNT10A;DAPK3;NFKB1;FGFR2;PSMB9;BMP2;KREMEN2;AMOTL2;SFRP1;PSME2;EGR1;JRK;SNAI2;ROR1;BAMBI;RUVBL2;ESR1;ZNF703;RAPGEF1;PDE6A;WNT4;PSMC3
11118,GO:0045143,0.887254279574433,0.36935172075011,1,27,homologous chromosome segregation,BP,BRIP1
2847,GO:0006325,0.887363537572662,0.146089615049866,42,660,chromatin organization,BP,TRIM16;HDAC9;DAPK3;TET3;TP53;CPA4;CDKN2A;RING1;DAXX;MCM2;TOX4;USP36;AKAP8L;GRWD1;LIF;SNAI2;AKAP8;NELFE;PRKCA;BRMS1;UBTF;UHRF1;RBBP5;SFPQ;BRD9;MTA2;HNRNPU;RUVBL2;SAFB;PRDM7;ESR1;CENPN;BRPF1;NOC2L;CENPO;IPO4;CHAF1A;RBM14;SMARCC2;SUPT16H;MKI67;TP63
12286,GO:0048599,0.887428550764278,0.368970048931064,1,27,oocyte development,BP,WNT4
8836,GO:0034620,0.887489644647873,0.198535895474284,7,131,cellular response to unfolded protein,BP,DAXX;DCTN1;TATDN2;CREB3;TUSC1;HSPA8;CXCL8
3091,GO:0006664,0.887639287899333,0.215797174110234,5,100,glycolipid metabolic process,BP,CLN6;ST6GALNAC5;PIGM;SMPD2;DPM3
18429,GO:1903509,0.887639287899333,0.215797174110234,5,100,liposaccharide metabolic process,BP,CLN6;ST6GALNAC5;PIGM;SMPD2;DPM3
7161,GO:0031023,0.887768689107803,0.205722557076941,6,115,microtubule organizing center organization,BP,GADD45A;DCTN1;CLASP1;CHMP4B;CNTROB;RBM14
10522,GO:0043436,0.887919639732631,0.141537954508299,54,817,oxoacid metabolic process,BP,ODC1;CYP1B1;NQO1;CYP1A1;FADS3;UGT1A6;PTGES;EDN1;B4GALT1;PANK2;NFKB1;IRS1;CARS2;SCD;NUP153;PSMB9;SLC7A5;PGD;TYMS;ACAA1;CHP1;STAT5A;SLC5A6;PGK1;PSME2;DHFR;IRS2;ACO1;IL15;AKR1C2;SYK;SLC7A2;PDGFB;AASS;PRUNE2;ACSL1;NUP214;CHST3;TPST1;CPT1A;DCXR;SCD5;INSIG1;QDPR;CS;THEM4;GPX4;AKR1C1;PSMC3;AARSD1;CTPS1;HSD17B10;GCLC;FADS1
11742,GO:0046578,0.887920164520914,0.179240613970335,11,190,regulation of Ras protein signal transduction,BP,NRG1;TGFB2;SQSTM1;TRIO;TNK1;ARHGEF28;ROBO1;RASGRP4;SPRY4;RAPGEF1;CYTH1
3177,GO:0006790,0.88793068408185,0.166955782946461,16,274,sulfur compound metabolic process,BP,PTGES;MAT2A;B4GALT1;G6PD;SCD;HMGCS1;STAT5A;SLC5A6;AASS;ACSL1;CHST3;TPST1;SCD5;ACBD6;THEM4;GCLC
6258,GO:0019842,0.888140712118869,0.228671441337526,4,83,vitamin binding,MF,P3H2;P4HA2;TYMS;DHFR
6579,GO:0022406,0.888326959134378,0.186298849570528,9,163,membrane docking,BP,CHP1;ICAM1;CC2D2A;FGFR1OP;DCTN1;CLASP1;CEP41;KIF24;TUBB
68,GO:0000139,0.888429271991864,0.146567157221116,38,583,Golgi membrane,CC,HLA-B;GBP1;B4GALT1;EMP2;STEAP4;GNPTAB;LFNG;GALNT18;MYO1B;HS3ST2;PKMYT1;CHP1;ARFRP1;GOSR1;ST6GALNAC5;ZDHHC3;HLA-F;GPER1;AP4S1;PDGFB;TAPBPL;CAMK1G;SLC35A4;TAPBP;M6PR;CHST3;APH1A;TPST1;CREB3;GALNT2;MANEAL;GLIPR2;TRAPPC5;TMEM165;MGAT2;VPS52;CYTH1;CLTA
9962,GO:0042339,0.888676948886005,0.366227654250271,1,27,keratan sulfate metabolic process,BP,B4GALT1
4968,GO:0015077,0.888754016029612,0.185632385047909,9,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC5A6;KCNA7;COX5B;SLC4A11;KCNIP3;SLC4A2;SLC3A2;SLC25A22;SLC2A6
3030,GO:0006576,0.888826304136257,0.365524719408136,1,28,cellular biogenic amine metabolic process,BP,ODC1
6770,GO:0030204,0.888959665269369,0.365604575082805,1,27,chondroitin sulfate metabolic process,BP,CHST3
16643,GO:0097502,0.889068952125026,0.364989705243646,1,28,mannosylation,BP,DPM3
19283,GO:1905515,0.889127584700316,0.282677455719796,2,47,non-motile cilium assembly,BP,CC2D2A;DCTN1
10652,GO:0043687,0.88936757311,0.160339113889275,19,318,post-translational protein modification,BP,IGFBP3;CYR61;FN1;FBN1;PRSS23;SPSB1;KLHL21;TNC;PSMB9;LYPD6B;PSME2;COPS3;RBBP5;KEAP1;CD109;LAMC1;RNF7;ASB6;PSMC3
16339,GO:0090568,0.889380398574989,0.364675925585035,1,27,nuclear transcriptional repressor complex,CC,MTA2
5561,GO:0016573,0.889452577381687,0.19561323788818,7,131,histone acetylation,BP,TRIM16;CPA4;LIF;SNAI2;RUVBL2;BRPF1;NOC2L
4254,GO:0009581,0.890148724771351,0.280738484038337,2,47,detection of external stimulus,BP,NMT2;PDE6A
454,GO:0001227,0.890238379846597,0.183595916975693,9,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,IRX2;NFKB1;NFX1;ZFP42;SNAI2;MAFK;ZNF263;KCNIP3;ETS2
11685,GO:0046467,0.890467378030754,0.201530308032492,6,117,membrane lipid biosynthetic process,BP,CYR61;TNF;ST6GALNAC5;PIGM;SMPD2;DPM3
3561,GO:0007601,0.89058075237155,0.224712386910762,4,82,visual perception,BP,CYP1B1;CLN6;NOB1;PDE6A
2538,GO:0005795,0.890692011379831,0.201250669849138,6,115,Golgi stack,CC,B4GALT1;GOSR1;NSFL1C;APH1A;GALNT2;MGAT2
8970,GO:0035050,0.891657578357849,0.277861844161519,2,47,embryonic heart tube development,BP,SRF;CITED2
10796,GO:0044270,0.891684640256108,0.145075249172425,33,543,cellular nitrogen compound catabolic process,BP,HSPB1;TET3;NOCT;NUP153;PSMB9;ZC3H12A;PABPC4;PGK1;PSME2;CTIF;POP1;ZFP36L1;RPLP2;DKC1;FEN1;RPLP1;PRKCA;ZFP36L2;RPS2;RPS9;DNASE1;NUP214;TATDN2;HNRNPU;RPL27A;HSPA8;EDC4;METTL16;SMUG1;DHX34;PSMC3;POLR2G;MAGOH
17071,GO:0099565,0.891799384521175,0.277590773914049,2,47,chemical synaptic transmission, postsynaptic,BP,BAIAP2;ADRB2
6626,GO:0022857,0.892454248240907,0.143639288564802,34,533,transmembrane transporter activity,MF,SLC16A2;JPH2;TAP1;TFRC;PANX1;SLC7A5;SLC16A9;JPH1;SLC39A1;SLCO3A1;SLC7A5P2;ITGAV;SLC5A6;FXYD3;EBP;KCNA7;ABCG2;SLC7A2;COX5B;SLC35A4;SLC43A2;TAPBP;M6PR;SLC4A11;KCNIP3;SLC22A4;TAP2;TOMM40;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC25A44;SLC2A6
6336,GO:0021510,0.892494368842142,0.276260482575548,2,47,spinal cord development,BP,NEFL;ABT1
17333,GO:0198738,0.892617124326082,0.150510696568307,24,390,cell-cell signaling by wnt,BP,RUNX1;CYLD;WNT10A;DAPK3;NFKB1;FGFR2;PSMB9;BMP2;KREMEN2;AMOTL2;SFRP1;PSME2;EGR1;JRK;SNAI2;ROR1;BAMBI;RUVBL2;ESR1;ZNF703;RAPGEF1;PDE6A;WNT4;PSMC3
9945,GO:0042304,0.892661423024584,0.357003124988924,1,28,regulation of fatty acid biosynthetic process,BP,INSIG1
3083,GO:0006656,0.892730630469338,0.356848046254548,1,28,phosphatidylcholine biosynthetic process,BP,PCYT1A
11411,GO:0045815,0.893190255815328,0.239502958605668,3,77,positive regulation of gene expression, epigenetic,BP,CD3EAP;POLR1A;POLR1E
2828,GO:0006294,0.893263190422437,0.35530675556649,1,29,nucleotide-excision repair, preincision complex assembly,BP,PARP1
18238,GO:1903046,0.893514057073959,0.196876670109531,6,116,meiotic cell cycle process,BP,LIF;NSUN2;MYH9;ORAOV1;WNT4;BRIP1
6197,GO:0019674,0.893590468762548,0.27401069743162,2,48,NAD metabolic process,BP,PGK1;CD38
4221,GO:0009395,0.89381882713646,0.354403476410692,1,28,phospholipid catabolic process,BP,GPCPD1
7948,GO:0032543,0.894262320977317,0.195349562383319,6,129,mitochondrial translation,BP,MRPS12;MRPS24;ERAL1;MRPL20;MRPL33;MRPS2
5058,GO:0015267,0.894320101286937,0.177676950818996,9,163,channel activity,MF,JPH2;PANX1;JPH1;ITGAV;FXYD3;KCNA7;SLC4A11;KCNIP3;TOMM40
6607,GO:0022803,0.894320101286937,0.177676950818996,9,163,passive transmembrane transporter activity,MF,JPH2;PANX1;JPH1;ITGAV;FXYD3;KCNA7;SLC4A11;KCNIP3;TOMM40
2505,GO:0005758,0.8943997892825,0.237764909053395,3,71,mitochondrial intermembrane space,CC,PANK2;LYN;THEM4
5899,GO:0018105,0.894701896708763,0.166757854746414,12,209,peptidyl-serine phosphorylation,BP,IKBKE;DAPK3;IL24;TNF;LIF;SGK1;PRKCA;SYK;PDGFB;CAMK1G;SMAD7;CAB39
4032,GO:0009064,0.89498013877549,0.271332660151593,2,48,glutamine family amino acid metabolic process,BP,CTPS1;GCLC
8449,GO:0033572,0.894989820274839,0.351413981782021,1,29,transferrin transport,BP,TFRC
5574,GO:0016591,0.895294282605586,0.203532191383141,5,103,DNA-directed RNA polymerase II, holoenzyme,CC,TP53;TAF4B;EDF1;GTF2E1;POLR2G
4357,GO:0009953,0.895887494247158,0.26957751563556,2,48,dorsal/ventral pattern formation,BP,EDN1;SFRP1
6235,GO:0019787,0.895956465951246,0.14538464633169,25,401,ubiquitin-like protein transferase activity,MF,TRIM56;BIRC3;SPSB1;TRAF3;KLHL21;ZBED1;UBE2C;UBE4B;RNF19B;PRPF19;KCTD10;TRAF2;NEDD4L;RNF115;UHRF1;KEAP1;UBE2J2;DTX4;HERC2;KBTBD12;RNF7;MPHOSPH8;TNFAIP3;RNF144B;HERC6
12717,GO:0050953,0.896032841037996,0.215595387780115,4,83,sensory perception of light stimulus,BP,CYP1B1;CLN6;NOB1;PDE6A
14269,GO:0061337,0.896041817950594,0.235241530345233,3,66,cardiac conduction,BP,FLNA;FXYD3;KCNIP3
20176,GO:2001022,0.896044406478442,0.235156086630256,3,67,positive regulation of response to DNA damage stimulus,BP,NPAS2;TIMELESS;PARP1
12616,GO:0050798,0.896181354063716,0.34871033824589,1,29,activated T cell proliferation,BP,CD274
4373,GO:0009994,0.896327393794788,0.348723473671146,1,28,oocyte differentiation,BP,WNT4
3565,GO:0007606,0.89694044556378,0.346980481303218,1,29,sensory perception of chemical stimulus,BP,NAV2
23,GO:0000045,0.897697983779882,0.212749828119595,4,84,autophagosome assembly,BP,UBQLN2;NSFL1C;ATG101;CHMP4B
12511,GO:0050654,0.897737593222874,0.345502634719663,1,28,chondroitin sulfate proteoglycan metabolic process,BP,CHST3
7258,GO:0031225,0.897854663302598,0.231783980227608,3,69,anchored component of membrane,CC,LYPD6B;CD109;EFNA1
5678,GO:0016790,0.898271611918494,0.343932807390368,1,29,thiolester hydrolase activity,MF,THEM4
4071,GO:0009124,0.898466868757783,0.181953498387756,7,135,nucleoside monophosphate biosynthetic process,BP,NUP153;TYMS;TK1;PGK1;COX5B;NUP214;PARP1
5731,GO:0016877,0.898504071669735,0.343743501795464,1,28,ligase activity, forming carbon-sulfur bonds,MF,ACSL1
13608,GO:0060078,0.898647408054365,0.26420643223265,2,48,regulation of postsynaptic membrane potential,BP,BAIAP2;ADRB2
12405,GO:0048846,0.899293716546826,0.341924856402408,1,28,axon extension involved in axon guidance,BP,SEMA3C
17944,GO:1902284,0.899293716546826,0.341924856402408,1,28,neuron projection extension involved in neuron projection guidance,BP,SEMA3C
402,GO:0001078,0.899425618068347,0.197010096474939,5,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NFX1;ZFP42;SNAI2;KCNIP3;ETS2
5226,GO:0015837,0.899456668812343,0.341204322408857,1,29,amine transport,BP,OXTR
3798,GO:0008375,0.900235183455638,0.260956818552178,2,49,acetylglucosaminyltransferase activity,MF,LFNG;MGAT2
2908,GO:0006418,0.900353184150435,0.260724884046507,2,49,tRNA aminoacylation for protein translation,BP,CARS2;AARSD1
12779,GO:0051054,0.900361993396262,0.164988384176614,10,181,positive regulation of DNA metabolic process,BP,PML;TFRC;CSF2;DKC1;NPAS2;PDGFB;JUN;TIMELESS;HSP90AB1;PARP1
6449,GO:0021766,0.900469404912119,0.26049635767753,2,49,hippocampus development,BP,NEFL;SRF
5624,GO:0016684,0.900823106846511,0.337140397167917,1,32,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX4
99,GO:0000209,0.900850333046415,0.149693122009391,16,276,protein polyubiquitination,BP,TRIM56;SPSB1;PSMB9;UBE2C;UBE4B;RNF19B;PSME2;PRPF19;TRAF2;NEDD4L;RNF115;UBE2J2;TNFAIP3;PSMC3;RNF144B;HERC6
10976,GO:0044764,0.90094726499896,0.337751580941184,1,29,multi-organism cellular process,BP,BIRC3
2273,GO:0005216,0.901972035687026,0.171081300977265,8,149,ion channel activity,MF,JPH2;PANX1;JPH1;ITGAV;FXYD3;KCNA7;SLC4A11;KCNIP3
2295,GO:0005254,0.902199073694762,0.334833823292103,1,29,chloride channel activity,MF,FXYD3
12670,GO:0050877,0.902225121600578,0.137369732674421,25,406,nervous system process,BP,NRG1;NEFL;CYP1B1;SOD2;EDN1;NAV2;CLN6;FOSL1;ICAM1;WDR1;GPER1;SRF;SGK1;SNAI2;FEN1;NOB1;OXTR;TNFRSF21;ROR1;MARVELD2;JUN;PARD3;CNTNAP1;DAG1;PDE6A
5965,GO:0018393,0.902422026637647,0.175954747086922,7,134,internal peptidyl-lysine acetylation,BP,TRIM16;CPA4;LIF;SNAI2;RUVBL2;BRPF1;NOC2L
10324,GO:0043113,0.902506168577728,0.334115480727048,1,29,receptor clustering,BP,FLNA
10891,GO:0044431,0.902587899216416,0.126043894269306,47,717,Golgi apparatus part,CC,CTGF;SDC4;HLA-B;GBP1;B4GALT1;EMP2;STEAP4;GNPTAB;LFNG;GALNT18;HSPG2;MYO1B;RAB32;HS3ST2;PKMYT1;CHP1;ARFRP1;GOSR1;ST6GALNAC5;ZDHHC3;HLA-F;GPER1;HS3ST1;AP4S1;PDGFB;NSFL1C;TAPBPL;CAMK1G;SLC35A4;SLC35C2;TAPBP;M6PR;CHST3;APH1A;TPST1;CREB3;GALNT2;MANEAL;GLIPR2;TRAPPC5;DAG1;TMEM165;MGAT2;WNT4;VPS52;CYTH1;CLTA
7969,GO:0032580,0.902848810251764,0.222972324294939,3,67,Golgi cisterna membrane,CC,B4GALT1;APH1A;GALNT2
2543,GO:0005802,0.903141435808024,0.164756628292621,9,167,trans-Golgi network,CC,MYO1B;RAB32;ARFRP1;GPER1;AP4S1;M6PR;TMEM165;VPS52;CLTA
13119,GO:0051656,0.903167710782486,0.139915122982071,21,348,establishment of organelle localization,BP,NEFL;LYN;LAMP1;CADPS2;GOSR1;KIF23;RRS1;NTN1;SYK;DCTN1;MYH9;ZW10;HNRNPU;CLASP1;BLOC1S2;TRAPPC5;CHMP4B;ACTN4;KIF22;RAB27A;CDCA5
7812,GO:0032365,0.903212228349136,0.332460048150068,1,29,intracellular lipid transport,BP,CPT1A
4145,GO:0009206,0.903237157719407,0.190676709125164,5,104,purine ribonucleoside triphosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
7717,GO:0032206,0.903599386897247,0.254307726457299,2,49,positive regulation of telomere maintenance,BP,PML;DKC1
11698,GO:0046486,0.903724540979636,0.141520078059204,19,317,glycerolipid metabolic process,BP,NRG1;PLBD1;PANK2;IRS1;FGFR2;ABHD4;GPCPD1;IRS2;AJUBA;PDGFB;ACSL1;LPCAT3;PCYT1A;PIGM;ESR1;SLC22A4;CPT1A;INSIG1;DPM3
9196,GO:0035578,0.903935198954736,0.220854811559946,3,69,azurophil granule lumen,CC,FTL;HRNR;TUBB
5324,GO:0016050,0.904416122500819,0.140593163049872,19,319,vesicle organization,BP,TAP1;SDC4;SQSTM1;RAB32;GOSR1;ANXA8;SNX12;SNX8;RUNDC1;TAPBP;TGFBRAP1;BLOC1S2;TRAPPC5;CHMP4B;INSIG1;TAP2;SGSM1;RAB27A;SNF8
5729,GO:0016874,0.904534870477055,0.172717730925034,7,134,ligase activity,MF,CARS2;ACSL1;AARSD1;CTPS1;GCLC;TTLL5;PARP1
7328,GO:0031338,0.90491209507954,0.251692354197682,2,49,regulation of vesicle fusion,BP,RUNDC1;SGSM1
5404,GO:0016242,0.904954869523584,0.328351050992633,1,29,negative regulation of macroautophagy,BP,CHMP4B
16923,GO:0098900,0.905049016286392,0.328128112728456,1,29,regulation of action potential,BP,FLNA
1963,GO:0004672,0.905258165008503,0.130009709718089,30,472,protein kinase activity,MF,NRG1;CSF2;MAP3K14;IKBKE;DAPK3;NUAK1;SQSTM1;CDKN1A;LYN;PKMYT1;TRIO;FGFR2;EPHB6;TNK1;EPHA2;CDK4;STAT5A;SGK1;FGFR1OP;RIPK4;PRKCA;SYK;CDKL1;CAMK1G;ROR1;CAB39;OXSR1;MAPK11;CLK4;CCL5
6218,GO:0019751,0.905540692805546,0.199346777551533,4,86,polyol metabolic process,BP,GPER1;DHFR;PPIP5K1;QDPR
12620,GO:0050804,0.905549095257067,0.157486193749757,10,182,modulation of chemical synaptic transmission,BP,EDN1;SQSTM1;BAIAP2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;CD38
17025,GO:0099177,0.905549095257067,0.157486193749757,10,182,regulation of trans-synaptic signaling,BP,EDN1;SQSTM1;BAIAP2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;CD38
7897,GO:0032465,0.905563210373391,0.217969519107733,3,68,regulation of cytokinesis,BP,KLHL21;KIF23;SVIL
7106,GO:0030902,0.905620610387275,0.19926030639797,4,85,hindbrain development,BP,MAFB;FLNA;ZNF365;BMP7
3772,GO:0008324,0.906082179086853,0.139665163263865,18,306,cation transmembrane transporter activity,MF,JPH2;TFRC;PANX1;JPH1;SLC39A1;ITGAV;SLC5A6;KCNA7;SLC7A2;COX5B;SLC4A11;KCNIP3;SLC22A4;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC2A6
7035,GO:0030808,0.906305614695773,0.198035468647295,4,86,regulation of nucleotide biosynthetic process,BP,NUP153;GPER1;NUP214;PARP1
17478,GO:1900371,0.906305614695773,0.198035468647295,4,86,regulation of purine nucleotide biosynthetic process,BP,NUP153;GPER1;NUP214;PARP1
3478,GO:0007338,0.906357069594634,0.248546552034209,2,51,single fertilization,BP,B4GALT1;UBAP2L
11712,GO:0046503,0.906602491191032,0.324117249261301,1,30,glycerolipid catabolic process,BP,GPCPD1
3911,GO:0008565,0.906825356094067,0.215452437766731,3,71,protein transporter activity,MF,TNPO3;TOMM40;IPO4
3088,GO:0006661,0.907629875841434,0.174689120823161,6,119,phosphatidylinositol biosynthetic process,BP,IRS1;FGFR2;IRS2;PDGFB;PIGM;DPM3
4091,GO:0009145,0.907679036976985,0.183370453196574,5,105,purine nucleoside triphosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
9831,GO:0042054,0.907693869778377,0.245981714053383,2,50,histone methyltransferase activity,MF,RBBP5;PRDM7
11758,GO:0046605,0.907875196941411,0.245616026175719,2,50,regulation of centrosome cycle,BP,CHMP4B;RBM14
8526,GO:0033762,0.909215438674795,0.317845769823234,1,30,response to glucagon,BP,QDPR
12736,GO:0050999,0.909245272458717,0.317773713108142,1,30,regulation of nitric-oxide synthase activity,BP,DHFR
3237,GO:0006891,0.909291079371309,0.317663056919194,1,30,intra-Golgi vesicle-mediated transport,BP,GOSR1
2513,GO:0005766,0.909513804734629,0.171606677010718,6,122,primary lysosome,CC,FTL;B4GALT1;HRNR;LAMP1;GLIPR1;TUBB
10082,GO:0042582,0.909513804734629,0.171606677010718,6,122,azurophil granule,CC,FTL;B4GALT1;HRNR;LAMP1;GLIPR1;TUBB
7605,GO:0031985,0.909678118869013,0.192222386493607,4,86,Golgi cisterna,CC,B4GALT1;GOSR1;APH1A;GALNT2
6984,GO:0030660,0.90982826094145,0.19186693810403,4,88,Golgi-associated vesicle membrane,CC,HLA-B;HLA-F;SPPL2A;CLTA
7301,GO:0031300,0.909934914137271,0.159004485247248,8,154,intrinsic component of organelle membrane,CC,LFNG;PXMP2;TPST1;GALNT2;CPT1A;CHCHD6;TOMM40;SLC25A44
2524,GO:0005778,0.910233735644364,0.240715524674276,2,51,peroxisomal membrane,CC,PXMP2;ACSL1
7561,GO:0031903,0.910233735644364,0.240715524674276,2,51,microbody membrane,CC,PXMP2;ACSL1
10312,GO:0043087,0.910627243779785,0.129141119315434,22,362,regulation of GTPase activity,BP,CCL20;AMOT;STARD13;SIPA1L3;CORO1C;EPHA2;ICAM1;ERRFI1;CDC42EP2;SFRP1;DOCK10;AJUBA;RUNDC1;RCC2;JUN;RHOG;SGSM1;RAPGEF1;WNT4;CCL22;CCL5;SH3BP4
12221,GO:0048471,0.911028260571591,0.121581141135646,32,513,perinuclear region of cytoplasm,CC,SPRR3;INHBA;ODC1;CTGF;NFKBIE;CYLD;TFRC;PTGES;HRNR;NOCT;CDKN1A;LYN;MYO1B;LAMP1;WWC1;FLNA;LCP1;CDK4;FUS;CTIF;GPER1;FGFR1OP;PRKCA;ACKR3;M6PR;GALNT2;ACTN4;SORBS2;RAPGEF1;VPS52;TRAF4;SNF8
10638,GO:0043647,0.911128320125147,0.23901495124427,2,50,inositol phosphate metabolic process,BP,GPER1;PPIP5K1
44,GO:0000096,0.911208354394114,0.313009562766973,1,30,sulfur amino acid metabolic process,BP,GCLC
3490,GO:0007368,0.911442249765717,0.207091247605247,3,69,determination of left/right symmetry,BP,CC2D2A;SRF;CITED2
7618,GO:0032008,0.911470550540122,0.312369820220954,1,30,positive regulation of TOR signaling,BP,TELO2
9071,GO:0035307,0.911485688644032,0.312332859307199,1,30,positive regulation of protein dephosphorylation,BP,HSP90AB1
5691,GO:0016811,0.911497299711832,0.206919502955905,3,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,HDAC9;BRMS1;MTA2
597,GO:0001764,0.911719973041301,0.188677363894501,4,86,neuron migration,BP,NRG1;FLNA;SRF;NTN1
4037,GO:0009069,0.911830334450581,0.311490642373947,1,30,serine family amino acid metabolic process,BP,GCLC
7180,GO:0031062,0.911845758727531,0.311452916779336,1,30,positive regulation of histone methylation,BP,NELFE
4030,GO:0009062,0.912019420342657,0.188061355150366,4,88,fatty acid catabolic process,BP,IRS1;ACAA1;IRS2;CPT1A
11654,GO:0046390,0.9120563432909,0.147929685712414,10,187,ribose phosphate biosynthetic process,BP,ADM;G6PD;PANK2;NUP153;PGK1;GPER1;COX5B;NUP214;CTPS1;PARP1
19106,GO:1905037,0.912417775067058,0.18741363994119,4,87,autophagosome organization,BP,UBQLN2;NSFL1C;ATG101;CHMP4B
6616,GO:0022838,0.91264141003339,0.154926374591737,8,152,substrate-specific channel activity,MF,JPH2;PANX1;JPH1;ITGAV;FXYD3;KCNA7;SLC4A11;KCNIP3
5081,GO:0015318,0.91264406998194,0.124723187806394,24,397,inorganic molecular entity transmembrane transporter activity,MF,SLC16A2;JPH2;TFRC;PANX1;SLC7A5;SLC16A9;JPH1;SLC39A1;SLC7A5P2;ITGAV;SLC5A6;FXYD3;KCNA7;SLC7A2;COX5B;SLC43A2;SLC4A11;KCNIP3;SLC22A4;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC2A6
10387,GO:0043209,0.912749856656035,0.15988735859703,7,139,myelin sheath,CC,CRYAB;NEFL;ACTG1;WDR1;HSPA8;CNTNAP1;TKT
2526,GO:0005782,0.913016084760706,0.308288250561347,1,31,peroxisomal matrix,CC,ACAA1
7565,GO:0031907,0.913016084760706,0.308288250561347,1,31,microbody lumen,CC,ACAA1
6466,GO:0021795,0.91359651753564,0.307152270866175,1,30,cerebral cortex cell migration,BP,ROBO1
5438,GO:0016301,0.913812279864752,0.114302444075797,41,633,kinase activity,MF,NRG1;CSF2;MAP3K14;IKBKE;DAPK3;NUAK1;SQSTM1;PANK2;IRS1;CDKN1A;TJP2;LYN;HMGXB3;PKMYT1;TRIO;FGFR2;EPHB6;TNK1;TK1;EPHA2;CDK4;STAT5A;PGK1;SGK1;FGFR1OP;RIPK4;IRS2;PRKCA;SYK;PPIP5K1;CDKL1;PDGFB;CAMK1G;ROR1;NOL9;CAB39;OXSR1;ESR1;MAPK11;CLK4;CCL5
5787,GO:0017016,0.91403179756649,0.122151836671573,25,407,Ras GTPase binding,MF,NRG1;NEFL;CSF2;DAPK3;IRS1;EHD1;CORO1C;TRIO;FGFR2;FLNA;CDC42EP2;ARHGEF28;IRS2;PDGFB;SPTBN1;RASGRP4;RUNDC1;RCC2;RCC1;TRAPPC5;SGSM1;RAPGEF1;IPO4;VPS52;SH3BP4
15747,GO:0072330,0.914067708782846,0.141985475507026,11,202,monocarboxylic acid biosynthetic process,BP,CYP1A1;FADS3;PTGES;EDN1;SCD;NUP153;PGK1;NUP214;SCD5;INSIG1;FADS1
10679,GO:0043928,0.914522075311835,0.304039043539242,1,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,EDC4
15470,GO:0071806,0.914607272335103,0.231414471035581,2,54,protein transmembrane transport,BP,HSPA8;TOMM40
6847,GO:0030315,0.914709298238447,0.304399461113473,1,30,T-tubule,CC,STAC
2731,GO:0006110,0.914864008879226,0.231217400409376,2,51,regulation of glycolytic process,BP,NUP153;NUP214
2819,GO:0006283,0.915255423399725,0.199716462110213,3,73,transcription-coupled nucleotide-excision repair,BP,PRPF19;COPS3;POLR2G
12931,GO:0051287,0.915488086105719,0.229809436920594,2,52,NAD binding,MF,QDPR;PARP1
18162,GO:1902911,0.915491021037012,0.181985035648468,4,88,protein kinase complex,CC,IRS1;CDKN1A;CDK4;CAB39
14995,GO:0070911,0.91560604083638,0.301603826642022,1,32,global genome nucleotide-excision repair,BP,PARP1
16499,GO:0097194,0.915848797373849,0.19872975061714,3,71,execution phase of apoptosis,BP,TP53;ZC3H12A;GPER1
6894,GO:0030426,0.915929345340995,0.161322758614535,6,121,growth cone,CC,NEFL;GPRIN1;L1CAM;ZFYVE27;DPYSL3;PARD3
10292,GO:0043039,0.916066378914747,0.228609185390196,2,52,tRNA aminoacylation,BP,CARS2;AARSD1
6992,GO:0030672,0.916242807499034,0.228242487091979,2,52,synaptic vesicle membrane,CC,DBNDD2;CLTA
17034,GO:0099501,0.916242807499034,0.228242487091979,2,52,exocytic vesicle membrane,CC,DBNDD2;CLTA
2947,GO:0006475,0.916370546315829,0.154232810905775,7,138,internal protein amino acid acetylation,BP,TRIM16;CPA4;LIF;SNAI2;RUVBL2;BRPF1;NOC2L
10957,GO:0044703,0.916586255586476,0.113600866947963,34,544,multi-organism reproductive process,BP,MMP9;INHBA;ADM;CYP1A1;TFCP2L1;EDN1;BIRC3;B4GALT1;EMP2;PANK2;TAF4B;JUNB;VMP1;FOSL1;FANCC;COL16A1;LIF;THBD;NSUN2;ETS1;OXTR;MAFF;ESR1;CCR6;HERC2;BCL2L2;UBAP2L;GPX4;WNT4;CD38;SLC4A2;BRIP1;TTLL5;TP63
12752,GO:0051020,0.916809504526279,0.113799999899602,33,523,GTPase binding,MF,NRG1;NEFL;CSF2;DAPK3;IRS1;EHD1;CORO1C;TRIO;FGFR2;FLNA;LCP1;ERRFI1;CDC42EP2;DOCK10;ARHGEF28;IRS2;PDGFB;SPTBN1;RASGRP4;RUNDC1;RCC2;RCC1;TRAPPC5;HERC2;SGSM1;RAPGEF1;IPO4;RILPL2;VPS52;CYTH1;CLTA;TBXA2R;SH3BP4
17671,GO:1901532,0.917269352478942,0.178277482755698,4,103,regulation of hematopoietic progenitor cell differentiation,BP,RUNX1;PSMB9;PSME2;PSMC3
19138,GO:1905114,0.917351216802813,0.117096802135121,26,429,cell surface receptor signaling pathway involved in cell-cell signaling,BP,RUNX1;CYLD;WNT10A;DAPK3;NFKB1;BAIAP2;FGFR2;PSMB9;BMP2;KREMEN2;ADRB2;AMOTL2;SFRP1;PSME2;EGR1;JRK;SNAI2;ROR1;BAMBI;RUVBL2;ESR1;ZNF703;RAPGEF1;PDE6A;WNT4;PSMC3
16037,GO:0086065,0.91744585536915,0.297273046753558,1,31,cell communication involved in cardiac conduction,BP,FLNA
10314,GO:0043094,0.917454552223367,0.29697851989415,1,32,cellular metabolic compound salvage,BP,TK1
7696,GO:0032153,0.91748614531805,0.195710527754394,3,70,cell division site,CC,SVIL;RHOB;MYH9
6429,GO:0021695,0.917667957932065,0.296714298165863,1,31,cerebellar cortex development,BP,ZNF365
9743,GO:0038202,0.917729293884538,0.296559883029236,1,31,TORC1 signaling,BP,TELO2
15916,GO:0072686,0.917917644249853,0.17770261260766,4,88,mitotic spindle,CC,KIF23;RCC2;HNRNPU;KIF22
9035,GO:0035249,0.918467226323887,0.294698338751771,1,31,synaptic transmission, glutamatergic,BP,OXTR
17688,GO:1901566,0.918855118104612,0.0985261571353922,101,1529,organonitrogen compound biosynthetic process,BP,CCL20;CYR61;INHBA;ODC1;ADM;HSPB1;SDC4;ABCF1;TGFB2;DAPK3;TET3;B4GALT1;NFE2L1;PANK2;NFKB1;LFNG;GALNT18;HSPG2;HS3ST2;TNF;CARS2;ENC1;CDKAL1;NUP153;BACE2;KRT17;TYMS;ZC3H12A;TK1;GEMIN5;CHP1;EIF5;CDK4;ITGAV;PMM2;LYPD6B;PABPC4;PGK1;NMT2;ST6GALNAC5;ZDHHC3;DPH2;CTIF;GPER1;HS3ST1;LARP4B;EGR1;ZFP36L1;RPLP2;DHFR;ACO1;RPLP1;IL15;ZFP36L2;PUM3;SYK;AJUBA;PDGFB;AASS;RPS2;RPS9;COX5B;IL1A;NUP214;SLC35C2;MRPS12;MRPS24;DNAJC1;ZDHHC6;ERAL1;CHST3;MRPL20;PCYT1A;GALNT2;CD109;RPL27A;PIGM;MRPL33;ESR1;TCOF1;EIF3B;RBM4;QDPR;SMPD2;METTL16;EFTUD2;EIF3I;EIF5A;DAG1;TMEM165;MGAT2;EEF1D;DPM3;MRPS2;AARSD1;CTPS1;POLR2G;GCLC;PARP1;CCL5;MAGOH
8937,GO:0034968,0.919078745027854,0.175599088108755,4,89,histone lysine methylation,BP,TET3;NELFE;RBBP5;PRDM7
5202,GO:0015800,0.919168564994869,0.292922602857002,1,31,acidic amino acid transport,BP,SLC25A22
18012,GO:1902494,0.919179290301223,0.100024016638176,81,1229,catalytic complex,CC,HDAC9;HSPB1;MAT2A;ELMSAN1;SPSB1;KLHL21;TP53;TAF4B;IRS1;CDKN1A;RING1;ENC1;PSMB9;UBE2C;SART1;UBE4B;DDX23;CDK4;TRMT61A;RNF19B;DAXX;TOX4;ABCF2;PPP1R3B;METTL1;PSME2;TFIP11;ABTB2;EDF1;POP1;PRPF19;DKC1;KCTD10;CBX5;TRAF2;ZFC3H1;POLR1A;SENP3;BRMS1;ALYREF;POLA1;WDR34;DCTN1;RBBP5;CRCP;MTA2;WDR4;KEAP1;HNRNPU;HNRNPF;PAGR1;UBE2J2;DCUN1D2;RUVBL2;PPP1R9B;DNTTIP1;ANAPC15;CAB39;HSPA8;BRPF1;BCS1L;GTF2E1;ZSWIM6;KBTBD12;EFTUD2;RNF7;MPHOSPH8;PHF5A;UBAP2L;POLR3H;DPM3;PSMC3;SMARCC2;RRM2;POLR1E;HSD17B10;RNF144B;POLR2G;GCLC;POP4;MAGOH
17687,GO:1901565,0.919938851249168,0.101416190440355,64,977,organonitrogen compound catabolic process,BP,NRG1;ODC1;PML;CYLD;SDC4;TET3;SPSB1;TP53;SQSTM1;HSPG2;UBQLN2;ADAMTS9;TNF;ENC1;BACE2;PSMB9;CLN6;C9ORF3;UBE2C;FLNA;CHP1;UBE4B;RNF19B;USP36;PSME2;ABTB2;PRPF19;SNX12;KCTD10;TRAF2;USP43;AASS;PTTG1IP;NSFL1C;NEDD4L;SNRNP70;RNF115;UHRF1;COPS3;SMAD7;KEAP1;UBE2J2;TRIB1;ANAPC15;HSPBP1;HSPA8;USP31;CHMP4B;HERC2;QDPR;SMPD2;SMUG1;RNF7;TINAGL1;RNF185;TNFAIP3;PSMC3;EFNA1;HSD17B10;RNF144B;CLTA;SNF8;GCLC;HSP90AB1
11901,GO:0046928,0.919981704264873,0.290855784316136,1,31,regulation of neurotransmitter secretion,BP,GPER1
10382,GO:0043202,0.920027335947361,0.190824329564252,3,71,lysosomal lumen,CC,SDC4;HSPG2;HSPA8
10157,GO:0042737,0.920874891157928,0.189083737257771,3,73,drug catabolic process,BP,CYP4B1;AASS;QDPR
16812,GO:0098659,0.921218592968222,0.287695196189579,1,31,inorganic cation import across plasma membrane,BP,STEAP4
17078,GO:0099587,0.921218592968222,0.287695196189579,1,31,inorganic ion import across plasma membrane,BP,STEAP4
549,GO:0001669,0.921405224123799,0.217294416576946,2,53,acrosomal vesicle,CC,CRCP;TBXA2R
10291,GO:0043038,0.921462171607213,0.217173654724436,2,53,amino acid activation,BP,CARS2;AARSD1
2976,GO:0006517,0.922109608391243,0.285136035671974,1,32,protein deglycosylation,BP,RNF185
5966,GO:0018394,0.922294072269071,0.144807573027777,7,140,peptidyl-lysine acetylation,BP,TRIM16;CPA4;LIF;SNAI2;RUVBL2;BRPF1;NOC2L
16290,GO:0090382,0.922323482773264,0.284332223724513,1,33,phagosome maturation,BP,RAB32
8115,GO:0032801,0.922627665829649,0.283800335615392,1,32,receptor catabolic process,BP,CLTA
6617,GO:0022839,0.922861993152575,0.157877423414084,5,106,ion gated channel activity,MF,JPH2;JPH1;ITGAV;KCNA7;KCNIP3
15143,GO:0071242,0.922946590296954,0.282976245541241,1,32,cellular response to ammonium ion,BP,PPP1R9B
8985,GO:0035091,0.923117705304694,0.13153688019228,10,187,phosphatidylinositol binding,MF,JPH2;MYO1B;MYO10;ANXA8;PARD3B;SNX12;LANCL2;SNX8;PARD3;MYO1E
5280,GO:0015932,0.923444366366002,0.281687233325717,1,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC35A4
3741,GO:0008276,0.923569939923291,0.183974790388576,3,72,protein methyltransferase activity,MF,RBBP5;PRDM7;METTL21A
7595,GO:0031966,0.923609322447189,0.104655799007573,34,578,mitochondrial membrane,CC,CYP24A1;STARD13;SOD2;IKBKE;RSAD2;LYN;RAB32;TYMS;PARL;GPER1;LGALS3;ABCG2;REEP1;PRKCA;COX5B;ACSL1;MRPS12;MRPS24;ERAL1;MTFP1;MRPL20;MRPL33;CPT1A;BCS1L;HERC2;BCL2L2;CHCHD6;THEM4;TOMM40;RNF185;MRPS2;SLC25A22;RNF144B;SLC25A44
18008,GO:1902476,0.923618582188378,0.281235291205688,1,32,chloride transmembrane transport,BP,FXYD3
6211,GO:0019730,0.923881409762066,0.279067231296854,1,39,antimicrobial humoral response,BP,HMGN2
17663,GO:1901505,0.924366697135978,0.279289805797486,1,32,carbohydrate derivative transmembrane transporter activity,MF,SLC35A4
15966,GO:0080008,0.924563109098413,0.278777746288413,1,32,Cul4-RING E3 ubiquitin ligase complex,CC,RNF7
17254,GO:0120034,0.924620698984327,0.181946339910401,3,72,positive regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP2;SRF;DPYSL3
10023,GO:0042455,0.925017526101743,0.277104074789994,1,34,ribonucleoside biosynthetic process,BP,CTPS1
16874,GO:0098803,0.925157724068222,0.208196554816422,2,66,respiratory chain complex,CC,COX5B;BCS1L
13511,GO:0055081,0.925855883365904,0.275393902673014,1,32,anion homeostasis,BP,GPCPD1
2515,GO:0005768,0.926024737462056,0.0985235491009904,43,677,endosome,CC,PML;TFRC;HLA-B;IKBKE;TRAF3;SQSTM1;STEAP4;MYO1B;RAB32;STOML1;LAMP1;EHD1;TNF;BACE2;KREMEN2;ADRB2;AMOTL2;ZFYVE27;HLA-F;ANXA8;GPER1;AP4S1;RHOB;SNX12;IL15;NEDD4L;SPPL2A;SNX8;RCC2;ACKR3;M6PR;TGFBRAP1;HSPA8;TRAPPC5;CHMP4B;ARRDC3;RAPGEF1;TMEM165;RAB27A;VPS52;SPG21;CLTA;SNF8
5782,GO:0017004,0.92634986880622,0.273609572169851,1,34,cytochrome complex assembly,BP,BCS1L
7176,GO:0031057,0.926434568840206,0.273871527841685,1,32,negative regulation of histone modification,BP,NOC2L
6615,GO:0022836,0.92656240887316,0.151486785655621,5,107,gated channel activity,MF,JPH2;JPH1;ITGAV;KCNA7;KCNIP3
3362,GO:0007098,0.926767677421984,0.151102277089578,5,108,centrosome cycle,BP,GADD45A;DCTN1;CHMP4B;CNTROB;RBM14
6356,GO:0021537,0.926889500078185,0.132777423960305,8,158,telencephalon development,BP,NRG1;INHBA;NEFL;FLNA;BMP2;SRF;ROBO1;OXTR
4031,GO:0009063,0.92698406074517,0.177298087210772,3,73,cellular amino acid catabolic process,BP,AASS;QDPR;HSD17B10
18477,GO:1903578,0.927021130741065,0.177225818162878,3,73,regulation of ATP metabolic process,BP,NUP153;NUP214;PARP1
8473,GO:0033613,0.927144906579621,0.204882569452185,2,54,activating transcription factor binding,MF,SRF;JUN
10895,GO:0044438,0.927167229515588,0.176883518676504,3,74,microbody part,CC,ACAA1;PXMP2;ACSL1
10896,GO:0044439,0.927167229515588,0.176883518676504,3,74,peroxisomal part,CC,ACAA1;PXMP2;ACSL1
5507,GO:0016458,0.927283375126049,0.120102984504862,12,237,gene silencing,BP,NUP153;ZC3H12A;ZC3H7B;SRRT;DDX17;AJUBA;UHRF1;NUP214;ESR1;RBM4;SNIP1;POLR2G
7037,GO:0030810,0.927459028124523,0.270915387235795,1,33,positive regulation of nucleotide biosynthetic process,BP,GPER1
17480,GO:1900373,0.927459028124523,0.270915387235795,1,33,positive regulation of purine nucleotide biosynthetic process,BP,GPER1
3434,GO:0007223,0.927726067964826,0.270456577878114,1,32,Wnt signaling pathway, calcium modulating pathway,BP,PDE6A
7594,GO:0031965,0.927826941967675,0.115628630969804,14,252,nuclear membrane,CC,DTX2;NUP153;CDK4;RRP12;AEN;DHCR7;DNAJB2;CMTM3;DNAJC1;RCC1;TNPO3;PHLPP1;IPO4;BRIP1
2521,GO:0005775,0.928433027204547,0.140646842965524,6,126,vacuolar lumen,CC,FTL;SDC4;HRNR;HSPG2;HSPA8;TUBB
12880,GO:0051213,0.928554561659667,0.174228111791336,3,73,dioxygenase activity,MF,P3H2;TET3;P4HA2
4059,GO:0009108,0.928939238045961,0.122718549905689,10,191,coenzyme biosynthetic process,BP,MAT2A;PANK2;SCD;NUP153;PGK1;DHFR;ACSL1;NUP214;SCD5;QDPR
332,GO:0000922,0.929017299636514,0.133960959464081,7,142,spindle pole,CC,KLHL21;NEDD9;CEP95;DCTN1;TBCCD1;ZW10;HNRNPU
17836,GO:1901998,0.929059784087808,0.266656425928852,1,33,toxin transport,BP,CD274
3326,GO:0007033,0.929115277311765,0.133802143160352,7,142,vacuole organization,BP,GNPTAB;UBQLN2;CLN6;NSFL1C;ATG101;CHMP4B;TMEM165
5798,GO:0017048,0.929203637289648,0.133695729433927,7,140,Rho GTPase binding,MF,DAPK3;CORO1C;TRIO;FLNA;CDC42EP2;ARHGEF28;RCC2
11656,GO:0046394,0.929412074680515,0.110361030983741,16,285,carboxylic acid biosynthetic process,BP,CYP1A1;FADS3;PTGES;EDN1;NFKB1;SCD;NUP153;PGK1;DHFR;SYK;PDGFB;AASS;NUP214;SCD5;INSIG1;FADS1
13623,GO:0060113,0.929468283878685,0.265563519776622,1,33,inner ear receptor cell differentiation,BP,SDC4
3667,GO:0008156,0.929517486914855,0.265431713500262,1,33,negative regulation of DNA replication,BP,TIMELESS
17602,GO:1901264,0.929681810356553,0.199253654690756,2,55,carbohydrate derivative transport,BP,SLC35A4;SLC35C2
6707,GO:0030117,0.929879430298696,0.155981612818235,4,92,membrane coat,CC,AP4S1;CHMP4B;CLTA;BAIAP2L2
12222,GO:0048475,0.929879430298696,0.155981612818235,4,92,coated membrane,CC,AP4S1;CHMP4B;CLTA;BAIAP2L2
10798,GO:0044272,0.929898936805678,0.132494887080667,7,144,sulfur compound biosynthetic process,BP,MAT2A;B4GALT1;SCD;ACSL1;CHST3;SCD5;GCLC
11329,GO:0045652,0.929974336716237,0.197817630827392,2,65,regulation of megakaryocyte differentiation,BP,RUNX1;RBBP5
6895,GO:0030427,0.930045688876463,0.137970606679117,6,125,site of polarized growth,CC,NEFL;GPRIN1;L1CAM;ZFYVE27;DPYSL3;PARD3
16568,GO:0097352,0.930134053036919,0.26354469437409,1,34,autophagosome maturation,BP,ADRB2
3784,GO:0008347,0.930195793110228,0.263610953900417,1,33,glial cell migration,BP,TGFB2
7038,GO:0030811,0.930294419041611,0.198005151296677,2,54,regulation of nucleotide catabolic process,BP,NUP153;NUP214
7722,GO:0032212,0.930583272309884,0.262567743006224,1,33,positive regulation of telomere maintenance via telomerase,BP,DKC1
128,GO:0000266,0.930951205948177,0.261575046272279,1,33,mitochondrial fission,BP,MTFP1
10356,GO:0043168,0.931021524855471,0.0823821844475583,139,1996,anion binding,MF,SAA1;RUNX1;CYR61;FN1;P3H2;CTGF;CCDC80;JPH2;ACTG1;TAP1;ABCF1;PTGES;MAP3K14;FBN1;GBP1;TXNRD1;MAT2A;IKBKE;DAPK3;NUAK1;NLRC5;TP53;P4HA2;PANK2;FST;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;LAYN;UBE2C;TYMS;CYB5R1;TNK1;TK1;EPHA2;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;ANXA8L1;PGK1;MCM2;LSG1;SFRP1;ABCF2;DHX37;ANXA8;DDX42;PARD3B;SGK1;RHOB;SNX12;DHFR;RIPK4;TSR1;ABCG2;AKR1C2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;NSFL1C;SPTBN1;DPYSL3;COL5A3;MYH9;CAMK1G;LANCL2;SNX8;DDX39A;ROR1;ACSL1;GPN1;NOL9;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;MICAL3;PCYT1A;OXSR1;HSPA8;SLC22A4;RCC1;MCM7;BCS1L;DUS2;PARD3;QDPR;RHOG;GPNMB;ACBD6;XRCC6;TAP2;KIF24;BMP7;URGCP;EFTUD2;KIF22;RAB27A;DHX34;AKR1C1;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;CLK4;BAIAP2L2;ORC4
2367,GO:0005484,0.931192466014896,0.260691541608832,1,34,SNAP receptor activity,MF,GOSR1
3919,GO:0008589,0.931438222757382,0.195484779102195,2,54,regulation of smoothened signaling pathway,BP,FGFR2;SFRP1
5327,GO:0016053,0.931648562100779,0.107203732421787,16,286,organic acid biosynthetic process,BP,CYP1A1;FADS3;PTGES;EDN1;NFKB1;SCD;NUP153;PGK1;DHFR;SYK;PDGFB;AASS;NUP214;SCD5;INSIG1;FADS1
5558,GO:0016570,0.931985953615773,0.0999153874384474,23,388,histone modification,BP,TRIM16;HDAC9;TET3;TP53;CPA4;RING1;USP36;AKAP8L;LIF;SNAI2;AKAP8;NELFE;PRKCA;BRMS1;UHRF1;RBBP5;SFPQ;MTA2;RUVBL2;PRDM7;BRPF1;NOC2L;RBM14
4970,GO:0015079,0.9322455459968,0.193698382910217,2,54,potassium ion transmembrane transporter activity,MF,KCNA7;KCNIP3
3560,GO:0007600,0.932515235610529,0.114702877903905,11,209,sensory perception,BP,CYP1B1;EDN1;NAV2;CLN6;ICAM1;WDR1;SNAI2;NOB1;ROR1;MARVELD2;PDE6A
16869,GO:0098798,0.932730206242039,0.116697146998139,10,218,mitochondrial protein complex,CC,COX5B;MRPS12;MRPS24;MRPL20;MRPL33;BCS1L;CHCHD6;TOMM40;MRPS2;HSD17B10
4330,GO:0009855,0.93288535567809,0.16561724652445,3,74,determination of bilateral symmetry,BP,CC2D2A;SRF;CITED2
7442,GO:0031572,0.93293488013417,0.256187155373533,1,33,G2 DNA damage checkpoint,BP,MAP3K14
7939,GO:0032527,0.93296103182833,0.255885678204288,1,34,protein exit from endoplasmic reticulum,BP,INSIG1
13278,GO:0051965,0.932979943069444,0.256064047562854,1,33,positive regulation of synapse assembly,BP,OXTR
3502,GO:0007405,0.933113802966163,0.2556981660894,1,33,neuroblast proliferation,BP,FGFR2
2718,GO:0006096,0.93326664968073,0.164857651623265,3,74,glycolytic process,BP,NUP153;PGK1;NUP214
12867,GO:0051188,0.933501132021131,0.10912313672496,13,241,cofactor biosynthetic process,BP,CYP1A1;MAT2A;NFE2L1;PANK2;SCD;NUP153;PGK1;DHFR;ACSL1;NUP214;SCD5;QDPR;GCLC
1704,GO:0004197,0.933687803349753,0.163963803681662,3,75,cysteine-type endopeptidase activity,MF,SFRP1;CAPNS1;TINAGL1
16864,GO:0098793,0.93369358379198,0.112930601398004,11,209,presynapse,CC,DBNDD2;LAMP1;BAIAP2;FOSL1;CADPS2;GPER1;ROR1;KCNIP3;HSPA8;ELK1;CLTA
10038,GO:0042490,0.933893201579489,0.253332933982495,1,34,mechanoreceptor differentiation,BP,SDC4
8888,GO:0034703,0.934496199097276,0.162400857318983,3,74,cation channel complex,CC,KCNA7;KCNIP3;CNTNAP1
19393,GO:1905898,0.93476718200813,0.25092696897832,1,34,positive regulation of response to endoplasmic reticulum stress,BP,UBQLN2
2978,GO:0006520,0.934863132473106,0.103955700451089,15,276,cellular amino acid metabolic process,BP,ODC1;NQO1;CARS2;PSMB9;SLC7A5;STAT5A;PSME2;SLC7A2;AASS;QDPR;PSMC3;AARSD1;CTPS1;HSD17B10;GCLC
15044,GO:0070988,0.934961512999936,0.187548720762777,2,55,demethylation,BP,CYP1A1;TET3
5583,GO:0016601,0.935138589309585,0.24990080253236,1,34,Rac protein signal transduction,BP,RHOG
2495,GO:0005743,0.935176398093759,0.0962466926882898,22,407,mitochondrial inner membrane,CC,SOD2;RSAD2;LYN;TYMS;PARL;LGALS3;COX5B;MRPS12;MRPS24;ERAL1;MTFP1;MRPL20;MRPL33;CPT1A;BCS1L;HERC2;CHCHD6;THEM4;TOMM40;MRPS2;SLC25A22;SLC25A44
10784,GO:0044242,0.935479863481045,0.12333306728773,7,146,cellular lipid catabolic process,BP,CYP1B1;IRS1;ACAA1;GPCPD1;IRS2;CPT1A;SMPD2
4237,GO:0009435,0.935535117940413,0.24880275377524,1,34,NAD biosynthetic process,BP,PGK1
4081,GO:0009135,0.935686703041134,0.145189559975808,4,93,purine nucleoside diphosphate metabolic process,BP,TJP2;NUP153;PGK1;NUP214
4120,GO:0009179,0.935686703041134,0.145189559975808,4,93,purine ribonucleoside diphosphate metabolic process,BP,TJP2;NUP153;PGK1;NUP214
19672,GO:1990939,0.93571499386791,0.248303802983505,1,34,ATP-dependent microtubule motor activity,MF,WDR34
5580,GO:0016597,0.935779292798232,0.248125318048389,1,34,amino acid binding,MF,GCLC
7282,GO:0031267,0.935971993583079,0.0920704311010788,27,447,small GTPase binding,MF,NRG1;NEFL;CSF2;DAPK3;IRS1;EHD1;CORO1C;TRIO;FGFR2;FLNA;ERRFI1;CDC42EP2;ARHGEF28;IRS2;PDGFB;SPTBN1;RASGRP4;RUNDC1;RCC2;RCC1;TRAPPC5;SGSM1;RAPGEF1;IPO4;RILPL2;VPS52;SH3BP4
9462,GO:0036064,0.936001534585512,0.144600592050208,4,93,ciliary basal body,CC,CYLD;WDR34;CEP41;RILPL2
10266,GO:0043005,0.936480883299866,0.0842581972878349,48,753,neuron projection,CC,CRYAB;NRG1;MAP2;NEFL;TENM3;SACS;NEFM;NQO1;HSPB1;TGFB2;LAMP1;BAIAP2;DST;GPRIN1;EPHB6;FOSL1;FLNA;EPHA2;L1CAM;MYO10;IQCJ-SCHIP1;FUS;ZFYVE27;GPER1;TXN2;KCNA7;DOCK10;ROBO1;SPTBN1;DPYSL3;CAMK1G;TNFRSF21;ROR1;PQBP1;PPP1R9B;KCNIP3;HSPA8;BLOC1S2;PARD3;QDPR;CNTNAP1;ACTN4;PHLPP1;ELK1;DAG1;PDE6A;RAB27A;TP63
4317,GO:0009799,0.936582886716911,0.158152712182345,3,75,specification of symmetry,BP,CC2D2A;SRF;CITED2
3427,GO:0007215,0.936987433959863,0.244758989742906,1,34,glutamate receptor signaling pathway,BP,ADRB2
3157,GO:0006757,0.937106244480811,0.157095362787941,3,75,ATP generation from ADP,BP,NUP153;PGK1;NUP214
2492,GO:0005740,0.937518870881232,0.0861338778848743,36,618,mitochondrial envelope,CC,CYP24A1;STARD13;SOD2;IKBKE;RSAD2;PANK2;LYN;RAB32;TYMS;PARL;ABCF2;GPER1;LGALS3;ABCG2;REEP1;PRKCA;COX5B;ACSL1;MRPS12;MRPS24;ERAL1;MTFP1;MRPL20;MRPL33;CPT1A;BCS1L;HERC2;BCL2L2;CHCHD6;THEM4;TOMM40;RNF185;MRPS2;SLC25A22;RNF144B;SLC25A44
3457,GO:0007269,0.937613998793888,0.156067493234669,3,75,neurotransmitter secretion,BP,CADPS2;GPER1;HSPA8
17104,GO:0099643,0.937613998793888,0.156067493234669,3,75,signal release from synapse,BP,CADPS2;GPER1;HSPA8
3569,GO:0007612,0.938278417835275,0.154719413530245,3,75,learning,BP,FOSL1;SRF;JUN
4063,GO:0009112,0.938329515404815,0.240778734188265,1,35,nucleobase metabolic process,BP,TYMS
5436,GO:0016298,0.938449357372403,0.154372017892002,3,75,lipase activity,MF,PLBD1;SMPD2;CCL5
10355,GO:0043167,0.938818746792151,0.0703639561205957,316,4366,ion binding,MF,HEPHL1;IGFBP3;SAA1;TRIM16;FTL;CRYAB;FTH1;MMP9;RUNX1;CYR61;HDAC9;S100P;FN1;C1R;P3H2;CYP1B1;CTGF;CYP24A1;DTX2;CCDC80;JPH2;ACTG1;TRIM47;CYP1A1;TAP1;PML;CYLD;PDLIM1;TRAF1;PCDH7;SOD2;ABCF1;PTGES;MAP3K14;FBN1;SH3RF2;GBP1;TXNRD1;TMPPE;MAT2A;TRIM56;IKBKE;BIRC3;MID1;DAPK3;TET3;B4GALT1;RSAD2;TRAF3;NUAK1;HRNR;NLRC5;TP53;SQSTM1;STEAP4;P4HA2;PANK2;NOCT;FST;CPA4;MPND;GNPTAB;LFNG;GALNT18;CDKN1A;HSPG2;ADAMTS9;LYN;MYO1B;RAB32;MCM5;CSRP1;EHD1;GNL3L;ZBED1;RING1;CARS2;PKMYT1;SCD;NAV2;DST;TRIO;FGFR2;CDKAL1;NUP153;TPM4;EPHB6;C9ORF3;LAYN;QPCT;UBE2C;TYMS;ZC3H12A;LCP1;CYB5R1;TNK1;TK1;CADPS2;KLF7;ZNF503;EPHA2;CHP1;EIF5;ARFRP1;UBE4B;COL27A1;DDX23;CDK4;ZNF142;ITGAV;KIF23;MYO10;GTPBP6;RNF19B;ZMAT2;NAT10;ANXA8L1;FUS;PGK1;MCM2;LSG1;CSRP2;XAF1;AKAP8L;ZC3H7B;OSR2;SFRP1;ABCF2;TRIM22;ZFYVE27;APTX;DHX37;ANXA8;DNPEP;DDX42;NFX1;THBD;ZNF787;ZFP42;TRIM29;SF1;EGR1;PARD3B;SGK1;SNAI2;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;RHOB;ADAM17;FEN1;SNX12;DHFR;RIPK4;NPAS2;TSR1;ACO1;TRAF2;ABCG2;AKR1C2;PRKCA;ZNF778;ZFP36L2;ZFC3H1;SYK;POLR1A;DDX17;AJUBA;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;POLA1;NSFL1C;SPTBN1;FHL2;ZNF407;COX5B;RNF115;DPYSL3;COL5A3;UHRF1;MYH9;ZNF234;NPNT;IL1A;ZNFX1;CAMK1G;TNIP2;ZNF101;LANCL2;ZNF263;DOHH;RASGRP4;SNX8;DDX39A;ZNF697;ROR1;PRUNE2;ACSL1;COL5A2;GPN1;SMAD7;TATDN2;NOL9;MTA2;TRIP6;ERAL1;HNRNPU;RRAD;CAPNS1;UBE2J2;RUVBL2;MAZ;ORC1;MICAL3;KCNIP3;KLF10;ZNF267;PCYT1A;GALNT2;STAC;FRAS1;OXSR1;HSPA8;GBE1;DTX4;ESR1;IKZF3;SLC22A4;RCC1;BRPF1;MCM7;SCD5;ZNF772;ZNF512;BCS1L;GTF2E1;RBM4;ZNF703;RPTN;HERC2;DUS2;PARD3;QDPR;RHOG;GPNMB;ZNF365;ACBD6;XRCC6;ZNF132;TRMT1;KLF6;TAP2;ZSWIM6;SMPD2;ACTN4;KIF24;GLIS3;BMP7;PHLPP1;ZNF34;URGCP;CISD3;TKT;EFTUD2;OVCH2;RNF7;CYP20A1;PHF5A;ZYX;KIF22;DAG1;PDE6A;RNF185;RAB27A;DHX34;AKR1C1;TRAF4;TUBB;CTDSP1;TNFAIP3;PSMC3;CYB561D2;BRIP1;RRM2;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;XPNPEP3;ATAD3C;ZC3H18;RNF144B;SRSF7;CREB5;NOL3;GCLC;HSP90AB1;SWAP70;FBLN2;MKI67;TTLL5;IRGQ;PARP1;CLK4;TP63;ZBTB12;C1S;TOP3A;BAIAP2L2;ORC4;APEX2
7304,GO:0031304,0.938849631830163,0.239111091621411,1,36,intrinsic component of mitochondrial inner membrane,CC,CHCHD6
7305,GO:0031305,0.938849631830163,0.239111091621411,1,36,integral component of mitochondrial inner membrane,CC,CHCHD6
3608,GO:0008047,0.939104139045111,0.0902835739462659,23,393,enzyme activator activity,MF,IGFBP3;NRG1;FN1;STARD13;SIPA1L3;CDKN1A;DNAJB1;BMP2;ERRFI1;CDC42EP2;DAXX;PSME2;DNAJB2;RPLP1;PDGFB;RUNDC1;AFAP1L2;DNAJC1;CAB39;JUN;SGSM1;PHACTR4;CCL5
7321,GO:0031330,0.939509564603128,0.109236815313587,9,180,negative regulation of cellular catabolic process,BP,PML;NOCT;DKC1;SNRNP70;HNRNPU;CHMP4B;DHX34;EFNA1;HSP90AB1
8688,GO:0034308,0.939517291068292,0.237419173904483,1,35,primary alcohol metabolic process,BP,CYP1B1
14730,GO:0070382,0.939771395220849,0.128066724586902,5,113,exocytic vesicle,CC,DBNDD2;LAMP1;DPYSL3;RAB27A;CLTA
3246,GO:0006903,0.940197973541455,0.150706654905267,3,77,vesicle targeting,BP,GOSR1;CLASP1;TRAPPC5
12232,GO:0048489,0.940653387127455,0.149822144278524,3,76,synaptic vesicle transport,BP,CADPS2;BLOC1S2;RAB27A
16628,GO:0097480,0.940653387127455,0.149822144278524,3,76,establishment of synaptic vesicle localization,BP,CADPS2;BLOC1S2;RAB27A
10220,GO:0042866,0.940735741383031,0.149653253742908,3,76,pyruvate biosynthetic process,BP,NUP153;PGK1;NUP214
3508,GO:0007416,0.940837842179794,0.149493323074982,3,75,synapse assembly,BP,NRG1;OXTR;SDK1
18807,GO:1904358,0.94112988787362,0.232818561723582,1,35,positive regulation of telomere maintenance via telomere lengthening,BP,DKC1
7617,GO:0032007,0.941232084829766,0.232525444569675,1,35,negative regulation of TOR signaling,BP,SH3BP4
7909,GO:0032482,0.941490301196934,0.172436946314282,2,58,Rab protein signal transduction,BP,RAB32;RAB27A
139,GO:0000289,0.941616995419941,0.231419773215639,1,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,POLR2G
10178,GO:0042769,0.941685164655194,0.230840671381008,1,37,DNA damage response, detection of DNA damage,BP,PARP1
4126,GO:0009185,0.941811696471099,0.133548839340718,4,95,ribonucleoside diphosphate metabolic process,BP,TJP2;NUP153;PGK1;NUP214
18035,GO:1902554,0.941871764116411,0.147269966849614,3,77,serine/threonine protein kinase complex,CC,CDKN1A;CDK4;CAB39
7884,GO:0032451,0.942341563255911,0.229331140003565,1,35,demethylase activity,MF,CYP1A1
721,GO:0001947,0.942464615425619,0.228975479056244,1,35,heart looping,BP,SRF
5664,GO:0016773,0.942816382396877,0.0793687348218924,36,579,phosphotransferase activity, alcohol group as acceptor,MF,NRG1;CSF2;MAP3K14;IKBKE;DAPK3;NUAK1;SQSTM1;PANK2;IRS1;CDKN1A;LYN;PKMYT1;TRIO;FGFR2;EPHB6;TNK1;EPHA2;CDK4;STAT5A;SGK1;FGFR1OP;RIPK4;IRS2;PRKCA;SYK;CDKL1;PDGFB;CAMK1G;ROR1;NOL9;CAB39;OXSR1;ESR1;MAPK11;CLK4;CCL5
13017,GO:0051452,0.943318349336822,0.226120263580315,1,37,intracellular pH reduction,BP,CLN6
9475,GO:0036094,0.943319408764019,0.0688058495017041,124,1808,small molecule binding,MF,RUNX1;P3H2;ACTG1;TAP1;BAG1;ABCF1;MAP3K14;GBP1;TXNRD1;MAT2A;IKBKE;DAPK3;G6PD;NUAK1;NLRC5;TP53;P4HA2;PANK2;LYN;MYO1B;RAB32;MCM5;EHD1;GNL3L;CARS2;PKMYT1;NAV2;TRIO;FGFR2;EPHB6;LAYN;UBE2C;TYMS;CYB5R1;TNK1;TK1;EPHA2;HMGCS1;EIF5;ARFRP1;UBE4B;DDX23;CDK4;KIF23;MYO10;GTPBP6;NAT10;PGK1;MCM2;LSG1;ABCF2;DHCR7;DHX37;DDX42;SGK1;RHOB;DHFR;RIPK4;TSR1;ABCG2;AKR1C2;PRKCA;SYK;DDX17;DDX47;PPIP5K1;CDKL1;DDX49;POLA1;UHRF1;MYH9;CAMK1G;LANCL2;DDX39A;ROR1;ACSL1;GPN1;CRCP;NOL9;M6PR;ERAL1;HNRNPU;RRAD;UBE2J2;RUVBL2;ORC1;MICAL3;HSPBP1;OXSR1;HSPA8;SLC22A4;MCM7;BCS1L;DUS2;QDPR;RHOG;XRCC6;TAP2;ACTN4;KIF24;URGCP;EFTUD2;KIF22;RAB27A;DHX34;AKR1C1;TUBB;PSMC3;BRIP1;MAPK11;AARSD1;CTPS1;DDX24;MYO1E;ATAD3C;GCLC;HSP90AB1;SWAP70;MKI67;TTLL5;IRGQ;PARP1;CLK4;ORC4
2830,GO:0006296,0.943403328799273,0.225873302212855,1,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,PARP1
9802,GO:0040029,0.94342846380601,0.0914947479920399,15,291,regulation of gene expression, epigenetic,BP,CD3EAP;NUP153;ZC3H12A;ZC3H7B;SRRT;POLR1A;AJUBA;UHRF1;NUP214;HNRNPU;ESR1;RBM4;SNIP1;POLR1E;POLR2G
19013,GO:1904837,0.943630731829215,0.224566696610918,1,41,beta-catenin-TCF complex assembly,BP,RBBP5
1457,GO:0003697,0.944331941169538,0.128682266707457,4,96,single-stranded DNA binding,MF,APTX;HNRNPU;MCM7;POLR2G
18474,GO:1903573,0.944347108725902,0.223305062963732,1,36,negative regulation of response to endoplasmic reticulum stress,BP,CREB3
3369,GO:0007131,0.94441823731684,0.223096921348506,1,36,reciprocal meiotic recombination,BP,BRIP1
9339,GO:0035825,0.94441823731684,0.223096921348506,1,36,homologous recombination,BP,BRIP1
3509,GO:0007417,0.94448782872789,0.0771928387818082,36,587,central nervous system development,BP,MAFB;NRG1;INHBA;MAP2;NEFL;G6PD;HSPG2;LYN;BAIAP2;NAV2;FGFR2;COL4A1;FLNA;HMGCS1;FANCC;BMP2;LIF;SFRP1;WDR1;SRF;ETS1;PRPF19;IRS2;NPAS2;ROBO1;OXTR;TNFRSF21;ROR1;YWHAH;ABT1;ZNF365;XRCC6;CNTNAP1;BMP7;DAG1;WNT4
10384,GO:0043204,0.944779841903099,0.16477914308474,2,58,perikaryon,CC,CRYAB;FUS
4074,GO:0009127,0.9450009008639,0.118547449104721,5,115,purine nucleoside monophosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
4113,GO:0009168,0.9450009008639,0.118547449104721,5,115,purine ribonucleoside monophosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
4984,GO:0015108,0.945060134186055,0.221214194627716,1,36,chloride transmembrane transporter activity,MF,FXYD3
4066,GO:0009116,0.945241516548166,0.126836761747751,4,99,nucleoside metabolic process,BP,TJP2;TK1;PDE6A;CTPS1
10580,GO:0043543,0.945334391262722,0.0973342665170997,10,198,protein acylation,BP,TRIM16;CPA4;NMT2;LIF;ZDHHC3;SNAI2;ZDHHC6;RUVBL2;BRPF1;NOC2L
10972,GO:0044743,0.945566974589626,0.219367035178885,1,38,protein transmembrane import into intracellular organelle,BP,TOMM40
2951,GO:0006479,0.94573912925104,0.106145979824227,7,149,protein methylation,BP,TET3;NELFE;RPS2;RBBP5;PRDM7;HSPA8;METTL21A
3706,GO:0008213,0.94573912925104,0.106145979824227,7,149,protein alkylation,BP,TET3;NELFE;RPS2;RBBP5;PRDM7;HSPA8;METTL21A
5557,GO:0016569,0.945826036316932,0.0810903362447271,23,396,covalent chromatin modification,BP,TRIM16;HDAC9;TET3;TP53;CPA4;RING1;USP36;AKAP8L;LIF;SNAI2;AKAP8;NELFE;PRKCA;BRMS1;UHRF1;RBBP5;SFPQ;MTA2;RUVBL2;PRDM7;BRPF1;NOC2L;RBM14
17841,GO:1902017,0.945980708935501,0.218318240169771,1,37,regulation of cilium assembly,BP,CYLD
5401,GO:0016239,0.946144954483311,0.161564606576427,2,58,positive regulation of macroautophagy,BP,ADRB2;SUPT5H
4183,GO:0009260,0.946403972342088,0.0981835172328496,9,184,ribonucleotide biosynthetic process,BP,ADM;PANK2;NUP153;PGK1;GPER1;COX5B;NUP214;CTPS1;PARP1
19508,GO:1990391,0.946510038383873,0.216932230313541,1,36,DNA repair complex,CC,XRCC6
14625,GO:0070192,0.946558033858917,0.216789782624497,1,36,chromosome organization involved in meiotic cell cycle,BP,BRIP1
5885,GO:0018023,0.947097412664516,0.215004929715044,1,37,peptidyl-lysine trimethylation,BP,TET3
17502,GO:1900542,0.947259168659319,0.114405037266544,5,115,regulation of purine nucleotide metabolic process,BP,ADM;NUP153;GPER1;NUP214;PARP1
2498,GO:0005746,0.947526166941988,0.157444005024619,2,72,mitochondrial respiratory chain,CC,COX5B;BCS1L
17702,GO:1901606,0.947678834552916,0.157851986717656,2,59,alpha-amino acid catabolic process,BP,AASS;QDPR
11432,GO:0045851,0.947740965475443,0.212913744254474,1,38,pH reduction,BP,CLN6
10914,GO:0044463,0.948039089203512,0.0682955534962778,57,891,cell projection part,CC,CRYAB;NRG1;MAP2;S100P;NEFL;SACS;NQO1;CYLD;HSPB1;B4GALT1;SQSTM1;LAMP1;EHD1;BAIAP2;WWC1;DST;GPRIN1;PDPN;FLNA;LCP1;EPHA2;ITGAV;L1CAM;MYO10;SLC5A6;FUS;TPM1;ZFYVE27;CC2D2A;GPER1;TXN2;DOCK10;ADAM17;WDR34;SPTBN1;DCTN1;DPYSL3;SPRY4;ROR1;PQBP1;CEP41;PPP1R9B;KCNIP3;HSPA8;BLOC1S2;CCR6;PARD3;CNTNAP1;THEM4;PHLPP1;ELK1;DAG1;PDE6A;RAB27A;RILPL2;HSP90AB1;TP63
17257,GO:0120038,0.948039089203512,0.0682955534962778,57,891,plasma membrane bounded cell projection part,CC,CRYAB;NRG1;MAP2;S100P;NEFL;SACS;NQO1;CYLD;HSPB1;B4GALT1;SQSTM1;LAMP1;EHD1;BAIAP2;WWC1;DST;GPRIN1;PDPN;FLNA;LCP1;EPHA2;ITGAV;L1CAM;MYO10;SLC5A6;FUS;TPM1;ZFYVE27;CC2D2A;GPER1;TXN2;DOCK10;ADAM17;WDR34;SPTBN1;DCTN1;DPYSL3;SPRY4;ROR1;PQBP1;CEP41;PPP1R9B;KCNIP3;HSPA8;BLOC1S2;CCR6;PARD3;CNTNAP1;THEM4;PHLPP1;ELK1;DAG1;PDE6A;RAB27A;RILPL2;HSP90AB1;TP63
60,GO:0000123,0.948052565195322,0.134282957626313,3,79,histone acetyltransferase complex,CC,RUVBL2;BRPF1;UBAP2L
2676,GO:0006029,0.948142864087629,0.156819654145434,2,58,proteoglycan metabolic process,BP,BMP2;CHST3
10639,GO:0043648,0.94832942530074,0.133697276023787,3,79,dicarboxylic acid metabolic process,BP,STAT5A;DHFR;GCLC
10690,GO:0043967,0.948910855565823,0.154909312848941,2,59,histone H4 acetylation,BP,TRIM16;RUVBL2
8079,GO:0032760,0.949033056510671,0.209033355296652,1,38,positive regulation of tumor necrosis factor production,BP,HSPB1
1965,GO:0004674,0.949045604255431,0.0766575187556158,23,394,protein serine/threonine kinase activity,MF,MAP3K14;IKBKE;DAPK3;NUAK1;SQSTM1;CDKN1A;PKMYT1;TRIO;FGFR2;EPHB6;EPHA2;CDK4;SGK1;RIPK4;PRKCA;SYK;CDKL1;CAMK1G;ROR1;CAB39;OXSR1;MAPK11;CLK4
8306,GO:0033138,0.949046313475112,0.154513904466021,2,60,positive regulation of peptidyl-serine phosphorylation,BP,TNF;LIF
17707,GO:1901616,0.949083624452348,0.209049901301906,1,37,organic hydroxy compound catabolic process,BP,CYP24A1
7928,GO:0032504,0.949524086635699,0.0738982348071841,27,461,multicellular organism reproduction,BP,INHBA;CYP1A1;TGFB2;EDN1;BIRC3;B4GALT1;PANK2;TAF4B;JUNB;FOSL1;FANCC;LIF;SFRP1;NSUN2;EGR1;ETS1;OXTR;ESR1;CCR6;HERC2;BCL2L2;GPX4;WNT4;SLC4A2;BRIP1;TTLL5;TP63
4110,GO:0009165,0.949528168926936,0.086782324348002,12,234,nucleotide biosynthetic process,BP,ADM;PANK2;NUP153;TYMS;TK1;PGK1;GPER1;COX5B;NUP214;RRM2;CTPS1;PARP1
11517,GO:0046031,0.949693170096305,0.130801784520568,3,79,ADP metabolic process,BP,NUP153;PGK1;NUP214
4857,GO:0014069,0.949869909206795,0.0991110836562836,7,148,postsynaptic density,CC,CRYAB;MAP2;LYN;BAIAP2;GPER1;SPTBN1;PPP1R9B
10910,GO:0044455,0.950021307962584,0.0986319669047358,7,166,mitochondrial membrane part,CC,LYN;COX5B;CPT1A;BCS1L;CHCHD6;TOMM40;SLC25A44
5326,GO:0016052,0.950273800077306,0.102890882814616,6,133,carbohydrate catabolic process,BP,MGAM;NUP153;PGK1;PPP1R3B;NUP214;DCXR
16627,GO:0097479,0.950435437302893,0.129218314640146,3,79,synaptic vesicle localization,BP,CADPS2;BLOC1S2;RAB27A
3568,GO:0007611,0.950976518720803,0.10163756772125,6,133,learning or memory,BP,FOSL1;SRF;SGK1;FEN1;OXTR;JUN
14288,GO:0061371,0.951002158116373,0.203220057262905,1,37,determination of heart left/right asymmetry,BP,SRF
5477,GO:0016410,0.951024369594986,0.127917452169058,3,80,N-acyltransferase activity,MF,NAT10;NMT2;BRPF1
8506,GO:0033683,0.951888993564008,0.200175103292524,1,39,nucleotide-excision repair, DNA incision,BP,PARP1
17053,GO:0099531,0.952004178592655,0.125813670476279,3,80,presynaptic process involved in chemical synaptic transmission,BP,CADPS2;GPER1;HSPA8
17075,GO:0099572,0.952114460019015,0.0952284987427105,7,149,postsynaptic specialization,CC,CRYAB;MAP2;LYN;BAIAP2;GPER1;SPTBN1;PPP1R9B
6100,GO:0019320,0.952279576726983,0.199128821282493,1,38,hexose catabolic process,BP,PGK1
11575,GO:0046128,0.952453036860053,0.146141890504706,2,62,purine ribonucleoside metabolic process,BP,TJP2;PDE6A
7484,GO:0031648,0.952468219942558,0.198546279840079,1,38,protein destabilization,BP,BMP2
7136,GO:0030968,0.952510184716938,0.104601058447977,5,117,endoplasmic reticulum unfolded protein response,BP,DCTN1;TATDN2;CREB3;TUSC1;CXCL8
6322,GO:0019985,0.952608107401267,0.197957196954843,1,39,translesion synthesis,BP,USP43
17694,GO:1901575,0.952633639135582,0.0586213960968454,107,1624,organic substance catabolic process,BP,NRG1;ODC1;CYP1B1;CYP24A1;CYP1A1;PML;CYLD;HSPB1;SDC4;PLBD1;TET3;MGAM;SPSB1;TP53;SQSTM1;NOCT;IRS1;HSPG2;UBQLN2;ADAMTS9;TNF;ENC1;NUP153;BACE2;PSMB9;CLN6;C9ORF3;UBE2C;ZC3H12A;FLNA;ACAA1;CHP1;UBE4B;CDK4;RNF19B;PABPC4;PGK1;USP36;PPP1R3B;PSME2;ABHD4;CTIF;ABTB2;POP1;PRPF19;ZFP36L1;RPLP2;GPCPD1;DKC1;FEN1;SNX12;KCTD10;IRS2;RPLP1;TRAF2;PRKCA;ZFP36L2;USP43;AASS;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;SNRNP70;DNASE1;RNF115;UHRF1;COPS3;PRUNE2;NUP214;SMAD7;TATDN2;YWHAH;KEAP1;HNRNPU;UBE2J2;TRIB1;ANAPC15;RPL27A;HSPBP1;HSPA8;USP31;CPT1A;DCXR;CHMP4B;HERC2;QDPR;EDC4;SMPD2;METTL16;SMUG1;RNF7;TINAGL1;RNF185;DHX34;TNFAIP3;PSMC3;EFNA1;HSD17B10;RNF144B;POLR2G;CLTA;SNF8;GCLC;HSP90AB1;MAGOH
2398,GO:0005543,0.952775634048945,0.076712574941399,16,295,phospholipid binding,MF,JPH2;MYO1B;MYO10;ANXA8L1;ANXA8;PARD3B;SNX12;NSFL1C;SPTBN1;LANCL2;SNX8;PCYT1A;HSPA8;PARD3;MYO1E;BAIAP2L2
2204,GO:0005089,0.952861878597393,0.14534124195758,2,59,Rho guanyl-nucleotide exchange factor activity,MF,TRIO;ARHGEF28
4485,GO:0010507,0.95342740812386,0.143886739021552,2,60,negative regulation of autophagy,BP,SNRNP70;CHMP4B
2491,GO:0005739,0.953600398798752,0.0583229967774306,91,1425,mitochondrion,CC,CRYAB;CYP1B1;CYP24A1;SACS;CYP1A1;TAP1;TFCP2L1;STARD13;SOD2;CD3EAP;PTGES;TXNRD1;IKBKE;RSAD2;TRAF3;TP53;PANK2;NFKB1;LYN;RAB32;KRT5;CARS2;TYMS;CYB5R1;SFN;MTUS1;XAF1;PARL;ABCF2;PUS1;LRRC75A-AS1;GPER1;TXN2;SGK1;AKAP8;FEN1;DHFR;LGALS3;ACO1;ABCG2;REEP1;PRKCA;IFIT3;AASS;COX5B;PXMP2;ACSL1;MAFF;GPN1;MRPS12;MRPS24;YWHAH;ERAL1;MTFP1;TRUB2;MRPL20;MRPL33;BLOC1S2;SLC22A4;CPT1A;TFDP1;BCS1L;HERC2;DUS2;ARGLU1;QDPR;BCL2L2;TRMT1;CS;CHCHD6;THEM4;CISD3;TOMM40;ELK1;RNF185;GPX4;MRPS2;HSD17B10;XPNPEP3;ATAD3C;SLC25A22;RNF144B;SLC25A44;NOL3;LRRC59;HSP90AB1;RPUSD4;PARP1;TP63;FADS1;APEX2
4068,GO:0009119,0.954040437764403,0.121298095594558,3,83,ribonucleoside metabolic process,BP,TJP2;PDE6A;CTPS1
7763,GO:0032279,0.954268594478929,0.0914754783240543,7,150,asymmetric synapse,CC,CRYAB;MAP2;LYN;BAIAP2;GPER1;SPTBN1;PPP1R9B
9296,GO:0035735,0.954285746575244,0.192737873259543,1,39,intraciliary transport involved in cilium assembly,BP,WDR34
17608,GO:1901293,0.954662668162634,0.0788171221475994,12,237,nucleoside phosphate biosynthetic process,BP,ADM;PANK2;NUP153;TYMS;TK1;PGK1;GPER1;COX5B;NUP214;RRM2;CTPS1;PARP1
3077,GO:0006644,0.955310915182608,0.0704333114880041,19,343,phospholipid metabolic process,BP,NRG1;PLBD1;IRS1;LYN;FGFR2;HMGCS1;ABHD4;GPCPD1;IRS2;AJUBA;PDGFB;LPCAT3;PCYT1A;PIGM;ESR1;SMPD2;GPX4;DPM3;FADS1
4098,GO:0009152,0.95550802718737,0.0859601124079813,8,172,purine ribonucleotide biosynthetic process,BP,ADM;PANK2;NUP153;PGK1;GPER1;COX5B;NUP214;PARP1
3499,GO:0007399,0.956124225887278,0.0549170810217066,98,1469,nervous system development,BP,MAFB;NRG1;RUNX1;INHBA;HDAC9;MAP2;FN1;NEFL;TENM3;ADM;NEFM;SDC4;WNT10A;IER2;TGFB2;DAPK3;DBNDD2;G6PD;HSPG2;LYN;EHD1;BAIAP2;EFNB2;NAV2;ENC1;TNC;GPRIN1;FGFR2;PBX1;COL4A1;SLC7A5;ZC3H12A;FLNA;KLF7;HMGCS1;FANCC;BMP2;UBE4B;L1CAM;TNFRSF12A;LIF;SFRP1;ZFYVE27;CC2D2A;WDR1;GPER1;SRF;ABTB2;DOCK10;ETS1;SGK1;SRRT;PRPF19;ZFP36L1;DHFR;VCL;IRS2;NPAS2;MAFK;PRKCA;NTN1;ROBO1;OXTR;SPTBN1;NEDD4L;DCTN1;DPYSL3;NOM1;SDK1;TNFRSF21;SEMA3C;SPEN;ROR1;YWHAH;ENAH;PQBP1;ABT1;PPP1R9B;JUN;BLOC1S2;PARD3;RHOG;ZNF365;XRCC6;ZSWIM6;CNTNAP1;EFNB1;LRFN4;BMP7;RAPGEF1;DAG1;WNT4;CTDSP1;SMARCC2;EFNA1;HES4;TP63;PHACTR4
2745,GO:0006140,0.95651994243504,0.0969774094978141,5,119,regulation of nucleotide metabolic process,BP,ADM;NUP153;GPER1;NUP214;PARP1
18464,GO:1903557,0.956778853309697,0.184716524004938,1,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,HSPB1
8653,GO:0034198,0.956999078310673,0.184157524779625,1,39,cellular response to amino acid starvation,BP,CDKN1A
3582,GO:0007626,0.957003037086782,0.103508629659605,4,101,locomotory behavior,BP,NRG1;NAV2;CLN6;ARRDC3
2561,GO:0005844,0.957008690335111,0.134502316872661,2,69,polysome,CC,FUS;LARP4B
11586,GO:0046148,0.957012129280711,0.183972072471412,1,40,pigment biosynthetic process,BP,NFE2L1
13723,GO:0060291,0.957268250818174,0.183296626139458,1,39,long-term synaptic potentiation,BP,SQSTM1
4675,GO:0010823,0.957677595568255,0.18184099547631,1,40,negative regulation of mitochondrion organization,BP,NOL3
1999,GO:0004722,0.957705035937789,0.13313201047918,2,62,protein serine/threonine phosphatase activity,MF,PHLPP1;CTDSP1
6555,GO:0021987,0.958006033101834,0.112636175964089,3,82,cerebral cortex development,BP,NEFL;FLNA;ROBO1
5328,GO:0016054,0.958035312734436,0.0790761642373704,9,189,organic acid catabolic process,BP,IRS1;ACAA1;CHP1;IRS2;AASS;CPT1A;DCXR;QDPR;HSD17B10
11657,GO:0046395,0.958035312734436,0.0790761642373704,9,189,carboxylic acid catabolic process,BP,IRS1;ACAA1;CHP1;IRS2;AASS;CPT1A;DCXR;QDPR;HSD17B10
10079,GO:0042578,0.95808681065087,0.0708757437093832,14,267,phosphoric ester hydrolase activity,MF,DUSP14;PTPN14;APTX;PPP1R3B;GPCPD1;DUSP1;SMPD2;PHLPP1;PDE6A;CTDSP1;PTPRB;DUSP8;CCL5;APEX2
6079,GO:0019233,0.958117860440206,0.180425027099806,1,40,sensory perception of pain,BP,EDN1
9932,GO:0042278,0.958136635810136,0.131929874512711,2,64,purine nucleoside metabolic process,BP,TJP2;PDE6A
16126,GO:0090114,0.958150228253659,0.13195223696014,2,63,COPII-coated vesicle budding,BP,TRAPPC5;INSIG1
16970,GO:0098984,0.958317829857444,0.0843455752882967,7,152,neuron to neuron synapse,CC,CRYAB;MAP2;LYN;BAIAP2;GPER1;SPTBN1;PPP1R9B
13115,GO:0051650,0.95887455192425,0.0776820349676777,9,188,establishment of vesicle localization,BP,CADPS2;GOSR1;KIF23;DCTN1;CLASP1;BLOC1S2;TRAPPC5;ACTN4;RAB27A
17291,GO:0140056,0.958938026451471,0.0832142224696976,7,155,organelle localization by membrane tethering,BP,CC2D2A;FGFR1OP;DCTN1;CLASP1;CEP41;KIF24;TUBB
6893,GO:0030425,0.959041481518222,0.064365676468957,20,361,dendrite,CC,CRYAB;NRG1;MAP2;SACS;NQO1;LAMP1;BAIAP2;FLNA;L1CAM;FUS;ZFYVE27;GPER1;TXN2;DOCK10;PPP1R9B;KCNIP3;HSPA8;ELK1;RAB27A;TP63
16612,GO:0097447,0.959041481518222,0.064365676468957,20,361,dendritic tree,CC,CRYAB;NRG1;MAP2;SACS;NQO1;LAMP1;BAIAP2;FLNA;L1CAM;FUS;ZFYVE27;GPER1;TXN2;DOCK10;PPP1R9B;KCNIP3;HSPA8;ELK1;RAB27A;TP63
4192,GO:0009295,0.959222189879246,0.176851648313508,1,40,nucleoid,CC,LRRC59
10123,GO:0042645,0.959222189879246,0.176851648313508,1,40,mitochondrial nucleoid,CC,LRRC59
5652,GO:0016747,0.959294233666631,0.0794921693434575,8,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ACAA1;NAT10;NMT2;ZDHHC3;ZDHHC6;LPCAT3;BRPF1;CPT1A
2294,GO:0005253,0.959607606440415,0.175597111556623,1,40,anion channel activity,MF,FXYD3
16862,GO:0098791,0.960163838260758,0.0557166169777881,40,659,Golgi subcompartment,CC,HLA-B;GBP1;B4GALT1;EMP2;STEAP4;GNPTAB;LFNG;GALNT18;MYO1B;RAB32;HS3ST2;PKMYT1;CHP1;ARFRP1;GOSR1;ST6GALNAC5;ZDHHC3;HLA-F;GPER1;AP4S1;PDGFB;NSFL1C;TAPBPL;CAMK1G;SLC35A4;TAPBP;M6PR;CHST3;APH1A;TPST1;CREB3;GALNT2;MANEAL;GLIPR2;TRAPPC5;TMEM165;MGAT2;VPS52;CYTH1;CLTA
4034,GO:0009066,0.960286093623489,0.173379139156435,1,40,aspartate family amino acid metabolic process,BP,AASS
12126,GO:0048199,0.960557051891622,0.125783787205209,2,64,vesicle targeting, to, from or within Golgi,BP,GOSR1;TRAPPC5
3762,GO:0008306,0.960713887861457,0.171974381934977,1,40,associative learning,BP,SRF
13126,GO:0051668,0.961002573195925,0.105911490272646,3,83,localization within membrane,BP,FLNA;INSIG1;RILPL2
1303,GO:0003143,0.961550064133253,0.169214305136075,1,40,embryonic heart tube morphogenesis,BP,SRF
6295,GO:0019905,0.961650456665538,0.123031041656909,2,63,syntaxin binding,MF,TXLNA;VPS52
4967,GO:0015075,0.961759398042012,0.0579129579185071,25,442,ion transmembrane transporter activity,MF,SLC16A2;JPH2;TFRC;PANX1;SLC7A5;SLC16A9;JPH1;SLC39A1;SLCO3A1;SLC7A5P2;ITGAV;SLC5A6;FXYD3;KCNA7;SLC7A2;COX5B;SLC43A2;SLC4A11;KCNIP3;SLC22A4;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC2A6
19186,GO:1905268,0.961874268979334,0.168138995621751,1,40,negative regulation of chromatin organization,BP,NOC2L
12288,GO:0048609,0.96207446093606,0.0570683722894735,26,456,multicellular organismal reproductive process,BP,INHBA;CYP1A1;TGFB2;EDN1;BIRC3;B4GALT1;PANK2;TAF4B;JUNB;FOSL1;FANCC;LIF;NSUN2;EGR1;ETS1;OXTR;ESR1;CCR6;HERC2;BCL2L2;GPX4;WNT4;SLC4A2;BRIP1;TTLL5;TP63
10375,GO:0043195,0.962291573854313,0.166620333325846,1,41,terminal bouton,CC,HSPA8
2523,GO:0005777,0.962358129924777,0.0924224200300764,4,105,peroxisome,CC,ACAA1;PXMP2;ACSL1;TKT
10080,GO:0042579,0.962358129924777,0.0924224200300764,4,105,microbody,CC,ACAA1;PXMP2;ACSL1;TKT
2754,GO:0006164,0.962611574944257,0.0737194835400589,8,176,purine nucleotide biosynthetic process,BP,ADM;PANK2;NUP153;PGK1;GPER1;COX5B;NUP214;PARP1
7621,GO:0032011,0.962786140507084,0.165098775766291,1,40,ARF protein signal transduction,BP,CYTH1
7622,GO:0032012,0.962786140507084,0.165098775766291,1,40,regulation of ARF protein signal transduction,BP,CYTH1
20177,GO:2001023,0.962901013284479,0.164461518684047,1,42,regulation of response to drug,BP,TP53
8304,GO:0033135,0.963043269222078,0.101230283334084,3,85,regulation of peptidyl-serine phosphorylation,BP,TNF;LIF;SMAD7
7156,GO:0031016,0.963333117418752,0.163134899338136,1,41,pancreas development,BP,IL6R
17772,GO:1901799,0.963642349075694,0.161971887062244,1,42,negative regulation of proteasomal protein catabolic process,BP,HSP90AB1
1487,GO:0003824,0.963683426257668,0.0424496307195575,308,4343,catalytic activity,MF,HEPHL1;FTH1;NRG1;MMP9;HDAC9;PLD5;C1R;ODC1;P3H2;CYP1B1;CYP24A1;DTX2;NQO1;CYP1A1;TAP1;DUSP14;CYLD;FADS3;SOD2;ABCF1;UGT1A6;CD3EAP;CSF2;PTGES;MAP3K14;FAM46B;SH3RF2;GBP1;USB1;TXNRD1;TMPPE;MAT2A;TRIM56;IKBKE;BIRC3;PLBD1;MID1;DAPK3;TET3;PRSS23;B4GALT1;MGAM;SPSB1;RSAD2;G6PD;TRAF3;GFOD1;NUAK1;KLHL21;SQSTM1;STEAP4;P4HA2;PANK2;NOCT;CPA4;MPND;GNPTAB;LFNG;IRS1;GALNT18;CDKN1A;TJP2;ADAMTS9;LYN;MYO1B;RAB32;MCM5;HMGXB3;HS3ST2;GNL3L;ZBED1;RING1;CARS2;PKMYT1;SCD;NAV2;TRIO;FGFR2;PTPN14;CDKAL1;BACE2;PSMB9;LSS;EPHB6;C9ORF3;QPCT;PGD;UBE2C;TYMS;ZC3H12A;CYB5R1;TNK1;TK1;ACAA1;EPHA2;HMGCS1;EIF5;ARFRP1;BMP2;UBE4B;DDX23;CDK4;KIF23;MYO10;GGCX;PMM2;TRMT61A;STAT5A;RNF19B;METTL13;NAT10;GANC;PGK1;MCM2;LSG1;EBP;NMT2;ST6GALNAC5;USP36;AEN;SFRP1;PARL;ABCF2;TRIM22;ZDHHC3;APTX;DHCR7;PUS1;DHX37;PPP1R3B;METTL1;ABHD4;DNPEP;DPH2;DDX42;NFX1;NSUN2;HS3ST1;TXN2;SGK1;POP1;PRPF19;CYP4B1;ABHD16B;RHOB;ADAM17;GPCPD1;DKC1;FEN1;DHFR;ISG20L2;FGFR1OP;KCTD10;RIPK4;IRS2;METTL2B;TSR1;ACO1;TRAF2;ABCG2;AKR1C2;PRKCA;SYK;POLR1A;DDX17;SENP3;GINS2;USP43;DDX47;NOB1;PPIP5K1;CDKL1;DDX49;PDGFB;AASS;BRMS1;PREP;POLA1;WDR34;NSUN5;NEDD4L;DCTN1;DNASE1;COLGALT1;COX5B;RNF115;DPYSL3;UHRF1;MYH9;SPPL2A;CAMK1G;LANCL2;DOHH;RBBP5;DDX39A;FTSJ3;ROR1;PRUNE2;ACSL1;GPN1;CRCP;TATDN2;NOL9;MTA2;TAPBP;WDR4;KEAP1;ZDHHC6;CHST3;RRAD;APH1A;CAPNS1;UBE2J2;TPST1;RUVBL2;LPCAT3;MICAL3;TRUB2;PARP14;PRDM7;RHBDL2;PCYT1A;GALNT2;DUSP1;CAB39;OXSR1;HSPA8;GBE1;PIGM;DTX4;ESR1;MANEAL;BLOC1S2;USP31;BRPF1;CPT1A;DCXR;MCM7;SCD5;NOP2;HERC2;DUS2;QDPR;RHOG;XRCC6;TRMT1;CS;TAP2;SMPD2;KBTBD12;THEM4;KIF24;METTL16;SMUG1;PHLPP1;TKT;EFTUD2;OVCH2;RNF7;MPHOSPH8;CYP20A1;TINAGL1;KIF22;UAP1L1;CGNL1;POLR3H;PDE6A;MGAT2;RAB27A;DHX34;GPX4;DPM3;AKR1C1;TUBB;CTDSP1;CD38;TNFAIP3;PSMC3;BRIP1;RRM2;MAPK11;AARSD1;METTL21A;CTPS1;POLR1E;DDX24;MYO1E;HSD17B10;SLC3A2;XPNPEP3;TRIML2;PTPRB;RNF144B;POLR2G;DUSP8;GCLC;TTLL5;HERC6;POP4;RPUSD4;PARP1;CLK4;OTUD6A;C1S;TOP3A;CCL5;FADS1;APEX2
3079,GO:0006650,0.963721104558705,0.0621770782684932,14,271,glycerophospholipid metabolic process,BP,NRG1;PLBD1;IRS1;FGFR2;ABHD4;GPCPD1;IRS2;AJUBA;PDGFB;LPCAT3;PCYT1A;PIGM;ESR1;DPM3
4484,GO:0010506,0.96406352443405,0.0616409494444202,14,272,regulation of autophagy,BP,HSPB1;DAPK3;UBQLN2;ZC3H12A;DRAM1;ADRB2;USP36;TRIM22;SNRNP70;SUPT5H;CAPNS1;ATG101;CHMP4B;SH3BP4
14772,GO:0070469,0.964101903895962,0.116018722035388,2,78,respiratory chain,CC,COX5B;BCS1L
16871,GO:0098800,0.964791598368609,0.0968754166618422,3,99,inner mitochondrial membrane protein complex,CC,COX5B;BCS1L;CHCHD6
5160,GO:0015698,0.964803361585963,0.097205547647751,3,85,inorganic anion transport,BP,FXYD3;SLC4A11;SLC4A2
3195,GO:0006821,0.965197383287104,0.156697191379587,1,42,chloride transport,BP,FXYD3
2755,GO:0006165,0.965332694429354,0.0959577899796134,3,86,nucleoside diphosphate phosphorylation,BP,NUP153;PGK1;NUP214
5676,GO:0016787,0.966288302932921,0.0418448427964119,121,1816,hydrolase activity,MF,MMP9;HDAC9;C1R;TAP1;DUSP14;CYLD;ABCF1;GBP1;USB1;TMPPE;PLBD1;PRSS23;MGAM;NOCT;CPA4;MPND;ADAMTS9;MYO1B;RAB32;MCM5;GNL3L;NAV2;PTPN14;BACE2;PSMB9;C9ORF3;ZC3H12A;EIF5;ARFRP1;DDX23;KIF23;MYO10;GANC;MCM2;LSG1;USP36;AEN;SFRP1;PARL;ABCF2;APTX;DHX37;PPP1R3B;ABHD4;DNPEP;DDX42;POP1;ABHD16B;RHOB;ADAM17;GPCPD1;FEN1;ISG20L2;TSR1;ABCG2;DDX17;SENP3;GINS2;USP43;DDX47;NOB1;DDX49;BRMS1;PREP;WDR34;DCTN1;DNASE1;DPYSL3;MYH9;SPPL2A;DDX39A;PRUNE2;GPN1;TATDN2;MTA2;TAPBP;RRAD;APH1A;CAPNS1;RUVBL2;RHBDL2;DUSP1;HSPA8;GBE1;MANEAL;USP31;MCM7;RHOG;XRCC6;TAP2;SMPD2;THEM4;KIF24;SMUG1;PHLPP1;EFTUD2;OVCH2;TINAGL1;KIF22;CGNL1;PDE6A;RAB27A;DHX34;TUBB;CTDSP1;CD38;TNFAIP3;PSMC3;BRIP1;AARSD1;DDX24;MYO1E;XPNPEP3;PTPRB;DUSP8;POP4;RPUSD4;OTUD6A;C1S;CCL5;APEX2
3076,GO:0006643,0.966327567805195,0.0671992014039264,8,177,membrane lipid metabolic process,BP,CYR61;CYP1B1;TNF;CLN6;ST6GALNAC5;PIGM;SMPD2;DPM3
7247,GO:0031201,0.967047753531093,0.150212424510895,1,43,SNARE complex,CC,GOSR1
13750,GO:0060324,0.967084262865353,0.150197588394947,1,42,face development,BP,SRF
13391,GO:0052689,0.96751030708409,0.090877513643973,3,87,carboxylic ester hydrolase activity,MF,PLBD1;ABHD4;AARSD1
13113,GO:0051648,0.968285116106745,0.0616311615536212,9,194,vesicle localization,BP,CADPS2;GOSR1;KIF23;DCTN1;CLASP1;BLOC1S2;TRAPPC5;ACTN4;RAB27A
16912,GO:0098876,0.96837686240723,0.105154707396887,2,66,vesicle-mediated transport to the plasma membrane,BP,ARFRP1;SPTBN1
4102,GO:0009156,0.968555521093613,0.0733074046592238,5,126,ribonucleoside monophosphate biosynthetic process,BP,NUP153;PGK1;COX5B;NUP214;PARP1
9631,GO:0036498,0.968816050027859,0.103923568659997,2,67,IRE1-mediated unfolded protein response,BP,DCTN1;TATDN2
5857,GO:0017156,0.968962295453512,0.103572250191941,2,66,calcium ion regulated exocytosis,BP,CADPS2;CHP1
19392,GO:1905897,0.969120285885529,0.103099583275111,2,67,regulation of response to endoplasmic reticulum stress,BP,UBQLN2;CREB3
6723,GO:0030134,0.96913829122949,0.103007701852475,2,68,COPII-coated ER to Golgi transport vesicle,CC,HLA-B;HLA-F
6709,GO:0030119,0.969139075491731,0.142879525109521,1,43,AP-type membrane coat adaptor complex,CC,AP4S1
7269,GO:0031248,0.969183183794727,0.0869238957148888,3,88,protein acetyltransferase complex,CC,RUVBL2;BRPF1;UBAP2L
18011,GO:1902493,0.969183183794727,0.0869238957148888,3,88,acetyltransferase complex,CC,RUVBL2;BRPF1;UBAP2L
16865,GO:0098794,0.96929641391807,0.0543894686410598,13,258,postsynapse,CC,CRYAB;MAP2;LYN;BAIAP2;CADPS2;FUS;GPER1;DOCK10;SPTBN1;PPP1R9B;HSPA8;DAG1;CLTA
2945,GO:0006473,0.969724656599149,0.0636308125992231,7,162,protein acetylation,BP,TRIM16;CPA4;LIF;SNAI2;RUVBL2;BRPF1;NOC2L
18275,GO:1903146,0.970037728876039,0.139580170196746,1,44,regulation of autophagy of mitochondrion,BP,USP36
6807,GO:0030258,0.970329003515627,0.0580712215433707,9,195,lipid modification,BP,NRG1;CYP1A1;IRS1;FGFR2;ACAA1;IRS2;PDGFB;ESR1;CPT1A
6746,GO:0030166,0.970376152244727,0.138471694166996,1,43,proteoglycan biosynthetic process,BP,CHST3
8424,GO:0033500,0.97057123389519,0.0651317077099855,6,146,carbohydrate homeostasis,BP,IRS1;ICAM1;GPER1;SRF;IRS2;GCLC
10092,GO:0042593,0.97057123389519,0.0651317077099855,6,146,glucose homeostasis,BP,IRS1;ICAM1;GPER1;SRF;IRS2;GCLC
13276,GO:0051963,0.970608811391361,0.137636640530736,1,43,regulation of synapse assembly,BP,OXTR
3567,GO:0007610,0.970713687068672,0.0495969803662268,16,311,behavior,BP,NRG1;CSF2;TP53;NAV2;CLN6;FOSL1;ADRB2;SRF;SGK1;FEN1;OXTR;SDK1;JUN;CPT1A;ARRDC3;DNAJC9
12873,GO:0051196,0.970856476451443,0.0983605261227265,2,67,regulation of coenzyme metabolic process,BP,NUP153;NUP214
4078,GO:0009132,0.97100803497651,0.0739482008460303,4,109,nucleoside diphosphate metabolic process,BP,TJP2;NUP153;PGK1;NUP214
17559,GO:1901136,0.971232435596887,0.0678533605709941,5,128,carbohydrate derivative catabolic process,BP,SDC4;HSPG2;ADAMTS9;CHP1;SMUG1
16778,GO:0098588,0.971980033843269,0.0356871944953998,99,1517,bounding membrane of organelle,CC,CYP24A1;JPH2;TAP1;PML;PCDH7;TFRC;HLA-B;GBP1;IKBKE;B4GALT1;MGAM;DBNDD2;RSAD2;EMP2;STEAP4;GNPTAB;LFNG;GALNT18;MYO1B;RAB32;STOML1;LAMP1;HS3ST2;EHD1;PKMYT1;VMP1;SIRPA;JPH1;ZC3H12A;CYB5R1;CHP1;ARFRP1;GOSR1;KREMEN2;DRAM1;ITGAV;ADRB2;ST6GALNAC5;ZFYVE27;ZDHHC3;DHCR7;HLA-F;ANXA8;IL7R;THBD;GPER1;AP4S1;RHOB;LGALS3;PDGFB;SPPL2A;TAPBPL;CAMK1G;GLIPR1;SNX8;BORCS7;LILRB3;PXMP2;ACSL1;RCC2;SLC35A4;SLC35C2;TAPBP;M6PR;CHST3;APH1A;TPST1;CREB3;GALNT2;TGFBRAP1;CD109;HSPA8;MANEAL;BLOC1S2;GLIPR2;CPT1A;TRAPPC5;CHMP4B;RHOG;BCL2L2;TAP2;PHLPP1;TOMM40;RAPGEF1;TMEM165;PDE6A;MGAT2;RNF185;RAB27A;WNT4;VPS52;CYTH1;SPG21;PTPRB;SLC25A44;CLTA;SNF8;HSP90AB1;LAIR1
7104,GO:0030900,0.972364385492764,0.0515781452162843,11,230,forebrain development,BP,NRG1;INHBA;NEFL;FGFR2;FLNA;BMP2;SRF;ETS1;ROBO1;OXTR;WNT4
3092,GO:0006665,0.972891892264379,0.064459975389907,5,127,sphingolipid metabolic process,BP,CYR61;TNF;CLN6;ST6GALNAC5;SMPD2
5690,GO:0016810,0.973265573598639,0.0689786751213874,4,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,HDAC9;BRMS1;DPYSL3;MTA2
3952,GO:0008654,0.973312603711872,0.0499751684125192,11,231,phospholipid biosynthetic process,BP,IRS1;FGFR2;HMGCS1;IRS2;AJUBA;PDGFB;LPCAT3;PCYT1A;PIGM;DPM3;FADS1
5134,GO:0015630,0.974697807086714,0.0342814810551242,60,967,microtubule cytoskeleton,CC,SAA1;CRYAB;MAP2;TAP1;CYLD;HSPB1;RELB;MID1;NUAK1;KLHL21;NLRC5;NEDD9;BAIAP2;DST;CHP1;CCDC85B;KIF23;CDC42EP2;SVIL;PLEKHA7;MTUS1;MCM2;CCDC124;PDE4DIP;NSUN2;PRPF19;FGFR1OP;AJUBA;CEP95;PHAX;WDR34;DCTN1;TCP11L1;SLAIN2;MYH9;TBCCD1;ZW10;RCC2;SMAD7;KEAP1;SPECC1;HNRNPU;CLASP1;CEP41;RUVBL2;MICAL3;BLOC1S2;DCXR;HERC2;CNTROB;ZNF365;KIF24;KANK4;INCENP;KIF22;POLR3H;RILPL2;TUBB;CLTA;TTLL5
4428,GO:0010257,0.974714448576899,0.121651100478084,1,55,NADH dehydrogenase complex assembly,BP,BCS1L
8224,GO:0032981,0.974714448576899,0.121651100478084,1,55,mitochondrial respiratory chain complex I assembly,BP,BCS1L
16975,GO:0099003,0.97484969136924,0.0732451242235091,3,90,vesicle-mediated transport in synapse,BP,CADPS2;BLOC1S2;RAB27A
5396,GO:0016233,0.974990119155044,0.120873051581315,1,51,telomere capping,BP,TFIP11
16867,GO:0098796,0.975099957621708,0.0355112430292346,42,727,membrane protein complex,CC,TAP1;TFRC;HLA-B;TRAF3;IRS1;HSPG2;LYN;CORO1C;BMP2;GOSR1;ITGAV;ABCF2;HLA-F;AP4S1;KCNA7;TRAF2;PRKCA;SYK;DCTN1;COX5B;MYH9;NPNT;SNX8;SMAD7;TAPBP;TRIP6;M6PR;APH1A;KCNIP3;BCS1L;CHMP4B;INSIG1;TAP2;CHCHD6;CNTNAP1;TOMM40;DAG1;RNF185;CLTA;SNF8;IL6R;BAIAP2L2
17701,GO:1901605,0.975106536539252,0.056231638170665,6,148,alpha-amino acid metabolic process,BP,ODC1;STAT5A;AASS;QDPR;CTPS1;GCLC
11908,GO:0046939,0.975489148334981,0.07162951886533,3,92,nucleotide phosphorylation,BP,NUP153;PGK1;NUP214
160,GO:0000323,0.97554478057039,0.0371692517511102,29,517,lytic vacuole,CC,FTL;FTH1;SDC4;PLBD1;B4GALT1;HRNR;SQSTM1;HSPG2;LYN;LAMP1;DRAM1;RNF19B;ADRB2;TRIM29;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;ARRDC3;TINAGL1;TMEM165;RAB27A;TUBB;TNFAIP3;CLTA;HSP90AB1
2511,GO:0005764,0.97554478057039,0.0371692517511102,29,517,lysosome,CC,FTL;FTH1;SDC4;PLBD1;B4GALT1;HRNR;SQSTM1;HSPG2;LYN;LAMP1;DRAM1;RNF19B;ADRB2;TRIM29;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;ARRDC3;TINAGL1;TMEM165;RAB27A;TUBB;TNFAIP3;CLTA;HSP90AB1
6722,GO:0030133,0.975558861593035,0.0450962002399651,12,252,transport vesicle,CC,HLA-B;EDN1;DBNDD2;LAMP1;CHP1;GOSR1;HLA-F;DPYSL3;M6PR;RAB27A;SPG21;CLTA
5559,GO:0016571,0.975761201932645,0.0634035801622627,4,111,histone methylation,BP,TET3;NELFE;RBBP5;PRDM7
12125,GO:0048194,0.975795352153314,0.0843631652796972,2,71,Golgi vesicle budding,BP,TRAPPC5;INSIG1
3202,GO:0006835,0.975870614506631,0.117926423063306,1,46,dicarboxylic acid transport,BP,SLC25A22
15822,GO:0072522,0.97610985374368,0.0494939672268042,8,186,purine-containing compound biosynthetic process,BP,ADM;PANK2;NUP153;PGK1;GPER1;COX5B;NUP214;PARP1
10014,GO:0042440,0.97668407409915,0.114664432623961,1,48,pigment metabolic process,BP,NFE2L1
5990,GO:0018958,0.976959389655458,0.113684148282345,1,47,phenol-containing compound metabolic process,BP,TGFB2
6818,GO:0030276,0.977723897624625,0.110730061557518,1,47,clathrin binding,MF,CLTA
3625,GO:0008080,0.977724609600313,0.0787602459285145,2,72,N-acetyltransferase activity,MF,NAT10;BRPF1
72,GO:0000149,0.978048115003649,0.0652371058922351,3,93,SNARE binding,MF,GOSR1;TXLNA;VPS52
13095,GO:0051606,0.978243343268976,0.0577248627561367,4,115,detection of stimulus,BP,NMT2;PDE6A;TIMELESS;PARP1
9614,GO:0036477,0.978250844858984,0.034002246327267,26,474,somatodendritic compartment,CC,CRYAB;NRG1;MAP2;SACS;NQO1;TGFB2;LAMP1;BAIAP2;ENC1;FLNA;L1CAM;MYO10;PMM2;FUS;ZFYVE27;GPER1;TXN2;DOCK10;PHAX;PPP1R9B;KCNIP3;HSPA8;PARD3;ELK1;RAB27A;TP63
17558,GO:1901135,0.978292373953413,0.0300478669656148,54,908,carbohydrate derivative metabolic process,BP,ADM;SDC4;TET3;B4GALT1;G6PD;PANK2;NFKB1;GNPTAB;LFNG;GALNT18;TJP2;HSPG2;ADAMTS9;HS3ST2;NUP153;BACE2;CLN6;PGD;TYMS;TK1;EPHA2;CHP1;BMP2;PMM2;PGK1;ST6GALNAC5;GPER1;HS3ST1;IL15;AKR1C2;PDGFB;COX5B;NUP214;SLC35C2;CHST3;TPST1;GALNT2;HSPA8;PIGM;DCXR;SMPD2;SMUG1;TKT;UAP1L1;DAG1;TMEM165;PDE6A;MGAT2;RNF185;DPM3;AKR1C1;RRM2;CTPS1;PARP1
14511,GO:0065002,0.97832061663064,0.108191020209448,1,50,intracellular protein transmembrane transport,BP,TOMM40
18013,GO:1902495,0.978427257071362,0.0573425384593071,4,112,transmembrane transporter complex,CC,ABCF2;KCNA7;KCNIP3;CNTNAP1
2833,GO:0006301,0.978654663000713,0.106951180407787,1,49,postreplication repair,BP,USP43
6362,GO:0021543,0.978695667854429,0.0567141440588264,4,113,pallium development,BP,NEFL;FLNA;SRF;ROBO1
13080,GO:0051588,0.978806136128504,0.106426668727834,1,48,regulation of neurotransmitter transport,BP,GPER1
9838,GO:0042073,0.979025614440185,0.10549197554184,1,49,intraciliary transport,BP,WDR34
9545,GO:0036297,0.979063267318975,0.105413572284739,1,48,interstrand cross-link repair,BP,FANCC
5403,GO:0016241,0.979127130808423,0.0481375899940243,6,151,regulation of macroautophagy,BP,UBQLN2;ADRB2;SUPT5H;CAPNS1;ATG101;CHMP4B
12623,GO:0050807,0.979294946879805,0.0620831077792561,3,93,regulation of synapse organization,BP,BAIAP2;OXTR;EFNA1
10155,GO:0042733,0.979394722202871,0.1041026743767,1,48,embryonic digit morphogenesis,BP,OSR2
5832,GO:0017112,0.979691185564904,0.10285625806604,1,49,Rab guanyl-nucleotide exchange factor activity,MF,TRAPPC5
2272,GO:0005215,0.980674507373124,0.0282875557991808,39,678,transporter activity,MF,SLC16A2;JPH2;TAP1;TFRC;PANX1;SLC7A5;SLC16A9;JPH1;SLC39A1;CHP1;SLCO3A1;SLC7A5P2;ITGAV;SLC5A6;FXYD3;EBP;ABCF2;KCNA7;ABCG2;SLC7A2;COX5B;SLC35A4;SLC43A2;TAPBP;M6PR;SLC4A11;KCNIP3;TCOF1;SLC22A4;TNPO3;TAP2;TOMM40;IPO4;SLC41A2;SLC4A2;SLC3A2;SLC25A22;SLC25A44;SLC2A6
2541,GO:0005798,0.980683352406065,0.0479040464240003,5,136,Golgi-associated vesicle,CC,HLA-B;HLA-F;SPPL2A;SPG21;CLTA
11112,GO:0045132,0.98099410162205,0.0976286592228841,1,49,meiotic chromosome segregation,BP,BRIP1
6114,GO:0019359,0.9814555681189,0.056500250733536,3,95,nicotinamide nucleotide biosynthetic process,BP,NUP153;PGK1;NUP214
6116,GO:0019363,0.9814555681189,0.056500250733536,3,95,pyridine nucleotide biosynthetic process,BP,NUP153;PGK1;NUP214
9358,GO:0035869,0.981457777950755,0.0956822151710055,1,50,ciliary transition zone,CC,CC2D2A
3511,GO:0007420,0.98165618070912,0.0294711029031095,24,448,brain development,BP,MAFB;NRG1;INHBA;NEFL;G6PD;HSPG2;BAIAP2;FGFR2;COL4A1;FLNA;HMGCS1;FANCC;BMP2;SFRP1;SRF;ETS1;IRS2;ROBO1;OXTR;YWHAH;ZNF365;XRCC6;BMP7;WNT4
16619,GO:0097458,0.981763080390669,0.0252677730147332,57,939,neuron part,CC,CRYAB;NRG1;MAP2;NEFL;TENM3;SACS;NEFM;NQO1;HSPB1;TGFB2;DBNDD2;SQSTM1;LYN;LAMP1;BAIAP2;ENC1;DST;GPRIN1;EPHB6;FOSL1;FLNA;CADPS2;EPHA2;L1CAM;MYO10;PMM2;IQCJ-SCHIP1;FUS;ZFYVE27;GPER1;TXN2;KCNA7;DOCK10;ROBO1;PHAX;SPTBN1;DPYSL3;CAMK1G;TNFRSF21;ROR1;PQBP1;PPP1R9B;KCNIP3;HSPA8;BLOC1S2;PARD3;QDPR;CNTNAP1;ACTN4;PHLPP1;ELK1;DAG1;PDE6A;RAB27A;SMARCC2;CLTA;TP63
7421,GO:0031514,0.981978630645627,0.0660147819114997,2,75,motile cilium,CC,SQSTM1;CCR6
5341,GO:0016079,0.98264793514201,0.0907935972337496,1,50,synaptic vesicle exocytosis,BP,CADPS2
6272,GO:0019866,0.983071767151211,0.0278180225541386,22,451,organelle inner membrane,CC,SOD2;RSAD2;LYN;TYMS;PARL;LGALS3;COX5B;MRPS12;MRPS24;ERAL1;MTFP1;MRPL20;MRPL33;CPT1A;BCS1L;HERC2;CHCHD6;THEM4;TOMM40;MRPS2;SLC25A22;SLC25A44
16302,GO:0090407,0.98312261360638,0.0266185189304853,27,500,organophosphate biosynthetic process,BP,ADM;G6PD;PANK2;IRS1;FGFR2;NUP153;TYMS;TK1;HMGCS1;PGK1;GPER1;IRS2;AJUBA;PPIP5K1;PDGFB;COX5B;NUP214;LPCAT3;PCYT1A;PIGM;DCXR;TKT;DPM3;RRM2;CTPS1;PARP1;FADS1
3435,GO:0007224,0.98313524528702,0.0520778907445794,3,97,smoothened signaling pathway,BP,FGFR2;SFRP1;CC2D2A
12679,GO:0050890,0.983140029861988,0.039838204422369,6,155,cognition,BP,FOSL1;SRF;SGK1;FEN1;OXTR;JUN
201,GO:0000422,0.983375359270086,0.061681717473462,2,77,autophagy of mitochondrion,BP,SQSTM1;USP36
14425,GO:0061726,0.983375359270086,0.061681717473462,2,77,mitochondrion disassembly,BP,SQSTM1;USP36
2717,GO:0006094,0.983421782593792,0.0875110217673773,1,51,gluconeogenesis,BP,PGK1
8960,GO:0035023,0.983571455519781,0.0509402101054765,3,96,regulation of Rho protein signal transduction,BP,TRIO;ARHGEF28;ROBO1
2506,GO:0005759,0.983623894790012,0.0278736708270834,19,393,mitochondrial matrix,CC,SOD2;TP53;CARS2;TYMS;PUS1;TXN2;AASS;MRPS12;MRPS24;ERAL1;TRUB2;MRPL20;MRPL33;CS;THEM4;MRPS2;HSD17B10;LRRC59;RPUSD4
1784,GO:0004402,0.983740735126377,0.0861712483478119,1,51,histone acetyltransferase activity,MF,BRPF1
6710,GO:0030120,0.984006270829401,0.0849964103485478,1,52,vesicle coat,CC,CLTA
7178,GO:0031060,0.984094251994353,0.0846784832487109,1,51,regulation of histone methylation,BP,NELFE
5679,GO:0016791,0.984184783095779,0.0329654861290102,9,209,phosphatase activity,MF,DUSP14;PTPN14;APTX;PPP1R3B;DUSP1;PHLPP1;CTDSP1;PTPRB;DUSP8
12870,GO:0051193,0.984205694056982,0.0591246136571886,2,76,regulation of cofactor metabolic process,BP,NUP153;NUP214
7616,GO:0032006,0.984478101918904,0.058272069127026,2,76,regulation of TOR signaling,BP,TELO2;SH3BP4
15825,GO:0072525,0.984684547962079,0.047946442586249,3,98,pyridine-containing compound biosynthetic process,BP,NUP153;PGK1;NUP214
17303,GO:0140096,0.984695659387282,0.0197263471724895,110,1695,catalytic activity, acting on a protein,MF,NRG1;MMP9;HDAC9;C1R;P3H2;DUSP14;CYLD;CSF2;MAP3K14;TRIM56;IKBKE;BIRC3;DAPK3;PRSS23;SPSB1;TRAF3;NUAK1;KLHL21;SQSTM1;P4HA2;CPA4;MPND;GALNT18;CDKN1A;ADAMTS9;LYN;ZBED1;PKMYT1;TRIO;FGFR2;PTPN14;BACE2;PSMB9;EPHB6;C9ORF3;QPCT;UBE2C;ZC3H12A;TNK1;EPHA2;UBE4B;CDK4;STAT5A;RNF19B;USP36;SFRP1;PARL;ZDHHC3;PPP1R3B;DNPEP;SGK1;PRPF19;ADAM17;FGFR1OP;KCTD10;RIPK4;TRAF2;PRKCA;SYK;SENP3;USP43;CDKL1;BRMS1;PREP;NEDD4L;COLGALT1;RNF115;UHRF1;SPPL2A;CAMK1G;RBBP5;ROR1;MTA2;KEAP1;ZDHHC6;APH1A;CAPNS1;UBE2J2;TPST1;PRDM7;RHBDL2;GALNT2;DUSP1;CAB39;OXSR1;DTX4;USP31;HERC2;KBTBD12;PHLPP1;OVCH2;RNF7;MPHOSPH8;TINAGL1;MGAT2;CTDSP1;TNFAIP3;MAPK11;METTL21A;XPNPEP3;PTPRB;RNF144B;DUSP8;TTLL5;HERC6;PARP1;CLK4;OTUD6A;C1S;CCL5
3254,GO:0006914,0.985282069857114,0.0244381749319214,22,427,autophagy,BP,HSPB1;DAPK3;TP53;SQSTM1;UBQLN2;VMP1;ZC3H12A;DRAM1;ADRB2;USP36;TRIM22;NSFL1C;SNRNP70;SUPT5H;CAPNS1;ATG101;HSPA8;CHMP4B;TOMM40;RNF185;SNF8;SH3BP4
14493,GO:0061919,0.985282069857114,0.0244381749319214,22,427,process utilizing autophagic mechanism,BP,HSPB1;DAPK3;TP53;SQSTM1;UBQLN2;VMP1;ZC3H12A;DRAM1;ADRB2;USP36;TRIM22;NSFL1C;SNRNP70;SUPT5H;CAPNS1;ATG101;HSPA8;CHMP4B;TOMM40;RNF185;SNF8;SH3BP4
8887,GO:0034702,0.985724686741011,0.0451297204023777,3,99,ion channel complex,CC,KCNA7;KCNIP3;CNTNAP1
7201,GO:0031090,0.985807061632117,0.0178638254320292,145,2223,organelle membrane,CC,CYP1B1;CYP24A1;DTX2;JPH2;CYP1A1;TAP1;PML;STARD13;PCDH7;TFRC;SOD2;GPRC5A;HLA-B;GBP1;IKBKE;B4GALT1;MGAM;DBNDD2;RSAD2;EMP2;STEAP4;GNPTAB;LFNG;GALNT18;LYN;MYO1B;RAB32;STOML1;LAMP1;HS3ST2;EHD1;PKMYT1;VMP1;NUP153;SIRPA;JPH1;TYMS;ZC3H12A;CYB5R1;CADPS2;CHP1;ARFRP1;GOSR1;CDK4;KREMEN2;DRAM1;ITGAV;SFN;RRP12;ADRB2;SLC5A6;ST6GALNAC5;AEN;PARL;ZFYVE27;ZDHHC3;DHCR7;HLA-F;ANXA8;IL7R;THBD;GPER1;DNAJB2;AP4S1;CYP4B1;RHOB;LGALS3;TRAF2;ABCG2;REEP1;PRKCA;CMTM3;PDGFB;COX5B;SPPL2A;TAPBPL;CAMK1G;GLIPR1;SNX8;BORCS7;LILRB3;PXMP2;ACSL1;RCC2;SLC35A4;SLC35C2;MRPS12;MRPS24;DNAJC1;YWHAH;TAPBP;M6PR;ERAL1;CHST3;APH1A;TPST1;CREB3;MTFP1;MRPL20;GALNT2;TGFBRAP1;CD109;HSPA8;MRPL33;MANEAL;BLOC1S2;RCC1;GLIPR2;CPT1A;TNPO3;BCS1L;TRAPPC5;CHMP4B;HERC2;RHOG;BCL2L2;TAP2;CHCHD6;THEM4;PHLPP1;TOMM40;SGSM1;RAPGEF1;IPO4;TMEM165;PDE6A;MGAT2;RNF185;RAB27A;WNT4;MRPS2;VPS52;CYTH1;SPG21;BRIP1;SLC25A22;PTPRB;RNF144B;SLC25A44;CLTA;SNF8;LRRC59;HSP90AB1;LAIR1;BAIAP2L2
19499,GO:1990351,0.985934800783824,0.03951029476684,4,120,transporter complex,CC,ABCF2;KCNA7;KCNIP3;CNTNAP1
17703,GO:1901607,0.98602290662874,0.076282061221094,1,53,alpha-amino acid biosynthetic process,BP,AASS
11690,GO:0046474,0.9861789427497,0.0302849743365354,8,194,glycerophospholipid biosynthetic process,BP,IRS1;FGFR2;IRS2;AJUBA;PDGFB;PCYT1A;PIGM;DPM3
14429,GO:0061733,0.98621462308293,0.0754430828466843,1,53,peptide-lysine-N-acetyltransferase activity,MF,BRPF1
19477,GO:1990204,0.986499888795863,0.0516126528260586,2,89,oxidoreductase complex,CC,BCS1L;RRM2
13106,GO:0051640,0.986799491847113,0.0209818174835754,28,522,organelle localization,BP,NEFL;LYN;LAMP1;CADPS2;GOSR1;KIF23;CC2D2A;RRS1;FGFR1OP;NTN1;SYK;DCTN1;MYH9;TBCCD1;ZW10;HNRNPU;CLASP1;CEP41;BLOC1S2;TRAPPC5;CHMP4B;ACTN4;KIF24;CLUH;KIF22;RAB27A;TUBB;CDCA5
16425,GO:0097060,0.986933186589497,0.0317575542661851,6,158,synaptic membrane,CC,CRYAB;BAIAP2;FOSL1;CADPS2;GPER1;DAG1
6099,GO:0019319,0.986939023306494,0.0722016744395387,1,54,hexose biosynthetic process,BP,PGK1
2715,GO:0006090,0.98719226953237,0.0410915023083211,3,101,pyruvate metabolic process,BP,NUP153;PGK1;NUP214
12619,GO:0050803,0.987606458728143,0.0399453880559293,3,101,regulation of synapse structure or activity,BP,BAIAP2;OXTR;EFNA1
4111,GO:0009166,0.987833629582398,0.0347826299938567,4,124,nucleotide catabolic process,BP,NUP153;PGK1;NUP214;SMUG1
13712,GO:0060271,0.987949577410192,0.0231165780534073,13,284,cilium assembly,BP,CYLD;EHD1;FLNA;CC2D2A;FGFR1OP;WDR34;DCTN1;CLASP1;CEP41;KIF24;RILPL2;TUBB;TTLL5
12130,GO:0048207,0.988006630613802,0.0673324494309895,1,56,vesicle targeting, rough ER to cis-Golgi,BP,TRAPPC5
12131,GO:0048208,0.988006630613802,0.0673324494309895,1,56,COPII vesicle coating,BP,TRAPPC5
8752,GO:0034404,0.988192876355852,0.0289854271057406,6,165,nucleobase-containing small molecule biosynthetic process,BP,NUP153;TK1;PGK1;NUP214;SMUG1;CTPS1
3595,GO:0008021,0.988228779966235,0.0381797617099799,3,104,synaptic vesicle,CC,DBNDD2;LAMP1;CLTA
17279,GO:0140013,0.988467309193295,0.0375218505643961,3,103,meiotic nuclear division,BP,LIF;WNT4;BRIP1
10898,GO:0044441,0.98864289513698,0.0223867290268625,12,269,ciliary part,CC,CYLD;SQSTM1;EHD1;CC2D2A;WDR34;DCTN1;CEP41;CCR6;PHLPP1;PDE6A;RAB27A;RILPL2
11868,GO:0046872,0.988666380841135,0.0140097405984668,198,2925,metal ion binding,MF,HEPHL1;IGFBP3;TRIM16;FTL;CRYAB;FTH1;MMP9;HDAC9;S100P;C1R;P3H2;CYP1B1;CYP24A1;DTX2;TRIM47;CYP1A1;PML;CYLD;PDLIM1;TRAF1;PCDH7;SOD2;FBN1;SH3RF2;TMPPE;MAT2A;TRIM56;BIRC3;MID1;TET3;B4GALT1;RSAD2;TRAF3;NUAK1;HRNR;TP53;SQSTM1;STEAP4;P4HA2;NOCT;CPA4;MPND;GNPTAB;LFNG;GALNT18;CDKN1A;HSPG2;ADAMTS9;CSRP1;EHD1;ZBED1;RING1;CARS2;PKMYT1;SCD;DST;CDKAL1;NUP153;TPM4;C9ORF3;QPCT;ZC3H12A;LCP1;TK1;CADPS2;KLF7;ZNF503;CHP1;COL27A1;ZNF142;ITGAV;GTPBP6;RNF19B;ZMAT2;ANXA8L1;FUS;MCM2;CSRP2;XAF1;AKAP8L;ZC3H7B;OSR2;TRIM22;ZFYVE27;APTX;ANXA8;DNPEP;NFX1;THBD;ZNF787;ZFP42;TRIM29;SF1;EGR1;SNAI2;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;ADAM17;FEN1;NPAS2;ACO1;TRAF2;PRKCA;ZNF778;ZFP36L2;ZFC3H1;POLR1A;AJUBA;NOB1;POLA1;FHL2;ZNF407;COX5B;RNF115;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;ZNF263;DOHH;RASGRP4;ZNF697;PRUNE2;COL5A2;SMAD7;TATDN2;MTA2;TRIP6;CAPNS1;MAZ;MICAL3;KCNIP3;KLF10;ZNF267;GALNT2;STAC;FRAS1;OXSR1;DTX4;ESR1;IKZF3;BRPF1;SCD5;ZNF772;ZNF512;GTF2E1;RBM4;ZNF703;RPTN;HERC2;ZNF365;ZNF132;TRMT1;KLF6;ZSWIM6;SMPD2;ACTN4;GLIS3;PHLPP1;ZNF34;CISD3;TKT;OVCH2;RNF7;CYP20A1;PHF5A;ZYX;DAG1;PDE6A;RNF185;TRAF4;CTDSP1;TNFAIP3;CYB561D2;BRIP1;RRM2;AARSD1;XPNPEP3;ATAD3C;ZC3H18;RNF144B;SRSF7;CREB5;NOL3;GCLC;SWAP70;FBLN2;PARP1;TP63;ZBTB12;C1S;TOP3A;APEX2
5296,GO:0015980,0.988897898713017,0.02480292685522,8,214,energy derivation by oxidation of organic compounds,BP,PANK2;IRS1;PPP1R3B;IRS2;ACO1;COX5B;GBE1;CS
13927,GO:0060589,0.989044017541039,0.0211792360151358,13,284,nucleoside-triphosphatase regulator activity,MF,STARD13;BAG1;SIPA1L3;DNAJB1;ERRFI1;CDC42EP2;DNAJB2;RUNDC1;DNAJC1;HSPBP1;JUN;SGSM1;SH3BP4
3465,GO:0007283,0.989143136901403,0.021475927111902,12,272,spermatogenesis,BP,BIRC3;PANK2;TAF4B;NSUN2;CCR6;HERC2;BCL2L2;GPX4;SLC4A2;BRIP1;TTLL5;TP63
10789,GO:0044255,0.98927524977802,0.0159201467818624,43,757,cellular lipid metabolic process,BP,NRG1;CYR61;CYP1B1;CYP1A1;SDC4;FADS3;PTGES;EDN1;PLBD1;PANK2;IRS1;HSPG2;LYN;TNF;SCD;FGFR2;CLN6;C9ORF3;ACAA1;HMGCS1;STAT5A;ST6GALNAC5;ABHD4;GPCPD1;IRS2;AKR1C2;AJUBA;PDGFB;ACSL1;LPCAT3;PCYT1A;PIGM;ESR1;SLC22A4;CPT1A;SCD5;INSIG1;SMPD2;THEM4;GPX4;DPM3;AKR1C1;FADS1
6982,GO:0030658,0.989377485834196,0.0308729517591792,4,126,transport vesicle membrane,CC,HLA-B;DBNDD2;HLA-F;CLTA
6368,GO:0021549,0.989386135986604,0.0609995375994615,1,56,cerebellum development,BP,ZNF365
6632,GO:0022900,0.989537911042259,0.0303724861251231,4,142,electron transport chain,BP,TXNRD1;P4HA2;COX5B;QDPR
13748,GO:0060322,0.989734199469828,0.0169622744132643,25,481,head development,BP,MAFB;NRG1;INHBA;NEFL;G6PD;HSPG2;BAIAP2;FGFR2;COL4A1;FLNA;HMGCS1;FANCC;BMP2;OSR2;SFRP1;SRF;ETS1;IRS2;ROBO1;OXTR;YWHAH;ZNF365;XRCC6;BMP7;WNT4
10986,GO:0044782,0.990664115826278,0.0182704056742682,13,290,cilium organization,BP,CYLD;EHD1;FLNA;CC2D2A;FGFR1OP;WDR34;DCTN1;CLASP1;CEP41;KIF24;RILPL2;TUBB;TTLL5
3951,GO:0008652,0.990747015001866,0.0544979187271362,1,58,cellular amino acid biosynthetic process,BP,AASS
12124,GO:0048193,0.990764514156035,0.0177161465969728,14,309,Golgi vesicle transport,BP,MYO1B;LAMP1;ARFRP1;GOSR1;KIF23;SPTBN1;DCTN1;SNX8;ZW10;TAPBP;TRAPPC5;INSIG1;KIF22;VPS52
17607,GO:1901292,0.990917008422694,0.0268895191091951,4,129,nucleoside phosphate catabolic process,BP,NUP153;PGK1;NUP214;SMUG1
10357,GO:0043169,0.990957398350964,0.0112381799639369,200,2967,cation binding,MF,HEPHL1;IGFBP3;TRIM16;FTL;CRYAB;FTH1;MMP9;HDAC9;S100P;C1R;P3H2;CYP1B1;CYP24A1;DTX2;TRIM47;CYP1A1;PML;CYLD;PDLIM1;TRAF1;PCDH7;SOD2;FBN1;SH3RF2;TMPPE;MAT2A;TRIM56;BIRC3;MID1;TET3;B4GALT1;RSAD2;TRAF3;NUAK1;HRNR;TP53;SQSTM1;STEAP4;P4HA2;NOCT;CPA4;MPND;GNPTAB;LFNG;GALNT18;CDKN1A;HSPG2;ADAMTS9;CSRP1;EHD1;ZBED1;RING1;CARS2;PKMYT1;SCD;DST;CDKAL1;NUP153;TPM4;C9ORF3;QPCT;ZC3H12A;LCP1;TK1;CADPS2;KLF7;ZNF503;CHP1;COL27A1;ZNF142;ITGAV;GTPBP6;RNF19B;ZMAT2;ANXA8L1;FUS;MCM2;CSRP2;XAF1;AKAP8L;ZC3H7B;OSR2;TRIM22;ZFYVE27;APTX;ANXA8;DNPEP;NFX1;THBD;ZNF787;ZFP42;TRIM29;SF1;EGR1;SNAI2;CYP4B1;ZFP36L1;ARHGEF28;AKAP8;ADAM17;FEN1;NPAS2;ACO1;TRAF2;PRKCA;ZNF778;ZFP36L2;ZFC3H1;POLR1A;AJUBA;NOB1;POLA1;FHL2;ZNF407;COX5B;RNF115;UHRF1;ZNF234;NPNT;IL1A;ZNFX1;TNIP2;ZNF101;ZNF263;DOHH;RASGRP4;ZNF697;PRUNE2;COL5A2;SMAD7;TATDN2;MTA2;TRIP6;CAPNS1;MAZ;MICAL3;KCNIP3;KLF10;ZNF267;PCYT1A;GALNT2;STAC;FRAS1;OXSR1;GBE1;DTX4;ESR1;IKZF3;BRPF1;SCD5;ZNF772;ZNF512;GTF2E1;RBM4;ZNF703;RPTN;HERC2;ZNF365;ZNF132;TRMT1;KLF6;ZSWIM6;SMPD2;ACTN4;GLIS3;PHLPP1;ZNF34;CISD3;TKT;OVCH2;RNF7;CYP20A1;PHF5A;ZYX;DAG1;PDE6A;RNF185;TRAF4;CTDSP1;TNFAIP3;CYB561D2;BRIP1;RRM2;AARSD1;XPNPEP3;ATAD3C;ZC3H18;RNF144B;SRSF7;CREB5;NOL3;GCLC;SWAP70;FBLN2;PARP1;TP63;ZBTB12;C1S;TOP3A;APEX2
3245,GO:0006901,0.991299535682766,0.0517683510961846,1,60,vesicle coating,BP,TRAPPC5
3244,GO:0006900,0.991349771360457,0.0354606157355936,2,86,vesicle budding from membrane,BP,TRAPPC5;INSIG1
3235,GO:0006888,0.991498439189342,0.0215934624112303,6,170,ER to Golgi vesicle-mediated transport,BP,GOSR1;SPTBN1;DCTN1;ZW10;TRAPPC5;INSIG1
2545,GO:0005813,0.991580692700569,0.0144911272366084,22,440,centrosome,CC,CYLD;RELB;NLRC5;CCDC85B;KIF23;PLEKHA7;PDE4DIP;FGFR1OP;CEP95;PHAX;DCTN1;SLAIN2;TBCCD1;SMAD7;HNRNPU;CLASP1;CEP41;RUVBL2;CNTROB;POLR3H;RILPL2;TTLL5
2547,GO:0005815,0.991598744235806,0.0132558509661249,33,611,microtubule organizing center,CC,TAP1;CYLD;RELB;NLRC5;CCDC85B;KIF23;PLEKHA7;MTUS1;CCDC124;PDE4DIP;FGFR1OP;AJUBA;CEP95;PHAX;WDR34;DCTN1;SLAIN2;TBCCD1;SMAD7;KEAP1;SPECC1;HNRNPU;CLASP1;CEP41;RUVBL2;BLOC1S2;HERC2;CNTROB;ZNF365;KIF24;POLR3H;RILPL2;TTLL5
2519,GO:0005773,0.991797926542192,0.0130365893779931,32,599,vacuole,CC,FTL;FTH1;SDC4;PLBD1;B4GALT1;HRNR;SQSTM1;HSPG2;UBQLN2;LYN;LAMP1;VMP1;DRAM1;RNF19B;ADRB2;THBD;TRIM29;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;ARRDC3;TINAGL1;TMEM165;RAB27A;TUBB;TNFAIP3;CLTA;HSP90AB1
8659,GO:0034212,0.991954537897484,0.0485565088405962,1,60,peptide N-acetyltransferase activity,MF,BRPF1
4067,GO:0009117,0.992071559552508,0.0135472363991882,23,476,nucleotide metabolic process,BP,ADM;G6PD;PANK2;TJP2;NUP153;PGD;TYMS;TK1;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;DCXR;SMUG1;TKT;PDE6A;CD38;RRM2;CTPS1;PARP1
5677,GO:0016788,0.992363231857941,0.0124333825275018,29,555,hydrolase activity, acting on ester bonds,MF,DUSP14;USB1;PLBD1;NOCT;PTPN14;ZC3H12A;AEN;APTX;PPP1R3B;ABHD4;POP1;GPCPD1;FEN1;ISG20L2;NOB1;DNASE1;TATDN2;DUSP1;SMPD2;THEM4;PHLPP1;PDE6A;CTDSP1;AARSD1;PTPRB;DUSP8;POP4;CCL5;APEX2
10889,GO:0044429,0.992395441537085,0.0113344789672931,46,852,mitochondrial part,CC,CYP24A1;STARD13;SOD2;IKBKE;RSAD2;TP53;PANK2;LYN;RAB32;CARS2;TYMS;PARL;ABCF2;PUS1;GPER1;TXN2;LGALS3;ABCG2;REEP1;PRKCA;AASS;COX5B;ACSL1;MRPS12;MRPS24;ERAL1;MTFP1;TRUB2;MRPL20;MRPL33;CPT1A;BCS1L;HERC2;BCL2L2;CS;CHCHD6;THEM4;TOMM40;RNF185;MRPS2;HSD17B10;SLC25A22;RNF144B;SLC25A44;LRRC59;RPUSD4
3456,GO:0007268,0.992446972957896,0.015021753055866,13,294,chemical synaptic transmission,BP,NQO1;EDN1;SQSTM1;BAIAP2;CADPS2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;HSPA8;CD38
16938,GO:0098916,0.992446972957896,0.015021753055866,13,294,anterograde trans-synaptic signaling,BP,NQO1;EDN1;SQSTM1;BAIAP2;CADPS2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;HSPA8;CD38
5474,GO:0016407,0.992576626448621,0.0311041032186677,2,88,acetyltransferase activity,MF,NAT10;BRPF1
4024,GO:0009056,0.992613974122434,0.00962126926240853,125,1982,catabolic process,BP,NRG1;MMP9;ODC1;CYP1B1;CYP24A1;CYP1A1;PML;CYLD;HSPB1;SDC4;PLBD1;DAPK3;TET3;MGAM;SPSB1;TP53;SQSTM1;NOCT;IRS1;HSPG2;UBQLN2;ADAMTS9;TNF;COL12A1;ENC1;VMP1;NUP153;BACE2;COL4A1;PSMB9;CLN6;C9ORF3;UBE2C;ZC3H12A;FLNA;ACAA1;CHP1;UBE4B;CDK4;DRAM1;RNF19B;ADRB2;PABPC4;PGK1;USP36;TRIM22;PPP1R3B;PSME2;ABHD4;CTIF;ABTB2;POP1;PRPF19;CYP4B1;ZFP36L1;RPLP2;GPCPD1;DKC1;FEN1;SNX12;KCTD10;IRS2;RPLP1;TRAF2;PRKCA;ZFP36L2;USP43;AASS;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;SNRNP70;DNASE1;RNF115;COL5A3;UHRF1;COPS3;PRUNE2;ACSL1;COL5A2;NUP214;SMAD7;TATDN2;SUPT5H;YWHAH;KEAP1;HNRNPU;CAPNS1;UBE2J2;TRIB1;ANAPC15;ATG101;RPL27A;HSPBP1;HSPA8;USP31;CPT1A;DCXR;CHMP4B;HERC2;QDPR;EDC4;SMPD2;METTL16;SMUG1;RNF7;TOMM40;TINAGL1;RNF185;COL4A4;DHX34;TNFAIP3;PSMC3;EFNA1;HSD17B10;RNF144B;POLR2G;CLTA;SNF8;GCLC;HSP90AB1;MAGOH;SH3BP4
284,GO:0000786,0.992674481307455,0.044518747794307,1,84,nucleosome,CC,MPHOSPH8
12137,GO:0048232,0.992955162452226,0.0144170792355103,12,282,male gamete generation,BP,BIRC3;PANK2;TAF4B;NSUN2;CCR6;HERC2;BCL2L2;GPX4;SLC4A2;BRIP1;TTLL5;TP63
6572,GO:0022037,0.9929700725675,0.043437082369772,1,61,metencephalon development,BP,ZNF365
2619,GO:0005930,0.992988710154877,0.0433181749727604,1,62,axoneme,CC,WDR34
17056,GO:0099537,0.99308010929679,0.0138524817797566,13,296,trans-synaptic signaling,BP,NQO1;EDN1;SQSTM1;BAIAP2;CADPS2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;HSPA8;CD38
2512,GO:0005765,0.993265252787554,0.0135076049996066,13,298,lysosomal membrane,CC,B4GALT1;LAMP1;DRAM1;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;TMEM165;CLTA;HSP90AB1
16902,GO:0098852,0.993265252787554,0.0135076049996066,13,298,lytic vacuole membrane,CC,B4GALT1;LAMP1;DRAM1;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;TMEM165;CLTA;HSP90AB1
3154,GO:0006753,0.993336635930993,0.0115043014988372,23,481,nucleoside phosphate metabolic process,BP,ADM;G6PD;PANK2;TJP2;NUP153;PGD;TYMS;TK1;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;DCXR;SMUG1;TKT;PDE6A;CD38;RRM2;CTPS1;PARP1
17055,GO:0099536,0.993377791381678,0.0132996515107897,13,297,synaptic signaling,BP,NQO1;EDN1;SQSTM1;BAIAP2;CADPS2;ADRB2;GPER1;SRF;OXTR;YWHAH;PPP1R9B;HSPA8;CD38
10802,GO:0044281,0.993521246369561,0.00878795372205307,91,1503,small molecule metabolic process,BP,IGFBP3;ODC1;CYP1B1;CYP24A1;C1QTNF1;ADM;NQO1;CYP1A1;FADS3;UGT1A6;PTGES;EDN1;TXNRD1;MAT2A;B4GALT1;G6PD;NFE2L1;PANK2;NFKB1;IRS1;TJP2;TNF;CARS2;SCD;NUP153;PSMB9;LSS;SLC7A5;CLN6;SLC16A9;PGD;TYMS;TK1;ACAA1;EPHA2;CHP1;HMGCS1;BMP2;PMM2;STAT5A;SLC5A6;PGK1;EBP;DHCR7;PPP1R3B;PSME2;GPER1;TXN2;EGR1;SNAI2;DHFR;IRS2;ACO1;ABCG2;IL15;AKR1C2;SYK;SLC7A2;PPIP5K1;PDGFB;AASS;COX5B;PRUNE2;ACSL1;NUP214;CHST3;TPST1;HSPA8;CPT1A;DCXR;SCD5;INSIG1;QDPR;CS;THEM4;SMUG1;TKT;UAP1L1;PDE6A;GPX4;WNT4;AKR1C1;CD38;PSMC3;RRM2;AARSD1;CTPS1;HSD17B10;GCLC;PARP1;FADS1
16398,GO:0097014,0.993544564462174,0.0404428729447865,1,63,ciliary plasm,CC,WDR34
11151,GO:0045202,0.993927785116414,0.0102540855010218,26,511,synapse,CC,CRYAB;NRG1;MAP2;DBNDD2;LYN;LAMP1;BAIAP2;FGFR2;FOSL1;CADPS2;FUS;GPER1;DOCK10;SPTBN1;MYH9;SDK1;ROR1;ENAH;PPP1R9B;KCNIP3;HSPA8;EFNB1;ELK1;DAG1;RAB27A;CLTA
6202,GO:0019693,0.994015244191744,0.0112191464821246,17,384,ribose phosphate metabolic process,BP,ADM;G6PD;PANK2;TJP2;NUP153;PGD;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;TKT;PDE6A;CTPS1;PARP1
11040,GO:0045017,0.99424400889838,0.0136666493206805,8,212,glycerolipid biosynthetic process,BP,IRS1;FGFR2;IRS2;AJUBA;PDGFB;PCYT1A;PIGM;DPM3
5399,GO:0016236,0.994439326104986,0.011901792853445,11,270,macroautophagy,BP,SQSTM1;UBQLN2;VMP1;ADRB2;NSFL1C;SUPT5H;CAPNS1;ATG101;CHMP4B;TOMM40;SNF8
6932,GO:0030534,0.994458923523687,0.0355989429685074,1,65,adult behavior,BP,SDK1
7568,GO:0031929,0.994890930291059,0.0225406702797022,2,92,TOR signaling,BP,TELO2;SH3BP4
10184,GO:0042775,0.994917175683299,0.0329302368596437,1,79,mitochondrial ATP synthesis coupled electron transport,BP,COX5B
5846,GO:0017137,0.995175509768827,0.0139379672488806,5,158,Rab GTPase binding,MF,EHD1;RUNDC1;TRAPPC5;SGSM1;VPS52
3366,GO:0007127,0.995263848234585,0.0312056073111957,1,67,meiosis I,BP,BRIP1
10182,GO:0042773,0.995320293806984,0.0307234604142506,1,80,ATP synthesis coupled electron transport,BP,COX5B
2520,GO:0005774,0.995420882919781,0.00905227615005381,15,342,vacuolar membrane,CC,B4GALT1;LAMP1;VMP1;DRAM1;THBD;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;TMEM165;CLTA;HSP90AB1
11203,GO:0045333,0.995453883920253,0.0145000173044167,4,154,cellular respiration,BP,PANK2;ACO1;COX5B;CS
18217,GO:1903008,0.995654361615232,0.0195739021425275,2,96,organelle disassembly,BP,SQSTM1;USP36
4070,GO:0009123,0.995775834848166,0.00951492187824006,10,270,nucleoside monophosphate metabolic process,BP,TJP2;NUP153;TYMS;TK1;PGK1;COX5B;NUP214;HSPA8;PDE6A;PARP1
11004,GO:0044815,0.995891750769331,0.0274499845254625,1,91,DNA packaging complex,CC,MPHOSPH8
14504,GO:0061982,0.995985356218646,0.027147641470536,1,69,meiosis I cell cycle process,BP,BRIP1
13515,GO:0055086,0.996204241115784,0.00657086545667972,26,546,nucleobase-containing small molecule metabolic process,BP,ADM;TXNRD1;G6PD;PANK2;TJP2;NUP153;PGD;TYMS;TK1;EPHA2;PMM2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;DCXR;SMUG1;TKT;UAP1L1;PDE6A;CD38;RRM2;CTPS1;PARP1
2716,GO:0006091,0.99626020347366,0.00748560316381333,15,363,generation of precursor metabolites and energy,BP,TXNRD1;P4HA2;PANK2;IRS1;NUP153;PGK1;PPP1R3B;IRS2;ACO1;AASS;COX5B;NUP214;GBE1;QDPR;CS
10803,GO:0044282,0.996891282771541,0.00675149251644458,12,301,small molecule catabolic process,BP,CYP24A1;CYP1A1;IRS1;ACAA1;CHP1;PGK1;IRS2;AASS;CPT1A;DCXR;QDPR;HSD17B10
3463,GO:0007276,0.997280203610726,0.00545568856385888,16,372,gamete generation,BP,INHBA;BIRC3;PANK2;TAF4B;FOSL1;FANCC;NSUN2;CCR6;HERC2;BCL2L2;GPX4;WNT4;SLC4A2;BRIP1;TTLL5;TP63
10911,GO:0044456,0.997286916779751,0.00518515285215841,19,420,synapse part,CC,CRYAB;MAP2;DBNDD2;LYN;LAMP1;BAIAP2;FOSL1;CADPS2;FUS;GPER1;DOCK10;SPTBN1;ROR1;PPP1R9B;KCNIP3;HSPA8;ELK1;DAG1;CLTA
11666,GO:0046434,0.997480915909364,0.00774046396814469,5,171,organophosphate catabolic process,BP,NUP153;PGK1;GPCPD1;NUP214;SMUG1
2618,GO:0005929,0.997601258635112,0.0050491760340184,14,339,cilium,CC,CYLD;SQSTM1;EHD1;CC2D2A;WDR34;DCTN1;CEP41;CCR6;PHLPP1;KIF22;PDE6A;RAB27A;RILPL2;TTLL5
11520,GO:0046034,0.99787375130947,0.00612714015339292,6,207,ATP metabolic process,BP,NUP153;PGK1;COX5B;NUP214;HSPA8;PARP1
4073,GO:0009126,0.997959445697264,0.00526254200082355,8,247,purine nucleoside monophosphate metabolic process,BP,TJP2;NUP153;PGK1;COX5B;NUP214;HSPA8;PDE6A;PARP1
4112,GO:0009167,0.997959445697264,0.00526254200082355,8,247,purine ribonucleoside monophosphate metabolic process,BP,TJP2;NUP153;PGK1;COX5B;NUP214;HSPA8;PDE6A;PARP1
8290,GO:0033108,0.998127765952904,0.0140990091644177,1,89,mitochondrial respiratory chain complex assembly,BP,BCS1L
10787,GO:0044248,0.998262439429472,0.00240481995470691,107,1796,cellular catabolic process,BP,CYP1B1;CYP24A1;CYP1A1;PML;CYLD;HSPB1;DAPK3;TET3;MGAM;SPSB1;TP53;SQSTM1;NOCT;IRS1;UBQLN2;ADAMTS9;TNF;ENC1;VMP1;NUP153;PSMB9;CLN6;C9ORF3;UBE2C;ZC3H12A;ACAA1;CHP1;UBE4B;DRAM1;RNF19B;ADRB2;PABPC4;PGK1;USP36;TRIM22;PPP1R3B;PSME2;CTIF;ABTB2;POP1;PRPF19;CYP4B1;ZFP36L1;RPLP2;GPCPD1;DKC1;FEN1;KCTD10;IRS2;RPLP1;PRKCA;ZFP36L2;USP43;AASS;RPS2;PTTG1IP;RPS9;NSFL1C;NEDD4L;SNRNP70;DNASE1;RNF115;UHRF1;COPS3;PRUNE2;ACSL1;NUP214;SMAD7;TATDN2;SUPT5H;KEAP1;HNRNPU;CAPNS1;UBE2J2;TRIB1;ANAPC15;ATG101;RPL27A;HSPBP1;HSPA8;USP31;CPT1A;DCXR;CHMP4B;HERC2;QDPR;EDC4;SMPD2;METTL16;SMUG1;RNF7;TOMM40;TINAGL1;RNF185;DHX34;TNFAIP3;PSMC3;EFNA1;HSD17B10;RNF144B;POLR2G;CLTA;SNF8;GCLC;HSP90AB1;MAGOH;SH3BP4
6309,GO:0019953,0.998303869304763,0.00332777586096619,19,435,sexual reproduction,BP,INHBA;BIRC3;B4GALT1;PANK2;TAF4B;FOSL1;FANCC;NSUN2;OXTR;CCR6;HERC2;BCL2L2;UBAP2L;GPX4;WNT4;SLC4A2;BRIP1;TTLL5;TP63
10894,GO:0044437,0.998363756285816,0.0031705402916085,20,452,vacuolar part,CC,FTL;SDC4;B4GALT1;HRNR;HSPG2;LAMP1;VMP1;DRAM1;THBD;SPPL2A;GLIPR1;BORCS7;M6PR;TGFBRAP1;HSPA8;BLOC1S2;TMEM165;TUBB;CLTA;HSP90AB1
17036,GO:0099504,0.998402589216072,0.0123532269524469,1,79,synaptic vesicle cycle,BP,CADPS2
6633,GO:0022904,0.998409229223453,0.0122390523510937,1,94,respiratory electron transport chain,BP,COX5B
2317,GO:0005319,0.9984264944523,0.0121888129500986,1,80,lipid transporter activity,MF,ABCG2
4087,GO:0009141,0.99858930389303,0.00373958023193179,8,256,nucleoside triphosphate metabolic process,BP,NUP153;TYMS;PGK1;COX5B;NUP214;HSPA8;CTPS1;PARP1
2738,GO:0006119,0.998657888603105,0.0105653882826175,1,96,oxidative phosphorylation,BP,COX5B
4138,GO:0009199,0.998771782959792,0.00347026742847425,7,238,ribonucleoside triphosphate metabolic process,BP,NUP153;PGK1;COX5B;NUP214;HSPA8;CTPS1;PARP1
4182,GO:0009259,0.998822663467738,0.00258663222907459,14,370,ribonucleotide metabolic process,BP,ADM;PANK2;TJP2;NUP153;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;PDE6A;CTPS1;PARP1
4106,GO:0009161,0.99886700435311,0.00305230402311899,8,258,ribonucleoside monophosphate metabolic process,BP,TJP2;NUP153;PGK1;COX5B;NUP214;HSPA8;PDE6A;PARP1
6189,GO:0019637,0.998894374341026,0.00180984625611961,43,848,organophosphate metabolic process,BP,NRG1;ADM;PLBD1;G6PD;PANK2;IRS1;TJP2;LYN;FGFR2;NUP153;PGD;TYMS;TK1;EPHA2;HMGCS1;PGK1;ABHD4;GPER1;GPCPD1;IRS2;AJUBA;PPIP5K1;PDGFB;COX5B;NUP214;TPST1;LPCAT3;PCYT1A;HSPA8;PIGM;ESR1;DCXR;SMPD2;SMUG1;TKT;PDE6A;GPX4;DPM3;CD38;RRM2;CTPS1;PARP1;FADS1
4096,GO:0009150,0.999021628368448,0.00222746306788592,13,356,purine ribonucleotide metabolic process,BP,ADM;PANK2;TJP2;NUP153;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;PDE6A;PARP1
15821,GO:0072521,0.999031766097369,0.00210391590962731,15,393,purine-containing compound metabolic process,BP,ADM;PANK2;TJP2;NUP153;SLC16A9;EPHA2;PGK1;GPER1;ABCG2;COX5B;NUP214;TPST1;HSPA8;PDE6A;PARP1
2210,GO:0005096,0.999081865634587,0.0026565462195481,7,225,GTPase activator activity,MF,STARD13;SIPA1L3;ERRFI1;CDC42EP2;RUNDC1;JUN;SGSM1
11156,GO:0045211,0.999122248973026,0.00477366981386337,2,115,postsynaptic membrane,CC,CADPS2;DAG1
7009,GO:0030695,0.999259548910769,0.00205889562791129,8,249,GTPase regulator activity,MF,STARD13;SIPA1L3;ERRFI1;CDC42EP2;RUNDC1;JUN;SGSM1;SH3BP4
2854,GO:0006342,0.999356263019382,0.00556062204107325,1,107,chromatin silencing,BP,UHRF1
4144,GO:0009205,0.999468377805899,0.00170851023070553,6,232,purine ribonucleoside triphosphate metabolic process,BP,NUP153;PGK1;COX5B;NUP214;HSPA8;PARP1
2753,GO:0006163,0.999529483492297,0.00111757711174688,13,372,purine nucleotide metabolic process,BP,ADM;PANK2;TJP2;NUP153;EPHA2;PGK1;GPER1;COX5B;NUP214;TPST1;HSPA8;PDE6A;PARP1
4090,GO:0009144,0.999640413544007,0.00118862143065249,6,239,purine nucleoside triphosphate metabolic process,BP,NUP153;PGK1;COX5B;NUP214;HSPA8;PARP1
137,GO:0000287,0.999662132319085,0.00159819100596334,3,156,magnesium ion binding,MF,S100P;OXSR1;GCLC
11410,GO:0045814,0.999797794237258,0.00199269409868359,1,121,negative regulation of gene expression, epigenetic,BP,UHRF1
1484,GO:0003796,0.999999999942034,0.927721971925209,0,1,lysozyme activity,MF,
8183,GO:0032919,0.999999999948298,0.938110962065967,0,1,spermine acetylation,BP,
8184,GO:0032920,0.999999999948298,0.938110962065967,0,1,putrescine acetylation,BP,
11602,GO:0046204,0.999999999948298,0.938110962065967,0,1,nor-spermidine metabolic process,BP,
12466,GO:0050313,0.999999999948298,0.938110962065967,0,1,sulfur dioxygenase activity,MF,
1611,GO:0004034,0.999999999952324,0.92123634676287,0,1,aldose 1-epimerase activity,MF,
9400,GO:0035945,0.999999999952324,0.92123634676287,0,1,mitochondrial ncRNA surveillance,BP,
9401,GO:0035946,0.999999999952324,0.92123634676287,0,1,mitochondrial mRNA surveillance,BP,
15066,GO:0071026,0.999999999952324,0.92123634676287,0,1,cytoplasmic RNA surveillance,BP,
20135,GO:2000827,0.999999999952324,0.92123634676287,0,1,mitochondrial RNA surveillance,BP,
2359,GO:0005459,0.999999999952338,0.863373326724782,0,2,UDP-galactose transmembrane transporter activity,MF,
15750,GO:0072334,0.999999999952338,0.863373326724782,0,2,UDP-galactose transmembrane transport,BP,
14600,GO:0070159,0.999999999953602,0.921367374178143,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14480,GO:0061880,0.999999999953695,0.925294587700762,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14481,GO:0061881,0.999999999953695,0.925294587700762,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
16788,GO:0098619,0.999999999953746,0.923429716185752,0,1,selenocysteine-tRNA ligase activity,MF,
108,GO:0000224,0.999999999953782,0.921191632889678,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
581,GO:0001733,0.999999999953782,0.921191632889678,0,1,galactosylceramide sulfotransferase activity,MF,
12545,GO:0050694,0.999999999953782,0.921191632889678,0,1,galactose 3-O-sulfotransferase activity,MF,
12546,GO:0050698,0.999999999953782,0.921191632889678,0,1,proteoglycan sulfotransferase activity,MF,
15038,GO:0070981,0.999999999953784,0.921473693039351,0,1,L-asparagine biosynthetic process,BP,
15039,GO:0070982,0.999999999953784,0.921473693039351,0,1,L-asparagine metabolic process,BP,
11121,GO:0045153,0.999999999954207,0.932919699640186,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
19225,GO:1905349,0.999999999954923,0.933143607786785,0,1,ciliary transition zone assembly,BP,
16523,GO:0097231,0.999999999955102,0.925138906719765,0,1,cell motility in response to calcium ion,BP,
19595,GO:1990716,0.999999999955102,0.925138906719765,0,1,axonemal central apparatus,CC,
12162,GO:0048270,0.999999999955493,0.922295115668396,0,1,methionine adenosyltransferase regulator activity,MF,
2761,GO:0006172,0.999999999955646,0.921573966696946,0,1,ADP biosynthetic process,BP,
16519,GO:0097226,0.999999999955646,0.921573966696946,0,1,sperm mitochondrial sheath,CC,
10073,GO:0042568,0.999999999956006,0.93808842887397,0,1,insulin-like growth factor binary complex,CC,
15064,GO:0071021,0.999999999956014,0.92521627715542,0,1,U2-type post-spliceosomal complex,CC,
19668,GO:1990930,0.999999999956106,0.92688806192769,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
7569,GO:0031930,0.99999999995636,0.928522107534397,0,1,mitochondria-nucleus signaling pathway,BP,
1838,GO:0004493,0.999999999956367,0.940325969729911,0,1,methylmalonyl-CoA epimerase activity,MF,
11702,GO:0046491,0.999999999956367,0.940325969729911,0,1,L-methylmalonyl-CoA metabolic process,BP,
15856,GO:0072572,0.999999999956405,0.922051755869369,0,1,poly-ADP-D-ribose binding,MF,
17138,GO:0102339,0.999999999956597,0.921188935676938,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17139,GO:0102340,0.999999999956597,0.921188935676938,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17140,GO:0102341,0.999999999956597,0.921188935676938,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17141,GO:0102342,0.999999999956597,0.921188935676938,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
15570,GO:0072019,0.999999999956746,0.922055883406219,0,1,proximal convoluted tubule development,BP,
15698,GO:0072229,0.999999999956746,0.922055883406219,0,1,metanephric proximal convoluted tubule development,BP,
18139,GO:1902858,0.999999999956746,0.922055883406219,0,1,propionyl-CoA metabolic process,BP,
18140,GO:1902860,0.999999999956746,0.922055883406219,0,1,propionyl-CoA biosynthetic process,BP,
1718,GO:0004310,0.999999999956926,0.922190031592937,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
13295,GO:0051996,0.999999999956926,0.922190031592937,0,1,squalene synthase activity,MF,
9433,GO:0036004,0.999999999957055,0.932496537674973,0,1,GAF domain binding,MF,
748,GO:0001978,0.999999999957283,0.921887457205652,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
749,GO:0001983,0.999999999957283,0.921887457205652,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
750,GO:0001985,0.999999999957283,0.921887457205652,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
755,GO:0001994,0.999999999957283,0.921887457205652,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
757,GO:0001997,0.999999999957283,0.921887457205652,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1289,GO:0003099,0.999999999957283,0.921887457205652,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2131,GO:0004936,0.999999999957283,0.921887457205652,0,1,alpha-adrenergic receptor activity,MF,
2132,GO:0004937,0.999999999957283,0.921887457205652,0,1,alpha1-adrenergic receptor activity,MF,
18666,GO:1903995,0.999999999957283,0.921887457205652,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18667,GO:1903997,0.999999999957283,0.921887457205652,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
9702,GO:0038101,0.999999999957382,0.924997725140954,0,1,sequestering of nodal from receptor via nodal binding,BP,
17383,GO:1900108,0.999999999957382,0.924997725140954,0,1,negative regulation of nodal signaling pathway,BP,
17410,GO:1900146,0.999999999957382,0.924997725140954,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17425,GO:1900176,0.999999999957382,0.924997725140954,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
3609,GO:0008048,0.999999999957765,0.921618436195888,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3119,GO:0006696,0.999999999957823,0.850304668647291,0,2,ergosterol biosynthetic process,BP,
3699,GO:0008204,0.999999999957823,0.850304668647291,0,2,ergosterol metabolic process,BP,
766,GO:0002017,0.999999999957845,0.923592741559242,0,1,regulation of blood volume by renal aldosterone,BP,
3639,GO:0008108,0.999999999958019,0.930573882812398,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5316,GO:0016034,0.999999999958019,0.930573882812398,0,1,maleylacetoacetate isomerase activity,MF,
17116,GO:0101030,0.999999999958019,0.930573882812398,0,1,tRNA-guanine transglycosylation,BP,
438,GO:0001172,0.999999999958136,0.880755556790544,0,2,transcription, RNA-templated,BP,
1564,GO:0003968,0.999999999958136,0.880755556790544,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
7346,GO:0031379,0.999999999958136,0.880755556790544,0,2,RNA-directed RNA polymerase complex,CC,
17476,GO:1900369,0.999999999958136,0.880755556790544,0,2,negative regulation of RNA interference,BP,
2221,GO:0005124,0.999999999958238,0.921335505615337,0,1,scavenger receptor binding,MF,
5424,GO:0016277,0.999999999958238,0.921335505615337,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17774,GO:1901804,0.999999999958238,0.921335505615337,0,1,beta-glucoside metabolic process,BP,
17775,GO:1901805,0.999999999958238,0.921335505615337,0,1,beta-glucoside catabolic process,BP,
18848,GO:1904457,0.999999999958238,0.921335505615337,0,1,positive regulation of neuronal action potential,BP,
7298,GO:0031296,0.99999999995833,0.933379212519138,0,1,B cell costimulation,BP,
12439,GO:0050080,0.999999999958331,0.921850121368503,0,1,malonyl-CoA decarboxylase activity,MF,
16468,GO:0097145,0.999999999958331,0.921850121368503,0,1,BAK complex,CC,
20302,GO:2001294,0.999999999958331,0.921850121368503,0,1,malonyl-CoA catabolic process,BP,
5429,GO:0016286,0.999999999958358,0.921214070565386,0,1,small conductance calcium-activated potassium channel activity,MF,
8179,GO:0032915,0.999999999958524,0.922145432445142,0,1,positive regulation of transforming growth factor beta2 production,BP,
2329,GO:0005344,0.999999999958957,0.92307769739469,0,1,oxygen carrier activity,MF,
12048,GO:0047888,0.999999999958957,0.92307769739469,0,1,fatty acid peroxidase activity,MF,
1066,GO:0002625,0.999999999959019,0.923104981587186,0,1,regulation of T cell antigen processing and presentation,BP,
1067,GO:0002626,0.999999999959019,0.923104981587186,0,1,negative regulation of T cell antigen processing and presentation,BP,
4397,GO:0010106,0.999999999959019,0.923104981587186,0,1,cellular response to iron ion starvation,BP,
18774,GO:1904282,0.999999999959019,0.923104981587186,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18775,GO:1904283,0.999999999959019,0.923104981587186,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20241,GO:2001186,0.999999999959019,0.923104981587186,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
15034,GO:0070976,0.99999999995911,0.921132286010251,0,1,TIR domain binding,MF,
7774,GO:0032298,0.999999999959154,0.921690551607499,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16460,GO:0097123,0.999999999959154,0.921690551607499,0,1,cyclin A1-CDK2 complex,CC,
4979,GO:0015098,0.999999999959194,0.923448733959317,0,1,molybdate ion transmembrane transporter activity,MF,
5152,GO:0015689,0.999999999959194,0.923448733959317,0,1,molybdate ion transport,BP,
10225,GO:0042903,0.999999999959262,0.850286538181258,0,2,tubulin deacetylase activity,MF,
2236,GO:0005142,0.999999999959299,0.921421080280349,0,1,interleukin-11 receptor binding,MF,
5843,GO:0017133,0.999999999959299,0.921421080280349,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10660,GO:0043783,0.999999999959299,0.921421080280349,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11174,GO:0045251,0.999999999959299,0.921421080280349,0,1,electron transfer flavoprotein complex,CC,
3813,GO:0008404,0.999999999959446,0.923755017078099,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3814,GO:0008405,0.999999999959446,0.923755017078099,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15374,GO:0071614,0.999999999959446,0.923755017078099,0,1,linoleic acid epoxygenase activity,MF,
13586,GO:0060053,0.999999999959564,0.848687573187661,0,2,neurofilament cytoskeleton,CC,
3558,GO:0007598,0.999999999959597,0.921424922704904,0,1,blood coagulation, extrinsic pathway,BP,
17580,GO:1901202,0.999999999959597,0.921424922704904,0,1,negative regulation of extracellular matrix assembly,BP,
18386,GO:1903394,0.999999999959597,0.921424922704904,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
2079,GO:0004833,0.999999999959759,0.926915328417916,0,1,tryptophan 2,3-dioxygenase activity,MF,
8525,GO:0033754,0.999999999959759,0.926915328417916,0,1,indoleamine 2,3-dioxygenase activity,MF,
8684,GO:0034275,0.999999999959759,0.926915328417916,0,1,kynurenic acid metabolic process,BP,
8685,GO:0034276,0.999999999959759,0.926915328417916,0,1,kynurenic acid biosynthetic process,BP,
9535,GO:0036269,0.999999999959759,0.926915328417916,0,1,swimming behavior,BP,
9012,GO:0035175,0.999999999959899,0.925205166594815,0,1,histone kinase activity (H3-S10 specific),MF,
15761,GO:0072354,0.999999999959899,0.925205166594815,0,1,histone kinase activity (H3-T3 specific),MF,
15762,GO:0072355,0.999999999959899,0.925205166594815,0,1,histone H3-T3 phosphorylation,BP,
1758,GO:0004361,0.999999999959902,0.925183003073247,0,1,glutaryl-CoA dehydrogenase activity,MF,
2265,GO:0005183,0.999999999959902,0.925183003073247,0,1,gonadotropin hormone-releasing hormone activity,MF,
7429,GO:0031530,0.999999999959902,0.925183003073247,0,1,gonadotropin-releasing hormone receptor binding,MF,
19421,GO:1990008,0.999999999959902,0.925183003073247,0,1,neurosecretory vesicle,CC,
18917,GO:1904631,0.999999999960072,0.921696489815204,0,1,response to glucoside,BP,
11722,GO:0046525,0.999999999960195,0.925030015421446,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
5974,GO:0018455,0.999999999960441,0.93163417559119,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19505,GO:1990384,0.999999999960441,0.93163417559119,0,1,hyaloid vascular plexus regression,BP,
461,GO:0001401,0.999999999960441,0.851692086980504,0,2,mitochondrial sorting and assembly machinery complex,CC,
5949,GO:0018293,0.999999999960466,0.933016823917138,0,1,protein-FAD linkage,BP,
6941,GO:0030549,0.999999999960467,0.934138307873483,0,1,acetylcholine receptor activator activity,MF,
9929,GO:0042275,0.99999999996056,0.927634401429495,0,1,error-free postreplication DNA repair,BP,
758,GO:0001998,0.999999999960705,0.923295855006808,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
778,GO:0002034,0.999999999960705,0.923295855006808,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1278,GO:0003072,0.999999999960705,0.923295855006808,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18512,GO:1903673,0.999999999960705,0.923295855006808,0,1,mitotic cleavage furrow formation,BP,
18941,GO:1904695,0.999999999960705,0.923295855006808,0,1,positive regulation of vascular smooth muscle contraction,BP,
1188,GO:0002835,0.999999999960717,0.848802053245058,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002838,0.999999999960717,0.848802053245058,0,2,negative regulation of immune response to tumor cell,BP,
1196,GO:0002856,0.999999999960717,0.848802053245058,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002859,0.999999999960717,0.848802053245058,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1036,GO:0002545,0.999999999960755,0.923576892937916,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1211,GO:0002880,0.999999999960755,0.923576892937916,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1212,GO:0002882,0.999999999960755,0.923576892937916,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1535,GO:0003920,0.999999999960755,0.923576892937916,0,1,GMP reductase activity,MF,
5289,GO:0015950,0.999999999960755,0.923576892937916,0,1,purine nucleotide interconversion,BP,
5290,GO:0015951,0.999999999960755,0.923576892937916,0,1,purine ribonucleotide interconversion,BP,
5612,GO:0016657,0.999999999960755,0.923576892937916,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18038,GO:1902560,0.999999999960755,0.923576892937916,0,1,GMP reductase complex,CC,
2487,GO:0005731,0.999999999960829,0.925116974054848,0,1,nucleolus organizer region,CC,
3348,GO:0007072,0.999999999960829,0.925116974054848,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7082,GO:0030874,0.999999999960829,0.925116974054848,0,1,nucleolar chromatin,CC,
16580,GO:0097372,0.999999999960829,0.925116974054848,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
2688,GO:0006050,0.999999999960843,0.926847295592825,0,1,mannosamine metabolic process,BP,
2689,GO:0006051,0.999999999960843,0.926847295592825,0,1,N-acetylmannosamine metabolic process,BP,
11109,GO:0045127,0.999999999960843,0.926847295592825,0,1,N-acetylglucosamine kinase activity,MF,
8412,GO:0033385,0.999999999960864,0.92112916314782,0,1,geranylgeranyl diphosphate metabolic process,BP,
8413,GO:0033386,0.999999999960864,0.92112916314782,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9255,GO:0035659,0.999999999960912,0.925171950132942,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
11128,GO:0045167,0.999999999960912,0.925171950132942,0,1,asymmetric protein localization involved in cell fate determination,BP,
14733,GO:0070390,0.999999999960912,0.925171950132942,0,1,transcription export complex 2,CC,
19043,GO:1904889,0.999999999960912,0.925171950132942,0,1,regulation of excitatory synapse assembly,BP,
19044,GO:1904891,0.999999999960912,0.925171950132942,0,1,positive regulation of excitatory synapse assembly,BP,
15192,GO:0071332,0.999999999960934,0.851334340636683,0,2,cellular response to fructose stimulus,BP,
18816,GO:1904383,0.999999999960974,0.921979543309595,0,1,response to sodium phosphate,BP,
18897,GO:1904585,0.999999999960974,0.921979543309595,0,1,response to putrescine,BP,
18898,GO:1904586,0.999999999960974,0.921979543309595,0,1,cellular response to putrescine,BP,
19636,GO:1990828,0.999999999960974,0.921979543309595,0,1,hepatocyte dedifferentiation,BP,
3586,GO:0007634,0.99999999996105,0.921284289629483,0,1,optokinetic behavior,BP,
14077,GO:0060876,0.99999999996105,0.921284289629483,0,1,semicircular canal formation,BP,
7557,GO:0031893,0.999999999961068,0.921817416447991,0,1,vasopressin receptor binding,MF,
7558,GO:0031896,0.999999999961068,0.921817416447991,0,1,V2 vasopressin receptor binding,MF,
15957,GO:0075519,0.999999999961103,0.944554507302874,0,1,microtubule-dependent intracellular transport of viral material,BP,
15958,GO:0075521,0.999999999961103,0.944554507302874,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15962,GO:0075606,0.999999999961103,0.944554507302874,0,1,transport of viral material towards nucleus,BP,
16522,GO:0097229,0.999999999961253,0.930714568102817,0,1,sperm end piece,CC,
10629,GO:0043626,0.99999999996129,0.930582646927085,0,1,PCNA complex,CC,
10997,GO:0044796,0.99999999996129,0.930582646927085,0,1,DNA polymerase processivity factor complex,CC,
1536,GO:0003921,0.999999999961342,0.921256080703156,0,1,GMP synthase activity,MF,
1537,GO:0003922,0.999999999961342,0.921256080703156,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
11980,GO:0047277,0.999999999961445,0.923084494689695,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
3134,GO:0006722,0.999999999961489,0.92133173441685,0,1,triterpenoid metabolic process,BP,
6215,GO:0019742,0.999999999961489,0.92133173441685,0,1,pentacyclic triterpenoid metabolic process,BP,
19059,GO:1904924,0.999999999961489,0.92133173441685,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19234,GO:1905370,0.999999999961489,0.92133173441685,0,1,serine-type endopeptidase complex,CC,
4017,GO:0009020,0.999999999961517,0.923017230700859,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13390,GO:0052666,0.999999999961517,0.923017230700859,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17207,GO:0106050,0.999999999961517,0.923017230700859,0,1,tRNA 2'-O-methyltransferase activity,MF,
19913,GO:2000409,0.999999999961545,0.92383876845168,0,1,positive regulation of T cell extravasation,BP,
19931,GO:2000451,0.999999999961545,0.92383876845168,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19933,GO:2000454,0.999999999961545,0.92383876845168,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
12031,GO:0047708,0.999999999961594,0.922406928637003,0,1,biotinidase activity,MF,
13793,GO:0060380,0.999999999961594,0.922406928637003,0,1,regulation of single-stranded telomeric DNA binding,BP,
13794,GO:0060381,0.999999999961594,0.922406928637003,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
12017,GO:0047578,0.999999999961629,0.921270891855568,0,1,4-hydroxyglutamate transaminase activity,MF,
1692,GO:0004167,0.999999999961831,0.896748847701735,0,2,dopachrome isomerase activity,MF,
5723,GO:0016862,0.999999999961831,0.896748847701735,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12450,GO:0050178,0.999999999961831,0.896748847701735,0,2,phenylpyruvate tautomerase activity,MF,
1877,GO:0004556,0.999999999961853,0.921882046359095,0,1,alpha-amylase activity,MF,
17179,GO:0103025,0.999999999961853,0.921882046359095,0,1,alpha-amylase activity (releasing maltohexaose),MF,
145,GO:0000296,0.999999999961976,0.921561420695428,0,1,spermine transport,BP,
7556,GO:0031883,0.999999999961999,0.92222201603516,0,1,taste receptor binding,MF,
11046,GO:0045027,0.999999999961999,0.92222201603516,0,1,DNA end binding,MF,
8140,GO:0032847,0.999999999962131,0.85267251779817,0,2,regulation of cellular pH reduction,BP,
1574,GO:0003983,0.999999999962231,0.922035368400221,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13164,GO:0051748,0.999999999962231,0.922035368400221,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
18009,GO:1902480,0.999999999962321,0.921303883860582,0,1,protein localization to mitotic spindle,BP,
9877,GO:0042138,0.999999999962404,0.921458953949341,0,1,meiotic DNA double-strand break formation,BP,
9141,GO:0035482,0.999999999962432,0.871716151570825,0,2,gastric motility,BP,
19217,GO:1905333,0.999999999962432,0.871716151570825,0,2,regulation of gastric motility,BP,
12891,GO:0051232,0.999999999962446,0.921382725491267,0,1,meiotic spindle elongation,BP,
10315,GO:0043095,0.999999999962492,0.944151762405816,0,1,regulation of GTP cyclohydrolase I activity,BP,
10321,GO:0043105,0.999999999962492,0.944151762405816,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10931,GO:0044549,0.999999999962492,0.944151762405816,0,1,GTP cyclohydrolase binding,MF,
18267,GO:1903126,0.99999999996258,0.922080907671129,0,1,negative regulation of centriole-centriole cohesion,BP,
20231,GO:2001173,0.99999999996258,0.922080907671129,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
525,GO:0001631,0.999999999962601,0.854736465108533,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,0.999999999962601,0.854736465108533,0,2,leukotriene B4 receptor activity,MF,
2153,GO:0004974,0.999999999962601,0.854736465108533,0,2,leukotriene receptor activity,MF,
14432,GO:0061737,0.999999999962601,0.854736465108533,0,2,leukotriene signaling pathway,BP,
1553,GO:0003952,0.999999999962645,0.921280555496471,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1580,GO:0003990,0.999999999962645,0.921280555496471,0,1,acetylcholinesterase activity,MF,
4822,GO:0014016,0.999999999962645,0.921280555496471,0,1,neuroblast differentiation,BP,
11672,GO:0046448,0.999999999962645,0.921280555496471,0,1,tropane alkaloid metabolic process,BP,
12605,GO:0050783,0.999999999962645,0.921280555496471,0,1,cocaine metabolic process,BP,
2233,GO:0005137,0.999999999962674,0.921944896248562,0,1,interleukin-5 receptor binding,MF,
2598,GO:0005895,0.999999999962674,0.921944896248562,0,1,interleukin-5 receptor complex,CC,
1568,GO:0003975,0.999999999962701,0.922031302110542,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4006,GO:0008963,0.999999999962701,0.922031302110542,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
3532,GO:0007518,0.999999999962751,0.921392423986914,0,1,myoblast fate determination,BP,
11264,GO:0045519,0.999999999962851,0.936431871521342,0,1,interleukin-23 receptor binding,MF,
14916,GO:0070743,0.999999999962851,0.936431871521342,0,1,interleukin-23 complex,CC,
5036,GO:0015211,0.999999999963054,0.921244385319233,0,1,purine nucleoside transmembrane transporter activity,MF,
7550,GO:0031859,0.999999999963094,0.923399504970022,0,1,platelet activating factor receptor binding,MF,
9876,GO:0042137,0.999999999963094,0.923399504970022,0,1,sequestering of neurotransmitter,BP,
16089,GO:0090065,0.999999999963157,0.956173384147943,0,1,regulation of production of siRNA involved in RNA interference,BP,
16818,GO:0098680,0.999999999963157,0.956173384147943,0,1,template-free RNA nucleotidyltransferase,MF,
18523,GO:1903704,0.999999999963157,0.956173384147943,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19561,GO:1990572,0.999999999963157,0.956173384147943,0,1,TERT-RMRP complex,CC,
4982,GO:0015105,0.99999999996317,0.93156064661526,0,1,arsenite transmembrane transporter activity,MF,
5161,GO:0015700,0.99999999996317,0.93156064661526,0,1,arsenite transport,BP,
5977,GO:0018479,0.999999999963235,0.92221281287284,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
6348,GO:0021524,0.999999999963367,0.851390779934742,0,2,visceral motor neuron differentiation,BP,
6044,GO:0019153,0.999999999963436,0.926566436126175,0,1,protein-disulfide reductase (glutathione) activity,MF,
15844,GO:0072555,0.999999999963436,0.926566436126175,0,1,17-beta-ketosteroid reductase activity,MF,
15864,GO:0072582,0.999999999963436,0.926566436126175,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
8725,GO:0034370,0.99999999996344,0.868472410575898,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8727,GO:0034372,0.99999999996344,0.868472410575898,0,2,very-low-density lipoprotein particle remodeling,BP,
6411,GO:0021649,0.999999999963461,0.921235369057263,0,1,vestibulocochlear nerve structural organization,BP,
9692,GO:0038085,0.999999999963461,0.921235369057263,0,1,vascular endothelial growth factor binding,MF,
13732,GO:0060301,0.999999999963461,0.921235369057263,0,1,positive regulation of cytokine activity,BP,
14349,GO:0061552,0.999999999963461,0.921235369057263,0,1,ganglion morphogenesis,BP,
16581,GO:0097374,0.999999999963461,0.921235369057263,0,1,sensory neuron axon guidance,BP,
17976,GO:1902378,0.999999999963461,0.921235369057263,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19012,GO:1904835,0.999999999963461,0.921235369057263,0,1,dorsal root ganglion morphogenesis,BP,
19109,GO:1905040,0.999999999963461,0.921235369057263,0,1,otic placode development,BP,
14250,GO:0061300,0.999999999963465,0.854478758920572,0,2,cerebellum vasculature development,BP,
1843,GO:0004499,0.99999999996349,0.922039446902556,0,1,N,N-dimethylaniline monooxygenase activity,MF,
9480,GO:0036114,0.99999999996352,0.927497017937747,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9481,GO:0036115,0.99999999996352,0.927497017937747,0,1,fatty-acyl-CoA catabolic process,BP,
9482,GO:0036116,0.99999999996352,0.927497017937747,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
17500,GO:1900533,0.99999999996352,0.927497017937747,0,1,palmitic acid metabolic process,BP,
17501,GO:1900535,0.99999999996352,0.927497017937747,0,1,palmitic acid biosynthetic process,BP,
3995,GO:0008893,0.99999999996354,0.936388620824846,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5681,GO:0016794,0.99999999996354,0.936388620824846,0,1,diphosphoric monoester hydrolase activity,MF,
9811,GO:0042000,0.999999999963577,0.921318538932651,0,1,translocation of peptides or proteins into host,BP,
10722,GO:0044053,0.999999999963577,0.921318538932651,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13198,GO:0051808,0.999999999963577,0.921318538932651,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
1542,GO:0003937,0.999999999963607,0.922235918365327,0,1,IMP cyclohydrolase activity,MF,
1941,GO:0004643,0.999999999963607,0.922235918365327,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13413,GO:0052798,0.999999999963607,0.922235918365327,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
6840,GO:0030305,0.999999999963687,0.924623914217641,0,1,heparanase activity,MF,
16410,GO:0097036,0.999999999963751,0.928899886800715,0,1,regulation of plasma membrane sterol distribution,BP,
17231,GO:0110021,0.999999999963925,0.849408905429719,0,2,cardiac muscle myoblast proliferation,BP,
17232,GO:0110022,0.999999999963925,0.849408905429719,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17233,GO:0110024,0.999999999963925,0.849408905429719,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
14617,GO:0070180,0.999999999963999,0.947589996830368,0,1,large ribosomal subunit rRNA binding,MF,
14778,GO:0070476,0.999999999963999,0.947589996830368,0,1,rRNA (guanine-N7)-methylation,BP,
4018,GO:0009032,0.999999999964056,0.925771954708972,0,1,thymidine phosphorylase activity,MF,
5365,GO:0016154,0.999999999964056,0.925771954708972,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
1714,GO:0004306,0.999999999964147,0.923771626859608,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1800,GO:0004441,0.999999999964173,0.922266443997396,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13427,GO:0052829,0.999999999964173,0.922266443997396,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
8403,GO:0033342,0.999999999964195,0.921200957033204,0,1,negative regulation of collagen binding,BP,
6467,GO:0021796,0.99999999996427,0.781541510596921,0,3,cerebral cortex regionalization,BP,
9292,GO:0035730,0.999999999964352,0.938223799748372,0,1,S-nitrosoglutathione binding,MF,
9293,GO:0035731,0.999999999964352,0.938223799748372,0,1,dinitrosyl-iron complex binding,MF,
9294,GO:0035732,0.999999999964352,0.938223799748372,0,1,nitric oxide storage,BP,
12435,GO:0050023,0.999999999964384,0.923738477242894,0,1,L-fuconate dehydratase activity,MF,
104,GO:0000215,0.999999999964392,0.863243622307879,0,2,tRNA 2'-phosphotransferase activity,MF,
8191,GO:0032929,0.999999999964412,0.854506649652004,0,2,negative regulation of superoxide anion generation,BP,
7270,GO:0031249,0.999999999964491,0.921307990873672,0,1,denatured protein binding,MF,
17978,GO:1902380,0.999999999964491,0.921307990873672,0,1,positive regulation of endoribonuclease activity,BP,
18957,GO:1904722,0.999999999964491,0.921307990873672,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1822,GO:0004475,0.999999999964559,0.926474578696807,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
4000,GO:0008905,0.999999999964559,0.926474578696807,0,1,mannose-phosphate guanylyltransferase activity,MF,
2912,GO:0006422,0.999999999964571,0.921463121310584,0,1,aspartyl-tRNA aminoacylation,BP,
2208,GO:0005094,0.999999999964632,0.861661384319553,0,2,Rho GDP-dissociation inhibitor activity,MF,
17888,GO:1902167,0.999999999964721,0.947485323455723,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18998,GO:1904803,0.999999999964721,0.947485323455723,0,1,regulation of translation involved in cellular response to UV,BP,
9778,GO:0039656,0.99999999996478,0.851470922773327,0,2,modulation by virus of host gene expression,BP,
11834,GO:0046778,0.99999999996478,0.851470922773327,0,2,modification by virus of host mRNA processing,BP,
15843,GO:0072554,0.999999999964792,0.921412556849627,0,1,blood vessel lumenization,BP,
17576,GO:1901189,0.999999999964792,0.921412556849627,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17611,GO:1901297,0.999999999964792,0.921412556849627,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19125,GO:1905068,0.999999999964792,0.921412556849627,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
8664,GO:0034224,0.999999999964899,0.921672986040222,0,1,cellular response to zinc ion starvation,BP,
7725,GO:0032216,0.999999999964906,0.921662910813088,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
14992,GO:0070903,0.99999999996495,0.922951530390703,0,1,mitochondrial tRNA thio-modification,BP,
109,GO:0000225,0.999999999965053,0.934067573839575,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
3170,GO:0006781,0.999999999965137,0.921937327054621,0,1,succinyl-CoA pathway,BP,
1934,GO:0004633,0.999999999965217,0.921762992714857,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1953,GO:0004657,0.999999999965217,0.921762992714857,0,1,proline dehydrogenase activity,MF,
8023,GO:0032658,0.999999999965254,0.924436735088789,0,1,regulation of interleukin-15 production,BP,
8068,GO:0032738,0.999999999965254,0.924436735088789,0,1,positive regulation of interleukin-15 production,BP,
9258,GO:0035664,0.999999999965254,0.924436735088789,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9259,GO:0035665,0.999999999965254,0.924436735088789,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
15955,GO:0075341,0.999999999965334,0.921547895205472,0,1,host cell PML body,CC,
8050,GO:0032707,0.999999999965436,0.921391532257178,0,1,negative regulation of interleukin-23 production,BP,
12036,GO:0047747,0.999999999965436,0.921391532257178,0,1,cholate-CoA ligase activity,MF,
9143,GO:0035485,0.999999999965445,0.923894153453868,0,1,adenine/guanine mispair binding,MF,
3102,GO:0006679,0.999999999965579,0.853066650551521,0,2,glucosylceramide biosynthetic process,BP,
13681,GO:0060214,0.99999999996563,0.927163914143178,0,1,endocardium formation,BP,
19142,GO:1905143,0.99999999996563,0.927163914143178,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19655,GO:1990889,0.999999999965664,0.923730233508379,0,1,H4K20me3 modified histone binding,MF,
2563,GO:0005846,0.999999999965686,0.849529136841057,0,2,nuclear cap binding complex,CC,
15090,GO:0071074,0.999999999965839,0.923347275415697,0,1,eukaryotic initiation factor eIF2 binding,MF,
18513,GO:1903674,0.999999999965839,0.923347275415697,0,1,regulation of cap-dependent translational initiation,BP,
18514,GO:1903676,0.999999999965839,0.923347275415697,0,1,positive regulation of cap-dependent translational initiation,BP,
1545,GO:0003940,0.999999999965841,0.921846630947099,0,1,L-iduronidase activity,MF,
3839,GO:0008444,0.999999999965841,0.921846630947099,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6775,GO:0030209,0.999999999965841,0.921846630947099,0,1,dermatan sulfate catabolic process,BP,
9601,GO:0036458,0.999999999965841,0.921846630947099,0,1,hepatocyte growth factor binding,MF,
17606,GO:1901291,0.999999999965916,0.923328818430085,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
10132,GO:0042668,0.999999999965947,0.864777093043536,0,2,auditory receptor cell fate determination,BP,
20162,GO:2000977,0.999999999965947,0.864777093043536,0,2,regulation of forebrain neuron differentiation,BP,
20163,GO:2000978,0.999999999965947,0.864777093043536,0,2,negative regulation of forebrain neuron differentiation,BP,
3207,GO:0006843,0.999999999965982,0.926500733309404,0,1,mitochondrial citrate transmembrane transport,BP,
16083,GO:0090044,0.999999999965982,0.926500733309404,0,1,positive regulation of tubulin deacetylation,BP,
19556,GO:1990546,0.999999999965982,0.926500733309404,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
916,GO:0002309,0.999999999966011,0.941229876221938,0,1,T cell proliferation involved in immune response,BP,
10695,GO:0043973,0.999999999966062,0.921810659797808,0,1,histone H3-K4 acetylation,BP,
3734,GO:0008269,0.999999999966128,0.92179894240517,0,1,JAK pathway signal transduction adaptor activity,MF,
4319,GO:0009810,0.999999999966128,0.92179894240517,0,1,stilbene metabolic process,BP,
8550,GO:0033885,0.999999999966128,0.92179894240517,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11609,GO:0046272,0.999999999966128,0.92179894240517,0,1,stilbene catabolic process,BP,
6447,GO:0021763,0.999999999966214,0.921713035621949,0,1,subthalamic nucleus development,BP,
13632,GO:0060127,0.999999999966214,0.921713035621949,0,1,prolactin secreting cell differentiation,BP,
13855,GO:0060459,0.999999999966214,0.921713035621949,0,1,left lung development,BP,
13856,GO:0060460,0.999999999966214,0.921713035621949,0,1,left lung morphogenesis,BP,
13920,GO:0060577,0.999999999966214,0.921713035621949,0,1,pulmonary vein morphogenesis,BP,
13921,GO:0060578,0.999999999966214,0.921713035621949,0,1,superior vena cava morphogenesis,BP,
2027,GO:0004766,0.999999999966323,0.93168947707714,0,1,spermidine synthase activity,MF,
5776,GO:0016998,0.999999999966333,0.854546023655991,0,2,cell wall macromolecule catabolic process,BP,
15817,GO:0072513,0.999999999966347,0.941856737350325,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
1396,GO:0003310,0.999999999966348,0.928678360013205,0,1,pancreatic A cell differentiation,BP,
6373,GO:0021558,0.999999999966348,0.928678360013205,0,1,trochlear nerve development,BP,
11499,GO:0045977,0.999999999966348,0.928678360013205,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13654,GO:0060164,0.999999999966348,0.928678360013205,0,1,regulation of timing of neuron differentiation,BP,
14196,GO:0061102,0.999999999966348,0.928678360013205,0,1,stomach neuroendocrine cell differentiation,BP,
14197,GO:0061105,0.999999999966348,0.928678360013205,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14198,GO:0061106,0.999999999966348,0.928678360013205,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15478,GO:0071820,0.999999999966348,0.928678360013205,0,1,N-box binding,MF,
15593,GO:0072071,0.999999999966348,0.928678360013205,0,1,kidney interstitial fibroblast differentiation,BP,
15644,GO:0072141,0.999999999966348,0.928678360013205,0,1,renal interstitial fibroblast development,BP,
19791,GO:2000226,0.999999999966348,0.928678360013205,0,1,regulation of pancreatic A cell differentiation,BP,
19792,GO:2000227,0.999999999966348,0.928678360013205,0,1,negative regulation of pancreatic A cell differentiation,BP,
11927,GO:0046970,0.999999999966429,0.923098136767208,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14302,GO:0061433,0.999999999966429,0.923098136767208,0,1,cellular response to caloric restriction,BP,
14765,GO:0070446,0.999999999966429,0.923098136767208,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
1641,GO:0004084,0.999999999966534,0.853212464297203,0,2,branched-chain-amino-acid transaminase activity,MF,
4045,GO:0009082,0.999999999966534,0.853212464297203,0,2,branched-chain amino acid biosynthetic process,BP,
4053,GO:0009098,0.999999999966534,0.853212464297203,0,2,leucine biosynthetic process,BP,
4054,GO:0009099,0.999999999966534,0.853212464297203,0,2,valine biosynthetic process,BP,
13384,GO:0052654,0.999999999966534,0.853212464297203,0,2,L-leucine transaminase activity,MF,
13385,GO:0052655,0.999999999966534,0.853212464297203,0,2,L-valine transaminase activity,MF,
13386,GO:0052656,0.999999999966534,0.853212464297203,0,2,L-isoleucine transaminase activity,MF,
6898,GO:0030432,0.999999999966577,0.870448625490633,0,2,peristalsis,BP,
2049,GO:0004798,0.999999999966579,0.860690713849393,0,2,thymidylate kinase activity,MF,
2791,GO:0006227,0.999999999966579,0.860690713849393,0,2,dUDP biosynthetic process,BP,
2794,GO:0006233,0.999999999966579,0.860690713849393,0,2,dTDP biosynthetic process,BP,
4085,GO:0009139,0.999999999966579,0.860690713849393,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4136,GO:0009196,0.999999999966579,0.860690713849393,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4137,GO:0009197,0.999999999966579,0.860690713849393,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11543,GO:0046072,0.999999999966579,0.860690713849393,0,2,dTDP metabolic process,BP,
11546,GO:0046077,0.999999999966579,0.860690713849393,0,2,dUDP metabolic process,BP,
2261,GO:0005175,0.999999999966623,0.945162747256052,0,1,CD27 receptor binding,MF,
4211,GO:0009353,0.999999999966636,0.930785277363419,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7430,GO:0031531,0.999999999966636,0.930785277363419,0,1,thyrotropin-releasing hormone receptor binding,MF,
5531,GO:0016508,0.999999999966651,0.781546065203022,0,3,long-chain-enoyl-CoA hydratase activity,MF,
1561,GO:0003962,0.99999999996668,0.924833678965921,0,1,cystathionine gamma-synthase activity,MF,
1664,GO:0004123,0.99999999996668,0.924833678965921,0,1,cystathionine gamma-lyase activity,MF,
5944,GO:0018272,0.99999999996668,0.924833678965921,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9370,GO:0035887,0.99999999996668,0.924833678965921,0,1,aortic smooth muscle cell differentiation,BP,
10919,GO:0044524,0.99999999996668,0.924833678965921,0,1,protein sulfhydration,BP,
10926,GO:0044540,0.99999999996668,0.924833678965921,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12055,GO:0047982,0.99999999996668,0.924833678965921,0,1,homocysteine desulfhydrase activity,MF,
15156,GO:0071266,0.99999999996668,0.924833678965921,0,1,'de novo' L-methionine biosynthetic process,BP,
15983,GO:0080146,0.99999999996668,0.924833678965921,0,1,L-cysteine desulfhydrase activity,MF,
19009,GO:1904829,0.99999999996668,0.924833678965921,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19010,GO:1904831,0.99999999996668,0.924833678965921,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
13127,GO:0051673,0.999999999966695,0.856127725267274,0,2,membrane disruption in other organism,BP,
254,GO:0000718,0.999999999966759,0.925019232617411,0,1,nucleotide-excision repair, DNA damage removal,BP,
1675,GO:0004139,0.999999999966759,0.925019232617411,0,1,deoxyribose-phosphate aldolase activity,MF,
10852,GO:0044349,0.999999999966759,0.925019232617411,0,1,DNA excision,BP,
11659,GO:0046403,0.999999999966759,0.925019232617411,0,1,polynucleotide 3'-phosphatase activity,MF,
16743,GO:0098503,0.999999999966759,0.925019232617411,0,1,DNA 3' dephosphorylation,BP,
16744,GO:0098504,0.999999999966759,0.925019232617411,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16746,GO:0098506,0.999999999966759,0.925019232617411,0,1,polynucleotide 3' dephosphorylation,BP,
18587,GO:1903837,0.999999999966929,0.92124645588115,0,1,regulation of mRNA 3'-UTR binding,BP,
18588,GO:1903839,0.999999999966929,0.92124645588115,0,1,positive regulation of mRNA 3'-UTR binding,BP,
2088,GO:0004853,0.999999999966989,0.92971705887093,0,1,uroporphyrinogen decarboxylase activity,MF,
12043,GO:0047801,0.999999999966989,0.922093587160657,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
10142,GO:0042709,0.999999999967007,0.921417271290918,0,1,succinate-CoA ligase complex,CC,
11173,GO:0045244,0.999999999967007,0.921417271290918,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17856,GO:1902045,0.999999999967007,0.921417271290918,0,1,negative regulation of Fas signaling pathway,BP,
19953,GO:2000504,0.999999999967007,0.921417271290918,0,1,positive regulation of blood vessel remodeling,BP,
8160,GO:0032889,0.999999999967078,0.921200208897684,0,1,regulation of vacuole fusion, non-autophagic,BP,
4745,GO:0010915,0.999999999967081,0.881202419344148,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4746,GO:0010916,0.999999999967081,0.881202419344148,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
1623,GO:0004057,0.999999999967083,0.921775912378692,0,1,arginyltransferase activity,MF,
12268,GO:0048561,0.9999999999671,0.921756597955701,0,1,establishment of animal organ orientation,BP,
6226,GO:0019777,0.999999999967118,0.858949050604764,0,2,Atg12 transferase activity,MF,
15944,GO:0072750,0.999999999967121,0.931523970744107,0,1,cellular response to leptomycin B,BP,
17634,GO:1901344,0.999999999967121,0.931523970744107,0,1,response to leptomycin B,BP,
17755,GO:1901707,0.999999999967121,0.931523970744107,0,1,leptomycin B binding,MF,
2237,GO:0005143,0.999999999967172,0.850048983052049,0,2,interleukin-12 receptor binding,MF,
13410,GO:0052794,0.999999999967189,0.849613328617447,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13411,GO:0052795,0.999999999967189,0.849613328617447,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13412,GO:0052796,0.999999999967189,0.849613328617447,0,2,exo-alpha-(2->8)-sialidase activity,MF,
222,GO:0000461,0.999999999967192,0.890280246761263,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
3549,GO:0007576,0.999999999967225,0.921186317245612,0,1,nucleolar fragmentation,BP,
833,GO:0002127,0.999999999967259,0.928931796177961,0,1,tRNA wobble base cytosine methylation,BP,
1246,GO:0002946,0.999999999967259,0.928931796177961,0,1,tRNA C5-cytosine methylation,BP,
7511,GO:0031694,0.999999999967303,0.934596925353434,0,1,alpha-2A adrenergic receptor binding,MF,
17577,GO:1901193,0.999999999967303,0.934596925353434,0,1,regulation of formation of translation preinitiation complex,BP,
17578,GO:1901194,0.999999999967303,0.934596925353434,0,1,negative regulation of formation of translation preinitiation complex,BP,
18936,GO:1904689,0.999999999967303,0.934596925353434,0,1,negative regulation of cytoplasmic translational initiation,BP,
11982,GO:0047288,0.999999999967334,0.85186135291771,0,2,monosialoganglioside sialyltransferase activity,MF,
5001,GO:0015143,0.99999999996737,0.923689275915042,0,1,urate transmembrane transporter activity,MF,
15797,GO:0072428,0.99999999996737,0.923689275915042,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17754,GO:1901702,0.99999999996737,0.923689275915042,0,1,salt transmembrane transporter activity,MF,
18633,GO:1903925,0.99999999996737,0.923689275915042,0,1,response to bisphenol A,BP,
18634,GO:1903926,0.99999999996737,0.923689275915042,0,1,cellular response to bisphenol A,BP,
13059,GO:0051552,0.999999999967427,0.921415379288723,0,1,flavone metabolic process,BP,
15037,GO:0070980,0.999999999967427,0.921415379288723,0,1,biphenyl catabolic process,BP,
18182,GO:1902951,0.999999999967446,0.849586451557391,0,2,negative regulation of dendritic spine maintenance,BP,
19335,GO:1905664,0.999999999967446,0.849586451557391,0,2,regulation of calcium ion import across plasma membrane,BP,
2047,GO:0004795,0.999999999967464,0.922158678086565,0,1,threonine synthase activity,MF,
4050,GO:0009088,0.999999999967464,0.922158678086565,0,1,threonine biosynthetic process,BP,
11643,GO:0046360,0.999999999967464,0.922158678086565,0,1,2-oxobutyrate biosynthetic process,BP,
11644,GO:0046361,0.999999999967464,0.922158678086565,0,1,2-oxobutyrate metabolic process,BP,
669,GO:0001878,0.99999999996747,0.921518211515292,0,1,response to yeast,BP,
4219,GO:0009386,0.99999999996747,0.921518211515292,0,1,translational attenuation,BP,
14475,GO:0061847,0.99999999996747,0.921518211515292,0,1,response to cholecystokinin,BP,
15322,GO:0071538,0.99999999996747,0.921518211515292,0,1,SH2 domain-mediated complex assembly,BP,
19642,GO:1990839,0.99999999996747,0.921518211515292,0,1,response to endothelin,BP,
19646,GO:1990859,0.99999999996747,0.921518211515292,0,1,cellular response to endothelin,BP,
14965,GO:0070860,0.999999999967491,0.921520532831126,0,1,RNA polymerase I core factor complex,CC,
10097,GO:0042602,0.999999999967542,0.940609810547619,0,1,riboflavin reductase (NADPH) activity,MF,
9241,GO:0035633,0.999999999967567,0.84893598391245,0,2,maintenance of permeability of blood-brain barrier,BP,
18739,GO:1904207,0.999999999967567,0.84893598391245,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18740,GO:1904209,0.999999999967567,0.84893598391245,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18934,GO:1904685,0.999999999967567,0.84893598391245,0,2,positive regulation of metalloendopeptidase activity,BP,
2749,GO:0006148,0.999999999967679,0.921320697128143,0,1,inosine catabolic process,BP,
3143,GO:0006738,0.999999999967679,0.921320697128143,0,1,nicotinamide riboside catabolic process,BP,
11704,GO:0046495,0.999999999967679,0.921320697128143,0,1,nicotinamide riboside metabolic process,BP,
14865,GO:0070637,0.999999999967679,0.921320697128143,0,1,pyridine nucleoside metabolic process,BP,
14866,GO:0070638,0.999999999967679,0.921320697128143,0,1,pyridine nucleoside catabolic process,BP,
9359,GO:0035870,0.999999999967745,0.861384697154677,0,2,dITP diphosphatase activity,MF,
5527,GO:0016503,0.999999999967852,0.931124460762441,0,1,pheromone receptor activity,MF,
11738,GO:0046554,0.999999999967852,0.931124460762441,0,1,malate dehydrogenase (NADP+) activity,MF,
19033,GO:1904877,0.999999999967968,0.922163118770115,0,1,positive regulation of DNA ligase activity,BP,
1638,GO:0004081,0.999999999967977,0.863621562161038,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3977,GO:0008796,0.999999999967977,0.863621562161038,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
11085,GO:0045085,0.999999999968031,0.924859821251696,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16841,GO:0098745,0.999999999968031,0.924859821251696,0,1,Dcp1-Dcp2 complex,CC,
17776,GO:1901834,0.999999999968031,0.924859821251696,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17777,GO:1901835,0.999999999968031,0.924859821251696,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18761,GO:1904246,0.999999999968031,0.924859821251696,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
18938,GO:1904691,0.999999999968093,0.922097838573786,0,1,negative regulation of type B pancreatic cell proliferation,BP,
11052,GO:0045041,0.999999999968111,0.854869825583928,0,2,protein import into mitochondrial intermembrane space,BP,
6832,GO:0030294,0.99999999996819,0.921797279545528,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
705,GO:0001928,0.999999999968209,0.92164593004273,0,1,regulation of exocyst assembly,BP,
13662,GO:0060178,0.999999999968209,0.92164593004273,0,1,regulation of exocyst localization,BP,
586,GO:0001740,0.999999999968211,0.784008211132177,0,3,Barr body,CC,
2617,GO:0005927,0.999999999968279,0.927248044516075,0,1,muscle tendon junction,CC,
8660,GO:0034213,0.999999999968279,0.927248044516075,0,1,quinolinate catabolic process,BP,
11870,GO:0046874,0.999999999968279,0.927248044516075,0,1,quinolinate metabolic process,BP,
2255,GO:0005169,0.999999999968294,0.863498294376003,0,2,neurotrophin TRKB receptor binding,MF,
12414,GO:0048859,0.999999999968294,0.863498294376003,0,2,formation of anatomical boundary,BP,
839,GO:0002144,0.999999999968302,0.922208230753681,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
17764,GO:1901740,0.999999999968354,0.923010590611406,0,1,negative regulation of myoblast fusion,BP,
18640,GO:1903943,0.999999999968354,0.923010590611406,0,1,regulation of hepatocyte apoptotic process,BP,
18641,GO:1903944,0.999999999968354,0.923010590611406,0,1,negative regulation of hepatocyte apoptotic process,BP,
19598,GO:1990729,0.999999999968354,0.923010590611406,0,1,primary miRNA modification,BP,
19606,GO:1990744,0.999999999968354,0.923010590611406,0,1,primary miRNA methylation,BP,
2801,GO:0006258,0.999999999968358,0.857870528379152,0,2,UDP-glucose catabolic process,BP,
12330,GO:0048682,0.9999999999684,0.848613319885852,0,2,sprouting of injured axon,BP,
18597,GO:1903860,0.9999999999684,0.848613319885852,0,2,negative regulation of dendrite extension,BP,
19764,GO:2000172,0.9999999999684,0.848613319885852,0,2,regulation of branching morphogenesis of a nerve,BP,
7268,GO:0031247,0.999999999968404,0.849961781729965,0,2,actin rod assembly,BP,
15979,GO:0080129,0.999999999968412,0.935323530100989,0,1,proteasome core complex assembly,BP,
1747,GO:0004347,0.99999999996849,0.922283111216923,0,1,glucose-6-phosphate isomerase activity,MF,
6085,GO:0019242,0.99999999996849,0.922283111216923,0,1,methylglyoxal biosynthetic process,BP,
5241,GO:0015864,0.999999999968539,0.84935658322271,0,2,pyrimidine nucleoside transport,BP,
3837,GO:0008442,0.999999999968554,0.922887375151268,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
781,GO:0002038,0.99999999996858,0.921626579208411,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4717,GO:0010879,0.99999999996858,0.921626579208411,0,1,cholesterol transport involved in cholesterol storage,BP,
9091,GO:0035352,0.99999999996858,0.921626579208411,0,1,NAD transmembrane transport,BP,
10339,GO:0043132,0.99999999996858,0.921626579208411,0,1,NAD transport,BP,
10946,GO:0044610,0.99999999996858,0.921626579208411,0,1,FMN transmembrane transporter activity,MF,
13153,GO:0051724,0.99999999996858,0.921626579208411,0,1,NAD transmembrane transporter activity,MF,
18692,GO:1904045,0.999999999968584,0.921789006549647,0,1,cellular response to aldosterone,BP,
7073,GO:0030860,0.999999999968669,0.848560169438062,0,2,regulation of polarized epithelial cell differentiation,BP,
3989,GO:0008859,0.999999999968687,0.938314275332272,0,1,exoribonuclease II activity,MF,
787,GO:0002046,0.99999999996871,0.937863729672047,0,1,opsin binding,MF,
9573,GO:0036372,0.99999999996871,0.937863729672047,0,1,opsin transport,BP,
12440,GO:0050104,0.999999999968781,0.927928703393656,0,1,L-gulonate 3-dehydrogenase activity,MF,
3845,GO:0008454,0.999999999968796,0.848477727217949,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
949,GO:0002368,0.999999999968807,0.921499970684581,0,1,B cell cytokine production,BP,
1194,GO:0002842,0.999999999968807,0.921499970684581,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9565,GO:0036351,0.999999999968807,0.921499970684581,0,1,histone H2A-K13 ubiquitination,BP,
9566,GO:0036352,0.999999999968807,0.921499970684581,0,1,histone H2A-K15 ubiquitination,BP,
780,GO:0002037,0.999999999968987,0.922119283342253,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
15986,GO:0080163,0.999999999968999,0.921351856053312,0,1,regulation of protein serine/threonine phosphatase activity,BP,
3869,GO:0008493,0.999999999969038,0.923726118178618,0,1,tetracycline transmembrane transporter activity,MF,
5262,GO:0015904,0.999999999969038,0.923726118178618,0,1,tetracycline transport,BP,
10805,GO:0044284,0.999999999969164,0.939599726084524,0,1,mitochondrial crista junction,CC,
19196,GO:1905286,0.999999999969169,0.848931839569731,0,2,serine-type peptidase complex,CC,
8298,GO:0033128,0.999999999969231,0.850465219837709,0,2,negative regulation of histone phosphorylation,BP,
8545,GO:0033872,0.999999999969237,0.922589124624773,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
5318,GO:0016036,0.999999999969262,0.921614398247954,0,1,cellular response to phosphate starvation,BP,
7326,GO:0031335,0.999999999969262,0.921614398247954,0,1,regulation of sulfur amino acid metabolic process,BP,
7327,GO:0031337,0.999999999969262,0.921614398247954,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9335,GO:0035814,0.999999999969262,0.921614398247954,0,1,negative regulation of renal sodium excretion,BP,
12523,GO:0050666,0.999999999969262,0.921614398247954,0,1,regulation of homocysteine metabolic process,BP,
12525,GO:0050668,0.999999999969262,0.921614398247954,0,1,positive regulation of homocysteine metabolic process,BP,
6230,GO:0019781,0.999999999969267,0.852126565514556,0,2,NEDD8 activating enzyme activity,MF,
5809,GO:0017064,0.999999999969281,0.922203661584672,0,1,fatty acid amide hydrolase activity,MF,
17122,GO:0102077,0.999999999969281,0.922203661584672,0,1,oleamide hydrolase activity,MF,
17186,GO:0103073,0.999999999969281,0.922203661584672,0,1,anandamide amidohydrolase activity,MF,
2796,GO:0006238,0.999999999969302,0.932249724378975,0,1,CMP salvage,BP,
4162,GO:0009224,0.999999999969302,0.932249724378975,0,1,CMP biosynthetic process,BP,
11521,GO:0046035,0.999999999969302,0.932249724378975,0,1,CMP metabolic process,BP,
1729,GO:0004324,0.999999999969364,0.923452550078856,0,1,ferredoxin-NADP+ reductase activity,MF,
4964,GO:0015039,0.999999999969364,0.923452550078856,0,1,NADPH-adrenodoxin reductase activity,MF,
5644,GO:0016730,0.999999999969364,0.923452550078856,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5645,GO:0016731,0.999999999969364,0.923452550078856,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
1625,GO:0004061,0.999999999969369,0.925351097400921,0,1,arylformamidase activity,MF,
4781,GO:0010967,0.999999999969369,0.925351097400921,0,1,regulation of polyamine biosynthetic process,BP,
12025,GO:0047658,0.999999999969369,0.925351097400921,0,1,alpha-amino-acid esterase activity,MF,
13451,GO:0052899,0.999999999969369,0.925351097400921,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13453,GO:0052902,0.999999999969369,0.925351097400921,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13454,GO:0052903,0.999999999969369,0.925351097400921,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13455,GO:0052904,0.999999999969369,0.925351097400921,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17617,GO:1901304,0.999999999969369,0.925351097400921,0,1,regulation of spermidine biosynthetic process,BP,
17618,GO:1901307,0.999999999969369,0.925351097400921,0,1,positive regulation of spermidine biosynthetic process,BP,
5821,GO:0017089,0.999999999969396,0.850342589460582,0,2,glycolipid transporter activity,MF,
1736,GO:0004334,0.99999999996944,0.928615660183885,0,1,fumarylacetoacetase activity,MF,
4596,GO:0010711,0.999999999969501,0.942612771334347,0,1,negative regulation of collagen catabolic process,BP,
13737,GO:0060309,0.999999999969501,0.942612771334347,0,1,elastin catabolic process,BP,
13738,GO:0060310,0.999999999969501,0.942612771334347,0,1,regulation of elastin catabolic process,BP,
13739,GO:0060311,0.999999999969501,0.942612771334347,0,1,negative regulation of elastin catabolic process,BP,
2799,GO:0006253,0.999999999969516,0.934823570603214,0,1,dCTP catabolic process,BP,
11537,GO:0046065,0.999999999969516,0.934823570603214,0,1,dCTP metabolic process,BP,
12044,GO:0047840,0.999999999969516,0.934823570603214,0,1,dCTP diphosphatase activity,MF,
15851,GO:0072563,0.999999999969521,0.853384900706036,0,2,endothelial microparticle,CC,
6409,GO:0021644,0.999999999969641,0.927403919482942,0,1,vagus nerve morphogenesis,BP,
2065,GO:0004819,0.999999999969738,0.848607679446668,0,2,glutamine-tRNA ligase activity,MF,
2915,GO:0006425,0.999999999969738,0.848607679446668,0,2,glutaminyl-tRNA aminoacylation,BP,
12606,GO:0050785,0.999999999969898,0.93052137872871,0,1,advanced glycation end-product receptor activity,MF,
18905,GO:1904596,0.999999999969898,0.93052137872871,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18906,GO:1904597,0.999999999969898,0.93052137872871,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18907,GO:1904599,0.999999999969898,0.93052137872871,0,1,advanced glycation end-product binding,MF,
18908,GO:1904603,0.999999999969898,0.93052137872871,0,1,regulation of advanced glycation end-product receptor activity,BP,
18909,GO:1904604,0.999999999969898,0.93052137872871,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19164,GO:1905204,0.999999999969898,0.93052137872871,0,1,negative regulation of connective tissue replacement,BP,
3840,GO:0008446,0.999999999969946,0.925581888386656,0,1,GDP-mannose 4,6-dehydratase activity,MF,
20238,GO:2001183,0.999999999969962,0.923545400436488,0,1,negative regulation of interleukin-12 secretion,BP,
14994,GO:0070905,0.999999999969988,0.849544333992722,0,2,serine binding,MF,
18475,GO:1903575,0.99999999996999,0.855240226413436,0,2,cornified envelope assembly,BP,
9527,GO:0036250,0.999999999970017,0.923230921692625,0,1,peroxisome transport along microtubule,BP,
10964,GO:0044721,0.999999999970017,0.923230921692625,0,1,protein import into peroxisome matrix, substrate release,BP,
4324,GO:0009822,0.999999999970033,0.925160916420376,0,1,alkaloid catabolic process,BP,
765,GO:0002016,0.99999999997004,0.944731404470763,0,1,regulation of blood volume by renin-angiotensin,BP,
767,GO:0002019,0.99999999997004,0.944731404470763,0,1,regulation of renal output by angiotensin,BP,
1281,GO:0003083,0.99999999997004,0.944731404470763,0,1,negative regulation of renal output by angiotensin,BP,
1293,GO:0003106,0.99999999997004,0.944731404470763,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4935,GO:0014895,0.99999999997004,0.944731404470763,0,1,smooth muscle hypertrophy,BP,
10107,GO:0042624,0.99999999997004,0.944731404470763,0,1,ATPase activity, uncoupled,MF,
20034,GO:2000656,0.999999999970079,0.923600691528103,0,1,regulation of apolipoprotein binding,BP,
20035,GO:2000657,0.999999999970079,0.923600691528103,0,1,negative regulation of apolipoprotein binding,BP,
6265,GO:0019858,0.999999999970094,0.864282827610169,0,2,cytosine metabolic process,BP,
14535,GO:0070037,0.999999999970125,0.936216109949951,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
513,GO:0001576,0.999999999970134,0.922278332632033,0,1,globoside biosynthetic process,BP,
1550,GO:0003948,0.999999999970134,0.922278332632033,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12495,GO:0050512,0.999999999970134,0.922278332632033,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
8397,GO:0033319,0.999999999970208,0.922259350377504,0,1,UDP-D-xylose metabolic process,BP,
8398,GO:0033320,0.999999999970208,0.922259350377504,0,1,UDP-D-xylose biosynthetic process,BP,
12087,GO:0048040,0.999999999970208,0.922259350377504,0,1,UDP-glucuronate decarboxylase activity,MF,
5581,GO:0016598,0.999999999970244,0.851693272458601,0,2,protein arginylation,BP,
5010,GO:0015168,0.999999999970252,0.851201819104377,0,2,glycerol transmembrane transporter activity,MF,
5056,GO:0015254,0.999999999970252,0.851201819104377,0,2,glycerol channel activity,MF,
5199,GO:0015793,0.999999999970252,0.851201819104377,0,2,glycerol transport,BP,
2479,GO:0005713,0.999999999970261,0.921251740498885,0,1,recombination nodule,CC,
2480,GO:0005715,0.999999999970261,0.921251740498885,0,1,late recombination nodule,CC,
5013,GO:0015173,0.999999999970261,0.921251740498885,0,1,aromatic amino acid transmembrane transporter activity,MF,
5031,GO:0015196,0.999999999970261,0.921251740498885,0,1,L-tryptophan transmembrane transporter activity,MF,
10300,GO:0043060,0.999999999970261,0.921251740498885,0,1,meiotic metaphase I plate congression,BP,
12911,GO:0051257,0.999999999970261,0.921251740498885,0,1,meiotic spindle midzone assembly,BP,
12951,GO:0051311,0.999999999970261,0.921251740498885,0,1,meiotic metaphase plate congression,BP,
18772,GO:1904271,0.999999999970261,0.921251740498885,0,1,L-proline import across plasma membrane,BP,
18879,GO:1904555,0.999999999970261,0.921251740498885,0,1,L-proline transmembrane transport,BP,
18880,GO:1904556,0.999999999970261,0.921251740498885,0,1,L-tryptophan transmembrane transport,BP,
19330,GO:1905647,0.999999999970261,0.921251740498885,0,1,proline import across plasma membrane,BP,
18420,GO:1903464,0.999999999970299,0.850831096552492,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
6479,GO:0021822,0.999999999970311,0.922049696709447,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
14004,GO:0060720,0.999999999970363,0.865103739893143,0,2,spongiotrophoblast cell proliferation,BP,
14005,GO:0060721,0.999999999970363,0.865103739893143,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14006,GO:0060722,0.999999999970363,0.865103739893143,0,2,cell proliferation involved in embryonic placenta development,BP,
14007,GO:0060723,0.999999999970363,0.865103739893143,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
16193,GO:0090214,0.999999999970363,0.865103739893143,0,2,spongiotrophoblast layer developmental growth,BP,
1848,GO:0004511,0.999999999970398,0.923391993822831,0,1,tyrosine 3-monooxygenase activity,MF,
3036,GO:0006585,0.999999999970398,0.923391993822831,0,1,dopamine biosynthetic process from tyrosine,BP,
8274,GO:0033076,0.999999999970398,0.923391993822831,0,1,isoquinoline alkaloid metabolic process,BP,
9028,GO:0035240,0.999999999970398,0.923391993822831,0,1,dopamine binding,MF,
9900,GO:0042214,0.999999999970398,0.923391993822831,0,1,terpene metabolic process,BP,
10003,GO:0042418,0.999999999970398,0.923391993822831,0,1,epinephrine biosynthetic process,BP,
13338,GO:0052314,0.999999999970398,0.923391993822831,0,1,phytoalexin metabolic process,BP,
1695,GO:0004170,0.999999999970421,0.923648751735694,0,1,dUTP diphosphatase activity,MF,
11548,GO:0046080,0.999999999970421,0.923648751735694,0,1,dUTP metabolic process,BP,
11549,GO:0046081,0.999999999970421,0.923648751735694,0,1,dUTP catabolic process,BP,
5240,GO:0015862,0.999999999970451,0.921467323644523,0,1,uridine transport,BP,
4395,GO:0010070,0.999999999970468,0.921319256519592,0,1,zygote asymmetric cell division,BP,
9270,GO:0035692,0.999999999970487,0.857581190456074,0,2,macrophage migration inhibitory factor receptor complex,CC,
1604,GO:0004027,0.999999999970493,0.93261126566661,0,1,alcohol sulfotransferase activity,MF,
13287,GO:0051977,0.999999999970493,0.921862427037395,0,1,lysophospholipid transport,BP,
13288,GO:0051978,0.999999999970493,0.921862427037395,0,1,lysophospholipid transporter activity,MF,
9276,GO:0035700,0.999999999970531,0.924465832341961,0,1,astrocyte chemotaxis,BP,
9499,GO:0036145,0.999999999970531,0.924465832341961,0,1,dendritic cell homeostasis,BP,
19934,GO:2000458,0.999999999970531,0.924465832341961,0,1,regulation of astrocyte chemotaxis,BP,
1003,GO:0002477,0.999999999970633,0.937640188193614,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002481,0.999999999970633,0.937640188193614,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
17949,GO:1902298,0.999999999970647,0.848995338784955,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19528,GO:1990426,0.999999999970647,0.848995338784955,0,2,mitotic recombination-dependent replication fork processing,BP,
19549,GO:1990505,0.999999999970647,0.848995338784955,0,2,mitotic DNA replication maintenance of fidelity,BP,
16305,GO:0090416,0.999999999970663,0.9211749196632,0,1,nicotinate transmembrane transporter activity,MF,
20215,GO:2001142,0.999999999970663,0.9211749196632,0,1,nicotinate transport,BP,
18960,GO:1904732,0.999999999970663,0.876687257046332,0,2,regulation of electron transfer activity,BP,
19076,GO:1904959,0.999999999970663,0.876687257046332,0,2,regulation of cytochrome-c oxidase activity,BP,
16246,GO:0090297,0.999999999970727,0.93165259469861,0,1,positive regulation of mitochondrial DNA replication,BP,
17789,GO:1901860,0.999999999970727,0.93165259469861,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19432,GO:1990046,0.999999999970727,0.93165259469861,0,1,stress-induced mitochondrial fusion,BP,
1161,GO:0002775,0.999999999970737,0.790076768748832,0,3,antimicrobial peptide production,BP,
1162,GO:0002778,0.999999999970737,0.790076768748832,0,3,antibacterial peptide production,BP,
1163,GO:0002784,0.999999999970737,0.790076768748832,0,3,regulation of antimicrobial peptide production,BP,
1165,GO:0002786,0.999999999970737,0.790076768748832,0,3,regulation of antibacterial peptide production,BP,
15378,GO:0071619,0.999999999970765,0.921603739190462,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20224,GO:2001163,0.999999999970765,0.921603739190462,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20225,GO:2001165,0.999999999970765,0.921603739190462,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
9630,GO:0036497,0.999999999970784,0.921374118091099,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17958,GO:1902310,0.999999999970784,0.921374118091099,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18626,GO:1903916,0.999999999970784,0.921374118091099,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18627,GO:1903917,0.999999999970784,0.921374118091099,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
14785,GO:0070488,0.999999999970792,0.902360660137294,0,2,neutrophil aggregation,BP,
11965,GO:0047166,0.99999999997082,0.923317793656732,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
9563,GO:0036343,0.999999999970824,0.948563708976548,0,1,psychomotor behavior,BP,
2018,GO:0004747,0.999999999970871,0.933153384775579,0,1,ribokinase activity,MF,
3970,GO:0008768,0.999999999970881,0.940420416977625,0,1,UDP-sugar diphosphatase activity,MF,
3999,GO:0008903,0.999999999970908,0.934968622223023,0,1,hydroxypyruvate isomerase activity,MF,
2252,GO:0005166,0.999999999970908,0.937439999362617,0,1,neurotrophin p75 receptor binding,MF,
3500,GO:0007402,0.999999999970908,0.937439999362617,0,1,ganglion mother cell fate determination,BP,
3612,GO:0008052,0.999999999970908,0.937439999362617,0,1,sensory organ boundary specification,BP,
4408,GO:0010160,0.999999999970908,0.937439999362617,0,1,formation of animal organ boundary,BP,
12420,GO:0048867,0.999999999970908,0.937439999362617,0,1,stem cell fate determination,BP,
14232,GO:0061193,0.999999999970908,0.937439999362617,0,1,taste bud development,BP,
16999,GO:0099082,0.999999999970908,0.937439999362617,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17000,GO:0099083,0.999999999970908,0.937439999362617,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17057,GO:0099538,0.999999999970908,0.937439999362617,0,1,synaptic signaling via neuropeptide,BP,
17058,GO:0099540,0.999999999970908,0.937439999362617,0,1,trans-synaptic signaling by neuropeptide,BP,
17066,GO:0099551,0.999999999970908,0.937439999362617,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
205,GO:0000430,0.999999999970913,0.856343134903607,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000432,0.999999999970913,0.856343134903607,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
4374,GO:0009996,0.999999999970945,0.851353518583127,0,2,negative regulation of cell fate specification,BP,
9521,GO:0036219,0.999999999970971,0.944101576585656,0,1,GTP diphosphatase activity,MF,
10959,GO:0044713,0.999999999970971,0.944101576585656,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10960,GO:0044714,0.999999999970971,0.944101576585656,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12029,GO:0047693,0.999999999970971,0.944101576585656,0,1,ATP diphosphatase activity,MF,
13766,GO:0060342,0.999999999971009,0.923584808702121,0,1,photoreceptor inner segment membrane,CC,
15165,GO:0071283,0.999999999971056,0.864751358908777,0,2,cellular response to iron(III) ion,BP,
10764,GO:0044209,0.999999999971063,0.870304521996451,0,2,AMP salvage,BP,
383,GO:0001018,0.99999999997109,0.850350253078753,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
7615,GO:0032002,0.99999999997109,0.850350253078753,0,2,interleukin-28 receptor complex,CC,
2632,GO:0005960,0.999999999971102,0.854674915237379,0,2,glycine cleavage complex,CC,
9140,GO:0035473,0.999999999971124,0.853790374879617,0,2,lipase binding,MF,
15063,GO:0071020,0.999999999971135,0.855480707360394,0,2,post-spliceosomal complex,CC,
3965,GO:0008747,0.999999999971162,0.927094288748388,0,1,N-acetylneuraminate lyase activity,MF,
3669,GO:0008158,0.99999999997123,0.864849487875141,0,2,hedgehog receptor activity,MF,
4029,GO:0009061,0.999999999971297,0.921346313407612,0,1,anaerobic respiration,BP,
11183,GO:0045274,0.999999999971297,0.921346313407612,0,1,plasma membrane respiratory chain complex II,CC,
11187,GO:0045282,0.999999999971297,0.921346313407612,0,1,plasma membrane succinate dehydrogenase complex,CC,
14894,GO:0070685,0.999999999971308,0.922174276368335,0,1,macropinocytic cup,CC,
2055,GO:0004807,0.999999999971331,0.928553225361401,0,1,triose-phosphate isomerase activity,MF,
9101,GO:0035370,0.999999999971407,0.848861096503588,0,2,UBC13-UEV1A complex,CC,
11524,GO:0046038,0.999999999971443,0.929238186682317,0,1,GMP catabolic process,BP,
13387,GO:0052657,0.999999999971443,0.929238186682317,0,1,guanine phosphoribosyltransferase activity,MF,
5661,GO:0016768,0.999999999971454,0.925396648318485,0,1,spermine synthase activity,MF,
2897,GO:0006404,0.999999999971633,0.797573685486439,0,3,RNA import into nucleus,BP,
14451,GO:0061770,0.999999999971653,0.921975646062436,0,1,translation elongation factor binding,MF,
14621,GO:0070184,0.999999999971653,0.921975646062436,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15840,GO:0072545,0.999999999971653,0.921975646062436,0,1,tyrosine binding,MF,
18172,GO:1902937,0.999999999971653,0.921975646062436,0,1,inward rectifier potassium channel complex,CC,
19014,GO:1904842,0.999999999971653,0.921975646062436,0,1,response to nitroglycerin,BP,
19015,GO:1904843,0.999999999971653,0.921975646062436,0,1,cellular response to nitroglycerin,BP,
18023,GO:1902524,0.999999999971678,0.854999834004028,0,2,positive regulation of protein K48-linked ubiquitination,BP,
4523,GO:0010585,0.999999999971685,0.923238071398551,0,1,glutamine secretion,BP,
18575,GO:1903803,0.999999999971685,0.923238071398551,0,1,L-glutamine import across plasma membrane,BP,
976,GO:0002430,0.999999999971694,0.921562664535731,0,1,complement receptor mediated signaling pathway,BP,
1927,GO:0004621,0.999999999971694,0.921562664535731,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2969,GO:0006507,0.999999999971694,0.921562664535731,0,1,GPI anchor release,BP,
4733,GO:0010897,0.999999999971694,0.921562664535731,0,1,negative regulation of triglyceride catabolic process,BP,
8563,GO:0034014,0.999999999971694,0.921562664535731,0,1,response to triglyceride,BP,
15244,GO:0071401,0.999999999971694,0.921562664535731,0,1,cellular response to triglyceride,BP,
341,GO:0000941,0.999999999971719,0.921657209842073,0,1,condensed nuclear chromosome inner kinetochore,CC,
13021,GO:0051456,0.999999999971719,0.921657209842073,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
16401,GO:0097018,0.999999999971725,0.921215336199662,0,1,renal albumin absorption,BP,
17407,GO:1900141,0.999999999971725,0.921215336199662,0,1,regulation of oligodendrocyte apoptotic process,BP,
17408,GO:1900142,0.999999999971725,0.921215336199662,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19961,GO:2000532,0.999999999971725,0.921215336199662,0,1,regulation of renal albumin absorption,BP,
19962,GO:2000533,0.999999999971725,0.921215336199662,0,1,negative regulation of renal albumin absorption,BP,
16303,GO:0090409,0.999999999971778,0.921563910761008,0,1,malonyl-CoA synthetase activity,MF,
16304,GO:0090410,0.999999999971778,0.921563910761008,0,1,malonate catabolic process,BP,
18494,GO:1903621,0.99999999997179,0.923108409950549,0,1,protein localization to photoreceptor connecting cilium,BP,
4,GO:0000010,0.999999999971803,0.853183090624139,0,2,trans-hexaprenyltranstransferase activity,MF,
12471,GO:0050347,0.999999999971803,0.853183090624139,0,2,trans-octaprenyltranstransferase activity,MF,
2586,GO:0005880,0.999999999971831,0.928576607322405,0,1,nuclear microtubule,CC,
18849,GO:1904464,0.999999999971897,0.9249336685164,0,1,regulation of matrix metallopeptidase secretion,BP,
18850,GO:1904465,0.999999999971897,0.9249336685164,0,1,negative regulation of matrix metallopeptidase secretion,BP,
19619,GO:1990773,0.999999999971897,0.9249336685164,0,1,matrix metallopeptidase secretion,BP,
10879,GO:0044416,0.999999999971922,0.855629445459481,0,2,induction by symbiont of host defense response,BP,
11829,GO:0046730,0.999999999971922,0.855629445459481,0,2,induction of host immune response by virus,BP,
11830,GO:0046732,0.999999999971922,0.855629445459481,0,2,active induction of host immune response by virus,BP,
13332,GO:0052251,0.999999999971922,0.855629445459481,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13359,GO:0052509,0.999999999971922,0.855629445459481,0,2,positive regulation by symbiont of host defense response,BP,
13360,GO:0052510,0.999999999971922,0.855629445459481,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
1058,GO:0002586,0.999999999971935,0.873919455963835,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
16795,GO:0098633,0.999999999971955,0.921195116971488,0,1,collagen fibril binding,MF,
18681,GO:1904027,0.999999999971955,0.921195116971488,0,1,negative regulation of collagen fibril organization,BP,
16464,GO:0097134,0.999999999971989,0.851330957816209,0,2,cyclin E1-CDK2 complex,CC,
5416,GO:0016263,0.999999999972004,0.853203346940962,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5419,GO:0016267,0.999999999972004,0.853203346940962,0,2,O-glycan processing, core 1,BP,
14295,GO:0061395,0.999999999972007,0.925122449994409,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
126,GO:0000257,0.999999999972012,0.930123465268635,0,1,nitrilase activity,MF,
5695,GO:0016815,0.999999999972012,0.930123465268635,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6037,GO:0019118,0.999999999972012,0.930123465268635,0,1,phenanthrene-epoxide hydrolase activity,MF,
6038,GO:0019119,0.999999999972012,0.930123465268635,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
9969,GO:0042356,0.999999999972012,0.930123465268635,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12502,GO:0050577,0.999999999972012,0.930123465268635,0,1,GDP-L-fucose synthase activity,MF,
8676,GO:0034247,0.999999999972022,0.931414298590073,0,1,snoRNA splicing,BP,
15460,GO:0071796,0.999999999972022,0.931414298590073,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15531,GO:0071920,0.999999999972023,0.849850597740172,0,2,cleavage body,CC,
19016,GO:1904844,0.99999999997204,0.871014903109728,0,2,response to L-glutamine,BP,
19017,GO:1904845,0.99999999997204,0.871014903109728,0,2,cellular response to L-glutamine,BP,
8559,GO:0033981,0.999999999972095,0.945878436450814,0,1,D-dopachrome decarboxylase activity,MF,
13687,GO:0060228,0.99999999997213,0.887539590552605,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
4327,GO:0009841,0.999999999972164,0.921411620177901,0,1,mitochondrial endopeptidase Clp complex,CC,
3022,GO:0006567,0.999999999972198,0.92675279812963,0,1,threonine catabolic process,BP,
3993,GO:0008890,0.999999999972198,0.92675279812963,0,1,glycine C-acetyltransferase activity,MF,
6164,GO:0019518,0.999999999972198,0.92675279812963,0,1,L-threonine catabolic process to glycine,BP,
15943,GO:0072749,0.999999999972225,0.924200830616222,0,1,cellular response to cytochalasin B,BP,
16940,GO:0098918,0.999999999972225,0.924200830616222,0,1,structural constituent of synapse,MF,
16964,GO:0098973,0.999999999972225,0.924200830616222,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16965,GO:0098974,0.999999999972225,0.924200830616222,0,1,postsynaptic actin cytoskeleton organization,BP,
17026,GO:0099186,0.999999999972225,0.924200830616222,0,1,structural constituent of postsynapse,MF,
17027,GO:0099188,0.999999999972225,0.924200830616222,0,1,postsynaptic cytoskeleton organization,BP,
17624,GO:1901328,0.999999999972225,0.924200830616222,0,1,response to cytochalasin B,BP,
269,GO:0000741,0.999999999972247,0.924807658908485,0,1,karyogamy,BP,
3483,GO:0007344,0.999999999972247,0.924807658908485,0,1,pronuclear fusion,BP,
13159,GO:0051732,0.999999999972247,0.924807658908485,0,1,polyribonucleotide kinase activity,MF,
13162,GO:0051736,0.999999999972247,0.924807658908485,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16517,GO:0097224,0.999999999972247,0.924807658908485,0,1,sperm connecting piece,CC,
18965,GO:1904744,0.999999999972277,0.863587037188153,0,2,positive regulation of telomeric DNA binding,BP,
9300,GO:0035744,0.999999999972299,0.93420920599079,0,1,T-helper 1 cell cytokine production,BP,
9908,GO:0042231,0.999999999972299,0.93420920599079,0,1,interleukin-13 biosynthetic process,BP,
9153,GO:0035504,0.999999999972301,0.927943597972523,0,1,regulation of myosin light chain kinase activity,BP,
9154,GO:0035505,0.999999999972301,0.927943597972523,0,1,positive regulation of myosin light chain kinase activity,BP,
10334,GO:0043126,0.999999999972301,0.927943597972523,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10335,GO:0043128,0.999999999972301,0.927943597972523,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
6326,GO:0020012,0.999999999972354,0.848475857699086,0,2,evasion or tolerance of host immune response,BP,
6999,GO:0030682,0.999999999972354,0.848475857699086,0,2,evasion or tolerance of host defense response,BP,
7000,GO:0030683,0.999999999972354,0.848475857699086,0,2,evasion or tolerance by virus of host immune response,BP,
13195,GO:0051805,0.999999999972354,0.848475857699086,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13197,GO:0051807,0.999999999972354,0.848475857699086,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
18610,GO:1903893,0.999999999972367,0.921223195001856,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
1900,GO:0004584,0.999999999972431,0.921404201017586,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
5945,GO:0018277,0.999999999972431,0.921404201017586,0,1,protein deamination,BP,
4890,GO:0014810,0.999999999972436,0.942392328182366,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
13803,GO:0060392,0.999999999972561,0.857602802598288,0,2,negative regulation of SMAD protein signal transduction,BP,
19111,GO:1905042,0.999999999972622,0.921692032253008,0,1,negative regulation of epithelium regeneration,BP,
6241,GO:0019800,0.999999999972676,0.928025822067637,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
3925,GO:0008597,0.999999999972683,0.852554330883023,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4734,GO:0010898,0.999999999972718,0.849589516409711,0,2,positive regulation of triglyceride catabolic process,BP,
48,GO:0000101,0.999999999972741,0.781541589994223,0,3,sulfur amino acid transport,BP,
5020,GO:0015183,0.999999999972741,0.781541589994223,0,3,L-aspartate transmembrane transporter activity,MF,
3642,GO:0008112,0.999999999972764,0.926860866570558,0,1,nicotinamide N-methyltransferase activity,MF,
7023,GO:0030760,0.999999999972764,0.926860866570558,0,1,pyridine N-methyltransferase activity,MF,
19456,GO:1990136,0.999999999972769,0.921211165746537,0,1,linoleate 9S-lipoxygenase activity,MF,
12047,GO:0047874,0.999999999972783,0.922167572219076,0,1,dolichyldiphosphatase activity,MF,
11983,GO:0047290,0.999999999972784,0.925942188278002,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
3889,GO:0008521,0.999999999972821,0.921139818177493,0,1,acetyl-CoA transmembrane transporter activity,MF,
5249,GO:0015876,0.999999999972821,0.921139818177493,0,1,acetyl-CoA transport,BP,
5268,GO:0015916,0.999999999972821,0.921139818177493,0,1,fatty-acyl-CoA transport,BP,
5347,GO:0016095,0.999999999972821,0.921139818177493,0,1,polyprenol catabolic process,BP,
17145,GO:0102389,0.999999999972821,0.921139818177493,0,1,polyprenol reductase activity,MF,
17627,GO:1901337,0.999999999972821,0.921139818177493,0,1,thioester transport,BP,
5317,GO:0016035,0.999999999972834,0.860662539068635,0,2,zeta DNA polymerase complex,CC,
5463,GO:0016344,0.99999999997287,0.848474961940257,0,2,meiotic chromosome movement towards spindle pole,BP,
4309,GO:0009786,0.999999999972874,0.856199858506798,0,2,regulation of asymmetric cell division,BP,
10470,GO:0043335,0.999999999972874,0.856199858506798,0,2,protein unfolding,BP,
5420,GO:0016269,0.999999999972891,0.921227760598463,0,1,O-glycan processing, core 3,BP,
11973,GO:0047224,0.999999999972891,0.921227760598463,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4058,GO:0009107,0.99999999997291,0.925599502743112,0,1,lipoate biosynthetic process,BP,
5774,GO:0016992,0.99999999997291,0.925599502743112,0,1,lipoate synthase activity,MF,
14675,GO:0070283,0.99999999997291,0.925599502743112,0,1,radical SAM enzyme activity,MF,
7185,GO:0031071,0.999999999972911,0.921375823731676,0,1,cysteine desulfurase activity,MF,
15929,GO:0072714,0.999999999972932,0.924880822974917,0,1,response to selenite ion,BP,
15930,GO:0072715,0.999999999972932,0.924880822974917,0,1,cellular response to selenite ion,BP,
18886,GO:1904569,0.999999999972932,0.924880822974917,0,1,regulation of selenocysteine incorporation,BP,
18887,GO:1904570,0.999999999972932,0.924880822974917,0,1,negative regulation of selenocysteine incorporation,BP,
18888,GO:1904572,0.999999999972932,0.924880822974917,0,1,negative regulation of mRNA binding,BP,
18889,GO:1904573,0.999999999972932,0.924880822974917,0,1,regulation of selenocysteine insertion sequence binding,BP,
18890,GO:1904574,0.999999999972932,0.924880822974917,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19171,GO:1905215,0.999999999972932,0.924880822974917,0,1,negative regulation of RNA binding,BP,
9721,GO:0038158,0.99999999997296,0.852838863668875,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
18891,GO:1904576,0.99999999997296,0.852838863668875,0,2,response to tunicamycin,BP,
18892,GO:1904577,0.99999999997296,0.852838863668875,0,2,cellular response to tunicamycin,BP,
5980,GO:0018738,0.999999999973014,0.933212119677892,0,1,S-formylglutathione hydrolase activity,MF,
4095,GO:0009149,0.999999999973041,0.863443557034747,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4151,GO:0009213,0.999999999973041,0.863443557034747,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7957,GO:0032556,0.999999999973041,0.863443557034747,0,2,pyrimidine deoxyribonucleotide binding,MF,
3973,GO:0008783,0.999999999973117,0.92183278200373,0,1,agmatinase activity,MF,
8415,GO:0033388,0.999999999973117,0.92183278200373,0,1,putrescine biosynthetic process from arginine,BP,
858,GO:0002189,0.999999999973181,0.921191975638815,0,1,ribose phosphate diphosphokinase complex,CC,
15394,GO:0071641,0.999999999973195,0.85008073354423,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
19975,GO:2000562,0.999999999973195,0.85008073354423,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19777,GO:2000195,0.999999999973196,0.850324590695193,0,2,negative regulation of female gonad development,BP,
1526,GO:0003905,0.999999999973203,0.935449677359257,0,1,alkylbase DNA N-glycosylase activity,MF,
3961,GO:0008725,0.999999999973203,0.935449677359257,0,1,DNA-3-methyladenine glycosylase activity,MF,
10656,GO:0043733,0.999999999973203,0.935449677359257,0,1,DNA-3-methylbase glycosylase activity,MF,
10675,GO:0043916,0.999999999973203,0.935449677359257,0,1,DNA-7-methylguanine glycosylase activity,MF,
13421,GO:0052821,0.999999999973203,0.935449677359257,0,1,DNA-7-methyladenine glycosylase activity,MF,
13422,GO:0052822,0.999999999973203,0.935449677359257,0,1,DNA-3-methylguanine glycosylase activity,MF,
12693,GO:0050910,0.999999999973245,0.848499741712732,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
13218,GO:0051877,0.999999999973245,0.848499741712732,0,2,pigment granule aggregation in cell center,BP,
16572,GO:0097360,0.999999999973245,0.848499741712732,0,2,chorionic trophoblast cell proliferation,BP,
17647,GO:1901382,0.999999999973245,0.848499741712732,0,2,regulation of chorionic trophoblast cell proliferation,BP,
624,GO:0001807,0.999999999973246,0.857628515501104,0,2,regulation of type IV hypersensitivity,BP,
2737,GO:0006117,0.999999999973265,0.921167816801543,0,1,acetaldehyde metabolic process,BP,
9172,GO:0035525,0.999999999973265,0.921167816801543,0,1,NF-kappaB p50/p65 complex,CC,
5217,GO:0015819,0.999999999973284,0.923529756256737,0,1,lysine transport,BP,
18059,GO:1902612,0.999999999973317,0.92112999416893,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18060,GO:1902613,0.999999999973317,0.92112999416893,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19489,GO:1990262,0.999999999973317,0.92112999416893,0,1,anti-Mullerian hormone signaling pathway,BP,
17013,GO:0099130,0.999999999973339,0.921747086744708,0,1,estrogen binding,MF,
18632,GO:1903924,0.999999999973339,0.921747086744708,0,1,estradiol binding,MF,
1630,GO:0004069,0.999999999973343,0.849491842742246,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2988,GO:0006532,0.999999999973343,0.849491842742246,0,2,aspartate biosynthetic process,BP,
2989,GO:0006533,0.999999999973343,0.849491842742246,0,2,aspartate catabolic process,BP,
6179,GO:0019550,0.999999999973343,0.849491842742246,0,2,glutamate catabolic process to aspartate,BP,
6180,GO:0019551,0.999999999973343,0.849491842742246,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
5708,GO:0016838,0.999999999973409,0.86573164668798,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
18454,GO:1903542,0.99999999997341,0.84901619603032,0,2,negative regulation of exosomal secretion,BP,
1590,GO:0004001,0.999999999973439,0.922448345766929,0,1,adenosine kinase activity,MF,
2003,GO:0004727,0.999999999973439,0.922448345766929,0,1,prenylated protein tyrosine phosphatase activity,MF,
2759,GO:0006169,0.999999999973439,0.922448345766929,0,1,adenosine salvage,BP,
2763,GO:0006175,0.999999999973439,0.922448345766929,0,1,dATP biosynthetic process,BP,
874,GO:0002225,0.999999999973455,0.857738139235361,0,2,positive regulation of antimicrobial peptide production,BP,
1152,GO:0002760,0.999999999973455,0.857738139235361,0,2,positive regulation of antimicrobial humoral response,BP,
1171,GO:0002803,0.999999999973455,0.857738139235361,0,2,positive regulation of antibacterial peptide production,BP,
1693,GO:0004168,0.999999999973501,0.921829347861365,0,1,dolichol kinase activity,MF,
10299,GO:0043048,0.999999999973501,0.921829347861365,0,1,dolichyl monophosphate biosynthetic process,BP,
18961,GO:1904734,0.999999999973503,0.951757099955575,0,1,positive regulation of electron transfer activity,BP,
19077,GO:1904960,0.999999999973503,0.951757099955575,0,1,positive regulation of cytochrome-c oxidase activity,BP,
3920,GO:0008591,0.999999999973525,0.924256385179525,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10128,GO:0042662,0.999999999973525,0.924256385179525,0,1,negative regulation of mesodermal cell fate specification,BP,
11409,GO:0045813,0.999999999973525,0.924256385179525,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14437,GO:0061743,0.999999999973525,0.924256385179525,0,1,motor learning,BP,
16102,GO:0090081,0.999999999973525,0.924256385179525,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16103,GO:0090082,0.999999999973525,0.924256385179525,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16289,GO:0090381,0.999999999973525,0.924256385179525,0,1,regulation of heart induction,BP,
16916,GO:0098883,0.999999999973525,0.924256385179525,0,1,synapse disassembly,BP,
17108,GO:0100012,0.999999999973525,0.924256385179525,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17610,GO:1901296,0.999999999973525,0.924256385179525,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17623,GO:1901321,0.999999999973525,0.924256385179525,0,1,positive regulation of heart induction,BP,
18943,GO:1904701,0.999999999973525,0.924256385179525,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18948,GO:1904711,0.999999999973525,0.924256385179525,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18958,GO:1904723,0.999999999973525,0.924256385179525,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19124,GO:1905067,0.999999999973525,0.924256385179525,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19357,GO:1905771,0.999999999973525,0.924256385179525,0,1,negative regulation of mesodermal cell differentiation,BP,
19395,GO:1905903,0.999999999973525,0.924256385179525,0,1,negative regulation of mesoderm formation,BP,
18560,GO:1903778,0.999999999973534,0.848501293793704,0,2,protein localization to vacuolar membrane,BP,
16286,GO:0090365,0.999999999973555,0.92188926657005,0,1,regulation of mRNA modification,BP,
16287,GO:0090367,0.999999999973555,0.92188926657005,0,1,negative regulation of mRNA modification,BP,
18305,GO:1903215,0.999999999973555,0.92188926657005,0,1,negative regulation of protein targeting to mitochondrion,BP,
20216,GO:2001144,0.999999999973555,0.92188926657005,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20217,GO:2001145,0.999999999973555,0.92188926657005,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
18,GO:0000033,0.999999999973575,0.790538441890277,0,3,alpha-1,3-mannosyltransferase activity,MF,
11463,GO:0045917,0.999999999973599,0.851144299021025,0,2,positive regulation of complement activation,BP,
19810,GO:2000259,0.999999999973599,0.851144299021025,0,2,positive regulation of protein activation cascade,BP,
13934,GO:0060598,0.999999999973665,0.932439366041625,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
1516,GO:0003877,0.9999999999737,0.922178761811936,0,1,ATP adenylyltransferase activity,MF,
2070,GO:0004824,0.9999999999737,0.922178761811936,0,1,lysine-tRNA ligase activity,MF,
2920,GO:0006430,0.9999999999737,0.922178761811936,0,1,lysyl-tRNA aminoacylation,BP,
7878,GO:0032440,0.999999999973701,0.932136629625716,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19327,GO:1905636,0.999999999973701,0.932136629625716,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
1916,GO:0004609,0.999999999973747,0.849367149572164,0,2,phosphatidylserine decarboxylase activity,MF,
8118,GO:0032804,0.999999999973753,0.853014804798438,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
10744,GO:0044111,0.999999999973753,0.853014804798438,0,2,development involved in symbiotic interaction,BP,
19313,GO:1905595,0.999999999973753,0.853014804798438,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19320,GO:1905602,0.999999999973753,0.853014804798438,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19586,GO:1990667,0.999999999973753,0.853014804798438,0,2,PCSK9-AnxA2 complex,CC,
1790,GO:0004419,0.999999999973799,0.927891541466512,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
9059,GO:0035281,0.999999999973805,0.861957165397017,0,2,pre-miRNA export from nucleus,BP,
10071,GO:0042565,0.999999999973805,0.861957165397017,0,2,RNA nuclear export complex,CC,
12953,GO:0051316,0.999999999973814,0.848959154013803,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
10843,GO:0044338,0.999999999973825,0.854805226362958,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
13594,GO:0060061,0.999999999973825,0.854805226362958,0,2,Spemann organizer formation,BP,
19072,GO:1904954,0.999999999973825,0.854805226362958,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
17159,GO:0102522,0.99999999997383,0.921782437577298,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
15180,GO:0071314,0.999999999973833,0.921129168268657,0,1,cellular response to cocaine,BP,
17969,GO:1902362,0.999999999973833,0.921129168268657,0,1,melanocyte apoptotic process,BP,
9599,GO:0036455,0.999999999973846,0.934668867670593,0,1,iron-sulfur transferase activity,MF,
4154,GO:0009216,0.999999999973877,0.849687949659741,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
11553,GO:0046086,0.999999999973877,0.849687949659741,0,2,adenosine biosynthetic process,BP,
8234,GO:0032996,0.999999999973903,0.923697432685645,0,1,Bcl3-Bcl10 complex,CC,
11082,GO:0045082,0.999999999973903,0.923697432685645,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
12449,GO:0050152,0.999999999973947,0.931707940327654,0,1,omega-amidase activity,MF,
1485,GO:0003810,0.999999999973951,0.781541556465625,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
12828,GO:0051133,0.999999999973971,0.805811554723525,0,3,regulation of NK T cell activation,BP,
12829,GO:0051135,0.999999999973971,0.805811554723525,0,3,positive regulation of NK T cell activation,BP,
7689,GO:0032139,0.999999999973998,0.789563795858547,0,3,dinucleotide insertion or deletion binding,MF,
18202,GO:1902990,0.999999999973998,0.789563795858547,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
12146,GO:0048250,0.99999999997401,0.856451377271711,0,2,iron import into the mitochondrion,BP,
4005,GO:0008962,0.999999999974022,0.849993889349706,0,2,phosphatidylglycerophosphatase activity,MF,
2129,GO:0004931,0.999999999974026,0.92256684366843,0,1,extracellularly ATP-gated cation channel activity,MF,
5535,GO:0016519,0.999999999974026,0.92256684366843,0,1,gastric inhibitory peptide receptor activity,MF,
9107,GO:0035381,0.999999999974026,0.92256684366843,0,1,ATP-gated ion channel activity,MF,
9738,GO:0038192,0.999999999974026,0.92256684366843,0,1,gastric inhibitory peptide signaling pathway,BP,
15159,GO:0071275,0.999999999974057,0.922011153205863,0,1,cellular response to aluminum ion,BP,
19339,GO:1905672,0.999999999974057,0.922011153205863,0,1,negative regulation of lysosome organization,BP,
2768,GO:0006185,0.999999999974121,0.937528854869947,0,1,dGDP biosynthetic process,BP,
4115,GO:0009170,0.999999999974121,0.937528854869947,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4124,GO:0009183,0.999999999974121,0.937528854869947,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11531,GO:0046054,0.999999999974121,0.937528854869947,0,1,dGMP metabolic process,BP,
11818,GO:0046711,0.999999999974121,0.937528854869947,0,1,GDP biosynthetic process,BP,
2148,GO:0004966,0.999999999974173,0.805572482310816,0,3,galanin receptor activity,MF,
6885,GO:0030389,0.999999999974179,0.944883363908745,0,1,fructosamine metabolic process,BP,
3610,GO:0008049,0.999999999974205,0.923377021385336,0,1,male courtship behavior,BP,
3851,GO:0008460,0.999999999974205,0.923377021385336,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
2357,GO:0005456,0.999999999974252,0.924155042574386,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5193,GO:0015782,0.999999999974252,0.924155042574386,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
668,GO:0001875,0.999999999974255,0.781546903817558,0,3,lipopolysaccharide receptor activity,MF,
10645,GO:0043654,0.999999999974255,0.781546903817558,0,3,recognition of apoptotic cell,BP,
1946,GO:0004649,0.999999999974263,0.852425016988854,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2333,GO:0005350,0.999999999974282,0.849044859417005,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5237,GO:0015855,0.999999999974282,0.849044859417005,0,2,pyrimidine nucleobase transport,BP,
14470,GO:0061833,0.999999999974282,0.849044859417005,0,2,protein localization to tricellular tight junction,BP,
19006,GO:1904823,0.999999999974282,0.849044859417005,0,2,purine nucleobase transmembrane transport,BP,
698,GO:0001918,0.999999999974286,0.921129195076591,0,1,farnesylated protein binding,MF,
3340,GO:0007056,0.99999999997432,0.849745804789644,0,2,spindle assembly involved in female meiosis,BP,
3341,GO:0007057,0.99999999997432,0.849745804789644,0,2,spindle assembly involved in female meiosis I,BP,
18093,GO:1902722,0.999999999974339,0.798966966900938,0,3,positive regulation of prolactin secretion,BP,
6881,GO:0030377,0.999999999974391,0.928883956672449,0,1,urokinase plasminogen activator receptor activity,MF,
9741,GO:0038195,0.999999999974391,0.928883956672449,0,1,urokinase plasminogen activator signaling pathway,BP,
8499,GO:0033676,0.999999999974392,0.929401792558678,0,1,double-stranded DNA-dependent ATPase activity,MF,
1519,GO:0003881,0.999999999974416,0.923640698703415,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
3347,GO:0007066,0.999999999974466,0.938746506776862,0,1,female meiosis sister chromatid cohesion,BP,
1723,GO:0004315,0.999999999974477,0.858200898170181,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
16489,GO:0097177,0.999999999974509,0.795707996536196,0,3,mitochondrial ribosome binding,MF,
792,GO:0002055,0.999999999974597,0.943477254699291,0,1,adenine binding,MF,
1588,GO:0003999,0.999999999974597,0.943477254699291,0,1,adenine phosphoribosyltransferase activity,MF,
1673,GO:0004137,0.999999999974598,0.848497520583847,0,2,deoxycytidine kinase activity,MF,
1547,GO:0003943,0.999999999974615,0.84871277406625,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
3648,GO:0008120,0.999999999974638,0.926116055798472,0,1,ceramide glucosyltransferase activity,MF,
17170,GO:0102769,0.999999999974638,0.926116055798472,0,1,dihydroceramide glucosyltransferase activity,MF,
3874,GO:0008503,0.999999999974667,0.86860348599629,0,2,benzodiazepine receptor activity,MF,
8097,GO:0032782,0.999999999974668,0.851515441227788,0,2,bile acid secretion,BP,
161,GO:0000332,0.999999999974693,0.9510519162262,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
239,GO:0000496,0.999999999974693,0.9510519162262,0,1,base pairing,MF,
240,GO:0000497,0.999999999974693,0.9510519162262,0,1,base pairing with DNA,MF,
1466,GO:0003721,0.999999999974693,0.9510519162262,0,1,telomerase RNA reverse transcriptase activity,MF,
12174,GO:0048295,0.999999999974696,0.851400971378141,0,2,positive regulation of isotype switching to IgE isotypes,BP,
4834,GO:0014040,0.999999999974697,0.848508324409743,0,2,positive regulation of Schwann cell differentiation,BP,
2120,GO:0004913,0.999999999974706,0.921359119875443,0,1,interleukin-4 receptor activity,MF,
2213,GO:0005105,0.999999999974721,0.921595848209818,0,1,type 1 fibroblast growth factor receptor binding,MF,
10667,GO:0043874,0.999999999974725,0.922674730893091,0,1,acireductone synthase activity,MF,
1256,GO:0003010,0.999999999974792,0.863213176457249,0,2,voluntary skeletal muscle contraction,BP,
4868,GO:0014721,0.999999999974792,0.863213176457249,0,2,twitch skeletal muscle contraction,BP,
4537,GO:0010609,0.999999999974795,0.848769510978486,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
14753,GO:0070426,0.999999999974804,0.848709292002459,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14760,GO:0070434,0.999999999974804,0.848709292002459,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14401,GO:0061656,0.999999999974808,0.93311429769446,0,1,SUMO conjugating enzyme activity,MF,
18287,GO:1903182,0.999999999974808,0.93311429769446,0,1,regulation of SUMO transferase activity,BP,
18546,GO:1903755,0.999999999974808,0.93311429769446,0,1,positive regulation of SUMO transferase activity,BP,
19500,GO:1990356,0.999999999974808,0.93311429769446,0,1,sumoylated E2 ligase complex,CC,
4213,GO:0009368,0.999999999974811,0.860674065597052,0,2,endopeptidase Clp complex,CC,
9129,GO:0035442,0.999999999974844,0.852683284650655,0,2,dipeptide transmembrane transport,BP,
10234,GO:0042938,0.999999999974844,0.852683284650655,0,2,dipeptide transport,BP,
16109,GO:0090088,0.999999999974844,0.852683284650655,0,2,regulation of oligopeptide transport,BP,
16110,GO:0090089,0.999999999974844,0.852683284650655,0,2,regulation of dipeptide transport,BP,
20156,GO:2000878,0.999999999974844,0.852683284650655,0,2,positive regulation of oligopeptide transport,BP,
20157,GO:2000880,0.999999999974844,0.852683284650655,0,2,positive regulation of dipeptide transport,BP,
20218,GO:2001148,0.999999999974844,0.852683284650655,0,2,regulation of dipeptide transmembrane transport,BP,
20219,GO:2001150,0.999999999974844,0.852683284650655,0,2,positive regulation of dipeptide transmembrane transport,BP,
18693,GO:1904046,0.999999999974847,0.867951294159227,0,2,negative regulation of vascular endothelial growth factor production,BP,
19119,GO:1905062,0.99999999997488,0.921132572925665,0,1,positive regulation of cardioblast proliferation,BP,
3129,GO:0006710,0.999999999974881,0.923632662895115,0,1,androgen catabolic process,BP,
9935,GO:0042284,0.999999999974942,0.923813458313817,0,1,sphingolipid delta-4 desaturase activity,MF,
3821,GO:0008418,0.999999999974988,0.934864948844687,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
312,GO:0000823,0.999999999975038,0.924340971014158,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,0.999999999975038,0.924340971014158,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,0.999999999975038,0.924340971014158,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11990,GO:0047326,0.999999999975038,0.924340971014158,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
9127,GO:0035438,0.999999999975144,0.92543101124423,0,1,cyclic-di-GMP binding,MF,
14328,GO:0061507,0.999999999975144,0.92543101124423,0,1,cyclic-GMP-AMP binding,MF,
3396,GO:0007174,0.999999999975157,0.92171913116424,0,1,epidermal growth factor catabolic process,BP,
7859,GO:0032419,0.999999999975157,0.92171913116424,0,1,extrinsic component of lysosome membrane,CC,
13836,GO:0060435,0.999999999975157,0.930732222550925,0,1,bronchiole development,BP,
13864,GO:0060480,0.999999999975157,0.930732222550925,0,1,lung goblet cell differentiation,BP,
19085,GO:1904979,0.999999999975157,0.92171913116424,0,1,negative regulation of endosome organization,BP,
19230,GO:1905365,0.999999999975157,0.92171913116424,0,1,regulation of intralumenal vesicle formation,BP,
19231,GO:1905366,0.999999999975157,0.92171913116424,0,1,negative regulation of intralumenal vesicle formation,BP,
8551,GO:0033897,0.999999999975158,0.932174270163453,0,1,ribonuclease T2 activity,MF,
10856,GO:0044355,0.999999999975176,0.92880455204807,0,1,clearance of foreign intracellular DNA,BP,
10857,GO:0044356,0.999999999975176,0.92880455204807,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16984,GO:0099046,0.999999999975176,0.92880455204807,0,1,clearance of foreign intracellular nucleic acids,BP,
3391,GO:0007168,0.999999999975186,0.848923435672015,0,2,receptor guanylyl cyclase signaling pathway,BP,
13531,GO:0055108,0.999999999975191,0.922893721677042,0,1,Golgi to transport vesicle transport,BP,
19506,GO:1990386,0.999999999975191,0.922893721677042,0,1,mitotic cleavage furrow ingression,BP,
19566,GO:1990583,0.999999999975191,0.922893721677042,0,1,phospholipase D activator activity,MF,
3047,GO:0006601,0.999999999975211,0.937174566006131,0,1,creatine biosynthetic process,BP,
7019,GO:0030731,0.999999999975211,0.937174566006131,0,1,guanidinoacetate N-methyltransferase activity,MF,
16979,GO:0099022,0.999999999975221,0.853218351656233,0,2,vesicle tethering,BP,
16983,GO:0099044,0.999999999975221,0.853218351656233,0,2,vesicle tethering to endoplasmic reticulum,BP,
3165,GO:0006776,0.999999999975257,0.797255261248542,0,3,vitamin A metabolic process,BP,
14014,GO:0060735,0.999999999975269,0.930089252615193,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18068,GO:1902629,0.999999999975269,0.930089252615193,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
4416,GO:0010189,0.999999999975283,0.925576026359068,0,1,vitamin E biosynthetic process,BP,
9972,GO:0042360,0.999999999975283,0.925576026359068,0,1,vitamin E metabolic process,BP,
18712,GO:1904121,0.999999999975283,0.925576026359068,0,1,phosphatidylethanolamine transporter activity,MF,
4082,GO:0009136,0.999999999975287,0.86399719047895,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4121,GO:0009180,0.999999999975287,0.86399719047895,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4129,GO:0009188,0.999999999975287,0.86399719047895,0,2,ribonucleoside diphosphate biosynthetic process,BP,
1956,GO:0004660,0.999999999975292,0.853421016213543,0,2,protein farnesyltransferase activity,MF,
2634,GO:0005965,0.999999999975292,0.853421016213543,0,2,protein farnesyltransferase complex,CC,
9266,GO:0035674,0.999999999975292,0.853421016213543,0,2,tricarboxylic acid transmembrane transport,BP,
16076,GO:0090034,0.999999999975292,0.853421016213543,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16077,GO:0090035,0.999999999975292,0.853421016213543,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
19904,GO:2000395,0.999999999975321,0.869104026934385,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19905,GO:2000397,0.999999999975321,0.869104026934385,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
16465,GO:0097135,0.999999999975369,0.848991407893687,0,2,cyclin E2-CDK2 complex,CC,
912,GO:0002299,0.999999999975412,0.927059641231693,0,1,alpha-beta intraepithelial T cell differentiation,BP,
913,GO:0002300,0.999999999975412,0.927059641231693,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002304,0.999999999975412,0.927059641231693,0,1,gamma-delta intraepithelial T cell differentiation,BP,
915,GO:0002305,0.999999999975412,0.927059641231693,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
7809,GO:0032358,0.999999999975482,0.940990575081731,0,1,oxidized pyrimidine DNA binding,MF,
14322,GO:0061481,0.999999999975482,0.940990575081731,0,1,response to TNF agonist,BP,
18032,GO:1902546,0.999999999975482,0.940990575081731,0,1,positive regulation of DNA N-glycosylase activity,BP,
20292,GO:2001272,0.999999999975482,0.940990575081731,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
2021,GO:0004750,0.999999999975494,0.921539436789573,0,1,ribulose-phosphate 3-epimerase activity,MF,
16681,GO:0097621,0.999999999975494,0.921539436789573,0,1,monoamine oxidase activity,MF,
5143,GO:0015670,0.999999999975519,0.925688209569202,0,1,carbon dioxide transport,BP,
8142,GO:0032849,0.999999999975519,0.925688209569202,0,1,positive regulation of cellular pH reduction,BP,
16057,GO:0086098,0.999999999975523,0.848480467231857,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17822,GO:1901979,0.999999999975523,0.848480467231857,0,2,regulation of inward rectifier potassium channel activity,BP,
16199,GO:0090226,0.999999999975547,0.941277857418206,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
1520,GO:0003882,0.999999999975562,0.921272076633671,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
7406,GO:0031475,0.99999999997559,0.92764895348562,0,1,myosin V complex,CC,
1897,GO:0004581,0.999999999975628,0.933716380483048,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
5465,GO:0016361,0.999999999975641,0.851510757299115,0,2,activin receptor activity, type I,MF,
12120,GO:0048179,0.999999999975641,0.851510757299115,0,2,activin receptor complex,CC,
7563,GO:0031905,0.999999999975655,0.796055922637152,0,3,early endosome lumen,CC,
2062,GO:0004816,0.999999999975679,0.848900222561638,0,2,asparagine-tRNA ligase activity,MF,
4986,GO:0015112,0.999999999975687,0.921141360158557,0,1,nitrate transmembrane transporter activity,MF,
5164,GO:0015706,0.999999999975687,0.921141360158557,0,1,nitrate transport,BP,
519,GO:0001595,0.999999999975691,0.933487862670019,0,1,angiotensin receptor activity,MF,
2135,GO:0004945,0.999999999975691,0.933487862670019,0,1,angiotensin type II receptor activity,MF,
16511,GO:0097210,0.999999999975767,0.84944790796426,0,2,response to gonadotropin-releasing hormone,BP,
16512,GO:0097211,0.999999999975767,0.84944790796426,0,2,cellular response to gonadotropin-releasing hormone,BP,
1837,GO:0004492,0.999999999975823,0.922154250150272,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2371,GO:0005499,0.999999999975847,0.849673546828836,0,2,vitamin D binding,MF,
13573,GO:0060040,0.999999999975847,0.849673546828836,0,2,retinal bipolar neuron differentiation,BP,
11389,GO:0045764,0.99999999997588,0.86522063732026,0,2,positive regulation of cellular amino acid metabolic process,BP,
6619,GO:0022841,0.999999999975919,0.785147089622531,0,3,potassium ion leak channel activity,MF,
6042,GO:0019145,0.999999999975943,0.921216186905534,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8519,GO:0033737,0.999999999975943,0.921216186905534,0,1,1-pyrroline dehydrogenase activity,MF,
11956,GO:0047105,0.999999999975943,0.921216186905534,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
10086,GO:0042586,0.999999999975944,0.934027228232917,0,1,peptide deformylase activity,MF,
6815,GO:0030272,0.99999999997604,0.939996725945005,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
18856,GO:1904481,0.99999999997605,0.921262781266299,0,1,response to tetrahydrofolate,BP,
18857,GO:1904482,0.99999999997605,0.921262781266299,0,1,cellular response to tetrahydrofolate,BP,
7365,GO:0031407,0.999999999976052,0.921398722749826,0,1,oxylipin metabolic process,BP,
12054,GO:0047977,0.999999999976052,0.921398722749826,0,1,hepoxilin-epoxide hydrolase activity,MF,
17768,GO:1901751,0.999999999976052,0.921398722749826,0,1,leukotriene A4 metabolic process,BP,
20304,GO:2001300,0.999999999976052,0.921398722749826,0,1,lipoxin metabolic process,BP,
20305,GO:2001301,0.999999999976052,0.921398722749826,0,1,lipoxin biosynthetic process,BP,
20306,GO:2001302,0.999999999976052,0.921398722749826,0,1,lipoxin A4 metabolic process,BP,
20307,GO:2001303,0.999999999976052,0.921398722749826,0,1,lipoxin A4 biosynthetic process,BP,
20308,GO:2001304,0.999999999976052,0.921398722749826,0,1,lipoxin B4 metabolic process,BP,
20309,GO:2001306,0.999999999976052,0.921398722749826,0,1,lipoxin B4 biosynthetic process,BP,
12050,GO:0047915,0.999999999976112,0.92552348041643,0,1,ganglioside galactosyltransferase activity,MF,
216,GO:0000451,0.999999999976179,0.851111797359005,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,0.999999999976179,0.851111797359005,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14536,GO:0070039,0.999999999976179,0.851111797359005,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
24,GO:0000048,0.999999999976179,0.921399630694136,0,1,peptidyltransferase activity,MF,
1250,GO:0002951,0.999999999976179,0.921399630694136,0,1,leukotriene-C(4) hydrolase,MF,
14761,GO:0070435,0.999999999976182,0.848516422848831,0,2,Shc-EGFR complex,CC,
2822,GO:0006286,0.999999999976189,0.864813358192672,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
4851,GO:0014063,0.999999999976198,0.933746320211066,0,1,negative regulation of serotonin secretion,BP,
15590,GO:0072061,0.999999999976199,0.856154178308467,0,2,inner medullary collecting duct development,BP,
19578,GO:1990622,0.999999999976202,0.866584496837577,0,2,CHOP-ATF3 complex,CC,
16242,GO:0090290,0.99999999997622,0.936453515259034,0,1,positive regulation of osteoclast proliferation,BP,
16248,GO:0090299,0.999999999976223,0.925747933939715,0,1,regulation of neural crest formation,BP,
16249,GO:0090301,0.999999999976223,0.925747933939715,0,1,negative regulation of neural crest formation,BP,
19843,GO:2000314,0.999999999976223,0.925747933939715,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
18942,GO:1904700,0.999999999976257,0.921158499950452,0,1,granulosa cell apoptotic process,BP,
18947,GO:1904708,0.999999999976257,0.921158499950452,0,1,regulation of granulosa cell apoptotic process,BP,
9274,GO:0035697,0.999999999976294,0.852930504787159,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9275,GO:0035698,0.999999999976294,0.852930504787159,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15914,GO:0072683,0.999999999976294,0.852930504787159,0,2,T cell extravasation,BP,
19912,GO:2000407,0.999999999976294,0.852930504787159,0,2,regulation of T cell extravasation,BP,
19930,GO:2000449,0.999999999976294,0.852930504787159,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19932,GO:2000452,0.999999999976294,0.852930504787159,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
14124,GO:0060987,0.999999999976306,0.921488865029293,0,1,lipid tube,CC,
3185,GO:0006808,0.999999999976318,0.867433198725821,0,2,regulation of nitrogen utilization,BP,
11796,GO:0046666,0.999999999976318,0.867433198725821,0,2,retinal cell programmed cell death,BP,
4223,GO:0009397,0.999999999976326,0.797552660212444,0,3,folic acid-containing compound catabolic process,BP,
5287,GO:0015942,0.999999999976326,0.797552660212444,0,3,formate metabolic process,BP,
10068,GO:0042560,0.999999999976326,0.797552660212444,0,3,pteridine-containing compound catabolic process,BP,
18199,GO:1902977,0.999999999976351,0.923266832740489,0,1,mitotic DNA replication preinitiation complex assembly,BP,
9139,GO:0035470,0.99999999997636,0.924223897417624,0,1,positive regulation of vascular wound healing,BP,
13980,GO:0060690,0.99999999997636,0.924223897417624,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13981,GO:0060691,0.99999999997636,0.924223897417624,0,1,epithelial cell maturation involved in salivary gland development,BP,
17375,GO:1900098,0.99999999997636,0.924223897417624,0,1,regulation of plasma cell differentiation,BP,
17376,GO:1900100,0.99999999997636,0.924223897417624,0,1,positive regulation of plasma cell differentiation,BP,
18423,GO:1903489,0.99999999997636,0.924223897417624,0,1,positive regulation of lactation,BP,
973,GO:0002424,0.999999999976361,0.848814305063439,0,2,T cell mediated immune response to tumor cell,BP,
1193,GO:0002840,0.999999999976361,0.848814305063439,0,2,regulation of T cell mediated immune response to tumor cell,BP,
11811,GO:0046696,0.999999999976361,0.848814305063439,0,2,lipopolysaccharide receptor complex,CC,
2113,GO:0004900,0.999999999976427,0.923830314089903,0,1,erythropoietin receptor activity,MF,
9723,GO:0038162,0.999999999976427,0.923830314089903,0,1,erythropoietin-mediated signaling pathway,BP,
16492,GO:0097180,0.999999999976447,0.872156591837021,0,2,serine protease inhibitor complex,CC,
12789,GO:0051083,0.999999999976476,0.852111767871668,0,2,'de novo' cotranslational protein folding,BP,
11886,GO:0046900,0.99999999997649,0.854953760824966,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
7810,GO:0032361,0.999999999976496,0.922745580518945,0,1,pyridoxal phosphate catabolic process,BP,
10206,GO:0042820,0.999999999976496,0.922745580518945,0,1,vitamin B6 catabolic process,BP,
4125,GO:0009184,0.9999999999765,0.927663522766244,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4133,GO:0009192,0.9999999999765,0.927663522766244,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10962,GO:0044716,0.9999999999765,0.927663522766244,0,1,8-oxo-GDP phosphatase activity,MF,
10963,GO:0044717,0.9999999999765,0.927663522766244,0,1,8-hydroxy-dADP phosphatase activity,MF,
11533,GO:0046057,0.9999999999765,0.927663522766244,0,1,dADP catabolic process,BP,
11539,GO:0046067,0.9999999999765,0.927663522766244,0,1,dGDP catabolic process,BP,
11819,GO:0046712,0.9999999999765,0.927663522766244,0,1,GDP catabolic process,BP,
11801,GO:0046680,0.999999999976509,0.922268815124738,0,1,response to DDT,BP,
20104,GO:2000775,0.999999999976509,0.922268815124738,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
1859,GO:0004522,0.999999999976511,0.927011320109521,0,1,ribonuclease A activity,MF,
3974,GO:0008785,0.999999999976511,0.927011320109521,0,1,alkyl hydroperoxide reductase activity,MF,
1731,GO:0004326,0.999999999976515,0.921229627437713,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1842,GO:0004498,0.999999999976515,0.921229627437713,0,1,calcidiol 1-monooxygenase activity,MF,
3986,GO:0008841,0.999999999976515,0.921229627437713,0,1,dihydrofolate synthase activity,MF,
11887,GO:0046901,0.999999999976515,0.921229627437713,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
1624,GO:0004060,0.999999999976607,0.922657348573847,0,1,arylamine N-acetyltransferase activity,MF,
16698,GO:0097644,0.999999999976642,0.865359447016078,0,2,calcitonin family binding,MF,
18410,GO:1903439,0.999999999976642,0.865359447016078,0,2,calcitonin family receptor complex,CC,
19516,GO:1990406,0.999999999976642,0.865359447016078,0,2,CGRP receptor complex,CC,
19518,GO:1990408,0.999999999976642,0.865359447016078,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
9411,GO:0035971,0.999999999976663,0.932745760812447,0,1,peptidyl-histidine dephosphorylation,BP,
1585,GO:0003996,0.999999999976679,0.921668652694103,0,1,acyl-CoA ligase activity,MF,
16761,GO:0098547,0.999999999976679,0.921668652694103,0,1,lumenal side of Golgi membrane,CC,
43,GO:0000095,0.999999999976691,0.921734555423885,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5207,GO:0015805,0.999999999976691,0.921734555423885,0,1,S-adenosyl-L-methionine transport,BP,
17815,GO:1901962,0.999999999976691,0.921734555423885,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
736,GO:0001966,0.999999999976722,0.930192077848368,0,1,thigmotaxis,BP,
15971,GO:0080058,0.999999999976722,0.930192077848368,0,1,protein deglutathionylation,BP,
16671,GO:0097573,0.999999999976722,0.930192077848368,0,1,glutathione oxidoreductase activity,MF,
10413,GO:0043250,0.999999999976724,0.927898965330265,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10414,GO:0043251,0.999999999976724,0.927898965330265,0,1,sodium-dependent organic anion transport,BP,
12469,GO:0050337,0.999999999976725,0.947433031074976,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
14447,GO:0061763,0.999999999976728,0.848490133999007,0,2,multivesicular body-lysosome fusion,BP,
16897,GO:0098842,0.99999999997673,0.849481863392707,0,2,postsynaptic early endosome,CC,
1510,GO:0003870,0.99999999997674,0.921450723558931,0,1,5-aminolevulinate synthase activity,MF,
5654,GO:0016749,0.99999999997674,0.921450723558931,0,1,N-succinyltransferase activity,MF,
1362,GO:0003245,0.999999999976746,0.853009065379107,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
7393,GO:0031445,0.999999999976746,0.853009065379107,0,2,regulation of heterochromatin assembly,BP,
7394,GO:0031453,0.999999999976746,0.853009065379107,0,2,positive regulation of heterochromatin assembly,BP,
7684,GO:0032129,0.999999999976746,0.853009065379107,0,2,histone deacetylase activity (H3-K9 specific),MF,
11406,GO:0045799,0.999999999976746,0.853009065379107,0,2,positive regulation of chromatin assembly or disassembly,BP,
11926,GO:0046969,0.999999999976746,0.853009065379107,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19298,GO:1905555,0.999999999976746,0.853009065379107,0,2,positive regulation blood vessel branching,BP,
19577,GO:1990619,0.999999999976746,0.853009065379107,0,2,histone H3-K9 deacetylation,BP,
8949,GO:0034991,0.999999999976774,0.848861825126325,0,2,nuclear meiotic cohesin complex,CC,
4379,GO:0010015,0.999999999976787,0.942490207935737,0,1,root morphogenesis,BP,
4393,GO:0010053,0.999999999976787,0.942490207935737,0,1,root epidermal cell differentiation,BP,
4394,GO:0010054,0.999999999976787,0.942490207935737,0,1,trichoblast differentiation,BP,
6602,GO:0022622,0.999999999976787,0.942490207935737,0,1,root system development,BP,
7534,GO:0031763,0.999999999976787,0.942490207935737,0,1,galanin receptor binding,MF,
7535,GO:0031764,0.999999999976787,0.942490207935737,0,1,type 1 galanin receptor binding,MF,
7536,GO:0031765,0.999999999976787,0.942490207935737,0,1,type 2 galanin receptor binding,MF,
7537,GO:0031766,0.999999999976787,0.942490207935737,0,1,type 3 galanin receptor binding,MF,
12196,GO:0048364,0.999999999976787,0.942490207935737,0,1,root development,BP,
12375,GO:0048764,0.999999999976787,0.942490207935737,0,1,trichoblast maturation,BP,
12376,GO:0048765,0.999999999976787,0.942490207935737,0,1,root hair cell differentiation,BP,
12377,GO:0048767,0.999999999976787,0.942490207935737,0,1,root hair elongation,BP,
13028,GO:0051464,0.999999999976787,0.942490207935737,0,1,positive regulation of cortisol secretion,BP,
15984,GO:0080147,0.999999999976787,0.942490207935737,0,1,root hair cell development,BP,
16336,GO:0090558,0.999999999976787,0.942490207935737,0,1,plant epidermis development,BP,
16354,GO:0090627,0.999999999976787,0.942490207935737,0,1,plant epidermal cell differentiation,BP,
17030,GO:0099402,0.999999999976787,0.942490207935737,0,1,plant organ development,BP,
18057,GO:1902606,0.999999999976787,0.942490207935737,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18058,GO:1902608,0.999999999976787,0.942490207935737,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18149,GO:1902890,0.999999999976787,0.942490207935737,0,1,regulation of root hair elongation,BP,
18150,GO:1902891,0.999999999976787,0.942490207935737,0,1,negative regulation of root hair elongation,BP,
18606,GO:1903888,0.999999999976787,0.942490207935737,0,1,regulation of plant epidermal cell differentiation,BP,
18607,GO:1903889,0.999999999976787,0.942490207935737,0,1,negative regulation of plant epidermal cell differentiation,BP,
19240,GO:1905392,0.999999999976787,0.942490207935737,0,1,plant organ morphogenesis,BP,
19251,GO:1905421,0.999999999976787,0.942490207935737,0,1,regulation of plant organ morphogenesis,BP,
19252,GO:1905422,0.999999999976787,0.942490207935737,0,1,negative regulation of plant organ morphogenesis,BP,
19721,GO:2000067,0.999999999976787,0.942490207935737,0,1,regulation of root morphogenesis,BP,
19821,GO:2000280,0.999999999976787,0.942490207935737,0,1,regulation of root development,BP,
20150,GO:2000851,0.999999999976787,0.942490207935737,0,1,positive regulation of glucocorticoid secretion,BP,
14486,GO:0061890,0.999999999976838,0.857124843251257,0,2,positive regulation of astrocyte activation,BP,
17193,GO:0106014,0.999999999976838,0.857124843251257,0,2,regulation of inflammatory response to wounding,BP,
17194,GO:0106015,0.999999999976838,0.857124843251257,0,2,negative regulation of inflammatory response to wounding,BP,
17497,GO:1900453,0.999999999976838,0.857124843251257,0,2,negative regulation of long term synaptic depression,BP,
18664,GO:1903980,0.999999999976838,0.857124843251257,0,2,positive regulation of microglial cell activation,BP,
19163,GO:1905203,0.999999999976838,0.857124843251257,0,2,regulation of connective tissue replacement,BP,
20248,GO:2001200,0.999999999976838,0.857124843251257,0,2,positive regulation of dendritic cell differentiation,BP,
13865,GO:0060481,0.999999999976847,0.857319073062752,0,2,lobar bronchus epithelium development,BP,
14035,GO:0060764,0.999999999976847,0.857319073062752,0,2,cell-cell signaling involved in mammary gland development,BP,
18952,GO:1904716,0.999999999976872,0.921396912963495,0,1,positive regulation of chaperone-mediated autophagy,BP,
5674,GO:0016784,0.999999999976883,0.928329131023866,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6261,GO:0019853,0.999999999976883,0.928329131023866,0,1,L-ascorbic acid biosynthetic process,BP,
6705,GO:0030108,0.999999999976883,0.928329131023866,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7564,GO:0031906,0.999999999976883,0.928329131023866,0,1,late endosome lumen,CC,
7841,GO:0032397,0.999999999976883,0.928329131023866,0,1,activating MHC class I receptor activity,MF,
10216,GO:0042839,0.999999999976883,0.928329131023866,0,1,D-glucuronate metabolic process,BP,
10217,GO:0042840,0.999999999976883,0.928329131023866,0,1,D-glucuronate catabolic process,BP,
12053,GO:0047939,0.999999999976883,0.928329131023866,0,1,L-glucuronate reductase activity,MF,
16631,GO:0097486,0.999999999976883,0.928329131023866,0,1,multivesicular body lumen,CC,
1917,GO:0004610,0.999999999976927,0.922757595649397,0,1,phosphoacetylglucosamine mutase activity,MF,
3652,GO:0008127,0.999999999976931,0.931268901542535,0,1,quercetin 2,3-dioxygenase activity,MF,
1947,GO:0004651,0.999999999976941,0.852963303066436,0,2,polynucleotide 5'-phosphatase activity,MF,
16747,GO:0098507,0.999999999976941,0.852963303066436,0,2,polynucleotide 5' dephosphorylation,BP,
997,GO:0002461,0.999999999976944,0.921486670859998,0,1,tolerance induction dependent upon immune response,BP,
1019,GO:0002519,0.999999999976944,0.921486670859998,0,1,natural killer cell tolerance induction,BP,
1078,GO:0002652,0.999999999976944,0.921486670859998,0,1,regulation of tolerance induction dependent upon immune response,BP,
8051,GO:0032712,0.999999999976944,0.921486670859998,0,1,negative regulation of interleukin-3 production,BP,
15402,GO:0071656,0.999999999976944,0.921486670859998,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17600,GO:1901257,0.999999999976944,0.921486670859998,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
11179,GO:0045263,0.999999999976954,0.929616879163515,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
1505,GO:0003860,0.999999999976976,0.923220227529883,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
3062,GO:0006624,0.999999999976999,0.868866805083389,0,2,vacuolar protein processing,BP,
19367,GO:1905799,0.999999999977002,0.945111874622504,0,1,regulation of intraciliary retrograde transport,BP,
5049,GO:0015234,0.999999999977013,0.852940524062381,0,2,thiamine transmembrane transporter activity,MF,
15539,GO:0071934,0.999999999977013,0.852940524062381,0,2,thiamine transmembrane transport,BP,
12725,GO:0050966,0.999999999977018,0.849584966826144,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
11331,GO:0045654,0.999999999977043,0.855251918326509,0,2,positive regulation of megakaryocyte differentiation,BP,
15551,GO:0071963,0.999999999977053,0.924818052253625,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
3495,GO:0007387,0.99999999997709,0.921132239814669,0,1,anterior compartment pattern formation,BP,
3496,GO:0007388,0.99999999997709,0.921132239814669,0,1,posterior compartment specification,BP,
1748,GO:0004348,0.999999999977122,0.848662799594569,0,2,glucosylceramidase activity,MF,
13283,GO:0051971,0.999999999977122,0.848662799594569,0,2,positive regulation of transmission of nerve impulse,BP,
16931,GO:0098908,0.999999999977122,0.848662799594569,0,2,regulation of neuronal action potential,BP,
10718,GO:0044035,0.999999999977146,0.926059775244814,0,1,multi-organism catabolic process,BP,
10745,GO:0044115,0.999999999977146,0.926059775244814,0,1,development of symbiont involved in interaction with host,BP,
10752,GO:0044145,0.999999999977146,0.926059775244814,0,1,modulation of development of symbiont involved in interaction with host,BP,
10754,GO:0044147,0.999999999977146,0.926059775244814,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10969,GO:0044730,0.999999999977146,0.926059775244814,0,1,bone sialoprotein binding,MF,
13326,GO:0052214,0.999999999977146,0.926059775244814,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13327,GO:0052227,0.999999999977146,0.926059775244814,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13328,GO:0052229,0.999999999977146,0.926059775244814,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13340,GO:0052360,0.999999999977146,0.926059775244814,0,1,catabolism by host of symbiont macromolecule,BP,
13341,GO:0052361,0.999999999977146,0.926059775244814,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13342,GO:0052362,0.999999999977146,0.926059775244814,0,1,catabolism by host of symbiont protein,BP,
13343,GO:0052363,0.999999999977146,0.926059775244814,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13344,GO:0052364,0.999999999977146,0.926059775244814,0,1,catabolism by host of substance in symbiont,BP,
13348,GO:0052416,0.999999999977146,0.926059775244814,0,1,metabolism by host of symbiont macromolecule,BP,
13349,GO:0052417,0.999999999977146,0.926059775244814,0,1,metabolism by host of symbiont protein,BP,
13350,GO:0052418,0.999999999977146,0.926059775244814,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13351,GO:0052419,0.999999999977146,0.926059775244814,0,1,metabolism by host of substance in symbiont,BP,
19310,GO:1905581,0.999999999977146,0.926059775244814,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19315,GO:1905597,0.999999999977146,0.926059775244814,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19317,GO:1905599,0.999999999977146,0.926059775244814,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
2123,GO:0004918,0.999999999977157,0.921239315849045,0,1,interleukin-8 receptor activity,MF,
6314,GO:0019959,0.999999999977157,0.921239315849045,0,1,interleukin-8 binding,MF,
9708,GO:0038112,0.999999999977157,0.921239315849045,0,1,interleukin-8-mediated signaling pathway,BP,
1807,GO:0004454,0.999999999977158,0.921314978080444,0,1,ketohexokinase activity,MF,
2005,GO:0004729,0.999999999977192,0.924823256266469,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14936,GO:0070818,0.999999999977192,0.924823256266469,0,1,protoporphyrinogen oxidase activity,MF,
4998,GO:0015140,0.999999999977202,0.853760487163572,0,2,malate transmembrane transporter activity,MF,
112,GO:0000229,0.999999999977213,0.926606074282935,0,1,cytoplasmic chromosome,CC,
127,GO:0000262,0.999999999977213,0.926606074282935,0,1,mitochondrial chromosome,CC,
1891,GO:0004573,0.999999999977246,0.921130802800866,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
14584,GO:0070124,0.999999999977271,0.862312180158001,0,2,mitochondrial translational initiation,BP,
19403,GO:1905936,0.999999999977276,0.8806503828629,0,2,regulation of germ cell proliferation,BP,
19805,GO:2000254,0.999999999977276,0.8806503828629,0,2,regulation of male germ cell proliferation,BP,
2684,GO:0006046,0.999999999977283,0.786149244938057,0,3,N-acetylglucosamine catabolic process,BP,
5963,GO:0018364,0.999999999977339,0.884823960597831,0,2,peptidyl-glutamine methylation,BP,
1881,GO:0004560,0.999999999977397,0.850438181348383,0,2,alpha-L-fucosidase activity,MF,
5277,GO:0015928,0.999999999977397,0.850438181348383,0,2,fucosidase activity,MF,
1632,GO:0004074,0.999999999977402,0.880028140089733,0,2,biliverdin reductase activity,MF,
963,GO:0002396,0.999999999977407,0.923325139392083,0,1,MHC protein complex assembly,BP,
964,GO:0002397,0.999999999977407,0.923325139392083,0,1,MHC class I protein complex assembly,BP,
1012,GO:0002501,0.999999999977407,0.923325139392083,0,1,peptide antigen assembly with MHC protein complex,BP,
1013,GO:0002502,0.999999999977407,0.923325139392083,0,1,peptide antigen assembly with MHC class I protein complex,BP,
7981,GO:0032595,0.999999999977408,0.921911204108644,0,1,B cell receptor transport within lipid bilayer,BP,
7983,GO:0032597,0.999999999977408,0.921911204108644,0,1,B cell receptor transport into membrane raft,BP,
7984,GO:0032599,0.999999999977408,0.921911204108644,0,1,protein transport out of membrane raft,BP,
7985,GO:0032600,0.999999999977408,0.921911204108644,0,1,chemokine receptor transport out of membrane raft,BP,
8177,GO:0032913,0.999999999977408,0.921911204108644,0,1,negative regulation of transforming growth factor beta3 production,BP,
8469,GO:0033606,0.999999999977408,0.921911204108644,0,1,chemokine receptor transport within lipid bilayer,BP,
15643,GO:0072139,0.999999999977408,0.921911204108644,0,1,glomerular parietal epithelial cell differentiation,BP,
20100,GO:2000768,0.999999999977408,0.921911204108644,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
5951,GO:0018307,0.999999999977423,0.864895922397339,0,2,enzyme active site formation,BP,
3021,GO:0006566,0.999999999977453,0.854607394284988,0,2,threonine metabolic process,BP,
8423,GO:0033499,0.999999999977501,0.857272959304684,0,2,galactose catabolic process via UDP-galactose,BP,
16527,GO:0097238,0.999999999977504,0.872593874232195,0,2,cellular response to methylglyoxal,BP,
11020,GO:0044855,0.999999999977507,0.921130518832304,0,1,plasma membrane raft distribution,BP,
11021,GO:0044856,0.999999999977507,0.921130518832304,0,1,plasma membrane raft localization,BP,
11023,GO:0044858,0.999999999977507,0.921130518832304,0,1,plasma membrane raft polarization,BP,
18622,GO:1903906,0.999999999977507,0.921130518832304,0,1,regulation of plasma membrane raft polarization,BP,
2461,GO:0005674,0.999999999977527,0.855443808951765,0,2,transcription factor TFIIF complex,CC,
4372,GO:0009992,0.999999999977529,0.921898356612912,0,1,cellular water homeostasis,BP,
5972,GO:0018423,0.999999999977537,0.85792222245071,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
2736,GO:0006116,0.99999999997756,0.850160471476086,0,2,NADH oxidation,BP,
20247,GO:2001199,0.999999999977561,0.926793189928511,0,1,negative regulation of dendritic cell differentiation,BP,
10439,GO:0043293,0.999999999977569,0.851701338762879,0,2,apoptosome,CC,
1894,GO:0004577,0.999999999977584,0.862252133844302,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
9557,GO:0036324,0.999999999977601,0.860709512313245,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
16277,GO:0090341,0.999999999977605,0.927080416511698,0,1,negative regulation of secretion of lysosomal enzymes,BP,
582,GO:0001735,0.999999999977617,0.848521882613348,0,2,prenylcysteine oxidase activity,MF,
6859,GO:0030328,0.999999999977617,0.848521882613348,0,2,prenylcysteine catabolic process,BP,
6860,GO:0030329,0.999999999977617,0.848521882613348,0,2,prenylcysteine metabolic process,BP,
1788,GO:0004416,0.999999999977625,0.853897716634891,0,2,hydroxyacylglutathione hydrolase activity,MF,
6086,GO:0019243,0.999999999977625,0.853897716634891,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
13087,GO:0051596,0.999999999977625,0.853897716634891,0,2,methylglyoxal catabolic process,BP,
14426,GO:0061727,0.999999999977625,0.853897716634891,0,2,methylglyoxal catabolic process to lactate,BP,
16558,GO:0097332,0.999999999977659,0.864137155360698,0,2,response to antipsychotic drug,BP,
9228,GO:0035614,0.99999999997766,0.795780024014962,0,3,snRNA stem-loop binding,MF,
1215,GO:0002885,0.999999999977664,0.856337693230789,0,2,positive regulation of hypersensitivity,BP,
4865,GO:0014717,0.999999999977664,0.856337693230789,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4866,GO:0014718,0.999999999977664,0.856337693230789,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4940,GO:0014901,0.999999999977664,0.856337693230789,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5393,GO:0016230,0.999999999977664,0.856337693230789,0,2,sphingomyelin phosphodiesterase activator activity,MF,
10453,GO:0043309,0.999999999977664,0.856337693230789,0,2,regulation of eosinophil degranulation,BP,
10454,GO:0043311,0.999999999977664,0.856337693230789,0,2,positive regulation of eosinophil degranulation,BP,
12293,GO:0048627,0.999999999977664,0.856337693230789,0,2,myoblast development,BP,
18043,GO:1902566,0.999999999977664,0.856337693230789,0,2,regulation of eosinophil activation,BP,
18044,GO:1902568,0.999999999977664,0.856337693230789,0,2,positive regulation of eosinophil activation,BP,
19778,GO:2000196,0.999999999977664,0.856337693230789,0,2,positive regulation of female gonad development,BP,
19896,GO:2000386,0.999999999977664,0.856337693230789,0,2,positive regulation of ovarian follicle development,BP,
8,GO:0000015,0.999999999977681,0.924109713317508,0,1,phosphopyruvate hydratase complex,CC,
1935,GO:0004634,0.999999999977681,0.924109713317508,0,1,phosphopyruvate hydratase activity,MF,
11612,GO:0046294,0.999999999977686,0.859616750731683,0,2,formaldehyde catabolic process,BP,
3811,GO:0008401,0.999999999977717,0.848491295446436,0,2,retinoic acid 4-hydroxylase activity,MF,
5104,GO:0015389,0.999999999977721,0.921750246382537,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5105,GO:0015390,0.999999999977721,0.921750246382537,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5106,GO:0015391,0.999999999977721,0.921750246382537,0,1,nucleobase:cation symporter activity,MF,
18773,GO:1904274,0.999999999977721,0.921750246382537,0,1,tricellular tight junction assembly,BP,
969,GO:0002416,0.99999999997775,0.924649058318101,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
6222,GO:0019770,0.99999999997775,0.924649058318101,0,1,IgG receptor activity,MF,
6270,GO:0019864,0.99999999997775,0.924649058318101,0,1,IgG binding,MF,
15436,GO:0071707,0.99999999997778,0.931837593925382,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
11048,GO:0045031,0.999999999977781,0.850139550846867,0,2,ATP-activated adenosine receptor activity,MF,
3852,GO:0008465,0.999999999977818,0.932382323022418,0,1,glycerate dehydrogenase activity,MF,
14294,GO:0061394,0.999999999977858,0.853420888730872,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
5710,GO:0016841,0.999999999977867,0.848575112248314,0,2,ammonia-lyase activity,MF,
1712,GO:0004304,0.999999999977867,0.924456114308581,0,1,estrone sulfotransferase activity,MF,
3087,GO:0006660,0.999999999977867,0.924456114308581,0,1,phosphatidylserine catabolic process,BP,
3130,GO:0006711,0.999999999977867,0.924456114308581,0,1,estrogen catabolic process,BP,
11219,GO:0045352,0.999999999977867,0.924456114308581,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11220,GO:0045353,0.999999999977867,0.924456114308581,0,1,interleukin-1 Type II receptor antagonist activity,MF,
14564,GO:0070091,0.999999999977913,0.781572043254746,0,3,glucagon secretion,BP,
14565,GO:0070092,0.999999999977913,0.781572043254746,0,3,regulation of glucagon secretion,BP,
2118,GO:0004909,0.999999999977916,0.850145510388775,0,2,interleukin-1, Type I, activating receptor activity,MF,
8754,GO:0034414,0.999999999977926,0.849021850224211,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10186,GO:0042779,0.999999999977926,0.849021850224211,0,2,tRNA 3'-trailer cleavage,BP,
10188,GO:0042781,0.999999999977926,0.849021850224211,0,2,3'-tRNA processing endoribonuclease activity,MF,
19185,GO:1905267,0.999999999977926,0.849021850224211,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
12608,GO:0050787,0.999999999977926,0.86476506344825,0,2,detoxification of mercury ion,BP,
18285,GO:1903179,0.999999999977926,0.86476506344825,0,2,regulation of dopamine biosynthetic process,BP,
18286,GO:1903181,0.999999999977926,0.86476506344825,0,2,positive regulation of dopamine biosynthetic process,BP,
19822,GO:2000282,0.999999999977926,0.86476506344825,0,2,regulation of cellular amino acid biosynthetic process,BP,
5430,GO:0016287,0.999999999977937,0.921134669844574,0,1,glycerone-phosphate O-acyltransferase activity,MF,
4321,GO:0009814,0.999999999977941,0.921822513160466,0,1,defense response, incompatible interaction,BP,
4322,GO:0009817,0.999999999977941,0.921822513160466,0,1,defense response to fungus, incompatible interaction,BP,
19207,GO:1905313,0.999999999977941,0.921822513160466,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19512,GO:1990402,0.999999999977941,0.921822513160466,0,1,embryonic liver development,BP,
8910,GO:0034739,0.999999999977942,0.853967961446163,0,2,histone deacetylase activity (H4-K16 specific),MF,
3853,GO:0008466,0.999999999977953,0.924219274820401,0,1,glycogenin glucosyltransferase activity,MF,
17166,GO:0102751,0.999999999977953,0.924219274820401,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
1846,GO:0004505,0.999999999977955,0.863510117150838,0,2,phenylalanine 4-monooxygenase activity,MF,
3650,GO:0008124,0.999999999977955,0.863510117150838,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
17785,GO:1901856,0.999999999977964,0.848831108544366,0,2,negative regulation of cellular respiration,BP,
5900,GO:0018106,0.999999999977984,0.943676428490314,0,1,peptidyl-histidine phosphorylation,BP,
12504,GO:0050613,0.999999999978007,0.853579245956411,0,2,delta14-sterol reductase activity,MF,
17121,GO:0102009,0.999999999978077,0.923475534945351,0,1,proline dipeptidase activity,MF,
2025,GO:0004757,0.999999999978096,0.928600026608026,0,1,sepiapterin reductase activity,MF,
4954,GO:0015018,0.999999999978097,0.928852145588348,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
9526,GO:0036245,0.999999999978118,0.855041931915804,0,2,cellular response to menadione,BP,
2998,GO:0006543,0.999999999978123,0.781555787704515,0,3,glutamine catabolic process,BP,
2965,GO:0006500,0.999999999978216,0.92206833991883,0,1,N-terminal protein palmitoylation,BP,
5879,GO:0018009,0.999999999978216,0.92206833991883,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
14387,GO:0061628,0.999999999978235,0.848870912906406,0,2,H3K27me3 modified histone binding,MF,
3780,GO:0008336,0.999999999978236,0.923514179924583,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4989,GO:0015117,0.999999999978236,0.923514179924583,0,1,thiosulfate transmembrane transporter activity,MF,
4995,GO:0015131,0.999999999978236,0.923514179924583,0,1,oxaloacetate transmembrane transporter activity,MF,
5165,GO:0015709,0.999999999978236,0.923514179924583,0,1,thiosulfate transport,BP,
5175,GO:0015729,0.999999999978236,0.923514179924583,0,1,oxaloacetate transport,BP,
5181,GO:0015743,0.999999999978236,0.923514179924583,0,1,malate transport,BP,
15256,GO:0071423,0.999999999978236,0.923514179924583,0,1,malate transmembrane transport,BP,
17966,GO:1902356,0.999999999978236,0.923514179924583,0,1,oxaloacetate(2-) transmembrane transport,BP,
1499,GO:0003845,0.999999999978249,0.858330233289777,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
7866,GO:0032427,0.999999999978252,0.849220679375026,0,2,GBD domain binding,MF,
19188,GO:1905271,0.999999999978263,0.946316059997483,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19189,GO:1905273,0.999999999978263,0.946316059997483,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
1759,GO:0004362,0.999999999978373,0.921613057221649,0,1,glutathione-disulfide reductase activity,MF,
16574,GO:0097362,0.999999999978386,0.848588624992027,0,2,MCM8-MCM9 complex,CC,
16659,GO:0097532,0.999999999978416,0.85292916013191,0,2,stress response to acid chemical,BP,
16660,GO:0097533,0.999999999978416,0.85292916013191,0,2,cellular stress response to acid chemical,BP,
71,GO:0000147,0.999999999978465,0.781541506249642,0,3,actin cortical patch assembly,BP,
147,GO:0000301,0.999999999978465,0.781541506249642,0,3,retrograde transport, vesicle recycling within Golgi,BP,
187,GO:0000404,0.999999999978465,0.781541506249642,0,3,heteroduplex DNA loop binding,MF,
295,GO:0000799,0.999999999978465,0.781541506249642,0,3,nuclear condensin complex,CC,
384,GO:0001025,0.999999999978465,0.781541506249642,0,3,RNA polymerase III transcription factor binding,MF,
430,GO:0001156,0.999999999978465,0.781541506249642,0,3,TFIIIC-class transcription factor binding,MF,
451,GO:0001224,0.999999999978465,0.781541506249642,0,3,RNA polymerase II transcription cofactor binding,MF,
700,GO:0001920,0.999999999978465,0.781541506249642,0,3,negative regulation of receptor recycling,BP,
722,GO:0001951,0.999999999978465,0.781541506249642,0,3,intestinal D-glucose absorption,BP,
857,GO:0002188,0.999999999978465,0.781541506249642,0,3,translation reinitiation,BP,
892,GO:0002265,0.999999999978465,0.781541506249642,0,3,astrocyte activation involved in immune response,BP,
928,GO:0002326,0.999999999978465,0.781541506249642,0,3,B cell lineage commitment,BP,
1335,GO:0003192,0.999999999978465,0.781541506249642,0,3,mitral valve formation,BP,
1426,GO:0003383,0.999999999978465,0.781541506249642,0,3,apical constriction,BP,
1431,GO:0003406,0.999999999978465,0.781541506249642,0,3,retinal pigment epithelium development,BP,
1512,GO:0003873,0.999999999978465,0.781541506249642,0,3,6-phosphofructo-2-kinase activity,MF,
1522,GO:0003886,0.999999999978465,0.781541506249642,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1691,GO:0004165,0.999999999978465,0.781541506249642,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1741,GO:0004340,0.999999999978465,0.781541506249642,0,3,glucokinase activity,MF,
1782,GO:0004396,0.999999999978465,0.781541506249642,0,3,hexokinase activity,MF,
1852,GO:0004515,0.999999999978465,0.781541506249642,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1869,GO:0004534,0.999999999978465,0.781541506249642,0,3,5'-3' exoribonuclease activity,MF,
1968,GO:0004677,0.999999999978465,0.781541506249642,0,3,DNA-dependent protein kinase activity,MF,
1986,GO:0004706,0.999999999978465,0.781541506249642,0,3,JUN kinase kinase kinase activity,MF,
2014,GO:0004741,0.999999999978465,0.781541506249642,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2078,GO:0004832,0.999999999978465,0.781541506249642,0,3,valine-tRNA ligase activity,MF,
2127,GO:0004924,0.999999999978465,0.781541506249642,0,3,oncostatin-M receptor activity,MF,
2151,GO:0004970,0.999999999978465,0.781541506249642,0,3,ionotropic glutamate receptor activity,MF,
2174,GO:0005010,0.999999999978465,0.781541506249642,0,3,insulin-like growth factor-activated receptor activity,MF,
2178,GO:0005025,0.999999999978465,0.781541506249642,0,3,transforming growth factor beta receptor activity, type I,MF,
2259,GO:0005173,0.999999999978465,0.781541506249642,0,3,stem cell factor receptor binding,MF,
2276,GO:0005220,0.999999999978465,0.781541506249642,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2315,GO:0005315,0.999999999978465,0.781541506249642,0,3,inorganic phosphate transmembrane transporter activity,MF,
2430,GO:0005610,0.999999999978465,0.781541506249642,0,3,laminin-5 complex,CC,
2581,GO:0005873,0.999999999978465,0.781541506249642,0,3,plus-end kinesin complex,CC,
2710,GO:0006083,0.999999999978465,0.781541506249642,0,3,acetate metabolic process,BP,
2928,GO:0006438,0.999999999978465,0.781541506249642,0,3,valyl-tRNA aminoacylation,BP,
3199,GO:0006828,0.999999999978465,0.781541506249642,0,3,manganese ion transport,BP,
3209,GO:0006848,0.999999999978465,0.781541506249642,0,3,pyruvate transport,BP,
3351,GO:0007079,0.999999999978465,0.781541506249642,0,3,mitotic chromosome movement towards spindle pole,BP,
3437,GO:0007227,0.999999999978465,0.781541506249642,0,3,signal transduction downstream of smoothened,BP,
3803,GO:0008381,0.999999999978465,0.781541506249642,0,3,mechanosensitive ion channel activity,MF,
3858,GO:0008475,0.999999999978465,0.781541506249642,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3990,GO:0008865,0.999999999978465,0.781541506249642,0,3,fructokinase activity,MF,
4002,GO:0008940,0.999999999978465,0.781541506249642,0,3,nitrate reductase activity,MF,
4170,GO:0009236,0.999999999978465,0.781541506249642,0,3,cobalamin biosynthetic process,BP,
4446,GO:0010360,0.999999999978465,0.781541506249642,0,3,negative regulation of anion channel activity,BP,
4562,GO:0010643,0.999999999978465,0.781541506249642,0,3,cell communication by chemical coupling,BP,
4608,GO:0010724,0.999999999978465,0.781541506249642,0,3,regulation of definitive erythrocyte differentiation,BP,
4741,GO:0010908,0.999999999978465,0.781541506249642,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4742,GO:0010909,0.999999999978465,0.781541506249642,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4780,GO:0010966,0.999999999978465,0.781541506249642,0,3,regulation of phosphate transport,BP,
4824,GO:0014022,0.999999999978465,0.781541506249642,0,3,neural plate elongation,BP,
4845,GO:0014052,0.999999999978465,0.781541506249642,0,3,regulation of gamma-aminobutyric acid secretion,BP,
4882,GO:0014744,0.999999999978465,0.781541506249642,0,3,positive regulation of muscle adaptation,BP,
4903,GO:0014832,0.999999999978465,0.781541506249642,0,3,urinary bladder smooth muscle contraction,BP,
4912,GO:0014848,0.999999999978465,0.781541506249642,0,3,urinary tract smooth muscle contraction,BP,
4985,GO:0015111,0.999999999978465,0.781541506249642,0,3,iodide transmembrane transporter activity,MF,
5052,GO:0015247,0.999999999978465,0.781541506249642,0,3,aminophospholipid transmembrane transporter activity,MF,
5066,GO:0015280,0.999999999978465,0.781541506249642,0,3,ligand-gated sodium channel activity,MF,
5109,GO:0015410,0.999999999978465,0.781541506249642,0,3,manganese-transporting ATPase activity,MF,
5170,GO:0015722,0.999999999978465,0.781541506249642,0,3,canalicular bile acid transport,BP,
5201,GO:0015798,0.999999999978465,0.781541506249642,0,3,myo-inositol transport,BP,
5342,GO:0016080,0.999999999978465,0.781541506249642,0,3,synaptic vesicle targeting,BP,
5437,GO:0016300,0.999999999978465,0.781541506249642,0,3,tRNA (uracil) methyltransferase activity,MF,
5442,GO:0016309,0.999999999978465,0.781541506249642,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5757,GO:0016917,0.999999999978465,0.781541506249642,0,3,GABA receptor activity,MF,
5766,GO:0016939,0.999999999978465,0.781541506249642,0,3,kinesin II complex,CC,
5891,GO:0018057,0.999999999978465,0.781541506249642,0,3,peptidyl-lysine oxidation,BP,
5922,GO:0018197,0.999999999978465,0.781541506249642,0,3,peptidyl-aspartic acid modification,BP,
5973,GO:0018444,0.999999999978465,0.781541506249642,0,3,translation release factor complex,CC,
6045,GO:0019158,0.999999999978465,0.781541506249642,0,3,mannokinase activity,MF,
6345,GO:0021521,0.999999999978465,0.781541506249642,0,3,ventral spinal cord interneuron specification,BP,
6387,GO:0021578,0.999999999978465,0.781541506249642,0,3,hindbrain maturation,BP,
6405,GO:0021626,0.999999999978465,0.781541506249642,0,3,central nervous system maturation,BP,
6406,GO:0021631,0.999999999978465,0.781541506249642,0,3,optic nerve morphogenesis,BP,
6441,GO:0021747,0.999999999978465,0.781541506249642,0,3,cochlear nucleus development,BP,
6455,GO:0021775,0.999999999978465,0.781541506249642,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6456,GO:0021776,0.999999999978465,0.781541506249642,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6477,GO:0021817,0.999999999978465,0.781541506249642,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6533,GO:0021936,0.999999999978465,0.781541506249642,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6561,GO:0022007,0.999999999978465,0.781541506249642,0,3,convergent extension involved in neural plate elongation,BP,
6681,GO:0030046,0.999999999978465,0.781541506249642,0,3,parallel actin filament bundle assembly,BP,
6682,GO:0030047,0.999999999978465,0.781541506249642,0,3,actin modification,BP,
6740,GO:0030158,0.999999999978465,0.781541506249642,0,3,protein xylosyltransferase activity,MF,
6790,GO:0030226,0.999999999978465,0.781541506249642,0,3,apolipoprotein receptor activity,MF,
6792,GO:0030229,0.999999999978465,0.781541506249642,0,3,very-low-density lipoprotein particle receptor activity,MF,
6880,GO:0030375,0.999999999978465,0.781541506249642,0,3,thyroid hormone receptor coactivator activity,MF,
6945,GO:0030553,0.999999999978465,0.781541506249642,0,3,cGMP binding,MF,
7032,GO:0030805,0.999999999978465,0.781541506249642,0,3,regulation of cyclic nucleotide catabolic process,BP,
7047,GO:0030820,0.999999999978465,0.781541506249642,0,3,regulation of cAMP catabolic process,BP,
7242,GO:0031166,0.999999999978465,0.781541506249642,0,3,integral component of vacuolar membrane,CC,
7308,GO:0031310,0.999999999978465,0.781541506249642,0,3,intrinsic component of vacuolar membrane,CC,
7451,GO:0031587,0.999999999978465,0.781541506249642,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7469,GO:0031627,0.999999999978465,0.781541506249642,0,3,telomeric loop formation,BP,
7551,GO:0031860,0.999999999978465,0.781541506249642,0,3,telomeric 3' overhang formation,BP,
7690,GO:0032142,0.999999999978465,0.781541506249642,0,3,single guanine insertion binding,MF,
7732,GO:0032227,0.999999999978465,0.781541506249642,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7743,GO:0032252,0.999999999978465,0.781541506249642,0,3,secretory granule localization,BP,
7766,GO:0032286,0.999999999978465,0.781541506249642,0,3,central nervous system myelin maintenance,BP,
7888,GO:0032455,0.999999999978465,0.781541506249642,0,3,nerve growth factor processing,BP,
7911,GO:0032484,0.999999999978465,0.781541506249642,0,3,Ral protein signal transduction,BP,
7912,GO:0032485,0.999999999978465,0.781541506249642,0,3,regulation of Ral protein signal transduction,BP,
7914,GO:0032487,0.999999999978465,0.781541506249642,0,3,regulation of Rap protein signal transduction,BP,
8093,GO:0032776,0.999999999978465,0.781541506249642,0,3,DNA methylation on cytosine,BP,
8165,GO:0032898,0.999999999978465,0.781541506249642,0,3,neurotrophin production,BP,
8294,GO:0033121,0.999999999978465,0.781541506249642,0,3,regulation of purine nucleotide catabolic process,BP,
8426,GO:0033504,0.999999999978465,0.781541506249642,0,3,floor plate development,BP,
8439,GO:0033557,0.999999999978465,0.781541506249642,0,3,Slx1-Slx4 complex,CC,
8445,GO:0033565,0.999999999978465,0.781541506249642,0,3,ESCRT-0 complex,CC,
8574,GO:0034040,0.999999999978465,0.781541506249642,0,3,lipid-transporting ATPase activity,MF,
8683,GO:0034274,0.999999999978465,0.781541506249642,0,3,Atg12-Atg5-Atg16 complex,CC,
8706,GO:0034343,0.999999999978465,0.781541506249642,0,3,type III interferon production,BP,
8707,GO:0034344,0.999999999978465,0.781541506249642,0,3,regulation of type III interferon production,BP,
8986,GO:0035092,0.999999999978465,0.781541506249642,0,3,sperm chromatin condensation,BP,
9164,GO:0035517,0.999999999978465,0.781541506249642,0,3,PR-DUB complex,CC,
9230,GO:0035616,0.999999999978465,0.781541506249642,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9310,GO:0035766,0.999999999978465,0.781541506249642,0,3,cell chemotaxis to fibroblast growth factor,BP,
9312,GO:0035768,0.999999999978465,0.781541506249642,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9325,GO:0035799,0.999999999978465,0.781541506249642,0,3,ureter maturation,BP,
9403,GO:0035948,0.999999999978465,0.781541506249642,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9661,GO:0038007,0.999999999978465,0.781541506249642,0,3,netrin-activated signaling pathway,BP,
9668,GO:0038026,0.999999999978465,0.781541506249642,0,3,reelin-mediated signaling pathway,BP,
9725,GO:0038165,0.999999999978465,0.781541506249642,0,3,oncostatin-M-mediated signaling pathway,BP,
9959,GO:0042328,0.999999999978465,0.781541506249642,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10501,GO:0043402,0.999999999978465,0.781541506249642,0,3,glucocorticoid mediated signaling pathway,BP,
10604,GO:0043578,0.999999999978465,0.781541506249642,0,3,nuclear matrix organization,BP,
10662,GO:0043812,0.999999999978465,0.781541506249642,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10813,GO:0044300,0.999999999978465,0.781541506249642,0,3,cerebellar mossy fiber,CC,
10815,GO:0044302,0.999999999978465,0.781541506249642,0,3,dentate gyrus mossy fiber,CC,
10822,GO:0044313,0.999999999978465,0.781541506249642,0,3,protein K6-linked deubiquitination,BP,
10842,GO:0044336,0.999999999978465,0.781541506249642,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10846,GO:0044341,0.999999999978465,0.781541506249642,0,3,sodium-dependent phosphate transport,BP,
10872,GO:0044396,0.999999999978465,0.781541506249642,0,3,actin cortical patch organization,BP,
10947,GO:0044611,0.999999999978465,0.781541506249642,0,3,nuclear pore inner ring,CC,
11152,GO:0045204,0.999999999978465,0.781541506249642,0,3,MAPK export from nucleus,BP,
11755,GO:0046601,0.999999999978465,0.781541506249642,0,3,positive regulation of centriole replication,BP,
11907,GO:0046935,0.999999999978465,0.781541506249642,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
11912,GO:0046946,0.999999999978465,0.781541506249642,0,3,hydroxylysine metabolic process,BP,
11913,GO:0046947,0.999999999978465,0.781541506249642,0,3,hydroxylysine biosynthetic process,BP,
12057,GO:0048003,0.999999999978465,0.781541506249642,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12059,GO:0048007,0.999999999978465,0.781541506249642,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12073,GO:0048021,0.999999999978465,0.781541506249642,0,3,regulation of melanin biosynthetic process,BP,
12294,GO:0048630,0.999999999978465,0.781541506249642,0,3,skeletal muscle tissue growth,BP,
12295,GO:0048631,0.999999999978465,0.781541506249642,0,3,regulation of skeletal muscle tissue growth,BP,
12296,GO:0048633,0.999999999978465,0.781541506249642,0,3,positive regulation of skeletal muscle tissue growth,BP,
12399,GO:0048840,0.999999999978465,0.781541506249642,0,3,otolith development,BP,
12459,GO:0050265,0.999999999978465,0.781541506249642,0,3,RNA uridylyltransferase activity,MF,
12640,GO:0050833,0.999999999978465,0.781541506249642,0,3,pyruvate transmembrane transporter activity,MF,
12975,GO:0051377,0.999999999978465,0.781541506249642,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13098,GO:0051610,0.999999999978465,0.781541506249642,0,3,serotonin uptake,BP,
13125,GO:0051666,0.999999999978465,0.781541506249642,0,3,actin cortical patch localization,BP,
13193,GO:0051799,0.999999999978465,0.781541506249642,0,3,negative regulation of hair follicle development,BP,
13456,GO:0052905,0.999999999978465,0.781541506249642,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13785,GO:0060371,0.999999999978465,0.781541506249642,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13788,GO:0060374,0.999999999978465,0.781541506249642,0,3,mast cell differentiation,BP,
13809,GO:0060398,0.999999999978465,0.781541506249642,0,3,regulation of growth hormone receptor signaling pathway,BP,
13916,GO:0060573,0.999999999978465,0.781541506249642,0,3,cell fate specification involved in pattern specification,BP,
13922,GO:0060579,0.999999999978465,0.781541506249642,0,3,ventral spinal cord interneuron fate commitment,BP,
13923,GO:0060581,0.999999999978465,0.781541506249642,0,3,cell fate commitment involved in pattern specification,BP,
14092,GO:0060920,0.999999999978465,0.781541506249642,0,3,cardiac pacemaker cell differentiation,BP,
14096,GO:0060926,0.999999999978465,0.781541506249642,0,3,cardiac pacemaker cell development,BP,
14121,GO:0060979,0.999999999978465,0.781541506249642,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14284,GO:0061364,0.999999999978465,0.781541506249642,0,3,apoptotic process involved in luteolysis,BP,
14340,GO:0061535,0.999999999978465,0.781541506249642,0,3,glutamate secretion, neurotransmission,BP,
14434,GO:0061739,0.999999999978465,0.781541506249642,0,3,protein lipidation involved in autophagosome assembly,BP,
14462,GO:0061817,0.999999999978465,0.781541506249642,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14592,GO:0070138,0.999999999978465,0.781541506249642,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14594,GO:0070140,0.999999999978465,0.781541506249642,0,3,SUMO-specific isopeptidase activity,MF,
14690,GO:0070305,0.999999999978465,0.781541506249642,0,3,response to cGMP,BP,
14720,GO:0070369,0.999999999978465,0.781541506249642,0,3,beta-catenin-TCF7L2 complex,CC,
14732,GO:0070384,0.999999999978465,0.781541506249642,0,3,Harderian gland development,BP,
14869,GO:0070644,0.999999999978465,0.781541506249642,0,3,vitamin D response element binding,MF,
14951,GO:0070842,0.999999999978465,0.781541506249642,0,3,aggresome assembly,BP,
15028,GO:0070966,0.999999999978465,0.781541506249642,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15096,GO:0071107,0.999999999978465,0.781541506249642,0,3,response to parathyroid hormone,BP,
15168,GO:0071286,0.999999999978465,0.781541506249642,0,3,cellular response to magnesium ion,BP,
15186,GO:0071321,0.999999999978465,0.781541506249642,0,3,cellular response to cGMP,BP,
15361,GO:0071596,0.999999999978465,0.781541506249642,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15422,GO:0071688,0.999999999978465,0.781541506249642,0,3,striated muscle myosin thick filament assembly,BP,
15442,GO:0071723,0.999999999978465,0.781541506249642,0,3,lipopeptide binding,MF,
15609,GO:0072093,0.999999999978465,0.781541506249642,0,3,metanephric renal vesicle formation,BP,
15700,GO:0072235,0.999999999978465,0.781541506249642,0,3,metanephric distal tubule development,BP,
15701,GO:0072236,0.999999999978465,0.781541506249642,0,3,metanephric loop of Henle development,BP,
15744,GO:0072320,0.999999999978465,0.781541506249642,0,3,volume-sensitive chloride channel activity,MF,
16042,GO:0086070,0.999999999978465,0.781541506249642,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16045,GO:0086075,0.999999999978465,0.781541506249642,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16060,GO:0089700,0.999999999978465,0.781541506249642,0,3,protein kinase D signaling,BP,
16127,GO:0090116,0.999999999978465,0.781541506249642,0,3,C-5 methylation of cytosine,BP,
16204,GO:0090234,0.999999999978465,0.781541506249642,0,3,regulation of kinetochore assembly,BP,
16225,GO:0090269,0.999999999978465,0.781541506249642,0,3,fibroblast growth factor production,BP,
16226,GO:0090270,0.999999999978465,0.781541506249642,0,3,regulation of fibroblast growth factor production,BP,
16244,GO:0090292,0.999999999978465,0.781541506249642,0,3,nuclear matrix anchoring at nuclear membrane,BP,
16312,GO:0090480,0.999999999978465,0.781541506249642,0,3,purine nucleotide-sugar transmembrane transport,BP,
16404,GO:0097025,0.999999999978465,0.781541506249642,0,3,MPP7-DLG1-LIN7 complex,CC,
16418,GO:0097051,0.999999999978465,0.781541506249642,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16712,GO:0097694,0.999999999978465,0.781541506249642,0,3,establishment of RNA localization to telomere,BP,
16713,GO:0097695,0.999999999978465,0.781541506249642,0,3,establishment of protein-containing complex localization to telomere,BP,
16732,GO:0097742,0.999999999978465,0.781541506249642,0,3,de novo centriole assembly,BP,
16757,GO:0098535,0.999999999978465,0.781541506249642,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16758,GO:0098536,0.999999999978465,0.781541506249642,0,3,deuterosome,CC,
16781,GO:0098592,0.999999999978465,0.781541506249642,0,3,cytoplasmic side of apical plasma membrane,CC,
16836,GO:0098735,0.999999999978465,0.781541506249642,0,3,positive regulation of the force of heart contraction,BP,
16883,GO:0098821,0.999999999978465,0.781541506249642,0,3,BMP receptor activity,MF,
16937,GO:0098915,0.999999999978465,0.781541506249642,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16949,GO:0098935,0.999999999978465,0.781541506249642,0,3,dendritic transport,BP,
16951,GO:0098937,0.999999999978465,0.781541506249642,0,3,anterograde dendritic transport,BP,
16977,GO:0099010,0.999999999978465,0.781541506249642,0,3,modification of postsynaptic structure,BP,
17023,GO:0099174,0.999999999978465,0.781541506249642,0,3,regulation of presynapse organization,BP,
17189,GO:0106001,0.999999999978465,0.781541506249642,0,3,intestinal hexose absorption,BP,
17195,GO:0106017,0.999999999978465,0.781541506249642,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17402,GO:1900133,0.999999999978465,0.781541506249642,0,3,regulation of renin secretion into blood stream,BP,
17650,GO:1901387,0.999999999978465,0.781541506249642,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17658,GO:1901475,0.999999999978465,0.781541506249642,0,3,pyruvate transmembrane transport,BP,
17676,GO:1901537,0.999999999978465,0.781541506249642,0,3,positive regulation of DNA demethylation,BP,
17804,GO:1901897,0.999999999978465,0.781541506249642,0,3,regulation of relaxation of cardiac muscle,BP,
17987,GO:1902412,0.999999999978465,0.781541506249642,0,3,regulation of mitotic cytokinesis,BP,
18014,GO:1902498,0.999999999978465,0.781541506249642,0,3,regulation of protein autoubiquitination,BP,
18098,GO:1902730,0.999999999978465,0.781541506249642,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18201,GO:1902988,0.999999999978465,0.781541506249642,0,3,neurofibrillary tangle assembly,BP,
18306,GO:1903223,0.999999999978465,0.781541506249642,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18396,GO:1903422,0.999999999978465,0.781541506249642,0,3,negative regulation of synaptic vesicle recycling,BP,
18444,GO:1903527,0.999999999978465,0.781541506249642,0,3,positive regulation of membrane tubulation,BP,
18577,GO:1903818,0.999999999978465,0.781541506249642,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18710,GO:1904116,0.999999999978465,0.781541506249642,0,3,response to vasopressin,BP,
18711,GO:1904117,0.999999999978465,0.781541506249642,0,3,cellular response to vasopressin,BP,
18725,GO:1904177,0.999999999978465,0.781541506249642,0,3,regulation of adipose tissue development,BP,
18726,GO:1904179,0.999999999978465,0.781541506249642,0,3,positive regulation of adipose tissue development,BP,
18822,GO:1904396,0.999999999978465,0.781541506249642,0,3,regulation of neuromuscular junction development,BP,
18837,GO:1904430,0.999999999978465,0.781541506249642,0,3,negative regulation of t-circle formation,BP,
18873,GO:1904533,0.999999999978465,0.781541506249642,0,3,regulation of telomeric loop disassembly,BP,
18939,GO:1904693,0.999999999978465,0.781541506249642,0,3,midbrain morphogenesis,BP,
18940,GO:1904694,0.999999999978465,0.781541506249642,0,3,negative regulation of vascular smooth muscle contraction,BP,
19018,GO:1904847,0.999999999978465,0.781541506249642,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19321,GO:1905606,0.999999999978465,0.781541506249642,0,3,regulation of presynapse assembly,BP,
19358,GO:1905773,0.999999999978465,0.781541506249642,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19441,GO:1990075,0.999999999978465,0.781541506249642,0,3,periciliary membrane compartment,CC,
19626,GO:1990785,0.999999999978465,0.781541506249642,0,3,response to water-immersion restraint stress,BP,
19645,GO:1990851,0.999999999978465,0.781541506249642,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19907,GO:2000402,0.999999999978465,0.781541506249642,0,3,negative regulation of lymphocyte migration,BP,
19925,GO:2000425,0.999999999978465,0.781541506249642,0,3,regulation of apoptotic cell clearance,BP,
19969,GO:2000544,0.999999999978465,0.781541506249642,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
20031,GO:2000653,0.999999999978465,0.781541506249642,0,3,regulation of genetic imprinting,BP,
20048,GO:2000671,0.999999999978465,0.781541506249642,0,3,regulation of motor neuron apoptotic process,BP,
20049,GO:2000672,0.999999999978465,0.781541506249642,0,3,negative regulation of motor neuron apoptotic process,BP,
20085,GO:2000741,0.999999999978465,0.781541506249642,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
20121,GO:2000807,0.999999999978465,0.781541506249642,0,3,regulation of synaptic vesicle clustering,BP,
3690,GO:0008193,0.999999999978465,0.857713585754395,0,2,tRNA guanylyltransferase activity,MF,
1836,GO:0004491,0.999999999978466,0.921878453477343,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4737,GO:0010904,0.999999999978466,0.921878453477343,0,1,regulation of UDP-glucose catabolic process,BP,
4738,GO:0010905,0.999999999978466,0.921878453477343,0,1,negative regulation of UDP-glucose catabolic process,BP,
5976,GO:0018478,0.999999999978466,0.921878453477343,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18749,GO:1904226,0.999999999978466,0.921878453477343,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18750,GO:1904227,0.999999999978466,0.921878453477343,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
10862,GO:0044378,0.999999999978497,0.855211713897318,0,2,non-sequence-specific DNA binding, bending,MF,
6875,GO:0030366,0.999999999978527,0.860270503430523,0,2,molybdopterin synthase activity,MF,
8460,GO:0033597,0.999999999978531,0.921997229128143,0,1,mitotic checkpoint complex,CC,
19495,GO:1990298,0.999999999978531,0.921997229128143,0,1,bub1-bub3 complex,CC,
13537,GO:0055120,0.999999999978589,0.93630226683831,0,1,striated muscle dense body,CC,
1849,GO:0004512,0.999999999978662,0.921632057797935,0,1,inositol-3-phosphate synthase activity,MF,
5728,GO:0016872,0.999999999978662,0.921632057797935,0,1,intramolecular lyase activity,MF,
16737,GO:0097752,0.999999999978716,0.781541521045568,0,3,regulation of DNA stability,BP,
4715,GO:0010877,0.999999999978717,0.860395009714058,0,2,lipid transport involved in lipid storage,BP,
6622,GO:0022848,0.999999999978724,0.78181922934046,0,3,acetylcholine-gated cation-selective channel activity,MF,
1727,GO:0004320,0.999999999978725,0.851757223349049,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5433,GO:0016295,0.999999999978725,0.851757223349049,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5434,GO:0016296,0.999999999978725,0.851757223349049,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5435,GO:0016297,0.999999999978725,0.851757223349049,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
16107,GO:0090086,0.99999999997875,0.807264805225782,0,3,negative regulation of protein deubiquitination,BP,
14699,GO:0070320,0.999999999978819,0.921137576752675,0,1,inward rectifier potassium channel inhibitor activity,MF,
17370,GO:1900085,0.999999999978819,0.921137576752675,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18487,GO:1903596,0.999999999978819,0.921137576752675,0,1,regulation of gap junction assembly,BP,
18488,GO:1903598,0.999999999978819,0.921137576752675,0,1,positive regulation of gap junction assembly,BP,
18491,GO:1903609,0.999999999978819,0.921137576752675,0,1,negative regulation of inward rectifier potassium channel activity,BP,
943,GO:0002357,0.999999999978845,0.921129476761211,0,1,defense response to tumor cell,BP,
15331,GO:0071547,0.999999999978845,0.921129476761211,0,1,piP-body,CC,
3976,GO:0008794,0.999999999978851,0.939344500702378,0,1,arsenate reductase (glutaredoxin) activity,MF,
6959,GO:0030611,0.999999999978851,0.939344500702378,0,1,arsenate reductase activity,MF,
19088,GO:1904990,0.999999999978871,0.921286179507575,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19089,GO:1904992,0.999999999978871,0.921286179507575,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
5999,GO:0019008,0.999999999978906,0.855838149219398,0,2,molybdopterin synthase complex,CC,
14484,GO:0061888,0.999999999978908,0.789511803210276,0,3,regulation of astrocyte activation,BP,
17323,GO:0150003,0.999999999978908,0.789511803210276,0,3,regulation of spontaneous synaptic transmission,BP,
5005,GO:0015152,0.999999999978911,0.922194562022723,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7629,GO:0032028,0.999999999978911,0.922194562022723,0,1,myosin head/neck binding,MF,
12211,GO:0048389,0.999999999978939,0.924446415230526,0,1,intermediate mesoderm development,BP,
12212,GO:0048390,0.999999999978939,0.924446415230526,0,1,intermediate mesoderm morphogenesis,BP,
12213,GO:0048391,0.999999999978939,0.924446415230526,0,1,intermediate mesoderm formation,BP,
12214,GO:0048392,0.999999999978939,0.924446415230526,0,1,intermediate mesodermal cell differentiation,BP,
13482,GO:0055018,0.999999999978939,0.924446415230526,0,1,regulation of cardiac muscle fiber development,BP,
13483,GO:0055020,0.999999999978939,0.924446415230526,0,1,positive regulation of cardiac muscle fiber development,BP,
13878,GO:0060503,0.999999999978939,0.924446415230526,0,1,bud dilation involved in lung branching,BP,
14213,GO:0061149,0.999999999978939,0.924446415230526,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14214,GO:0061150,0.999999999978939,0.924446415230526,0,1,renal system segmentation,BP,
14215,GO:0061151,0.999999999978939,0.924446415230526,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14219,GO:0061155,0.999999999978939,0.924446415230526,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14241,GO:0061216,0.999999999978939,0.924446415230526,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14244,GO:0061227,0.999999999978939,0.924446415230526,0,1,pattern specification involved in mesonephros development,BP,
15515,GO:0071893,0.999999999978939,0.924446415230526,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15611,GO:0072096,0.999999999978939,0.924446415230526,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15612,GO:0072097,0.999999999978939,0.924446415230526,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15613,GO:0072098,0.999999999978939,0.924446415230526,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15614,GO:0072099,0.999999999978939,0.924446415230526,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15615,GO:0072100,0.999999999978939,0.924446415230526,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15616,GO:0072101,0.999999999978939,0.924446415230526,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15672,GO:0072192,0.999999999978939,0.924446415230526,0,1,ureter epithelial cell differentiation,BP,
15676,GO:0072198,0.999999999978939,0.924446415230526,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15677,GO:0072199,0.999999999978939,0.924446415230526,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15678,GO:0072200,0.999999999978939,0.924446415230526,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17817,GO:1901964,0.999999999978939,0.924446415230526,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19684,GO:2000004,0.999999999978939,0.924446415230526,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19685,GO:2000005,0.999999999978939,0.924446415230526,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19686,GO:2000006,0.999999999978939,0.924446415230526,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19687,GO:2000007,0.999999999978939,0.924446415230526,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
1918,GO:0004611,0.999999999978942,0.922961286484353,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1919,GO:0004613,0.999999999978942,0.922961286484353,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
6176,GO:0019543,0.999999999978942,0.922961286484353,0,1,propionate catabolic process,BP,
11625,GO:0046327,0.999999999978942,0.922961286484353,0,1,glycerol biosynthetic process from pyruvate,BP,
2170,GO:0005006,0.999999999978971,0.848518018433581,0,2,epidermal growth factor-activated receptor activity,MF,
271,GO:0000773,0.999999999979037,0.937462195601698,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1915,GO:0004608,0.999999999979037,0.937462195601698,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11950,GO:0047035,0.999999999979037,0.937462195601698,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15974,GO:0080101,0.999999999979037,0.937462195601698,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
3863,GO:0008482,0.999999999979041,0.92146103326753,0,1,sulfite oxidase activity,MF,
9869,GO:0042128,0.999999999979041,0.92146103326753,0,1,nitrate assimilation,BP,
9256,GO:0035662,0.999999999979043,0.834167851715317,0,3,Toll-like receptor 4 binding,MF,
2503,GO:0005753,0.999999999979045,0.921839683963791,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4695,GO:0010849,0.999999999979045,0.921839683963791,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19817,GO:2000276,0.999999999979045,0.921839683963791,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
8672,GO:0034242,0.999999999979092,0.850205890518576,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
16748,GO:0098508,0.999999999979092,0.850205890518576,0,2,endothelial to hematopoietic transition,BP,
12534,GO:0050682,0.999999999979103,0.848988506921562,0,2,AF-2 domain binding,MF,
12946,GO:0051305,0.999999999979121,0.663089232572063,0,5,chromosome movement towards spindle pole,BP,
16648,GO:0097510,0.999999999979122,0.922466744043233,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
18543,GO:1903750,0.99999999997913,0.734028570482297,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18544,GO:1903751,0.99999999997913,0.734028570482297,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18120,GO:1902804,0.999999999979135,0.783759289646461,0,3,negative regulation of synaptic vesicle transport,BP,
19833,GO:2000301,0.999999999979135,0.783759289646461,0,3,negative regulation of synaptic vesicle exocytosis,BP,
5093,GO:0015367,0.999999999979143,0.924475569349408,0,1,oxoglutarate:malate antiporter activity,MF,
5180,GO:0015742,0.999999999979143,0.924475569349408,0,1,alpha-ketoglutarate transport,BP,
18741,GO:1904210,0.999999999979144,0.929750579102865,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18758,GO:1904239,0.999999999979144,0.929750579102865,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18759,GO:1904240,0.999999999979144,0.929750579102865,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
1945,GO:0004648,0.999999999979172,0.922134481687581,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
470,GO:0001512,0.999999999979174,0.934310772768184,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18827,GO:1904408,0.999999999979174,0.934310772768184,0,1,melatonin binding,MF,
19312,GO:1905594,0.999999999979174,0.934310772768184,0,1,resveratrol binding,MF,
14067,GO:0060846,0.999999999979192,0.78187215051349,0,3,blood vessel endothelial cell fate commitment,BP,
14068,GO:0060847,0.999999999979192,0.78187215051349,0,3,endothelial cell fate specification,BP,
16442,GO:0097101,0.999999999979192,0.78187215051349,0,3,blood vessel endothelial cell fate specification,BP,
122,GO:0000252,0.999999999979205,0.926540100830956,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11943,GO:0047012,0.999999999979205,0.926540100830956,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17183,GO:0103066,0.999999999979205,0.926540100830956,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17184,GO:0103067,0.999999999979205,0.926540100830956,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
2024,GO:0004756,0.99999999997923,0.848964806208529,0,2,selenide, water dikinase activity,MF,
5414,GO:0016260,0.99999999997923,0.848964806208529,0,2,selenocysteine biosynthetic process,BP,
5671,GO:0016781,0.99999999997923,0.848964806208529,0,2,phosphotransferase activity, paired acceptors,MF,
14705,GO:0070329,0.99999999997923,0.848964806208529,0,2,tRNA seleno-modification,BP,
953,GO:0002373,0.999999999979275,0.938700817615201,0,1,plasmacytoid dendritic cell cytokine production,BP,
1141,GO:0002736,0.999999999979275,0.938700817615201,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1142,GO:0002737,0.999999999979275,0.938700817615201,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17596,GO:1901253,0.999999999979275,0.938700817615201,0,1,negative regulation of intracellular transport of viral material,BP,
7707,GO:0032190,0.999999999979277,0.863577212062638,0,2,acrosin binding,MF,
9329,GO:0035803,0.999999999979277,0.863577212062638,0,2,egg coat formation,BP,
16910,GO:0098871,0.999999999979293,0.925385232034426,0,1,postsynaptic actin cytoskeleton,CC,
17074,GO:0099571,0.999999999979293,0.925385232034426,0,1,postsynaptic cytoskeleton,CC,
1197,GO:0002857,0.999999999979296,0.848487699881497,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002860,0.999999999979296,0.848487699881497,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
8939,GO:0034970,0.999999999979296,0.848487699881497,0,2,histone H3-R2 methylation,BP,
18621,GO:1903905,0.999999999979296,0.848487699881497,0,2,positive regulation of establishment of T cell polarity,BP,
9515,GO:0036194,0.999999999979304,0.797429425076379,0,3,muscle cell projection,CC,
9516,GO:0036195,0.999999999979304,0.797429425076379,0,3,muscle cell projection membrane,CC,
13708,GO:0060265,0.999999999979306,0.940799865050228,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
4886,GO:0014806,0.999999999979314,0.854201231458275,0,2,smooth muscle hyperplasia,BP,
4613,GO:0010730,0.999999999979319,0.781947610625336,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
8758,GO:0034421,0.999999999979319,0.781947610625336,0,3,post-translational protein acetylation,BP,
4012,GO:0009000,0.999999999979327,0.921254986203278,0,1,selenocysteine lyase activity,MF,
15414,GO:0071676,0.999999999979339,0.849779323004175,0,2,negative regulation of mononuclear cell migration,BP,
16072,GO:0090027,0.999999999979339,0.849779323004175,0,2,negative regulation of monocyte chemotaxis,BP,
8886,GO:0034699,0.999999999979362,0.781548804084556,0,3,response to luteinizing hormone,BP,
11518,GO:0046032,0.999999999979396,0.927439639735104,0,1,ADP catabolic process,BP,
11920,GO:0046963,0.999999999979448,0.85092250162694,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11921,GO:0046964,0.999999999979448,0.85092250162694,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18037,GO:1902559,0.999999999979448,0.85092250162694,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
8705,GO:0034342,0.99999999997946,0.84937688020307,0,2,response to type III interferon,BP,
13880,GO:0060510,0.999999999979465,0.859227243502128,0,2,Type II pneumocyte differentiation,BP,
3822,GO:0008419,0.999999999979501,0.921141591889539,0,1,RNA lariat debranching enzyme activity,MF,
176,GO:0000384,0.99999999997953,0.857623008339846,0,2,first spliceosomal transesterification activity,MF,
5834,GO:0017116,0.999999999979547,0.781549852508024,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
16300,GO:0090402,0.999999999979571,0.850107026713756,0,2,oncogene-induced cell senescence,BP,
8494,GO:0033650,0.999999999979595,0.924745709897479,0,1,host cell mitochondrion,CC,
10758,GO:0044190,0.999999999979595,0.924745709897479,0,1,host cell mitochondrial envelope,CC,
15804,GO:0072492,0.999999999979595,0.924745709897479,0,1,host cell mitochondrial intermembrane space,CC,
4450,GO:0010387,0.99999999997961,0.92155646913821,0,1,COP9 signalosome assembly,BP,
6161,GO:0019510,0.99999999997961,0.92155646913821,0,1,S-adenosylhomocysteine catabolic process,BP,
15158,GO:0071268,0.99999999997961,0.92155646913821,0,1,homocysteine biosynthetic process,BP,
1964,GO:0004673,0.999999999979696,0.869243312387857,0,2,protein histidine kinase activity,MF,
517,GO:0001582,0.999999999979701,0.921178337309819,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8262,GO:0033041,0.999999999979701,0.921178337309819,0,1,sweet taste receptor activity,MF,
10664,GO:0043843,0.999999999979701,0.921178337309819,0,1,ADP-specific glucokinase activity,MF,
18554,GO:1903767,0.999999999979701,0.921178337309819,0,1,sweet taste receptor complex,CC,
18555,GO:1903768,0.999999999979701,0.921178337309819,0,1,taste receptor complex,CC,
3208,GO:0006844,0.999999999979709,0.851055980119445,0,2,acyl carnitine transport,BP,
5044,GO:0015227,0.999999999979709,0.851055980119445,0,2,acyl carnitine transmembrane transporter activity,MF,
4361,GO:0009957,0.999999999979732,0.848733779307042,0,2,epidermal cell fate specification,BP,
13869,GO:0060486,0.999999999979732,0.848733779307042,0,2,Clara cell differentiation,BP,
14066,GO:0060844,0.999999999979732,0.848733779307042,0,2,arterial endothelial cell fate commitment,BP,
17575,GO:1901187,0.999999999979732,0.848733779307042,0,2,regulation of ephrin receptor signaling pathway,BP,
9113,GO:0035402,0.999999999979748,0.848478439553727,0,2,histone kinase activity (H3-T11 specific),MF,
9118,GO:0035407,0.999999999979748,0.848478439553727,0,2,histone H3-T11 phosphorylation,BP,
13006,GO:0051431,0.99999999997978,0.928214600379587,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
6972,GO:0030627,0.999999999979823,0.859621621412473,0,2,pre-mRNA 5'-splice site binding,MF,
625,GO:0001808,0.999999999979858,0.92251754407956,0,1,negative regulation of type IV hypersensitivity,BP,
1205,GO:0002865,0.999999999979858,0.92251754407956,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1214,GO:0002884,0.999999999979858,0.92251754407956,0,1,negative regulation of hypersensitivity,BP,
9471,GO:0036090,0.999999999979865,0.851310966640455,0,2,cleavage furrow ingression,BP,
6358,GO:0021539,0.999999999979872,0.854206758120092,0,2,subthalamus development,BP,
17485,GO:1900390,0.999999999979882,0.865535431043939,0,2,regulation of iron ion import,BP,
18839,GO:1904432,0.999999999979882,0.865535431043939,0,2,regulation of ferrous iron binding,BP,
18840,GO:1904434,0.999999999979882,0.865535431043939,0,2,positive regulation of ferrous iron binding,BP,
18841,GO:1904435,0.999999999979882,0.865535431043939,0,2,regulation of transferrin receptor binding,BP,
18842,GO:1904437,0.999999999979882,0.865535431043939,0,2,positive regulation of transferrin receptor binding,BP,
6011,GO:0019060,0.9999999999799,0.872571950010868,0,2,intracellular transport of viral protein in host cell,BP,
6954,GO:0030581,0.9999999999799,0.872571950010868,0,2,symbiont intracellular protein transport in host,BP,
13142,GO:0051708,0.9999999999799,0.872571950010868,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
8552,GO:0033906,0.999999999979903,0.850941402502024,0,2,hyaluronoglucuronidase activity,MF,
1546,GO:0003941,0.999999999979903,0.921240317594982,0,1,L-serine ammonia-lyase activity,MF,
3960,GO:0008721,0.999999999979903,0.921240317594982,0,1,D-serine ammonia-lyase activity,MF,
5718,GO:0016855,0.999999999979903,0.921240317594982,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5903,GO:0018114,0.999999999979903,0.921240317594982,0,1,threonine racemase activity,MF,
6882,GO:0030378,0.999999999979903,0.921240317594982,0,1,serine racemase activity,MF,
9568,GO:0036361,0.999999999979903,0.921240317594982,0,1,racemase activity, acting on amino acids and derivatives,MF,
11662,GO:0046416,0.999999999979903,0.921240317594982,0,1,D-amino acid metabolic process,BP,
11667,GO:0046437,0.999999999979903,0.921240317594982,0,1,D-amino acid biosynthetic process,BP,
12026,GO:0047661,0.999999999979903,0.921240317594982,0,1,amino-acid racemase activity,MF,
14615,GO:0070178,0.999999999979903,0.921240317594982,0,1,D-serine metabolic process,BP,
14616,GO:0070179,0.999999999979903,0.921240317594982,0,1,D-serine biosynthetic process,BP,
4437,GO:0010309,0.999999999979905,0.925617159482534,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19558,GO:1990565,0.999999999979905,0.925617159482534,0,1,HSP90-CDC37 chaperone complex,CC,
5331,GO:0016062,0.999999999979954,0.921174365926145,0,1,adaptation of rhodopsin mediated signaling,BP,
9570,GO:0036367,0.999999999979954,0.921174365926145,0,1,light adaption,BP,
2735,GO:0006114,0.999999999979966,0.783916299778741,0,3,glycerol biosynthetic process,BP,
5736,GO:0016882,0.999999999980014,0.865853558502636,0,2,cyclo-ligase activity,MF,
11792,GO:0046657,0.999999999980014,0.865853558502636,0,2,folic acid catabolic process,BP,
4900,GO:0014827,0.999999999980041,0.921731449309572,0,1,intestine smooth muscle contraction,BP,
16767,GO:0098560,0.999999999980044,0.848524480998347,0,2,cytoplasmic side of late endosome membrane,CC,
15784,GO:0072387,0.999999999980045,0.85013063815191,0,2,flavin adenine dinucleotide metabolic process,BP,
18980,GO:1904768,0.999999999980048,0.865530718563188,0,2,all-trans-retinol binding,MF,
11949,GO:0047025,0.99999999998007,0.863518741615019,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
5983,GO:0018872,0.999999999980072,0.921250671135108,0,1,arsonoacetate metabolic process,BP,
7024,GO:0030791,0.999999999980072,0.921250671135108,0,1,arsenite methyltransferase activity,MF,
7025,GO:0030792,0.999999999980072,0.921250671135108,0,1,methylarsonite methyltransferase activity,MF,
18471,GO:1903569,0.999999999980097,0.921393317735502,0,1,positive regulation of protein localization to ciliary membrane,BP,
17225,GO:0106104,0.999999999980116,0.921278099671742,0,1,regulation of glutamate receptor clustering,BP,
18953,GO:1904717,0.999999999980116,0.921278099671742,0,1,regulation of AMPA glutamate receptor clustering,BP,
18954,GO:1904719,0.999999999980116,0.921278099671742,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
19183,GO:1905258,0.999999999980121,0.870589493482512,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19184,GO:1905259,0.999999999980121,0.870589493482512,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
12984,GO:0051387,0.999999999980141,0.849641198742225,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
11169,GO:0045234,0.99999999998015,0.92441743153882,0,1,protein palmitoleylation,BP,
6268,GO:0019862,0.999999999980176,0.926970074465741,0,1,IgA binding,MF,
17118,GO:0102005,0.999999999980184,0.927795419681185,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
19849,GO:2000321,0.999999999980193,0.864172032850333,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19857,GO:2000330,0.999999999980193,0.864172032850333,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
3526,GO:0007500,0.999999999980194,0.851528574599468,0,2,mesodermal cell fate determination,BP,
8282,GO:0033084,0.999999999980194,0.851528574599468,0,2,regulation of immature T cell proliferation in thymus,BP,
8285,GO:0033088,0.999999999980194,0.851528574599468,0,2,negative regulation of immature T cell proliferation in thymus,BP,
9424,GO:0035990,0.999999999980194,0.851528574599468,0,2,tendon cell differentiation,BP,
9425,GO:0035992,0.999999999980194,0.851528574599468,0,2,tendon formation,BP,
14128,GO:0060994,0.999999999980194,0.851528574599468,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15610,GO:0072095,0.999999999980194,0.851528574599468,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15618,GO:0072103,0.999999999980194,0.851528574599468,0,2,glomerulus vasculature morphogenesis,BP,
15619,GO:0072104,0.999999999980194,0.851528574599468,0,2,glomerular capillary formation,BP,
15664,GO:0072179,0.999999999980194,0.851528574599468,0,2,nephric duct formation,BP,
15670,GO:0072190,0.999999999980194,0.851528574599468,0,2,ureter urothelium development,BP,
15671,GO:0072191,0.999999999980194,0.851528574599468,0,2,ureter smooth muscle development,BP,
15673,GO:0072193,0.999999999980194,0.851528574599468,0,2,ureter smooth muscle cell differentiation,BP,
15675,GO:0072197,0.999999999980194,0.851528574599468,0,2,ureter morphogenesis,BP,
15720,GO:0072278,0.999999999980194,0.851528574599468,0,2,metanephric comma-shaped body morphogenesis,BP,
17816,GO:1901963,0.999999999980194,0.851528574599468,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19749,GO:2000137,0.999999999980194,0.851528574599468,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
14575,GO:0070103,0.999999999980201,0.925272117538218,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14576,GO:0070104,0.999999999980201,0.925272117538218,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17901,GO:1902205,0.999999999980201,0.925272117538218,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17902,GO:1902206,0.999999999980201,0.925272117538218,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17906,GO:1902215,0.999999999980201,0.925272117538218,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17915,GO:1902227,0.999999999980201,0.925272117538218,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17921,GO:1902233,0.999999999980201,0.925272117538218,0,1,negative regulation of positive thymic T cell selection,BP,
18654,GO:1903970,0.999999999980201,0.925272117538218,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18657,GO:1903973,0.999999999980201,0.925272117538218,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
6136,GO:0019402,0.999999999980375,0.930140595019975,0,1,galactitol metabolic process,BP,
14383,GO:0061623,0.999999999980375,0.930140595019975,0,1,glycolytic process from galactose,BP,
3,GO:0000009,0.999999999980388,0.921380988135075,0,1,alpha-1,6-mannosyltransferase activity,MF,
13460,GO:0052917,0.999999999980388,0.921380988135075,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
8593,GO:0034092,0.999999999980427,0.79749301752168,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8643,GO:0034183,0.999999999980427,0.79749301752168,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
11757,GO:0046604,0.999999999980427,0.79749301752168,0,3,positive regulation of mitotic centrosome separation,BP,
14850,GO:0070602,0.999999999980427,0.79749301752168,0,3,regulation of centromeric sister chromatid cohesion,BP,
11806,GO:0046687,0.999999999980443,0.935271104587473,0,1,response to chromate,BP,
15146,GO:0071247,0.999999999980443,0.935271104587473,0,1,cellular response to chromate,BP,
17910,GO:1902220,0.999999999980443,0.935271104587473,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
11079,GO:0045079,0.999999999980449,0.92560538361541,0,1,negative regulation of chemokine biosynthetic process,BP,
19501,GO:1990357,0.999999999980458,0.789386960074955,0,3,terminal web,CC,
3489,GO:0007356,0.999999999980473,0.85150187477172,0,2,thorax and anterior abdomen determination,BP,
20203,GO:2001074,0.999999999980473,0.85150187477172,0,2,regulation of metanephric ureteric bud development,BP,
20204,GO:2001076,0.999999999980473,0.85150187477172,0,2,positive regulation of metanephric ureteric bud development,BP,
1612,GO:0004040,0.999999999980537,0.849462546204319,0,2,amidase activity,MF,
13837,GO:0060437,0.999999999980537,0.849462546204319,0,2,lung growth,BP,
17457,GO:1900244,0.999999999980537,0.849462546204319,0,2,positive regulation of synaptic vesicle endocytosis,BP,
5300,GO:0015990,0.999999999980567,0.942245795087151,0,1,electron transport coupled proton transport,BP,
13151,GO:0051722,0.999999999980581,0.921260522182835,0,1,protein C-terminal methylesterase activity,MF,
13152,GO:0051723,0.999999999980581,0.921260522182835,0,1,protein methylesterase activity,MF,
13985,GO:0060697,0.999999999980599,0.921129192939012,0,1,positive regulation of phospholipid catabolic process,BP,
17418,GO:1900161,0.999999999980599,0.921129192939012,0,1,regulation of phospholipid scramblase activity,BP,
17419,GO:1900163,0.999999999980599,0.921129192939012,0,1,positive regulation of phospholipid scramblase activity,BP,
20088,GO:2000752,0.999999999980599,0.921129192939012,0,1,regulation of glucosylceramide catabolic process,BP,
20089,GO:2000753,0.999999999980599,0.921129192939012,0,1,positive regulation of glucosylceramide catabolic process,BP,
20090,GO:2000754,0.999999999980599,0.921129192939012,0,1,regulation of sphingomyelin catabolic process,BP,
20091,GO:2000755,0.999999999980599,0.921129192939012,0,1,positive regulation of sphingomyelin catabolic process,BP,
14614,GO:0070176,0.999999999980599,0.924293792478731,0,1,DRM complex,CC,
16173,GO:0090191,0.999999999980603,0.852695739751596,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
2696,GO:0006061,0.999999999980612,0.929467685081113,0,1,sorbitol biosynthetic process,BP,
5989,GO:0018931,0.999999999980612,0.929467685081113,0,1,naphthalene metabolic process,BP,
6138,GO:0019406,0.999999999980612,0.929467685081113,0,1,hexitol biosynthetic process,BP,
10661,GO:0043795,0.999999999980612,0.929467685081113,0,1,glyceraldehyde oxidoreductase activity,MF,
16306,GO:0090420,0.999999999980612,0.929467685081113,0,1,naphthalene-containing compound metabolic process,BP,
13323,GO:0052203,0.999999999980613,0.851866508629479,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
7195,GO:0031084,0.999999999980638,0.781554158525061,0,3,BLOC-2 complex,CC,
9448,GO:0036034,0.999999999980641,0.848762551742204,0,2,mediator complex assembly,BP,
20232,GO:2001176,0.999999999980641,0.848762551742204,0,2,regulation of mediator complex assembly,BP,
20233,GO:2001178,0.999999999980641,0.848762551742204,0,2,positive regulation of mediator complex assembly,BP,
11815,GO:0046707,0.999999999980681,0.854285938669489,0,2,IDP metabolic process,BP,
11816,GO:0046709,0.999999999980681,0.854285938669489,0,2,IDP catabolic process,BP,
6852,GO:0030321,0.999999999980719,0.848483430478595,0,2,transepithelial chloride transport,BP,
15281,GO:0071461,0.999999999980722,0.859227245501415,0,2,cellular response to redox state,BP,
6751,GO:0030172,0.999999999980737,0.934392265767215,0,1,troponin C binding,MF,
8217,GO:0032971,0.999999999980737,0.934392265767215,0,1,regulation of muscle filament sliding,BP,
8218,GO:0032972,0.999999999980737,0.934392265767215,0,1,regulation of muscle filament sliding speed,BP,
19567,GO:1990584,0.999999999980737,0.934392265767215,0,1,cardiac Troponin complex,CC,
1814,GO:0004464,0.999999999980747,0.890606310533795,0,2,leukotriene-C4 synthase activity,MF,
497,GO:0001552,0.999999999980753,0.923139444242202,0,1,ovarian follicle atresia,BP,
19876,GO:2000355,0.999999999980753,0.923139444242202,0,1,negative regulation of ovarian follicle development,BP,
15802,GO:0072487,0.999999999980755,0.663344135007729,0,5,MSL complex,CC,
13971,GO:0060678,0.999999999980761,0.921634812122085,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15631,GO:0072127,0.999999999980761,0.921634812122085,0,1,renal capsule development,BP,
15632,GO:0072128,0.999999999980761,0.921634812122085,0,1,renal capsule morphogenesis,BP,
15633,GO:0072129,0.999999999980761,0.921634812122085,0,1,renal capsule formation,BP,
15634,GO:0072130,0.999999999980761,0.921634812122085,0,1,renal capsule specification,BP,
15688,GO:0072213,0.999999999980761,0.921634812122085,0,1,metanephric capsule development,BP,
15713,GO:0072265,0.999999999980761,0.921634812122085,0,1,metanephric capsule morphogenesis,BP,
15714,GO:0072266,0.999999999980761,0.921634812122085,0,1,metanephric capsule formation,BP,
15715,GO:0072267,0.999999999980761,0.921634812122085,0,1,metanephric capsule specification,BP,
2318,GO:0005324,0.999999999980768,0.848845160402983,0,2,long-chain fatty acid transporter activity,MF,
5265,GO:0015910,0.999999999980768,0.848845160402983,0,2,peroxisomal long-chain fatty acid import,BP,
967,GO:0002414,0.999999999980796,0.851715249770544,0,2,immunoglobulin transcytosis in epithelial cells,BP,
6221,GO:0019763,0.999999999980796,0.851715249770544,0,2,immunoglobulin receptor activity,MF,
2229,GO:0005132,0.999999999980869,0.867550123096426,0,2,type I interferon receptor binding,MF,
11947,GO:0047021,0.999999999980875,0.932306466212633,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12455,GO:0050221,0.999999999980875,0.932306466212633,0,1,prostaglandin-E2 9-reductase activity,MF,
8573,GO:0034039,0.99999999998088,0.853052232902579,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
11635,GO:0046340,0.9999999999809,0.848474586289139,0,2,diacylglycerol catabolic process,BP,
17059,GO:0099541,0.9999999999809,0.848474586289139,0,2,trans-synaptic signaling by lipid,BP,
17060,GO:0099542,0.9999999999809,0.848474586289139,0,2,trans-synaptic signaling by endocannabinoid,BP,
15280,GO:0071460,0.999999999980911,0.870303629956126,0,2,cellular response to cell-matrix adhesion,BP,
14440,GO:0061750,0.999999999980915,0.921477983445511,0,1,acid sphingomyelin phosphodiesterase activity,MF,
18547,GO:1903756,0.999999999980923,0.848683053709697,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18548,GO:1903758,0.999999999980923,0.848683053709697,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
1032,GO:0002541,0.999999999980984,0.849946386188393,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
13663,GO:0060179,0.999999999981019,0.783798062109091,0,3,male mating behavior,BP,
16043,GO:0086072,0.999999999981045,0.92124855110439,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16051,GO:0086082,0.999999999981045,0.92124855110439,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
2257,GO:0005171,0.999999999981046,0.922506744147003,0,1,hepatocyte growth factor receptor binding,MF,
1933,GO:0004632,0.999999999981049,0.931921321216749,0,1,phosphopantothenate--cysteine ligase activity,MF,
2227,GO:0005130,0.999999999981063,0.927692712959097,0,1,granulocyte colony-stimulating factor receptor binding,MF,
9384,GO:0035915,0.999999999981082,0.922509438852282,0,1,pore formation in membrane of other organism,BP,
19887,GO:2000374,0.999999999981082,0.922509438852282,0,1,regulation of oxygen metabolic process,BP,
10499,GO:0043400,0.999999999981103,0.868150562052635,0,2,cortisol secretion,BP,
13026,GO:0051462,0.999999999981103,0.868150562052635,0,2,regulation of cortisol secretion,BP,
8572,GO:0034038,0.999999999981137,0.933389072595921,0,1,deoxyhypusine synthase activity,MF,
19,GO:0000035,0.999999999981191,0.894126053265185,0,2,acyl binding,MF,
20,GO:0000036,0.999999999981191,0.894126053265185,0,2,acyl carrier activity,MF,
4173,GO:0009245,0.999999999981191,0.894126053265185,0,2,lipid A biosynthetic process,BP,
10951,GO:0044620,0.999999999981191,0.894126053265185,0,2,ACP phosphopantetheine attachment site binding,MF,
11703,GO:0046493,0.999999999981191,0.894126053265185,0,2,lipid A metabolic process,BP,
12869,GO:0051192,0.999999999981191,0.894126053265185,0,2,prosthetic group binding,MF,
17604,GO:1901269,0.999999999981191,0.894126053265185,0,2,lipooligosaccharide metabolic process,BP,
17605,GO:1901271,0.999999999981191,0.894126053265185,0,2,lipooligosaccharide biosynthetic process,BP,
4380,GO:0010025,0.999999999981217,0.849479454352993,0,2,wax biosynthetic process,BP,
4411,GO:0010166,0.999999999981217,0.849479454352993,0,2,wax metabolic process,BP,
15968,GO:0080019,0.999999999981217,0.849479454352993,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17177,GO:0102965,0.999999999981217,0.849479454352993,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
9479,GO:0036112,0.999999999981217,0.854343778724079,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
5229,GO:0015842,0.999999999981221,0.852653815328733,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16822,GO:0098700,0.999999999981221,0.852653815328733,0,2,neurotransmitter loading into synaptic vesicle,BP,
19117,GO:1905051,0.999999999981232,0.870010833761832,0,2,regulation of base-excision repair,BP,
19118,GO:1905053,0.999999999981232,0.870010833761832,0,2,positive regulation of base-excision repair,BP,
9724,GO:0038163,0.999999999981273,0.937796545191353,0,1,thrombopoietin-mediated signaling pathway,BP,
19405,GO:1905938,0.999999999981273,0.937796545191353,0,1,positive regulation of germ cell proliferation,BP,
19807,GO:2000256,0.999999999981273,0.937796545191353,0,1,positive regulation of male germ cell proliferation,BP,
4696,GO:0010851,0.999999999981274,0.851320817387858,0,2,cyclase regulator activity,MF,
4697,GO:0010853,0.999999999981274,0.851320817387858,0,2,cyclase activator activity,MF,
6804,GO:0030249,0.999999999981274,0.851320817387858,0,2,guanylate cyclase regulator activity,MF,
6805,GO:0030250,0.999999999981274,0.851320817387858,0,2,guanylate cyclase activator activity,MF,
16514,GO:0097213,0.999999999981287,0.921700970863917,0,1,regulation of lysosomal membrane permeability,BP,
6853,GO:0030322,0.999999999981315,0.849265066849417,0,2,stabilization of membrane potential,BP,
18594,GO:1903850,0.999999999981344,0.92113940282192,0,1,regulation of cristae formation,BP,
18595,GO:1903852,0.999999999981344,0.92113940282192,0,1,positive regulation of cristae formation,BP,
18876,GO:1904542,0.999999999981344,0.92113940282192,0,1,regulation of free ubiquitin chain polymerization,BP,
18877,GO:1904544,0.999999999981344,0.92113940282192,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19037,GO:1904881,0.999999999981344,0.92113940282192,0,1,cellular response to hydrogen sulfide,BP,
6089,GO:0019255,0.999999999981345,0.850809103256304,0,2,glucose 1-phosphate metabolic process,BP,
1651,GO:0004103,0.999999999981376,0.853048121434569,0,2,choline kinase activity,MF,
17636,GO:1901355,0.999999999981379,0.849256088099585,0,2,response to rapamycin,BP,
19333,GO:1905661,0.999999999981379,0.849256088099585,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19334,GO:1905663,0.999999999981379,0.849256088099585,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
1772,GO:0004377,0.999999999981381,0.921193708202178,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1650,GO:0004098,0.999999999981386,0.923407032761269,0,1,cerebroside-sulfatase activity,MF,
16122,GO:0090108,0.999999999981391,0.922366388784023,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16169,GO:0090187,0.999999999981391,0.922366388784023,0,1,positive regulation of pancreatic juice secretion,BP,
16276,GO:0090340,0.999999999981391,0.922366388784023,0,1,positive regulation of secretion of lysosomal enzymes,BP,
10681,GO:0043932,0.999999999981423,0.849111431683637,0,2,ossification involved in bone remodeling,BP,
5308,GO:0016015,0.99999999998143,0.853348531112448,0,2,morphogen activity,MF,
6381,GO:0021569,0.99999999998147,0.926579630827036,0,1,rhombomere 3 development,BP,
6382,GO:0021570,0.99999999998147,0.926579630827036,0,1,rhombomere 4 development,BP,
8585,GO:0034066,0.999999999981481,0.857796782321824,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
1760,GO:0004363,0.999999999981491,0.923384499300784,0,1,glutathione synthase activity,MF,
4241,GO:0009439,0.999999999981492,0.867646903108498,0,2,cyanate metabolic process,BP,
4242,GO:0009440,0.999999999981492,0.867646903108498,0,2,cyanate catabolic process,BP,
3506,GO:0007412,0.999999999981519,0.860879246795633,0,2,axon target recognition,BP,
10207,GO:0042822,0.999999999981566,0.78291320785444,0,3,pyridoxal phosphate metabolic process,BP,
543,GO:0001661,0.999999999981574,0.849266924694463,0,2,conditioned taste aversion,BP,
13673,GO:0060199,0.999999999981574,0.849266924694463,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13676,GO:0060203,0.999999999981574,0.849266924694463,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
15667,GO:0072185,0.999999999981625,0.921406043470647,0,1,metanephric cap development,BP,
15668,GO:0072186,0.999999999981625,0.921406043470647,0,1,metanephric cap morphogenesis,BP,
16114,GO:0090094,0.999999999981625,0.921406043470647,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16115,GO:0090095,0.999999999981625,0.921406043470647,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16116,GO:0090096,0.999999999981625,0.921406043470647,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
14181,GO:0061078,0.999999999981637,0.948062471999857,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16266,GO:0090323,0.999999999981637,0.948062471999857,0,1,prostaglandin secretion involved in immune response,BP,
18500,GO:1903636,0.999999999981637,0.948062471999857,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18501,GO:1903638,0.999999999981637,0.948062471999857,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18503,GO:1903645,0.999999999981637,0.948062471999857,0,1,negative regulation of chaperone-mediated protein folding,BP,
8903,GO:0034722,0.999999999981637,0.928063366367,0,1,gamma-glutamyl-peptidase activity,MF,
936,GO:0002337,0.999999999981665,0.857780115422589,0,2,B-1a B cell differentiation,BP,
2086,GO:0004850,0.999999999981671,0.924182460194441,0,1,uridine phosphorylase activity,MF,
2786,GO:0006218,0.999999999981671,0.924182460194441,0,1,uridine catabolic process,BP,
11564,GO:0046108,0.999999999981671,0.924182460194441,0,1,uridine metabolic process,BP,
12457,GO:0050253,0.999999999981701,0.848473260192023,0,2,retinyl-palmitate esterase activity,MF,
5991,GO:0018963,0.999999999981702,0.850565176642316,0,2,phthalate metabolic process,BP,
3080,GO:0006651,0.999999999981721,0.863847364918497,0,2,diacylglycerol biosynthetic process,BP,
13392,GO:0052692,0.999999999981737,0.929189419572861,0,1,raffinose alpha-galactosidase activity,MF,
16582,GO:0097376,0.999999999981737,0.929189419572861,0,1,interneuron axon guidance,BP,
16501,GO:0097196,0.999999999981763,0.850327785596302,0,2,Shu complex,CC,
16062,GO:0089709,0.999999999981787,0.848719459070886,0,2,L-histidine transmembrane transport,BP,
6110,GO:0019353,0.999999999981794,0.921132475416292,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8431,GO:0033526,0.999999999981794,0.921132475416292,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
4884,GO:0014802,0.999999999981838,0.859585516597314,0,2,terminal cisterna,CC,
10129,GO:0042663,0.999999999981839,0.851381601898291,0,2,regulation of endodermal cell fate specification,BP,
19404,GO:1905937,0.999999999981863,0.939067577095311,0,1,negative regulation of germ cell proliferation,BP,
19806,GO:2000255,0.999999999981863,0.939067577095311,0,1,negative regulation of male germ cell proliferation,BP,
8109,GO:0032795,0.999999999981903,0.935618586478495,0,1,heterotrimeric G-protein binding,MF,
10370,GO:0043185,0.999999999981909,0.922316933217487,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14857,GO:0070625,0.999999999981909,0.922316933217487,0,1,zymogen granule exocytosis,BP,
1907,GO:0004595,0.999999999981918,0.921541841738236,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
12429,GO:0048880,0.999999999981927,0.848475508703078,0,2,sensory system development,BP,
3440,GO:0007231,0.999999999981959,0.852866963726741,0,2,osmosensory signaling pathway,BP,
6886,GO:0030395,0.999999999981984,0.948167783461186,0,1,lactose binding,MF,
8609,GO:0034117,0.999999999981984,0.948167783461186,0,1,erythrocyte aggregation,BP,
8610,GO:0034118,0.999999999981984,0.948167783461186,0,1,regulation of erythrocyte aggregation,BP,
8611,GO:0034120,0.999999999981984,0.948167783461186,0,1,positive regulation of erythrocyte aggregation,BP,
12081,GO:0048030,0.999999999981984,0.948167783461186,0,1,disaccharide binding,MF,
19746,GO:2000124,0.999999999981987,0.848675662892597,0,2,regulation of endocannabinoid signaling pathway,BP,
19830,GO:2000298,0.999999999981987,0.848675662892597,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
7223,GO:0031117,0.999999999981988,0.848482339454857,0,2,positive regulation of microtubule depolymerization,BP,
5555,GO:0016561,0.999999999982026,0.850408859873822,0,2,protein import into peroxisome matrix, translocation,BP,
17550,GO:1901090,0.999999999982026,0.850408859873822,0,2,regulation of protein tetramerization,BP,
17551,GO:1901091,0.999999999982026,0.850408859873822,0,2,negative regulation of protein tetramerization,BP,
17552,GO:1901093,0.999999999982026,0.850408859873822,0,2,regulation of protein homotetramerization,BP,
17553,GO:1901094,0.999999999982026,0.850408859873822,0,2,negative regulation of protein homotetramerization,BP,
10422,GO:0043262,0.999999999982061,0.786896617361337,0,3,adenosine-diphosphatase activity,MF,
14530,GO:0070026,0.999999999982094,0.864246712425049,0,2,nitric oxide binding,MF,
19679,GO:1990983,0.999999999982129,0.921164208936482,0,1,tRNA demethylation,BP,
19680,GO:1990984,0.999999999982129,0.921164208936482,0,1,tRNA demethylase activity,MF,
16403,GO:0097021,0.999999999982153,0.851440183080729,0,2,lymphocyte migration into lymphoid organs,BP,
300,GO:0000806,0.99999999998217,0.848989868498978,0,2,Y chromosome,CC,
13826,GO:0060423,0.99999999998217,0.848989868498978,0,2,foregut regionalization,BP,
13827,GO:0060424,0.99999999998217,0.848989868498978,0,2,lung field specification,BP,
13875,GO:0060492,0.99999999998217,0.848989868498978,0,2,lung induction,BP,
6690,GO:0030060,0.999999999982176,0.800451800920522,0,3,L-malate dehydrogenase activity,MF,
1548,GO:0003944,0.999999999982196,0.921802276403108,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
9999,GO:0042414,0.999999999982208,0.85055723978829,0,2,epinephrine metabolic process,BP,
11803,GO:0046684,0.999999999982208,0.85055723978829,0,2,response to pyrethroid,BP,
7966,GO:0032571,0.999999999982211,0.848552099349743,0,2,response to vitamin K,BP,
15176,GO:0071307,0.999999999982211,0.848552099349743,0,2,cellular response to vitamin K,BP,
20046,GO:2000669,0.999999999982211,0.848552099349743,0,2,negative regulation of dendritic cell apoptotic process,BP,
6107,GO:0019344,0.999999999982224,0.784939584781627,0,3,cysteine biosynthetic process,BP,
5307,GO:0016013,0.999999999982242,0.848761483937486,0,2,syntrophin complex,CC,
9210,GO:0035594,0.999999999982294,0.783411272739063,0,3,ganglioside binding,MF,
17458,GO:1900245,0.999999999982345,0.781558080265801,0,3,positive regulation of MDA-5 signaling pathway,BP,
14540,GO:0070051,0.999999999982372,0.84850608461986,0,2,fibrinogen binding,MF,
14438,GO:0061744,0.99999999998239,0.873745492729188,0,2,motor behavior,BP,
10164,GO:0042748,0.999999999982399,0.786854205758738,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
11565,GO:0046110,0.999999999982399,0.786854205758738,0,3,xanthine metabolic process,BP,
16927,GO:0098904,0.999999999982414,0.848582696969414,0,2,regulation of AV node cell action potential,BP,
10099,GO:0042608,0.999999999982417,0.786504647045031,0,3,T cell receptor binding,MF,
1600,GO:0004019,0.999999999982421,0.921129497252655,0,1,adenylosuccinate synthase activity,MF,
19707,GO:2000048,0.999999999982457,0.864368418760904,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
1070,GO:0002636,0.999999999982466,0.927389661823483,0,1,positive regulation of germinal center formation,BP,
2752,GO:0006157,0.999999999982466,0.927389661823483,0,1,deoxyadenosine catabolic process,BP,
9954,GO:0042321,0.999999999982466,0.927389661823483,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9955,GO:0042323,0.999999999982466,0.927389661823483,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11555,GO:0046090,0.999999999982466,0.927389661823483,0,1,deoxyadenosine metabolic process,BP,
11566,GO:0046111,0.999999999982466,0.927389661823483,0,1,xanthine biosynthetic process,BP,
11572,GO:0046124,0.999999999982466,0.927389661823483,0,1,purine deoxyribonucleoside catabolic process,BP,
13656,GO:0060167,0.999999999982466,0.927389661823483,0,1,regulation of adenosine receptor signaling pathway,BP,
13657,GO:0060169,0.999999999982466,0.927389661823483,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13816,GO:0060407,0.999999999982466,0.927389661823483,0,1,negative regulation of penile erection,BP,
14660,GO:0070256,0.999999999982466,0.927389661823483,0,1,negative regulation of mucus secretion,BP,
11746,GO:0046586,0.999999999982487,0.865338082920304,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
14931,GO:0070782,0.99999999998252,0.921987373686641,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
11122,GO:0045155,0.999999999982565,0.859334182185506,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
7196,GO:0031085,0.999999999982588,0.848479823476325,0,2,BLOC-3 complex,CC,
7384,GO:0031436,0.999999999982591,0.848499362678516,0,2,BRCA1-BARD1 complex,CC,
1236,GO:0002924,0.999999999982593,0.9216487347706,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9857,GO:0042105,0.999999999982593,0.9216487347706,0,1,alpha-beta T cell receptor complex,CC,
3422,GO:0007207,0.999999999982612,0.849346511481254,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
11093,GO:0045098,0.999999999982636,0.92572398799805,0,1,type III intermediate filament,CC,
12142,GO:0048244,0.999999999982636,0.92572398799805,0,1,phytanoyl-CoA dioxygenase activity,MF,
16437,GO:0097089,0.999999999982636,0.92572398799805,0,1,methyl-branched fatty acid metabolic process,BP,
2884,GO:0006386,0.999999999982641,0.942099607870782,0,1,termination of RNA polymerase III transcription,BP,
10831,GO:0044324,0.999999999982644,0.939390807666323,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19693,GO:2000016,0.999999999982644,0.939390807666323,0,1,negative regulation of determination of dorsal identity,BP,
11966,GO:0047179,0.999999999982647,0.87323916225974,0,2,platelet-activating factor acetyltransferase activity,MF,
9618,GO:0036482,0.999999999982693,0.864774677198066,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18189,GO:1902958,0.999999999982693,0.864774677198066,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18379,GO:1903383,0.999999999982693,0.864774677198066,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18380,GO:1903384,0.999999999982693,0.864774677198066,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
17352,GO:1900039,0.999999999982745,0.933606863783235,0,1,positive regulation of cellular response to hypoxia,BP,
17859,GO:1902071,0.999999999982745,0.933606863783235,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17860,GO:1902073,0.999999999982745,0.933606863783235,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
15385,GO:0071630,0.999999999982753,0.781587586468157,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
19048,GO:1904895,0.999999999982784,0.925712043113603,0,1,ESCRT complex assembly,BP,
19050,GO:1904902,0.999999999982784,0.925712043113603,0,1,ESCRT III complex assembly,BP,
245,GO:0000701,0.999999999982786,0.859754513833302,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
16148,GO:0090158,0.999999999982806,0.664169007379591,0,5,endoplasmic reticulum membrane organization,BP,
12028,GO:0047685,0.999999999982808,0.927847087861513,0,1,amine sulfotransferase activity,MF,
7369,GO:0031416,0.999999999982845,0.862074841716673,0,2,NatB complex,CC,
16782,GO:0098594,0.999999999982853,0.943452398706739,0,1,mucin granule,CC,
19235,GO:1905371,0.999999999982877,0.85470907034332,0,2,ceramide phosphoethanolamine metabolic process,BP,
19236,GO:1905373,0.999999999982877,0.85470907034332,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
4692,GO:0010845,0.999999999982878,0.921147160093503,0,1,positive regulation of reciprocal meiotic recombination,BP,
10060,GO:0042543,0.99999999998289,0.948405149137951,0,1,protein N-linked glycosylation via arginine,BP,
2275,GO:0005219,0.999999999982941,0.863981651656625,0,2,ryanodine-sensitive calcium-release channel activity,MF,
423,GO:0001128,0.999999999982974,0.930434179569639,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
5806,GO:0017060,0.999999999982986,0.84907451399502,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
16203,GO:0090233,0.999999999982997,0.921136299157224,0,1,negative regulation of spindle checkpoint,BP,
17993,GO:1902426,0.999999999982997,0.921136299157224,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19221,GO:1905341,0.999999999982997,0.921136299157224,0,1,negative regulation of protein localization to kinetochore,BP,
17850,GO:1902037,0.99999999998302,0.781551022428046,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
18485,GO:1903593,0.99999999998307,0.800570083241035,0,3,regulation of histamine secretion by mast cell,BP,
18486,GO:1903595,0.99999999998307,0.800570083241035,0,3,positive regulation of histamine secretion by mast cell,BP,
12032,GO:0047710,0.999999999983075,0.935418097476162,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
18616,GO:1903899,0.999999999983087,0.785082250611741,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
2349,GO:0005412,0.99999999998311,0.849380842732774,0,2,glucose:sodium symporter activity,MF,
14423,GO:0061723,0.999999999983111,0.848606569777179,0,2,glycophagy,BP,
20201,GO:2001069,0.999999999983111,0.848606569777179,0,2,glycogen binding,MF,
17959,GO:1902311,0.999999999983116,0.924554150747104,0,1,regulation of copper ion transmembrane transport,BP,
4778,GO:0010963,0.999999999983152,0.928709809098809,0,1,regulation of L-arginine import,BP,
15017,GO:0070947,0.999999999983152,0.928709809098809,0,1,neutrophil mediated killing of fungus,BP,
15022,GO:0070953,0.999999999983152,0.928709809098809,0,1,regulation of neutrophil mediated killing of fungus,BP,
15027,GO:0070965,0.999999999983152,0.928709809098809,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19972,GO:2000552,0.999999999983152,0.928709809098809,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
557,GO:0001680,0.999999999983182,0.921597157248498,0,1,tRNA 3'-terminal CCA addition,BP,
2057,GO:0004810,0.999999999983182,0.921597157248498,0,1,tRNA adenylyltransferase activity,MF,
13464,GO:0052927,0.999999999983182,0.921597157248498,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13465,GO:0052928,0.999999999983182,0.921597157248498,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13466,GO:0052929,0.999999999983182,0.921597157248498,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19632,GO:1990817,0.999999999983182,0.921597157248498,0,1,RNA adenylyltransferase activity,MF,
13862,GO:0060478,0.999999999983183,0.858206716070789,0,2,acrosomal vesicle exocytosis,BP,
19881,GO:2000367,0.999999999983183,0.858206716070789,0,2,regulation of acrosomal vesicle exocytosis,BP,
19882,GO:2000368,0.999999999983183,0.858206716070789,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
9623,GO:0036488,0.999999999983206,0.867978493424743,0,2,CHOP-C/EBP complex,CC,
5303,GO:0016005,0.999999999983217,0.84850331603032,0,2,phospholipase A2 activator activity,MF,
12039,GO:0047756,0.999999999983254,0.849645083944943,0,2,chondroitin 4-sulfotransferase activity,MF,
5743,GO:0016890,0.999999999983273,0.854874378581094,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
9812,GO:0042007,0.999999999983283,0.929205659098636,0,1,interleukin-18 binding,MF,
3641,GO:0008111,0.999999999983296,0.922916054995745,0,1,alpha-methylacyl-CoA racemase activity,MF,
2043,GO:0004790,0.999999999983332,0.921179513239183,0,1,thioether S-methyltransferase activity,MF,
7022,GO:0030748,0.999999999983332,0.921179513239183,0,1,amine N-methyltransferase activity,MF,
17165,GO:0102707,0.999999999983332,0.921179513239183,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
389,GO:0001034,0.999999999983339,0.924242434062004,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
6096,GO:0019303,0.999999999983376,0.870606914013384,0,2,D-ribose catabolic process,BP,
3128,GO:0006707,0.999999999983389,0.730666458311407,0,4,cholesterol catabolic process,BP,
5356,GO:0016127,0.999999999983389,0.730666458311407,0,4,sterol catabolic process,BP,
3646,GO:0008118,0.999999999983408,0.921745510954958,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
12013,GO:0047536,0.999999999983408,0.921745510954958,0,1,2-aminoadipate transaminase activity,MF,
2007,GO:0004731,0.999999999983424,0.848649157994058,0,2,purine-nucleoside phosphorylase activity,MF,
14420,GO:0061711,0.999999999983427,0.854393288449941,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
1488,GO:0003826,0.999999999983445,0.851611179783336,0,2,alpha-ketoacid dehydrogenase activity,MF,
1506,GO:0003863,0.999999999983445,0.851611179783336,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
3878,GO:0008508,0.99999999998345,0.856922284034296,0,2,bile acid:sodium symporter activity,MF,
12139,GO:0048239,0.999999999983477,0.849425198099856,0,2,negative regulation of DNA recombination at telomere,BP,
15918,GO:0072695,0.999999999983477,0.849425198099856,0,2,regulation of DNA recombination at telomere,BP,
3933,GO:0008614,0.999999999983531,0.849398817574734,0,2,pyridoxine metabolic process,BP,
3934,GO:0008615,0.999999999983531,0.849398817574734,0,2,pyridoxine biosynthetic process,BP,
1509,GO:0003868,0.999999999983531,0.924322043546399,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
7839,GO:0032393,0.999999999983539,0.865116083639638,0,2,MHC class I receptor activity,MF,
9492,GO:0036128,0.999999999983546,0.921129518617822,0,1,CatSper complex,CC,
9220,GO:0035606,0.999999999983585,0.882274594053869,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
19087,GO:1904983,0.9999999999836,0.922110667820518,0,1,glycine import into mitochondrion,BP,
18108,GO:1902746,0.999999999983604,0.921325062596354,0,1,regulation of lens fiber cell differentiation,BP,
9641,GO:0036509,0.999999999983625,0.850469764067106,0,2,trimming of terminal mannose on B branch,BP,
9643,GO:0036511,0.999999999983625,0.850469764067106,0,2,trimming of first mannose on A branch,BP,
9644,GO:0036512,0.999999999983625,0.850469764067106,0,2,trimming of second mannose on A branch,BP,
626,GO:0001809,0.999999999983633,0.929666897504461,0,1,positive regulation of type IV hypersensitivity,BP,
13860,GO:0060467,0.999999999983633,0.929666897504461,0,1,negative regulation of fertilization,BP,
19877,GO:2000359,0.999999999983633,0.929666897504461,0,1,regulation of binding of sperm to zona pellucida,BP,
19878,GO:2000360,0.999999999983633,0.929666897504461,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19897,GO:2000387,0.999999999983633,0.929666897504461,0,1,regulation of antral ovarian follicle growth,BP,
19898,GO:2000388,0.999999999983633,0.929666897504461,0,1,positive regulation of antral ovarian follicle growth,BP,
7092,GO:0030886,0.999999999983666,0.853444159741971,0,2,negative regulation of myeloid dendritic cell activation,BP,
7870,GO:0032431,0.999999999983679,0.863891862334387,0,2,activation of phospholipase A2 activity,BP,
7786,GO:0032311,0.999999999983685,0.866033586400177,0,2,angiogenin-PRI complex,CC,
8579,GO:0034057,0.999999999983695,0.848544176969874,0,2,RNA strand-exchange activity,MF,
8178,GO:0032914,0.999999999983703,0.783645584341139,0,3,positive regulation of transforming growth factor beta1 production,BP,
17524,GO:1901004,0.999999999983705,0.931744910899268,0,1,ubiquinone-6 metabolic process,BP,
17525,GO:1901006,0.999999999983705,0.931744910899268,0,1,ubiquinone-6 biosynthetic process,BP,
11024,GO:0044860,0.999999999983727,0.721833134487604,0,4,protein localization to plasma membrane raft,BP,
5047,GO:0015230,0.999999999983743,0.848930937027485,0,2,FAD transmembrane transporter activity,MF,
9090,GO:0035350,0.999999999983743,0.848930937027485,0,2,FAD transmembrane transport,BP,
15977,GO:0080121,0.999999999983743,0.848930937027485,0,2,AMP transport,BP,
5619,GO:0016672,0.99999999998379,0.874553064267064,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11131,GO:0045174,0.99999999998379,0.874553064267064,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12503,GO:0050610,0.99999999998379,0.874553064267064,0,2,methylarsonate reductase activity,MF,
1642,GO:0004085,0.999999999983791,0.923281311183388,0,1,butyryl-CoA dehydrogenase activity,MF,
6185,GO:0019605,0.999999999983791,0.923281311183388,0,1,butyrate metabolic process,BP,
11642,GO:0046359,0.999999999983791,0.923281311183388,0,1,butyrate catabolic process,BP,
13448,GO:0052890,0.999999999983791,0.923281311183388,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
5383,GO:0016206,0.99999999998382,0.848919715908274,0,2,catechol O-methyltransferase activity,MF,
11460,GO:0045914,0.99999999998382,0.848919715908274,0,2,negative regulation of catecholamine metabolic process,BP,
11494,GO:0045963,0.99999999998382,0.848919715908274,0,2,negative regulation of dopamine metabolic process,BP,
17123,GO:0102084,0.99999999998382,0.848919715908274,0,2,L-dopa O-methyltransferase activity,MF,
17175,GO:0102938,0.99999999998382,0.848919715908274,0,2,orcinol O-methyltransferase activity,MF,
17892,GO:1902174,0.999999999983828,0.851920323311694,0,2,positive regulation of keratinocyte apoptotic process,BP,
1513,GO:0003874,0.999999999983864,0.938815124257837,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4243,GO:0009441,0.999999999983864,0.938815124257837,0,1,glycolate metabolic process,BP,
5956,GO:0018323,0.999999999983864,0.938815124257837,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8689,GO:0034309,0.999999999983864,0.938815124257837,0,1,primary alcohol biosynthetic process,BP,
9608,GO:0036470,0.999999999983864,0.938815124257837,0,1,tyrosine 3-monooxygenase activator activity,MF,
9609,GO:0036471,0.999999999983864,0.938815124257837,0,1,cellular response to glyoxal,BP,
9615,GO:0036478,0.999999999983864,0.938815124257837,0,1,L-dopa decarboxylase activator activity,MF,
9650,GO:0036524,0.999999999983864,0.938815124257837,0,1,protein deglycase activity,MF,
9651,GO:0036525,0.999999999983864,0.938815124257837,0,1,protein deglycation,BP,
9652,GO:0036526,0.999999999983864,0.938815124257837,0,1,peptidyl-cysteine deglycation,BP,
9653,GO:0036527,0.999999999983864,0.938815124257837,0,1,peptidyl-arginine deglycation,BP,
9654,GO:0036528,0.999999999983864,0.938815124257837,0,1,peptidyl-lysine deglycation,BP,
9655,GO:0036529,0.999999999983864,0.938815124257837,0,1,protein deglycation, glyoxal removal,BP,
9656,GO:0036530,0.999999999983864,0.938815124257837,0,1,protein deglycation, methylglyoxal removal,BP,
9657,GO:0036531,0.999999999983864,0.938815124257837,0,1,glutathione deglycation,BP,
11208,GO:0045340,0.999999999983864,0.938815124257837,0,1,mercury ion binding,MF,
11613,GO:0046295,0.999999999983864,0.938815124257837,0,1,glycolate biosynthetic process,BP,
17203,GO:0106044,0.999999999983864,0.938815124257837,0,1,guanine deglycation,BP,
17204,GO:0106045,0.999999999983864,0.938815124257837,0,1,guanine deglycation, methylglyoxal removal,BP,
17205,GO:0106046,0.999999999983864,0.938815124257837,0,1,guanine deglycation, glyoxal removal,BP,
17288,GO:0140041,0.999999999983864,0.938815124257837,0,1,cellular detoxification of methylglyoxal,BP,
18251,GO:1903072,0.999999999983864,0.938815124257837,0,1,regulation of death-inducing signaling complex assembly,BP,
18252,GO:1903073,0.999999999983864,0.938815124257837,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18266,GO:1903122,0.999999999983864,0.938815124257837,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18278,GO:1903167,0.999999999983864,0.938815124257837,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18279,GO:1903168,0.999999999983864,0.938815124257837,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18283,GO:1903176,0.999999999983864,0.938815124257837,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18284,GO:1903178,0.999999999983864,0.938815124257837,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18288,GO:1903184,0.999999999983864,0.938815124257837,0,1,L-dopa metabolic process,BP,
18289,GO:1903185,0.999999999983864,0.938815124257837,0,1,L-dopa biosynthetic process,BP,
18290,GO:1903189,0.999999999983864,0.938815124257837,0,1,glyoxal metabolic process,BP,
18291,GO:1903195,0.999999999983864,0.938815124257837,0,1,regulation of L-dopa biosynthetic process,BP,
18292,GO:1903197,0.999999999983864,0.938815124257837,0,1,positive regulation of L-dopa biosynthetic process,BP,
18293,GO:1903198,0.999999999983864,0.938815124257837,0,1,regulation of L-dopa decarboxylase activity,BP,
18294,GO:1903200,0.999999999983864,0.938815124257837,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19818,GO:2000277,0.999999999983864,0.938815124257837,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19824,GO:2000284,0.999999999983864,0.938815124257837,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
20004,GO:2000616,0.999999999983873,0.850731213204269,0,2,negative regulation of histone H3-K9 acetylation,BP,
10920,GO:0044528,0.999999999983896,0.721735783435024,0,4,regulation of mitochondrial mRNA stability,BP,
15106,GO:0071149,0.9999999999839,0.849227673831667,0,2,TEAD-2-YAP complex,CC,
2074,GO:0004828,0.999999999983949,0.851723032968043,0,2,serine-tRNA ligase activity,MF,
2924,GO:0006434,0.999999999983949,0.851723032968043,0,2,seryl-tRNA aminoacylation,BP,
11999,GO:0047408,0.99999999998398,0.851851796589183,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12000,GO:0047409,0.99999999998398,0.851851796589183,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
5448,GO:0016320,0.999999999983993,0.858294611685857,0,2,endoplasmic reticulum membrane fusion,BP,
11952,GO:0047045,0.999999999984016,0.932344365933244,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
9016,GO:0035189,0.999999999984038,0.782162789989118,0,3,Rb-E2F complex,CC,
3291,GO:0006982,0.999999999984039,0.868476176365348,0,2,response to lipid hydroperoxide,BP,
8393,GO:0033306,0.999999999984063,0.850764186873659,0,2,phytol metabolic process,BP,
18282,GO:1903173,0.999999999984063,0.850764186873659,0,2,fatty alcohol metabolic process,BP,
20128,GO:2000819,0.999999999984073,0.848479143031586,0,2,regulation of nucleotide-excision repair,BP,
11633,GO:0046338,0.999999999984075,0.848474751364437,0,2,phosphatidylethanolamine catabolic process,BP,
8387,GO:0033291,0.999999999984085,0.953082592274269,0,1,eukaryotic 80S initiation complex,CC,
8784,GO:0034463,0.999999999984085,0.953082592274269,0,1,90S preribosome assembly,BP,
7155,GO:0031014,0.999999999984108,0.884274186313109,0,2,troponin T binding,MF,
63,GO:0000126,0.999999999984117,0.84847271660468,0,2,transcription factor TFIIIB complex,CC,
80,GO:0000160,0.999999999984117,0.84847271660468,0,2,phosphorelay signal transduction system,BP,
124,GO:0000254,0.999999999984117,0.84847271660468,0,2,C-4 methylsterol oxidase activity,MF,
153,GO:0000308,0.999999999984117,0.84847271660468,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000309,0.999999999984117,0.84847271660468,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
158,GO:0000320,0.999999999984117,0.84847271660468,0,2,re-entry into mitotic cell cycle,BP,
189,GO:0000406,0.999999999984117,0.84847271660468,0,2,double-strand/single-strand DNA junction binding,MF,
309,GO:0000820,0.999999999984117,0.84847271660468,0,2,regulation of glutamine family amino acid metabolic process,BP,
348,GO:0000961,0.999999999984117,0.84847271660468,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
385,GO:0001026,0.999999999984117,0.84847271660468,0,2,TFIIIB-type transcription factor activity,MF,
397,GO:0001069,0.999999999984117,0.84847271660468,0,2,regulatory region RNA binding,MF,
429,GO:0001147,0.999999999984117,0.84847271660468,0,2,transcription termination site sequence-specific DNA binding,MF,
432,GO:0001160,0.999999999984117,0.84847271660468,0,2,transcription termination site DNA binding,MF,
452,GO:0001225,0.999999999984117,0.84847271660468,0,2,RNA polymerase II transcription coactivator binding,MF,
477,GO:0001520,0.999999999984117,0.84847271660468,0,2,outer dense fiber,CC,
496,GO:0001550,0.999999999984117,0.84847271660468,0,2,ovarian cumulus expansion,BP,
500,GO:0001555,0.999999999984117,0.84847271660468,0,2,oocyte growth,BP,
515,GO:0001579,0.999999999984117,0.84847271660468,0,2,medium-chain fatty acid transport,BP,
577,GO:0001729,0.999999999984117,0.84847271660468,0,2,ceramide kinase activity,MF,
588,GO:0001743,0.999999999984117,0.84847271660468,0,2,optic placode formation,BP,
593,GO:0001757,0.999999999984117,0.84847271660468,0,2,somite specification,BP,
638,GO:0001827,0.999999999984117,0.84847271660468,0,2,inner cell mass cell fate commitment,BP,
639,GO:0001828,0.999999999984117,0.84847271660468,0,2,inner cell mass cellular morphogenesis,BP,
670,GO:0001880,0.999999999984117,0.84847271660468,0,2,Mullerian duct regression,BP,
678,GO:0001888,0.999999999984117,0.84847271660468,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
686,GO:0001905,0.999999999984117,0.84847271660468,0,2,activation of membrane attack complex,BP,
739,GO:0001969,0.999999999984117,0.84847271660468,0,2,regulation of activation of membrane attack complex,BP,
803,GO:0002071,0.999999999984117,0.84847271660468,0,2,glandular epithelial cell maturation,BP,
807,GO:0002079,0.999999999984117,0.84847271660468,0,2,inner acrosomal membrane,CC,
834,GO:0002133,0.999999999984117,0.84847271660468,0,2,polycystin complex,CC,
856,GO:0002184,0.999999999984117,0.84847271660468,0,2,cytoplasmic translational termination,BP,
911,GO:0002296,0.999999999984117,0.84847271660468,0,2,T-helper 1 cell lineage commitment,BP,
925,GO:0002322,0.999999999984117,0.84847271660468,0,2,B cell proliferation involved in immune response,BP,
932,GO:0002331,0.999999999984117,0.84847271660468,0,2,pre-B cell allelic exclusion,BP,
1025,GO:0002528,0.999999999984117,0.84847271660468,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1046,GO:0002572,0.999999999984117,0.84847271660468,0,2,pro-T cell differentiation,BP,
1257,GO:0003011,0.999999999984117,0.84847271660468,0,2,involuntary skeletal muscle contraction,BP,
1314,GO:0003162,0.999999999984117,0.84847271660468,0,2,atrioventricular node development,BP,
1315,GO:0003163,0.999999999984117,0.84847271660468,0,2,sinoatrial node development,BP,
1320,GO:0003169,0.999999999984117,0.84847271660468,0,2,coronary vein morphogenesis,BP,
1348,GO:0003213,0.999999999984117,0.84847271660468,0,2,cardiac right atrium morphogenesis,BP,
1364,GO:0003249,0.999999999984117,0.84847271660468,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1365,GO:0003250,0.999999999984117,0.84847271660468,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1387,GO:0003294,0.999999999984117,0.84847271660468,0,2,atrial ventricular junction remodeling,BP,
1406,GO:0003340,0.999999999984117,0.84847271660468,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1417,GO:0003357,0.999999999984117,0.84847271660468,0,2,noradrenergic neuron differentiation,BP,
1433,GO:0003408,0.999999999984117,0.84847271660468,0,2,optic cup formation involved in camera-type eye development,BP,
1442,GO:0003430,0.999999999984117,0.84847271660468,0,2,growth plate cartilage chondrocyte growth,BP,
1470,GO:0003726,0.999999999984117,0.84847271660468,0,2,double-stranded RNA adenosine deaminase activity,MF,
1489,GO:0003827,0.999999999984117,0.84847271660468,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1490,GO:0003828,0.999999999984117,0.84847271660468,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1491,GO:0003829,0.999999999984117,0.84847271660468,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1493,GO:0003835,0.999999999984117,0.84847271660468,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1504,GO:0003858,0.999999999984117,0.84847271660468,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1515,GO:0003876,0.999999999984117,0.84847271660468,0,2,AMP deaminase activity,MF,
1533,GO:0003918,0.999999999984117,0.84847271660468,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1573,GO:0003980,0.999999999984117,0.84847271660468,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1577,GO:0003987,0.999999999984117,0.84847271660468,0,2,acetate-CoA ligase activity,MF,
1579,GO:0003989,0.999999999984117,0.84847271660468,0,2,acetyl-CoA carboxylase activity,MF,
1593,GO:0004008,0.999999999984117,0.84847271660468,0,2,copper-exporting ATPase activity,MF,
1631,GO:0004070,0.999999999984117,0.84847271660468,0,2,aspartate carbamoyltransferase activity,MF,
1643,GO:0004087,0.999999999984117,0.84847271660468,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1644,GO:0004088,0.999999999984117,0.84847271660468,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1666,GO:0004127,0.999999999984117,0.84847271660468,0,2,cytidylate kinase activity,MF,
1684,GO:0004151,0.999999999984117,0.84847271660468,0,2,dihydroorotase activity,MF,
1732,GO:0004329,0.999999999984117,0.84847271660468,0,2,formate-tetrahydrofolate ligase activity,MF,
1766,GO:0004370,0.999999999984117,0.84847271660468,0,2,glycerol kinase activity,MF,
1828,GO:0004483,0.999999999984117,0.84847271660468,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1887,GO:0004568,0.999999999984117,0.84847271660468,0,2,chitinase activity,MF,
1890,GO:0004572,0.999999999984117,0.84847271660468,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1960,GO:0004666,0.999999999984117,0.84847271660468,0,2,prostaglandin-endoperoxide synthase activity,MF,
1972,GO:0004687,0.999999999984117,0.84847271660468,0,2,myosin light chain kinase activity,MF,
2064,GO:0004818,0.999999999984117,0.84847271660468,0,2,glutamate-tRNA ligase activity,MF,
2068,GO:0004822,0.999999999984117,0.84847271660468,0,2,isoleucine-tRNA ligase activity,MF,
2069,GO:0004823,0.999999999984117,0.84847271660468,0,2,leucine-tRNA ligase activity,MF,
2089,GO:0004854,0.999999999984117,0.84847271660468,0,2,xanthine dehydrogenase activity,MF,
2107,GO:0004886,0.999999999984117,0.84847271660468,0,2,9-cis retinoic acid receptor activity,MF,
2126,GO:0004923,0.999999999984117,0.84847271660468,0,2,leukemia inhibitory factor receptor activity,MF,
2147,GO:0004965,0.999999999984117,0.84847271660468,0,2,G-protein coupled GABA receptor activity,MF,
2150,GO:0004969,0.999999999984117,0.84847271660468,0,2,histamine receptor activity,MF,
2152,GO:0004972,0.999999999984117,0.84847271660468,0,2,NMDA glutamate receptor activity,MF,
2191,GO:0005052,0.999999999984117,0.84847271660468,0,2,peroxisome matrix targeting signal-1 binding,MF,
2219,GO:0005119,0.999999999984117,0.84847271660468,0,2,smoothened binding,MF,
2282,GO:0005234,0.999999999984117,0.84847271660468,0,2,extracellularly glutamate-gated ion channel activity,MF,
2321,GO:0005329,0.999999999984117,0.84847271660468,0,2,dopamine transmembrane transporter activity,MF,
2336,GO:0005365,0.999999999984117,0.84847271660468,0,2,myo-inositol transmembrane transporter activity,MF,
2354,GO:0005436,0.999999999984117,0.84847271660468,0,2,sodium:phosphate symporter activity,MF,
2358,GO:0005457,0.999999999984117,0.84847271660468,0,2,GDP-fucose transmembrane transporter activity,MF,
2411,GO:0005584,0.999999999984117,0.84847271660468,0,2,collagen type I trimer,CC,
2428,GO:0005607,0.999999999984117,0.84847271660468,0,2,laminin-2 complex,CC,
2429,GO:0005608,0.999999999984117,0.84847271660468,0,2,laminin-3 complex,CC,
2507,GO:0005760,0.999999999984117,0.84847271660468,0,2,gamma DNA polymerase complex,CC,
2594,GO:0005889,0.999999999984117,0.84847271660468,0,2,potassium:proton exchanging ATPase complex,CC,
2602,GO:0005900,0.999999999984117,0.84847271660468,0,2,oncostatin-M receptor complex,CC,
2623,GO:0005943,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2624,GO:0005945,0.999999999984117,0.84847271660468,0,2,6-phosphofructokinase complex,CC,
2677,GO:0006030,0.999999999984117,0.84847271660468,0,2,chitin metabolic process,BP,
2678,GO:0006032,0.999999999984117,0.84847271660468,0,2,chitin catabolic process,BP,
2683,GO:0006045,0.999999999984117,0.84847271660468,0,2,N-acetylglucosamine biosynthetic process,BP,
2774,GO:0006196,0.999999999984117,0.84847271660468,0,2,AMP catabolic process,BP,
2888,GO:0006393,0.999999999984117,0.84847271660468,0,2,termination of mitochondrial transcription,BP,
2914,GO:0006424,0.999999999984117,0.84847271660468,0,2,glutamyl-tRNA aminoacylation,BP,
2918,GO:0006428,0.999999999984117,0.84847271660468,0,2,isoleucyl-tRNA aminoacylation,BP,
2919,GO:0006429,0.999999999984117,0.84847271660468,0,2,leucyl-tRNA aminoacylation,BP,
3003,GO:0006548,0.999999999984117,0.84847271660468,0,2,histidine catabolic process,BP,
3095,GO:0006668,0.999999999984117,0.84847271660468,0,2,sphinganine-1-phosphate metabolic process,BP,
3173,GO:0006784,0.999999999984117,0.84847271660468,0,2,heme a biosynthetic process,BP,
3210,GO:0006850,0.999999999984117,0.84847271660468,0,2,mitochondrial pyruvate transmembrane transport,BP,
3279,GO:0006957,0.999999999984117,0.84847271660468,0,2,complement activation, alternative pathway,BP,
3438,GO:0007228,0.999999999984117,0.84847271660468,0,2,positive regulation of hh target transcription factor activity,BP,
3510,GO:0007418,0.999999999984117,0.84847271660468,0,2,ventral midline development,BP,
3537,GO:0007529,0.999999999984117,0.84847271660468,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3539,GO:0007538,0.999999999984117,0.84847271660468,0,2,primary sex determination,BP,
3540,GO:0007542,0.999999999984117,0.84847271660468,0,2,primary sex determination, germ-line,BP,
3615,GO:0008061,0.999999999984117,0.84847271660468,0,2,chitin binding,MF,
3618,GO:0008065,0.999999999984117,0.84847271660468,0,2,establishment of blood-nerve barrier,BP,
3638,GO:0008107,0.999999999984117,0.84847271660468,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3640,GO:0008109,0.999999999984117,0.84847271660468,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3714,GO:0008228,0.999999999984117,0.84847271660468,0,2,opsonization,BP,
3722,GO:0008240,0.999999999984117,0.84847271660468,0,2,tripeptidyl-peptidase activity,MF,
3738,GO:0008273,0.999999999984117,0.84847271660468,0,2,calcium, potassium:sodium antiporter activity,MF,
3745,GO:0008282,0.999999999984117,0.84847271660468,0,2,inward rectifying potassium channel,CC,
3771,GO:0008321,0.999999999984117,0.84847271660468,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3824,GO:0008422,0.999999999984117,0.84847271660468,0,2,beta-glucosidase activity,MF,
3842,GO:0008449,0.999999999984117,0.84847271660468,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
3876,GO:0008506,0.999999999984117,0.84847271660468,0,2,sucrose:proton symporter activity,MF,
3884,GO:0008515,0.999999999984117,0.84847271660468,0,2,sucrose transmembrane transporter activity,MF,
3906,GO:0008545,0.999999999984117,0.84847271660468,0,2,JUN kinase kinase activity,MF,
3916,GO:0008582,0.999999999984117,0.84847271660468,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3923,GO:0008594,0.999999999984117,0.84847271660468,0,2,photoreceptor cell morphogenesis,BP,
4065,GO:0009115,0.999999999984117,0.84847271660468,0,2,xanthine catabolic process,BP,
4167,GO:0009233,0.999999999984117,0.84847271660468,0,2,menaquinone metabolic process,BP,
4180,GO:0009257,0.999999999984117,0.84847271660468,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4208,GO:0009330,0.999999999984117,0.84847271660468,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4209,GO:0009331,0.999999999984117,0.84847271660468,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4228,GO:0009405,0.999999999984117,0.84847271660468,0,2,pathogenesis,BP,
4250,GO:0009450,0.999999999984117,0.84847271660468,0,2,gamma-aminobutyric acid catabolic process,BP,
4276,GO:0009637,0.999999999984117,0.84847271660468,0,2,response to blue light,BP,
4286,GO:0009669,0.999999999984117,0.84847271660468,0,2,sucrose:cation symporter activity,MF,
4295,GO:0009726,0.999999999984117,0.84847271660468,0,2,detection of endogenous stimulus,BP,
4308,GO:0009785,0.999999999984117,0.84847271660468,0,2,blue light signaling pathway,BP,
4333,GO:0009882,0.999999999984117,0.84847271660468,0,2,blue light photoreceptor activity,MF,
4528,GO:0010593,0.999999999984117,0.84847271660468,0,2,negative regulation of lamellipodium assembly,BP,
4564,GO:0010645,0.999999999984117,0.84847271660468,0,2,regulation of cell communication by chemical coupling,BP,
4570,GO:0010652,0.999999999984117,0.84847271660468,0,2,positive regulation of cell communication by chemical coupling,BP,
4630,GO:0010751,0.999999999984117,0.84847271660468,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4631,GO:0010752,0.999999999984117,0.84847271660468,0,2,regulation of cGMP-mediated signaling,BP,
4646,GO:0010768,0.999999999984117,0.84847271660468,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4706,GO:0010868,0.999999999984117,0.84847271660468,0,2,negative regulation of triglyceride biosynthetic process,BP,
4776,GO:0010961,0.999999999984117,0.84847271660468,0,2,cellular magnesium ion homeostasis,BP,
4799,GO:0010991,0.999999999984117,0.84847271660468,0,2,negative regulation of SMAD protein complex assembly,BP,
4813,GO:0014004,0.999999999984117,0.84847271660468,0,2,microglia differentiation,BP,
4814,GO:0014005,0.999999999984117,0.84847271660468,0,2,microglia development,BP,
4892,GO:0014816,0.999999999984117,0.84847271660468,0,2,skeletal muscle satellite cell differentiation,BP,
4920,GO:0014858,0.999999999984117,0.84847271660468,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4929,GO:0014886,0.999999999984117,0.84847271660468,0,2,transition between slow and fast fiber,BP,
4953,GO:0015016,0.999999999984117,0.84847271660468,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4976,GO:0015093,0.999999999984117,0.84847271660468,0,2,ferrous iron transmembrane transporter activity,MF,
5006,GO:0015154,0.999999999984117,0.84847271660468,0,2,disaccharide transmembrane transporter activity,MF,
5007,GO:0015157,0.999999999984117,0.84847271660468,0,2,oligosaccharide transmembrane transporter activity,MF,
5021,GO:0015184,0.999999999984117,0.84847271660468,0,2,L-cystine transmembrane transporter activity,MF,
5062,GO:0015275,0.999999999984117,0.84847271660468,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5082,GO:0015319,0.999999999984117,0.84847271660468,0,2,sodium:inorganic phosphate symporter activity,MF,
5083,GO:0015321,0.999999999984117,0.84847271660468,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
5090,GO:0015350,0.999999999984117,0.84847271660468,0,2,methotrexate transmembrane transporter activity,MF,
5097,GO:0015373,0.999999999984117,0.84847271660468,0,2,anion:sodium symporter activity,MF,
5120,GO:0015467,0.999999999984117,0.84847271660468,0,2,G-protein activated inward rectifier potassium channel activity,MF,
5147,GO:0015679,0.999999999984117,0.84847271660468,0,2,plasma membrane copper ion transport,BP,
5150,GO:0015684,0.999999999984117,0.84847271660468,0,2,ferrous iron transport,BP,
5189,GO:0015766,0.999999999984117,0.84847271660468,0,2,disaccharide transport,BP,
5190,GO:0015770,0.999999999984117,0.84847271660468,0,2,sucrose transport,BP,
5191,GO:0015772,0.999999999984117,0.84847271660468,0,2,oligosaccharide transport,BP,
5194,GO:0015783,0.999999999984117,0.84847271660468,0,2,GDP-fucose transmembrane transport,BP,
5211,GO:0015810,0.999999999984117,0.84847271660468,0,2,aspartate transmembrane transport,BP,
5212,GO:0015811,0.999999999984117,0.84847271660468,0,2,L-cystine transport,BP,
5258,GO:0015888,0.999999999984117,0.84847271660468,0,2,thiamine transport,BP,
5446,GO:0016314,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5447,GO:0016316,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5466,GO:0016362,0.999999999984117,0.84847271660468,0,2,activin receptor activity, type II,MF,
5484,GO:0016418,0.999999999984117,0.84847271660468,0,2,S-acetyltransferase activity,MF,
5537,GO:0016524,0.999999999984117,0.84847271660468,0,2,latrotoxin receptor activity,MF,
5571,GO:0016586,0.999999999984117,0.84847271660468,0,2,RSC-type complex,CC,
5634,GO:0016715,0.999999999984117,0.84847271660468,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5641,GO:0016726,0.999999999984117,0.84847271660468,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5649,GO:0016743,0.999999999984117,0.84847271660468,0,2,carboxyl- or carbamoyltransferase activity,MF,
5734,GO:0016880,0.999999999984117,0.84847271660468,0,2,acid-ammonia (or amide) ligase activity,MF,
5751,GO:0016899,0.999999999984117,0.84847271660468,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5789,GO:0017018,0.999999999984117,0.84847271660468,0,2,myosin phosphatase activity,MF,
5823,GO:0017095,0.999999999984117,0.84847271660468,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5861,GO:0017161,0.999999999984117,0.84847271660468,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5992,GO:0018992,0.999999999984117,0.84847271660468,0,2,germ-line sex determination,BP,
6000,GO:0019034,0.999999999984117,0.84847271660468,0,2,viral replication complex,CC,
6004,GO:0019045,0.999999999984117,0.84847271660468,0,2,latent virus replication,BP,
6005,GO:0019046,0.999999999984117,0.84847271660468,0,2,release from viral latency,BP,
6017,GO:0019072,0.999999999984117,0.84847271660468,0,2,viral genome packaging,BP,
6018,GO:0019074,0.999999999984117,0.84847271660468,0,2,viral RNA genome packaging,BP,
6019,GO:0019075,0.999999999984117,0.84847271660468,0,2,virus maturation,BP,
6026,GO:0019085,0.999999999984117,0.84847271660468,0,2,early viral transcription,BP,
6032,GO:0019100,0.999999999984117,0.84847271660468,0,2,male germ-line sex determination,BP,
6078,GO:0019230,0.999999999984117,0.84847271660468,0,2,proprioception,BP,
6111,GO:0019355,0.999999999984117,0.84847271660468,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6141,GO:0019413,0.999999999984117,0.84847271660468,0,2,acetate biosynthetic process,BP,
6142,GO:0019417,0.999999999984117,0.84847271660468,0,2,sulfur oxidation,BP,
6144,GO:0019427,0.999999999984117,0.84847271660468,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6157,GO:0019482,0.999999999984117,0.84847271660468,0,2,beta-alanine metabolic process,BP,
6175,GO:0019542,0.999999999984117,0.84847271660468,0,2,propionate biosynthetic process,BP,
6213,GO:0019732,0.999999999984117,0.84847271660468,0,2,antifungal humoral response,BP,
6316,GO:0019961,0.999999999984117,0.84847271660468,0,2,interferon binding,MF,
6391,GO:0021590,0.999999999984117,0.84847271660468,0,2,cerebellum maturation,BP,
6425,GO:0021691,0.999999999984117,0.84847271660468,0,2,cerebellar Purkinje cell layer maturation,BP,
6427,GO:0021693,0.999999999984117,0.84847271660468,0,2,cerebellar Purkinje cell layer structural organization,BP,
6432,GO:0021698,0.999999999984117,0.84847271660468,0,2,cerebellar cortex structural organization,BP,
6433,GO:0021699,0.999999999984117,0.84847271660468,0,2,cerebellar cortex maturation,BP,
6448,GO:0021764,0.999999999984117,0.84847271660468,0,2,amygdala development,BP,
6469,GO:0021798,0.999999999984117,0.84847271660468,0,2,forebrain dorsal/ventral pattern formation,BP,
6476,GO:0021816,0.999999999984117,0.84847271660468,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6493,GO:0021849,0.999999999984117,0.84847271660468,0,2,neuroblast division in subventricular zone,BP,
6519,GO:0021896,0.999999999984117,0.84847271660468,0,2,forebrain astrocyte differentiation,BP,
6520,GO:0021897,0.999999999984117,0.84847271660468,0,2,forebrain astrocyte development,BP,
6522,GO:0021902,0.999999999984117,0.84847271660468,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6531,GO:0021934,0.999999999984117,0.84847271660468,0,2,hindbrain tangential cell migration,BP,
6532,GO:0021935,0.999999999984117,0.84847271660468,0,2,cerebellar granule cell precursor tangential migration,BP,
6534,GO:0021937,0.999999999984117,0.84847271660468,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6535,GO:0021938,0.999999999984117,0.84847271660468,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6536,GO:0021940,0.999999999984117,0.84847271660468,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6547,GO:0021965,0.999999999984117,0.84847271660468,0,2,spinal cord ventral commissure morphogenesis,BP,
6558,GO:0021997,0.999999999984117,0.84847271660468,0,2,neural plate axis specification,BP,
6635,GO:0023016,0.999999999984117,0.84847271660468,0,2,signal transduction by trans-phosphorylation,BP,
6800,GO:0030241,0.999999999984117,0.84847271660468,0,2,skeletal muscle myosin thick filament assembly,BP,
6914,GO:0030505,0.999999999984117,0.84847271660468,0,2,inorganic diphosphate transport,BP,
6933,GO:0030538,0.999999999984117,0.84847271660468,0,2,embryonic genitalia morphogenesis,BP,
7033,GO:0030806,0.999999999984117,0.84847271660468,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7048,GO:0030821,0.999999999984117,0.84847271660468,0,2,negative regulation of cAMP catabolic process,BP,
7111,GO:0030910,0.999999999984117,0.84847271660468,0,2,olfactory placode formation,BP,
7160,GO:0031022,0.999999999984117,0.84847271660468,0,2,nuclear migration along microfilament,BP,
7168,GO:0031048,0.999999999984117,0.84847271660468,0,2,chromatin silencing by small RNA,BP,
7182,GO:0031064,0.999999999984117,0.84847271660468,0,2,negative regulation of histone deacetylation,BP,
7192,GO:0031081,0.999999999984117,0.84847271660468,0,2,nuclear pore distribution,BP,
7232,GO:0031127,0.999999999984117,0.84847271660468,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7254,GO:0031213,0.999999999984117,0.84847271660468,0,2,RSF complex,CC,
7271,GO:0031251,0.999999999984117,0.84847271660468,0,2,PAN complex,CC,
7352,GO:0031393,0.999999999984117,0.84847271660468,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7361,GO:0031403,0.999999999984117,0.84847271660468,0,2,lithium ion binding,MF,
7437,GO:0031547,0.999999999984117,0.84847271660468,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7454,GO:0031590,0.999999999984117,0.84847271660468,0,2,wybutosine metabolic process,BP,
7455,GO:0031591,0.999999999984117,0.84847271660468,0,2,wybutosine biosynthetic process,BP,
7506,GO:0031685,0.999999999984117,0.84847271660468,0,2,adenosine receptor binding,MF,
7529,GO:0031749,0.999999999984117,0.84847271660468,0,2,D2 dopamine receptor binding,MF,
7530,GO:0031752,0.999999999984117,0.84847271660468,0,2,D5 dopamine receptor binding,MF,
7552,GO:0031862,0.999999999984117,0.84847271660468,0,2,prostanoid receptor binding,MF,
7613,GO:0031999,0.999999999984117,0.84847271660468,0,2,negative regulation of fatty acid beta-oxidation,BP,
7643,GO:0032053,0.999999999984117,0.84847271660468,0,2,ciliary basal body organization,BP,
7681,GO:0032116,0.999999999984117,0.84847271660468,0,2,SMC loading complex,CC,
7691,GO:0032143,0.999999999984117,0.84847271660468,0,2,single thymine insertion binding,MF,
7702,GO:0032181,0.999999999984117,0.84847271660468,0,2,dinucleotide repeat insertion binding,MF,
7723,GO:0032213,0.999999999984117,0.84847271660468,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7724,GO:0032214,0.999999999984117,0.84847271660468,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7726,GO:0032217,0.999999999984117,0.84847271660468,0,2,riboflavin transmembrane transporter activity,MF,
7727,GO:0032218,0.999999999984117,0.84847271660468,0,2,riboflavin transport,BP,
7777,GO:0032301,0.999999999984117,0.84847271660468,0,2,MutSalpha complex,CC,
7778,GO:0032302,0.999999999984117,0.84847271660468,0,2,MutSbeta complex,CC,
7879,GO:0032444,0.999999999984117,0.84847271660468,0,2,activin responsive factor complex,CC,
7905,GO:0032474,0.999999999984117,0.84847271660468,0,2,otolith morphogenesis,BP,
8070,GO:0032741,0.999999999984117,0.84847271660468,0,2,positive regulation of interleukin-18 production,BP,
8112,GO:0032798,0.999999999984117,0.84847271660468,0,2,Swi5-Sfr1 complex,CC,
8151,GO:0032877,0.999999999984117,0.84847271660468,0,2,positive regulation of DNA endoreduplication,BP,
8168,GO:0032902,0.999999999984117,0.84847271660468,0,2,nerve growth factor production,BP,
8180,GO:0032916,0.999999999984117,0.84847271660468,0,2,positive regulation of transforming growth factor beta3 production,BP,
8203,GO:0032954,0.999999999984117,0.84847271660468,0,2,regulation of cytokinetic process,BP,
8295,GO:0033122,0.999999999984117,0.84847271660468,0,2,negative regulation of purine nucleotide catabolic process,BP,
8317,GO:0033149,0.999999999984117,0.84847271660468,0,2,FFAT motif binding,MF,
8388,GO:0033292,0.999999999984117,0.84847271660468,0,2,T-tubule organization,BP,
8391,GO:0033300,0.999999999984117,0.84847271660468,0,2,dehydroascorbic acid transmembrane transporter activity,MF,
8467,GO:0033604,0.999999999984117,0.84847271660468,0,2,negative regulation of catecholamine secretion,BP,
8480,GO:0033625,0.999999999984117,0.84847271660468,0,2,positive regulation of integrin activation,BP,
8507,GO:0033684,0.999999999984117,0.84847271660468,0,2,regulation of luteinizing hormone secretion,BP,
8508,GO:0033686,0.999999999984117,0.84847271660468,0,2,positive regulation of luteinizing hormone secretion,BP,
8513,GO:0033691,0.999999999984117,0.84847271660468,0,2,sialic acid binding,MF,
8529,GO:0033768,0.999999999984117,0.84847271660468,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8534,GO:0033842,0.999999999984117,0.84847271660468,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8590,GO:0034087,0.999999999984117,0.84847271660468,0,2,establishment of mitotic sister chromatid cohesion,BP,
8647,GO:0034188,0.999999999984117,0.84847271660468,0,2,apolipoprotein A-I receptor activity,MF,
8648,GO:0034189,0.999999999984117,0.84847271660468,0,2,very-low-density lipoprotein particle binding,MF,
8755,GO:0034416,0.999999999984117,0.84847271660468,0,2,bisphosphoglycerate phosphatase activity,MF,
8767,GO:0034437,0.999999999984117,0.84847271660468,0,2,glycoprotein transporter activity,MF,
8800,GO:0034499,0.999999999984117,0.84847271660468,0,2,late endosome to Golgi transport,BP,
8810,GO:0034515,0.999999999984117,0.84847271660468,0,2,proteasome storage granule,CC,
8824,GO:0034597,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8840,GO:0034627,0.999999999984117,0.84847271660468,0,2,'de novo' NAD biosynthetic process,BP,
8841,GO:0034628,0.999999999984117,0.84847271660468,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8853,GO:0034647,0.999999999984117,0.84847271660468,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8866,GO:0034665,0.999999999984117,0.84847271660468,0,2,integrin alpha1-beta1 complex,CC,
8868,GO:0034667,0.999999999984117,0.84847271660468,0,2,integrin alpha3-beta1 complex,CC,
8871,GO:0034673,0.999999999984117,0.84847271660468,0,2,inhibin-betaglycan-ActRII complex,CC,
8875,GO:0034680,0.999999999984117,0.84847271660468,0,2,integrin alpha10-beta1 complex,CC,
8902,GO:0034721,0.999999999984117,0.84847271660468,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8911,GO:0034750,0.999999999984117,0.84847271660468,0,2,Scrib-APC-beta-catenin complex,CC,
8931,GO:0034776,0.999999999984117,0.84847271660468,0,2,response to histamine,BP,
8987,GO:0035093,0.999999999984117,0.84847271660468,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
9046,GO:0035261,0.999999999984117,0.84847271660468,0,2,external genitalia morphogenesis,BP,
9057,GO:0035279,0.999999999984117,0.84847271660468,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9082,GO:0035332,0.999999999984117,0.84847271660468,0,2,positive regulation of hippo signaling,BP,
9104,GO:0035373,0.999999999984117,0.84847271660468,0,2,chondroitin sulfate proteoglycan binding,MF,
9150,GO:0035500,0.999999999984117,0.84847271660468,0,2,MH2 domain binding,MF,
9173,GO:0035526,0.999999999984117,0.84847271660468,0,2,retrograde transport, plasma membrane to Golgi,BP,
9193,GO:0035574,0.999999999984117,0.84847271660468,0,2,histone H4-K20 demethylation,BP,
9194,GO:0035575,0.999999999984117,0.84847271660468,0,2,histone demethylase activity (H4-K20 specific),MF,
9222,GO:0035608,0.999999999984117,0.84847271660468,0,2,protein deglutamylation,BP,
9338,GO:0035822,0.999999999984117,0.84847271660468,0,2,gene conversion,BP,
9340,GO:0035838,0.999999999984117,0.84847271660468,0,2,growing cell tip,CC,
9349,GO:0035860,0.999999999984117,0.84847271660468,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9468,GO:0036080,0.999999999984117,0.84847271660468,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9494,GO:0036135,0.999999999984117,0.84847271660468,0,2,Schwann cell migration,BP,
9508,GO:0036156,0.999999999984117,0.84847271660468,0,2,inner dynein arm,CC,
9549,GO:0036309,0.999999999984117,0.84847271660468,0,2,protein localization to M-band,BP,
9571,GO:0036369,0.999999999984117,0.84847271660468,0,2,transcription factor catabolic process,BP,
9596,GO:0036451,0.999999999984117,0.84847271660468,0,2,cap mRNA methylation,BP,
9607,GO:0036466,0.999999999984117,0.84847271660468,0,2,synaptic vesicle recycling via endosome,BP,
9649,GO:0036518,0.999999999984117,0.84847271660468,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9663,GO:0038018,0.999999999984117,0.84847271660468,0,2,Wnt receptor catabolic process,BP,
9667,GO:0038025,0.999999999984117,0.84847271660468,0,2,reelin receptor activity,MF,
9681,GO:0038049,0.999999999984117,0.84847271660468,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9687,GO:0038064,0.999999999984117,0.84847271660468,0,2,collagen receptor activity,MF,
9709,GO:0038113,0.999999999984117,0.84847271660468,0,2,interleukin-9-mediated signaling pathway,BP,
9712,GO:0038124,0.999999999984117,0.84847271660468,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9749,GO:0039019,0.999999999984117,0.84847271660468,0,2,pronephric nephron development,BP,
9760,GO:0039519,0.999999999984117,0.84847271660468,0,2,modulation by virus of host autophagy,BP,
9810,GO:0040038,0.999999999984117,0.84847271660468,0,2,polar body extrusion after meiotic divisions,BP,
9821,GO:0042030,0.999999999984117,0.84847271660468,0,2,ATPase inhibitor activity,MF,
9919,GO:0042264,0.999999999984117,0.84847271660468,0,2,peptidyl-aspartic acid hydroxylation,BP,
9925,GO:0042271,0.999999999984117,0.84847271660468,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9926,GO:0042272,0.999999999984117,0.84847271660468,0,2,nuclear RNA export factor complex,CC,
10008,GO:0042426,0.999999999984117,0.84847271660468,0,2,choline catabolic process,BP,
10042,GO:0042494,0.999999999984117,0.84847271660468,0,2,detection of bacterial lipoprotein,BP,
10044,GO:0042496,0.999999999984117,0.84847271660468,0,2,detection of diacyl bacterial lipopeptide,BP,
10057,GO:0042539,0.999999999984117,0.84847271660468,0,2,hypotonic salinity response,BP,
10208,GO:0042823,0.999999999984117,0.84847271660468,0,2,pyridoxal phosphate biosynthetic process,BP,
10245,GO:0042978,0.999999999984117,0.84847271660468,0,2,ornithine decarboxylase activator activity,MF,
10260,GO:0042998,0.999999999984117,0.84847271660468,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10437,GO:0043291,0.999999999984117,0.84847271660468,0,2,RAVE complex,CC,
10457,GO:0043314,0.999999999984117,0.84847271660468,0,2,negative regulation of neutrophil degranulation,BP,
10543,GO:0043490,0.999999999984117,0.84847271660468,0,2,malate-aspartate shuttle,BP,
10578,GO:0043541,0.999999999984117,0.84847271660468,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10607,GO:0043585,0.999999999984117,0.84847271660468,0,2,nose morphogenesis,BP,
10619,GO:0043614,0.999999999984117,0.84847271660468,0,2,multi-eIF complex,CC,
10650,GO:0043682,0.999999999984117,0.84847271660468,0,2,copper-transporting ATPase activity,MF,
10714,GO:0044028,0.999999999984117,0.84847271660468,0,2,DNA hypomethylation,BP,
10715,GO:0044029,0.999999999984117,0.84847271660468,0,2,hypomethylation of CpG island,BP,
10820,GO:0044308,0.999999999984117,0.84847271660468,0,2,axonal spine,CC,
10830,GO:0044323,0.999999999984117,0.84847271660468,0,2,retinoic acid-responsive element binding,MF,
10840,GO:0044334,0.999999999984117,0.84847271660468,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10918,GO:0044501,0.999999999984117,0.84847271660468,0,2,modulation of signal transduction in other organism,BP,
10956,GO:0044691,0.999999999984117,0.84847271660468,0,2,tooth eruption,BP,
10980,GO:0044771,0.999999999984117,0.84847271660468,0,2,meiotic cell cycle phase transition,BP,
11002,GO:0044805,0.999999999984117,0.84847271660468,0,2,late nucleophagy,BP,
11011,GO:0044830,0.999999999984117,0.84847271660468,0,2,modulation by host of viral RNA genome replication,BP,
11032,GO:0045004,0.999999999984117,0.84847271660468,0,2,DNA replication proofreading,BP,
11117,GO:0045142,0.999999999984117,0.84847271660468,0,2,triplex DNA binding,MF,
11120,GO:0045145,0.999999999984117,0.84847271660468,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11146,GO:0045196,0.999999999984117,0.84847271660468,0,2,establishment or maintenance of neuroblast polarity,BP,
11150,GO:0045200,0.999999999984117,0.84847271660468,0,2,establishment of neuroblast polarity,BP,
11155,GO:0045210,0.999999999984117,0.84847271660468,0,2,FasL biosynthetic process,BP,
11198,GO:0045322,0.999999999984117,0.84847271660468,0,2,unmethylated CpG binding,MF,
11223,GO:0045356,0.999999999984117,0.84847271660468,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11236,GO:0045409,0.999999999984117,0.84847271660468,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11387,GO:0045762,0.999999999984117,0.84847271660468,0,2,positive regulation of adenylate cyclase activity,BP,
11388,GO:0045763,0.999999999984117,0.84847271660468,0,2,negative regulation of cellular amino acid metabolic process,BP,
11496,GO:0045967,0.999999999984117,0.84847271660468,0,2,negative regulation of growth rate,BP,
11498,GO:0045976,0.999999999984117,0.84847271660468,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11541,GO:0046069,0.999999999984117,0.84847271660468,0,2,cGMP catabolic process,BP,
11588,GO:0046160,0.999999999984117,0.84847271660468,0,2,heme a metabolic process,BP,
11592,GO:0046167,0.999999999984117,0.84847271660468,0,2,glycerol-3-phosphate biosynthetic process,BP,
11899,GO:0046922,0.999999999984117,0.84847271660468,0,2,peptide-O-fucosyltransferase activity,MF,
11974,GO:0047237,0.999999999984117,0.84847271660468,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11987,GO:0047322,0.999999999984117,0.84847271660468,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12022,GO:0047623,0.999999999984117,0.84847271660468,0,2,adenosine-phosphate deaminase activity,MF,
12040,GO:0047757,0.999999999984117,0.84847271660468,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12074,GO:0048022,0.999999999984117,0.84847271660468,0,2,negative regulation of melanin biosynthetic process,BP,
12095,GO:0048073,0.999999999984117,0.84847271660468,0,2,regulation of eye pigmentation,BP,
12114,GO:0048165,0.999999999984117,0.84847271660468,0,2,fused antrum stage,BP,
12173,GO:0048294,0.999999999984117,0.84847271660468,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12187,GO:0048319,0.999999999984117,0.84847271660468,0,2,axial mesoderm morphogenesis,BP,
12199,GO:0048369,0.999999999984117,0.84847271660468,0,2,lateral mesoderm morphogenesis,BP,
12200,GO:0048370,0.999999999984117,0.84847271660468,0,2,lateral mesoderm formation,BP,
12201,GO:0048371,0.999999999984117,0.84847271660468,0,2,lateral mesodermal cell differentiation,BP,
12202,GO:0048372,0.999999999984117,0.84847271660468,0,2,lateral mesodermal cell fate commitment,BP,
12203,GO:0048377,0.999999999984117,0.84847271660468,0,2,lateral mesodermal cell fate specification,BP,
12204,GO:0048378,0.999999999984117,0.84847271660468,0,2,regulation of lateral mesodermal cell fate specification,BP,
12364,GO:0048743,0.999999999984117,0.84847271660468,0,2,positive regulation of skeletal muscle fiber development,BP,
12374,GO:0048763,0.999999999984117,0.84847271660468,0,2,calcium-induced calcium release activity,MF,
12378,GO:0048769,0.999999999984117,0.84847271660468,0,2,sarcomerogenesis,BP,
12392,GO:0048817,0.999999999984117,0.84847271660468,0,2,negative regulation of hair follicle maturation,BP,
12406,GO:0048850,0.999999999984117,0.84847271660468,0,2,hypophysis morphogenesis,BP,
12442,GO:0050119,0.999999999984117,0.84847271660468,0,2,N-acetylglucosamine deacetylase activity,MF,
12476,GO:0050405,0.999999999984117,0.84847271660468,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12485,GO:0050436,0.999999999984117,0.84847271660468,0,2,microfibril binding,MF,
12492,GO:0050508,0.999999999984117,0.84847271660468,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12493,GO:0050509,0.999999999984117,0.84847271660468,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12516,GO:0050659,0.999999999984117,0.84847271660468,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12687,GO:0050904,0.999999999984117,0.84847271660468,0,2,diapedesis,BP,
12720,GO:0050957,0.999999999984117,0.84847271660468,0,2,equilibrioception,BP,
12986,GO:0051389,0.999999999984117,0.84847271660468,0,2,inactivation of MAPKK activity,BP,
13023,GO:0051458,0.999999999984117,0.84847271660468,0,2,corticotropin secretion,BP,
13024,GO:0051459,0.999999999984117,0.84847271660468,0,2,regulation of corticotropin secretion,BP,
13025,GO:0051461,0.999999999984117,0.84847271660468,0,2,positive regulation of corticotropin secretion,BP,
13045,GO:0051525,0.999999999984117,0.84847271660468,0,2,NFAT protein binding,MF,
13062,GO:0051562,0.999999999984117,0.84847271660468,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13063,GO:0051563,0.999999999984117,0.84847271660468,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13099,GO:0051611,0.999999999984117,0.84847271660468,0,2,regulation of serotonin uptake,BP,
13100,GO:0051612,0.999999999984117,0.84847271660468,0,2,negative regulation of serotonin uptake,BP,
13123,GO:0051664,0.999999999984117,0.84847271660468,0,2,nuclear pore localization,BP,
13149,GO:0051717,0.999999999984117,0.84847271660468,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13271,GO:0051958,0.999999999984117,0.84847271660468,0,2,methotrexate transport,BP,
13297,GO:0052027,0.999999999984117,0.84847271660468,0,2,modulation by symbiont of host signal transduction pathway,BP,
13331,GO:0052250,0.999999999984117,0.84847271660468,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
13409,GO:0052746,0.999999999984117,0.84847271660468,0,2,inositol phosphorylation,BP,
13415,GO:0052805,0.999999999984117,0.84847271660468,0,2,imidazole-containing compound catabolic process,BP,
13418,GO:0052812,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13425,GO:0052827,0.999999999984117,0.84847271660468,0,2,inositol pentakisphosphate phosphatase activity,MF,
13426,GO:0052828,0.999999999984117,0.84847271660468,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13543,GO:0060003,0.999999999984117,0.84847271660468,0,2,copper ion export,BP,
13562,GO:0060025,0.999999999984117,0.84847271660468,0,2,regulation of synaptic activity,BP,
13612,GO:0060083,0.999999999984117,0.84847271660468,0,2,smooth muscle contraction involved in micturition,BP,
13629,GO:0060124,0.999999999984117,0.84847271660468,0,2,positive regulation of growth hormone secretion,BP,
13635,GO:0060134,0.999999999984117,0.84847271660468,0,2,prepulse inhibition,BP,
13645,GO:0060151,0.999999999984117,0.84847271660468,0,2,peroxisome localization,BP,
13646,GO:0060152,0.999999999984117,0.84847271660468,0,2,microtubule-based peroxisome localization,BP,
13667,GO:0060187,0.999999999984117,0.84847271660468,0,2,cell pole,CC,
13747,GO:0060319,0.999999999984117,0.84847271660468,0,2,primitive erythrocyte differentiation,BP,
13795,GO:0060382,0.999999999984117,0.84847271660468,0,2,regulation of DNA strand elongation,BP,
13810,GO:0060399,0.999999999984117,0.84847271660468,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13820,GO:0060414,0.999999999984117,0.84847271660468,0,2,aorta smooth muscle tissue morphogenesis,BP,
13832,GO:0060430,0.999999999984117,0.84847271660468,0,2,lung saccule development,BP,
13871,GO:0060488,0.999999999984117,0.84847271660468,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13872,GO:0060489,0.999999999984117,0.84847271660468,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13873,GO:0060490,0.999999999984117,0.84847271660468,0,2,lateral sprouting involved in lung morphogenesis,BP,
13986,GO:0060698,0.999999999984117,0.84847271660468,0,2,endoribonuclease inhibitor activity,MF,
13989,GO:0060701,0.999999999984117,0.84847271660468,0,2,negative regulation of ribonuclease activity,BP,
13990,GO:0060702,0.999999999984117,0.84847271660468,0,2,negative regulation of endoribonuclease activity,BP,
14012,GO:0060733,0.999999999984117,0.84847271660468,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14047,GO:0060800,0.999999999984117,0.84847271660468,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14050,GO:0060816,0.999999999984117,0.84847271660468,0,2,random inactivation of X chromosome,BP,
14051,GO:0060819,0.999999999984117,0.84847271660468,0,2,inactivation of X chromosome by genetic imprinting,BP,
14093,GO:0060921,0.999999999984117,0.84847271660468,0,2,sinoatrial node cell differentiation,BP,
14098,GO:0060931,0.999999999984117,0.84847271660468,0,2,sinoatrial node cell development,BP,
14106,GO:0060948,0.999999999984117,0.84847271660468,0,2,cardiac vascular smooth muscle cell development,BP,
14129,GO:0060995,0.999999999984117,0.84847271660468,0,2,cell-cell signaling involved in kidney development,BP,
14173,GO:0061055,0.999999999984117,0.84847271660468,0,2,myotome development,BP,
14230,GO:0061187,0.999999999984117,0.84847271660468,0,2,regulation of chromatin silencing at rDNA,BP,
14231,GO:0061188,0.999999999984117,0.84847271660468,0,2,negative regulation of chromatin silencing at rDNA,BP,
14246,GO:0061289,0.999999999984117,0.84847271660468,0,2,Wnt signaling pathway involved in kidney development,BP,
14247,GO:0061290,0.999999999984117,0.84847271660468,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14271,GO:0061341,0.999999999984117,0.84847271660468,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14273,GO:0061346,0.999999999984117,0.84847271660468,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
14309,GO:0061443,0.999999999984117,0.84847271660468,0,2,endocardial cushion cell differentiation,BP,
14327,GO:0061505,0.999999999984117,0.84847271660468,0,2,DNA topoisomerase II activity,MF,
14365,GO:0061582,0.999999999984117,0.84847271660468,0,2,intestinal epithelial cell migration,BP,
14395,GO:0061643,0.999999999984117,0.84847271660468,0,2,chemorepulsion of axon,BP,
14406,GO:0061669,0.999999999984117,0.84847271660468,0,2,spontaneous neurotransmitter secretion,BP,
14439,GO:0061749,0.999999999984117,0.84847271660468,0,2,forked DNA-dependent helicase activity,MF,
14446,GO:0061762,0.999999999984117,0.84847271660468,0,2,CAMKK-AMPK signaling cascade,BP,
14476,GO:0061849,0.999999999984117,0.84847271660468,0,2,telomeric G-quadruplex DNA binding,MF,
14479,GO:0061857,0.999999999984117,0.84847271660468,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14510,GO:0065001,0.999999999984117,0.84847271660468,0,2,specification of axis polarity,BP,
14541,GO:0070052,0.999999999984117,0.84847271660468,0,2,collagen V binding,MF,
14611,GO:0070170,0.999999999984117,0.84847271660468,0,2,regulation of tooth mineralization,BP,
14662,GO:0070259,0.999999999984117,0.84847271660468,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14708,GO:0070336,0.999999999984117,0.84847271660468,0,2,flap-structured DNA binding,MF,
14711,GO:0070340,0.999999999984117,0.84847271660468,0,2,detection of bacterial lipopeptide,BP,
14729,GO:0070381,0.999999999984117,0.84847271660468,0,2,endosome to plasma membrane transport vesicle,CC,
14762,GO:0070436,0.999999999984117,0.84847271660468,0,2,Grb2-EGFR complex,CC,
14872,GO:0070649,0.999999999984117,0.84847271660468,0,2,formin-nucleated actin cable assembly,BP,
14926,GO:0070777,0.999999999984117,0.84847271660468,0,2,D-aspartate transport,BP,
14928,GO:0070779,0.999999999984117,0.84847271660468,0,2,D-aspartate import across plasma membrane,BP,
14943,GO:0070829,0.999999999984117,0.84847271660468,0,2,heterochromatin maintenance,BP,
14947,GO:0070837,0.999999999984117,0.84847271660468,0,2,dehydroascorbic acid transport,BP,
14961,GO:0070853,0.999999999984117,0.84847271660468,0,2,myosin VI binding,MF,
14973,GO:0070877,0.999999999984117,0.84847271660468,0,2,microprocessor complex,CC,
15049,GO:0070993,0.999999999984117,0.84847271660468,0,2,translation preinitiation complex,CC,
15093,GO:0071104,0.999999999984117,0.84847271660468,0,2,response to interleukin-9,BP,
15098,GO:0071109,0.999999999984117,0.84847271660468,0,2,superior temporal gyrus development,BP,
15104,GO:0071144,0.999999999984117,0.84847271660468,0,2,heteromeric SMAD protein complex,CC,
15105,GO:0071148,0.999999999984117,0.84847271660468,0,2,TEAD-1-YAP complex,CC,
15153,GO:0071262,0.999999999984117,0.84847271660468,0,2,regulation of translational initiation in response to starvation,BP,
15154,GO:0071264,0.999999999984117,0.84847271660468,0,2,positive regulation of translational initiation in response to starvation,BP,
15210,GO:0071355,0.999999999984117,0.84847271660468,0,2,cellular response to interleukin-9,BP,
15222,GO:0071374,0.999999999984117,0.84847271660468,0,2,cellular response to parathyroid hormone stimulus,BP,
15232,GO:0071386,0.999999999984117,0.84847271660468,0,2,cellular response to corticosterone stimulus,BP,
15253,GO:0071420,0.999999999984117,0.84847271660468,0,2,cellular response to histamine,BP,
15254,GO:0071421,0.999999999984117,0.84847271660468,0,2,manganese ion transmembrane transport,BP,
15282,GO:0071462,0.999999999984117,0.84847271660468,0,2,cellular response to water stimulus,BP,
15293,GO:0071477,0.999999999984117,0.84847271660468,0,2,cellular hypotonic salinity response,BP,
15299,GO:0071483,0.999999999984117,0.84847271660468,0,2,cellular response to blue light,BP,
15300,GO:0071484,0.999999999984117,0.84847271660468,0,2,cellular response to light intensity,BP,
15360,GO:0071595,0.999999999984117,0.84847271660468,0,2,Nem1-Spo7 phosphatase complex,CC,
15395,GO:0071642,0.999999999984117,0.84847271660468,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15429,GO:0071698,0.999999999984117,0.84847271660468,0,2,olfactory placode development,BP,
15430,GO:0071699,0.999999999984117,0.84847271660468,0,2,olfactory placode morphogenesis,BP,
15443,GO:0071724,0.999999999984117,0.84847271660468,0,2,response to diacyl bacterial lipopeptide,BP,
15445,GO:0071726,0.999999999984117,0.84847271660468,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15528,GO:0071910,0.999999999984117,0.84847271660468,0,2,determination of liver left/right asymmetry,BP,
15530,GO:0071918,0.999999999984117,0.84847271660468,0,2,urea transmembrane transport,BP,
15535,GO:0071929,0.999999999984117,0.84847271660468,0,2,alpha-tubulin acetylation,BP,
15548,GO:0071955,0.999999999984117,0.84847271660468,0,2,recycling endosome to Golgi transport,BP,
15571,GO:0072021,0.999999999984117,0.84847271660468,0,2,ascending thin limb development,BP,
15585,GO:0072053,0.999999999984117,0.84847271660468,0,2,renal inner medulla development,BP,
15586,GO:0072054,0.999999999984117,0.84847271660468,0,2,renal outer medulla development,BP,
15608,GO:0072092,0.999999999984117,0.84847271660468,0,2,ureteric bud invasion,BP,
15641,GO:0072137,0.999999999984117,0.84847271660468,0,2,condensed mesenchymal cell proliferation,BP,
15648,GO:0072156,0.999999999984117,0.84847271660468,0,2,distal tubule morphogenesis,BP,
15662,GO:0072177,0.999999999984117,0.84847271660468,0,2,mesonephric duct development,BP,
15682,GO:0072204,0.999999999984117,0.84847271660468,0,2,cell-cell signaling involved in metanephros development,BP,
15693,GO:0072218,0.999999999984117,0.84847271660468,0,2,metanephric ascending thin limb development,BP,
15726,GO:0072289,0.999999999984117,0.84847271660468,0,2,metanephric nephron tubule formation,BP,
15767,GO:0072361,0.999999999984117,0.84847271660468,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15770,GO:0072364,0.999999999984117,0.84847271660468,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15774,GO:0072368,0.999999999984117,0.84847271660468,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15775,GO:0072369,0.999999999984117,0.84847271660468,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15801,GO:0072434,0.999999999984117,0.84847271660468,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15969,GO:0080023,0.999999999984117,0.84847271660468,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15998,GO:0086006,0.999999999984117,0.84847271660468,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
15999,GO:0086007,0.999999999984117,0.84847271660468,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16007,GO:0086015,0.999999999984117,0.84847271660468,0,2,SA node cell action potential,BP,
16009,GO:0086017,0.999999999984117,0.84847271660468,0,2,Purkinje myocyte action potential,BP,
16010,GO:0086018,0.999999999984117,0.84847271660468,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16012,GO:0086020,0.999999999984117,0.84847271660468,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16013,GO:0086021,0.999999999984117,0.84847271660468,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16019,GO:0086029,0.999999999984117,0.84847271660468,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16027,GO:0086045,0.999999999984117,0.84847271660468,0,2,membrane depolarization during AV node cell action potential,BP,
16030,GO:0086048,0.999999999984117,0.84847271660468,0,2,membrane depolarization during bundle of His cell action potential,BP,
16031,GO:0086053,0.999999999984117,0.84847271660468,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16040,GO:0086068,0.999999999984117,0.84847271660468,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16047,GO:0086077,0.999999999984117,0.84847271660468,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16101,GO:0090080,0.999999999984117,0.84847271660468,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16191,GO:0090210,0.999999999984117,0.84847271660468,0,2,regulation of establishment of blood-brain barrier,BP,
16197,GO:0090222,0.999999999984117,0.84847271660468,0,2,centrosome-templated microtubule nucleation,BP,
16227,GO:0090271,0.999999999984117,0.84847271660468,0,2,positive regulation of fibroblast growth factor production,BP,
16293,GO:0090386,0.999999999984117,0.84847271660468,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16294,GO:0090387,0.999999999984117,0.84847271660468,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16330,GO:0090541,0.999999999984117,0.84847271660468,0,2,MIT domain binding,MF,
16333,GO:0090554,0.999999999984117,0.84847271660468,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16334,GO:0090556,0.999999999984117,0.84847271660468,0,2,phosphatidylserine-translocating ATPase activity,MF,
16377,GO:0090694,0.999999999984117,0.84847271660468,0,2,Scc2-Scc4 cohesin loading complex,CC,
16380,GO:0090722,0.999999999984117,0.84847271660468,0,2,receptor-receptor interaction,MF,
16399,GO:0097016,0.999999999984117,0.84847271660468,0,2,L27 domain binding,MF,
16449,GO:0097109,0.999999999984117,0.84847271660468,0,2,neuroligin family protein binding,MF,
16451,GO:0097111,0.999999999984117,0.84847271660468,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16475,GO:0097155,0.999999999984117,0.84847271660468,0,2,fasciculation of sensory neuron axon,BP,
16503,GO:0097198,0.999999999984117,0.84847271660468,0,2,histone H3-K36 trimethylation,BP,
16537,GO:0097274,0.999999999984117,0.84847271660468,0,2,urea homeostasis,BP,
16551,GO:0097309,0.999999999984117,0.84847271660468,0,2,cap1 mRNA methylation,BP,
16571,GO:0097359,0.999999999984117,0.84847271660468,0,2,UDP-glucosylation,BP,
16575,GO:0097363,0.999999999984117,0.84847271660468,0,2,protein O-GlcNAc transferase activity,MF,
16614,GO:0097450,0.999999999984117,0.84847271660468,0,2,astrocyte end-foot,CC,
16615,GO:0097451,0.999999999984117,0.84847271660468,0,2,glial limiting end-foot,CC,
16618,GO:0097457,0.999999999984117,0.84847271660468,0,2,hippocampal mossy fiber,CC,
16667,GO:0097543,0.999999999984117,0.84847271660468,0,2,ciliary inversin compartment,CC,
16672,GO:0097574,0.999999999984117,0.84847271660468,0,2,lateral part of cell,CC,
16673,GO:0097575,0.999999999984117,0.84847271660468,0,2,lateral cell cortex,CC,
16689,GO:0097632,0.999999999984117,0.84847271660468,0,2,extrinsic component of phagophore assembly site membrane,CC,
16690,GO:0097635,0.999999999984117,0.84847271660468,0,2,extrinsic component of autophagosome membrane,CC,
16691,GO:0097636,0.999999999984117,0.84847271660468,0,2,intrinsic component of autophagosome membrane,CC,
16692,GO:0097637,0.999999999984117,0.84847271660468,0,2,integral component of autophagosome membrane,CC,
16702,GO:0097651,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16708,GO:0097681,0.999999999984117,0.84847271660468,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16776,GO:0098582,0.999999999984117,0.84847271660468,0,2,innate vocalization behavior,BP,
16817,GO:0098679,0.999999999984117,0.84847271660468,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16853,GO:0098770,0.999999999984117,0.84847271660468,0,2,FBXO family protein binding,MF,
16866,GO:0098795,0.999999999984117,0.84847271660468,0,2,mRNA cleavage involved in gene silencing,BP,
16919,GO:0098886,0.999999999984117,0.84847271660468,0,2,modification of dendritic spine,BP,
16947,GO:0098928,0.999999999984117,0.84847271660468,0,2,presynaptic signal transduction,BP,
16950,GO:0098936,0.999999999984117,0.84847271660468,0,2,intrinsic component of postsynaptic membrane,CC,
16962,GO:0098971,0.999999999984117,0.84847271660468,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16968,GO:0098982,0.999999999984117,0.84847271660468,0,2,GABA-ergic synapse,CC,
16969,GO:0098983,0.999999999984117,0.84847271660468,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
16976,GO:0099004,0.999999999984117,0.84847271660468,0,2,calmodulin dependent kinase signaling pathway,BP,
16978,GO:0099011,0.999999999984117,0.84847271660468,0,2,neuronal dense core vesicle exocytosis,BP,
16987,GO:0099055,0.999999999984117,0.84847271660468,0,2,integral component of postsynaptic membrane,CC,
16992,GO:0099073,0.999999999984117,0.84847271660468,0,2,mitochondrion-derived vesicle,CC,
17004,GO:0099093,0.999999999984117,0.84847271660468,0,2,calcium export from the mitochondrion,BP,
17028,GO:0099240,0.999999999984117,0.84847271660468,0,2,intrinsic component of synaptic membrane,CC,
17031,GO:0099403,0.999999999984117,0.84847271660468,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17032,GO:0099404,0.999999999984117,0.84847271660468,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17048,GO:0099525,0.999999999984117,0.84847271660468,0,2,presynaptic dense core vesicle exocytosis,BP,
17049,GO:0099526,0.999999999984117,0.84847271660468,0,2,presynapse to nucleus signaling pathway,BP,
17054,GO:0099532,0.999999999984117,0.84847271660468,0,2,synaptic vesicle endosomal processing,BP,
17086,GO:0099609,0.999999999984117,0.84847271660468,0,2,microtubule lateral binding,MF,
17105,GO:0099699,0.999999999984117,0.84847271660468,0,2,integral component of synaptic membrane,CC,
17215,GO:0106073,0.999999999984117,0.84847271660468,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17227,GO:0110009,0.999999999984117,0.84847271660468,0,2,formin-nucleated actin cable organization,BP,
17296,GO:0140066,0.999999999984117,0.84847271660468,0,2,peptidyl-lysine crotonylation,BP,
17314,GO:0140135,0.999999999984117,0.84847271660468,0,2,mechanosensitive cation channel activity,MF,
17317,GO:0140192,0.999999999984117,0.84847271660468,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17388,GO:1900114,0.999999999984117,0.84847271660468,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17411,GO:1900147,0.999999999984117,0.84847271660468,0,2,regulation of Schwann cell migration,BP,
17422,GO:1900169,0.999999999984117,0.84847271660468,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17444,GO:1900220,0.999999999984117,0.84847271660468,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17461,GO:1900248,0.999999999984117,0.84847271660468,0,2,negative regulation of cytoplasmic translational elongation,BP,
17470,GO:1900275,0.999999999984117,0.84847271660468,0,2,negative regulation of phospholipase C activity,BP,
17482,GO:1900377,0.999999999984117,0.84847271660468,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17483,GO:1900378,0.999999999984117,0.84847271660468,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17505,GO:1900623,0.999999999984117,0.84847271660468,0,2,regulation of monocyte aggregation,BP,
17506,GO:1900625,0.999999999984117,0.84847271660468,0,2,positive regulation of monocyte aggregation,BP,
17544,GO:1901073,0.999999999984117,0.84847271660468,0,2,glucosamine-containing compound biosynthetic process,BP,
17562,GO:1901143,0.999999999984117,0.84847271660468,0,2,insulin catabolic process,BP,
17660,GO:1901491,0.999999999984117,0.84847271660468,0,2,negative regulation of lymphangiogenesis,BP,
17664,GO:1901509,0.999999999984117,0.84847271660468,0,2,regulation of endothelial tube morphogenesis,BP,
17670,GO:1901529,0.999999999984117,0.84847271660468,0,2,positive regulation of anion channel activity,BP,
17673,GO:1901534,0.999999999984117,0.84847271660468,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17675,GO:1901536,0.999999999984117,0.84847271660468,0,2,negative regulation of DNA demethylation,BP,
17681,GO:1901552,0.999999999984117,0.84847271660468,0,2,positive regulation of endothelial cell development,BP,
17727,GO:1901656,0.999999999984117,0.84847271660468,0,2,glycoside transport,BP,
17783,GO:1901843,0.999999999984117,0.84847271660468,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17793,GO:1901873,0.999999999984117,0.84847271660468,0,2,regulation of post-translational protein modification,BP,
17794,GO:1901874,0.999999999984117,0.84847271660468,0,2,negative regulation of post-translational protein modification,BP,
17834,GO:1901993,0.999999999984117,0.84847271660468,0,2,regulation of meiotic cell cycle phase transition,BP,
17835,GO:1901994,0.999999999984117,0.84847271660468,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17934,GO:1902261,0.999999999984117,0.84847271660468,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17939,GO:1902269,0.999999999984117,0.84847271660468,0,2,positive regulation of polyamine transmembrane transport,BP,
17951,GO:1902302,0.999999999984117,0.84847271660468,0,2,regulation of potassium ion export,BP,
18022,GO:1902523,0.999999999984117,0.84847271660468,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18041,GO:1902564,0.999999999984117,0.84847271660468,0,2,negative regulation of neutrophil activation,BP,
18092,GO:1902715,0.999999999984117,0.84847271660468,0,2,positive regulation of interferon-gamma secretion,BP,
18095,GO:1902724,0.999999999984117,0.84847271660468,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18097,GO:1902728,0.999999999984117,0.84847271660468,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18099,GO:1902731,0.999999999984117,0.84847271660468,0,2,negative regulation of chondrocyte proliferation,BP,
18121,GO:1902805,0.999999999984117,0.84847271660468,0,2,positive regulation of synaptic vesicle transport,BP,
18137,GO:1902856,0.999999999984117,0.84847271660468,0,2,negative regulation of non-motile cilium assembly,BP,
18154,GO:1902896,0.999999999984117,0.84847271660468,0,2,terminal web assembly,BP,
18185,GO:1902954,0.999999999984117,0.84847271660468,0,2,regulation of early endosome to recycling endosome transport,BP,
18193,GO:1902962,0.999999999984117,0.84847271660468,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18194,GO:1902963,0.999999999984117,0.84847271660468,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18208,GO:1902996,0.999999999984117,0.84847271660468,0,2,regulation of neurofibrillary tangle assembly,BP,
18258,GO:1903095,0.999999999984117,0.84847271660468,0,2,ribonuclease III complex,CC,
18263,GO:1903116,0.999999999984117,0.84847271660468,0,2,positive regulation of actin filament-based movement,BP,
18273,GO:1903142,0.999999999984117,0.84847271660468,0,2,positive regulation of establishment of endothelial barrier,BP,
18311,GO:1903233,0.999999999984117,0.84847271660468,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18314,GO:1903238,0.999999999984117,0.84847271660468,0,2,positive regulation of leukocyte tethering or rolling,BP,
18332,GO:1903292,0.999999999984117,0.84847271660468,0,2,protein localization to Golgi membrane,BP,
18334,GO:1903294,0.999999999984117,0.84847271660468,0,2,regulation of glutamate secretion, neurotransmission,BP,
18335,GO:1903296,0.999999999984117,0.84847271660468,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18376,GO:1903378,0.999999999984117,0.84847271660468,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18381,GO:1903385,0.999999999984117,0.84847271660468,0,2,regulation of homophilic cell adhesion,BP,
18408,GO:1903436,0.999999999984117,0.84847271660468,0,2,regulation of mitotic cytokinetic process,BP,
18409,GO:1903438,0.999999999984117,0.84847271660468,0,2,positive regulation of mitotic cytokinetic process,BP,
18424,GO:1903490,0.999999999984117,0.84847271660468,0,2,positive regulation of mitotic cytokinesis,BP,
18443,GO:1903526,0.999999999984117,0.84847271660468,0,2,negative regulation of membrane tubulation,BP,
18519,GO:1903691,0.999999999984117,0.84847271660468,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18550,GO:1903760,0.999999999984117,0.84847271660468,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18562,GO:1903781,0.999999999984117,0.84847271660468,0,2,positive regulation of cardiac conduction,BP,
18569,GO:1903796,0.999999999984117,0.84847271660468,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18601,GO:1903874,0.999999999984117,0.84847271660468,0,2,ferrous iron transmembrane transport,BP,
18643,GO:1903949,0.999999999984117,0.84847271660468,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18672,GO:1904017,0.999999999984117,0.84847271660468,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18777,GO:1904289,0.999999999984117,0.84847271660468,0,2,regulation of mitotic DNA damage checkpoint,BP,
18794,GO:1904327,0.999999999984117,0.84847271660468,0,2,protein localization to cytosolic proteasome complex,BP,
18812,GO:1904379,0.999999999984117,0.84847271660468,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18814,GO:1904381,0.999999999984117,0.84847271660468,0,2,Golgi apparatus mannose trimming,BP,
18823,GO:1904398,0.999999999984117,0.84847271660468,0,2,positive regulation of neuromuscular junction development,BP,
18847,GO:1904455,0.999999999984117,0.84847271660468,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18854,GO:1904475,0.999999999984117,0.84847271660468,0,2,regulation of Ras GTPase binding,BP,
18870,GO:1904529,0.999999999984117,0.84847271660468,0,2,regulation of actin filament binding,BP,
18874,GO:1904534,0.999999999984117,0.84847271660468,0,2,negative regulation of telomeric loop disassembly,BP,
18881,GO:1904562,0.999999999984117,0.84847271660468,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18912,GO:1904616,0.999999999984117,0.84847271660468,0,2,regulation of actin binding,BP,
18964,GO:1904743,0.999999999984117,0.84847271660468,0,2,negative regulation of telomeric DNA binding,BP,
18976,GO:1904761,0.999999999984117,0.84847271660468,0,2,negative regulation of myofibroblast differentiation,BP,
19019,GO:1904849,0.999999999984117,0.84847271660468,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19024,GO:1904862,0.999999999984117,0.84847271660468,0,2,inhibitory synapse assembly,BP,
19026,GO:1904868,0.999999999984117,0.84847271660468,0,2,telomerase catalytic core complex assembly,BP,
19038,GO:1904882,0.999999999984117,0.84847271660468,0,2,regulation of telomerase catalytic core complex assembly,BP,
19039,GO:1904884,0.999999999984117,0.84847271660468,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19052,GO:1904907,0.999999999984117,0.84847271660468,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19053,GO:1904908,0.999999999984117,0.84847271660468,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19061,GO:1904928,0.999999999984117,0.84847271660468,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19100,GO:1905024,0.999999999984117,0.84847271660468,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19127,GO:1905071,0.999999999984117,0.84847271660468,0,2,occluding junction disassembly,BP,
19128,GO:1905073,0.999999999984117,0.84847271660468,0,2,regulation of occluding junction disassembly,BP,
19129,GO:1905075,0.999999999984117,0.84847271660468,0,2,positive regulation of occluding junction disassembly,BP,
19139,GO:1905123,0.999999999984117,0.84847271660468,0,2,regulation of glucosylceramidase activity,BP,
19146,GO:1905150,0.999999999984117,0.84847271660468,0,2,regulation of voltage-gated sodium channel activity,BP,
19155,GO:1905167,0.999999999984117,0.84847271660468,0,2,positive regulation of lysosomal protein catabolic process,BP,
19175,GO:1905224,0.999999999984117,0.84847271660468,0,2,clathrin-coated pit assembly,BP,
19272,GO:1905462,0.999999999984117,0.84847271660468,0,2,regulation of DNA duplex unwinding,BP,
19292,GO:1905538,0.999999999984117,0.84847271660468,0,2,polysome binding,MF,
19324,GO:1905616,0.999999999984117,0.84847271660468,0,2,regulation of miRNA mediated inhibition of translation,BP,
19325,GO:1905618,0.999999999984117,0.84847271660468,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19342,GO:1905696,0.999999999984117,0.84847271660468,0,2,regulation of polysome binding,BP,
19362,GO:1905778,0.999999999984117,0.84847271660468,0,2,negative regulation of exonuclease activity,BP,
19364,GO:1905793,0.999999999984117,0.84847271660468,0,2,protein localization to pericentriolar material,BP,
19373,GO:1905838,0.999999999984117,0.84847271660468,0,2,regulation of telomeric D-loop disassembly,BP,
19374,GO:1905839,0.999999999984117,0.84847271660468,0,2,negative regulation of telomeric D-loop disassembly,BP,
19447,GO:1990112,0.999999999984117,0.84847271660468,0,2,RQC complex,CC,
19448,GO:1990116,0.999999999984117,0.84847271660468,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19460,GO:1990164,0.999999999984117,0.84847271660468,0,2,histone H2A phosphorylation,BP,
19529,GO:1990428,0.999999999984117,0.84847271660468,0,2,miRNA transport,BP,
19539,GO:1990452,0.999999999984117,0.84847271660468,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19585,GO:1990666,0.999999999984117,0.84847271660468,0,2,PCSK9-LDLR complex,CC,
19596,GO:1990723,0.999999999984117,0.84847271660468,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19651,GO:1990879,0.999999999984117,0.84847271660468,0,2,CST complex,CC,
19664,GO:1990923,0.999999999984117,0.84847271660468,0,2,PET complex,CC,
19666,GO:1990927,0.999999999984117,0.84847271660468,0,2,calcium ion regulated lysosome exocytosis,BP,
19667,GO:1990928,0.999999999984117,0.84847271660468,0,2,response to amino acid starvation,BP,
19694,GO:2000017,0.999999999984117,0.84847271660468,0,2,positive regulation of determination of dorsal identity,BP,
19758,GO:2000156,0.999999999984117,0.84847271660468,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19804,GO:2000253,0.999999999984117,0.84847271660468,0,2,positive regulation of feeding behavior,BP,
19834,GO:2000302,0.999999999984117,0.84847271660468,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19868,GO:2000346,0.999999999984117,0.84847271660468,0,2,negative regulation of hepatocyte proliferation,BP,
19902,GO:2000393,0.999999999984117,0.84847271660468,0,2,negative regulation of lamellipodium morphogenesis,BP,
19927,GO:2000427,0.999999999984117,0.84847271660468,0,2,positive regulation of apoptotic cell clearance,BP,
19968,GO:2000543,0.999999999984117,0.84847271660468,0,2,positive regulation of gastrulation,BP,
19970,GO:2000546,0.999999999984117,0.84847271660468,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19976,GO:2000563,0.999999999984117,0.84847271660468,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19992,GO:2000588,0.999999999984117,0.84847271660468,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
20001,GO:2000611,0.999999999984117,0.84847271660468,0,2,positive regulation of thyroid hormone generation,BP,
20008,GO:2000620,0.999999999984117,0.84847271660468,0,2,positive regulation of histone H4-K16 acetylation,BP,
20056,GO:2000683,0.999999999984117,0.84847271660468,0,2,regulation of cellular response to X-ray,BP,
20061,GO:2000697,0.999999999984117,0.84847271660468,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20112,GO:2000790,0.999999999984117,0.84847271660468,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20113,GO:2000791,0.999999999984117,0.84847271660468,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20114,GO:2000793,0.999999999984117,0.84847271660468,0,2,cell proliferation involved in heart valve development,BP,
20123,GO:2000809,0.999999999984117,0.84847271660468,0,2,positive regulation of synaptic vesicle clustering,BP,
20139,GO:2000832,0.999999999984117,0.84847271660468,0,2,negative regulation of steroid hormone secretion,BP,
20146,GO:2000847,0.999999999984117,0.84847271660468,0,2,negative regulation of corticosteroid hormone secretion,BP,
20149,GO:2000850,0.999999999984117,0.84847271660468,0,2,negative regulation of glucocorticoid secretion,BP,
20170,GO:2001013,0.999999999984117,0.84847271660468,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20172,GO:2001015,0.999999999984117,0.84847271660468,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20181,GO:2001027,0.999999999984117,0.84847271660468,0,2,negative regulation of endothelial cell chemotaxis,BP,
20205,GO:2001106,0.999999999984117,0.84847271660468,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20262,GO:2001226,0.999999999984117,0.84847271660468,0,2,negative regulation of chloride transport,BP,
20263,GO:2001228,0.999999999984117,0.84847271660468,0,2,regulation of response to gamma radiation,BP,
20277,GO:2001245,0.999999999984117,0.84847271660468,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20303,GO:2001295,0.999999999984117,0.84847271660468,0,2,malonyl-CoA biosynthetic process,BP,
9910,GO:0042245,0.999999999984139,0.848505000839097,0,2,RNA repair,BP,
580,GO:0001732,0.999999999984142,0.850218138645762,0,2,formation of cytoplasmic translation initiation complex,BP,
16876,GO:0098808,0.999999999984142,0.850218138645762,0,2,mRNA cap binding,MF,
7714,GO:0032203,0.999999999984142,0.923775790251669,0,1,telomere formation via telomerase,BP,
13983,GO:0060694,0.999999999984142,0.923775790251669,0,1,regulation of cholesterol transporter activity,BP,
15754,GO:0072343,0.999999999984142,0.923775790251669,0,1,pancreatic stellate cell proliferation,BP,
17683,GO:1901558,0.999999999984142,0.923775790251669,0,1,response to metformin,BP,
19300,GO:1905563,0.999999999984142,0.923775790251669,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19793,GO:2000229,0.999999999984142,0.923775790251669,0,1,regulation of pancreatic stellate cell proliferation,BP,
19794,GO:2000230,0.999999999984142,0.923775790251669,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
3005,GO:0006550,0.999999999984143,0.854070924532828,0,2,isoleucine catabolic process,BP,
15917,GO:0072687,0.999999999984154,0.721879346191069,0,4,meiotic spindle,CC,
13079,GO:0051586,0.99999999998418,0.927262127604371,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13262,GO:0051944,0.99999999998418,0.927262127604371,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13154,GO:0051725,0.999999999984183,0.85844024393414,0,2,protein de-ADP-ribosylation,BP,
12585,GO:0050757,0.999999999984249,0.921144740524091,0,1,thymidylate synthase biosynthetic process,BP,
12586,GO:0050758,0.999999999984249,0.921144740524091,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12587,GO:0050760,0.999999999984249,0.921144740524091,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
15372,GO:0071611,0.999999999984254,0.84880484642619,0,2,granulocyte colony-stimulating factor production,BP,
15401,GO:0071655,0.999999999984254,0.84880484642619,0,2,regulation of granulocyte colony-stimulating factor production,BP,
1954,GO:0004658,0.999999999984279,0.851288865076816,0,2,propionyl-CoA carboxylase activity,MF,
1669,GO:0004132,0.999999999984287,0.922580742448278,0,1,dCMP deaminase activity,MF,
373,GO:0000994,0.999999999984287,0.924495100362272,0,1,RNA polymerase III core binding,MF,
1826,GO:0004479,0.999999999984296,0.921129919684188,0,1,methionyl-tRNA formyltransferase activity,MF,
6323,GO:0019988,0.999999999984296,0.921129919684188,0,1,charged-tRNA amino acid modification,BP,
15546,GO:0071951,0.999999999984296,0.921129919684188,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17812,GO:1901917,0.999999999984296,0.921129919684188,0,1,regulation of exoribonuclease activity,BP,
17813,GO:1901919,0.999999999984296,0.921129919684188,0,1,positive regulation of exoribonuclease activity,BP,
19363,GO:1905779,0.999999999984296,0.921129919684188,0,1,positive regulation of exonuclease activity,BP,
1850,GO:0004513,0.999999999984313,0.921513596468212,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11984,GO:0047291,0.999999999984313,0.921513596468212,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
1301,GO:0003139,0.999999999984318,0.726078753320457,0,4,secondary heart field specification,BP,
6332,GO:0021501,0.999999999984336,0.922292708141533,0,1,prechordal plate formation,BP,
6366,GO:0021547,0.999999999984336,0.922292708141533,0,1,midbrain-hindbrain boundary initiation,BP,
20086,GO:2000742,0.999999999984336,0.922292708141533,0,1,regulation of anterior head development,BP,
20087,GO:2000744,0.999999999984336,0.922292708141533,0,1,positive regulation of anterior head development,BP,
14531,GO:0070032,0.999999999984347,0.850249289518407,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14532,GO:0070033,0.999999999984347,0.850249289518407,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
5773,GO:0016979,0.99999999998438,0.929303435689015,0,1,lipoate-protein ligase activity,MF,
19253,GO:1905424,0.999999999984387,0.849890512724251,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19254,GO:1905426,0.999999999984387,0.849890512724251,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
12151,GO:0048257,0.999999999984426,0.848655894124978,0,2,3'-flap endonuclease activity,MF,
7856,GO:0032416,0.999999999984461,0.922733624738572,0,1,negative regulation of sodium:proton antiporter activity,BP,
16545,GO:0097291,0.999999999984461,0.922733624738572,0,1,renal phosphate ion absorption,BP,
1316,GO:0003164,0.999999999984462,0.789232356046542,0,3,His-Purkinje system development,BP,
6508,GO:0021882,0.999999999984485,0.849273950258118,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6516,GO:0021893,0.999999999984485,0.849273950258118,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9367,GO:0035881,0.999999999984485,0.849273950258118,0,2,amacrine cell differentiation,BP,
14178,GO:0061074,0.999999999984485,0.849273950258118,0,2,regulation of neural retina development,BP,
14179,GO:0061075,0.999999999984485,0.849273950258118,0,2,positive regulation of neural retina development,BP,
18141,GO:1902866,0.999999999984485,0.849273950258118,0,2,regulation of retina development in camera-type eye,BP,
18142,GO:1902868,0.999999999984485,0.849273950258118,0,2,positive regulation of retina development in camera-type eye,BP,
18143,GO:1902869,0.999999999984485,0.849273950258118,0,2,regulation of amacrine cell differentiation,BP,
18144,GO:1902871,0.999999999984485,0.849273950258118,0,2,positive regulation of amacrine cell differentiation,BP,
3163,GO:0006772,0.999999999984486,0.924331497925407,0,1,thiamine metabolic process,BP,
9970,GO:0042357,0.999999999984486,0.924331497925407,0,1,thiamine diphosphate metabolic process,BP,
12468,GO:0050333,0.999999999984486,0.924331497925407,0,1,thiamin-triphosphatase activity,MF,
15089,GO:0071073,0.99999999998452,0.789302521146675,0,3,positive regulation of phospholipid biosynthetic process,BP,
1806,GO:0004452,0.999999999984529,0.857718802404965,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12729,GO:0050992,0.999999999984529,0.857718802404965,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12730,GO:0050993,0.999999999984529,0.857718802404965,0,2,dimethylallyl diphosphate metabolic process,BP,
2361,GO:0005462,0.999999999984546,0.849277860862285,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19492,GO:1990269,0.999999999984546,0.849277860862285,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19559,GO:1990569,0.999999999984546,0.849277860862285,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
15369,GO:0071606,0.999999999984595,0.922874727875383,0,1,chemokine (C-C motif) ligand 4 production,BP,
15396,GO:0071643,0.999999999984595,0.922874727875383,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15397,GO:0071644,0.999999999984595,0.922874727875383,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15885,GO:0072615,0.999999999984595,0.922874727875383,0,1,interleukin-17 secretion,BP,
19130,GO:1905076,0.999999999984595,0.922874727875383,0,1,regulation of interleukin-17 secretion,BP,
19131,GO:1905077,0.999999999984595,0.922874727875383,0,1,negative regulation of interleukin-17 secretion,BP,
19245,GO:1905403,0.999999999984595,0.922874727875383,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
12815,GO:0051120,0.999999999984596,0.848721035313639,0,2,hepoxilin A3 synthase activity,MF,
1363,GO:0003247,0.999999999984613,0.926053544884991,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1557,GO:0003956,0.999999999984613,0.926053544884991,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2484,GO:0005724,0.999999999984613,0.926053544884991,0,1,nuclear telomeric heterochromatin,CC,
7419,GO:0031509,0.999999999984613,0.926053544884991,0,1,telomeric heterochromatin assembly,BP,
7577,GO:0031940,0.999999999984613,0.926053544884991,0,1,positive regulation of chromatin silencing at telomere,BP,
18100,GO:1902732,0.999999999984613,0.926053544884991,0,1,positive regulation of chondrocyte proliferation,BP,
19293,GO:1905547,0.999999999984613,0.926053544884991,0,1,regulation of telomeric heterochromatin assembly,BP,
19294,GO:1905549,0.999999999984613,0.926053544884991,0,1,positive regulation of telomeric heterochromatin assembly,BP,
2456,GO:0005668,0.999999999984615,0.858650771376126,0,2,RNA polymerase transcription factor SL1 complex,CC,
1028,GO:0002536,0.999999999984647,0.867122991240016,0,2,respiratory burst involved in inflammatory response,BP,
13707,GO:0060264,0.999999999984647,0.867122991240016,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13709,GO:0060266,0.999999999984647,0.867122991240016,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14216,GO:0061152,0.999999999984665,0.85983024043393,0,2,trachea submucosa development,BP,
14217,GO:0061153,0.999999999984665,0.85983024043393,0,2,trachea gland development,BP,
16709,GO:0097682,0.999999999984675,0.922199105347119,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
19676,GO:1990967,0.999999999984686,0.851747864653145,0,2,multi-organism toxin transport,BP,
8844,GO:0034635,0.999999999984689,0.849950749105822,0,2,glutathione transport,BP,
10235,GO:0042939,0.999999999984689,0.849950749105822,0,2,tripeptide transport,BP,
10833,GO:0044326,0.999999999984689,0.849950749105822,0,2,dendritic spine neck,CC,
17,GO:0000032,0.999999999984714,0.924534390909847,0,1,cell wall mannoprotein biosynthetic process,BP,
1823,GO:0004476,0.999999999984714,0.924534390909847,0,1,mannose-6-phosphate isomerase activity,MF,
2692,GO:0006056,0.999999999984714,0.924534390909847,0,1,mannoprotein metabolic process,BP,
2693,GO:0006057,0.999999999984714,0.924534390909847,0,1,mannoprotein biosynthetic process,BP,
7416,GO:0031506,0.999999999984714,0.924534390909847,0,1,cell wall glycoprotein biosynthetic process,BP,
10061,GO:0042546,0.999999999984714,0.924534390909847,0,1,cell wall biogenesis,BP,
10720,GO:0044038,0.999999999984714,0.924534390909847,0,1,cell wall macromolecule biosynthetic process,BP,
14375,GO:0061611,0.999999999984714,0.924534390909847,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14847,GO:0070589,0.999999999984714,0.924534390909847,0,1,cellular component macromolecule biosynthetic process,BP,
15846,GO:0072557,0.999999999984716,0.870886207816961,0,2,IPAF inflammasome complex,CC,
8451,GO:0033577,0.999999999984745,0.848532175606392,0,2,protein glycosylation in endoplasmic reticulum,BP,
15269,GO:0071442,0.99999999998476,0.783218197840748,0,3,positive regulation of histone H3-K14 acetylation,BP,
8310,GO:0033142,0.999999999984781,0.921857136162312,0,1,progesterone receptor binding,MF,
11971,GO:0047220,0.999999999984797,0.921129215963219,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
14104,GO:0060940,0.999999999984825,0.84865116117795,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
10766,GO:0044211,0.999999999984828,0.794217457499856,0,3,CTP salvage,BP,
19242,GO:1905395,0.999999999984845,0.869082738603643,0,2,response to flavonoid,BP,
1528,GO:0003908,0.999999999984851,0.931893379279827,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
7387,GO:0031439,0.999999999984872,0.848637452973404,0,2,positive regulation of mRNA cleavage,BP,
18955,GO:1904720,0.999999999984872,0.848637452973404,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
10328,GO:0043120,0.999999999984901,0.787979204329657,0,3,tumor necrosis factor binding,MF,
19281,GO:1905502,0.999999999984916,0.933310288573241,0,1,acetyl-CoA binding,MF,
7096,GO:0030891,0.999999999984938,0.741766567471782,0,4,VCB complex,CC,
13403,GO:0052739,0.99999999998494,0.922381489023908,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13404,GO:0052740,0.99999999998494,0.922381489023908,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18878,GO:1904550,0.99999999998494,0.922381489023908,0,1,response to arachidonic acid,BP,
19852,GO:2000324,0.99999999998494,0.922381489023908,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
898,GO:0002277,0.999999999984952,0.939716169663488,0,1,myeloid dendritic cell activation involved in immune response,BP,
1054,GO:0002582,0.999999999984952,0.939716169663488,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002585,0.999999999984952,0.939716169663488,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002588,0.999999999984952,0.939716169663488,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5792,GO:0017024,0.999999999984952,0.939716169663488,0,1,myosin I binding,MF,
1762,GO:0004365,0.999999999984975,0.930998863676161,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6251,GO:0019828,0.999999999984975,0.930998863676161,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9219,GO:0035605,0.999999999984975,0.930998863676161,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10669,GO:0043891,0.999999999984975,0.930998863676161,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
18173,GO:1902938,0.999999999984982,0.848474199394085,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
13979,GO:0060689,0.999999999984983,0.784167716918174,0,3,cell differentiation involved in salivary gland development,BP,
2245,GO:0005157,0.999999999984986,0.921299840227735,0,1,macrophage colony-stimulating factor receptor binding,MF,
10037,GO:0042488,0.999999999984986,0.921299840227735,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13942,GO:0060611,0.999999999984986,0.921299840227735,0,1,mammary gland fat development,BP,
17916,GO:1902228,0.999999999984986,0.921299840227735,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18655,GO:1903971,0.999999999984986,0.921299840227735,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18658,GO:1903974,0.999999999984986,0.921299840227735,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18713,GO:1904124,0.999999999984986,0.921299840227735,0,1,microglial cell migration,BP,
18714,GO:1904139,0.999999999984986,0.921299840227735,0,1,regulation of microglial cell migration,BP,
18715,GO:1904141,0.999999999984986,0.921299840227735,0,1,positive regulation of microglial cell migration,BP,
19588,GO:1990682,0.999999999984986,0.921299840227735,0,1,CSF1-CSF1R complex,CC,
14671,GO:0070274,0.999999999984992,0.855838243752271,0,2,RES complex,CC,
3169,GO:0006780,0.99999999998502,0.857605007400922,0,2,uroporphyrinogen III biosynthetic process,BP,
11711,GO:0046502,0.99999999998502,0.857605007400922,0,2,uroporphyrinogen III metabolic process,BP,
4099,GO:0009153,0.999999999985037,0.86481699721839,0,2,purine deoxyribonucleotide biosynthetic process,BP,
1775,GO:0004382,0.999999999985051,0.849678335037196,0,2,guanosine-diphosphatase activity,MF,
8881,GO:0034693,0.999999999985062,0.921258288710559,0,1,U11/U12 snRNP,CC,
7370,GO:0031417,0.999999999985064,0.781548271434458,0,3,NatC complex,CC,
2497,GO:0005745,0.99999999998507,0.848476693402355,0,2,m-AAA complex,CC,
15702,GO:0072237,0.999999999985072,0.849326412715219,0,2,metanephric proximal tubule development,BP,
1923,GO:0004617,0.999999999985101,0.922634375891355,0,1,phosphoglycerate dehydrogenase activity,MF,
16462,GO:0097125,0.999999999985143,0.852915390737029,0,2,cyclin B1-CDK1 complex,CC,
13299,GO:0052031,0.99999999998516,0.788134249546778,0,3,modulation by symbiont of host defense response,BP,
13333,GO:0052255,0.99999999998516,0.788134249546778,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13365,GO:0052552,0.99999999998516,0.788134249546778,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13366,GO:0052553,0.99999999998516,0.788134249546778,0,3,modulation by symbiont of host immune response,BP,
15961,GO:0075528,0.99999999998516,0.788134249546778,0,3,modulation by virus of host immune response,BP,
8617,GO:0034128,0.99999999998517,0.781545218761398,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
3683,GO:0008184,0.999999999985172,0.848472716714747,0,2,glycogen phosphorylase activity,MF,
17134,GO:0102250,0.999999999985172,0.848472716714747,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17156,GO:0102499,0.999999999985172,0.848472716714747,0,2,SHG alpha-glucan phosphorylase activity,MF,
8503,GO:0033680,0.999999999985175,0.848481776858838,0,2,ATP-dependent DNA/RNA helicase activity,MF,
7775,GO:0032299,0.999999999985179,0.79760338051665,0,3,ribonuclease H2 complex,CC,
1882,GO:0004561,0.999999999985202,0.921129252837753,0,1,alpha-N-acetylglucosaminidase activity,MF,
7353,GO:0031394,0.999999999985205,0.856093477972676,0,2,positive regulation of prostaglandin biosynthetic process,BP,
9540,GO:0036292,0.999999999985205,0.856093477972676,0,2,DNA rewinding,BP,
20297,GO:2001280,0.999999999985205,0.856093477972676,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
268,GO:0000738,0.999999999985205,0.733395597363135,0,4,DNA catabolic process, exonucleolytic,BP,
6347,GO:0021523,0.999999999985233,0.852324044334051,0,2,somatic motor neuron differentiation,BP,
5904,GO:0018117,0.999999999985245,0.92591764604482,0,1,protein adenylylation,BP,
5916,GO:0018175,0.999999999985245,0.92591764604482,0,1,protein nucleotidylation,BP,
10942,GO:0044601,0.999999999985245,0.92591764604482,0,1,protein denucleotidylation,BP,
10943,GO:0044602,0.999999999985245,0.92591764604482,0,1,protein deadenylylation,BP,
10944,GO:0044603,0.999999999985245,0.92591764604482,0,1,protein adenylylhydrolase activity,MF,
14908,GO:0070733,0.999999999985245,0.92591764604482,0,1,protein adenylyltransferase activity,MF,
18155,GO:1902897,0.99999999998525,0.850482134711065,0,2,regulation of postsynaptic density protein 95 clustering,BP,
19382,GO:1905874,0.99999999998525,0.850482134711065,0,2,regulation of postsynaptic density organization,BP,
16487,GO:0097169,0.999999999985258,0.818378065051143,0,3,AIM2 inflammasome complex,CC,
6012,GO:0019061,0.999999999985272,0.9215997826687,0,1,uncoating of virus,BP,
10614,GO:0043602,0.999999999985291,0.921213651458024,0,1,nitrate catabolic process,BP,
11605,GO:0046210,0.999999999985291,0.921213651458024,0,1,nitric oxide catabolic process,BP,
12034,GO:0047726,0.999999999985291,0.921213651458024,0,1,iron-cytochrome-c reductase activity,MF,
16281,GO:0090345,0.999999999985291,0.921213651458024,0,1,cellular organohalogen metabolic process,BP,
16282,GO:0090346,0.999999999985291,0.921213651458024,0,1,cellular organofluorine metabolic process,BP,
1034,GO:0002543,0.999999999985294,0.848745170751506,0,2,activation of blood coagulation via clotting cascade,BP,
17198,GO:0106020,0.999999999985306,0.848948763045466,0,2,regulation of vesicle docking,BP,
11736,GO:0046548,0.999999999985347,0.781618366423045,0,3,retinal rod cell development,BP,
10205,GO:0042819,0.999999999985359,0.782394625624399,0,3,vitamin B6 biosynthetic process,BP,
8780,GO:0034457,0.999999999985363,0.804149767291634,0,3,Mpp10 complex,CC,
8917,GO:0034756,0.999999999985383,0.797259602368351,0,3,regulation of iron ion transport,BP,
18323,GO:1903276,0.999999999985409,0.853209719741057,0,2,regulation of sodium ion export across plasma membrane,BP,
18324,GO:1903278,0.999999999985409,0.853209719741057,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18331,GO:1903288,0.999999999985409,0.853209719741057,0,2,positive regulation of potassium ion import,BP,
11359,GO:0045716,0.999999999985418,0.791563496897252,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
1932,GO:0004631,0.999999999985452,0.931287023986103,0,1,phosphomevalonate kinase activity,MF,
2417,GO:0005591,0.999999999985465,0.921148536850153,0,1,collagen type VIII trimer,CC,
2423,GO:0005598,0.999999999985465,0.921148536850153,0,1,short-chain collagen trimer,CC,
7120,GO:0030935,0.999999999985465,0.921148536850153,0,1,sheet-forming collagen trimer,CC,
16804,GO:0098646,0.999999999985465,0.921148536850153,0,1,collagen sheet,CC,
1427,GO:0003400,0.999999999985472,0.921941105766169,0,1,regulation of COPII vesicle coating,BP,
2205,GO:0005090,0.999999999985472,0.921941105766169,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13956,GO:0060661,0.999999999985472,0.921941105766169,0,1,submandibular salivary gland formation,BP,
15194,GO:0071335,0.999999999985472,0.921941105766169,0,1,hair follicle cell proliferation,BP,
15195,GO:0071336,0.999999999985472,0.921941105766169,0,1,regulation of hair follicle cell proliferation,BP,
15196,GO:0071338,0.999999999985472,0.921941105766169,0,1,positive regulation of hair follicle cell proliferation,BP,
16125,GO:0090113,0.999999999985472,0.921941105766169,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
3176,GO:0006789,0.999999999985477,0.848971642165747,0,2,bilirubin conjugation,BP,
5151,GO:0015688,0.999999999985491,0.867853288668302,0,2,iron chelate transport,BP,
5260,GO:0015891,0.999999999985491,0.867853288668302,0,2,siderophore transport,BP,
11668,GO:0046439,0.999999999985497,0.663415439721606,0,5,L-cysteine metabolic process,BP,
17158,GO:0102521,0.999999999985498,0.848685305439969,0,2,tRNA-4-demethylwyosine synthase activity,MF,
14182,GO:0061081,0.999999999985509,0.689810774663406,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
6349,GO:0021526,0.999999999985524,0.92366490954783,0,1,medial motor column neuron differentiation,BP,
18061,GO:1902616,0.999999999985524,0.92366490954783,0,1,acyl carnitine transmembrane transport,BP,
14767,GO:0070458,0.999999999985528,0.800971720555078,0,3,cellular detoxification of nitrogen compound,BP,
18082,GO:1902683,0.999999999985556,0.848902627584894,0,2,regulation of receptor localization to synapse,BP,
13679,GO:0060212,0.999999999985599,0.924091709547139,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17416,GO:1900152,0.999999999985599,0.924091709547139,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
16715,GO:0097698,0.999999999985617,0.928078413731744,0,1,telomere maintenance via base-excision repair,BP,
1507,GO:0003865,0.999999999985643,0.848948342014338,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
8528,GO:0033765,0.999999999985643,0.848948342014338,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9263,GO:0035671,0.999999999985643,0.848948342014338,0,2,enone reductase activity,MF,
12038,GO:0047751,0.999999999985643,0.848948342014338,0,2,cholestenone 5-alpha-reductase activity,MF,
999,GO:0002468,0.999999999985654,0.727614241193264,0,4,dendritic cell antigen processing and presentation,BP,
1063,GO:0002604,0.999999999985654,0.727614241193264,0,4,regulation of dendritic cell antigen processing and presentation,BP,
8537,GO:0033860,0.999999999985656,0.816966427083635,0,3,regulation of NAD(P)H oxidase activity,BP,
8539,GO:0033864,0.999999999985656,0.816966427083635,0,3,positive regulation of NAD(P)H oxidase activity,BP,
9840,GO:0042078,0.999999999985686,0.793513017849646,0,3,germ-line stem cell division,BP,
12103,GO:0048133,0.999999999985686,0.793513017849646,0,3,male germ-line stem cell asymmetric division,BP,
16833,GO:0098728,0.999999999985686,0.793513017849646,0,3,germline stem cell asymmetric division,BP,
16257,GO:0090310,0.999999999985695,0.848472732666424,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
11225,GO:0045358,0.999999999985715,0.859829552601261,0,2,negative regulation of interferon-beta biosynthetic process,BP,
5078,GO:0015307,0.999999999985719,0.854141904421923,0,2,drug:proton antiporter activity,MF,
11761,GO:0046618,0.999999999985719,0.854141904421923,0,2,drug export,BP,
1676,GO:0004140,0.999999999985723,0.850127444694809,0,2,dephospho-CoA kinase activity,MF,
19502,GO:1990379,0.999999999985774,0.860615204083343,0,2,lipid transport across blood brain barrier,BP,
2680,GO:0006041,0.999999999985777,0.723184219466821,0,4,glucosamine metabolic process,BP,
440,GO:0001181,0.999999999985795,0.853265601819502,0,2,transcription factor activity, core RNA polymerase I binding,MF,
5606,GO:0016647,0.999999999985801,0.853495363918909,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11749,GO:0046592,0.999999999985801,0.853495363918909,0,2,polyamine oxidase activity,MF,
13452,GO:0052901,0.999999999985801,0.853495363918909,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
3828,GO:0008427,0.99999999998581,0.864113272105324,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4700,GO:0010858,0.99999999998581,0.864113272105324,0,2,calcium-dependent protein kinase regulator activity,MF,
17436,GO:1900208,0.999999999985812,0.86058271663845,0,2,regulation of cardiolipin metabolic process,BP,
17437,GO:1900210,0.999999999985812,0.86058271663845,0,2,positive regulation of cardiolipin metabolic process,BP,
15101,GO:0071139,0.999999999985831,0.848497162662548,0,2,resolution of recombination intermediates,BP,
15102,GO:0071140,0.999999999985831,0.848497162662548,0,2,resolution of mitotic recombination intermediates,BP,
18372,GO:1903373,0.999999999985832,0.781965936834772,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
5216,GO:0015817,0.999999999985879,0.921129187102907,0,1,histidine transport,BP,
7531,GO:0031753,0.999999999985879,0.921129187102907,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7532,GO:0031755,0.999999999985879,0.921129187102907,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
14151,GO:0061031,0.999999999985894,0.857364641856475,0,2,endodermal digestive tract morphogenesis,BP,
2115,GO:0004905,0.999999999985896,0.85598782223137,0,2,type I interferon receptor activity,MF,
9757,GO:0039513,0.999999999985906,0.921129564042292,0,1,suppression by virus of host catalytic activity,BP,
9759,GO:0039516,0.999999999985906,0.921129564042292,0,1,modulation by virus of host catalytic activity,BP,
9777,GO:0039650,0.999999999985906,0.921129564042292,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13305,GO:0052053,0.999999999985906,0.921129564042292,0,1,negative regulation by symbiont of host catalytic activity,BP,
13312,GO:0052148,0.999999999985906,0.921129564042292,0,1,modulation by symbiont of host catalytic activity,BP,
13321,GO:0052199,0.999999999985906,0.921129564042292,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13166,GO:0051754,0.999999999985937,0.781756680769473,0,3,meiotic sister chromatid cohesion, centromeric,BP,
2695,GO:0006060,0.999999999985941,0.856218160449529,0,2,sorbitol metabolic process,BP,
11648,GO:0046370,0.999999999985941,0.856218160449529,0,2,fructose biosynthetic process,BP,
13374,GO:0052593,0.999999999985944,0.848492046936903,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13375,GO:0052594,0.999999999985944,0.848492046936903,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13376,GO:0052595,0.999999999985944,0.848492046936903,0,2,aliphatic-amine oxidase activity,MF,
13377,GO:0052596,0.999999999985944,0.848492046936903,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
15358,GO:0071586,0.999999999985957,0.855140701617498,0,2,CAAX-box protein processing,BP,
15976,GO:0080120,0.999999999985957,0.855140701617498,0,2,CAAX-box protein maturation,BP,
17432,GO:1900195,0.999999999985967,0.850822752042702,0,2,positive regulation of oocyte maturation,BP,
15862,GO:0072578,0.999999999986018,0.672152920939795,0,5,neurotransmitter-gated ion channel clustering,BP,
1137,GO:0002729,0.999999999986031,0.861275149199208,0,2,positive regulation of natural killer cell cytokine production,BP,
533,GO:0001651,0.999999999986036,0.860114069831053,0,2,dense fibrillar component,CC,
8454,GO:0033590,0.999999999986037,0.78633610622485,0,3,response to cobalamin,BP,
15019,GO:0070949,0.999999999986038,0.855456021318235,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15023,GO:0070960,0.999999999986038,0.855456021318235,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15024,GO:0070961,0.999999999986038,0.855456021318235,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
17414,GO:1900150,0.999999999986038,0.855456021318235,0,2,regulation of defense response to fungus,BP,
6249,GO:0019826,0.999999999986085,0.849412961017193,0,2,oxygen sensor activity,MF,
15221,GO:0071373,0.999999999986103,0.848480638746038,0,2,cellular response to luteinizing hormone stimulus,BP,
6463,GO:0021784,0.999999999986115,0.944984839907801,0,1,postganglionic parasympathetic fiber development,BP,
6674,GO:0030035,0.999999999986132,0.781541625612213,0,3,microspike assembly,BP,
10870,GO:0044393,0.999999999986132,0.781541625612213,0,3,microspike,CC,
9514,GO:0036179,0.999999999986146,0.921129694170028,0,1,osteoclast maturation,BP,
9483,GO:0036117,0.999999999986157,0.850054515697368,0,2,hyaluranon cable,CC,
4794,GO:0010985,0.999999999986161,0.688749234889411,0,5,negative regulation of lipoprotein particle clearance,BP,
951,GO:0002370,0.999999999986178,0.793335047304689,0,3,natural killer cell cytokine production,BP,
1135,GO:0002727,0.999999999986178,0.793335047304689,0,3,regulation of natural killer cell cytokine production,BP,
7970,GO:0032581,0.999999999986186,0.923877032070598,0,1,ER-dependent peroxisome organization,BP,
17224,GO:0106101,0.999999999986186,0.923877032070598,0,1,ER-dependent peroxisome localization,BP,
11988,GO:0047323,0.999999999986195,0.922085121727792,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13346,GO:0052381,0.999999999986195,0.922085121727792,0,1,tRNA dimethylallyltransferase activity,MF,
3196,GO:0006824,0.999999999986221,0.849363102239776,0,2,cobalt ion transport,BP,
8965,GO:0035033,0.999999999986223,0.855905317595574,0,2,histone deacetylase regulator activity,MF,
12267,GO:0048560,0.999999999986228,0.849754739242791,0,2,establishment of anatomical structure orientation,BP,
1418,GO:0003360,0.999999999986234,0.782480705409465,0,3,brainstem development,BP,
15330,GO:0071546,0.99999999998625,0.84847300550778,0,2,pi-body,CC,
1913,GO:0004605,0.999999999986268,0.781544235908006,0,3,phosphatidate cytidylyltransferase activity,MF,
822,GO:0002094,0.9999999999863,0.852974718120939,0,2,polyprenyltransferase activity,MF,
53,GO:0000110,0.999999999986305,0.786302363604165,0,3,nucleotide-excision repair factor 1 complex,CC,
4544,GO:0010621,0.999999999986312,0.935176940741416,0,1,negative regulation of transcription by transcription factor localization,BP,
9512,GO:0036164,0.999999999986312,0.935176940741416,0,1,cell-abiotic substrate adhesion,BP,
3057,GO:0006617,0.999999999986318,0.86631373296251,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
9417,GO:0035983,0.999999999986322,0.78363670845163,0,3,response to trichostatin A,BP,
9418,GO:0035984,0.999999999986322,0.78363670845163,0,3,cellular response to trichostatin A,BP,
1266,GO:0003032,0.999999999986331,0.848953939821683,0,2,detection of oxygen,BP,
13134,GO:0051694,0.999999999986332,0.849400829312616,0,2,pointed-end actin filament capping,BP,
18359,GO:1903348,0.999999999986357,0.781547769280188,0,3,positive regulation of bicellular tight junction assembly,BP,
13965,GO:0060671,0.99999999998638,0.784934885489684,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13966,GO:0060672,0.99999999998638,0.784934885489684,0,3,epithelial cell morphogenesis involved in placental branching,BP,
11610,GO:0046292,0.999999999986386,0.791807337536991,0,3,formaldehyde metabolic process,BP,
5368,GO:0016165,0.999999999986389,0.848738743568419,0,2,linoleate 13S-lipoxygenase activity,MF,
1854,GO:0004517,0.99999999998641,0.848589633246954,0,2,nitric-oxide synthase activity,MF,
4878,GO:0014740,0.99999999998641,0.848589633246954,0,2,negative regulation of muscle hyperplasia,BP,
17661,GO:1901492,0.999999999986427,0.849566892210828,0,2,positive regulation of lymphangiogenesis,BP,
16141,GO:0090149,0.999999999986434,0.848792070143658,0,2,mitochondrial membrane fission,BP,
9416,GO:0035981,0.999999999986451,0.854253033101209,0,2,tongue muscle cell differentiation,BP,
18126,GO:1902811,0.999999999986451,0.854253033101209,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20188,GO:2001035,0.999999999986451,0.854253033101209,0,2,regulation of tongue muscle cell differentiation,BP,
20189,GO:2001037,0.999999999986451,0.854253033101209,0,2,positive regulation of tongue muscle cell differentiation,BP,
11310,GO:0045627,0.999999999986452,0.788590155145135,0,3,positive regulation of T-helper 1 cell differentiation,BP,
2067,GO:0004821,0.999999999986457,0.850227175309704,0,2,histidine-tRNA ligase activity,MF,
2917,GO:0006427,0.999999999986457,0.850227175309704,0,2,histidyl-tRNA aminoacylation,BP,
8769,GO:0034441,0.999999999986461,0.924289100286138,0,1,plasma lipoprotein particle oxidation,BP,
17349,GO:1900036,0.999999999986513,0.921456883337742,0,1,positive regulation of cellular response to heat,BP,
9029,GO:0035241,0.999999999986517,0.781730415305276,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
11945,GO:0047016,0.999999999986518,0.921871302069744,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
14056,GO:0060830,0.999999999986525,0.796433569129506,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
51,GO:0000105,0.999999999986537,0.848731196426558,0,2,histidine biosynthetic process,BP,
9524,GO:0036228,0.999999999986537,0.848731196426558,0,2,protein localization to nuclear inner membrane,BP,
15941,GO:0072740,0.99999999998655,0.923483230204572,0,1,cellular response to anisomycin,BP,
17462,GO:1900259,0.99999999998655,0.923483230204572,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17463,GO:1900260,0.99999999998655,0.923483230204572,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
10668,GO:0043890,0.999999999986561,0.921389754844951,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
9576,GO:0036378,0.999999999986568,0.853358671936053,0,2,calcitriol biosynthetic process from calciol,BP,
7154,GO:0031013,0.999999999986577,0.864635915147588,0,2,troponin I binding,MF,
18048,GO:1902576,0.999999999986587,0.721886148640727,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
3220,GO:0006867,0.999999999986589,0.92112926183058,0,1,asparagine transport,BP,
5019,GO:0015182,0.999999999986589,0.92112926183058,0,1,L-asparagine transmembrane transporter activity,MF,
5026,GO:0015190,0.999999999986589,0.92112926183058,0,1,L-leucine transmembrane transporter activity,MF,
5027,GO:0015191,0.999999999986589,0.92112926183058,0,1,L-methionine transmembrane transporter activity,MF,
5139,GO:0015658,0.999999999986589,0.92112926183058,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5219,GO:0015821,0.999999999986589,0.92112926183058,0,1,methionine transport,BP,
10666,GO:0043865,0.999999999986589,0.92112926183058,0,1,methionine transmembrane transporter activity,MF,
8747,GO:0034395,0.999999999986608,0.927219930891892,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
19420,GO:1990005,0.999999999986611,0.852207120641132,0,2,granular vesicle,CC,
5653,GO:0016748,0.999999999986638,0.848768938537103,0,2,succinyltransferase activity,MF,
6645,GO:0023041,0.99999999998664,0.784950421589761,0,3,neuronal signal transduction,BP,
4359,GO:0009955,0.999999999986643,0.921812344792268,0,1,adaxial/abaxial pattern specification,BP,
9278,GO:0035709,0.999999999986643,0.921812344792268,0,1,memory T cell activation,BP,
16308,GO:0090427,0.999999999986643,0.921812344792268,0,1,activation of meiosis,BP,
19691,GO:2000011,0.999999999986643,0.921812344792268,0,1,regulation of adaxial/abaxial pattern formation,BP,
19979,GO:2000567,0.999999999986643,0.921812344792268,0,1,regulation of memory T cell activation,BP,
19980,GO:2000568,0.999999999986643,0.921812344792268,0,1,positive regulation of memory T cell activation,BP,
20198,GO:2001055,0.999999999986643,0.921812344792268,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
10651,GO:0043686,0.999999999986659,0.792574152197623,0,3,co-translational protein modification,BP,
19084,GO:1904978,0.999999999986665,0.782042156647173,0,3,regulation of endosome organization,BP,
4922,GO:0014866,0.999999999986677,0.783138097068529,0,3,skeletal myofibril assembly,BP,
10921,GO:0044530,0.999999999986692,0.78259995464508,0,3,supraspliceosomal complex,CC,
1540,GO:0003933,0.999999999986704,0.923054031199114,0,1,GTP cyclohydrolase activity,MF,
1541,GO:0003934,0.999999999986704,0.923054031199114,0,1,GTP cyclohydrolase I activity,MF,
9429,GO:0035998,0.999999999986704,0.923054031199114,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
3365,GO:0007113,0.99999999998671,0.796827839276955,0,3,endomitotic cell cycle,BP,
1649,GO:0004096,0.999999999986721,0.79331270553132,0,3,catalase activity,MF,
14852,GO:0070611,0.999999999986722,0.921145428074798,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14853,GO:0070612,0.999999999986722,0.921145428074798,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
8308,GO:0033140,0.999999999986745,0.850868881422557,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2136,GO:0004947,0.99999999998676,0.858048433343661,0,2,bradykinin receptor activity,MF,
8560,GO:0033989,0.99999999998676,0.921134535431109,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9478,GO:0036111,0.99999999998676,0.921134535431109,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10936,GO:0044594,0.99999999998676,0.921134535431109,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
14177,GO:0061073,0.999999999986778,0.848476042604934,0,2,ciliary body morphogenesis,BP,
15052,GO:0071001,0.999999999986783,0.79913198360494,0,3,U4/U6 snRNP,CC,
1689,GO:0004163,0.999999999986787,0.92428441274974,0,1,diphosphomevalonate decarboxylase activity,MF,
15346,GO:0071568,0.999999999986788,0.86097396851856,0,2,UFM1 transferase activity,MF,
8380,GO:0033277,0.99999999998679,0.848951346765071,0,2,abortive mitotic cell cycle,BP,
2350,GO:0005415,0.999999999986819,0.849151073756641,0,2,nucleoside:sodium symporter activity,MF,
5239,GO:0015860,0.999999999986819,0.849151073756641,0,2,purine nucleoside transmembrane transport,BP,
10514,GO:0043418,0.999999999986828,0.781715955090507,0,3,homocysteine catabolic process,BP,
18184,GO:1902953,0.999999999986879,0.721921150476829,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
17169,GO:0102758,0.999999999986907,0.933726356990983,0,1,very-long-chain enoyl-CoA reductase activity,MF,
8728,GO:0034374,0.999999999986981,0.794814181859513,0,3,low-density lipoprotein particle remodeling,BP,
6088,GO:0019254,0.999999999986985,0.848494422438677,0,2,carnitine metabolic process, CoA-linked,BP,
8555,GO:0033961,0.999999999986992,0.924792105611471,0,1,cis-stilbene-oxide hydrolase activity,MF,
18541,GO:1903748,0.999999999987005,0.725332583554251,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
3653,GO:0008131,0.999999999987009,0.781559313249883,0,3,primary amine oxidase activity,MF,
2415,GO:0005589,0.999999999987025,0.854825931031366,0,2,collagen type VI trimer,CC,
16805,GO:0098647,0.999999999987025,0.854825931031366,0,2,collagen beaded filament,CC,
19692,GO:2000015,0.999999999987028,0.797038472596948,0,3,regulation of determination of dorsal identity,BP,
3401,GO:0007181,0.999999999987036,0.856414780904132,0,2,transforming growth factor beta receptor complex assembly,BP,
9727,GO:0038171,0.999999999987043,0.781730182057949,0,3,cannabinoid signaling pathway,BP,
15534,GO:0071926,0.999999999987043,0.781730182057949,0,3,endocannabinoid signaling pathway,BP,
11527,GO:0046041,0.999999999987058,0.861398640592992,0,2,ITP metabolic process,BP,
8718,GO:0034363,0.999999999987065,0.933567141957882,0,1,intermediate-density lipoprotein particle,CC,
8720,GO:0034365,0.999999999987065,0.933567141957882,0,1,discoidal high-density lipoprotein particle,CC,
8726,GO:0034371,0.999999999987065,0.933567141957882,0,1,chylomicron remodeling,BP,
11892,GO:0046911,0.999999999987065,0.933567141957882,0,1,metal chelating activity,MF,
16384,GO:0090731,0.999999999987065,0.933567141957882,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17717,GO:1901630,0.999999999987065,0.933567141957882,0,1,negative regulation of presynaptic membrane organization,BP,
18211,GO:1903000,0.999999999987065,0.933567141957882,0,1,regulation of lipid transport across blood brain barrier,BP,
18212,GO:1903002,0.999999999987065,0.933567141957882,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19376,GO:1905853,0.999999999987065,0.933567141957882,0,1,regulation of heparan sulfate binding,BP,
19377,GO:1905855,0.999999999987065,0.933567141957882,0,1,positive regulation of heparan sulfate binding,BP,
19378,GO:1905858,0.999999999987065,0.933567141957882,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19379,GO:1905860,0.999999999987065,0.933567141957882,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19387,GO:1905890,0.999999999987065,0.933567141957882,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
3575,GO:0007619,0.999999999987068,0.783604129754051,0,3,courtship behavior,BP,
5080,GO:0015317,0.99999999998707,0.925511855494507,0,1,phosphate:proton symporter activity,MF,
1812,GO:0004462,0.999999999987076,0.922501365278499,0,1,lactoylglutathione lyase activity,MF,
13717,GO:0060282,0.999999999987092,0.783706346771982,0,3,positive regulation of oocyte development,BP,
19386,GO:1905881,0.999999999987092,0.783706346771982,0,3,positive regulation of oogenesis,BP,
2323,GO:0005332,0.999999999987128,0.922769670278579,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5022,GO:0015185,0.999999999987128,0.922769670278579,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6544,GO:0021956,0.999999999987128,0.922769670278579,0,1,central nervous system interneuron axonogenesis,BP,
8651,GO:0034196,0.999999999987169,0.921160184794628,0,1,acylglycerol transport,BP,
8652,GO:0034197,0.999999999987169,0.921160184794628,0,1,triglyceride transport,BP,
10871,GO:0044395,0.999999999987169,0.921160184794628,0,1,protein targeting to vacuolar membrane,BP,
17499,GO:1900483,0.999999999987169,0.921160184794628,0,1,regulation of protein targeting to vacuolar membrane,BP,
658,GO:0001849,0.999999999987182,0.862238645413563,0,2,complement component C1q binding,MF,
2051,GO:0004801,0.999999999987194,0.932268623943444,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
5981,GO:0018773,0.999999999987205,0.925546786963548,0,1,acetylpyruvate hydrolase activity,MF,
8812,GO:0034545,0.999999999987205,0.925546786963548,0,1,fumarylpyruvate hydrolase activity,MF,
12021,GO:0047621,0.999999999987205,0.925546786963548,0,1,acylpyruvate hydrolase activity,MF,
13364,GO:0052550,0.999999999987205,0.925546786963548,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13370,GO:0052567,0.999999999987205,0.925546786963548,0,1,response to defense-related host reactive oxygen species production,BP,
6730,GO:0030144,0.999999999987229,0.781785194464825,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
16400,GO:0097017,0.99999999998726,0.848553348327006,0,2,renal protein absorption,BP,
19576,GO:1990617,0.999999999987284,0.869046869132647,0,2,CHOP-ATF4 complex,CC,
12337,GO:0048696,0.999999999987331,0.928003346359829,0,1,regulation of collateral sprouting in absence of injury,BP,
12338,GO:0048697,0.999999999987331,0.928003346359829,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13595,GO:0060064,0.999999999987331,0.928003346359829,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19277,GO:1905474,0.999999999987331,0.928003346359829,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
665,GO:0001868,0.999999999987336,0.923494804692083,0,1,regulation of complement activation, lectin pathway,BP,
666,GO:0001869,0.999999999987336,0.923494804692083,0,1,negative regulation of complement activation, lectin pathway,BP,
9805,GO:0040032,0.999999999987336,0.923494804692083,0,1,post-embryonic body morphogenesis,BP,
4833,GO:0014038,0.999999999987397,0.784696033309468,0,3,regulation of Schwann cell differentiation,BP,
8531,GO:0033814,0.999999999987411,0.929173196238193,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12506,GO:0050632,0.999999999987411,0.929173196238193,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14811,GO:0070538,0.999999999987411,0.929173196238193,0,1,oleic acid binding,MF,
17641,GO:1901373,0.999999999987411,0.929173196238193,0,1,lipid hydroperoxide transport,BP,
13075,GO:0051582,0.999999999987414,0.854583682624956,0,2,positive regulation of neurotransmitter uptake,BP,
5764,GO:0016936,0.999999999987415,0.85597480568427,0,2,galactoside binding,MF,
151,GO:0000306,0.99999999998743,0.720346035368959,0,4,extrinsic component of vacuolar membrane,CC,
11859,GO:0046848,0.999999999987451,0.929851519630547,0,1,hydroxyapatite binding,MF,
813,GO:0002085,0.999999999987466,0.78794780410928,0,3,inhibition of neuroepithelial cell differentiation,BP,
11298,GO:0045608,0.999999999987466,0.78794780410928,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
3806,GO:0008391,0.999999999987479,0.850910289179261,0,2,arachidonic acid monooxygenase activity,MF,
3807,GO:0008392,0.999999999987479,0.850910289179261,0,2,arachidonic acid epoxygenase activity,MF,
7919,GO:0032494,0.999999999987481,0.663139233127792,0,5,response to peptidoglycan,BP,
3731,GO:0008265,0.999999999987492,0.921130492389211,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17174,GO:0102867,0.999999999987492,0.921130492389211,0,1,molybdenum cofactor sulfurtransferase activity,MF,
11748,GO:0046588,0.999999999987514,0.939437158128879,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
7509,GO:0031691,0.999999999987527,0.85119974030569,0,2,alpha-1A adrenergic receptor binding,MF,
7510,GO:0031692,0.999999999987527,0.85119974030569,0,2,alpha-1B adrenergic receptor binding,MF,
7533,GO:0031762,0.999999999987527,0.85119974030569,0,2,follicle-stimulating hormone receptor binding,MF,
10138,GO:0042699,0.999999999987527,0.85119974030569,0,2,follicle-stimulating hormone signaling pathway,BP,
2694,GO:0006059,0.999999999987552,0.796393476042981,0,3,hexitol metabolic process,BP,
15303,GO:0071492,0.999999999987558,0.851063542315673,0,2,cellular response to UV-A,BP,
518,GO:0001588,0.999999999987618,0.869305673053496,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2139,GO:0004952,0.999999999987618,0.869305673053496,0,2,dopamine neurotransmitter receptor activity,MF,
1786,GO:0004408,0.999999999987667,0.921566410375546,0,1,holocytochrome-c synthase activity,MF,
5781,GO:0017003,0.999999999987667,0.921566410375546,0,1,protein-heme linkage,BP,
5784,GO:0017006,0.999999999987667,0.921566410375546,0,1,protein-tetrapyrrole linkage,BP,
5892,GO:0018063,0.999999999987667,0.921566410375546,0,1,cytochrome c-heme linkage,BP,
4601,GO:0010716,0.999999999987674,0.800374756904688,0,3,negative regulation of extracellular matrix disassembly,BP,
2392,GO:0005534,0.999999999987682,0.789188667338895,0,3,galactose binding,MF,
16423,GO:0097058,0.999999999987707,0.924307897017164,0,1,CRLF-CLCF1 complex,CC,
16424,GO:0097059,0.999999999987707,0.924307897017164,0,1,CNTFR-CLCF1 complex,CC,
6517,GO:0021894,0.999999999987707,0.936001584409116,0,1,cerebral cortex GABAergic interneuron development,BP,
3594,GO:0008020,0.999999999987714,0.848489571883907,0,2,G-protein coupled photoreceptor activity,MF,
4791,GO:0010982,0.999999999987719,0.848872058733921,0,2,regulation of high-density lipoprotein particle clearance,BP,
4792,GO:0010983,0.999999999987719,0.848872058733921,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
6257,GO:0019841,0.999999999987741,0.762227259524452,0,4,retinol binding,MF,
2161,GO:0004993,0.999999999987784,0.792766611930456,0,3,G-protein coupled serotonin receptor activity,MF,
3423,GO:0007210,0.999999999987784,0.792766611930456,0,3,serotonin receptor signaling pathway,BP,
10363,GO:0043176,0.999999999987784,0.792766611930456,0,3,amine binding,MF,
12976,GO:0051378,0.999999999987784,0.792766611930456,0,3,serotonin binding,MF,
15312,GO:0071502,0.999999999987784,0.792766611930456,0,3,cellular response to temperature stimulus,BP,
16816,GO:0098664,0.999999999987784,0.792766611930456,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
17079,GO:0099589,0.999999999987784,0.792766611930456,0,3,serotonin receptor activity,MF,
3020,GO:0006565,0.999999999987806,0.848621708240299,0,2,L-serine catabolic process,BP,
3535,GO:0007525,0.999999999987807,0.848502904192374,0,2,somatic muscle development,BP,
16641,GO:0097500,0.99999999998784,0.781582742668139,0,3,receptor localization to non-motile cilium,BP,
8446,GO:0033566,0.999999999987842,0.848642589097008,0,2,gamma-tubulin complex localization,BP,
18402,GO:1903430,0.999999999987855,0.739077203323709,0,4,negative regulation of cell maturation,BP,
1680,GO:0004145,0.999999999987892,0.876915604563803,0,2,diamine N-acetyltransferase activity,MF,
6243,GO:0019809,0.999999999987892,0.876915604563803,0,2,spermidine binding,MF,
8181,GO:0032917,0.999999999987892,0.876915604563803,0,2,polyamine acetylation,BP,
8182,GO:0032918,0.999999999987892,0.876915604563803,0,2,spermidine acetylation,BP,
17498,GO:1900477,0.999999999987916,0.922331628611993,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
897,GO:0002276,0.999999999987971,0.849439608494542,0,2,basophil activation involved in immune response,BP,
11270,GO:0045575,0.999999999987971,0.849439608494542,0,2,basophil activation,BP,
1867,GO:0004531,0.999999999987984,0.92270399397021,0,1,deoxyribonuclease II activity,MF,
2790,GO:0006226,0.999999999987989,0.789349049691128,0,3,dUMP biosynthetic process,BP,
4634,GO:0010756,0.999999999987995,0.785180594504548,0,3,positive regulation of plasminogen activation,BP,
12134,GO:0048211,0.999999999987998,0.848472742171235,0,2,Golgi vesicle docking,BP,
7248,GO:0031204,0.999999999988001,0.804375002180154,0,3,posttranslational protein targeting to membrane, translocation,BP,
4555,GO:0010636,0.999999999988004,0.848511383043393,0,2,positive regulation of mitochondrial fusion,BP,
553,GO:0001674,0.999999999988008,0.84900778776786,0,2,female germ cell nucleus,CC,
10085,GO:0042585,0.999999999988008,0.84900778776786,0,2,germinal vesicle,CC,
5042,GO:0015222,0.999999999988013,0.850564159069722,0,2,serotonin transmembrane transporter activity,MF,
1244,GO:0002944,0.999999999988029,0.848909896768235,0,2,cyclin K-CDK12 complex,CC,
1245,GO:0002945,0.999999999988029,0.848909896768235,0,2,cyclin K-CDK13 complex,CC,
7103,GO:0030899,0.999999999988033,0.875643219757037,0,2,calcium-dependent ATPase activity,MF,
15525,GO:0071907,0.999999999988078,0.790866564691056,0,3,determination of digestive tract left/right asymmetry,BP,
7148,GO:0030997,0.99999999998808,0.78234916238705,0,3,regulation of centriole-centriole cohesion,BP,
1272,GO:0003064,0.999999999988093,0.923898444916496,0,1,regulation of heart rate by hormone,BP,
19399,GO:1905912,0.999999999988093,0.923898444916496,0,1,regulation of calcium ion export across plasma membrane,BP,
19400,GO:1905913,0.999999999988093,0.923898444916496,0,1,negative regulation of calcium ion export across plasma membrane,BP,
10111,GO:0042628,0.99999999998812,0.921636193049588,0,1,mating plug formation,BP,
11194,GO:0045297,0.99999999998812,0.921636193049588,0,1,post-mating behavior,BP,
14199,GO:0061107,0.99999999998812,0.921636193049588,0,1,seminal vesicle development,BP,
14200,GO:0061108,0.99999999998812,0.921636193049588,0,1,seminal vesicle epithelium development,BP,
18534,GO:1903723,0.999999999988168,0.939483552005852,0,1,negative regulation of centriole elongation,BP,
3519,GO:0007468,0.999999999988175,0.922469386270235,0,1,regulation of rhodopsin gene expression,BP,
11440,GO:0045872,0.999999999988175,0.922469386270235,0,1,positive regulation of rhodopsin gene expression,BP,
4591,GO:0010698,0.999999999988183,0.873283751333864,0,2,acetyltransferase activator activity,MF,
1209,GO:0002875,0.999999999988212,0.926166395703905,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2235,GO:0005141,0.999999999988212,0.926166395703905,0,1,interleukin-10 receptor binding,MF,
18699,GO:1904057,0.999999999988212,0.926166395703905,0,1,negative regulation of sensory perception of pain,BP,
888,GO:0002254,0.999999999988242,0.850388194184555,0,2,kinin cascade,BP,
942,GO:0002353,0.999999999988242,0.850388194184555,0,2,plasma kallikrein-kinin cascade,BP,
11239,GO:0045415,0.999999999988257,0.783952665834859,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
19338,GO:1905671,0.999999999988262,0.782775672014441,0,3,regulation of lysosome organization,BP,
13314,GO:0052151,0.999999999988277,0.861500302494587,0,2,positive regulation by symbiont of host apoptotic process,BP,
13639,GO:0060139,0.999999999988277,0.861500302494587,0,2,positive regulation of apoptotic process by virus,BP,
19724,GO:2000078,0.999999999988277,0.861500302494587,0,2,positive regulation of type B pancreatic cell development,BP,
1629,GO:0004066,0.999999999988294,0.848901093506483,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2986,GO:0006529,0.999999999988294,0.848901093506483,0,2,asparagine biosynthetic process,BP,
4645,GO:0010767,0.999999999988298,0.781546778200066,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
18625,GO:1903912,0.999999999988298,0.721936544012915,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
6106,GO:0019343,0.999999999988313,0.851911325373676,0,2,cysteine biosynthetic process via cystathionine,BP,
16956,GO:0098957,0.999999999988335,0.723141063142247,0,4,anterograde axonal transport of mitochondrion,BP,
1351,GO:0003219,0.999999999988344,0.852435586223449,0,2,cardiac right ventricle formation,BP,
15123,GO:0071209,0.999999999988346,0.805798516222395,0,3,U7 snRNA binding,MF,
4403,GO:0010139,0.999999999988386,0.926332025028424,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4409,GO:0010164,0.999999999988386,0.926332025028424,0,1,response to cesium ion,BP,
6869,GO:0030343,0.999999999988386,0.926332025028424,0,1,vitamin D3 25-hydroxylase activity,MF,
14868,GO:0070643,0.999999999988386,0.926332025028424,0,1,vitamin D 25-hydroxylase activity,MF,
811,GO:0002083,0.999999999988402,0.926016259618457,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11985,GO:0047293,0.999999999988402,0.926016259618457,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
6342,GO:0021516,0.999999999988413,0.848475550836712,0,2,dorsal spinal cord development,BP,
1559,GO:0003958,0.999999999988445,0.6632397214384,0,5,NADPH-hemoprotein reductase activity,MF,
14008,GO:0060729,0.999999999988448,0.785584279432999,0,3,intestinal epithelial structure maintenance,BP,
12699,GO:0050917,0.999999999988456,0.848518015917541,0,2,sensory perception of umami taste,BP,
3416,GO:0007198,0.99999999998847,0.860095667136551,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
4850,GO:0014062,0.99999999998847,0.860095667136551,0,2,regulation of serotonin secretion,BP,
7734,GO:0032229,0.99999999998847,0.860095667136551,0,2,negative regulation of synaptic transmission, GABAergic,BP,
10252,GO:0042986,0.999999999988473,0.850261462277171,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
15271,GO:0071449,0.999999999988524,0.939228924150269,0,1,cellular response to lipid hydroperoxide,BP,
815,GO:0002087,0.999999999988526,0.663089692917374,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
5796,GO:0017040,0.999999999988575,0.739512366712041,0,4,N-acylsphingosine amidohydrolase activity,MF,
8402,GO:0033341,0.999999999988585,0.848538853240178,0,2,regulation of collagen binding,BP,
9879,GO:0042144,0.999999999988606,0.848538164056674,0,2,vacuole fusion, non-autophagic,BP,
16674,GO:0097576,0.999999999988606,0.848538164056674,0,2,vacuole fusion,BP,
5804,GO:0017057,0.999999999988623,0.862729425657944,0,2,6-phosphogluconolactonase activity,MF,
9373,GO:0035897,0.999999999988626,0.666408084320228,0,5,proteolysis in other organism,BP,
9613,GO:0036476,0.999999999988641,0.800915479652051,0,3,neuron death in response to hydrogen peroxide,BP,
18301,GO:1903207,0.999999999988641,0.800915479652051,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18302,GO:1903208,0.999999999988641,0.800915479652051,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
2164,GO:0004999,0.999999999988647,0.921129171309999,0,1,vasoactive intestinal polypeptide receptor activity,MF,
11222,GO:0045355,0.999999999988686,0.859675801989314,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
19361,GO:1905777,0.99999999998871,0.781542148252692,0,3,regulation of exonuclease activity,BP,
9676,GO:0038037,0.999999999988721,0.797097486533462,0,3,G-protein coupled receptor dimeric complex,CC,
16701,GO:0097648,0.999999999988721,0.797097486533462,0,3,G-protein coupled receptor complex,CC,
2531,GO:0005787,0.999999999988733,0.695542183341498,0,5,signal peptidase complex,CC,
6415,GO:0021678,0.999999999988737,0.823041704512567,0,3,third ventricle development,BP,
13005,GO:0051430,0.999999999988808,0.850651949333484,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
20136,GO:2000828,0.999999999988808,0.850651949333484,0,2,regulation of parathyroid hormone secretion,BP,
14605,GO:0070164,0.999999999988837,0.725211865462203,0,4,negative regulation of adiponectin secretion,BP,
11641,GO:0046356,0.999999999988839,0.864020810088958,0,2,acetyl-CoA catabolic process,BP,
7249,GO:0031205,0.999999999988864,0.873259514455165,0,2,endoplasmic reticulum Sec complex,CC,
5996,GO:0019002,0.99999999998887,0.853136311859541,0,2,GMP binding,MF,
18893,GO:1904578,0.999999999988883,0.800527369558139,0,3,response to thapsigargin,BP,
18894,GO:1904579,0.999999999988883,0.800527369558139,0,3,cellular response to thapsigargin,BP,
4638,GO:0010760,0.999999999988911,0.76392966667415,0,4,negative regulation of macrophage chemotaxis,BP,
19287,GO:1905522,0.999999999988911,0.76392966667415,0,4,negative regulation of macrophage migration,BP,
10521,GO:0043435,0.999999999988936,0.848501096616336,0,2,response to corticotropin-releasing hormone,BP,
15224,GO:0071376,0.999999999988936,0.848501096616336,0,2,cellular response to corticotropin-releasing hormone stimulus,BP,
19920,GO:2000418,0.999999999988946,0.848488484198382,0,2,positive regulation of eosinophil migration,BP,
6308,GO:0019948,0.99999999998896,0.848597677311623,0,2,SUMO activating enzyme activity,MF,
1958,GO:0004662,0.999999999988966,0.853422563634749,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2627,GO:0005953,0.999999999988966,0.853422563634749,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
14260,GO:0061314,0.99999999998897,0.663292799898249,0,5,Notch signaling involved in heart development,BP,
6808,GO:0030259,0.999999999988982,0.724295050741494,0,4,lipid glycosylation,BP,
1815,GO:0004465,0.999999999989008,0.782570296467748,0,3,lipoprotein lipase activity,MF,
7250,GO:0031208,0.999999999989016,0.848513851501928,0,2,POZ domain binding,MF,
10934,GO:0044565,0.999999999989025,0.855499591746657,0,2,dendritic cell proliferation,BP,
15477,GO:0071819,0.999999999989036,0.873065857860442,0,2,DUBm complex,CC,
7544,GO:0031826,0.999999999989043,0.788796783339913,0,3,type 2A serotonin receptor binding,MF,
19538,GO:1990450,0.999999999989051,0.922273567274165,0,1,linear polyubiquitin binding,MF,
1981,GO:0004699,0.999999999989052,0.781541531532442,0,3,calcium-independent protein kinase C activity,MF,
16392,GO:0097003,0.999999999989053,0.849351404674205,0,2,adipokinetic hormone receptor activity,MF,
8757,GO:0034418,0.999999999989072,0.849436294139808,0,2,urate biosynthetic process,BP,
7418,GO:0031508,0.999999999989092,0.86020627085079,0,2,pericentric heterochromatin assembly,BP,
12397,GO:0048822,0.999999999989094,0.782359922279244,0,3,enucleate erythrocyte development,BP,
12857,GO:0051176,0.999999999989108,0.781954279654214,0,3,positive regulation of sulfur metabolic process,BP,
49,GO:0000103,0.999999999989108,0.791333302732331,0,3,sulfate assimilation,BP,
848,GO:0002169,0.999999999989129,0.848524775233963,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1830,GO:0004485,0.999999999989129,0.848524775233963,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19162,GO:1905202,0.999999999989129,0.848524775233963,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
11313,GO:0045630,0.999999999989144,0.673406143533223,0,5,positive regulation of T-helper 2 cell differentiation,BP,
5387,GO:0016212,0.999999999989153,0.849171145112599,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9495,GO:0036137,0.999999999989153,0.849171145112599,0,2,kynurenine aminotransferase activity,MF,
16419,GO:0097052,0.999999999989153,0.849171145112599,0,2,L-kynurenine metabolic process,BP,
18393,GO:1903416,0.999999999989161,0.784196807456022,0,3,response to glycoside,BP,
5564,GO:0016576,0.999999999989164,0.783711938791625,0,3,histone dephosphorylation,BP,
15072,GO:0071033,0.999999999989164,0.679012528853306,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
1139,GO:0002731,0.999999999989177,0.864659763828888,0,2,negative regulation of dendritic cell cytokine production,BP,
17595,GO:1901252,0.999999999989177,0.864659763828888,0,2,regulation of intracellular transport of viral material,BP,
5917,GO:0018192,0.999999999989191,0.921268541982465,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7881,GO:0032447,0.999999999989191,0.921268541982465,0,1,protein urmylation,BP,
9940,GO:0042292,0.999999999989191,0.921268541982465,0,1,URM1 activating enzyme activity,MF,
14372,GO:0061604,0.999999999989191,0.921268541982465,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14373,GO:0061605,0.999999999989191,0.921268541982465,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16884,GO:0098822,0.999999999989191,0.921268541982465,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
9716,GO:0038131,0.999999999989194,0.850502435439278,0,2,neuregulin receptor activity,MF,
19303,GO:1905573,0.999999999989194,0.850502435439278,0,2,ganglioside GM1 binding,MF,
19306,GO:1905576,0.999999999989194,0.850502435439278,0,2,ganglioside GT1b binding,MF,
1567,GO:0003974,0.999999999989204,0.926370685258559,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1571,GO:0003978,0.999999999989204,0.926370685258559,0,1,UDP-glucose 4-epimerase activity,MF,
9391,GO:0035928,0.999999999989207,0.807414377702629,0,3,rRNA import into mitochondrion,BP,
12996,GO:0051413,0.999999999989251,0.921211988821171,0,1,response to cortisone,BP,
6027,GO:0019086,0.999999999989256,0.726563633481457,0,4,late viral transcription,BP,
5390,GO:0016222,0.999999999989274,0.848505865953081,0,2,procollagen-proline 4-dioxygenase complex,CC,
5827,GO:0017102,0.999999999989274,0.848505865953081,0,2,methionyl glutamyl tRNA synthetase complex,CC,
19004,GO:1904815,0.999999999989283,0.850448602453645,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
3503,GO:0007406,0.999999999989284,0.72042685173676,0,4,negative regulation of neuroblast proliferation,BP,
4898,GO:0014825,0.999999999989313,0.941614844564354,0,1,stomach fundus smooth muscle contraction,BP,
4911,GO:0014847,0.999999999989313,0.941614844564354,0,1,proximal stomach smooth muscle contraction,BP,
7545,GO:0031839,0.999999999989313,0.941614844564354,0,1,type 1 neuromedin U receptor binding,MF,
7546,GO:0031840,0.999999999989313,0.941614844564354,0,1,type 2 neuromedin U receptor binding,MF,
9142,GO:0035483,0.999999999989313,0.941614844564354,0,1,gastric emptying,BP,
10231,GO:0042922,0.999999999989313,0.941614844564354,0,1,neuromedin U receptor binding,MF,
10916,GO:0044495,0.999999999989313,0.941614844564354,0,1,modulation of blood pressure in other organism,BP,
10917,GO:0044497,0.999999999989313,0.941614844564354,0,1,positive regulation of blood pressure in other organism,BP,
17263,GO:0120060,0.999999999989313,0.941614844564354,0,1,regulation of gastric emptying,BP,
17264,GO:0120061,0.999999999989313,0.941614844564354,0,1,negative regulation of gastric emptying,BP,
17265,GO:0120063,0.999999999989313,0.941614844564354,0,1,stomach smooth muscle contraction,BP,
17266,GO:0120068,0.999999999989313,0.941614844564354,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17267,GO:0120069,0.999999999989313,0.941614844564354,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
1091,GO:0002679,0.999999999989368,0.798722057069667,0,3,respiratory burst involved in defense response,BP,
13711,GO:0060268,0.999999999989368,0.798722057069667,0,3,negative regulation of respiratory burst,BP,
2740,GO:0006121,0.999999999989375,0.736488637325724,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
15516,GO:0071894,0.999999999989384,0.849349465107073,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
18559,GO:1903775,0.999999999989384,0.849349465107073,0,2,regulation of DNA double-strand break processing,BP,
5470,GO:0016403,0.999999999989388,0.85727032529564,0,2,dimethylargininase activity,MF,
6867,GO:0030337,0.999999999989388,0.857181283655308,0,2,DNA polymerase processivity factor activity,MF,
9257,GO:0035663,0.999999999989461,0.851519657235864,0,2,Toll-like receptor 2 binding,MF,
11997,GO:0047391,0.999999999989461,0.851519657235864,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
15853,GO:0072566,0.999999999989461,0.851519657235864,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19861,GO:2000338,0.999999999989461,0.851519657235864,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19862,GO:2000340,0.999999999989461,0.851519657235864,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
1401,GO:0003335,0.999999999989515,0.921188273729043,0,1,corneocyte development,BP,
1402,GO:0003336,0.999999999989515,0.921188273729043,0,1,corneocyte desquamation,BP,
19348,GO:1905715,0.999999999989515,0.921188273729043,0,1,regulation of cornification,BP,
19349,GO:1905716,0.999999999989515,0.921188273729043,0,1,negative regulation of cornification,BP,
18515,GO:1903677,0.999999999989528,0.785024242165703,0,3,regulation of cap-independent translational initiation,BP,
18516,GO:1903679,0.999999999989528,0.785024242165703,0,3,positive regulation of cap-independent translational initiation,BP,
9873,GO:0042134,0.999999999989552,0.863963437154637,0,2,rRNA primary transcript binding,MF,
8247,GO:0033018,0.999999999989555,0.850495653375221,0,2,sarcoplasmic reticulum lumen,CC,
12994,GO:0051410,0.999999999989564,0.679575624621594,0,5,detoxification of nitrogen compound,BP,
16697,GO:0097643,0.999999999989574,0.939460349645805,0,1,amylin receptor activity,MF,
18411,GO:1903440,0.999999999989574,0.939460349645805,0,1,amylin receptor complex,CC,
19517,GO:1990407,0.999999999989574,0.939460349645805,0,1,calcitonin gene-related peptide binding,MF,
18449,GO:1903537,0.999999999989581,0.848706298614981,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18450,GO:1903538,0.999999999989581,0.848706298614981,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
2012,GO:0004739,0.99999999998959,0.854332174487295,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
13950,GO:0060631,0.999999999989593,0.781556778566563,0,3,regulation of meiosis I,BP,
17801,GO:1901894,0.999999999989613,0.787961445193863,0,3,regulation of calcium-transporting ATPase activity,BP,
10262,GO:0043000,0.999999999989648,0.855521428183161,0,2,Golgi to plasma membrane CFTR protein transport,BP,
2031,GO:0004771,0.999999999989648,0.663097839141161,0,5,sterol esterase activity,MF,
841,GO:0002153,0.999999999989663,0.921311462156009,0,1,steroid receptor RNA activator RNA binding,MF,
11471,GO:0045925,0.999999999989663,0.921311462156009,0,1,positive regulation of female receptivity,BP,
237,GO:0000494,0.999999999989672,0.933766297027815,0,1,box C/D snoRNA 3'-end processing,BP,
8557,GO:0033967,0.999999999989672,0.933766297027815,0,1,box C/D snoRNA metabolic process,BP,
8935,GO:0034963,0.999999999989672,0.933766297027815,0,1,box C/D snoRNA processing,BP,
9436,GO:0036009,0.999999999989672,0.933766297027815,0,1,protein-glutamine N-methyltransferase activity,MF,
19486,GO:1990258,0.999999999989672,0.933766297027815,0,1,histone glutamine methylation,BP,
19487,GO:1990259,0.999999999989672,0.933766297027815,0,1,histone-glutamine methyltransferase activity,MF,
18649,GO:1903961,0.999999999989676,0.781963616498918,0,3,positive regulation of anion transmembrane transport,BP,
136,GO:0000285,0.99999999998974,0.788886196252696,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
8417,GO:0033477,0.999999999989749,0.9227939986267,0,1,S-methylmethionine metabolic process,BP,
11963,GO:0047150,0.999999999989749,0.9227939986267,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14386,GO:0061627,0.999999999989749,0.9227939986267,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
3218,GO:0006864,0.999999999989787,0.855283110239658,0,2,pyrimidine nucleotide transport,BP,
5040,GO:0015218,0.999999999989787,0.855283110239658,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19552,GO:1990519,0.999999999989787,0.855283110239658,0,2,pyrimidine nucleotide import into mitochondrion,BP,
8759,GO:0034423,0.999999999989789,0.921146279481316,0,1,autophagosome lumen,CC,
19923,GO:2000422,0.999999999989789,0.921146279481316,0,1,regulation of eosinophil chemotaxis,BP,
19924,GO:2000424,0.999999999989789,0.921146279481316,0,1,positive regulation of eosinophil chemotaxis,BP,
5,GO:0000011,0.999999999989796,0.921129163145696,0,1,vacuole inheritance,BP,
54,GO:0000111,0.999999999989796,0.921129163145696,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,0.999999999989796,0.921129163145696,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000121,0.999999999989796,0.921129163145696,0,1,glycerol-1-phosphatase activity,MF,
78,GO:0000155,0.999999999989796,0.921129163145696,0,1,phosphorelay sensor kinase activity,MF,
100,GO:0000210,0.999999999989796,0.921129163145696,0,1,NAD+ diphosphatase activity,MF,
118,GO:0000246,0.999999999989796,0.921129163145696,0,1,delta24(24-1) sterol reductase activity,MF,
192,GO:0000409,0.999999999989796,0.921129163145696,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,0.999999999989796,0.921129163145696,0,1,positive regulation of transcription by galactose,BP,
194,GO:0000412,0.999999999989796,0.921129163145696,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000415,0.999999999989796,0.921129163145696,0,1,negative regulation of histone H3-K36 methylation,BP,
198,GO:0000416,0.999999999989796,0.921129163145696,0,1,positive regulation of histone H3-K36 methylation,BP,
199,GO:0000417,0.999999999989796,0.921129163145696,0,1,HIR complex,CC,
206,GO:0000431,0.999999999989796,0.921129163145696,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000435,0.999999999989796,0.921129163145696,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
293,GO:0000797,0.999999999989796,0.921129163145696,0,1,condensin core heterodimer,CC,
310,GO:0000821,0.999999999989796,0.921129163145696,0,1,regulation of arginine metabolic process,BP,
334,GO:0000928,0.999999999989796,0.921129163145696,0,1,gamma-tubulin small complex, spindle pole body,CC,
379,GO:0001011,0.999999999989796,0.921129163145696,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
406,GO:0001087,0.999999999989796,0.921129163145696,0,1,transcription factor activity, TFIIB-class binding,MF,
410,GO:0001096,0.999999999989796,0.921129163145696,0,1,TFIIF-class transcription factor binding,MF,
453,GO:0001226,0.999999999989796,0.921129163145696,0,1,RNA polymerase II transcription corepressor binding,MF,
476,GO:0001519,0.999999999989796,0.921129163145696,0,1,peptide amidation,BP,
484,GO:0001534,0.999999999989796,0.921129163145696,0,1,radial spoke,CC,
485,GO:0001536,0.999999999989796,0.921129163145696,0,1,radial spoke stalk,CC,
491,GO:0001543,0.999999999989796,0.921129163145696,0,1,ovarian follicle rupture,BP,
492,GO:0001544,0.999999999989796,0.921129163145696,0,1,initiation of primordial ovarian follicle growth,BP,
493,GO:0001545,0.999999999989796,0.921129163145696,0,1,primary ovarian follicle growth,BP,
509,GO:0001572,0.999999999989796,0.921129163145696,0,1,lactosylceramide biosynthetic process,BP,
520,GO:0001605,0.999999999989796,0.921129163145696,0,1,adrenomedullin receptor activity,MF,
529,GO:0001640,0.999999999989796,0.921129163145696,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,0.999999999989796,0.921129163145696,0,1,group III metabotropic glutamate receptor activity,MF,
558,GO:0001681,0.999999999989796,0.921129163145696,0,1,sialate O-acetylesterase activity,MF,
573,GO:0001715,0.999999999989796,0.921129163145696,0,1,ectodermal cell fate specification,BP,
602,GO:0001770,0.999999999989796,0.921129163145696,0,1,establishment of natural killer cell polarity,BP,
619,GO:0001792,0.999999999989796,0.921129163145696,0,1,polymeric immunoglobulin receptor activity,MF,
620,GO:0001794,0.999999999989796,0.921129163145696,0,1,type IIa hypersensitivity,BP,
621,GO:0001796,0.999999999989796,0.921129163145696,0,1,regulation of type IIa hypersensitivity,BP,
622,GO:0001798,0.999999999989796,0.921129163145696,0,1,positive regulation of type IIa hypersensitivity,BP,
641,GO:0001831,0.999999999989796,0.921129163145696,0,1,trophectodermal cellular morphogenesis,BP,
644,GO:0001834,0.999999999989796,0.921129163145696,0,1,trophectodermal cell proliferation,BP,
645,GO:0001835,0.999999999989796,0.921129163145696,0,1,blastocyst hatching,BP,
740,GO:0001970,0.999999999989796,0.921129163145696,0,1,positive regulation of activation of membrane attack complex,BP,
741,GO:0001971,0.999999999989796,0.921129163145696,0,1,negative regulation of activation of membrane attack complex,BP,
809,GO:0002081,0.999999999989796,0.921129163145696,0,1,outer acrosomal membrane,CC,
814,GO:0002086,0.999999999989796,0.921129163145696,0,1,diaphragm contraction,BP,
825,GO:0002100,0.999999999989796,0.921129163145696,0,1,tRNA wobble adenosine to inosine editing,BP,
828,GO:0002114,0.999999999989796,0.921129163145696,0,1,interleukin-33 receptor activity,MF,
831,GO:0002118,0.999999999989796,0.921129163145696,0,1,aggressive behavior,BP,
832,GO:0002121,0.999999999989796,0.921129163145696,0,1,inter-male aggressive behavior,BP,
921,GO:0002316,0.999999999989796,0.921129163145696,0,1,follicular B cell differentiation,BP,
933,GO:0002332,0.999999999989796,0.921129163145696,0,1,transitional stage B cell differentiation,BP,
934,GO:0002333,0.999999999989796,0.921129163145696,0,1,transitional one stage B cell differentiation,BP,
958,GO:0002380,0.999999999989796,0.921129163145696,0,1,immunoglobulin secretion involved in immune response,BP,
962,GO:0002386,0.999999999989796,0.921129163145696,0,1,immune response in mucosal-associated lymphoid tissue,BP,
966,GO:0002408,0.999999999989796,0.921129163145696,0,1,myeloid dendritic cell chemotaxis,BP,
968,GO:0002415,0.999999999989796,0.921129163145696,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
978,GO:0002432,0.999999999989796,0.921129163145696,0,1,granuloma formation,BP,
988,GO:0002445,0.999999999989796,0.921129163145696,0,1,type II hypersensitivity,BP,
1017,GO:0002514,0.999999999989796,0.921129163145696,0,1,B cell tolerance induction,BP,
1041,GO:0002560,0.999999999989796,0.921129163145696,0,1,basophil mediated immunity,BP,
1042,GO:0002561,0.999999999989796,0.921129163145696,0,1,basophil degranulation,BP,
1064,GO:0002605,0.999999999989796,0.921129163145696,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1069,GO:0002635,0.999999999989796,0.921129163145696,0,1,negative regulation of germinal center formation,BP,
1076,GO:0002649,0.999999999989796,0.921129163145696,0,1,regulation of tolerance induction to self antigen,BP,
1077,GO:0002651,0.999999999989796,0.921129163145696,0,1,positive regulation of tolerance induction to self antigen,BP,
1079,GO:0002661,0.999999999989796,0.921129163145696,0,1,regulation of B cell tolerance induction,BP,
1080,GO:0002663,0.999999999989796,0.921129163145696,0,1,positive regulation of B cell tolerance induction,BP,
1084,GO:0002669,0.999999999989796,0.921129163145696,0,1,positive regulation of T cell anergy,BP,
1136,GO:0002728,0.999999999989796,0.921129163145696,0,1,negative regulation of natural killer cell cytokine production,BP,
1140,GO:0002732,0.999999999989796,0.921129163145696,0,1,positive regulation of dendritic cell cytokine production,BP,
1164,GO:0002785,0.999999999989796,0.921129163145696,0,1,negative regulation of antimicrobial peptide production,BP,
1166,GO:0002787,0.999999999989796,0.921129163145696,0,1,negative regulation of antibacterial peptide production,BP,
1222,GO:0002892,0.999999999989796,0.921129163145696,0,1,regulation of type II hypersensitivity,BP,
1223,GO:0002894,0.999999999989796,0.921129163145696,0,1,positive regulation of type II hypersensitivity,BP,
1231,GO:0002913,0.999999999989796,0.921129163145696,0,1,positive regulation of lymphocyte anergy,BP,
1247,GO:0002947,0.999999999989796,0.921129163145696,0,1,tumor necrosis factor receptor superfamily complex,CC,
1263,GO:0003017,0.999999999989796,0.921129163145696,0,1,lymph circulation,BP,
1268,GO:0003050,0.999999999989796,0.921129163145696,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1294,GO:0003127,0.999999999989796,0.921129163145696,0,1,detection of nodal flow,BP,
1298,GO:0003131,0.999999999989796,0.921129163145696,0,1,mesodermal-endodermal cell signaling,BP,
1317,GO:0003165,0.999999999989796,0.921129163145696,0,1,Purkinje myocyte development,BP,
1319,GO:0003167,0.999999999989796,0.921129163145696,0,1,atrioventricular bundle cell differentiation,BP,
1336,GO:0003193,0.999999999989796,0.921129163145696,0,1,pulmonary valve formation,BP,
1337,GO:0003195,0.999999999989796,0.921129163145696,0,1,tricuspid valve formation,BP,
1352,GO:0003220,0.999999999989796,0.921129163145696,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1353,GO:0003221,0.999999999989796,0.921129163145696,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1356,GO:0003226,0.999999999989796,0.921129163145696,0,1,right ventricular compact myocardium morphogenesis,BP,
1366,GO:0003251,0.999999999989796,0.921129163145696,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1367,GO:0003252,0.999999999989796,0.921129163145696,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1375,GO:0003270,0.999999999989796,0.921129163145696,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1386,GO:0003292,0.999999999989796,0.921129163145696,0,1,cardiac septum cell differentiation,BP,
1411,GO:0003345,0.999999999989796,0.921129163145696,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1419,GO:0003363,0.999999999989796,0.921129163145696,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1421,GO:0003366,0.999999999989796,0.921129163145696,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1430,GO:0003404,0.999999999989796,0.921129163145696,0,1,optic vesicle morphogenesis,BP,
1434,GO:0003409,0.999999999989796,0.921129163145696,0,1,optic cup structural organization,BP,
1497,GO:0003842,0.999999999989796,0.921129163145696,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1508,GO:0003867,0.999999999989796,0.921129163145696,0,1,4-aminobutyrate transaminase activity,MF,
1514,GO:0003875,0.999999999989796,0.921129163145696,0,1,ADP-ribosylarginine hydrolase activity,MF,
1517,GO:0003878,0.999999999989796,0.921129163145696,0,1,ATP citrate synthase activity,MF,
1558,GO:0003957,0.999999999989796,0.921129163145696,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1565,GO:0003972,0.999999999989796,0.921129163145696,0,1,RNA ligase (ATP) activity,MF,
1566,GO:0003973,0.999999999989796,0.921129163145696,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1572,GO:0003979,0.999999999989796,0.921129163145696,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1596,GO:0004014,0.999999999989796,0.921129163145696,0,1,adenosylmethionine decarboxylase activity,MF,
1602,GO:0004021,0.999999999989796,0.921129163145696,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1608,GO:0004031,0.999999999989796,0.921129163145696,0,1,aldehyde oxidase activity,MF,
1614,GO:0004043,0.999999999989796,0.921129163145696,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1615,GO:0004044,0.999999999989796,0.921129163145696,0,1,amidophosphoribosyltransferase activity,MF,
1634,GO:0004077,0.999999999989796,0.921129163145696,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1635,GO:0004078,0.999999999989796,0.921129163145696,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1636,GO:0004079,0.999999999989796,0.921129163145696,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1637,GO:0004080,0.999999999989796,0.921129163145696,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1640,GO:0004083,0.999999999989796,0.921129163145696,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1647,GO:0004092,0.999999999989796,0.921129163145696,0,1,carnitine O-acetyltransferase activity,MF,
1658,GO:0004113,0.999999999989796,0.921129163145696,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1662,GO:0004118,0.999999999989796,0.921129163145696,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1670,GO:0004133,0.999999999989796,0.921129163145696,0,1,glycogen debranching enzyme activity,MF,
1671,GO:0004134,0.999999999989796,0.921129163145696,0,1,4-alpha-glucanotransferase activity,MF,
1672,GO:0004135,0.999999999989796,0.921129163145696,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1682,GO:0004148,0.999999999989796,0.921129163145696,0,1,dihydrolipoyl dehydrogenase activity,MF,
1683,GO:0004149,0.999999999989796,0.921129163145696,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1687,GO:0004157,0.999999999989796,0.921129163145696,0,1,dihydropyrimidinase activity,MF,
1721,GO:0004313,0.999999999989796,0.921129163145696,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1724,GO:0004316,0.999999999989796,0.921129163145696,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1725,GO:0004317,0.999999999989796,0.921129163145696,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1726,GO:0004319,0.999999999989796,0.921129163145696,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1730,GO:0004325,0.999999999989796,0.921129163145696,0,1,ferrochelatase activity,MF,
1738,GO:0004336,0.999999999989796,0.921129163145696,0,1,galactosylceramidase activity,MF,
1743,GO:0004343,0.999999999989796,0.921129163145696,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1744,GO:0004344,0.999999999989796,0.921129163145696,0,1,glucose dehydrogenase activity,MF,
1749,GO:0004349,0.999999999989796,0.921129163145696,0,1,glutamate 5-kinase activity,MF,
1750,GO:0004350,0.999999999989796,0.921129163145696,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1752,GO:0004352,0.999999999989796,0.921129163145696,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1753,GO:0004353,0.999999999989796,0.921129163145696,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1754,GO:0004356,0.999999999989796,0.921129163145696,0,1,glutamate-ammonia ligase activity,MF,
1757,GO:0004360,0.999999999989796,0.921129163145696,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1764,GO:0004367,0.999999999989796,0.921129163145696,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1765,GO:0004368,0.999999999989796,0.921129163145696,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1767,GO:0004371,0.999999999989796,0.921129163145696,0,1,glycerone kinase activity,MF,
1769,GO:0004373,0.999999999989796,0.921129163145696,0,1,glycogen (starch) synthase activity,MF,
1770,GO:0004375,0.999999999989796,0.921129163145696,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1773,GO:0004378,0.999999999989796,0.921129163145696,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1780,GO:0004394,0.999999999989796,0.921129163145696,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1783,GO:0004397,0.999999999989796,0.921129163145696,0,1,histidine ammonia-lyase activity,MF,
1791,GO:0004420,0.999999999989796,0.921129163145696,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1794,GO:0004423,0.999999999989796,0.921129163145696,0,1,iduronate-2-sulfatase activity,MF,
1802,GO:0004446,0.999999999989796,0.921129163145696,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1827,GO:0004482,0.999999999989796,0.921129163145696,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1829,GO:0004484,0.999999999989796,0.921129163145696,0,1,mRNA guanylyltransferase activity,MF,
1831,GO:0004486,0.999999999989796,0.921129163145696,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1834,GO:0004489,0.999999999989796,0.921129163145696,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1839,GO:0004494,0.999999999989796,0.921129163145696,0,1,methylmalonyl-CoA mutase activity,MF,
1844,GO:0004500,0.999999999989796,0.921129163145696,0,1,dopamine beta-monooxygenase activity,MF,
1845,GO:0004504,0.999999999989796,0.921129163145696,0,1,peptidylglycine monooxygenase activity,MF,
1847,GO:0004506,0.999999999989796,0.921129163145696,0,1,squalene monooxygenase activity,MF,
1853,GO:0004516,0.999999999989796,0.921129163145696,0,1,nicotinate phosphoribosyltransferase activity,MF,
1886,GO:0004567,0.999999999989796,0.921129163145696,0,1,beta-mannosidase activity,MF,
1888,GO:0004569,0.999999999989796,0.921129163145696,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1892,GO:0004574,0.999999999989796,0.921129163145696,0,1,oligo-1,6-glucosidase activity,MF,
1895,GO:0004578,0.999999999989796,0.921129163145696,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1909,GO:0004597,0.999999999989796,0.921129163145696,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1910,GO:0004598,0.999999999989796,0.921129163145696,0,1,peptidylamidoglycolate lyase activity,MF,
1936,GO:0004637,0.999999999989796,0.921129163145696,0,1,phosphoribosylamine-glycine ligase activity,MF,
1937,GO:0004638,0.999999999989796,0.921129163145696,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1938,GO:0004639,0.999999999989796,0.921129163145696,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1939,GO:0004641,0.999999999989796,0.921129163145696,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1940,GO:0004642,0.999999999989796,0.921129163145696,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1942,GO:0004644,0.999999999989796,0.921129163145696,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1950,GO:0004654,0.999999999989796,0.921129163145696,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1951,GO:0004655,0.999999999989796,0.921129163145696,0,1,porphobilinogen synthase activity,MF,
1961,GO:0004668,0.999999999989796,0.921129163145696,0,1,protein-arginine deiminase activity,MF,
1962,GO:0004671,0.999999999989796,0.921129163145696,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1967,GO:0004676,0.999999999989796,0.921129163145696,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1971,GO:0004686,0.999999999989796,0.921129163145696,0,1,elongation factor-2 kinase activity,MF,
1976,GO:0004692,0.999999999989796,0.921129163145696,0,1,cGMP-dependent protein kinase activity,MF,
2008,GO:0004733,0.999999999989796,0.921129163145696,0,1,pyridoxamine-phosphate oxidase activity,MF,
2010,GO:0004736,0.999999999989796,0.921129163145696,0,1,pyruvate carboxylase activity,MF,
2015,GO:0004742,0.999999999989796,0.921129163145696,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2016,GO:0004743,0.999999999989796,0.921129163145696,0,1,pyruvate kinase activity,MF,
2032,GO:0004772,0.999999999989796,0.921129163145696,0,1,sterol O-acyltransferase activity,MF,
2033,GO:0004773,0.999999999989796,0.921129163145696,0,1,steryl-sulfatase activity,MF,
2037,GO:0004777,0.999999999989796,0.921129163145696,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2080,GO:0004835,0.999999999989796,0.921129163145696,0,1,tubulin-tyrosine ligase activity,MF,
2090,GO:0004855,0.999999999989796,0.921129163145696,0,1,xanthine oxidase activity,MF,
2091,GO:0004856,0.999999999989796,0.921129163145696,0,1,xylulokinase activity,MF,
2105,GO:0004882,0.999999999989796,0.921129163145696,0,1,androgen receptor activity,MF,
2106,GO:0004883,0.999999999989796,0.921129163145696,0,1,glucocorticoid receptor activity,MF,
2110,GO:0004890,0.999999999989796,0.921129163145696,0,1,GABA-A receptor activity,MF,
2125,GO:0004921,0.999999999989796,0.921129163145696,0,1,interleukin-11 receptor activity,MF,
2137,GO:0004948,0.999999999989796,0.921129163145696,0,1,calcitonin receptor activity,MF,
2146,GO:0004962,0.999999999989796,0.921129163145696,0,1,endothelin receptor activity,MF,
2149,GO:0004968,0.999999999989796,0.921129163145696,0,1,gonadotropin-releasing hormone receptor activity,MF,
2156,GO:0004980,0.999999999989796,0.921129163145696,0,1,melanocyte-stimulating hormone receptor activity,MF,
2160,GO:0004992,0.999999999989796,0.921129163145696,0,1,platelet activating factor receptor activity,MF,
2162,GO:0004996,0.999999999989796,0.921129163145696,0,1,thyroid-stimulating hormone receptor activity,MF,
2168,GO:0005004,0.999999999989796,0.921129163145696,0,1,GPI-linked ephrin receptor activity,MF,
2172,GO:0005008,0.999999999989796,0.921129163145696,0,1,hepatocyte growth factor-activated receptor activity,MF,
2173,GO:0005009,0.999999999989796,0.921129163145696,0,1,insulin-activated receptor activity,MF,
2175,GO:0005011,0.999999999989796,0.921129163145696,0,1,macrophage colony-stimulating factor receptor activity,MF,
2179,GO:0005026,0.999999999989796,0.921129163145696,0,1,transforming growth factor beta receptor activity, type II,MF,
2180,GO:0005030,0.999999999989796,0.921129163145696,0,1,neurotrophin receptor activity,MF,
2182,GO:0005034,0.999999999989796,0.921129163145696,0,1,osmosensor activity,MF,
2185,GO:0005042,0.999999999989796,0.921129163145696,0,1,netrin receptor activity,MF,
2218,GO:0005115,0.999999999989796,0.921129163145696,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2225,GO:0005128,0.999999999989796,0.921129163145696,0,1,erythropoietin receptor binding,MF,
2231,GO:0005135,0.999999999989796,0.921129163145696,0,1,interleukin-3 receptor binding,MF,
2232,GO:0005136,0.999999999989796,0.921129163145696,0,1,interleukin-4 receptor binding,MF,
2256,GO:0005170,0.999999999989796,0.921129163145696,0,1,neurotrophin TRKC receptor binding,MF,
2268,GO:0005199,0.999999999989796,0.921129163145696,0,1,structural constituent of cell wall,MF,
2283,GO:0005237,0.999999999989796,0.921129163145696,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2300,GO:0005275,0.999999999989796,0.921129163145696,0,1,amine transmembrane transporter activity,MF,
2307,GO:0005294,0.999999999989796,0.921129163145696,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2308,GO:0005295,0.999999999989796,0.921129163145696,0,1,neutral amino acid:sodium symporter activity,MF,
2309,GO:0005298,0.999999999989796,0.921129163145696,0,1,proline:sodium symporter activity,MF,
2310,GO:0005308,0.999999999989796,0.921129163145696,0,1,creatine transmembrane transporter activity,MF,
2311,GO:0005309,0.999999999989796,0.921129163145696,0,1,creatine:sodium symporter activity,MF,
2316,GO:0005316,0.999999999989796,0.921129163145696,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2322,GO:0005330,0.999999999989796,0.921129163145696,0,1,dopamine:sodium symporter activity,MF,
2324,GO:0005335,0.999999999989796,0.921129163145696,0,1,serotonin:sodium symporter activity,MF,
2337,GO:0005366,0.999999999989796,0.921129163145696,0,1,myo-inositol:proton symporter activity,MF,
2338,GO:0005367,0.999999999989796,0.921129163145696,0,1,myo-inositol:sodium symporter activity,MF,
2339,GO:0005368,0.999999999989796,0.921129163145696,0,1,taurine transmembrane transporter activity,MF,
2340,GO:0005369,0.999999999989796,0.921129163145696,0,1,taurine:sodium symporter activity,MF,
2352,GO:0005427,0.999999999989796,0.921129163145696,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2360,GO:0005461,0.999999999989796,0.921129163145696,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2362,GO:0005464,0.999999999989796,0.921129163145696,0,1,UDP-xylose transmembrane transporter activity,MF,
2365,GO:0005477,0.999999999989796,0.921129163145696,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2373,GO:0005502,0.999999999989796,0.921129163145696,0,1,11-cis retinal binding,MF,
2374,GO:0005503,0.999999999989796,0.921129163145696,0,1,all-trans retinal binding,MF,
2383,GO:0005519,0.999999999989796,0.921129163145696,0,1,cytoskeletal regulatory protein binding,MF,
2408,GO:0005579,0.999999999989796,0.921129163145696,0,1,membrane attack complex,CC,
2412,GO:0005586,0.999999999989796,0.921129163145696,0,1,collagen type III trimer,CC,
2416,GO:0005590,0.999999999989796,0.921129163145696,0,1,collagen type VII trimer,CC,
2418,GO:0005592,0.999999999989796,0.921129163145696,0,1,collagen type XI trimer,CC,
2424,GO:0005600,0.999999999989796,0.921129163145696,0,1,collagen type XIII trimer,CC,
2475,GO:0005691,0.999999999989796,0.921129163145696,0,1,U6atac snRNP,CC,
2556,GO:0005833,0.999999999989796,0.921129163145696,0,1,hemoglobin complex,CC,
2576,GO:0005863,0.999999999989796,0.921129163145696,0,1,striated muscle myosin thick filament,CC,
2600,GO:0005898,0.999999999989796,0.921129163145696,0,1,interleukin-13 receptor complex,CC,
2637,GO:0005969,0.999999999989796,0.921129163145696,0,1,serine-pyruvate aminotransferase complex,CC,
2649,GO:0005985,0.999999999989796,0.921129163145696,0,1,sucrose metabolic process,BP,
2652,GO:0005991,0.999999999989796,0.921129163145696,0,1,trehalose metabolic process,BP,
2655,GO:0005998,0.999999999989796,0.921129163145696,0,1,xylulose catabolic process,BP,
2687,GO:0006049,0.999999999989796,0.921129163145696,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2734,GO:0006113,0.999999999989796,0.921129163145696,0,1,fermentation,BP,
2743,GO:0006127,0.999999999989796,0.921129163145696,0,1,glycerophosphate shuttle,BP,
2748,GO:0006147,0.999999999989796,0.921129163145696,0,1,guanine catabolic process,BP,
2762,GO:0006174,0.999999999989796,0.921129163145696,0,1,dADP phosphorylation,BP,
2769,GO:0006186,0.999999999989796,0.921129163145696,0,1,dGDP phosphorylation,BP,
2782,GO:0006212,0.999999999989796,0.921129163145696,0,1,uracil catabolic process,BP,
2784,GO:0006214,0.999999999989796,0.921129163145696,0,1,thymidine catabolic process,BP,
2800,GO:0006256,0.999999999989796,0.921129163145696,0,1,UDP catabolic process,BP,
2843,GO:0006311,0.999999999989796,0.921129163145696,0,1,meiotic gene conversion,BP,
2845,GO:0006313,0.999999999989796,0.921129163145696,0,1,transposition, DNA-mediated,BP,
2855,GO:0006343,0.999999999989796,0.921129163145696,0,1,establishment of chromatin silencing,BP,
2938,GO:0006463,0.999999999989796,0.921129163145696,0,1,steroid hormone receptor complex assembly,BP,
2952,GO:0006480,0.999999999989796,0.921129163145696,0,1,N-terminal protein amino acid methylation,BP,
2980,GO:0006522,0.999999999989796,0.921129163145696,0,1,alanine metabolic process,BP,
2981,GO:0006524,0.999999999989796,0.921129163145696,0,1,alanine catabolic process,BP,
2997,GO:0006542,0.999999999989796,0.921129163145696,0,1,glutamine biosynthetic process,BP,
3012,GO:0006557,0.999999999989796,0.921129163145696,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3038,GO:0006589,0.999999999989796,0.921129163145696,0,1,octopamine biosynthetic process,BP,
3041,GO:0006592,0.999999999989796,0.921129163145696,0,1,ornithine biosynthetic process,BP,
3093,GO:0006666,0.999999999989796,0.921129163145696,0,1,3-keto-sphinganine metabolic process,BP,
3096,GO:0006669,0.999999999989796,0.921129163145696,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3098,GO:0006671,0.999999999989796,0.921129163145696,0,1,phytosphingosine metabolic process,BP,
3106,GO:0006683,0.999999999989796,0.921129163145696,0,1,galactosylceramide catabolic process,BP,
3136,GO:0006726,0.999999999989796,0.921129163145696,0,1,eye pigment biosynthetic process,BP,
3147,GO:0006742,0.999999999989796,0.921129163145696,0,1,NADP catabolic process,BP,
3156,GO:0006756,0.999999999989796,0.921129163145696,0,1,AMP phosphorylation,BP,
3308,GO:0007008,0.999999999989796,0.921129163145696,0,1,outer mitochondrial membrane organization,BP,
3311,GO:0007014,0.999999999989796,0.921129163145696,0,1,actin ubiquitination,BP,
3375,GO:0007146,0.999999999989796,0.921129163145696,0,1,meiotic recombination nodule assembly,BP,
3376,GO:0007147,0.999999999989796,0.921129163145696,0,1,female meiosis II,BP,
3414,GO:0007196,0.999999999989796,0.921129163145696,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3421,GO:0007206,0.999999999989796,0.921129163145696,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3436,GO:0007225,0.999999999989796,0.921129163145696,0,1,patched ligand maturation,BP,
3470,GO:0007290,0.999999999989796,0.921129163145696,0,1,spermatid nucleus elongation,BP,
3487,GO:0007352,0.999999999989796,0.921129163145696,0,1,zygotic specification of dorsal/ventral axis,BP,
3492,GO:0007371,0.999999999989796,0.921129163145696,0,1,ventral midline determination,BP,
3501,GO:0007403,0.999999999989796,0.921129163145696,0,1,glial cell fate determination,BP,
3522,GO:0007495,0.999999999989796,0.921129163145696,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3523,GO:0007497,0.999999999989796,0.921129163145696,0,1,posterior midgut development,BP,
3529,GO:0007509,0.999999999989796,0.921129163145696,0,1,mesoderm migration involved in gastrulation,BP,
3577,GO:0007621,0.999999999989796,0.921129163145696,0,1,negative regulation of female receptivity,BP,
3580,GO:0007624,0.999999999989796,0.921129163145696,0,1,ultradian rhythm,BP,
3614,GO:0008057,0.999999999989796,0.921129163145696,0,1,eye pigment granule organization,BP,
3623,GO:0008078,0.999999999989796,0.921129163145696,0,1,mesodermal cell migration,BP,
3644,GO:0008116,0.999999999989796,0.921129163145696,0,1,prostaglandin-I synthase activity,MF,
3645,GO:0008117,0.999999999989796,0.921129163145696,0,1,sphinganine-1-phosphate aldolase activity,MF,
3647,GO:0008119,0.999999999989796,0.921129163145696,0,1,thiopurine S-methyltransferase activity,MF,
3651,GO:0008126,0.999999999989796,0.921129163145696,0,1,acetylesterase activity,MF,
3711,GO:0008218,0.999999999989796,0.921129163145696,0,1,bioluminescence,BP,
3728,GO:0008254,0.999999999989796,0.921129163145696,0,1,3'-nucleotidase activity,MF,
3729,GO:0008260,0.999999999989796,0.921129163145696,0,1,3-oxoacid CoA-transferase activity,MF,
3733,GO:0008267,0.999999999989796,0.921129163145696,0,1,poly-glutamine tract binding,MF,
3744,GO:0008281,0.999999999989796,0.921129163145696,0,1,sulfonylurea receptor activity,MF,
3753,GO:0008294,0.999999999989796,0.921129163145696,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3782,GO:0008343,0.999999999989796,0.921129163145696,0,1,adult feeding behavior,BP,
3785,GO:0008348,0.999999999989796,0.921129163145696,0,1,negative regulation of antimicrobial humoral response,BP,
3790,GO:0008355,0.999999999989796,0.921129163145696,0,1,olfactory learning,BP,
3810,GO:0008398,0.999999999989796,0.921129163145696,0,1,sterol 14-demethylase activity,MF,
3825,GO:0008424,0.999999999989796,0.921129163145696,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3832,GO:0008431,0.999999999989796,0.921129163145696,0,1,vitamin E binding,MF,
3834,GO:0008434,0.999999999989796,0.921129163145696,0,1,calcitriol receptor activity,MF,
3843,GO:0008452,0.999999999989796,0.921129163145696,0,1,RNA ligase activity,MF,
3844,GO:0008453,0.999999999989796,0.921129163145696,0,1,alanine-glyoxylate transaminase activity,MF,
3847,GO:0008456,0.999999999989796,0.921129163145696,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3848,GO:0008457,0.999999999989796,0.921129163145696,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3849,GO:0008458,0.999999999989796,0.921129163145696,0,1,carnitine O-octanoyltransferase activity,MF,
3856,GO:0008470,0.999999999989796,0.921129163145696,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3860,GO:0008478,0.999999999989796,0.921129163145696,0,1,pyridoxal kinase activity,MF,
3868,GO:0008489,0.999999999989796,0.921129163145696,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3871,GO:0008495,0.999999999989796,0.921129163145696,0,1,protoheme IX farnesyltransferase activity,MF,
3872,GO:0008496,0.999999999989796,0.921129163145696,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3877,GO:0008507,0.999999999989796,0.921129163145696,0,1,sodium:iodide symporter activity,MF,
3881,GO:0008511,0.999999999989796,0.921129163145696,0,1,sodium:potassium:chloride symporter activity,MF,
3886,GO:0008518,0.999999999989796,0.921129163145696,0,1,reduced folate carrier activity,MF,
3888,GO:0008520,0.999999999989796,0.921129163145696,0,1,L-ascorbate:sodium symporter activity,MF,
3908,GO:0008555,0.999999999989796,0.921129163145696,0,1,chloride-transporting ATPase activity,MF,
3915,GO:0008579,0.999999999989796,0.921129163145696,0,1,JUN kinase phosphatase activity,MF,
3921,GO:0008592,0.999999999989796,0.921129163145696,0,1,regulation of Toll signaling pathway,BP,
3929,GO:0008609,0.999999999989796,0.921129163145696,0,1,alkylglycerone-phosphate synthase activity,MF,
3957,GO:0008700,0.999999999989796,0.921129163145696,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3958,GO:0008705,0.999999999989796,0.921129163145696,0,1,methionine synthase activity,MF,
3964,GO:0008746,0.999999999989796,0.921129163145696,0,1,NAD(P)+ transhydrogenase activity,MF,
3966,GO:0008750,0.999999999989796,0.921129163145696,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3967,GO:0008753,0.999999999989796,0.921129163145696,0,1,NADPH dehydrogenase (quinone) activity,MF,
3969,GO:0008761,0.999999999989796,0.921129163145696,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3975,GO:0008792,0.999999999989796,0.921129163145696,0,1,arginine decarboxylase activity,MF,
3978,GO:0008798,0.999999999989796,0.921129163145696,0,1,beta-aspartyl-peptidase activity,MF,
3979,GO:0008802,0.999999999989796,0.921129163145696,0,1,betaine-aldehyde dehydrogenase activity,MF,
3981,GO:0008808,0.999999999989796,0.921129163145696,0,1,cardiolipin synthase activity,MF,
3982,GO:0008817,0.999999999989796,0.921129163145696,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3985,GO:0008832,0.999999999989796,0.921129163145696,0,1,dGTPase activity,MF,
3987,GO:0008852,0.999999999989796,0.921129163145696,0,1,exodeoxyribonuclease I activity,MF,
3991,GO:0008887,0.999999999989796,0.921129163145696,0,1,glycerate kinase activity,MF,
3994,GO:0008892,0.999999999989796,0.921129163145696,0,1,guanine deaminase activity,MF,
3997,GO:0008897,0.999999999989796,0.921129163145696,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
3998,GO:0008900,0.999999999989796,0.921129163145696,0,1,potassium:proton exchanging ATPase activity,MF,
4009,GO:0008973,0.999999999989796,0.921129163145696,0,1,phosphopentomutase activity,MF,
4013,GO:0009007,0.999999999989796,0.921129163145696,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4015,GO:0009013,0.999999999989796,0.921129163145696,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4042,GO:0009078,0.999999999989796,0.921129163145696,0,1,pyruvate family amino acid metabolic process,BP,
4043,GO:0009080,0.999999999989796,0.921129163145696,0,1,pyruvate family amino acid catabolic process,BP,
4086,GO:0009140,0.999999999989796,0.921129163145696,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4105,GO:0009159,0.999999999989796,0.921129163145696,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4134,GO:0009193,0.999999999989796,0.921129163145696,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4135,GO:0009195,0.999999999989796,0.921129163145696,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4160,GO:0009222,0.999999999989796,0.921129163145696,0,1,pyrimidine ribonucleotide catabolic process,BP,
4168,GO:0009234,0.999999999989796,0.921129163145696,0,1,menaquinone biosynthetic process,BP,
4171,GO:0009237,0.999999999989796,0.921129163145696,0,1,siderophore metabolic process,BP,
4181,GO:0009258,0.999999999989796,0.921129163145696,0,1,10-formyltetrahydrofolate catabolic process,BP,
4198,GO:0009305,0.999999999989796,0.921129163145696,0,1,protein biotinylation,BP,
4210,GO:0009346,0.999999999989796,0.921129163145696,0,1,citrate lyase complex,CC,
4214,GO:0009372,0.999999999989796,0.921129163145696,0,1,quorum sensing,BP,
4218,GO:0009384,0.999999999989796,0.921129163145696,0,1,N-acylmannosamine kinase activity,MF,
4225,GO:0009400,0.999999999989796,0.921129163145696,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4238,GO:0009436,0.999999999989796,0.921129163145696,0,1,glyoxylate catabolic process,BP,
4244,GO:0009443,0.999999999989796,0.921129163145696,0,1,pyridoxal 5'-phosphate salvage,BP,
4273,GO:0009631,0.999999999989796,0.921129163145696,0,1,cold acclimation,BP,
4280,GO:0009646,0.999999999989796,0.921129163145696,0,1,response to absence of light,BP,
4287,GO:0009674,0.999999999989796,0.921129163145696,0,1,potassium:sodium symporter activity,MF,
4293,GO:0009720,0.999999999989796,0.921129163145696,0,1,detection of hormone stimulus,BP,
4307,GO:0009758,0.999999999989796,0.921129163145696,0,1,carbohydrate utilization,BP,
4360,GO:0009956,0.999999999989796,0.921129163145696,0,1,radial pattern formation,BP,
4383,GO:0010034,0.999999999989796,0.921129163145696,0,1,response to acetate,BP,
4406,GO:0010157,0.999999999989796,0.921129163145696,0,1,response to chlorate,BP,
4423,GO:0010232,0.999999999989796,0.921129163145696,0,1,vascular transport,BP,
4430,GO:0010260,0.999999999989796,0.921129163145696,0,1,animal organ senescence,BP,
4442,GO:0010335,0.999999999989796,0.921129163145696,0,1,response to non-ionic osmotic stress,BP,
4444,GO:0010348,0.999999999989796,0.921129163145696,0,1,lithium:proton antiporter activity,MF,
4453,GO:0010412,0.999999999989796,0.921129163145696,0,1,mannan metabolic process,BP,
4456,GO:0010428,0.999999999989796,0.921129163145696,0,1,methyl-CpNpG binding,MF,
4457,GO:0010430,0.999999999989796,0.921129163145696,0,1,fatty acid omega-oxidation,BP,
4469,GO:0010465,0.999999999989796,0.921129163145696,0,1,nerve growth factor receptor activity,MF,
4487,GO:0010509,0.999999999989796,0.921129163145696,0,1,polyamine homeostasis,BP,
4542,GO:0010615,0.999999999989796,0.921129163145696,0,1,positive regulation of cardiac muscle adaptation,BP,
4569,GO:0010650,0.999999999989796,0.921129163145696,0,1,positive regulation of cell communication by electrical coupling,BP,
4592,GO:0010700,0.999999999989796,0.921129163145696,0,1,negative regulation of norepinephrine secretion,BP,
4607,GO:0010722,0.999999999989796,0.921129163145696,0,1,regulation of ferrochelatase activity,BP,
4632,GO:0010754,0.999999999989796,0.921129163145696,0,1,negative regulation of cGMP-mediated signaling,BP,
4661,GO:0010808,0.999999999989796,0.921129163145696,0,1,positive regulation of synaptic vesicle priming,BP,
4666,GO:0010814,0.999999999989796,0.921129163145696,0,1,substance P catabolic process,BP,
4668,GO:0010816,0.999999999989796,0.921129163145696,0,1,calcitonin catabolic process,BP,
4694,GO:0010848,0.999999999989796,0.921129163145696,0,1,regulation of chromatin disassembly,BP,
4698,GO:0010856,0.999999999989796,0.921129163145696,0,1,adenylate cyclase activator activity,MF,
4701,GO:0010859,0.999999999989796,0.921129163145696,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4754,GO:0010931,0.999999999989796,0.921129163145696,0,1,macrophage tolerance induction,BP,
4755,GO:0010932,0.999999999989796,0.921129163145696,0,1,regulation of macrophage tolerance induction,BP,
4756,GO:0010933,0.999999999989796,0.921129163145696,0,1,positive regulation of macrophage tolerance induction,BP,
4805,GO:0010999,0.999999999989796,0.921129163145696,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4817,GO:0014011,0.999999999989796,0.921129163145696,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4831,GO:0014036,0.999999999989796,0.921129163145696,0,1,neural crest cell fate specification,BP,
4846,GO:0014053,0.999999999989796,0.921129163145696,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4847,GO:0014054,0.999999999989796,0.921129163145696,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4852,GO:0014064,0.999999999989796,0.921129163145696,0,1,positive regulation of serotonin secretion,BP,
4873,GO:0014734,0.999999999989796,0.921129163145696,0,1,skeletal muscle hypertrophy,BP,
4877,GO:0014739,0.999999999989796,0.921129163145696,0,1,positive regulation of muscle hyperplasia,BP,
4905,GO:0014835,0.999999999989796,0.921129163145696,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4909,GO:0014843,0.999999999989796,0.921129163145696,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4910,GO:0014846,0.999999999989796,0.921129163145696,0,1,esophagus smooth muscle contraction,BP,
4914,GO:0014852,0.999999999989796,0.921129163145696,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4915,GO:0014853,0.999999999989796,0.921129163145696,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4921,GO:0014859,0.999999999989796,0.921129163145696,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4927,GO:0014878,0.999999999989796,0.921129163145696,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4943,GO:0014908,0.999999999989796,0.921129163145696,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4955,GO:0015019,0.999999999989796,0.921129163145696,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4973,GO:0015086,0.999999999989796,0.921129163145696,0,1,cadmium ion transmembrane transporter activity,MF,
4974,GO:0015087,0.999999999989796,0.921129163145696,0,1,cobalt ion transmembrane transporter activity,MF,
4977,GO:0015094,0.999999999989796,0.921129163145696,0,1,lead ion transmembrane transporter activity,MF,
4992,GO:0015127,0.999999999989796,0.921129163145696,0,1,bilirubin transmembrane transporter activity,MF,
4994,GO:0015130,0.999999999989796,0.921129163145696,0,1,mevalonate transmembrane transporter activity,MF,
4996,GO:0015136,0.999999999989796,0.921129163145696,0,1,sialic acid transmembrane transporter activity,MF,
5030,GO:0015195,0.999999999989796,0.921129163145696,0,1,L-threonine transmembrane transporter activity,MF,
5032,GO:0015203,0.999999999989796,0.921129163145696,0,1,polyamine transmembrane transporter activity,MF,
5046,GO:0015229,0.999999999989796,0.921129163145696,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5057,GO:0015265,0.999999999989796,0.921129163145696,0,1,urea channel activity,MF,
5061,GO:0015272,0.999999999989796,0.921129163145696,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5069,GO:0015292,0.999999999989796,0.921129163145696,0,1,uniporter activity,MF,
5084,GO:0015322,0.999999999989796,0.921129163145696,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5085,GO:0015327,0.999999999989796,0.921129163145696,0,1,cystine:glutamate antiporter activity,MF,
5086,GO:0015328,0.999999999989796,0.921129163145696,0,1,cystine secondary active transmembrane transporter activity,MF,
5092,GO:0015362,0.999999999989796,0.921129163145696,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5095,GO:0015369,0.999999999989796,0.921129163145696,0,1,calcium:proton antiporter activity,MF,
5098,GO:0015375,0.999999999989796,0.921129163145696,0,1,glycine:sodium symporter activity,MF,
5100,GO:0015378,0.999999999989796,0.921129163145696,0,1,sodium:chloride symporter activity,MF,
5110,GO:0015420,0.999999999989796,0.921129163145696,0,1,cobalamin-transporting ATPase activity,MF,
5111,GO:0015421,0.999999999989796,0.921129163145696,0,1,oligopeptide-transporting ATPase activity,MF,
5112,GO:0015431,0.999999999989796,0.921129163145696,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5113,GO:0015432,0.999999999989796,0.921129163145696,0,1,bile acid-exporting ATPase activity,MF,
5115,GO:0015439,0.999999999989796,0.921129163145696,0,1,heme-transporting ATPase activity,MF,
5122,GO:0015489,0.999999999989796,0.921129163145696,0,1,putrescine transmembrane transporter activity,MF,
5127,GO:0015538,0.999999999989796,0.921129163145696,0,1,sialic acid:proton symporter activity,MF,
5154,GO:0015692,0.999999999989796,0.921129163145696,0,1,lead ion transport,BP,
5156,GO:0015694,0.999999999989796,0.921129163145696,0,1,mercury ion transport,BP,
5171,GO:0015723,0.999999999989796,0.921129163145696,0,1,bilirubin transport,BP,
5174,GO:0015728,0.999999999989796,0.921129163145696,0,1,mevalonate transport,BP,
5177,GO:0015734,0.999999999989796,0.921129163145696,0,1,taurine transport,BP,
5178,GO:0015739,0.999999999989796,0.921129163145696,0,1,sialic acid transport,BP,
5196,GO:0015787,0.999999999989796,0.921129163145696,0,1,UDP-glucuronic acid transmembrane transport,BP,
5197,GO:0015790,0.999999999989796,0.921129163145696,0,1,UDP-xylose transmembrane transport,BP,
5223,GO:0015826,0.999999999989796,0.921129163145696,0,1,threonine transport,BP,
5232,GO:0015847,0.999999999989796,0.921129163145696,0,1,putrescine transport,BP,
5253,GO:0015881,0.999999999989796,0.921129163145696,0,1,creatine transmembrane transport,BP,
5254,GO:0015882,0.999999999989796,0.921129163145696,0,1,L-ascorbic acid transmembrane transport,BP,
5314,GO:0016031,0.999999999989796,0.921129163145696,0,1,tRNA import into mitochondrion,BP,
5339,GO:0016077,0.999999999989796,0.921129163145696,0,1,snoRNA catabolic process,BP,
5348,GO:0016098,0.999999999989796,0.921129163145696,0,1,monoterpenoid metabolic process,BP,
5351,GO:0016103,0.999999999989796,0.921129163145696,0,1,diterpenoid catabolic process,BP,
5353,GO:0016115,0.999999999989796,0.921129163145696,0,1,terpenoid catabolic process,BP,
5363,GO:0016149,0.999999999989796,0.921129163145696,0,1,translation release factor activity, codon specific,MF,
5366,GO:0016155,0.999999999989796,0.921129163145696,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5373,GO:0016182,0.999999999989796,0.921129163145696,0,1,synaptic vesicle budding from endosome,BP,
5376,GO:0016189,0.999999999989796,0.921129163145696,0,1,synaptic vesicle to endosome fusion,BP,
5386,GO:0016211,0.999999999989796,0.921129163145696,0,1,ammonia ligase activity,MF,
5388,GO:0016213,0.999999999989796,0.921129163145696,0,1,linoleoyl-CoA desaturase activity,MF,
5394,GO:0016231,0.999999999989796,0.921129163145696,0,1,beta-N-acetylglucosaminidase activity,MF,
5395,GO:0016232,0.999999999989796,0.921129163145696,0,1,HNK-1 sulfotransferase activity,MF,
5400,GO:0016237,0.999999999989796,0.921129163145696,0,1,lysosomal microautophagy,BP,
5405,GO:0016243,0.999999999989796,0.921129163145696,0,1,regulation of autophagosome size,BP,
5428,GO:0016282,0.999999999989796,0.921129163145696,0,1,eukaryotic 43S preinitiation complex,CC,
5456,GO:0016332,0.999999999989796,0.921129163145696,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5469,GO:0016402,0.999999999989796,0.921129163145696,0,1,pristanoyl-CoA oxidase activity,MF,
5471,GO:0016404,0.999999999989796,0.921129163145696,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5480,GO:0016414,0.999999999989796,0.921129163145696,0,1,O-octanoyltransferase activity,MF,
5481,GO:0016415,0.999999999989796,0.921129163145696,0,1,octanoyltransferase activity,MF,
5494,GO:0016430,0.999999999989796,0.921129163145696,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5522,GO:0016492,0.999999999989796,0.921129163145696,0,1,G-protein coupled neurotensin receptor activity,MF,
5530,GO:0016507,0.999999999989796,0.921129163145696,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5536,GO:0016520,0.999999999989796,0.921129163145696,0,1,growth hormone-releasing hormone receptor activity,MF,
5545,GO:0016534,0.999999999989796,0.921129163145696,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5573,GO:0016590,0.999999999989796,0.921129163145696,0,1,ACF complex,CC,
5579,GO:0016596,0.999999999989796,0.921129163145696,0,1,thienylcyclohexylpiperidine binding,MF,
5594,GO:0016623,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5601,GO:0016639,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5603,GO:0016642,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5609,GO:0016652,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5642,GO:0016727,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5655,GO:0016751,0.999999999989796,0.921129163145696,0,1,S-succinyltransferase activity,MF,
5675,GO:0016785,0.999999999989796,0.921129163145696,0,1,transferase activity, transferring selenium-containing groups,MF,
5680,GO:0016793,0.999999999989796,0.921129163145696,0,1,triphosphoric monoester hydrolase activity,MF,
5689,GO:0016807,0.999999999989796,0.921129163145696,0,1,cysteine-type carboxypeptidase activity,MF,
5712,GO:0016843,0.999999999989796,0.921129163145696,0,1,amine-lyase activity,MF,
5713,GO:0016844,0.999999999989796,0.921129163145696,0,1,strictosidine synthase activity,MF,
5753,GO:0016901,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5759,GO:0016920,0.999999999989796,0.921129163145696,0,1,pyroglutamyl-peptidase activity,MF,
5765,GO:0016938,0.999999999989796,0.921129163145696,0,1,kinesin I complex,CC,
5767,GO:0016941,0.999999999989796,0.921129163145696,0,1,natriuretic peptide receptor activity,MF,
5769,GO:0016964,0.999999999989796,0.921129163145696,0,1,alpha-2 macroglobulin receptor activity,MF,
5783,GO:0017005,0.999999999989796,0.921129163145696,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5790,GO:0017020,0.999999999989796,0.921129163145696,0,1,myosin phosphatase regulator activity,MF,
5807,GO:0017061,0.999999999989796,0.921129163145696,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5818,GO:0017084,0.999999999989796,0.921129163145696,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5820,GO:0017087,0.999999999989796,0.921129163145696,0,1,mitochondrial processing peptidase complex,CC,
5833,GO:0017113,0.999999999989796,0.921129163145696,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5838,GO:0017125,0.999999999989796,0.921129163145696,0,1,deoxycytidyl transferase activity,MF,
5839,GO:0017126,0.999999999989796,0.921129163145696,0,1,nucleologenesis,BP,
5864,GO:0017168,0.999999999989796,0.921129163145696,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5868,GO:0017177,0.999999999989796,0.921129163145696,0,1,glucosidase II complex,CC,
5869,GO:0017178,0.999999999989796,0.921129163145696,0,1,diphthine-ammonia ligase activity,MF,
5880,GO:0018011,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-alanine methylation,BP,
5881,GO:0018012,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5882,GO:0018013,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-glycine methylation,BP,
5883,GO:0018016,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-proline dimethylation,BP,
5887,GO:0018025,0.999999999989796,0.921129163145696,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5890,GO:0018032,0.999999999989796,0.921129163145696,0,1,protein amidation,BP,
5895,GO:0018094,0.999999999989796,0.921129163145696,0,1,protein polyglycylation,BP,
5897,GO:0018101,0.999999999989796,0.921129163145696,0,1,protein citrullination,BP,
5914,GO:0018166,0.999999999989796,0.921129163145696,0,1,C-terminal protein-tyrosinylation,BP,
5919,GO:0018194,0.999999999989796,0.921129163145696,0,1,peptidyl-alanine modification,BP,
5937,GO:0018217,0.999999999989796,0.921129163145696,0,1,peptidyl-aspartic acid phosphorylation,BP,
5943,GO:0018271,0.999999999989796,0.921129163145696,0,1,biotin-protein ligase activity,MF,
5953,GO:0018315,0.999999999989796,0.921129163145696,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5955,GO:0018322,0.999999999989796,0.921129163145696,0,1,protein tyrosinylation,BP,
5967,GO:0018395,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5968,GO:0018400,0.999999999989796,0.921129163145696,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
5993,GO:0018993,0.999999999989796,0.921129163145696,0,1,somatic sex determination,BP,
6001,GO:0019035,0.999999999989796,0.921129163145696,0,1,viral integration complex,CC,
6024,GO:0019082,0.999999999989796,0.921129163145696,0,1,viral protein processing,BP,
6030,GO:0019089,0.999999999989796,0.921129163145696,0,1,transmission of virus,BP,
6033,GO:0019101,0.999999999989796,0.921129163145696,0,1,female somatic sex determination,BP,
6047,GO:0019171,0.999999999989796,0.921129163145696,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6050,GO:0019187,0.999999999989796,0.921129163145696,0,1,beta-1,4-mannosyltransferase activity,MF,
6055,GO:0019202,0.999999999989796,0.921129163145696,0,1,amino acid kinase activity,MF,
6092,GO:0019276,0.999999999989796,0.921129163145696,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6093,GO:0019285,0.999999999989796,0.921129163145696,0,1,glycine betaine biosynthetic process from choline,BP,
6095,GO:0019290,0.999999999989796,0.921129163145696,0,1,siderophore biosynthetic process,BP,
6112,GO:0019357,0.999999999989796,0.921129163145696,0,1,nicotinate nucleotide biosynthetic process,BP,
6113,GO:0019358,0.999999999989796,0.921129163145696,0,1,nicotinate nucleotide salvage,BP,
6117,GO:0019364,0.999999999989796,0.921129163145696,0,1,pyridine nucleotide catabolic process,BP,
6118,GO:0019365,0.999999999989796,0.921129163145696,0,1,pyridine nucleotide salvage,BP,
6128,GO:0019376,0.999999999989796,0.921129163145696,0,1,galactolipid catabolic process,BP,
6158,GO:0019483,0.999999999989796,0.921129163145696,0,1,beta-alanine biosynthetic process,BP,
6181,GO:0019556,0.999999999989796,0.921129163145696,0,1,histidine catabolic process to glutamate and formamide,BP,
6182,GO:0019557,0.999999999989796,0.921129163145696,0,1,histidine catabolic process to glutamate and formate,BP,
6192,GO:0019659,0.999999999989796,0.921129163145696,0,1,glucose catabolic process to lactate,BP,
6193,GO:0019660,0.999999999989796,0.921129163145696,0,1,glycolytic fermentation,BP,
6194,GO:0019661,0.999999999989796,0.921129163145696,0,1,glucose catabolic process to lactate via pyruvate,BP,
6195,GO:0019666,0.999999999989796,0.921129163145696,0,1,nitrogenous compound fermentation,BP,
6198,GO:0019676,0.999999999989796,0.921129163145696,0,1,ammonia assimilation cycle,BP,
6199,GO:0019677,0.999999999989796,0.921129163145696,0,1,NAD catabolic process,BP,
6227,GO:0019778,0.999999999989796,0.921129163145696,0,1,Atg12 activating enzyme activity,MF,
6228,GO:0019779,0.999999999989796,0.921129163145696,0,1,Atg8 activating enzyme activity,MF,
6229,GO:0019780,0.999999999989796,0.921129163145696,0,1,FAT10 activating enzyme activity,MF,
6231,GO:0019782,0.999999999989796,0.921129163145696,0,1,ISG15 activating enzyme activity,MF,
6240,GO:0019799,0.999999999989796,0.921129163145696,0,1,tubulin N-acetyltransferase activity,MF,
6244,GO:0019810,0.999999999989796,0.921129163145696,0,1,putrescine binding,MF,
6245,GO:0019811,0.999999999989796,0.921129163145696,0,1,cocaine binding,MF,
6317,GO:0019962,0.999999999989796,0.921129163145696,0,1,type I interferon binding,MF,
6318,GO:0019964,0.999999999989796,0.921129163145696,0,1,interferon-gamma binding,MF,
6320,GO:0019970,0.999999999989796,0.921129163145696,0,1,interleukin-11 binding,MF,
6325,GO:0020003,0.999999999989796,0.921129163145696,0,1,symbiont-containing vacuole,CC,
6334,GO:0021503,0.999999999989796,0.921129163145696,0,1,neural fold bending,BP,
6335,GO:0021508,0.999999999989796,0.921129163145696,0,1,floor plate formation,BP,
6338,GO:0021512,0.999999999989796,0.921129163145696,0,1,spinal cord anterior/posterior patterning,BP,
6350,GO:0021527,0.999999999989796,0.921129163145696,0,1,spinal cord association neuron differentiation,BP,
6357,GO:0021538,0.999999999989796,0.921129163145696,0,1,epithalamus development,BP,
6360,GO:0021541,0.999999999989796,0.921129163145696,0,1,ammon gyrus development,BP,
6369,GO:0021553,0.999999999989796,0.921129163145696,0,1,olfactory nerve development,BP,
6380,GO:0021566,0.999999999989796,0.921129163145696,0,1,hypoglossal nerve development,BP,
6386,GO:0021577,0.999999999989796,0.921129163145696,0,1,hindbrain structural organization,BP,
6388,GO:0021586,0.999999999989796,0.921129163145696,0,1,pons maturation,BP,
6390,GO:0021589,0.999999999989796,0.921129163145696,0,1,cerebellum structural organization,BP,
6393,GO:0021592,0.999999999989796,0.921129163145696,0,1,fourth ventricle development,BP,
6401,GO:0021615,0.999999999989796,0.921129163145696,0,1,glossopharyngeal nerve morphogenesis,BP,
6402,GO:0021618,0.999999999989796,0.921129163145696,0,1,hypoglossal nerve morphogenesis,BP,
6403,GO:0021622,0.999999999989796,0.921129163145696,0,1,oculomotor nerve morphogenesis,BP,
6404,GO:0021623,0.999999999989796,0.921129163145696,0,1,oculomotor nerve formation,BP,
6412,GO:0021650,0.999999999989796,0.921129163145696,0,1,vestibulocochlear nerve formation,BP,
6422,GO:0021685,0.999999999989796,0.921129163145696,0,1,cerebellar granular layer structural organization,BP,
6424,GO:0021688,0.999999999989796,0.921129163145696,0,1,cerebellar molecular layer formation,BP,
6437,GO:0021718,0.999999999989796,0.921129163145696,0,1,superior olivary nucleus development,BP,
6438,GO:0021722,0.999999999989796,0.921129163145696,0,1,superior olivary nucleus maturation,BP,
6439,GO:0021730,0.999999999989796,0.921129163145696,0,1,trigeminal sensory nucleus development,BP,
6440,GO:0021740,0.999999999989796,0.921129163145696,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6443,GO:0021757,0.999999999989796,0.921129163145696,0,1,caudate nucleus development,BP,
6444,GO:0021758,0.999999999989796,0.921129163145696,0,1,putamen development,BP,
6450,GO:0021768,0.999999999989796,0.921129163145696,0,1,nucleus accumbens development,BP,
6452,GO:0021771,0.999999999989796,0.921129163145696,0,1,lateral geniculate nucleus development,BP,
6457,GO:0021778,0.999999999989796,0.921129163145696,0,1,oligodendrocyte cell fate specification,BP,
6458,GO:0021779,0.999999999989796,0.921129163145696,0,1,oligodendrocyte cell fate commitment,BP,
6459,GO:0021780,0.999999999989796,0.921129163145696,0,1,glial cell fate specification,BP,
6468,GO:0021797,0.999999999989796,0.921129163145696,0,1,forebrain anterior/posterior pattern specification,BP,
6473,GO:0021812,0.999999999989796,0.921129163145696,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6501,GO:0021870,0.999999999989796,0.921129163145696,0,1,Cajal-Retzius cell differentiation,BP,
6507,GO:0021881,0.999999999989796,0.921129163145696,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6537,GO:0021941,0.999999999989796,0.921129163145696,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6548,GO:0021966,0.999999999989796,0.921129163145696,0,1,corticospinal neuron axon guidance,BP,
6549,GO:0021972,0.999999999989796,0.921129163145696,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6554,GO:0021986,0.999999999989796,0.921129163145696,0,1,habenula development,BP,
6557,GO:0021993,0.999999999989796,0.921129163145696,0,1,initiation of neural tube closure,BP,
6559,GO:0021998,0.999999999989796,0.921129163145696,0,1,neural plate mediolateral regionalization,BP,
6566,GO:0022012,0.999999999989796,0.921129163145696,0,1,subpallium cell proliferation in forebrain,BP,
6567,GO:0022018,0.999999999989796,0.921129163145696,0,1,lateral ganglionic eminence cell proliferation,BP,
6623,GO:0022849,0.999999999989796,0.921129163145696,0,1,glutamate-gated calcium ion channel activity,MF,
6624,GO:0022851,0.999999999989796,0.921129163145696,0,1,GABA-gated chloride ion channel activity,MF,
6639,GO:0023024,0.999999999989796,0.921129163145696,0,1,MHC class I protein complex binding,MF,
6676,GO:0030037,0.999999999989796,0.921129163145696,0,1,actin filament reorganization involved in cell cycle,BP,
6703,GO:0030103,0.999999999989796,0.921129163145696,0,1,vasopressin secretion,BP,
6799,GO:0030240,0.999999999989796,0.921129163145696,0,1,skeletal muscle thin filament assembly,BP,
6829,GO:0030290,0.999999999989796,0.921129163145696,0,1,sphingolipid activator protein activity,MF,
6874,GO:0030351,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6883,GO:0030379,0.999999999989796,0.921129163145696,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6902,GO:0030474,0.999999999989796,0.921129163145696,0,1,spindle pole body duplication,BP,
6913,GO:0030504,0.999999999989796,0.921129163145696,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6930,GO:0030523,0.999999999989796,0.921129163145696,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6947,GO:0030572,0.999999999989796,0.921129163145696,0,1,phosphatidyltransferase activity,MF,
6955,GO:0030586,0.999999999989796,0.921129163145696,0,1,[methionine synthase] reductase activity,MF,
6962,GO:0030616,0.999999999989796,0.921129163145696,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6969,GO:0030623,0.999999999989796,0.921129163145696,0,1,U5 snRNA binding,MF,
6970,GO:0030624,0.999999999989796,0.921129163145696,0,1,U6atac snRNA binding,MF,
6980,GO:0030653,0.999999999989796,0.921129163145696,0,1,beta-lactam antibiotic metabolic process,BP,
7010,GO:0030696,0.999999999989796,0.921129163145696,0,1,tRNA (m5U54) methyltransferase activity,MF,
7011,GO:0030697,0.999999999989796,0.921129163145696,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7012,GO:0030702,0.999999999989796,0.921129163145696,0,1,chromatin silencing at centromere,BP,
7014,GO:0030718,0.999999999989796,0.921129163145696,0,1,germ-line stem cell population maintenance,BP,
7017,GO:0030729,0.999999999989796,0.921129163145696,0,1,acetoacetate-CoA ligase activity,MF,
7020,GO:0030735,0.999999999989796,0.921129163145696,0,1,carnosine N-methyltransferase activity,MF,
7034,GO:0030807,0.999999999989796,0.921129163145696,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7049,GO:0030822,0.999999999989796,0.921129163145696,0,1,positive regulation of cAMP catabolic process,BP,
7061,GO:0030846,0.999999999989796,0.921129163145696,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7062,GO:0030849,0.999999999989796,0.921129163145696,0,1,autosome,CC,
7074,GO:0030862,0.999999999989796,0.921129163145696,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7088,GO:0030882,0.999999999989796,0.921129163145696,0,1,lipid antigen binding,MF,
7089,GO:0030883,0.999999999989796,0.921129163145696,0,1,endogenous lipid antigen binding,MF,
7090,GO:0030884,0.999999999989796,0.921129163145696,0,1,exogenous lipid antigen binding,MF,
7121,GO:0030936,0.999999999989796,0.921129163145696,0,1,transmembrane collagen trimer,CC,
7134,GO:0030961,0.999999999989796,0.921129163145696,0,1,peptidyl-arginine hydroxylation,BP,
7169,GO:0031049,0.999999999989796,0.921129163145696,0,1,programmed DNA elimination,BP,
7171,GO:0031052,0.999999999989796,0.921129163145696,0,1,chromosome breakage,BP,
7212,GO:0031104,0.999999999989796,0.921129163145696,0,1,dendrite regeneration,BP,
7239,GO:0031151,0.999999999989796,0.921129163145696,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7240,GO:0031161,0.999999999989796,0.921129163145696,0,1,phosphatidylinositol catabolic process,BP,
7246,GO:0031179,0.999999999989796,0.921129163145696,0,1,peptide modification,BP,
7292,GO:0031289,0.999999999989796,0.921129163145696,0,1,actin phosphorylation,BP,
7303,GO:0031302,0.999999999989796,0.921129163145696,0,1,intrinsic component of endosome membrane,CC,
7312,GO:0031315,0.999999999989796,0.921129163145696,0,1,extrinsic component of mitochondrial outer membrane,CC,
7343,GO:0031370,0.999999999989796,0.921129163145696,0,1,eukaryotic initiation factor 4G binding,MF,
7347,GO:0031380,0.999999999989796,0.921129163145696,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7349,GO:0031389,0.999999999989796,0.921129163145696,0,1,Rad17 RFC-like complex,CC,
7363,GO:0031405,0.999999999989796,0.921129163145696,0,1,lipoic acid binding,MF,
7381,GO:0031433,0.999999999989796,0.921129163145696,0,1,telethonin binding,MF,
7386,GO:0031438,0.999999999989796,0.921129163145696,0,1,negative regulation of mRNA cleavage,BP,
7391,GO:0031443,0.999999999989796,0.921129163145696,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7395,GO:0031455,0.999999999989796,0.921129163145696,0,1,glycine betaine metabolic process,BP,
7396,GO:0031456,0.999999999989796,0.921129163145696,0,1,glycine betaine biosynthetic process,BP,
7397,GO:0031460,0.999999999989796,0.921129163145696,0,1,glycine betaine transport,BP,
7432,GO:0031533,0.999999999989796,0.921129163145696,0,1,mRNA cap methyltransferase complex,CC,
7438,GO:0031554,0.999999999989796,0.921129163145696,0,1,regulation of DNA-templated transcription, termination,BP,
7468,GO:0031626,0.999999999989796,0.921129163145696,0,1,beta-endorphin binding,MF,
7472,GO:0031630,0.999999999989796,0.921129163145696,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7504,GO:0031682,0.999999999989796,0.921129163145696,0,1,G-protein gamma-subunit binding,MF,
7507,GO:0031686,0.999999999989796,0.921129163145696,0,1,A1 adenosine receptor binding,MF,
7518,GO:0031704,0.999999999989796,0.921129163145696,0,1,apelin receptor binding,MF,
7522,GO:0031714,0.999999999989796,0.921129163145696,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7523,GO:0031715,0.999999999989796,0.921129163145696,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7538,GO:0031775,0.999999999989796,0.921129163145696,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7539,GO:0031798,0.999999999989796,0.921129163145696,0,1,type 1 metabotropic glutamate receptor binding,MF,
7541,GO:0031811,0.999999999989796,0.921129163145696,0,1,G-protein coupled nucleotide receptor binding,MF,
7542,GO:0031812,0.999999999989796,0.921129163145696,0,1,P2Y1 nucleotide receptor binding,MF,
7553,GO:0031867,0.999999999989796,0.921129163145696,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7554,GO:0031870,0.999999999989796,0.921129163145696,0,1,thromboxane A2 receptor binding,MF,
7593,GO:0031962,0.999999999989796,0.921129163145696,0,1,mineralocorticoid receptor binding,MF,
7630,GO:0032029,0.999999999989796,0.921129163145696,0,1,myosin tail binding,MF,
7653,GO:0032072,0.999999999989796,0.921129163145696,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7664,GO:0032093,0.999999999989796,0.921129163145696,0,1,SAM domain binding,MF,
7683,GO:0032127,0.999999999989796,0.921129163145696,0,1,dense core granule membrane,CC,
7692,GO:0032144,0.999999999989796,0.921129163145696,0,1,4-aminobutyrate transaminase complex,CC,
7693,GO:0032145,0.999999999989796,0.921129163145696,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7701,GO:0032173,0.999999999989796,0.921129163145696,0,1,septin collar,CC,
7708,GO:0032194,0.999999999989796,0.921129163145696,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7710,GO:0032197,0.999999999989796,0.921129163145696,0,1,transposition, RNA-mediated,BP,
7718,GO:0032207,0.999999999989796,0.921129163145696,0,1,regulation of telomere maintenance via recombination,BP,
7719,GO:0032208,0.999999999989796,0.921129163145696,0,1,negative regulation of telomere maintenance via recombination,BP,
7728,GO:0032222,0.999999999989796,0.921129163145696,0,1,regulation of synaptic transmission, cholinergic,BP,
7729,GO:0032224,0.999999999989796,0.921129163145696,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7744,GO:0032253,0.999999999989796,0.921129163145696,0,1,dense core granule localization,BP,
7780,GO:0032304,0.999999999989796,0.921129163145696,0,1,negative regulation of icosanoid secretion,BP,
7825,GO:0032378,0.999999999989796,0.921129163145696,0,1,negative regulation of intracellular lipid transport,BP,
7828,GO:0032381,0.999999999989796,0.921129163145696,0,1,negative regulation of intracellular sterol transport,BP,
7831,GO:0032384,0.999999999989796,0.921129163145696,0,1,negative regulation of intracellular cholesterol transport,BP,
7863,GO:0032423,0.999999999989796,0.921129163145696,0,1,regulation of mismatch repair,BP,
7864,GO:0032425,0.999999999989796,0.921129163145696,0,1,positive regulation of mismatch repair,BP,
7867,GO:0032428,0.999999999989796,0.921129163145696,0,1,beta-N-acetylgalactosaminidase activity,MF,
7890,GO:0032458,0.999999999989796,0.921129163145696,0,1,slow endocytic recycling,BP,
7900,GO:0032468,0.999999999989796,0.921129163145696,0,1,Golgi calcium ion homeostasis,BP,
7902,GO:0032470,0.999999999989796,0.921129163145696,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7923,GO:0032498,0.999999999989796,0.921129163145696,0,1,detection of muramyl dipeptide,BP,
7924,GO:0032499,0.999999999989796,0.921129163145696,0,1,detection of peptidoglycan,BP,
7925,GO:0032500,0.999999999989796,0.921129163145696,0,1,muramyl dipeptide binding,MF,
7961,GO:0032560,0.999999999989796,0.921129163145696,0,1,guanyl deoxyribonucleotide binding,MF,
7964,GO:0032567,0.999999999989796,0.921129163145696,0,1,dGTP binding,MF,
7967,GO:0032574,0.999999999989796,0.921129163145696,0,1,5'-3' RNA helicase activity,MF,
7968,GO:0032575,0.999999999989796,0.921129163145696,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8002,GO:0032625,0.999999999989796,0.921129163145696,0,1,interleukin-21 production,BP,
8037,GO:0032685,0.999999999989796,0.921129163145696,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8084,GO:0032765,0.999999999989796,0.921129163145696,0,1,positive regulation of mast cell cytokine production,BP,
8089,GO:0032771,0.999999999989796,0.921129163145696,0,1,regulation of monophenol monooxygenase activity,BP,
8090,GO:0032773,0.999999999989796,0.921129163145696,0,1,positive regulation of monophenol monooxygenase activity,BP,
8092,GO:0032775,0.999999999989796,0.921129163145696,0,1,DNA methylation on adenine,BP,
8141,GO:0032848,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular pH reduction,BP,
8158,GO:0032887,0.999999999989796,0.921129163145696,0,1,regulation of spindle elongation,BP,
8159,GO:0032888,0.999999999989796,0.921129163145696,0,1,regulation of mitotic spindle elongation,BP,
8166,GO:0032899,0.999999999989796,0.921129163145696,0,1,regulation of neurotrophin production,BP,
8167,GO:0032901,0.999999999989796,0.921129163145696,0,1,positive regulation of neurotrophin production,BP,
8176,GO:0032912,0.999999999989796,0.921129163145696,0,1,negative regulation of transforming growth factor beta2 production,BP,
8220,GO:0032977,0.999999999989796,0.921129163145696,0,1,membrane insertase activity,MF,
8221,GO:0032978,0.999999999989796,0.921129163145696,0,1,protein insertion into membrane from inner side,BP,
8222,GO:0032979,0.999999999989796,0.921129163145696,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8251,GO:0033026,0.999999999989796,0.921129163145696,0,1,negative regulation of mast cell apoptotic process,BP,
8254,GO:0033030,0.999999999989796,0.921129163145696,0,1,negative regulation of neutrophil apoptotic process,BP,
8260,GO:0033037,0.999999999989796,0.921129163145696,0,1,polysaccharide localization,BP,
8269,GO:0033058,0.999999999989796,0.921129163145696,0,1,directional locomotion,BP,
8280,GO:0033082,0.999999999989796,0.921129163145696,0,1,regulation of extrathymic T cell differentiation,BP,
8296,GO:0033123,0.999999999989796,0.921129163145696,0,1,positive regulation of purine nucleotide catabolic process,BP,
8326,GO:0033167,0.999999999989796,0.921129163145696,0,1,ARC complex,CC,
8327,GO:0033168,0.999999999989796,0.921129163145696,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8364,GO:0033241,0.999999999989796,0.921129163145696,0,1,regulation of cellular amine catabolic process,BP,
8365,GO:0033242,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular amine catabolic process,BP,
8377,GO:0033274,0.999999999989796,0.921129163145696,0,1,response to vitamin B2,BP,
8383,GO:0033283,0.999999999989796,0.921129163145696,0,1,organic acid-transporting ATPase activity,MF,
8384,GO:0033284,0.999999999989796,0.921129163145696,0,1,carboxylic acid-transporting ATPase activity,MF,
8385,GO:0033285,0.999999999989796,0.921129163145696,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8386,GO:0033290,0.999999999989796,0.921129163145696,0,1,eukaryotic 48S preinitiation complex,CC,
8392,GO:0033301,0.999999999989796,0.921129163145696,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8396,GO:0033316,0.999999999989796,0.921129163145696,0,1,meiotic spindle assembly checkpoint,BP,
8399,GO:0033326,0.999999999989796,0.921129163145696,0,1,cerebrospinal fluid secretion,BP,
8401,GO:0033328,0.999999999989796,0.921129163145696,0,1,peroxisome membrane targeting sequence binding,MF,
8404,GO:0033343,0.999999999989796,0.921129163145696,0,1,positive regulation of collagen binding,BP,
8408,GO:0033364,0.999999999989796,0.921129163145696,0,1,mast cell secretory granule organization,BP,
8420,GO:0033488,0.999999999989796,0.921129163145696,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8427,GO:0033505,0.999999999989796,0.921129163145696,0,1,floor plate morphogenesis,BP,
8457,GO:0033593,0.999999999989796,0.921129163145696,0,1,BRCA2-MAGE-D1 complex,CC,
8465,GO:0033602,0.999999999989796,0.921129163145696,0,1,negative regulation of dopamine secretion,BP,
8470,GO:0033608,0.999999999989796,0.921129163145696,0,1,formyl-CoA transferase activity,MF,
8471,GO:0033609,0.999999999989796,0.921129163145696,0,1,oxalate metabolic process,BP,
8490,GO:0033644,0.999999999989796,0.921129163145696,0,1,host cell membrane,CC,
8502,GO:0033679,0.999999999989796,0.921129163145696,0,1,3'-5' DNA/RNA helicase activity,MF,
8504,GO:0033681,0.999999999989796,0.921129163145696,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8516,GO:0033695,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8522,GO:0033746,0.999999999989796,0.921129163145696,0,1,histone demethylase activity (H3-R2 specific),MF,
8523,GO:0033749,0.999999999989796,0.921129163145696,0,1,histone demethylase activity (H4-R3 specific),MF,
8530,GO:0033787,0.999999999989796,0.921129163145696,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8532,GO:0033823,0.999999999989796,0.921129163145696,0,1,procollagen glucosyltransferase activity,MF,
8536,GO:0033858,0.999999999989796,0.921129163145696,0,1,N-acetylgalactosamine kinase activity,MF,
8538,GO:0033862,0.999999999989796,0.921129163145696,0,1,UMP kinase activity,MF,
8547,GO:0033878,0.999999999989796,0.921129163145696,0,1,hormone-sensitive lipase activity,MF,
8553,GO:0033919,0.999999999989796,0.921129163145696,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8554,GO:0033925,0.999999999989796,0.921129163145696,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8562,GO:0034012,0.999999999989796,0.921129163145696,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8575,GO:0034041,0.999999999989796,0.921129163145696,0,1,sterol-transporting ATPase activity,MF,
8633,GO:0034150,0.999999999989796,0.921129163145696,0,1,toll-like receptor 6 signaling pathway,BP,
8639,GO:0034164,0.999999999989796,0.921129163145696,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8641,GO:0034166,0.999999999989796,0.921129163145696,0,1,toll-like receptor 10 signaling pathway,BP,
8656,GO:0034203,0.999999999989796,0.921129163145696,0,1,glycolipid translocation,BP,
8669,GO:0034238,0.999999999989796,0.921129163145696,0,1,macrophage fusion,BP,
8670,GO:0034239,0.999999999989796,0.921129163145696,0,1,regulation of macrophage fusion,BP,
8671,GO:0034241,0.999999999989796,0.921129163145696,0,1,positive regulation of macrophage fusion,BP,
8675,GO:0034245,0.999999999989796,0.921129163145696,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8708,GO:0034346,0.999999999989796,0.921129163145696,0,1,positive regulation of type III interferon production,BP,
8712,GO:0034353,0.999999999989796,0.921129163145696,0,1,RNA pyrophosphohydrolase activity,MF,
8713,GO:0034355,0.999999999989796,0.921129163145696,0,1,NAD salvage,BP,
8721,GO:0034366,0.999999999989796,0.921129163145696,0,1,spherical high-density lipoprotein particle,CC,
8739,GO:0034386,0.999999999989796,0.921129163145696,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8756,GO:0034417,0.999999999989796,0.921129163145696,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8782,GO:0034459,0.999999999989796,0.921129163145696,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8791,GO:0034474,0.999999999989796,0.921129163145696,0,1,U2 snRNA 3'-end processing,BP,
8808,GO:0034512,0.999999999989796,0.921129163145696,0,1,box C/D snoRNA binding,MF,
8816,GO:0034584,0.999999999989796,0.921129163145696,0,1,piRNA binding,MF,
8818,GO:0034589,0.999999999989796,0.921129163145696,0,1,hydroxyproline transport,BP,
8819,GO:0034590,0.999999999989796,0.921129163145696,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8826,GO:0034602,0.999999999989796,0.921129163145696,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8843,GO:0034634,0.999999999989796,0.921129163145696,0,1,glutathione transmembrane transporter activity,MF,
8847,GO:0034640,0.999999999989796,0.921129163145696,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8849,GO:0034642,0.999999999989796,0.921129163145696,0,1,mitochondrion migration along actin filament,BP,
8855,GO:0034649,0.999999999989796,0.921129163145696,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8858,GO:0034653,0.999999999989796,0.921129163145696,0,1,retinoic acid catabolic process,BP,
8869,GO:0034669,0.999999999989796,0.921129163145696,0,1,integrin alpha4-beta7 complex,CC,
8870,GO:0034670,0.999999999989796,0.921129163145696,0,1,chemotaxis to arachidonic acid,BP,
8872,GO:0034676,0.999999999989796,0.921129163145696,0,1,integrin alpha6-beta4 complex,CC,
8873,GO:0034677,0.999999999989796,0.921129163145696,0,1,integrin alpha7-beta1 complex,CC,
8876,GO:0034681,0.999999999989796,0.921129163145696,0,1,integrin alpha11-beta1 complex,CC,
8906,GO:0034727,0.999999999989796,0.921129163145696,0,1,piecemeal microautophagy of the nucleus,BP,
8909,GO:0034736,0.999999999989796,0.921129163145696,0,1,cholesterol O-acyltransferase activity,MF,
8918,GO:0034757,0.999999999989796,0.921129163145696,0,1,negative regulation of iron ion transport,BP,
8919,GO:0034759,0.999999999989796,0.921129163145696,0,1,regulation of iron ion transmembrane transport,BP,
8920,GO:0034760,0.999999999989796,0.921129163145696,0,1,negative regulation of iron ion transmembrane transport,BP,
8930,GO:0034775,0.999999999989796,0.921129163145696,0,1,glutathione transmembrane transport,BP,
8933,GO:0034875,0.999999999989796,0.921129163145696,0,1,caffeine oxidase activity,MF,
8934,GO:0034959,0.999999999989796,0.921129163145696,0,1,endothelin maturation,BP,
8940,GO:0034971,0.999999999989796,0.921129163145696,0,1,histone H3-R17 methylation,BP,
8946,GO:0034986,0.999999999989796,0.921129163145696,0,1,iron chaperone activity,MF,
8952,GO:0034998,0.999999999989796,0.921129163145696,0,1,oligosaccharyltransferase I complex,CC,
8969,GO:0035037,0.999999999989796,0.921129163145696,0,1,sperm entry,BP,
8974,GO:0035063,0.999999999989796,0.921129163145696,0,1,nuclear speck organization,BP,
9000,GO:0035120,0.999999999989796,0.921129163145696,0,1,post-embryonic appendage morphogenesis,BP,
9001,GO:0035127,0.999999999989796,0.921129163145696,0,1,post-embryonic limb morphogenesis,BP,
9002,GO:0035128,0.999999999989796,0.921129163145696,0,1,post-embryonic forelimb morphogenesis,BP,
9015,GO:0035188,0.999999999989796,0.921129163145696,0,1,hatching,BP,
9022,GO:0035226,0.999999999989796,0.921129163145696,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9023,GO:0035227,0.999999999989796,0.921129163145696,0,1,regulation of glutamate-cysteine ligase activity,BP,
9024,GO:0035229,0.999999999989796,0.921129163145696,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9034,GO:0035248,0.999999999989796,0.921129163145696,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9047,GO:0035262,0.999999999989796,0.921129163145696,0,1,gonad morphogenesis,BP,
9055,GO:0035276,0.999999999989796,0.921129163145696,0,1,ethanol binding,MF,
9066,GO:0035299,0.999999999989796,0.921129163145696,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9092,GO:0035354,0.999999999989796,0.921129163145696,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9093,GO:0035355,0.999999999989796,0.921129163145696,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9097,GO:0035359,0.999999999989796,0.921129163145696,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9111,GO:0035400,0.999999999989796,0.921129163145696,0,1,histone tyrosine kinase activity,MF,
9112,GO:0035401,0.999999999989796,0.921129163145696,0,1,histone kinase activity (H3-Y41 specific),MF,
9117,GO:0035406,0.999999999989796,0.921129163145696,0,1,histone-tyrosine phosphorylation,BP,
9120,GO:0035409,0.999999999989796,0.921129163145696,0,1,histone H3-Y41 phosphorylation,BP,
9128,GO:0035441,0.999999999989796,0.921129163145696,0,1,cell migration involved in vasculogenesis,BP,
9130,GO:0035443,0.999999999989796,0.921129163145696,0,1,tripeptide transmembrane transport,BP,
9138,GO:0035469,0.999999999989796,0.921129163145696,0,1,determination of pancreatic left/right asymmetry,BP,
9149,GO:0035498,0.999999999989796,0.921129163145696,0,1,carnosine metabolic process,BP,
9151,GO:0035501,0.999999999989796,0.921129163145696,0,1,MH1 domain binding,MF,
9156,GO:0035508,0.999999999989796,0.921129163145696,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9163,GO:0035516,0.999999999989796,0.921129163145696,0,1,oxidative DNA demethylase activity,MF,
9175,GO:0035538,0.999999999989796,0.921129163145696,0,1,carbohydrate response element binding,MF,
9178,GO:0035544,0.999999999989796,0.921129163145696,0,1,negative regulation of SNARE complex assembly,BP,
9189,GO:0035568,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-proline methylation,BP,
9190,GO:0035570,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-serine methylation,BP,
9191,GO:0035572,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-serine dimethylation,BP,
9192,GO:0035573,0.999999999989796,0.921129163145696,0,1,N-terminal peptidyl-serine trimethylation,BP,
9203,GO:0035585,0.999999999989796,0.921129163145696,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9223,GO:0035609,0.999999999989796,0.921129163145696,0,1,C-terminal protein deglutamylation,BP,
9224,GO:0035610,0.999999999989796,0.921129163145696,0,1,protein side chain deglutamylation,BP,
9225,GO:0035611,0.999999999989796,0.921129163145696,0,1,protein branching point deglutamylation,BP,
9234,GO:0035622,0.999999999989796,0.921129163145696,0,1,intrahepatic bile duct development,BP,
9235,GO:0035623,0.999999999989796,0.921129163145696,0,1,renal glucose absorption,BP,
9245,GO:0035638,0.999999999989796,0.921129163145696,0,1,signal maturation,BP,
9249,GO:0035642,0.999999999989796,0.921129163145696,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9261,GO:0035668,0.999999999989796,0.921129163145696,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9262,GO:0035669,0.999999999989796,0.921129163145696,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9273,GO:0035695,0.999999999989796,0.921129163145696,0,1,mitophagy by induced vacuole formation,BP,
9280,GO:0035711,0.999999999989796,0.921129163145696,0,1,T-helper 1 cell activation,BP,
9281,GO:0035712,0.999999999989796,0.921129163145696,0,1,T-helper 2 cell activation,BP,
9305,GO:0035750,0.999999999989796,0.921129163145696,0,1,protein localization to myelin sheath abaxonal region,BP,
9320,GO:0035790,0.999999999989796,0.921129163145696,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9332,GO:0035811,0.999999999989796,0.921129163145696,0,1,negative regulation of urine volume,BP,
9341,GO:0035841,0.999999999989796,0.921129163145696,0,1,new growing cell tip,CC,
9345,GO:0035851,0.999999999989796,0.921129163145696,0,1,Krueppel-associated box domain binding,MF,
9351,GO:0035862,0.999999999989796,0.921129163145696,0,1,dITP metabolic process,BP,
9352,GO:0035863,0.999999999989796,0.921129163145696,0,1,dITP catabolic process,BP,
9386,GO:0035922,0.999999999989796,0.921129163145696,0,1,foramen ovale closure,BP,
9397,GO:0035935,0.999999999989796,0.921129163145696,0,1,androgen secretion,BP,
9398,GO:0035936,0.999999999989796,0.921129163145696,0,1,testosterone secretion,BP,
9399,GO:0035938,0.999999999989796,0.921129163145696,0,1,estradiol secretion,BP,
9404,GO:0035962,0.999999999989796,0.921129163145696,0,1,response to interleukin-13,BP,
9405,GO:0035963,0.999999999989796,0.921129163145696,0,1,cellular response to interleukin-13,BP,
9415,GO:0035978,0.999999999989796,0.921129163145696,0,1,histone H2A-S139 phosphorylation,BP,
9428,GO:0035995,0.999999999989796,0.921129163145696,0,1,detection of muscle stretch,BP,
9454,GO:0036046,0.999999999989796,0.921129163145696,0,1,protein demalonylation,BP,
9455,GO:0036047,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine demalonylation,BP,
9456,GO:0036048,0.999999999989796,0.921129163145696,0,1,protein desuccinylation,BP,
9457,GO:0036049,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine desuccinylation,BP,
9458,GO:0036054,0.999999999989796,0.921129163145696,0,1,protein-malonyllysine demalonylase activity,MF,
9459,GO:0036055,0.999999999989796,0.921129163145696,0,1,protein-succinyllysine desuccinylase activity,MF,
9465,GO:0036071,0.999999999989796,0.921129163145696,0,1,N-glycan fucosylation,BP,
9469,GO:0036085,0.999999999989796,0.921129163145696,0,1,GDP-fucose import into Golgi lumen,BP,
9476,GO:0036105,0.999999999989796,0.921129163145696,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9490,GO:0036125,0.999999999989796,0.921129163145696,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9496,GO:0036138,0.999999999989796,0.921129163145696,0,1,peptidyl-histidine hydroxylation,BP,
9497,GO:0036139,0.999999999989796,0.921129163145696,0,1,peptidyl-histidine dioxygenase activity,MF,
9498,GO:0036140,0.999999999989796,0.921129163145696,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9519,GO:0036215,0.999999999989796,0.921129163145696,0,1,response to stem cell factor,BP,
9520,GO:0036216,0.999999999989796,0.921129163145696,0,1,cellular response to stem cell factor stimulus,BP,
9528,GO:0036255,0.999999999989796,0.921129163145696,0,1,response to methylamine,BP,
9532,GO:0036261,0.999999999989796,0.921129163145696,0,1,7-methylguanosine cap hypermethylation,BP,
9539,GO:0036290,0.999999999989796,0.921129163145696,0,1,protein trans-autophosphorylation,BP,
9556,GO:0036317,0.999999999989796,0.921129163145696,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9559,GO:0036335,0.999999999989796,0.921129163145696,0,1,intestinal stem cell homeostasis,BP,
9572,GO:0036371,0.999999999989796,0.921129163145696,0,1,protein localization to T-tubule,BP,
9580,GO:0036392,0.999999999989796,0.921129163145696,0,1,chemokine (C-C motif) ligand 20 production,BP,
9582,GO:0036398,0.999999999989796,0.921129163145696,0,1,TCR signalosome,CC,
9583,GO:0036399,0.999999999989796,0.921129163145696,0,1,TCR signalosome assembly,BP,
9586,GO:0036404,0.999999999989796,0.921129163145696,0,1,conversion of ds siRNA to ss siRNA,BP,
9587,GO:0036414,0.999999999989796,0.921129163145696,0,1,histone citrullination,BP,
9619,GO:0036483,0.999999999989796,0.921129163145696,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9622,GO:0036487,0.999999999989796,0.921129163145696,0,1,nitric-oxide synthase inhibitor activity,MF,
9628,GO:0036494,0.999999999989796,0.921129163145696,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9634,GO:0036501,0.999999999989796,0.921129163145696,0,1,UFD1-NPL4 complex,CC,
9635,GO:0036502,0.999999999989796,0.921129163145696,0,1,Derlin-1-VIMP complex,CC,
9637,GO:0036505,0.999999999989796,0.921129163145696,0,1,prosaposin receptor activity,MF,
9648,GO:0036517,0.999999999989796,0.921129163145696,0,1,chemoattraction of serotonergic neuron axon,BP,
9659,GO:0038002,0.999999999989796,0.921129163145696,0,1,endocrine signaling,BP,
9664,GO:0038021,0.999999999989796,0.921129163145696,0,1,leptin receptor activity,MF,
9677,GO:0038039,0.999999999989796,0.921129163145696,0,1,G-protein coupled receptor heterodimeric complex,CC,
9682,GO:0038051,0.999999999989796,0.921129163145696,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9685,GO:0038062,0.999999999989796,0.921129163145696,0,1,protein tyrosine kinase collagen receptor activity,MF,
9693,GO:0038086,0.999999999989796,0.921129163145696,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9695,GO:0038091,0.999999999989796,0.921129163145696,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9705,GO:0038109,0.999999999989796,0.921129163145696,0,1,Kit signaling pathway,BP,
9711,GO:0038123,0.999999999989796,0.921129163145696,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9719,GO:0038154,0.999999999989796,0.921129163145696,0,1,interleukin-11-mediated signaling pathway,BP,
9722,GO:0038161,0.999999999989796,0.921129163145696,0,1,prolactin signaling pathway,BP,
9728,GO:0038172,0.999999999989796,0.921129163145696,0,1,interleukin-33-mediated signaling pathway,BP,
9731,GO:0038181,0.999999999989796,0.921129163145696,0,1,bile acid receptor activity,MF,
9732,GO:0038183,0.999999999989796,0.921129163145696,0,1,bile acid signaling pathway,BP,
9733,GO:0038186,0.999999999989796,0.921129163145696,0,1,lithocholic acid receptor activity,MF,
9740,GO:0038194,0.999999999989796,0.921129163145696,0,1,thyroid-stimulating hormone signaling pathway,BP,
9745,GO:0039003,0.999999999989796,0.921129163145696,0,1,pronephric field specification,BP,
9746,GO:0039007,0.999999999989796,0.921129163145696,0,1,pronephric nephron morphogenesis,BP,
9747,GO:0039008,0.999999999989796,0.921129163145696,0,1,pronephric nephron tubule morphogenesis,BP,
9748,GO:0039017,0.999999999989796,0.921129163145696,0,1,pattern specification involved in pronephros development,BP,
9750,GO:0039020,0.999999999989796,0.921129163145696,0,1,pronephric nephron tubule development,BP,
9751,GO:0039022,0.999999999989796,0.921129163145696,0,1,pronephric duct development,BP,
9752,GO:0039023,0.999999999989796,0.921129163145696,0,1,pronephric duct morphogenesis,BP,
9753,GO:0039502,0.999999999989796,0.921129163145696,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9754,GO:0039503,0.999999999989796,0.921129163145696,0,1,suppression by virus of host innate immune response,BP,
9758,GO:0039514,0.999999999989796,0.921129163145696,0,1,suppression by virus of host JAK-STAT cascade,BP,
9761,GO:0039520,0.999999999989796,0.921129163145696,0,1,induction by virus of host autophagy,BP,
9762,GO:0039521,0.999999999989796,0.921129163145696,0,1,suppression by virus of host autophagy,BP,
9773,GO:0039552,0.999999999989796,0.921129163145696,0,1,RIG-I binding,MF,
9774,GO:0039562,0.999999999989796,0.921129163145696,0,1,suppression by virus of host STAT activity,BP,
9775,GO:0039563,0.999999999989796,0.921129163145696,0,1,suppression by virus of host STAT1 activity,BP,
9776,GO:0039564,0.999999999989796,0.921129163145696,0,1,suppression by virus of host STAT2 activity,BP,
9783,GO:0039695,0.999999999989796,0.921129163145696,0,1,DNA-templated viral transcription,BP,
9786,GO:0039713,0.999999999989796,0.921129163145696,0,1,viral factory,CC,
9787,GO:0039714,0.999999999989796,0.921129163145696,0,1,cytoplasmic viral factory,CC,
9803,GO:0040030,0.999999999989796,0.921129163145696,0,1,regulation of molecular function, epigenetic,BP,
9813,GO:0042008,0.999999999989796,0.921129163145696,0,1,interleukin-18 receptor activity,MF,
9825,GO:0042040,0.999999999989796,0.921129163145696,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9842,GO:0042084,0.999999999989796,0.921129163145696,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9878,GO:0042140,0.999999999989796,0.921129163145696,0,1,late meiotic recombination nodule assembly,BP,
9909,GO:0042241,0.999999999989796,0.921129163145696,0,1,interleukin-18 biosynthetic process,BP,
9920,GO:0042265,0.999999999989796,0.921129163145696,0,1,peptidyl-asparagine hydroxylation,BP,
9934,GO:0042282,0.999999999989796,0.921129163145696,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9952,GO:0042316,0.999999999989796,0.921129163145696,0,1,penicillin metabolic process,BP,
9953,GO:0042320,0.999999999989796,0.921129163145696,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9966,GO:0042352,0.999999999989796,0.921129163145696,0,1,GDP-L-fucose salvage,BP,
9973,GO:0042361,0.999999999989796,0.921129163145696,0,1,menaquinone catabolic process,BP,
9980,GO:0042371,0.999999999989796,0.921129163145696,0,1,vitamin K biosynthetic process,BP,
9984,GO:0042377,0.999999999989796,0.921129163145696,0,1,vitamin K catabolic process,BP,
10015,GO:0042441,0.999999999989796,0.921129163145696,0,1,eye pigment metabolic process,BP,
10035,GO:0042483,0.999999999989796,0.921129163145696,0,1,negative regulation of odontogenesis,BP,
10043,GO:0042495,0.999999999989796,0.921129163145696,0,1,detection of triacyl bacterial lipopeptide,BP,
10045,GO:0042497,0.999999999989796,0.921129163145696,0,1,triacyl lipopeptide binding,MF,
10070,GO:0042564,0.999999999989796,0.921129163145696,0,1,NLS-dependent protein nuclear import complex,CC,
10094,GO:0042595,0.999999999989796,0.921129163145696,0,1,behavioral response to starvation,BP,
10113,GO:0042631,0.999999999989796,0.921129163145696,0,1,cellular response to water deprivation,BP,
10126,GO:0042660,0.999999999989796,0.921129163145696,0,1,positive regulation of cell fate specification,BP,
10130,GO:0042665,0.999999999989796,0.921129163145696,0,1,regulation of ectodermal cell fate specification,BP,
10131,GO:0042666,0.999999999989796,0.921129163145696,0,1,negative regulation of ectodermal cell fate specification,BP,
10139,GO:0042700,0.999999999989796,0.921129163145696,0,1,luteinizing hormone signaling pathway,BP,
10151,GO:0042728,0.999999999989796,0.921129163145696,0,1,flavin-containing compound catabolic process,BP,
10177,GO:0042766,0.999999999989796,0.921129163145696,0,1,nucleosome mobilization,BP,
10183,GO:0042774,0.999999999989796,0.921129163145696,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10201,GO:0042806,0.999999999989796,0.921129163145696,0,1,fucose binding,MF,
10215,GO:0042835,0.999999999989796,0.921129163145696,0,1,BRE binding,MF,
10218,GO:0042851,0.999999999989796,0.921129163145696,0,1,L-alanine metabolic process,BP,
10219,GO:0042853,0.999999999989796,0.921129163145696,0,1,L-alanine catabolic process,BP,
10233,GO:0042937,0.999999999989796,0.921129163145696,0,1,tripeptide transmembrane transporter activity,MF,
10238,GO:0042946,0.999999999989796,0.921129163145696,0,1,glucoside transport,BP,
10239,GO:0042947,0.999999999989796,0.921129163145696,0,1,glucoside transmembrane transporter activity,MF,
10254,GO:0042988,0.999999999989796,0.921129163145696,0,1,X11-like protein binding,MF,
10261,GO:0042999,0.999999999989796,0.921129163145696,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10264,GO:0043002,0.999999999989796,0.921129163145696,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10265,GO:0043004,0.999999999989796,0.921129163145696,0,1,cytoplasmic sequestering of CFTR protein,BP,
10288,GO:0043033,0.999999999989796,0.921129163145696,0,1,isoamylase complex,CC,
10290,GO:0043035,0.999999999989796,0.921129163145696,0,1,chromatin insulator sequence binding,MF,
10293,GO:0043041,0.999999999989796,0.921129163145696,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10338,GO:0043131,0.999999999989796,0.921129163145696,0,1,erythrocyte enucleation,BP,
10340,GO:0043136,0.999999999989796,0.921129163145696,0,1,glycerol-3-phosphatase activity,MF,
10351,GO:0043159,0.999999999989796,0.921129163145696,0,1,acrosomal matrix,CC,
10367,GO:0043181,0.999999999989796,0.921129163145696,0,1,vacuolar sequestering,BP,
10392,GO:0043221,0.999999999989796,0.921129163145696,0,1,SMC family protein binding,MF,
10419,GO:0043257,0.999999999989796,0.921129163145696,0,1,laminin-8 complex,CC,
10429,GO:0043273,0.999999999989796,0.921129163145696,0,1,CTPase activity,MF,
10458,GO:0043315,0.999999999989796,0.921129163145696,0,1,positive regulation of neutrophil degranulation,BP,
10460,GO:0043317,0.999999999989796,0.921129163145696,0,1,regulation of cytotoxic T cell degranulation,BP,
10461,GO:0043318,0.999999999989796,0.921129163145696,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10465,GO:0043324,0.999999999989796,0.921129163145696,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10471,GO:0043337,0.999999999989796,0.921129163145696,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10473,GO:0043354,0.999999999989796,0.921129163145696,0,1,enucleate erythrocyte maturation,BP,
10483,GO:0043375,0.999999999989796,0.921129163145696,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10484,GO:0043376,0.999999999989796,0.921129163145696,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10496,GO:0043396,0.999999999989796,0.921129163145696,0,1,corticotropin-releasing hormone secretion,BP,
10497,GO:0043397,0.999999999989796,0.921129163145696,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10516,GO:0043423,0.999999999989796,0.921129163145696,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10529,GO:0043465,0.999999999989796,0.921129163145696,0,1,regulation of fermentation,BP,
10534,GO:0043474,0.999999999989796,0.921129163145696,0,1,pigment metabolic process involved in pigmentation,BP,
10576,GO:0043538,0.999999999989796,0.921129163145696,0,1,regulation of actin phosphorylation,BP,
10581,GO:0043544,0.999999999989796,0.921129163145696,0,1,lipoamide binding,MF,
10617,GO:0043606,0.999999999989796,0.921129163145696,0,1,formamide metabolic process,BP,
10618,GO:0043610,0.999999999989796,0.921129163145696,0,1,regulation of carbohydrate utilization,BP,
10632,GO:0043629,0.999999999989796,0.921129163145696,0,1,ncRNA polyadenylation,BP,
10633,GO:0043630,0.999999999989796,0.921129163145696,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10658,GO:0043739,0.999999999989796,0.921129163145696,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10659,GO:0043754,0.999999999989796,0.921129163145696,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10665,GO:0043849,0.999999999989796,0.921129163145696,0,1,Ras palmitoyltransferase activity,MF,
10674,GO:0043914,0.999999999989796,0.921129163145696,0,1,NADPH:sulfur oxidoreductase activity,MF,
10692,GO:0043969,0.999999999989796,0.921129163145696,0,1,histone H2B acetylation,BP,
10704,GO:0043990,0.999999999989796,0.921129163145696,0,1,histone H2A-S1 phosphorylation,BP,
10708,GO:0043997,0.999999999989796,0.921129163145696,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10709,GO:0043998,0.999999999989796,0.921129163145696,0,1,H2A histone acetyltransferase activity,MF,
10712,GO:0044007,0.999999999989796,0.921129163145696,0,1,dissemination or transmission of symbiont from host,BP,
10749,GO:0044128,0.999999999989796,0.921129163145696,0,1,positive regulation of growth of symbiont in host,BP,
10755,GO:0044148,0.999999999989796,0.921129163145696,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10762,GO:0044207,0.999999999989796,0.921129163145696,0,1,translation initiation ternary complex,CC,
10773,GO:0044218,0.999999999989796,0.921129163145696,0,1,other organism cell membrane,CC,
10774,GO:0044220,0.999999999989796,0.921129163145696,0,1,host cell perinuclear region of cytoplasm,CC,
10775,GO:0044221,0.999999999989796,0.921129163145696,0,1,host cell synapse,CC,
10777,GO:0044228,0.999999999989796,0.921129163145696,0,1,host cell surface,CC,
10778,GO:0044231,0.999999999989796,0.921129163145696,0,1,host cell presynaptic membrane,CC,
10801,GO:0044279,0.999999999989796,0.921129163145696,0,1,other organism membrane,CC,
10812,GO:0044299,0.999999999989796,0.921129163145696,0,1,C-fiber,CC,
10814,GO:0044301,0.999999999989796,0.921129163145696,0,1,climbing fiber,CC,
10817,GO:0044305,0.999999999989796,0.921129163145696,0,1,calyx of Held,CC,
10819,GO:0044307,0.999999999989796,0.921129163145696,0,1,dendritic branch,CC,
10824,GO:0044316,0.999999999989796,0.921129163145696,0,1,cone cell pedicle,CC,
10835,GO:0044328,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10836,GO:0044329,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10837,GO:0044330,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10841,GO:0044335,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10877,GO:0044414,0.999999999989796,0.921129163145696,0,1,suppression of host defenses,BP,
10941,GO:0044599,0.999999999989796,0.921129163145696,0,1,AP-5 adaptor complex,CC,
10952,GO:0044648,0.999999999989796,0.921129163145696,0,1,histone H3-K4 dimethylation,BP,
10970,GO:0044732,0.999999999989796,0.921129163145696,0,1,mitotic spindle pole body,CC,
10971,GO:0044736,0.999999999989796,0.921129163145696,0,1,acid-sensing ion channel activity,MF,
10985,GO:0044779,0.999999999989796,0.921129163145696,0,1,meiotic spindle checkpoint,BP,
10989,GO:0044785,0.999999999989796,0.921129163145696,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11026,GO:0044868,0.999999999989796,0.921129163145696,0,1,modulation by host of viral molecular function,BP,
11039,GO:0045016,0.999999999989796,0.921129163145696,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11049,GO:0045032,0.999999999989796,0.921129163145696,0,1,ADP-activated adenosine receptor activity,MF,
11081,GO:0045081,0.999999999989796,0.921129163145696,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11091,GO:0045092,0.999999999989796,0.921129163145696,0,1,interleukin-18 receptor complex,CC,
11110,GO:0045128,0.999999999989796,0.921129163145696,0,1,negative regulation of reciprocal meiotic recombination,BP,
11138,GO:0045183,0.999999999989796,0.921129163145696,0,1,translation factor activity, non-nucleic acid binding,MF,
11141,GO:0045186,0.999999999989796,0.921129163145696,0,1,zonula adherens assembly,BP,
11153,GO:0045208,0.999999999989796,0.921129163145696,0,1,MAPK phosphatase export from nucleus,BP,
11154,GO:0045209,0.999999999989796,0.921129163145696,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11162,GO:0045219,0.999999999989796,0.921129163145696,0,1,regulation of FasL biosynthetic process,BP,
11163,GO:0045221,0.999999999989796,0.921129163145696,0,1,negative regulation of FasL biosynthetic process,BP,
11229,GO:0045381,0.999999999989796,0.921129163145696,0,1,regulation of interleukin-18 biosynthetic process,BP,
11233,GO:0045403,0.999999999989796,0.921129163145696,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
11383,GO:0045751,0.999999999989796,0.921129163145696,0,1,negative regulation of Toll signaling pathway,BP,
11392,GO:0045769,0.999999999989796,0.921129163145696,0,1,negative regulation of asymmetric cell division,BP,
11405,GO:0045795,0.999999999989796,0.921129163145696,0,1,positive regulation of cell volume,BP,
11412,GO:0045819,0.999999999989796,0.921129163145696,0,1,positive regulation of glycogen catabolic process,BP,
11439,GO:0045870,0.999999999989796,0.921129163145696,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11445,GO:0045887,0.999999999989796,0.921129163145696,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11509,GO:0045993,0.999999999989796,0.921129163145696,0,1,negative regulation of translational initiation by iron,BP,
11528,GO:0046048,0.999999999989796,0.921129163145696,0,1,UDP metabolic process,BP,
11556,GO:0046092,0.999999999989796,0.921129163145696,0,1,deoxycytidine metabolic process,BP,
11574,GO:0046127,0.999999999989796,0.921129163145696,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11593,GO:0046168,0.999999999989796,0.921129163145696,0,1,glycerol-3-phosphate catabolic process,BP,
11596,GO:0046176,0.999999999989796,0.921129163145696,0,1,aldonic acid catabolic process,BP,
11597,GO:0046177,0.999999999989796,0.921129163145696,0,1,D-gluconate catabolic process,BP,
11611,GO:0046293,0.999999999989796,0.921129163145696,0,1,formaldehyde biosynthetic process,BP,
11615,GO:0046316,0.999999999989796,0.921129163145696,0,1,gluconokinase activity,MF,
11616,GO:0046317,0.999999999989796,0.921129163145696,0,1,regulation of glucosylceramide biosynthetic process,BP,
11617,GO:0046318,0.999999999989796,0.921129163145696,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11631,GO:0046333,0.999999999989796,0.921129163145696,0,1,octopamine metabolic process,BP,
11640,GO:0046355,0.999999999989796,0.921129163145696,0,1,mannan catabolic process,BP,
11650,GO:0046380,0.999999999989796,0.921129163145696,0,1,N-acetylneuraminate biosynthetic process,BP,
11694,GO:0046478,0.999999999989796,0.921129163145696,0,1,lactosylceramide metabolic process,BP,
11706,GO:0046497,0.999999999989796,0.921129163145696,0,1,nicotinate nucleotide metabolic process,BP,
11708,GO:0046499,0.999999999989796,0.921129163145696,0,1,S-adenosylmethioninamine metabolic process,BP,
11721,GO:0046523,0.999999999989796,0.921129163145696,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11728,GO:0046534,0.999999999989796,0.921129163145696,0,1,positive regulation of photoreceptor cell differentiation,BP,
11733,GO:0046544,0.999999999989796,0.921129163145696,0,1,development of secondary male sexual characteristics,BP,
11741,GO:0046577,0.999999999989796,0.921129163145696,0,1,long-chain-alcohol oxidase activity,MF,
11747,GO:0046587,0.999999999989796,0.921129163145696,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11762,GO:0046619,0.999999999989796,0.921129163145696,0,1,optic placode formation involved in camera-type eye formation,BP,
11766,GO:0046623,0.999999999989796,0.921129163145696,0,1,sphingolipid-translocating ATPase activity,MF,
11797,GO:0046668,0.999999999989796,0.921129163145696,0,1,regulation of retinal cell programmed cell death,BP,
11798,GO:0046671,0.999999999989796,0.921129163145696,0,1,negative regulation of retinal cell programmed cell death,BP,
11827,GO:0046725,0.999999999989796,0.921129163145696,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11831,GO:0046745,0.999999999989796,0.921129163145696,0,1,viral capsid secondary envelopment,BP,
11838,GO:0046786,0.999999999989796,0.921129163145696,0,1,viral replication complex formation and maintenance,BP,
11841,GO:0046811,0.999999999989796,0.921129163145696,0,1,histone deacetylase inhibitor activity,MF,
11898,GO:0046921,0.999999999989796,0.921129163145696,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11918,GO:0046958,0.999999999989796,0.921129163145696,0,1,nonassociative learning,BP,
11940,GO:0046986,0.999999999989796,0.921129163145696,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11941,GO:0046996,0.999999999989796,0.921129163145696,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11946,GO:0047017,0.999999999989796,0.921129163145696,0,1,prostaglandin-F synthase activity,MF,
11958,GO:0047117,0.999999999989796,0.921129163145696,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11964,GO:0047159,0.999999999989796,0.921129163145696,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11968,GO:0047186,0.999999999989796,0.921129163145696,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11969,GO:0047191,0.999999999989796,0.921129163145696,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11976,GO:0047256,0.999999999989796,0.921129163145696,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11977,GO:0047263,0.999999999989796,0.921129163145696,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11978,GO:0047273,0.999999999989796,0.921129163145696,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11979,GO:0047275,0.999999999989796,0.921129163145696,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11981,GO:0047280,0.999999999989796,0.921129163145696,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11986,GO:0047298,0.999999999989796,0.921129163145696,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11989,GO:0047325,0.999999999989796,0.921129163145696,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11991,GO:0047341,0.999999999989796,0.921129163145696,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11992,GO:0047349,0.999999999989796,0.921129163145696,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
11993,GO:0047369,0.999999999989796,0.921129163145696,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
11998,GO:0047395,0.999999999989796,0.921129163145696,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12003,GO:0047451,0.999999999989796,0.921129163145696,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12004,GO:0047464,0.999999999989796,0.921129163145696,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12014,GO:0047545,0.999999999989796,0.921129163145696,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12016,GO:0047560,0.999999999989796,0.921129163145696,0,1,3-dehydrosphinganine reductase activity,MF,
12020,GO:0047620,0.999999999989796,0.921129163145696,0,1,acylglycerol kinase activity,MF,
12024,GO:0047635,0.999999999989796,0.921129163145696,0,1,alanine-oxo-acid transaminase activity,MF,
12027,GO:0047676,0.999999999989796,0.921129163145696,0,1,arachidonate-CoA ligase activity,MF,
12035,GO:0047734,0.999999999989796,0.921129163145696,0,1,CDP-glycerol diphosphatase activity,MF,
12041,GO:0047760,0.999999999989796,0.921129163145696,0,1,butyrate-CoA ligase activity,MF,
12042,GO:0047800,0.999999999989796,0.921129163145696,0,1,cysteamine dioxygenase activity,MF,
12051,GO:0047933,0.999999999989796,0.921129163145696,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12052,GO:0047936,0.999999999989796,0.921129163145696,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12058,GO:0048006,0.999999999989796,0.921129163145696,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12066,GO:0048014,0.999999999989796,0.921129163145696,0,1,Tie signaling pathway,BP,
12075,GO:0048023,0.999999999989796,0.921129163145696,0,1,positive regulation of melanin biosynthetic process,BP,
12082,GO:0048033,0.999999999989796,0.921129163145696,0,1,heme o metabolic process,BP,
12083,GO:0048034,0.999999999989796,0.921129163145696,0,1,heme O biosynthetic process,BP,
12091,GO:0048058,0.999999999989796,0.921129163145696,0,1,compound eye corneal lens development,BP,
12096,GO:0048075,0.999999999989796,0.921129163145696,0,1,positive regulation of eye pigmentation,BP,
12112,GO:0048160,0.999999999989796,0.921129163145696,0,1,primary follicle stage,BP,
12135,GO:0048213,0.999999999989796,0.921129163145696,0,1,Golgi vesicle prefusion complex stabilization,BP,
12157,GO:0048264,0.999999999989796,0.921129163145696,0,1,determination of ventral identity,BP,
12188,GO:0048320,0.999999999989796,0.921129163145696,0,1,axial mesoderm formation,BP,
12191,GO:0048338,0.999999999989796,0.921129163145696,0,1,mesoderm structural organization,BP,
12195,GO:0048352,0.999999999989796,0.921129163145696,0,1,paraxial mesoderm structural organization,BP,
12215,GO:0048403,0.999999999989796,0.921129163145696,0,1,brain-derived neurotrophic factor binding,MF,
12291,GO:0048619,0.999999999989796,0.921129163145696,0,1,embryonic hindgut morphogenesis,BP,
12325,GO:0048677,0.999999999989796,0.921129163145696,0,1,axon extension involved in regeneration,BP,
12367,GO:0048749,0.999999999989796,0.921129163145696,0,1,compound eye development,BP,
12410,GO:0048855,0.999999999989796,0.921129163145696,0,1,adenohypophysis morphogenesis,BP,
12419,GO:0048866,0.999999999989796,0.921129163145696,0,1,stem cell fate specification,BP,
12426,GO:0048874,0.999999999989796,0.921129163145696,0,1,homeostasis of number of cells in a free-living population,BP,
12437,GO:0050046,0.999999999989796,0.921129163145696,0,1,lathosterol oxidase activity,MF,
12441,GO:0050115,0.999999999989796,0.921129163145696,0,1,myosin-light-chain-phosphatase activity,MF,
12443,GO:0050124,0.999999999989796,0.921129163145696,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12446,GO:0050144,0.999999999989796,0.921129163145696,0,1,nucleoside deoxyribosyltransferase activity,MF,
12448,GO:0050146,0.999999999989796,0.921129163145696,0,1,nucleoside phosphotransferase activity,MF,
12451,GO:0050185,0.999999999989796,0.921129163145696,0,1,phosphatidylinositol deacylase activity,MF,
12452,GO:0050201,0.999999999989796,0.921129163145696,0,1,fucokinase activity,MF,
12458,GO:0050262,0.999999999989796,0.921129163145696,0,1,ribosylnicotinamide kinase activity,MF,
12460,GO:0050277,0.999999999989796,0.921129163145696,0,1,sedoheptulokinase activity,MF,
12461,GO:0050290,0.999999999989796,0.921129163145696,0,1,sphingomyelin phosphodiesterase D activity,MF,
12470,GO:0050346,0.999999999989796,0.921129163145696,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12472,GO:0050353,0.999999999989796,0.921129163145696,0,1,trimethyllysine dioxygenase activity,MF,
12473,GO:0050354,0.999999999989796,0.921129163145696,0,1,triokinase activity,MF,
12474,GO:0050355,0.999999999989796,0.921129163145696,0,1,triphosphatase activity,MF,
12475,GO:0050379,0.999999999989796,0.921129163145696,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12486,GO:0050444,0.999999999989796,0.921129163145696,0,1,aquacobalamin reductase (NADPH) activity,MF,
12499,GO:0050560,0.999999999989796,0.921129163145696,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12500,GO:0050561,0.999999999989796,0.921129163145696,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12505,GO:0050614,0.999999999989796,0.921129163145696,0,1,delta24-sterol reductase activity,MF,
12509,GO:0050652,0.999999999989796,0.921129163145696,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12510,GO:0050653,0.999999999989796,0.921129163145696,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12684,GO:0050897,0.999999999989796,0.921129163145696,0,1,cobalt ion binding,MF,
12697,GO:0050915,0.999999999989796,0.921129163145696,0,1,sensory perception of sour taste,BP,
12706,GO:0050924,0.999999999989796,0.921129163145696,0,1,positive regulation of negative chemotaxis,BP,
12710,GO:0050928,0.999999999989796,0.921129163145696,0,1,negative regulation of positive chemotaxis,BP,
12711,GO:0050929,0.999999999989796,0.921129163145696,0,1,induction of negative chemotaxis,BP,
12719,GO:0050955,0.999999999989796,0.921129163145696,0,1,thermoception,BP,
12721,GO:0050960,0.999999999989796,0.921129163145696,0,1,detection of temperature stimulus involved in thermoception,BP,
12726,GO:0050968,0.999999999989796,0.921129163145696,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12757,GO:0051025,0.999999999989796,0.921129163145696,0,1,negative regulation of immunoglobulin secretion,BP,
12763,GO:0051032,0.999999999989796,0.921129163145696,0,1,nucleic acid transmembrane transporter activity,MF,
12764,GO:0051033,0.999999999989796,0.921129163145696,0,1,RNA transmembrane transporter activity,MF,
12786,GO:0051068,0.999999999989796,0.921129163145696,0,1,dihydrolipoamide metabolic process,BP,
12795,GO:0051089,0.999999999989796,0.921129163145696,0,1,constitutive protein ectodomain proteolysis,BP,
12808,GO:0051102,0.999999999989796,0.921129163145696,0,1,DNA ligation involved in DNA recombination,BP,
12832,GO:0051139,0.999999999989796,0.921129163145696,0,1,metal ion:proton antiporter activity,MF,
12888,GO:0051228,0.999999999989796,0.921129163145696,0,1,mitotic spindle disassembly,BP,
12889,GO:0051230,0.999999999989796,0.921129163145696,0,1,spindle disassembly,BP,
12919,GO:0051267,0.999999999989796,0.921129163145696,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12941,GO:0051300,0.999999999989796,0.921129163145696,0,1,spindle pole body organization,BP,
12949,GO:0051308,0.999999999989796,0.921129163145696,0,1,male meiosis chromosome separation,BP,
12999,GO:0051417,0.999999999989796,0.921129163145696,0,1,microtubule nucleation by spindle pole body,BP,
13007,GO:0051433,0.999999999989796,0.921129163145696,0,1,BH2 domain binding,MF,
13020,GO:0051455,0.999999999989796,0.921129163145696,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13027,GO:0051463,0.999999999989796,0.921129163145696,0,1,negative regulation of cortisol secretion,BP,
13029,GO:0051466,0.999999999989796,0.921129163145696,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13078,GO:0051585,0.999999999989796,0.921129163145696,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13089,GO:0051598,0.999999999989796,0.921129163145696,0,1,meiotic recombination checkpoint,BP,
13101,GO:0051615,0.999999999989796,0.921129163145696,0,1,histamine uptake,BP,
13102,GO:0051620,0.999999999989796,0.921129163145696,0,1,norepinephrine uptake,BP,
13103,GO:0051621,0.999999999989796,0.921129163145696,0,1,regulation of norepinephrine uptake,BP,
13104,GO:0051622,0.999999999989796,0.921129163145696,0,1,negative regulation of norepinephrine uptake,BP,
13131,GO:0051685,0.999999999989796,0.921129163145696,0,1,maintenance of ER location,BP,
13132,GO:0051686,0.999999999989796,0.921129163145696,0,1,establishment of ER localization,BP,
13156,GO:0051728,0.999999999989796,0.921129163145696,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13157,GO:0051729,0.999999999989796,0.921129163145696,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13175,GO:0051780,0.999999999989796,0.921129163145696,0,1,behavioral response to nutrient,BP,
13181,GO:0051786,0.999999999989796,0.921129163145696,0,1,all-trans-retinol 13,14-reductase activity,MF,
13190,GO:0051796,0.999999999989796,0.921129163145696,0,1,negative regulation of timing of catagen,BP,
13194,GO:0051800,0.999999999989796,0.921129163145696,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13201,GO:0051821,0.999999999989796,0.921129163145696,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13205,GO:0051833,0.999999999989796,0.921129163145696,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13214,GO:0051866,0.999999999989796,0.921129163145696,0,1,general adaptation syndrome,BP,
13225,GO:0051885,0.999999999989796,0.921129163145696,0,1,positive regulation of timing of anagen,BP,
13226,GO:0051886,0.999999999989796,0.921129163145696,0,1,negative regulation of timing of anagen,BP,
13229,GO:0051892,0.999999999989796,0.921129163145696,0,1,negative regulation of cardioblast differentiation,BP,
13243,GO:0051908,0.999999999989796,0.921129163145696,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13255,GO:0051933,0.999999999989796,0.921129163145696,0,1,amino acid neurotransmitter reuptake,BP,
13257,GO:0051935,0.999999999989796,0.921129163145696,0,1,glutamate reuptake,BP,
13261,GO:0051941,0.999999999989796,0.921129163145696,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13263,GO:0051945,0.999999999989796,0.921129163145696,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13264,GO:0051946,0.999999999989796,0.921129163145696,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13298,GO:0052029,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13300,GO:0052037,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host defense response,BP,
13309,GO:0052097,0.999999999989796,0.921129163145696,0,1,interspecies quorum sensing,BP,
13310,GO:0052106,0.999999999989796,0.921129163145696,0,1,quorum sensing involved in interaction with host,BP,
13315,GO:0052167,0.999999999989796,0.921129163145696,0,1,modulation by symbiont of host innate immune response,BP,
13316,GO:0052170,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host innate immune response,BP,
13334,GO:0052261,0.999999999989796,0.921129163145696,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13335,GO:0052306,0.999999999989796,0.921129163145696,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13336,GO:0052309,0.999999999989796,0.921129163145696,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13357,GO:0052493,0.999999999989796,0.921129163145696,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13367,GO:0052561,0.999999999989796,0.921129163145696,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13368,GO:0052562,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host immune response,BP,
13372,GO:0052590,0.999999999989796,0.921129163145696,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13373,GO:0052591,0.999999999989796,0.921129163145696,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13396,GO:0052717,0.999999999989796,0.921129163145696,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13397,GO:0052718,0.999999999989796,0.921129163145696,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13400,GO:0052725,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13401,GO:0052726,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13416,GO:0052810,0.999999999989796,0.921129163145696,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13423,GO:0052825,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13424,GO:0052826,0.999999999989796,0.921129163145696,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13428,GO:0052830,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13429,GO:0052831,0.999999999989796,0.921129163145696,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13433,GO:0052835,0.999999999989796,0.921129163145696,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13446,GO:0052858,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine acetyltransferase activity,MF,
13457,GO:0052906,0.999999999989796,0.921129163145696,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13459,GO:0052909,0.999999999989796,0.921129163145696,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13461,GO:0052918,0.999999999989796,0.921129163145696,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13463,GO:0052926,0.999999999989796,0.921129163145696,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13470,GO:0055005,0.999999999989796,0.921129163145696,0,1,ventricular cardiac myofibril assembly,BP,
13490,GO:0055028,0.999999999989796,0.921129163145696,0,1,cortical microtubule,CC,
13494,GO:0055048,0.999999999989796,0.921129163145696,0,1,anastral spindle assembly,BP,
13524,GO:0055095,0.999999999989796,0.921129163145696,0,1,lipoprotein particle mediated signaling,BP,
13525,GO:0055096,0.999999999989796,0.921129163145696,0,1,low-density lipoprotein particle mediated signaling,BP,
13528,GO:0055103,0.999999999989796,0.921129163145696,0,1,ligase regulator activity,MF,
13532,GO:0055113,0.999999999989796,0.921129163145696,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13541,GO:0060001,0.999999999989796,0.921129163145696,0,1,minus-end directed microfilament motor activity,MF,
13545,GO:0060005,0.999999999989796,0.921129163145696,0,1,vestibular reflex,BP,
13546,GO:0060007,0.999999999989796,0.921129163145696,0,1,linear vestibuloocular reflex,BP,
13549,GO:0060010,0.999999999989796,0.921129163145696,0,1,Sertoli cell fate commitment,BP,
13551,GO:0060012,0.999999999989796,0.921129163145696,0,1,synaptic transmission, glycinergic,BP,
13553,GO:0060014,0.999999999989796,0.921129163145696,0,1,granulosa cell differentiation,BP,
13555,GO:0060018,0.999999999989796,0.921129163145696,0,1,astrocyte fate commitment,BP,
13567,GO:0060031,0.999999999989796,0.921129163145696,0,1,mediolateral intercalation,BP,
13568,GO:0060032,0.999999999989796,0.921129163145696,0,1,notochord regression,BP,
13593,GO:0060060,0.999999999989796,0.921129163145696,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13598,GO:0060067,0.999999999989796,0.921129163145696,0,1,cervix development,BP,
13602,GO:0060072,0.999999999989796,0.921129163145696,0,1,large conductance calcium-activated potassium channel activity,MF,
13613,GO:0060084,0.999999999989796,0.921129163145696,0,1,synaptic transmission involved in micturition,BP,
13620,GO:0060092,0.999999999989796,0.921129163145696,0,1,regulation of synaptic transmission, glycinergic,BP,
13630,GO:0060125,0.999999999989796,0.921129163145696,0,1,negative regulation of growth hormone secretion,BP,
13649,GO:0060156,0.999999999989796,0.921129163145696,0,1,milk ejection reflex,BP,
13659,GO:0060171,0.999999999989796,0.921129163145696,0,1,stereocilium membrane,CC,
13665,GO:0060183,0.999999999989796,0.921129163145696,0,1,apelin receptor signaling pathway,BP,
13666,GO:0060184,0.999999999989796,0.921129163145696,0,1,cell cycle switching,BP,
13674,GO:0060200,0.999999999989796,0.921129163145696,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13675,GO:0060201,0.999999999989796,0.921129163145696,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13686,GO:0060221,0.999999999989796,0.921129163145696,0,1,retinal rod cell differentiation,BP,
13695,GO:0060245,0.999999999989796,0.921129163145696,0,1,detection of cell density,BP,
13696,GO:0060246,0.999999999989796,0.921129163145696,0,1,detection of cell density by contact stimulus,BP,
13697,GO:0060248,0.999999999989796,0.921129163145696,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13718,GO:0060283,0.999999999989796,0.921129163145696,0,1,negative regulation of oocyte development,BP,
13722,GO:0060290,0.999999999989796,0.921129163145696,0,1,transdifferentiation,BP,
13753,GO:0060327,0.999999999989796,0.921129163145696,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13780,GO:0060366,0.999999999989796,0.921129163145696,0,1,lambdoid suture morphogenesis,BP,
13781,GO:0060367,0.999999999989796,0.921129163145696,0,1,sagittal suture morphogenesis,BP,
13784,GO:0060370,0.999999999989796,0.921129163145696,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13789,GO:0060375,0.999999999989796,0.921129163145696,0,1,regulation of mast cell differentiation,BP,
13790,GO:0060377,0.999999999989796,0.921129163145696,0,1,negative regulation of mast cell differentiation,BP,
13791,GO:0060378,0.999999999989796,0.921129163145696,0,1,regulation of brood size,BP,
13796,GO:0060383,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA strand elongation,BP,
13799,GO:0060386,0.999999999989796,0.921129163145696,0,1,synapse assembly involved in innervation,BP,
13811,GO:0060400,0.999999999989796,0.921129163145696,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13851,GO:0060454,0.999999999989796,0.921129163145696,0,1,positive regulation of gastric acid secretion,BP,
13859,GO:0060465,0.999999999989796,0.921129163145696,0,1,pharynx development,BP,
13883,GO:0060516,0.999999999989796,0.921129163145696,0,1,primary prostatic bud elongation,BP,
13884,GO:0060517,0.999999999989796,0.921129163145696,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13899,GO:0060542,0.999999999989796,0.921129163145696,0,1,regulation of strand invasion,BP,
13913,GO:0060566,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA-templated transcription, termination,BP,
13933,GO:0060596,0.999999999989796,0.921129163145696,0,1,mammary placode formation,BP,
13935,GO:0060599,0.999999999989796,0.921129163145696,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13946,GO:0060620,0.999999999989796,0.921129163145696,0,1,regulation of cholesterol import,BP,
13959,GO:0060665,0.999999999989796,0.921129163145696,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13962,GO:0060668,0.999999999989796,0.921129163145696,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13995,GO:0060709,0.999999999989796,0.921129163145696,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14009,GO:0060730,0.999999999989796,0.921129163145696,0,1,regulation of intestinal epithelial structure maintenance,BP,
14010,GO:0060731,0.999999999989796,0.921129163145696,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14013,GO:0060734,0.999999999989796,0.921129163145696,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14040,GO:0060769,0.999999999989796,0.921129163145696,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14042,GO:0060775,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14043,GO:0060784,0.999999999989796,0.921129163145696,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14049,GO:0060809,0.999999999989796,0.921129163145696,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14052,GO:0060821,0.999999999989796,0.921129163145696,0,1,inactivation of X chromosome by DNA methylation,BP,
14053,GO:0060823,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14065,GO:0060843,0.999999999989796,0.921129163145696,0,1,venous endothelial cell differentiation,BP,
14069,GO:0060849,0.999999999989796,0.921129163145696,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14071,GO:0060853,0.999999999989796,0.921129163145696,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14075,GO:0060873,0.999999999989796,0.921129163145696,0,1,anterior semicircular canal development,BP,
14076,GO:0060875,0.999999999989796,0.921129163145696,0,1,lateral semicircular canal development,BP,
14078,GO:0060887,0.999999999989796,0.921129163145696,0,1,limb epidermis development,BP,
14082,GO:0060901,0.999999999989796,0.921129163145696,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14084,GO:0060904,0.999999999989796,0.921129163145696,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14087,GO:0060912,0.999999999989796,0.921129163145696,0,1,cardiac cell fate specification,BP,
14094,GO:0060922,0.999999999989796,0.921129163145696,0,1,atrioventricular node cell differentiation,BP,
14097,GO:0060928,0.999999999989796,0.921129163145696,0,1,atrioventricular node cell development,BP,
14099,GO:0060932,0.999999999989796,0.921129163145696,0,1,His-Purkinje system cell differentiation,BP,
14108,GO:0060957,0.999999999989796,0.921129163145696,0,1,endocardial cell fate commitment,BP,
14142,GO:0061010,0.999999999989796,0.921129163145696,0,1,gall bladder development,BP,
14152,GO:0061032,0.999999999989796,0.921129163145696,0,1,visceral serous pericardium development,BP,
14153,GO:0061034,0.999999999989796,0.921129163145696,0,1,olfactory bulb mitral cell layer development,BP,
14158,GO:0061040,0.999999999989796,0.921129163145696,0,1,female gonad morphogenesis,BP,
14174,GO:0061056,0.999999999989796,0.921129163145696,0,1,sclerotome development,BP,
14190,GO:0061091,0.999999999989796,0.921129163145696,0,1,regulation of phospholipid translocation,BP,
14191,GO:0061092,0.999999999989796,0.921129163145696,0,1,positive regulation of phospholipid translocation,BP,
14202,GO:0061113,0.999999999989796,0.921129163145696,0,1,pancreas morphogenesis,BP,
14210,GO:0061141,0.999999999989796,0.921129163145696,0,1,lung ciliated cell differentiation,BP,
14224,GO:0061163,0.999999999989796,0.921129163145696,0,1,endoplasmic reticulum polarization,BP,
14251,GO:0061301,0.999999999989796,0.921129163145696,0,1,cerebellum vasculature morphogenesis,BP,
14265,GO:0061324,0.999999999989796,0.921129163145696,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14274,GO:0061347,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14275,GO:0061348,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14276,GO:0061349,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14277,GO:0061350,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14279,GO:0061354,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14296,GO:0061400,0.999999999989796,0.921129163145696,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14310,GO:0061444,0.999999999989796,0.921129163145696,0,1,endocardial cushion cell development,BP,
14311,GO:0061445,0.999999999989796,0.921129163145696,0,1,endocardial cushion cell fate commitment,BP,
14324,GO:0061485,0.999999999989796,0.921129163145696,0,1,memory T cell proliferation,BP,
14325,GO:0061495,0.999999999989796,0.921129163145696,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14329,GO:0061508,0.999999999989796,0.921129163145696,0,1,CDP phosphorylation,BP,
14334,GO:0061517,0.999999999989796,0.921129163145696,0,1,macrophage proliferation,BP,
14335,GO:0061518,0.999999999989796,0.921129163145696,0,1,microglial cell proliferation,BP,
14336,GO:0061519,0.999999999989796,0.921129163145696,0,1,macrophage homeostasis,BP,
14338,GO:0061528,0.999999999989796,0.921129163145696,0,1,aspartate secretion,BP,
14339,GO:0061534,0.999999999989796,0.921129163145696,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14341,GO:0061536,0.999999999989796,0.921129163145696,0,1,glycine secretion,BP,
14342,GO:0061537,0.999999999989796,0.921129163145696,0,1,glycine secretion, neurotransmission,BP,
14344,GO:0061547,0.999999999989796,0.921129163145696,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14351,GO:0061565,0.999999999989796,0.921129163145696,0,1,dAMP phosphorylation,BP,
14352,GO:0061566,0.999999999989796,0.921129163145696,0,1,CMP phosphorylation,BP,
14353,GO:0061567,0.999999999989796,0.921129163145696,0,1,dCMP phosphorylation,BP,
14354,GO:0061568,0.999999999989796,0.921129163145696,0,1,GDP phosphorylation,BP,
14355,GO:0061569,0.999999999989796,0.921129163145696,0,1,UDP phosphorylation,BP,
14356,GO:0061570,0.999999999989796,0.921129163145696,0,1,dCDP phosphorylation,BP,
14357,GO:0061571,0.999999999989796,0.921129163145696,0,1,TDP phosphorylation,BP,
14359,GO:0061573,0.999999999989796,0.921129163145696,0,1,actin filament bundle retrograde transport,BP,
14364,GO:0061580,0.999999999989796,0.921129163145696,0,1,colon epithelial cell migration,BP,
14370,GO:0061598,0.999999999989796,0.921129163145696,0,1,molybdopterin adenylyltransferase activity,MF,
14371,GO:0061599,0.999999999989796,0.921129163145696,0,1,molybdopterin molybdotransferase activity,MF,
14394,GO:0061642,0.999999999989796,0.921129163145696,0,1,chemoattraction of axon,BP,
14397,GO:0061646,0.999999999989796,0.921129163145696,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14403,GO:0061663,0.999999999989796,0.921129163145696,0,1,NEDD8 ligase activity,MF,
14410,GO:0061685,0.999999999989796,0.921129163145696,0,1,diphthine methylesterase activity,MF,
14414,GO:0061697,0.999999999989796,0.921129163145696,0,1,protein-glutaryllysine deglutarylase activity,MF,
14415,GO:0061698,0.999999999989796,0.921129163145696,0,1,protein deglutarylation,BP,
14416,GO:0061699,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine deglutarylation,BP,
14419,GO:0061709,0.999999999989796,0.921129163145696,0,1,reticulophagy,BP,
14431,GO:0061736,0.999999999989796,0.921129163145696,0,1,engulfment of target by autophagosome,BP,
14442,GO:0061753,0.999999999989796,0.921129163145696,0,1,substrate localization to autophagosome,BP,
14445,GO:0061760,0.999999999989796,0.921129163145696,0,1,antifungal innate immune response,BP,
14448,GO:0061767,0.999999999989796,0.921129163145696,0,1,negative regulation of lung blood pressure,BP,
14449,GO:0061768,0.999999999989796,0.921129163145696,0,1,magnesium:sodium antiporter activity,MF,
14450,GO:0061769,0.999999999989796,0.921129163145696,0,1,ribosylnicotinate kinase activity,MF,
14453,GO:0061772,0.999999999989796,0.921129163145696,0,1,drug transport across blood-nerve barrier,BP,
14455,GO:0061780,0.999999999989796,0.921129163145696,0,1,mitotic cohesin loading,BP,
14457,GO:0061789,0.999999999989796,0.921129163145696,0,1,dense core granule priming,BP,
14458,GO:0061792,0.999999999989796,0.921129163145696,0,1,secretory granule maturation,BP,
14459,GO:0061798,0.999999999989796,0.921129163145696,0,1,GTP 3',8'-cyclase activity,MF,
14460,GO:0061799,0.999999999989796,0.921129163145696,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14466,GO:0061825,0.999999999989796,0.921129163145696,0,1,podosome core,CC,
14468,GO:0061828,0.999999999989796,0.921129163145696,0,1,apical tubulobulbar complex,CC,
14469,GO:0061829,0.999999999989796,0.921129163145696,0,1,basal tubulobulbar complex,CC,
14485,GO:0061889,0.999999999989796,0.921129163145696,0,1,negative regulation of astrocyte activation,BP,
14487,GO:0061896,0.999999999989796,0.921129163145696,0,1,all-trans retinol 3,4-desaturase activity,MF,
14488,GO:0061897,0.999999999989796,0.921129163145696,0,1,all-trans retinal 3,4-desaturase activity,MF,
14489,GO:0061898,0.999999999989796,0.921129163145696,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14490,GO:0061899,0.999999999989796,0.921129163145696,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14494,GO:0061920,0.999999999989796,0.921129163145696,0,1,protein propionyltransferase activity,MF,
14495,GO:0061921,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine propionylation,BP,
14496,GO:0061930,0.999999999989796,0.921129163145696,0,1,regulation of erythrocyte enucleation,BP,
14497,GO:0061931,0.999999999989796,0.921129163145696,0,1,positive regulation of erythrocyte enucleation,BP,
14498,GO:0061944,0.999999999989796,0.921129163145696,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14518,GO:0065010,0.999999999989796,0.921129163145696,0,1,extracellular membrane-bounded organelle,CC,
14521,GO:0070004,0.999999999989796,0.921129163145696,0,1,cysteine-type exopeptidase activity,MF,
14537,GO:0070042,0.999999999989796,0.921129163145696,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14546,GO:0070060,0.999999999989796,0.921129163145696,0,1,'de novo' actin filament nucleation,BP,
14556,GO:0070077,0.999999999989796,0.921129163145696,0,1,histone arginine demethylation,BP,
14557,GO:0070078,0.999999999989796,0.921129163145696,0,1,histone H3-R2 demethylation,BP,
14558,GO:0070079,0.999999999989796,0.921129163145696,0,1,histone H4-R3 demethylation,BP,
14567,GO:0070095,0.999999999989796,0.921129163145696,0,1,fructose-6-phosphate binding,MF,
14568,GO:0070096,0.999999999989796,0.921129163145696,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14581,GO:0070121,0.999999999989796,0.921129163145696,0,1,Kupffer's vesicle development,BP,
14583,GO:0070123,0.999999999989796,0.921129163145696,0,1,transforming growth factor beta receptor activity, type III,MF,
14589,GO:0070130,0.999999999989796,0.921129163145696,0,1,negative regulation of mitochondrial translation,BP,
14597,GO:0070143,0.999999999989796,0.921129163145696,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14598,GO:0070145,0.999999999989796,0.921129163145696,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14606,GO:0070165,0.999999999989796,0.921129163145696,0,1,positive regulation of adiponectin secretion,BP,
14612,GO:0070171,0.999999999989796,0.921129163145696,0,1,negative regulation of tooth mineralization,BP,
14613,GO:0070172,0.999999999989796,0.921129163145696,0,1,positive regulation of tooth mineralization,BP,
14620,GO:0070183,0.999999999989796,0.921129163145696,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14628,GO:0070195,0.999999999989796,0.921129163145696,0,1,growth hormone receptor complex,CC,
14663,GO:0070260,0.999999999989796,0.921129163145696,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14667,GO:0070267,0.999999999989796,0.921129163145696,0,1,oncosis,BP,
14674,GO:0070280,0.999999999989796,0.921129163145696,0,1,pyridoxal binding,MF,
14680,GO:0070292,0.999999999989796,0.921129163145696,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
14707,GO:0070335,0.999999999989796,0.921129163145696,0,1,aspartate binding,MF,
14709,GO:0070337,0.999999999989796,0.921129163145696,0,1,3'-flap-structured DNA binding,MF,
14713,GO:0070343,0.999999999989796,0.921129163145696,0,1,white fat cell proliferation,BP,
14717,GO:0070350,0.999999999989796,0.921129163145696,0,1,regulation of white fat cell proliferation,BP,
14727,GO:0070376,0.999999999989796,0.921129163145696,0,1,regulation of ERK5 cascade,BP,
14728,GO:0070377,0.999999999989796,0.921129163145696,0,1,negative regulation of ERK5 cascade,BP,
14740,GO:0070407,0.999999999989796,0.921129163145696,0,1,oxidation-dependent protein catabolic process,BP,
14741,GO:0070408,0.999999999989796,0.921129163145696,0,1,carbamoyl phosphate metabolic process,BP,
14742,GO:0070409,0.999999999989796,0.921129163145696,0,1,carbamoyl phosphate biosynthetic process,BP,
14746,GO:0070413,0.999999999989796,0.921129163145696,0,1,trehalose metabolism in response to stress,BP,
14748,GO:0070418,0.999999999989796,0.921129163145696,0,1,DNA-dependent protein kinase complex,CC,
14769,GO:0070460,0.999999999989796,0.921129163145696,0,1,thyroid-stimulating hormone secretion,BP,
14771,GO:0070463,0.999999999989796,0.921129163145696,0,1,tubulin-dependent ATPase activity,MF,
14779,GO:0070478,0.999999999989796,0.921129163145696,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14780,GO:0070481,0.999999999989796,0.921129163145696,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14782,GO:0070483,0.999999999989796,0.921129163145696,0,1,detection of hypoxia,BP,
14786,GO:0070489,0.999999999989796,0.921129163145696,0,1,T cell aggregation,BP,
14797,GO:0070510,0.999999999989796,0.921129163145696,0,1,regulation of histone H4-K20 methylation,BP,
14798,GO:0070512,0.999999999989796,0.921129163145696,0,1,positive regulation of histone H4-K20 methylation,BP,
14812,GO:0070539,0.999999999989796,0.921129163145696,0,1,linoleic acid binding,MF,
14817,GO:0070548,0.999999999989796,0.921129163145696,0,1,L-glutamine aminotransferase activity,MF,
14818,GO:0070550,0.999999999989796,0.921129163145696,0,1,rDNA condensation,BP,
14819,GO:0070551,0.999999999989796,0.921129163145696,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14821,GO:0070553,0.999999999989796,0.921129163145696,0,1,nicotinic acid receptor activity,MF,
14824,GO:0070560,0.999999999989796,0.921129163145696,0,1,protein secretion by platelet,BP,
14836,GO:0070573,0.999999999989796,0.921129163145696,0,1,metallodipeptidase activity,MF,
14848,GO:0070593,0.999999999989796,0.921129163145696,0,1,dendrite self-avoidance,BP,
14855,GO:0070615,0.999999999989796,0.921129163145696,0,1,nucleosome-dependent ATPase activity,MF,
14859,GO:0070627,0.999999999989796,0.921129163145696,0,1,ferrous iron import,BP,
14861,GO:0070631,0.999999999989796,0.921129163145696,0,1,spindle pole body localization,BP,
14862,GO:0070632,0.999999999989796,0.921129163145696,0,1,establishment of spindle pole body localization,BP,
14873,GO:0070650,0.999999999989796,0.921129163145696,0,1,actin filament bundle distribution,BP,
14874,GO:0070651,0.999999999989796,0.921129163145696,0,1,nonfunctional rRNA decay,BP,
14895,GO:0070694,0.999999999989796,0.921129163145696,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14902,GO:0070715,0.999999999989796,0.921129163145696,0,1,sodium-dependent organic cation transport,BP,
14910,GO:0070735,0.999999999989796,0.921129163145696,0,1,protein-glycine ligase activity,MF,
14911,GO:0070736,0.999999999989796,0.921129163145696,0,1,protein-glycine ligase activity, initiating,MF,
14919,GO:0070762,0.999999999989796,0.921129163145696,0,1,nuclear pore transmembrane ring,CC,
14921,GO:0070772,0.999999999989796,0.921129163145696,0,1,PAS complex,CC,
14923,GO:0070774,0.999999999989796,0.921129163145696,0,1,phytoceramidase activity,MF,
14930,GO:0070781,0.999999999989796,0.921129163145696,0,1,response to biotin,BP,
14940,GO:0070826,0.999999999989796,0.921129163145696,0,1,paraferritin complex,CC,
14952,GO:0070843,0.999999999989796,0.921129163145696,0,1,misfolded protein transport,BP,
14953,GO:0070844,0.999999999989796,0.921129163145696,0,1,polyubiquitinated protein transport,BP,
14954,GO:0070845,0.999999999989796,0.921129163145696,0,1,polyubiquitinated misfolded protein transport,BP,
14955,GO:0070846,0.999999999989796,0.921129163145696,0,1,Hsp90 deacetylation,BP,
14962,GO:0070856,0.999999999989796,0.921129163145696,0,1,myosin VI light chain binding,MF,
14982,GO:0070890,0.999999999989796,0.921129163145696,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14987,GO:0070898,0.999999999989796,0.921129163145696,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14988,GO:0070899,0.999999999989796,0.921129163145696,0,1,mitochondrial tRNA wobble uridine modification,BP,
14993,GO:0070904,0.999999999989796,0.921129163145696,0,1,transepithelial L-ascorbic acid transport,BP,
15002,GO:0070926,0.999999999989796,0.921129163145696,0,1,regulation of ATP:ADP antiporter activity,BP,
15003,GO:0070931,0.999999999989796,0.921129163145696,0,1,Golgi-associated vesicle lumen,CC,
15020,GO:0070950,0.999999999989796,0.921129163145696,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15021,GO:0070951,0.999999999989796,0.921129163145696,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15025,GO:0070962,0.999999999989796,0.921129163145696,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15026,GO:0070963,0.999999999989796,0.921129163145696,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15033,GO:0070975,0.999999999989796,0.921129163145696,0,1,FHA domain binding,MF,
15040,GO:0070984,0.999999999989796,0.921129163145696,0,1,SET domain binding,MF,
15050,GO:0070995,0.999999999989796,0.921129163145696,0,1,NADPH oxidation,BP,
15085,GO:0071062,0.999999999989796,0.921129163145696,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15086,GO:0071065,0.999999999989796,0.921129163145696,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15094,GO:0071105,0.999999999989796,0.921129163145696,0,1,response to interleukin-11,BP,
15099,GO:0071110,0.999999999989796,0.921129163145696,0,1,histone biotinylation,BP,
15100,GO:0071133,0.999999999989796,0.921129163145696,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15112,GO:0071164,0.999999999989796,0.921129163145696,0,1,RNA trimethylguanosine synthase activity,MF,
15137,GO:0071228,0.999999999989796,0.921129163145696,0,1,cellular response to tumor cell,BP,
15145,GO:0071245,0.999999999989796,0.921129163145696,0,1,cellular response to carbon monoxide,BP,
15151,GO:0071258,0.999999999989796,0.921129163145696,0,1,cellular response to gravity,BP,
15173,GO:0071301,0.999999999989796,0.921129163145696,0,1,cellular response to vitamin B1,BP,
15188,GO:0071324,0.999999999989796,0.921129163145696,0,1,cellular response to disaccharide stimulus,BP,
15190,GO:0071329,0.999999999989796,0.921129163145696,0,1,cellular response to sucrose stimulus,BP,
15203,GO:0071348,0.999999999989796,0.921129163145696,0,1,cellular response to interleukin-11,BP,
15233,GO:0071387,0.999999999989796,0.921129163145696,0,1,cellular response to cortisol stimulus,BP,
15237,GO:0071393,0.999999999989796,0.921129163145696,0,1,cellular response to progesterone stimulus,BP,
15257,GO:0071424,0.999999999989796,0.921129163145696,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15268,GO:0071441,0.999999999989796,0.921129163145696,0,1,negative regulation of histone H3-K14 acetylation,BP,
15275,GO:0071454,0.999999999989796,0.921129163145696,0,1,cellular response to anoxia,BP,
15283,GO:0071464,0.999999999989796,0.921129163145696,0,1,cellular response to hydrostatic pressure,BP,
15288,GO:0071471,0.999999999989796,0.921129163145696,0,1,cellular response to non-ionic osmotic stress,BP,
15301,GO:0071485,0.999999999989796,0.921129163145696,0,1,cellular response to absence of light,BP,
15302,GO:0071486,0.999999999989796,0.921129163145696,0,1,cellular response to high light intensity,BP,
15319,GO:0071528,0.999999999989796,0.921129163145696,0,1,tRNA re-export from nucleus,BP,
15324,GO:0071540,0.999999999989796,0.921129163145696,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15341,GO:0071561,0.999999999989796,0.921129163145696,0,1,nucleus-vacuole junction,CC,
15344,GO:0071566,0.999999999989796,0.921129163145696,0,1,UFM1 activating enzyme activity,MF,
15348,GO:0071573,0.999999999989796,0.921129163145696,0,1,shelterin complex assembly,BP,
15365,GO:0071602,0.999999999989796,0.921129163145696,0,1,phytosphingosine biosynthetic process,BP,
15373,GO:0071612,0.999999999989796,0.921129163145696,0,1,IP-10 production,BP,
15375,GO:0071615,0.999999999989796,0.921129163145696,0,1,oxidative deethylation,BP,
15381,GO:0071623,0.999999999989796,0.921129163145696,0,1,negative regulation of granulocyte chemotaxis,BP,
15386,GO:0071633,0.999999999989796,0.921129163145696,0,1,dihydroceramidase activity,MF,
15404,GO:0071658,0.999999999989796,0.921129163145696,0,1,regulation of IP-10 production,BP,
15405,GO:0071660,0.999999999989796,0.921129163145696,0,1,positive regulation of IP-10 production,BP,
15407,GO:0071665,0.999999999989796,0.921129163145696,0,1,gamma-catenin-TCF7L2 complex,CC,
15411,GO:0071673,0.999999999989796,0.921129163145696,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15416,GO:0071678,0.999999999989796,0.921129163145696,0,1,olfactory bulb axon guidance,BP,
15421,GO:0071684,0.999999999989796,0.921129163145696,0,1,organism emergence from protective structure,BP,
15423,GO:0071691,0.999999999989796,0.921129163145696,0,1,cardiac muscle thin filament assembly,BP,
15431,GO:0071701,0.999999999989796,0.921129163145696,0,1,regulation of MAPK export from nucleus,BP,
15440,GO:0071713,0.999999999989796,0.921129163145696,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15444,GO:0071725,0.999999999989796,0.921129163145696,0,1,response to triacyl bacterial lipopeptide,BP,
15446,GO:0071727,0.999999999989796,0.921129163145696,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15451,GO:0071765,0.999999999989796,0.921129163145696,0,1,nuclear inner membrane organization,BP,
15458,GO:0071789,0.999999999989796,0.921129163145696,0,1,spindle pole body localization to nuclear envelope,BP,
15459,GO:0071790,0.999999999989796,0.921129163145696,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15466,GO:0071802,0.999999999989796,0.921129163145696,0,1,negative regulation of podosome assembly,BP,
15471,GO:0071812,0.999999999989796,0.921129163145696,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15479,GO:0071821,0.999999999989796,0.921129163145696,0,1,FANCM-MHF complex,CC,
15490,GO:0071848,0.999999999989796,0.921129163145696,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15503,GO:0071873,0.999999999989796,0.921129163145696,0,1,response to norepinephrine,BP,
15504,GO:0071874,0.999999999989796,0.921129163145696,0,1,cellular response to norepinephrine stimulus,BP,
15507,GO:0071878,0.999999999989796,0.921129163145696,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15511,GO:0071885,0.999999999989796,0.921129163145696,0,1,N-terminal protein N-methyltransferase activity,MF,
15526,GO:0071908,0.999999999989796,0.921129163145696,0,1,determination of intestine left/right asymmetry,BP,
15527,GO:0071909,0.999999999989796,0.921129163145696,0,1,determination of stomach left/right asymmetry,BP,
15529,GO:0071914,0.999999999989796,0.921129163145696,0,1,prominosome,CC,
15556,GO:0071988,0.999999999989796,0.921129163145696,0,1,protein localization to spindle pole body,BP,
15557,GO:0071997,0.999999999989796,0.921129163145696,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15559,GO:0072003,0.999999999989796,0.921129163145696,0,1,kidney rudiment formation,BP,
15560,GO:0072004,0.999999999989796,0.921129163145696,0,1,kidney field specification,BP,
15572,GO:0072025,0.999999999989796,0.921129163145696,0,1,distal convoluted tubule development,BP,
15576,GO:0072036,0.999999999989796,0.921129163145696,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15587,GO:0072055,0.999999999989796,0.921129163145696,0,1,renal cortex development,BP,
15588,GO:0072059,0.999999999989796,0.921129163145696,0,1,cortical collecting duct development,BP,
15589,GO:0072060,0.999999999989796,0.921129163145696,0,1,outer medullary collecting duct development,BP,
15591,GO:0072069,0.999999999989796,0.921129163145696,0,1,DCT cell differentiation,BP,
15627,GO:0072114,0.999999999989796,0.921129163145696,0,1,pronephros morphogenesis,BP,
15654,GO:0072166,0.999999999989796,0.921129163145696,0,1,posterior mesonephric tubule development,BP,
15666,GO:0072183,0.999999999989796,0.921129163145696,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15674,GO:0072194,0.999999999989796,0.921129163145696,0,1,kidney smooth muscle tissue development,BP,
15685,GO:0072208,0.999999999989796,0.921129163145696,0,1,metanephric smooth muscle tissue development,BP,
15689,GO:0072214,0.999999999989796,0.921129163145696,0,1,metanephric cortex development,BP,
15694,GO:0072219,0.999999999989796,0.921129163145696,0,1,metanephric cortical collecting duct development,BP,
15695,GO:0072221,0.999999999989796,0.921129163145696,0,1,metanephric distal convoluted tubule development,BP,
15704,GO:0072240,0.999999999989796,0.921129163145696,0,1,metanephric DCT cell differentiation,BP,
15706,GO:0072244,0.999999999989796,0.921129163145696,0,1,metanephric glomerular epithelium development,BP,
15707,GO:0072248,0.999999999989796,0.921129163145696,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15708,GO:0072249,0.999999999989796,0.921129163145696,0,1,metanephric glomerular visceral epithelial cell development,BP,
15719,GO:0072274,0.999999999989796,0.921129163145696,0,1,metanephric glomerular basement membrane development,BP,
15724,GO:0072285,0.999999999989796,0.921129163145696,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15725,GO:0072287,0.999999999989796,0.921129163145696,0,1,metanephric distal tubule morphogenesis,BP,
15728,GO:0072299,0.999999999989796,0.921129163145696,0,1,negative regulation of metanephric glomerulus development,BP,
15731,GO:0072302,0.999999999989796,0.921129163145696,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15733,GO:0072304,0.999999999989796,0.921129163145696,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15734,GO:0072305,0.999999999989796,0.921129163145696,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15736,GO:0072308,0.999999999989796,0.921129163145696,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15737,GO:0072309,0.999999999989796,0.921129163145696,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15740,GO:0072312,0.999999999989796,0.921129163145696,0,1,metanephric glomerular epithelial cell differentiation,BP,
15741,GO:0072313,0.999999999989796,0.921129163145696,0,1,metanephric glomerular epithelial cell development,BP,
15768,GO:0072362,0.999999999989796,0.921129163145696,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15769,GO:0072363,0.999999999989796,0.921129163145696,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15771,GO:0072365,0.999999999989796,0.921129163145696,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15772,GO:0072366,0.999999999989796,0.921129163145696,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15779,GO:0072382,0.999999999989796,0.921129163145696,0,1,minus-end-directed vesicle transport along microtubule,BP,
15786,GO:0072389,0.999999999989796,0.921129163145696,0,1,flavin adenine dinucleotide catabolic process,BP,
15793,GO:0072414,0.999999999989796,0.921129163145696,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15800,GO:0072432,0.999999999989796,0.921129163145696,0,1,response to G1 DNA damage checkpoint signaling,BP,
15818,GO:0072517,0.999999999989796,0.921129163145696,0,1,host cell viral assembly compartment,CC,
15819,GO:0072518,0.999999999989796,0.921129163145696,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15832,GO:0072534,0.999999999989796,0.921129163145696,0,1,perineuronal net,CC,
15833,GO:0072535,0.999999999989796,0.921129163145696,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15845,GO:0072556,0.999999999989796,0.921129163145696,0,1,other organism presynaptic membrane,CC,
15849,GO:0072560,0.999999999989796,0.921129163145696,0,1,type B pancreatic cell maturation,BP,
15855,GO:0072570,0.999999999989796,0.921129163145696,0,1,ADP-D-ribose binding,MF,
15863,GO:0072579,0.999999999989796,0.921129163145696,0,1,glycine receptor clustering,BP,
15867,GO:0072586,0.999999999989796,0.921129163145696,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15868,GO:0072587,0.999999999989796,0.921129163145696,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15871,GO:0072590,0.999999999989796,0.921129163145696,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15872,GO:0072591,0.999999999989796,0.921129163145696,0,1,citrate-L-glutamate ligase activity,MF,
15886,GO:0072616,0.999999999989796,0.921129163145696,0,1,interleukin-18 secretion,BP,
15887,GO:0072619,0.999999999989796,0.921129163145696,0,1,interleukin-21 secretion,BP,
15894,GO:0072658,0.999999999989796,0.921129163145696,0,1,maintenance of protein location in membrane,BP,
15896,GO:0072660,0.999999999989796,0.921129163145696,0,1,maintenance of protein location in plasma membrane,BP,
15911,GO:0072680,0.999999999989796,0.921129163145696,0,1,extracellular matrix-dependent thymocyte migration,BP,
15912,GO:0072681,0.999999999989796,0.921129163145696,0,1,fibronectin-dependent thymocyte migration,BP,
15915,GO:0072684,0.999999999989796,0.921129163145696,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15921,GO:0072702,0.999999999989796,0.921129163145696,0,1,response to methyl methanesulfonate,BP,
15922,GO:0072703,0.999999999989796,0.921129163145696,0,1,cellular response to methyl methanesulfonate,BP,
15935,GO:0072720,0.999999999989796,0.921129163145696,0,1,response to dithiothreitol,BP,
15945,GO:0072752,0.999999999989796,0.921129163145696,0,1,cellular response to rapamycin,BP,
15946,GO:0072755,0.999999999989796,0.921129163145696,0,1,cellular response to benomyl,BP,
15950,GO:0075109,0.999999999989796,0.921129163145696,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15951,GO:0075111,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15952,GO:0075112,0.999999999989796,0.921129163145696,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15953,GO:0075114,0.999999999989796,0.921129163145696,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15992,GO:0085032,0.999999999989796,0.921129163145696,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16015,GO:0086024,0.999999999989796,0.921129163145696,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16021,GO:0086038,0.999999999989796,0.921129163145696,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16022,GO:0086039,0.999999999989796,0.921129163145696,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16023,GO:0086040,0.999999999989796,0.921129163145696,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16026,GO:0086044,0.999999999989796,0.921129163145696,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16028,GO:0086046,0.999999999989796,0.921129163145696,0,1,membrane depolarization during SA node cell action potential,BP,
16029,GO:0086047,0.999999999989796,0.921129163145696,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16032,GO:0086054,0.999999999989796,0.921129163145696,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16033,GO:0086055,0.999999999989796,0.921129163145696,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16034,GO:0086056,0.999999999989796,0.921129163145696,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16035,GO:0086057,0.999999999989796,0.921129163145696,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16046,GO:0086076,0.999999999989796,0.921129163145696,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16048,GO:0086078,0.999999999989796,0.921129163145696,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16049,GO:0086079,0.999999999989796,0.921129163145696,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16053,GO:0086089,0.999999999989796,0.921129163145696,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16055,GO:0086092,0.999999999989796,0.921129163145696,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16058,GO:0086100,0.999999999989796,0.921129163145696,0,1,endothelin receptor signaling pathway,BP,
16069,GO:0090024,0.999999999989796,0.921129163145696,0,1,negative regulation of neutrophil chemotaxis,BP,
16091,GO:0090067,0.999999999989796,0.921129163145696,0,1,regulation of thalamus size,BP,
16129,GO:0090119,0.999999999989796,0.921129163145696,0,1,vesicle-mediated cholesterol transport,BP,
16137,GO:0090138,0.999999999989796,0.921129163145696,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16159,GO:0090176,0.999999999989796,0.921129163145696,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16180,GO:0090198,0.999999999989796,0.921129163145696,0,1,negative regulation of chemokine secretion,BP,
16192,GO:0090212,0.999999999989796,0.921129163145696,0,1,negative regulation of establishment of blood-brain barrier,BP,
16216,GO:0090251,0.999999999989796,0.921129163145696,0,1,protein localization involved in establishment of planar polarity,BP,
16220,GO:0090260,0.999999999989796,0.921129163145696,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16228,GO:0090272,0.999999999989796,0.921129163145696,0,1,negative regulation of fibroblast growth factor production,BP,
16236,GO:0090284,0.999999999989796,0.921129163145696,0,1,positive regulation of protein glycosylation in Golgi,BP,
16269,GO:0090326,0.999999999989796,0.921129163145696,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16288,GO:0090370,0.999999999989796,0.921129163145696,0,1,negative regulation of cholesterol efflux,BP,
16295,GO:0090389,0.999999999989796,0.921129163145696,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16310,GO:0090461,0.999999999989796,0.921129163145696,0,1,glutamate homeostasis,BP,
16311,GO:0090472,0.999999999989796,0.921129163145696,0,1,dibasic protein processing,BP,
16329,GO:0090537,0.999999999989796,0.921129163145696,0,1,CERF complex,CC,
16347,GO:0090600,0.999999999989796,0.921129163145696,0,1,alpha-1,3-glucosidase activity,MF,
16348,GO:0090601,0.999999999989796,0.921129163145696,0,1,enucleation,BP,
16351,GO:0090616,0.999999999989796,0.921129163145696,0,1,mitochondrial mRNA 3'-end processing,BP,
16352,GO:0090624,0.999999999989796,0.921129163145696,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16353,GO:0090625,0.999999999989796,0.921129163145696,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16367,GO:0090667,0.999999999989796,0.921129163145696,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16368,GO:0090668,0.999999999989796,0.921129163145696,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16389,GO:0093001,0.999999999989796,0.921129163145696,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16402,GO:0097020,0.999999999989796,0.921129163145696,0,1,COPII adaptor activity,MF,
16405,GO:0097026,0.999999999989796,0.921129163145696,0,1,dendritic cell dendrite assembly,BP,
16408,GO:0097029,0.999999999989796,0.921129163145696,0,1,mature conventional dendritic cell differentiation,BP,
16411,GO:0097037,0.999999999989796,0.921129163145696,0,1,heme export,BP,
16414,GO:0097045,0.999999999989796,0.921129163145696,0,1,phosphatidylserine exposure on blood platelet,BP,
16434,GO:0097070,0.999999999989796,0.921129163145696,0,1,ductus arteriosus closure,BP,
16436,GO:0097086,0.999999999989796,0.921129163145696,0,1,amniotic stem cell differentiation,BP,
16448,GO:0097108,0.999999999989796,0.921129163145696,0,1,hedgehog family protein binding,MF,
16452,GO:0097112,0.999999999989796,0.921129163145696,0,1,gamma-aminobutyric acid receptor clustering,BP,
16455,GO:0097116,0.999999999989796,0.921129163145696,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16456,GO:0097117,0.999999999989796,0.921129163145696,0,1,guanylate kinase-associated protein clustering,BP,
16457,GO:0097118,0.999999999989796,0.921129163145696,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16476,GO:0097156,0.999999999989796,0.921129163145696,0,1,fasciculation of motor neuron axon,BP,
16480,GO:0097161,0.999999999989796,0.921129163145696,0,1,DH domain binding,MF,
16481,GO:0097162,0.999999999989796,0.921129163145696,0,1,MADS box domain binding,MF,
16484,GO:0097166,0.999999999989796,0.921129163145696,0,1,lens epithelial cell proliferation,BP,
16486,GO:0097168,0.999999999989796,0.921129163145696,0,1,mesenchymal stem cell proliferation,BP,
16515,GO:0097222,0.999999999989796,0.921129163145696,0,1,mitochondrial mRNA polyadenylation,BP,
16524,GO:0097232,0.999999999989796,0.921129163145696,0,1,lamellar body membrane,CC,
16525,GO:0097233,0.999999999989796,0.921129163145696,0,1,alveolar lamellar body membrane,CC,
16535,GO:0097272,0.999999999989796,0.921129163145696,0,1,ammonia homeostasis,BP,
16536,GO:0097273,0.999999999989796,0.921129163145696,0,1,creatinine homeostasis,BP,
16538,GO:0097275,0.999999999989796,0.921129163145696,0,1,cellular ammonia homeostasis,BP,
16539,GO:0097276,0.999999999989796,0.921129163145696,0,1,cellular creatinine homeostasis,BP,
16540,GO:0097277,0.999999999989796,0.921129163145696,0,1,cellular urea homeostasis,BP,
16547,GO:0097298,0.999999999989796,0.921129163145696,0,1,regulation of nucleus size,BP,
16552,GO:0097310,0.999999999989796,0.921129163145696,0,1,cap2 mRNA methylation,BP,
16559,GO:0097338,0.999999999989796,0.921129163145696,0,1,response to clozapine,BP,
16584,GO:0097382,0.999999999989796,0.921129163145696,0,1,deoxynucleoside-diphosphatase activity,MF,
16585,GO:0097383,0.999999999989796,0.921129163145696,0,1,dIDP diphosphatase activity,MF,
16588,GO:0097393,0.999999999989796,0.921129163145696,0,1,telomeric repeat-containing RNA transcription,BP,
16589,GO:0097394,0.999999999989796,0.921129163145696,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16611,GO:0097444,0.999999999989796,0.921129163145696,0,1,spine apparatus,CC,
16625,GO:0097473,0.999999999989796,0.921129163145696,0,1,retinal rod cell apoptotic process,BP,
16638,GO:0097497,0.999999999989796,0.921129163145696,0,1,blood vessel endothelial cell delamination,BP,
16646,GO:0097505,0.999999999989796,0.921129163145696,0,1,Rad6-Rad18 complex,CC,
16665,GO:0097541,0.999999999989796,0.921129163145696,0,1,axonemal basal plate,CC,
16677,GO:0097598,0.999999999989796,0.921129163145696,0,1,sperm cytoplasmic droplet,CC,
16679,GO:0097603,0.999999999989796,0.921129163145696,0,1,temperature-gated ion channel activity,MF,
16687,GO:0097630,0.999999999989796,0.921129163145696,0,1,intrinsic component of omegasome membrane,CC,
16688,GO:0097631,0.999999999989796,0.921129163145696,0,1,integral component of omegasome membrane,CC,
16703,GO:0097655,0.999999999989796,0.921129163145696,0,1,serpin family protein binding,MF,
16711,GO:0097692,0.999999999989796,0.921129163145696,0,1,histone H3-K4 monomethylation,BP,
16716,GO:0097699,0.999999999989796,0.921129163145696,0,1,vascular endothelial cell response to fluid shear stress,BP,
16721,GO:0097712,0.999999999989796,0.921129163145696,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16736,GO:0097749,0.999999999989796,0.921129163145696,0,1,membrane tubulation,BP,
16738,GO:0097753,0.999999999989796,0.921129163145696,0,1,membrane bending,BP,
16752,GO:0098530,0.999999999989796,0.921129163145696,0,1,positive regulation of strand invasion,BP,
16789,GO:0098621,0.999999999989796,0.921129163145696,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16792,GO:0098629,0.999999999989796,0.921129163145696,0,1,trans-Golgi network membrane organization,BP,
16806,GO:0098648,0.999999999989796,0.921129163145696,0,1,collagen anchoring fibril,CC,
16808,GO:0098652,0.999999999989796,0.921129163145696,0,1,collagen type VII anchoring fibril,CC,
16824,GO:0098705,0.999999999989796,0.921129163145696,0,1,copper ion import across plasma membrane,BP,
16831,GO:0098725,0.999999999989796,0.921129163145696,0,1,symmetric cell division,BP,
16837,GO:0098736,0.999999999989796,0.921129163145696,0,1,negative regulation of the force of heart contraction,BP,
16842,GO:0098746,0.999999999989796,0.921129163145696,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16844,GO:0098749,0.999999999989796,0.921129163145696,0,1,cerebellar neuron development,BP,
16888,GO:0098829,0.999999999989796,0.921129163145696,0,1,intestinal folate absorption,BP,
16889,GO:0098830,0.999999999989796,0.921129163145696,0,1,presynaptic endosome,CC,
16891,GO:0098833,0.999999999989796,0.921129163145696,0,1,presynaptic endocytic zone,CC,
16892,GO:0098835,0.999999999989796,0.921129163145696,0,1,presynaptic endocytic zone membrane,CC,
16894,GO:0098838,0.999999999989796,0.921129163145696,0,1,reduced folate transmembrane transport,BP,
16911,GO:0098875,0.999999999989796,0.921129163145696,0,1,epididymosome,CC,
16918,GO:0098885,0.999999999989796,0.921129163145696,0,1,modification of postsynaptic actin cytoskeleton,BP,
16921,GO:0098888,0.999999999989796,0.921129163145696,0,1,extrinsic component of presynaptic membrane,CC,
16922,GO:0098890,0.999999999989796,0.921129163145696,0,1,extrinsic component of postsynaptic membrane,CC,
16929,GO:0098906,0.999999999989796,0.921129163145696,0,1,regulation of Purkinje myocyte action potential,BP,
16930,GO:0098907,0.999999999989796,0.921129163145696,0,1,regulation of SA node cell action potential,BP,
16935,GO:0098912,0.999999999989796,0.921129163145696,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16943,GO:0098923,0.999999999989796,0.921129163145696,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16944,GO:0098924,0.999999999989796,0.921129163145696,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16945,GO:0098926,0.999999999989796,0.921129163145696,0,1,postsynaptic signal transduction,BP,
16952,GO:0098939,0.999999999989796,0.921129163145696,0,1,dendritic transport of mitochondrion,BP,
16954,GO:0098948,0.999999999989796,0.921129163145696,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16959,GO:0098968,0.999999999989796,0.921129163145696,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16963,GO:0098972,0.999999999989796,0.921129163145696,0,1,anterograde dendritic transport of mitochondrion,BP,
16967,GO:0098978,0.999999999989796,0.921129163145696,0,1,glutamatergic synapse,CC,
16971,GO:0098985,0.999999999989796,0.921129163145696,0,1,asymmetric, glutamatergic, excitatory synapse,CC,
16972,GO:0098988,0.999999999989796,0.921129163145696,0,1,G-protein coupled glutamate receptor activity,MF,
16982,GO:0099039,0.999999999989796,0.921129163145696,0,1,sphingolipid translocation,BP,
16988,GO:0099060,0.999999999989796,0.921129163145696,0,1,integral component of postsynaptic specialization membrane,CC,
16989,GO:0099061,0.999999999989796,0.921129163145696,0,1,integral component of postsynaptic density membrane,CC,
16995,GO:0099077,0.999999999989796,0.921129163145696,0,1,histone-dependent DNA binding,MF,
17003,GO:0099089,0.999999999989796,0.921129163145696,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17006,GO:0099095,0.999999999989796,0.921129163145696,0,1,ligand-gated anion channel activity,MF,
17007,GO:0099098,0.999999999989796,0.921129163145696,0,1,microtubule polymerization based movement,BP,
17017,GO:0099146,0.999999999989796,0.921129163145696,0,1,intrinsic component of postsynaptic density membrane,CC,
17018,GO:0099159,0.999999999989796,0.921129163145696,0,1,regulation of modification of postsynaptic structure,BP,
17019,GO:0099163,0.999999999989796,0.921129163145696,0,1,synaptic signaling by nitric oxide,BP,
17029,GO:0099243,0.999999999989796,0.921129163145696,0,1,extrinsic component of synaptic membrane,CC,
17044,GO:0099519,0.999999999989796,0.921129163145696,0,1,dense core granule cytoskeletal transport,BP,
17050,GO:0099527,0.999999999989796,0.921129163145696,0,1,postsynapse to nucleus signaling pathway,BP,
17061,GO:0099543,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by soluble gas,BP,
17062,GO:0099545,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17064,GO:0099548,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by nitric oxide,BP,
17067,GO:0099552,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17068,GO:0099553,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17069,GO:0099557,0.999999999989796,0.921129163145696,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17077,GO:0099580,0.999999999989796,0.921129163145696,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17084,GO:0099606,0.999999999989796,0.921129163145696,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17085,GO:0099607,0.999999999989796,0.921129163145696,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17088,GO:0099617,0.999999999989796,0.921129163145696,0,1,matrix side of mitochondrial inner membrane,CC,
17093,GO:0099627,0.999999999989796,0.921129163145696,0,1,neurotransmitter receptor cycle,BP,
17095,GO:0099630,0.999999999989796,0.921129163145696,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17107,GO:0100002,0.999999999989796,0.921129163145696,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17109,GO:0100057,0.999999999989796,0.921129163145696,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17120,GO:0102008,0.999999999989796,0.921129163145696,0,1,cytosolic dipeptidase activity,MF,
17125,GO:0102113,0.999999999989796,0.921129163145696,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17127,GO:0102131,0.999999999989796,0.921129163145696,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17128,GO:0102132,0.999999999989796,0.921129163145696,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17131,GO:0102166,0.999999999989796,0.921129163145696,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17132,GO:0102167,0.999999999989796,0.921129163145696,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17133,GO:0102200,0.999999999989796,0.921129163145696,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17157,GO:0102500,0.999999999989796,0.921129163145696,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17160,GO:0102524,0.999999999989796,0.921129163145696,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17163,GO:0102571,0.999999999989796,0.921129163145696,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17164,GO:0102704,0.999999999989796,0.921129163145696,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17171,GO:0102773,0.999999999989796,0.921129163145696,0,1,dihydroceramide kinase activity,MF,
17172,GO:0102797,0.999999999989796,0.921129163145696,0,1,geranial:oxygen oxidoreductase activity,MF,
17173,GO:0102798,0.999999999989796,0.921129163145696,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17181,GO:0103046,0.999999999989796,0.921129163145696,0,1,alanylglutamate dipeptidase activity,MF,
17192,GO:0106005,0.999999999989796,0.921129163145696,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17199,GO:0106022,0.999999999989796,0.921129163145696,0,1,positive regulation of vesicle docking,BP,
17201,GO:0106028,0.999999999989796,0.921129163145696,0,1,neuron projection retraction,BP,
17217,GO:0106075,0.999999999989796,0.921129163145696,0,1,peptide N-succinyltransferase activity,MF,
17219,GO:0106078,0.999999999989796,0.921129163145696,0,1,histone succinyltransferase activity,MF,
17221,GO:0106088,0.999999999989796,0.921129163145696,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17222,GO:0106089,0.999999999989796,0.921129163145696,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17226,GO:0110008,0.999999999989796,0.921129163145696,0,1,ncRNA deadenylation,BP,
17236,GO:0110028,0.999999999989796,0.921129163145696,0,1,positive regulation of mitotic spindle organization,BP,
17237,GO:0110029,0.999999999989796,0.921129163145696,0,1,negative regulation of meiosis I,BP,
17239,GO:0110057,0.999999999989796,0.921129163145696,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17240,GO:0110059,0.999999999989796,0.921129163145696,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17246,GO:0120012,0.999999999989796,0.921129163145696,0,1,intermembrane sphingolipid transfer,BP,
17248,GO:0120016,0.999999999989796,0.921129163145696,0,1,intermembrane sphingolipid transfer activity,MF,
17249,GO:0120017,0.999999999989796,0.921129163145696,0,1,intermembrane ceramide transfer activity,MF,
17259,GO:0120043,0.999999999989796,0.921129163145696,0,1,stereocilium shaft,CC,
17260,GO:0120044,0.999999999989796,0.921129163145696,0,1,stereocilium base,CC,
17268,GO:0120077,0.999999999989796,0.921129163145696,0,1,angiogenic sprout fusion,BP,
17269,GO:0120078,0.999999999989796,0.921129163145696,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17270,GO:0120092,0.999999999989796,0.921129163145696,0,1,crotonyl-CoA hydratase activity,MF,
17271,GO:0120093,0.999999999989796,0.921129163145696,0,1,regulation of peptidyl-lysine crotonylation,BP,
17272,GO:0120094,0.999999999989796,0.921129163145696,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17278,GO:0140009,0.999999999989796,0.921129163145696,0,1,L-aspartate import across plasma membrane,BP,
17294,GO:0140064,0.999999999989796,0.921129163145696,0,1,peptide crotonyltransferase activity,MF,
17295,GO:0140065,0.999999999989796,0.921129163145696,0,1,peptide butyryltransferase activity,MF,
17297,GO:0140067,0.999999999989796,0.921129163145696,0,1,peptidyl-lysine butyrylation,BP,
17298,GO:0140068,0.999999999989796,0.921129163145696,0,1,histone crotonyltransferase activity,MF,
17299,GO:0140069,0.999999999989796,0.921129163145696,0,1,histone butyryltransferase activity,MF,
17320,GO:0140196,0.999999999989796,0.921129163145696,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17321,GO:0140199,0.999999999989796,0.921129163145696,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17322,GO:0140200,0.999999999989796,0.921129163145696,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17330,GO:0150031,0.999999999989796,0.921129163145696,0,1,regulation of protein localization to lysosome,BP,
17331,GO:0150033,0.999999999989796,0.921129163145696,0,1,negative regulation of protein localization to lysosome,BP,
17362,GO:1900062,0.999999999989796,0.921129163145696,0,1,regulation of replicative cell aging,BP,
17367,GO:1900081,0.999999999989796,0.921129163145696,0,1,regulation of arginine catabolic process,BP,
17368,GO:1900082,0.999999999989796,0.921129163145696,0,1,negative regulation of arginine catabolic process,BP,
17374,GO:1900095,0.999999999989796,0.921129163145696,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17400,GO:1900130,0.999999999989796,0.921129163145696,0,1,regulation of lipid binding,BP,
17401,GO:1900131,0.999999999989796,0.921129163145696,0,1,negative regulation of lipid binding,BP,
17403,GO:1900134,0.999999999989796,0.921129163145696,0,1,negative regulation of renin secretion into blood stream,BP,
17404,GO:1900135,0.999999999989796,0.921129163145696,0,1,positive regulation of renin secretion into blood stream,BP,
17406,GO:1900139,0.999999999989796,0.921129163145696,0,1,negative regulation of arachidonic acid secretion,BP,
17412,GO:1900148,0.999999999989796,0.921129163145696,0,1,negative regulation of Schwann cell migration,BP,
17413,GO:1900149,0.999999999989796,0.921129163145696,0,1,positive regulation of Schwann cell migration,BP,
17423,GO:1900170,0.999999999989796,0.921129163145696,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17431,GO:1900194,0.999999999989796,0.921129163145696,0,1,negative regulation of oocyte maturation,BP,
17433,GO:1900200,0.999999999989796,0.921129163145696,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17434,GO:1900204,0.999999999989796,0.921129163145696,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17435,GO:1900205,0.999999999989796,0.921129163145696,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17438,GO:1900211,0.999999999989796,0.921129163145696,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17439,GO:1900212,0.999999999989796,0.921129163145696,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17440,GO:1900214,0.999999999989796,0.921129163145696,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17441,GO:1900215,0.999999999989796,0.921129163145696,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17442,GO:1900217,0.999999999989796,0.921129163145696,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17443,GO:1900218,0.999999999989796,0.921129163145696,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17448,GO:1900224,0.999999999989796,0.921129163145696,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17456,GO:1900243,0.999999999989796,0.921129163145696,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17471,GO:1900276,0.999999999989796,0.921129163145696,0,1,regulation of proteinase activated receptor activity,BP,
17477,GO:1900370,0.999999999989796,0.921129163145696,0,1,positive regulation of RNA interference,BP,
17494,GO:1900450,0.999999999989796,0.921129163145696,0,1,negative regulation of glutamate receptor signaling pathway,BP,
17508,GO:1900736,0.999999999989796,0.921129163145696,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17509,GO:1900737,0.999999999989796,0.921129163145696,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17518,GO:1900753,0.999999999989796,0.921129163145696,0,1,doxorubicin transport,BP,
17521,GO:1900827,0.999999999989796,0.921129163145696,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17523,GO:1901003,0.999999999989796,0.921129163145696,0,1,negative regulation of fermentation,BP,
17545,GO:1901074,0.999999999989796,0.921129163145696,0,1,regulation of engulfment of apoptotic cell,BP,
17546,GO:1901076,0.999999999989796,0.921129163145696,0,1,positive regulation of engulfment of apoptotic cell,BP,
17548,GO:1901078,0.999999999989796,0.921129163145696,0,1,negative regulation of relaxation of muscle,BP,
17549,GO:1901086,0.999999999989796,0.921129163145696,0,1,benzylpenicillin metabolic process,BP,
17564,GO:1901147,0.999999999989796,0.921129163145696,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17582,GO:1901207,0.999999999989796,0.921129163145696,0,1,regulation of heart looping,BP,
17597,GO:1901254,0.999999999989796,0.921129163145696,0,1,positive regulation of intracellular transport of viral material,BP,
17622,GO:1901318,0.999999999989796,0.921129163145696,0,1,negative regulation of flagellated sperm motility,BP,
17630,GO:1901340,0.999999999989796,0.921129163145696,0,1,negative regulation of store-operated calcium channel activity,BP,
17666,GO:1901523,0.999999999989796,0.921129163145696,0,1,icosanoid catabolic process,BP,
17680,GO:1901551,0.999999999989796,0.921129163145696,0,1,negative regulation of endothelial cell development,BP,
17682,GO:1901555,0.999999999989796,0.921129163145696,0,1,response to paclitaxel,BP,
17684,GO:1901561,0.999999999989796,0.921129163145696,0,1,response to benomyl,BP,
17696,GO:1901580,0.999999999989796,0.921129163145696,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17697,GO:1901581,0.999999999989796,0.921129163145696,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17698,GO:1901582,0.999999999989796,0.921129163145696,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17699,GO:1901585,0.999999999989796,0.921129163145696,0,1,regulation of acid-sensing ion channel activity,BP,
17700,GO:1901594,0.999999999989796,0.921129163145696,0,1,response to capsazepine,BP,
17718,GO:1901631,0.999999999989796,0.921129163145696,0,1,positive regulation of presynaptic membrane organization,BP,
17719,GO:1901639,0.999999999989796,0.921129163145696,0,1,XDP catabolic process,BP,
17720,GO:1901640,0.999999999989796,0.921129163145696,0,1,XTP binding,MF,
17721,GO:1901641,0.999999999989796,0.921129163145696,0,1,ITP binding,MF,
17741,GO:1901675,0.999999999989796,0.921129163145696,0,1,negative regulation of histone H3-K27 acetylation,BP,
17745,GO:1901680,0.999999999989796,0.921129163145696,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17760,GO:1901726,0.999999999989796,0.921129163145696,0,1,negative regulation of histone deacetylase activity,BP,
17802,GO:1901895,0.999999999989796,0.921129163145696,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17805,GO:1901898,0.999999999989796,0.921129163145696,0,1,negative regulation of relaxation of cardiac muscle,BP,
17814,GO:1901950,0.999999999989796,0.921129163145696,0,1,dense core granule transport,BP,
17823,GO:1901980,0.999999999989796,0.921129163145696,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17840,GO:1902010,0.999999999989796,0.921129163145696,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17851,GO:1902038,0.999999999989796,0.921129163145696,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17865,GO:1902098,0.999999999989796,0.921129163145696,0,1,calcitriol binding,MF,
17869,GO:1902102,0.999999999989796,0.921129163145696,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17870,GO:1902103,0.999999999989796,0.921129163145696,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17880,GO:1902121,0.999999999989796,0.921129163145696,0,1,lithocholic acid binding,MF,
17881,GO:1902145,0.999999999989796,0.921129163145696,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17882,GO:1902151,0.999999999989796,0.921129163145696,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17883,GO:1902153,0.999999999989796,0.921129163145696,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17891,GO:1902173,0.999999999989796,0.921129163145696,0,1,negative regulation of keratinocyte apoptotic process,BP,
17896,GO:1902178,0.999999999989796,0.921129163145696,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17903,GO:1902211,0.999999999989796,0.921129163145696,0,1,regulation of prolactin signaling pathway,BP,
17904,GO:1902213,0.999999999989796,0.921129163145696,0,1,positive regulation of prolactin signaling pathway,BP,
17925,GO:1902238,0.999999999989796,0.921129163145696,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17926,GO:1902239,0.999999999989796,0.921129163145696,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17931,GO:1902257,0.999999999989796,0.921129163145696,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17940,GO:1902271,0.999999999989796,0.921129163145696,0,1,D3 vitamins binding,MF,
17942,GO:1902282,0.999999999989796,0.921129163145696,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17943,GO:1902283,0.999999999989796,0.921129163145696,0,1,negative regulation of primary amine oxidase activity,BP,
17948,GO:1902296,0.999999999989796,0.921129163145696,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17952,GO:1902304,0.999999999989796,0.921129163145696,0,1,positive regulation of potassium ion export,BP,
17961,GO:1902319,0.999999999989796,0.921129163145696,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17970,GO:1902363,0.999999999989796,0.921129163145696,0,1,regulation of protein localization to spindle pole body,BP,
17971,GO:1902365,0.999999999989796,0.921129163145696,0,1,positive regulation of protein localization to spindle pole body,BP,
17977,GO:1902379,0.999999999989796,0.921129163145696,0,1,chemoattractant activity involved in axon guidance,MF,
17979,GO:1902387,0.999999999989796,0.921129163145696,0,1,ceramide 1-phosphate binding,MF,
17980,GO:1902388,0.999999999989796,0.921129163145696,0,1,ceramide 1-phosphate transporter activity,MF,
17981,GO:1902389,0.999999999989796,0.921129163145696,0,1,ceramide 1-phosphate transport,BP,
17995,GO:1902442,0.999999999989796,0.921129163145696,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17996,GO:1902443,0.999999999989796,0.921129163145696,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
18000,GO:1902460,0.999999999989796,0.921129163145696,0,1,regulation of mesenchymal stem cell proliferation,BP,
18001,GO:1902462,0.999999999989796,0.921129163145696,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
18003,GO:1902464,0.999999999989796,0.921129163145696,0,1,regulation of histone H3-K27 trimethylation,BP,
18004,GO:1902466,0.999999999989796,0.921129163145696,0,1,positive regulation of histone H3-K27 trimethylation,BP,
18010,GO:1902488,0.999999999989796,0.921129163145696,0,1,cholangiocyte apoptotic process,BP,
18015,GO:1902499,0.999999999989796,0.921129163145696,0,1,positive regulation of protein autoubiquitination,BP,
18016,GO:1902504,0.999999999989796,0.921129163145696,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
18026,GO:1902528,0.999999999989796,0.921129163145696,0,1,regulation of protein linear polyubiquitination,BP,
18027,GO:1902530,0.999999999989796,0.921129163145696,0,1,positive regulation of protein linear polyubiquitination,BP,
18042,GO:1902565,0.999999999989796,0.921129163145696,0,1,positive regulation of neutrophil activation,BP,
18063,GO:1902618,0.999999999989796,0.921129163145696,0,1,cellular response to fluoride,BP,
18065,GO:1902623,0.999999999989796,0.921129163145696,0,1,negative regulation of neutrophil migration,BP,
18069,GO:1902630,0.999999999989796,0.921129163145696,0,1,regulation of membrane hyperpolarization,BP,
18070,GO:1902631,0.999999999989796,0.921129163145696,0,1,negative regulation of membrane hyperpolarization,BP,
18083,GO:1902685,0.999999999989796,0.921129163145696,0,1,positive regulation of receptor localization to synapse,BP,
18085,GO:1902688,0.999999999989796,0.921129163145696,0,1,regulation of NAD metabolic process,BP,
18086,GO:1902689,0.999999999989796,0.921129163145696,0,1,negative regulation of NAD metabolic process,BP,
18088,GO:1902710,0.999999999989796,0.921129163145696,0,1,GABA receptor complex,CC,
18089,GO:1902711,0.999999999989796,0.921129163145696,0,1,GABA-A receptor complex,CC,
18094,GO:1902723,0.999999999989796,0.921129163145696,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18096,GO:1902725,0.999999999989796,0.921129163145696,0,1,negative regulation of satellite cell differentiation,BP,
18101,GO:1902737,0.999999999989796,0.921129163145696,0,1,dendritic filopodium,CC,
18114,GO:1902769,0.999999999989796,0.921129163145696,0,1,regulation of choline O-acetyltransferase activity,BP,
18115,GO:1902771,0.999999999989796,0.921129163145696,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18116,GO:1902773,0.999999999989796,0.921129163145696,0,1,GTPase activator complex,CC,
18130,GO:1902823,0.999999999989796,0.921129163145696,0,1,negative regulation of late endosome to lysosome transport,BP,
18132,GO:1902838,0.999999999989796,0.921129163145696,0,1,regulation of nuclear migration along microtubule,BP,
18133,GO:1902846,0.999999999989796,0.921129163145696,0,1,positive regulation of mitotic spindle elongation,BP,
18134,GO:1902847,0.999999999989796,0.921129163145696,0,1,regulation of neuronal signal transduction,BP,
18160,GO:1902908,0.999999999989796,0.921129163145696,0,1,regulation of melanosome transport,BP,
18161,GO:1902910,0.999999999989796,0.921129163145696,0,1,positive regulation of melanosome transport,BP,
18163,GO:1902912,0.999999999989796,0.921129163145696,0,1,pyruvate kinase complex,CC,
18174,GO:1902939,0.999999999989796,0.921129163145696,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18175,GO:1902941,0.999999999989796,0.921129163145696,0,1,regulation of voltage-gated chloride channel activity,BP,
18176,GO:1902943,0.999999999989796,0.921129163145696,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18179,GO:1902948,0.999999999989796,0.921129163145696,0,1,negative regulation of tau-protein kinase activity,BP,
18186,GO:1902955,0.999999999989796,0.921129163145696,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18188,GO:1902957,0.999999999989796,0.921129163145696,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18200,GO:1902983,0.999999999989796,0.921129163145696,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18209,GO:1902997,0.999999999989796,0.921129163145696,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18210,GO:1902998,0.999999999989796,0.921129163145696,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18214,GO:1903004,0.999999999989796,0.921129163145696,0,1,regulation of protein K63-linked deubiquitination,BP,
18215,GO:1903006,0.999999999989796,0.921129163145696,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18216,GO:1903007,0.999999999989796,0.921129163145696,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18226,GO:1903027,0.999999999989796,0.921129163145696,0,1,regulation of opsonization,BP,
18227,GO:1903028,0.999999999989796,0.921129163145696,0,1,positive regulation of opsonization,BP,
18237,GO:1903045,0.999999999989796,0.921129163145696,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18259,GO:1903096,0.999999999989796,0.921129163145696,0,1,protein localization to meiotic spindle midzone,BP,
18260,GO:1903108,0.999999999989796,0.921129163145696,0,1,regulation of mitochondrial transcription,BP,
18261,GO:1903109,0.999999999989796,0.921129163145696,0,1,positive regulation of mitochondrial transcription,BP,
18272,GO:1903141,0.999999999989796,0.921129163145696,0,1,negative regulation of establishment of endothelial barrier,BP,
18274,GO:1903143,0.999999999989796,0.921129163145696,0,1,adrenomedullin receptor complex,CC,
18309,GO:1903231,0.999999999989796,0.921129163145696,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18317,GO:1903244,0.999999999989796,0.921129163145696,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18318,GO:1903248,0.999999999989796,0.921129163145696,0,1,regulation of citrulline biosynthetic process,BP,
18319,GO:1903249,0.999999999989796,0.921129163145696,0,1,negative regulation of citrulline biosynthetic process,BP,
18321,GO:1903259,0.999999999989796,0.921129163145696,0,1,exon-exon junction complex disassembly,BP,
18327,GO:1903282,0.999999999989796,0.921129163145696,0,1,regulation of glutathione peroxidase activity,BP,
18328,GO:1903284,0.999999999989796,0.921129163145696,0,1,positive regulation of glutathione peroxidase activity,BP,
18329,GO:1903285,0.999999999989796,0.921129163145696,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18356,GO:1903336,0.999999999989796,0.921129163145696,0,1,negative regulation of vacuolar transport,BP,
18370,GO:1903367,0.999999999989796,0.921129163145696,0,1,positive regulation of fear response,BP,
18377,GO:1903381,0.999999999989796,0.921129163145696,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18378,GO:1903382,0.999999999989796,0.921129163145696,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18382,GO:1903387,0.999999999989796,0.921129163145696,0,1,positive regulation of homophilic cell adhesion,BP,
18390,GO:1903406,0.999999999989796,0.921129163145696,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18391,GO:1903408,0.999999999989796,0.921129163145696,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18394,GO:1903420,0.999999999989796,0.921129163145696,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18406,GO:1903434,0.999999999989796,0.921129163145696,0,1,negative regulation of constitutive secretory pathway,BP,
18413,GO:1903442,0.999999999989796,0.921129163145696,0,1,response to lipoic acid,BP,
18414,GO:1903444,0.999999999989796,0.921129163145696,0,1,negative regulation of brown fat cell differentiation,BP,
18416,GO:1903450,0.999999999989796,0.921129163145696,0,1,regulation of G1 to G0 transition,BP,
18417,GO:1903452,0.999999999989796,0.921129163145696,0,1,positive regulation of G1 to G0 transition,BP,
18418,GO:1903461,0.999999999989796,0.921129163145696,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18421,GO:1903465,0.999999999989796,0.921129163145696,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18433,GO:1903515,0.999999999989796,0.921129163145696,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18435,GO:1903517,0.999999999989796,0.921129163145696,0,1,negative regulation of single strand break repair,BP,
18456,GO:1903544,0.999999999989796,0.921129163145696,0,1,response to butyrate,BP,
18457,GO:1903545,0.999999999989796,0.921129163145696,0,1,cellular response to butyrate,BP,
18467,GO:1903565,0.999999999989796,0.921129163145696,0,1,negative regulation of protein localization to cilium,BP,
18470,GO:1903568,0.999999999989796,0.921129163145696,0,1,negative regulation of protein localization to ciliary membrane,BP,
18472,GO:1903570,0.999999999989796,0.921129163145696,0,1,regulation of protein kinase D signaling,BP,
18473,GO:1903572,0.999999999989796,0.921129163145696,0,1,positive regulation of protein kinase D signaling,BP,
18480,GO:1903584,0.999999999989796,0.921129163145696,0,1,regulation of histone deubiquitination,BP,
18481,GO:1903586,0.999999999989796,0.921129163145696,0,1,positive regulation of histone deubiquitination,BP,
18492,GO:1903613,0.999999999989796,0.921129163145696,0,1,regulation of protein tyrosine phosphatase activity,BP,
18493,GO:1903615,0.999999999989796,0.921129163145696,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18520,GO:1903697,0.999999999989796,0.921129163145696,0,1,negative regulation of microvillus assembly,BP,
18521,GO:1903699,0.999999999989796,0.921129163145696,0,1,tarsal gland development,BP,
18527,GO:1903709,0.999999999989796,0.921129163145696,0,1,uterine gland development,BP,
18529,GO:1903717,0.999999999989796,0.921129163145696,0,1,response to ammonia,BP,
18530,GO:1903718,0.999999999989796,0.921129163145696,0,1,cellular response to ammonia,BP,
18535,GO:1903724,0.999999999989796,0.921129163145696,0,1,positive regulation of centriole elongation,BP,
18549,GO:1903759,0.999999999989796,0.921129163145696,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18551,GO:1903762,0.999999999989796,0.921129163145696,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18553,GO:1903764,0.999999999989796,0.921129163145696,0,1,regulation of potassium ion export across plasma membrane,BP,
18556,GO:1903770,0.999999999989796,0.921129163145696,0,1,negative regulation of beta-galactosidase activity,BP,
18570,GO:1903797,0.999999999989796,0.921129163145696,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18578,GO:1903823,0.999999999989796,0.921129163145696,0,1,telomere single strand break repair,BP,
18579,GO:1903824,0.999999999989796,0.921129163145696,0,1,negative regulation of telomere single strand break repair,BP,
18602,GO:1903881,0.999999999989796,0.921129163145696,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18603,GO:1903883,0.999999999989796,0.921129163145696,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18604,GO:1903884,0.999999999989796,0.921129163145696,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18605,GO:1903886,0.999999999989796,0.921129163145696,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18635,GO:1903929,0.999999999989796,0.921129163145696,0,1,primary palate development,BP,
18642,GO:1903947,0.999999999989796,0.921129163145696,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18644,GO:1903952,0.999999999989796,0.921129163145696,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18645,GO:1903954,0.999999999989796,0.921129163145696,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18663,GO:1903979,0.999999999989796,0.921129163145696,0,1,negative regulation of microglial cell activation,BP,
18670,GO:1904000,0.999999999989796,0.921129163145696,0,1,positive regulation of eating behavior,BP,
18677,GO:1904022,0.999999999989796,0.921129163145696,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18678,GO:1904023,0.999999999989796,0.921129163145696,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18679,GO:1904024,0.999999999989796,0.921129163145696,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18689,GO:1904041,0.999999999989796,0.921129163145696,0,1,regulation of cystathionine beta-synthase activity,BP,
18690,GO:1904042,0.999999999989796,0.921129163145696,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18695,GO:1904048,0.999999999989796,0.921129163145696,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18696,GO:1904050,0.999999999989796,0.921129163145696,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18697,GO:1904054,0.999999999989796,0.921129163145696,0,1,regulation of cholangiocyte proliferation,BP,
18698,GO:1904056,0.999999999989796,0.921129163145696,0,1,positive regulation of cholangiocyte proliferation,BP,
18701,GO:1904059,0.999999999989796,0.921129163145696,0,1,regulation of locomotor rhythm,BP,
18721,GO:1904167,0.999999999989796,0.921129163145696,0,1,regulation of thyroid hormone receptor activity,BP,
18722,GO:1904168,0.999999999989796,0.921129163145696,0,1,negative regulation of thyroid hormone receptor activity,BP,
18723,GO:1904170,0.999999999989796,0.921129163145696,0,1,regulation of bleb assembly,BP,
18724,GO:1904172,0.999999999989796,0.921129163145696,0,1,positive regulation of bleb assembly,BP,
18729,GO:1904192,0.999999999989796,0.921129163145696,0,1,regulation of cholangiocyte apoptotic process,BP,
18730,GO:1904193,0.999999999989796,0.921129163145696,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18731,GO:1904195,0.999999999989796,0.921129163145696,0,1,regulation of granulosa cell proliferation,BP,
18732,GO:1904197,0.999999999989796,0.921129163145696,0,1,positive regulation of granulosa cell proliferation,BP,
18733,GO:1904199,0.999999999989796,0.921129163145696,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18734,GO:1904200,0.999999999989796,0.921129163145696,0,1,iodide transmembrane transport,BP,
18735,GO:1904201,0.999999999989796,0.921129163145696,0,1,regulation of iodide transport,BP,
18736,GO:1904202,0.999999999989796,0.921129163145696,0,1,negative regulation of iodide transport,BP,
18737,GO:1904204,0.999999999989796,0.921129163145696,0,1,regulation of skeletal muscle hypertrophy,BP,
18738,GO:1904206,0.999999999989796,0.921129163145696,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18743,GO:1904212,0.999999999989796,0.921129163145696,0,1,regulation of iodide transmembrane transport,BP,
18744,GO:1904213,0.999999999989796,0.921129163145696,0,1,negative regulation of iodide transmembrane transport,BP,
18751,GO:1904229,0.999999999989796,0.921129163145696,0,1,regulation of succinate dehydrogenase activity,BP,
18752,GO:1904231,0.999999999989796,0.921129163145696,0,1,positive regulation of succinate dehydrogenase activity,BP,
18753,GO:1904232,0.999999999989796,0.921129163145696,0,1,regulation of aconitate hydratase activity,BP,
18754,GO:1904234,0.999999999989796,0.921129163145696,0,1,positive regulation of aconitate hydratase activity,BP,
18762,GO:1904247,0.999999999989796,0.921129163145696,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18769,GO:1904265,0.999999999989796,0.921129163145696,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18770,GO:1904266,0.999999999989796,0.921129163145696,0,1,regulation of Schwann cell chemotaxis,BP,
18771,GO:1904268,0.999999999989796,0.921129163145696,0,1,positive regulation of Schwann cell chemotaxis,BP,
18778,GO:1904290,0.999999999989796,0.921129163145696,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18782,GO:1904298,0.999999999989796,0.921129163145696,0,1,regulation of transcytosis,BP,
18783,GO:1904300,0.999999999989796,0.921129163145696,0,1,positive regulation of transcytosis,BP,
18784,GO:1904301,0.999999999989796,0.921129163145696,0,1,regulation of maternal process involved in parturition,BP,
18785,GO:1904303,0.999999999989796,0.921129163145696,0,1,positive regulation of maternal process involved in parturition,BP,
18788,GO:1904313,0.999999999989796,0.921129163145696,0,1,response to methamphetamine hydrochloride,BP,
18790,GO:1904316,0.999999999989796,0.921129163145696,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18791,GO:1904317,0.999999999989796,0.921129163145696,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18797,GO:1904339,0.999999999989796,0.921129163145696,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18820,GO:1904393,0.999999999989796,0.921129163145696,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18821,GO:1904395,0.999999999989796,0.921129163145696,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18824,GO:1904404,0.999999999989796,0.921129163145696,0,1,response to formaldehyde,BP,
18828,GO:1904412,0.999999999989796,0.921129163145696,0,1,regulation of cardiac ventricle development,BP,
18829,GO:1904414,0.999999999989796,0.921129163145696,0,1,positive regulation of cardiac ventricle development,BP,
18843,GO:1904447,0.999999999989796,0.921129163145696,0,1,folic acid import across plasma membrane,BP,
18844,GO:1904448,0.999999999989796,0.921129163145696,0,1,regulation of aspartate secretion,BP,
18845,GO:1904450,0.999999999989796,0.921129163145696,0,1,positive regulation of aspartate secretion,BP,
18846,GO:1904454,0.999999999989796,0.921129163145696,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18855,GO:1904477,0.999999999989796,0.921129163145696,0,1,positive regulation of Ras GTPase binding,BP,
18860,GO:1904499,0.999999999989796,0.921129163145696,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18861,GO:1904501,0.999999999989796,0.921129163145696,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18871,GO:1904530,0.999999999989796,0.921129163145696,0,1,negative regulation of actin filament binding,BP,
18872,GO:1904531,0.999999999989796,0.921129163145696,0,1,positive regulation of actin filament binding,BP,
18875,GO:1904535,0.999999999989796,0.921129163145696,0,1,positive regulation of telomeric loop disassembly,BP,
18882,GO:1904565,0.999999999989796,0.921129163145696,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18883,GO:1904566,0.999999999989796,0.921129163145696,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18884,GO:1904567,0.999999999989796,0.921129163145696,0,1,response to wortmannin,BP,
18885,GO:1904568,0.999999999989796,0.921129163145696,0,1,cellular response to wortmannin,BP,
18903,GO:1904594,0.999999999989796,0.921129163145696,0,1,regulation of termination of RNA polymerase II transcription,BP,
18904,GO:1904595,0.999999999989796,0.921129163145696,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18913,GO:1904617,0.999999999989796,0.921129163145696,0,1,negative regulation of actin binding,BP,
18914,GO:1904618,0.999999999989796,0.921129163145696,0,1,positive regulation of actin binding,BP,
18922,GO:1904647,0.999999999989796,0.921129163145696,0,1,response to rotenone,BP,
18949,GO:1904713,0.999999999989796,0.921129163145696,0,1,beta-catenin destruction complex binding,MF,
18956,GO:1904721,0.999999999989796,0.921129163145696,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18979,GO:1904766,0.999999999989796,0.921129163145696,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18983,GO:1904777,0.999999999989796,0.921129163145696,0,1,negative regulation of protein localization to cell cortex,BP,
18987,GO:1904782,0.999999999989796,0.921129163145696,0,1,negative regulation of NMDA glutamate receptor activity,BP,
18989,GO:1904784,0.999999999989796,0.921129163145696,0,1,NLRP1 inflammasome complex assembly,BP,
18990,GO:1904790,0.999999999989796,0.921129163145696,0,1,regulation of shelterin complex assembly,BP,
18991,GO:1904792,0.999999999989796,0.921129163145696,0,1,positive regulation of shelterin complex assembly,BP,
18992,GO:1904793,0.999999999989796,0.921129163145696,0,1,regulation of euchromatin binding,BP,
18994,GO:1904797,0.999999999989796,0.921129163145696,0,1,negative regulation of core promoter binding,BP,
18996,GO:1904799,0.999999999989796,0.921129163145696,0,1,regulation of neuron remodeling,BP,
18997,GO:1904800,0.999999999989796,0.921129163145696,0,1,negative regulation of neuron remodeling,BP,
18999,GO:1904806,0.999999999989796,0.921129163145696,0,1,regulation of protein oxidation,BP,
19000,GO:1904808,0.999999999989796,0.921129163145696,0,1,positive regulation of protein oxidation,BP,
19007,GO:1904826,0.999999999989796,0.921129163145696,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19008,GO:1904828,0.999999999989796,0.921129163145696,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19020,GO:1904850,0.999999999989796,0.921129163145696,0,1,negative regulation of establishment of protein localization to telomere,BP,
19022,GO:1904854,0.999999999989796,0.921129163145696,0,1,proteasome core complex binding,MF,
19034,GO:1904878,0.999999999989796,0.921129163145696,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19054,GO:1904910,0.999999999989796,0.921129163145696,0,1,regulation of establishment of RNA localization to telomere,BP,
19055,GO:1904911,0.999999999989796,0.921129163145696,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19056,GO:1904913,0.999999999989796,0.921129163145696,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19057,GO:1904914,0.999999999989796,0.921129163145696,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19063,GO:1904933,0.999999999989796,0.921129163145696,0,1,regulation of cell proliferation in midbrain,BP,
19064,GO:1904934,0.999999999989796,0.921129163145696,0,1,negative regulation of cell proliferation in midbrain,BP,
19066,GO:1904947,0.999999999989796,0.921129163145696,0,1,folic acid import into mitochondrion,BP,
19073,GO:1904955,0.999999999989796,0.921129163145696,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19079,GO:1904971,0.999999999989796,0.921129163145696,0,1,regulation of viral translation,BP,
19080,GO:1904973,0.999999999989796,0.921129163145696,0,1,positive regulation of viral translation,BP,
19083,GO:1904977,0.999999999989796,0.921129163145696,0,1,lymphatic endothelial cell migration,BP,
19086,GO:1904980,0.999999999989796,0.921129163145696,0,1,positive regulation of endosome organization,BP,
19094,GO:1904998,0.999999999989796,0.921129163145696,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19101,GO:1905026,0.999999999989796,0.921129163145696,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19103,GO:1905033,0.999999999989796,0.921129163145696,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19104,GO:1905034,0.999999999989796,0.921129163145696,0,1,regulation of antifungal innate immune response,BP,
19105,GO:1905035,0.999999999989796,0.921129163145696,0,1,negative regulation of antifungal innate immune response,BP,
19112,GO:1905044,0.999999999989796,0.921129163145696,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19113,GO:1905045,0.999999999989796,0.921129163145696,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19132,GO:1905089,0.999999999989796,0.921129163145696,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19133,GO:1905090,0.999999999989796,0.921129163145696,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19136,GO:1905099,0.999999999989796,0.921129163145696,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19137,GO:1905103,0.999999999989796,0.921129163145696,0,1,integral component of lysosomal membrane,CC,
19140,GO:1905132,0.999999999989796,0.921129163145696,0,1,regulation of meiotic chromosome separation,BP,
19141,GO:1905133,0.999999999989796,0.921129163145696,0,1,negative regulation of meiotic chromosome separation,BP,
19147,GO:1905152,0.999999999989796,0.921129163145696,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19149,GO:1905154,0.999999999989796,0.921129163145696,0,1,negative regulation of membrane invagination,BP,
19151,GO:1905161,0.999999999989796,0.921129163145696,0,1,protein localization to phagocytic vesicle,BP,
19152,GO:1905162,0.999999999989796,0.921129163145696,0,1,regulation of phagosome maturation,BP,
19156,GO:1905168,0.999999999989796,0.921129163145696,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19157,GO:1905169,0.999999999989796,0.921129163145696,0,1,regulation of protein localization to phagocytic vesicle,BP,
19158,GO:1905171,0.999999999989796,0.921129163145696,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19159,GO:1905172,0.999999999989796,0.921129163145696,0,1,RISC complex binding,MF,
19165,GO:1905205,0.999999999989796,0.921129163145696,0,1,positive regulation of connective tissue replacement,BP,
19173,GO:1905222,0.999999999989796,0.921129163145696,0,1,atrioventricular canal morphogenesis,BP,
19174,GO:1905223,0.999999999989796,0.921129163145696,0,1,epicardium morphogenesis,BP,
19177,GO:1905242,0.999999999989796,0.921129163145696,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19182,GO:1905255,0.999999999989796,0.921129163145696,0,1,regulation of RNA binding transcription factor activity,BP,
19190,GO:1905274,0.999999999989796,0.921129163145696,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19192,GO:1905277,0.999999999989796,0.921129163145696,0,1,negative regulation of epithelial tube formation,BP,
19194,GO:1905279,0.999999999989796,0.921129163145696,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19195,GO:1905285,0.999999999989796,0.921129163145696,0,1,fibrous ring of heart morphogenesis,BP,
19200,GO:1905301,0.999999999989796,0.921129163145696,0,1,regulation of macropinocytosis,BP,
19201,GO:1905302,0.999999999989796,0.921129163145696,0,1,negative regulation of macropinocytosis,BP,
19202,GO:1905304,0.999999999989796,0.921129163145696,0,1,regulation of cardiac myofibril assembly,BP,
19203,GO:1905305,0.999999999989796,0.921129163145696,0,1,negative regulation of cardiac myofibril assembly,BP,
19204,GO:1905309,0.999999999989796,0.921129163145696,0,1,positive regulation of cohesin loading,BP,
19209,GO:1905317,0.999999999989796,0.921129163145696,0,1,inferior endocardial cushion morphogenesis,BP,
19218,GO:1905335,0.999999999989796,0.921129163145696,0,1,regulation of aggrephagy,BP,
19219,GO:1905337,0.999999999989796,0.921129163145696,0,1,positive regulation of aggrephagy,BP,
19223,GO:1905344,0.999999999989796,0.921129163145696,0,1,prostaglandin catabolic process,BP,
19227,GO:1905355,0.999999999989796,0.921129163145696,0,1,spine apparatus assembly,BP,
19228,GO:1905359,0.999999999989796,0.921129163145696,0,1,protein localization to meiotic spindle,BP,
19247,GO:1905405,0.999999999989796,0.921129163145696,0,1,regulation of mitotic cohesin loading,BP,
19248,GO:1905406,0.999999999989796,0.921129163145696,0,1,positive regulation of mitotic cohesin loading,BP,
19249,GO:1905407,0.999999999989796,0.921129163145696,0,1,regulation of creatine transmembrane transporter activity,BP,
19250,GO:1905408,0.999999999989796,0.921129163145696,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19257,GO:1905435,0.999999999989796,0.921129163145696,0,1,regulation of histone H3-K4 trimethylation,BP,
19258,GO:1905437,0.999999999989796,0.921129163145696,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19259,GO:1905438,0.999999999989796,0.921129163145696,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19260,GO:1905443,0.999999999989796,0.921129163145696,0,1,regulation of clathrin coat assembly,BP,
19261,GO:1905445,0.999999999989796,0.921129163145696,0,1,positive regulation of clathrin coat assembly,BP,
19263,GO:1905447,0.999999999989796,0.921129163145696,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19269,GO:1905458,0.999999999989796,0.921129163145696,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19273,GO:1905463,0.999999999989796,0.921129163145696,0,1,negative regulation of DNA duplex unwinding,BP,
19274,GO:1905464,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA duplex unwinding,BP,
19275,GO:1905468,0.999999999989796,0.921129163145696,0,1,regulation of clathrin-coated pit assembly,BP,
19276,GO:1905469,0.999999999989796,0.921129163145696,0,1,negative regulation of clathrin-coated pit assembly,BP,
19289,GO:1905524,0.999999999989796,0.921129163145696,0,1,negative regulation of protein autoubiquitination,BP,
19290,GO:1905535,0.999999999989796,0.921129163145696,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19291,GO:1905537,0.999999999989796,0.921129163145696,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19302,GO:1905572,0.999999999989796,0.921129163145696,0,1,ganglioside GM1 transport to membrane,BP,
19304,GO:1905574,0.999999999989796,0.921129163145696,0,1,ganglioside GM2 binding,MF,
19305,GO:1905575,0.999999999989796,0.921129163145696,0,1,ganglioside GM3 binding,MF,
19307,GO:1905577,0.999999999989796,0.921129163145696,0,1,ganglioside GP1c binding,MF,
19311,GO:1905590,0.999999999989796,0.921129163145696,0,1,fibronectin fibril organization,BP,
19314,GO:1905596,0.999999999989796,0.921129163145696,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19316,GO:1905598,0.999999999989796,0.921129163145696,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19319,GO:1905601,0.999999999989796,0.921129163145696,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19322,GO:1905610,0.999999999989796,0.921129163145696,0,1,regulation of mRNA cap binding,BP,
19323,GO:1905612,0.999999999989796,0.921129163145696,0,1,positive regulation of mRNA cap binding,BP,
19328,GO:1905642,0.999999999989796,0.921129163145696,0,1,negative regulation of DNA methylation,BP,
19329,GO:1905643,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA methylation,BP,
19340,GO:1905687,0.999999999989796,0.921129163145696,0,1,regulation of diacylglycerol kinase activity,BP,
19341,GO:1905689,0.999999999989796,0.921129163145696,0,1,positive regulation of diacylglycerol kinase activity,BP,
19343,GO:1905698,0.999999999989796,0.921129163145696,0,1,positive regulation of polysome binding,BP,
19344,GO:1905705,0.999999999989796,0.921129163145696,0,1,cellular response to paclitaxel,BP,
19347,GO:1905711,0.999999999989796,0.921129163145696,0,1,response to phosphatidylethanolamine,BP,
19351,GO:1905720,0.999999999989796,0.921129163145696,0,1,cytoplasmic microtubule bundle,CC,
19354,GO:1905767,0.999999999989796,0.921129163145696,0,1,regulation of double-stranded telomeric DNA binding,BP,
19355,GO:1905768,0.999999999989796,0.921129163145696,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19359,GO:1905774,0.999999999989796,0.921129163145696,0,1,regulation of DNA helicase activity,BP,
19360,GO:1905776,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA helicase activity,BP,
19365,GO:1905794,0.999999999989796,0.921129163145696,0,1,response to puromycin,BP,
19366,GO:1905795,0.999999999989796,0.921129163145696,0,1,cellular response to puromycin,BP,
19375,GO:1905843,0.999999999989796,0.921129163145696,0,1,regulation of cellular response to gamma radiation,BP,
19383,GO:1905878,0.999999999989796,0.921129163145696,0,1,invadopodium disassembly,BP,
19385,GO:1905880,0.999999999989796,0.921129163145696,0,1,negative regulation of oogenesis,BP,
19388,GO:1905891,0.999999999989796,0.921129163145696,0,1,regulation of cellular response to thapsigargin,BP,
19389,GO:1905892,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular response to thapsigargin,BP,
19390,GO:1905894,0.999999999989796,0.921129163145696,0,1,regulation of cellular response to tunicamycin,BP,
19391,GO:1905895,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular response to tunicamycin,BP,
19401,GO:1905927,0.999999999989796,0.921129163145696,0,1,regulation of invadopodium disassembly,BP,
19402,GO:1905929,0.999999999989796,0.921129163145696,0,1,positive regulation of invadopodium disassembly,BP,
19419,GO:1990003,0.999999999989796,0.921129163145696,0,1,IDP phosphatase activity,MF,
19422,GO:1990009,0.999999999989796,0.921129163145696,0,1,retinal cell apoptotic process,BP,
19424,GO:1990026,0.999999999989796,0.921129163145696,0,1,hippocampal mossy fiber expansion,CC,
19425,GO:1990029,0.999999999989796,0.921129163145696,0,1,vasomotion,BP,
19426,GO:1990031,0.999999999989796,0.921129163145696,0,1,pinceau fiber,CC,
19427,GO:1990032,0.999999999989796,0.921129163145696,0,1,parallel fiber,CC,
19429,GO:1990036,0.999999999989796,0.921129163145696,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19434,GO:1990048,0.999999999989796,0.921129163145696,0,1,anterograde neuronal dense core vesicle transport,BP,
19436,GO:1990051,0.999999999989796,0.921129163145696,0,1,activation of protein kinase C activity,BP,
19440,GO:1990074,0.999999999989796,0.921129163145696,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19452,GO:1990127,0.999999999989796,0.921129163145696,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19455,GO:1990134,0.999999999989796,0.921129163145696,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19467,GO:1990172,0.999999999989796,0.921129163145696,0,1,G-protein coupled receptor catabolic process,BP,
19469,GO:1990174,0.999999999989796,0.921129163145696,0,1,phosphodiesterase decapping endonuclease activity,MF,
19470,GO:1990175,0.999999999989796,0.921129163145696,0,1,EH domain binding,MF,
19485,GO:1990256,0.999999999989796,0.921129163145696,0,1,signal clustering,BP,
19488,GO:1990261,0.999999999989796,0.921129163145696,0,1,pre-mRNA catabolic process,BP,
19493,GO:1990275,0.999999999989796,0.921129163145696,0,1,preribosome binding,MF,
19498,GO:1990332,0.999999999989796,0.921129163145696,0,1,Ire1 complex,CC,
19507,GO:1990390,0.999999999989796,0.921129163145696,0,1,protein K33-linked ubiquitination,BP,
19519,GO:1990409,0.999999999989796,0.921129163145696,0,1,adrenomedullin binding,MF,
19525,GO:1990421,0.999999999989796,0.921129163145696,0,1,subtelomeric heterochromatin,CC,
19532,GO:1990439,0.999999999989796,0.921129163145696,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19537,GO:1990448,0.999999999989796,0.921129163145696,0,1,exon-exon junction complex binding,MF,
19541,GO:1990456,0.999999999989796,0.921129163145696,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19547,GO:1990502,0.999999999989796,0.921129163145696,0,1,dense core granule maturation,BP,
19551,GO:1990518,0.999999999989796,0.921129163145696,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19553,GO:1990523,0.999999999989796,0.921129163145696,0,1,bone regeneration,BP,
19560,GO:1990570,0.999999999989796,0.921129163145696,0,1,GDP-mannose transmembrane transport,BP,
19564,GO:1990578,0.999999999989796,0.921129163145696,0,1,perinuclear endoplasmic reticulum membrane,CC,
19565,GO:1990579,0.999999999989796,0.921129163145696,0,1,peptidyl-serine trans-autophosphorylation,BP,
19573,GO:1990603,0.999999999989796,0.921129163145696,0,1,dark adaptation,BP,
19575,GO:1990613,0.999999999989796,0.921129163145696,0,1,mitochondrial membrane fusion,BP,
19579,GO:1990630,0.999999999989796,0.921129163145696,0,1,IRE1-RACK1-PP2A complex,CC,
19583,GO:1990646,0.999999999989796,0.921129163145696,0,1,cellular response to prolactin,BP,
19584,GO:1990654,0.999999999989796,0.921129163145696,0,1,sebum secreting cell proliferation,BP,
19590,GO:1990700,0.999999999989796,0.921129163145696,0,1,nucleolar chromatin organization,BP,
19591,GO:1990705,0.999999999989796,0.921129163145696,0,1,cholangiocyte proliferation,BP,
19592,GO:1990707,0.999999999989796,0.921129163145696,0,1,nuclear subtelomeric heterochromatin,CC,
19594,GO:1990715,0.999999999989796,0.921129163145696,0,1,mRNA CDS binding,MF,
19600,GO:1990736,0.999999999989796,0.921129163145696,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19602,GO:1990738,0.999999999989796,0.921129163145696,0,1,pseudouridine 5'-phosphatase activity,MF,
19603,GO:1990739,0.999999999989796,0.921129163145696,0,1,granulosa cell proliferation,BP,
19609,GO:1990751,0.999999999989796,0.921129163145696,0,1,Schwann cell chemotaxis,BP,
19611,GO:1990755,0.999999999989796,0.921129163145696,0,1,mitotic spindle microtubule depolymerization,BP,
19618,GO:1990771,0.999999999989796,0.921129163145696,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19625,GO:1990784,0.999999999989796,0.921129163145696,0,1,response to dsDNA,BP,
19627,GO:1990786,0.999999999989796,0.921129163145696,0,1,cellular response to dsDNA,BP,
19629,GO:1990796,0.999999999989796,0.921129163145696,0,1,photoreceptor cell terminal bouton,CC,
19665,GO:1990926,0.999999999989796,0.921129163145696,0,1,short-term synaptic potentiation,BP,
19669,GO:1990931,0.999999999989796,0.921129163145696,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19671,GO:1990938,0.999999999989796,0.921129163145696,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19674,GO:1990955,0.999999999989796,0.921129163145696,0,1,G-rich single-stranded DNA binding,MF,
19677,GO:1990968,0.999999999989796,0.921129163145696,0,1,modulation by host of RNA binding by virus,BP,
19678,GO:1990969,0.999999999989796,0.921129163145696,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19683,GO:2000003,0.999999999989796,0.921129163145696,0,1,positive regulation of DNA damage checkpoint,BP,
19714,GO:2000055,0.999999999989796,0.921129163145696,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19744,GO:2000118,0.999999999989796,0.921129163145696,0,1,regulation of sodium-dependent phosphate transport,BP,
19761,GO:2000167,0.999999999989796,0.921129163145696,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19765,GO:2000173,0.999999999989796,0.921129163145696,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19766,GO:2000174,0.999999999989796,0.921129163145696,0,1,regulation of pro-T cell differentiation,BP,
19767,GO:2000176,0.999999999989796,0.921129163145696,0,1,positive regulation of pro-T cell differentiation,BP,
19780,GO:2000199,0.999999999989796,0.921129163145696,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19781,GO:2000200,0.999999999989796,0.921129163145696,0,1,regulation of ribosomal subunit export from nucleus,BP,
19782,GO:2000202,0.999999999989796,0.921129163145696,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19783,GO:2000206,0.999999999989796,0.921129163145696,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19784,GO:2000208,0.999999999989796,0.921129163145696,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19787,GO:2000211,0.999999999989796,0.921129163145696,0,1,regulation of glutamate metabolic process,BP,
19788,GO:2000212,0.999999999989796,0.921129163145696,0,1,negative regulation of glutamate metabolic process,BP,
19823,GO:2000283,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19828,GO:2000295,0.999999999989796,0.921129163145696,0,1,regulation of hydrogen peroxide catabolic process,BP,
19829,GO:2000297,0.999999999989796,0.921129163145696,0,1,negative regulation of synapse maturation,BP,
19831,GO:2000299,0.999999999989796,0.921129163145696,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19837,GO:2000307,0.999999999989796,0.921129163145696,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19838,GO:2000309,0.999999999989796,0.921129163145696,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19853,GO:2000325,0.999999999989796,0.921129163145696,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19854,GO:2000327,0.999999999989796,0.921129163145696,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19856,GO:2000329,0.999999999989796,0.921129163145696,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19858,GO:2000331,0.999999999989796,0.921129163145696,0,1,regulation of terminal button organization,BP,
19879,GO:2000361,0.999999999989796,0.921129163145696,0,1,regulation of prostaglandin-E synthase activity,BP,
19880,GO:2000363,0.999999999989796,0.921129163145696,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19893,GO:2000382,0.999999999989796,0.921129163145696,0,1,positive regulation of mesoderm development,BP,
19894,GO:2000383,0.999999999989796,0.921129163145696,0,1,regulation of ectoderm development,BP,
19895,GO:2000384,0.999999999989796,0.921129163145696,0,1,negative regulation of ectoderm development,BP,
19910,GO:2000405,0.999999999989796,0.921129163145696,0,1,negative regulation of T cell migration,BP,
19914,GO:2000410,0.999999999989796,0.921129163145696,0,1,regulation of thymocyte migration,BP,
19915,GO:2000412,0.999999999989796,0.921129163145696,0,1,positive regulation of thymocyte migration,BP,
19916,GO:2000413,0.999999999989796,0.921129163145696,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19917,GO:2000415,0.999999999989796,0.921129163145696,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
19926,GO:2000426,0.999999999989796,0.921129163145696,0,1,negative regulation of apoptotic cell clearance,BP,
19939,GO:2000468,0.999999999989796,0.921129163145696,0,1,regulation of peroxidase activity,BP,
19940,GO:2000470,0.999999999989796,0.921129163145696,0,1,positive regulation of peroxidase activity,BP,
19950,GO:2000491,0.999999999989796,0.921129163145696,0,1,positive regulation of hepatic stellate cell activation,BP,
19965,GO:2000537,0.999999999989796,0.921129163145696,0,1,regulation of B cell chemotaxis,BP,
19966,GO:2000538,0.999999999989796,0.921129163145696,0,1,positive regulation of B cell chemotaxis,BP,
19981,GO:2000569,0.999999999989796,0.921129163145696,0,1,regulation of T-helper 2 cell activation,BP,
19982,GO:2000570,0.999999999989796,0.921129163145696,0,1,positive regulation of T-helper 2 cell activation,BP,
19988,GO:2000583,0.999999999989796,0.921129163145696,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19989,GO:2000584,0.999999999989796,0.921129163145696,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19995,GO:2000592,0.999999999989796,0.921129163145696,0,1,regulation of metanephric DCT cell differentiation,BP,
19996,GO:2000594,0.999999999989796,0.921129163145696,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19998,GO:2000606,0.999999999989796,0.921129163145696,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19999,GO:2000607,0.999999999989796,0.921129163145696,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20002,GO:2000612,0.999999999989796,0.921129163145696,0,1,regulation of thyroid-stimulating hormone secretion,BP,
20015,GO:2000631,0.999999999989796,0.921129163145696,0,1,regulation of pre-miRNA processing,BP,
20016,GO:2000632,0.999999999989796,0.921129163145696,0,1,negative regulation of pre-miRNA processing,BP,
20032,GO:2000654,0.999999999989796,0.921129163145696,0,1,regulation of cellular response to testosterone stimulus,BP,
20033,GO:2000655,0.999999999989796,0.921129163145696,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20038,GO:2000661,0.999999999989796,0.921129163145696,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20057,GO:2000685,0.999999999989796,0.921129163145696,0,1,positive regulation of cellular response to X-ray,BP,
20058,GO:2000690,0.999999999989796,0.921129163145696,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20059,GO:2000691,0.999999999989796,0.921129163145696,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20063,GO:2000699,0.999999999989796,0.921129163145696,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20064,GO:2000701,0.999999999989796,0.921129163145696,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20065,GO:2000702,0.999999999989796,0.921129163145696,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20066,GO:2000703,0.999999999989796,0.921129163145696,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20068,GO:2000706,0.999999999989796,0.921129163145696,0,1,negative regulation of dense core granule biogenesis,BP,
20078,GO:2000733,0.999999999989796,0.921129163145696,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20079,GO:2000734,0.999999999989796,0.921129163145696,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20084,GO:2000740,0.999999999989796,0.921129163145696,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20095,GO:2000759,0.999999999989796,0.921129163145696,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20096,GO:2000761,0.999999999989796,0.921129163145696,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20116,GO:2000795,0.999999999989796,0.921129163145696,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20117,GO:2000797,0.999999999989796,0.921129163145696,0,1,regulation of amniotic stem cell differentiation,BP,
20118,GO:2000798,0.999999999989796,0.921129163145696,0,1,negative regulation of amniotic stem cell differentiation,BP,
20119,GO:2000804,0.999999999989796,0.921129163145696,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20120,GO:2000806,0.999999999989796,0.921129163145696,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20122,GO:2000808,0.999999999989796,0.921129163145696,0,1,negative regulation of synaptic vesicle clustering,BP,
20126,GO:2000812,0.999999999989796,0.921129163145696,0,1,regulation of barbed-end actin filament capping,BP,
20129,GO:2000820,0.999999999989796,0.921129163145696,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20137,GO:2000830,0.999999999989796,0.921129163145696,0,1,positive regulation of parathyroid hormone secretion,BP,
20141,GO:2000834,0.999999999989796,0.921129163145696,0,1,regulation of androgen secretion,BP,
20142,GO:2000836,0.999999999989796,0.921129163145696,0,1,positive regulation of androgen secretion,BP,
20143,GO:2000843,0.999999999989796,0.921129163145696,0,1,regulation of testosterone secretion,BP,
20144,GO:2000845,0.999999999989796,0.921129163145696,0,1,positive regulation of testosterone secretion,BP,
20155,GO:2000864,0.999999999989796,0.921129163145696,0,1,regulation of estradiol secretion,BP,
20158,GO:2000909,0.999999999989796,0.921129163145696,0,1,regulation of sterol import,BP,
20168,GO:2000987,0.999999999989796,0.921129163145696,0,1,positive regulation of behavioral fear response,BP,
20183,GO:2001029,0.999999999989796,0.921129163145696,0,1,regulation of cellular glucuronidation,BP,
20184,GO:2001031,0.999999999989796,0.921129163145696,0,1,positive regulation of cellular glucuronidation,BP,
20206,GO:2001108,0.999999999989796,0.921129163145696,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20207,GO:2001109,0.999999999989796,0.921129163145696,0,1,regulation of lens epithelial cell proliferation,BP,
20208,GO:2001111,0.999999999989796,0.921129163145696,0,1,positive regulation of lens epithelial cell proliferation,BP,
20210,GO:2001136,0.999999999989796,0.921129163145696,0,1,negative regulation of endocytic recycling,BP,
20220,GO:2001151,0.999999999989796,0.921129163145696,0,1,regulation of renal water transport,BP,
20221,GO:2001153,0.999999999989796,0.921129163145696,0,1,positive regulation of renal water transport,BP,
20251,GO:2001203,0.999999999989796,0.921129163145696,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20256,GO:2001213,0.999999999989796,0.921129163145696,0,1,negative regulation of vasculogenesis,BP,
20264,GO:2001229,0.999999999989796,0.921129163145696,0,1,negative regulation of response to gamma radiation,BP,
20278,GO:2001246,0.999999999989796,0.921129163145696,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20279,GO:2001247,0.999999999989796,0.921129163145696,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20282,GO:2001253,0.999999999989796,0.921129163145696,0,1,regulation of histone H3-K36 trimethylation,BP,
8932,GO:0034777,0.999999999989807,0.921711518329291,0,1,recycling endosome lumen,CC,
3809,GO:0008396,0.999999999989839,0.921347887520968,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
18256,GO:1903093,0.999999999989843,0.805445417296179,0,3,regulation of protein K48-linked deubiquitination,BP,
15873,GO:0072592,0.999999999989849,0.850249968393903,0,2,oxygen metabolic process,BP,
688,GO:0001907,0.999999999989866,0.802046430909191,0,3,killing by symbiont of host cells,BP,
10711,GO:0044004,0.999999999989866,0.802046430909191,0,3,disruption by symbiont of host cell,BP,
10924,GO:0044533,0.999999999989866,0.802046430909191,0,3,positive regulation of apoptotic process in other organism,BP,
13303,GO:0052042,0.999999999989866,0.802046430909191,0,3,positive regulation by symbiont of host programmed cell death,BP,
13339,GO:0052330,0.999999999989866,0.802046430909191,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13358,GO:0052501,0.999999999989866,0.802046430909191,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13853,GO:0060456,0.999999999989875,0.782591423407038,0,3,positive regulation of digestive system process,BP,
130,GO:0000270,0.999999999989878,0.862627695006829,0,2,peptidoglycan metabolic process,BP,
3963,GO:0008745,0.999999999989878,0.862627695006829,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4178,GO:0009253,0.999999999989878,0.862627695006829,0,2,peptidoglycan catabolic process,BP,
5310,GO:0016019,0.999999999989878,0.862627695006829,0,2,peptidoglycan receptor activity,MF,
13144,GO:0051710,0.999999999989878,0.862627695006829,0,2,regulation of cytolysis in other organism,BP,
13146,GO:0051714,0.999999999989878,0.862627695006829,0,2,positive regulation of cytolysis in other organism,BP,
14441,GO:0061752,0.999999999989879,0.850964913211567,0,2,telomeric repeat-containing RNA binding,MF,
14165,GO:0061047,0.99999999998989,0.784834658798202,0,3,positive regulation of branching involved in lung morphogenesis,BP,
5153,GO:0015691,0.999999999989916,0.782848155126881,0,3,cadmium ion transport,BP,
14837,GO:0070574,0.999999999989916,0.782848155126881,0,3,cadmium ion transmembrane transport,BP,
16234,GO:0090281,0.999999999989916,0.782848155126881,0,3,negative regulation of calcium ion import,BP,
17363,GO:1900063,0.999999999989916,0.782848155126881,0,3,regulation of peroxisome organization,BP,
13987,GO:0060699,0.999999999989929,0.727030335328883,0,4,regulation of endoribonuclease activity,BP,
16133,GO:0090131,0.999999999989933,0.926786446794542,0,1,mesenchyme migration,BP,
1914,GO:0004607,0.999999999989949,0.930278193857893,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1619,GO:0004052,0.999999999989979,0.848796598316974,0,2,arachidonate 12-lipoxygenase activity,MF,
14889,GO:0070676,0.999999999989985,0.791744140847116,0,3,intralumenal vesicle formation,BP,
2370,GO:0005497,0.999999999989989,0.869625406314835,0,2,androgen binding,MF,
18228,GO:1903031,0.999999999989994,0.85082728015349,0,2,regulation of microtubule plus-end binding,BP,
18229,GO:1903033,0.999999999989994,0.85082728015349,0,2,positive regulation of microtubule plus-end binding,BP,
3819,GO:0008413,0.999999999989996,0.87106151537319,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9176,GO:0035539,0.999999999989996,0.87106151537319,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
4939,GO:0014900,0.999999999990041,0.724746025611297,0,4,muscle hyperplasia,BP,
14547,GO:0070061,0.999999999990051,0.786866304907412,0,3,fructose binding,MF,
18125,GO:1902809,0.999999999990051,0.786866304907412,0,3,regulation of skeletal muscle fiber differentiation,BP,
11309,GO:0045626,0.999999999990052,0.848684553086304,0,2,negative regulation of T-helper 1 cell differentiation,BP,
1677,GO:0004142,0.999999999990055,0.786970894995221,0,3,diacylglycerol cholinephosphotransferase activity,MF,
18668,GO:1903998,0.999999999990059,0.798925810276322,0,3,regulation of eating behavior,BP,
18700,GO:1904058,0.999999999990059,0.798925810276322,0,3,positive regulation of sensory perception of pain,BP,
7862,GO:0032422,0.999999999990061,0.782308149517588,0,3,purine-rich negative regulatory element binding,MF,
1737,GO:0004335,0.999999999990067,0.856774064436937,0,2,galactokinase activity,MF,
14382,GO:0061622,0.999999999990067,0.856774064436937,0,2,glycolytic process through glucose-1-phosphate,BP,
14813,GO:0070541,0.999999999990084,0.789261547937615,0,3,response to platinum ion,BP,
18422,GO:1903487,0.99999999999012,0.851323590800244,0,2,regulation of lactation,BP,
19524,GO:1990418,0.99999999999012,0.851323590800244,0,2,response to insulin-like growth factor stimulus,BP,
8336,GO:0033181,0.999999999990129,0.925628954171144,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
11384,GO:0045759,0.999999999990134,0.855441528230974,0,2,negative regulation of action potential,BP,
7607,GO:0031990,0.999999999990149,0.848800040212786,0,2,mRNA export from nucleus in response to heat stress,BP,
8751,GO:0034402,0.999999999990149,0.848800040212786,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
1793,GO:0004422,0.99999999999015,0.857882692658452,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2765,GO:0006178,0.99999999999015,0.857882692658452,0,2,guanine salvage,BP,
7749,GO:0032263,0.99999999999015,0.857882692658452,0,2,GMP salvage,BP,
11558,GO:0046099,0.99999999999015,0.857882692658452,0,2,guanine biosynthetic process,BP,
3996,GO:0008894,0.999999999990154,0.921130440539056,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
20105,GO:2000777,0.999999999990172,0.85053371646148,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
14262,GO:0061317,0.999999999990173,0.851615466775202,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17609,GO:1901295,0.999999999990173,0.851615466775202,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19123,GO:1905066,0.999999999990173,0.851615466775202,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
4130,GO:0009189,0.999999999990182,0.806913781056633,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
18031,GO:1902544,0.999999999990225,0.86676909542964,0,2,regulation of DNA N-glycosylase activity,BP,
11727,GO:0046533,0.99999999999025,0.720564763965884,0,4,negative regulation of photoreceptor cell differentiation,BP,
5544,GO:0016533,0.999999999990258,0.860456767178278,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
1627,GO:0004064,0.9999999999903,0.789599254205504,0,3,arylesterase activity,MF,
9147,GO:0035494,0.999999999990303,0.783855311494054,0,3,SNARE complex disassembly,BP,
1059,GO:0002587,0.999999999990306,0.929986990191826,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10825,GO:0044317,0.999999999990306,0.929986990191826,0,1,rod spherule,CC,
10861,GO:0044375,0.999999999990313,0.865280203577608,0,2,regulation of peroxisome size,BP,
9307,GO:0035752,0.999999999990317,0.923403266783993,0,1,lysosomal lumen pH elevation,BP,
9558,GO:0036333,0.999999999990358,0.921146424208526,0,1,hepatocyte homeostasis,BP,
18981,GO:1904772,0.999999999990358,0.921146424208526,0,1,response to tetrachloromethane,BP,
3759,GO:0008300,0.999999999990371,0.848482532035673,0,2,isoprenoid catabolic process,BP,
6049,GO:0019185,0.999999999990371,0.848482532035673,0,2,snRNA-activating protein complex,CC,
6140,GO:0019408,0.999999999990371,0.848482532035673,0,2,dolichol biosynthetic process,BP,
12323,GO:0048674,0.999999999990378,0.921281793469853,0,1,collateral sprouting of injured axon,BP,
12331,GO:0048686,0.999999999990378,0.921281793469853,0,1,regulation of sprouting of injured axon,BP,
12332,GO:0048687,0.999999999990378,0.921281793469853,0,1,positive regulation of sprouting of injured axon,BP,
12333,GO:0048688,0.999999999990378,0.921281793469853,0,1,negative regulation of sprouting of injured axon,BP,
12334,GO:0048689,0.999999999990378,0.921281793469853,0,1,formation of growth cone in injured axon,BP,
12335,GO:0048693,0.999999999990378,0.921281793469853,0,1,regulation of collateral sprouting of injured axon,BP,
12336,GO:0048694,0.999999999990378,0.921281793469853,0,1,positive regulation of collateral sprouting of injured axon,BP,
19308,GO:1905578,0.999999999990378,0.921281793469853,0,1,regulation of ERBB3 signaling pathway,BP,
19309,GO:1905580,0.999999999990378,0.921281793469853,0,1,positive regulation of ERBB3 signaling pathway,BP,
19409,GO:1905942,0.999999999990378,0.921281793469853,0,1,regulation of formation of growth cone in injured axon,BP,
19410,GO:1905943,0.999999999990378,0.921281793469853,0,1,negative regulation of formation of growth cone in injured axon,BP,
486,GO:0001537,0.999999999990383,0.849140090208589,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
2474,GO:0005690,0.999999999990383,0.849140090208589,0,2,U4atac snRNP,CC,
15054,GO:0071005,0.999999999990383,0.849140090208589,0,2,U2-type precatalytic spliceosome,CC,
11739,GO:0046570,0.999999999990411,0.931986646539193,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
14735,GO:0070401,0.999999999990414,0.853146555803333,0,2,NADP+ binding,MF,
2630,GO:0005956,0.999999999990442,0.860824297881511,0,2,protein kinase CK2 complex,CC,
14209,GO:0061140,0.999999999990454,0.799700942459396,0,3,lung secretory cell differentiation,BP,
2155,GO:0004979,0.999999999990486,0.923713798311347,0,1,beta-endorphin receptor activity,MF,
7473,GO:0031635,0.999999999990486,0.923713798311347,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7668,GO:0032097,0.999999999990486,0.923713798311347,0,1,positive regulation of response to food,BP,
7671,GO:0032100,0.999999999990486,0.923713798311347,0,1,positive regulation of appetite,BP,
9680,GO:0038047,0.999999999990486,0.923713798311347,0,1,morphine receptor activity,MF,
11720,GO:0046521,0.999999999990486,0.923713798311347,0,1,sphingoid catabolic process,BP,
14283,GO:0061358,0.999999999990486,0.923713798311347,0,1,negative regulation of Wnt protein secretion,BP,
2077,GO:0004831,0.999999999990506,0.849252497949349,0,2,tyrosine-tRNA ligase activity,MF,
2927,GO:0006437,0.999999999990506,0.849252497949349,0,2,tyrosyl-tRNA aminoacylation,BP,
15989,GO:0080184,0.999999999990511,0.848876971740969,0,2,response to phenylpropanoid,BP,
14922,GO:0070773,0.999999999990512,0.930382045116724,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15328,GO:0071544,0.999999999990512,0.930382045116724,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15506,GO:0071877,0.999999999990512,0.930382045116724,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15510,GO:0071881,0.999999999990512,0.930382045116724,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16056,GO:0086096,0.999999999990512,0.930382045116724,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17318,GO:0140193,0.999999999990512,0.930382045116724,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17319,GO:0140194,0.999999999990512,0.930382045116724,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
19875,GO:2000354,0.999999999990546,0.731350376811189,0,4,regulation of ovarian follicle development,BP,
19631,GO:1990812,0.999999999990566,0.781554725305642,0,3,growth cone filopodium,CC,
1943,GO:0004645,0.999999999990581,0.723514233706855,0,4,phosphorylase activity,MF,
14975,GO:0070883,0.99999999999059,0.68132458086283,0,5,pre-miRNA binding,MF,
7759,GO:0032275,0.99999999999059,0.663451600777627,0,5,luteinizing hormone secretion,BP,
7264,GO:0031232,0.999999999990599,0.788995843781183,0,3,extrinsic component of external side of plasma membrane,CC,
15391,GO:0071638,0.999999999990604,0.864220333562457,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
3725,GO:0008251,0.999999999990612,0.84847409211838,0,2,tRNA-specific adenosine deaminase activity,MF,
20246,GO:2001198,0.99999999999062,0.794367300793869,0,3,regulation of dendritic cell differentiation,BP,
8650,GO:0034191,0.999999999990637,0.783281367490592,0,3,apolipoprotein A-I receptor binding,MF,
3980,GO:0008803,0.99999999999064,0.937573353070296,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
19433,GO:1990047,0.999999999990652,0.921586753257655,0,1,spindle matrix,CC,
17712,GO:1901622,0.999999999990686,0.921165623835677,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
8501,GO:0033678,0.999999999990688,0.921138998403652,0,1,5'-3' DNA/RNA helicase activity,MF,
8505,GO:0033682,0.999999999990688,0.921138998403652,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
12133,GO:0048210,0.999999999990703,0.793136375460457,0,3,Golgi vesicle fusion to target membrane,BP,
805,GO:0002074,0.999999999990718,0.782036983933184,0,3,extraocular skeletal muscle development,BP,
791,GO:0002054,0.999999999990768,0.800672745897738,0,3,nucleobase binding,MF,
793,GO:0002060,0.999999999990768,0.800672745897738,0,3,purine nucleobase binding,MF,
16880,GO:0098814,0.999999999990768,0.669850926528972,0,5,spontaneous synaptic transmission,BP,
512,GO:0001575,0.999999999990798,0.851628852277534,0,2,globoside metabolic process,BP,
609,GO:0001777,0.999999999990804,0.941711483672689,0,1,T cell homeostatic proliferation,BP,
944,GO:0002358,0.999999999990804,0.941711483672689,0,1,B cell homeostatic proliferation,BP,
8219,GO:0032976,0.999999999990804,0.941711483672689,0,1,release of matrix enzymes from mitochondria,BP,
16467,GO:0097144,0.999999999990804,0.941711483672689,0,1,BAX complex,CC,
19449,GO:1990117,0.999999999990804,0.941711483672689,0,1,B cell receptor apoptotic signaling pathway,BP,
20294,GO:2001274,0.99999999999082,0.848475344344034,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
18131,GO:1902824,0.999999999990831,0.864362169879697,0,2,positive regulation of late endosome to lysosome transport,BP,
18357,GO:1903337,0.999999999990831,0.864362169879697,0,2,positive regulation of vacuolar transport,BP,
7572,GO:0031933,0.99999999999084,0.786297480687989,0,3,telomeric heterochromatin,CC,
5517,GO:0016480,0.999999999990863,0.803159904282316,0,3,negative regulation of transcription by RNA polymerase III,BP,
11810,GO:0046695,0.999999999990871,0.791769579754644,0,3,SLIK (SAGA-like) complex,CC,
7159,GO:0031021,0.999999999990879,0.801893422925854,0,3,interphase microtubule organizing center,CC,
3090,GO:0006663,0.999999999990885,0.786474881983469,0,3,platelet activating factor biosynthetic process,BP,
3927,GO:0008607,0.999999999990885,0.786474881983469,0,3,phosphorylase kinase regulator activity,MF,
6637,GO:0023021,0.999999999990889,0.782012712243731,0,3,termination of signal transduction,BP,
12011,GO:0047499,0.999999999990898,0.668641697537825,0,5,calcium-independent phospholipase A2 activity,MF,
6546,GO:0021960,0.999999999990903,0.781544570143524,0,3,anterior commissure morphogenesis,BP,
19540,GO:1990454,0.999999999990903,0.781544570143524,0,3,L-type voltage-gated calcium channel complex,CC,
1851,GO:0004514,0.999999999990912,0.7867340283311,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
19604,GO:1990742,0.999999999990924,0.875714204286614,0,2,microvesicle,CC,
13163,GO:0051747,0.999999999990928,0.86996028055992,0,2,cytosine C-5 DNA demethylase activity,MF,
4687,GO:0010836,0.999999999990976,0.787042356656205,0,3,negative regulation of protein ADP-ribosylation,BP,
13313,GO:0052150,0.999999999991005,0.673368019792057,0,5,modulation by symbiont of host apoptotic process,BP,
13847,GO:0060448,0.99999999999101,0.787651445906269,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
18459,GO:1903547,0.999999999991011,0.873503370037137,0,2,regulation of growth hormone activity,BP,
11181,GO:0045272,0.999999999991019,0.814833322183905,0,3,plasma membrane respiratory chain complex I,CC,
7842,GO:0032398,0.999999999991019,0.925558468567998,0,1,MHC class Ib protein complex,CC,
8009,GO:0032639,0.999999999991019,0.925558468567998,0,1,TRAIL production,BP,
8033,GO:0032679,0.999999999991019,0.925558468567998,0,1,regulation of TRAIL production,BP,
8078,GO:0032759,0.999999999991019,0.925558468567998,0,1,positive regulation of TRAIL production,BP,
19978,GO:2000566,0.999999999991019,0.925558468567998,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20242,GO:2001187,0.999999999991019,0.925558468567998,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
726,GO:0001955,0.999999999991024,0.676237932141625,0,5,blood vessel maturation,BP,
6872,GO:0030348,0.999999999991031,0.850609508897129,0,2,syntaxin-3 binding,MF,
11461,GO:0045915,0.999999999991039,0.681774822076804,0,5,positive regulation of catecholamine metabolic process,BP,
11495,GO:0045964,0.999999999991039,0.681774822076804,0,5,positive regulation of dopamine metabolic process,BP,
2887,GO:0006391,0.999999999991067,0.786084114558508,0,3,transcription initiation from mitochondrial promoter,BP,
5950,GO:0018298,0.999999999991085,0.781557033244015,0,3,protein-chromophore linkage,BP,
13379,GO:0052642,0.999999999991085,0.924164163404495,0,1,lysophosphatidic acid phosphatase activity,MF,
20310,GO:2001311,0.999999999991085,0.924164163404495,0,1,lysobisphosphatidic acid metabolic process,BP,
1715,GO:0004307,0.999999999991096,0.862305409512998,0,2,ethanolaminephosphotransferase activity,MF,
13239,GO:0051902,0.999999999991116,0.677475135323939,0,5,negative regulation of mitochondrial depolarization,BP,
18727,GO:1904180,0.999999999991116,0.677475135323939,0,5,negative regulation of membrane depolarization,BP,
5272,GO:0015920,0.999999999991118,0.921135523657211,0,1,lipopolysaccharide transport,BP,
7922,GO:0032497,0.999999999991118,0.921135523657211,0,1,detection of lipopolysaccharide,BP,
14793,GO:0070506,0.999999999991118,0.921135523657211,0,1,high-density lipoprotein particle receptor activity,MF,
3473,GO:0007308,0.999999999991128,0.921171137067292,0,1,oocyte construction,BP,
3474,GO:0007309,0.999999999991128,0.921171137067292,0,1,oocyte axis specification,BP,
3475,GO:0007314,0.999999999991128,0.921171137067292,0,1,oocyte anterior/posterior axis specification,BP,
3476,GO:0007315,0.999999999991128,0.921171137067292,0,1,pole plasm assembly,BP,
3792,GO:0008358,0.999999999991128,0.921171137067292,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7015,GO:0030719,0.999999999991128,0.921171137067292,0,1,P granule organization,BP,
9309,GO:0035755,0.999999999991128,0.921171137067292,0,1,cardiolipin hydrolase activity,MF,
7235,GO:0031134,0.999999999991169,0.78395773545512,0,3,sister chromatid biorientation,BP,
18498,GO:1903630,0.999999999991171,0.932803613670099,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18499,GO:1903632,0.999999999991171,0.932803613670099,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
1544,GO:0003939,0.999999999991203,0.921197995713398,0,1,L-iditol 2-dehydrogenase activity,MF,
2697,GO:0006062,0.999999999991203,0.921197995713398,0,1,sorbitol catabolic process,BP,
6139,GO:0019407,0.999999999991203,0.921197995713398,0,1,hexitol catabolic process,BP,
6165,GO:0019519,0.999999999991203,0.921197995713398,0,1,pentitol metabolic process,BP,
6168,GO:0019527,0.999999999991203,0.921197995713398,0,1,pentitol catabolic process,BP,
7313,GO:0031320,0.999999999991203,0.921197995713398,0,1,hexitol dehydrogenase activity,MF,
11723,GO:0046526,0.999999999991203,0.921197995713398,0,1,D-xylulose reductase activity,MF,
12847,GO:0051160,0.999999999991203,0.921197995713398,0,1,L-xylitol catabolic process,BP,
12848,GO:0051164,0.999999999991203,0.921197995713398,0,1,L-xylitol metabolic process,BP,
17900,GO:1902202,0.999999999991214,0.852289213049279,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
6971,GO:0030626,0.999999999991228,0.850648391303666,0,2,U12 snRNA binding,MF,
10703,GO:0043988,0.999999999991236,0.791091014626582,0,3,histone H3-S28 phosphorylation,BP,
843,GO:0002155,0.999999999991256,0.782353736203293,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
13710,GO:0060267,0.999999999991282,0.799728058781981,0,3,positive regulation of respiratory burst,BP,
2751,GO:0006154,0.999999999991295,0.854279809704427,0,2,adenosine catabolic process,BP,
11562,GO:0046103,0.999999999991295,0.854279809704427,0,2,inosine biosynthetic process,BP,
919,GO:0002314,0.999999999991303,0.8544865543158,0,2,germinal center B cell differentiation,BP,
8085,GO:0032767,0.999999999991311,0.806020249577364,0,3,copper-dependent protein binding,MF,
12382,GO:0048787,0.999999999991312,0.720717691929694,0,4,presynaptic active zone membrane,CC,
14073,GO:0060857,0.999999999991317,0.921594541615557,0,1,establishment of glial blood-brain barrier,BP,
16953,GO:0098943,0.99999999999132,0.855957768458443,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
11897,GO:0046920,0.999999999991322,0.664523701121027,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
12236,GO:0048499,0.999999999991342,0.793259753371596,0,3,synaptic vesicle membrane organization,BP,
1620,GO:0004053,0.999999999991355,0.857077259597468,0,2,arginase activity,MF,
6178,GO:0019547,0.999999999991355,0.857077259597468,0,2,arginine catabolic process to ornithine,BP,
18225,GO:1903026,0.999999999991382,0.724250264104565,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
8521,GO:0033745,0.999999999991423,0.784140339834474,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
10146,GO:0042720,0.999999999991452,0.873865699365807,0,2,mitochondrial inner membrane peptidase complex,CC,
8548,GO:0033882,0.999999999991479,0.933966810735781,0,1,choloyl-CoA hydrolase activity,MF,
11164,GO:0045222,0.999999999991479,0.933966810735781,0,1,CD4 biosynthetic process,BP,
11165,GO:0045223,0.999999999991479,0.933966810735781,0,1,regulation of CD4 biosynthetic process,BP,
11166,GO:0045225,0.999999999991479,0.933966810735781,0,1,negative regulation of CD4 biosynthetic process,BP,
13420,GO:0052815,0.999999999991479,0.933966810735781,0,1,medium-chain acyl-CoA hydrolase activity,MF,
8127,GO:0032815,0.999999999991505,0.681606275533572,0,5,negative regulation of natural killer cell activation,BP,
12691,GO:0050908,0.999999999991509,0.726809240960202,0,4,detection of light stimulus involved in visual perception,BP,
12723,GO:0050962,0.999999999991509,0.726809240960202,0,4,detection of light stimulus involved in sensory perception,BP,
5364,GO:0016150,0.99999999999153,0.926293528766431,0,1,translation release factor activity, codon nonspecific,MF,
6515,GO:0021892,0.999999999991564,0.794912348169248,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
18620,GO:1903903,0.999999999991584,0.781556459229387,0,3,regulation of establishment of T cell polarity,BP,
14726,GO:0070375,0.999999999991588,0.781772572787736,0,3,ERK5 cascade,BP,
10101,GO:0042610,0.999999999991612,0.922336553912532,0,1,CD8 receptor binding,MF,
19255,GO:1905429,0.999999999991612,0.922336553912532,0,1,response to glycine,BP,
19256,GO:1905430,0.999999999991612,0.922336553912532,0,1,cellular response to glycine,BP,
12741,GO:0051006,0.999999999991613,0.725529928690813,0,4,positive regulation of lipoprotein lipase activity,BP,
14285,GO:0061365,0.999999999991613,0.725529928690813,0,4,positive regulation of triglyceride lipase activity,BP,
2224,GO:0005127,0.999999999991636,0.784238999519661,0,3,ciliary neurotrophic factor receptor binding,MF,
13353,GO:0052428,0.999999999991661,0.738083838712973,0,4,modulation by host of symbiont molecular function,BP,
937,GO:0002339,0.999999999991665,0.868112172909954,0,2,B cell selection,BP,
941,GO:0002352,0.999999999991665,0.868112172909954,0,2,B cell negative selection,BP,
3023,GO:0006568,0.999999999991671,0.673715152313065,0,5,tryptophan metabolic process,BP,
3037,GO:0006586,0.999999999991671,0.673715152313065,0,5,indolalkylamine metabolic process,BP,
11909,GO:0046940,0.99999999999168,0.672638406392197,0,5,nucleoside monophosphate phosphorylation,BP,
12447,GO:0050145,0.99999999999168,0.672638406392197,0,5,nucleoside phosphate kinase activity,MF,
9672,GO:0038031,0.999999999991688,0.663111075266112,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
1809,GO:0004458,0.999999999991706,0.921161932945113,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
2004,GO:0004728,0.999999999991706,0.921161932945113,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4011,GO:0008995,0.999999999991706,0.921161932945113,0,1,ribonuclease E activity,MF,
5750,GO:0016898,0.999999999991706,0.921161932945113,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6163,GO:0019516,0.999999999991706,0.921161932945113,0,1,lactate oxidation,BP,
16214,GO:0090247,0.999999999991706,0.921161932945113,0,1,cell motility involved in somitogenic axis elongation,BP,
16215,GO:0090249,0.999999999991706,0.921161932945113,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17591,GO:1901229,0.999999999991706,0.921161932945113,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17592,GO:1901231,0.999999999991706,0.921161932945113,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17593,GO:1901232,0.999999999991706,0.921161932945113,0,1,regulation of convergent extension involved in axis elongation,BP,
17594,GO:1901233,0.999999999991706,0.921161932945113,0,1,negative regulation of convergent extension involved in axis elongation,BP,
9493,GO:0036132,0.999999999991726,0.790926780660227,0,3,13-prostaglandin reductase activity,MF,
12012,GO:0047522,0.999999999991726,0.790926780660227,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
8081,GO:0032762,0.999999999991766,0.786710170915398,0,3,mast cell cytokine production,BP,
8082,GO:0032763,0.999999999991766,0.786710170915398,0,3,regulation of mast cell cytokine production,BP,
8237,GO:0033004,0.999999999991766,0.786710170915398,0,3,negative regulation of mast cell activation,BP,
8240,GO:0033007,0.999999999991766,0.786710170915398,0,3,negative regulation of mast cell activation involved in immune response,BP,
9326,GO:0035800,0.999999999991785,0.856492233376421,0,2,deubiquitinase activator activity,MF,
19760,GO:2000158,0.999999999991785,0.856492233376421,0,2,positive regulation of ubiquitin-specific protease activity,BP,
18609,GO:1903892,0.999999999991807,0.848491743955885,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
10258,GO:0042996,0.999999999991815,0.663189562212758,0,5,regulation of Golgi to plasma membrane protein transport,BP,
16461,GO:0097124,0.999999999991817,0.848989873221078,0,2,cyclin A2-CDK2 complex,CC,
18669,GO:1903999,0.999999999991821,0.867344174468127,0,2,negative regulation of eating behavior,BP,
18786,GO:1904304,0.999999999991821,0.867344174468127,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18787,GO:1904306,0.999999999991821,0.867344174468127,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
19803,GO:2000252,0.999999999991821,0.867344174468127,0,2,negative regulation of feeding behavior,BP,
20130,GO:2000821,0.999999999991821,0.867344174468127,0,2,regulation of grooming behavior,BP,
10487,GO:0043382,0.999999999991825,0.796003645075111,0,3,positive regulation of memory T cell differentiation,BP,
19855,GO:2000328,0.999999999991825,0.796003645075111,0,3,regulation of T-helper 17 cell lineage commitment,BP,
19581,GO:1990637,0.999999999991834,0.784981620223518,0,3,response to prolactin,BP,
12118,GO:0048170,0.999999999991842,0.720249661912723,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
6131,GO:0019389,0.999999999991856,0.921144072628086,0,1,glucuronoside metabolic process,BP,
6132,GO:0019391,0.999999999991856,0.921144072628086,0,1,glucuronoside catabolic process,BP,
17146,GO:0102390,0.999999999991856,0.921144072628086,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
15536,GO:0071930,0.999999999991862,0.781545024936408,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
19442,GO:1990086,0.999999999991862,0.781545024936408,0,3,lens fiber cell apoptotic process,BP,
3007,GO:0006552,0.999999999991876,0.672009828810645,0,5,leucine catabolic process,BP,
2528,GO:0005784,0.999999999991909,0.766624306012636,0,4,Sec61 translocon complex,CC,
15149,GO:0071256,0.999999999991909,0.766624306012636,0,4,translocon complex,CC,
17540,GO:1901069,0.999999999991927,0.862015169863205,0,2,guanosine-containing compound catabolic process,BP,
6056,GO:0019203,0.999999999991933,0.666642558311428,0,5,carbohydrate phosphatase activity,MF,
12464,GO:0050308,0.999999999991933,0.666642558311428,0,5,sugar-phosphatase activity,MF,
3429,GO:0007217,0.999999999991937,0.921173271891279,0,1,tachykinin receptor signaling pathway,BP,
2009,GO:0004735,0.999999999991947,0.854600637798292,0,2,pyrroline-5-carboxylate reductase activity,MF,
521,GO:0001608,0.999999999991967,0.669151690719698,0,5,G-protein coupled nucleotide receptor activity,MF,
9207,GO:0035589,0.999999999991967,0.669151690719698,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
11047,GO:0045028,0.999999999991967,0.669151690719698,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
2447,GO:0005656,0.999999999991969,0.788464815355015,0,3,nuclear pre-replicative complex,CC,
2808,GO:0006267,0.999999999991969,0.788464815355015,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9578,GO:0036387,0.999999999991969,0.788464815355015,0,3,pre-replicative complex,CC,
9579,GO:0036388,0.999999999991969,0.788464815355015,0,3,pre-replicative complex assembly,BP,
17950,GO:1902299,0.999999999991969,0.788464815355015,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
7998,GO:0032618,0.999999999991976,0.855603778949413,0,2,interleukin-15 production,BP,
328,GO:0000916,0.999999999991988,0.921892893936236,0,1,actomyosin contractile ring contraction,BP,
9518,GO:0036213,0.999999999991988,0.921892893936236,0,1,contractile ring contraction,BP,
1902,GO:0004587,0.999999999992019,0.922865282398804,0,1,ornithine-oxo-acid transaminase activity,MF,
4399,GO:0010121,0.999999999992019,0.922865282398804,0,1,arginine catabolic process to proline via ornithine,BP,
6159,GO:0019493,0.999999999992019,0.922865282398804,0,1,arginine catabolic process to proline,BP,
6177,GO:0019544,0.999999999992019,0.922865282398804,0,1,arginine catabolic process to glutamate,BP,
18053,GO:1902595,0.999999999992036,0.855911948827264,0,2,regulation of DNA replication origin binding,BP,
2772,GO:0006193,0.999999999992038,0.93514561066202,0,1,ITP catabolic process,BP,
4142,GO:0009203,0.999999999992038,0.93514561066202,0,1,ribonucleoside triphosphate catabolic process,BP,
4146,GO:0009207,0.999999999992038,0.93514561066202,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9522,GO:0036220,0.999999999992038,0.93514561066202,0,1,ITP diphosphatase activity,MF,
9523,GO:0036222,0.999999999992038,0.93514561066202,0,1,XTP diphosphatase activity,MF,
1878,GO:0004557,0.999999999992057,0.855897839516223,0,2,alpha-galactosidase activity,MF,
13655,GO:0060166,0.999999999992057,0.855897839516223,0,2,olfactory pit development,BP,
12698,GO:0050916,0.999999999992063,0.782510686763222,0,3,sensory perception of sweet taste,BP,
18533,GO:1903722,0.999999999992075,0.865380821100516,0,2,regulation of centriole elongation,BP,
2478,GO:0005712,0.999999999992077,0.848585635044268,0,2,chiasma,CC,
3343,GO:0007060,0.999999999992077,0.848585635044268,0,2,male meiosis chromosome segregation,BP,
11489,GO:0045950,0.999999999992077,0.848585635044268,0,2,negative regulation of mitotic recombination,BP,
356,GO:0000973,0.99999999999208,0.784972240625628,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
6421,GO:0021684,0.99999999999208,0.784972240625628,0,3,cerebellar granular layer formation,BP,
6436,GO:0021707,0.99999999999208,0.784972240625628,0,3,cerebellar granule cell differentiation,BP,
19841,GO:2000312,0.999999999992103,0.781823133217958,0,3,regulation of kainate selective glutamate receptor activity,BP,
18760,GO:1904245,0.999999999992107,0.851909404961857,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
18257,GO:1903094,0.999999999992135,0.874421497231139,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19759,GO:2000157,0.999999999992135,0.874421497231139,0,2,negative regulation of ubiquitin-specific protease activity,BP,
13653,GO:0060161,0.999999999992145,0.781674751270414,0,3,positive regulation of dopamine receptor signaling pathway,BP,
4629,GO:0010750,0.999999999992147,0.921176607971892,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
8458,GO:0033594,0.999999999992147,0.921176607971892,0,1,response to hydroxyisoflavone,BP,
10267,GO:0043006,0.999999999992147,0.921176607971892,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
16633,GO:0097489,0.999999999992147,0.921176607971892,0,1,multivesicular body, internal vesicle lumen,CC,
3730,GO:0008263,0.999999999992151,0.84858172905983,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
2066,GO:0004820,0.999999999992156,0.853518473558388,0,2,glycine-tRNA ligase activity,MF,
2916,GO:0006426,0.999999999992156,0.853518473558388,0,2,glycyl-tRNA aminoacylation,BP,
14599,GO:0070150,0.999999999992156,0.853518473558388,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
13462,GO:0052925,0.999999999992162,0.927670813862365,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
8966,GO:0035034,0.999999999992172,0.849540149572265,0,2,histone acetyltransferase regulator activity,MF,
3001,GO:0006546,0.999999999992175,0.788308246173739,0,3,glycine catabolic process,BP,
6152,GO:0019464,0.999999999992175,0.788308246173739,0,3,glycine decarboxylation via glycine cleavage system,BP,
13434,GO:0052836,0.999999999992178,0.857245998910312,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13435,GO:0052839,0.999999999992178,0.857245998910312,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
5876,GO:0017198,0.999999999992209,0.939926443048978,0,1,N-terminal peptidyl-serine acetylation,BP,
5877,GO:0018002,0.999999999992209,0.939926443048978,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7118,GO:0030920,0.999999999992209,0.939926443048978,0,1,peptidyl-serine acetylation,BP,
14477,GO:0061850,0.999999999992209,0.939926443048978,0,1,growth cone leading edge,CC,
15549,GO:0071960,0.999999999992209,0.939926443048978,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19476,GO:1990190,0.999999999992209,0.939926443048978,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20070,GO:2000718,0.999999999992209,0.939926443048978,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20071,GO:2000719,0.999999999992209,0.939926443048978,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
9552,GO:0036313,0.999999999992247,0.848625067955507,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
1688,GO:0004161,0.999999999992249,0.854929981052,0,2,dimethylallyltranstransferase activity,MF,
1739,GO:0004337,0.999999999992249,0.854929981052,0,2,geranyltranstransferase activity,MF,
8410,GO:0033383,0.999999999992249,0.854929981052,0,2,geranyl diphosphate metabolic process,BP,
8411,GO:0033384,0.999999999992249,0.854929981052,0,2,geranyl diphosphate biosynthetic process,BP,
8621,GO:0034137,0.999999999992255,0.80444923739619,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
3448,GO:0007258,0.999999999992269,0.726192103979187,0,4,JUN phosphorylation,BP,
1789,GO:0004418,0.999999999992288,0.928413719366506,0,1,hydroxymethylbilane synthase activity,MF,
5913,GO:0018160,0.999999999992288,0.928413719366506,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6371,GO:0021555,0.999999999992304,0.855427050353797,0,2,midbrain-hindbrain boundary morphogenesis,BP,
6372,GO:0021557,0.999999999992304,0.855427050353797,0,2,oculomotor nerve development,BP,
11129,GO:0045168,0.999999999992304,0.855427050353797,0,2,cell-cell signaling involved in cell fate commitment,BP,
11629,GO:0046331,0.999999999992304,0.855427050353797,0,2,lateral inhibition,BP,
2305,GO:0005290,0.999999999992312,0.848472829583002,0,2,L-histidine transmembrane transporter activity,MF,
3841,GO:0008448,0.999999999992314,0.923963352345356,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3831,GO:0008430,0.999999999992348,0.924674323194642,0,1,selenium binding,MF,
12540,GO:0050689,0.999999999992355,0.674465532010765,0,5,negative regulation of defense response to virus by host,BP,
1674,GO:0004138,0.999999999992357,0.937064473544221,0,1,deoxyguanosine kinase activity,MF,
3936,GO:0008617,0.999999999992357,0.937064473544221,0,1,guanosine metabolic process,BP,
5285,GO:0015938,0.999999999992357,0.937064473544221,0,1,coenzyme A catabolic process,BP,
8543,GO:0033869,0.999999999992357,0.937064473544221,0,1,nucleoside bisphosphate catabolic process,BP,
8566,GO:0034031,0.999999999992357,0.937064473544221,0,1,ribonucleoside bisphosphate catabolic process,BP,
8569,GO:0034034,0.999999999992357,0.937064473544221,0,1,purine nucleoside bisphosphate catabolic process,BP,
10136,GO:0042695,0.99999999999238,0.677470354676977,0,5,thelarche,BP,
14021,GO:0060744,0.99999999999238,0.677470354676977,0,5,mammary gland branching involved in thelarche,BP,
1696,GO:0004174,0.999999999992393,0.848741631104242,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5607,GO:0016649,0.999999999992393,0.848741631104242,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
11995,GO:0047374,0.999999999992433,0.859603560253914,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
14000,GO:0060715,0.999999999992449,0.782821605747052,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
11885,GO:0046899,0.999999999992471,0.848486451241928,0,2,nucleoside triphosphate adenylate kinase activity,MF,
15111,GO:0071163,0.999999999992531,0.793324548863065,0,3,DNA replication preinitiation complex assembly,BP,
5124,GO:0015499,0.999999999992533,0.921140793472102,0,1,formate transmembrane transporter activity,MF,
5140,GO:0015660,0.999999999992533,0.921140793472102,0,1,formate efflux transmembrane transporter activity,MF,
5172,GO:0015724,0.999999999992533,0.921140793472102,0,1,formate transport,BP,
5200,GO:0015797,0.999999999992533,0.921140793472102,0,1,mannitol transport,BP,
11826,GO:0046724,0.999999999992533,0.921140793472102,0,1,oxalic acid secretion,BP,
16441,GO:0097100,0.999999999992534,0.682771397730934,0,5,supercoiled DNA binding,MF,
12543,GO:0050692,0.999999999992542,0.850910793706574,0,2,DBD domain binding,MF,
15175,GO:0071306,0.999999999992542,0.850910793706574,0,2,cellular response to vitamin E,BP,
18071,GO:1902636,0.999999999992549,0.863916151588988,0,2,kinociliary basal body,CC,
1616,GO:0004045,0.999999999992555,0.756877266220162,0,4,aminoacyl-tRNA hydrolase activity,MF,
19563,GO:1990575,0.999999999992575,0.848719368135769,0,2,mitochondrial L-ornithine transmembrane transport,BP,
3937,GO:0008622,0.999999999992578,0.683412558093894,0,5,epsilon DNA polymerase complex,CC,
2124,GO:0004920,0.999999999992582,0.723055651271456,0,4,interleukin-10 receptor activity,MF,
13004,GO:0051429,0.999999999992586,0.789577181321722,0,3,corticotropin-releasing hormone receptor binding,MF,
12049,GO:0047894,0.99999999999259,0.861644760379558,0,2,flavonol 3-sulfotransferase activity,MF,
18129,GO:1902822,0.999999999992595,0.796178798581999,0,3,regulation of late endosome to lysosome transport,BP,
11601,GO:0046203,0.999999999992595,0.863707539227137,0,2,spermidine catabolic process,BP,
4735,GO:0010899,0.999999999992646,0.806641826081074,0,3,regulation of phosphatidylcholine catabolic process,BP,
13664,GO:0060180,0.999999999992657,0.781696206276799,0,3,female mating behavior,BP,
12682,GO:0050893,0.999999999992677,0.849259688291915,0,2,sensory processing,BP,
14983,GO:0070893,0.999999999992678,0.848472735511574,0,2,transposon integration,BP,
14984,GO:0070894,0.999999999992678,0.848472735511574,0,2,regulation of transposon integration,BP,
14985,GO:0070895,0.999999999992678,0.848472735511574,0,2,negative regulation of transposon integration,BP,
5532,GO:0016509,0.999999999992707,0.782189363476787,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
1824,GO:0004477,0.999999999992717,0.72055484179406,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1833,GO:0004488,0.999999999992717,0.72055484179406,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
8038,GO:0032687,0.999999999992718,0.672105880387973,0,5,negative regulation of interferon-alpha production,BP,
18270,GO:1903136,0.999999999992728,0.698303416977764,0,5,cuprous ion binding,MF,
4789,GO:0010979,0.999999999992756,0.84856526445942,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4790,GO:0010980,0.999999999992756,0.84856526445942,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
11167,GO:0045226,0.999999999992795,0.848478239000952,0,2,extracellular polysaccharide biosynthetic process,BP,
11649,GO:0046379,0.999999999992795,0.848478239000952,0,2,extracellular polysaccharide metabolic process,BP,
1983,GO:0004703,0.999999999992796,0.84851334964644,0,2,G-protein coupled receptor kinase activity,MF,
12030,GO:0047696,0.999999999992796,0.84851334964644,0,2,beta-adrenergic receptor kinase activity,MF,
4711,GO:0010873,0.999999999992828,0.817971302255544,0,3,positive regulation of cholesterol esterification,BP,
4378,GO:0010009,0.999999999992832,0.663192188156852,0,5,cytoplasmic side of endosome membrane,CC,
3017,GO:0006562,0.999999999992851,0.849056601357824,0,2,proline catabolic process,BP,
4401,GO:0010133,0.999999999992851,0.849056601357824,0,2,proline catabolic process to glutamate,BP,
10760,GO:0044205,0.999999999992852,0.782609555924,0,3,'de novo' UMP biosynthetic process,BP,
14088,GO:0060913,0.999999999992877,0.921132194077027,0,1,cardiac cell fate determination,BP,
15403,GO:0071657,0.999999999992877,0.921132194077027,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17601,GO:1901258,0.999999999992877,0.921132194077027,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
8542,GO:0033867,0.999999999992877,0.925966804673455,0,1,Fas-activated serine/threonine kinase activity,MF,
7869,GO:0032430,0.999999999992879,0.795745553069611,0,3,positive regulation of phospholipase A2 activity,BP,
2585,GO:0005879,0.999999999992903,0.669441649683027,0,5,axonemal microtubule,CC,
5551,GO:0016557,0.999999999992914,0.794834335798568,0,3,peroxisome membrane biogenesis,BP,
16420,GO:0097055,0.999999999992915,0.849120891357863,0,2,agmatine biosynthetic process,BP,
17567,GO:1901162,0.999999999992915,0.849120891357863,0,2,primary amino compound biosynthetic process,BP,
14801,GO:0070524,0.999999999992929,0.92934434732609,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
922,GO:0002317,0.999999999992933,0.810239655248559,0,3,plasma cell differentiation,BP,
19582,GO:1990641,0.999999999992944,0.850292843640544,0,2,response to iron ion starvation,BP,
2240,GO:0005150,0.999999999992961,0.851537509407308,0,2,interleukin-1, Type I receptor binding,MF,
2241,GO:0005151,0.999999999992961,0.851537509407308,0,2,interleukin-1, Type II receptor binding,MF,
11680,GO:0046462,0.999999999992961,0.851537509407308,0,2,monoacylglycerol metabolic process,BP,
13382,GO:0052651,0.999999999992961,0.851537509407308,0,2,monoacylglycerol catabolic process,BP,
18747,GO:1904220,0.999999999992962,0.722721959802634,0,4,regulation of serine C-palmitoyltransferase activity,BP,
28,GO:0000053,0.999999999992968,0.924042574504057,0,1,argininosuccinate metabolic process,BP,
1621,GO:0004055,0.999999999992968,0.924042574504057,0,1,argininosuccinate synthase activity,MF,
16247,GO:0090298,0.999999999992969,0.781543926909267,0,3,negative regulation of mitochondrial DNA replication,BP,
17788,GO:1901859,0.999999999992969,0.781543926909267,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
8357,GO:0033227,0.999999999992975,0.783942918063286,0,3,dsRNA transport,BP,
19708,GO:2000049,0.999999999992975,0.783942918063286,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
2187,GO:0005046,0.999999999993042,0.853994845385406,0,2,KDEL sequence binding,MF,
14828,GO:0070564,0.999999999993043,0.849445990916532,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
62,GO:0000125,0.999999999993053,0.691221910411571,0,5,PCAF complex,CC,
6305,GO:0019934,0.999999999993061,0.672044222870802,0,5,cGMP-mediated signaling,BP,
16438,GO:0097090,0.999999999993061,0.672044222870802,0,5,presynaptic membrane organization,BP,
20025,GO:2000646,0.999999999993061,0.672044222870802,0,5,positive regulation of receptor catabolic process,BP,
7187,GO:0031074,0.999999999993068,0.793963317861535,0,3,nucleocytoplasmic transport complex,CC,
13731,GO:0060300,0.999999999993095,0.787955278176755,0,3,regulation of cytokine activity,BP,
15547,GO:0071953,0.999999999993096,0.8485208129367,0,2,elastic fiber,CC,
1618,GO:0004047,0.999999999993098,0.855818326804477,0,2,aminomethyltransferase activity,MF,
9396,GO:0035933,0.999999999993105,0.799668651702146,0,3,glucocorticoid secretion,BP,
20148,GO:2000849,0.999999999993105,0.799668651702146,0,3,regulation of glucocorticoid secretion,BP,
6884,GO:0030388,0.999999999993111,0.728510712582559,0,4,fructose 1,6-bisphosphate metabolic process,BP,
5370,GO:0016175,0.999999999993114,0.870526740839291,0,2,superoxide-generating NADPH oxidase activity,MF,
444,GO:0001192,0.999999999993119,0.940231689740195,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,0.999999999993119,0.940231689740195,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
12488,GO:0050473,0.999999999993122,0.848490419683515,0,2,arachidonate 15-lipoxygenase activity,MF,
7109,GO:0030905,0.999999999993137,0.721650617760261,0,4,retromer, tubulation complex,CC,
19601,GO:1990737,0.999999999993146,0.784930234482219,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
8098,GO:0032783,0.999999999993179,0.732187586865204,0,4,ELL-EAF complex,CC,
1318,GO:0003166,0.999999999993216,0.856821490534287,0,2,bundle of His development,BP,
14150,GO:0061030,0.999999999993216,0.856821490534287,0,2,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15537,GO:0071931,0.999999999993216,0.856821490534287,0,2,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
17289,GO:0140052,0.999999999993219,0.781547868855469,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
3938,GO:0008623,0.99999999999323,0.848632421455153,0,2,CHRAC,CC,
9961,GO:0042335,0.999999999993231,0.782094491043795,0,3,cuticle development,BP,
5449,GO:0016321,0.999999999993234,0.782315544045591,0,3,female meiosis chromosome segregation,BP,
13597,GO:0060066,0.999999999993234,0.85219693865249,0,2,oviduct development,BP,
19238,GO:1905384,0.999999999993234,0.85219693865249,0,2,regulation of protein localization to presynapse,BP,
19239,GO:1905386,0.999999999993234,0.85219693865249,0,2,positive regulation of protein localization to presynapse,BP,
1179,GO:0002826,0.999999999993272,0.782040107761412,0,3,negative regulation of T-helper 1 type immune response,BP,
15267,GO:0071440,0.999999999993287,0.664510286408882,0,5,regulation of histone H3-K14 acetylation,BP,
16513,GO:0097212,0.999999999993296,0.850625988934663,0,2,lysosomal membrane organization,BP,
13074,GO:0051581,0.999999999993318,0.782381728215739,0,3,negative regulation of neurotransmitter uptake,BP,
13269,GO:0051956,0.999999999993318,0.782381728215739,0,3,negative regulation of amino acid transport,BP,
9283,GO:0035720,0.999999999993327,0.785260686563109,0,3,intraciliary anterograde transport,BP,
10498,GO:0043398,0.999999999993377,0.791712174022952,0,3,HLH domain binding,MF,
1500,GO:0003846,0.999999999993378,0.848600039275144,0,2,2-acylglycerol O-acyltransferase activity,MF,
1679,GO:0004144,0.999999999993378,0.848600039275144,0,2,diacylglycerol O-acyltransferase activity,MF,
12456,GO:0050252,0.999999999993378,0.848600039275144,0,2,retinol O-fatty-acyltransferase activity,MF,
15243,GO:0071400,0.999999999993378,0.848600039275144,0,2,cellular response to oleic acid,BP,
7362,GO:0031404,0.999999999993385,0.792727512250743,0,3,chloride ion binding,MF,
5911,GO:0018153,0.999999999993399,0.849357240552206,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5942,GO:0018262,0.999999999993399,0.849357240552206,0,2,isopeptide cross-linking,BP,
2570,GO:0005854,0.999999999993418,0.861432814231614,0,2,nascent polypeptide-associated complex,CC,
1804,GO:0004449,0.999999999993423,0.791612598909901,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
2691,GO:0006055,0.999999999993426,0.932363337311949,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11651,GO:0046381,0.999999999993426,0.932363337311949,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12002,GO:0047444,0.999999999993426,0.932363337311949,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12487,GO:0050462,0.999999999993426,0.932363337311949,0,1,N-acetylneuraminate synthase activity,MF,
11740,GO:0046573,0.999999999993448,0.926041098001951,0,1,lactonohydrolase activity,MF,
17119,GO:0102007,0.999999999993448,0.926041098001951,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
19453,GO:1990130,0.999999999993477,0.666580002476189,0,5,GATOR1 complex,CC,
15567,GO:0072014,0.999999999993477,0.726652612225376,0,4,proximal tubule development,BP,
9814,GO:0042015,0.999999999993502,0.782719699075209,0,3,interleukin-20 binding,MF,
8273,GO:0033065,0.999999999993521,0.864726765995773,0,2,Rad51C-XRCC3 complex,CC,
16152,GO:0090164,0.999999999993533,0.848479901918262,0,2,asymmetric Golgi ribbon formation,BP,
15826,GO:0072526,0.999999999993538,0.726091100367435,0,4,pyridine-containing compound catabolic process,BP,
5705,GO:0016833,0.999999999993545,0.672452702740268,0,5,oxo-acid-lyase activity,MF,
7576,GO:0031938,0.999999999993546,0.854988807793399,0,2,regulation of chromatin silencing at telomere,BP,
218,GO:0000454,0.999999999993562,0.819622847511048,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
2192,GO:0005053,0.999999999993563,0.928153904217342,0,1,peroxisome matrix targeting signal-2 binding,MF,
169,GO:0000350,0.999999999993577,0.788815159130514,0,3,generation of catalytic spliceosome for second transesterification step,BP,
18118,GO:1902775,0.999999999993583,0.78157046336583,0,3,mitochondrial large ribosomal subunit assembly,BP,
14054,GO:0060825,0.999999999993624,0.854950044612651,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19842,GO:2000313,0.999999999993624,0.854950044612651,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
5306,GO:0016012,0.999999999993625,0.852186774376279,0,2,sarcoglycan complex,CC,
9933,GO:0042281,0.999999999993625,0.852186774376279,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
7144,GO:0030984,0.999999999993629,0.860187805672469,0,2,kininogen binding,MF,
14867,GO:0070640,0.999999999993635,0.786042423670952,0,3,vitamin D3 metabolic process,BP,
14034,GO:0060763,0.999999999993635,0.848629944586241,0,2,mammary duct terminal end bud growth,BP,
18661,GO:1903977,0.999999999993635,0.848629944586241,0,2,positive regulation of glial cell migration,BP,
14145,GO:0061015,0.999999999993636,0.865876382382108,0,2,snRNA import into nucleus,BP,
8834,GO:0034617,0.999999999993644,0.783569725583776,0,3,tetrahydrobiopterin binding,MF,
2891,GO:0006398,0.999999999993652,0.666460619903922,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
19673,GO:1990948,0.99999999999366,0.731022228489172,0,5,ubiquitin ligase inhibitor activity,MF,
1813,GO:0004463,0.999999999993673,0.922351410579969,0,1,leukotriene-A4 hydrolase activity,MF,
15925,GO:0072708,0.999999999993711,0.721730669971477,0,4,response to sorbitol,BP,
11532,GO:0046056,0.999999999993714,0.854492180171473,0,2,dADP metabolic process,BP,
14929,GO:0070780,0.999999999993718,0.85954945351474,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
7942,GO:0032532,0.999999999993727,0.785826852419757,0,3,regulation of microvillus length,BP,
19522,GO:1990415,0.999999999993731,0.783331004891042,0,3,Pex17p-Pex14p docking complex,CC,
19530,GO:1990429,0.999999999993731,0.783331004891042,0,3,peroxisomal importomer complex,CC,
8289,GO:0033106,0.999999999993731,0.85850199475205,0,2,cis-Golgi network membrane,CC,
13619,GO:0060091,0.999999999993741,0.675257734285689,0,5,kinocilium,CC,
16729,GO:0097732,0.999999999993741,0.675257734285689,0,5,9+2 non-motile cilium,CC,
13207,GO:0051835,0.999999999993748,0.788171326491152,0,3,positive regulation of synapse structural plasticity,BP,
16555,GO:0097325,0.999999999993754,0.848472721323907,0,2,melanocyte proliferation,BP,
6592,GO:0022605,0.999999999993774,0.739403489306459,0,4,mammalian oogenesis stage,BP,
8735,GO:0034382,0.999999999993787,0.753057023584195,0,4,chylomicron remnant clearance,BP,
15484,GO:0071830,0.999999999993787,0.753057023584195,0,4,triglyceride-rich lipoprotein particle clearance,BP,
14326,GO:0061502,0.9999999999938,0.723862160262201,0,4,early endosome to recycling endosome transport,BP,
2574,GO:0005861,0.999999999993813,0.761071082125505,0,4,troponin complex,CC,
6214,GO:0019740,0.999999999993819,0.79900781910865,0,3,nitrogen utilization,BP,
17936,GO:1902263,0.999999999993819,0.79900781910865,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
5542,GO:0016531,0.99999999999382,0.73224558105452,0,5,copper chaperone activity,MF,
4123,GO:0009182,0.999999999993824,0.801102144316723,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
11538,GO:0046066,0.999999999993824,0.801102144316723,0,3,dGDP metabolic process,BP,
2881,GO:0006382,0.999999999993849,0.664442314384165,0,5,adenosine to inosine editing,BP,
14361,GO:0061575,0.999999999993868,0.763534992699661,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
13734,GO:0060304,0.999999999993892,0.663088225044577,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
9182,GO:0035552,0.999999999993895,0.786458470474997,0,3,oxidative single-stranded DNA demethylation,BP,
1595,GO:0004013,0.999999999993899,0.781904120671229,0,3,adenosylhomocysteinase activity,MF,
5686,GO:0016802,0.999999999993899,0.781904120671229,0,3,trialkylsulfonium hydrolase activity,MF,
16218,GO:0090258,0.999999999993917,0.848482149409609,0,2,negative regulation of mitochondrial fission,BP,
16993,GO:0099074,0.999999999993917,0.848482149409609,0,2,mitochondrion to lysosome transport,BP,
16994,GO:0099075,0.999999999993917,0.848482149409609,0,2,mitochondrion-derived vesicle mediated transport,BP,
18988,GO:1904783,0.999999999993917,0.848482149409609,0,2,positive regulation of NMDA glutamate receptor activity,BP,
6353,GO:0021534,0.99999999999392,0.673686883593013,0,5,cell proliferation in hindbrain,BP,
6528,GO:0021924,0.99999999999392,0.673686883593013,0,5,cell proliferation in external granule layer,BP,
6529,GO:0021930,0.99999999999392,0.673686883593013,0,5,cerebellar granule cell precursor proliferation,BP,
8790,GO:0034473,0.999999999993936,0.804109580503005,0,3,U1 snRNA 3'-end processing,BP,
8793,GO:0034476,0.999999999993936,0.804109580503005,0,3,U5 snRNA 3'-end processing,BP,
10859,GO:0044362,0.999999999993942,0.679852365468646,0,5,negative regulation of molecular function in other organism,BP,
13324,GO:0052204,0.999999999993942,0.679852365468646,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
5698,GO:0016822,0.999999999993954,0.859471858135294,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5699,GO:0016823,0.999999999993954,0.859471858135294,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
2157,GO:0004984,0.999999999993958,0.81204451935232,0,3,olfactory receptor activity,MF,
12694,GO:0050911,0.999999999993958,0.81204451935232,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
4876,GO:0014738,0.999999999993978,0.781649209245177,0,3,regulation of muscle hyperplasia,BP,
11867,GO:0046870,0.999999999993978,0.781649209245177,0,3,cadmium ion binding,MF,
15084,GO:0071051,0.999999999993986,0.702085886743964,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
4014,GO:0009008,0.999999999994003,0.670838922849204,0,5,DNA-methyltransferase activity,MF,
7916,GO:0032489,0.999999999994023,0.729692089645003,0,4,regulation of Cdc42 protein signal transduction,BP,
8749,GO:0034398,0.999999999994037,0.663096427448964,0,5,telomere tethering at nuclear periphery,BP,
11560,GO:0046101,0.999999999994038,0.731873395796839,0,4,hypoxanthine biosynthetic process,BP,
2036,GO:0004776,0.999999999994044,0.855564973791806,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
8083,GO:0032764,0.999999999994054,0.854083542441854,0,2,negative regulation of mast cell cytokine production,BP,
10449,GO:0043305,0.999999999994054,0.854083542441854,0,2,negative regulation of mast cell degranulation,BP,
18484,GO:1903589,0.999999999994054,0.854083542441854,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
9233,GO:0035621,0.999999999994054,0.850074929248683,0,2,ER to Golgi ceramide transport,BP,
14020,GO:0060743,0.999999999994075,0.921180707768997,0,1,epithelial cell maturation involved in prostate gland development,BP,
14243,GO:0061218,0.999999999994075,0.785431733754479,0,3,negative regulation of mesonephros development,BP,
850,GO:0002176,0.999999999994138,0.811211152739136,0,3,male germ cell proliferation,BP,
9474,GO:0036093,0.999999999994138,0.811211152739136,0,3,germ cell proliferation,BP,
159,GO:0000322,0.99999999999414,0.789482084566712,0,3,storage vacuole,CC,
8025,GO:0032661,0.999999999994142,0.666714847135946,0,5,regulation of interleukin-18 production,BP,
19543,GO:1990460,0.999999999994146,0.782626943823684,0,3,leptin receptor binding,MF,
2207,GO:0005093,0.999999999994152,0.848848407315032,0,2,Rab GDP-dissociation inhibitor activity,MF,
15047,GO:0070991,0.999999999994154,0.781590849150268,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
12210,GO:0048388,0.999999999994184,0.855587141995884,0,2,endosomal lumen acidification,BP,
4610,GO:0010727,0.999999999994208,0.720258940705258,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
15048,GO:0070992,0.999999999994212,0.877908306027056,0,2,translation initiation complex,CC,
2330,GO:0005345,0.999999999994214,0.675360873521444,0,5,purine nucleobase transmembrane transporter activity,MF,
321,GO:0000839,0.999999999994238,0.786033454408172,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
9389,GO:0035926,0.99999999999424,0.663449617358218,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
4448,GO:0010370,0.999999999994259,0.849896496000315,0,2,perinucleolar chromocenter,CC,
3836,GO:0008441,0.999999999994269,0.848591667266604,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
9888,GO:0042166,0.999999999994285,0.720141454984178,0,4,acetylcholine binding,MF,
8492,GO:0033647,0.999999999994296,0.665994510742198,0,5,host intracellular organelle,CC,
8493,GO:0033648,0.999999999994296,0.665994510742198,0,5,host intracellular membrane-bounded organelle,CC,
5087,GO:0015333,0.999999999994297,0.781541526579974,0,3,peptide:proton symporter activity,MF,
19527,GO:1990425,0.999999999994313,0.85842306031995,0,2,ryanodine receptor complex,CC,
1075,GO:0002645,0.999999999994328,0.671358498832828,0,5,positive regulation of tolerance induction,BP,
1661,GO:0004117,0.999999999994328,0.921132773648183,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2041,GO:0004782,0.999999999994328,0.921132773648183,0,1,sulfinoalanine decarboxylase activity,MF,
3895,GO:0008531,0.999999999994328,0.921132773648183,0,1,riboflavin kinase activity,MF,
4166,GO:0009231,0.999999999994328,0.921132773648183,0,1,riboflavin biosynthetic process,BP,
4224,GO:0009398,0.999999999994328,0.921132773648183,0,1,FMN biosynthetic process,BP,
9998,GO:0042412,0.999999999994328,0.921132773648183,0,1,taurine biosynthetic process,BP,
11614,GO:0046305,0.999999999994328,0.921132773648183,0,1,alkanesulfonate biosynthetic process,BP,
11671,GO:0046444,0.999999999994328,0.921132773648183,0,1,FMN metabolic process,BP,
7123,GO:0030943,0.999999999994338,0.785395995002575,0,3,mitochondrion targeting sequence binding,MF,
9099,GO:0035363,0.999999999994349,0.724032931063636,0,4,histone locus body,CC,
16413,GO:0097039,0.999999999994353,0.665243906858737,0,5,protein linear polyubiquitination,BP,
19614,GO:1990761,0.999999999994357,0.84848706650875,0,2,growth cone lamellipodium,CC,
13053,GO:0051543,0.999999999994366,0.921413495590467,0,1,regulation of elastin biosynthetic process,BP,
13054,GO:0051545,0.999999999994366,0.921413495590467,0,1,negative regulation of elastin biosynthetic process,BP,
5770,GO:0016971,0.999999999994372,0.781715324871119,0,3,flavin-linked sulfhydryl oxidase activity,MF,
2076,GO:0004830,0.999999999994382,0.848477604414043,0,2,tryptophan-tRNA ligase activity,MF,
2926,GO:0006436,0.999999999994382,0.848477604414043,0,2,tryptophanyl-tRNA aminoacylation,BP,
18745,GO:1904217,0.999999999994395,0.784621352214788,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18746,GO:1904219,0.999999999994395,0.784621352214788,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18748,GO:1904222,0.999999999994395,0.784621352214788,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
11143,GO:0045188,0.999999999994422,0.854239898916522,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9718,GO:0038145,0.999999999994433,0.785202731827059,0,3,macrophage colony-stimulating factor signaling pathway,BP,
3153,GO:0006751,0.999999999994445,0.676030399461813,0,5,glutathione catabolic process,BP,
7392,GO:0031444,0.999999999994455,0.937130493244325,0,1,slow-twitch skeletal muscle fiber contraction,BP,
13052,GO:0051542,0.999999999994456,0.848734644076563,0,2,elastin biosynthetic process,BP,
661,GO:0001855,0.999999999994464,0.926746081806474,0,1,complement component C4b binding,MF,
7081,GO:0030870,0.999999999994482,0.663832040293212,0,5,Mre11 complex,CC,
16164,GO:0090182,0.999999999994499,0.855102112505738,0,2,regulation of secretion of lysosomal enzymes,BP,
1810,GO:0004459,0.99999999999451,0.793182584769654,0,3,L-lactate dehydrogenase activity,MF,
4019,GO:0009041,0.999999999994511,0.79279666786354,0,3,uridylate kinase activity,MF,
4084,GO:0009138,0.999999999994511,0.79279666786354,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
12093,GO:0048069,0.999999999994515,0.664102942180407,0,5,eye pigmentation,BP,
2364,GO:0005476,0.999999999994518,0.850808650213669,0,2,carnitine:acyl carnitine antiporter activity,MF,
14890,GO:0070678,0.999999999994561,0.921135981812379,0,1,preprotein binding,MF,
3675,GO:0008172,0.999999999994565,0.672088537329374,0,5,S-methyltransferase activity,MF,
14261,GO:0061316,0.999999999994578,0.784436591609976,0,3,canonical Wnt signaling pathway involved in heart development,BP,
16135,GO:0090135,0.99999999999458,0.784108205986806,0,3,actin filament branching,BP,
12046,GO:0047860,0.999999999994595,0.931763418199774,0,1,diiodophenylpyruvate reductase activity,MF,
6015,GO:0019065,0.999999999994605,0.781548646086542,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15956,GO:0075509,0.999999999994605,0.781548646086542,0,3,endocytosis involved in viral entry into host cell,BP,
19864,GO:2000342,0.99999999999461,0.848723550144234,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
20261,GO:2001225,0.999999999994615,0.666371664288449,0,5,regulation of chloride transport,BP,
11536,GO:0046061,0.999999999994643,0.806481157314111,0,3,dATP catabolic process,BP,
19613,GO:1990758,0.999999999994645,0.923976454717875,0,1,mitotic sister chromatid biorientation,BP,
1779,GO:0004392,0.999999999994684,0.857542934187168,0,2,heme oxygenase (decyclizing) activity,MF,
3175,GO:0006788,0.999999999994684,0.857542934187168,0,2,heme oxidation,BP,
17149,GO:0102485,0.9999999999947,0.848472724125708,0,2,dATP phosphohydrolase activity,MF,
17150,GO:0102486,0.9999999999947,0.848472724125708,0,2,dCTP phosphohydrolase activity,MF,
17151,GO:0102487,0.9999999999947,0.848472724125708,0,2,dUTP phosphohydrolase activity,MF,
17152,GO:0102488,0.9999999999947,0.848472724125708,0,2,dTTP phosphohydrolase activity,MF,
17153,GO:0102489,0.9999999999947,0.848472724125708,0,2,GTP phosphohydrolase activity,MF,
17154,GO:0102490,0.9999999999947,0.848472724125708,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17155,GO:0102491,0.9999999999947,0.848472724125708,0,2,dGTP phosphohydrolase activity,MF,
18833,GO:1904426,0.9999999999947,0.848472724125708,0,2,positive regulation of GTP binding,BP,
659,GO:0001850,0.99999999999475,0.924029269278721,0,1,complement component C3a binding,MF,
660,GO:0001851,0.99999999999475,0.924029269278721,0,1,complement component C3b binding,MF,
17735,GO:1901664,0.999999999994775,0.790741009093293,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17736,GO:1901666,0.999999999994775,0.790741009093293,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
13866,GO:0060482,0.999999999994783,0.789690726846856,0,3,lobar bronchus development,BP,
13893,GO:0060535,0.999999999994783,0.789690726846856,0,3,trachea cartilage morphogenesis,BP,
16275,GO:0090336,0.999999999994783,0.789690726846856,0,3,positive regulation of brown fat cell differentiation,BP,
1795,GO:0004427,0.999999999994786,0.798985231738764,0,3,inorganic diphosphatase activity,MF,
11056,GO:0045053,0.999999999994796,0.663093094194446,0,5,protein retention in Golgi apparatus,BP,
1840,GO:0004496,0.999999999994817,0.922353898493729,0,1,mevalonate kinase activity,MF,
13449,GO:0052894,0.999999999994817,0.922353898493729,0,1,norspermine:oxygen oxidoreductase activity,MF,
13450,GO:0052895,0.999999999994817,0.922353898493729,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
349,GO:0000962,0.999999999994819,0.848571454311804,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
8781,GO:0034458,0.999999999994819,0.848571454311804,0,2,3'-5' RNA helicase activity,MF,
11044,GO:0045025,0.999999999994819,0.848571454311804,0,2,mitochondrial degradosome,CC,
9277,GO:0035701,0.999999999994858,0.781982539475981,0,3,hematopoietic stem cell migration,BP,
10512,GO:0043415,0.99999999999486,0.726559015705761,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10513,GO:0043416,0.99999999999486,0.726559015705761,0,4,regulation of skeletal muscle tissue regeneration,BP,
18056,GO:1902605,0.999999999994885,0.921130201416616,0,1,heterotrimeric G-protein complex assembly,BP,
20000,GO:2000609,0.999999999994928,0.783611961906671,0,3,regulation of thyroid hormone generation,BP,
20222,GO:2001160,0.999999999994935,0.859639695344631,0,2,regulation of histone H3-K79 methylation,BP,
20223,GO:2001162,0.999999999994935,0.859639695344631,0,2,positive regulation of histone H3-K79 methylation,BP,
12962,GO:0051344,0.999999999994942,0.79118793806294,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
17598,GO:1901255,0.999999999994961,0.85364084875759,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17474,GO:1900365,0.999999999994969,0.782259836744789,0,3,positive regulation of mRNA polyadenylation,BP,
6225,GO:0019776,0.999999999994973,0.790946450417466,0,3,Atg8 ligase activity,MF,
9183,GO:0035553,0.999999999994979,0.786428544628621,0,3,oxidative single-stranded RNA demethylation,BP,
9629,GO:0036496,0.999999999994985,0.855368126053699,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
12235,GO:0048496,0.999999999994994,0.781717900846559,0,3,maintenance of animal organ identity,BP,
12432,GO:0048936,0.999999999995003,0.783220775419535,0,3,peripheral nervous system neuron axonogenesis,BP,
952,GO:0002371,0.999999999995009,0.733621087922726,0,4,dendritic cell cytokine production,BP,
1138,GO:0002730,0.999999999995009,0.733621087922726,0,4,regulation of dendritic cell cytokine production,BP,
13879,GO:0060509,0.999999999995076,0.666703083687561,0,5,Type I pneumocyte differentiation,BP,
219,GO:0000455,0.999999999995089,0.852314829455522,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
1781,GO:0004395,0.999999999995101,0.931874769557499,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3826,GO:0008425,0.999999999995101,0.931874769557499,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3956,GO:0008689,0.999999999995101,0.931874769557499,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4454,GO:0010420,0.999999999995101,0.931874769557499,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4652,GO:0010795,0.999999999995101,0.931874769557499,0,1,regulation of ubiquinone biosynthetic process,BP,
6953,GO:0030580,0.999999999995101,0.931874769557499,0,1,quinone cofactor methyltransferase activity,MF,
10937,GO:0044595,0.999999999995101,0.931874769557499,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10938,GO:0044596,0.999999999995101,0.931874769557499,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13165,GO:0051750,0.999999999995101,0.931874769557499,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14343,GO:0061542,0.999999999995101,0.931874769557499,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15199,GO:0071344,0.99999999999513,0.862813219878194,0,2,diphosphate metabolic process,BP,
8048,GO:0032701,0.999999999995152,0.853113023768503,0,2,negative regulation of interleukin-18 production,BP,
11900,GO:0046923,0.999999999995153,0.674688365699053,0,5,ER retention sequence binding,MF,
9242,GO:0035634,0.999999999995156,0.879702228743849,0,2,response to stilbenoid,BP,
494,GO:0001546,0.999999999995163,0.925893178057032,0,1,preantral ovarian follicle growth,BP,
12113,GO:0048162,0.999999999995163,0.925893178057032,0,1,multi-layer follicle stage,BP,
1722,GO:0004314,0.99999999999519,0.850277107381542,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5485,GO:0016419,0.99999999999519,0.850277107381542,0,2,S-malonyltransferase activity,MF,
5486,GO:0016420,0.99999999999519,0.850277107381542,0,2,malonyltransferase activity,MF,
424,GO:0001129,0.99999999999519,0.784183447233892,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,0.99999999999519,0.784183447233892,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
927,GO:0002325,0.999999999995203,0.933626745205064,0,1,natural killer cell differentiation involved in immune response,BP,
8132,GO:0032824,0.999999999995203,0.933626745205064,0,1,negative regulation of natural killer cell differentiation,BP,
8134,GO:0032826,0.999999999995203,0.933626745205064,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8135,GO:0032827,0.999999999995203,0.933626745205064,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
19454,GO:1990131,0.999999999995211,0.793034362146436,0,3,Gtr1-Gtr2 GTPase complex,CC,
16235,GO:0090283,0.999999999995223,0.785124266179663,0,3,regulation of protein glycosylation in Golgi,BP,
1633,GO:0004075,0.999999999995224,0.78158946238479,0,3,biotin carboxylase activity,MF,
255,GO:0000720,0.999999999995232,0.790146156664234,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
86,GO:0000173,0.999999999995245,0.925899288088944,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
9964,GO:0042350,0.999999999995281,0.792989606641772,0,3,GDP-L-fucose biosynthetic process,BP,
4496,GO:0010521,0.999999999995284,0.794371142631689,0,3,telomerase inhibitor activity,MF,
12292,GO:0048625,0.999999999995291,0.781764910971105,0,3,myoblast fate commitment,BP,
12321,GO:0048671,0.999999999995291,0.781764910971105,0,3,negative regulation of collateral sprouting,BP,
11433,GO:0045852,0.999999999995294,0.783481218443336,0,3,pH elevation,BP,
13019,GO:0051454,0.999999999995294,0.783481218443336,0,3,intracellular pH elevation,BP,
1534,GO:0003919,0.999999999995303,0.922928901257255,0,1,FMN adenylyltransferase activity,MF,
3150,GO:0006747,0.999999999995303,0.922928901257255,0,1,FAD biosynthetic process,BP,
11670,GO:0046443,0.999999999995303,0.922928901257255,0,1,FAD metabolic process,BP,
15785,GO:0072388,0.999999999995303,0.922928901257255,0,1,flavin adenine dinucleotide biosynthetic process,BP,
1959,GO:0004663,0.999999999995308,0.730371283793611,0,4,Rab geranylgeranyltransferase activity,MF,
7277,GO:0031260,0.999999999995336,0.935512923052141,0,1,pseudopodium membrane,CC,
13603,GO:0060073,0.999999999995364,0.720477620170007,0,4,micturition,BP,
103,GO:0000214,0.999999999995371,0.725439299787643,0,4,tRNA-intron endonuclease complex,CC,
9269,GO:0035691,0.99999999999538,0.931016760909866,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9271,GO:0035693,0.99999999999538,0.931016760909866,0,1,NOS2-CD74 complex,CC,
10124,GO:0042658,0.99999999999538,0.931016760909866,0,1,MHC class II protein binding, via antigen binding groove,MF,
15345,GO:0071567,0.999999999995393,0.863820342563216,0,2,UFM1 hydrolase activity,MF,
16383,GO:0090725,0.999999999995395,0.865788813682649,0,2,peripheral region of growth cone,CC,
19475,GO:1990189,0.999999999995395,0.865788813682649,0,2,peptide-serine-N-acetyltransferase activity,MF,
7677,GO:0032106,0.999999999995401,0.784633932407151,0,3,positive regulation of response to extracellular stimulus,BP,
7680,GO:0032109,0.999999999995401,0.784633932407151,0,3,positive regulation of response to nutrient levels,BP,
11620,GO:0046322,0.999999999995407,0.720374367777418,0,4,negative regulation of fatty acid oxidation,BP,
9662,GO:0038016,0.999999999995423,0.848810187940135,0,2,insulin receptor internalization,BP,
18483,GO:1903588,0.99999999999543,0.790300514225954,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
4963,GO:0015038,0.999999999995438,0.704224332327338,0,5,glutathione disulfide oxidoreductase activity,MF,
339,GO:0000939,0.999999999995448,0.789295753498799,0,3,condensed chromosome inner kinetochore,CC,
19825,GO:2000286,0.999999999995451,0.781608306033217,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
4628,GO:0010749,0.999999999995456,0.781581768211559,0,3,regulation of nitric oxide mediated signal transduction,BP,
14253,GO:0061303,0.999999999995458,0.729125948256858,0,4,cornea development in camera-type eye,BP,
2900,GO:0006407,0.999999999995489,0.800808439154305,0,3,rRNA export from nucleus,BP,
15542,GO:0071942,0.999999999995501,0.793837333582888,0,3,XPC complex,CC,
2061,GO:0004815,0.999999999995525,0.848780359364717,0,2,aspartate-tRNA ligase activity,MF,
11905,GO:0046933,0.999999999995531,0.813447808604102,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12110,GO:0048149,0.999999999995538,0.721905318439515,0,4,behavioral response to ethanol,BP,
6598,GO:0022615,0.999999999995559,0.728969813518671,0,4,protein to membrane docking,BP,
8549,GO:0033883,0.999999999995562,0.862484931857486,0,2,pyridoxal phosphatase activity,MF,
4306,GO:0009757,0.999999999995572,0.681031475456672,0,5,hexose mediated signaling,BP,
4415,GO:0010182,0.999999999995572,0.681031475456672,0,5,sugar mediated signaling pathway,BP,
4426,GO:0010255,0.999999999995572,0.681031475456672,0,5,glucose mediated signaling pathway,BP,
4433,GO:0010269,0.999999999995619,0.801104307449999,0,3,response to selenium ion,BP,
4609,GO:0010726,0.999999999995623,0.849833167922915,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
16121,GO:0090107,0.999999999995632,0.790365771364033,0,3,regulation of high-density lipoprotein particle assembly,BP,
11839,GO:0046790,0.999999999995667,0.787268393702536,0,3,virion binding,MF,
1808,GO:0004457,0.999999999995673,0.730634468908756,0,4,lactate dehydrogenase activity,MF,
8629,GO:0034145,0.999999999995681,0.669770243443022,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
12496,GO:0050542,0.999999999995685,0.76781427153502,0,4,icosanoid binding,MF,
12497,GO:0050543,0.999999999995685,0.76781427153502,0,4,icosatetraenoic acid binding,MF,
12498,GO:0050544,0.999999999995685,0.76781427153502,0,4,arachidonic acid binding,MF,
12045,GO:0047844,0.999999999995698,0.678774917546312,0,5,deoxycytidine deaminase activity,MF,
10590,GO:0043553,0.999999999995705,0.781681851512407,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
9212,GO:0035597,0.999999999995707,0.922611634970401,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
12284,GO:0048597,0.999999999995719,0.808436922571814,0,3,post-embryonic camera-type eye morphogenesis,BP,
18469,GO:1903567,0.999999999995759,0.848716056206331,0,2,regulation of protein localization to ciliary membrane,BP,
11939,GO:0046985,0.999999999995761,0.788889265998438,0,3,positive regulation of hemoglobin biosynthetic process,BP,
8035,GO:0032681,0.999999999995771,0.92113188654076,0,1,regulation of lymphotoxin A production,BP,
8080,GO:0032761,0.999999999995771,0.92113188654076,0,1,positive regulation of lymphotoxin A production,BP,
10274,GO:0043016,0.999999999995771,0.92113188654076,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10275,GO:0043017,0.999999999995771,0.92113188654076,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11234,GO:0045404,0.999999999995771,0.92113188654076,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
6942,GO:0030550,0.999999999995776,0.792189270534992,0,3,acetylcholine receptor inhibitor activity,MF,
13034,GO:0051490,0.999999999995797,0.784962902737864,0,3,negative regulation of filopodium assembly,BP,
4347,GO:0009912,0.999999999995817,0.676040770645394,0,5,auditory receptor cell fate commitment,BP,
13626,GO:0060120,0.999999999995817,0.676040770645394,0,5,inner ear receptor cell fate commitment,BP,
10929,GO:0044547,0.999999999995832,0.663711173961062,0,5,DNA topoisomerase binding,MF,
14100,GO:0060935,0.999999999995838,0.781705888451925,0,3,cardiac fibroblast cell differentiation,BP,
14101,GO:0060936,0.999999999995838,0.781705888451925,0,3,cardiac fibroblast cell development,BP,
14102,GO:0060938,0.999999999995838,0.781705888451925,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14103,GO:0060939,0.999999999995838,0.781705888451925,0,3,epicardium-derived cardiac fibroblast cell development,BP,
16939,GO:0098917,0.999999999995842,0.795384752602935,0,3,retrograde trans-synaptic signaling,BP,
572,GO:0001714,0.99999999999585,0.729812704647059,0,4,endodermal cell fate specification,BP,
3875,GO:0008504,0.999999999995855,0.721659627121172,0,4,monoamine transmembrane transporter activity,MF,
11731,GO:0046541,0.999999999995858,0.921130157490053,0,1,saliva secretion,BP,
15550,GO:0071962,0.999999999995862,0.799958512665355,0,3,mitotic sister chromatid cohesion, centromeric,BP,
10232,GO:0042923,0.999999999995863,0.851208819961389,0,2,neuropeptide binding,MF,
1805,GO:0004450,0.999999999995887,0.85228634543158,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
2719,GO:0006097,0.999999999995887,0.85228634543158,0,2,glyoxylate cycle,BP,
14559,GO:0070081,0.999999999995892,0.784201554321133,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14560,GO:0070083,0.999999999995892,0.784201554321133,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
12792,GO:0051086,0.999999999995899,0.922977624064454,0,1,chaperone mediated protein folding independent of cofactor,BP,
2073,GO:0004827,0.999999999995903,0.793189733147476,0,3,proline-tRNA ligase activity,MF,
2923,GO:0006433,0.999999999995903,0.793189733147476,0,3,prolyl-tRNA aminoacylation,BP,
14187,GO:0061086,0.999999999995916,0.721894451063352,0,4,negative regulation of histone H3-K27 methylation,BP,
5184,GO:0015747,0.999999999995945,0.850873364567586,0,2,urate transport,BP,
12314,GO:0048664,0.999999999995946,0.797263271644593,0,3,neuron fate determination,BP,
9701,GO:0038098,0.999999999995952,0.922547535070231,0,1,sequestering of BMP from receptor via BMP binding,BP,
2176,GO:0005021,0.999999999995967,0.84857055364792,0,2,vascular endothelial growth factor-activated receptor activity,MF,
6410,GO:0021648,0.999999999995967,0.84857055364792,0,2,vestibulocochlear nerve morphogenesis,BP,
6481,GO:0021824,0.999999999995967,0.84857055364792,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6485,GO:0021828,0.999999999995967,0.84857055364792,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6496,GO:0021856,0.999999999995967,0.84857055364792,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
9736,GO:0038190,0.999999999995967,0.84857055364792,0,2,VEGF-activated neuropilin signaling pathway,BP,
13798,GO:0060385,0.999999999995967,0.84857055364792,0,2,axonogenesis involved in innervation,BP,
14120,GO:0060978,0.999999999995967,0.84857055364792,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
14308,GO:0061441,0.999999999995967,0.84857055364792,0,2,renal artery morphogenesis,BP,
16443,GO:0097102,0.999999999995967,0.84857055364792,0,2,endothelial tip cell fate specification,BP,
17962,GO:1902336,0.999999999995967,0.84857055364792,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
18373,GO:1903375,0.999999999995967,0.84857055364792,0,2,facioacoustic ganglion development,BP,
19628,GO:1990791,0.999999999995967,0.84857055364792,0,2,dorsal root ganglion development,BP,
11745,GO:0046581,0.999999999995985,0.782980388502252,0,3,intercellular canaliculus,CC,
499,GO:0001554,0.999999999995991,0.663087477374356,0,5,luteolysis,BP,
1045,GO:0002568,0.999999999995991,0.663087477374356,0,5,somatic diversification of T cell receptor genes,BP,
1092,GO:0002681,0.999999999995991,0.663087477374356,0,5,somatic recombination of T cell receptor gene segments,BP,
1660,GO:0004115,0.999999999995991,0.663087477374356,0,5,3',5'-cyclic-AMP phosphodiesterase activity,MF,
4216,GO:0009378,0.999999999995991,0.663087477374356,0,5,four-way junction helicase activity,MF,
4381,GO:0010032,0.999999999995991,0.663087477374356,0,5,meiotic chromosome condensation,BP,
4535,GO:0010606,0.999999999995991,0.663087477374356,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4816,GO:0014010,0.999999999995991,0.663087477374356,0,5,Schwann cell proliferation,BP,
4844,GO:0014051,0.999999999995991,0.663087477374356,0,5,gamma-aminobutyric acid secretion,BP,
5692,GO:0016812,0.999999999995991,0.663087477374356,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6475,GO:0021815,0.999999999995991,0.663087477374356,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6801,GO:0030242,0.999999999995991,0.663087477374356,0,5,autophagy of peroxisome,BP,
6901,GO:0030473,0.999999999995991,0.663087477374356,0,5,nuclear migration along microtubule,BP,
6904,GO:0030479,0.999999999995991,0.663087477374356,0,5,actin cortical patch,CC,
7311,GO:0031314,0.999999999995991,0.663087477374356,0,5,extrinsic component of mitochondrial inner membrane,CC,
7641,GO:0032051,0.999999999995991,0.663087477374356,0,5,clathrin light chain binding,MF,
8320,GO:0033153,0.999999999995991,0.663087477374356,0,5,T cell receptor V(D)J recombination,BP,
8950,GO:0034992,0.999999999995991,0.663087477374356,0,5,microtubule organizing center attachment site,CC,
8951,GO:0034993,0.999999999995991,0.663087477374356,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
9646,GO:0036514,0.999999999995991,0.663087477374356,0,5,dopaminergic neuron axon guidance,BP,
9829,GO:0042048,0.999999999995991,0.663087477374356,0,5,olfactory behavior,BP,
10329,GO:0043121,0.999999999995991,0.663087477374356,0,5,neurotrophin binding,MF,
10593,GO:0043559,0.999999999995991,0.663087477374356,0,5,insulin binding,MF,
10663,GO:0043813,0.999999999995991,0.663087477374356,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10992,GO:0044789,0.999999999995991,0.663087477374356,0,5,modulation by host of viral release from host cell,BP,
10993,GO:0044791,0.999999999995991,0.663087477374356,0,5,positive regulation by host of viral release from host cell,BP,
11078,GO:0045078,0.999999999995991,0.663087477374356,0,5,positive regulation of interferon-gamma biosynthetic process,BP,
12290,GO:0048617,0.999999999995991,0.663087477374356,0,5,embryonic foregut morphogenesis,BP,
12462,GO:0050291,0.999999999995991,0.663087477374356,0,5,sphingosine N-acyltransferase activity,MF,
12930,GO:0051286,0.999999999995991,0.663087477374356,0,5,cell tip,CC,
12974,GO:0051371,0.999999999995991,0.663087477374356,0,5,muscle alpha-actinin binding,MF,
13109,GO:0051643,0.999999999995991,0.663087477374356,0,5,endoplasmic reticulum localization,BP,
13552,GO:0060013,0.999999999995991,0.663087477374356,0,5,righting reflex,BP,
14337,GO:0061525,0.999999999995991,0.663087477374356,0,5,hindgut development,BP,
14396,GO:0061645,0.999999999995991,0.663087477374356,0,5,endocytic patch,CC,
14430,GO:0061734,0.999999999995991,0.663087477374356,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15337,GO:0071557,0.999999999995991,0.663087477374356,0,5,histone H3-K27 demethylation,BP,
15338,GO:0071558,0.999999999995991,0.663087477374356,0,5,histone demethylase activity (H3-K27 specific),MF,
15418,GO:0071680,0.999999999995991,0.663087477374356,0,5,response to indole-3-methanol,BP,
15419,GO:0071681,0.999999999995991,0.663087477374356,0,5,cellular response to indole-3-methanol,BP,
16044,GO:0086073,0.999999999995991,0.663087477374356,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16052,GO:0086083,0.999999999995991,0.663087477374356,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16238,GO:0090286,0.999999999995991,0.663087477374356,0,5,cytoskeletal anchoring at nuclear membrane,BP,
16602,GO:0097427,0.999999999995991,0.663087477374356,0,5,microtubule bundle,CC,
16623,GO:0097470,0.999999999995991,0.663087477374356,0,5,ribbon synapse,CC,
16784,GO:0098597,0.999999999995991,0.663087477374356,0,5,observational learning,BP,
16890,GO:0098831,0.999999999995991,0.663087477374356,0,5,presynaptic active zone cytoplasmic component,CC,
17220,GO:0106083,0.999999999995991,0.663087477374356,0,5,nuclear membrane protein complex,CC,
17223,GO:0106094,0.999999999995991,0.663087477374356,0,5,nuclear membrane microtubule tethering complex,CC,
17674,GO:1901535,0.999999999995991,0.663087477374356,0,5,regulation of DNA demethylation,BP,
18442,GO:1903525,0.999999999995991,0.663087477374356,0,5,regulation of membrane tubulation,BP,
18984,GO:1904778,0.999999999995991,0.663087477374356,0,5,positive regulation of protein localization to cell cortex,BP,
18986,GO:1904781,0.999999999995991,0.663087477374356,0,5,positive regulation of protein localization to centrosome,BP,
19040,GO:1904885,0.999999999995991,0.663087477374356,0,5,beta-catenin destruction complex assembly,BP,
19065,GO:1904938,0.999999999995991,0.663087477374356,0,5,planar cell polarity pathway involved in axon guidance,BP,
9982,GO:0042374,0.999999999995999,0.861240791665283,0,2,phylloquinone metabolic process,BP,
9983,GO:0042376,0.999999999995999,0.861240791665283,0,2,phylloquinone catabolic process,BP,
17733,GO:1901662,0.999999999995999,0.861240791665283,0,2,quinone catabolic process,BP,
311,GO:0000822,0.999999999996012,0.781541506402689,0,3,inositol hexakisphosphate binding,MF,
18067,GO:1902626,0.99999999999604,0.823329459946267,0,3,assembly of large subunit precursor of preribosome,BP,
17803,GO:1901896,0.999999999996049,0.855441858379269,0,2,positive regulation of calcium-transporting ATPase activity,BP,
6377,GO:0021562,0.999999999996064,0.719967866106958,0,4,vestibulocochlear nerve development,BP,
6407,GO:0021636,0.999999999996064,0.719967866106958,0,4,trigeminal nerve morphogenesis,BP,
6408,GO:0021637,0.999999999996064,0.719967866106958,0,4,trigeminal nerve structural organization,BP,
14347,GO:0061550,0.999999999996064,0.719967866106958,0,4,cranial ganglion development,BP,
16634,GO:0097490,0.999999999996064,0.719967866106958,0,4,sympathetic neuron projection extension,BP,
16635,GO:0097491,0.999999999996064,0.719967866106958,0,4,sympathetic neuron projection guidance,BP,
18742,GO:1904211,0.999999999996076,0.851582445718769,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18963,GO:1904742,0.999999999996097,0.7327107761939,0,4,regulation of telomeric DNA binding,BP,
9272,GO:0035694,0.999999999996099,0.724812316193235,0,4,mitochondrial protein catabolic process,BP,
18528,GO:1903715,0.999999999996099,0.724812316193235,0,4,regulation of aerobic respiration,BP,
3026,GO:0006572,0.999999999996127,0.798734019721959,0,3,tyrosine catabolic process,BP,
8171,GO:0032907,0.99999999999618,0.782205150911147,0,3,transforming growth factor beta3 production,BP,
8174,GO:0032910,0.99999999999618,0.782205150911147,0,3,regulation of transforming growth factor beta3 production,BP,
9506,GO:0036153,0.999999999996183,0.921129163219734,0,1,triglyceride acyl-chain remodeling,BP,
12917,GO:0051264,0.999999999996183,0.921129163219734,0,1,mono-olein transacylation activity,MF,
12918,GO:0051265,0.999999999996183,0.921129163219734,0,1,diolein transacylation activity,MF,
16358,GO:0090649,0.999999999996187,0.665697528408082,0,5,response to oxygen-glucose deprivation,BP,
16359,GO:0090650,0.999999999996187,0.665697528408082,0,5,cellular response to oxygen-glucose deprivation,BP,
13554,GO:0060017,0.999999999996187,0.667606003441987,0,5,parathyroid gland development,BP,
8283,GO:0033085,0.9999999999962,0.674357028268956,0,5,negative regulation of T cell differentiation in thymus,BP,
1601,GO:0004020,0.99999999999621,0.848524187873567,0,2,adenylylsulfate kinase activity,MF,
2039,GO:0004779,0.99999999999621,0.848524187873567,0,2,sulfate adenylyltransferase activity,MF,
2040,GO:0004781,0.99999999999621,0.848524187873567,0,2,sulfate adenylyltransferase (ATP) activity,MF,
7379,GO:0031431,0.999999999996221,0.848472716604923,0,2,Dbf4-dependent protein kinase complex,CC,
10110,GO:0042627,0.999999999996244,0.818081074476756,0,3,chylomicron,CC,
1763,GO:0004366,0.999999999996256,0.663091442808556,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
17113,GO:0101006,0.999999999996273,0.795614911277313,0,3,protein histidine phosphatase activity,MF,
307,GO:0000818,0.999999999996273,0.849046656934447,0,2,nuclear MIS12/MIND complex,CC,
16928,GO:0098905,0.999999999996279,0.867033740830149,0,2,regulation of bundle of His cell action potential,BP,
12156,GO:0048263,0.999999999996281,0.735291216603864,0,4,determination of dorsal identity,BP,
15249,GO:0071409,0.999999999996286,0.785646759473291,0,3,cellular response to cycloheximide,BP,
12744,GO:0051012,0.999999999996297,0.852166499000046,0,2,microtubule sliding,BP,
14095,GO:0060923,0.999999999996305,0.665544192835936,0,5,cardiac muscle cell fate commitment,BP,
2075,GO:0004829,0.999999999996323,0.781743653553265,0,3,threonine-tRNA ligase activity,MF,
2925,GO:0006435,0.999999999996323,0.781743653553265,0,3,threonyl-tRNA aminoacylation,BP,
5045,GO:0015228,0.999999999996326,0.782012143977671,0,3,coenzyme A transmembrane transporter activity,MF,
5252,GO:0015880,0.999999999996326,0.782012143977671,0,3,coenzyme A transport,BP,
9089,GO:0035349,0.999999999996326,0.782012143977671,0,3,coenzyme A transmembrane transport,BP,
15091,GO:0071077,0.999999999996326,0.782012143977671,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15095,GO:0071106,0.999999999996326,0.782012143977671,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15978,GO:0080122,0.999999999996326,0.782012143977671,0,3,AMP transmembrane transporter activity,MF,
13614,GO:0060086,0.999999999996329,0.848472937713183,0,2,circadian temperature homeostasis,BP,
10945,GO:0044609,0.999999999996331,0.84933788767407,0,2,DBIRD complex,CC,
19816,GO:2000275,0.999999999996341,0.865432151878997,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
4612,GO:0010729,0.999999999996351,0.92260598581394,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
177,GO:0000386,0.999999999996355,0.785009856828953,0,3,second spliceosomal transesterification activity,MF,
2228,GO:0005131,0.999999999996359,0.720408425870418,0,4,growth hormone receptor binding,MF,
1622,GO:0004056,0.999999999996376,0.922800118132518,0,1,argininosuccinate lyase activity,MF,
10020,GO:0042450,0.999999999996376,0.922800118132518,0,1,arginine biosynthetic process via ornithine,BP,
7628,GO:0032027,0.999999999996388,0.784663100703714,0,3,myosin light chain binding,MF,
1599,GO:0004018,0.999999999996407,0.928245049491192,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14858,GO:0070626,0.999999999996407,0.928245049491192,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16350,GO:0090615,0.999999999996416,0.850461970116365,0,2,mitochondrial mRNA processing,BP,
13051,GO:0051541,0.999999999996435,0.73690662888736,0,4,elastin metabolic process,BP,
142,GO:0000293,0.999999999996436,0.781546179267102,0,3,ferric-chelate reductase activity,MF,
1372,GO:0003263,0.99999999999644,0.683576982671291,0,5,cardioblast proliferation,BP,
16610,GO:0097443,0.999999999996447,0.663163957416626,0,5,sorting endosome,CC,
9965,GO:0042351,0.999999999996449,0.860900157665166,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
13775,GO:0060353,0.999999999996458,0.78975065692021,0,3,regulation of cell adhesion molecule production,BP,
13776,GO:0060355,0.999999999996458,0.78975065692021,0,3,positive regulation of cell adhesion molecule production,BP,
16564,GO:0097344,0.99999999999647,0.854006235439942,0,2,Rix1 complex,CC,
8011,GO:0032641,0.999999999996477,0.8484752254003,0,2,lymphotoxin A production,BP,
9851,GO:0042097,0.999999999996477,0.8484752254003,0,2,interleukin-4 biosynthetic process,BP,
9860,GO:0042109,0.999999999996477,0.8484752254003,0,2,lymphotoxin A biosynthetic process,BP,
11232,GO:0045402,0.999999999996477,0.8484752254003,0,2,regulation of interleukin-4 biosynthetic process,BP,
19295,GO:1905550,0.999999999996477,0.858755098104829,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19296,GO:1905552,0.999999999996477,0.858755098104829,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19535,GO:1990442,0.999999999996485,0.817815926764315,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
1835,GO:0004490,0.999999999996494,0.926659177122423,0,1,methylglutaconyl-CoA hydratase activity,MF,
12434,GO:0050011,0.999999999996494,0.926659177122423,0,1,itaconyl-CoA hydratase activity,MF,
1746,GO:0004346,0.999999999996504,0.926066010215057,0,1,glucose-6-phosphatase activity,MF,
12465,GO:0050309,0.999999999996504,0.926066010215057,0,1,sugar-terminal-phosphatase activity,MF,
16128,GO:0090118,0.999999999996505,0.666638068432697,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
3935,GO:0008616,0.999999999996514,0.799394191579734,0,3,queuosine biosynthetic process,BP,
11569,GO:0046116,0.999999999996514,0.799394191579734,0,3,queuosine metabolic process,BP,
6742,GO:0030160,0.99999999999652,0.783598599554448,0,3,GKAP/Homer scaffold activity,MF,
162,GO:0000333,0.999999999996521,0.876037638951203,0,2,telomerase catalytic core complex,CC,
2154,GO:0004977,0.999999999996532,0.850853686625671,0,2,melanocortin receptor activity,MF,
3862,GO:0008481,0.999999999996532,0.850853686625671,0,2,sphinganine kinase activity,MF,
5800,GO:0017050,0.999999999996532,0.850853686625671,0,2,D-erythro-sphingosine kinase activity,MF,
17214,GO:0106072,0.999999999996532,0.850853686625671,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
16594,GO:0097409,0.999999999996537,0.923020556608153,0,1,glial cytoplasmic inclusion,CC,
16597,GO:0097414,0.999999999996537,0.923020556608153,0,1,classical Lewy body,CC,
16620,GO:0097462,0.999999999996537,0.923020556608153,0,1,Lewy neurite,CC,
19431,GO:1990038,0.999999999996537,0.923020556608153,0,1,Lewy body corona,CC,
4710,GO:0010872,0.999999999996584,0.694001234984641,0,5,regulation of cholesterol esterification,BP,
16453,GO:0097113,0.999999999996586,0.729725943970647,0,4,AMPA glutamate receptor clustering,BP,
16710,GO:0097688,0.999999999996586,0.729725943970647,0,4,glutamate receptor clustering,BP,
10713,GO:0044020,0.999999999996599,0.726415523301319,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11267,GO:0045542,0.999999999996608,0.663148318334769,0,5,positive regulation of cholesterol biosynthetic process,BP,
14125,GO:0060988,0.99999999999662,0.848804074517127,0,2,lipid tube assembly,BP,
18191,GO:1902960,0.99999999999662,0.848804074517127,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19180,GO:1905246,0.99999999999662,0.848804074517127,0,2,negative regulation of aspartic-type peptidase activity,BP,
12833,GO:0051140,0.99999999999662,0.874818955511706,0,2,regulation of NK T cell proliferation,BP,
12834,GO:0051142,0.99999999999662,0.874818955511706,0,2,positive regulation of NK T cell proliferation,BP,
4665,GO:0010813,0.999999999996652,0.855105339872788,0,2,neuropeptide catabolic process,BP,
2504,GO:0005757,0.999999999996714,0.738995267221275,0,4,mitochondrial permeability transition pore complex,CC,
10,GO:0000019,0.999999999996754,0.781645526121987,0,3,regulation of mitotic recombination,BP,
7687,GO:0032137,0.999999999996754,0.781645526121987,0,3,guanine/thymine mispair binding,MF,
1065,GO:0002606,0.999999999996779,0.789932188226726,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
10488,GO:0043383,0.999999999996779,0.789932188226726,0,3,negative T cell selection,BP,
11062,GO:0045060,0.999999999996779,0.789932188226726,0,3,negative thymic T cell selection,BP,
14085,GO:0060907,0.999999999996779,0.789932188226726,0,3,positive regulation of macrophage cytokine production,BP,
2022,GO:0004751,0.999999999996808,0.923950290353096,0,1,ribose-5-phosphate isomerase activity,MF,
2983,GO:0006526,0.999999999996824,0.667280674586392,0,5,arginine biosynthetic process,BP,
1652,GO:0004104,0.999999999996835,0.848616711675949,0,2,cholinesterase activity,MF,
8371,GO:0033265,0.999999999996835,0.848616711675949,0,2,choline binding,MF,
9977,GO:0042365,0.999999999996848,0.798952434851124,0,3,water-soluble vitamin catabolic process,BP,
1607,GO:0004030,0.999999999996861,0.663262636971318,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
17020,GO:0099170,0.999999999996875,0.781541724511826,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17063,GO:0099547,0.999999999996875,0.781541724511826,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17076,GO:0099578,0.999999999996875,0.781541724511826,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
13077,GO:0051584,0.999999999996884,0.7443192995725,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13260,GO:0051940,0.999999999996884,0.7443192995725,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
13741,GO:0060313,0.999999999996906,0.799772660141449,0,3,negative regulation of blood vessel remodeling,BP,
5409,GO:0016250,0.999999999996907,0.921129403167509,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5700,GO:0016826,0.999999999996907,0.921129403167509,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
10084,GO:0042584,0.999999999996927,0.721741436089898,0,4,chromaffin granule membrane,CC,
1603,GO:0004022,0.999999999996937,0.921143296695628,0,1,alcohol dehydrogenase (NAD) activity,MF,
5975,GO:0018467,0.999999999996937,0.921143296695628,0,1,formaldehyde dehydrogenase activity,MF,
13240,GO:0051903,0.999999999996937,0.921143296695628,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
8436,GO:0033553,0.999999999996956,0.723394636423491,0,4,rDNA heterochromatin,CC,
7658,GO:0032079,0.999999999996971,0.735411083016752,0,4,positive regulation of endodeoxyribonuclease activity,BP,
16766,GO:0098559,0.999999999996997,0.781664901388643,0,3,cytoplasmic side of early endosome membrane,CC,
5613,GO:0016661,0.999999999997007,0.6726002568349,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
1996,GO:0004719,0.999999999997008,0.78476103120785,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
4797,GO:0010989,0.999999999997016,0.781628364931255,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
9511,GO:0036159,0.999999999997021,0.671000553669071,0,5,inner dynein arm assembly,BP,
12148,GO:0048254,0.999999999997027,0.739956948817859,0,4,snoRNA localization,BP,
7731,GO:0032226,0.99999999999705,0.671213542663743,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
1511,GO:0003872,0.999999999997077,0.781556526689384,0,3,6-phosphofructokinase activity,MF,
18599,GO:1903862,0.999999999997083,0.679370441794398,0,5,positive regulation of oxidative phosphorylation,BP,
19262,GO:1905446,0.999999999997083,0.679370441794398,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
18419,GO:1903463,0.999999999997083,0.783714033692297,0,3,regulation of mitotic cell cycle DNA replication,BP,
6526,GO:0021914,0.999999999997097,0.848517480666942,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7947,GO:0032542,0.999999999997097,0.848517480666942,0,2,sulfiredoxin activity,MF,
13835,GO:0060434,0.999999999997097,0.848517480666942,0,2,bronchus morphogenesis,BP,
17126,GO:0102121,0.999999999997097,0.848517480666942,0,2,ceramidase activity,MF,
15351,GO:0071579,0.999999999997101,0.922668922196485,0,1,regulation of zinc ion transport,BP,
15352,GO:0071580,0.999999999997101,0.922668922196485,0,1,regulation of zinc ion transmembrane transport,BP,
15353,GO:0071581,0.999999999997101,0.922668922196485,0,1,regulation of zinc ion transmembrane import,BP,
15354,GO:0071582,0.999999999997101,0.922668922196485,0,1,negative regulation of zinc ion transport,BP,
15355,GO:0071583,0.999999999997101,0.922668922196485,0,1,negative regulation of zinc ion transmembrane transport,BP,
15356,GO:0071584,0.999999999997101,0.922668922196485,0,1,negative regulation of zinc ion transmembrane import,BP,
15357,GO:0071585,0.999999999997101,0.922668922196485,0,1,detoxification of cadmium ion,BP,
19466,GO:1990170,0.999999999997101,0.922668922196485,0,1,stress response to cadmium ion,BP,
4736,GO:0010900,0.999999999997133,0.95070081628689,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
18312,GO:1903236,0.999999999997165,0.798946299926281,0,3,regulation of leukocyte tethering or rolling,BP,
11315,GO:0045632,0.99999999999717,0.733720653057701,0,4,negative regulation of mechanoreceptor differentiation,BP,
20165,GO:2000981,0.99999999999717,0.733720653057701,0,4,negative regulation of inner ear receptor cell differentiation,BP,
13973,GO:0060683,0.999999999997174,0.921129356252554,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19511,GO:1990401,0.999999999997174,0.921129356252554,0,1,embryonic lung development,BP,
19612,GO:1990756,0.999999999997209,0.786539484225661,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
12169,GO:0048289,0.99999999999724,0.722369740982376,0,4,isotype switching to IgE isotypes,BP,
12172,GO:0048293,0.99999999999724,0.722369740982376,0,4,regulation of isotype switching to IgE isotypes,BP,
9354,GO:0035865,0.999999999997252,0.796703096033454,0,3,cellular response to potassium ion,BP,
1357,GO:0003228,0.999999999997267,0.784075432191236,0,3,atrial cardiac muscle tissue development,BP,
13474,GO:0055009,0.999999999997267,0.784075432191236,0,3,atrial cardiac muscle tissue morphogenesis,BP,
17779,GO:1901837,0.999999999997267,0.85115043985192,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
1023,GO:0002524,0.999999999997286,0.727654400993617,0,4,hypersensitivity,BP,
3527,GO:0007501,0.999999999997291,0.784195286242045,0,3,mesodermal cell fate specification,BP,
4461,GO:0010454,0.999999999997291,0.784195286242045,0,3,negative regulation of cell fate commitment,BP,
10127,GO:0042661,0.999999999997291,0.784195286242045,0,3,regulation of mesodermal cell fate specification,BP,
19356,GO:1905770,0.999999999997291,0.784195286242045,0,3,regulation of mesodermal cell differentiation,BP,
19394,GO:1905902,0.999999999997291,0.784195286242045,0,3,regulation of mesoderm formation,BP,
6858,GO:0030327,0.999999999997313,0.781586797717838,0,3,prenylated protein catabolic process,BP,
14997,GO:0070915,0.999999999997322,0.725605337201353,0,4,lysophosphatidic acid receptor activity,MF,
1944,GO:0004647,0.999999999997323,0.850895541963601,0,2,phosphoserine phosphatase activity,MF,
15620,GO:0072106,0.999999999997364,0.801785620037374,0,3,regulation of ureteric bud formation,BP,
15621,GO:0072107,0.999999999997364,0.801785620037374,0,3,positive regulation of ureteric bud formation,BP,
19193,GO:1905278,0.999999999997364,0.801785620037374,0,3,positive regulation of epithelial tube formation,BP,
15847,GO:0072558,0.999999999997365,0.809986830169465,0,3,NLRP1 inflammasome complex,CC,
11603,GO:0046208,0.999999999997375,0.797814153956049,0,3,spermine catabolic process,BP,
6014,GO:0019064,0.999999999997385,0.782581351133106,0,3,fusion of virus membrane with host plasma membrane,BP,
9779,GO:0039663,0.999999999997385,0.782581351133106,0,3,membrane fusion involved in viral entry into host cell,BP,
10999,GO:0044800,0.999999999997385,0.782581351133106,0,3,multi-organism membrane fusion,BP,
13615,GO:0060087,0.999999999997393,0.742512565289301,0,4,relaxation of vascular smooth muscle,BP,
7099,GO:0030895,0.999999999997406,0.921130033177888,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
5259,GO:0015889,0.999999999997433,0.797018666994865,0,3,cobalamin transport,BP,
17515,GO:1900747,0.99999999999745,0.725276142265309,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18034,GO:1902548,0.99999999999745,0.725276142265309,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
4837,GO:0014043,0.999999999997476,0.851344946450157,0,2,negative regulation of neuron maturation,BP,
5584,GO:0016602,0.999999999997489,0.731539097028022,0,4,CCAAT-binding factor complex,CC,
13210,GO:0051852,0.999999999997503,0.737108738307921,0,4,disruption by host of symbiont cells,BP,
13216,GO:0051873,0.999999999997503,0.737108738307921,0,4,killing by host of symbiont cells,BP,
4003,GO:0008941,0.999999999997505,0.850345704645946,0,2,nitric oxide dioxygenase activity,MF,
5629,GO:0016708,0.999999999997505,0.850345704645946,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
7946,GO:0032541,0.999999999997511,0.675541864399342,0,5,cortical endoplasmic reticulum,CC,
3415,GO:0007197,0.999999999997518,0.848473632596164,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5755,GO:0016907,0.999999999997518,0.848473632596164,0,2,G-protein coupled acetylcholine receptor activity,MF,
4795,GO:0010986,0.999999999997533,0.724079922343177,0,4,positive regulation of lipoprotein particle clearance,BP,
4869,GO:0014722,0.999999999997544,0.744004380276211,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
3044,GO:0006597,0.999999999997568,0.852403931033021,0,2,spermine biosynthetic process,BP,
10327,GO:0043117,0.999999999997574,0.782129887234664,0,3,positive regulation of vascular permeability,BP,
17398,GO:1900126,0.999999999997574,0.782129887234664,0,3,negative regulation of hyaluronan biosynthetic process,BP,
14299,GO:0061419,0.99999999999759,0.663292400685212,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
4843,GO:0014049,0.999999999997596,0.730573973555551,0,4,positive regulation of glutamate secretion,BP,
12727,GO:0050974,0.999999999997611,0.664343694049938,0,5,detection of mechanical stimulus involved in sensory perception,BP,
7080,GO:0030868,0.999999999997636,0.790751269249301,0,3,smooth endoplasmic reticulum membrane,CC,
16601,GO:0097425,0.999999999997636,0.790751269249301,0,3,smooth endoplasmic reticulum part,CC,
18025,GO:1902527,0.999999999997641,0.747945869450038,0,4,positive regulation of protein monoubiquitination,BP,
10104,GO:0042613,0.999999999997654,0.807522376495298,0,3,MHC class II protein complex,CC,
16283,GO:0090360,0.999999999997657,0.783520109101416,0,3,platelet-derived growth factor production,BP,
16284,GO:0090361,0.999999999997657,0.783520109101416,0,3,regulation of platelet-derived growth factor production,BP,
13008,GO:0051434,0.999999999997668,0.736080044000414,0,4,BH3 domain binding,MF,
16185,GO:0090204,0.999999999997736,0.804043545758615,0,3,protein localization to nuclear pore,BP,
294,GO:0000798,0.999999999997742,0.78189995097691,0,3,nuclear cohesin complex,CC,
7097,GO:0030893,0.999999999997742,0.78189995097691,0,3,meiotic cohesin complex,CC,
4867,GO:0014719,0.999999999997757,0.792249190569134,0,3,skeletal muscle satellite cell activation,BP,
15121,GO:0071207,0.999999999997764,0.852046339708192,0,2,histone pre-mRNA stem-loop binding,MF,
2325,GO:0005337,0.999999999997766,0.663915417765327,0,5,nucleoside transmembrane transporter activity,MF,
5238,GO:0015858,0.999999999997766,0.663915417765327,0,5,nucleoside transport,BP,
17722,GO:1901642,0.999999999997766,0.663915417765327,0,5,nucleoside transmembrane transport,BP,
15982,GO:0080144,0.999999999997775,0.850684146773495,0,2,amino acid homeostasis,BP,
1306,GO:0003150,0.999999999997777,0.721259281904416,0,4,muscular septum morphogenesis,BP,
1742,GO:0004342,0.999999999997804,0.850856444086884,0,2,glucosamine-6-phosphate deaminase activity,MF,
2681,GO:0006043,0.999999999997804,0.850856444086884,0,2,glucosamine catabolic process,BP,
16207,GO:0090238,0.999999999997805,0.740939377787909,0,4,positive regulation of arachidonic acid secretion,BP,
2631,GO:0005958,0.99999999999782,0.785512103673335,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
18565,GO:1903789,0.99999999999783,0.664159053468635,0,5,regulation of amino acid transmembrane transport,BP,
13294,GO:0051990,0.999999999997852,0.848810557886965,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
4215,GO:0009374,0.999999999997855,0.663215293276775,0,5,biotin binding,MF,
19617,GO:1990769,0.999999999997862,0.849002230748113,0,2,proximal neuron projection,CC,
7661,GO:0032090,0.999999999997869,0.865595109195384,0,2,Pyrin domain binding,MF,
12491,GO:0050501,0.999999999997914,0.78299865135721,0,3,hyaluronan synthase activity,MF,
9414,GO:0035977,0.99999999999796,0.7215795241006,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
16621,GO:0097466,0.99999999999796,0.7215795241006,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
18815,GO:1904382,0.99999999999796,0.7215795241006,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18899,GO:1904587,0.99999999999796,0.7215795241006,0,4,response to glycoprotein,BP,
15076,GO:0071042,0.999999999997963,0.740674306567821,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15081,GO:0071047,0.999999999997963,0.740674306567821,0,4,polyadenylation-dependent mRNA catabolic process,BP,
9407,GO:0035965,0.999999999997983,0.665462722708173,0,5,cardiolipin acyl-chain remodeling,BP,
12350,GO:0048712,0.999999999998003,0.672084709855404,0,5,negative regulation of astrocyte differentiation,BP,
11784,GO:0046642,0.99999999999801,0.78302280310354,0,3,negative regulation of alpha-beta T cell proliferation,BP,
17547,GO:1901077,0.999999999998032,0.721139091213781,0,4,regulation of relaxation of muscle,BP,
13984,GO:0060696,0.999999999998034,0.684635418267927,0,5,regulation of phospholipid catabolic process,BP,
15892,GO:0072656,0.999999999998049,0.678831465628948,0,5,maintenance of protein location in mitochondrion,BP,
16616,GO:0097452,0.999999999998053,0.738241085694334,0,4,GAIT complex,CC,
4491,GO:0010513,0.999999999998058,0.856897657970389,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
14297,GO:0061408,0.999999999998061,0.782303112183417,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
17691,GO:1901569,0.999999999998068,0.668344996683389,0,5,fatty acid derivative catabolic process,BP,
15070,GO:0071030,0.999999999998078,0.852237816212754,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15082,GO:0071048,0.999999999998078,0.852237816212754,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
4902,GO:0014831,0.999999999998106,0.736380355009427,0,4,gastro-intestinal system smooth muscle contraction,BP,
12159,GO:0048266,0.999999999998115,0.678823917110209,0,5,behavioral response to pain,BP,
2626,GO:0005952,0.999999999998129,0.663344855417693,0,5,cAMP-dependent protein kinase complex,CC,
9308,GO:0035754,0.999999999998131,0.663841651323434,0,5,B cell chemotaxis,BP,
10628,GO:0043625,0.999999999998142,0.736801583785824,0,4,delta DNA polymerase complex,CC,
10961,GO:0044715,0.999999999998163,0.865484648147269,0,2,8-oxo-dGDP phosphatase activity,MF,
10683,GO:0043946,0.999999999998184,0.924812853133974,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10684,GO:0043947,0.999999999998184,0.924812853133974,0,1,positive regulation by host of symbiont catalytic activity,BP,
13352,GO:0052422,0.999999999998184,0.924812853133974,0,1,modulation by host of symbiont catalytic activity,BP,
9941,GO:0042296,0.999999999998204,0.737311744498285,0,4,ISG15 transferase activity,MF,
9755,GO:0039506,0.999999999998243,0.848473085911199,0,2,modulation by virus of host molecular function,BP,
9756,GO:0039507,0.999999999998243,0.848473085911199,0,2,suppression by virus of host molecular function,BP,
13306,GO:0052055,0.999999999998243,0.848473085911199,0,2,modulation by symbiont of host molecular function,BP,
13307,GO:0052056,0.999999999998243,0.848473085911199,0,2,negative regulation by symbiont of host molecular function,BP,
13069,GO:0051572,0.99999999999828,0.783361682066323,0,3,negative regulation of histone H3-K4 methylation,BP,
15475,GO:0071817,0.999999999998282,0.686070418206817,0,5,MMXD complex,CC,
16973,GO:0098989,0.999999999998287,0.854661280712569,0,2,NMDA selective glutamate receptor signaling pathway,BP,
4247,GO:0009447,0.999999999998306,0.81144573254734,0,3,putrescine catabolic process,BP,
1885,GO:0004566,0.999999999998311,0.852062655348821,0,2,beta-glucuronidase activity,MF,
12831,GO:0051138,0.999999999998314,0.720155005963357,0,4,positive regulation of NK T cell differentiation,BP,
18075,GO:1902659,0.999999999998325,0.794584169571195,0,3,regulation of glucose mediated signaling pathway,BP,
18076,GO:1902661,0.999999999998325,0.794584169571195,0,3,positive regulation of glucose mediated signaling pathway,BP,
2035,GO:0004775,0.999999999998329,0.856047899534533,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
15798,GO:0072429,0.999999999998337,0.781984052164251,0,3,response to intra-S DNA damage checkpoint signaling,BP,
4965,GO:0015057,0.999999999998404,0.781622067339376,0,3,thrombin-activated receptor activity,MF,
10769,GO:0044214,0.999999999998404,0.781622067339376,0,3,spanning component of plasma membrane,CC,
15476,GO:0071818,0.999999999998417,0.782847107151738,0,3,BAT3 complex,CC,
15778,GO:0072379,0.999999999998417,0.782847107151738,0,3,ER membrane insertion complex,CC,
8119,GO:0032805,0.999999999998417,0.859930607673674,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
16454,GO:0097114,0.999999999998417,0.859930607673674,0,2,NMDA glutamate receptor clustering,BP,
17716,GO:1901629,0.999999999998417,0.859930607673674,0,2,regulation of presynaptic membrane organization,BP,
18183,GO:1902952,0.999999999998417,0.859930607673674,0,2,positive regulation of dendritic spine maintenance,BP,
18206,GO:1902994,0.999999999998417,0.859930607673674,0,2,regulation of phospholipid efflux,BP,
18207,GO:1902995,0.999999999998417,0.859930607673674,0,2,positive regulation of phospholipid efflux,BP,
8287,GO:0033091,0.999999999998424,0.921162380011069,0,1,positive regulation of immature T cell proliferation,BP,
1663,GO:0004122,0.999999999998445,0.921157277159602,0,1,cystathionine beta-synthase activity,MF,
2991,GO:0006535,0.999999999998445,0.921157277159602,0,1,cysteine biosynthetic process from serine,BP,
4052,GO:0009093,0.999999999998445,0.921157277159602,0,1,cysteine catabolic process,BP,
5614,GO:0016662,0.999999999998445,0.921157277159602,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6151,GO:0019448,0.999999999998445,0.921157277159602,0,1,L-cysteine catabolic process,BP,
12477,GO:0050421,0.999999999998445,0.921157277159602,0,1,nitrite reductase (NO-forming) activity,MF,
14529,GO:0070025,0.999999999998445,0.921157277159602,0,1,carbon monoxide binding,MF,
16877,GO:0098809,0.999999999998445,0.921157277159602,0,1,nitrite reductase activity,MF,
11266,GO:0045541,0.999999999998447,0.687150298002837,0,5,negative regulation of cholesterol biosynthetic process,BP,
16187,GO:0090206,0.999999999998447,0.687150298002837,0,5,negative regulation of cholesterol metabolic process,BP,
11337,GO:0045660,0.999999999998452,0.922806252642926,0,1,positive regulation of neutrophil differentiation,BP,
2985,GO:0006528,0.999999999998461,0.790917875090305,0,3,asparagine metabolic process,BP,
8284,GO:0033087,0.999999999998469,0.78780903943398,0,3,negative regulation of immature T cell proliferation,BP,
5091,GO:0015355,0.999999999998519,0.728350283644396,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
9426,GO:0035993,0.999999999998559,0.784853807524281,0,3,deltoid tuberosity development,BP,
14266,GO:0061325,0.999999999998559,0.784853807524281,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
16529,GO:0097241,0.999999999998578,0.848951478803789,0,2,hematopoietic stem cell migration to bone marrow,BP,
649,GO:0001839,0.999999999998602,0.664816171552296,0,5,neural plate morphogenesis,BP,
17277,GO:0140007,0.999999999998637,0.723444482061717,0,4,KICSTOR complex,CC,
19428,GO:1990034,0.999999999998639,0.783891535839131,0,3,calcium ion export across plasma membrane,BP,
20227,GO:2001168,0.999999999998647,0.719976532961442,0,4,positive regulation of histone H2B ubiquitination,BP,
11178,GO:0045259,0.999999999998668,0.856952174683613,0,2,proton-transporting ATP synthase complex,CC,
14627,GO:0070194,0.99999999999867,0.849200283442273,0,2,synaptonemal complex disassembly,BP,
2292,GO:0005250,0.999999999998674,0.848645196722464,0,2,A-type (transient outward) potassium channel activity,MF,
11126,GO:0045163,0.999999999998674,0.848645196722464,0,2,clustering of voltage-gated potassium channels,BP,
16000,GO:0086008,0.999999999998674,0.848645196722464,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16682,GO:0097623,0.999999999998674,0.848645196722464,0,2,potassium ion export across plasma membrane,BP,
11970,GO:0047192,0.999999999998679,0.783398791498925,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
15014,GO:0070943,0.999999999998691,0.791754141379059,0,3,neutrophil mediated killing of symbiont cell,BP,
12811,GO:0051106,0.999999999998691,0.664441434605945,0,5,positive regulation of DNA ligation,BP,
8339,GO:0033184,0.999999999998709,0.663171941160319,0,5,positive regulation of histone ubiquitination,BP,
102,GO:0000213,0.999999999998714,0.724055455326876,0,4,tRNA-intron endonuclease activity,MF,
1518,GO:0003880,0.999999999998724,0.790246345396563,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2953,GO:0006481,0.999999999998724,0.790246345396563,0,3,C-terminal protein methylation,BP,
9063,GO:0035290,0.999999999998738,0.781631633218784,0,3,trunk segmentation,BP,
9620,GO:0036484,0.999999999998738,0.781631633218784,0,3,trunk neural crest cell migration,BP,
9621,GO:0036486,0.999999999998738,0.781631633218784,0,3,ventral trunk neural crest cell migration,BP,
14348,GO:0061551,0.999999999998738,0.781631633218784,0,3,trigeminal ganglion development,BP,
16219,GO:0090259,0.999999999998738,0.781631633218784,0,3,regulation of retinal ganglion cell axon guidance,BP,
16626,GO:0097475,0.999999999998738,0.781631633218784,0,3,motor neuron migration,BP,
17327,GO:0150018,0.999999999998738,0.781631633218784,0,3,basal dendrite development,BP,
17328,GO:0150019,0.999999999998738,0.781631633218784,0,3,basal dendrite morphogenesis,BP,
17329,GO:0150020,0.999999999998738,0.781631633218784,0,3,basal dendrite arborization,BP,
17571,GO:1901166,0.999999999998738,0.781631633218784,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
17711,GO:1901621,0.999999999998752,0.663127844328861,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14831,GO:0070568,0.999999999998758,0.674202340686886,0,5,guanylyltransferase activity,MF,
6204,GO:0019695,0.999999999998786,0.720007035511389,0,4,choline metabolic process,BP,
3801,GO:0008379,0.999999999998795,0.720449000025926,0,5,thioredoxin peroxidase activity,MF,
3777,GO:0008331,0.999999999998798,0.783909213839605,0,3,high voltage-gated calcium channel activity,MF,
7368,GO:0031415,0.999999999998829,0.736871383747293,0,4,NatA complex,CC,
19430,GO:1990037,0.999999999998829,0.787210121661496,0,3,Lewy body core,CC,
1771,GO:0004376,0.999999999998829,0.720687217239902,0,4,glycolipid mannosyltransferase activity,MF,
14233,GO:0061196,0.999999999998838,0.720742765858381,0,4,fungiform papilla development,BP,
14234,GO:0061197,0.999999999998838,0.720742765858381,0,4,fungiform papilla morphogenesis,BP,
17933,GO:1902260,0.999999999998839,0.787961141062743,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
2034,GO:0004774,0.99999999999886,0.788766398616621,0,3,succinate-CoA ligase activity,MF,
1151,GO:0002759,0.999999999998887,0.729949467334038,0,4,regulation of antimicrobial humoral response,BP,
860,GO:0002191,0.999999999998892,0.785035552224849,0,3,cap-dependent translational initiation,BP,
4803,GO:0010997,0.999999999998905,0.666856725041151,0,5,anaphase-promoting complex binding,MF,
9488,GO:0036123,0.999999999998918,0.674156565005297,0,5,histone H3-K9 dimethylation,BP,
18019,GO:1902512,0.999999999998924,0.811170766106854,0,3,positive regulation of apoptotic DNA fragmentation,BP,
9547,GO:0036302,0.999999999998924,0.663291552296866,0,5,atrioventricular canal development,BP,
13947,GO:0060623,0.999999999998925,0.782508621801051,0,3,regulation of chromosome condensation,BP,
1361,GO:0003241,0.999999999998946,0.78572036779955,0,3,growth involved in heart morphogenesis,BP,
370,GO:0000991,0.999999999998957,0.855398140268345,0,2,transcription factor activity, core RNA polymerase II binding,MF,
18798,GO:1904340,0.999999999998964,0.785505783031838,0,3,positive regulation of dopaminergic neuron differentiation,BP,
19075,GO:1904958,0.999999999998964,0.785505783031838,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
3893,GO:0008527,0.999999999998972,0.702626069190113,0,5,taste receptor activity,MF,
4885,GO:0014805,0.999999999999009,0.748821296044423,0,4,smooth muscle adaptation,BP,
13974,GO:0060684,0.999999999999031,0.723115176441993,0,4,epithelial-mesenchymal cell signaling,BP,
1685,GO:0004152,0.999999999999043,0.92237644202024,0,1,dihydroorotate dehydrogenase activity,MF,
18476,GO:1903576,0.999999999999043,0.92237644202024,0,1,response to L-arginine,BP,
9423,GO:0035989,0.999999999999064,0.722478024314315,0,4,tendon development,BP,
15723,GO:0072284,0.999999999999064,0.722478024314315,0,4,metanephric S-shaped body morphogenesis,BP,
9166,GO:0035519,0.999999999999073,0.750644213982255,0,4,protein K29-linked ubiquitination,BP,
10823,GO:0044314,0.999999999999073,0.750644213982255,0,4,protein K27-linked ubiquitination,BP,
7137,GO:0030969,0.999999999999106,0.781693260525958,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7385,GO:0031437,0.999999999999106,0.781693260525958,0,3,regulation of mRNA cleavage,BP,
14543,GO:0070054,0.999999999999106,0.781693260525958,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14544,GO:0070055,0.999999999999106,0.781693260525958,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
13616,GO:0060088,0.999999999999133,0.676509235435381,0,5,auditory receptor cell stereocilium organization,BP,
14623,GO:0070189,0.999999999999136,0.728328285319379,0,4,kynurenine metabolic process,BP,
10259,GO:0042997,0.999999999999182,0.781661806876882,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
183,GO:0000395,0.999999999999203,0.671802684884031,0,5,mRNA 5'-splice site recognition,BP,
13970,GO:0060677,0.999999999999206,0.665476268426181,0,5,ureteric bud elongation,BP,
15683,GO:0072205,0.999999999999206,0.665476268426181,0,5,metanephric collecting duct development,BP,
15692,GO:0072217,0.999999999999206,0.665476268426181,0,5,negative regulation of metanephros development,BP,
17387,GO:1900113,0.999999999999209,0.67415525054794,0,5,negative regulation of histone H3-K9 trimethylation,BP,
1524,GO:0003896,0.999999999999211,0.78815648053938,0,3,DNA primase activity,MF,
5780,GO:0017002,0.999999999999215,0.665462340479473,0,5,activin-activated receptor activity,MF,
1312,GO:0003160,0.99999999999923,0.786904698550255,0,3,endocardium morphogenesis,BP,
11195,GO:0045298,0.999999999999231,0.735598128085934,0,4,tubulin complex,CC,
15041,GO:0070985,0.999999999999231,0.862514437826216,0,2,TFIIK complex,CC,
18002,GO:1902463,0.999999999999237,0.86240083705846,0,2,protein localization to cell leading edge,BP,
3428,GO:0007216,0.999999999999239,0.66891428736047,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
578,GO:0001730,0.999999999999253,0.727782259195112,0,4,2'-5'-oligoadenylate synthetase activity,MF,
13647,GO:0060154,0.99999999999927,0.793656124187964,0,3,cellular process regulating host cell cycle in response to virus,BP,
6960,GO:0030613,0.999999999999304,0.821498976588812,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6961,GO:0030614,0.999999999999304,0.821498976588812,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
19640,GO:1990834,0.999999999999353,0.781736648902656,0,3,response to odorant,BP,
4226,GO:0009403,0.999999999999354,0.670981247523876,0,5,toxin biosynthetic process,BP,
3829,GO:0008428,0.999999999999358,0.783519634092876,0,3,ribonuclease inhibitor activity,MF,
9168,GO:0035521,0.999999999999364,0.719906197401535,0,4,monoubiquitinated histone deubiquitination,BP,
9169,GO:0035522,0.999999999999364,0.719906197401535,0,4,monoubiquitinated histone H2A deubiquitination,BP,
4495,GO:0010520,0.999999999999371,0.848489295419644,0,2,regulation of reciprocal meiotic recombination,BP,
14083,GO:0060903,0.999999999999371,0.848489295419644,0,2,positive regulation of meiosis I,BP,
1562,GO:0003963,0.999999999999377,0.84920338269349,0,2,RNA-3'-phosphate cyclase activity,MF,
3482,GO:0007342,0.999999999999379,0.751159173884332,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
4263,GO:0009608,0.999999999999393,0.862609491987094,0,2,response to symbiont,BP,
4264,GO:0009609,0.999999999999393,0.862609491987094,0,2,response to symbiotic bacterium,BP,
16893,GO:0098837,0.999999999999411,0.784068580269485,0,3,postsynaptic recycling endosome,CC,
11029,GO:0044878,0.999999999999418,0.731844636846548,0,4,mitotic cytokinesis checkpoint,BP,
13168,GO:0051765,0.999999999999426,0.85143143920209,0,2,inositol tetrakisphosphate kinase activity,MF,
11378,GO:0045743,0.99999999999944,0.672413441522458,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
4728,GO:0010890,0.999999999999476,0.807178667752558,0,3,positive regulation of sequestering of triglyceride,BP,
3787,GO:0008352,0.999999999999506,0.921139609123421,0,1,katanin complex,CC,
1587,GO:0003998,0.999999999999509,0.882278526566585,0,2,acylphosphatase activity,MF,
13897,GO:0060539,0.999999999999543,0.665455396926566,0,5,diaphragm development,BP,
10148,GO:0042723,0.999999999999556,0.788389045496926,0,3,thiamine-containing compound metabolic process,BP,
18624,GO:1903911,0.999999999999569,0.782256370713914,0,3,positive regulation of receptor clustering,BP,
9574,GO:0036374,0.999999999999592,0.78181499367482,0,3,glutathione hydrolase activity,MF,
17176,GO:0102953,0.999999999999592,0.78181499367482,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17185,GO:0103068,0.999999999999592,0.78181499367482,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17766,GO:1901748,0.999999999999592,0.78181499367482,0,3,leukotriene D4 metabolic process,BP,
17767,GO:1901750,0.999999999999592,0.78181499367482,0,3,leukotriene D4 biosynthetic process,BP,
16421,GO:0097056,0.999999999999602,0.725885298287258,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
2038,GO:0004778,0.999999999999618,0.926179026590321,0,1,succinyl-CoA hydrolase activity,MF,
8103,GO:0032788,0.999999999999618,0.926179026590321,0,1,saturated monocarboxylic acid metabolic process,BP,
8104,GO:0032789,0.999999999999618,0.926179026590321,0,1,unsaturated monocarboxylic acid metabolic process,BP,
7848,GO:0032407,0.999999999999628,0.668604072931896,0,5,MutSalpha complex binding,MF,
3105,GO:0006682,0.99999999999964,0.783183548069317,0,3,galactosylceramide biosynthetic process,BP,
6127,GO:0019375,0.99999999999964,0.783183548069317,0,3,galactolipid biosynthetic process,BP,
1233,GO:0002921,0.99999999999964,0.66516611203571,0,5,negative regulation of humoral immune response,BP,
5017,GO:0015180,0.999999999999653,0.66317581774517,0,5,L-alanine transmembrane transporter activity,MF,
5209,GO:0015808,0.999999999999653,0.66317581774517,0,5,L-alanine transport,BP,
6627,GO:0022858,0.999999999999653,0.66317581774517,0,5,alanine transmembrane transporter activity,MF,
12023,GO:0047631,0.999999999999657,0.700749705543962,0,5,ADP-ribose diphosphatase activity,MF,
15926,GO:0072709,0.99999999999966,0.850641286896077,0,2,cellular response to sorbitol,BP,
15940,GO:0072739,0.99999999999966,0.850641286896077,0,2,response to anisomycin,BP,
1415,GO:0003352,0.999999999999662,0.663173762698295,0,5,regulation of cilium movement,BP,
1416,GO:0003356,0.999999999999662,0.663173762698295,0,5,regulation of cilium beat frequency,BP,
13727,GO:0060295,0.999999999999662,0.663173762698295,0,5,regulation of cilium movement involved in cell motility,BP,
13728,GO:0060296,0.999999999999662,0.663173762698295,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
17843,GO:1902019,0.999999999999662,0.663173762698295,0,5,regulation of cilium-dependent cell motility,BP,
7685,GO:0032133,0.999999999999683,0.729465947237191,0,4,chromosome passenger complex,CC,
14235,GO:0061198,0.999999999999683,0.782472829283804,0,3,fungiform papilla formation,BP,
7329,GO:0031339,0.9999999999997,0.785859101747689,0,3,negative regulation of vesicle fusion,BP,
10657,GO:0043734,0.999999999999704,0.73814717842352,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
6008,GO:0019050,0.999999999999725,0.793656469659301,0,3,suppression by virus of host apoptotic process,BP,
9763,GO:0039526,0.999999999999725,0.793656469659301,0,3,modulation by virus of host apoptotic process,BP,
3926,GO:0008603,0.999999999999731,0.666153601845688,0,5,cAMP-dependent protein kinase regulator activity,MF,
2758,GO:0006168,0.999999999999732,0.809384825105298,0,3,adenine salvage,BP,
11550,GO:0046083,0.999999999999732,0.809384825105298,0,3,adenine metabolic process,BP,
11551,GO:0046084,0.999999999999732,0.809384825105298,0,3,adenine biosynthetic process,BP,
16941,GO:0098920,0.999999999999733,0.921131192760762,0,1,retrograde trans-synaptic signaling by lipid,BP,
16942,GO:0098921,0.999999999999733,0.921131192760762,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
5024,GO:0015187,0.99999999999974,0.664968170909029,0,5,glycine transmembrane transporter activity,MF,
14981,GO:0070889,0.999999999999747,0.848779350722714,0,2,platelet alpha granule organization,BP,
20301,GO:2001293,0.999999999999761,0.782153315727293,0,3,malonyl-CoA metabolic process,BP,
4761,GO:0010940,0.999999999999762,0.692834239484453,0,5,positive regulation of necrotic cell death,BP,
2013,GO:0004740,0.99999999999977,0.781897878176025,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2635,GO:0005967,0.99999999999977,0.781897878176025,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
19318,GO:1905600,0.999999999999778,0.785725654924757,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20024,GO:2000645,0.999999999999778,0.785725654924757,0,3,negative regulation of receptor catabolic process,BP,
14141,GO:0061009,0.999999999999783,0.788122400795011,0,3,common bile duct development,BP,
15408,GO:0071670,0.999999999999809,0.677019038202593,0,5,smooth muscle cell chemotaxis,BP,
8797,GO:0034485,0.999999999999829,0.720324851452719,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
18545,GO:1903753,0.999999999999829,0.720324851452719,0,4,negative regulation of p38MAPK cascade,BP,
17857,GO:1902047,0.999999999999887,0.674119648392741,0,5,polyamine transmembrane transport,BP,
14946,GO:0070836,0.999999999999891,0.782429854330777,0,3,caveola assembly,BP,
18365,GO:1903361,0.999999999999892,0.672887291380488,0,5,protein localization to basolateral plasma membrane,BP,
1690,GO:0004164,0.999999999999904,0.924359973396181,0,1,diphthine synthase activity,MF,
1735,GO:0004333,0.999999999999904,0.924359973396181,0,1,fumarate hydratase activity,MF,
1751,GO:0004351,0.999999999999942,0.848714411420998,0,2,glutamate decarboxylase activity,MF,
2995,GO:0006540,0.999999999999942,0.848714411420998,0,2,glutamate decarboxylation to succinate,BP,
2636,GO:0005968,0.999999999999948,0.726135761886264,0,4,Rab-protein geranylgeranyltransferase complex,CC,
6950,GO:0030576,0.99999999999999,0.78249659078774,0,3,Cajal body organization,BP,
20007,GO:2000619,0.999999999999995,0.790914459368376,0,3,negative regulation of histone H4-K16 acetylation,BP,
7,GO:0000014,1,0.563730799307721,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
26,GO:0000050,1,0.45127577887692,0,10,urea cycle,BP,
27,GO:0000052,1,0.570204759077232,0,7,citrulline metabolic process,BP,
31,GO:0000056,1,0.596539130646318,0,7,ribosomal small subunit export from nucleus,BP,
45,GO:0000097,1,0.324443892457308,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.564992917243452,0,7,sulfur amino acid catabolic process,BP,
52,GO:0000109,1,0.45040596461303,0,10,nucleotide-excision repair complex,CC,
61,GO:0000124,1,0.364430572404069,0,13,SAGA complex,CC,
66,GO:0000137,1,0.442424150302782,0,10,Golgi cis cisterna,CC,
69,GO:0000145,1,0.270250087115931,0,16,exocyst,CC,
73,GO:0000150,1,0.528858950293369,0,8,recombinase activity,MF,
76,GO:0000153,1,0.424670372187823,0,11,cytoplasmic ubiquitin ligase complex,CC,
79,GO:0000159,1,0.195646135270629,0,20,protein phosphatase type 2A complex,CC,
88,GO:0000176,1,0.39030466367729,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.317497326069071,0,15,cytoplasmic exosome (RNase complex),CC,
92,GO:0000182,1,0.442318399949509,0,10,rDNA binding,MF,
93,GO:0000183,1,0.0997251787774178,0,39,chromatin silencing at rDNA,BP,
105,GO:0000217,1,0.155188971805392,0,23,DNA secondary structure binding,MF,
113,GO:0000235,1,0.518541447471499,0,8,astral microtubule,CC,
114,GO:0000242,1,0.211104147883329,0,19,pericentriolar material,CC,
144,GO:0000295,1,0.413562920111644,0,11,adenine nucleotide transmembrane transporter activity,MF,
182,GO:0000394,1,0.26984661280134,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000400,1,0.276018692788357,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.61076694149065,0,6,Y-form DNA binding,MF,
188,GO:0000405,1,0.5626937065122,0,7,bubble DNA binding,MF,
195,GO:0000413,1,0.104512237135039,0,30,protein peptidyl-prolyl isomerization,BP,
211,GO:0000439,1,0.484726117592028,0,9,core TFIIH complex,CC,
220,GO:0000459,1,0.587586329122672,0,7,exonucleolytic trimming involved in rRNA processing,BP,
226,GO:0000467,1,0.587586329122672,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
242,GO:0000506,1,0.509697160298493,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.166316887532257,0,22,embryonic axis specification,BP,
249,GO:0000707,1,0.528696197620054,0,8,meiotic DNA recombinase assembly,BP,
251,GO:0000712,1,0.482520218102193,0,9,resolution of meiotic recombination intermediates,BP,
256,GO:0000722,1,0.328911584017741,0,14,telomere maintenance via recombination,BP,
263,GO:0000730,1,0.448536609473163,0,10,DNA recombinase assembly,BP,
276,GO:0000778,1,0.378825240222286,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.198686732704017,0,20,condensed nuclear chromosome, centromeric region,CC,
292,GO:0000796,1,0.562570381877626,0,7,condensin complex,CC,
299,GO:0000805,1,0.564690700999923,0,7,X chromosome,CC,
304,GO:0000813,1,0.530783339031906,0,8,ESCRT I complex,CC,
319,GO:0000835,1,0.614278401593419,0,6,ER ubiquitin ligase complex,CC,
331,GO:0000921,1,0.439638859224188,0,10,septin ring assembly,BP,
333,GO:0000923,1,0.61076682278482,0,6,equatorial microtubule organizing center,CC,
336,GO:0000931,1,0.518173385837962,0,8,gamma-tubulin large complex,CC,
340,GO:0000940,1,0.345562893411684,0,13,condensed chromosome outer kinetochore,CC,
355,GO:0000972,1,0.567229364745529,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
378,GO:0001010,1,0.31982672632535,0,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001016,1,0.579357755570115,0,7,RNA polymerase III regulatory region DNA binding,MF,
394,GO:0001055,1,0.4439771008396,0,11,RNA polymerase II activity,MF,
426,GO:0001133,1,0.347244390212258,0,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001161,1,0.445592714575676,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001162,1,0.525230762833041,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001206,1,0.610996075277011,0,6,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
449,GO:0001222,1,0.355395276897926,0,13,transcription corepressor binding,MF,
460,GO:0001325,1,0.29139764588635,0,15,formation of extrachromosomal circular DNA,BP,
466,GO:0001504,1,0.283288700442271,0,16,neurotransmitter uptake,BP,
471,GO:0001514,1,0.569017330230515,0,7,selenocysteine incorporation,BP,
475,GO:0001518,1,0.61076682278482,0,6,voltage-gated sodium channel complex,CC,
482,GO:0001530,1,0.465970776913145,0,10,lipopolysaccharide binding,MF,
487,GO:0001539,1,0.317791785458931,0,14,cilium or flagellum-dependent cell motility,BP,
490,GO:0001542,1,0.610851013275691,0,6,ovulation from ovarian follicle,BP,
501,GO:0001556,1,0.254017035696497,0,17,oocyte maturation,BP,
504,GO:0001561,1,0.616745060102385,0,6,fatty acid alpha-oxidation,BP,
505,GO:0001562,1,0.495224204897347,0,9,response to protozoan,BP,
523,GO:0001614,1,0.617315419943563,0,6,purinergic nucleotide receptor activity,MF,
544,GO:0001662,1,0.241772065362785,0,18,behavioral fear response,BP,
551,GO:0001672,1,0.565579452262265,0,7,regulation of chromatin assembly or disassembly,BP,
552,GO:0001673,1,0.450616591878597,0,10,male germ cell nucleus,CC,
554,GO:0001675,1,0.523701317348698,0,8,acrosome assembly,BP,
567,GO:0001708,1,0.0645255912698503,0,34,cell fate specification,BP,
568,GO:0001709,1,0.258763270954869,0,17,cell fate determination,BP,
569,GO:0001710,1,0.615049220333262,0,6,mesodermal cell fate commitment,BP,
570,GO:0001711,1,0.44654241524267,0,10,endodermal cell fate commitment,BP,
579,GO:0001731,1,0.525798451134605,0,8,formation of translation preinitiation complex,BP,
587,GO:0001741,1,0.415617306060111,0,11,XY body,CC,
590,GO:0001754,1,0.228924822901808,0,18,eye photoreceptor cell differentiation,BP,
599,GO:0001766,1,0.623796518660195,0,6,membrane raft polarization,BP,
612,GO:0001780,1,0.481565978082302,0,9,neutrophil homeostasis,BP,
650,GO:0001840,1,0.519524631994888,0,8,neural plate development,BP,
655,GO:0001845,1,0.491977739735451,0,9,phagolysosome assembly,BP,
671,GO:0001881,1,0.104700169545116,0,28,receptor recycling,BP,
676,GO:0001886,1,0.571154374953489,0,7,endothelial cell morphogenesis,BP,
696,GO:0001916,1,0.541807165243931,0,8,positive regulation of T cell mediated cytotoxicity,BP,
699,GO:0001919,1,0.195667249954557,0,20,regulation of receptor recycling,BP,
701,GO:0001921,1,0.345590418942731,0,13,positive regulation of receptor recycling,BP,
716,GO:0001941,1,0.219890706169395,0,19,postsynaptic membrane organization,BP,
729,GO:0001958,1,0.252806869666778,0,17,endochondral ossification,BP,
733,GO:0001963,1,0.340837391710308,0,14,synaptic transmission, dopaminergic,BP,
735,GO:0001965,1,0.281317623060708,0,16,G-protein alpha-subunit binding,MF,
742,GO:0001972,1,0.486431432677411,0,9,retinoic acid binding,MF,
786,GO:0002043,1,0.450436068355965,0,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
789,GO:0002052,1,0.375167521629226,0,12,positive regulation of neuroblast proliferation,BP,
800,GO:0002068,1,0.232484106984089,0,18,glandular epithelial cell development,BP,
806,GO:0002076,1,0.408782203241547,0,11,osteoblast development,BP,
808,GO:0002080,1,0.442810240204447,0,10,acrosomal membrane,CC,
810,GO:0002082,1,0.327773442221445,0,14,regulation of oxidative phosphorylation,BP,
812,GO:0002084,1,0.483055706913238,0,9,protein depalmitoylation,BP,
821,GO:0002093,1,0.573959517766206,0,7,auditory receptor cell morphogenesis,BP,
824,GO:0002098,1,0.380812440431834,0,12,tRNA wobble uridine modification,BP,
829,GO:0002115,1,0.349370534796169,0,13,store-operated calcium entry,BP,
830,GO:0002116,1,0.439655115301719,0,10,semaphorin receptor complex,CC,
840,GO:0002151,1,0.612544828410102,0,6,G-quadruplex RNA binding,MF,
852,GO:0002178,1,0.412109222930016,0,11,palmitoyltransferase complex,CC,
864,GO:0002199,1,0.567800719077573,0,7,zona pellucida receptor complex,CC,
868,GO:0002209,1,0.241772065362785,0,18,behavioral defense response,BP,
875,GO:0002227,1,0.582136714343072,0,10,innate immune response in mucosa,BP,
910,GO:0002295,1,0.572984149062644,0,7,T-helper cell lineage commitment,BP,
924,GO:0002320,1,0.351363439832544,0,13,lymphoid progenitor cell differentiation,BP,
929,GO:0002327,1,0.61076682278482,0,6,immature B cell differentiation,BP,
930,GO:0002328,1,0.486454929109592,0,9,pro-B cell differentiation,BP,
938,GO:0002347,1,0.444210560056668,0,10,response to tumor cell,BP,
946,GO:0002363,1,0.487257243389232,0,9,alpha-beta T cell lineage commitment,BP,
961,GO:0002385,1,0.454896804510512,0,13,mucosal immune response,BP,
970,GO:0002418,1,0.523601685346582,0,8,immune response to tumor cell,BP,
1044,GO:0002566,1,0.29526489212989,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1100,GO:0002689,1,0.601770352027949,0,7,negative regulation of leukocyte chemotaxis,BP,
1127,GO:0002716,1,0.487886802979124,0,9,negative regulation of natural killer cell mediated immunity,BP,
1145,GO:0002741,1,0.564723704114099,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1187,GO:0002834,1,0.611260842433033,0,6,regulation of response to tumor cell,BP,
1190,GO:0002837,1,0.611260842433033,0,6,regulation of immune response to tumor cell,BP,
1255,GO:0003009,1,0.235996704941049,0,19,skeletal muscle contraction,BP,
1262,GO:0003016,1,0.251830706003798,0,17,respiratory system process,BP,
1282,GO:0003084,1,0.630095969672193,0,6,positive regulation of systemic arterial blood pressure,BP,
1284,GO:0003091,1,0.195754896820104,0,20,renal water homeostasis,BP,
1349,GO:0003214,1,0.611563582597496,0,6,cardiac left ventricle morphogenesis,BP,
1355,GO:0003223,1,0.612359251935903,0,6,ventricular compact myocardium morphogenesis,BP,
1373,GO:0003264,1,0.62964125706579,0,6,regulation of cardioblast proliferation,BP,
1395,GO:0003309,1,0.2740664707079,0,16,type B pancreatic cell differentiation,BP,
1398,GO:0003323,1,0.297565318337974,0,15,type B pancreatic cell development,BP,
1407,GO:0003341,1,0.151884673399738,0,24,cilium movement,BP,
1414,GO:0003351,1,0.508619931600591,0,9,epithelial cilium movement,BP,
1422,GO:0003373,1,0.518173385837962,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1423,GO:0003374,1,0.518173385837962,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1424,GO:0003376,1,0.479398500914785,0,9,sphingosine-1-phosphate signaling pathway,BP,
1449,GO:0003680,1,0.612742341541557,0,6,AT DNA binding,MF,
1453,GO:0003689,1,0.527266536441726,0,8,DNA clamp loader activity,MF,
1477,GO:0003747,1,0.614709360960322,0,6,translation release factor activity,MF,
1478,GO:0003755,1,0.104512237135039,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1479,GO:0003756,1,0.253126758012334,0,17,protein disulfide isomerase activity,MF,
1494,GO:0003836,1,0.614611528606994,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1552,GO:0003951,1,0.344458544328624,0,13,NAD+ kinase activity,MF,
1555,GO:0003954,1,0.0804361314469311,0,40,NADH dehydrogenase activity,MF,
1582,GO:0003993,1,0.625534442148047,0,6,acid phosphatase activity,MF,
1584,GO:0003995,1,0.351014962481342,0,13,acyl-CoA dehydrogenase activity,MF,
1589,GO:0004000,1,0.614949453821125,0,6,adenosine deaminase activity,MF,
1594,GO:0004012,1,0.343493469363354,0,13,phospholipid-translocating ATPase activity,MF,
1597,GO:0004016,1,0.61076682278482,0,6,adenylate cyclase activity,MF,
1605,GO:0004028,1,0.563310207701344,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1606,GO:0004029,1,0.34401178575471,0,13,aldehyde dehydrogenase (NAD) activity,MF,
1628,GO:0004065,1,0.563962285532837,0,7,arylsulfatase activity,MF,
1665,GO:0004126,1,0.586617242383987,0,7,cytidine deaminase activity,MF,
1678,GO:0004143,1,0.518173772329627,0,8,diacylglycerol kinase activity,MF,
1702,GO:0004185,1,0.522219733520962,0,8,serine-type carboxypeptidase activity,MF,
1709,GO:0004300,1,0.534811702020269,0,8,enoyl-CoA hydratase activity,MF,
1711,GO:0004303,1,0.589087197153325,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1720,GO:0004312,1,0.48936742786823,0,9,fatty acid synthase activity,MF,
1776,GO:0004383,1,0.61076682278482,0,6,guanylate cyclase activity,MF,
1796,GO:0004430,1,0.611241079637049,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1798,GO:0004438,1,0.316473065175935,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1799,GO:0004439,1,0.518509821309466,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1874,GO:0004550,1,0.411261074794003,0,12,nucleoside diphosphate kinase activity,MF,
1875,GO:0004551,1,0.402735734009178,0,12,nucleotide diphosphatase activity,MF,
1880,GO:0004559,1,0.344302713806634,0,13,alpha-mannosidase activity,MF,
1889,GO:0004571,1,0.563895071131686,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1893,GO:0004576,1,0.467898194595084,0,10,oligosaccharyl transferase activity,MF,
1896,GO:0004579,1,0.501139887554677,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1908,GO:0004596,1,0.457205385789507,0,10,peptide alpha-N-acetyltransferase activity,MF,
1948,GO:0004652,1,0.518436810249705,0,8,polynucleotide adenylyltransferase activity,MF,
1955,GO:0004659,1,0.299818527053138,0,15,prenyltransferase activity,MF,
1966,GO:0004675,1,0.374274101332229,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1969,GO:0004679,1,0.565193391065552,0,7,AMP-activated protein kinase activity,MF,
1974,GO:0004690,1,0.565001508061886,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1975,GO:0004691,1,0.613406000899563,0,6,cAMP-dependent protein kinase activity,MF,
1988,GO:0004708,1,0.376400175220068,0,12,MAP kinase kinase activity,MF,
1990,GO:0004711,1,0.564621182236512,0,7,ribosomal protein S6 kinase activity,MF,
2000,GO:0004723,1,0.563006668039305,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2054,GO:0004806,1,0.4403642726914,0,10,triglyceride lipase activity,MF,
2093,GO:0004859,1,0.596272280216564,0,7,phospholipase inhibitor activity,MF,
2096,GO:0004862,1,0.570824726898835,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2177,GO:0005024,1,0.562570381877626,0,7,transforming growth factor beta-activated receptor activity,MF,
2198,GO:0005078,1,0.562570381877626,0,7,MAP-kinase scaffold activity,MF,
2209,GO:0005095,1,0.424949776601683,0,11,GTPase inhibitor activity,MF,
2212,GO:0005104,1,0.440215277011561,0,10,fibroblast growth factor receptor binding,MF,
2251,GO:0005165,1,0.572537239024161,0,7,neurotrophin receptor binding,MF,
2253,GO:0005167,1,0.572537239024161,0,7,neurotrophin TRK receptor binding,MF,
2254,GO:0005168,1,0.61076682278482,0,6,neurotrophin TRKA receptor binding,MF,
2258,GO:0005172,1,0.537077951518258,0,8,vascular endothelial growth factor receptor binding,MF,
2277,GO:0005225,1,0.518173385837962,0,8,volume-sensitive anion channel activity,MF,
2278,GO:0005227,1,0.379507283390043,0,12,calcium activated cation channel activity,MF,
2279,GO:0005229,1,0.439641207343364,0,10,intracellular calcium activated chloride channel activity,MF,
2280,GO:0005230,1,0.478192004962711,0,9,extracellular ligand-gated ion channel activity,MF,
2281,GO:0005231,1,0.563649175268818,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2284,GO:0005242,1,0.563095966535903,0,7,inward rectifier potassium channel activity,MF,
2289,GO:0005247,1,0.570762348690757,0,7,voltage-gated chloride channel activity,MF,
2290,GO:0005248,1,0.518173385837962,0,8,voltage-gated sodium channel activity,MF,
2331,GO:0005346,1,0.413562920111644,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2332,GO:0005347,1,0.527696143619717,0,8,ATP transmembrane transporter activity,MF,
2342,GO:0005375,1,0.632244784697645,0,6,copper ion transmembrane transporter activity,MF,
2346,GO:0005388,1,0.518173385837962,0,8,calcium-transporting ATPase activity,MF,
2355,GO:0005451,1,0.47761703717408,0,9,monovalent cation:proton antiporter activity,MF,
2372,GO:0005501,1,0.395144327119757,0,12,retinoid binding,MF,
2375,GO:0005504,1,0.374312717420635,0,14,fatty acid binding,MF,
2379,GO:0005513,1,0.529787098765111,0,8,detection of calcium ion,BP,
2387,GO:0005523,1,0.560277246985297,0,8,tropomyosin binding,MF,
2390,GO:0005527,1,0.409812706709475,0,12,macrolide binding,MF,
2391,GO:0005528,1,0.409812706709475,0,12,FK506 binding,MF,
2400,GO:0005545,1,0.372958064912583,0,12,1-phosphatidylinositol binding,MF,
2403,GO:0005548,1,0.0328496219871952,0,42,phospholipid transporter activity,MF,
2437,GO:0005637,1,0.0273366397699775,0,45,nuclear inner membrane,CC,
2439,GO:0005639,1,0.518989634178272,0,8,integral component of nuclear inner membrane,CC,
2444,GO:0005652,1,0.482577951312495,0,9,nuclear lamina,CC,
2451,GO:0005663,1,0.627537710435775,0,6,DNA replication factor C complex,CC,
2462,GO:0005675,1,0.358042622947886,0,13,holo TFIIH complex,CC,
2463,GO:0005677,1,0.480630461952162,0,9,chromatin silencing complex,CC,
2467,GO:0005683,1,0.624110995448632,0,7,U7 snRNP,CC,
2471,GO:0005687,1,0.455155635346944,0,11,U4 snRNP,CC,
2472,GO:0005688,1,0.580349824884818,0,8,U6 snRNP,CC,
2496,GO:0005744,1,0.373994493270138,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2499,GO:0005747,1,0.0711771098195729,0,42,mitochondrial respiratory chain complex I,CC,
2529,GO:0005785,1,0.583065898412402,0,7,signal recognition particle receptor complex,CC,
2530,GO:0005786,1,0.636950501846495,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2534,GO:0005790,1,0.164121820078336,0,23,smooth endoplasmic reticulum,CC,
2548,GO:0005816,1,0.562570381877626,0,7,spindle pole body,CC,
2549,GO:0005818,1,0.518541447471499,0,8,aster,CC,
2555,GO:0005832,1,0.443705523571021,0,10,chaperonin-containing T-complex,CC,
2557,GO:0005834,1,0.221115855431565,0,19,heterotrimeric G-protein complex,CC,
2562,GO:0005845,1,0.422241789022465,0,11,mRNA cap binding complex,CC,
2564,GO:0005847,1,0.272987126477887,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2565,GO:0005849,1,0.232494510895602,0,18,mRNA cleavage factor complex,CC,
2567,GO:0005851,1,0.621105388867484,0,6,eukaryotic translation initiation factor 2B complex,CC,
2572,GO:0005858,1,0.531529978593856,0,8,axonemal dynein complex,CC,
2573,GO:0005859,1,0.582948098627211,0,7,muscle myosin complex,CC,
2596,GO:0005891,1,0.488616285569891,0,9,voltage-gated calcium channel complex,CC,
2613,GO:0005922,1,0.446553080277281,0,10,connexin complex,CC,
2621,GO:0005940,1,0.47731403481714,0,9,septin ring,CC,
2622,GO:0005942,1,0.269322307589829,0,16,phosphatidylinositol 3-kinase complex,CC,
2657,GO:0006000,1,0.414071174515141,0,11,fructose metabolic process,BP,
2659,GO:0006002,1,0.620454259664697,0,6,fructose 6-phosphate metabolic process,BP,
2661,GO:0006004,1,0.344289915836398,0,13,fucose metabolic process,BP,
2664,GO:0006011,1,0.618141887760338,0,6,UDP-glucose metabolic process,BP,
2682,GO:0006044,1,0.347815325275947,0,13,N-acetylglucosamine metabolic process,BP,
2690,GO:0006054,1,0.449638527028336,0,10,N-acetylneuraminate metabolic process,BP,
2702,GO:0006067,1,0.414798576589881,0,11,ethanol metabolic process,BP,
2703,GO:0006068,1,0.575628494428063,0,7,ethanol catabolic process,BP,
2704,GO:0006069,1,0.61163007987703,0,6,ethanol oxidation,BP,
2705,GO:0006071,1,0.416452058204194,0,11,glycerol metabolic process,BP,
2706,GO:0006072,1,0.562573746766941,0,7,glycerol-3-phosphate metabolic process,BP,
2712,GO:0006085,1,0.229750053208422,0,18,acetyl-CoA biosynthetic process,BP,
2713,GO:0006086,1,0.346029390269724,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2714,GO:0006089,1,0.419419469393919,0,11,lactate metabolic process,BP,
2725,GO:0006104,1,0.619795228380684,0,6,succinyl-CoA metabolic process,BP,
2729,GO:0006108,1,0.62709243881488,0,6,malate metabolic process,BP,
2732,GO:0006111,1,0.165029987217774,0,22,regulation of gluconeogenesis,BP,
2739,GO:0006120,1,0.0557853230491776,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2741,GO:0006122,1,0.37985353839869,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2746,GO:0006144,1,0.219490713484099,0,19,purine nucleobase metabolic process,BP,
2750,GO:0006152,1,0.625186931272951,0,6,purine nucleoside catabolic process,BP,
2766,GO:0006182,1,0.297344925971464,0,15,cGMP biosynthetic process,BP,
2767,GO:0006183,1,0.528498156082126,0,9,GTP biosynthetic process,BP,
2770,GO:0006188,1,0.448458114070885,0,10,IMP biosynthetic process,BP,
2771,GO:0006189,1,0.616226970589705,0,6,'de novo' IMP biosynthetic process,BP,
2773,GO:0006195,1,0.0714213666080719,0,34,purine nucleotide catabolic process,BP,
2775,GO:0006198,1,0.518173385837962,0,8,cAMP catabolic process,BP,
2778,GO:0006207,1,0.611601708017215,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2785,GO:0006216,1,0.636810158942809,0,6,cytidine catabolic process,BP,
2789,GO:0006222,1,0.487327636537373,0,9,UMP biosynthetic process,BP,
2792,GO:0006228,1,0.57109536943453,0,8,UTP biosynthetic process,BP,
2805,GO:0006264,1,0.444637493240225,0,10,mitochondrial DNA replication,BP,
2826,GO:0006290,1,0.577059351023317,0,7,pyrimidine dimer repair,BP,
2831,GO:0006297,1,0.167476263778263,0,23,nucleotide-excision repair, DNA gap filling,BP,
2832,GO:0006298,1,0.0834077631343343,0,31,mismatch repair,BP,
2841,GO:0006309,1,0.262946846078328,0,17,apoptotic DNA fragmentation,BP,
2844,GO:0006312,1,0.17040740279028,0,22,mitotic recombination,BP,
2858,GO:0006348,1,0.550867767474795,0,8,chromatin silencing at telomere,BP,
2859,GO:0006349,1,0.344785211171467,0,13,regulation of gene expression by genetic imprinting,BP,
2867,GO:0006359,1,0.144931033326553,0,24,regulation of transcription by RNA polymerase III,BP,
2885,GO:0006388,1,0.345306357953973,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2886,GO:0006390,1,0.354390397603979,0,13,mitochondrial transcription,BP,
2934,GO:0006451,1,0.569017330230515,0,7,translational readthrough,BP,
2946,GO:0006474,1,0.329043086540626,0,14,N-terminal protein amino acid acetylation,BP,
2954,GO:0006482,1,0.0921961518014627,0,29,protein demethylation,BP,
2957,GO:0006488,1,0.201674772396361,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2958,GO:0006489,1,0.566125650049706,0,7,dolichyl diphosphate biosynthetic process,BP,
2959,GO:0006490,1,0.185754969783057,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2982,GO:0006525,1,0.302562868001513,0,15,arginine metabolic process,BP,
2984,GO:0006527,1,0.492077424544827,0,9,arginine catabolic process,BP,
2987,GO:0006531,1,0.613435834155002,0,6,aspartate metabolic process,BP,
2994,GO:0006538,1,0.611674936243,0,6,glutamate catabolic process,BP,
2999,GO:0006544,1,0.52625418137918,0,8,glycine metabolic process,BP,
3006,GO:0006551,1,0.573327766613982,0,7,leucine metabolic process,BP,
3010,GO:0006555,1,0.25653993490726,0,17,methionine metabolic process,BP,
3015,GO:0006560,1,0.616763727457859,0,6,proline metabolic process,BP,
3018,GO:0006563,1,0.481016431254729,0,9,L-serine metabolic process,BP,
3019,GO:0006564,1,0.615368999360656,0,6,L-serine biosynthetic process,BP,
3032,GO:0006578,1,0.612511343200286,0,6,amino-acid betaine biosynthetic process,BP,
3034,GO:0006582,1,0.490109205638674,0,9,melanin metabolic process,BP,
3039,GO:0006590,1,0.478541665935847,0,9,thyroid hormone generation,BP,
3056,GO:0006616,1,0.653265679095057,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3059,GO:0006621,1,0.527837047405807,0,8,protein retention in ER lumen,BP,
3063,GO:0006625,1,0.251972719380815,0,17,protein targeting to peroxisome,BP,
3065,GO:0006627,1,0.632989308915229,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3078,GO:0006646,1,0.408528005749598,0,11,phosphatidylethanolamine biosynthetic process,BP,
3081,GO:0006654,1,0.0859937958585277,0,30,phosphatidic acid biosynthetic process,BP,
3082,GO:0006655,1,0.441979467920566,0,10,phosphatidylglycerol biosynthetic process,BP,
3097,GO:0006670,1,0.460089226551524,0,10,sphingosine metabolic process,BP,
3100,GO:0006677,1,0.322489148367743,0,14,glycosylceramide metabolic process,BP,
3101,GO:0006678,1,0.567141871843452,0,7,glucosylceramide metabolic process,BP,
3104,GO:0006681,1,0.613562082461683,0,6,galactosylceramide metabolic process,BP,
3109,GO:0006686,1,0.627849756075561,0,6,sphingomyelin biosynthetic process,BP,
3120,GO:0006699,1,0.215282797302516,0,19,bile acid biosynthetic process,BP,
3124,GO:0006703,1,0.542604755715111,0,8,estrogen biosynthetic process,BP,
3148,GO:0006743,1,0.312732750862139,0,15,ubiquinone metabolic process,BP,
3149,GO:0006744,1,0.339543021129587,0,14,ubiquinone biosynthetic process,BP,
3162,GO:0006771,1,0.615718691146769,0,6,riboflavin metabolic process,BP,
3166,GO:0006777,1,0.616329818649906,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3171,GO:0006782,1,0.580489706158333,0,7,protoporphyrinogen IX biosynthetic process,BP,
3174,GO:0006787,1,0.640640437579279,0,6,porphyrin-containing compound catabolic process,BP,
3193,GO:0006817,1,0.378211026802848,0,12,phosphate ion transport,BP,
3201,GO:0006833,1,0.613184763885371,0,6,water transport,BP,
3214,GO:0006857,1,0.521653775562573,0,8,oligopeptide transport,BP,
3216,GO:0006862,1,0.277779855021261,0,16,nucleotide transport,BP,
3217,GO:0006863,1,0.627360551601521,0,6,purine nucleobase transport,BP,
3226,GO:0006878,1,0.376065404506928,0,13,cellular copper ion homeostasis,BP,
3229,GO:0006882,1,0.2092284102709,0,21,cellular zinc ion homeostasis,BP,
3231,GO:0006884,1,0.253698491840886,0,17,cell volume homeostasis,BP,
3240,GO:0006895,1,0.210717002806488,0,19,Golgi to endosome transport,BP,
3247,GO:0006904,1,0.0504848658260171,0,37,vesicle docking involved in exocytosis,BP,
3251,GO:0006910,1,0.61236288658316,0,6,phagocytosis, recognition,BP,
3287,GO:0006975,1,0.567824932818593,0,7,DNA damage induced protein phosphorylation,BP,
3295,GO:0006987,1,0.530211285831064,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3298,GO:0006995,1,0.473188212748946,0,10,cellular response to nitrogen starvation,BP,
3324,GO:0007031,1,0.109100447797584,0,28,peroxisome organization,BP,
3329,GO:0007039,1,0.38113420167014,0,12,protein catabolic process in the vacuole,BP,
3359,GO:0007095,1,0.212204558962565,0,19,mitotic G2 DNA damage checkpoint,BP,
3364,GO:0007100,1,0.351185726238429,0,13,mitotic centrosome separation,BP,
3368,GO:0007130,1,0.56405320888634,0,7,synaptonemal complex assembly,BP,
3370,GO:0007135,1,0.622981784806721,0,6,meiosis II,BP,
3371,GO:0007140,1,0.159746668445068,0,23,male meiotic nuclear division,BP,
3372,GO:0007141,1,0.394519806950202,0,12,male meiosis I,BP,
3373,GO:0007143,1,0.237674315762526,0,18,female meiotic nuclear division,BP,
3374,GO:0007144,1,0.624275789453224,0,6,female meiosis I,BP,
3381,GO:0007158,1,0.61076682278482,0,6,neuron cell-cell adhesion,BP,
3394,GO:0007172,1,0.564174144541076,0,7,signal complex assembly,BP,
3410,GO:0007191,1,0.615125021402615,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3412,GO:0007194,1,0.572855236715401,0,7,negative regulation of adenylate cyclase activity,BP,
3425,GO:0007213,1,0.452570248133128,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3426,GO:0007214,1,0.613938006893225,0,6,gamma-aminobutyric acid signaling pathway,BP,
3446,GO:0007256,1,0.61076682278482,0,6,activation of JNKK activity,BP,
3451,GO:0007263,1,0.530723158299491,0,8,nitric oxide mediated signal transduction,BP,
3458,GO:0007270,1,0.618007333134803,0,6,neuron-neuron synaptic transmission,BP,
3461,GO:0007274,1,0.477446303870686,0,9,neuromuscular synaptic transmission,BP,
3469,GO:0007289,1,0.417340830695186,0,11,spermatid nucleus differentiation,BP,
3485,GO:0007350,1,0.375352065596602,0,12,blastoderm segmentation,BP,
3486,GO:0007351,1,0.48031035854703,0,9,tripartite regional subdivision,BP,
3507,GO:0007413,1,0.317294423638624,0,14,axonal fasciculation,BP,
3517,GO:0007440,1,0.61076682278482,0,6,foregut morphogenesis,BP,
3521,GO:0007494,1,0.562599373262889,0,7,midgut development,BP,
3573,GO:0007617,1,0.407375952223944,0,11,mating behavior,BP,
3581,GO:0007625,1,0.645142154185941,0,6,grooming behavior,BP,
3583,GO:0007628,1,0.380784151092289,0,12,adult walking behavior,BP,
3585,GO:0007632,1,0.0596511977143785,0,35,visual behavior,BP,
3587,GO:0007635,1,0.61076682278482,0,6,chemosensory behavior,BP,
3588,GO:0007638,1,0.518173385837962,0,8,mechanosensory behavior,BP,
3598,GO:0008024,1,0.519044823183716,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3606,GO:0008045,1,0.32260567771593,0,14,motor neuron axon guidance,BP,
3621,GO:0008074,1,0.61076682278482,0,6,guanylate cyclase complex, soluble,CC,
3624,GO:0008079,1,0.614709360960322,0,6,translation termination factor activity,MF,
3649,GO:0008121,1,0.611297590672033,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3656,GO:0008137,1,0.0942898131579347,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3687,GO:0008190,1,0.542690347702265,0,8,eukaryotic initiation factor 4E binding,MF,
3688,GO:0008191,1,0.59325905317275,0,7,metalloendopeptidase inhibitor activity,MF,
3692,GO:0008195,1,0.477276614787127,0,9,phosphatidate phosphatase activity,MF,
3693,GO:0008198,1,0.266308453068318,0,17,ferrous iron binding,MF,
3707,GO:0008214,1,0.0921961518014627,0,29,protein dealkylation,BP,
3708,GO:0008215,1,0.637929265545591,0,6,spermine metabolic process,BP,
3709,GO:0008216,1,0.599127897688864,0,7,spermidine metabolic process,BP,
3721,GO:0008239,1,0.614669969759822,0,6,dipeptidyl-peptidase activity,MF,
3723,GO:0008242,1,0.529899859120635,0,8,omega peptidase activity,MF,
3724,GO:0008250,1,0.415902970947005,0,12,oligosaccharyltransferase complex,CC,
3726,GO:0008252,1,0.413516391641654,0,11,nucleotidase activity,MF,
3727,GO:0008253,1,0.487359797148694,0,9,5'-nucleotidase activity,MF,
3737,GO:0008272,1,0.564034883545068,0,7,sulfate transport,BP,
3739,GO:0008274,1,0.518173385837962,0,8,gamma-tubulin ring complex,CC,
3752,GO:0008290,1,0.618712505155783,0,6,F-actin capping protein complex,CC,
3756,GO:0008297,1,0.622166575192374,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3760,GO:0008301,1,0.347181787923148,0,13,DNA binding, bending,MF,
3764,GO:0008308,1,0.386802013865529,0,12,voltage-gated anion channel activity,MF,
3768,GO:0008312,1,0.58713835034868,0,7,7S RNA binding,MF,
3769,GO:0008318,1,0.570768411914769,0,7,protein prenyltransferase activity,MF,
3774,GO:0008328,1,0.232037365970491,0,18,ionotropic glutamate receptor complex,CC,
3775,GO:0008329,1,0.572073938515777,0,7,signaling pattern recognition receptor activity,MF,
3779,GO:0008334,1,0.16223483575044,0,24,histone mRNA metabolic process,BP,
3783,GO:0008344,1,0.0462843386630187,0,39,adult locomotory behavior,BP,
3786,GO:0008349,1,0.440031397508477,0,10,MAP kinase kinase kinase kinase activity,MF,
3788,GO:0008353,1,0.281761954396515,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3789,GO:0008354,1,0.563067064141372,0,7,germ cell migration,BP,
3805,GO:0008385,1,0.490634653608737,0,9,IkappaB kinase complex,CC,
3820,GO:0008417,1,0.440556966626474,0,10,fucosyltransferase activity,MF,
3830,GO:0008429,1,0.545349098132843,0,8,phosphatidylethanolamine binding,MF,
3833,GO:0008432,1,0.5357095209916,0,8,JUN kinase binding,MF,
3838,GO:0008443,1,0.610778564143798,0,6,phosphofructokinase activity,MF,
3855,GO:0008469,1,0.523304576267265,0,8,histone-arginine N-methyltransferase activity,MF,
3857,GO:0008474,1,0.446651305302141,0,10,palmitoyl-(protein) hydrolase activity,MF,
3864,GO:0008483,1,0.377349656057276,0,12,transaminase activity,MF,
3865,GO:0008484,1,0.373966689947,0,12,sulfuric ester hydrolase activity,MF,
3873,GO:0008499,1,0.411016536820943,0,11,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3891,GO:0008525,1,0.614284764426284,0,6,phosphatidylcholine transporter activity,MF,
3892,GO:0008526,1,0.519225429627912,0,8,phosphatidylinositol transporter activity,MF,
3896,GO:0008532,1,0.446243590454371,0,10,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3902,GO:0008541,1,0.582275484087262,0,7,proteasome regulatory particle, lid subcomplex,CC,
3903,GO:0008542,1,0.0808336127524762,0,31,visual learning,BP,
3907,GO:0008553,1,0.488234810852846,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3912,GO:0008568,1,0.443049107190596,0,10,microtubule-severing ATPase activity,MF,
3913,GO:0008569,1,0.409306073856174,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3924,GO:0008595,1,0.48031035854703,0,9,anterior/posterior axis specification, embryo,BP,
3941,GO:0008627,1,0.571232523423396,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3944,GO:0008635,1,0.490674205811931,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3946,GO:0008641,1,0.441630731474609,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3954,GO:0008656,1,0.340807567934145,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3983,GO:0008821,1,0.491703809320671,0,9,crossover junction endodeoxyribonuclease activity,MF,
4008,GO:0008970,1,0.563376008218472,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4033,GO:0009065,1,0.199541955197775,0,20,glutamine family amino acid catabolic process,BP,
4038,GO:0009070,1,0.32041552305941,0,14,serine family amino acid biosynthetic process,BP,
4039,GO:0009071,1,0.616853501646227,0,6,serine family amino acid catabolic process,BP,
4047,GO:0009084,1,0.321286581074542,0,14,glutamine family amino acid biosynthetic process,BP,
4049,GO:0009086,1,0.414903812449254,0,11,methionine biosynthetic process,BP,
4060,GO:0009109,1,0.430828326963571,0,11,coenzyme catabolic process,BP,
4064,GO:0009113,1,0.358612525811254,0,13,purine nucleobase biosynthetic process,BP,
4072,GO:0009125,1,0.490677234922164,0,9,nucleoside monophosphate catabolic process,BP,
4075,GO:0009128,1,0.532721008464124,0,8,purine nucleoside monophosphate catabolic process,BP,
4080,GO:0009134,1,0.578569342655092,0,7,nucleoside diphosphate catabolic process,BP,
4089,GO:0009143,1,0.432730098363748,0,11,nucleoside triphosphate catabolic process,BP,
4092,GO:0009146,1,0.640906255498874,0,6,purine nucleoside triphosphate catabolic process,BP,
4097,GO:0009151,1,0.474507291276761,0,10,purine deoxyribonucleotide metabolic process,BP,
4100,GO:0009154,1,0.179105964678844,0,22,purine ribonucleotide catabolic process,BP,
4101,GO:0009155,1,0.635776349703685,0,6,purine deoxyribonucleotide catabolic process,BP,
4104,GO:0009158,1,0.532721008464124,0,8,ribonucleoside monophosphate catabolic process,BP,
4109,GO:0009164,1,0.212699041834777,0,20,nucleoside catabolic process,BP,
4114,GO:0009169,1,0.532721008464124,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4116,GO:0009173,1,0.487327636537373,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4117,GO:0009174,1,0.487327636537373,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4132,GO:0009191,1,0.628134925991009,0,6,ribonucleoside diphosphate catabolic process,BP,
4143,GO:0009204,1,0.591745473539229,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4152,GO:0009214,1,0.439604389862749,0,10,cyclic nucleotide catabolic process,BP,
4153,GO:0009215,1,0.511536152316429,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4169,GO:0009235,1,0.360616788645478,0,13,cobalamin metabolic process,BP,
4175,GO:0009249,1,0.619710629162139,0,7,protein lipoylation,BP,
4184,GO:0009261,1,0.164954345211426,0,23,ribonucleotide catabolic process,BP,
4202,GO:0009310,1,0.431512927927154,0,11,amine catabolic process,BP,
4205,GO:0009313,1,0.479085688867037,0,9,oligosaccharide catabolic process,BP,
4234,GO:0009414,1,0.626117752414993,0,6,response to water deprivation,BP,
4235,GO:0009415,1,0.452206626999192,0,10,response to water,BP,
4258,GO:0009593,1,0.144145540646287,0,25,detection of chemical stimulus,BP,
4259,GO:0009595,1,0.485247148556253,0,9,detection of biotic stimulus,BP,
4305,GO:0009756,1,0.627417289683964,0,6,carbohydrate mediated signaling,BP,
4365,GO:0009972,1,0.636810158942809,0,6,cytidine deamination,BP,
4366,GO:0009975,1,0.477687870903173,0,9,cyclase activity,MF,
4389,GO:0010042,1,0.387573262596416,0,12,response to manganese ion,BP,
4398,GO:0010107,1,0.228930342610389,0,18,potassium ion import,BP,
4414,GO:0010181,1,0.442861328718719,0,10,FMN binding,MF,
4421,GO:0010225,1,0.357120274801512,0,13,response to UV-C,BP,
4422,GO:0010226,1,0.29910327370965,0,15,response to lithium ion,BP,
4425,GO:0010248,1,0.628399025552517,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4431,GO:0010265,1,0.629533887463158,0,6,SCF complex assembly,BP,
4438,GO:0010310,1,0.450437062522656,0,10,regulation of hydrogen peroxide metabolic process,BP,
4443,GO:0010340,1,0.571182561376185,0,7,carboxyl-O-methyltransferase activity,MF,
4445,GO:0010359,1,0.61076789054263,0,6,regulation of anion channel activity,BP,
4455,GO:0010421,1,0.424768766820634,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4459,GO:0010452,1,0.480375645081225,0,9,histone H3-K36 methylation,BP,
4479,GO:0010485,1,0.229547976389905,0,18,H4 histone acetyltransferase activity,MF,
4488,GO:0010510,1,0.407891496644903,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4498,GO:0010523,1,0.366578861048237,0,13,negative regulation of calcium ion transport into cytosol,BP,
4500,GO:0010528,1,0.414486987323355,0,11,regulation of transposition,BP,
4501,GO:0010529,1,0.414486987323355,0,11,negative regulation of transposition,BP,
4518,GO:0010571,1,0.610766822793708,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4527,GO:0010592,1,0.323742491356054,0,14,positive regulation of lamellipodium assembly,BP,
4532,GO:0010603,1,0.562570381877626,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4554,GO:0010635,1,0.523082721212291,0,8,regulation of mitochondrial fusion,BP,
4563,GO:0010644,1,0.217074438689418,0,19,cell communication by electrical coupling,BP,
4568,GO:0010649,1,0.483611867070506,0,9,regulation of cell communication by electrical coupling,BP,
4578,GO:0010663,1,0.614948125183365,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4581,GO:0010666,1,0.614948125183365,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4587,GO:0010677,1,0.19845730842052,0,20,negative regulation of cellular carbohydrate metabolic process,BP,
4641,GO:0010763,1,0.478030525724871,0,9,positive regulation of fibroblast migration,BP,
4642,GO:0010764,1,0.614325804756707,0,6,negative regulation of fibroblast migration,BP,
4650,GO:0010792,1,0.610771450391699,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4660,GO:0010807,1,0.613284307269832,0,6,regulation of synaptic vesicle priming,BP,
4677,GO:0010825,1,0.611226755093905,0,6,positive regulation of centrosome duplication,BP,
4704,GO:0010866,1,0.35286660077847,0,13,regulation of triglyceride biosynthetic process,BP,
4705,GO:0010867,1,0.481310093085036,0,9,positive regulation of triglyceride biosynthetic process,BP,
4718,GO:0010880,1,0.310755531530596,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4719,GO:0010881,1,0.431052367690614,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4720,GO:0010882,1,0.31104653191067,0,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4725,GO:0010887,1,0.617309933634186,0,6,negative regulation of cholesterol storage,BP,
4727,GO:0010889,1,0.537423979412811,0,8,regulation of sequestering of triglyceride,BP,
4747,GO:0010917,1,0.536423512091356,0,8,negative regulation of mitochondrial membrane potential,BP,
4748,GO:0010918,1,0.57818037802749,0,7,positive regulation of mitochondrial membrane potential,BP,
4775,GO:0010960,1,0.562599373262889,0,7,magnesium ion homeostasis,BP,
4793,GO:0010984,1,0.428461365376012,0,11,regulation of lipoprotein particle clearance,BP,
4796,GO:0010988,1,0.621982697167033,0,6,regulation of low-density lipoprotein particle clearance,BP,
4802,GO:0010996,1,0.377116049625039,0,12,response to auditory stimulus,BP,
4804,GO:0010998,1,0.445151247699942,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4820,GO:0014014,1,0.174591095118043,0,22,negative regulation of gliogenesis,BP,
4835,GO:0014041,1,0.573594246571696,0,7,regulation of neuron maturation,BP,
4840,GO:0014046,1,0.500518551200193,0,9,dopamine secretion,BP,
4841,GO:0014047,1,0.214214118784593,0,19,glutamate secretion,BP,
4848,GO:0014059,1,0.500518551200193,0,9,regulation of dopamine secretion,BP,
4855,GO:0014067,1,0.479042827514801,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
4872,GO:0014733,1,0.527180256197835,0,8,regulation of skeletal muscle adaptation,BP,
4907,GO:0014841,1,0.563720037435192,0,7,skeletal muscle satellite cell proliferation,BP,
4908,GO:0014842,1,0.563720037435192,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4918,GO:0014856,1,0.563720037435192,0,7,skeletal muscle cell proliferation,BP,
4919,GO:0014857,1,0.563720037435192,0,7,regulation of skeletal muscle cell proliferation,BP,
4950,GO:0015012,1,0.195041105714064,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4962,GO:0015037,1,0.412265175280381,0,12,peptide disulfide oxidoreductase activity,MF,
4966,GO:0015074,1,0.442960401330837,0,10,DNA integration,BP,
4987,GO:0015114,1,0.563221398983088,0,7,phosphate ion transmembrane transporter activity,MF,
4988,GO:0015116,1,0.612356654304736,0,6,sulfate transmembrane transporter activity,MF,
5029,GO:0015194,1,0.566589302811116,0,7,L-serine transmembrane transporter activity,MF,
5034,GO:0015205,1,0.622072771098342,0,6,nucleobase transmembrane transporter activity,MF,
5037,GO:0015215,1,0.301596803354028,0,15,nucleotide transmembrane transporter activity,MF,
5038,GO:0015216,1,0.413562920111644,0,11,purine nucleotide transmembrane transporter activity,MF,
5039,GO:0015217,1,0.486078728726653,0,9,ADP transmembrane transporter activity,MF,
5059,GO:0015269,1,0.572475659346767,0,7,calcium-activated potassium channel activity,MF,
5073,GO:0015296,1,0.562570381877626,0,7,anion:cation symporter activity,MF,
5076,GO:0015299,1,0.375699441735983,0,12,solute:proton antiporter activity,MF,
5099,GO:0015377,1,0.61076682278482,0,6,cation:chloride symporter activity,MF,
5101,GO:0015379,1,0.61076682278482,0,6,potassium:chloride symporter activity,MF,
5102,GO:0015385,1,0.518542946509023,0,8,sodium:proton antiporter activity,MF,
5103,GO:0015386,1,0.562971571962646,0,7,potassium:proton antiporter activity,MF,
5117,GO:0015450,1,0.619169589067142,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5119,GO:0015464,1,0.612879806277532,0,6,acetylcholine receptor activity,MF,
5121,GO:0015485,1,0.0941867344839969,0,30,cholesterol binding,MF,
5128,GO:0015556,1,0.566077949942267,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5131,GO:0015605,1,0.184300197448464,0,21,organophosphate ester transmembrane transporter activity,MF,
5141,GO:0015662,1,0.168502824551361,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5179,GO:0015740,1,0.478513296010614,0,9,C4-dicarboxylate transport,BP,
5185,GO:0015748,1,0.00506869345056101,0,66,organophosphate ester transport,BP,
5198,GO:0015791,1,0.612739762632859,0,6,polyol transport,BP,
5213,GO:0015812,1,0.611855050076021,0,6,gamma-aminobutyric acid transport,BP,
5215,GO:0015816,1,0.612499269899675,0,6,glycine transport,BP,
5221,GO:0015824,1,0.610848134207371,0,6,proline transport,BP,
5222,GO:0015825,1,0.566589302811116,0,7,L-serine transport,BP,
5231,GO:0015846,1,0.621220887800948,0,6,polyamine transport,BP,
5235,GO:0015851,1,0.577856007140522,0,7,nucleobase transport,BP,
5242,GO:0015865,1,0.380914820957182,0,12,purine nucleotide transport,BP,
5243,GO:0015866,1,0.486078728726653,0,9,ADP transport,BP,
5244,GO:0015867,1,0.486048550282358,0,9,ATP transport,BP,
5245,GO:0015868,1,0.380914820957182,0,12,purine ribonucleotide transport,BP,
5246,GO:0015871,1,0.610940274591744,0,6,choline transport,BP,
5247,GO:0015872,1,0.31467752527154,0,15,dopamine transport,BP,
5267,GO:0015914,1,0.0253568756783356,0,46,phospholipid transport,BP,
5271,GO:0015919,1,0.272271871611468,0,16,peroxisomal membrane transport,BP,
5273,GO:0015923,1,0.31711708649533,0,14,mannosidase activity,MF,
5274,GO:0015924,1,0.478400655373788,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5275,GO:0015925,1,0.616227819361526,0,6,galactosidase activity,MF,
5278,GO:0015929,1,0.376217831057091,0,12,hexosaminidase activity,MF,
5291,GO:0015959,1,0.570060012422278,0,7,diadenosine polyphosphate metabolic process,BP,
5299,GO:0015988,1,0.205421360241989,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5301,GO:0015991,1,0.218034341777814,0,20,ATP hydrolysis coupled proton transport,BP,
5309,GO:0016018,1,0.462076922338558,0,10,cyclosporin A binding,MF,
5313,GO:0016024,1,0.346426156213862,0,13,CDP-diacylglycerol biosynthetic process,BP,
5321,GO:0016045,1,0.57195974575464,0,7,detection of bacterium,BP,
5322,GO:0016048,1,0.574296237740619,0,7,detection of temperature stimulus,BP,
5338,GO:0016075,1,0.318291328860617,0,15,rRNA catabolic process,BP,
5343,GO:0016081,1,0.61147355300421,0,6,synaptic vesicle docking,BP,
5345,GO:0016093,1,0.625533821297053,0,6,polyprenol metabolic process,BP,
5362,GO:0016139,1,0.568947489550509,0,7,glycoside catabolic process,BP,
5384,GO:0016208,1,0.502356993170698,0,9,AMP binding,MF,
5391,GO:0016226,1,0.22608643946209,0,20,iron-sulfur cluster assembly,BP,
5406,GO:0016246,1,0.30841024435268,0,15,RNA interference,BP,
5411,GO:0016255,1,0.570161891900471,0,7,attachment of GPI anchor to protein,BP,
5417,GO:0016264,1,0.562787359721491,0,7,gap junction assembly,BP,
5421,GO:0016272,1,0.632609264930806,0,7,prefoldin complex,CC,
5422,GO:0016273,1,0.409016970936304,0,11,arginine N-methyltransferase activity,MF,
5423,GO:0016274,1,0.409016970936304,0,11,protein-arginine N-methyltransferase activity,MF,
5427,GO:0016281,1,0.492239194021767,0,9,eukaryotic translation initiation factor 4F complex,CC,
5440,GO:0016307,1,0.322689870278897,0,14,phosphatidylinositol phosphate kinase activity,MF,
5441,GO:0016308,1,0.617154591321887,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5450,GO:0016322,1,0.611320627273303,0,6,neuron remodeling,BP,
5479,GO:0016413,1,0.612222308372031,0,6,O-acetyltransferase activity,MF,
5487,GO:0016421,1,0.612832315127248,0,6,CoA carboxylase activity,MF,
5500,GO:0016442,1,0.408244766988272,0,11,RISC complex,CC,
5503,GO:0016446,1,0.320579243227045,0,14,somatic hypermutation of immunoglobulin genes,BP,
5510,GO:0016461,1,0.592440319960634,0,7,unconventional myosin complex,CC,
5512,GO:0016469,1,0.162315734268674,0,24,proton-transporting two-sector ATPase complex,CC,
5513,GO:0016471,1,0.425928845290795,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5525,GO:0016500,1,0.61139955725558,0,6,protein-hormone receptor activity,MF,
5526,GO:0016502,1,0.617315419943563,0,6,nucleotide receptor activity,MF,
5529,GO:0016505,1,0.290978198715553,0,16,peptidase activator activity involved in apoptotic process,MF,
5541,GO:0016530,1,0.674473779008186,0,6,metallochaperone activity,MF,
5548,GO:0016553,1,0.415334285334802,0,11,base conversion or substitution editing,BP,
5549,GO:0016554,1,0.625217706991367,0,6,cytidine to uridine editing,BP,
5552,GO:0016558,1,0.378347188703919,0,12,protein import into peroxisome matrix,BP,
5553,GO:0016559,1,0.59685159246633,0,7,peroxisome fission,BP,
5565,GO:0016577,1,0.108533690540087,0,27,histone demethylation,BP,
5568,GO:0016580,1,0.412515508534156,0,11,Sin3 complex,CC,
5570,GO:0016584,1,0.60412057548044,0,7,nucleosome positioning,BP,
5572,GO:0016589,1,0.576204559817441,0,7,NURF complex,CC,
5576,GO:0016593,1,0.526024175676923,0,8,Cdc73/Paf1 complex,CC,
5590,GO:0016615,1,0.625921305810345,0,6,malate dehydrogenase activity,MF,
5593,GO:0016620,1,0.120359528050992,0,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5595,GO:0016624,1,0.52917760801761,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5599,GO:0016635,1,0.626502731069195,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5600,GO:0016638,1,0.373223896078717,0,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5602,GO:0016641,1,0.439941792448778,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5617,GO:0016670,1,0.562931011062413,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5623,GO:0016681,1,0.611297590672033,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5648,GO:0016742,1,0.611966084034729,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5662,GO:0016769,1,0.351285345004648,0,13,transferase activity, transferring nitrogenous groups,MF,
5666,GO:0016775,1,0.635602957676387,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
5673,GO:0016783,1,0.40512116575545,0,12,sulfurtransferase activity,MF,
5688,GO:0016805,1,0.566637604221874,0,7,dipeptidase activity,MF,
5693,GO:0016813,1,0.623838519782049,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5694,GO:0016814,1,0.159315335540617,0,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
5704,GO:0016832,1,0.572152920150223,0,7,aldehyde-lyase activity,MF,
5709,GO:0016840,1,0.458639803702752,0,10,carbon-nitrogen lyase activity,MF,
5711,GO:0016842,1,0.586853115680481,0,7,amidine-lyase activity,MF,
5714,GO:0016846,1,0.602361202394759,0,7,carbon-sulfur lyase activity,MF,
5717,GO:0016854,1,0.362408808842465,0,13,racemase and epimerase activity,MF,
5719,GO:0016857,1,0.453395306385452,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5720,GO:0016859,1,0.0972390247484304,0,31,cis-trans isomerase activity,MF,
5722,GO:0016861,1,0.535968357750455,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5725,GO:0016864,1,0.253126758012334,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
5737,GO:0016884,1,0.454756014115333,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5738,GO:0016885,1,0.520449441783959,0,8,ligase activity, forming carbon-carbon bonds,MF,
5745,GO:0016892,1,0.625646592910562,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5754,GO:0016903,1,0.0637341598340871,0,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
5760,GO:0016922,1,0.232002143732795,0,18,ligand-dependent nuclear receptor binding,MF,
5772,GO:0016973,1,0.454342438355978,0,10,poly(A)+ mRNA export from nucleus,BP,
5779,GO:0017001,1,0.11571449876482,0,28,antibiotic catabolic process,BP,
5785,GO:0017014,1,0.472725596996806,0,10,protein nitrosylation,BP,
5805,GO:0017059,1,0.526108859595993,0,8,serine C-palmitoyltransferase complex,CC,
5813,GO:0017075,1,0.317731629935389,0,14,syntaxin-1 binding,MF,
5826,GO:0017101,1,0.386799711335935,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5830,GO:0017110,1,0.354350991916988,0,13,nucleoside-diphosphatase activity,MF,
5835,GO:0017119,1,0.374140620959951,0,12,Golgi transport complex,CC,
5836,GO:0017121,1,0.565779821818468,0,7,phospholipid scrambling,BP,
5841,GO:0017128,1,0.613678917479934,0,6,phospholipid scramblase activity,MF,
5856,GO:0017154,1,0.439655115301719,0,10,semaphorin receptor activity,MF,
5859,GO:0017158,1,0.0330904772216925,0,42,regulation of calcium ion-dependent exocytosis,BP,
5862,GO:0017162,1,0.526369292782134,0,8,aryl hydrocarbon receptor binding,MF,
5865,GO:0017169,1,0.577464961435453,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5867,GO:0017176,1,0.596784443779239,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5872,GO:0017185,1,0.518179745757235,0,8,peptidyl-lysine hydroxylation,BP,
5875,GO:0017196,1,0.62249834995675,0,6,N-terminal peptidyl-methionine acetylation,BP,
5888,GO:0018026,1,0.480619748169082,0,9,peptidyl-lysine monomethylation,BP,
5889,GO:0018027,1,0.323746499576155,0,14,peptidyl-lysine dimethylation,BP,
5893,GO:0018065,1,0.457343119638774,0,11,protein-cofactor linkage,BP,
5905,GO:0018119,1,0.472725596996806,0,10,peptidyl-cysteine S-nitrosylation,BP,
5912,GO:0018158,1,0.50126944786846,0,9,protein oxidation,BP,
5920,GO:0018195,1,0.262041403779287,0,17,peptidyl-arginine modification,BP,
5929,GO:0018206,1,0.454329833546202,0,10,peptidyl-methionine modification,BP,
5936,GO:0018216,1,0.346984335896499,0,13,peptidyl-arginine methylation,BP,
5958,GO:0018342,1,0.484232925661961,0,9,protein prenylation,BP,
5960,GO:0018344,1,0.619666423400443,0,6,protein geranylgeranylation,BP,
6053,GO:0019200,1,0.216492464211216,0,19,carbohydrate kinase activity,MF,
6082,GO:0019238,1,0.613349789796486,0,6,cyclohydrolase activity,MF,
6097,GO:0019317,1,0.61076682278482,0,6,fucose catabolic process,BP,
6126,GO:0019374,1,0.613562082461683,0,6,galactolipid metabolic process,BP,
6129,GO:0019377,1,0.410542049224648,0,11,glycolipid catabolic process,BP,
6130,GO:0019388,1,0.531800017737672,0,8,galactose catabolic process,BP,
6134,GO:0019400,1,0.331587537788149,0,14,alditol metabolic process,BP,
6137,GO:0019405,1,0.615737594673332,0,6,alditol catabolic process,BP,
6146,GO:0019432,1,0.131712972613892,0,25,triglyceride biosynthetic process,BP,
6147,GO:0019433,1,0.421981475344303,0,11,triglyceride catabolic process,BP,
6154,GO:0019471,1,0.380965638798439,0,12,4-hydroxyproline metabolic process,BP,
6187,GO:0019626,1,0.578703915942082,0,7,short-chain fatty acid catabolic process,BP,
6188,GO:0019627,1,0.45127577887692,0,10,urea metabolic process,BP,
6207,GO:0019720,1,0.616329818649906,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6212,GO:0019731,1,0.344497672863249,0,17,antibacterial humoral response,BP,
6223,GO:0019773,1,0.625509530090138,0,7,proteasome core complex, alpha-subunit complex,CC,
6233,GO:0019784,1,0.584497568888327,0,7,NEDD8-specific protease activity,MF,
6252,GO:0019829,1,0.0696334520708798,0,34,cation-transporting ATPase activity,MF,
6256,GO:0019840,1,0.363949390651085,0,13,isoprenoid binding,MF,
6262,GO:0019855,1,0.543325260744229,0,8,calcium channel inhibitor activity,MF,
6263,GO:0019856,1,0.611601708017215,0,6,pyrimidine nucleobase biosynthetic process,BP,
6274,GO:0019869,1,0.593560944270254,0,7,chloride channel inhibitor activity,MF,
6285,GO:0019894,1,0.0614686871395361,0,34,kinesin binding,MF,
6296,GO:0019907,1,0.575552479511884,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6297,GO:0019908,1,0.277322915750022,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6298,GO:0019911,1,0.529517996501878,0,8,structural constituent of myelin sheath,MF,
6302,GO:0019919,1,0.568043852819347,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6337,GO:0021511,1,0.518200737915373,0,8,spinal cord patterning,BP,
6339,GO:0021513,1,0.562600074929639,0,7,spinal cord dorsal/ventral patterning,BP,
6344,GO:0021520,1,0.614147098014311,0,6,spinal cord motor neuron cell fate specification,BP,
6351,GO:0021532,1,0.11118866342204,0,27,neural tube patterning,BP,
6352,GO:0021533,1,0.480978796845536,0,9,cell differentiation in hindbrain,BP,
6361,GO:0021542,1,0.528611537343645,0,8,dentate gyrus development,BP,
6374,GO:0021559,1,0.610839285030635,0,6,trigeminal nerve development,BP,
6376,GO:0021561,1,0.614453251428906,0,6,facial nerve development,BP,
6392,GO:0021591,1,0.26556377186425,0,17,ventricular system development,BP,
6399,GO:0021610,1,0.614453251428906,0,6,facial nerve morphogenesis,BP,
6413,GO:0021670,1,0.532269980528311,0,8,lateral ventricle development,BP,
6417,GO:0021680,1,0.293737385682214,0,15,cerebellar Purkinje cell layer development,BP,
6418,GO:0021681,1,0.576737143100011,0,7,cerebellar granular layer development,BP,
6426,GO:0021692,1,0.518556986544919,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6431,GO:0021697,1,0.380165972665247,0,12,cerebellar cortex formation,BP,
6464,GO:0021785,1,0.610837274244507,0,6,branchiomotor neuron axon guidance,BP,
6465,GO:0021794,1,0.566325820905533,0,7,thalamus development,BP,
6470,GO:0021799,1,0.180826927745255,0,21,cerebral cortex radially oriented cell migration,BP,
6472,GO:0021801,1,0.251248980623437,0,17,cerebral cortex radial glia guided migration,BP,
6474,GO:0021814,1,0.563132878295406,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6478,GO:0021819,1,0.446759997596691,0,10,layer formation in cerebral cortex,BP,
6499,GO:0021861,1,0.576564537276309,0,7,forebrain radial glial cell differentiation,BP,
6518,GO:0021895,1,0.451069061402598,0,10,cerebral cortex neuron differentiation,BP,
6524,GO:0021904,1,0.229817472551517,0,18,dorsal/ventral neural tube patterning,BP,
6525,GO:0021910,1,0.610799056939925,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6540,GO:0021952,1,0.300079635110213,0,15,central nervous system projection neuron axonogenesis,BP,
6543,GO:0021955,1,0.199277319906732,0,20,central nervous system neuron axonogenesis,BP,
6571,GO:0022030,1,0.251248980623437,0,17,telencephalon glial cell migration,BP,
6573,GO:0022038,1,0.359595846733283,0,13,corpus callosum development,BP,
6587,GO:0022417,1,0.51232271630945,0,9,protein maturation by protein folding,BP,
6609,GO:0022821,1,0.47761703717408,0,9,potassium ion antiporter activity,MF,
6610,GO:0022824,1,0.562770361598539,0,7,transmitter-gated ion channel activity,MF,
6614,GO:0022835,1,0.562770361598539,0,7,transmitter-gated channel activity,MF,
6625,GO:0022853,1,0.064126108342777,0,35,active ion transmembrane transporter activity,MF,
6629,GO:0022889,1,0.566589302811116,0,7,serine transmembrane transporter activity,MF,
6656,GO:0030007,1,0.565712551343271,0,7,cellular potassium ion homeostasis,BP,
6660,GO:0030014,1,0.293680891701262,0,15,CCR4-NOT complex,CC,
6673,GO:0030033,1,0.297706126255078,0,15,microvillus assembly,BP,
6692,GO:0030062,1,0.620293032661807,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6697,GO:0030091,1,0.599973973240654,0,7,protein repair,BP,
6711,GO:0030121,1,0.617529106517225,0,6,AP-1 adaptor complex,CC,
6712,GO:0030122,1,0.381907065446873,0,12,AP-2 adaptor complex,CC,
6713,GO:0030123,1,0.48265710458872,0,9,AP-3 adaptor complex,CC,
6716,GO:0030126,1,0.307386820541763,0,15,COPI vesicle coat,CC,
6717,GO:0030127,1,0.325366287660841,0,14,COPII vesicle coat,CC,
6718,GO:0030128,1,0.351755485452716,0,13,clathrin coat of endocytic vesicle,CC,
6720,GO:0030131,1,0.104212567047512,0,28,clathrin adaptor complex,CC,
6726,GO:0030137,1,0.162849287720268,0,23,COPI-coated vesicle,CC,
6739,GO:0030157,1,0.615540589928568,0,6,pancreatic juice secretion,BP,
6749,GO:0030169,1,0.610771042019753,0,6,low-density lipoprotein particle binding,MF,
6750,GO:0030170,1,0.0734216358938968,0,32,pyridoxal phosphate binding,MF,
6753,GO:0030174,1,0.615146434850331,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6767,GO:0030201,1,0.140858631678653,0,24,heparan sulfate proteoglycan metabolic process,BP,
6771,GO:0030205,1,0.48227191155408,0,9,dermatan sulfate metabolic process,BP,
6773,GO:0030207,1,0.483378038713612,0,9,chondroitin sulfate catabolic process,BP,
6774,GO:0030208,1,0.523188497456905,0,8,dermatan sulfate biosynthetic process,BP,
6806,GO:0030252,1,0.562612889945374,0,7,growth hormone secretion,BP,
6826,GO:0030285,1,0.563734368593973,0,7,integral component of synaptic vesicle membrane,CC,
6841,GO:0030306,1,0.61076682278482,0,6,ADP-ribosylation factor binding,MF,
6844,GO:0030309,1,0.484484142857737,0,9,poly-N-acetyllactosamine metabolic process,BP,
6845,GO:0030311,1,0.484484142857737,0,9,poly-N-acetyllactosamine biosynthetic process,BP,
6871,GO:0030346,1,0.6316007944615,0,6,protein phosphatase 2B binding,MF,
6890,GO:0030422,1,0.503130622060266,0,9,production of siRNA involved in RNA interference,BP,
6909,GO:0030497,1,0.449029350588948,0,10,fatty acid elongation,BP,
6912,GO:0030502,1,0.612014864188011,0,6,negative regulation of bone mineralization,BP,
6934,GO:0030539,1,0.477538793324878,0,9,male genitalia development,BP,
6943,GO:0030551,1,0.274661890331027,0,16,cyclic nucleotide binding,MF,
6944,GO:0030552,1,0.405042514792093,0,11,cAMP binding,MF,
6957,GO:0030594,1,0.190805460120287,0,21,neurotransmitter receptor activity,MF,
6966,GO:0030620,1,0.64831041975781,0,6,U2 snRNA binding,MF,
6986,GO:0030663,1,0.243989766357283,0,18,COPI-coated vesicle membrane,CC,
6990,GO:0030669,1,0.137906216426764,0,25,clathrin-coated endocytic vesicle membrane,CC,
6995,GO:0030676,1,0.404992837216018,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
7027,GO:0030800,1,0.447643282660616,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7030,GO:0030803,1,0.527647400244381,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7039,GO:0030812,1,0.523009264551828,0,8,negative regulation of nucleotide catabolic process,BP,
7040,GO:0030813,1,0.405478505647811,0,11,positive regulation of nucleotide catabolic process,BP,
7042,GO:0030815,1,0.447643282660616,0,10,negative regulation of cAMP metabolic process,BP,
7045,GO:0030818,1,0.527647400244381,0,8,negative regulation of cAMP biosynthetic process,BP,
7050,GO:0030823,1,0.323242732777725,0,14,regulation of cGMP metabolic process,BP,
7051,GO:0030825,1,0.487637739777931,0,9,positive regulation of cGMP metabolic process,BP,
7052,GO:0030826,1,0.528412158470958,0,8,regulation of cGMP biosynthetic process,BP,
7053,GO:0030828,1,0.573685446627313,0,7,positive regulation of cGMP biosynthetic process,BP,
7083,GO:0030877,1,0.440311919258619,0,10,beta-catenin destruction complex,CC,
7087,GO:0030881,1,0.623441145229748,0,6,beta-2-microglobulin binding,MF,
7101,GO:0030897,1,0.316641950302857,0,14,HOPS complex,CC,
7114,GO:0030914,1,0.393582365885271,0,12,STAGA complex,CC,
7115,GO:0030915,1,0.589134144479095,0,7,Smc5-Smc6 complex,CC,
7124,GO:0030947,1,0.218638677836752,0,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7125,GO:0030948,1,0.525650435474014,0,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7126,GO:0030949,1,0.56673438173206,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7131,GO:0030955,1,0.478556038826923,0,9,potassium ion binding,MF,
7133,GO:0030957,1,0.451717436547695,0,10,Tat protein binding,MF,
7135,GO:0030964,1,0.0711771098195729,0,42,NADH dehydrogenase complex,CC,
7138,GO:0030970,1,0.137544335948391,0,25,retrograde protein transport, ER to cytosol,BP,
7145,GO:0030990,1,0.0903846510180375,0,30,intraciliary transport particle,CC,
7146,GO:0030991,1,0.518200737915373,0,8,intraciliary transport particle A,CC,
7147,GO:0030992,1,0.221526936221189,0,19,intraciliary transport particle B,CC,
7151,GO:0031010,1,0.450346010317492,0,10,ISWI-type complex,CC,
7166,GO:0031045,1,0.622046661789567,0,6,dense core granule,CC,
7173,GO:0031054,1,0.348817326932077,0,13,pre-miRNA processing,BP,
7179,GO:0031061,1,0.273623903318585,0,16,negative regulation of histone methylation,BP,
7189,GO:0031077,1,0.581937043929857,0,7,post-embryonic camera-type eye development,BP,
7191,GO:0031080,1,0.44901149914683,0,10,nuclear pore outer ring,CC,
7213,GO:0031105,1,0.47731403481714,0,9,septin complex,CC,
7214,GO:0031106,1,0.373249245818549,0,12,septin ring organization,BP,
7221,GO:0031115,1,0.480531699879187,0,9,negative regulation of microtubule polymerization,BP,
7230,GO:0031125,1,0.426376249981224,0,12,rRNA 3'-end processing,BP,
7241,GO:0031163,1,0.22608643946209,0,20,metallo-sulfur cluster assembly,BP,
7251,GO:0031209,1,0.518173385837962,0,8,SCAR complex,CC,
7253,GO:0031211,1,0.526108859595993,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7256,GO:0031223,1,0.61076682278482,0,6,auditory behavior,BP,
7262,GO:0031229,1,0.518989634178272,0,8,intrinsic component of nuclear inner membrane,CC,
7265,GO:0031233,1,0.389079677810518,0,12,intrinsic component of external side of plasma membrane,CC,
7267,GO:0031235,1,0.404913567954336,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7280,GO:0031264,1,0.483404954588989,0,9,death-inducing signaling complex,CC,
7281,GO:0031265,1,0.613860954015805,0,6,CD95 death-inducing signaling complex,CC,
7287,GO:0031279,1,0.217296102906972,0,19,regulation of cyclase activity,BP,
7288,GO:0031280,1,0.572855236715401,0,7,negative regulation of cyclase activity,BP,
7289,GO:0031281,1,0.447390448788711,0,10,positive regulation of cyclase activity,BP,
7293,GO:0031290,1,0.317497506501565,0,14,retinal ganglion cell axon guidance,BP,
7310,GO:0031313,1,0.568297001753759,0,7,extrinsic component of endosome membrane,CC,
7323,GO:0031332,1,0.408244766988272,0,11,RNAi effector complex,CC,
7330,GO:0031340,1,0.619554535980677,0,6,positive regulation of vesicle fusion,BP,
7340,GO:0031362,1,0.489618514631493,0,9,anchored component of external side of plasma membrane,CC,
7344,GO:0031371,1,0.52695731062838,0,8,ubiquitin conjugating enzyme complex,CC,
7348,GO:0031386,1,0.427934177703881,0,12,protein tag,MF,
7350,GO:0031390,1,0.527266536441726,0,8,Ctf18 RFC-like complex,CC,
7360,GO:0031402,1,0.519562321441426,0,8,sodium ion binding,MF,
7367,GO:0031414,1,0.496384267468953,0,9,N-terminal protein acetyltransferase complex,CC,
7372,GO:0031419,1,0.619139129287843,0,6,cobalamin binding,MF,
7373,GO:0031420,1,0.344414581002233,0,13,alkali metal ion binding,MF,
7380,GO:0031432,1,0.569061575256249,0,7,titin binding,MF,
7390,GO:0031442,1,0.479840171993171,0,9,positive regulation of mRNA 3'-end processing,BP,
7401,GO:0031464,1,0.386110466790803,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7446,GO:0031580,1,0.623796518660195,0,6,membrane raft distribution,BP,
7452,GO:0031588,1,0.479549363762673,0,9,nucleotide-activated protein kinase complex,CC,
7471,GO:0031629,1,0.452079531672135,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7505,GO:0031683,1,0.38308803035545,0,12,G-protein beta/gamma-subunit complex binding,MF,
7516,GO:0031701,1,0.519839674432298,0,8,angiotensin receptor binding,MF,
7517,GO:0031702,1,0.563957685621216,0,7,type 1 angiotensin receptor binding,MF,
7543,GO:0031821,1,0.616438216138653,0,6,G-protein coupled serotonin receptor binding,MF,
7574,GO:0031936,1,0.519221566151043,0,8,negative regulation of chromatin silencing,BP,
7575,GO:0031937,1,0.520945224721831,0,8,positive regulation of chromatin silencing,BP,
7589,GO:0031957,1,0.563111897000179,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7623,GO:0032020,1,0.642090952719616,0,6,ISG15-protein conjugation,BP,
7626,GO:0032025,1,0.447389510011294,0,10,response to cobalt ion,BP,
7627,GO:0032026,1,0.477277277118111,0,9,response to magnesium ion,BP,
7632,GO:0032039,1,0.345206902176605,0,13,integrator complex,CC,
7637,GO:0032045,1,0.525416661371154,0,8,guanyl-nucleotide exchange factor complex,CC,
7638,GO:0032048,1,0.321964422377436,0,14,cardiolipin metabolic process,BP,
7639,GO:0032049,1,0.520970651005968,0,8,cardiolipin biosynthetic process,BP,
7645,GO:0032056,1,0.612670786098175,0,6,positive regulation of translation in response to stress,BP,
7650,GO:0032069,1,0.100305359848524,0,29,regulation of nuclease activity,BP,
7651,GO:0032070,1,0.497378308130103,0,9,regulation of deoxyribonuclease activity,BP,
7652,GO:0032071,1,0.580299988816877,0,7,regulation of endodeoxyribonuclease activity,BP,
7654,GO:0032074,1,0.612325181328016,0,6,negative regulation of nuclease activity,BP,
7655,GO:0032075,1,0.285737902686866,0,16,positive regulation of nuclease activity,BP,
7666,GO:0032095,1,0.537784723490433,0,8,regulation of response to food,BP,
7667,GO:0032096,1,0.632104156664799,0,6,negative regulation of response to food,BP,
7669,GO:0032098,1,0.537784723490433,0,8,regulation of appetite,BP,
7670,GO:0032099,1,0.632104156664799,0,6,negative regulation of appetite,BP,
7682,GO:0032119,1,0.552682416654072,0,8,sequestering of zinc ion,BP,
7686,GO:0032135,1,0.617037784594958,0,6,DNA insertion or deletion binding,MF,
7699,GO:0032156,1,0.439638859224188,0,10,septin cytoskeleton,CC,
7700,GO:0032160,1,0.47731403481714,0,9,septin filament array,CC,
7706,GO:0032185,1,0.34378052378698,0,13,septin cytoskeleton organization,BP,
7709,GO:0032196,1,0.32386231484688,0,14,transposition,BP,
7730,GO:0032225,1,0.420982211805332,0,11,regulation of synaptic transmission, dopaminergic,BP,
7742,GO:0032241,1,0.563274668112444,0,7,positive regulation of nucleobase-containing compound transport,BP,
7747,GO:0032261,1,0.587421778962483,0,7,purine nucleotide salvage,BP,
7765,GO:0032281,1,0.448055837840577,0,10,AMPA glutamate receptor complex,CC,
7767,GO:0032287,1,0.527744838131677,0,8,peripheral nervous system myelin maintenance,BP,
7776,GO:0032300,1,0.372995791675001,0,12,mismatch repair complex,CC,
7787,GO:0032324,1,0.570636171173389,0,7,molybdopterin cofactor biosynthetic process,BP,
7788,GO:0032328,1,0.610848199674936,0,6,alanine transport,BP,
7792,GO:0032332,1,0.37312759076916,0,12,positive regulation of chondrocyte differentiation,BP,
7807,GO:0032356,1,0.45202328037979,0,10,oxidized DNA binding,MF,
7808,GO:0032357,1,0.490207961490364,0,9,oxidized purine DNA binding,MF,
7813,GO:0032366,1,0.258248426546397,0,17,intracellular sterol transport,BP,
7814,GO:0032367,1,0.258248426546397,0,17,intracellular cholesterol transport,BP,
7824,GO:0032377,1,0.575340330529621,0,7,regulation of intracellular lipid transport,BP,
7827,GO:0032380,1,0.575340330529621,0,7,regulation of intracellular sterol transport,BP,
7830,GO:0032383,1,0.575340330529621,0,7,regulation of intracellular cholesterol transport,BP,
7836,GO:0032389,1,0.562645283332442,0,7,MutLalpha complex,CC,
7837,GO:0032391,1,0.145590310818122,0,24,photoreceptor connecting cilium,CC,
7846,GO:0032404,1,0.527850902194349,0,8,mismatch repair complex binding,MF,
7860,GO:0032420,1,0.146295338796591,0,24,stereocilium,CC,
7861,GO:0032421,1,0.105915770181311,0,28,stereocilium bundle,CC,
7865,GO:0032426,1,0.5651886450122,0,7,stereocilium tip,CC,
7885,GO:0032452,1,0.127954953412956,0,25,histone demethylase activity,MF,
7886,GO:0032453,1,0.61076682278482,0,6,histone demethylase activity (H3-K4 specific),MF,
7887,GO:0032454,1,0.372937611986962,0,12,histone demethylase activity (H3-K9 specific),MF,
7896,GO:0032464,1,0.629236802483226,0,6,positive regulation of protein homooligomerization,BP,
7898,GO:0032466,1,0.620915543963534,0,6,negative regulation of cytokinesis,BP,
7903,GO:0032471,1,0.593658371585711,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7933,GO:0032510,1,0.612472246611916,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7937,GO:0032525,1,0.613526505407071,0,6,somite rostral/caudal axis specification,BP,
7940,GO:0032528,1,0.233871127677257,0,18,microvillus organization,BP,
7941,GO:0032530,1,0.479895042206278,0,9,regulation of microvillus organization,BP,
7943,GO:0032534,1,0.610766916089236,0,6,regulation of microvillus assembly,BP,
7979,GO:0032593,1,0.630025754667372,0,6,insulin-responsive compartment,CC,
7989,GO:0032607,1,0.168754741265778,0,22,interferon-alpha production,BP,
8000,GO:0032621,1,0.614108264044626,0,6,interleukin-18 production,BP,
8014,GO:0032647,1,0.181724550040083,0,21,regulation of interferon-alpha production,BP,
8036,GO:0032682,1,0.453469200246106,0,10,negative regulation of chemokine production,BP,
8055,GO:0032717,1,0.390574020518947,0,12,negative regulation of interleukin-8 production,BP,
8059,GO:0032727,1,0.270533755510147,0,16,positive regulation of interferon-alpha production,BP,
8067,GO:0032736,1,0.614370722762571,0,6,positive regulation of interleukin-13 production,BP,
8074,GO:0032753,1,0.448536635320348,0,10,positive regulation of interleukin-4 production,BP,
8075,GO:0032754,1,0.611429365494546,0,6,positive regulation of interleukin-5 production,BP,
8095,GO:0032780,1,0.529814558484841,0,8,negative regulation of ATPase activity,BP,
8105,GO:0032790,1,0.528218821777085,0,8,ribosome disassembly,BP,
8107,GO:0032793,1,0.440443064352891,0,10,positive regulation of CREB transcription factor activity,BP,
8120,GO:0032806,1,0.134341767196867,0,25,carboxy-terminal domain protein kinase complex,CC,
8123,GO:0032809,1,0.562705000937173,0,7,neuronal cell body membrane,CC,
8149,GO:0032875,1,0.562570381877626,0,7,regulation of DNA endoreduplication,BP,
8152,GO:0032878,1,0.193336206408479,0,20,regulation of establishment or maintenance of cell polarity,BP,
8169,GO:0032905,1,0.612791890658385,0,6,transforming growth factor beta1 production,BP,
8172,GO:0032908,1,0.612791890658385,0,6,regulation of transforming growth factor beta1 production,BP,
8189,GO:0032927,1,0.621879325961603,0,6,positive regulation of activin receptor signaling pathway,BP,
8192,GO:0032930,1,0.551769805140185,0,8,positive regulation of superoxide anion generation,BP,
8194,GO:0032934,1,0.0738313533923509,0,33,sterol binding,MF,
8197,GO:0032941,1,0.263522565782494,0,17,secretion by tissue,BP,
8245,GO:0033015,1,0.640640437579279,0,6,tetrapyrrole catabolic process,BP,
8271,GO:0033061,1,0.486969755766606,0,9,DNA recombinase mediator complex,CC,
8272,GO:0033063,1,0.573993795208183,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8299,GO:0033129,1,0.524125298053845,0,8,positive regulation of histone phosphorylation,BP,
8300,GO:0033130,1,0.612333504748869,0,6,acetylcholine receptor binding,MF,
8301,GO:0033131,1,0.636962252993282,0,6,regulation of glucokinase activity,BP,
8318,GO:0033151,1,0.38027633113385,0,12,V(D)J recombination,BP,
8328,GO:0033169,1,0.343509732983379,0,13,histone H3-K9 demethylation,BP,
8329,GO:0033170,1,0.527266536441726,0,8,protein-DNA loading ATPase activity,MF,
8331,GO:0033176,1,0.220676483661479,0,20,proton-transporting V-type ATPase complex,CC,
8332,GO:0033177,1,0.51046090162606,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8333,GO:0033178,1,0.468305753006201,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8334,GO:0033179,1,0.549135212284917,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8335,GO:0033180,1,0.545373634732269,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8337,GO:0033182,1,0.440243424345144,0,10,regulation of histone ubiquitination,BP,
8352,GO:0033210,1,0.563226530220324,0,7,leptin-mediated signaling pathway,BP,
8360,GO:0033235,1,0.454147869102835,0,10,positive regulation of protein sumoylation,BP,
8363,GO:0033240,1,0.581386413063252,0,7,positive regulation of cellular amine metabolic process,BP,
8369,GO:0033262,1,0.378217196104272,0,12,regulation of nuclear cell cycle DNA replication,BP,
8379,GO:0033276,1,0.333314658549409,0,14,transcription factor TFTC complex,CC,
8430,GO:0033523,1,0.377273760135487,0,12,histone H2B ubiquitination,BP,
8432,GO:0033539,1,0.3857374202867,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8438,GO:0033555,1,0.0788687716497384,0,32,multicellular organismal response to stress,BP,
8489,GO:0033643,1,0.479369757557405,0,9,host cell part,CC,
8491,GO:0033646,1,0.565037164029862,0,7,host intracellular part,CC,
8518,GO:0033700,1,0.638898701439287,0,6,phospholipid efflux,BP,
8571,GO:0034036,1,0.612568059897104,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8576,GO:0034045,1,0.270782186056889,0,16,phagophore assembly site membrane,CC,
8584,GO:0034063,1,0.343809756432044,0,13,stress granule assembly,BP,
8589,GO:0034086,1,0.386498100059216,0,12,maintenance of sister chromatid cohesion,BP,
8591,GO:0034088,1,0.386498100059216,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8592,GO:0034091,1,0.536729238615728,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8596,GO:0034098,1,0.482629697370567,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8625,GO:0034141,1,0.61485041348282,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8642,GO:0034182,1,0.536729238615728,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8645,GO:0034185,1,0.376799665829831,0,12,apolipoprotein binding,MF,
8654,GO:0034199,1,0.439775096038791,0,10,activation of protein kinase A activity,BP,
8657,GO:0034204,1,0.291389241050845,0,15,lipid translocation,BP,
8667,GO:0034236,1,0.411546123450454,0,11,protein kinase A catalytic subunit binding,MF,
8690,GO:0034310,1,0.575628494428063,0,7,primary alcohol catabolic process,BP,
8694,GO:0034315,1,0.318106940745254,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8714,GO:0034356,1,0.375551138524066,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8716,GO:0034361,1,0.598490053875166,0,7,very-low-density lipoprotein particle,CC,
8717,GO:0034362,1,0.63170205118895,0,6,low-density lipoprotein particle,CC,
8723,GO:0034368,1,0.508406325315541,0,9,protein-lipid complex remodeling,BP,
8724,GO:0034369,1,0.508406325315541,0,9,plasma lipoprotein particle remodeling,BP,
8729,GO:0034375,1,0.550079464228289,0,8,high-density lipoprotein particle remodeling,BP,
8730,GO:0034377,1,0.284491180288851,0,16,plasma lipoprotein particle assembly,BP,
8732,GO:0034379,1,0.6316160047958,0,6,very-low-density lipoprotein particle assembly,BP,
8733,GO:0034380,1,0.489211227648333,0,9,high-density lipoprotein particle assembly,BP,
8737,GO:0034384,1,0.623288294411436,0,6,high-density lipoprotein particle clearance,BP,
8738,GO:0034385,1,0.598490053875166,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8748,GO:0034397,1,0.477355948948061,0,9,telomere localization,BP,
8760,GO:0034427,1,0.478918936201487,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8763,GO:0034433,1,0.594653532758122,0,7,steroid esterification,BP,
8764,GO:0034434,1,0.594653532758122,0,7,sterol esterification,BP,
8765,GO:0034435,1,0.594653532758122,0,7,cholesterol esterification,BP,
8774,GO:0034451,1,0.16572572697721,0,22,centriolar satellite,CC,
8775,GO:0034452,1,0.440146815616522,0,10,dynactin binding,MF,
8785,GO:0034464,1,0.482298984620846,0,9,BBSome,CC,
8792,GO:0034475,1,0.564506182236666,0,8,U4 snRNA 3'-end processing,BP,
8798,GO:0034497,1,0.375194057218721,0,12,protein localization to phagophore assembly site,BP,
8804,GO:0034505,1,0.375759445807663,0,12,tooth mineralization,BP,
8811,GO:0034518,1,0.388909243573834,0,12,RNA cap binding complex,CC,
8817,GO:0034587,1,0.518197188640189,0,8,piRNA metabolic process,BP,
8820,GO:0034593,1,0.151003653327139,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8822,GO:0034595,1,0.343716585899039,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8823,GO:0034596,1,0.518173385837962,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8846,GO:0034638,1,0.639963902709628,0,6,phosphatidylcholine catabolic process,BP,
8861,GO:0034656,1,0.0656630955348454,0,35,nucleobase-containing small molecule catabolic process,BP,
8865,GO:0034663,1,0.495794250814231,0,9,endoplasmic reticulum chaperone complex,CC,
8889,GO:0034704,1,0.159227067090833,0,23,calcium channel complex,CC,
8891,GO:0034706,1,0.518173385837962,0,8,sodium channel complex,CC,
8892,GO:0034707,1,0.387073420246349,0,12,chloride channel complex,CC,
8894,GO:0034709,1,0.433984106815835,0,12,methylosome,CC,
8898,GO:0034715,1,0.659138453313828,0,6,pICln-Sm protein complex,CC,
8901,GO:0034720,1,0.61076682278482,0,6,histone H3-K4 demethylation,BP,
8927,GO:0034770,1,0.478625268487902,0,9,histone H4-K20 methylation,BP,
8928,GO:0034773,1,0.612492238230878,0,6,histone H4-K20 trimethylation,BP,
8938,GO:0034969,1,0.443958305589946,0,10,histone arginine methylation,BP,
8941,GO:0034975,1,0.317126756941698,0,14,protein folding in endoplasmic reticulum,BP,
8944,GO:0034982,1,0.461924173200403,0,10,mitochondrial protein processing,BP,
8954,GO:0035005,1,0.61076682278482,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8955,GO:0035014,1,0.61076682278482,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
8957,GO:0035020,1,0.299116717722529,0,15,regulation of Rac protein signal transduction,BP,
8961,GO:0035024,1,0.249874537867762,0,17,negative regulation of Rho protein signal transduction,BP,
8964,GO:0035032,1,0.612914949636617,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8979,GO:0035068,1,0.481215349277239,0,9,micro-ribonucleoprotein complex,CC,
8983,GO:0035089,1,0.345219796556015,0,13,establishment of apical/basal cell polarity,BP,
8991,GO:0035098,1,0.269995421630983,0,16,ESC/E(Z) complex,CC,
9011,GO:0035174,1,0.621456597157354,0,6,histone serine kinase activity,MF,
9020,GO:0035197,1,0.482162953380252,0,9,siRNA binding,MF,
9026,GO:0035235,1,0.481947578984027,0,9,ionotropic glutamate receptor signaling pathway,BP,
9030,GO:0035242,1,0.568043852819347,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9032,GO:0035246,1,0.409016970936304,0,11,peptidyl-arginine N-methylation,BP,
9033,GO:0035247,1,0.482003234549969,0,9,peptidyl-arginine omega-N-methylation,BP,
9037,GO:0035251,1,0.575275150194669,0,7,UDP-glucosyltransferase activity,MF,
9038,GO:0035252,1,0.614863212989783,0,6,UDP-xylosyltransferase activity,MF,
9039,GO:0035253,1,0.48079603250068,0,9,ciliary rootlet,CC,
9042,GO:0035256,1,0.616942003879171,0,6,G-protein coupled glutamate receptor binding,MF,
9058,GO:0035280,1,0.567212204188643,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9075,GO:0035315,1,0.133309070452359,0,25,hair cell differentiation,BP,
9115,GO:0035404,1,0.486157950554244,0,9,histone-serine phosphorylation,BP,
9124,GO:0035434,1,0.632244784697645,0,6,copper ion transmembrane transport,BP,
9125,GO:0035435,1,0.520117108080588,0,8,phosphate ion transmembrane transport,BP,
9146,GO:0035493,1,0.320951470691046,0,14,SNARE complex assembly,BP,
9167,GO:0035520,1,0.477290779142964,0,9,monoubiquitinated protein deubiquitination,BP,
9177,GO:0035542,1,0.563779827377195,0,7,regulation of SNARE complex assembly,BP,
9185,GO:0035561,1,0.180535806448635,0,21,regulation of chromatin binding,BP,
9186,GO:0035562,1,0.518173898186806,0,8,negative regulation of chromatin binding,BP,
9187,GO:0035563,1,0.378557700574678,0,12,positive regulation of chromatin binding,BP,
9204,GO:0035586,1,0.570114460655946,0,7,purinergic receptor activity,MF,
9205,GO:0035587,1,0.448913189828813,0,10,purinergic receptor signaling pathway,BP,
9206,GO:0035588,1,0.52831894149972,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9208,GO:0035590,1,0.568602741065739,0,7,purinergic nucleotide receptor signaling pathway,BP,
9226,GO:0035612,1,0.518560789726418,0,8,AP-2 adaptor complex binding,MF,
9229,GO:0035615,1,0.414928798697763,0,11,clathrin adaptor activity,MF,
9238,GO:0035627,1,0.61487594698922,0,6,ceramide transport,BP,
9247,GO:0035640,1,0.384451145956071,0,12,exploration behavior,BP,
9248,GO:0035641,1,0.577577229407496,0,7,locomotory exploration behavior,BP,
9264,GO:0035672,1,0.613798812708472,0,6,oligopeptide transmembrane transport,BP,
9284,GO:0035721,1,0.395566887762584,0,12,intraciliary retrograde transport,BP,
9303,GO:0035748,1,0.611429365494546,0,6,myelin sheath abaxonal region,CC,
9315,GO:0035773,1,0.043997165434607,0,40,insulin secretion involved in cellular response to glucose stimulus,BP,
9316,GO:0035774,1,0.22395804674108,0,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9343,GO:0035845,1,0.572852457544483,0,7,photoreceptor cell outer segment organization,BP,
9348,GO:0035859,1,0.348705734477326,0,13,Seh1-associated complex,CC,
9353,GO:0035864,1,0.625359770907862,0,6,response to potassium ion,BP,
9368,GO:0035883,1,0.254492987336584,0,17,enteroendocrine cell differentiation,BP,
9375,GO:0035900,1,0.639132277027227,0,6,response to isolation stress,BP,
9406,GO:0035964,1,0.617110929071167,0,6,COPI-coated vesicle budding,BP,
9437,GO:0036010,1,0.227940918300166,0,18,protein localization to endosome,BP,
9452,GO:0036041,1,0.657129423755901,0,6,long-chain fatty acid binding,MF,
9467,GO:0036075,1,0.252806869666778,0,17,replacement ossification,BP,
9470,GO:0036089,1,0.570786833288173,0,7,cleavage furrow formation,BP,
9489,GO:0036124,1,0.32165739822774,0,14,histone H3-K9 trimethylation,BP,
9501,GO:0036148,1,0.405883544795781,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9510,GO:0036158,1,0.631116807239521,0,6,outer dynein arm assembly,BP,
9538,GO:0036289,1,0.613332734049168,0,6,peptidyl-serine autophosphorylation,BP,
9543,GO:0036295,1,0.353317730358806,0,13,cellular response to increased oxygen levels,BP,
9550,GO:0036310,1,0.522829893401822,0,8,annealing helicase activity,MF,
9551,GO:0036312,1,0.477335296500514,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9567,GO:0036353,1,0.529123705974312,0,8,histone H2A-K119 monoubiquitination,BP,
9575,GO:0036376,1,0.565712551343271,0,7,sodium ion export across plasma membrane,BP,
9591,GO:0036442,1,0.186012937461563,0,22,proton-exporting ATPase activity,MF,
9592,GO:0036444,1,0.518173385837962,0,8,calcium import into the mitochondrion,BP,
9606,GO:0036465,1,0.0489898360369028,0,37,synaptic vesicle recycling,BP,
9617,GO:0036481,1,0.630361500445821,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9624,GO:0036490,1,0.519788982489792,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
9625,GO:0036491,1,0.564324251660789,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9626,GO:0036492,1,0.612507833035484,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9633,GO:0036500,1,0.450963266618004,0,10,ATF6-mediated unfolded protein response,BP,
9675,GO:0038036,1,0.612627885367314,0,6,sphingosine-1-phosphate receptor activity,MF,
9720,GO:0038155,1,0.622096088760121,0,6,interleukin-23-mediated signaling pathway,BP,
9734,GO:0038187,1,0.572073938515777,0,7,pattern recognition receptor activity,MF,
9766,GO:0039530,1,0.48755190039084,0,9,MDA-5 signaling pathway,BP,
9768,GO:0039532,1,0.446752058001606,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9769,GO:0039533,1,0.619215894044121,0,6,regulation of MDA-5 signaling pathway,BP,
9772,GO:0039536,1,0.570950859036794,0,7,negative regulation of RIG-I signaling pathway,BP,
9799,GO:0040018,1,0.217018230455955,0,19,positive regulation of multicellular organism growth,BP,
9807,GO:0040034,1,0.573922472390786,0,7,regulation of development, heterochronic,BP,
9818,GO:0042023,1,0.518173385837962,0,8,DNA endoreduplication,BP,
9826,GO:0042043,1,0.478754169708511,0,9,neurexin family protein binding,MF,
9830,GO:0042053,1,0.452237140080532,0,10,regulation of dopamine metabolic process,BP,
9837,GO:0042069,1,0.452237140080532,0,10,regulation of catecholamine metabolic process,BP,
9856,GO:0042104,1,0.297024619121686,0,16,positive regulation of activated T cell proliferation,BP,
9865,GO:0042118,1,0.519820889429269,0,8,endothelial cell activation,BP,
9874,GO:0042135,1,0.408663708904077,0,11,neurotransmitter catabolic process,BP,
9881,GO:0042148,1,0.528696197620054,0,8,strand invasion,BP,
9885,GO:0042159,1,0.382556031905348,0,12,lipoprotein catabolic process,BP,
9887,GO:0042165,1,0.232398278050322,0,18,neurotransmitter binding,MF,
9889,GO:0042167,1,0.640640437579279,0,6,heme catabolic process,BP,
9901,GO:0042219,1,0.258462988819765,0,17,cellular modified amino acid catabolic process,BP,
9906,GO:0042226,1,0.445862599224941,0,10,interleukin-6 biosynthetic process,BP,
9930,GO:0042276,1,0.231464664252502,0,19,error-prone translesion synthesis,BP,
9936,GO:0042285,1,0.614863212989783,0,6,xylosyltransferase activity,MF,
9943,GO:0042301,1,0.61178312529799,0,6,phosphate ion binding,MF,
9963,GO:0042340,1,0.564284202811309,0,7,keratan sulfate catabolic process,BP,
9967,GO:0042354,1,0.61076682278482,0,6,L-fucose metabolic process,BP,
9968,GO:0042355,1,0.61076682278482,0,6,L-fucose catabolic process,BP,
9976,GO:0042364,1,0.522798456274608,0,8,water-soluble vitamin biosynthetic process,BP,
9993,GO:0042402,1,0.468492626850239,0,10,cellular biogenic amine catabolic process,BP,
9994,GO:0042403,1,0.440769688678132,0,10,thyroid hormone metabolic process,BP,
10000,GO:0042415,1,0.569060911034495,0,7,norepinephrine metabolic process,BP,
10010,GO:0042430,1,0.526769776026551,0,8,indole-containing compound metabolic process,BP,
10012,GO:0042438,1,0.532104360413972,0,8,melanin biosynthetic process,BP,
10021,GO:0042451,1,0.227336099345423,0,20,purine nucleoside biosynthetic process,BP,
10022,GO:0042454,1,0.338785098256071,0,14,ribonucleoside catabolic process,BP,
10024,GO:0042461,1,0.23308160754287,0,18,photoreceptor cell development,BP,
10025,GO:0042462,1,0.374999116770695,0,12,eye photoreceptor cell development,BP,
10029,GO:0042473,1,0.618626100334731,0,6,outer ear morphogenesis,BP,
10039,GO:0042491,1,0.200877865334057,0,20,inner ear auditory receptor cell differentiation,BP,
10062,GO:0042551,1,0.120907887007147,0,26,neuron maturation,BP,
10078,GO:0042577,1,0.562979653673459,0,7,lipid phosphatase activity,MF,
10088,GO:0042588,1,0.485735427678075,0,9,zymogen granule,CC,
10089,GO:0042589,1,0.571001344352055,0,7,zymogen granule membrane,CC,
10095,GO:0042596,1,0.241772065362785,0,18,fear response,BP,
10108,GO:0042625,1,0.064126108342777,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10125,GO:0042659,1,0.564499915391866,0,7,regulation of cell fate specification,BP,
10135,GO:0042693,1,0.617207646023033,0,6,muscle cell fate commitment,BP,
10149,GO:0042726,1,0.567131884818745,0,7,flavin-containing compound metabolic process,BP,
10161,GO:0042744,1,0.407828781973374,0,12,hydrogen peroxide catabolic process,BP,
10167,GO:0042753,1,0.612095745863824,0,6,positive regulation of circadian rhythm,BP,
10172,GO:0042759,1,0.493859637018133,0,9,long-chain fatty acid biosynthetic process,BP,
10174,GO:0042761,1,0.449029350588948,0,10,very long-chain fatty acid biosynthetic process,BP,
10175,GO:0042762,1,0.293696054603851,0,15,regulation of sulfur metabolic process,BP,
10191,GO:0042790,1,0.380577982599703,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10194,GO:0042796,1,0.614293871379461,0,6,snRNA transcription by RNA polymerase III,BP,
10202,GO:0042809,1,0.299709260987433,0,15,vitamin D receptor binding,MF,
10212,GO:0042827,1,0.419157582772408,0,11,platelet dense granule,CC,
10213,GO:0042832,1,0.495224204897347,0,9,defense response to protozoan,BP,
10214,GO:0042834,1,0.576258240616856,0,7,peptidoglycan binding,MF,
10223,GO:0042891,1,0.567456009849251,0,7,antibiotic transport,BP,
10224,GO:0042895,1,0.616070554091693,0,6,antibiotic transmembrane transporter activity,MF,
10240,GO:0042953,1,0.61688888412842,0,6,lipoprotein transport,BP,
10243,GO:0042975,1,0.48048123488359,0,9,peroxisome proliferator activated receptor binding,MF,
10255,GO:0042989,1,0.667942017161372,0,6,sequestering of actin monomers,BP,
10272,GO:0043014,1,0.156854891379863,0,23,alpha-tubulin binding,MF,
10279,GO:0043023,1,0.427635892456063,0,11,ribosomal large subunit binding,MF,
10297,GO:0043046,1,0.563348867526298,0,7,DNA methylation involved in gamete generation,BP,
10298,GO:0043047,1,0.408281884110494,0,11,single-stranded telomeric DNA binding,MF,
10307,GO:0043073,1,0.3825226980998,0,12,germ cell nucleus,CC,
10318,GO:0043101,1,0.365960895512553,0,13,purine-containing compound salvage,BP,
10319,GO:0043102,1,0.623148383504926,0,6,amino acid salvage,BP,
10344,GO:0043140,1,0.562570381877626,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10346,GO:0043142,1,0.349743095882282,0,13,single-stranded DNA-dependent ATPase activity,MF,
10360,GO:0043173,1,0.338737424625187,0,14,nucleotide salvage,BP,
10365,GO:0043178,1,0.0226924479009957,0,48,alcohol binding,MF,
10371,GO:0043186,1,0.578787731128041,0,7,P granule,CC,
10374,GO:0043194,1,0.484555743005988,0,9,axon initial segment,CC,
10381,GO:0043201,1,0.440405572671737,0,10,response to leucine,BP,
10383,GO:0043203,1,0.625223733484462,0,6,axon hillock,CC,
10388,GO:0043217,1,0.379828727121851,0,12,myelin maintenance,BP,
10389,GO:0043218,1,0.383507699949612,0,12,compact myelin,CC,
10391,GO:0043220,1,0.485215463974622,0,9,Schmidt-Lanterman incisure,CC,
10394,GO:0043225,1,0.518173385837962,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10411,GO:0043248,1,0.414941489862328,0,12,proteasome assembly,BP,
10472,GO:0043353,1,0.568703443145339,0,7,enucleate erythrocyte differentiation,BP,
10481,GO:0043373,1,0.572984149062644,0,7,CD4-positive, alpha-beta T cell lineage commitment,BP,
10515,GO:0043422,1,0.447497898662723,0,10,protein kinase B binding,MF,
10524,GO:0043455,1,0.566240862586863,0,7,regulation of secondary metabolic process,BP,
10526,GO:0043457,1,0.281024590416731,0,16,regulation of cellular respiration,BP,
10561,GO:0043517,1,0.426531017561118,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10582,GO:0043545,1,0.570636171173389,0,7,molybdopterin cofactor metabolic process,BP,
10583,GO:0043546,1,0.61098696813542,0,6,molybdopterin cofactor binding,MF,
10592,GO:0043558,1,0.324372888578861,0,14,regulation of translational initiation in response to stress,BP,
10594,GO:0043560,1,0.440081438566924,0,10,insulin receptor substrate binding,MF,
10595,GO:0043562,1,0.473188212748946,0,10,cellular response to nitrogen levels,BP,
10602,GO:0043574,1,0.232070845156077,0,18,peroxisomal transport,BP,
10603,GO:0043576,1,0.345422432020515,0,13,regulation of respiratory gaseous exchange,BP,
10606,GO:0043584,1,0.443454094553438,0,10,nose development,BP,
10623,GO:0043619,1,0.482519501134855,0,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10636,GO:0043633,1,0.541160565845904,0,8,polyadenylation-dependent RNA catabolic process,BP,
10637,GO:0043634,1,0.587524909120064,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10640,GO:0043649,1,0.360459197560882,0,13,dicarboxylic acid catabolic process,BP,
10641,GO:0043650,1,0.518805584651935,0,8,dicarboxylic acid biosynthetic process,BP,
10644,GO:0043653,1,0.553850742057684,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10646,GO:0043656,1,0.565037164029862,0,7,intracellular region of host,CC,
10653,GO:0043691,1,0.530397492382024,0,8,reverse cholesterol transport,BP,
10687,GO:0043951,1,0.487468292943378,0,9,negative regulation of cAMP-mediated signaling,BP,
10693,GO:0043970,1,0.380192240729866,0,12,histone H3-K9 acetylation,BP,
10697,GO:0043981,1,0.294981322221852,0,15,histone H4-K5 acetylation,BP,
10698,GO:0043982,1,0.294981322221852,0,15,histone H4-K8 acetylation,BP,
10699,GO:0043983,1,0.567847605862205,0,7,histone H4-K12 acetylation,BP,
10700,GO:0043984,1,0.212893225404485,0,19,histone H4-K16 acetylation,BP,
10701,GO:0043985,1,0.616308558319053,0,6,histone H4-R3 methylation,BP,
10706,GO:0043995,1,0.440884441025122,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10707,GO:0043996,1,0.440884441025122,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10717,GO:0044033,1,0.617112760448924,0,6,multi-organism metabolic process,BP,
10727,GO:0044065,1,0.521082048727932,0,8,regulation of respiratory system process,BP,
10734,GO:0044090,1,0.37550584651948,0,12,positive regulation of vacuole organization,BP,
10756,GO:0044154,1,0.564317815264328,0,7,histone H3-K14 acetylation,BP,
10768,GO:0044213,1,0.445592714575676,0,10,intronic transcription regulatory region DNA binding,MF,
10776,GO:0044224,1,0.612072937781579,0,6,juxtaparanode region of axon,CC,
10799,GO:0044273,1,0.0831580703221006,0,31,sulfur compound catabolic process,BP,
10807,GO:0044292,1,0.449802944347028,0,10,dendrite terminus,CC,
10808,GO:0044294,1,0.56266364732845,0,7,dendritic growth cone,CC,
10811,GO:0044298,1,0.562705000937173,0,7,cell body membrane,CC,
10827,GO:0044320,1,0.44011861669689,0,10,cellular response to leptin stimulus,BP,
10838,GO:0044331,1,0.351010918160357,0,13,cell-cell adhesion mediated by cadherin,BP,
10853,GO:0044351,1,0.623155417657604,0,6,macropinocytosis,BP,
10858,GO:0044359,1,0.626210226578698,0,6,modulation of molecular function in other organism,BP,
10902,GO:0044447,1,0.279152158508071,0,16,axoneme part,CC,
10908,GO:0044453,1,0.518989634178272,0,8,nuclear membrane part,CC,
10922,GO:0044531,1,0.626885473514716,0,6,modulation of programmed cell death in other organism,BP,
10923,GO:0044532,1,0.626885473514716,0,6,modulation of apoptotic process in other organism,BP,
10928,GO:0044546,1,0.478299298145119,0,9,NLRP3 inflammasome complex assembly,BP,
10930,GO:0044548,1,0.433839260494586,0,11,S100 protein binding,MF,
10932,GO:0044550,1,0.328752180638184,0,14,secondary metabolite biosynthetic process,BP,
10978,GO:0044769,1,0.257035276088016,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11001,GO:0044804,1,0.233614520315686,0,18,autophagy of nucleus,BP,
11003,GO:0044806,1,0.562576391749487,0,7,G-quadruplex DNA unwinding,BP,
11027,GO:0044872,1,0.61688888412842,0,6,lipoprotein localization,BP,
11030,GO:0045002,1,0.563918765225082,0,7,double-strand break repair via single-strand annealing,BP,
11031,GO:0045003,1,0.448536609473163,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11034,GO:0045006,1,0.476122810543795,0,10,DNA deamination,BP,
11045,GO:0045026,1,0.28800021797317,0,16,plasma membrane fusion,BP,
11050,GO:0045039,1,0.660087474074162,0,6,protein import into mitochondrial inner membrane,BP,
11051,GO:0045040,1,0.652758092537684,0,6,protein import into mitochondrial outer membrane,BP,
11053,GO:0045046,1,0.612604792951986,0,6,protein import into peroxisome membrane,BP,
11059,GO:0045056,1,0.321617794860273,0,14,transcytosis,BP,
11066,GO:0045064,1,0.451717767411008,0,10,T-helper 2 cell differentiation,BP,
11108,GO:0045125,1,0.444450089529083,0,10,bioactive lipid receptor activity,MF,
11116,GO:0045141,1,0.518259510553147,0,8,meiotic telomere clustering,BP,
11124,GO:0045161,1,0.520208918209782,0,8,neuronal ion channel clustering,BP,
11132,GO:0045176,1,0.480646805279905,0,9,apical protein localization,BP,
11148,GO:0045198,1,0.441813112418149,0,10,establishment of epithelial cell apical/basal polarity,BP,
11171,GO:0045239,1,0.350079060816399,0,13,tricarboxylic acid cycle enzyme complex,CC,
11172,GO:0045240,1,0.411092088478833,0,11,dihydrolipoyl dehydrogenase complex,CC,
11175,GO:0045252,1,0.56847081103669,0,7,oxoglutarate dehydrogenase complex,CC,
11176,GO:0045254,1,0.566721541534847,0,7,pyruvate dehydrogenase complex,CC,
11180,GO:0045271,1,0.0711771098195729,0,42,respiratory chain complex I,CC,
11192,GO:0045295,1,0.477276614787127,0,9,gamma-catenin binding,MF,
11202,GO:0045332,1,0.316371674812912,0,14,phospholipid translocation,BP,
11217,GO:0045350,1,0.618947724765992,0,6,interferon-beta biosynthetic process,BP,
11218,GO:0045351,1,0.529004232112143,0,8,type I interferon biosynthetic process,BP,
11224,GO:0045357,1,0.618947724765992,0,6,regulation of interferon-beta biosynthetic process,BP,
11235,GO:0045408,1,0.484070538343848,0,9,regulation of interleukin-6 biosynthetic process,BP,
11237,GO:0045410,1,0.617543139934783,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11253,GO:0045475,1,0.523274782406973,0,8,locomotor rhythm,BP,
11255,GO:0045494,1,0.19591170936027,0,20,photoreceptor cell maintenance,BP,
11256,GO:0045495,1,0.578787731128041,0,7,pole plasm,CC,
11260,GO:0045505,1,0.19806066177237,0,21,dynein intermediate chain binding,MF,
11293,GO:0045603,1,0.520040601673603,0,8,positive regulation of endothelial cell differentiation,BP,
11307,GO:0045624,1,0.458817883934108,0,10,positive regulation of T-helper cell differentiation,BP,
11311,GO:0045628,1,0.530967973504291,0,8,regulation of T-helper 2 cell differentiation,BP,
11330,GO:0045653,1,0.409734216277387,0,17,negative regulation of megakaryocyte differentiation,BP,
11354,GO:0045686,1,0.355022888990008,0,13,negative regulation of glial cell differentiation,BP,
11362,GO:0045721,1,0.563905953517951,0,7,negative regulation of gluconeogenesis,BP,
11363,GO:0045722,1,0.479496721717205,0,9,positive regulation of gluconeogenesis,BP,
11364,GO:0045723,1,0.486176785077586,0,9,positive regulation of fatty acid biosynthetic process,BP,
11365,GO:0045724,1,0.235895364281289,0,18,positive regulation of cilium assembly,BP,
11369,GO:0045730,1,0.341596570183335,0,14,respiratory burst,BP,
11385,GO:0045760,1,0.611406825054959,0,6,positive regulation of action potential,BP,
11386,GO:0045761,1,0.412307754441222,0,11,regulation of adenylate cyclase activity,BP,
11402,GO:0045792,1,0.564833890288099,0,7,negative regulation of cell size,BP,
11413,GO:0045820,1,0.616465850874686,0,6,negative regulation of glycolytic process,BP,
11414,GO:0045821,1,0.440229465489185,0,10,positive regulation of glycolytic process,BP,
11424,GO:0045837,1,0.536423512091356,0,8,negative regulation of membrane potential,BP,
11425,GO:0045838,1,0.456254165844078,0,10,positive regulation of membrane potential,BP,
11429,GO:0045842,1,0.535751472423488,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11438,GO:0045869,1,0.571120780189239,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11443,GO:0045879,1,0.194131661065028,0,20,negative regulation of smoothened signaling pathway,BP,
11458,GO:0045912,1,0.155152312839264,0,23,negative regulation of carbohydrate metabolic process,BP,
11466,GO:0045920,1,0.232534886314544,0,18,negative regulation of exocytosis,BP,
11486,GO:0045945,1,0.442155827543225,0,10,positive regulation of transcription by RNA polymerase III,BP,
11490,GO:0045953,1,0.529691737258464,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11492,GO:0045955,1,0.56421962706268,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11493,GO:0045956,1,0.416618605273339,0,11,positive regulation of calcium ion-dependent exocytosis,BP,
11516,GO:0046030,1,0.405651009578829,0,11,inositol trisphosphate phosphatase activity,MF,
11519,GO:0046033,1,0.454448209121422,0,10,AMP metabolic process,BP,
11525,GO:0046039,1,0.124154098322352,0,27,GTP metabolic process,BP,
11526,GO:0046040,1,0.380450094939576,0,12,IMP metabolic process,BP,
11529,GO:0046049,1,0.487327636537373,0,9,UMP metabolic process,BP,
11530,GO:0046051,1,0.526034649919317,0,9,UTP metabolic process,BP,
11540,GO:0046068,1,0.154237061255434,0,23,cGMP metabolic process,BP,
11552,GO:0046085,1,0.615829518954648,0,6,adenosine metabolic process,BP,
11554,GO:0046087,1,0.636810158942809,0,6,cytidine metabolic process,BP,
11567,GO:0046112,1,0.219207686943368,0,19,nucleobase biosynthetic process,BP,
11576,GO:0046129,1,0.227336099345423,0,20,purine ribonucleoside biosynthetic process,BP,
11577,GO:0046130,1,0.625186931272951,0,6,purine ribonucleoside catabolic process,BP,
11580,GO:0046133,1,0.542064238166256,0,8,pyrimidine ribonucleoside catabolic process,BP,
11582,GO:0046135,1,0.368028761111212,0,13,pyrimidine nucleoside catabolic process,BP,
11587,GO:0046149,1,0.640640437579279,0,6,pigment catabolic process,BP,
11589,GO:0046164,1,0.090426048213125,0,30,alcohol catabolic process,BP,
11595,GO:0046174,1,0.23381613182747,0,18,polyol catabolic process,BP,
11599,GO:0046185,1,0.491926114292322,0,9,aldehyde catabolic process,BP,
11632,GO:0046337,1,0.319205797550791,0,14,phosphatidylethanolamine metabolic process,BP,
11634,GO:0046339,1,0.380055457372114,0,12,diacylglycerol metabolic process,BP,
11636,GO:0046341,1,0.319943978548794,0,14,CDP-diacylglycerol metabolic process,BP,
11637,GO:0046348,1,0.527865687370428,0,8,amino sugar catabolic process,BP,
11677,GO:0046459,1,0.359767857547762,0,13,short-chain fatty acid metabolic process,BP,
11678,GO:0046460,1,0.113743023086798,0,27,neutral lipid biosynthetic process,BP,
11679,GO:0046461,1,0.28078202620725,0,16,neutral lipid catabolic process,BP,
11681,GO:0046463,1,0.113743023086798,0,27,acylglycerol biosynthetic process,BP,
11682,GO:0046464,1,0.28078202620725,0,16,acylglycerol catabolic process,BP,
11683,GO:0046465,1,0.566125650049706,0,7,dolichyl diphosphate metabolic process,BP,
11688,GO:0046471,1,0.130535340648061,0,25,phosphatidylglycerol metabolic process,BP,
11689,GO:0046473,1,0.0791940314093743,0,31,phosphatidic acid metabolic process,BP,
11693,GO:0046477,1,0.616251680306868,0,6,glycosylceramide catabolic process,BP,
11695,GO:0046479,1,0.445234902441217,0,10,glycosphingolipid catabolic process,BP,
11697,GO:0046485,1,0.574558482933687,0,7,ether lipid metabolic process,BP,
11699,GO:0046487,1,0.621106879434135,0,6,glyoxylate metabolic process,BP,
11707,GO:0046498,1,0.632727184644055,0,6,S-adenosylhomocysteine metabolic process,BP,
11710,GO:0046501,1,0.492481764139223,0,9,protoporphyrinogen IX metabolic process,BP,
11715,GO:0046512,1,0.535323173608425,0,8,sphingosine biosynthetic process,BP,
11717,GO:0046514,1,0.421254653842151,0,11,ceramide catabolic process,BP,
11718,GO:0046519,1,0.39031894160985,0,12,sphingoid metabolic process,BP,
11719,GO:0046520,1,0.493074236558587,0,9,sphingoid biosynthetic process,BP,
11724,GO:0046527,1,0.325308239911894,0,14,glucosyltransferase activity,MF,
11725,GO:0046530,1,0.102430871334402,0,28,photoreceptor cell differentiation,BP,
11732,GO:0046543,1,0.57477508437696,0,7,development of secondary female sexual characteristics,BP,
11750,GO:0046596,1,0.258164895650423,0,18,regulation of viral entry into host cell,BP,
11751,GO:0046597,1,0.405517172739793,0,12,negative regulation of viral entry into host cell,BP,
11752,GO:0046598,1,0.636918750747281,0,6,positive regulation of viral entry into host cell,BP,
11756,GO:0046602,1,0.529304274783657,0,8,regulation of mitotic centrosome separation,BP,
11760,GO:0046607,1,0.487389888795654,0,9,positive regulation of centrosome cycle,BP,
11767,GO:0046624,1,0.614571754440845,0,6,sphingolipid transporter activity,MF,
11814,GO:0046703,1,0.530818866974225,0,9,natural killer cell lectin-like receptor binding,MF,
11825,GO:0046719,1,0.578556067276147,0,7,regulation by virus of viral protein levels in host cell,BP,
11848,GO:0046826,1,0.59936198592428,0,7,negative regulation of protein export from nucleus,BP,
11852,GO:0046833,1,0.563274668112444,0,7,positive regulation of RNA export from nucleus,BP,
11856,GO:0046838,1,0.443384924390415,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11857,GO:0046839,1,0.0921687991239545,0,29,phospholipid dephosphorylation,BP,
11865,GO:0046855,1,0.443384924390415,0,10,inositol phosphate dephosphorylation,BP,
11866,GO:0046856,1,0.177962395052074,0,21,phosphatidylinositol dephosphorylation,BP,
11902,GO:0046929,1,0.520513598322682,0,8,negative regulation of neurotransmitter secretion,BP,
11915,GO:0046950,1,0.567434665014014,0,7,cellular ketone body metabolic process,BP,
11916,GO:0046951,1,0.616047382603501,0,6,ketone body biosynthetic process,BP,
11919,GO:0046961,1,0.257035276088016,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11928,GO:0046972,1,0.440884441025122,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11930,GO:0046975,1,0.614731600584182,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11994,GO:0047372,1,0.521487254909397,0,8,acylglycerol lipase activity,MF,
12001,GO:0047429,1,0.506858133255977,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12005,GO:0047484,1,0.62014787986202,0,6,regulation of response to osmotic stress,BP,
12010,GO:0047498,1,0.610793798291059,0,6,calcium-dependent phospholipase A2 activity,MF,
12064,GO:0048012,1,0.410192226296958,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12079,GO:0048027,1,0.199966020234508,0,22,mRNA 5'-UTR binding,MF,
12085,GO:0048038,1,0.349627017106033,0,14,quinone binding,MF,
12086,GO:0048039,1,0.632116537558215,0,6,ubiquinone binding,MF,
12098,GO:0048096,1,0.527590746192968,0,8,chromatin-mediated maintenance of transcription,BP,
12104,GO:0048143,1,0.523487067239823,0,8,astrocyte activation,BP,
12111,GO:0048156,1,0.411599796207157,0,11,tau protein binding,MF,
12116,GO:0048168,1,0.095781945196522,0,29,regulation of neuronal synaptic plasticity,BP,
12117,GO:0048169,1,0.253771940366863,0,17,regulation of long-term neuronal synaptic plasticity,BP,
12119,GO:0048172,1,0.617066891162789,0,6,regulation of short-term neuronal synaptic plasticity,BP,
12127,GO:0048200,1,0.617110929071167,0,6,Golgi transport vesicle coating,BP,
12129,GO:0048205,1,0.617110929071167,0,6,COPI coating of Golgi vesicle,BP,
12136,GO:0048227,1,0.533603161845832,0,8,plasma membrane to endosome transport,BP,
12147,GO:0048251,1,0.519227241667576,0,8,elastic fiber assembly,BP,
12158,GO:0048265,1,0.531863272930088,0,8,response to pain,BP,
12163,GO:0048273,1,0.616446912216237,0,6,mitogen-activated protein kinase p38 binding,MF,
12164,GO:0048278,1,0.0111499865169339,0,56,vesicle docking,BP,
12165,GO:0048280,1,0.45122425602894,0,10,vesicle fusion with Golgi apparatus,BP,
12182,GO:0048308,1,0.30061365510856,0,15,organelle inheritance,BP,
12185,GO:0048313,1,0.326386075578333,0,14,Golgi inheritance,BP,
12192,GO:0048339,1,0.316872706264855,0,14,paraxial mesoderm development,BP,
12193,GO:0048340,1,0.562570381877626,0,7,paraxial mesoderm morphogenesis,BP,
12230,GO:0048487,1,0.0831649520645778,0,32,beta-tubulin binding,MF,
12231,GO:0048488,1,0.0942808410655571,0,29,synaptic vesicle endocytosis,BP,
12237,GO:0048500,1,0.505036225151055,0,9,signal recognition particle,CC,
12238,GO:0048505,1,0.61630329981369,0,6,regulation of timing of cell differentiation,BP,
12252,GO:0048531,1,0.350626805922578,0,13,beta-1,3-galactosyltransferase activity,MF,
12253,GO:0048532,1,0.442258641256667,0,10,anatomical structure arrangement,BP,
12257,GO:0048537,1,0.623144944120836,0,6,mucosal-associated lymphoid tissue development,BP,
12260,GO:0048541,1,0.623144944120836,0,6,Peyer's patch development,BP,
12305,GO:0048643,1,0.319508874650757,0,14,positive regulation of skeletal muscle tissue development,BP,
12315,GO:0048665,1,0.565684183074627,0,7,neuron fate specification,BP,
12318,GO:0048668,1,0.259375022573422,0,17,collateral sprouting,BP,
12320,GO:0048670,1,0.391326788204482,0,12,regulation of collateral sprouting,BP,
12322,GO:0048672,1,0.500661249253923,0,9,positive regulation of collateral sprouting,BP,
12327,GO:0048679,1,0.23774015194531,0,18,regulation of axon regeneration,BP,
12329,GO:0048681,1,0.415108636316804,0,11,negative regulation of axon regeneration,BP,
12341,GO:0048702,1,0.56269487068085,0,7,embryonic neurocranium morphogenesis,BP,
12342,GO:0048703,1,0.566404607497208,0,7,embryonic viscerocranium morphogenesis,BP,
12353,GO:0048715,1,0.492007809622053,0,9,negative regulation of oligodendrocyte differentiation,BP,
12361,GO:0048739,1,0.613046797295551,0,6,cardiac muscle fiber development,BP,
12384,GO:0048791,1,0.23029392924292,0,18,calcium ion-regulated exocytosis of neurotransmitter,BP,
12401,GO:0048842,1,0.610837274244507,0,6,positive regulation of axon extension involved in axon guidance,BP,
12408,GO:0048853,1,0.565579984480783,0,7,forebrain morphogenesis,BP,
12425,GO:0048873,1,0.223855298977682,0,19,homeostasis of number of cells within a tissue,BP,
12427,GO:0048875,1,0.56846278613858,0,7,chemical homeostasis within a tissue,BP,
12438,GO:0050072,1,0.573821032203832,0,7,m7G(5')pppN diphosphatase activity,MF,
12445,GO:0050136,1,0.0942898131579347,0,38,NADH dehydrogenase (quinone) activity,MF,
12467,GO:0050321,1,0.411646679887866,0,11,tau-protein kinase activity,MF,
12479,GO:0050428,1,0.612568059897104,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12508,GO:0050651,1,0.447584097271513,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12512,GO:0050655,1,0.41257453639599,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12521,GO:0050664,1,0.627452627004057,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12524,GO:0050667,1,0.410210840777817,0,11,homocysteine metabolic process,BP,
12538,GO:0050687,1,0.184055742453493,0,21,negative regulation of defense response to virus,BP,
12541,GO:0050690,1,0.18920515072735,0,21,regulation of defense response to virus by virus,BP,
12548,GO:0050700,1,0.425860613299806,0,11,CARD domain binding,MF,
12589,GO:0050765,1,0.487729393845902,0,9,negative regulation of phagocytosis,BP,
12604,GO:0050780,1,0.44259156165373,0,10,dopamine receptor binding,MF,
12626,GO:0050811,1,0.498741264016935,0,9,GABA receptor binding,MF,
12627,GO:0050812,1,0.375690673765535,0,12,regulation of acyl-CoA biosynthetic process,BP,
12628,GO:0050815,1,0.624018398245286,0,6,phosphoserine residue binding,MF,
12639,GO:0050832,1,0.356941476646698,0,14,defense response to fungus,BP,
12643,GO:0050847,1,0.565553639598688,0,7,progesterone receptor signaling pathway,BP,
12672,GO:0050879,1,0.122298107873163,0,27,multicellular organismal movement,BP,
12674,GO:0050881,1,0.122298107873163,0,27,musculoskeletal movement,BP,
12675,GO:0050882,1,0.611452695181564,0,6,voluntary musculoskeletal movement,BP,
12689,GO:0050906,1,0.134003923133489,0,26,detection of stimulus involved in sensory perception,BP,
12690,GO:0050907,1,0.4840197446957,0,10,detection of chemical stimulus involved in sensory perception,BP,
12692,GO:0050909,1,0.395658185353281,0,12,sensory perception of taste,BP,
12695,GO:0050912,1,0.647188856159315,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12696,GO:0050913,1,0.596796971833352,0,7,sensory perception of bitter taste,BP,
12716,GO:0050951,1,0.528974796369644,0,8,sensory perception of temperature stimulus,BP,
12722,GO:0050961,1,0.574296237740619,0,7,detection of temperature stimulus involved in sensory perception,BP,
12724,GO:0050965,1,0.574296237740619,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12728,GO:0050982,1,0.373644566149543,0,12,detection of mechanical stimulus,BP,
12735,GO:0050998,1,0.41076228447807,0,11,nitric-oxide synthase binding,MF,
12739,GO:0051004,1,0.458644799337878,0,10,regulation of lipoprotein lipase activity,BP,
12743,GO:0051011,1,0.439604389862749,0,10,microtubule minus-end binding,MF,
12745,GO:0051013,1,0.615052576234754,0,6,microtubule severing,BP,
12748,GO:0051016,1,0.379865452413235,0,12,barbed-end actin filament capping,BP,
12751,GO:0051019,1,0.120562383065785,0,26,mitogen-activated protein kinase binding,MF,
12760,GO:0051029,1,0.646550548962987,0,6,rRNA transport,BP,
12770,GO:0051045,1,0.576754678717928,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12802,GO:0051096,1,0.627406150521241,0,6,positive regulation of helicase activity,BP,
12819,GO:0051124,1,0.61076682278482,0,6,synaptic growth at neuromuscular junction,BP,
12820,GO:0051125,1,0.165611284710054,0,22,regulation of actin nucleation,BP,
12821,GO:0051126,1,0.61630180560045,0,6,negative regulation of actin nucleation,BP,
12822,GO:0051127,1,0.37293816138531,0,12,positive regulation of actin nucleation,BP,
12864,GO:0051185,1,0.611543620462041,0,6,coenzyme transmembrane transporter activity,MF,
12866,GO:0051187,1,0.0699280294687772,0,35,cofactor catabolic process,BP,
12868,GO:0051189,1,0.570636171173389,0,7,prosthetic group metabolic process,BP,
12871,GO:0051194,1,0.344534517129776,0,13,positive regulation of cofactor metabolic process,BP,
12872,GO:0051195,1,0.481981650417563,0,9,negative regulation of cofactor metabolic process,BP,
12874,GO:0051197,1,0.440229465489185,0,10,positive regulation of coenzyme metabolic process,BP,
12875,GO:0051198,1,0.616465850874686,0,6,negative regulation of coenzyme metabolic process,BP,
12925,GO:0051280,1,0.469141308188803,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12929,GO:0051284,1,0.469141308188803,0,10,positive regulation of sequestering of calcium ion,BP,
12948,GO:0051307,1,0.37703595580082,0,12,meiotic chromosome separation,BP,
12957,GO:0051339,1,0.204210597957382,0,20,regulation of lyase activity,BP,
12960,GO:0051342,1,0.625416851521941,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12967,GO:0051349,1,0.489445975243498,0,9,positive regulation of lyase activity,BP,
12968,GO:0051350,1,0.492136893104273,0,9,negative regulation of lyase activity,BP,
12969,GO:0051351,1,0.576249024823879,0,7,positive regulation of ligase activity,BP,
12983,GO:0051386,1,0.563347053658298,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
12998,GO:0051415,1,0.61076682278482,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13000,GO:0051418,1,0.518173385837962,0,8,microtubule nucleation by microtubule organizing center,BP,
13003,GO:0051428,1,0.455352386668224,0,10,peptide hormone receptor binding,MF,
13015,GO:0051450,1,0.53262168862378,0,8,myoblast proliferation,BP,
13044,GO:0051503,1,0.380914820957182,0,12,adenine nucleotide transport,BP,
13060,GO:0051560,1,0.236416957792773,0,18,mitochondrial calcium ion homeostasis,BP,
13061,GO:0051561,1,0.495625891295951,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13064,GO:0051567,1,0.122587920168401,0,26,histone H3-K9 methylation,BP,
13067,GO:0051570,1,0.257100888561714,0,17,regulation of histone H3-K9 methylation,BP,
13070,GO:0051573,1,0.485245727949769,0,9,negative regulation of histone H3-K9 methylation,BP,
13071,GO:0051574,1,0.575518617202984,0,7,positive regulation of histone H3-K9 methylation,BP,
13073,GO:0051580,1,0.494281231402969,0,9,regulation of neurotransmitter uptake,BP,
13076,GO:0051583,1,0.643631057765833,0,6,dopamine uptake involved in synaptic transmission,BP,
13081,GO:0051589,1,0.350152943747059,0,13,negative regulation of neurotransmitter transport,BP,
13088,GO:0051597,1,0.615797652016779,0,6,response to methylmercury,BP,
13091,GO:0051601,1,0.566456068604515,0,7,exocyst localization,BP,
13124,GO:0051665,1,0.574572943178892,0,7,membrane raft localization,BP,
13129,GO:0051683,1,0.57092532533107,0,7,establishment of Golgi localization,BP,
13143,GO:0051709,1,0.591803850332349,0,7,regulation of killing of cells of other organism,BP,
13145,GO:0051712,1,0.591803850332349,0,7,positive regulation of killing of cells of other organism,BP,
13177,GO:0051782,1,0.328799539534703,0,14,negative regulation of cell division,BP,
13185,GO:0051791,1,0.573774622936897,0,7,medium-chain fatty acid metabolic process,BP,
13200,GO:0051818,1,0.634987827490908,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13212,GO:0051864,1,0.518173385837962,0,8,histone demethylase activity (H3-K36 specific),MF,
13220,GO:0051880,1,0.562570381877626,0,7,G-quadruplex DNA binding,MF,
13223,GO:0051883,1,0.634987827490908,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13247,GO:0051920,1,0.576653483954398,0,8,peroxiredoxin activity,MF,
13256,GO:0051934,1,0.643631057765833,0,6,catecholamine uptake involved in synaptic transmission,BP,
13259,GO:0051938,1,0.61175393141387,0,6,L-glutamate import,BP,
13268,GO:0051955,1,0.352037927576179,0,13,regulation of amino acid transport,BP,
13270,GO:0051957,1,0.620172151234558,0,6,positive regulation of amino acid transport,BP,
13296,GO:0051998,1,0.571182561376185,0,7,protein carboxyl O-methyltransferase activity,MF,
13301,GO:0052040,1,0.626885473514716,0,6,modulation by symbiont of host programmed cell death,BP,
13317,GO:0052173,1,0.618877735398493,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13322,GO:0052200,1,0.618877735398493,0,6,response to host defenses,BP,
13325,GO:0052205,1,0.626210226578698,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13330,GO:0052248,1,0.626885473514716,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13354,GO:0052433,1,0.626885473514716,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13378,GO:0052629,1,0.405032452215789,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13380,GO:0052646,1,0.519884837348179,0,8,alditol phosphate metabolic process,BP,
13381,GO:0052650,1,0.576589069329402,0,7,NADP-retinol dehydrogenase activity,MF,
13388,GO:0052658,1,0.611140200848957,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13389,GO:0052659,1,0.477568461924307,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13406,GO:0052743,1,0.405150357194315,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13407,GO:0052744,1,0.316473065175935,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13408,GO:0052745,1,0.211608330079458,0,19,inositol phosphate phosphatase activity,MF,
13447,GO:0052866,1,0.117955857862162,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13499,GO:0055064,1,0.481338862982886,0,9,chloride ion homeostasis,BP,
13502,GO:0055069,1,0.2092284102709,0,21,zinc ion homeostasis,BP,
13503,GO:0055070,1,0.304099797789895,0,16,copper ion homeostasis,BP,
13506,GO:0055075,1,0.31813979670008,0,14,potassium ion homeostasis,BP,
13518,GO:0055089,1,0.412248122830947,0,11,fatty acid homeostasis,BP,
13519,GO:0055090,1,0.335590245791506,0,14,acylglycerol homeostasis,BP,
13527,GO:0055102,1,0.549218337935072,0,8,lipase inhibitor activity,MF,
13529,GO:0055105,1,0.674354196156095,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13536,GO:0055119,1,0.414894153428368,0,11,relaxation of cardiac muscle,BP,
13556,GO:0060019,1,0.496037171861019,0,9,radial glial cell differentiation,BP,
13557,GO:0060020,1,0.613039028541075,0,6,Bergmann glial cell differentiation,BP,
13569,GO:0060033,1,0.617735317101239,0,6,anatomical structure regression,BP,
13604,GO:0060074,1,0.479581052210194,0,9,synapse maturation,BP,
13607,GO:0060077,1,0.479401316022432,0,9,inhibitory synapse,CC,
13610,GO:0060080,1,0.61076682278482,0,6,inhibitory postsynaptic potential,BP,
13611,GO:0060081,1,0.58312566378371,0,7,membrane hyperpolarization,BP,
13624,GO:0060117,1,0.413102750533119,0,11,auditory receptor cell development,BP,
13685,GO:0060219,1,0.610912962345671,0,6,camera-type eye photoreceptor cell differentiation,BP,
13693,GO:0060242,1,0.577810794115894,0,7,contact inhibition,BP,
13701,GO:0060253,1,0.494650371020769,0,9,negative regulation of glial cell proliferation,BP,
13703,GO:0060259,1,0.575088323493266,0,7,regulation of feeding behavior,BP,
13706,GO:0060263,1,0.542473485560133,0,8,regulation of respiratory burst,BP,
13716,GO:0060281,1,0.612627725879612,0,6,regulation of oocyte development,BP,
13720,GO:0060285,1,0.317791785458931,0,14,cilium-dependent cell motility,BP,
13725,GO:0060293,1,0.578787731128041,0,7,germ plasm,CC,
13726,GO:0060294,1,0.520498130977761,0,8,cilium movement involved in cell motility,BP,
13740,GO:0060312,1,0.62568436966359,0,6,regulation of blood vessel remodeling,BP,
13743,GO:0060315,1,0.552567010534372,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13749,GO:0060323,1,0.0820991315112215,0,31,head morphogenesis,BP,
13751,GO:0060325,1,0.122665440323715,0,26,face morphogenesis,BP,
13797,GO:0060384,1,0.296753919953907,0,15,innervation,BP,
13839,GO:0060439,1,0.485310508601693,0,9,trachea morphogenesis,BP,
13840,GO:0060440,1,0.614634575805359,0,6,trachea formation,BP,
13863,GO:0060479,1,0.325596502650756,0,14,lung cell differentiation,BP,
13870,GO:0060487,1,0.353508246929448,0,13,lung epithelial cell differentiation,BP,
13988,GO:0060700,1,0.487306586100355,0,9,regulation of ribonuclease activity,BP,
14002,GO:0060717,1,0.564097904153933,0,7,chorion development,BP,
14038,GO:0060767,1,0.488900586353914,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14039,GO:0060768,1,0.530792292753676,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14041,GO:0060770,1,0.62563804224871,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14044,GO:0060788,1,0.447564930743503,0,10,ectodermal placode formation,BP,
14045,GO:0060789,1,0.621823012013952,0,6,hair follicle placode formation,BP,
14057,GO:0060831,1,0.343604192249215,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14059,GO:0060837,1,0.61291482896139,0,6,blood vessel endothelial cell differentiation,BP,
14070,GO:0060850,1,0.615002863913837,0,6,regulation of transcription involved in cell fate commitment,BP,
14072,GO:0060856,1,0.48032107861569,0,9,establishment of blood-brain barrier,BP,
14079,GO:0060896,1,0.522791154361004,0,8,neural plate pattern specification,BP,
14080,GO:0060897,1,0.616208810720022,0,6,neural plate regionalization,BP,
14086,GO:0060911,1,0.564656902632603,0,7,cardiac cell fate commitment,BP,
14089,GO:0060914,1,0.422449212850068,0,11,heart formation,BP,
14119,GO:0060977,1,0.442652380417336,0,10,coronary vasculature morphogenesis,BP,
14122,GO:0060982,1,0.56646994699618,0,7,coronary artery morphogenesis,BP,
14126,GO:0060992,1,0.40731685461344,0,11,response to fungicide,BP,
14176,GO:0061072,1,0.619000822588507,0,6,iris morphogenesis,BP,
14186,GO:0061085,1,0.478972514013719,0,9,regulation of histone H3-K27 methylation,BP,
14188,GO:0061087,1,0.611511940572322,0,6,positive regulation of histone H3-K27 methylation,BP,
14189,GO:0061088,1,0.612519324392902,0,6,regulation of sequestering of zinc ion,BP,
14223,GO:0061162,1,0.292853955475173,0,15,establishment of monopolar cell polarity,BP,
14225,GO:0061178,1,0.0608419786476874,0,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14226,GO:0061179,1,0.607385455658587,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14240,GO:0061213,1,0.327029960675607,0,14,positive regulation of mesonephros development,BP,
14242,GO:0061217,1,0.278802969944441,0,16,regulation of mesonephros development,BP,
14264,GO:0061323,1,0.419320163214393,0,11,cell proliferation involved in heart morphogenesis,BP,
14270,GO:0061339,1,0.292853955475173,0,15,establishment or maintenance of monopolar cell polarity,BP,
14313,GO:0061450,1,0.545681536711921,0,8,trophoblast cell migration,BP,
14345,GO:0061548,1,0.51826052223125,0,8,ganglion development,BP,
14346,GO:0061549,1,0.610837274244507,0,6,sympathetic ganglion development,BP,
14374,GO:0061608,1,0.491842148344808,0,9,nuclear import signal receptor activity,MF,
14398,GO:0061647,1,0.0542241628599605,0,36,histone H3-K9 modification,BP,
14405,GO:0061668,1,0.616847239606821,0,6,mitochondrial ribosome assembly,BP,
14408,GO:0061676,1,0.620476863951605,0,6,importin-alpha family protein binding,MF,
14411,GO:0061687,1,0.632580476812147,0,7,detoxification of inorganic compound,BP,
14417,GO:0061700,1,0.481976981887715,0,9,GATOR2 complex,CC,
14418,GO:0061702,1,0.589978598779502,0,7,inflammasome complex,CC,
14428,GO:0061732,1,0.614992733197757,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14454,GO:0061778,1,0.439641207343364,0,10,intracellular chloride channel activity,MF,
14464,GO:0061820,1,0.477276614787127,0,9,telomeric D-loop disassembly,BP,
14505,GO:0061983,1,0.622981784806721,0,6,meiosis II cell cycle process,BP,
14506,GO:0062009,1,0.522701727183463,0,8,secondary palate development,BP,
14514,GO:0065005,1,0.241423108602089,0,18,protein-lipid complex assembly,BP,
14527,GO:0070016,1,0.439604389862749,0,10,armadillo repeat domain binding,MF,
14552,GO:0070070,1,0.522470081031286,0,8,proton-transporting V-type ATPase complex assembly,BP,
14553,GO:0070071,1,0.380577167530575,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14554,GO:0070072,1,0.522470081031286,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14555,GO:0070076,1,0.127963523287511,0,25,histone lysine demethylation,BP,
14587,GO:0070127,1,0.521870793498252,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14588,GO:0070129,1,0.237824536980525,0,18,regulation of mitochondrial translation,BP,
14590,GO:0070131,1,0.41631330964692,0,11,positive regulation of mitochondrial translation,BP,
14596,GO:0070142,1,0.611937339361113,0,6,synaptic vesicle budding,BP,
14607,GO:0070166,1,0.480886996043648,0,9,enamel mineralization,BP,
14609,GO:0070168,1,0.563772801384438,0,7,negative regulation of biomineral tissue development,BP,
14618,GO:0070181,1,0.576780499151101,0,8,small ribosomal subunit rRNA binding,MF,
14622,GO:0070187,1,0.613329071823532,0,6,shelterin complex,CC,
14626,GO:0070193,1,0.441150241060653,0,10,synaptonemal complex organization,BP,
14658,GO:0070254,1,0.548117327251242,0,8,mucus secretion,BP,
14659,GO:0070255,1,0.580990076272767,0,7,regulation of mucus secretion,BP,
14661,GO:0070257,1,0.626503038187405,0,6,positive regulation of mucus secretion,BP,
14669,GO:0070269,1,0.537142535210139,0,8,pyroptosis,BP,
14673,GO:0070279,1,0.0734216358938968,0,32,vitamin B6 binding,MF,
14676,GO:0070286,1,0.418399463805051,0,11,axonemal dynein complex assembly,BP,
14704,GO:0070328,1,0.335590245791506,0,14,triglyceride homeostasis,BP,
14731,GO:0070383,1,0.625217706991367,0,6,DNA cytosine deamination,BP,
14737,GO:0070403,1,0.381671926369091,0,12,NAD+ binding,MF,
14743,GO:0070410,1,0.566988724371467,0,7,co-SMAD binding,MF,
14770,GO:0070461,1,0.128732594884044,0,26,SAGA-type complex,CC,
14789,GO:0070493,1,0.565792261335156,0,7,thrombin-activated receptor signaling pathway,BP,
14799,GO:0070513,1,0.541245087761855,0,8,death domain binding,MF,
14815,GO:0070544,1,0.518173385837962,0,8,histone H3-K36 demethylation,BP,
14833,GO:0070570,1,0.201712542853103,0,20,regulation of neuron projection regeneration,BP,
14834,GO:0070571,1,0.352237326205632,0,13,negative regulation of neuron projection regeneration,BP,
14840,GO:0070578,1,0.484687880499455,0,9,RISC-loading complex,CC,
14849,GO:0070601,1,0.530535520029799,0,8,centromeric sister chromatid cohesion,BP,
14875,GO:0070652,1,0.534043141319325,0,8,HAUS complex,CC,
14891,GO:0070679,1,0.61076682278482,0,6,inositol 1,4,5 trisphosphate binding,MF,
14907,GO:0070728,1,0.611879567933581,0,6,leucine binding,MF,
14909,GO:0070734,1,0.245115341243994,0,18,histone H3-K27 methylation,BP,
14935,GO:0070816,1,0.298266091635867,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14956,GO:0070847,1,0.543106250825985,0,8,core mediator complex,CC,
14968,GO:0070863,1,0.52298168958038,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14996,GO:0070914,1,0.421366369422971,0,11,UV-damage excision repair,BP,
15000,GO:0070922,1,0.483138372419669,0,9,small RNA loading onto RISC,BP,
15007,GO:0070935,1,0.408006472758486,0,11,3'-UTR-mediated mRNA stabilization,BP,
15030,GO:0070971,1,0.29650179158469,0,15,endoplasmic reticulum exit site,CC,
15043,GO:0070987,1,0.246639830088826,0,18,error-free translesion synthesis,BP,
15065,GO:0071025,1,0.320308906085828,0,15,RNA surveillance,BP,
15067,GO:0071027,1,0.377534240193039,0,13,nuclear RNA surveillance,BP,
15068,GO:0071028,1,0.377534240193039,0,13,nuclear mRNA surveillance,BP,
15069,GO:0071029,1,0.637856873237194,0,6,nuclear ncRNA surveillance,BP,
15074,GO:0071035,1,0.637856873237194,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15078,GO:0071044,1,0.423434062981534,0,11,histone mRNA catabolic process,BP,
15080,GO:0071046,1,0.637856873237194,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15103,GO:0071141,1,0.562570381877626,0,7,SMAD protein complex,CC,
15118,GO:0071203,1,0.613474648875961,0,6,WASH complex,CC,
15119,GO:0071204,1,0.627127747216203,0,6,histone pre-mRNA 3'end processing complex,CC,
15140,GO:0071233,1,0.519117598961304,0,8,cellular response to leucine,BP,
15155,GO:0071265,1,0.576285396576469,0,7,L-methionine biosynthetic process,BP,
15157,GO:0071267,1,0.623148383504926,0,6,L-methionine salvage,BP,
15164,GO:0071281,1,0.578400211023481,0,7,cellular response to iron ion,BP,
15167,GO:0071285,1,0.527321422446418,0,8,cellular response to lithium ion,BP,
15169,GO:0071287,1,0.614923311667058,0,6,cellular response to manganese ion,BP,
15184,GO:0071318,1,0.384440626648835,0,12,cellular response to ATP,BP,
15198,GO:0071340,1,0.61433773244925,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15215,GO:0071361,1,0.518334491096576,0,8,cellular response to ethanol,BP,
15225,GO:0071377,1,0.172305974796431,0,22,cellular response to glucagon stimulus,BP,
15276,GO:0071455,1,0.612552630505886,0,6,cellular response to hyperoxia,BP,
15308,GO:0071498,1,0.254538522107243,0,17,cellular response to fluid shear stress,BP,
15309,GO:0071499,1,0.56748456103099,0,7,cellular response to laminar fluid shear stress,BP,
15317,GO:0071514,1,0.229705599389048,0,18,genetic imprinting,BP,
15323,GO:0071539,1,0.118655464891484,0,26,protein localization to centrosome,BP,
15329,GO:0071545,1,0.379927368376089,0,12,inositol phosphate catabolic process,BP,
15347,GO:0071569,1,0.628811654701545,0,6,protein ufmylation,BP,
15350,GO:0071578,1,0.612158711030837,0,6,zinc ion import across plasma membrane,BP,
15371,GO:0071609,1,0.52458033034514,0,8,chemokine (C-C motif) ligand 5 production,BP,
15383,GO:0071625,1,0.405218372889987,0,11,vocalization behavior,BP,
15389,GO:0071636,1,0.520142596733998,0,8,positive regulation of transforming growth factor beta production,BP,
15398,GO:0071649,1,0.566805955072804,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
15427,GO:0071696,1,0.412283077646723,0,11,ectodermal placode development,BP,
15428,GO:0071697,1,0.447564930743503,0,10,ectodermal placode morphogenesis,BP,
15472,GO:0071813,1,0.37814261682463,0,12,lipoprotein particle binding,MF,
15473,GO:0071814,1,0.37814261682463,0,12,protein-lipid complex binding,MF,
15481,GO:0071825,1,0.148563362868355,0,24,protein-lipid complex subunit organization,BP,
15483,GO:0071827,1,0.175081117002846,0,22,plasma lipoprotein particle organization,BP,
15497,GO:0071867,1,0.143547062956991,0,24,response to monoamine,BP,
15498,GO:0071868,1,0.155794513502509,0,23,cellular response to monoamine stimulus,BP,
15499,GO:0071869,1,0.143547062956991,0,24,response to catecholamine,BP,
15500,GO:0071870,1,0.155794513502509,0,23,cellular response to catecholamine stimulus,BP,
15501,GO:0071871,1,0.478798659697645,0,9,response to epinephrine,BP,
15502,GO:0071872,1,0.519594141964152,0,8,cellular response to epinephrine stimulus,BP,
15538,GO:0071933,1,0.564549138559422,0,7,Arp2/3 complex binding,MF,
15541,GO:0071941,1,0.415803605872098,0,11,nitrogen cycle metabolic process,BP,
15554,GO:0071986,1,0.610805597827604,0,6,Ragulator complex,CC,
15569,GO:0072017,1,0.562570381877626,0,7,distal tubule development,BP,
15580,GO:0072044,1,0.524751095079001,0,8,collecting duct development,BP,
15584,GO:0072050,1,0.624750227832854,0,6,S-shaped body morphogenesis,BP,
15669,GO:0072189,1,0.564597405998233,0,7,ureter development,BP,
15679,GO:0072201,1,0.61296731648086,0,6,negative regulation of mesenchymal cell proliferation,BP,
15721,GO:0072282,1,0.622507477366519,0,6,metanephric nephron tubule morphogenesis,BP,
15759,GO:0072349,1,0.477276614787127,0,9,modified amino acid transmembrane transporter activity,MF,
15777,GO:0072378,1,0.573363979263197,0,7,blood coagulation, fibrin clot formation,BP,
15789,GO:0072396,1,0.611112757077027,0,6,response to cell cycle checkpoint signaling,BP,
15791,GO:0072402,1,0.611112757077027,0,6,response to DNA integrity checkpoint signaling,BP,
15795,GO:0072423,1,0.611112757077027,0,6,response to DNA damage checkpoint signaling,BP,
15796,GO:0072425,1,0.405263150630844,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15805,GO:0072497,1,0.615326804664188,0,6,mesenchymal stem cell differentiation,BP,
15823,GO:0072523,1,0.0513928793081013,0,38,purine-containing compound catabolic process,BP,
15830,GO:0072530,1,0.520399289722093,0,8,purine-containing compound transmembrane transport,BP,
15831,GO:0072531,1,0.619331441432252,0,6,pyrimidine-containing compound transmembrane transport,BP,
15841,GO:0072546,1,0.439604389862749,0,10,ER membrane protein complex,CC,
15848,GO:0072559,1,0.640520535874219,0,6,NLRP3 inflammasome complex,CC,
15881,GO:0072606,1,0.340194097071576,0,14,interleukin-8 secretion,BP,
15888,GO:0072641,1,0.61076682278482,0,6,type I interferon secretion,BP,
15889,GO:0072642,1,0.61076682278482,0,6,interferon-alpha secretion,BP,
15897,GO:0072662,1,0.251972719380815,0,17,protein localization to peroxisome,BP,
15898,GO:0072663,1,0.251972719380815,0,17,establishment of protein localization to peroxisome,BP,
15901,GO:0072669,1,0.601341804163312,0,7,tRNA-splicing ligase complex,CC,
15919,GO:0072697,1,0.410172223840042,0,11,protein localization to cell cortex,BP,
15954,GO:0075136,1,0.618877735398493,0,6,response to host,BP,
15990,GO:0085020,1,0.586632745015035,0,7,protein K6-linked ubiquitination,BP,
16004,GO:0086012,1,0.413767218633178,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16024,GO:0086042,1,0.610846018519924,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16036,GO:0086064,1,0.277673545051643,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
16039,GO:0086067,1,0.610846018519924,0,6,AV node cell to bundle of His cell communication,BP,
16041,GO:0086069,1,0.487723770561158,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16050,GO:0086080,1,0.518240586891633,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16054,GO:0086091,1,0.247927810494579,0,17,regulation of heart rate by cardiac conduction,BP,
16059,GO:0086103,1,0.56822960561803,0,7,G-protein coupled receptor signaling pathway involved in heart process,BP,
16079,GO:0090037,1,0.614963312369646,0,6,positive regulation of protein kinase C signaling,BP,
16081,GO:0090042,1,0.487430160504441,0,9,tubulin deacetylation,BP,
16082,GO:0090043,1,0.573310286491006,0,7,regulation of tubulin deacetylation,BP,
16084,GO:0090045,1,0.619720280158549,0,6,positive regulation of deacetylase activity,BP,
16094,GO:0090070,1,0.533608779069824,0,8,positive regulation of ribosome biogenesis,BP,
16098,GO:0090075,1,0.281321085570762,0,16,relaxation of muscle,BP,
16120,GO:0090103,1,0.376262585586697,0,12,cochlea morphogenesis,BP,
16130,GO:0090128,1,0.613715030267516,0,6,regulation of synapse maturation,BP,
16138,GO:0090140,1,0.218564474821916,0,19,regulation of mitochondrial fission,BP,
16139,GO:0090141,1,0.357565194271057,0,13,positive regulation of mitochondrial fission,BP,
16143,GO:0090151,1,0.430793440269531,0,12,establishment of protein localization to mitochondrial membrane,BP,
16150,GO:0090161,1,0.405401479433691,0,11,Golgi ribbon formation,BP,
16153,GO:0090166,1,0.618218223710167,0,6,Golgi disassembly,BP,
16171,GO:0090189,1,0.35556273519958,0,13,regulation of branching involved in ureteric bud morphogenesis,BP,
16172,GO:0090190,1,0.417049937328828,0,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,
16177,GO:0090195,1,0.487311912923144,0,9,chemokine secretion,BP,
16178,GO:0090196,1,0.574397028318452,0,7,regulation of chemokine secretion,BP,
16179,GO:0090197,1,0.62360556582416,0,6,positive regulation of chemokine secretion,BP,
16186,GO:0090205,1,0.610822867922691,0,6,positive regulation of cholesterol metabolic process,BP,
16189,GO:0090208,1,0.408863025922131,0,11,positive regulation of triglyceride metabolic process,BP,
16196,GO:0090220,1,0.518259510553147,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16202,GO:0090232,1,0.525364522265388,0,8,positive regulation of spindle checkpoint,BP,
16208,GO:0090239,1,0.419427352984479,0,11,regulation of histone H4 acetylation,BP,
16209,GO:0090240,1,0.582599311974198,0,7,positive regulation of histone H4 acetylation,BP,
16224,GO:0090267,1,0.570376978420503,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16274,GO:0090335,1,0.523898899094745,0,8,regulation of brown fat cell differentiation,BP,
16280,GO:0090344,1,0.223588490175692,0,19,negative regulation of cell aging,BP,
16291,GO:0090383,1,0.201384329655608,0,21,phagosome acidification,BP,
16292,GO:0090385,1,0.624070333661517,0,6,phagosome-lysosome fusion,BP,
16309,GO:0090435,1,0.579446292625333,0,7,protein localization to nuclear envelope,BP,
16315,GO:0090493,1,0.643631057765833,0,6,catecholamine uptake,BP,
16316,GO:0090494,1,0.643631057765833,0,6,dopamine uptake,BP,
16324,GO:0090520,1,0.479398500914785,0,9,sphingolipid mediated signaling pathway,BP,
16328,GO:0090533,1,0.565712551343271,0,7,cation-transporting ATPase complex,CC,
16357,GO:0090647,1,0.619093801662269,0,6,modulation of age-related behavioral decline,BP,
16360,GO:0090656,1,0.29139764588635,0,15,t-circle formation,BP,
16361,GO:0090657,1,0.404914398010753,0,11,telomeric loop disassembly,BP,
16362,GO:0090659,1,0.350721136509718,0,13,walking behavior,BP,
16364,GO:0090662,1,0.200810399412265,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16386,GO:0090735,1,0.448536609473163,0,10,DNA repair complex assembly,BP,
16387,GO:0090737,1,0.29139764588635,0,15,telomere maintenance via telomere trimming,BP,
16390,GO:0095500,1,0.416846118012339,0,11,acetylcholine receptor signaling pathway,BP,
16391,GO:0097001,1,0.52323350928744,0,8,ceramide binding,MF,
16394,GO:0097009,1,0.358758746301766,0,13,energy homeostasis,BP,
16409,GO:0097035,1,0.122741947317548,0,26,regulation of membrane lipid distribution,BP,
16412,GO:0097038,1,0.453993038120488,0,10,perinuclear endoplasmic reticulum,CC,
16417,GO:0097050,1,0.520938156917462,0,8,type B pancreatic cell apoptotic process,BP,
16427,GO:0097062,1,0.348982197705587,0,13,dendritic spine maintenance,BP,
16446,GO:0097106,1,0.563903276895429,0,7,postsynaptic density organization,BP,
16459,GO:0097120,1,0.195254485651647,0,20,receptor localization to synapse,BP,
16471,GO:0097151,1,0.61076682278482,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16473,GO:0097153,1,0.404755715989571,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16493,GO:0097186,1,0.296452593710635,0,15,amelogenesis,BP,
16505,GO:0097200,1,0.430746112772144,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16507,GO:0097202,1,0.388863088783913,0,12,activation of cysteine-type endopeptidase activity,BP,
16543,GO:0097284,1,0.410882194968437,0,11,hepatocyte apoptotic process,BP,
16553,GO:0097320,1,0.320023238360677,0,14,plasma membrane tubulation,BP,
16554,GO:0097322,1,0.617243759282878,0,6,7SK snRNA binding,MF,
16562,GO:0097342,1,0.613819129046901,0,6,ripoptosome,CC,
16569,GO:0097354,1,0.484232925661961,0,9,prenylation,BP,
16586,GO:0097384,1,0.573514543662688,0,7,cellular lipid biosynthetic process,BP,
16587,GO:0097386,1,0.409604142909146,0,11,glial cell projection,CC,
16603,GO:0097428,1,0.493183535741113,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16604,GO:0097431,1,0.122827138405095,0,26,mitotic spindle pole,CC,
16613,GO:0097449,1,0.611003581065172,0,6,astrocyte projection,CC,
16622,GO:0097468,1,0.424768766820634,0,11,programmed cell death in response to reactive oxygen species,BP,
16640,GO:0097499,1,0.618038968138922,0,6,protein localization to non-motile cilium,BP,
16642,GO:0097501,1,0.632580476812147,0,7,stress response to metal ion,BP,
16664,GO:0097539,1,0.439604389862749,0,10,ciliary transition fiber,CC,
16668,GO:0097546,1,0.134571379718604,0,25,ciliary base,CC,
16680,GO:0097617,1,0.346610881364009,0,13,annealing activity,MF,
16706,GO:0097677,1,0.634524411585899,0,6,STAT family protein binding,MF,
16745,GO:0098505,1,0.443272841196507,0,10,G-rich strand telomeric DNA binding,MF,
16754,GO:0098532,1,0.655225540648045,0,6,histone H3-K27 trimethylation,BP,
16760,GO:0098543,1,0.57195974575464,0,7,detection of other organism,BP,
16769,GO:0098563,1,0.299960020238049,0,15,intrinsic component of synaptic vesicle membrane,CC,
16775,GO:0098581,1,0.526826147563255,0,8,detection of external biotic stimulus,BP,
16786,GO:0098599,1,0.446651305302141,0,10,palmitoyl hydrolase activity,MF,
16820,GO:0098693,1,0.0678545873789359,0,33,regulation of synaptic vesicle cycle,BP,
16823,GO:0098703,1,0.611568812204658,0,6,calcium ion import across plasma membrane,BP,
16827,GO:0098712,1,0.61175393141387,0,6,L-glutamate import across plasma membrane,BP,
16829,GO:0098719,1,0.47761703717408,0,9,sodium ion import across plasma membrane,BP,
16830,GO:0098722,1,0.571190715892228,0,7,asymmetric stem cell division,BP,
16835,GO:0098734,1,0.446651305302141,0,10,macromolecule depalmitoylation,BP,
16843,GO:0098748,1,0.414928798697763,0,11,endocytic adaptor activity,MF,
16857,GO:0098779,1,0.533543534461507,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16860,GO:0098787,1,0.318513520368719,0,14,mRNA cleavage involved in mRNA processing,BP,
16861,GO:0098789,1,0.407564025748645,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16863,GO:0098792,1,0.440800735170644,0,10,xenophagy,BP,
16878,GO:0098810,1,0.546060254481389,0,8,neurotransmitter reuptake,BP,
16887,GO:0098828,1,0.61076682278482,0,6,modulation of inhibitory postsynaptic potential,BP,
16895,GO:0098839,1,0.567739981117557,0,7,postsynaptic density membrane,CC,
16900,GO:0098845,1,0.613471239674082,0,6,postsynaptic endosome,CC,
16901,GO:0098847,1,0.348076882782107,0,13,sequence-specific single stranded DNA binding,MF,
16913,GO:0098877,1,0.440210008807357,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16914,GO:0098878,1,0.232037365970491,0,18,neurotransmitter receptor complex,CC,
16934,GO:0098911,1,0.477280977233272,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16960,GO:0098969,1,0.4779340761752,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16974,GO:0098993,1,0.532303957194043,0,8,anchored component of synaptic vesicle membrane,CC,
16986,GO:0099054,1,0.406681349470951,0,11,presynapse assembly,BP,
16990,GO:0099068,1,0.479372798972287,0,9,postsynapse assembly,BP,
16991,GO:0099072,1,0.271121201551485,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
17001,GO:0099084,1,0.563903276895429,0,7,postsynaptic specialization organization,BP,
17014,GO:0099131,1,0.200810399412265,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
17015,GO:0099132,1,0.0957181049232065,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
17016,GO:0099133,1,0.518173385837962,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17021,GO:0099172,1,0.35079695974431,0,13,presynapse organization,BP,
17033,GO:0099500,1,0.452079531672135,0,10,vesicle fusion to plasma membrane,BP,
17051,GO:0099528,1,0.485495084771526,0,9,G-protein coupled neurotransmitter receptor activity,MF,
17070,GO:0099563,1,0.37414559114487,0,12,modification of synaptic structure,BP,
17080,GO:0099590,1,0.616156740852571,0,6,neurotransmitter receptor internalization,BP,
17097,GO:0099632,1,0.347004084208413,0,13,protein transport within plasma membrane,BP,
17098,GO:0099634,1,0.567739981117557,0,7,postsynaptic specialization membrane,CC,
17099,GO:0099637,1,0.347004084208413,0,13,neurotransmitter receptor transport,BP,
17100,GO:0099638,1,0.610916140343455,0,6,endosome to plasma membrane protein transport,BP,
17101,GO:0099639,1,0.610916140343455,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17117,GO:0101031,1,0.410673346103641,0,11,chaperone complex,CC,
17161,GO:0102567,1,0.375328753568081,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17162,GO:0102568,1,0.375328753568081,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17190,GO:0106003,1,0.484888300516171,0,9,amyloid-beta complex,CC,
17196,GO:0106018,1,0.316473065175935,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17197,GO:0106019,1,0.439889861731254,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17202,GO:0106030,1,0.317294423638624,0,14,neuron projection fasciculation,BP,
17211,GO:0106068,1,0.589134144479095,0,7,SUMO ligase complex,CC,
17253,GO:0120033,1,0.215637323100343,0,19,negative regulation of plasma membrane bounded cell projection assembly,BP,
17286,GO:0140035,1,0.611372013457863,0,6,ubiquitination-like modification-dependent protein binding,MF,
17287,GO:0140036,1,0.611372013457863,0,6,ubiquitin-dependent protein binding,MF,
17312,GO:0140115,1,0.480040467696308,0,9,export across plasma membrane,BP,
17324,GO:0150005,1,0.456108176735116,0,10,enzyme activator complex,CC,
17325,GO:0150011,1,0.562570381877626,0,7,regulation of neuron projection arborization,BP,
17326,GO:0150012,1,0.562570381877626,0,7,positive regulation of neuron projection arborization,BP,
17339,GO:1900017,1,0.481770742241309,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17347,GO:1900029,1,0.420238677597664,0,11,positive regulation of ruffle assembly,BP,
17356,GO:1900044,1,0.518293418852942,0,8,regulation of protein K63-linked ubiquitination,BP,
17377,GO:1900101,1,0.134153327367335,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
17378,GO:1900102,1,0.406292764009449,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17379,GO:1900103,1,0.35433779885074,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
17386,GO:1900112,1,0.48524622962393,0,9,regulation of histone H3-K9 trimethylation,BP,
17392,GO:1900118,1,0.571322954285367,0,7,negative regulation of execution phase of apoptosis,BP,
17447,GO:1900223,1,0.614596018687204,0,6,positive regulation of amyloid-beta clearance,BP,
17449,GO:1900225,1,0.478299298145119,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17455,GO:1900242,1,0.61157769226784,0,6,regulation of synaptic vesicle endocytosis,BP,
17464,GO:1900262,1,0.621482989965002,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17465,GO:1900264,1,0.621482989965002,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17467,GO:1900272,1,0.625333044388967,0,6,negative regulation of long-term synaptic potentiation,BP,
17486,GO:1900402,1,0.518173520932058,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17490,GO:1900424,1,0.358326914060269,0,13,regulation of defense response to bacterium,BP,
17492,GO:1900426,1,0.584491167928807,0,7,positive regulation of defense response to bacterium,BP,
17528,GO:1901018,1,0.491080423317364,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17534,GO:1901029,1,0.579764251266709,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17537,GO:1901032,1,0.363930884270696,0,13,negative regulation of response to reactive oxygen species,BP,
17541,GO:1901070,1,0.391500311505272,0,13,guanosine-containing compound biosynthetic process,BP,
17542,GO:1901071,1,0.272236244432514,0,16,glucosamine-containing compound metabolic process,BP,
17561,GO:1901142,1,0.610878276029246,0,6,insulin metabolic process,BP,
17566,GO:1901160,1,0.563312556388327,0,7,primary amino compound metabolic process,BP,
17568,GO:1901163,1,0.545681536711921,0,8,regulation of trophoblast cell migration,BP,
17588,GO:1901223,1,0.534326467853415,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17612,GO:1901298,1,0.494657199281674,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17629,GO:1901339,1,0.61076682278482,0,6,regulation of store-operated calcium channel activity,BP,
17653,GO:1901407,1,0.482925518284107,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17654,GO:1901409,1,0.56915577813425,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17667,GO:1901524,1,0.325832573277451,0,14,regulation of mitophagy,BP,
17668,GO:1901525,1,0.610901198001026,0,6,negative regulation of mitophagy,BP,
17669,GO:1901526,1,0.533543534461507,0,8,positive regulation of mitophagy,BP,
17672,GO:1901533,1,0.622515058944777,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17704,GO:1901611,1,0.494979866678493,0,9,phosphatidylglycerol binding,MF,
17705,GO:1901612,1,0.629454965271887,0,6,cardiolipin binding,MF,
17709,GO:1901618,1,0.296431234778674,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17710,GO:1901620,1,0.56275162933543,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17729,GO:1901658,1,0.120899447451705,0,27,glycosyl compound catabolic process,BP,
17731,GO:1901660,1,0.612603821050348,0,6,calcium ion export,BP,
17734,GO:1901663,1,0.339543021129587,0,14,quinone biosynthetic process,BP,
17744,GO:1901679,1,0.52415921721118,0,8,nucleotide transmembrane transport,BP,
17747,GO:1901682,1,0.230271904675641,0,18,sulfur compound transmembrane transporter activity,MF,
17748,GO:1901685,1,0.335949342100395,0,16,glutathione derivative metabolic process,BP,
17749,GO:1901687,1,0.335949342100395,0,16,glutathione derivative biosynthetic process,BP,
17759,GO:1901725,1,0.610773615273295,0,6,regulation of histone deacetylase activity,BP,
17771,GO:1901798,1,0.304247187255111,0,16,positive regulation of signal transduction by p53 class mediator,BP,
17778,GO:1901836,1,0.413021610786619,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17780,GO:1901838,1,0.485312533450901,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17784,GO:1901844,1,0.570036511647039,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17818,GO:1901970,1,0.535751472423488,0,8,positive regulation of mitotic sister chromatid separation,BP,
17821,GO:1901978,1,0.48390076446464,0,9,positive regulation of cell cycle checkpoint,BP,
17842,GO:1902018,1,0.485543030200013,0,9,negative regulation of cilium assembly,BP,
17868,GO:1902101,1,0.535751472423488,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17886,GO:1902165,1,0.332181568937069,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17887,GO:1902166,1,0.380668903376146,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17913,GO:1902224,1,0.567434665014014,0,7,ketone body metabolic process,BP,
17919,GO:1902231,1,0.645936069663173,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17924,GO:1902237,1,0.453062674481599,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17932,GO:1902259,1,0.48198473355538,0,9,regulation of delayed rectifier potassium channel activity,BP,
17945,GO:1902285,1,0.372980652216382,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17946,GO:1902287,1,0.404949448264479,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
17967,GO:1902358,1,0.612356654304736,0,6,sulfate transmembrane transport,BP,
17989,GO:1902415,1,0.489013716182136,0,9,regulation of mRNA binding,BP,
17990,GO:1902416,1,0.574063349657174,0,7,positive regulation of mRNA binding,BP,
17994,GO:1902430,1,0.525380620034425,0,8,negative regulation of amyloid-beta formation,BP,
18005,GO:1902473,1,0.565040748379142,0,7,regulation of protein localization to synapse,BP,
18006,GO:1902474,1,0.613448599331297,0,6,positive regulation of protein localization to synapse,BP,
18017,GO:1902510,1,0.592441595020186,0,7,regulation of apoptotic DNA fragmentation,BP,
18074,GO:1902656,1,0.611568812204658,0,6,calcium ion import into cytosol,BP,
18079,GO:1902669,1,0.563569192283586,0,7,positive regulation of axon guidance,BP,
18087,GO:1902692,1,0.270186332422983,0,16,regulation of neuroblast proliferation,BP,
18102,GO:1902739,1,0.61076682278482,0,6,regulation of interferon-alpha secretion,BP,
18103,GO:1902741,1,0.61076682278482,0,6,positive regulation of interferon-alpha secretion,BP,
18117,GO:1902774,1,0.622247753473298,0,6,late endosome to lysosome transport,BP,
18119,GO:1902803,1,0.194897412583172,0,20,regulation of synaptic vesicle transport,BP,
18136,GO:1902855,1,0.450417258868508,0,10,regulation of non-motile cilium assembly,BP,
18138,GO:1902857,1,0.576347572256011,0,7,positive regulation of non-motile cilium assembly,BP,
18165,GO:1902914,1,0.297453890156324,0,15,regulation of protein polyubiquitination,BP,
18166,GO:1902915,1,0.610908280433968,0,6,negative regulation of protein polyubiquitination,BP,
18167,GO:1902916,1,0.528829016864939,0,8,positive regulation of protein polyubiquitination,BP,
18177,GO:1902946,1,0.518233166990716,0,8,protein localization to early endosome,BP,
18181,GO:1902950,1,0.619830365368473,0,6,regulation of dendritic spine maintenance,BP,
18195,GO:1902965,1,0.61076682278482,0,6,regulation of protein localization to early endosome,BP,
18196,GO:1902966,1,0.61076682278482,0,6,positive regulation of protein localization to early endosome,BP,
18204,GO:1902992,1,0.445727747864286,0,10,negative regulation of amyloid precursor protein catabolic process,BP,
18236,GO:1903044,1,0.522235382418393,0,8,protein localization to membrane raft,BP,
18276,GO:1903147,1,0.530596548427878,0,8,negative regulation of autophagy of mitochondrion,BP,
18298,GO:1903204,1,0.326298318136454,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18300,GO:1903206,1,0.363930884270696,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18338,GO:1903299,1,0.586700810797214,0,7,regulation of hexokinase activity,BP,
18342,GO:1903306,1,0.376506934864068,0,12,negative regulation of regulated secretory pathway,BP,
18360,GO:1903349,1,0.613333027330191,0,6,omegasome membrane,CC,
18361,GO:1903350,1,0.416997148840401,0,11,response to dopamine,BP,
18362,GO:1903351,1,0.416997148840401,0,11,cellular response to dopamine,BP,
18389,GO:1903405,1,0.483113876972324,0,9,protein localization to nuclear body,BP,
18395,GO:1903421,1,0.348812428065949,0,13,regulation of synaptic vesicle recycling,BP,
18401,GO:1903429,1,0.304928138410195,0,15,regulation of cell maturation,BP,
18403,GO:1903431,1,0.564129216643421,0,7,positive regulation of cell maturation,BP,
18412,GO:1903441,1,0.562761496329802,0,7,protein localization to ciliary membrane,BP,
18431,GO:1903513,1,0.137544335948391,0,25,endoplasmic reticulum to cytosol transport,BP,
18451,GO:1903539,1,0.4779340761752,0,9,protein localization to postsynaptic membrane,BP,
18452,GO:1903540,1,0.4779340761752,0,9,establishment of protein localization to postsynaptic membrane,BP,
18479,GO:1903580,1,0.188623136326663,0,21,positive regulation of ATP metabolic process,BP,
18489,GO:1903599,1,0.2618251627952,0,17,positive regulation of autophagy of mitochondrion,BP,
18490,GO:1903608,1,0.569311145211484,0,7,protein localization to cytoplasmic stress granule,BP,
18495,GO:1903624,1,0.545689643563584,0,8,regulation of DNA catabolic process,BP,
18506,GO:1903651,1,0.477286418190785,0,9,positive regulation of cytoplasmic transport,BP,
18573,GO:1903800,1,0.567439659085331,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18586,GO:1903831,1,0.416846118012339,0,11,signal transduction involved in cellular response to ammonium ion,BP,
18611,GO:1903894,1,0.356132991539486,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18613,GO:1903896,1,0.575709561206713,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18614,GO:1903897,1,0.480934968203109,0,9,regulation of PERK-mediated unfolded protein response,BP,
18659,GO:1903975,1,0.616242631663604,0,6,regulation of glial cell migration,BP,
18716,GO:1904152,1,0.385496978940246,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18717,GO:1904153,1,0.488809472800232,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18767,GO:1904262,1,0.409036986763208,0,11,negative regulation of TORC1 signaling,BP,
18780,GO:1904293,1,0.355866759488504,0,13,negative regulation of ERAD pathway,BP,
18799,GO:1904350,1,0.522450680596104,0,8,regulation of protein catabolic process in the vacuole,BP,
18802,GO:1904353,1,0.131368759760612,0,25,regulation of telomere capping,BP,
18803,GO:1904354,1,0.51875537865444,0,8,negative regulation of telomere capping,BP,
18804,GO:1904355,1,0.275222895869051,0,16,positive regulation of telomere capping,BP,
18830,GO:1904415,1,0.612428400173356,0,6,regulation of xenophagy,BP,
18831,GO:1904417,1,0.612428400173356,0,6,positive regulation of xenophagy,BP,
18832,GO:1904424,1,0.480216099643452,0,9,regulation of GTP binding,BP,
18836,GO:1904429,1,0.562570381877626,0,7,regulation of t-circle formation,BP,
18853,GO:1904469,1,0.562788838640291,0,7,positive regulation of tumor necrosis factor secretion,BP,
18867,GO:1904526,1,0.480325405269274,0,9,regulation of microtubule binding,BP,
18869,GO:1904528,1,0.614667325778995,0,6,positive regulation of microtubule binding,BP,
18925,GO:1904667,1,0.688212235156466,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18932,GO:1904683,1,0.611100416898504,0,6,regulation of metalloendopeptidase activity,BP,
18982,GO:1904776,1,0.61076682278482,0,6,regulation of protein localization to cell cortex,BP,
18985,GO:1904779,1,0.610889146250733,0,6,regulation of protein localization to centrosome,BP,
19023,GO:1904861,1,0.565327169467027,0,7,excitatory synapse assembly,BP,
19025,GO:1904867,1,0.483113876972324,0,9,protein localization to Cajal body,BP,
19027,GO:1904869,1,0.523006667034906,0,8,regulation of protein localization to Cajal body,BP,
19028,GO:1904871,1,0.523006667034906,0,8,positive regulation of protein localization to Cajal body,BP,
19041,GO:1904886,1,0.230066576173408,0,18,beta-catenin destruction complex disassembly,BP,
19049,GO:1904896,1,0.452084126324217,0,10,ESCRT complex disassembly,BP,
19051,GO:1904903,1,0.452084126324217,0,10,ESCRT III complex disassembly,BP,
19058,GO:1904923,1,0.384231950985713,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19060,GO:1904925,1,0.417072252652437,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19071,GO:1904953,1,0.522915508249567,0,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19114,GO:1905048,1,0.356097146776872,0,13,regulation of metallopeptidase activity,BP,
19115,GO:1905049,1,0.622757998606211,0,6,negative regulation of metallopeptidase activity,BP,
19116,GO:1905050,1,0.571971446443723,0,7,positive regulation of metallopeptidase activity,BP,
19134,GO:1905097,1,0.614527479130567,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19143,GO:1905144,1,0.416846118012339,0,11,response to acetylcholine,BP,
19144,GO:1905145,1,0.416846118012339,0,11,cellular response to acetylcholine,BP,
19145,GO:1905146,1,0.484159799025546,0,9,lysosomal protein catabolic process,BP,
19148,GO:1905153,1,0.612522458247275,0,6,regulation of membrane invagination,BP,
19153,GO:1905165,1,0.611283092012545,0,6,regulation of lysosomal protein catabolic process,BP,
19170,GO:1905214,1,0.414861750120881,0,11,regulation of RNA binding,BP,
19172,GO:1905216,1,0.528760268574951,0,8,positive regulation of RNA binding,BP,
19178,GO:1905244,1,0.519393118648866,0,8,regulation of modification of synaptic structure,BP,
19229,GO:1905360,1,0.221115855431565,0,19,GTPase complex,CC,
19267,GO:1905456,1,0.573387070477898,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19282,GO:1905508,1,0.109276201957525,0,27,protein localization to microtubule organizing center,BP,
19336,GO:1905666,1,0.477276614787127,0,9,regulation of protein localization to endosome,BP,
19337,GO:1905668,1,0.477276614787127,0,9,positive regulation of protein localization to endosome,BP,
19371,GO:1905820,1,0.493468766939242,0,9,positive regulation of chromosome separation,BP,
19384,GO:1905879,1,0.612627725879612,0,6,regulation of oogenesis,BP,
19416,GO:1905961,1,0.526108859595993,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19435,GO:1990050,1,0.630872452234114,0,6,phosphatidic acid transporter activity,MF,
19450,GO:1990124,1,0.573616275393405,0,7,messenger ribonucleoprotein complex,CC,
19451,GO:1990126,1,0.274593994761438,0,16,retrograde transport, endosome to plasma membrane,BP,
19468,GO:1990173,1,0.444981372013637,0,10,protein localization to nucleoplasm,BP,
19482,GO:1990247,1,0.562570381877626,0,7,N6-methyladenosine-containing RNA binding,MF,
19483,GO:1990253,1,0.478565196807294,0,9,cellular response to leucine starvation,BP,
19497,GO:1990316,1,0.518231366383821,0,8,Atg1/ULK1 kinase complex,CC,
19504,GO:1990381,1,0.351306678414865,0,13,ubiquitin-specific protease binding,MF,
19523,GO:1990416,1,0.613255480420346,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19542,GO:1990459,1,0.617464099498725,0,6,transferrin receptor binding,MF,
19544,GO:1990462,1,0.564934287140208,0,7,omegasome,CC,
19657,GO:1990907,1,0.405202547378745,0,11,beta-catenin-TCF complex,CC,
19658,GO:1990909,1,0.52204273258171,0,8,Wnt signalosome,CC,
19704,GO:2000042,1,0.479585352210213,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19722,GO:2000074,1,0.572423452299501,0,7,regulation of type B pancreatic cell development,BP,
19728,GO:2000096,1,0.612863071816757,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19732,GO:2000105,1,0.348889643794696,0,13,positive regulation of DNA-dependent DNA replication,BP,
19741,GO:2000114,1,0.227923967271163,0,18,regulation of establishment of cell polarity,BP,
19748,GO:2000136,1,0.419054319830101,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19776,GO:2000194,1,0.583230817009649,0,7,regulation of female gonad development,BP,
19797,GO:2000234,1,0.533608779069824,0,8,positive regulation of rRNA processing,BP,
19826,GO:2000288,1,0.617502036160951,0,6,positive regulation of myoblast proliferation,BP,
19827,GO:2000291,1,0.568774646050138,0,7,regulation of myoblast proliferation,BP,
19832,GO:2000300,1,0.21161231396664,0,19,regulation of synaptic vesicle exocytosis,BP,
19839,GO:2000310,1,0.478622070983027,0,9,regulation of NMDA receptor activity,BP,
19850,GO:2000322,1,0.565110154620566,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19851,GO:2000323,1,0.612690603357997,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19936,GO:2000465,1,0.611263862983331,0,6,regulation of glycogen (starch) synthase activity,BP,
19943,GO:2000480,1,0.570824726898835,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19945,GO:2000482,1,0.369327908751123,0,13,regulation of interleukin-8 secretion,BP,
19947,GO:2000484,1,0.536943034685424,0,8,positive regulation of interleukin-8 secretion,BP,
19984,GO:2000574,1,0.538820184448596,0,8,regulation of microtubule motor activity,BP,
19997,GO:2000601,1,0.61076682278482,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20003,GO:2000615,1,0.448138642413323,0,10,regulation of histone H3-K9 acetylation,BP,
20005,GO:2000617,1,0.62096218031498,0,6,positive regulation of histone H3-K9 acetylation,BP,
20022,GO:2000643,1,0.518184028345975,0,8,positive regulation of early endosome to late endosome transport,BP,
20023,GO:2000644,1,0.486316755848559,0,9,regulation of receptor catabolic process,BP,
20050,GO:2000674,1,0.520938156917462,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20054,GO:2000678,1,0.35167571263085,0,14,negative regulation of transcription regulatory region DNA binding,BP,
20098,GO:2000766,1,0.61970066166381,0,6,negative regulation of cytoplasmic translation,BP,
20099,GO:2000767,1,0.520483484154932,0,8,positive regulation of cytoplasmic translation,BP,
20102,GO:2000773,1,0.32776291801158,0,14,negative regulation of cellular senescence,BP,
20106,GO:2000778,1,0.277612636311867,0,16,positive regulation of interleukin-6 secretion,BP,
20111,GO:2000786,1,0.40551832365301,0,11,positive regulation of autophagosome assembly,BP,
20160,GO:2000973,1,0.622509179059256,0,6,regulation of pro-B cell differentiation,BP,
20178,GO:2001024,1,0.241468543279721,0,18,negative regulation of response to drug,BP,
20179,GO:2001025,1,0.400795382386668,0,12,positive regulation of response to drug,BP,
20191,GO:2001039,1,0.363930884270696,0,13,negative regulation of cellular response to drug,BP,
20192,GO:2001040,1,0.620803800640985,0,6,positive regulation of cellular response to drug,BP,
20212,GO:2001138,1,0.635692959961389,0,6,regulation of phospholipid transport,BP,
20213,GO:2001140,1,0.635692959961389,0,6,positive regulation of phospholipid transport,BP,
20230,GO:2001171,1,0.255857691752597,0,17,positive regulation of ATP biosynthetic process,BP,
20283,GO:2001256,1,0.522726804636954,0,8,regulation of store-operated calcium entry,BP,
6495,GO:0021855,1.00000000000001,0.782127167983268,0,3,hypothalamus cell migration,BP,
10485,GO:0043379,1.00000000000001,0.675359794218324,0,5,memory T cell differentiation,BP,
16378,GO:0090713,1.00000000000001,0.675359794218324,0,5,immunological memory process,BP,
16379,GO:0090715,1.00000000000001,0.675359794218324,0,5,immunological memory formation process,BP,
9846,GO:0042091,1.00000000000002,0.85083861058338,0,2,interleukin-10 biosynthetic process,BP,
11074,GO:0045074,1.00000000000002,0.85083861058338,0,2,regulation of interleukin-10 biosynthetic process,BP,
371,GO:0000992,1.00000000000004,0.84862266792432,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0001002,1.00000000000004,0.84862266792432,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,1.00000000000004,0.84862266792432,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
18660,GO:1903976,1.00000000000005,0.785554427352898,0,3,negative regulation of glial cell migration,BP,
2366,GO:0005483,1.00000000000005,0.78385528787265,0,3,soluble NSF attachment protein activity,MF,
637,GO:0001826,1.00000000000006,0.663096940719583,0,5,inner cell mass cell differentiation,BP,
1576,GO:0003986,1.00000000000006,0.809589563513965,0,3,acetyl-CoA hydrolase activity,MF,
11215,GO:0045348,1.00000000000009,0.788456693967178,0,3,positive regulation of MHC class II biosynthetic process,BP,
11972,GO:0047223,1.0000000000001,0.781627312770839,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
13584,GO:0060051,1.0000000000001,0.852361969443843,0,2,negative regulation of protein glycosylation,BP,
16237,GO:0090285,1.0000000000001,0.852361969443843,0,2,negative regulation of protein glycosylation in Golgi,BP,
6511,GO:0021886,1.00000000000011,0.795986828647495,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6512,GO:0021888,1.00000000000011,0.795986828647495,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
17846,GO:1902031,1.00000000000011,0.667413034827248,0,5,regulation of NADP metabolic process,BP,
6041,GO:0019144,1.00000000000012,0.865275756166291,0,2,ADP-sugar diphosphatase activity,MF,
1655,GO:0004109,1.00000000000013,0.848558316515475,0,2,coproporphyrinogen oxidase activity,MF,
12740,GO:0051005,1.00000000000014,0.809027978632111,0,3,negative regulation of lipoprotein lipase activity,BP,
522,GO:0001609,1.00000000000015,0.785158220684392,0,3,G-protein coupled adenosine receptor activity,MF,
6104,GO:0019336,1.00000000000018,0.668277104465631,0,5,phenol-containing compound catabolic process,BP,
6186,GO:0019614,1.00000000000018,0.668277104465631,0,5,catechol-containing compound catabolic process,BP,
10007,GO:0042424,1.00000000000018,0.668277104465631,0,5,catecholamine catabolic process,BP,
16317,GO:0090498,1.00000000000019,0.84896969518654,0,2,extrinsic component of Golgi membrane,CC,
4990,GO:0015119,1.00000000000019,0.782445610164057,0,3,hexose phosphate transmembrane transporter activity,MF,
5079,GO:0015315,1.00000000000019,0.782445610164057,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5126,GO:0015526,1.00000000000019,0.782445610164057,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14332,GO:0061513,1.00000000000019,0.782445610164057,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
7345,GO:0031372,1.0000000000002,0.854516600934973,0,2,UBC13-MMS2 complex,CC,
8666,GO:0034235,1.00000000000021,0.666158525398354,0,5,GPI anchor binding,MF,
4278,GO:0009644,1.00000000000021,0.849544576032587,0,2,response to high light intensity,BP,
18375,GO:1903377,1.00000000000023,0.733718602980264,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
6160,GO:0019509,1.00000000000028,0.675307586565874,0,5,L-methionine salvage from methylthioadenosine,BP,
6153,GO:0019470,1.00000000000028,0.720491192215201,0,4,4-hydroxyproline catabolic process,BP,
9160,GO:0035513,1.00000000000029,0.724414291811223,0,4,oxidative RNA demethylation,BP,
9162,GO:0035515,1.00000000000029,0.724414291811223,0,4,oxidative RNA demethylase activity,MF,
4302,GO:0009750,1.0000000000003,0.722458944323916,0,4,response to fructose,BP,
16063,GO:0089717,1.00000000000031,0.663155839992005,0,5,spanning component of membrane,CC,
16600,GO:0097422,1.00000000000034,0.663853049498932,0,5,tubular endosome,CC,
1456,GO:0003696,1.00000000000036,0.721394523475145,0,4,satellite DNA binding,MF,
9585,GO:0036403,1.00000000000039,0.921148380525651,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
2823,GO:0006287,1.0000000000004,0.670820730203522,0,5,base-excision repair, gap-filling,BP,
3103,GO:0006680,1.00000000000041,0.781716634988728,0,3,glucosylceramide catabolic process,BP,
10004,GO:0042420,1.00000000000041,0.725518505991169,0,4,dopamine catabolic process,BP,
16285,GO:0090362,1.00000000000043,0.849456254846377,0,2,positive regulation of platelet-derived growth factor production,BP,
4842,GO:0014048,1.00000000000044,0.672934110830172,0,5,regulation of glutamate secretion,BP,
19750,GO:2000138,1.00000000000046,0.665683542809502,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
2060,GO:0004814,1.00000000000047,0.785108418391265,0,3,arginine-tRNA ligase activity,MF,
2910,GO:0006420,1.00000000000047,0.785108418391265,0,3,arginyl-tRNA aminoacylation,BP,
18369,GO:1903365,1.00000000000047,0.79209646122667,0,3,regulation of fear response,BP,
20131,GO:2000822,1.00000000000047,0.79209646122667,0,3,regulation of behavioral fear response,BP,
4057,GO:0009106,1.00000000000047,0.852590800904547,0,2,lipoate metabolic process,BP,
511,GO:0001574,1.00000000000051,0.723788905815251,0,4,ganglioside biosynthetic process,BP,
613,GO:0001781,1.00000000000051,0.669044697619485,0,5,neutrophil apoptotic process,BP,
8253,GO:0033029,1.00000000000051,0.669044697619485,0,5,regulation of neutrophil apoptotic process,BP,
4332,GO:0009881,1.00000000000051,0.719899145506131,0,4,photoreceptor activity,MF,
10996,GO:0044795,1.00000000000055,0.934007075601849,0,1,trans-Golgi network to recycling endosome transport,BP,
12177,GO:0048298,1.00000000000056,0.720996415286249,0,4,positive regulation of isotype switching to IgA isotypes,BP,
11292,GO:0045602,1.00000000000056,0.673203462292711,0,5,negative regulation of endothelial cell differentiation,BP,
4402,GO:0010138,1.00000000000059,0.733987302483679,0,4,pyrimidine ribonucleotide salvage,BP,
10761,GO:0044206,1.00000000000059,0.733987302483679,0,4,UMP salvage,BP,
10173,GO:0042760,1.00000000000059,0.663755061131648,0,5,very long-chain fatty acid catabolic process,BP,
16097,GO:0090074,1.0000000000006,0.673205678163567,0,5,negative regulation of protein homodimerization activity,BP,
14864,GO:0070634,1.00000000000062,0.785504271881662,0,3,transepithelial ammonium transport,BP,
10866,GO:0044388,1.00000000000063,0.690345598486855,0,5,small protein activating enzyme binding,MF,
7091,GO:0030885,1.00000000000064,0.799201654884776,0,3,regulation of myeloid dendritic cell activation,BP,
15015,GO:0070944,1.00000000000065,0.852542239030467,0,2,neutrophil mediated killing of bacterium,BP,
15016,GO:0070945,1.00000000000065,0.852542239030467,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
13280,GO:0051967,1.00000000000065,0.792248513310522,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
14856,GO:0070618,1.00000000000065,0.921134945360154,0,1,Grb2-Sos complex,CC,
7656,GO:0032076,1.00000000000066,0.921132015658854,0,1,negative regulation of deoxyribonuclease activity,BP,
13991,GO:0060703,1.00000000000066,0.921132015658854,0,1,deoxyribonuclease inhibitor activity,MF,
14716,GO:0070346,1.00000000000066,0.921132015658854,0,1,positive regulation of fat cell proliferation,BP,
18018,GO:1902511,1.00000000000066,0.921132015658854,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18496,GO:1903625,1.00000000000066,0.921132015658854,0,1,negative regulation of DNA catabolic process,BP,
19569,GO:1990590,1.00000000000067,0.85229602482217,0,2,ATF1-ATF4 transcription factor complex,CC,
14806,GO:0070531,1.00000000000071,0.663125275000714,0,5,BRCA1-A complex,CC,
8323,GO:0033159,1.00000000000072,0.781614633216426,0,3,negative regulation of protein import into nucleus, translocation,BP,
3686,GO:0008188,1.00000000000072,0.685398168253567,0,5,neuropeptide receptor activity,MF,
6521,GO:0021898,1.00000000000073,0.782279598500142,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
4462,GO:0010455,1.00000000000074,0.73343283302387,0,4,positive regulation of cell fate commitment,BP,
9989,GO:0042392,1.00000000000078,0.671746270441344,0,5,sphingosine-1-phosphate phosphatase activity,MF,
13186,GO:0051792,1.00000000000078,0.734172098680048,0,4,medium-chain fatty acid biosynthetic process,BP,
2085,GO:0004849,1.00000000000079,0.673888048688347,0,5,uridine kinase activity,MF,
3094,GO:0006667,1.0000000000008,0.850745828731395,0,2,sphinganine metabolic process,BP,
11025,GO:0044861,1.0000000000008,0.850745828731395,0,2,protein transport into plasma membrane raft,BP,
11714,GO:0046511,1.0000000000008,0.850745828731395,0,2,sphinganine biosynthetic process,BP,
18325,GO:1903279,1.0000000000008,0.850745828731395,0,2,regulation of calcium:sodium antiporter activity,BP,
18326,GO:1903281,1.0000000000008,0.850745828731395,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19284,GO:1905516,1.00000000000083,0.676368192813175,0,5,positive regulation of fertilization,BP,
11035,GO:0045007,1.00000000000083,0.797978153721982,0,3,depurination,BP,
2597,GO:0005892,1.00000000000086,0.720140677403763,0,4,acetylcholine-gated channel complex,CC,
8989,GO:0035095,1.00000000000086,0.720140677403763,0,4,behavioral response to nicotine,BP,
16957,GO:0098960,1.00000000000086,0.720140677403763,0,4,postsynaptic neurotransmitter receptor activity,MF,
17052,GO:0099529,1.00000000000086,0.720140677403763,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18789,GO:1904315,1.00000000000086,0.720140677403763,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
1248,GO:0002949,1.00000000000087,0.78941366067801,0,3,tRNA threonylcarbamoyladenosine modification,BP,
2020,GO:0004749,1.00000000000088,0.722640173990897,0,4,ribose phosphate diphosphokinase activity,MF,
5668,GO:0016778,1.00000000000088,0.722640173990897,0,4,diphosphotransferase activity,MF,
5534,GO:0016517,1.00000000000088,0.922840261487932,0,1,interleukin-12 receptor activity,MF,
9815,GO:0042019,1.00000000000088,0.922840261487932,0,1,interleukin-23 binding,MF,
9816,GO:0042020,1.00000000000088,0.922840261487932,0,1,interleukin-23 receptor activity,MF,
9817,GO:0042022,1.00000000000088,0.922840261487932,0,1,interleukin-12 receptor complex,CC,
15834,GO:0072536,1.00000000000088,0.922840261487932,0,1,interleukin-23 receptor complex,CC,
16245,GO:0090296,1.00000000000089,0.728113545493605,0,4,regulation of mitochondrial DNA replication,BP,
17787,GO:1901858,1.00000000000089,0.728113545493605,0,4,regulation of mitochondrial DNA metabolic process,BP,
8649,GO:0034190,1.0000000000009,0.721487581648734,0,4,apolipoprotein receptor binding,MF,
10246,GO:0042979,1.00000000000091,0.731860947201171,0,4,ornithine decarboxylase regulator activity,MF,
17937,GO:1902267,1.00000000000091,0.731860947201171,0,4,regulation of polyamine transmembrane transport,BP,
11570,GO:0046121,1.00000000000093,0.790177760606436,0,3,deoxyribonucleoside catabolic process,BP,
15012,GO:0070940,1.00000000000093,0.670350141777288,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
4465,GO:0010459,1.00000000000094,0.735254871183148,0,4,negative regulation of heart rate,BP,
9100,GO:0035368,1.00000000000094,0.723320162987195,0,4,selenocysteine insertion sequence binding,MF,
1816,GO:0004466,1.00000000000095,0.730146461862988,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
5825,GO:0017099,1.00000000000095,0.730146461862988,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
10133,GO:0042670,1.00000000000095,0.781728459302894,0,3,retinal cone cell differentiation,BP,
11737,GO:0046549,1.00000000000095,0.781728459302894,0,3,retinal cone cell development,BP,
19490,GO:1990264,1.00000000000101,0.848991232471919,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
8453,GO:0033588,1.00000000000102,0.667333868834822,0,5,Elongator holoenzyme complex,CC,
18615,GO:1903898,1.00000000000102,0.665154363813515,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18801,GO:1904352,1.00000000000103,0.725212230011141,0,4,positive regulation of protein catabolic process in the vacuole,BP,
13559,GO:0060022,1.00000000000104,0.664353585520943,0,5,hard palate development,BP,
14388,GO:0061629,1.00000000000105,0.782642582509073,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
17129,GO:0102148,1.00000000000106,0.784091866874743,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
1227,GO:0002904,1.00000000000107,0.803377881115194,0,3,positive regulation of B cell apoptotic process,BP,
16955,GO:0098953,1.00000000000109,0.788436699186617,0,3,receptor diffusion trapping,BP,
16961,GO:0098970,1.00000000000109,0.788436699186617,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
17094,GO:0099628,1.00000000000109,0.788436699186617,0,3,neurotransmitter receptor diffusion trapping,BP,
7528,GO:0031748,1.00000000000111,0.666430097203679,0,5,D1 dopamine receptor binding,MF,
14407,GO:0061673,1.00000000000113,0.663558350966155,0,5,mitotic spindle astral microtubule,CC,
923,GO:0002318,1.00000000000114,0.78199687966795,0,3,myeloid progenitor cell differentiation,BP,
8281,GO:0033083,1.00000000000119,0.725684594989043,0,4,regulation of immature T cell proliferation,BP,
212,GO:0000444,1.00000000000121,0.731673223609133,0,4,MIS12/MIND type complex,CC,
13560,GO:0060023,1.00000000000122,0.72478998420063,0,4,soft palate development,BP,
16751,GO:0098528,1.00000000000122,0.72478998420063,0,4,skeletal muscle fiber differentiation,BP,
17382,GO:1900107,1.00000000000125,0.852036442273397,0,2,regulation of nodal signaling pathway,BP,
17409,GO:1900145,1.00000000000125,0.852036442273397,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17424,GO:1900175,1.00000000000125,0.852036442273397,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19462,GO:1990166,1.00000000000125,0.781777252917414,0,3,protein localization to site of double-strand break,BP,
16925,GO:0098902,1.00000000000126,0.677596826967197,0,5,regulation of membrane depolarization during action potential,BP,
14566,GO:0070094,1.00000000000128,0.921165148051338,0,1,positive regulation of glucagon secretion,BP,
20041,GO:2000664,1.00000000000128,0.782389082105941,0,3,positive regulation of interleukin-5 secretion,BP,
20044,GO:2000667,1.00000000000128,0.782389082105941,0,3,positive regulation of interleukin-13 secretion,BP,
19986,GO:2000580,1.0000000000013,0.748369327421489,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19987,GO:2000582,1.0000000000013,0.748369327421489,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
12209,GO:0048387,1.00000000000131,0.666918528728152,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
2072,GO:0004826,1.00000000000133,0.667382921322206,0,5,phenylalanine-tRNA ligase activity,MF,
2922,GO:0006432,1.00000000000133,0.667382921322206,0,5,phenylalanyl-tRNA aminoacylation,BP,
14603,GO:0070162,1.00000000000134,0.667994632780183,0,5,adiponectin secretion,BP,
14604,GO:0070163,1.00000000000134,0.667994632780183,0,5,regulation of adiponectin secretion,BP,
3045,GO:0006598,1.00000000000135,0.69855759517287,0,5,polyamine catabolic process,BP,
20006,GO:2000618,1.00000000000137,0.671041196269275,0,5,regulation of histone H4-K16 acetylation,BP,
16705,GO:0097676,1.00000000000138,0.782274799262908,0,3,histone H3-K36 dimethylation,BP,
91,GO:0000179,1.00000000000138,0.730611143124551,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
18330,GO:1903286,1.00000000000139,0.785905209627034,0,3,regulation of potassium ion import,BP,
18249,GO:1903070,1.00000000000139,0.789163917330236,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
4323,GO:0009820,1.00000000000139,0.724932375349904,0,4,alkaloid metabolic process,BP,
1053,GO:0002581,1.0000000000014,0.856632563325162,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
8862,GO:0034657,1.0000000000014,0.723013777880252,0,4,GID complex,CC,
2459,GO:0005672,1.0000000000014,0.739337155580636,0,4,transcription factor TFIIA complex,CC,
1899,GO:0004583,1.00000000000141,0.72303656876048,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
462,GO:0001405,1.00000000000141,0.673844897360756,0,5,presequence translocase-associated import motor,CC,
17884,GO:1902162,1.00000000000141,0.873056769746721,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17885,GO:1902164,1.00000000000141,0.873056769746721,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
13889,GO:0060528,1.00000000000144,0.781706506649592,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
10083,GO:0042583,1.00000000000144,0.664797736995241,0,5,chromaffin granule,CC,
12858,GO:0051177,1.00000000000145,0.733858808857774,0,4,meiotic sister chromatid cohesion,BP,
7279,GO:0031262,1.00000000000145,0.74880035949358,0,4,Ndc80 complex,CC,
10376,GO:0043196,1.00000000000146,0.853597683447554,0,2,varicosity,CC,
6043,GO:0019150,1.00000000000147,0.922424940126865,0,1,D-ribulokinase activity,MF,
18665,GO:1903984,1.00000000000148,0.782705965291043,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19928,GO:2000434,1.0000000000015,0.886736890154604,0,2,regulation of protein neddylation,BP,
19929,GO:2000435,1.0000000000015,0.886736890154604,0,2,negative regulation of protein neddylation,BP,
6135,GO:0019401,1.00000000000152,0.728610706098158,0,4,alditol biosynthetic process,BP,
4432,GO:0010266,1.00000000000152,0.800085883682627,0,3,response to vitamin B1,BP,
5947,GO:0018282,1.00000000000152,0.848699940703678,0,2,metal incorporation into metallo-sulfur cluster,BP,
5948,GO:0018283,1.00000000000152,0.848699940703678,0,2,iron incorporation into metallo-sulfur cluster,BP,
5962,GO:0018352,1.00000000000152,0.852127988590328,0,2,protein-pyridoxal-5-phosphate linkage,BP,
10844,GO:0044339,1.00000000000152,0.787374982741541,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
12319,GO:0048669,1.00000000000152,0.787374982741541,0,3,collateral sprouting in absence of injury,BP,
18187,GO:1902956,1.00000000000154,0.796558798763054,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
9534,GO:0036266,1.00000000000154,0.9211834642242,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15902,GO:0072671,1.00000000000154,0.9211834642242,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
18995,GO:1904798,1.00000000000155,0.72365692413126,0,4,positive regulation of core promoter binding,BP,
13621,GO:0060099,1.00000000000155,0.664993343494523,0,5,regulation of phagocytosis, engulfment,BP,
13622,GO:0060100,1.00000000000155,0.664993343494523,0,5,positive regulation of phagocytosis, engulfment,BP,
19150,GO:1905155,1.00000000000155,0.664993343494523,0,5,positive regulation of membrane invagination,BP,
19197,GO:1905288,1.00000000000155,0.664993343494523,0,5,vascular associated smooth muscle cell apoptotic process,BP,
19270,GO:1905459,1.00000000000155,0.664993343494523,0,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19271,GO:1905461,1.00000000000155,0.664993343494523,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
1292,GO:0003105,1.00000000000156,0.801570552279674,0,3,negative regulation of glomerular filtration,BP,
8731,GO:0034378,1.00000000000156,0.792127410226665,0,3,chylomicron assembly,BP,
8456,GO:0033592,1.00000000000157,0.663143523773378,0,5,RNA strand annealing activity,MF,
8772,GO:0034448,1.00000000000158,0.732843296479921,0,4,EGO complex,CC,
10150,GO:0042727,1.00000000000162,0.850133970644654,0,2,flavin-containing compound biosynthetic process,BP,
388,GO:0001032,1.00000000000164,0.723915530524577,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
16147,GO:0090156,1.00000000000165,0.79138478222662,0,3,cellular sphingolipid homeostasis,BP,
14259,GO:0061312,1.00000000000167,0.667706207090475,0,5,BMP signaling pathway involved in heart development,BP,
17450,GO:1900226,1.00000000000167,0.721424039741525,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
19700,GO:2000035,1.00000000000169,0.790437487555831,0,3,regulation of stem cell division,BP,
2727,GO:0006106,1.00000000000172,0.785225295639592,0,3,fumarate metabolic process,BP,
15399,GO:0071650,1.00000000000174,0.787423677516002,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
11692,GO:0046476,1.0000000000018,0.668079541377363,0,5,glycosylceramide biosynthetic process,BP,
20132,GO:2000823,1.0000000000018,0.755892150152268,0,4,regulation of androgen receptor activity,BP,
20133,GO:2000825,1.0000000000018,0.755892150152268,0,4,positive regulation of androgen receptor activity,BP,
2230,GO:0005134,1.00000000000181,0.783171177428938,0,3,interleukin-2 receptor binding,MF,
11135,GO:0045179,1.00000000000182,0.663806714282578,0,5,apical cortex,CC,
16573,GO:0097361,1.00000000000184,0.737642996058007,0,4,CIA complex,CC,
3033,GO:0006580,1.00000000000186,0.921134082231102,0,1,ethanolamine metabolic process,BP,
18277,GO:1903165,1.00000000000186,0.921134082231102,0,1,response to polycyclic arene,BP,
18931,GO:1904681,1.00000000000186,0.921134082231102,0,1,response to 3-methylcholanthrene,BP,
12738,GO:0051001,1.00000000000186,0.73723710658503,0,4,negative regulation of nitric-oxide synthase activity,BP,
7646,GO:0032057,1.00000000000187,0.723006498536822,0,4,negative regulation of translational initiation in response to stress,BP,
2658,GO:0006001,1.00000000000188,0.720877386143896,0,4,fructose catabolic process,BP,
14384,GO:0061624,1.00000000000188,0.720877386143896,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
9434,GO:0036005,1.00000000000191,0.666194325400937,0,5,response to macrophage colony-stimulating factor,BP,
9435,GO:0036006,1.00000000000191,0.666194325400937,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9231,GO:0035617,1.00000000000191,0.782162308434529,0,3,stress granule disassembly,BP,
2071,GO:0004825,1.00000000000194,0.848472716623902,0,2,methionine-tRNA ligase activity,MF,
2921,GO:0006431,1.00000000000194,0.848472716623902,0,2,methionyl-tRNA aminoacylation,BP,
9819,GO:0042025,1.00000000000194,0.781896844780304,0,3,host cell nucleus,CC,
10738,GO:0044094,1.00000000000194,0.781896844780304,0,3,host cell nuclear part,CC,
9735,GO:0038189,1.00000000000194,0.720602655642158,0,4,neuropilin signaling pathway,BP,
3955,GO:0008670,1.00000000000195,0.863760539847749,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
7918,GO:0032493,1.00000000000196,0.784348332339545,0,3,response to bacterial lipoprotein,BP,
14679,GO:0070291,1.00000000000196,0.784348332339545,0,3,N-acylethanolamine metabolic process,BP,
14710,GO:0070339,1.00000000000196,0.784348332339545,0,3,response to bacterial lipopeptide,BP,
15130,GO:0071220,1.00000000000196,0.784348332339545,0,3,cellular response to bacterial lipoprotein,BP,
15131,GO:0071221,1.00000000000196,0.784348332339545,0,3,cellular response to bacterial lipopeptide,BP,
6903,GO:0030478,1.00000000000199,0.71988590200031,0,4,actin cap,CC,
377,GO:0001007,1.000000000002,0.721279198623535,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
1985,GO:0004705,1.00000000000201,0.788388381691816,0,3,JUN kinase activity,MF,
5756,GO:0016909,1.00000000000201,0.788388381691816,0,3,SAP kinase activity,MF,
10153,GO:0042731,1.00000000000202,0.730094016974676,0,4,PH domain binding,MF,
7847,GO:0032405,1.00000000000204,0.673356412082318,0,5,MutLalpha complex binding,MF,
5173,GO:0015727,1.00000000000204,0.721004387635351,0,4,lactate transport,BP,
9362,GO:0035873,1.00000000000204,0.721004387635351,0,4,lactate transmembrane transport,BP,
3146,GO:0006741,1.00000000000204,0.722858923061521,0,4,NADP biosynthetic process,BP,
204,GO:0000429,1.00000000000205,0.788791697000129,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
209,GO:0000436,1.00000000000205,0.788791697000129,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
13651,GO:0060158,1.00000000000206,0.726791295858438,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
9918,GO:0042262,1.00000000000206,0.704556875928851,0,5,DNA protection,BP,
10013,GO:0042439,1.00000000000207,0.665472852639956,0,5,ethanolamine-containing compound metabolic process,BP,
11333,GO:0045656,1.00000000000208,0.664417018943702,0,5,negative regulation of monocyte differentiation,BP,
1344,GO:0003207,1.00000000000208,0.723247709044892,0,4,cardiac chamber formation,BP,
1347,GO:0003211,1.00000000000208,0.723247709044892,0,4,cardiac ventricle formation,BP,
14212,GO:0061146,1.00000000000209,0.784275121144321,0,3,Peyer's patch morphogenesis,BP,
8344,GO:0033192,1.0000000000021,0.663601628510024,0,5,calmodulin-dependent protein phosphatase activity,MF,
9288,GO:0035726,1.00000000000212,0.737406200833492,0,4,common myeloid progenitor cell proliferation,BP,
6242,GO:0019808,1.00000000000215,0.807742982048352,0,3,polyamine binding,MF,
5144,GO:0015671,1.00000000000217,0.850523311022734,0,2,oxygen transport,BP,
17182,GO:0103053,1.00000000000218,0.86458761744025,0,2,1-ethyladenine demethylase activity,MF,
13690,GO:0060232,1.0000000000022,0.721401905201054,0,4,delamination,BP,
9289,GO:0035727,1.00000000000223,0.848472716672995,0,2,lysophosphatidic acid binding,MF,
16966,GO:0098976,1.00000000000223,0.782162164611782,0,3,excitatory chemical synaptic transmission,BP,
11216,GO:0045349,1.00000000000224,0.729391718592464,0,4,interferon-alpha biosynthetic process,BP,
11221,GO:0045354,1.00000000000224,0.729391718592464,0,4,regulation of interferon-alpha biosynthetic process,BP,
4993,GO:0015129,1.00000000000227,0.782756834015303,0,3,lactate transmembrane transporter activity,MF,
9365,GO:0035879,1.00000000000227,0.782756834015303,0,3,plasma membrane lactate transport,BP,
14360,GO:0061574,1.00000000000228,0.783385052757475,0,3,ASAP complex,CC,
14366,GO:0061588,1.00000000000229,0.719944255469008,0,4,calcium activated phospholipid scrambling,BP,
14367,GO:0061589,1.00000000000229,0.719944255469008,0,4,calcium activated phosphatidylserine scrambling,BP,
14368,GO:0061590,1.00000000000229,0.719944255469008,0,4,calcium activated phosphatidylcholine scrambling,BP,
14369,GO:0061591,1.00000000000229,0.719944255469008,0,4,calcium activated galactosylceramide scrambling,BP,
14538,GO:0070044,1.0000000000023,0.723528318019991,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
12218,GO:0048408,1.0000000000023,0.740956981841316,0,4,epidermal growth factor binding,MF,
4684,GO:0010832,1.00000000000231,0.666675416583692,0,5,negative regulation of myotube differentiation,BP,
2011,GO:0004738,1.00000000000232,0.667675000390571,0,5,pyruvate dehydrogenase activity,MF,
8827,GO:0034603,1.00000000000232,0.667675000390571,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8828,GO:0034604,1.00000000000232,0.667675000390571,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
16325,GO:0090521,1.00000000000232,0.719885327826071,0,4,glomerular visceral epithelial cell migration,BP,
14700,GO:0070324,1.00000000000233,0.668404561025887,0,5,thyroid hormone binding,MF,
1543,GO:0003938,1.00000000000235,0.852458047212867,0,2,IMP dehydrogenase activity,MF,
6738,GO:0030156,1.00000000000235,0.943502119768218,0,1,benzodiazepine receptor binding,MF,
15148,GO:0071253,1.00000000000236,0.663173449953588,0,5,connexin binding,MF,
16008,GO:0086016,1.00000000000236,0.663173449953588,0,5,AV node cell action potential,BP,
16017,GO:0086027,1.00000000000236,0.663173449953588,0,5,AV node cell to bundle of His cell signaling,BP,
3075,GO:0006642,1.00000000000237,0.781764154243866,0,3,triglyceride mobilization,BP,
4249,GO:0009449,1.00000000000237,0.781764154243866,0,3,gamma-aminobutyric acid biosynthetic process,BP,
14702,GO:0070326,1.00000000000239,0.797061151361499,0,3,very-low-density lipoprotein particle receptor binding,MF,
11297,GO:0045607,1.00000000000239,0.675832777144149,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11314,GO:0045631,1.00000000000239,0.675832777144149,0,5,regulation of mechanoreceptor differentiation,BP,
20164,GO:2000980,1.00000000000239,0.675832777144149,0,5,regulation of inner ear receptor cell differentiation,BP,
15263,GO:0071435,1.00000000000242,0.781700394026891,0,3,potassium ion export,BP,
8771,GO:0034447,1.00000000000242,0.757756996491264,0,4,very-low-density lipoprotein particle clearance,BP,
17847,GO:1902033,1.00000000000244,0.666299444223902,0,5,regulation of hematopoietic stem cell proliferation,BP,
19846,GO:2000318,1.00000000000249,0.734423908731762,0,4,positive regulation of T-helper 17 type immune response,BP,
8702,GO:0034338,1.0000000000025,0.782604237563463,0,3,short-chain carboxylesterase activity,MF,
9282,GO:0035718,1.00000000000251,0.864079573479854,0,2,macrophage migration inhibitory factor binding,MF,
6640,GO:0023025,1.00000000000251,0.849102064567326,0,2,MHC class Ib protein complex binding,MF,
6643,GO:0023030,1.00000000000251,0.849102064567326,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
9366,GO:0035880,1.00000000000251,0.849102064567326,0,2,embryonic nail plate morphogenesis,BP,
386,GO:0001030,1.00000000000254,0.665628973428175,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1.00000000000254,0.665628973428175,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
15972,GO:0080084,1.00000000000254,0.665628973428175,0,5,5S rDNA binding,MF,
191,GO:0000408,1.00000000000256,0.685915826968547,0,5,EKC/KEOPS complex,CC,
15583,GO:0072049,1.00000000000256,0.736363624167363,0,4,comma-shaped body morphogenesis,BP,
2081,GO:0004839,1.00000000000257,0.663179664820076,0,5,ubiquitin activating enzyme activity,MF,
19659,GO:1990910,1.00000000000258,0.801263132610065,0,3,response to hypobaric hypoxia,BP,
8814,GO:0034552,1.0000000000026,0.739825376320262,0,4,respiratory chain complex II assembly,BP,
8815,GO:0034553,1.0000000000026,0.739825376320262,0,4,mitochondrial respiratory chain complex II assembly,BP,
15110,GO:0071159,1.00000000000263,0.86680547029892,0,2,NF-kappaB complex,CC,
17657,GO:1901474,1.00000000000264,0.723676292763712,0,4,azole transmembrane transporter activity,MF,
14964,GO:0070859,1.00000000000265,0.78197111771751,0,3,positive regulation of bile acid biosynthetic process,BP,
18764,GO:1904253,1.00000000000265,0.78197111771751,0,3,positive regulation of bile acid metabolic process,BP,
17475,GO:1900368,1.00000000000266,0.811280336476261,0,3,regulation of RNA interference,BP,
9094,GO:0035356,1.00000000000268,0.677834532301393,0,5,cellular triglyceride homeostasis,BP,
657,GO:0001848,1.00000000000271,0.680094015213901,0,5,complement binding,MF,
17065,GO:0099550,1.00000000000272,0.795382999786746,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
1295,GO:0003128,1.00000000000273,0.671064500259335,0,5,heart field specification,BP,
7132,GO:0030956,1.00000000000274,0.807809928359478,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12501,GO:0050567,1.00000000000274,0.807809928359478,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14892,GO:0070681,1.00000000000274,0.807809928359478,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
1033,GO:0002542,1.00000000000274,0.922432710936208,0,1,Factor XII activation,BP,
13246,GO:0051919,1.00000000000274,0.922432710936208,0,1,positive regulation of fibrinolysis,BP,
14678,GO:0070290,1.00000000000274,0.720203690967092,0,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
8766,GO:0034436,1.00000000000275,0.795458403326473,0,3,glycoprotein transport,BP,
4435,GO:0010286,1.00000000000277,0.682068847758942,0,5,heat acclimation,BP,
14721,GO:0070370,1.00000000000277,0.682068847758942,0,5,cellular heat acclimation,BP,
851,GO:0002177,1.00000000000277,0.794813161740262,0,3,manchette,CC,
5633,GO:0016714,1.00000000000279,0.797348143747772,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
10927,GO:0044545,1.00000000000282,0.665017442129007,0,5,NSL complex,CC,
20299,GO:2001287,1.00000000000284,0.854519070236602,0,2,negative regulation of caveolin-mediated endocytosis,BP,
8500,GO:0033677,1.00000000000287,0.781551487703134,0,3,DNA/RNA helicase activity,MF,
7745,GO:0032258,1.0000000000029,0.849285207185138,0,2,protein localization by the Cvt pathway,BP,
1206,GO:0002866,1.00000000000293,0.803934112645979,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
18623,GO:1903909,1.00000000000294,0.720544427549923,0,4,regulation of receptor clustering,BP,
2667,GO:0006014,1.00000000000294,0.804387855920143,0,3,D-ribose metabolic process,BP,
15032,GO:0070973,1.00000000000297,0.724857143146798,0,4,protein localization to endoplasmic reticulum exit site,BP,
9267,GO:0035686,1.000000000003,0.804800996599246,0,3,sperm fibrous sheath,CC,
15179,GO:0071313,1.000000000003,0.789496977508939,0,3,cellular response to caffeine,BP,
15250,GO:0071415,1.000000000003,0.789496977508939,0,3,cellular response to purine-containing compound,BP,
16221,GO:0090261,1.00000000000302,0.734170405413028,0,4,positive regulation of inclusion body assembly,BP,
4315,GO:0009794,1.00000000000306,0.725815744427206,0,4,regulation of mitotic cell cycle, embryonic,BP,
11248,GO:0045448,1.00000000000306,0.725815744427206,0,4,mitotic cell cycle, embryonic,BP,
244,GO:0000700,1.00000000000307,0.729552249369194,0,4,mismatch base pair DNA N-glycosylase activity,MF,
16749,GO:0098518,1.00000000000307,0.788996804395122,0,3,polynucleotide phosphatase activity,MF,
14404,GO:0061665,1.00000000000308,0.666769850345253,0,5,SUMO ligase activity,MF,
15305,GO:0071494,1.00000000000309,0.737608213234705,0,4,cellular response to UV-C,BP,
13090,GO:0051599,1.00000000000311,0.722358715093725,0,4,response to hydrostatic pressure,BP,
19091,GO:1904995,1.00000000000311,0.867366416900117,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19381,GO:1905867,1.00000000000312,0.790753670033548,0,3,epididymis development,BP,
12629,GO:0050816,1.00000000000313,0.795345357940888,0,3,phosphothreonine residue binding,MF,
6109,GO:0019348,1.00000000000314,0.679118081283061,0,5,dolichol metabolic process,BP,
2625,GO:0005947,1.00000000000315,0.673218208100225,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
3016,GO:0006561,1.00000000000316,0.726451922531496,0,4,proline biosynthetic process,BP,
13539,GO:0055129,1.00000000000316,0.726451922531496,0,4,L-proline biosynthetic process,BP,
8303,GO:0033133,1.00000000000316,0.739721652910421,0,4,positive regulation of glucokinase activity,BP,
15487,GO:0071839,1.00000000000317,0.731969165881522,0,4,apoptotic process in bone marrow,BP,
11929,GO:0046974,1.00000000000317,0.663088770273423,0,5,histone methyltransferase activity (H3-K9 specific),MF,
6359,GO:0021540,1.00000000000319,0.741334116918739,0,4,corpus callosum morphogenesis,BP,
6090,GO:0019262,1.0000000000032,0.67548713582106,0,5,N-acetylneuraminate catabolic process,BP,
16458,GO:0097119,1.00000000000321,0.721590021753179,0,4,postsynaptic density protein 95 clustering,BP,
13,GO:0000026,1.00000000000322,0.781600091873738,0,3,alpha-1,2-mannosyltransferase activity,MF,
16210,GO:0090241,1.00000000000323,0.728699727797168,0,4,negative regulation of histone H4 acetylation,BP,
2993,GO:0006537,1.00000000000326,0.719897998130104,0,4,glutamate biosynthetic process,BP,
6538,GO:0021942,1.00000000000326,0.782269788878109,0,3,radial glia guided migration of Purkinje cell,BP,
9780,GO:0039689,1.00000000000326,0.782269788878109,0,3,negative stranded viral RNA replication,BP,
13086,GO:0051595,1.00000000000331,0.803761816419151,0,3,response to methylglyoxal,BP,
210,GO:0000438,1.00000000000333,0.792128543015717,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
5752,GO:0016900,1.00000000000334,0.876963948786623,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11953,GO:0047057,1.00000000000334,0.876963948786623,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
10489,GO:0043385,1.00000000000334,0.921130340919178,0,1,mycotoxin metabolic process,BP,
10490,GO:0043387,1.00000000000334,0.921130340919178,0,1,mycotoxin catabolic process,BP,
11607,GO:0046222,1.00000000000334,0.921130340919178,0,1,aflatoxin metabolic process,BP,
11608,GO:0046223,1.00000000000334,0.921130340919178,0,1,aflatoxin catabolic process,BP,
17642,GO:1901376,1.00000000000334,0.921130340919178,0,1,organic heteropentacyclic compound metabolic process,BP,
17643,GO:1901377,1.00000000000334,0.921130340919178,0,1,organic heteropentacyclic compound catabolic process,BP,
18563,GO:1903786,1.00000000000334,0.921130340919178,0,1,regulation of glutathione biosynthetic process,BP,
18564,GO:1903788,1.00000000000334,0.921130340919178,0,1,positive regulation of glutathione biosynthetic process,BP,
18024,GO:1902525,1.00000000000338,0.688936811793024,0,5,regulation of protein monoubiquitination,BP,
12155,GO:0048262,1.00000000000338,0.6772795533088,0,5,determination of dorsal/ventral asymmetry,BP,
4326,GO:0009838,1.0000000000034,0.674104623578778,0,5,abscission,BP,
1756,GO:0004359,1.00000000000341,0.781684262501141,0,3,glutaminase activity,MF,
16195,GO:0090219,1.00000000000343,0.720014126596267,0,4,negative regulation of lipid kinase activity,BP,
2670,GO:0006021,1.00000000000347,0.725572987666843,0,4,inositol biosynthetic process,BP,
7402,GO:0031465,1.00000000000348,0.685236230104602,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
18937,GO:1904690,1.0000000000035,0.723093097317891,0,4,positive regulation of cytoplasmic translational initiation,BP,
3086,GO:0006659,1.00000000000355,0.720571480837359,0,4,phosphatidylserine biosynthetic process,BP,
6428,GO:0021694,1.00000000000357,0.663578230643887,0,5,cerebellar Purkinje cell layer formation,BP,
6435,GO:0021702,1.00000000000357,0.663578230643887,0,5,cerebellar Purkinje cell differentiation,BP,
17244,GO:0110096,1.0000000000036,0.691397196249737,0,5,cellular response to aldehyde,BP,
20166,GO:2000983,1.00000000000362,0.881379397809141,0,2,regulation of ATP citrate synthase activity,BP,
20167,GO:2000984,1.00000000000362,0.881379397809141,0,2,negative regulation of ATP citrate synthase activity,BP,
6080,GO:0019236,1.00000000000363,0.857680403810849,0,2,response to pheromone,BP,
12223,GO:0048476,1.00000000000364,0.683104720026914,0,5,Holliday junction resolvase complex,CC,
17935,GO:1902262,1.00000000000364,0.736550790391888,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
10316,GO:0043096,1.00000000000365,0.691415906042571,0,5,purine nucleobase salvage,BP,
9487,GO:0036122,1.00000000000368,0.782745145261097,0,3,BMP binding,MF,
16932,GO:0098909,1.00000000000369,0.677603018137485,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18608,GO:1903891,1.0000000000037,0.719974497469947,0,4,regulation of ATF6-mediated unfolded protein response,BP,
9981,GO:0042373,1.00000000000371,0.693678395230093,0,5,vitamin K metabolic process,BP,
19268,GO:1905457,1.00000000000375,0.796561024230793,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20161,GO:2000974,1.00000000000375,0.796561024230793,0,3,negative regulation of pro-B cell differentiation,BP,
1734,GO:0004332,1.00000000000375,0.858637608673652,0,2,fructose-bisphosphate aldolase activity,MF,
107,GO:0000221,1.00000000000375,0.782449465656828,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
1716,GO:0004308,1.00000000000377,0.721344456604829,0,4,exo-alpha-sialidase activity,MF,
5775,GO:0016997,1.00000000000377,0.721344456604829,0,4,alpha-sialidase activity,MF,
15359,GO:0071593,1.00000000000377,0.787736325587911,0,3,lymphocyte aggregation,BP,
8958,GO:0035021,1.00000000000377,0.720295413537307,0,4,negative regulation of Rac protein signal transduction,BP,
13694,GO:0060244,1.00000000000377,0.784101566194884,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
5758,GO:0016918,1.00000000000378,0.702092614214404,0,5,retinal binding,MF,
8646,GO:0034186,1.00000000000378,0.727334653142032,0,4,apolipoprotein A-I binding,MF,
15474,GO:0071816,1.00000000000379,0.726227009307676,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
5415,GO:0016262,1.0000000000038,0.7836933562383,0,3,protein N-acetylglucosaminyltransferase activity,MF,
9561,GO:0036337,1.00000000000382,0.720138950225785,0,4,Fas signaling pathway,BP,
18458,GO:1903546,1.00000000000383,0.721541026765407,0,4,protein localization to photoreceptor outer segment,BP,
12128,GO:0048203,1.00000000000385,0.85038919046282,0,2,vesicle targeting, trans-Golgi to endosome,BP,
10719,GO:0044036,1.00000000000385,0.790046569033793,0,3,cell wall macromolecule metabolic process,BP,
15335,GO:0071554,1.00000000000385,0.790046569033793,0,3,cell wall organization or biogenesis,BP,
17316,GO:0140161,1.00000000000387,0.790731201845141,0,3,monocarboxylate:sodium symporter activity,MF,
5987,GO:0018916,1.00000000000387,0.74483933546886,0,4,nitrobenzene metabolic process,BP,
10702,GO:0043987,1.00000000000388,0.723965994834517,0,4,histone H3-S10 phosphorylation,BP,
17714,GO:1901626,1.0000000000039,0.673745153776127,0,5,regulation of postsynaptic membrane organization,BP,
704,GO:0001927,1.00000000000393,0.781980037733596,0,3,exocyst assembly,BP,
16146,GO:0090155,1.00000000000395,0.728952354663912,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17361,GO:1900060,1.00000000000395,0.728952354663912,0,4,negative regulation of ceramide biosynthetic process,BP,
11647,GO:0046368,1.00000000000395,0.73043070134839,0,4,GDP-L-fucose metabolic process,BP,
6087,GO:0019249,1.00000000000396,0.796549942612833,0,3,lactate biosynthetic process,BP,
4839,GO:0014045,1.00000000000396,0.723045194105802,0,4,establishment of endothelial blood-brain barrier,BP,
6563,GO:0022009,1.00000000000396,0.723045194105802,0,4,central nervous system vasculogenesis,BP,
14157,GO:0061038,1.00000000000396,0.723045194105802,0,4,uterus morphogenesis,BP,
3108,GO:0006685,1.00000000000396,0.666079393000397,0,5,sphingomyelin catabolic process,BP,
3754,GO:0008295,1.00000000000403,0.732037213306612,0,4,spermidine biosynthetic process,BP,
7141,GO:0030976,1.00000000000403,0.66438126696685,0,5,thiamine pyrophosphate binding,MF,
1052,GO:0002580,1.00000000000403,0.80498293834227,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
9864,GO:0042117,1.00000000000405,0.663691590904255,0,5,monocyte activation,BP,
14624,GO:0070191,1.00000000000406,0.850334186442218,0,2,methionine-R-sulfoxide reductase activity,MF,
3025,GO:0006570,1.00000000000408,0.737530183904014,0,4,tyrosine metabolic process,BP,
743,GO:0001973,1.00000000000408,0.67125660642635,0,5,adenosine receptor signaling pathway,BP,
8681,GO:0034271,1.00000000000409,0.782289968322893,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8682,GO:0034272,1.00000000000409,0.782289968322893,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
19474,GO:1990188,1.00000000000413,0.921148852037779,0,1,euchromatin binding,MF,
17855,GO:1902044,1.00000000000414,0.848738122257545,0,2,regulation of Fas signaling pathway,BP,
5346,GO:0016094,1.00000000000416,0.781550548173018,0,3,polyprenol biosynthetic process,BP,
11686,GO:0046469,1.00000000000416,0.669563707495823,0,5,platelet activating factor metabolic process,BP,
662,GO:0001865,1.00000000000418,0.663336347144546,0,5,NK T cell differentiation,BP,
12830,GO:0051136,1.00000000000418,0.663336347144546,0,5,regulation of NK T cell differentiation,BP,
10009,GO:0042428,1.00000000000421,0.720280121004667,0,4,serotonin metabolic process,BP,
15270,GO:0071447,1.00000000000426,0.676121379141845,0,5,cellular response to hydroperoxide,BP,
18558,GO:1903774,1.00000000000429,0.787519636443877,0,3,positive regulation of viral budding via host ESCRT complex,BP,
16253,GO:0090306,1.00000000000429,0.720965176747119,0,4,spindle assembly involved in meiosis,BP,
7982,GO:0032596,1.00000000000431,0.666218804614199,0,5,protein transport into membrane raft,BP,
14932,GO:0070813,1.00000000000436,0.683355495946562,0,5,hydrogen sulfide metabolic process,BP,
16765,GO:0098556,1.00000000000437,0.751560713040264,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
9546,GO:0036301,1.00000000000439,0.781847462496664,0,3,macrophage colony-stimulating factor production,BP,
17599,GO:1901256,1.00000000000439,0.781847462496664,0,3,regulation of macrophage colony-stimulating factor production,BP,
10445,GO:0043301,1.00000000000442,0.667473510937225,0,5,negative regulation of leukocyte degranulation,BP,
6183,GO:0019563,1.00000000000443,0.668433633303113,0,5,glycerol catabolic process,BP,
1440,GO:0003419,1.00000000000447,0.848550547363207,0,2,growth plate cartilage chondrocyte proliferation,BP,
1441,GO:0003420,1.00000000000447,0.848550547363207,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
16608,GO:0097441,1.00000000000447,0.788388617255486,0,3,basal dendrite,CC,
516,GO:0001580,1.00000000000448,0.702588551038619,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
6216,GO:0019747,1.0000000000045,0.939669559975977,0,1,regulation of isoprenoid metabolic process,BP,
6889,GO:0030421,1.0000000000045,0.939669559975977,0,1,defecation,BP,
6523,GO:0021903,1.00000000000451,0.670393562407201,0,5,rostrocaudal neural tube patterning,BP,
5592,GO:0016618,1.00000000000451,0.791287141205346,0,3,hydroxypyruvate reductase activity,MF,
6814,GO:0030267,1.00000000000451,0.791287141205346,0,3,glyoxylate reductase (NADP) activity,MF,
19630,GO:1990809,1.00000000000452,0.720402787261672,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19605,GO:1990743,1.00000000000452,0.785566952221334,0,3,protein sialylation,BP,
19615,GO:1990763,1.00000000000452,0.669128209139719,0,5,arrestin family protein binding,MF,
14074,GO:0060872,1.00000000000453,0.724912075998517,0,4,semicircular canal development,BP,
9867,GO:0042126,1.00000000000453,0.720210344064528,0,4,nitrate metabolic process,BP,
18269,GO:1903135,1.00000000000455,0.796551334755043,0,3,cupric ion binding,MF,
2595,GO:0005890,1.00000000000455,0.723904634306785,0,4,sodium:potassium-exchanging ATPase complex,CC,
15150,GO:0071257,1.00000000000458,0.663087717968427,0,5,cellular response to electrical stimulus,BP,
12259,GO:0048539,1.00000000000461,0.724063493538135,0,4,bone marrow development,BP,
146,GO:0000298,1.00000000000462,0.728635533714007,0,4,endopolyphosphatase activity,MF,
3866,GO:0008486,1.00000000000462,0.728635533714007,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
5293,GO:0015961,1.00000000000462,0.728635533714007,0,4,diadenosine polyphosphate catabolic process,BP,
8761,GO:0034431,1.00000000000462,0.728635533714007,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8762,GO:0034432,1.00000000000462,0.728635533714007,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
13436,GO:0052840,1.00000000000462,0.728635533714007,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13437,GO:0052841,1.00000000000462,0.728635533714007,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13438,GO:0052842,1.00000000000462,0.728635533714007,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13439,GO:0052843,1.00000000000462,0.728635533714007,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13440,GO:0052844,1.00000000000462,0.728635533714007,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13441,GO:0052845,1.00000000000462,0.728635533714007,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13442,GO:0052846,1.00000000000462,0.728635533714007,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13443,GO:0052847,1.00000000000462,0.728635533714007,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13444,GO:0052848,1.00000000000462,0.728635533714007,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
15327,GO:0071543,1.00000000000462,0.728635533714007,0,4,diphosphoinositol polyphosphate metabolic process,BP,
17806,GO:1901906,1.00000000000462,0.728635533714007,0,4,diadenosine pentaphosphate metabolic process,BP,
17807,GO:1901907,1.00000000000462,0.728635533714007,0,4,diadenosine pentaphosphate catabolic process,BP,
17808,GO:1901908,1.00000000000462,0.728635533714007,0,4,diadenosine hexaphosphate metabolic process,BP,
17809,GO:1901909,1.00000000000462,0.728635533714007,0,4,diadenosine hexaphosphate catabolic process,BP,
17810,GO:1901910,1.00000000000462,0.728635533714007,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17811,GO:1901911,1.00000000000462,0.728635533714007,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
3319,GO:0007023,1.00000000000462,0.743996008687483,0,4,post-chaperonin tubulin folding pathway,BP,
16018,GO:0086028,1.00000000000464,0.735635636424045,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16025,GO:0086043,1.00000000000464,0.735635636424045,0,4,bundle of His cell action potential,BP,
17520,GO:1900825,1.00000000000464,0.735635636424045,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
7748,GO:0032262,1.00000000000465,0.67989837952023,0,5,pyrimidine nucleotide salvage,BP,
5377,GO:0016191,1.00000000000465,0.720000317669194,0,4,synaptic vesicle uncoating,BP,
7512,GO:0031697,1.00000000000465,0.720000317669194,0,4,beta-1 adrenergic receptor binding,MF,
1495,GO:0003839,1.00000000000466,0.743842028727825,0,4,gamma-glutamylcyclotransferase activity,MF,
2347,GO:0005391,1.00000000000466,0.666790435299724,0,5,sodium:potassium-exchanging ATPase activity,MF,
3909,GO:0008556,1.00000000000466,0.666790435299724,0,5,potassium-transporting ATPase activity,MF,
5505,GO:0016453,1.00000000000467,0.729771924644022,0,4,C-acetyltransferase activity,MF,
4667,GO:0010815,1.00000000000467,0.725599244411306,0,4,bradykinin catabolic process,BP,
1997,GO:0004720,1.00000000000468,0.663285535169991,0,5,protein-lysine 6-oxidase activity,MF,
7122,GO:0030942,1.0000000000047,0.793529806525164,0,3,endoplasmic reticulum signal peptide binding,MF,
7540,GO:0031802,1.00000000000473,0.782567473078685,0,3,type 5 metabotropic glutamate receptor binding,MF,
623,GO:0001806,1.00000000000474,0.789975783848932,0,3,type IV hypersensitivity,BP,
1213,GO:0002883,1.00000000000474,0.789975783848932,0,3,regulation of hypersensitivity,BP,
15947,GO:0072757,1.00000000000474,0.720328336043754,0,4,cellular response to camptothecin,BP,
3024,GO:0006569,1.00000000000474,0.790585659250354,0,3,tryptophan catabolic process,BP,
6150,GO:0019441,1.00000000000474,0.790585659250354,0,3,tryptophan catabolic process to kynurenine,BP,
10011,GO:0042436,1.00000000000474,0.790585659250354,0,3,indole-containing compound catabolic process,BP,
11606,GO:0046218,1.00000000000474,0.790585659250354,0,3,indolalkylamine catabolic process,BP,
2266,GO:0005184,1.00000000000474,0.81158981782743,0,3,neuropeptide hormone activity,MF,
16617,GO:0097454,1.00000000000476,0.788617631043881,0,3,Schwann cell microvillus,CC,
7200,GO:0031089,1.00000000000477,0.667895045486564,0,5,platelet dense granule lumen,CC,
14452,GO:0061771,1.00000000000477,0.79378988722006,0,3,response to caloric restriction,BP,
18868,GO:1904527,1.00000000000477,0.781558620980782,0,3,negative regulation of microtubule binding,BP,
15755,GO:0072344,1.00000000000478,0.72392196196484,0,4,rescue of stalled ribosome,BP,
18313,GO:1903237,1.0000000000048,0.941638989543167,0,1,negative regulation of leukocyte tethering or rolling,BP,
12179,GO:0048304,1.00000000000481,0.667182512315334,0,5,positive regulation of isotype switching to IgG isotypes,BP,
17715,GO:1901628,1.00000000000481,0.792224554839739,0,3,positive regulation of postsynaptic membrane organization,BP,
1903,GO:0004588,1.00000000000483,0.921140462037001,0,1,orotate phosphoribosyltransferase activity,MF,
1904,GO:0004590,1.00000000000483,0.921140462037001,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
8094,GO:0032777,1.00000000000484,0.723541486326591,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
6253,GO:0019834,1.00000000000485,0.797184934362685,0,3,phospholipase A2 inhibitor activity,MF,
8419,GO:0033484,1.00000000000486,0.796055411736031,0,3,nitric oxide homeostasis,BP,
18246,GO:1903059,1.00000000000491,0.726787243710157,0,4,regulation of protein lipidation,BP,
18247,GO:1903061,1.00000000000491,0.726787243710157,0,4,positive regulation of protein lipidation,BP,
17614,GO:1901300,1.00000000000491,0.731712952723781,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
703,GO:0001923,1.00000000000491,0.790115437027496,0,3,B-1 B cell differentiation,BP,
20291,GO:2001271,1.00000000000492,0.782712816575479,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
19562,GO:1990573,1.00000000000493,0.783635485406321,0,3,potassium ion import across plasma membrane,BP,
6661,GO:0030015,1.00000000000495,0.663466230105128,0,5,CCR4-NOT core complex,CC,
14810,GO:0070537,1.00000000000496,0.7815615015495,0,3,histone H2A K63-linked deubiquitination,BP,
11931,GO:0046976,1.00000000000496,0.663591883120606,0,5,histone methyltransferase activity (H3-K27 specific),MF,
6505,GO:0021877,1.00000000000499,0.663713808549342,0,5,forebrain neuron fate commitment,BP,
11726,GO:0046532,1.00000000000499,0.663713808549342,0,5,regulation of photoreceptor cell differentiation,BP,
18468,GO:1903566,1.00000000000499,0.781765669411475,0,3,positive regulation of protein localization to cilium,BP,
10741,GO:0044107,1.000000000005,0.725594561846788,0,4,cellular alcohol metabolic process,BP,
10742,GO:0044108,1.000000000005,0.725594561846788,0,4,cellular alcohol biosynthetic process,BP,
4351,GO:0009922,1.00000000000504,0.66815698581502,0,5,fatty acid elongase activity,MF,
6119,GO:0019367,1.00000000000504,0.66815698581502,0,5,fatty acid elongation, saturated fatty acid,BP,
6120,GO:0019368,1.00000000000504,0.66815698581502,0,5,fatty acid elongation, unsaturated fatty acid,BP,
8838,GO:0034625,1.00000000000504,0.66815698581502,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8839,GO:0034626,1.00000000000504,0.66815698581502,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
17135,GO:0102336,1.00000000000504,0.66815698581502,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17136,GO:0102337,1.00000000000504,0.66815698581502,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17137,GO:0102338,1.00000000000504,0.66815698581502,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17168,GO:0102756,1.00000000000504,0.66815698581502,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17929,GO:1902255,1.00000000000504,0.83873546662266,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
1538,GO:0003923,1.00000000000506,0.666421481932196,0,5,GPI-anchor transamidase activity,MF,
10176,GO:0042765,1.00000000000506,0.666421481932196,0,5,GPI-anchor transamidase complex,CC,
17914,GO:1902226,1.00000000000513,0.852447147543138,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18653,GO:1903969,1.00000000000513,0.852447147543138,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18656,GO:1903972,1.00000000000513,0.852447147543138,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
8616,GO:0034127,1.00000000000516,0.721272642831475,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9106,GO:0035376,1.00000000000517,0.67061307746699,0,5,sterol import,BP,
14795,GO:0070508,1.00000000000517,0.67061307746699,0,5,cholesterol import,BP,
3215,GO:0006858,1.00000000000518,0.791489314082472,0,3,extracellular transport,BP,
728,GO:0001957,1.00000000000525,0.723114737291619,0,4,intramembranous ossification,BP,
9466,GO:0036072,1.00000000000525,0.723114737291619,0,4,direct ossification,BP,
9374,GO:0035898,1.00000000000525,0.783549004180138,0,3,parathyroid hormone secretion,BP,
11462,GO:0045916,1.00000000000525,0.783549004180138,0,3,negative regulation of complement activation,BP,
19809,GO:2000258,1.00000000000525,0.783549004180138,0,3,negative regulation of protein activation cascade,BP,
19580,GO:1990635,1.00000000000526,0.721450352848282,0,4,proximal dendrite,CC,
12407,GO:0048852,1.00000000000529,0.782240205547166,0,3,diencephalon morphogenesis,BP,
3611,GO:0008050,1.00000000000531,0.848640650723856,0,2,female courtship behavior,BP,
5802,GO:0017055,1.00000000000531,0.848640650723856,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11470,GO:0045924,1.00000000000531,0.848640650723856,0,2,regulation of female receptivity,BP,
13833,GO:0060431,1.00000000000531,0.782017903862724,0,3,primary lung bud formation,BP,
3835,GO:0008440,1.00000000000536,0.722395595795553,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3355,GO:0007089,1.00000000000538,0.722817612305226,0,4,traversing start control point of mitotic cell cycle,BP,
16296,GO:0090394,1.00000000000538,0.722817612305226,0,4,negative regulation of excitatory postsynaptic potential,BP,
13042,GO:0051499,1.00000000000539,0.856726767698345,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13043,GO:0051500,1.00000000000539,0.856726767698345,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
2216,GO:0005113,1.00000000000539,0.66391421964898,0,5,patched binding,MF,
7567,GO:0031915,1.0000000000054,0.666395732248328,0,5,positive regulation of synaptic plasticity,BP,
9438,GO:0036015,1.00000000000546,0.808305157997017,0,3,response to interleukin-3,BP,
9439,GO:0036016,1.00000000000546,0.808305157997017,0,3,cellular response to interleukin-3,BP,
14683,GO:0070295,1.00000000000546,0.784624330995869,0,3,renal water absorption,BP,
16590,GO:0097396,1.00000000000546,0.720000870769673,0,4,response to interleukin-17,BP,
16591,GO:0097398,1.00000000000546,0.720000870769673,0,4,cellular response to interleukin-17,BP,
16592,GO:0097400,1.00000000000546,0.720000870769673,0,4,interleukin-17-mediated signaling pathway,BP,
16416,GO:0097049,1.0000000000055,0.665038694831691,0,5,motor neuron apoptotic process,BP,
17357,GO:1900045,1.0000000000055,0.663241039650592,0,5,negative regulation of protein K63-linked ubiquitination,BP,
19866,GO:2000344,1.00000000000553,0.734301879373851,0,4,positive regulation of acrosome reaction,BP,
1249,GO:0002950,1.00000000000555,0.787286404266697,0,3,ceramide phosphoethanolamine synthase activity,MF,
8342,GO:0033188,1.00000000000555,0.787286404266697,0,3,sphingomyelin synthase activity,MF,
12007,GO:0047493,1.00000000000555,0.787286404266697,0,3,ceramide cholinephosphotransferase activity,MF,
2756,GO:0006166,1.00000000000557,0.687698635280684,0,5,purine ribonucleoside salvage,BP,
173,GO:0000379,1.00000000000559,0.784438020182959,0,3,tRNA-type intron splice site recognition and cleavage,BP,
8124,GO:0032810,1.00000000000559,0.853955021516882,0,2,sterol response element binding,MF,
1617,GO:0004046,1.00000000000559,0.788947483659975,0,3,aminoacylase activity,MF,
14463,GO:0061819,1.00000000000561,0.782418927227538,0,3,telomeric DNA-containing double minutes formation,BP,
19352,GO:1905764,1.00000000000561,0.782418927227538,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19353,GO:1905765,1.00000000000561,0.782418927227538,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19572,GO:1990599,1.00000000000561,0.782418927227538,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
14033,GO:0060762,1.00000000000561,0.726574772864465,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
6007,GO:0019049,1.00000000000561,0.720429519254001,0,4,evasion or tolerance of host defenses by virus,BP,
10876,GO:0044413,1.00000000000561,0.720429519254001,0,4,avoidance of host defenses,BP,
10878,GO:0044415,1.00000000000561,0.720429519254001,0,4,evasion or tolerance of host defenses,BP,
13204,GO:0051832,1.00000000000561,0.720429519254001,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13206,GO:0051834,1.00000000000561,0.720429519254001,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
11884,GO:0046898,1.00000000000564,0.723770220559053,0,4,response to cycloheximide,BP,
19220,GO:1905340,1.00000000000566,0.723483325245352,0,4,regulation of protein localization to kinetochore,BP,
19222,GO:1905342,1.00000000000566,0.723483325245352,0,4,positive regulation of protein localization to kinetochore,BP,
6978,GO:0030644,1.00000000000566,0.855689971546344,0,2,cellular chloride ion homeostasis,BP,
4595,GO:0010710,1.00000000000567,0.799772664590128,0,3,regulation of collagen catabolic process,BP,
1694,GO:0004169,1.00000000000567,0.698853987472071,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
4952,GO:0015015,1.0000000000057,0.721026131726816,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
15310,GO:0071500,1.00000000000572,0.693869385253222,0,5,cellular response to nitrosative stress,BP,
13940,GO:0060605,1.00000000000572,0.792004003348232,0,3,tube lumen cavitation,BP,
13957,GO:0060662,1.00000000000572,0.792004003348232,0,3,salivary gland cavitation,BP,
5445,GO:0016312,1.00000000000574,0.720773883927101,0,4,inositol bisphosphate phosphatase activity,MF,
10204,GO:0042816,1.00000000000574,0.664976688169319,0,5,vitamin B6 metabolic process,BP,
2341,GO:0005372,1.00000000000575,0.728267049171696,0,4,water transmembrane transporter activity,MF,
5054,GO:0015250,1.00000000000575,0.728267049171696,0,4,water channel activity,MF,
1224,GO:0002901,1.00000000000576,0.753985618852163,0,4,mature B cell apoptotic process,BP,
1228,GO:0002905,1.00000000000576,0.753985618852163,0,4,regulation of mature B cell apoptotic process,BP,
1229,GO:0002906,1.00000000000576,0.753985618852163,0,4,negative regulation of mature B cell apoptotic process,BP,
20052,GO:2000676,1.00000000000577,0.723724544442214,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
8594,GO:0034093,1.00000000000583,0.673086414598038,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8644,GO:0034184,1.00000000000583,0.673086414598038,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
19706,GO:2000047,1.00000000000583,0.677589252850412,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
13605,GO:0060075,1.00000000000585,0.782271415150167,0,3,regulation of resting membrane potential,BP,
17496,GO:1900452,1.00000000000586,0.727226987221341,0,4,regulation of long term synaptic depression,BP,
18662,GO:1903978,1.00000000000586,0.727226987221341,0,4,regulation of microglial cell activation,BP,
18935,GO:1904688,1.00000000000588,0.67578435131197,0,5,regulation of cytoplasmic translational initiation,BP,
7351,GO:0031392,1.00000000000589,0.726351775897634,0,4,regulation of prostaglandin biosynthetic process,BP,
8255,GO:0033031,1.00000000000589,0.726351775897634,0,4,positive regulation of neutrophil apoptotic process,BP,
20296,GO:2001279,1.00000000000589,0.726351775897634,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
5369,GO:0016174,1.00000000000589,0.720809313988233,0,4,NAD(P)H oxidase activity,MF,
4434,GO:0010273,1.0000000000059,0.744347055679574,0,5,detoxification of copper ion,BP,
5375,GO:0016188,1.0000000000059,0.674216443389415,0,5,synaptic vesicle maturation,BP,
19465,GO:1990169,1.0000000000059,0.744347055679574,0,5,stress response to copper ion,BP,
1051,GO:0002579,1.00000000000594,0.742300066839048,0,4,positive regulation of antigen processing and presentation,BP,
17786,GO:1901857,1.00000000000595,0.68837192166034,0,5,positive regulation of cellular respiration,BP,
8362,GO:0033239,1.00000000000596,0.720264162954433,0,4,negative regulation of cellular amine metabolic process,BP,
5577,GO:0016594,1.00000000000599,0.664791809727457,0,5,glycine binding,MF,
13369,GO:0052564,1.000000000006,0.671892441178466,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13371,GO:0052572,1.000000000006,0.671892441178466,0,5,response to host immune response,BP,
9232,GO:0035620,1.00000000000604,0.78531514238521,0,3,ceramide transporter activity,MF,
4001,GO:0008934,1.00000000000605,0.725176974917058,0,4,inositol monophosphate 1-phosphatase activity,MF,
13430,GO:0052832,1.00000000000605,0.725176974917058,0,4,inositol monophosphate 3-phosphatase activity,MF,
13431,GO:0052833,1.00000000000605,0.725176974917058,0,4,inositol monophosphate 4-phosphatase activity,MF,
13432,GO:0052834,1.00000000000605,0.725176974917058,0,4,inositol monophosphate phosphatase activity,MF,
6103,GO:0019323,1.00000000000607,0.738996901425159,0,4,pentose catabolic process,BP,
7110,GO:0030906,1.00000000000608,0.730970651987716,0,4,retromer, cargo-selective complex,CC,
5771,GO:0016972,1.00000000000608,0.720044961852645,0,4,thiol oxidase activity,MF,
345,GO:0000958,1.00000000000608,0.781632462905618,0,3,mitochondrial mRNA catabolic process,BP,
14282,GO:0061357,1.00000000000608,0.78169384665711,0,3,positive regulation of Wnt protein secretion,BP,
8455,GO:0033591,1.00000000000608,0.733559806307345,0,4,response to L-ascorbic acid,BP,
18466,GO:1903564,1.00000000000612,0.720091338639223,0,4,regulation of protein localization to cilium,BP,
18340,GO:1903301,1.00000000000616,0.681360796569018,0,5,positive regulation of hexokinase activity,BP,
3897,GO:0008534,1.00000000000619,0.751184585247216,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
6693,GO:0030070,1.0000000000062,0.781684085878703,0,3,insulin processing,BP,
16742,GO:0098502,1.00000000000624,0.79995908602911,0,3,DNA dephosphorylation,BP,
1905,GO:0004591,1.00000000000629,0.727433284086966,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
3931,GO:0008611,1.00000000000632,0.674528111801573,0,5,ether lipid biosynthetic process,BP,
11713,GO:0046504,1.00000000000632,0.674528111801573,0,5,glycerol ether biosynthetic process,BP,
17662,GO:1901503,1.00000000000632,0.674528111801573,0,5,ether biosynthetic process,BP,
15410,GO:0071672,1.00000000000633,0.79795895428663,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
11542,GO:0046070,1.00000000000635,0.751842022262113,0,4,dGTP metabolic process,BP,
15409,GO:0071671,1.0000000000064,0.735008411628084,0,4,regulation of smooth muscle cell chemotaxis,BP,
2723,GO:0006102,1.00000000000642,0.674647247611712,0,5,isocitrate metabolic process,BP,
1086,GO:0002674,1.00000000000642,0.736464126830099,0,4,negative regulation of acute inflammatory response,BP,
13969,GO:0060676,1.00000000000643,0.740458666969731,0,4,ureteric bud formation,BP,
15657,GO:0072172,1.00000000000643,0.740458666969731,0,4,mesonephric tubule formation,BP,
8047,GO:0032700,1.00000000000644,0.668035484199728,0,5,negative regulation of interleukin-17 production,BP,
18971,GO:1904751,1.00000000000644,0.796675293863809,0,3,positive regulation of protein localization to nucleolus,BP,
8959,GO:0035022,1.00000000000645,0.738197092939653,0,4,positive regulation of Rac protein signal transduction,BP,
1656,GO:0004111,1.00000000000646,0.731249216820495,0,4,creatine kinase activity,MF,
1626,GO:0004062,1.00000000000647,0.742073552487618,0,4,aryl sulfotransferase activity,MF,
11361,GO:0045719,1.00000000000649,0.663627049628441,0,5,negative regulation of glycogen biosynthetic process,BP,
11568,GO:0046113,1.00000000000649,0.663627049628441,0,5,nucleobase catabolic process,BP,
14970,GO:0070874,1.00000000000649,0.663627049628441,0,5,negative regulation of glycogen metabolic process,BP,
16885,GO:0098826,1.0000000000065,0.720404925110053,0,4,endoplasmic reticulum tubular network membrane,CC,
2776,GO:0006203,1.00000000000653,0.802350212223577,0,3,dGTP catabolic process,BP,
18576,GO:1903817,1.00000000000654,0.72580516586703,0,4,negative regulation of voltage-gated potassium channel activity,BP,
1581,GO:0003991,1.00000000000667,0.922356389785848,0,1,acetylglutamate kinase activity,MF,
1613,GO:0004042,1.00000000000667,0.922356389785848,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
17180,GO:0103045,1.00000000000667,0.922356389785848,0,1,methione N-acyltransferase activity,MF,
16750,GO:0098519,1.00000000000668,0.667767965171215,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
8496,GO:0033668,1.0000000000067,0.731045008335829,0,4,negative regulation by symbiont of host apoptotic process,BP,
13302,GO:0052041,1.0000000000067,0.731045008335829,0,4,negative regulation by symbiont of host programmed cell death,BP,
13356,GO:0052490,1.0000000000067,0.731045008335829,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
6816,GO:0030274,1.00000000000673,0.720470266959423,0,4,LIM domain binding,MF,
12997,GO:0051414,1.0000000000068,0.673068408473655,0,5,response to cortisol,BP,
1713,GO:0004305,1.00000000000681,0.723786588733131,0,4,ethanolamine kinase activity,MF,
13721,GO:0060287,1.00000000000682,0.728474978397576,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13169,GO:0051766,1.00000000000689,0.665400336798279,0,5,inositol trisphosphate kinase activity,MF,
7199,GO:0031088,1.00000000000689,0.681478887208481,0,5,platelet dense granule membrane,CC,
9642,GO:0036510,1.0000000000069,0.783381176037081,0,3,trimming of terminal mannose on C branch,BP,
19757,GO:2000152,1.00000000000691,0.748918131610408,0,4,regulation of ubiquitin-specific protease activity,BP,
4165,GO:0009227,1.00000000000693,0.790198725045185,0,3,nucleotide-sugar catabolic process,BP,
1645,GO:0004089,1.00000000000695,0.666370499446329,0,5,carbonate dehydratase activity,MF,
20173,GO:2001016,1.00000000000695,0.72478998434256,0,4,positive regulation of skeletal muscle cell differentiation,BP,
9638,GO:0036506,1.00000000000695,0.782504600291038,0,3,maintenance of unfolded protein,BP,
18811,GO:1904378,1.00000000000695,0.782504600291038,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
1082,GO:0002666,1.00000000000696,0.728863549915555,0,4,positive regulation of T cell tolerance induction,BP,
10935,GO:0044571,1.00000000000696,0.754222444060518,0,4,[2Fe-2S] cluster assembly,BP,
16520,GO:0097227,1.00000000000697,0.719941259297902,0,4,sperm annulus,CC,
8466,GO:0033603,1.00000000000697,0.801794534339849,0,3,positive regulation of dopamine secretion,BP,
14808,GO:0070535,1.00000000000699,0.663508124018128,0,5,histone H2A K63-linked ubiquitination,BP,
2026,GO:0004758,1.00000000000701,0.664864388891207,0,5,serine C-palmitoyltransferase activity,MF,
5506,GO:0016454,1.00000000000701,0.664864388891207,0,5,C-palmitoyltransferase activity,MF,
18244,GO:1903054,1.00000000000702,0.679335811346864,0,5,negative regulation of extracellular matrix organization,BP,
2700,GO:0006065,1.00000000000705,0.782310517484284,0,3,UDP-glucuronate biosynthetic process,BP,
11658,GO:0046398,1.00000000000705,0.782310517484284,0,3,UDP-glucuronate metabolic process,BP,
5028,GO:0015193,1.00000000000707,0.663175746671638,0,5,L-proline transmembrane transporter activity,MF,
9171,GO:0035524,1.00000000000707,0.663175746671638,0,5,proline transmembrane transport,BP,
3620,GO:0008073,1.00000000000707,0.862585584213712,0,2,ornithine decarboxylase inhibitor activity,MF,
17938,GO:1902268,1.00000000000707,0.862585584213712,0,2,negative regulation of polyamine transmembrane transport,BP,
9440,GO:0036017,1.00000000000709,0.776031572224031,0,4,response to erythropoietin,BP,
9441,GO:0036018,1.00000000000709,0.776031572224031,0,4,cellular response to erythropoietin,BP,
16510,GO:0097209,1.00000000000712,0.727747427156215,0,4,epidermal lamellar body,CC,
5554,GO:0016560,1.00000000000713,0.72152784117641,0,4,protein import into peroxisome matrix, docking,BP,
7750,GO:0032264,1.00000000000717,0.727870094484498,0,4,IMP salvage,BP,
11557,GO:0046098,1.00000000000717,0.727870094484498,0,4,guanine metabolic process,BP,
2779,GO:0006208,1.0000000000072,0.849162963989784,0,2,pyrimidine nucleobase catabolic process,BP,
2780,GO:0006210,1.0000000000072,0.849162963989784,0,2,thymine catabolic process,BP,
6266,GO:0019859,1.0000000000072,0.849162963989784,0,2,thymine metabolic process,BP,
19723,GO:2000077,1.0000000000072,0.849162963989784,0,2,negative regulation of type B pancreatic cell development,BP,
14893,GO:0070682,1.00000000000721,0.787510330067626,0,3,proteasome regulatory particle assembly,BP,
7420,GO:0031510,1.00000000000724,0.788077198802748,0,3,SUMO activating enzyme complex,CC,
14718,GO:0070358,1.00000000000724,0.682388187907386,0,5,actin polymerization-dependent cell motility,BP,
12756,GO:0051024,1.00000000000725,0.73342483207181,0,4,positive regulation of immunoglobulin secretion,BP,
5009,GO:0015166,1.00000000000725,0.722200741557033,0,4,polyol transmembrane transporter activity,MF,
10949,GO:0044614,1.00000000000725,0.719884842366416,0,4,nuclear pore cytoplasmic filaments,CC,
344,GO:0000957,1.00000000000728,0.663164661473168,0,5,mitochondrial RNA catabolic process,BP,
16491,GO:0097179,1.00000000000729,0.770251783681164,0,4,protease inhibitor complex,CC,
18705,GO:1904090,1.00000000000729,0.770251783681164,0,4,peptidase inhibitor complex,CC,
7647,GO:0032058,1.00000000000729,0.720076329784549,0,4,positive regulation of translational initiation in response to stress,BP,
15756,GO:0072345,1.0000000000073,0.663857956176934,0,5,NAADP-sensitive calcium-release channel activity,MF,
7657,GO:0032077,1.00000000000731,0.684344227879589,0,5,positive regulation of deoxyribonuclease activity,BP,
9704,GO:0038108,1.00000000000736,0.781643188132974,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
19597,GO:1990726,1.00000000000737,0.729826576273964,0,5,Lsm1-7-Pat1 complex,CC,
18718,GO:1904154,1.00000000000738,0.788790563477694,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
4407,GO:0010159,1.00000000000741,0.784356546970425,0,3,specification of animal organ position,BP,
13691,GO:0060235,1.00000000000741,0.784356546970425,0,3,lens induction in camera-type eye,BP,
13972,GO:0060681,1.00000000000741,0.784356546970425,0,3,branch elongation involved in ureteric bud branching,BP,
14220,GO:0061156,1.00000000000741,0.784356546970425,0,3,pulmonary artery morphogenesis,BP,
15617,GO:0072102,1.00000000000741,0.784356546970425,0,3,glomerulus morphogenesis,BP,
3488,GO:0007354,1.00000000000744,0.784331951222104,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
9152,GO:0035502,1.00000000000744,0.784331951222104,0,3,metanephric part of ureteric bud development,BP,
11226,GO:0045359,1.00000000000748,0.719888262146661,0,4,positive regulation of interferon-beta biosynthetic process,BP,
779,GO:0002036,1.00000000000752,0.72104810519422,0,4,regulation of L-glutamate import across plasma membrane,BP,
4773,GO:0010958,1.00000000000752,0.72104810519422,0,4,regulation of amino acid import across plasma membrane,BP,
17340,GO:1900019,1.00000000000758,0.719921931061093,0,4,regulation of protein kinase C activity,BP,
17341,GO:1900020,1.00000000000758,0.719921931061093,0,4,positive regulation of protein kinase C activity,BP,
9254,GO:0035658,1.00000000000759,0.7829935547128,0,3,Mon1-Ccz1 complex,CC,
13952,GO:0060633,1.0000000000076,0.720027350032899,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
19752,GO:2000143,1.0000000000076,0.720027350032899,0,4,negative regulation of DNA-templated transcription, initiation,BP,
14456,GO:0061783,1.00000000000766,0.80026895630158,0,3,peptidoglycan muralytic activity,MF,
7157,GO:0031017,1.00000000000767,0.739260398036784,0,4,exocrine pancreas development,BP,
18671,GO:1904016,1.00000000000767,0.719949589177374,0,4,response to Thyroglobulin triiodothyronine,BP,
17543,GO:1901072,1.00000000000768,0.666997519252496,0,5,glucosamine-containing compound catabolic process,BP,
19515,GO:1990405,1.00000000000768,0.720083058410109,0,4,protein antigen binding,MF,
6143,GO:0019418,1.00000000000769,0.756326666216065,0,4,sulfide oxidation,BP,
14642,GO:0070221,1.00000000000769,0.756326666216065,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14399,GO:0061649,1.0000000000077,0.782315712938357,0,3,ubiquitin modification-dependent histone binding,MF,
5041,GO:0015220,1.00000000000773,0.72008924737343,0,4,choline transmembrane transporter activity,MF,
16382,GO:0090724,1.00000000000776,0.722232535168592,0,4,central region of growth cone,CC,
10933,GO:0044557,1.00000000000777,0.683931739094943,0,5,relaxation of smooth muscle,BP,
3736,GO:0008271,1.00000000000777,0.663095852499869,0,5,secondary active sulfate transmembrane transporter activity,MF,
6170,GO:0019531,1.00000000000777,0.663095852499869,0,5,oxalate transmembrane transporter activity,MF,
6171,GO:0019532,1.00000000000777,0.663095852499869,0,5,oxalate transport,BP,
8117,GO:0032803,1.00000000000779,0.675642725443468,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
5148,GO:0015680,1.00000000000779,0.819526365883815,0,3,intracellular copper ion transport,BP,
18694,GO:1904047,1.00000000000779,0.783162003477333,0,3,S-adenosyl-L-methionine binding,MF,
18371,GO:1903371,1.00000000000781,0.720275822590057,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
11938,GO:0046984,1.00000000000783,0.726653512942,0,4,regulation of hemoglobin biosynthetic process,BP,
4729,GO:0010891,1.00000000000786,0.6658688621751,0,5,negative regulation of sequestering of triglyceride,BP,
17491,GO:1900425,1.00000000000793,0.666023526981487,0,5,negative regulation of defense response to bacterium,BP,
16340,GO:0090571,1.00000000000793,0.7877405284043,0,3,RNA polymerase II transcription repressor complex,CC,
17555,GO:1901097,1.00000000000794,0.720995768045654,0,4,negative regulation of autophagosome maturation,BP,
9924,GO:0042270,1.00000000000798,0.78868194712567,0,3,protection from natural killer cell mediated cytotoxicity,BP,
129,GO:0000268,1.00000000000804,0.725376267555026,0,4,peroxisome targeting sequence binding,MF,
11917,GO:0046952,1.00000000000805,0.782327926643359,0,3,ketone body catabolic process,BP,
4732,GO:0010896,1.00000000000806,0.782938652043469,0,3,regulation of triglyceride catabolic process,BP,
14820,GO:0070552,1.00000000000813,0.782021679944962,0,3,BRISC complex,CC,
16168,GO:0090186,1.00000000000819,0.668269737212184,0,5,regulation of pancreatic juice secretion,BP,
3557,GO:0007597,1.00000000000821,0.675563846300782,0,5,blood coagulation, intrinsic pathway,BP,
10320,GO:0043103,1.00000000000822,0.793819395881312,0,3,hypoxanthine salvage,BP,
2188,GO:0005047,1.00000000000823,0.667489699972164,0,5,signal recognition particle binding,MF,
7566,GO:0031914,1.00000000000823,0.792744747871806,0,3,negative regulation of synaptic plasticity,BP,
9627,GO:0036493,1.00000000000824,0.783768740615091,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
19521,GO:1990414,1.00000000000826,0.721137103189501,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
18835,GO:1904428,1.00000000000828,0.791440335255591,0,3,negative regulation of tubulin deacetylation,BP,
11660,GO:0046404,1.00000000000831,0.787977409944891,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13160,GO:0051733,1.00000000000831,0.787977409944891,0,3,polydeoxyribonucleotide kinase activity,MF,
13161,GO:0051734,1.00000000000831,0.787977409944891,0,3,ATP-dependent polynucleotide kinase activity,MF,
2764,GO:0006177,1.00000000000832,0.673686080050396,0,5,GMP biosynthetic process,BP,
3028,GO:0006574,1.00000000000833,0.724019310246693,0,4,valine catabolic process,BP,
3689,GO:0008192,1.00000000000833,0.790054150190474,0,3,RNA guanylyltransferase activity,MF,
7826,GO:0032379,1.00000000000835,0.792588383039427,0,3,positive regulation of intracellular lipid transport,BP,
7829,GO:0032382,1.00000000000835,0.792588383039427,0,3,positive regulation of intracellular sterol transport,BP,
7832,GO:0032385,1.00000000000835,0.792588383039427,0,3,positive regulation of intracellular cholesterol transport,BP,
8175,GO:0032911,1.00000000000847,0.782026745706635,0,3,negative regulation of transforming growth factor beta1 production,BP,
18800,GO:1904351,1.00000000000847,0.782026745706635,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19154,GO:1905166,1.00000000000847,0.782026745706635,0,3,negative regulation of lysosomal protein catabolic process,BP,
1502,GO:0003854,1.00000000000847,0.786766907394876,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
838,GO:0002143,1.00000000000849,0.725539740994938,0,4,tRNA wobble position uridine thiolation,BP,
1639,GO:0004082,1.00000000000849,0.854006178547594,0,2,bisphosphoglycerate mutase activity,MF,
1925,GO:0004619,1.00000000000849,0.854006178547594,0,2,phosphoglycerate mutase activity,MF,
11729,GO:0046538,1.00000000000849,0.854006178547594,0,2,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
17245,GO:0120009,1.00000000000853,0.664549173157341,0,5,intermembrane lipid transfer,BP,
17247,GO:0120013,1.00000000000853,0.664549173157341,0,5,intermembrane lipid transfer activity,MF,
17848,GO:1902035,1.00000000000854,0.723368954541539,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
8908,GO:0034729,1.00000000000855,0.791828474017261,0,3,histone H3-K79 methylation,BP,
13516,GO:0055087,1.00000000000855,0.791828474017261,0,3,Ski complex,CC,
10241,GO:0042954,1.00000000000856,0.663102948015813,0,5,lipoprotein transporter activity,MF,
11019,GO:0044854,1.00000000000857,0.722917841999455,0,4,plasma membrane raft assembly,BP,
11022,GO:0044857,1.00000000000857,0.722917841999455,0,4,plasma membrane raft organization,BP,
10369,GO:0043184,1.00000000000857,0.683523657947573,0,5,vascular endothelial growth factor receptor 2 binding,MF,
2363,GO:0005471,1.00000000000857,0.79546847946055,0,3,ATP:ADP antiporter activity,MF,
5035,GO:0015207,1.00000000000857,0.79546847946055,0,3,adenine transmembrane transporter activity,MF,
4611,GO:0010728,1.00000000000858,0.721414010369604,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
10005,GO:0042421,1.00000000000862,0.783461758227292,0,3,norepinephrine biosynthetic process,BP,
17570,GO:1901165,1.00000000000862,0.674652906191758,0,5,positive regulation of trophoblast cell migration,BP,
14963,GO:0070857,1.00000000000867,0.663452037557853,0,5,regulation of bile acid biosynthetic process,BP,
17243,GO:0110095,1.00000000000871,0.807012714123292,0,3,cellular detoxification of aldehyde,BP,
16488,GO:0097176,1.00000000000874,0.726020127051523,0,4,epoxide metabolic process,BP,
17430,GO:1900193,1.00000000000875,0.665107618920692,0,5,regulation of oocyte maturation,BP,
10390,GO:0043219,1.00000000000878,0.728112468978539,0,4,lateral loop,CC,
16686,GO:0097629,1.0000000000088,0.665873273264431,0,5,extrinsic component of omegasome membrane,CC,
7769,GO:0032289,1.00000000000882,0.782246708970836,0,3,central nervous system myelin formation,BP,
6952,GO:0030579,1.00000000000884,0.66918044083548,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
10571,GO:0043533,1.00000000000888,0.663337566233491,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
4991,GO:0015125,1.00000000000888,0.727055096487038,0,4,bile acid transmembrane transporter activity,MF,
9581,GO:0036396,1.0000000000089,0.787349513915076,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11190,GO:0045293,1.0000000000089,0.787349513915076,0,3,mRNA editing complex,CC,
4889,GO:0014809,1.00000000000892,0.807724548340032,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
12234,GO:0048495,1.00000000000894,0.722286044362415,0,4,Roundabout binding,MF,
15942,GO:0072741,1.00000000000895,0.78213278247428,0,3,protein localization to cell division site,BP,
18264,GO:1903119,1.00000000000895,0.78213278247428,0,3,protein localization to actin cytoskeleton,BP,
18859,GO:1904498,1.00000000000895,0.78213278247428,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19471,GO:1990179,1.00000000000895,0.78213278247428,0,3,protein localization to actomyosin contractile ring,BP,
10147,GO:0042721,1.00000000000897,0.69448552097907,0,5,mitochondrial inner membrane protein insertion complex,CC,
9174,GO:0035529,1.00000000000898,0.684404386799468,0,5,NADH pyrophosphatase activity,MF,
16190,GO:0090209,1.00000000000898,0.729951397129159,0,4,negative regulation of triglyceride metabolic process,BP,
5060,GO:0015271,1.00000000000901,0.663222306539346,0,5,outward rectifier potassium channel activity,MF,
8406,GO:0033353,1.00000000000903,0.720218878280381,0,4,S-adenosylmethionine cycle,BP,
1931,GO:0004630,1.00000000000907,0.66808354023604,0,5,phospholipase D activity,MF,
1884,GO:0004565,1.00000000000908,0.720018293433266,0,4,beta-galactosidase activity,MF,
1575,GO:0003985,1.00000000000908,0.787466076638995,0,3,acetyl-CoA C-acetyltransferase activity,MF,
13901,GO:0060545,1.00000000000911,0.850428663716072,0,2,positive regulation of necroptotic process,BP,
20254,GO:2001206,1.00000000000912,0.782457209550461,0,3,positive regulation of osteoclast development,BP,
13652,GO:0060159,1.00000000000912,0.726033457213738,0,4,regulation of dopamine receptor signaling pathway,BP,
1819,GO:0004470,1.00000000000913,0.728631393413406,0,4,malic enzyme activity,MF,
4004,GO:0008948,1.00000000000915,0.723768793522295,0,4,oxaloacetate decarboxylase activity,MF,
18552,GO:1903763,1.00000000000915,0.720334184519631,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
8786,GO:0034465,1.00000000000918,0.737187977724751,0,4,response to carbon monoxide,BP,
15878,GO:0072602,1.0000000000092,0.72010637834854,0,4,interleukin-4 secretion,BP,
2108,GO:0004887,1.00000000000921,0.722479754292622,0,4,thyroid hormone receptor activity,MF,
19264,GO:1905448,1.00000000000923,0.737561002753053,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
10170,GO:0042756,1.00000000000923,0.792414520159071,0,3,drinking behavior,BP,
11571,GO:0046122,1.00000000000924,0.869019219384665,0,2,purine deoxyribonucleoside metabolic process,BP,
10525,GO:0043456,1.00000000000925,0.786638903663629,0,3,regulation of pentose-phosphate shunt,BP,
5129,GO:0015562,1.00000000000929,0.719893933949372,0,4,efflux transmembrane transporter activity,MF,
5915,GO:0018171,1.00000000000929,0.74366546957978,0,4,peptidyl-cysteine oxidation,BP,
14562,GO:0070086,1.0000000000093,0.7373924746748,0,4,ubiquitin-dependent endocytosis,BP,
8302,GO:0033132,1.00000000000931,0.861126150742316,0,2,negative regulation of glucokinase activity,BP,
18339,GO:1903300,1.00000000000931,0.861126150742316,0,2,negative regulation of hexokinase activity,BP,
11441,GO:0045875,1.00000000000933,0.676623651685927,0,5,negative regulation of sister chromatid cohesion,BP,
5543,GO:0016532,1.00000000000934,0.809897528908944,0,3,superoxide dismutase copper chaperone activity,MF,
7245,GO:0031177,1.00000000000934,0.823597214812215,0,3,phosphopantetheine binding,MF,
9402,GO:0035947,1.00000000000935,0.663087650216661,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
20187,GO:2001034,1.00000000000942,0.663709736006664,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
3206,GO:0006842,1.00000000000953,0.724083939299003,0,4,tricarboxylic acid transport,BP,
4997,GO:0015137,1.00000000000953,0.724083939299003,0,4,citrate transmembrane transporter activity,MF,
5000,GO:0015142,1.00000000000953,0.724083939299003,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5183,GO:0015746,1.00000000000953,0.724083939299003,0,4,citrate transport,BP,
16595,GO:0097411,1.00000000000958,0.729638997212159,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
12463,GO:0050294,1.00000000000961,0.803570448309092,0,3,steroid sulfotransferase activity,MF,
9088,GO:0035339,1.00000000000962,0.730905575372808,0,4,SPOTS complex,CC,
19135,GO:1905098,1.00000000000968,0.724316604284877,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
5065,GO:0015279,1.0000000000097,0.668551547299862,0,5,store-operated calcium channel activity,MF,
1920,GO:0004614,1.00000000000972,0.721248061138139,0,4,phosphoglucomutase activity,MF,
2045,GO:0004792,1.00000000000976,0.799325630961543,0,3,thiosulfate sulfurtransferase activity,MF,
5402,GO:0016240,1.00000000000976,0.737335540994517,0,4,autophagosome membrane docking,BP,
1883,GO:0004563,1.00000000000979,0.665251665770948,0,5,beta-N-acetylhexosaminidase activity,MF,
9726,GO:0038166,1.00000000000979,0.675320343719517,0,5,angiotensin-activated signaling pathway,BP,
6174,GO:0019541,1.0000000000098,0.783096257278566,0,3,propionate metabolic process,BP,
10368,GO:0043183,1.00000000000982,0.861030946543796,0,2,vascular endothelial growth factor receptor 1 binding,MF,
7555,GO:0031871,1.00000000000983,0.784002554229601,0,3,proteinase activated receptor binding,MF,
971,GO:0002420,1.00000000000984,0.720177034816017,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
972,GO:0002423,1.00000000000984,0.720177034816017,0,4,natural killer cell mediated immune response to tumor cell,BP,
1195,GO:0002855,1.00000000000984,0.720177034816017,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002858,1.00000000000984,0.720177034816017,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
4240,GO:0009438,1.00000000000986,0.682012641737602,0,5,methylglyoxal metabolic process,BP,
13733,GO:0060302,1.00000000000986,0.855336536088301,0,2,negative regulation of cytokine activity,BP,
6828,GO:0030289,1.0000000000099,0.73319619694886,0,4,protein phosphatase 4 complex,CC,
4693,GO:0010847,1.00000000000994,0.723734360156668,0,4,regulation of chromatin assembly,BP,
2911,GO:0006421,1.00000000000994,0.781935322493541,0,3,asparaginyl-tRNA aminoacylation,BP,
19937,GO:2000466,1.00000000000997,0.782177358526707,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19938,GO:2000467,1.00000000000997,0.782177358526707,0,3,positive regulation of glycogen (starch) synthase activity,BP,
6891,GO:0030423,1.00000000000999,0.72872241753615,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
8981,GO:0035087,1.00000000000999,0.72872241753615,0,4,siRNA loading onto RISC involved in RNA interference,BP,
19509,GO:1990393,1.00000000001001,0.664052586973709,0,5,3M complex,CC,
5292,GO:0015960,1.00000000001002,0.782432584345518,0,3,diadenosine polyphosphate biosynthetic process,BP,
5294,GO:0015965,1.00000000001002,0.782432584345518,0,3,diadenosine tetraphosphate metabolic process,BP,
5295,GO:0015966,1.00000000001002,0.782432584345518,0,3,diadenosine tetraphosphate biosynthetic process,BP,
8425,GO:0033503,1.00000000001006,0.722402307981542,0,4,HULC complex,CC,
5969,GO:0018401,1.00000000001008,0.663850117352666,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
1768,GO:0004372,1.00000000001008,0.849117132366495,0,2,glycine hydroxymethyltransferase activity,MF,
2046,GO:0004793,1.00000000001008,0.849117132366495,0,2,threonine aldolase activity,MF,
3000,GO:0006545,1.00000000001008,0.849117132366495,0,2,glycine biosynthetic process,BP,
3962,GO:0008732,1.00000000001008,0.849117132366495,0,2,L-allo-threonine aldolase activity,MF,
6091,GO:0019264,1.00000000001008,0.849117132366495,0,2,glycine biosynthetic process from serine,BP,
15923,GO:0072706,1.00000000001009,0.92117246305253,0,1,response to sodium dodecyl sulfate,BP,
15924,GO:0072707,1.00000000001009,0.92117246305253,0,1,cellular response to sodium dodecyl sulfate,BP,
4928,GO:0014883,1.00000000001014,0.732393519451708,0,4,transition between fast and slow fiber,BP,
4560,GO:0010641,1.00000000001014,0.720116045054952,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
17613,GO:1901299,1.00000000001016,0.676116425366297,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
14595,GO:0070141,1.00000000001017,0.665147018246988,0,5,response to UV-A,BP,
18320,GO:1903251,1.00000000001018,0.669582365559298,0,5,multi-ciliated epithelial cell differentiation,BP,
14305,GO:0061438,1.00000000001021,0.722561346965385,0,4,renal system vasculature morphogenesis,BP,
14306,GO:0061439,1.00000000001021,0.722561346965385,0,4,kidney vasculature morphogenesis,BP,
8452,GO:0033578,1.00000000001023,0.666145573236858,0,5,protein glycosylation in Golgi,BP,
1957,GO:0004661,1.00000000001028,0.672748616718644,0,5,protein geranylgeranyltransferase activity,MF,
5413,GO:0016259,1.00000000001031,0.722101870237901,0,4,selenocysteine metabolic process,BP,
5906,GO:0018125,1.00000000001032,0.788864092119765,0,3,peptidyl-cysteine methylation,BP,
16366,GO:0090666,1.00000000001033,0.723799552528862,0,4,scaRNA localization to Cajal body,BP,
16771,GO:0098574,1.00000000001034,0.719928769154558,0,4,cytoplasmic side of lysosomal membrane,CC,
6560,GO:0021999,1.00000000001038,0.668995137586096,0,5,neural plate anterior/posterior regionalization,BP,
9390,GO:0035927,1.0000000000104,0.743718654008916,0,4,RNA import into mitochondrion,BP,
10527,GO:0043461,1.00000000001041,0.728582066032261,0,4,proton-transporting ATP synthase complex assembly,BP,
3530,GO:0007512,1.00000000001048,0.670005165688916,0,5,adult heart development,BP,
20290,GO:2001270,1.0000000000105,0.736513304090989,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
6747,GO:0030167,1.00000000001055,0.784507378218229,0,3,proteoglycan catabolic process,BP,
6766,GO:0030200,1.00000000001055,0.784507378218229,0,3,heparan sulfate proteoglycan catabolic process,BP,
4904,GO:0014834,1.00000000001055,0.784986952701233,0,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
347,GO:0000960,1.00000000001057,0.719968630404497,0,4,regulation of mitochondrial RNA catabolic process,BP,
14941,GO:0070827,1.00000000001057,0.719968630404497,0,4,chromatin maintenance,BP,
320,GO:0000836,1.00000000001059,0.666899543376267,0,5,Hrd1p ubiquitin ligase complex,CC,
1217,GO:0002887,1.00000000001062,0.724646155360677,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
47,GO:0000099,1.00000000001063,0.719884919369937,0,4,sulfur amino acid transmembrane transporter activity,MF,
14927,GO:0070778,1.00000000001063,0.719884919369937,0,4,L-aspartate transmembrane transport,BP,
4948,GO:0014916,1.00000000001063,0.783174961022761,0,3,regulation of lung blood pressure,BP,
8350,GO:0033206,1.00000000001065,0.719886747602628,0,4,meiotic cytokinesis,BP,
13187,GO:0051793,1.00000000001067,0.782624260025505,0,3,medium-chain fatty acid catabolic process,BP,
1189,GO:0002836,1.00000000001068,0.781869983811119,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002839,1.00000000001068,0.781869983811119,0,3,positive regulation of immune response to tumor cell,BP,
3861,GO:0008479,1.00000000001068,0.743882222457405,0,4,queuine tRNA-ribosyltransferase activity,MF,
11123,GO:0045159,1.00000000001069,0.721140152833346,0,4,myosin II binding,MF,
16483,GO:0097165,1.00000000001074,0.669149626406058,0,5,nuclear stress granule,CC,
862,GO:0002193,1.00000000001076,0.781781995839007,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
14064,GO:0060842,1.00000000001076,0.781781995839007,0,3,arterial endothelial cell differentiation,BP,
7917,GO:0032490,1.00000000001079,0.719889814400201,0,4,detection of molecule of bacterial origin,BP,
2668,GO:0006015,1.00000000001079,0.782319813896248,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
11655,GO:0046391,1.00000000001079,0.782319813896248,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
14582,GO:0070122,1.0000000000108,0.72009627364095,0,4,isopeptidase activity,MF,
106,GO:0000220,1.00000000001081,0.685212608490693,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
13202,GO:0051823,1.00000000001081,0.725992155189036,0,4,regulation of synapse structural plasticity,BP,
1269,GO:0003056,1.00000000001081,0.66464845427736,0,5,regulation of vascular smooth muscle contraction,BP,
5033,GO:0015204,1.00000000001082,0.784055541441761,0,3,urea transmembrane transporter activity,MF,
5228,GO:0015840,1.00000000001082,0.784055541441761,0,3,urea transport,BP,
16637,GO:0097494,1.00000000001084,0.726252916798136,0,4,regulation of vesicle size,BP,
16429,GO:0097065,1.00000000001092,0.720794415287512,0,4,anterior head development,BP,
7713,GO:0032202,1.00000000001104,0.724168867737351,0,4,telomere assembly,BP,
13774,GO:0060352,1.00000000001115,0.670059289396541,0,5,cell adhesion molecule production,BP,
18482,GO:1903587,1.00000000001117,0.674955361081023,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
1202,GO:0002862,1.00000000001122,0.751257874755362,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
13282,GO:0051969,1.00000000001124,0.723676349221674,0,4,regulation of transmission of nerve impulse,BP,
16156,GO:0090170,1.00000000001125,0.724866550634273,0,4,regulation of Golgi inheritance,BP,
4207,GO:0009328,1.00000000001129,0.722375513066004,0,4,phenylalanine-tRNA ligase complex,CC,
8319,GO:0033152,1.00000000001135,0.728255909213449,0,4,immunoglobulin V(D)J recombination,BP,
18497,GO:1903626,1.00000000001139,0.747179004228124,0,4,positive regulation of DNA catabolic process,BP,
14641,GO:0070213,1.00000000001163,0.719935847403107,0,4,protein auto-ADP-ribosylation,BP,
15461,GO:0071797,1.00000000001163,0.722225781335299,0,4,LUBAC complex,CC,
11855,GO:0046836,1.00000000001167,0.677929763089157,0,5,glycolipid transport,BP,
1801,GO:0004445,1.00000000001175,0.663492805629059,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
8821,GO:0034594,1.00000000001175,0.663492805629059,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
6735,GO:0030151,1.00000000001176,0.720145313086711,0,4,molybdenum ion binding,MF,
8474,GO:0033615,1.00000000001178,0.785845424177017,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
5959,GO:0018343,1.0000000000118,0.786099882173962,0,3,protein farnesylation,BP,
10336,GO:0043129,1.00000000001181,0.668272260077219,0,5,surfactant homeostasis,BP,
14539,GO:0070050,1.00000000001182,0.720912585515849,0,4,neuron cellular homeostasis,BP,
11119,GO:0045144,1.00000000001183,0.67634767051717,0,5,meiotic sister chromatid segregation,BP,
16131,GO:0090129,1.00000000001184,0.666287964280212,0,5,positive regulation of synapse maturation,BP,
9917,GO:0042256,1.00000000001186,0.686662974163728,0,5,mature ribosome assembly,BP,
18112,GO:1902766,1.00000000001198,0.859352137913001,0,2,skeletal muscle satellite cell migration,BP,
10763,GO:0044208,1.00000000001199,0.855028193944402,0,2,'de novo' AMP biosynthetic process,BP,
12985,GO:0051388,1.00000000001202,0.719886873330993,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
196,GO:0000414,1.00000000001204,0.719884842225443,0,4,regulation of histone H3-K36 methylation,BP,
250,GO:0000710,1.00000000001204,0.719884842225443,0,4,meiotic mismatch repair,BP,
374,GO:0000995,1.00000000001204,0.719884842225443,0,4,transcription factor activity, core RNA polymerase III binding,MF,
610,GO:0001778,1.00000000001204,0.719884842225443,0,4,plasma membrane repair,BP,
759,GO:0001999,1.00000000001204,0.719884842225443,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
760,GO:0002001,1.00000000001204,0.719884842225443,0,4,renin secretion into blood stream,BP,
788,GO:0002051,1.00000000001204,0.719884842225443,0,4,osteoblast fate commitment,BP,
931,GO:0002329,1.00000000001204,0.719884842225443,0,4,pre-B cell differentiation,BP,
1324,GO:0003175,1.00000000001204,0.719884842225443,0,4,tricuspid valve development,BP,
1332,GO:0003186,1.00000000001204,0.719884842225443,0,4,tricuspid valve morphogenesis,BP,
1334,GO:0003190,1.00000000001204,0.719884842225443,0,4,atrioventricular valve formation,BP,
1436,GO:0003415,1.00000000001204,0.719884842225443,0,4,chondrocyte hypertrophy,BP,
1461,GO:0003708,1.00000000001204,0.719884842225443,0,4,retinoic acid receptor activity,MF,
1733,GO:0004331,1.00000000001204,0.719884842225443,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1818,GO:0004468,1.00000000001204,0.719884842225443,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1973,GO:0004689,1.00000000001204,0.719884842225443,0,4,phosphorylase kinase activity,MF,
2344,GO:0005384,1.00000000001204,0.719884842225443,0,4,manganese ion transmembrane transporter activity,MF,
2485,GO:0005726,1.00000000001204,0.719884842225443,0,4,perichromatin fibrils,CC,
2629,GO:0005955,1.00000000001204,0.719884842225443,0,4,calcineurin complex,CC,
2633,GO:0005964,1.00000000001204,0.719884842225443,0,4,phosphorylase kinase complex,CC,
2660,GO:0006003,1.00000000001204,0.719884842225443,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2747,GO:0006145,1.00000000001204,0.719884842225443,0,4,purine nucleobase catabolic process,BP,
3518,GO:0007442,1.00000000001204,0.719884842225443,0,4,hindgut morphogenesis,BP,
3619,GO:0008066,1.00000000001204,0.719884842225443,0,4,glutamate receptor activity,MF,
3740,GO:0008275,1.00000000001204,0.719884842225443,0,4,gamma-tubulin small complex,CC,
3885,GO:0008517,1.00000000001204,0.719884842225443,0,4,folic acid transmembrane transporter activity,MF,
4016,GO:0009019,1.00000000001204,0.719884842225443,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4546,GO:0010624,1.00000000001204,0.719884842225443,0,4,regulation of Schwann cell proliferation,BP,
4547,GO:0010626,1.00000000001204,0.719884842225443,0,4,negative regulation of Schwann cell proliferation,BP,
4836,GO:0014042,1.00000000001204,0.719884842225443,0,4,positive regulation of neuron maturation,BP,
4951,GO:0015014,1.00000000001204,0.719884842225443,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5132,GO:0015616,1.00000000001204,0.719884842225443,0,4,DNA translocase activity,MF,
5163,GO:0015705,1.00000000001204,0.719884842225443,0,4,iodide transport,BP,
5269,GO:0015917,1.00000000001204,0.719884842225443,0,4,aminophospholipid transport,BP,
5374,GO:0016185,1.00000000001204,0.719884842225443,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5850,GO:0017146,1.00000000001204,0.719884842225443,0,4,NMDA selective glutamate receptor complex,CC,
5894,GO:0018076,1.00000000001204,0.719884842225443,0,4,N-terminal peptidyl-lysine acetylation,BP,
5957,GO:0018335,1.00000000001204,0.719884842225443,0,4,protein succinylation,BP,
5982,GO:0018812,1.00000000001204,0.719884842225443,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6084,GO:0019240,1.00000000001204,0.719884842225443,0,4,citrulline biosynthetic process,BP,
6172,GO:0019534,1.00000000001204,0.719884842225443,0,4,toxin transmembrane transporter activity,MF,
6340,GO:0021514,1.00000000001204,0.719884842225443,0,4,ventral spinal cord interneuron differentiation,BP,
6545,GO:0021957,1.00000000001204,0.719884842225443,0,4,corticospinal tract morphogenesis,BP,
6568,GO:0022027,1.00000000001204,0.719884842225443,0,4,interkinetic nuclear migration,BP,
6768,GO:0030202,1.00000000001204,0.719884842225443,0,4,heparin metabolic process,BP,
6776,GO:0030210,1.00000000001204,0.719884842225443,0,4,heparin biosynthetic process,BP,
6964,GO:0030618,1.00000000001204,0.719884842225443,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7128,GO:0030951,1.00000000001204,0.719884842225443,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7164,GO:0031034,1.00000000001204,0.719884842225443,0,4,myosin filament assembly,BP,
7450,GO:0031585,1.00000000001204,0.719884842225443,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7688,GO:0032138,1.00000000001204,0.719884842225443,0,4,single base insertion or deletion binding,MF,
7705,GO:0032184,1.00000000001204,0.719884842225443,0,4,SUMO polymer binding,MF,
7739,GO:0032237,1.00000000001204,0.719884842225443,0,4,activation of store-operated calcium channel activity,BP,
7764,GO:0032280,1.00000000001204,0.719884842225443,0,4,symmetric synapse,CC,
7770,GO:0032290,1.00000000001204,0.719884842225443,0,4,peripheral nervous system myelin formation,BP,
7910,GO:0032483,1.00000000001204,0.719884842225443,0,4,regulation of Rab protein signal transduction,BP,
8150,GO:0032876,1.00000000001204,0.719884842225443,0,4,negative regulation of DNA endoreduplication,BP,
8381,GO:0033278,1.00000000001204,0.719884842225443,0,4,cell proliferation in midbrain,BP,
8854,GO:0034648,1.00000000001204,0.719884842225443,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9123,GO:0035426,1.00000000001204,0.719884842225443,0,4,extracellular matrix-cell signaling,BP,
9179,GO:0035546,1.00000000001204,0.719884842225443,0,4,interferon-beta secretion,BP,
9180,GO:0035547,1.00000000001204,0.719884842225443,0,4,regulation of interferon-beta secretion,BP,
9181,GO:0035549,1.00000000001204,0.719884842225443,0,4,positive regulation of interferon-beta secretion,BP,
9265,GO:0035673,1.00000000001204,0.719884842225443,0,4,oligopeptide transmembrane transporter activity,MF,
9447,GO:0036033,1.00000000001204,0.719884842225443,0,4,mediator complex binding,MF,
9460,GO:0036056,1.00000000001204,0.719884842225443,0,4,filtration diaphragm,CC,
9461,GO:0036057,1.00000000001204,0.719884842225443,0,4,slit diaphragm,CC,
9647,GO:0036515,1.00000000001204,0.719884842225443,0,4,serotonergic neuron axon guidance,BP,
9670,GO:0038028,1.00000000001204,0.719884842225443,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9710,GO:0038114,1.00000000001204,0.719884842225443,0,4,interleukin-21-mediated signaling pathway,BP,
9942,GO:0042297,1.00000000001204,0.719884842225443,0,4,vocal learning,BP,
10118,GO:0042636,1.00000000001204,0.719884842225443,0,4,negative regulation of hair cycle,BP,
10120,GO:0042640,1.00000000001204,0.719884842225443,0,4,anagen,BP,
10196,GO:0042799,1.00000000001204,0.719884842225443,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10308,GO:0043083,1.00000000001204,0.719884842225443,0,4,synaptic cleft,CC,
10601,GO:0043570,1.00000000001204,0.719884842225443,0,4,maintenance of DNA repeat elements,BP,
10626,GO:0043622,1.00000000001204,0.719884842225443,0,4,cortical microtubule organization,BP,
11125,GO:0045162,1.00000000001204,0.719884842225443,0,4,clustering of voltage-gated sodium channels,BP,
11404,GO:0045794,1.00000000001204,0.719884842225443,0,4,negative regulation of cell volume,BP,
11828,GO:0046726,1.00000000001204,0.719884842225443,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11975,GO:0047238,1.00000000001204,0.719884842225443,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12101,GO:0048104,1.00000000001204,0.719884842225443,0,4,establishment of body hair or bristle planar orientation,BP,
12102,GO:0048105,1.00000000001204,0.719884842225443,0,4,establishment of body hair planar orientation,BP,
12194,GO:0048341,1.00000000001204,0.719884842225443,0,4,paraxial mesoderm formation,BP,
12216,GO:0048406,1.00000000001204,0.719884842225443,0,4,nerve growth factor binding,MF,
12246,GO:0048520,1.00000000001204,0.719884842225443,0,4,positive regulation of behavior,BP,
12383,GO:0048788,1.00000000001204,0.719884842225443,0,4,cytoskeleton of presynaptic active zone,CC,
12385,GO:0048793,1.00000000001204,0.719884842225443,0,4,pronephros development,BP,
12494,GO:0050510,1.00000000001204,0.719884842225443,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13001,GO:0051425,1.00000000001204,0.719884842225443,0,4,PTB domain binding,MF,
13031,GO:0051481,1.00000000001204,0.719884842225443,0,4,negative regulation of cytosolic calcium ion concentration,BP,
13121,GO:0051660,1.00000000001204,0.719884842225443,0,4,establishment of centrosome localization,BP,
13224,GO:0051884,1.00000000001204,0.719884842225443,0,4,regulation of timing of anagen,BP,
13277,GO:0051964,1.00000000001204,0.719884842225443,0,4,negative regulation of synapse assembly,BP,
13417,GO:0052811,1.00000000001204,0.719884842225443,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13497,GO:0055059,1.00000000001204,0.719884842225443,0,4,asymmetric neuroblast division,BP,
13520,GO:0055091,1.00000000001204,0.719884842225443,0,4,phospholipid homeostasis,BP,
13566,GO:0060029,1.00000000001204,0.719884842225443,0,4,convergent extension involved in organogenesis,BP,
13592,GO:0060059,1.00000000001204,0.719884842225443,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13628,GO:0060123,1.00000000001204,0.719884842225443,0,4,regulation of growth hormone secretion,BP,
13746,GO:0060318,1.00000000001204,0.719884842225443,0,4,definitive erythrocyte differentiation,BP,
14465,GO:0061821,1.00000000001204,0.719884842225443,0,4,telomeric D-loop binding,MF,
14528,GO:0070022,1.00000000001204,0.719884842225443,0,4,transforming growth factor beta receptor complex,CC,
14591,GO:0070137,1.00000000001204,0.719884842225443,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14593,GO:0070139,1.00000000001204,0.719884842225443,0,4,SUMO-specific endopeptidase activity,MF,
14934,GO:0070815,1.00000000001204,0.719884842225443,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14972,GO:0070876,1.00000000001204,0.719884842225443,0,4,SOSS complex,CC,
15166,GO:0071284,1.00000000001204,0.719884842225443,0,4,cellular response to lead ion,BP,
15400,GO:0071651,1.00000000001204,0.719884842225443,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15406,GO:0071664,1.00000000001204,0.719884842225443,0,4,catenin-TCF7L2 complex,CC,
15518,GO:0071896,1.00000000001204,0.719884842225443,0,4,protein localization to adherens junction,BP,
15773,GO:0072367,1.00000000001204,0.719884842225443,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15782,GO:0072385,1.00000000001204,0.719884842225443,0,4,minus-end-directed organelle transport along microtubule,BP,
15948,GO:0075044,1.00000000001204,0.719884842225443,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15949,GO:0075071,1.00000000001204,0.719884842225443,0,4,autophagy involved in symbiotic interaction,BP,
16014,GO:0086023,1.00000000001204,0.719884842225443,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16020,GO:0086036,1.00000000001204,0.719884842225443,0,4,regulation of cardiac muscle cell membrane potential,BP,
16200,GO:0090230,1.00000000001204,0.719884842225443,0,4,regulation of centromere complex assembly,BP,
16256,GO:0090309,1.00000000001204,0.719884842225443,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16439,GO:0097091,1.00000000001204,0.719884842225443,0,4,synaptic vesicle clustering,BP,
16444,GO:0097104,1.00000000001204,0.719884842225443,0,4,postsynaptic membrane assembly,BP,
16445,GO:0097105,1.00000000001204,0.719884842225443,0,4,presynaptic membrane assembly,BP,
16447,GO:0097107,1.00000000001204,0.719884842225443,0,4,postsynaptic density assembly,BP,
16783,GO:0098596,1.00000000001204,0.719884842225443,0,4,imitative learning,BP,
16785,GO:0098598,1.00000000001204,0.719884842225443,0,4,learned vocalization behavior or vocal learning,BP,
16796,GO:0098634,1.00000000001204,0.719884842225443,0,4,cell-matrix adhesion mediator activity,MF,
16798,GO:0098639,1.00000000001204,0.719884842225443,0,4,collagen binding involved in cell-matrix adhesion,MF,
16821,GO:0098698,1.00000000001204,0.719884842225443,0,4,postsynaptic specialization assembly,BP,
16847,GO:0098756,1.00000000001204,0.719884842225443,0,4,response to interleukin-21,BP,
16848,GO:0098757,1.00000000001204,0.719884842225443,0,4,cellular response to interleukin-21,BP,
16899,GO:0098844,1.00000000001204,0.719884842225443,0,4,postsynaptic endocytic zone membrane,CC,
16917,GO:0098884,1.00000000001204,0.719884842225443,0,4,postsynaptic neurotransmitter receptor internalization,BP,
17073,GO:0099569,1.00000000001204,0.719884842225443,0,4,presynaptic cytoskeleton,CC,
17130,GO:0102158,1.00000000001204,0.719884842225443,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17142,GO:0102343,1.00000000001204,0.719884842225443,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17143,GO:0102344,1.00000000001204,0.719884842225443,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17144,GO:0102345,1.00000000001204,0.719884842225443,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17148,GO:0102420,1.00000000001204,0.719884842225443,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17218,GO:0106077,1.00000000001204,0.719884842225443,0,4,histone succinylation,BP,
17451,GO:1900227,1.00000000001204,0.719884842225443,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17481,GO:1900376,1.00000000001204,0.719884842225443,0,4,regulation of secondary metabolite biosynthetic process,BP,
17631,GO:1901341,1.00000000001204,0.719884842225443,0,4,positive regulation of store-operated calcium channel activity,BP,
17909,GO:1902219,1.00000000001204,0.719884842225443,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
18106,GO:1902744,1.00000000001204,0.719884842225443,0,4,negative regulation of lamellipodium organization,BP,
18127,GO:1902816,1.00000000001204,0.719884842225443,0,4,regulation of protein localization to microtubule,BP,
18128,GO:1902817,1.00000000001204,0.719884842225443,0,4,negative regulation of protein localization to microtubule,BP,
18838,GO:1904431,1.00000000001204,0.719884842225443,0,4,positive regulation of t-circle formation,BP,
18933,GO:1904684,1.00000000001204,0.719884842225443,0,4,negative regulation of metalloendopeptidase activity,BP,
19372,GO:1905832,1.00000000001204,0.719884842225443,0,4,positive regulation of spindle assembly,BP,
19481,GO:1990246,1.00000000001204,0.719884842225443,0,4,uniplex complex,CC,
19550,GO:1990511,1.00000000001204,0.719884842225443,0,4,piRNA biosynthetic process,BP,
19884,GO:2000370,1.00000000001204,0.719884842225443,0,4,positive regulation of clathrin-dependent endocytosis,BP,
20051,GO:2000675,1.00000000001204,0.719884842225443,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20083,GO:2000739,1.00000000001204,0.719884842225443,0,4,regulation of mesenchymal stem cell differentiation,BP,
4051,GO:0009092,1.00000000001204,0.728454020387571,0,4,homoserine metabolic process,BP,
6108,GO:0019346,1.00000000001204,0.728454020387571,0,4,transsulfuration,BP,
14933,GO:0070814,1.00000000001204,0.728454020387571,0,4,hydrogen sulfide biosynthetic process,BP,
1832,GO:0004487,1.00000000001207,0.782268827440256,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
16741,GO:0098501,1.00000000001216,0.682309303854828,0,5,polynucleotide dephosphorylation,BP,
8695,GO:0034316,1.00000000001216,0.722416275573006,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9899,GO:0042182,1.00000000001217,0.677372948430324,0,5,ketone catabolic process,BP,
14790,GO:0070494,1.00000000001222,0.785934893660599,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14791,GO:0070495,1.00000000001222,0.785934893660599,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
4127,GO:0009186,1.00000000001222,0.689476069455744,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
15134,GO:0071224,1.00000000001223,0.781602497183677,0,3,cellular response to peptidoglycan,BP,
9791,GO:0040009,1.00000000001225,0.720220809942038,0,4,regulation of growth rate,BP,
6046,GO:0019166,1.00000000001225,0.788631009670167,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
2824,GO:0006288,1.00000000001227,0.791516366079309,0,3,base-excision repair, DNA ligation,BP,
13184,GO:0051790,1.00000000001227,0.728954140148518,0,4,short-chain fatty acid biosynthetic process,BP,
10171,GO:0042758,1.00000000001233,0.726650685126906,0,4,long-chain fatty acid catabolic process,BP,
12368,GO:0048752,1.00000000001235,0.786998842161325,0,3,semicircular canal morphogenesis,BP,
18355,GO:1903335,1.00000000001238,0.73339325499165,0,4,regulation of vacuolar transport,BP,
8338,GO:0033183,1.00000000001243,0.781722469831837,0,3,negative regulation of histone ubiquitination,BP,
17619,GO:1901314,1.00000000001243,0.781722469831837,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17620,GO:1901315,1.00000000001243,0.781722469831837,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
1820,GO:0004471,1.00000000001244,0.782006694570722,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1821,GO:0004473,1.00000000001244,0.782006694570722,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
10145,GO:0042719,1.00000000001246,0.705210407243841,0,5,mitochondrial intermembrane space protein transporter complex,CC,
4260,GO:0009597,1.00000000001259,0.665125688189136,0,5,detection of virus,BP,
6793,GO:0030233,1.00000000001263,0.925979140656056,0,1,deoxynucleotide transmembrane transporter activity,MF,
6839,GO:0030302,1.00000000001263,0.925979140656056,0,1,deoxynucleotide transport,BP,
7140,GO:0030974,1.00000000001263,0.925979140656056,0,1,thiamine pyrophosphate transmembrane transport,BP,
15079,GO:0071045,1.00000000001263,0.925979140656056,0,1,nuclear histone mRNA catabolic process,BP,
15384,GO:0071629,1.00000000001263,0.925979140656056,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16307,GO:0090422,1.00000000001263,0.925979140656056,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
14499,GO:0061945,1.00000000001268,0.787554254391361,0,3,regulation of protein K48-linked ubiquitination,BP,
12655,GO:0050859,1.00000000001274,0.784034007244267,0,3,negative regulation of B cell receptor signaling pathway,BP,
18776,GO:1904288,1.00000000001277,0.720164315173282,0,4,BAT3 complex binding,MF,
8121,GO:0032807,1.00000000001278,0.724401157181021,0,4,DNA ligase IV complex,CC,
17863,GO:1902083,1.0000000000128,0.663313209241666,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19762,GO:2000169,1.0000000000128,0.663313209241666,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
17384,GO:1900109,1.00000000001285,0.862631128054123,0,2,regulation of histone H3-K9 dimethylation,BP,
17385,GO:1900110,1.00000000001285,0.862631128054123,0,2,negative regulation of histone H3-K9 dimethylation,BP,
15320,GO:0071532,1.00000000001286,0.719915058778031,0,4,ankyrin repeat binding,MF,
8106,GO:0032792,1.00000000001288,0.734705114040552,0,4,negative regulation of CREB transcription factor activity,BP,
6420,GO:0021683,1.00000000001289,0.666365454020877,0,5,cerebellar granular layer morphogenesis,BP,
4083,GO:0009137,1.00000000001298,0.730947624007883,0,4,purine nucleoside diphosphate catabolic process,BP,
4122,GO:0009181,1.00000000001298,0.730947624007883,0,4,purine ribonucleoside diphosphate catabolic process,BP,
15936,GO:0072733,1.00000000001298,0.787020799936249,0,3,response to staurosporine,BP,
15937,GO:0072734,1.00000000001298,0.787020799936249,0,3,cellular response to staurosporine,BP,
9161,GO:0035514,1.00000000001303,0.801335758284156,0,3,DNA demethylase activity,MF,
12186,GO:0048318,1.00000000001304,0.687886248413196,0,5,axial mesoderm development,BP,
19985,GO:2000576,1.00000000001315,0.689326894619612,0,5,positive regulation of microtubule motor activity,BP,
15071,GO:0071031,1.00000000001316,0.861226228118678,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15083,GO:0071049,1.00000000001316,0.861226228118678,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
10486,GO:0043380,1.00000000001321,0.733207201253747,0,4,regulation of memory T cell differentiation,BP,
15838,GO:0072540,1.00000000001321,0.733207201253747,0,4,T-helper 17 cell lineage commitment,BP,
16915,GO:0098881,1.00000000001324,0.781768720343468,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16958,GO:0098967,1.00000000001324,0.781768720343468,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
12265,GO:0048550,1.00000000001328,0.668275843246121,0,5,negative regulation of pinocytosis,BP,
19557,GO:1990564,1.00000000001331,0.680924231213769,0,5,protein polyufmylation,BP,
19570,GO:1990592,1.00000000001331,0.680924231213769,0,5,protein K69-linked ufmylation,BP,
18612,GO:1903895,1.00000000001334,0.72009414912131,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
1719,GO:0004311,1.00000000001336,0.78244176561552,0,3,farnesyltranstransferase activity,MF,
1374,GO:0003266,1.00000000001341,0.683574451465183,0,5,regulation of secondary heart field cardioblast proliferation,BP,
8835,GO:0034618,1.00000000001343,0.721646631136527,0,4,arginine binding,MF,
9509,GO:0036157,1.00000000001344,0.80167799611004,0,3,outer dynein arm,CC,
15265,GO:0071438,1.00000000001346,0.7259469734631,0,4,invadopodium membrane,CC,
19398,GO:1905908,1.0000000000135,0.729607945536771,0,4,positive regulation of amyloid fibril formation,BP,
13266,GO:0051953,1.00000000001351,0.663800473909336,0,5,negative regulation of amine transport,BP,
14003,GO:0060718,1.00000000001351,0.663800473909336,0,5,chorionic trophoblast cell differentiation,BP,
12513,GO:0050656,1.00000000001359,0.720928607288542,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
842,GO:0002154,1.0000000000136,0.663776720412749,0,5,thyroid hormone mediated signaling pathway,BP,
3988,GO:0008853,1.00000000001361,0.786412649386065,0,3,exodeoxyribonuclease III activity,MF,
7611,GO:0031997,1.00000000001364,0.790525691121994,0,3,N-terminal myristoylation domain binding,MF,
12961,GO:0051343,1.00000000001364,0.790525691121994,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
3766,GO:0008310,1.00000000001365,0.733318916470024,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
16920,GO:0098887,1.00000000001365,0.663249572138223,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
1501,GO:0003847,1.00000000001368,0.743443787377265,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
3972,GO:0008781,1.0000000000137,0.862290459599817,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
17206,GO:0106049,1.00000000001385,0.67327127106341,0,5,regulation of cellular response to osmotic stress,BP,
17908,GO:1902218,1.00000000001385,0.67327127106341,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
10854,GO:0044352,1.00000000001391,0.723739230595081,0,4,pinosome,CC,
10855,GO:0044354,1.00000000001391,0.723739230595081,0,4,macropinosome,CC,
2566,GO:0005850,1.00000000001402,0.719909429611099,0,4,eukaryotic translation initiation factor 2 complex,CC,
7294,GO:0031291,1.00000000001402,0.798639839909329,0,3,Ran protein signal transduction,BP,
3002,GO:0006547,1.00000000001408,0.720104186532715,0,4,histidine metabolic process,BP,
4179,GO:0009256,1.00000000001408,0.720104186532715,0,4,10-formyltetrahydrofolate metabolic process,BP,
13414,GO:0052803,1.00000000001408,0.720104186532715,0,4,imidazole-containing compound metabolic process,BP,
576,GO:0001727,1.00000000001412,0.664948702375463,0,5,lipid kinase activity,MF,
7503,GO:0031681,1.00000000001412,0.664948702375463,0,5,G-protein beta-subunit binding,MF,
20226,GO:2001166,1.00000000001421,0.6638573901575,0,5,regulation of histone H2B ubiquitination,BP,
11450,GO:0045900,1.00000000001422,0.727559819114498,0,4,negative regulation of translational elongation,BP,
16395,GO:0097010,1.00000000001427,0.781607335161828,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
11559,GO:0046100,1.00000000001431,0.675659364493144,0,5,hypoxanthine metabolic process,BP,
4999,GO:0015141,1.00000000001441,0.783565446124851,0,3,succinate transmembrane transporter activity,MF,
5182,GO:0015744,1.00000000001441,0.783565446124851,0,3,succinate transport,BP,
15255,GO:0071422,1.00000000001441,0.783565446124851,0,3,succinate transmembrane transport,BP,
15073,GO:0071034,1.00000000001446,0.730707440560712,0,4,CUT catabolic process,BP,
15077,GO:0071043,1.00000000001446,0.730707440560712,0,4,CUT metabolic process,BP,
2087,GO:0004852,1.00000000001459,0.930226477609486,0,1,uroporphyrinogen-III synthase activity,MF,
15252,GO:0071418,1.00000000001459,0.930226477609486,0,1,cellular response to amine stimulus,BP,
9453,GO:0036042,1.0000000000146,0.748958485898342,0,4,long-chain fatty acyl-CoA binding,MF,
11201,GO:0045329,1.00000000001462,0.664981277334174,0,5,carnitine biosynthetic process,BP,
14330,GO:0061511,1.00000000001467,0.734232974477404,0,4,centriole elongation,BP,
10620,GO:0043615,1.0000000000147,0.667149605758881,0,5,astrocyte cell migration,BP,
15075,GO:0071038,1.00000000001478,0.692495551028592,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16504,GO:0097199,1.00000000001486,0.681999247944926,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
6094,GO:0019287,1.00000000001492,0.793922967983261,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
1698,GO:0004176,1.00000000001497,0.720105646128124,0,4,ATP-dependent peptidase activity,MF,
6220,GO:0019755,1.00000000001498,0.725776120883682,0,4,one-carbon compound transport,BP,
2438,GO:0005638,1.00000000001503,0.723207465593629,0,4,lamin filament,CC,
17569,GO:1901164,1.00000000001507,0.808906902674686,0,3,negative regulation of trophoblast cell migration,BP,
15555,GO:0071987,1.00000000001519,0.719905890721415,0,4,WD40-repeat domain binding,MF,
4893,GO:0014819,1.00000000001529,0.705723284124356,0,5,regulation of skeletal muscle contraction,BP,
14768,GO:0070459,1.0000000000154,0.683964353485811,0,5,prolactin secretion,BP,
16262,GO:0090315,1.00000000001541,0.722109521858371,0,4,negative regulation of protein targeting to membrane,BP,
594,GO:0001758,1.00000000001544,0.782461097947128,0,3,retinal dehydrogenase activity,MF,
11808,GO:0046689,1.00000000001549,0.679248535784867,0,5,response to mercury ion,BP,
15162,GO:0071279,1.00000000001549,0.729672734395339,0,4,cellular response to cobalt ion,BP,
5142,GO:0015669,1.0000000000155,0.787308680387095,0,3,gas transport,BP,
19166,GO:1905206,1.00000000001555,0.67398331846521,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
18220,GO:1903012,1.00000000001555,0.72072837714629,0,4,positive regulation of bone development,BP,
15122,GO:0071208,1.00000000001557,0.756975490985638,0,4,histone pre-mRNA DCP binding,MF,
13347,GO:0052405,1.00000000001573,0.801297492241058,0,3,negative regulation by host of symbiont molecular function,BP,
12816,GO:0051121,1.00000000001576,0.720174714604161,0,4,hepoxilin metabolic process,BP,
12817,GO:0051122,1.00000000001576,0.720174714604161,0,4,hepoxilin biosynthetic process,BP,
5255,GO:0015884,1.00000000001582,0.677304061807425,0,5,folic acid transport,BP,
123,GO:0000253,1.00000000001583,0.748658474752161,0,4,3-keto sterol reductase activity,MF,
4299,GO:0009744,1.00000000001586,0.781699189911327,0,3,response to sucrose,BP,
8687,GO:0034285,1.00000000001586,0.781699189911327,0,3,response to disaccharide,BP,
1861,GO:0004525,1.00000000001589,0.722776682826778,0,4,ribonuclease III activity,MF,
7773,GO:0032296,1.00000000001589,0.722776682826778,0,4,double-stranded RNA-specific ribonuclease activity,MF,
11312,GO:0045629,1.00000000001589,0.788561714171343,0,3,negative regulation of T-helper 2 cell differentiation,BP,
16567,GO:0097350,1.00000000001589,0.788561714171343,0,3,neutrophil clearance,BP,
1978,GO:0004694,1.00000000001591,0.719887507737761,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
11000,GO:0044803,1.00000000001591,0.720842734892866,0,4,multi-organism membrane organization,BP,
13682,GO:0060215,1.00000000001592,0.663119240565607,0,5,primitive hemopoiesis,BP,
16267,GO:0090324,1.00000000001599,0.665160593173527,0,5,negative regulation of oxidative phosphorylation,BP,
4556,GO:0010637,1.00000000001605,0.669335564034861,0,5,negative regulation of mitochondrial fusion,BP,
1560,GO:0003960,1.00000000001615,0.792113652741894,0,3,NADPH:quinone reductase activity,MF,
9297,GO:0035739,1.00000000001619,0.721249395200084,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
15370,GO:0071608,1.00000000001619,0.721249395200084,0,4,macrophage inflammatory protein-1 alpha production,BP,
15393,GO:0071640,1.00000000001619,0.721249395200084,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
19974,GO:2000561,1.00000000001619,0.721249395200084,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
7513,GO:0031698,1.00000000001622,0.722991593139771,0,4,beta-2 adrenergic receptor binding,MF,
17459,GO:1900246,1.00000000001622,0.663101541771027,0,5,positive regulation of RIG-I signaling pathway,BP,
5051,GO:0015245,1.00000000001626,0.663805732973082,0,5,fatty acid transmembrane transporter activity,MF,
3660,GO:0008142,1.00000000001626,0.722493203181506,0,4,oxysterol binding,MF,
14318,GO:0061470,1.00000000001626,0.722493203181506,0,4,T follicular helper cell differentiation,BP,
9507,GO:0036155,1.00000000001628,0.66406014950805,0,5,acylglycerol acyl-chain remodeling,BP,
9159,GO:0035511,1.00000000001631,0.679910416965272,0,5,oxidative DNA demethylation,BP,
15135,GO:0071225,1.00000000001636,0.719910808699707,0,4,cellular response to muramyl dipeptide,BP,
10163,GO:0042747,1.00000000001647,0.737090548790167,0,4,circadian sleep/wake cycle, REM sleep,BP,
11007,GO:0044821,1.00000000001651,0.7198945580927,0,4,meiotic telomere tethering at nuclear periphery,BP,
14629,GO:0070197,1.00000000001651,0.7198945580927,0,4,meiotic attachment of telomere to nuclear envelope,BP,
16528,GO:0097240,1.00000000001651,0.7198945580927,0,4,chromosome attachment to the nuclear envelope,BP,
13526,GO:0055100,1.00000000001656,0.782350949106234,0,3,adiponectin binding,MF,
6301,GO:0019918,1.00000000001657,0.720168916610181,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9031,GO:0035243,1.00000000001657,0.720168916610181,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
12328,GO:0048680,1.00000000001661,0.733352825142924,0,4,positive regulation of axon regeneration,BP,
14835,GO:0070572,1.00000000001661,0.733352825142924,0,4,positive regulation of neuron projection regeneration,BP,
12581,GO:0050747,1.00000000001662,0.68132014183711,0,5,positive regulation of lipoprotein metabolic process,BP,
18568,GO:1903795,1.00000000001671,0.719886100510956,0,4,regulation of inorganic anion transmembrane transport,BP,
19554,GO:1990535,1.00000000001671,0.719886100510956,0,4,neuron projection maintenance,BP,
50,GO:0000104,1.00000000001673,0.679249849328325,0,5,succinate dehydrogenase activity,MF,
2500,GO:0005749,1.00000000001673,0.679249849328325,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
3680,GO:0008177,1.00000000001673,0.679249849328325,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
11177,GO:0045257,1.00000000001673,0.679249849328325,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11182,GO:0045273,1.00000000001673,0.679249849328325,0,5,respiratory chain complex II,CC,
11186,GO:0045281,1.00000000001673,0.679249849328325,0,5,succinate dehydrogenase complex,CC,
11188,GO:0045283,1.00000000001673,0.679249849328325,0,5,fumarate reductase complex,CC,
16632,GO:0097487,1.00000000001674,0.795505701250471,0,3,multivesicular body, internal vesicle,CC,
16170,GO:0090188,1.00000000001687,0.724537093214758,0,4,negative regulation of pancreatic juice secretion,BP,
3221,GO:0006868,1.00000000001691,0.721533507608967,0,4,glutamine transport,BP,
5023,GO:0015186,1.00000000001691,0.721533507608967,0,4,L-glutamine transmembrane transporter activity,MF,
18265,GO:1903121,1.00000000001703,0.734803710895703,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
3571,GO:0007614,1.00000000001705,0.681333872673256,0,5,short-term memory,BP,
6551,GO:0021979,1.00000000001705,0.733191710138234,0,4,hypothalamus cell differentiation,BP,
3112,GO:0006689,1.0000000000173,0.72261232745661,0,4,ganglioside catabolic process,BP,
6367,GO:0021548,1.00000000001739,0.667146805459883,0,5,pons development,BP,
17997,GO:1902445,1.00000000001741,0.811639947249533,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
18062,GO:1902617,1.00000000001747,0.73737440946098,0,4,response to fluoride,BP,
7117,GO:0030917,1.00000000001748,0.726703270869302,0,4,midbrain-hindbrain boundary development,BP,
15486,GO:0071838,1.00000000001757,0.731864306131529,0,4,cell proliferation in bone marrow,BP,
8261,GO:0033038,1.00000000001757,0.762765627392184,0,4,bitter taste receptor activity,MF,
9444,GO:0036021,1.0000000000176,0.724030277674031,0,4,endolysosome lumen,CC,
9770,GO:0039534,1.00000000001775,0.729841681013831,0,4,negative regulation of MDA-5 signaling pathway,BP,
14773,GO:0070470,1.00000000001781,0.750729894477211,0,4,plasma membrane respiratory chain,CC,
13135,GO:0051697,1.00000000001805,0.724833337068761,0,4,protein delipidation,BP,
12753,GO:0051021,1.00000000001806,0.722420573337684,0,4,GDP-dissociation inhibitor binding,MF,
12754,GO:0051022,1.00000000001806,0.722420573337684,0,4,Rho GDP-dissociation inhibitor binding,MF,
1204,GO:0002864,1.00000000001811,0.741629068255241,0,4,regulation of acute inflammatory response to antigenic stimulus,BP,
899,GO:0002278,1.00000000001819,0.72726371560129,0,4,eosinophil activation involved in immune response,BP,
990,GO:0002447,1.00000000001819,0.72726371560129,0,4,eosinophil mediated immunity,BP,
10451,GO:0043307,1.00000000001819,0.72726371560129,0,4,eosinophil activation,BP,
10452,GO:0043308,1.00000000001819,0.72726371560129,0,4,eosinophil degranulation,BP,
15842,GO:0072553,1.00000000001842,0.731966024090869,0,4,terminal button organization,BP,
17761,GO:1901727,1.00000000001848,0.7198928468426,0,4,positive regulation of histone deacetylase activity,BP,
13147,GO:0051715,1.00000000001854,0.82014055987862,0,3,cytolysis in other organism,BP,
7631,GO:0032036,1.00000000001854,0.679629693695409,0,5,myosin heavy chain binding,MF,
6896,GO:0030430,1.00000000001868,0.722711990844678,0,4,host cell cytoplasm,CC,
8495,GO:0033655,1.00000000001868,0.722711990844678,0,4,host cell cytoplasm part,CC,
4248,GO:0009448,1.00000000001871,0.720089942885021,0,4,gamma-aminobutyric acid metabolic process,BP,
11535,GO:0046060,1.00000000001884,0.69743470442342,0,5,dATP metabolic process,BP,
1803,GO:0004448,1.00000000001886,0.674653156429441,0,5,isocitrate dehydrogenase activity,MF,
11113,GO:0045134,1.0000000000189,0.720908922326883,0,4,uridine-diphosphatase activity,MF,
18397,GO:1903423,1.0000000000189,0.663861235629665,0,5,positive regulation of synaptic vesicle recycling,BP,
4155,GO:0009217,1.00000000001892,0.685373582363181,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
14280,GO:0061355,1.00000000001899,0.722046046068939,0,4,Wnt protein secretion,BP,
14281,GO:0061356,1.00000000001899,0.722046046068939,0,4,regulation of Wnt protein secretion,BP,
7290,GO:0031282,1.00000000001901,0.667174357652562,0,5,regulation of guanylate cyclase activity,BP,
7291,GO:0031284,1.00000000001901,0.667174357652562,0,5,positive regulation of guanylate cyclase activity,BP,
4079,GO:0009133,1.00000000001916,0.743616501271414,0,4,nucleoside diphosphate biosynthetic process,BP,
14800,GO:0070522,1.00000000001923,0.720693111926837,0,4,ERCC4-ERCC1 complex,CC,
18864,GO:1904505,1.00000000001923,0.720693111926837,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18865,GO:1904506,1.00000000001923,0.720693111926837,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
9304,GO:0035749,1.00000000001928,0.672819081936159,0,5,myelin sheath adaxonal region,CC,
2856,GO:0006344,1.0000000000193,0.719898910900296,0,4,maintenance of chromatin silencing,BP,
2757,GO:0006167,1.00000000001949,0.685456625981828,0,5,AMP biosynthetic process,BP,
19297,GO:1905553,1.00000000001958,0.793778031769043,0,3,regulation of blood vessel branching,BP,
9122,GO:0035425,1.0000000000196,0.784397861488518,0,3,autocrine signaling,BP,
13926,GO:0060586,1.00000000001964,0.664992435723255,0,5,multicellular organismal iron ion homeostasis,BP,
8665,GO:0034227,1.00000000001992,0.672742633769792,0,5,tRNA thio-modification,BP,
1288,GO:0003097,1.00000000002006,0.722724703820854,0,4,renal water transport,BP,
3602,GO:0008035,1.00000000002012,0.720197835197115,0,4,high-density lipoprotein particle binding,MF,
4172,GO:0009240,1.00000000002015,0.680936327135638,0,5,isopentenyl diphosphate biosynthetic process,BP,
11701,GO:0046490,1.00000000002015,0.680936327135638,0,5,isopentenyl diphosphate metabolic process,BP,
11561,GO:0046102,1.00000000002018,0.787054619673392,0,3,inosine metabolic process,BP,
5236,GO:0015853,1.00000000002031,0.738941404232936,0,4,adenine transport,BP,
2242,GO:0005152,1.00000000002044,0.784364777670787,0,3,interleukin-1 receptor antagonist activity,MF,
9472,GO:0036091,1.00000000002045,0.72300742322089,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
5167,GO:0015712,1.0000000000205,0.724581414707423,0,4,hexose phosphate transport,BP,
5187,GO:0015760,1.0000000000205,0.724581414707423,0,4,glucose-6-phosphate transport,BP,
17685,GO:1901563,1.00000000002071,0.663496015569094,0,5,response to camptothecin,BP,
17659,GO:1901490,1.00000000002078,0.720813352655874,0,4,regulation of lymphangiogenesis,BP,
16154,GO:0090168,1.00000000002089,0.728660260889597,0,4,Golgi reassembly,BP,
10276,GO:0043020,1.00000000002096,0.813175104640893,0,3,NADPH oxidase complex,CC,
11465,GO:0045919,1.00000000002112,0.736097574463904,0,4,positive regulation of cytolysis,BP,
6398,GO:0021604,1.00000000002153,0.667089355142999,0,5,cranial nerve structural organization,BP,
6400,GO:0021612,1.00000000002153,0.667089355142999,0,5,facial nerve structural organization,BP,
1787,GO:0004415,1.00000000002221,0.666253034152443,0,5,hyalurononglucosaminidase activity,MF,
11308,GO:0045625,1.00000000002259,0.669235918728835,0,5,regulation of T-helper 1 cell differentiation,BP,
13779,GO:0060364,1.00000000002272,0.72096131406945,0,4,frontal suture morphogenesis,BP,
19568,GO:1990589,1.00000000002338,0.852151339034687,0,2,ATF4-CREB1 transcription factor complex,CC,
14896,GO:0070695,1.00000000002339,0.66357587023394,0,5,FHF complex,CC,
1598,GO:0004017,1.00000000002351,0.663764190210544,0,5,adenylate kinase activity,MF,
342,GO:0000942,1.00000000002365,0.721986234840365,0,4,condensed nuclear chromosome outer kinetochore,CC,
18993,GO:1904796,1.00000000002415,0.66656224922822,0,5,regulation of core promoter binding,BP,
17346,GO:1900028,1.00000000002529,0.724560216121247,0,4,negative regulation of ruffle assembly,BP,
1270,GO:0003057,1.00000000002575,0.782299937424007,0,3,regulation of the force of heart contraction by chemical signal,BP,
19946,GO:2000483,1.00000000002792,0.688009254302457,0,5,negative regulation of interleukin-8 secretion,BP,
